advancing science, linking peoplepure.au.dk/portal/files/118234756/17_07_Final... · Final Programme 25th United European Gastroenterology Week Barcelona, Spain October 28 – November

Final Programme

25th United European Gastroenterology WeekBarcelona, SpainOctober 28 – November 1, 2017 Venue: Fira Gran Via

advancing science, linking people

Celebrating

of UEG Week25 years

Find out more, visit www.ueg.eu/week/25years

Join our Anniversary Activities:

Anniversary Session & Celebration(Wednesday at 13:30 in Hall 7)

Art Exhibition showing the history of 25 years (walkway to Halls 6/7)

Dedicated Anniversary Area in Hall 8.0:• Make a donation and take a piece of UEG Week home with you

• Photobooth• Anniversary Wheel

Get your pedometer watch at the Congress Material Counter

17_08_Inserat_UEGWEEK_FP_Celebration_160x220mm_RZ.indd 1 14.09.17 15:46

3

265 Ultrasound Learning Area

269 Surgical Learning Area

275 UEG Evidence Based Medicine Course

277 21th ESGENA Conference

291 Common Interest Group Meetings

293 Business Meetings

295 Industry Sponsored Symposia

303 Congress Information

309 Metro Map of Barcelona

310 Acknowledgements

313 List of Exhibitors and Exhibition Floor Plans

317 List of Reviewers

323 Index of Authors and Co-Authors

373 Floor Plans Fira Gran Via

5 Welcome Address

7 About UEG

8 Awards and Grants

13 Scientific Information

21 Young GI Network

25 Scientific Programme Overview

35 Postgraduate Teaching Programme

Scientific Programme by Day 46 Monday October 30, 2017 67 Tuesday October 31, 2017 94 Wednesday November 1, 2017

Poster Sessions by Day 110 Monday October 30, 2017 160 Tuesday October 31, 2017 211 Wednesday November 1, 2017

261 ESGE Learning Area

Table of Contents : UEG Week Final Programme

Table of Contents

Printed in accordance with the ʻEnvironmentally Compatible Printed Matterʼ guideline of the Austrian Eco-label.Druckerei Schmidbauer GmbH • UWNr. 897 (Eco-label license number 897)

• Create your personal programme itinerary• Watch live-streamed sessions, find floorplans, Industry Sponsored

Symposia, exhibitor profiles and more

Available at:

Download the UEG Week App

Participate in Q & A and audience voting dedicated sessions via the app.

UEG Week Appincl. Q&A Tool

Q & A Tool

Audience Voting Tool

The Q & A tool is available in the following session rooms:

• Hall 6• Room A1• Room A2• Room C1

• Room C2• Room F1• Room F2• Room F3

The audience voting tool is available in the following session rooms:

Hall 6, Room C1 & C2Room C1 & C2

Sat – SunMon – Tue

17_09_Inserat_UEGWEEK_FP_App_160x220mm_RZ.indd 1 14.09.17 12:26

5

notably through the expansion of our activities through online learning or the UEG Week Live concept, the need for clinicians and scientists to meet face to face and to discuss clinical innovations and research challenges is still the main focus.

Do not miss this year’s highlight, the special anniver-sary session on Wednesday with updates on the major advances on gastroenterology and hepatology over the last 25 years!

I warmly welcome you in Barcelona for the special an-niversary of the 25th UEG Week 2017 which I am certain will be another resounding success.

Michael MannsUEG President

Barcelona has proven to be a highly successful host city for UEG Weeks over the last years. The development of the scientific programme for the 25th UEG Week 2017 is now complete, and will contain some exciting new ini-tiatives, which will ensure that postgraduate education and training in gastroenterology and hepatology remain at the ‘cutting edge’.

High quality continued professional education have become of utmost importance since revalidation and re-licencing of medical practitioners becomes widely accepted. Although UEG Week is a congress firmly based in Europe, we are delighted to welcome increasing num-bers of participants from around the world, this year from Asia, North and South America, the Middle East, Africa and Australia. Presentation of new research results from countries outside Europe enriches our programme and provides the opportunity for European investigators to develop new international research collaborations.

While there is no doubt that UEG will continue to engage with advanced digital technologies to enhance e-learning,

Welcome Address : UEG Week Final Programme

Welcome Address from the UEG President to the 25th UEG Week Barcelona 2017

Celebrating the 25th United European Gastroenterology Week at the heart of UEG’s activities.

Any open questions? We are happy to help, visit us at the UEG Booth in Hall 8.0or send an email to [email protected]

Engage and connect with the community or simply discover UEG Week at your fingertips wherever you are

#uegweek

#WeekChat

CMECredits

17_09_Inserat_UEGWEEK_FP_new_media_160x220mm_RZ.indd 1 14.09.17 11:51

7

OrganiserUnited European Gastroenterology GmbHHouse of European GastroenterologyWickenburggasse 11080 Vienna, AustriaT +43 1 997 16 39F +43 1 997 16 39 [email protected]

UEG Week Official Registration and Housing Agency Mondial Congress & EventsOperngasse 20b 1040 ViennaAustriaT +43 1 58804 0 F +43 1 58804 [email protected] [email protected]

Mission & GoalsThe UEG’s mission is continually to improve standards of care in gastroenterology, and promote ever greater understanding of digestive and liver disease – among the public and medical experts alike. As part of that work, the UEG runs a number of education and training courses facilitated by highly respected experts. They also organise UEG Week – the largest and most prestigious meeting of its kind in Europe. UEG Week has been running since 1992, in a variety of major cities, and now attracts up to 14,000 people from across the world.

UEG is committed to:• Raising awareness and expanding knowledge of GI and

liver diseases among the public and medical profes-sion, to deliver benefits for patients

• Coordinating the activities of clinical and scientific as-sociations in our field

• Harmonising and improving clinical standards across Europe

• Fostering basic and clinical research in the field, and raising the profile of this work worldwide

• Promoting and delivering excellence in clinical and scientific education.

UEG consisting of 16 Ordinary Member Societies and 47 National Societies is a vibrant organisation that con-stantly adapts to the changing requirements of scientific research and health care.

For detailed information please visit the websites www.ueg.eu/about-ueg/structure/boards-committees and www.ueg.eu/about-ueg/who-we-are

About UEG and UEG Week : UEG Week Final Programme

About UEG and UEG Week

Visit our social media profiles: Like us on Facebook at www.facebook.com/myUEG Tweet us on @my_ueg

8

UEG Week Final Programme : Awards and Grants

Professor Jesper Lagergren is an internationally re-nowned surgeon. His research focuses on the causes, prevention and treatment of oesophageal and gastric cancer and related disorders, such as gastro-oesoph-ageal reflux disease (GORD) and obesity. He has been author of nearly 300 peer reviewed scientific articles. The Prize money will support him to extend his research projects towards large-scale and well-designed studies and with these prerequisites given, Professor Lagergren aims to positively influence clinical decision-making.

Award Ceremony at the Opening SessionMonday, October 30, 2017 // 08:00 – 12:00Hall 608:57 – 09:12 Project presentation and award ceremony

Research Prize 2017: The aetiology, prevention and treat-ment of oesophageal cancer.

The UEG Research Prize is awarded for excellence in basic science, translational or clinical research in the areas of gastroenterology, hepatology and related disciplines. The recipient’s previous work must have had an impact in its field and its quality must be internationally recognised.

Jesper Lagergren is awarded the distinguished UEG Re-search Prize 2017 for his outstanding project ‘The aeti-ology, prevention and treatment of oesophageal cancer’. The overarching goal of his research is to improve clinical practice and to contribute with an improved prognosis to future patients’ survivorship. He is currently serving as Professor and Consultant of Surgery at the Department of Molecular Medicine and Surgery at the Karolinska Institu-tet in Stockholm, Sweden. Since 2016, he is also member of the Nobel Assembly. In parallel, he is Professor and Chair of Upper Gastrointestinal Cancer at King's College London and Honorary Consultant of Surgery at Guy's and St. Thomas' NHS Foundation Trust. He is leading collaborating research groups at Karolinska Institutet and King’s College.

Awards and GrantsUEG Research Prize

Jesper LagergrenUEG Research Prize 2017

Stockholm, Sweden

€ 100,000 awarded for the most outstanding research programme

Awards and Grants : UEG Week Final Programme

9

Professor Axon was elected ESGE President 2000-2002 and initiated an interest in quality, ethics and guidelines, areas that remain important ESGE activities today. During his Presidency of OMED (now WEO) from 2005-2008 the organisation thrived and has remained a vibrant con-tributor to world endoscopy since then. His involvement with UEG (former UEGF) started with his membership on the Scientific Committee 1996-1999 and culminated in his Chairmanship of UEGF Council 2006-2007. During his Presidency UEG has expanded its activities further and Professor Axon played a part in its success.

Award Ceremony at the Opening SessionMonday, October 30, 2017 // 08:00 – 12:00Hall 609:34 – 09:44 Laudation and presentation of the award

The UEG Lifetime Achievement Award recognizes out-standing individuals whose pioneering and inventiveness throughout their careers have improved the Federation and inspired others.

Professor Anthony Axon has been a clinical Gastro-entero-logist for 40 years - safe, high quality clinical medicine has been the driving force in his practice, his teaching, research, and during his national and inter-national activities. He was the first to draw attention to the requirement for effective disinfection in endoscopy, and to recognise the need for a closed disinfection sys-tem. As a pioneer in ERCP he chaired the committee that recommended the Cambridge endoscopic classification of chronic pancreatitis. He furthermore published on the early recognition and pathogenesis of GI cancer, the value of endoscopy in dyspepsia and in IBD. His investigations in gastritis, peptic ulcer and gastric cancer began before H pylori was identified and afterwards he became active in drawing attention to the pathological role of Hp, its diagnosis and treatment.

UEG Lifetime Achievement Award

Anthony AxonUEG Lifetime Achievement Award 2017

Leeds, United Kingdom

Recipients have proven lifelong excellence and leadership in the field

10

UEG Week Final Programme : Awards and Grants

Group, an international academic research institute with focus on gastroenterology, neuroimmunology, pain and metabolic syndrome and has an appointment as visiting professor at the School of Medicine of the University of California. Another strong interest of Clive H. Wilder-Smith lies in the beneficial effects of food and natural nutrition. As coordinator of ‘Food Intolerance Diagnostics’, he is part of a network which concentrates their research on the beneficial effects of food and natural nutrition and provides information, diagnostic services and treatment to individuals with adverse reactions to food.

Clive H. Wilder-Smith is member of various renowned international associations and societies in the field of gastroenterology, nutrition and pain, reviewer of inter-national gastroenterology and pain journals and has received over 30 international and national prizes for his research projects. He has published more than 120 original articles in journals, book chapters and over 200 abstracts from congress presentations.

Award Ceremony at the Opening SessionMonday, October 30, 2017 // 08:00 – 12:00Hall 611:02 – 11:07 Presentation of the award

UEG Journal Best Paper Award 2017: Gastro-oesopha-geal reflux is common in oligosymptomatic patients with dental erosion: A pH-impedance and endoscopic study

UEG Journal provides an international forum for research in gastroenterology, publishing original articles, which describe basic research, translational and clinical studies of interest to gastroenterologists and researchers in relat-ed fields. In 2017, the UEG Journal continues to go from strength to strength with another impressive increase in Impact Factor, hitting 3.673 and a position of 21 out of 79 titles in the Gastroenterology and Hepatology category of the Journal Citation Reports®.

With the Best Paper Award, we recognize the first named author of the best original scientific research, published in UEG Journal in the past year. The winning article is selected by the editors, presided over by Chief Editor Professor Jan Tack.

The UEG Journal Best Paper Award 2017 is given to Clive H. Wilder-Smith (Managing Director of the Brain-Gut Research Group and Consultant at the Department of Preventive, Restorative and Paediatric Dentistry at Bern University, Switzerland) as the first author of the winning article: Gastro-oesophageal reflux is common in oligo-symptomatic patients with dental erosion: A pH-impedance and endoscopic study. The article is available for down-load at ueg.sagepub.com

As clinical gastroenterologist, Clive H. Wilder-Smith is practicing as senior partner in a private gastroenterology group practice and as consultant at BeauSite Clinic in Bern, Switzerland. Focusing on gastroenterology and pain in his research activities, he leads the Brain-Gut Research

UEG Journal Best Paper Award

Clive H. Wilder-SmithUEG Journal Best Paper Award 2017

Bern, Switzerland

Recognition of the first-named author for the best original research, published in the UEG Journal in 2016.

Awards and Grants : UEG Week Final Programme

11

National Scholar Awards ªThe National Scholar Award is designed to support promis- ing young investigators at a junior level and to encour-age them to work towards the more senior UEG Rising Star Award. The award recognises the highest scoring abstract, presented by a colleague below the age of 35, from every UEG National Member country.

Top Abstract Prizes ªThe presenting first authors of the top five accepted abstracts to UEG Week are awarded the Top Abstract Prize every year. The prize money of € 10,000 is to be spent on future research. In case of industry sponsored multi-centre studies, the author is required to waive the monetary part of the prize. Awarded abstracts must neither been previously presented at an international meeting nor been fully published.

Oral Free Paper PrizesThe best presenter of every Free Paper and Posters in the Spotlight session is awarded this prize. The winners are selected by the session chairs, who take the quality of research, the originality of the presented work as well as the presentation itself into account. Prize-winners receive a certificate of excellence.

Travel GrantsUEG offers travel grants of € 1,000 to the presenters of the best abstracts submitted to UEG Week. 200 Grants are available to clinicians and scientists, 140 to basic scientists of 40 years of age or younger.

Poster Champ AwardEvery day during lunch break, the highest scoring post-ers are presented in the interactive Poster Champ ses-sions at the e-poster terminals in the scientific centre. The best presenter of each session receives the Poster Champ Award. Awardees receive a certificate and free registration to next year’s UEG Postgraduate Teaching Programme.

International Scholarship AwardUEG awards 30 international scholarships to young gastroenterologists, aged 40 and below. Awardees re-ceive € 1,000 to help cover travel expenses and free registration to UEG Week including the Postgraduate Training Programme. The scholarships are restricted to citizens of countries with a Human Development Index (HDI) of less than 0.8 according to the latest Human Development Report.

Rising Star Awards ªEvery year, the UEG National Societies Committee and the UEG Scientific Committee jointly select 6-8 clinical scientists as UEG Rising Stars. The selection is based on a track record of international quality research and on scientific independence. This initiative provides a durable platform for these young researchers to further improve and progress in their professional career.

International Scholars 2016

Make ww.ueg.eu your mobile landing page for the complete congress experience

Wherever you are

We bring the scientific presentations from the lecture

halls directly to your screen. Follow the livestream on

the UEG website and get updated on the latest GI

and liver topics!

Visit www.live.ueg.eu/week

Livestreams including

Q&A options

Dynamic programme

overview on currently

streaming sessions

Daily updates

on our Social Wall

UEG Week 24/7

features all recorded

sessions from the

previous days

17_09_Inserat_UEGWEEK_FP_uegweeklive_160x220mm_RZ.indd 1 14.09.17 11:36

Scientific Information

14

UEG Week Final Programme : Scientific Information

• The Translational/Basic Science pathway including topics that will affect clinical practice within the foreseeable future, thereby being attractive for both, basic/translational scientists and clinicians.

• The Young GI Track, where sessions of special interest for young GI fellows will be highlighted in the pro-gramme. The mentoring programme for our young colleagues will be expanded additionally.

• Our clinically oriented one-day symposium within the meeting, entitled ‘Advances in Clinical Gastroen-terology and Hepatology’, focusing on ‘Functional GI disorders and GORD’ this year.

• The Today’s Science; Tomorrow’s Medicine initiative with this year's topic ‘Host microbiota crosstalk’, which will focus on research as well as clinical impli-cations from one of the hottest research areas today: the role of gut microbiota in health and disease.

• For the practical minded, we will again offer the popular Live Endoscopy sessions and we will further extend our Hands-on Training areas: A surgical sec-tion will complete the well-established endoscopy and ultrasound learning areas.

• The UEG Week Scientific Centre – a place where all possibilities to present an abstract are united, featur-ing the UEG Week Hotspot, the e-poster lounges, the e-poster terminals as well as the poster exhibition.

• UEG Week is celebrating its 25th anniversary this year! On Wednesday there will be a special anniversary session dedicated to the past and the future of gastro-enterology and hepatology in the UEG Week Scientific Centre, followed by a celebration, don't miss this!

• Clinical trials revisited feature a recently published clinical trial, followed by a critical review and a panel discussion with experts in the field.

• Posters in the Spotlight sessions, Poster Champ ses-sions and the Exemplary Clinical Cases promise ex-citing poster sessions.

• Therapy updates, where the current state-of-the-art treatment options in some of the major GI and liver diseases are presented.

• From guidelines to clinical practice sessions give you a concise update on European guidelines and their implementation in everyday clinical practice.

Welcome by the Chair Scientific Committee

I would like to welcome all of you to the 25th UEG Week 2017 in Barcelona – the place to be for clinicians as well as for researchers!

This year's anniversary programme features the latest advances in clinical management, the best research in GI and liver disease and includes several different kinds of symposia and fora, where cutting edge gastroenterology and hepatology is being discussed.

I would like to draw your attention to some of the highlights in 2017:

Scientific Information : UEG Week Final Programme

15

• As science remains the most important feature of our meeting, we have again worked hard to offer a large number of sessions devoted to original research.

As you can easily understand from this, the 25th UEG Week is the place to be for you!

Magnus SimrénChair of the UEG Scientific Committee

Thank you!

• Wednesday afternoon features the What’s new in…? session, which will again provide delegates with a comprehensive summary of recent changes in the management of major GI and liver diseases, as well as major scientific advances.

• With the Postgraduate Teaching Programme 2017, the 3-year curriculum is going to start again with year one, providing all major updates in GI & hepatology. A great mix of teaching methods with a focus on in-teractivity is employed.

UEG Scientific Committee

Visit the Scientific Centre in Hall 7hosting all possibilities to present an abstract

Thrilling symposia and debates at the UEG Week HotspotThis extraordinary setting is home to Abstracts on Fire sessions revealing frontiers in research as well as Clinical trials revisited sessions and most controversial discussions.

Advances in Clinical Gastroenterology and Hepatology This clinically oriented one-day symposium focuses on functional GI disorders and gastroesophageal reflux disease where substantial progress has been made and which has changed clinical practice.

Even more exciting poster formats Poster Champ Sessions Poster in the Spotlight Sessions Clinical Cases

Today’s Science; Tomorrow’s MedicineThis two day symposium on Host microbiota crosstalk presents the latest scientific advances in this fascinating research area and how these findings influence medicine today and tomorrow.

From guidelines to clinical practice sessionsWhere experts discuss how to incorporate the latest European guidelines on major diseases into clinical practice.

Download the app to create your personal programme itinerary

Highlights recommended by the Scientific Chair

17_09_Inserat_UEGWEEK_FP_highlights_160x220mm_RZ.indd 1 07.09.17 16:36


17

SaturdayOctober 28, 2017

Sunday October 29, 2017

Monday October 30, 2017

Tuesday October 31, 2017

Wednesday November 1, 2017

Opening Session

Postgraduate Teaching Programme Symposia

Translational/Basic Science Pathway

Today’s Science; Tomorrow’s Medicine (TSTM)

Advances in Clinical GI and Hepatology

UEG Week Hotspot

Live Endoscopy Video Case Session

Free Paper Sessions

Scientific Centre: Poster Exhibition / Poster Champ Sessions / Posters in the Spotlight

Round Table Discussions

ESGE Learning Area

Ultrasound Learning Area

Surgical Learning Area

Business Meetings / Common Interest Groups

Industry Sponsored Symposia

Technical Exhibition

21st ESGENA Conference

OverviewScientific Programme

18


attractive for both basic/translational scientists and clinicians.

Interactive FormatsThe UEG Scientific Committee continuously works on improving session formats used in the programme with the purpose of making symposia modern interactive experiences. We have once again more debates, where two speakers argue opposing cases, and more tandem talks, where experts present different aspects of the same problem.

Symposia with a panel discussion at the end have also increased. All speakers will be on stage, take up contro-versial comments and discuss burning questions. Panel discussions are great for understanding what the speak-ers REALLY think! These discussions are always lively and informative – make sure you stay and see for yourself!

Finally, we also continue to encourage wide use of cases to illustrate talks and anchor them in medical experience. For all these sessions we work hard to improve our Facul-ty instructions to increase interactivity with the audience, by interactive chairing and encouraging audience voting.

Today’s Science; Tomorrow’s MedicineUEG Week hosts again the two-days ‘Today’s Science; Tomorrow’s Medicine’ initiative in the main programme. In 2017, the theme is ‘Host microbiota crosstalk’.

Top class scientists have been invited to discuss how the current stage of knowledge is ready to be used in clinical practice, and to establish strategies to foster further pro-gression of knowledge in this area. The Today’s Science; Tomorrow’s Medicine symposium is a combination of both, invited sessions featuring the world’s top scientists and Free Paper sessions where work is presented by young and established researchers.

UEG Week HotspotThe UEG Week Hotspot is THE place to be at UEG Week 2017, where the most controversial sessions, hottest debates and interactive abstract discussions will take place. These sessions promise to be most intense! Heat-ed discussions of the UEG ‘Abstracts on Fire’ (frontiers in research) and breaking news will be launched. Also featured at the Hotspot are the clinical trials revisited sessions, where the latest results from recent large clini-cal trials will be presented and discussed by experienced investigators. Do not miss to pass by this high-tech sci-entific environment and attend these exciting sessions taking place from Monday until Wednesday!

Postgraduate Teaching Programme (PGT)The UEG Week Postgraduate Teaching comprises two days of excellent ‘Continuing Medical Education’, focusing on the relevance for the clinical day-to-day business and provides profound updates of latest developments in GI and hepatology topics. The interactive session formats include tricky clinical cases, controversial debates and exciting video cases – a perfect mix for gastroenterolo-gists in training and in practice as well as established GI physicians and general practitioners.

In 2017, the PGT starts the second cycle of the three-year PGT Curriculum, which follows recommendations of the EBGH Blue Book and permits participants to get perfectly prepared for their professional career. Delegates can start the curriculum at any year of the cycle and will receive a certificate once they have completed all three years.

PGT Syllabus contributions are available in the online programme, the UEG Week 2017 App and in our UEG Education Library at www.ueg.eu/education/library, where congress delegates can access recordings of all PGT sessions free of charge. The detailed curriculum and all learning objectives are available at www.ueg.eu/week/postgraduate-teaching.

Please see further information on page 35 and following.

Opening SessionThe opening session is held on Monday morning and includes official speeches and the opening of the scien-tific core programme, with a mixture of invited speak-ers and presentations of the best submitted abstracts. UEG awards the UEG Research Prize, the UEG Lifetime Achievement Award and the UEG Journal Best Paper Award at the opening session.

SymposiaInterdisciplinary symposia cover new approaches to di-agnosis and treatment, and place major emphasis on innovative, technical advances in the non-invasive man-agement of gastrointestinal and hepatic disorders and translational/basic science, including state-of-the-art lectures. Therapy updates on latest treatment options, guidelines in clinical practice, and the one-day sympo-sium advances in clinical GI and hepatology on ‘Func-tional GI disorders and GORD’ on Wednesday present the hot topics in 2017.

Translational/Basic Science PathwayThese sessions include topics that will potentially affect clinical practice within the near future, thereby being

Format Descriptions


19

Video Case SessionThe Video Case session is an excellent platform for brief information on recent issues of endoscopy. During this session short videos showing examples of new, unex-pected or exceptional endoscopic practice are present-ed and briefly discussed. Thus, the Video Case session presents unusual cases or new technologies based on diagnostic and therapeutic endoscopy.

Round Table DiscussionsFor each of these sessions we have invited four experts who will discuss common clinical situations based on a case presentation, scenario or specific problem. Four Round Table Discussions per day take place from Mon-day to Wednesday, 12:45-13:45, in the Rooms A2, A3, B2 and B3. No extra charge applies and no pre-booking is required. But come early as there are limited seats which will be filled on a first-come, first-served basis.

ESGE Learning AreaThe ESGE Learning Area incorporates different education-al formats in order to provide both beginner endoscopists as well as proven experts a platform for skill enhance-ment and professional discourse. In cooperation with ESGENA, the Hands-on Training Centre gives practical insight into basic and advanced endoscopic techniques. Participants can test their skills under the guidance of ex-pert doctor and nurse tutors. Lively talks between young experts and established senior discussants are held in the Lecture Theatre where debate on the how and why of current procedures prompts audience involvement. Video teaching is an essential part of endoscopy training. The DVD learning centre shows continuous films from the ESGE eLibrary and also includes videos contributed by the ASGE and JGES. The learning area is open to all delegates during the general opening hours of the congress.


The Ultrasound Learning Area (ULA)Please see further information on page 265 and following.

Surgical Learning AreaPlease see further information on page 269 and following.

Business Meetings> upon invitation only Association, board and committee meetings for

elected (UEG) leadership.

Please see further information on page 293.

Live EndoscopyLive endoscopy is included in the core programme on Tuesday. Top international experts demonstrate cut-ting-edge techniques alongside basic procedures trans-mitted directly from the Evangelisches Hospital Düs-seldorf to the auditorium. The use of multiple parallel cases and experienced chairs ensure interactive learning without unnecessary gaps.

Free Paper SessionsThe most important feature of UEG Week is science and we are constantly trying to attract the best science to our meeting. This is recognised in the core programme with a large number of Free Paper sessions devoted to original research, and an impressive number of mixed sessions where invited talks and free paper presentations alternate.

Posters in the SpotlightPosters in the Spotlight sessions boost science even fur-ther and have become a fixture at UEG Week. The Posters in the Spotlight are an excellent platform for in-depth scientific exchange with faculty and peers in a relaxed atmosphere and present an ideal opportunity to assist highly interactive and expert-led poster presentations.

Poster Exhibition/E-PostersPoster sessions feature a very spacious room layout and poster format. Printed posters are displayed and changed daily from 09:00 – 17:00 (Mon & Tue) and 09:00 – 14:00 (Wed) in Hall 7. All accepted posters also have the oppor-tunity to get published electronically in addition to the printed poster. All e-posters which were uploaded prior to UEG Week can be searched for and viewed on the six e-poster terminals in the poster exhibition, from Monday until Wednesday. E-posters allow all poster presenters to include interactive media files, such as radiology images,endoscopy videos, etc.

Poster Champ SessionsThere will be four Poster Champ sessions in parallel from Monday until Wednesday from 12:30 – 13:30. 2-minutes presentations of the highest scoring posters are followed by 3-minutes Q&As from the chairs. The Poster Champ of each session will be awarded during the official award ceremony at the E-Poster Lounge I at 13:45 each day. All Poster Champs get a certificate and free registration to the Postgraduate Teaching Programme of next year’s UEG Week in Vienna. Poster Champ sessions take place at the e-poster terminals in Hall 7.


20


Disclosure Policy

UEG is committed to ensuring scientific rigour and ob-jectivity in all of its educational activities. These include all aspects of the educational programme at UEG Week including those that are directly and jointly sponsored activities.

All presenters, whether invited faculty or abstract pre-senters, are required to disclose to those organising and attending meetings any relevant financial or other relationship that may lead to a potential bias. UEG re-serves the right to review the information disclosed for potential conflicts of interest. Please note that the sole responsibility for the content of each presentation lies with the presenting author.

The UEG Scientific Committee requires all presenters to disclose any financial relationship with or any advisory role in the Biomedical Industry and the Biomedical Tech-nology Industry during the past two years. These and any other potential conflicts of interest should be disclosed during introductory comments to the presentation.

Invited speakers and oral abstract presenters are request-ed to disclose potential conflicts of interest on a Power-Point slide to be shown immediately at the beginning of the presentation. Poster presenters are requested to disclose potential conflicts of interest at the bottom of their poster.

Conflicts of interest may exist through a financial rela-tionship or when the individual has the opportunity to influence the content of a presentation, and can involve grants, honoraria, shares, paid positions on advisory boards, etc. Conflicts of interest are frequent and ex-pected, and do not preclude an individual from giving a presentation providing the conflict is disclosed. If there is any doubt about the relevance of a potential conflict of interest UEG requires all presenters to err on the safe side and to disclose it.

Common Interest Group Meetings> open to all delegates Activities taking place outside of the core scientific

programme and open to all UEG Week delegates.


ESGENA ConferenceThe Conference of the European Society of Gastroenter-ology and Endoscopy Nurses and Associates (ESGENA) is an associated meeting at the congress with separate scientific programme and registration.


Other Scientific Information

The 25th UEG Week Barcelona 2017, Spain, October 28 – November 1, 2017, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 31 European CME credits

(ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.

Live educational activities, occurring outside of Cana-da, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certifica-tion Programme of The Royal College of Physicians and Surgeons of Canada.

In order to obtain CME credits, UEG requires feedback on its educational activities. Therefore, we kindly ask all delegates to complete the online evaluation form after conclusion of the congress. The evaluation form is avail-able as of Wednesday, November 1, 2017 via the congress app and on www.ueg.eu/myueg. The CME Certificate of EACCME will be available for download after completion of the online evaluation.

Young GI Network

This initiative provides young delegates with the oppor-tunity to network, exchange scientific ideas and discuss the congress programme with peers and senior experts. All delegates up to the age of 40 are invited to access the lounge and to participate in the activities.

Young GI LoungeThis comfortable area in Hall 8.0 is the place to meet for trainees and fellows at UEG Week. Form new collabora-tions over a cup of coffee, meet UEG Young Talent Group members and senior experts in the field, and attend special coaching sessions.

Opening hours Saturday October 28 09:00 – 17:00 Sunday October 29 09:00 – 17:00 Monday October 30 09:00 – 17:00 Tuesday October 31 09:00 – 17:00 Wednesday November 1 09:00 – 14:00

Access is granted to UEG Week delegates below the age of 40 and dedicated Young GI Network mentors.

Find out more on www.ueg.eu/week

Mix and mingle in the Young GI Lounge in Hall 8.0 New friends, scientific exchange, coaching sessions and coffee are waiting for you!

Join the Young GI Network on facebook

17_07_Inserat_UEGWEEK_FP_YoungGI_160x220mm_RZ.indd 1 14.09.17 11:53


23

Mentoring ProgrammeYoung congress participants have the possibility to net-work with senior experts and receive scientific guidance in small groups. Registration is required; remaining spots can be booked onsite in the Young GI Lounge on a first-come, first-served basis.

Monday, October 30 > 10:00 – 10:30 // 12:00 – 13:00Tuesday, October 31 > 10:00 – 10:30 // 12:00 – 13:00

Meeting point for pre-registered delegates: 10:00, Young GI Lounge

Young GI Network – Let's meet!This special event for young congress delegates takes place in Restaurante Bestial at the beach and provides an informal atmosphere to network with colleagues from all over the world. The event is limited to congress delegates and registration is required. Remaining tickets can be bought for € 15 at the congress registration counter on a first-come, first-served basis. Guests are asked to present their ticket and congress badge at the restaurant entrance.

Sunday, October 29 19:00 – 24:00Restaurante Bestial Barcelona, Ramon Trias Fargas, 2-4, 08005 Barcelona

Young GI Network – Let’s tweet! Participate in the next round of moderated social me-dia debates. Join in the discussion and ask the experts or express your point of view by including the hashtag #WeekChat.

Sunday October 29 13:00 – 14:00 Twitter discussion: Transition from fellowship

to faculty Expert: Björn Rembacken

Tuesday October 31 17:15 – 18:00 Facebook discussion (Group ‘Young GI

Network’): Career tips for PhD students Expert: Luigi Ricciardiello

Meet the Web EditorsMeet the UEG Education Web Editorial Team each day in the lunch break at the UEG Education Booth in Hall 8.0.

Young GI Track This part of the UEG Week Pathways Tool will highlight sessions from the scientific programme at UEG Week that we consider of particular interest for junior congress delegates. The UEG Week Pathways Tool is available as part of the UEG Week App and as pdf on our website for download.

Young GI SessionsJoin our special coaching and information sessions which are aimed at junior delegates in particular. Registration is not required.

Sunday, October 2913:00 – 14:00 Young GI LoungeCheck your CV: Tips and tricks from experts

Monday, October 3012:15 – 13:15 E-Poster Lounge 1Moving GI education into the future: Current challenges, future needs

13:00 – 14:00 Young GI LoungeVisiting Fellowship Programme information meeting

15:45 – 17:15 E-Poster Lounge 2Rising Stars in pancreatology from Europe and the USA

Tuesday, October 3113:00 – 14:00 Young GI LoungeCareer Chat: Top advice from female leaders and their fellows

15:45 – 17:15 E-Poster Lounge 1How to submit a good paper

For further details go to the UEG Week 2017 App or the online programme at www.ueg.eu/week/programme

Guided Poster ToursReview posters in your field of interest in small groups to-gether with a senior expert. Registration is not required.

Monday October 30 12:30 – 13:30 Tuesday October 31 12:30 – 13:30 Wednesday November 1 12:30 – 13:30

Meeting point: Poster Service Desk (Hall 7)

Young GI Network

We support your application for research funding in Horizon 2020!

Find out more, visit www.ueg.eu/research

Horizon 2020, the present EU Framework Programme for Research and Innovation, holds € 80bn support for researchers.

JOIN OUR SESSION TO LEARN • about ways and options to have your ideas

funded in Horizon 2020• how your colleagues are managing their grants• how UEG can effectively support your

application to EU fundingPage 90

EU funding: What UEG can offer

TUESDAYOctober 31, 2017

15:45 – 17:15Hall 8.0, Room E1

17_09_Inserat_UEGWEEK_FP_Horizon_160x220mm_RZ.indd 1 12.09.17 13:54

Scientific Programme Overview

The scientific programme is as of September 12, 2017.Later changes are published in the online programme and in the UEG Week congress app.

2726

UEG Week Final Programme : Scientific Programme Overview

Saturday, October 28, 2017

Postgraduate Teaching Programme Overview

Sunday, October 29, 2017 }}

Hall 6Voting Room

Room C1Voting Room

Room C2Voting Room

Room F3 Hall 8.0

09:0

0 –

10:3

0 Plenary I

09:00 – 18:00

ESGE Learning Area



Early management of acute pancreatitis

10:30 – 11:00 Coffee Break

11:0

0 –

13:0

0

Video Case Session Parallel Sessions

Video Case Session I: Diagnosis and management of biliary and pancreatic strictures

Extraintestinal ma-nifestations of IBD and co-morbidity

H. pylori: From epidemiology to clinical management

Update on the management of pancreatic adenocarcinoma

13:00 – 14:00 Lunch Break

14:0

0 –

16:3

0

Video Case Session Parallel Sessions

14:00 – 17:30

ESGENA

Video Case Session 2: Endoscopic stenting in the upper GI tract, endoscopy in IBD and lower GI bleeding

Management of gastro-oesophageal reflux disease (GORD)

Therapy update in GI cancers

Assessment of liver function: Pearls for the clinician

Hall 6Voting Room

Room C1Voting Room

Room C2Voting Room

Room F3 Room F2 Room A3 Room E4 Room E1 Room E2 Room E3 Hall 8.0

08:3

0 –

10:3

0 Parallel Sessions

09:00 – 18:30

ESGENA

09:00 – 18:00

ESGE Learning Area



All you wanted to know about coeliac disease – but did not dare to ask!

Dyspepsia and gastroparesis: How to diagnose and treat?

The changing epidemiology of viral hepatitis

Advanced diagnostic endoscopy

Faecal inconti-nence: Mecha- nisms, diagnostic tests and treatment

10:30 – 11:00 Coffee Break 10:30 – 11:00 Coffee Break

11:0

0 –

13:0

0

Clinical Case Based Sessions

Early management of IBD

Benign causes of oesophageal dysphagia

Optimising the outcome for patients with upper GI bleeding

Update on GI infections for the gastroenterologist

Management of early colorectal cancer

Management of abdominal emergencies

Diagnostic work-up of a liver nodule

Malignant biliary obstruction: Diag-nostic and thera-peutic approach

Best clinical prac-tice for patients with chronic intestinal failure

Management of non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)

13:00 – 14:00 Lunch Break 13:00 – 14:00 Lunch Break

14:0

0 –

16:0

0 Plenary II

Refractory IBD: How can we optimise the management?

16:15 – 17:45 and 18:00 – 19:30 Industry Sponsored Symposia 16:15 – 17:45 and 18:00 – 19:30 Industry Sponsored Symposia

Scientific Programme Overview : UEG Week Final Programme

27

}}

Missed a session? Watch it on www.ueg.eu/week/24-7

17_08_Inserat_Week24_7_FP_86_5x85_RZ.indd 1 24.08.17 11:46Hall 6Voting Room

Room C1Voting Room

Room C2Voting Room

Room F3 Room F2 Room A3 Room E4 Room E1 Room E2 Room E3 Hall 8.0

08:3

0 –

10:3

0 Parallel Sessions

09:00 – 18:30

ESGENA

09:00 – 18:00

ESGE Learning Area



All you wanted to know about coeliac disease – but did not dare to ask!

Dyspepsia and gastroparesis: How to diagnose and treat?

The changing epidemiology of viral hepatitis

Advanced diagnostic endoscopy

Faecal inconti-nence: Mecha- nisms, diagnostic tests and treatment


11:0

0 –

13:0

0

Clinical Case Based Sessions

Early management of IBD

Benign causes of oesophageal dysphagia

Optimising the outcome for patients with upper GI bleeding

Update on GI infections for the gastroenterologist

Management of early colorectal cancer

Management of abdominal emergencies

Diagnostic work-up of a liver nodule

Malignant biliary obstruction: Diag-nostic and thera-peutic approach

Best clinical prac-tice for patients with chronic intestinal failure

Management of non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)


14:0

0 –

16:0

0 Plenary II

Refractory IBD: How can we optimise the management?

16:15 – 17:45 and 18:00 – 19:30 Industry Sponsored Symposia 16:15 – 17:45 and 18:00 – 19:30 Industry Sponsored Symposia

Attention to time change on Sunday morning from 3:00 am to 2:00 am.

2928


* RTD – Round Table Discussion / TSTM – Today’s Science; Tomorrow’s Medicine / FPS – Free Paper Session

Monday, October 30, 2017 }}


Scientific Centre (Hall 7)

Hall 6 Room C1Voting Room

Room C2Voting Room

Room F3 Room F2 Room F1 Room A2 Room A1 Room A3 Room B2 Room B3 Room E4 Room 7.1 Room E1 Room E2 Room E3 Room B5 E-Poster Lounge 1

E-Poster Lounge 2

Hotspot Hall 8.0

07:00 – 08:00 Industry Sponsored Symposia 07:00 – 08:00 Industry Sponsored Symposia

08:0

0 –

10:0

0

Opening Session: Part 1

09:00 – 18:00

ESGE Learning Area




10:3

0 –

12:0

0


Symposium Symposium Free Paper Session

Symposium Symposium Symposium Symposium Symposium Free Paper Session

Translational/Basic Science

TSTM* Free Paper Session

Symposium Free Paper Session

Free Paper Session

Free Paper Session

Posters in the Spotlight


FPS*: Abstracts on Fire

Adverse food reactions: How to diagnose and manage?

GORD from infancy to old age

Clinical trials in Crohn's disease

Optimising screening colonoscopy

Innovative therapeutic endoscopy in Japan and Europe

Fatty liver disease: Update 2017

Minimal invasive approach for pancreato- hepato-biliary tumours

Hot topics from Latin America

Disease burden in IBD

Neurodegener- ative diseases of the GI tract: From mecha-nism to therapy

Composition and functions of the healthy gut microbiota

Imaging, screening and surveillance of colorectal cancer

Multidisciplinary management of liver metastases in colorectal cancer

Advanced endoscopic treatment of upper GI neoplasia

Diagnosis and management of cirrhosis: Unmet needs

Bariatric surgery, obesity and weight loss

Therapeutic observations in IBD

Basic science models to understand human disease

Advances in endoscopic resection of early colorectal neoplasia

12:0

0 –

14:0

0


RTD*12:45 – 13:45

RTD*12:45 – 13:45

RTD*12:45 – 13:45

RTD*12:45 – 13:45


13:45Poster Champ Award Ceremony

Symposium12:15 – 13:15

Clinical management of cholan– giopathies

Pitfalls in the diagnosis of coeliac disease

Challenging cases of walled- off necrosis following acute pancreatitis

A young patient with chronic right lower quadrant pain

Cross-cultural differences and challenges for a career choice in GI

14:0

0 –

15:3

0

Symposium Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Session

Free Paper Session

Free Paper Session


TSTM FPS* Free Paper Session


Free Paper Session

Free Paper Session



Symposium

Best of DDW Cancer and IBD Management of early Barrett's neoplasia: When and how to resect or ablate?

Therapy update: Hepatocellular carcinoma (HCC) in 2017

How to manage malignant duodenal obstruction?

From guide-lines to clinical practice: Func- tional bowel disorders

ERCP: The "difficult" patient

Imaging and endoscopy in IBD

Late breaking abstracts I

Coeliac disease and wheat- related disorder

The gut microbiome: A key regulator of serotonin synthesis in the gut-brain axis

New concepts in host-microbiota crosstalks

IBS: Searching for biomarkers

Hereditary colorectal cancer: From genes to clinic

Advances in endoscopic imaging: What does the future hold?

Challenges in pancreatic and biliary surgery

Drugs, liver and pancreas

Upper GI dysmotility: Understanding the symptoms and providing effective therapy

Colorectal neoplasia: Improving detection and outcome

Clinical trials revisited: Antibi- otics in lower GI diseases – Should they be used?


15:4

5 –

17:1

5

Symposium Symposium Symposium Symposium Free Paper Session

Symposium Symposium Symposium Free Paper Session

Free Paper Session




Free Paper Session

Free Paper Session

Symposium Symposium Symposium

How to define therapeutic response in Crohn's disease?

The severly constipated patient not responding to standard therapies: What to do?

Managing collections in acute pancreatitis

Therapy update: Prevention and treatment of endoscopic complications

Clinical trials in ulcerative colitis

From guide-lines to clinical practice: Coeliac disease

Alcoholic liver disease: Anything new?

H. pylori eradication: Unanswered questions

Late breaking abstracts II

ERCP: When the going gets tough

Immunotherapy in cancer

Microbiota crosstalk in health

Sporadic and hereditary colon cancer

How to treat duodenal adenomas?

Gluten-related disorders

General hepatology

Upper GI motility and brain-gut interactions

Moving GI education into the future: Current challenges, future needs

Rising Stars in pancreatology from Europe and the USA

Progress in the management of cholangiocarcinoma



2928

}}Scientific Centre (Hall 7)


Room C2Voting Room


E-Poster Lounge 2

Hotspot Hall 8.0


08:0

0 –

10:0

0


09:00 – 18:00

ESGE Learning Area




10:3

0 –

12:0

0


Symposium Symposium Free Paper Session

Symposium Symposium Symposium Symposium Symposium Free Paper Session




Free Paper Session

Free Paper Session




Adverse food reactions: How to diagnose and manage?

GORD from infancy to old age

Clinical trials in Crohn's disease

Optimising screening colonoscopy

Innovative therapeutic endoscopy in Japan and Europe

Fatty liver disease: Update 2017

Minimal invasive approach for pancreato- hepato-biliary tumours

Hot topics from Latin America

Disease burden in IBD

Neurodegener- ative diseases of the GI tract: From mecha-nism to therapy

Composition and functions of the healthy gut microbiota

Imaging, screening and surveillance of colorectal cancer

Multidisciplinary management of liver metastases in colorectal cancer

Advanced endoscopic treatment of upper GI neoplasia

Diagnosis and management of cirrhosis: Unmet needs

Bariatric surgery, obesity and weight loss

Therapeutic observations in IBD

Basic science models to understand human disease

Advances in endoscopic resection of early colorectal neoplasia

12:0

0 –

14:0

0


RTD*12:45 – 13:45

RTD*12:45 – 13:45

RTD*12:45 – 13:45

RTD*12:45 – 13:45




Clinical management of cholan– giopathies

Pitfalls in the diagnosis of coeliac disease

Challenging cases of walled- off necrosis following acute pancreatitis

A young patient with chronic right lower quadrant pain

Cross-cultural differences and challenges for a career choice in GI

14:0

0 –

15:3

0


Free Paper Session

Free Paper Session




Free Paper Session

Free Paper Session



Symposium

Best of DDW Cancer and IBD Management of early Barrett's neoplasia: When and how to resect or ablate?

Therapy update: Hepatocellular carcinoma (HCC) in 2017

How to manage malignant duodenal obstruction?

From guide-lines to clinical practice: Func- tional bowel disorders

ERCP: The "difficult" patient

Imaging and endoscopy in IBD

Late breaking abstracts I

Coeliac disease and wheat- related disorder

The gut microbiome: A key regulator of serotonin synthesis in the gut-brain axis

New concepts in host-microbiota crosstalks

IBS: Searching for biomarkers

Hereditary colorectal cancer: From genes to clinic

Advances in endoscopic imaging: What does the future hold?

Challenges in pancreatic and biliary surgery

Drugs, liver and pancreas

Upper GI dysmotility: Understanding the symptoms and providing effective therapy

Colorectal neoplasia: Improving detection and outcome

Clinical trials revisited: Antibi- otics in lower GI diseases – Should they be used?


15:4

5 –

17:1

5

Symposium Symposium Symposium Symposium Free Paper Session

Symposium Symposium Symposium Free Paper Session

Free Paper Session




Free Paper Session

Free Paper Session

Symposium Symposium Symposium

How to define therapeutic response in Crohn's disease?

The severly constipated patient not responding to standard therapies: What to do?

Managing collections in acute pancreatitis

Therapy update: Prevention and treatment of endoscopic complications

Clinical trials in ulcerative colitis

From guide-lines to clinical practice: Coeliac disease

Alcoholic liver disease: Anything new?

H. pylori eradication: Unanswered questions

Late breaking abstracts II

ERCP: When the going gets tough

Immunotherapy in cancer

Microbiota crosstalk in health

Sporadic and hereditary colon cancer

How to treat duodenal adenomas?

Gluten-related disorders

General hepatology

Upper GI motility and brain-gut interactions

Moving GI education into the future: Current challenges, future needs

Rising Stars in pancreatology from Europe and the USA

Progress in the management of cholangiocarcinoma


12:00 – 14:00Poster

Sessions

3130




Room C2Voting Room


E-Poster Lounge 2

Hotspot Hall 8.0


08:3

0 –

10:0

0

Live endoscopy


Free Paper Session



Free Paper Session

Free Paper Session

Free Paper Session

Free Paper Session


09:00 – 18:00

ESGE Learning Area



Eosinophilic oesophagitis (EoE): European harmonisation

Chronic diarrhea: Diagnostic and therapeutic approach

Therapy update: Ulcerative colitis

Endoscopic and surgical interventions for metabolic disorders

From guidelines to clinical practice: Auto- immune liver disease

Pancreatic tumours: Diagnosis and treatment

Recurrences after colorectal EMR/ESD: How to avoid, how to treat?

Detection and removal of colorectal polyps: Latest techniques

Diagnosis and treatment of GORD

Understanding the basis for GI pain

Clinical implications of host microbiota interactions

The microbiome and IBD

Symptom patterns in functional GI disorders

Acute and chronic pancreatitis: Risk factors and prevention

Progress in endoscopic diagnosis

New insights in microbiota: Gut and liver aspects

09:00 – 10:00Exemplary clinical cases I

09:00 – 10:00Exemplary clinical cases II

Laryngopha- ryngeal reflux (LPR)


10:3

0 –

12:0

0

Live endoscopy


Free Paper Session




Free Paper Session

Free Paper Session




Perianal fistulising Crohn's disease: From pathophysiology to management

Treating patients with acute cholecystitis and cholangitis

Therapy update: Evidence for the efficacy of probiotics?

Optimising the diagnosis of IBS

From guidelines to clinical practice: Colorectal cancer

Evidence-based approach to achalasia

Lifestyle-related liver disease: Risks and management

Longterm management in IBD with biologics

Evidence-based management of Barrett's and oesophageal adenocarcinoma

Genetics of pancreatic disease and lessons for clinical practice

Gut microbiota and digestive disorders

H. pylori: Treatment and antibiotic resistance

Intestinal ultrasound: How and when?

Diverticular disease: From bench to bedside

Mechanisms of carcinogenesis in the pancreas

Microbiology and immunology of the small intestine

Pancreatic and biliary neo-plasia: Basic and clinical observations

Advances in the management of functional GI disorders

Predicting and optimising IBD outcome

12:0

0 –

14:0

0


RTD*12:45 – 13:45

RTD*12:45 – 13:45

RTD*12:45 – 13:45

RTD*12:45 – 13:45




Therapy-resis-tent reflux sym-ptoms: What can we offer to the patient?

Autoimmune pancreatitis: Diagnostic and therapeutic challenges

Management of malignant dysphagia

Use and abuse of GI function tests

The role of academia in drug development

14:0

0 –

15:3

0

Live endoscopy


Free Paper Session




Free Paper Session

Free Paper Session



Symposium

Management of dysplasia in ulcerative colitis

Proctology made easy

Therapy update: Faecal inconti-nence

How to manage early gastric cancer?

From guidelines to clinical practice: Pancreatic diseases

Malignant colorectal polyp: What to do?

The role of the GI microen-vironment in IBS

Late breaking abstracts III

Impacts of biologics in IBD

Which GI diseases are inherited?

How to modulate the microbiome?

Optimising your colonoscopy practice

From fibrosis to cirrhosis: Diagnostic challenges and novel therapies

H. pylori: From pathophysiolo-gy to the clinic

Pancreatic cancer: Risk factors and screening

Carcinogenesis and tumour progression in GI cancer

Optimising our diagnostic tools in gastroen-terology and hepatology

How to improve the success rate in therapeutic endoscopy?

Clinical trials revisited: New drugs in liver diseases


15:4

5 –

17:1

5

Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Session

Free Paper Session




Free Paper Session

Free Paper Session

Symposium

Exemplary clinical cases III


Multidisciplinary management of complicated luminal Crohn's disease

Case finding and surveillance of Barrett's oesophagus

East meets West: Oesophageal cancer

Therapy update: Nutritional therapy in gastroenterology

Common mis-takes in biliary obstruction management

From guidelines to clinical practice: Upper GI bleeding

Improved testing for upper and lower GI dysmotility

Update on diverticular disease

Potential future targets in IBD

Quality assurance in colonoscopy: Room for improvement?

Emerging biomarkers in GI cancer medicine

Microbiota: Future directions

Randomised controlled trials in functional lower GI disorders


Autoimmune and cholestatic liver diseases: Novelties

From preven-tion to therapy of oesophagogastric cancer

Nerves and barrier function in health and disease

How to submit a good paper

Hepatobiliary and pancreatic malignancies: From bench to bedside



* RTD – Round Table Discussion / TSTM – Today’s Science; Tomorrow’s Medicine / FPS – Free Paper Session

Tuesday, October 31, 2017 }}


31



Room C2Voting Room


E-Poster Lounge 2

Hotspot Hall 8.0


08:3

0 –

10:0

0

Live endoscopy


Free Paper Session



Free Paper Session

Free Paper Session

Free Paper Session

Free Paper Session


09:00 – 18:00

ESGE Learning Area



Eosinophilic oesophagitis (EoE): European harmonisation

Chronic diarrhea: Diagnostic and therapeutic approach

Therapy update: Ulcerative colitis

Endoscopic and surgical interventions for metabolic disorders

From guidelines to clinical practice: Auto- immune liver disease

Pancreatic tumours: Diagnosis and treatment

Recurrences after colorectal EMR/ESD: How to avoid, how to treat?

Detection and removal of colorectal polyps: Latest techniques

Diagnosis and treatment of GORD

Understanding the basis for GI pain

Clinical implications of host microbiota interactions

The microbiome and IBD

Symptom patterns in functional GI disorders

Acute and chronic pancreatitis: Risk factors and prevention

Progress in endoscopic diagnosis

New insights in microbiota: Gut and liver aspects

09:00 – 10:00Exemplary clinical cases I

09:00 – 10:00Exemplary clinical cases II

Laryngopha- ryngeal reflux (LPR)


10:3

0 –

12:0

0

Live endoscopy


Free Paper Session




Free Paper Session

Free Paper Session




Perianal fistulising Crohn's disease: From pathophysiology to management

Treating patients with acute cholecystitis and cholangitis

Therapy update: Evidence for the efficacy of probiotics?

Optimising the diagnosis of IBS

From guidelines to clinical practice: Colorectal cancer

Evidence-based approach to achalasia

Lifestyle-related liver disease: Risks and management

Longterm management in IBD with biologics

Evidence-based management of Barrett's and oesophageal adenocarcinoma

Genetics of pancreatic disease and lessons for clinical practice

Gut microbiota and digestive disorders

H. pylori: Treatment and antibiotic resistance

Intestinal ultrasound: How and when?

Diverticular disease: From bench to bedside

Mechanisms of carcinogenesis in the pancreas

Microbiology and immunology of the small intestine

Pancreatic and biliary neo-plasia: Basic and clinical observations

Advances in the management of functional GI disorders

Predicting and optimising IBD outcome

12:0

0 –

14:0

0


RTD*12:45 – 13:45

RTD*12:45 – 13:45

RTD*12:45 – 13:45

RTD*12:45 – 13:45




Therapy-resis-tent reflux sym-ptoms: What can we offer to the patient?

Autoimmune pancreatitis: Diagnostic and therapeutic challenges

Management of malignant dysphagia

Use and abuse of GI function tests

The role of academia in drug development

14:0

0 –

15:3

0

Live endoscopy


Free Paper Session




Free Paper Session

Free Paper Session



Symposium

Management of dysplasia in ulcerative colitis

Proctology made easy

Therapy update: Faecal inconti-nence

How to manage early gastric cancer?

From guidelines to clinical practice: Pancreatic diseases

Malignant colorectal polyp: What to do?

The role of the GI microen-vironment in IBS

Late breaking abstracts III

Impacts of biologics in IBD

Which GI diseases are inherited?

How to modulate the microbiome?

Optimising your colonoscopy practice

From fibrosis to cirrhosis: Diagnostic challenges and novel therapies

H. pylori: From pathophysiolo-gy to the clinic

Pancreatic cancer: Risk factors and screening

Carcinogenesis and tumour progression in GI cancer

Optimising our diagnostic tools in gastroen-terology and hepatology

How to improve the success rate in therapeutic endoscopy?

Clinical trials revisited: New drugs in liver diseases


15:4

5 –

17:1

5

Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium Free Paper Session

Free Paper Session




Free Paper Session

Free Paper Session

Symposium

Exemplary clinical cases III


Multidisciplinary management of complicated luminal Crohn's disease

Case finding and surveillance of Barrett's oesophagus

East meets West: Oesophageal cancer

Therapy update: Nutritional therapy in gastroenterology

Common mis-takes in biliary obstruction management

From guidelines to clinical practice: Upper GI bleeding

Improved testing for upper and lower GI dysmotility

Update on diverticular disease

Potential future targets in IBD

Quality assurance in colonoscopy: Room for improvement?

Emerging biomarkers in GI cancer medicine

Microbiota: Future directions

Randomised controlled trials in functional lower GI disorders


Autoimmune and cholestatic liver diseases: Novelties

From preven-tion to therapy of oesophagogastric cancer

Nerves and barrier function in health and disease

How to submit a good paper

Hepatobiliary and pancreatic malignancies: From bench to bedside


}}

12:00 – 14:00Poster

Sessions

3332


* RTD – Round Table Discussion / FPS – Free Paper Session

Scientific Programme OverviewWednesday, November 1, 2017 }}


Hall 6 Room F2 Room F1 Room A2 Room A1 Room A3 Room B2 Room B3 Room E4 Room 7.1 Room E1 Room E2 Room E3 E-Poster Lounge 1

E-Poster Lounge 2

Hotspot Hall 8.0

08:3

0 –

10:0

0

Symposium Advances in ClinicalGI & Hepatology

Symposium Symposium Symposium Symposium Symposium Translational/Basic Science

Free Paper Session Free Paper Session Symposium Free Paper Session Free Paper Session Posters in the Spotlight


Symposium

09:00 – 14:00

ESGE Learning Area



Update on new treatments in IBD

New therapeutic options for functional GI disorders

Resolving the enigma of coeliac disease

Quality in Endoscopy: How to use and interpret performance measures?

Pancreato-biliary EUS: How to do it better?

Viral hepatitis: Moving towards elimination

Submucosal endoscopy: Indications, techniques and outcomes

Intestinal failure: Understanding the cause and treatment options

Endoscopic management of GI bleeding: What is new?

Long-term complications in IBD

Update on gastric precancerous conditions and lesions

Pathogenesis of IBD Can colonic polyps be diagnosed in real time?

Detecting and removing colonic lesions

Clinical observations in oesophageal cancer

Controversies around serrated colorectal lesions


10:3

0 –

12:0

0


Video Case Session

Symposium Symposium Symposium Symposium Translational/Basic Science




Diagnostic and therapeutic challenges in pancreatology

Organic-functional overlap syndromes: Continuum or distinct diseases?

Patient education in IBD

Endoscopic resection of the difficult polyp

Management of advanced liver cirrhosis

Long-term adverse effects of bariatric surgery

Microbiota in liver disease

Hot topics in GORD and EoE

Safety and long-term outcomes with biologics in IBD

Therapeutic approaches targeting the tumour environment in pancreatic cancer: Hope or hype?

Endoluminal and transluminal interventions in the upper GI tract

Bugs in lower GI diseases

Bugs and viruses causing GI diseases

Progress in our understanding of colorectal inflamma-tion and neoplasia

Diagnosis and treatment of upper GI diseases in children and adults

12:0

0 –

14:0

0


RTD*12:45 – 13:45

RTD*12:45 – 13:45

RTD*12:45 – 13:45

RTD*12:45 – 13:45




Management of severe acute colitis

Endoscopic management of complications following upper GI surgery

Diagnostic and therapeutic approach to patients with anal bloodloss

Infectious complications of liver cirrhosis

25th UEG Week Anniversary Session: Major advances in gastroenterology and hepatology over the last 25 years

14:0

0 –

15:3

0


Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium

IBD: What's new in 2017?

Treatment of GORD beyond acid inhibition

Endoscopy: What's new in 2017?

Hepatology: What's new in 2017?

Pancreatology: What's new in 2017?

H. pylori: What's new in 2017?

Colorectal cancer: What's new in 2017?

Neurogastro- enterology and motility: What's new in 2017?

Upper GI cancer: What's new in 2017?

Diagnostic tools for GI diseases: What's new in 2017?


33

}}Scientific Centre (Hall 7)

Hall 6 Room F2 Room F1 Room A2 Room A1 Room A3 Room B2 Room B3 Room E4 Room 7.1 Room E1 Room E2 Room E3 E-Poster Lounge 1

E-Poster Lounge 2

Hotspot Hall 8.0

08:3

0 –

10:0

0


Symposium Symposium Symposium Symposium Symposium Translational/Basic Science



Symposium

09:00 – 14:00

ESGE Learning Area



Update on new treatments in IBD

New therapeutic options for functional GI disorders

Resolving the enigma of coeliac disease

Quality in Endoscopy: How to use and interpret performance measures?

Pancreato-biliary EUS: How to do it better?

Viral hepatitis: Moving towards elimination

Submucosal endoscopy: Indications, techniques and outcomes

Intestinal failure: Understanding the cause and treatment options

Endoscopic management of GI bleeding: What is new?

Long-term complications in IBD

Update on gastric precancerous conditions and lesions

Pathogenesis of IBD Can colonic polyps be diagnosed in real time?

Detecting and removing colonic lesions

Clinical observations in oesophageal cancer

Controversies around serrated colorectal lesions


10:3

0 –

12:0

0


Video Case Session

Symposium Symposium Symposium Symposium Translational/Basic Science




Diagnostic and therapeutic challenges in pancreatology

Organic-functional overlap syndromes: Continuum or distinct diseases?

Patient education in IBD

Endoscopic resection of the difficult polyp

Management of advanced liver cirrhosis

Long-term adverse effects of bariatric surgery

Microbiota in liver disease

Hot topics in GORD and EoE

Safety and long-term outcomes with biologics in IBD

Therapeutic approaches targeting the tumour environment in pancreatic cancer: Hope or hype?

Endoluminal and transluminal interventions in the upper GI tract

Bugs in lower GI diseases

Bugs and viruses causing GI diseases

Progress in our understanding of colorectal inflamma-tion and neoplasia

Diagnosis and treatment of upper GI diseases in children and adults

12:0

0 –

14:0

0


RTD*12:45 – 13:45

RTD*12:45 – 13:45

RTD*12:45 – 13:45

RTD*12:45 – 13:45




Management of severe acute colitis

Endoscopic management of complications following upper GI surgery

Diagnostic and therapeutic approach to patients with anal bloodloss

Infectious complications of liver cirrhosis

25th UEG Week Anniversary Session: Major advances in gastroenterology and hepatology over the last 25 years

14:0

0 –

15:3

0


Symposium Symposium Symposium Symposium Symposium Symposium Symposium Symposium

IBD: What's new in 2017?

Treatment of GORD beyond acid inhibition

Endoscopy: What's new in 2017?

Hepatology: What's new in 2017?

Pancreatology: What's new in 2017?

H. pylori: What's new in 2017?

Colorectal cancer: What's new in 2017?

Neurogastro- enterology and motility: What's new in 2017?

Upper GI cancer: What's new in 2017?

Diagnostic tools for GI diseases: What's new in 2017?

12:00 – 14:00Poster

Sessions

Available in the UEG Week App or visit

www.ueg.eu/week/programme

UEG Week PathwaysSee at one glance which sessions are most relevant and interesting for your specialty

Choose among 198 sessions, up to 20 run in parallel each day. The UEG Week Pathways help you navigate through this huge choice, searching the online scientific programme by topic.

17_08_Inserat_UEGWEEK_FP_pathways_305x220mm_RZ.indd 1 14.09.17 12:25

Postgraduate Teaching Programme

Overview Icons

Live Stream

Q&A

Audience Voting

Recorded Session

PGT Programme CommitteeMatthieu Allez, FranceMarianna Arvanitakis, Belgium Ian Jenkins, United KingdomDominique Thabut, FranceHerbert Tilg, Austria

PGT Syllabus contributions are available in the online programme, the UEG Week App and in our UEG Educa-tion Library at www.ueg.eu/education/library.

36

Saturday, October 28, 2017UEG Week Final Programme : Postgraduate Teaching Programme


Live Stream Q&A Audience Voting Recorded Session

Parallel Session11:00 – 13:00 Room C1Extraintestinal manifestations of IBD and co-morbidityChairs: Severine Vermeire, Belgium

James Lindsay, United Kingdom

Tandem Talks11:00 – 11:15 IP008Epidemiology and genetics of extraintestinal manifes-tations: East meets West – the WestTine Jess, Denmark

11:15 – 11:30 IP009Epidemiology and genetics of extraintestinal manifes-tations: East meets West – the EastSiew Chien Ng, Hong Kong PRC

11:30 – 11:45 IP010Dermatological extraintestinal manifestations: Clinical manifestations and diagnostic strategyTim Raine, United Kingdom

11:45 – 12:00 IP011Dermatological extraintestinal manifestations: Thera-peutic considerationsStephan Vavricka, Switzerland

12:00 – 12:15 IP012Athritis, arthralgias and metabolic bone disease: Clini-cal manifestations and diagnostic strategyTimothy Orchard, United Kingdom

12:15 – 12:30 IP013Athritis, arthralgias and metabolic bone disease: Ther-apeutic considerationsMartine De Vos, Belgium

12:30 – 12:45 IP014Hepato-pancreatico-biliary extraintestinal manifesta-tions: Clinical manifestations and diagnostic strategyPascal Juillerat, Switzerland

12:45 – 13:00 IP015Hepato-pancreatico-biliary extraintestinal manifesta-tions: Therapeutic considerationsFranck Carbonnel, France

Postgraduate Teaching ProgrammeSaturday, October 28, 2017

Plenary I09:00 – 10:30 Hall 6Early management of acute pancreatitisChairs: Julia Mayerle, Germany

Ross Carter, United Kingdom

09:00 – 09:30 IP001Common mistakes in the initial management of acute pancreatitisMarkus M. Lerch, Germany

09:30 – 10:00 IP002Indications and techniques for endoscopic intervention in acute pancreatitisDjuna L. Cahen, The Netherlands

10:00 – 10:30 IP003The complicated case Ross Carter, United Kingdom

Parallel Session11:00 – 13:00 Hall 6Video Case Session I: Diagnosis and management of biliary and pancreatic stricturesChairs: Marianna Arvanitakis, Belgium

Thierry Ponchon, France

11:00 – 11:30 IP004Endoscopic diagnosis and treatment of biliary stenosisTorsten Beyna, Germany

11:30 – 12:00 IP005Endoscopic management of malignant hilar stenosisAndrea Tringali, Italy

12:00 – 12:30 IP006EUS diagnosis of pancreatic lesionsPeter Vilmann, Denmark

12:30 – 13:00 IP007Endoscopic drainage of pancreacic ductsMyriam Delhaye, Belgium

Postgraduate Teaching Programme : UEG Week Final Programme

37


Satu

rday

, Oct

ober

28,

201

7

Q&A Audience Voting Recorded Session Live Stream

Parallel Session14:00 – 16:30 Hall 6Video Case Session 2: Endoscopic stenting in the up-per GI tract, endoscopy in IBD and lower GI bleedingChairs: Mario Dinis-Ribeiro, Portugal

Lars Aabakken, Norway

14:00 – 14:30 IP024Esophageal stenting: Tips and tricksManon C. W. Spaander, The Netherlands

14:30 – 15:00 IP025Duodenal stenting: Tips and tricksAlessandro Repici, Italy

15:00 – 15:30 IP026Endoscopic management of lower GI bleedingIan Gralnek, Israel

15:30 – 16:00 IP027Colonoscopic surveillance of IBDHelmut Neumann, Germany

16:00 – 16:30 IP028Endoscopic management of IBD related stenosisEdward Despott, United Kingdom

Parallel Session14:00 – 16:30 Room C1Management of gastro-oesophageal reflux disease (GORD)Chairs: Albert Jan Bredenoord, The Netherlands

Frank Zerbib, France

14:00 – 14:30 IP029Pathophysiology: What is relevant for GORD manage-ment?André Smout, The Netherlands

14:30 – 15:00 IP030Supra-oesophageal GORDRadu Tutuian, Switzerland

15:00 – 15:30 IP031Diagnostics: GORD phenotypesSabine Roman, France

15:30 – 16:00 IP032Medical management of GORDJutta Keller, Germany

16:00 – 16:30 IP033New surgical and endoscopic treatments for GORDStephen Attwood, United Kingdom

Parallel Session11:00 – 13:00 Room C2H. pylori: From epidemiology to clinical managementChairs: John Atherton, United Kingdom

Emad El-Omar, Australia

11:00 – 11:30 IP016The epidemiology of H. pylori infection and associated diseasesMarcis Leja, Latvia

11:30 – 12:00 IP017H. pylori and extra-gastric diseases: Fact or fiction?Antonio Gasbarrini, Italy

12:00 – 12:30 IP018Testing for H. pylori: Who and how?Tamara Matysiak Budnik, France

12:30 – 13:00 IP019Optimal H. pylori treatment in 2017Francis Megraud, France

Parallel Session11:00 – 13:00 Room F3Update on the management of pancreatic adenocar-cinomaChairs: Markus M. Lerch, Germany

Marc G. H. Besselink, The Netherlands

11:00 – 11:30 IP020Initial assessment of a pancreatic mass and biliary managementJulia Mayerle, Germany

11:30 – 12:00 IP021The limits of surgery for pancreatic adenocarcinomaMarc G.H. Besselink, The Netherlands

12:00 – 12:30 IP022Pain management and endoscopic palliationAsbjørn Drewes, Denmark

12:30 – 13:00 IP023Chemotherapy for locally advanced and metastasized pancreatic adenocarcinomaJean-Luc Van Laethem, Belgium

38

Saturday, October 28, 2017UEG Week Final Programme : Postgraduate Teaching Programme



Parallel Session14:00 – 16:30 Room F3Assessment of liver function: Pearls for the clinicianChairs: Laurent Castera, France

Soo Aleman, Sweden

14:00 – 14:30 IP040Assessment of liver function in acute liver failureClaire Francoz, France

14:30 – 15:00 IP041Assessment of liver function in advanced chronic liver diseaseJean-François Dufour, Switzerland

Debates15:00 – 15:15 IP042How to diagnose liver cirrhosis in 2017: A liver biopsy is necessary!Karoline Lackner, Austria

15:15 – 15:30 IP043How to diagnose liver cirrhosis in 2017: A liver biopsy is not necessary!Maja Thiele, Denmark

15:30 – 15:45 IP044How to diagnose portal hypertension in 2017: Endosco-py and hepatic venous pressure gradient measurement are still necessary!Jaime Bosch, Spain

15:45 – 16:00 IP045How to diagnose portal hypertension in 2017: Non-in-vasive tests are enough!Dominique Thabut, France

Tandem Talks16:00 – 16:15 IP046How to assess liver function before surgery: Before general surgeryYves Panis, France

16:15 – 16:30 IP047How to assess liver function before surgery: Before hepatic surgeryConstantino Fondevila, Spain

Parallel Session14:00 – 16:30 Room C2Therapy update in GI cancersChairs: Thomas Seufferlein, Germany

Rob Glynne-Jones, United Kingdom

Debate14:00 – 14:15 IP034Adenocarcinoma of oesophagogastric junction and gastric cancer: We only need good quality surgery!Markus Schäfer, Switzerland

14:15 – 14:30 IP035Adenocarcinoma of oesophagogastric junction and gastric cancer: Neoadjuvant or perioperative treatment gives the best value for the patient!Michel Ducreux, France

14:30 – 15:00 IP036Immunotherapy in GI cancerMarkus Moehler, Germany

15:00 – 15:30 IP037Colorectal cancer: Adjuvant treatment – according to molecular subtyping, immunoscore or simply TNM staging?Rob Glynne-Jones, United Kingdom

15:30 – 16:00 IP038Colorectal cancer: Therapeutic strategies in metastatic colorectal cancerDieter Hahnloser, Switzerland

16:00 – 16:30 IP039Pancreatic ductal adenocarcinoma: Novel approaches in the adjuvant and palliative settingJean-Luc Van Laethem, Belgium


39

Sunday, October 29, 2017

Sund

ay, O

ctob

er 2

9, 2

017


09:30 – 10:00 IP056Treatment options for gastroparesisGuillaume Gourcerol, France

10:00 – 10:30 IP057Management of functional dyspepsiaTim Vanuytsel, Belgium

Parallel Session08:30 – 10:30 Room C2The changing epidemiology of viral hepatitisChairs: Michael Manns, Germany

Maria Buti, Spain

Debate08:30 – 08:45 IP058Chronic hepatitis B: Do treatment criteria need to be expanded – YesThomas Berg, Germany

08:45 – 09:00 IP059Chronic hepatitis B: Do treatment criteria need to be expanded – NoAlessio Aghemo, Italy

09:00 – 09:30 IP060How to manage hepatitis B reactivation in GI diseaseRafael Esteban, Spain

09:30 – 10:00 IP061Hepatitis E and immunosuppressionSven Pischke, Germany

10:00 – 10:30 IP062Long term management of patients with chronic hepa-titis B with nucleos(t)ide analogs (NUCs)Georgios Papatheodoridis, Greece

Parallel Session08:30 – 10:30 Room F3Advanced diagnostic endoscopyChairs: Horst Neuhaus, Germany

Evelien Dekker, The Netherlands

08:30 – 09:00 IP063Current and future technologies for gastrointestinal endoscopyJacques J. Bergman, The Netherlands

Postgraduate Teaching ProgrammeSunday, October 29, 2017

Parallel Session08:30 – 10:30 Hall 6All you wanted to know about coeliac disease – but did not dare to ask!Chairs: Knut E. A. Lundin, Norway

Katri Kaukinen, Finland

08:30 – 09:00 IP048Diagnosis of coeliac disease: Clinical, serology, HLA, biopsyDavid Surendran Sanders, United Kingdom

Tandem Talks09:00 – 09:15 IP049Experimental diagnostic approaches: Antibody-based diagnosisKatri Kaukinen, Finland

09:15 – 09:30 IP050Experimental diagnostic approaches: T-cell based assaysKnut E. A. Lundin, Norway

09:30 – 10:00 IP051Treatment of coeliac diseaseCarolina Ciacci, Italy

10:00 – 10:30 IP052Follow-up of coeliac disease: What to do with non-re-sponsive patientsJeremy Woodward, United Kingdom

Parallel Session08:30 – 10:30 Room C1Dyspepsia and gastroparesis: How to diagnose and treat?Chairs: Jan Tack, Belgium

Hans Törnblom, Sweden

08:30 – 09:00 IP053Functional dyspepsia and gastroparesis: Definitions, overlap and distinctionsDaniel Pohl, Switzerland

Debate09:00 – 09:15 IP054Dyspepsia, nausea and vomiting: GI physiology tests are useful in clinical practice – ProJutta Keller, Germany

09:15 – 09:30 IP055Dyspepsia, nausea and vomiting: GI physiology tests are useful in clinical practice – ConHeinz Florian Hammer, Austria


40

UEG Week Final Programme : Postgraduate Teaching Programme



Clinical Case Based Session11:00 – 13:00 Hall 6Early management of IBDChairs: Ailsa Hart, United Kingdom

Matthieu Allez, FranceModerator: Stephan Vavricka, Switzerland

11:00 – 11:30 IP074Case presentation: Ulcerative colitisPhilip Hendy, United Kingdom

11:30 – 12:00 IP075An overview of early ulcerative colitisAilsa Hart, United Kingdom

12:00 – 12:30 IP076Case presentation: Crohn’s diseasePhilip Hendy, United Kingdom

12:30 – 13:00 IP077Prognostication and how it may inform management strategies in early Crohn’s diseaseMatthieu Allez, France

Clinical Case Based Session11:00 – 13:00 Room C1Benign causes of oesophageal dysphagiaChairs: Mark Fox, Switzerland

Sabine Roman, FranceModerator: Nathalie Rommel, Belgium

11:00 – 11:30 IP078Case presentation: AchalasiaMichael Hollenstein, Switzerland

11:30 – 12:00 IP079Clinical assessment and investigation of swallowing disordersMark Fox, Switzerland

12:00 – 12:30 IP080Case presentation: Eosinophilic esophagitis (EoE)Michael Hollenstein, Switzerland

12:30 – 13:00 IP081Therapeutic management of benign oesophageal dysphagiaSabine Roman, France

Tandem Talks09:00 – 09:15 P064Impact of advanced endoscopy on management of early GI neoplasia: Upper GI tractKrish Ragunath, United Kingdom

09:15 – 09:30 IP065Impact of advanced endoscopy on management of early GI neoplasia: Lower GI tractAna Wilson, United Kingdom

Debate09:30 – 09:45 IP066Is cholangioscopy ready for prime time? ProTorsten Beyna, Germany

09:45 – 10:00 IP067Is cholangioscopy ready for prime time? ConAndrea Tringali, Italy

10:00 – 10:30 IP068Progress in EUS based imaging and guided tissue samplingMarc Barthet, France

Parallel Session08:30 – 10:30 Room F2Faecal incontinence: Mechanisms, diagnostic tests and treatmentChairs: Anton Emmanuel, United Kingdom

Søren Laurberg, Denmark

08:30 – 09:00 IP069The continence mechanism and case-finding of the incontinent patientAnton Emmanuel, United Kingdom

Debate09:00 – 09:15 IP070Physiological and radiological assessment of faecal incontinence: The tests are essential – ProHenriette Heinrich, United Kingdom

09:15 – 09:30 IP071Physiological and radiological assessment of faecal incontinence: The tests are essential – ConSøren Laurberg, Denmark

09:30 – 10:00 IP072Conservative therapies: Should we use an algorithm or just try anything available?Satish Rao, USA

10:00 – 10:30 IP073Surgical and neuromodulation therapies: When should the GI refer and for what?Ronan O'Connell, Ireland


41


Sund

ay, O

ctob

er 2

9, 2

017


Clinical Case Based Session11:00 – 13:00 Room F2Management of early colorectal cancerChairs: Simon Bach, United Kingdom

Monique van Leerdam, The NetherlandsModerator: Cesare Hassan, Italy

11:00 – 11:30 IP090Case presentation: Endoscopic resection of a malignant polyp in the colonArthur Kooyker, The Netherlands

11:30 – 12:00 IP091Evaluation and resection of colonic lesionsMonique van Leerdam, The Netherlands

12:00 – 12:30 IP092Case presentation: A patient with a small rectal cancerArthur Kooyker, The Netherlands

12:30 – 13:00 IP093Multimodality treatment of rectal cancersSimon Bach, United Kingdom

Clinical Case Based Session11:00 – 13:00 Room A3Management of abdominal emergenciesChairs: Josef Watfah, United Kingdom

Marja A. Boermeester, The NetherlandsModerator: Tim Vanuytsel, Belgium

11:00 – 11:30 IP094Case presentation: Acute abdomen and septic shockJan Gooszen, The Netherlands

11:30 – 12:00 IP095Diagnostic work-up of the acute abdomenMarja A. Boermeester, The Netherlands

12:00 – 12:30 IP096Case presentation: Recurrent abdominal bleedingJan Gooszen, The Netherlands

12:30 – 13:00 IP097Initial management of the acute abdomenJosef Watfah, United Kingdom

Clinical Case Based Session11:00 – 13:00 Room C2Optimising the outcome for patients with upper GI bleedingChairs: Ian Gralnek, Israel

Christopher John Hawkey, United KingdomModerator: Mostafa Ibrahim, Belgium

11:00 – 11:30 IP082Case presentation: Peptic ulcer bleeding due to NOACSarmed Sami, United Kingdom

11:30 – 12:00 IP083Bleeding peptic ulcer in 2017Christopher John Hawkey, United Kingdom

12:00 – 12:30 IP084Case presentation: Endoscopic management of gastric varicesSarmed Sami, United Kingdom

12:30 – 13:00 IP085Management of gastric variceal haemorrhage: A sticky wicket?Ian Gralnek, Israel

Clinical Case Based Session11:00 – 13:00 Room F3Update on GI infections for the gastroenterologistChairs: Harry Sokol, France

Christoph Högenauer, AustriaModerator: Edward Despott, United Kingdom

11:00 – 11:30 IP086Case presentation: Acute severe hemorrhagic colitisCecilia Landman, France

11:30 – 12:00 IP087Management of infectious colitisChristoph Högenauer, Austria

12:00 – 12:30 IP088Case presentation: Relapsing colitisCecilia Landman, France

12:30 – 13:00 IP089The clinical burden of clostridium difficile infectionHarry Sokol, France


42

UEG Week Final Programme : Postgraduate Teaching Programme



Clinical Case Based Session11:00 – 13:00 Room E2Best clinical practice for patients with chronic intes-tinal failureChairs: André Van Gossum, Belgium

Francisca Joly, FranceModerator: Ioannis Papanikolaou, Greece

11:00 – 11:30 IP106Case presentation: Intestinal adaptation of a very short gutLaure Billiauws, France

11:30 – 12:00 IP107Chronic intestinal failure: How to promote intestinal rehabilitationAndré Van Gossum, Belgium

12:00 – 12:30 IP108Case presentation: Liver abnormalities in case of short bowel syndromeLaure Billiauws, France

12:30 – 13:00 IP109Prevention and treatment of home parenteral nutrition complicationsFrancisca Joly, France

Clinical Case Based Session11:00 – 13:00 Room E3Management of non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)Chairs: Helena Cortez-Pinto, Portugal

Herbert Tilg, AustriaModerator: Alessio Aghemo, Italy

11:00 – 11:30 IP110Case presentation: Non-alcoholic fatty liver disease (NAFLD)Pedro Marques Da Costa, Portugal

11:30 – 12:00 IP111Epidemiology of ALD and NAFLD and how to differenti-ate between them. Implications for cardiovascular riskHelena Cortez-Pinto, Portugal

12:00 – 12:30 IP112Case presentation: Alcoholic liver disease (ALD)Pedro Marques Da Costa, Portugal

12:30 – 13:00 IP113Risk stratification and treatment for NAFLD and ALDHerbert Tilg, Austria

Clinical Case Based Session11:00 – 13:00 Room E4Diagnostic work-up of a liver noduleChairs: Dina Tiniakos, United Kingdom

Jean-François Dufour, SwitzerlandModerator: Christophe Moreno, Belgium

11:00 – 11:30 IP098Case presentation: Liver nodules in non-cirrhotic liverMaria Guarino, Switzerland

11:30 – 12:00 IP099To biopsy or not to biopsy a liver nodule?Dina Tiniakos, United Kingdom

12:00 – 12:30 IP100Case presentation: Liver nodule in cirrhotic liverMaria Guarino, Switzerland

12:30 – 13:00 IP101How to manage a liver nodule in a cirrhotic patientJean-François Dufour, Switzerland

Clinical Case Based Session11:00 – 13:00 Room E1Malignant biliary obstruction: Diagnostic and thera-peutic approachChairs: Paul Fockens, The Netherlands

Torsten Beyna, GermanyModerator: Michael B Wallace, USA

11:00 – 11:30 IP102Case presentation: Malignant biliary strictureChristian Gerges, Germany

11:30 – 12:00 IP103Diagnostic approach to indeterminate biliary stricturesTorsten Beyna, Germany

12:00 – 12:30 IP104Case presentation: Benign biliary strictureChristian Gerges, Germany

12:30 – 13:00 IP105The role of endoscopy in the treatment of (pre-)neo-plastic biliary obstructionPaul Fockens, The Netherlands


43


Sund

ay, O

ctob

er 2

9, 2

017


Tandem Talks15:00 – 15:15 IP116Optimal surgical-medical collaboration in dealing with refractory Crohn's disease: The medical approachYoram Bouhnik, France

15:15 – 15:30 IP117Optimal surgical-medical collaboration in dealing with refractory Crohn's disease: The surgical approachYves Panis, France

15:30 – 15:45 IP118Optimal surgical-medical collaboration in dealing with refractory ulcerative colitis: The medical approachAilsa Hart, United Kingdom

15:45 – 16:00 IP119Optimal surgical-medical collaboration in dealing with refractory ulcerative colitis: The surgical approachJanindra Warusavitarne, United Kingdom

Plenary II14:00 – 16:00 Hall 6Refractory IBD: How can we optimise the managment?Chairs: Iris Dotan, Israel

Geert D'Haens, The Netherlands

14:00 – 14:30 IP114Definition and mechanisms of treatment failure in clostridium difficile and ulcerative colitisBritta Siegmund, Germany

14:30 – 15:00 IP115Taking the next step: What are the best options for patients failing second line therapy?Julian Panés, Spain

Visit the ESGE (endoscopic training in cooperation with ESGENA), the Ultrasound and the Surgical Learning Areas.

Find more information on pages 261–273

Improve your practical skills in Hall 8.0

17_09_Inserat_UEGWEEK_FP_handson_136x62mm_RZ.indd 1 14.09.17 11:39

Experience two days of world-class continuing medical education for medical and surgical gastroenterologists in training and in practice.

Join the 3-year cycle to get all major updates in GI & hepatology and you will be perfectly prepared for your professional career!

Full registration for UEG Week is not required.

Enter the PGT 3-year curriculum!

Find out more, visit www.ueg.eu/week

Postgraduate Teaching ProgrammeOctober 20–21, 2018Vienna, Austria

Keep on track with your training

Major updates

Increasedinteractivity

Clinicalcases

17_09_Inserat_UEGWEEK_FP_PGT_160x220mm_RZ.indd 1 14.09.17 11:38

Scientific Programmeby Day

Overview Icons

Live Stream ª Rising Star Q&A ª Top Abstract Prize Audience Voting ª National Scholar Recorded Session

Monday, October 30, 2017

46

UEG Week Final Programme : Scientific Programme by Day


ª Rising Star ª Top Abstract Prize ª National Scholar

09:39 – 09:44 IP126UEG Lifetime Achievement Award 2017Anthony Axon, United Kingdom

Tandem Talks09:44 – 09:54 IP127Host microbial crosstalk in IBD: The microbiologist's point of viewHarry Sokol, France

09:54 – 10:04 IP128Host microbial crosstalk in IBD: The immunologist's point of viewArthur Kaser, United Kingdom

Opening Session10:30 – 12:00 Hall 6Opening Session: Part IIChairs: Magnus Simrén, Sweden

Paul Fockens, The Netherlands

10:30 – 10:50 IP129What's new in gastroenterology in 2017?C. Janneke van der Woude, The Netherlands

10:50 – 11:02 OP003DIFFERENTIALLY O-GLYCOSYLATED CARBOXYL ESTER LIPASE CAUSES A MODY8-LIKE PHENOTYPE IN MICE ªBaris Mercanoglu, Germany; G. Wolters-Eisfeld; C. Güngör; J. R. Izbicki; M. Bockhorn

11:02 – 11:07 IP130UEG Journal Best Paper Award 2017Clive H. Wilder-Smith, Switzerland

11:07 – 11:27 IP131What's new in endoscopy in 2017?Mario Dinis-Ribeiro, Portugal

11:27 – 11:39 OP004BENEFITS OF H. PYLORI ERADICATION IN PREVENT-ING GASTRIC CANCER IN THE OLDER POPULATION: RESULTS FROM A POPULATION-BASED STUDY. ªWai Keung Leung, Hong Kong PRC; I. O. Wong; E. W. Chan; A. Y. Wong; K. F. Yeung; L. Chen; I. C. Wong; K. S. Cheung

11:39 – 11:59 IP132What's new in hepatology in 2017?Thomas Berg, Germany

Scientific Programme by DayMonday, October 30, 2017

Opening Session08:00 – 10:00 Hall 6Opening Session: Part IChairs: Magnus Simrén, Sweden

Michael Manns, Germany

08:00 – 08:05 IP120Words of welcomeMagnus Simrén, Sweden

08:05 – 08:25 IP121How have prospective clincial trials changed the man-agement of acute pancreatitisMarc G. H. Besselink, The Netherlands

08:25 – 08:37 OP001DIAGNOSTIC YIELD OF “ARTIFICIAL INTELLIGENCE” -ASSISTED ENDOCYTOSCOPY FOR COLORECTAL POLYPS: A PROSPECTIVE STUDY ªYuichi Mori, Japan; S.-E. Kudo; M. Misawa; K. Takeda; K. Ichimasa; Y. Ogawa; Y. maeda; T. Kudo; K. Wakamura; T. Hayashi; T. Baba; F. Ishida; H. Inoue; M. Oda; K. Mori

08:37 – 08:57 IP122Inventing the future of minimally invasive therapiesJacques Marescaux, France

08:57 – 09:12 IP123UEG Research Prize 2017Jesper Lagergren, Sweden

09:12 – 09:22 IP124Presidential addressMichael Manns, Germany

09:22 – 09:34 OP002GENOME-WIDE ASSOCIATION STUDY IDENTIFIES INVERSION IN THE CTRB1-CTRB2 LOCUS TO MODIFY RISK FOR ALCOHOLIC AND NON-ALCOHOLIC CHRONIC PANCREATITIS ªJonas Rosendahl, Germany; H. Kirsten; E. Hegyi; P. Kovacs; F. U. Weiss; H. Laumen; P. Lichtner; C. Ruffert; J.-M. Chen; E. Masson; S. Beer; C. Zimmer; K. Seltsam; A. PanEuropean Working Group on Alcoholic Chronic Pancreatitis; J. Mössner; C. Férec; P. Michl; J. P. H. Drenth; H. Witt; M. Scholz; M. Sahin-Tóth

09:34 – 09:39 IP125Laudation UEG Lifetime Achievement AwardeeBjorn Rembacken, United Kingdom

Scientific Programme by Day : UEG Week Final Programme

47


Mon

day,

Oct

ober

30,

201

7


Free Paper Session10:30 – 12:00 Room F3Clinical trials in Crohn's diseaseChairs: Raja Atreya, Germany

Matthieu Allez, France

10:30 – 10:42 IP142State-of-the-art introductionMatthieu Allez, France

10:42 – 10:54 OP005EFFECT OF DISEASE DURATION AND LOCATION ON CLINICAL REMISSION IN CROHN’S DISEASE PATIENTS TREATED WITH FILGOTINIB, A SELECTIVE JAK1 INHIBITOR: POST-HOC ANALYSIS FROM THE PHASE 2 FITZROY STUDYSéverine Vermeire, Belgium; A. Van der Aa; C. Jamoul; C. Tasset; P. Harrison; G. R. D'Haens

10:54 – 11:06 OP006EXPOSURE-RESPONSE TO SC USTEKINUMAB IN MOD-ERATE –SEVERE CROHN’S DISEASE: RESULTS FROM THE IM-UNITI MAINTENANCE STUDYO. J. Adedokun; Z. Xu; C. Gasink; D. Jacobstein; P. Szapary; J. Johanns; L.-L. Gao; H. M. Davis; S. Hanauer; B. G. Feagan; S. Ghosh; William Sandborn, USA

11:06 – 11:18 OP007SAFETY AND EFFICACY OF UPADACITINIB (ABT-494), AN ORAL JAK1 INHIBITOR, AS INDUCTION THERAPY IN PATIENTS WITH CROHN’S DISEASE: RESULTS FROM CELESTWilliam Sanborn, USA; B. Feagan; J. Panes; G. D’Haens; J.-F. Colombel; Q. Zhou; B. Huang; J. V. Enejosa; A. L. Pangan; A. P. Lacerda

11:18 – 11:30 OP008EFFICACY AND SAFETY OF OPEN-LABEL MAINTE-NANCE THERAPY WITH SUBCUTANEOUS RISANKI-ZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN’S DISEASEBrian Feagan, Canada; J. Panés; M. Ferrante; A. Kaser; G. R. D'Haens; W. J. Sandborn; E. Louis; M. F. Neurath; D. Franchimont; O. Dewit; U. Seidler; K.-J. Kim; C. Selinger; S. J. Padula; I. Herichova; A. M. Robinson; K. Wallace; J. Zhao; A. Soaita; S. Visvanathan; D. Hall; W. O. Böcher

11:30 – 11:42 OP009ENDOSCOPIC AND CLINICAL EFFICACY DEMONSTRATED WITH ORAL OZANIMOD IN MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASEBrian Feagan, Canada; W. J. Sandborn; G. D'Haens; B. G. Levesque; B. E. Skolnick; C. Li; D. Penenberg; R. Aranda; A. Olson

Symposium10:30 – 12:00 Room C1Adverse food reactions: How to diagnose and manage?Chairs: Shanti Lynne Eswaran, USA

Yvonne McKenzie, United Kingdom

10:30 – 10:52 IP133AllergiesAlexander R. Moschen, Austria

10:52 – 11:14 IP134Carbohydrate intolerancePeter R. Gibson, Australia

11:14 – 11:36 IP135Non-coeliac wheat sensitivityUmberto Volta, Italy

11:36 – 11:58PANEL DISCUSSION

Symposium10:30 – 12:00 Room C2GORD from infancy to old ageChairs: Sibylle Koletzko, Germany

Frank Zerbib, France

Tandem Talks10:30 – 10:40 IP136Clinical presentation in infants and childrenCarlo Di Lorenzo, USA

10:40 – 10:50 IP137Clinical presentation in adultsRadu Tutuian, Switzerland

10:50 – 11:12 IP138Is the pathophysiology of GORD age-dependent and if so, so what?Daniel Sifrim, United Kingdom

Tandem Talks11:12 – 11:22 IP139Management of GORD in paediatric practiceCarlo Di Lorenzo, USA

11:22 – 11:32 IP140Management of GORD in adultsRadu Tutuian, Switzerland

11:32 – 11:54 IP141When should the surgeon step in?Stephen Attwood, United Kingdom


48




11:15 – 11:30 IP150Recent advances in colorectal endoscopic submucosal dissection (ESD): European curriculaAlanna Ebigbo, Germany

11:30 – 11:45 IP151EUS-guided gastroenterostomy: Japanese current status and perspectiveTakao Itoi, Japan

11:45 – 12:00 IP152EUS-guided gastroenterostomy: European current status and perspectiveMarc Barthet, France

Symposium10:30 – 12:00 Room A2Fatty liver disease: Update 2017Chairs: Frank Tacke, Germany

Helen Reeves, United Kingdom

Debate10:30 – 10:40 IP153Diagnosing NAFLD, NASH and ASH: We need a liver biopsyDina Tiniakos, United Kingdom

10:40 – 10:50 IP154Diagnosing NAFLD, NASH and ASH: We do not need a liver biopsyLaurent Castera, France

10:50 – 11:12 IP155Long-term surveillance and management of patients with fatty liver diseaseElisabetta Bugianesi, Italy

11:12 – 11:24 OP011AN ESCHERICHIA COLI PATHOGEN ISOLATED FROM A NON-ALCOHOLIC STEATOHEPATITIS PATIENT PRO-MOTES THE DEVELOPMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE IN HIGH FAT DIET MICENa Wu, China; J. Tan; J. Xu; Y. Song; F. Zhang; Y. L. Liu

11:24 – 11:36 OP012DIET-DEPENDENT ACID LOAD IS ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE GENERAL POPULATION: THE ROTTERDAM STUDYLouise Alferink, The Netherlands; J. C. Kiefte- de Jong; N. S. Erler; J. D. Schoufour; E. J. Hoorn; M. A. Ikram; H. L. A. Janssen; H. J. Metselaar; O. H. Franco; S. Darwish Murad

11:36 – 11:58 IP156An update on therapeutic optionsVlad Ratziu, France

11:42 – 11:54 OP010EXPOSURE-RESPONSE RELATIONSHIPS FOR THE EFFECT OF UPADACITINIB ON CLINICAL AND ENDO-SCOPIC EFFICACY ENDPOINTS IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE – ANALYSIS OF CELEST STUDYMohamed-Eslam Mohamed, USA; B. Klünder; A. P. Lacerda; A. A. Othman

Symposium10:30 – 12:00 Room F2Optimising screening colonoscopyChairs: Cesare Hassan, Italy

Brian P. Saunders, United Kingdom

10:30 – 10:52 IP143Optimising bowel preparationAndrea May, Germany

10:52 – 11:14 IP144Is adenoma detection rate the optimal quality param-eter?Michal Filip Kaminski, Poland

11:14 – 11:36 IP145Training and expertise in colonoscopy for doctors and nursesMatthew David Rutter, United Kingdom

11:36 – 11:58 IP146New technologiesIan Gralnek, Israel

Symposium10:30 – 12:00 Room F1Innovative therapeutic endoscopy in Japan and EuropeChairs: Thierry Ponchon, France

Haruhiro Inoue, Japan

Tandem Talks10:30 – 10:45 IP147Cell sheet transplantation and steroid therapy to man-age a severe stricture after circumferential mucosal resection in the oesophagusNaoyuki Yamaguchi, Japan

10:45 – 11:00 IP148Biodegradable stentsManon C. W. Spaander, The Netherlands

11:00 – 11:15 IP149Recent advances in colorectal endoscopic submucosal dissection (ESD): Technical advancesHironori Yamamoto, Japan


49


Mon

day,

Oct

ober

30,

201

7


Free Paper Session10:30 – 12:00 Room B2Disease burden in IBDChairs: Martine De Vos, Belgium

Radislav Nakov, Bulgaria

10:30 – 10:42 IP164State-of-the-art introductionMartine De Vos, Belgium

10:42 – 10:54 OP015IMPACT OF INTERVENTIONS FOR MODERATE TO SEVERE ULCERATIVE COLITIS ON HEALTH-RELATED QUALITY OF LIFE: SYSTEMATIC REVIEW AND NET-WORK META-ANALYSISPaschalis Paschos, Greece; A. Katsoula; O. Giouleme; M. Sarigianni; E. Athanasiadou; A. Tsapas

10:54 – 11:06 OP016THE INCIDENCE OF MILD OPPORTUNISTIC SELF-RE-PORTED INFECTIONS IN PATIENTS WITH IMMUNE-ME-DIATED INFLAMMATORY DISEASESLisa van Wijnen, The Netherlands; A. Wolters; M. J. Pierik; D. M. Jonkers; M. de Jong; A. Peters; A. A. M. Masclee; P. Steijlen; A. Tubergen

11:06 – 11:18 OP017TREAT TO TARGET FOR CROHN’S DISEASE WITH ADALIMUMAB TREATMENT IS COST EFFECTIVE OVER 48 WEEKS: AN ECONOMIC ASSESSMENT OF THE CALM TRIALRemo Panaccione, Canada; J.-F. Colombel; P. Bossuyt; M. Lukas; F. Baert; T. Vanásek; A. Danalıoğlu; G. Novacek; A. Armuzzi; W. Reinisch; S. Johnson; M. Davis; E. Neimark; J. Petersson; A. M. Robinson; R. Thakkar; W.-J. Lee; M. Skup

11:18 – 11:30 OP018HEALTHCARE RESOURCE UTILIZATION AND QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS BY DISEASE SEVERITY: BASELINE DATA FROM ICONICSubrata Ghosh, United Kingdom; L. Peyrin-Biroulet; F. Casellas; C. O'Shea; W. J. Lee; B. Pappalardo; J. Petersson

11:30 – 11:42 OP019RISK FACTORS FOR POSTOPERATIVE INFECTION AFTER LOWER GASTROINTESTINAL SURGERY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: FINDINGS FROM A LARGE EPIDEMIOLOGICAL STUDYH. Liang; B. Jiang; Trevor Lissoos, USA; S. Manne; P. Dolin

11:42 – 11:54 OP020DISEASE BURDEN AND FACTORS ASSOCIATED WITH ULCERATIVE COLITIS PROGRESSION IN SWEDENJ. Stålhammar; Per Hällström, Sweden; L. Agréus; H. Beydogan; L. Arnheim Dahlström; M. Skup; W.-J. Lee

Symposium10:30 – 12:00 Room A1Minimal invasive approach for pancreato-hepato-bil-iary tumoursChairs: Marco J. Bruno, The Netherlands

Robert Hawes, USA

10:30 – 10:52 IP157Endoscopic ampullectomyTodd H. Baron, USA

10:52 – 11:14 IP158EUS-guided and ERCP local therapyD. Nageshwar Reddy, India

11:14 – 11:36 IP159Minimally invasive surgery: Robotic and laparoscopic surgeryDavid Fuks, France

11:36 – 11:58 IP160Local treatment for symptomatic liver cystsMarc Giovannini, France

Symposium10:30 – 12:00 Room A3Hot topics from Latin AmericaChairs: Michael Manns, Germany

Enio Chaves Oliveira, Brazil

10:30 – 10:52 IP161Epidemiology of coeliac disease in Latin AmericaEdgardo Smecuol, Argentina

10:52 – 11:14 IP162Colonic diverticular disease treatment in 2017Mauro Bafutto, Brazil

11:14 – 11:36 IP163Diagnostic and therapeutic impact of colon capsule endoscopy in a real-life practice settingEduardo Alfredo Gutiérrez Galiana, Uruguay

11:36 – 11:48 OP013IN VIVO DETECTION OF COLONIC MUCOSA MICRO-IN-FLAMMATION BY CONFOCAL LASER ENDOMICROSCOPY PROBE (P-CLE) IN PATIENTS WITH IRRITABLE BOWEL SYNDROME.Carlos Robles-Medranda, Ecuador; M. Valero; J. Ospina; M. Puga-Tejada; G. Muñoz-Jurado; M. Soria; H. Alvarado-Escobar; R. Oleas-Narea; H. Pitanga-Lukashok

11:48 – 12:00 OP014STRUCTURAL ANALYSIS OF VARIABILITY AND INTER-ACTION OF HELICOBACTER PYLORI ONCOGENIC EFFEC-TOR CAGA N-TERMINAL WITH PHOSPHATIDYLSERINE ªCindy Ulloa, Colombia; M. D. P. Delgado; C. A. Jaramillo


50




Free Paper Session10:30 – 12:00 Room 7.1Imaging, screening and surveillance of colorectal cancerChairs: Jaroslaw Regula, Poland

Elisabeth Waldmann, Austria

10:30 – 10:42 IP173State-of-the-art introductionJaroslaw Regula, Poland

10:42 – 10:54 OP021DIFFERENCES IN ADENOMA AND PROXIMAL SERRATED POLYP DETECTION AND ITS EFFECT ON THE LONG-TERM IMPACT OF A BIENNIAL FIT-BASED COLORECTAL CANCER SCREENING PROGRAM – A MICROSIMULA-TION STUDYMaxime Bronzwaer, The Netherlands; M. Greuter; A. Bleijenberg; J. IJspeert; E. Dekker; V. M. H. Coupé

10:54 – 11:06 OP022HEAD-TO-HEAD COMPARISON OF DIAGNOSTIC PERFORMANCE OF NINE QUANTITATIVE FAECAL IMMUNOCHEMICAL TESTS FOR COLORECTAL CANCER SCREENINGAnton Gies, Germany; K. Cuk; P. Schrotz-King; H. Brenner

11:06 – 11:18 OP023ADENOMA DETECTION RATE ACCORDING TO AGE: COLONOSCOPY SCREENING SHOULD START AT 45 YEARS OLDDavid Karsenti, France; G. Tharsis; F. Venezia; P. Cattan; G. Tordjman; A. Gillet; K. Nahon-Uzan; J. Samama; M. Cavicchi

11:18 – 11:30 OP024TAILORING COLONOSCOPY COLORECTAL CANCER SCREENING IN CHILDHOOD CANCER SURVIVORS: A MODELING STUDYAndrea Gini, The Netherlands; D. C. Hodgson; R. G. S. Meester; H. Keshavarz; S. Ahmed; I. Lansdorp-Vogelaar

11:30 – 11:42 OP025FOLLOW UP OF COLORECTAL CANCER (CRC) PATIENTS INCLUDING 18FDGPET-CT (PET-CT): AN OPEN-LABEL MULTICENTER RANDOMIZED TRIAL (CLINICAL TRIAL: NCT 00624260). Iradj Sobhani, France; I. Baumgaertner; C. Tounigand; E. Ette; F. Brunetti; C. Gagniere; A. Luciani; I. Durand-Zaleski; S. Bastuji-Garin; G. ITEP Study

11:42 – 11:54 OP026MRI TO PREDICT SUCCESSFUL SPHINCTER PRESERVA-TION AFTER PREOPERATIVE CHEMORADIOTHERAPY FOR DISTAL RECTAL TUMOURS.Doenja M. Lambregts, The Netherlands; J. Krdzalic; M. Maas; S. M. Engelen; J. J. van Griethuysen; G. L. Beets; R. G. H. Beets-Tan

Translational Basic Science10:30 – 12:00 Room B3Neurodegenerative diseases of the GI tract: From mechanism to therapyChairs: Nicolas Cenac, France

Guy E. Boeckxstaens, Belgium

10:30 – 10:52 IP165How do GI neurones develop?Pieter Vanden Berghe, Belgium

10:52 – 11:14 IP166Mechanisms of neurodegenerationKeith A. Sharkey, Canada

11:14 – 11:36 IP167Achalasia, pseudoobstruction, Hirschsprung's disease: Clinical aspectsRoberto De Giorgio, Italy

11:36 – 11:58 IP168Transplantation of neuronsNikhil Thapar, United Kingdom

Today's Science, Tomorrow's Medicine10:30 – 12:00 Room E4Composition and functions of the healthy gut microbiotaChairs: Manimozhiyan Arumugam, Denmark

Antonio Gasbarrini, Italy

10:30 – 10:52 IP169Composition of an healthy gut microbiotaMirjana Rajilic-Stojanovic, Serbia

10:52 – 11:14 IP170Gut microbioita and immune developmentDirk Haller, Germany

11:14 – 11:36 IP171Gut microbiota and metabolismFredrik Bäckhed, Sweden

11:36 – 11:58 IP172The role of microbiota in human evolutionJoel Doré, France


51


Mon

day,

Oct

ober

30,

201

7


11:06 – 11:18 OP029SHOULD TAKING BIOPSY SAMPLES FROM APPARENTLY NON-CANCEROUS TISSUES AROUND THE LESION BE PERFORMED TO DETERMINE RESECTION MARGINS BE-FORE GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION?Masayuki Shibata, Japan; N. Kawata; K. Takizawa; N. Kakushima; M. Tanaka; M. Yoshida; S. Ito; K. Imai; H. ishiwatari; K. Hotta; H. Matsubayashi; H. Ono

11:18 – 11:30 OP030ARGON PLASMA COAGULATION FOR THE TREATMENT OF EARLY ESOPHAGEAL AND GASTRIC TUMORS IN HIGH-RISK PATIENTS: A RETROSPECTIVE, MULTI-CENTER, COLLABORATIVE STUDYSatoshi Tanabe, Japan; H. Nagase; Y. Sato; T. Sagawa; M. Murakami; K. Niimi; M. Fujishiro; J. Fujisaki; H. Doyama; N. Muguruma; Y. Takeda; K. Ishido; C. Katada

11:30 – 11:42 OP031PHASE II STUDY OF COLD SNARE POLYPECTOMY FOR SUPERFICIAL NON-AMPULLARY DUODENAL EPITHELI-AL TUMOR (D-CSP TRIAL)Kohei Takizawa, Japan; N. Kakushima; M. Tanaka; N. Kawata; M. Yoshida; K. Imai; S. Ito; H. ishiwatari; K. Hotta; H. Matsubayashi; K. Mori; H. Ono

11:42 – 11:54 OP032ENDOSCOPIC AMPULLECTOMY FOR NON-INVASIVE AMPULLARY LESIONS: A SINGLE-CENTRE 10 YEAR RETROSPECTIVE COHORT STUDYRichard Lee, Australia; A. Huelsen; L. Hourigan

Free Paper Session10:30 – 12:00 Room E3Diagnosis and management of cirrhosis: Unmet needsChairs: Jasmohan S. Bajaj, USA

Michael Trauner, Austria

10:30 – 10:42 IP180State-of-the-art introductionJasmohan S. Bajaj, USA

10:42 – 10:54 OP033VON WILLEBRAND FACTOR ANTIGEN IS LINKED TO BACTERIAL TRANSLOCATION, INFLAMMATION, AS WELL AS PROCOAGULANT IMBALANCE AND PREDICTS COMPLICATIONS OF CIRRHOSIS INDEPENDENTLY OF PORTAL HYPERTENSION SEVERITYMattias Mandorfer, Austria; P. Schwabl; R. Paternostro; K. Pomej; J. Thaler; C. Ay; M. Fritzer-Szekeres; P. Quehenberger; M. Trauner; M. Peck-Radosavljevic; T. Reiberger; A. Ferlitsch

Symposium10:30 – 12:00 Room E1Multidisciplinary management of liver metastases in colorectal cancerChairs: Rodrigo Perez, Brazil

Tamara Matysiak Budnik, France

Tandem Talks10:30 – 10:40 IP174Imaging: MRI and PET-CT for all? The clinician's perspectiveThomas Seufferlein, Germany

10:40 – 10:50 IP175Imaging: MRI and PET-CT for all? The radiologist's perspectiveAndrew Plumb, United Kingdom

10:50 – 11:12 IP176Strategy for liver limited metastasisMichel Ducreux, France

11:12 – 11:34 IP177Surgery for liver metastasis: What can be achieved?Bernard Nordlinger, France

11:34 – 11:56 IP178Loco-regional therapeutic approachAlban Denys, Switzerland

Free Paper Session10:30 – 12:00 Room E2Advanced endoscopic treatment of upper GI neoplasiaChairs: Alexander Meining, Germany

Ping-Hong Zhou, China

10:30 – 10:42 IP179State-of-the-art introductionAlexander Meining, Germany

10:42 – 10:54 OP027LONG TERM OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER IN ELDERLY PATIENTSYu Sato, Japan; T. Michida; M. Kato; H. Saiki; Y. Tokuda; K. Yamamoto; N. Tatsumi; T. Ito

10:54 – 11:06 OP028INCIDENCE OF SUBSEQUENT PRIMARY CANCERS AFTER ENDOSCOPIC RESECTION OF OESOPHAGEAL SQUAMOUS CELL CARCINOMASMitsuhiro Nikaido, Japan; S. Miyamoto; M. Muto; T. Setoyama; T. Horimatsu; H. Seno


52




10:54 – 11:06 OP040EROSIVE ESOPHAGITIS IS PREVALENT AND PREDICT-ABLE BY PRE-OPERATIVE GERDQ QUESTIONNAIRE IN OBESE INDIVIDUALS AND IS ASSOCIATED WITH THE NEED FOR CONTINUED PPI USE AFTER LAPAROSCOPIC SLEEVE GASTRECTOMYA. I. Sharara; Hussein Rimmani, Lebanon; A. I. Al Abbas; B. Safadi; R. H. Shayto; H. Aridi; Y. Shaib; R. Alami

11:06 – 11:18 OP041DEFECTS IN ENTEROENDOCRINE CELL DEVELOPMENT IN MORBIDLY OBESE HUMANS ARE NORMALIZED AFTER SLEEVE GASTRECTOMYAnne Christin Meyer-Gerspach, Switzerland; A. W. Moran; B. K. Wölnerhanssen; G. Burdyga; R. Peterli; M. Manz; M. Thumshirn; K. Daly; C. Beglinger; S. P. Shirazi-Beechey

11:18 – 11:30 OP042A WEIGHT LOSS INTERVENTION REDUCES BOWEL SYMPTOMS: A PROSPECTIVE STUDY IN SUBJECTS WITH MORBID OBESITYMartin Aasbrenn, Norway; S. Lydersen; P. Gronaas Farup

11:30 – 11:42 OP043DYNAMICS OF DECREASE OF ABDOMINAL FAT AFTER BARIATRIC SURGERY: A NONINVASIVE ASSESSMENT OVER 24 MONTHS BY MRIAnne Christin Meyer-Gerspach, Switzerland; B. K. Wölnerhanssen; D. Nabers; M. Moor; S. Borgwardt; R. Peterli; C. Beglinger; O. Bieri

11:42 – 11:54 OP044FINAL RESULTS OF MULTI-CENTER, PROSPECTIVE, CONTROLLED TRIAL OF THE DUODENO-JEJUNAL BYPASS LINER FOR THE TREATMENT OF TYPE 2 DIA-BETES MELLITUS IN OBESE PATIENTS: EFFICACY AND FACTORS PREDICTING A SUBOPTIMAL EFFECTMarek Benes, Czech Republic; P. Drastich; T. Hucl; J. Spicak

Free Paper Session10:30 – 12:00 HotspotAbstracts on Fire: Advances in endoscopic resection of early colorectal neoplasiaChairs: Michael John Bourke, Australia

Mathieu Pioche, France

10:30 – 10:40 OP045UNDERWATER ENDOSCOPIC COLORECTAL POLYP RESECTION IS A SAFER AND MORE EFFECTIVE TECH-NIQUE THAN GAS INSUFFLATION POLYPECTOMY FOR EVERYDAY CLINICAL PRACTICEMauro Liggi, Italy; S. Cadoni; P. Gallittu; D. Mura; M. Koo

10:54 – 11:06 OP034CLASS 1 OBESITY IS ASSOCIATED WITH INCREASED RISK FOR PORTAL VEIN THROMBOSIS IN HOSPITALIZED PATIENTS WITH CIRRHOSIS: A NATIONWIDE ANALYSISP. T. Kroener; J. E. Corral; Juan Gutierrez, Uruguay; M. A. D'assunção; I. Jovanovic; G. Schwingel; K. Mönkemüller

11:06 – 11:18 OP035EVALUATION OF CONTROLLED ATTENUATED PARAM-ETER (CAP) FOR ASSESSMENT OF LIVER STEATOSIS IN AN UNSELECTED POPULATION: A SINGLE CENTER REAL LIFE EXPERIENCEStephan Baumeler, Switzerland; I. Bergamin; B. Becker; W. Jochum; J. Neuweiler; D. Semela

11:18 – 11:30 OP036A RANDOMIZED CONTROLLED TRIAL COMPARING NITAZOXANIDE PLUS LACTULOSE VERSUS LACTULOSE ALONE IN TREATMENT OF OVERT HEPATIC ENCEPHA-LOPATHY.Sherief Abd-Elsalam, Egypt; R. badawi; N. Elwan; A. Elfert

11:30 – 11:42 OP037DIAGNOSTIC ACCURACY OF ANATOMIC CT ANGIOG-RAPHY-BASED VIRTUAL HEPATIC VENOUS PRESSURE GRADIENT IN PATIENTS WITH PORTAL HYPERTENSIONXiaolong Qi, China; J. Hou; W. An; R. Qi; L. Wang; Y. Liu; C. Liu; C. Liu; Y. Xiang; J. Hui; Z. Liu; Y. Zhao; Y. Zhu; J. Huang; J. Chen; J. Zhao; W. Xiong; J. Dong; X. Qi; G. Si; B. Liu; J. Wei; J. Zhou; J. Tian; G. Li; X. He; Y. Yang; F. Liu; Z. Li; G. Chess

11:42 – 11:54 OP038EFFECT OF GRANULOCYTE COLONY-STIMULATING FAC-TOR (G-CSF) ON MORTALITY AND COMPLICATIONS VIZ. SEPSIS, ENCEPHALOPATHY, HEPATORENAL SYNDROME, AND GASTROINTESTINAL BLEED IN SEVERE ALCOHOLIC HEPATITIS- A RANDOMIZED CONTROLLED STUDY.Abhinav Sharma, India; A. Setia; R. R. Rai

Free Paper Session10:30 – 12:00 Room B5Bariatric surgery, obesity and weight lossChairs: Giles Major, United Kingdom

Mario Morino, Italy

10:30 – 10:42 IP181State-of-the-art introductionMario Morino, Italy

10:42 – 10:54 OP039INTRAGASTRIC BALLOON-INDUCED WEIGHT LOSS PRIOR TO SURGERY IN SUPER-OBESE PATIENTS – A SINGLE CENTER EXPERIENCEIrina Mocanu, Portugal; A. Laranjo; S. Pires; N. Veloso; I. Medeiros; M. Rocha; S. Silva; M. Amaro; M. Carvalho


53


Mon

day,

Oct

ober

30,

201

7


11:50 – 12:00 OP053A NOVEL TEMPERATURE-RESPONSIVE, BIODEGRAD-ABLE AND INJECTABLE COLLAGEN SOL FOR ENDO-SCOPIC CLOSURE OF COLONIC PERFORATION HOLE: AN ANIMAL STUDY.Toshio Uraoka, Japan; S. Kinoshita; S. Yunoki; T. Narita; Y. Takatori; H. Mori; Y. Hirai; S. Banno; Y. Kubosawa; Y. Sunata; M. Shimoda; N. Yahagi

Round Table Discussion12:45 – 13:45 Room A2Clinical management of cholangiopathiesChair: Michael Trauner, AustriaExperts: Olivier Chazouillères, France

Annarosa Floreani, Italy Celso Matos, Belgium Michael Trauner, Austria

Round Table Discussion12:45 – 13:45 Room A3Pitfalls in the diagnosis of coeliac diseaseChair: Sibylle Koletzko, GermanyExperts: Lars Agréus, Sweden

Sibylle Koletzko, Germany Kalle Kurppa, Finland David Surendran Sanders, United Kingdom

Round Table Discussion12:45 – 13:45 Room B2Challenging cases of walled-off necrosis following acute pancreatitisChair: Thomas Rösch, GermanyExperts: Ross Carter, United Kingdom

Ulrike Denzer, Germany Thomas Rösch, Germany Hjalmar van Santvoort, The Netherlands

Round Table Discussion12:45 – 13:45 Room B3A young patient with chronic right lower quadrant painChair: Dieter Hahnloser, SwitzerlandExperts: Alessandro Armuzzi, Italy

Marja A. Boermeester, The Netherlands Shanti Lynne Eswaran, USA Dieter Hahnloser, Switzerland

10:40 – 10:50 OP046HAS THE SAFETY OF COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION BEEN MAINTAINED EVEN IN THE REGIONAL GENERAL HOSPITAL IN JAPAN? : A MULTICENTER PROSPECTIVE COHORT STUDYYuko Hiraga, Japan; S. Tanaka; S. Oka; K. Boda; S. Nagata; M. Kunihiro; R. Higashi; T. Kuwai; A. Furudoi; K. Nakadoi; H. Kanao; M. Terasaki; H. Okanobu; M. Higashiyama; K. Chayama

10:50 – 11:00 OP047WHAT ARE THE RESULTS OF RECTAL ESD IN FRANCE : A LARGE RETROSPECTIVE MULTICENTRE STUDY IN EXPERTS CENTERSJeremie Albouys, France; M.-A. Guillaumot; V. Lepilliez; S. Chaussade; M. Pioche; S. Leblanc; M. Barret; R. Legros; F. Prat; J. Rivory; D. Sautereau; T. Ponchon; J. Jacques

11:00 – 11:10 OP048EFFICACY OF TRACTION-ASSISTED COLORECTAL EN-DOSCOPIC SUBMUCOSAL DISSECTION USING CLIP AND THREAD: A PROSPECTIVE RANDOMIZED STUDYYasushi Yamasaki, Japan; Y. Takeuchi; N. Uedo; T. Kanesaka; R. Ishihara; H. Okada; H. Iishi

11:10 – 11:20 OP049EFFICACY OF ENDOSCOPIC SUBMUCOSAL DISSECTION USING THE “CLIP-FLAP METHOD” FOR COLORECTAL TUMORSKatsumi Yamamoto, Japan; S. Hayashi; H. Saiki; T. Nishida; N. Tatsumi; T. Michida; T. Ito

11:20 – 11:30 OP050EFFICACY AND SAFETY OF ENDOSCOPIC FULL-THICK-NESS RESECTION IN THE COLORECTUM WITH THE FTRD SYSTEM– INTERIM RESULTS OF A GERMAN REGISTRY.Arthur Schmidt, Germany; B. Meier; A. Fischer; M. Wegener; T. Wiedbrauck; M. Repp; G. Fitzel; G. Hübner; D. Albers; B. Schumacher; A. Erhardt; K. Gutberlet; A. Bielich; D. Scholz; M. Caselitz; T. Frieling; M. Breidert; C. Rasch; K. Fellermann; K. Caca

11:30 – 11:40 OP051MINIMISING THE RISK OF DELAYED BLEEDING IN COLONIC ENDOSCOPIC SUBMUCOSAL DISSECTION: IS THERE A ROLE FOR A NOVEL HAEMOSTATIC PEPTIDE?Sharmila Subramaniam, United Kingdom; K. Kandiah; A. Fujimoto; N. Yahagi; T. Uraoka; P. Bhandari

11:40 – 11:50 OP052ENEMA OF MESENCHYMAL STEM CELL CULTURE SUPERNATANT PREVENTS RECTAL STRICTURE FORMATION AFTER CIRCUMFERENTIAL ENDOSCOPIC SUBMUCOSAL DISSECTION IN PIGSMomoko Tsuda, Japan; S. Ohnishi; T. Mizushima; S. Abiko; Y. Shimizu; N. Sakamoto


54




14:22 – 14:44 IP191How can we prevent and detect early IBD related cancers?Laurence Egan, Ireland

14:44 – 15:06 IP192Drug related cancers in IBDVito Annese, Italy

15:06 – 15:28 IP193IBD management in a patient with a recent cancerKrisztina Barbara Gecse, Hungary

Symposium14:00 – 15:30 Room C2Management of early Barrett's neoplasia: When and how to resect or ablate?Chairs: Raf Bisschops, Belgium

Marcia Irene Canto, USA

Tandem Talks14:00 – 14:10 IP194Detection and characterisation of early Barrett's neo-plasia; EndoscopyKrish Ragunath, United Kingdom

14:10 – 14:20 IP195Detection and characterisation of early Barrett's neo-plasia: HistopathologyMichael Vieth, Germany

14:20 – 14:42 IP196Optimising endoscopic resectionAlexander Meining, Germany

14:42 – 15:04 IP197Ablation of neoplasia and non-neoplastic Barrett's epitheliumJacques J. Bergman, The Netherlands

15:04 – 15:26 IP198Approach to local recurrencePierre Henri Deprez, Belgium

Symposium14:00 – 15:30 Room F3Therapy update: Hepatocellular carcinoma (HCC) in 2017Chairs: Alejandro Forner, Spain

Helen Reeves, United Kingdom

14:00 – 14:22 IP199HCC standard of care 2017Arndt Vogel, Germany

14:22 – 14:44 IP200Surgery and liver transplantation for HCCPatrizia Burra, Italy

Symposium12:45 – 13:30 HotspotCross-cultural differences and challenges for a career choice in GIChair: Marianna Arvanitakis, Belgium

12:45 – 13:00 IP182Trans-european training in GI: Getting the best by crossing frontiersIsabelle Cremers, Portugal

13:00 – 13:15 IP183Training in GI outside EuropeNaima Amrani, Morocco

13:15 – 13:30 IP184Local issues regarding training in GI: Does everybody get the same?Marcel Tantau, Romania

Symposium14:00 – 15:30 Hall 6Best of DDWChairs: Michael Manns, Germany

Sheila Eileen Crowe, USA

14:00 – 14:18 IP185LiverJohn Vierling, USA

14:18 – 14:36 IP186Oesophagus and upper GIJohn Y. Kao, USA

14:36 – 14:54 IP187IBDDario Sorrentino, USA

14:54 – 15:12 IP188Pancreatic disordersRodger A. Liddle, USA

15:12 – 15:30 IP189OncologyLinda Rabeneck, Canada

Symposium14:00 – 15:30 Room C1Cancer and IBDChairs: Franck Carbonnel, France

Martine De Vos, Belgium

14:00 – 14:22 IP190Who are the patients at risk?Laurent Beaugerie, France


55


Mon

day,

Oct

ober

30,

201

7


Symposium14:00 – 15:30 Room A2ERCP: The "difficult" patientChairs: Marcel Tantau, Romania

Marianna Arvanitakis, Belgium

14:00 – 14:22 IP210ERCP in pregnancyJeanin E. van Hooft, The Netherlands

14:22 – 14:44 IP211ERCP in the elderlyStefan Seewald, Switzerland

14:44 – 15:06 IP212ERCP in the intensive care patientRobert Hawes, USA

Tandem Talks15:06 – 15:16 IP213ERCP in children: IndicationsFilippo Torroni, Italy

15:16 – 15:26 IP214ERCP in children: TechniqueGuido Costamagna, Italy

Free Paper Session14:00 – 15:30 Room A1Imaging and endoscopy in IBDChairs: Cathage Moran, Ireland

Pascal Juillerat, Switzerland

14:00 – 14:12 IP215State-of-the-art introductionCathage Moran, Ireland

14:12 – 14:24 OP054EARLY MUCOSAL HEALING IN PATIENTS WITH MODER-ATE TO SEVERE ULCERATIVE COLITIS TREATED WITH GOLIMUMAB PREDICTS FAVORABLE OUTCOMES: DATA FROM THE REAL LIFE BE-SMART COHORT.Peter Bossuyt, Belgium; F. Baert; F. D’Heygere; A. Nakad; E. Louis; F. fontaine; D. Franchimont; O. Dewit; P. Van Hootegem; S. Vanden Branden; G. Lambrecht; M. Ferrante

14:24 – 14:36 OP055PREDICTION OF CLINICAL OUTCOMES IN CROHN’S DIS-EASE BY USING CONFOCAL LASER ENDOMICROSCOPY: A PROSPECTIVE MULTICENTER STUDY. Gian Eugenio Tontini, Italy; J. Mudter; M. Vieth; C. Günther; V. Milani; R. Atreya; T. Rath; A. Nägel; G. Hatem; G. C. Sturniolo; M. Vecchi; M. F. Neurath; P. R. Galle; A. Buda; H. Neumann

14:44 – 15:06 IP201Immunotherapy for HCC?Olivier Rosmorduc, France

15:06 – 15:28 IP202Is there an increased risk of HCC after hepatitis C virus clearance?Maria Reig, Spain

Symposium14:00 – 15:30 Room F2How to manage malignant duodenal obstruction?Chairs: Ulf Peter Neumann, Germany

Bas L. A. M. Weusten, The Netherlands

14:00 – 14:22 IP203Endoscopic stentingPeter D. Siersema, The Netherlands

14:22 – 14:44 IP204EUS-guided creation of a gastroenteric bypassTakao Itoi, Japan

14:44 – 15:06 IP205SurgeryGiovanni Zaninotto, United Kingdom


Symposium14:00 – 15:30 Room F1From guidelines to clinical practice: Functional bowel disordersChairs: Hans Törnblom, Sweden

Fermin Mearín Manrique, Spain

14:00 – 14:22 IP206Dietary management of IBS in adultsYvonne McKenzie, United Kingdom

14:22 – 14:44 IP207Chronic constipation in adultsDaniel Pohl, Switzerland

14:44 – 15:06 IP208Management of constipation in childrenCarlo Di Lorenzo, USA

15:06 – 15:28 IP209Hamonising European research on IBSDaisy Mae Jonkers, The Netherlands


56




14:24 – 14:36 OP061BACTERIAL MODULATION OF INTESTINAL INNATE ACTIVATION INDUCED BY WHEAT AMYLASE TRYPSIN INHIBITORS (ATIS) IN NOD-DQ8 MICE.Victor F. Zevallos, Germany; J. McCarville; A. Caminero; E. Verdu; D. Schuppan

14:36 – 14:48 OP062HLA-DQ:GLUTEN TETRAMER TEST IN BLOOD GIVES BETTER DETECTION OF CELIAC PATIENTS THAN BIOP-SY AFTER 14-DAY GLUTEN CHALLENGEVikas Sarna, Norway; G. I. Skodje; H. M. Reims; L. F. Risnes; S. Dahal-Koirala; L. Sollid; K. E. A. Lundin

14:48 – 15:00 OP063RAPID HOME TESTS THAT REVEAL GLUTEN FREE DIET TRANSGRESSIONSAlfonso Rodriguez-Herrera, Spain; R. Domínguez-Flores; C. Sousa; A. Muñoz-Suano; M. Arévalo-Rodríguez; F. León; A. Cebolla

15:00 – 15:12 OP064‘CELIAC-LITE SCORE’: A PREDICTIVE SCORE OF RE-SPONSE TO A GLUTEN-FREE DIET IN PATIENTS WITH LYMPHOCYTIC ENTERITIS AND SUSPICION OF COELIAC DISEASEFernando Fernández-Bañares, Spain; A. Carrasco; M. Rosinach; B. Arau; R. García-Puig; C. González; Y. Zabana; M. Esteve

15:12 – 15:24 OP065EFFECTIVE GLUTEN DEGRADATION IN NON-COELIAC GLUTEN-SENSITIVE SUBJECTS BY ASPERGILLUS NIGER DERIVED ENZYME: A PLACEBO-CONTROLLED RAN-DOMIZED CLINICAL TRIALJulia König, Sweden; S. Holster; M. J. Bruins; R. J. Brummer

Translational Basic Science14:00 – 15:30 Room B3The gut microbiome: A key regulator of serotonin synthesis in the gut-brain axisChairs: Robin Spiller, United Kingdom

Muriel Derrien, France

14:00 – 14:22 IP217Revealing the secrets of serotonin signalling in the gutGary M Mawe, USA

14:22 – 14:44 IP218The gut microbiome and host serotonin synthesisMirjana Rajilic-Stojanovic, Serbia

14:44 – 15:06 IP219The neurobiology of gut-brain axis disorders: Focus on serotonin and tryptophan metabolismGerard Clarke, Ireland

14:36 – 14:48 OP056HISTOLOGICAL PREDICTORS OF RELAPSE IN ULCER-ATIVE COLITIS: WHICH FEATURES MATTER MOST?Begona Gonzalez Suarez, USA; E. U. Yee; T. Zenlea; L. Rosenberg; K. S. Nande; J. D. Goldsmith; A. C. Moss

14:48 – 15:00 OP057DEVELOPMENT AND VALIDATION OF THE “MINI INDEX” (MUCOSAL INFLAMMATION -NON INVASIVE INDEX) FOR CROHN’S DISEASE ON A LARGE PROSPEC-TIVE PEDIATRIC COHORT ªA. Ben Shoham; Maarten Cozijnsen, The Netherlands; B. Kang; B.-H. Choe; Y. H. Choe; R. K. Russell; F. M. Ruemmele; J. C. Escher; L. de Ridder; S. Koletzko; J. Martin de Carpi; J. S. Hyams; T. D. Walters; A. M. Griffiths; D. Turner

15:00 – 15:12 OP058LITTLE BENEFIT OF ENDOSCOPIC BASED THERAPEU-TIC MANAGEMENT IN POSTOPERATIVE RECURRENT CROHN'S DISEASE: RESULTS OF A RETROSPECTIVE STUDY.Pauline Rivière, France; S. Vermeire; G. Van Assche; P. Rutgeerts; A. de Buck Van Overstraeten; A. Wolthuis; A. D'Hoore; M. Ferrante

15:12 – 15:24 OP059TOFACITINIB FOR MAINTENANCE THERAPY IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS IN THE PHASE 3 OCTAVE SUSTAIN TRIAL: RESULTS BY LOCAL AND CENTRAL ENDOSCOPIC ASSESSMENTSBrian Feagan, Canada; S. Vermeire; W. J. Sandborn; W. Reinisch; J. Panés; D. Tarabar; C. Su; W. Niezychowski; H. Zhang; G. Friedman; D. Woodworth; B. E. Sands

Free Paper Session14:00 – 15:30 Room A3Late breaking abstracts I

Free Paper Session14:00 – 15:30 Room B2Coeliac disease and wheat-related disorderChairs: Kalle Kurppa, Finland

Michael Schumann, Germany

14:00 – 14:12 IP216State-of-the-art introductionKalle Kurppa, Finland

14:12 – 14:24 OP060GLUTEN INGESTION AND INTRADERMAL INJECTION OF PEPTIDES THAT ACTIVATE GLUTEN-SPECIFIC CD4+ T CELLS ELICIT A CYTOKINE SIGNATURE DOMINATED BY INTERLEUKIN-2 IN CELIAC DISEASEJ. A. Tye-Din; J. J. Dzuris; A. K. Russell; S. Wang; K. E. Goldstein; L. J. Williams; Robert Anderson, USA


57


Mon

day,

Oct

ober

30,

201

7


15:12 – 15:24 OP072STUDY ON THE ANTI-INFLAMMATORY MECHANISMS OF ROSEBURIA INTESTINALIS MEDIATED BY INDUCING THE DIFFERENTIATION OF THE TREG CELLS VIA TLR5 OF THE INTESTINAL EPITHELIAL CELLS IN INFLAMMA-TORY BOWEL DISEASE Zhaohua Shen, China; C. Zhu; Y. Quan; W. Yuan; Z. Yang; S. Wu; X. Wang

Free Paper Session14:00 – 15:30 Room 7.1IBS: Searching for biomarkersChairs: Henriette Heinrich, United Kingdom

Nathalie Vergnolle, France

14:00 – 14:12 IP221State-of-the-art introductionNathalie Vergnolle, France

14:12 – 14:34 IP222SEARCHING FOR BIOLOGICAL FACTORS IN A BIOPSY-CHOSOCIAL MODEL OF IRRITABLE BOWEL SYNDROMEYukari Tanaka, Japan

14:34 – 14:46 OP073IBS PATIENTS HAVE LOWER LEVELS OF COLONIC MUCOSAL PRO-INFLAMMATORY CYTOKINES WHICH REMAIN STABLE OVER TIMEBradley Schmidt, USA; G. Saffouri; J. Chen; H. Lekatz; M. Grover; D. Knights; G. Farrugia; P. Kashyap

14:46 – 14:58 OP074STRESS REGULATES SPECIFIC SEX-RELATED MOLEC-ULAR ALTERATIONS IN EPITHELIAL BARRIER REGU-LATORY GENES IN THE JEJUNAL MUCOSA OF HEALTHY VOLUNTEERSBruno Kotska Rodiño Janeiro, Spain; M. PIGRAU; A. Nieto; T. Pribic; L. Hernández; E. Salvo-Romero; B. Lobo Alvarez; A. M. González-Castro; M. Fortea; M. Gallart; C. Pardo-Camacho; I. de Torres; C. Martinez; D. Guagnozzi; T. Pérez-Berezo; F. Azpiroz; M. Vicario; J. Santos; C. Alonso Cotoner

14:58 – 15:10 OP075ACUTE STRESS IMPACTS CLOCK GENES AND BARRIER INTEGRITY IN THE INTESTINAL MUCOSA IN HEALTH.Marc Pigrau Pastor, Spain; B. K. Rodiño Janeiro; E. Salvo Romero; A. Nieto; L. Hernández; T. Pribic; B. Lobo Alvarez; A. M. González-Castro; M. Fortea; C. Pardo-Camacho; D. Guagnozzi; C. Martinez; T. Pérez-Berezo; I. de Torres; F. Azpiroz; M. Vicario; C. Alonso Cotoner; J. Santos

15:06 – 15:28 IP220Targeting the serotonin system in Irritable Bowel Syndrome: What have we learned?ILesley Houghton, United Kingdom

Today's Science, Tomorrow's Medicine14:00 – 15:30 Room E4TSTM Free Paper: New concepts in host-microbiota crosstalksChairs: Johannes Roksund Hov, Norway

Franco Scaldaferri, Italy

14:00 – 14:12 OP066EXOSOMES RELEASED FROM INTESTINAL EPITHELIAL CELLS INFECTED WITH CROHN’S DISEASE-ASSOCIATED ADHERENT-INVASIVE E. COLI TRANSFER MIRNAS INTO RECIPIENT CELLS TO INHIBIT AUTOPHAGY ªªAnaïs Larabi, France; J. Carriere; G. Dalmasso; J. Delmas; N. Barnich; H. T. T. Nguyen

14:12 – 14:24 OP067DIETARY EMULSIFIERS DIRECTLY IMPACT THE TRANSCRIPTOME OF A CROHN’S DISEASE-ASSOCIAT-ED ESCHERICHIA COLI, INCREASING ITS ABILITY TO INDUCE INTESTINAL INFLAMMATIONBenoit Chassaing, USA; A. T. Gewirtz

14:24 – 14:36 OP068GUT DYSBIOSIS CAN LEAD TO VISCERAL HYPERSENSI-TIVITY AND DEPRESSION IN GERM-FREE RATSLu Zhang, China; J. Zhang; S. Zhu; W. Zhang; L. Duan

14:36 – 14:48 OP069INFLAMMATION MODULATION BY STOMACH MICRO-BIOTA VIA TLR2 /NF-κB SIGNALING PATHWAY IN HP-INDUCED GASTRIC CANCER ªYini Dang, China; G. Zhang

14:48 – 15:00 OP070CARD9 MEDIATES SUSCEPTIBILITY TO INTESTINAL PATHOGENS THROUGH MICROBIOTA MODULATION AND CONTROL OF BACTERIAL VIRULENCE.Bruno Lamas, France; M. L. Richard; M.-L. Michel; N. Waldschmitt; V. Zacharioudaki; M. Delacre; J. M. Natividad; G. Da Costa; J. Planchais; C. Bridonneau; P. Langella; M. Chamaillard; H. Sokol

15:00 – 15:12 OP071A C-TYPE LECTIN TRIGGERS IMMUNE SURVEILLANCE BY INNATE LYMPHOID CELLS FOR ERADICATION OF ATTACHING-AND-EFFACING BACTERIANadine Waldschmitt, France; S. Kitamoto; T. Secher; V. Zacharioudaki; E. Floquet; M. Delacre; B. Lamas; P. Pham; A. Six; M. L. Richard; J.-C. Dagorn; P. Langella; G. Eberl; B. Ryffel; J. L. Iovanna; L. F. Poulin; H. Sokol; N. Kamada; M. Chamaillard


58




14:36 – 14:48 OP079THE MOLECULAR BASIS OF 5-AMINOLEVULINIC ACID (ALA) MEDIATED LASER-BASED PHOTODYNAMIC ENDOSCOPIC DIAGNOSIS (LPDED) FOR DIVERSE EARLY GASTRIC CANCERHiroki Kurumi, Japan; K. Ogihara; T. Kanda; K. Yashima; K. Kawaguchi; K. Matsumoto; Y. Takeda; H. Isomoto

14:48 – 15:00 OP080VISUALIZATION OF ABSORBED LIPID IN NORMAL DUODENAL EPITHELIUM BY MAGNIFYING ENDOSCOPY WITH NARROW-BAND IMAGING: AN OPEN-LABEL, RANDOMIZED, CONTROLLED STUDYHaruhiko Takahashi, Japan; K. Yao; T. Nagahama; M. Miyaoka; T. Ueki

15:00 – 15:12 OP081APPLICATION OF VIRTUAL REALITY IN ENDOSCOPYAlexander Hann, Germany; B. Walter; S. Schmidt; A. Meining

15:12 – 15:24 OP082ARE WE MISSING OPPORTUNITIES TO DIAGNOSE UP-PER GASTROINTESTINAL CANCER AT ENDOSCOPY?Sue Priestley, United Kingdom; B. Ashall; V. Theis; A. Bassi

Free Paper Session14:00 – 15:30 Room E3Challenges in pancreatic and biliary surgeryChairs: Johanna Laukkarinen, Finland

Hjalmar van Santvoort, The Netherlands

14:00 – 14:12 IP228State-of-the-art introductionJohanna Laukkarinen, Finland

14:12 – 14:24 OP083INTERLEUKIN-13 RECEPTOR α2 PREDICTS PROGNOSIS IN SURGICALLY RESECTED PANCREATIC CANCER PATIENTSToshio Fujisawa, Japan; H. Isayama

14:24 – 14:36 OP084PERFORMANCE OF A MULTIDISCIPLINARY TEAM IN PREDICTING AND MANAGING RESECTABLE PANCRE-ATIC CANCERShailendra Singh, USA; B. Rao; A. Gulati; M. Garg; A. Kulkarni; M. Mitre; K. Farah; S. Morrissey; M. Dhawan; S. Thakkar

14:36 – 14:48 OP085DEFECTS IN PROTEIN PROCESSING MAY UNDERLIE THE DEVELOPMENT OF HEPATIC CYSTS IN PATIENTS WITH POLYCYSTIC LIVER DISEASE.Liyanne van de Laarschot, The Netherlands; S. A. B. Hermsen; T. F. Wijnants; E. S. Wills; H. J. Wessels; J. P. H. Drenth

15:10 – 15:22 OP076DIFFERENT RELATIONSHIPS BETWEEN INTESTINAL PARASITES AND BACTERIAL RICHNESS AND DIVERSITY IN INDIVIDUALS WITH IRRITABLE BOWEL SYNDROME AND HEALTHY CONTROLSLaura Rindom Krogsgaard, Denmark; L. O´Brien Andersen; T. Bech Johannesen; A. L. Engsbro; C. Rune Stensvold; N. Larsen; H. Vedel Nielsen; P. Bytzer

Symposium14:00 – 15:30 Room E1Hereditary colorectal cancer: From genes to clinicChairs: Yasmijn van Herwaarden, The Netherlands

Luigi Ricciardiello, Italy

14:00 – 14:22 IP223New colorectal cancer predisposing genes in 2017Ian Tomlinson, United Kingdom

14:22 – 14:44 IP224Genetic testing for whom?Karin Dahan, Belgium

14:44 – 15:06 IP225Controversies in endoscopic surveillance strategiesMichael Bretthauer, Norway

15:06 – 15:28 IP226Surgical perspectives of hereditary colorectal cancerGabriela Möslein, Germany

Free Paper Session14:00 – 15:30 Room E2Advances in endoscopic imaging: What does the future hold?Chairs: Fabian Emura, Colombia

Oliver Pech, Germany

14:00 – 14:12 IP227State-of-the-art introductionOliver Pech, Germany

14:12 – 14:24 OP077ENDOSCOPIC MACROSCOPIC TYPE IS A SIGNIFICANT PREDICTOR FOR HISTOLOGICAL TYPES OF EARLY GASTRIC CANCERTakashi Kanesaka, Japan; T. Nagahama; N. Uedo; H. Doyama; T. Ueo; K. Uchita; H. Ishikawa; K. Yao

14:24 – 14:36 OP078IRREGULARLY BRANCHED MICROVESSELS ARE A RELI-ABLE MARKER FOR PREDICTING DEEP SUBMUCOSAL INVASION OF SUPERFICIAL ESOPHAGEAL CANCER WITH MAGNIFYING ENDOSCOPYYoichiro Ono, Japan; Y. Takaki; K. Yao; S. Ishikawa; M. Miyaoka; T. Nagahama; H. Fumihito; T. Ueki; T. Matsui; H. Tanabe; A. Ohta; S. Haraoka; A. Iwashita; K. Mikami; T. Maekawa


59


Mon

day,

Oct

ober

30,

201

7


15:00 – 15:12 OP093STATINS AND RISK OF ACUTE PANCREATITIS – A ME-TA-ANALYSIS OF OBSERVATIONAL STUDIESGoran Poropat, Croatia; L. Archibugi; T. Korpela; K. Cardenas-Jaen; E. de-Madaria; G. Capurso

15:12 – 15:24 OP094CLINICAL SIGNIFICANCE OF PATHOGENIC CTRC, CFTR AND SPINK1 MUTATIONS IN CHILDHOOD-ONSET PAN-CREATITIS (DATA ANALYSIS FROM APPLE STUDY) ªBalazs Nemeth, Hungary; A. Parniczky; C. Pienar; M. Sahin-Toth; P. Hegyi

Symposium14:00 – 15:30 HotspotClinical trials revisited: Antibiotics in lower GI diseas-es – Should they be used?Chair: Antonio Gasbarrini, Italy

14:00 – 14:15 IP230Trial presentation: Randomised clinical trial of obser-vational versus antibiotic treatment for a first episode of CT-proven uncomplicated acute diverticulitisMarja A. Boermeester, The Netherlands

14:15 – 14:30 IP231Critical reviewGiovanni Barbara, Italy


Giovanni Barbara, Italy Marja A. Boermeester, The Netherlands Charles H. Knowles, United KingdomAnne Peery, USA

14:45 – 15:00 IP232Trial presentation: Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predomi-nant Irritable Bowel SyndromeSatish Rao, USA

15:00 – 15:15 IP233Critical reviewAlexander Charles Ford, United Kingdom


Alexander Charles Ford, United KingdomJutta Keller, Germany Satish Rao, USAJan Tack, Belgium

14:48 – 15:00 OP086A DEDICATED BILIARY THEATRE LIST IMPROVES EARLY DEFINITIVE MANAGEMENT AND REDUCES READMIS-SIONS IN ACUTE GALLSTONE PANCREATITISMatthew Goldsworthy, United Kingdom; P. J. Gardiner; R. A. Adair; A. M. Smith; C. Macutkiewicz

15:00 – 15:12 OP087GENERATION AND TRANSPLANTATION OF BIOENGI-NEERED BILE DUCTS FOR RECONSTRUCTION OF THE EXTRAHEPATIC BILIARY TREEFotis Sampaziotis, United Kingdom; A. Justin; O. Tysoe; S. Sawiak; E. Godfrey; S. Upponi; N. L. Berntsen; L. Valestrand; T. H. Karlsen; E. Melum; A. Markaki; K. Saeb-Parsy; L. Vallier

15:12 – 15:24 OP088A SYSTEMATIC REVIEW ON THE DEVELOPMENT OF MALIGNANCY IN 2904 PATIENTS WITH CONGENITAL CHOLEDOCHAL MALFORMATIONAnneke ten Hove, The Netherlands; J. B. F. Hulscher; V. E. de Meijer; R. H. J. de Kleine

Free Paper Session14:00 – 15:30 Room B5Drugs, liver and pancreasChairs: Carolina Ciacci, Italy

Omid Sadr-Azodi, Sweden

14:00 – 14:12 IP229State-of-the-art introductionOmid Sadr-Azodi, Sweden

14:12 – 14:24 OP089A NOVEL IN VITRO TEST FOR CAUSALITY ASSESSMENT IN POLYMEDICATED PATIENTS WITH DRUG-INDUCED LIVER INJURY: CASES WITH DRUG RECHALLENGEAndreas Benesic, Germany; D. Dragoi; I. Rotter; M.-L. Buchholtz; A. Leitl; A. L. Gerbes

14:24 – 14:36 OP090SCREENING RATE FOR HEPATITIS B VIRUS AMONG CANCER PATIENTS RECEIVING CHEMOTHERAPY IN TAIWAN: A NATIONWIDE POPULATION-BASED STUDYWei Chih Sun, Taiwan; K.-H. LIN; H.-C. YU; W.-C. CHEN; W.-L. TSAI; H.-H. CHAN; P.-I. HSU; H.-C. LIN; P.-L. TANG; J.-S. CHENG

14:36 – 14:48 OP091NODULAR REGENERATIVE HYPERPLASIA IN INFLAMMA-TORY BOWEL DISEASE: LOW IMPACT IN DAILY PRACTICEMelek Simsek, The Netherlands; B. Meijer; K. H. N. de Boer; C. J. J. Mulder

14:48 – 15:00 OP092CAN MESALAZINE AFFECT THE PROGNOSIS OF ACUTE PANCREATITIS? EVIDENCE FROM THE INTESTINEL. Huang; W. Yang; Jing Li, China; Y. Tai; C. Ye; S. Tang; C. Tang


60




Symposium15:45 – 17:15 Room C2Managing collections in acute pancreatitisChairs: Markus M. Lerch, Germany

Jacques Deviere, Belgium

15:45 – 16:07 IP242Is there a need for early interventions for acute collec-tions?Hjalmar van Santvoort, The Netherlands

16:07 – 16:29 IP243Abdominal compartment syndrome: Diagnosis and treatmentSandra van Brunschot, The Netherlands

16:29 – 16:51 IP244Timing and indications for interventions in walled-off necrosis: Do we need fine needle aspiration?Enrique de-Madaria, Spain

16:51 – 17:13 IP245Walled-off necrosis: Which technique is best and which route to choose?Ross Carter, United Kingdom

Symposium15:45 – 17:15 Room F3Therapy update: Prevention and treatment of endo-scopic complicationsChairs: Andrea May, Germany

Pierre Eisendrath, Belgium

15:45 – 16:07 IP246Polypectomy, endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD)Alessandro Repici, Italy

16:07 – 16:29 IP247Peroral endoscopic myotomy (POEM) and pneumatic dilatationGuido Costamagna, Italy

16:29 – 16:51 IP248ERCPD. Nageshwar Reddy, India

16:51 – 17:13 IP249EUS-guided interventionsPaul Fockens, The Netherlands

Symposium15:45 – 17:15 Hall 6How to define therapeutic response in Crohn's disease?Chairs: Siew Chien Ng, Hong Kong PRC

Raja Atreya, Germany

15:45 – 16:07 IP234Therapeutic objectives: Clinical features and biomarkersAlessandro Armuzzi, Italy

16:07 – 16:29 IP235The role of endoscopy in the assessment of therapeutic responseOliver Pech, Germany

16:29 – 16:51 IP236The role of imaging in the assessment of therapeutic responseFrancesca Maccioni, Italy

16:51 – 17:13 IP237Are we ready for patient reported outcome measures?Johan Burisch, Denmark

Symposium15:45 – 17:15 Room C1The severly constipated patient not responding to standard therapies: What to do?Chairs: Lin Chang, USA

Robin Spiller, United Kingdom

Tandem Talks15:45 – 15:55 IP238Diagnostic approach: The gastroenterologist's viewMark Fox, Switzerland

15:55 – 16:05 IP239Diagnostic approach: The radiologist's viewAndrew Plumb, United Kingdom

16:05 – 16:27 IP240Optimising medical and behavioral therapy José Maria Remes-Troche, Mexico

16:27 – 16:49 IP241Surgical treatment options Emma Carrington, United Kingdom



61


Mon

day,

Oct

ober

30,

201

7


Symposium15:45 – 17:15 Room F1From guidelines to clinical practice: Coeliac diseaseChairs: Kalle Kurppa, Finland

Edgardo Smecuol, Argentina

15:45 – 16:07 IP251When to consider coeliac disease in primary care?Lars Agréus, Sweden

16:07 – 16:29 IP252Optimal diagnostic approachMichael Schumann, Germany

16:29 – 16:51 IP253When to question the diagnosis?Sibylle Koletzko, Germany

16:51 – 17:13 IP254Monitoring: Who and how?Katri Kaukinen, Finland

Symposium15:45 – 17:15 Room A2Alcoholic liver disease: Anything new?Chairs: Markus Cornberg, Germany

John Vierling, USA

15:45 – 16:07 IP255An easy diagnosis?Christophe Moreno, Belgium

16:07 – 16:29 IP256Natural historyHelena Cortez-Pinto, Portugal

16:29 – 16:41 OP101TARGETING LIVER INFLAMMATION USING MINCLE-TARGET-ED LIPOSOMES AS A NOVEL DRUG DELIVERY SYSTEM ªM. Szachniewicz; M. Bartneck; F. Tacke; Ruchi Bansal, The Netherlands

16:41 – 16:53 OP102IGA ANTIBODIES AGAINST FILAMENTOUS-ACTIN ARE FREQUENTLY DETECTED IN PATIENTS WITH CIRRHOSIS AND INDICATE A PROGRESSIVE DISEASE COURSET. Tornai; B. Balogh; N. Sipeki; Z. Vitalis; I. Tornai; P. Antal-Szalmas; G. L. Norman; T. Bruns; Mária Papp, Hungary

Debate16:53 – 17:03 IP257Steroids are still useful to treat acute acoholic hepatitisAlexandre Louvet, France

17:03 – 17:13 IP258Steroids are contraindicated in acute acoholic hepatitisPatrizia Burra, Italy

Free Paper Session15:45 – 17:15 Room F2Clinical trials in ulcerative colitisChairs: Krisztina Barbara Gecse, The Netherlands

Christoph Högenauer, Austria

15:45 – 15:57 IP250State-of-the-art introductionChristoph Högenauer, Austria

15:57 – 16:09 OP095TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF ULCERATIVE COLITIS: OPEN-LA-BEL, LONG-TERM EXTENSION STUDYG. R. Lichtenstein; E. V. Loftus Jr; Stuart Bloom, United Kingdom; N. Lawendy; G. Friedman; H. Zhang; W. Wang; A. J. Thorpe; C. Nduaka; C. Su

16:09 – 16:21 OP096SAFETY AND EFFICACY OF LONG-TERM TREATMENT WITH OZANIMOD, AN ORAL S1P RECEPTOR MODULA-TOR, IN MODERATE TO SEVERE ULCERATIVE COLITIS: TOUCHSTONE EXTENSION 2-YEAR FOLLOW-UPWilliam Sandborn, USA; B. G. Feagan; G. D'Haens; S. Hanauer; D. C. Wolf; S. Vermeire; S. Ghosh; C. Li; D. Penenberg; A. Petersen; R. Aranda; A. Olson

16:21 – 16:33 OP097VEDOLIZUMAB DEMONSTRATES EARLY SYMPTOMATIC IMPROVEMENT IN ULCERATIVE COLITIS: A GEMINI 1 POST HOC ANALYSISBrian Feagan, Canada; K. Lasch; J. M. Khalid; C. Cao; A. M. Wojtowicz; A. James; J.-F. Colombel

16:33 – 16:45 OP098INDIGO NATURALIS IS EFFECTIVE FOR INDUCING CLIN-ICAL REMISSION AND MUCOSAL HEALING IN PATIENTS WITH ULCERATIVE COLITIS (INDIGO STUDY)Makoto Naganuma, Japan; S. Sugimoto; K. Mitsuyama; T. Kobayashi; N. Yoshimura; K. Matsuoka; T. Hisamatsu; K. Watanabe; T. Abe; Y. Suzuki; T. Hibi; T. Kanai

16:45 – 16:45 OP099SUBMUCOSAL INJECTION OF THE RNA OLIGONUCLEOTIDE STNM01 IN ACTIVE ULCERATIVE COLITIS INDUCES MUCO-SAL HEALING AND REVERSES TISSUE REMODELINGRaja Atreya, Germany; T. Kühbacher; M. J. Waldner; S. Hirschmann; O. Drvarov; R. A. Hashem; C. Maaser; T. Kucharzik; J. Dinter; J. Mertens; C. Schramm; B. Holler; J. Mössner; K. Suzuki; N. Yokoyama; S. Terai; H. Yoneyama; H. Asakura; T. Hibi; M. F. Neurath

16:45 – 16:57 OP100EARLY RELAPSE OF ULCERATIVE COLITIS AFTER DISCONTINUATION OF TREATMENT IN PATIENTS RE-SPONDING TO GOLIMUMAB P. J. Hamlin; S. Sebastian; P. Irving; D. R. Gaya; C. Wheeler; A. Rose; G. Gillespie; Chris Probert, United Kingdom


62




16:21 – 16:33 OP105UTILITY OF NEWLY DEVELOPED SHORT TYPE DOUBLE BALLOON ENDOSCOPY FOR ERCP IN POSTOPERATIVE PATIENTS WITH SURGICAL ANATOMIC VARIATIONS; A LARGE CASE SERIES Masaaki Shimatani, Japan; M. Tokuhara; M. Masuda; S. Miyamoto; M. Sakao; H. Miyoshi; T. Ikeura; M. Takaoka; K. Uchida; K. Okazaki

16:33 – 16:45 OP106AN INTERNATIONAL, MULTICENTER, COMPARATIVE TRIAL OF EUS-GUIDED GASTROGASTROSTOMY-ASSIST-ED ERCP VERSUS ENTEROSCOPY-ASSISTED ERCP IN PATIENTS WITH ROUX-EN-Y GASTRIC BYPASS ANATOMYMajidah Bukhari, USA; A. A. Siddiqui; J. Nieto; R. Kunda; N. K. Ahuja; S. S. Irani; A. Shah; T. Kowalski; D. Loren; O. I. Brewer Gutierrez; O. Sanaei; L. Fayad; Y.-I. Chen; S. Ngamruengphong; V. Kumbhari; Y. Haito-Chavez; V. Singh; H. Dakour Aridi; M. A. Khashab

16:45 – 16:57 OP107AN INTERNATIONAL MULTICENTER STUDY ON DIGITAL SINGLE OPERATOR CHOLANGIOSCOPY FOR THE MAN-AGEMENT OF DIFFICULT BILE DUCT STONES IN 407 PATIENTSOlaya Brewer Gutierrez, USA; S. Ngamruengphong; N. Bekkali; I. Raijman; R. Sturgess; D. V. Sejpal; H. D. Aridi; S. Sherman; R. J. Shah; R. Kwon; J. L. Buxbaum; C. Zulli; W. Wassef; D. G. Adler; V. Kushnir; A. Y. Wang; K. Krishnan; V. Kaul; D. Tzimas; C. J. DiMaio; S. Ho; B. T. Petersen; M. S. Lee; B. J. Elmunzer; G. Webster; Y. I. Chen; L. K. Dwyer; S. Inamdar; V. B. Patrick; A. Attwell; A. Hosmer; C. Ko; A. Maurano; A. Sarkar; L. J. Taylor; M. H. Gregory; D. S. Strand; A. Raza; S. Kothari; J. P. Harris; N. Kumta; A. Manvar; M. Topazian; Y. N. Lee; C. M. Spiceland; M. A. Bukhari; O. Sanaei; M. A. Khashab

16:57 – 17:09 OP108ERCP WITH PANCREATOSCOPY-GUIDED LASER LITH-OTRIPSY FOR CHRONIC PANCREATITIS COMPLICATED BY PANCREATIC DUCT STONES: A FIVE YEAR SINGLE CENTER EXPERIENCEApostolos Malachias, Greece; D. Kypraios; S. Stavrinidis; S. L. Hatzinicolaou; D. Dimitroulopoulos; G. Sofianidis; D. Xinopoulos

Symposium15:45 – 17:15 Room A1H. pylori eradication: Unanswered questionsChairs: Marcis Leja, Latvia

Jan Bornschein, Germany

15:45 – 16:07 IP259Optimal age to treatXavier Calvet Calvo, Spain

16:07 – 16:29 IP260Should every H. pylori positive person undergo eradi-cation treatment?Peter Malfertheiner, Germany

16:29 – 16:51 IP261Widespread use of antibiotics: The public health perspectiveMarcis Leja, Latvia

16:51 – 17:13 IP262Do we need to test for resistance?Francis Megraud, France

Free Paper Session15:45 – 17:15 Room A3Late breaking abstracts II

Free Paper Session15:45 – 17:15 Room B2ERCP: When the going gets toughChairs: Erwan Bories, France

Michael John Bourke, Australia

15:45 – 15:57 IP263State-of-the-art introductionMichael John Bourke, Australia

15:57 – 16:09 OP103SELF-CONFORMABLE COVERED VS SELF-CONFORMABLE UNCOVERED METALLIC STENTS IN THE PALLIATIVE TREATMENT OF MALIGNANT EXTRA-HEPATIC BILIARY STRICTURE: A MULTICENTRIC RANDOMIZED STUDYBenedetto Mangiavillano, Italy; A. De Ceglie; R. Filiberti; A. Caruso; L. De Luca; S. Signorelli; M. Marini; P. Ravelli; A. Parodi; R. Conigliaro; M. Conio

16:09 – 16:21 OP104CLINICAL EFFICACY OF ANTI-MIGRATION FEATURES IN FULLY-COVERED SELF-EXPANDABLE METALLIC STENTS FOR ANASTOMOTIC BILIARY STRICTURES AFTER LIVER TRANSPLANTATION: A RETROSPECTIVE COHORT COM-PARISON OF STANDARD AND ANTI-MIGRATION STENTS.Benoit Bordacahar, France; M. Barret; M.-A. Guillaumot; O. Scatton; F. Perdigao; S. Leblanc; S. Chaussade; F. Prat


63


Mon

day,

Oct

ober

30,

201

7


15:57 – 16:19 IP273New prevention strategy for colorectal cancer ~met-formin chemopreventionTakuma Higurashi, Japan

16:19 – 16:31 OP109LONG-TERM USE OF ASPIRIN IS MORE EFFECTIVE TO REDUCE THE INCIDENCES OF GASTROINTESTINAL CANCERS THAN NON-GASTROINTESTINAL CANCERS: A 10-YEAR POPULATION-BASED STUDY IN HONG KONGKelvin Kf Tsoi, Hong Kong PRC; F. C. Chan; H. W. Hirai; J. J. Y. Sung

16:31 – 16:43 OP110USE OF ASPIRIN AFTER CURATIVE SURGERY CAN REDUCE MORTALITY DUE TO COLORECTAL CANCER: A 10-YEAR POPULATION-BASED STUDY IN HONG KONGJ. JY Sung, Hong Kong PRC; F. C. Chan; H. W. Hirai; K. Kf Tsoi

16:43 – 16:55 OP111COLORECTAL CANCER INCIDENCE IN PATIENTS WITH LYNCH SYNDROME: FIRST REPORT OF A MULTI-CENTER NATION-WIDE STUDYAriadna Sánchez García, Spain; M. Navarro; T. Ocaña; M. Pineda; L. Moreno; F. Rodriguez Moranta; A. Soriano Izquierdo; T. Ramon y Cajal; G. Llort; C. Yagüe; M. D. Pico Sala; R. Jover; A. Lopez Fernandez; E. Martinez de Castro; C. Alvarez Urturi; X. Bessa Casserras; L. Rivas; D. Rodríguez-Alcalde; A. Dacal Rivas; M. Herraiz; C. Garau Colom; L. Bujanda Fernández de Piérola; L. Cid Gómez; C. Poves; M. Garzon-Benavides; Á. E. Pizarro Moreno; I. Salces; M. Ponce; M. Carrillo Palau; E. Aguirre; E. Saperas Franch; A. Virgili; D. Fisas; V. Piñol; G. Jung; S. Carballal; L. Rivero Sánchez; M. Pellisé Urquiza; M. Serra; J. Balmana; G. Capella; J. Brunet; A. Castells; L. Moreira; F. Balaguer

16:55 – 17:07 OP112CLINICAL AND MOLECULAR CHARACTERIZATION OF LYNCH-LIKE SYNDROMEMaria Dolores Pico Sala, Spain; R. Jover; M. Giner-Calabuig; M. Alustiza; J. L. Soto; A. Castillejo; A. B. Sánchez; A. Sánchez García; F. Balaguer; L. Moreira; A. Castells; M. Pellisé Urquiza; T. Ramon y Cajal; M. Carrillo Palau; G. Llort; C. Yagüe; A. Lopez Fernandez; J. Balmana; E. Martinez de Castro; C. Alvarez Urturi; X. Bessa Casserras; L. Rivas; D. Rodríguez-Alcalde; A. Dacal Rivas; M. Herraiz; C. Garau Colom; L. Bujanda Fernández de Piérola; L. Cid Gómez; C. Poves; M. Garzon-Benavides; Á. E. Pizarro Moreno; A. Gomez; I. Salces; M. Ponce; E. Aguirre; E. Saperas Franch; V. Piñol; M. Serra

Translational Basic Science15:45 – 17:15 Room B3Immunotherapy in cancerChairs: Markus Moehler, Germany

Laurence Egan, Ireland

15:45 – 16:07 IP264What is immunotherapy and how to study it?Pierre Coulie, Belgium

16:07 – 16:29 IP265Manipulation of the immune system: Lessons learned from IBDMatthieu Allez, France

16:29 – 16:51 IP266Cross-talk between microbiome and immunotherapyPatricia Lepage, France

16:51 – 17:13 IP267Applications of immunotherapy in GI cancerEric Van Cutsem, Belgium

Today's Science, Tomorrow's Medicine15:45 – 17:15 Room E4Microbiota crosstalk in healthChairs: Giovanni Barbara, Italy

Dario Sorrentino, USA

15:45 – 16:07 IP268Microbiota and the mucoepithelial systemMalin Johansson, Sweden

16:07 – 16:29 IP269Rising Star: Gut microbiota and immune co-development Charlotte Hedin, Sweden

16:29 – 16:51 IP270Microbiota and the neuroenteric/neuroendocrine systemsRoberto De Giorgio, Italy

16:51 – 17:13 IP271Microbial interactions – with the host and with each otherManimozhiyan Arumugam, Denmark

Free Paper Session15:45 – 17:15 Room 7.1Sporadic and hereditary colon cancerChairs: Jaroslaw Regula, Poland

Tomer Adar, USA

15:45 – 15:57 IP272State-of-the-art introductionJaroslaw Regula, Poland


64




16:33 – 16:45 OP116RISK OF LYMPHOMAS AND GASTROINTESTINAL CARCINOMAS AFTER A DIAGNOSIS OF CELIAC DISEASE BASED ON A NATIONWIDE POPULATION-BASED CASE-CONTROL STUDY.Tom van Gils, The Netherlands; P. Nijeboer; L. I. H. Overbeek; M. Hauptmann; D. A. R. Castelijn; G. Bouma; C. J. J. Mulder; F. E. van Leeuwen; D. de Jong

16:45 – 16:57 OP117THE ROLE OF TMPRSS6 VARIANT RS855791 IN IRON-REFRACTORY IRON DEFICIENCY ANAEMIA (IRI-DA) IN CELIAC DISEASENicola Imperatore, Italy; R. Tortora; L. De Falco; A. Iolascon; N. Gerbino; D. Nudo; L. Montesano; F. Nastro; N. Caporaso; A. Rispo

16:57 – 17:09 OP118SAFETY AND TOLERABILITY, IMMUNOLOGICAL AND IN-TESTINAL EFFECTS, AND PHARMACOKINETICS (PK) OF DOSE TITRATION PRECEDING MAINTENANCE DOSES OF NEXVAX2® IN HLA-DQ2.5+ CELIAC DISEASE (CED)A. J. Daveson; H. Ee; J. M. Andrews; T. King; K. E. Goldstein; L. J. Williams; A. Treohan; M. P. Cooreman; Robert Anderson, USA

Free Paper Session15:45 – 17:15 Room E3General hepatologyChairs: Ivana Mikolasevic, Croatia

Georgios Papatheodoridis, Greece

15:45 – 15:57 IP279State-of-the-art introductionGeorgios Papatheodoridis, Greece

15:57 – 16:09 OP119HIGH TUMOR RECURRENCE AFTER HEPATITIS C TREATMENT WITH ORAL DIRECT ACTING ANTIVIRALS IN PATIENTS WITH HISTORY OF HEPATOCELLULAR CARCINOMA IN COMPLETE REMISSION ªBeatriz Merchan Gomez, Spain; M. Maroto Castellanos; M. J. Devesa Medina; L. Redero Brioso; S. Izquierdo Rubio; E. Rey

16:09 – 16:21 OP120BRG1 POSITIVELY REGULATES LIVER REGENERA-TION AFTER PARTIAL HEPATECTOMY IN MICE. Baocai Wang, Germany; M. Lu; K. Benedikt; N. Hüser; S. Zhong; G. von Figura; D. Hartmann

16:21 – 16:33 OP121HVPG AND TRANSIENT ELASTOGRAPHY ARE THE BEST PROGNOSTIC FACTOR IN PATIENTS WITH HEPATOCELLU-LAR CARCINOMA SUBMITTED TO HEPATIC RESECTIONBogdan Dumitru Procopet, Romania; E. Mois; A. Horhat; A. Bugariu; H. Stefanescu; F. Graur; M. Tantau; N. Al Hajjar

Symposium15:45 – 17:15 Room E1How to treat duodenal adenomas?Chairs: Helmut Messmann, Germany

Krish Ragunath, United Kingdom

15:45 – 16:07 IP274Endoscopic resectionBas L. A. M. Weusten, The Netherlands

16:07 – 16:29 IP275Endoscopic papillectomyRobert Hawes, USA

16:29 – 16:51 IP276How to manage local recurrence?Alexander Meining, Germany

16:51 – 17:13 IP277SurgeryMarco Del Chiaro, Sweden

Free Paper Session15:45 – 17:15 Room E2Gluten-related disordersChairs: Imran Aziz, Sweden

David Surendran Sanders, United Kingdom

15:45 – 15:57 IP278State-of-the-art introductionDavid Surendran Sanders, United Kingdom

15:57 – 16:09 OP113THE PREVALENCE OF NON-CELIAC GLUTEN SENSI-TIVITY IN PATIENTS WITH ABDOMINAL PAIN AND BLOATINGM. Di Stefano; G. Di Fede; Irene Benedetti, Italy; M. Bresciani; C. Pedroni; A. Gabriele; M. Bergonzi; E. V. Pesatori; G. F. Manfredi; G. R. Corazza

16:09 – 16:21 OP114PROSPECTIVE EVALUATION OF TRANSGLUTAMINASE ANTIBODY CUT-OFF LIMITS TO PREDICT SCREEN-DE-TECTED COELIAC DISEASEIlma Rita Korponay-Szabo, Hungary; J. Gyimesi; G. Castillejo; S. Vriezinga; R. Auricchio; A. Chmielewska; K. Werkstetter; P. Crespo; C. Hartman; E. Martinez; P. Szillat; H. Szajewska; I. Polanco; R. Shamir; S. Koletzko; C. Ribes Koninckx; R. Troncone; M. L. Mearin Manrique

16:21 – 16:33 OP115RECTO-SIGMOID SENSORIMOTOR ACTIVITY IN SELF-REPORTED NON-CELIAC GLUTEN SENSITIVITY: A COMPARISON WITH IRRITABLE BOWEL SYNDROME AND HEALTHY VOLUNTEERS.M. Di Stefano; I. Benedetti; E. V. Pesatori; G. F. Manfredi; Manuela Bergonzi, Italy; E. Pagani; B. Valvo; E. Miceli; G. R. Corazza


65


Mon

day,

Oct

ober

30,

201

7


16:33 – 16:45 OP128RELAMORELIN IN PATIENTS WITH DIABETIC GAST-ROPARESIS: EFFICACY AND SAFETY RESULTS FROM A PHASE 2B RANDOMISED, DOUBLE-BLIND, PLACE-BO-CONTROLLED, 12-WEEK STUDY (RM-131-009)Michael Camilleri, USA; R. W. McCallum; J. Tack; S. C. Spence; K. Gottesdiener; F. T. Fiedorek

16:45 – 16:57 OP129THE ACCURACY OF ALCAT 5 IN DIAGNOSING NON-CE-LIAC GLUTEN SENSITIVITY IN FUNCTIONAL PATIENTS WITH ABDOMINAL PAIN AND BLOATINGM. Di Stefano; Irene Benedetti, Italy; M. Bresciani; A. Gabriele; M. Deamici; E. V. Pesatori; G. F. Manfredi; M. Bergonzi; C. Torre; C. Pedroni; D. Iozzi; G. L. Marseglia; G. Di Fede

16:57 – 17:09 OP130CHRONIC INTESTINAL PSEUDO-OBSTRUCTION IN CHILDREN: THE EARLY OUTCOMES OF THE NATIONAL PAEDIATRIC PSEUDOOBSTRUCTION DIAGNOSTIC SER-VICE IN QUATERNARY CARE SETTING.Anna Rybak, United Kingdom; K. Larmour; E. Saliakellis; J. Brind; K. Lindley; F. Valitutti; O. Borrelli; N. Thapar

Symposium15:45 – 17:15 E-Poster Lounge 1Moving GI education into the future: Current chal-lenges, future needsChairs: Heinz Florian Hammer, Austria

Isabelle Cremers, Portugal

15:45 – 16:00 IP281Translating the Blue Book into practiceIan Barrison, United Kingdom


16:15 – 16:30 IP282How to assess effectiveness of educationHeinz Florian Hammer, Austria


16:45 – 17:00 IP283How to educate patients: New approachesC. Janneke van der Woude, The Netherlands


16:33 – 16:45 OP122INNOVATIVE THERAPEUTIC EFFICACY OF A NOVEL REIC/DKK-3 EXPRESSING ADENOVIRAL VECTOR FOR HEPATOCELLULAR CARCINOMAHiroaki Sawahara, Japan; H. Shiraha; D. Uchida; H. Kato; A. Oyama; M. Mandai; T. Mimura; M. Watanabe; M. Sakaguchi; T. Yagi; Y. Nasu; H. Kumon; H. Okada

16:45 – 16:57 OP123EFFECT OF INTERFERON FREE DIRECT ACTING ANTIVIRAL THERAPY FOR HEPATITIS C VIRUS IN THE CARDIAC CONDUCTION SYSTEMOlga Neva López-García, Spain; D. García-Arribas; M. J. Devesa Medina; C. Olmos; J. Higueras Nafría; B. Merchan Gomez; S. Izquierdo Rubio; F. Cuenca Alarcón; M. Maroto Castellanos; E. Rey

16:57 – 17:09 OP124NON-ALCOHOLIC STEATOHEPATITIS IS THE MOST RAP-IDLY GROWING INDICATION FOR LIVER TRANSPLANTA-TION IN IRANIAN PATIENTS ªAhad Eshraghian, Iran; S. Nikeghbalian; S. A. Taghavi; M. R. Fattahi; S. Ali Malek-Hosseini

Free Paper Session15:45 – 17:15 Room B5Upper GI motility and brain-gut interactionsChairs: Fernando Azpiroz, Spain

Henriette Heinrich, United Kingdom

15:45 – 15:57 IP280State-of-the-art introductionFernando Azpiroz, Spain

15:57 – 16:09 OP125RESPONSES TO GASTRIC GAS IN PATIENTS WITH FUNCTIONAL GASTRODUODENAL DISORDERSELBA NOEMI CABALLERO DE GARCIA, Spain; B. BENSLAIMAN SEYID-JEBARI; J. SERRA PUEYO

16:09 – 16:21 OP126INTRAGASTRIC FRUCTOSE INFUSION AND EMOTIONAL STATE INTERACT IN HOMEOSTATIC AND HEDONIC BRAIN REGIONSJulie Iven, Belgium; J. Biesiekierski; D. Zhao; E. Deloose; L. Van Oudenhove; J. Tack

16:21 – 16:33 OP127DDP-4 INHIBITOR, VILDAGLIPTIN INHIBITS GASTRIC ACCOMMODATION AND FOOD INTAKE IN HUMANSAlessandra ROTONDO, Belgium; J. Biesiekierski; I. Masuy; J. Tack


66




Symposium15:45 – 17:15 HotspotProgress in the management of cholangiocarcinomaChair: Daniel Bléro, Belgium

15:45 – 15:48 IP292IntroductionDaniel Bléro, Belgium

15:48 – 15:53 IP293Diagnosis of early disease is challenging!Stefan Seewald, Switzerland


16:08 – 16:13 IP294Cholangioscopy is not really useful!Jörg Albert, Germany


16:28 – 16:33 IP295Endoscopy is only palliative!Andrea Tringali, Italy


16:48 – 16:53 IP296Surgery – as always – is the only solution!Ulf Peter Neumann, Germany


17:08 – 17:11 IP297ConclusionDaniel Bléro, Belgium

Symposium15:45 – 17:15 E-Poster Lounge 2Rising Stars in pancreatology from Europe and the USAChairs: Luigi Ricciardiello, Italy

Linda Rabeneck, Canada

15:45 – 15:50 IP284Words of welcomeLuigi Ricciardiello, Italy

15:50 – 15:53 IP285Introduction of Marc Besselink, UEG Rising Star 2011Thomas M. Gress, Germany

15:53 – 16:08 IP286Multicenter research in acute pancreatitisMarc G. H. Besselink, The Netherlands

16:08 – 16:16Questions and answers

16:16 – 16:19 IP287Introduction of Vinciane Rebours, UEG Rising Star 2017Luigi Ricciardiello, Italy

16:19 – 16:34 IP288Effect of inflammation on pancreatic cancer developmentVinciane Rebours, France


16:42 – 16:45 IP289Introduction of Laura D. Wood, AGA Research ScholarLinda Rabeneck, Canada

16:45 – 17:00 IP290Characterisation of the moment of invasion in pancre-atic cancerLaura D. Wood, USA


17:08 – 17:13 IP291Closing remarksLinda Rabeneck, Canada


67

Tuesday, October 31, 2017

Tues

day,

Oct

ober

31,

201

7


Tandem Talks08:52 – 09:02 IP304Microscopic colitis: Clinician's viewAndreas Münch, Sweden

09:02 – 09:12 IP305Microscopic colitis: Pathologist's viewCord Langner, Austria

09:12 – 09:34 IP306Bile acid diarrhea Julian Walters, United Kingdom

09:34 – 09:56 IP307Intestinal malabsorptionJutta Keller, Germany

Symposium08:30 – 10:00 Room F3Therapy update: Ulcerative colitisChairs: Janindra Warusavitarne, United Kingdom

Pierre Michetti, Switzerland

08:30 – 08:52 IP308Management of acute severe colitisGeert D'Haens, The Netherlands

08:52 – 09:14 IP309Optimal use of biologics in ulcerative colitisWalter Reinisch, Austria

09:14 – 09:36 IP310Are we ready to use small molecules?Subrata Ghosh, Canada

09:36 – 09:58 IP311Surgical options in ulcerative colitisChristianne Johanna Buskens

Symposium08:30 – 10:00 Room F2Endoscopic and surgical interventions for metabolic disordersChairs: Jacques J. Bergman, The Netherlands

Mario Morino, Italy

08:30 – 08:52 IP312The endocrinologist's perspectiveStephan Martin, Germany

08:52 – 09:14 IP313Endoscopic optionsJacques Deviere, Belgium

Scientific Programme by DayTuesday, October 31, 2017

Live Endoscopy08:30 – 10:00 Hall 6Live endoscopyChairs: Thierry Ponchon, France

Jeanin E. van Hooft, The Netherlands Christian Gerges, Germany

Experts: Marc Barthet, France Philipp Bender, Germany Torsten Beyna, Germany Karel Caca, Germany Pierre Henri Deprez, Belgium Jennis Kandler, Germany Horst Neuhaus, Germany André Ragheb, Germany

Symposium08:30 – 10:00 Room C1Eosinophilic oesophagitis (EoE): European harmonisationChairs: Stephen Attwood, United Kingdom

Peter R. Gibson, Australia

08:30 – 08:52 IP298Clinical presentation and epidemiologyAlbert Jan Bredenoord, The Netherlands

08:52 – 09:14 IP299Diagnosis of EoO and PPI-responsive eosinophiliaAlfredo Lucendo Villarin, Spain

09:14 – 09:36 IP300Medical treatment: Today's standards and future optionsStephan Miehlke, Germany

Tandem Talks09:36 – 09:46 IP301Is dietary treatment a feasible option for children?Alexandra Papadopoulou, Greece

09:46 – 09:56 IP302Is dietary treatment a feasible option for adults?Javier Molina Infante, Spain

Symposium08:30 – 10:00 Room C2Chronic diarrhea: Diagnostic and therapeutic approachChairs: Anne Peery, USA

Vito Annese, Italy

08:30 – 08:52 IP303Diagnostic approachAlexander Charles Ford, United Kingdom


68




09:46 – 09:56 IP323Chemotherapy in advanced pancreatic cancer: Are the elderly fit for the novel regimens?Jean-Luc Van Laethem, Belgium

Symposium08:30 – 10:00 Room A1Recurrences after colorectal endoscopic mucosal resection (EMR)/endoscopic submucosal dissection (ESD): How to avoid, how to treat?Chairs: Evelien Dekker, The Netherlands

Edoardo Savarino, Italy

08:30 – 08:52 IP324Risk factors for recurrenceJames Edward East, United Kingdom

08:52 – 09:14 IP325Optimising endoscopic resectionMichael John Bourke, Australia

09:14 – 09:36 IP326Tips and tricks for treament of recurrenceMichael B Wallace, USA

09:36 – 09:48 OP131OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR SUPERFICIAL ESOPHAGEAL CANCER IN AN ELDER-LY POPULATIONToshiro Iizuka, Japan; D. Kikuchi; Y. Ochiai; S. Hoteya

09:48 – 10:00 OP132BALLOON-ASSISTED ENDOSCOPY FACILITATES ENDO-SCOPIC SUBMUCOSAL DISSECTION OF COLONOSCOPI-CALLY DIFFICULT SUPERFICIAL RIGHT COLON TUMORSTakeshi Yamashina, Japan; Y. Hayashi; H. Sakamoto; Y. Miura; S. Shinozaki; T. Yano; K. Sunada; A. K. Lefor; H. Yamamoto

Free Paper Session08:30 – 10:00 Room A3Detection and removal of colorectal polyps: Latest techniquesChairs: Mihai Ciocirlan, Romania

Michal Filip Kaminski, Poland

08:30 – 08:42 IP327State-of-the-art introductionMichal Filip Kaminski, Poland

08:42 – 08:54 OP133AUTOMATIC POLYP DETECTION IN COLONOSCOPY PROCEDURE USING DEEP LEARNING AND IMAGE PRO-CESSING TECHNIQUESDror Zur, Israel; M. Zaltzhendler

09:14 – 09:36 IP314Surgical optionsRamon Vilallonga, Spain


Symposium08:30 – 10:00 Room F1From guidelines to clinical practice: Autoimmune liver diseaseChairs: Tom Hemming Karlsen, Norway

Marco Marzioni, Italy

08:30 – 08:52 IP315Autoimmune hepatitisKalliopi Zachou, Greece

08:52 – 09:14 IP316Primary biliary cholangitisAnnarosa Floreani, Italy

09:14 – 09:36 IP317Primary sclerosing cholangitisMichael Trauner, Austria

09:36 – 09:58 IP318European registry on autoimmune hepatitisRodrigo Liberal, United Kingdom

Symposium08:30 – 10:00 Room A2Pancreatic tumours: Diagnosis and treatmentChairs: Thomas M. Gress, Germany

Rodger A. Liddle, USA

08:30 – 08:52 IP319Pancreatic preneoplastic lesions under the microscopeCaroline Verbeke, Sweden

08:52 – 09:14 IP320Rising Star: Pancreatic cystic neoplasias: Diagnostic approach and when to resect? ªStefano Crippa, Italy

09:14 – 09:36 IP321Pancreatic neuroendcrine tumours: Can we follow-up and which ones need to be resected?Gabriele Capurso, Italy

Tandem Talks09:36 – 09:46 IP322Chemotherapy in advanced pancreatic cancer: Moving towards more toxic chemotherapy regimens?Thomas Seufferlein, Germany


69


Tues

day,

Oct

ober

31,

201

7


08:54 – 09:06 OP134IMPROVED DETECTION OF RIGHT-SIDED ADENOMAS BY G-EYE® COLONOSCOPY IN PATIENTS UNDERGOING COLORECTAL CANCER SCREENING- A PROSPECTIVE, RANDOMIZE, MULTICENTRE STUDYH. Shirin; B. Shpak; J. Epshtein; P. Vilmann; A. Hoffman; S. Sanduleanu; P. A. Testoni; S. Ishaq; D. N. Reddy; S. A. Gross; P. D. Siersema; H. Neumann; M. Goetz; D. Abramowich; M. Moshkowitz; M. Mizrahi; J. Hendel; J. W. Rey; R. de Ridder; E. Viale; H. Chaudhari; M. B. Pochapin; M. Yair; M. Shnell; S. Yaari; T. Stigaard; R. Simantov; N. Gluck; E. Israeli; S. Sloth; S. Matalon; A. Vilkin; A. Benson; A. Maliar; A. Waizbard; T. Hershcovici; E. Shachar; S. Rochberger; E. Tsvang; M. Braverman; H. Jacob; Y. Brachman; J. G. Karstensen; D. Teubner; R. Bogie; Ralf Kiesslich, Germany

09:06 – 09:18 OP135A STANDARDIZED IMAGING PROTOCOL IS ACCURATE FOR THE ENDOSCOPIC PREDICTION OF DYSPLASIA WITHIN SESSILE SERRATED POLYPS ªDavid Tate, Australia; H. Awadie; M. Jayanna; L. Desomer; R. Lee; S. Heitman; K. Goodrick; D. McLeod; H. Mahajan; M. J. Bourke

09:18 – 09:30 OP136RANDOMIZED CONTROLLED TRIAL OF THE USE-FULNESS OF COLD SNARE POLYPECTOMY (CSP) FOR OUTPATIENTSKensei Ohtsu, Japan; S. Sou; T. Noda; T. Karashima; T. Takeda; K. Imamura; R. sakemi; H. Terabe; Y. Morimitsu

09:30 – 09:42 OP137IS COLD-SNARE POLYPECTOMY ALWAYS ADEQUATE FOR REMOVAL OF SMALL COLORECTAL POLYPS WITH ADVANCED HISTOLOGY?Yuichi Shimodate, Japan; M. Mizuno; J. Itakura; R. Takezawa; M. Kobayashi; T. Yamazaki; A. Doi; N. Nishimura; H. Mouri; K. Matsueda; H. Yamamoto

09:42 – 09:54 OP138MANAGEMENT AND RISK FACTORS FOR INCOMPLETE RESECTION ASSOCIATED WITH COLD FORCEPS POL-YPECTOMY FOR DIMINUTIVE COLORECTAL POLYPS: A SINGLE-INSTITUTION RETROSPECTIVE COHORT STUDYNaoki Asayama, Japan; S. Nagata; Y. Ogawa; H. Tamari; Y. Shimohara; T. Aoyama; A. Fukumoto; S. Mukai; M. Kaneko

Free Paper Session08:30 – 10:00 Room B2Diagnosis and treatment of GORDChairs: Massimiliano di Pietro, United Kingdom

Peter Banovcin, Slovak Republic

08:30 – 08:42 IP328State-of-the-art introductionMassimiliano di Pietro, United Kingdom

08:42 – 08:54 OP139COMPREHENSIVE QUANTITATIVE ANALYSIS OF RELA-TIONSHIP BETWEEN ACIDIC LARYNGOPHARYNGEAL REFLUX (LPR) AND SYMPTOMS AND SIGNS OF LARYN-GEAL INJURY BY DUAL PHARYNGEAL AND ESOPHA-GEAL 24-HOUR PH/IMPEDANCE MONITORING.Martin Ďuriček, Slovak Republic; P. Banovcin; T. Haličková; R. Hyrdel; M. Kollarik

08:54 – 09:06 OP140ESOPHAGEAL MEAN NOCTURNAL BASELINE IMPED-ANCE PREDICTS SYMPTOMATIC OUTCOME IN GERD EVEN WHEN ACID EXPOSURE TIME IS INCONCLUSIVE ON ESOPHAGEAL REFLUX MONITORINGArvind Rengarajan, USA; E. Savarino; A. Patel; S. Roman; R. Yadlapati; J. Pandolfino; C. P. Gyawali

09:06 – 09:18 OP141 HIGH RESOLUTION MANOMETRY IS SUPERIOR TO ENDOSCOPY AND RADIOLOGY IN ASSESSING AND GRADING SLIDING HIATAL HERNIA. A PROSPECTIVE COMPARISON WITH SURGICAL IN VIVOSalvatore Tolone, Italy; E. Savarino; G. Zaninotto; N. de Bortoli; I. Martinucci; M. Furnari; M. Frazzoni; L. Frazzoni; V. Savarino; L. Docimo

09:18 – 09:30 OP142THE EFFECT OF BILE REFLUX ON BASELINE IMPED-ANCE VALUE AND CHEMICAL CLEARANCE IN PATIENTS WITH NERD.Irene Martinucci, Italy; N. de Bortoli; M. Frazzoni; S. Tolone; L. Frazzoni; E. Marabotto; L. Macchia; R. Tutuian; S. Santi; V. Savarino; S. Marchi; E. Savarino

09:30 – 09:42 OP143REDUCTION OF DAY TIME ACID GASTRO OESOPHA-GEAL REFLUX BY TREATING INCREASED SUPRAGAS-TRIC BELCHINGEtienne Glasinovic, United Kingdom; E. Wynter; J. Arguero; P. Hajek; D. Sifrim

09:42 – 09:54 OP144POST-REFLUX SWALLOW-INDUCED PERISTALTIC WAVE INDEX AND MEAN NOCTURNAL BASELINE IMPEDANCE PREDICT HEARTBURN RESPONSE TO PROTON PUMP IN-HIBITORS BETTER THAN ACID EXPOSURE TIME IN GERDL. Frazzoni; Marco Della Coletta, Italy; M. Frazzoni; N. de Bortoli; S. Tolone; M. Furnari; I. Martinucci; S. Marchi; R. Conigliaro; L. Fuccio; V. Savarino; E. Savarino


70




09:06 – 09:18 OP148IS THE MICROBIOME IMPLICATED IN THE DEVELOP-MENT OF GENUINE IRRITABLE BOWEL SYNDROME-TYPE SYMPTOMS IN INFLAMMATORY BOWEL DISEASE?David John Gracie, United Kingdom; O. Shutkever; C. Young; H. Wood; M. Taylor; P. J. Hamlin; A. C. Ford; P. Quirke

09:18 – 09:30 OP149THE COMPLEMENT SYSTEM AS A REGULATOR OF THE HOST-MICROBIOTA RELATIONSHIP IN IBD ªSimon Reider, Austria; W. Posch; A. Pfister; R. Koch; D. Orth-Höller; R. Würzner; D. Wilflingseder; H. Tilg; A. R. Moschen

09:30 – 09:42 OP150METABONOMIC AND MICROBIOTA PROFILE OF CROHN'S PATIENTS IS A PREDICTOR OF PRIMARY NON-RESPONSE TO ANTI-TNF THERAPYNik Ding, Australia; M. Sarafian; A. Perdones-Montero; R. Misra; P. Hendy; L. Penez; E. Holmes; A. Hart

09:42 – 09:54 OP151WITHDRAWN

Free Paper Session08:30 – 10:00 Room 7.1The microbiome and IBDChairs: Arthur Kaser, United Kingdom

Marianne Rebecca Spalinger, Switzerland

08:30 – 08:42 IP333State-of-the-art introductionArthur Kaser, United Kingdom

08:42 – 08:54 OP152PANETH CELLS DYSFUNCTION AND DEATH IS DIRECTLY LINKED TO IFN-LAMBDA SIGNALINGClaudia Günther, Germany; B. Buchen; H. Neumann; S. Wirtz; M. F. Neurath; C. Becker

08:54 – 09:06 OP153THE STIMULATION OF MACROPHAGES WITH MICRO-BIAL-DERIVED COMPOUNDS SUPPORTS INCREASED IL-19 EXPRESSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND COLITIS MODELSA. Steinert; I. Linas; P. Hruz; M. Ibrahim; K. Radulovic; A. Schlitzer; L. Terracciano; A. Macpherson; Jan Hendrik Niess, Switzerland

09:06 – 09:18 OP154CD1D MODULATES COLONIC INFLAMMATION IN NOD2−/− MICE BY ALTERING THE COMPOSITION OF INTESTINAL MICROBIOTAS.-N. Hong; Chansu Lee, Republic of Korea; Y.-H. Kim

Translational Basic Science08:30 – 10:00 Room B3Understanding the basis for GI painChairs: Nathalie Vergnolle, France

Roberto De Giorgio, Italy

08:30 – 08:52 IP329Visceral nociception: Where can it go wrong?Ashley Blackshaw, United Kingdom

08:52 – 09:14 IP330Rising Star: Neuroimmune mechanisms ªNicolas Cenac, France

09:14 – 09:36 IP331Gut microbiota brain interactionsKeith A. Sharkey, Canada

09:36 – 09:58 IP332How can knowledge of visceral pain mechanisms help patients?Guy E. Boeckxstaens, Belgium

Today's Science, Tomorrow's Medicine08:30 – 10:00 Room E4TSTM Free Paper: Clinical implications of host micro-biota interactionsChairs: Alexander R. Moschen, Austria

Krisztina Barbara Gecse, The Netherlands

08:30 – 08:42 OP145ANALYSIS OF 1792 GUT METAGENOMES REVEALS MI-CROBIAL TREATMENT TARGETS FOR INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROMEArnau Vich Vila, The Netherlands; F. Imhann; V. Collij; T. Gurry; A. Kurilshikov; S. Jankipersadsing; Z. Mujagic; M.-J. Bonder; X. Jiang; L. Franke; G. Dijkstra; E. A. M. Festen; J. Fu; R. Xavier; E. Alm; C. Wijmenga; D. M. Jonkers; A. Zhernakova; R. K. Weersma

08:42 – 08:54 OP146IDENTIFICATION OF A MICROBIOTA BENEFICIAL AGAINST COLITIS AND COLITIS-ASSOCIATED CANCERE. Viennois; A. Pujada; A. T. Gewirtz; Benoit Chassaing, USA; D. Merlin

08:54 – 09:06 OP147PROTECTIVE ROLE OF ESCHERICHIA COLI NISSLE 1917 ON INTESTINAL PERMEABILITY IN IRRITABLE BOWEL SYNDROME: AN IN VITRO STUDY.Daniele Fuschi, Italy; M. R. Barbaro; P. Dino; M. Carapelle; E. Capelli; C. Cremon; V. Stanghellini; G. Barbara


71


Tues

day,

Oct

ober

31,

201

7


09:30 – 09:42 OP162DO THE NEW ROME IV DIAGNOSTIC CRITERIA FOR OPIOID-INDUCED CONSTIPATION IDENTIFY PATIENTS WITH A GREATER BIOPSYCHOSOCIAL BURDEN?Anton Emmanuel, United Kingdom; V. Banerji; G. Hall; A. Lass; V. Andresen

09:42 – 09:54 OP163USERS OF WEAK OPIOIDS HAVE A SMALLER SPEC-TRUM OF CONSTIPATION SYMPTOMS, BUT A SIMILAR DEGREE OF BOTHER FROM CONSTIPATION, AS USERS OF POTENT OPIOIDSViola Andresen, Germany; A. Lass; V. Banerji; G. Hall; A. V. Emmanuel

Free Paper Session08:30 – 10:00 Room E2Acute and chronic pancreatitis: Risk factors and preventionChairs: Jonas Rosendahl, Germany

Sandra van Brunschot, The Netherlands

08:30 – 08:42 IP335State-of-the-art introductionJonas Rosendahl, Germany

08:42 – 08:54 OP164ENDOSCOPIC ULTRASOUND-BASED MULTIMODAL EVALUATION OF THE PANCREAS FOR THE DIAGNOSIS OF EARLY CHRONIC PANCREATITISJulio Iglesias-Garcia, Spain; J. Lariño Noia; A. Álvarez-Castro; L. Nieto; S. Lojo; S. Leal; J. E. Dominguez-Muñoz

08:54 – 09:06 OP165THE IMPACT OF BARIATRIC SURGERY ON ACUTE PANCREATITIS MORTALITY AND OTHER OUTCOMES: A NATIONWIDE ANALYSISPaul Thomas Kroener, USA; M. S. Abougergi; V. Popov; C. C. Thompson

09:06 – 09:18 OP166THE OBESITY PARADOX IN ACUTE PANCREATITIS: AN INDIVIDUAL PATIENT DATA META-ANALYSISXavier Smeets, The Netherlands; I. Knoester; K. Grooteman; V. K. Singh; G. I. Papachristou; A. Duarte Rojo; G. Robles-Diaz; M. G. H. Besselink; H. van Santvoort; W. Kievit; H. van Goor; M. J. Bruno; J. P. H. Drenth; E. Van Geenen

09:18 – 09:30 OP167STATIN CONSUMPTION IS ASSOCIATED TO A LOWER RISK OF POST-ENDOSCOPIC RETROGRADE CHOLAN-GIOPANCREATOGRAPHY PANCREATITISEnrique de-Madaria, Spain; K. Cárdenas-Jaén; A. B. Fernández-Laso; J. Millastre-Bocos; A. Torralba-Gallego; S. Martín-Arriero; E. Alfaro-Almajano; G. García-Rayado; E. Martínez-Moneo

09:18 – 09:30 OP155ADAPTATION OF ADHERENT-INVASIVE E. COLI TO GUT ENVIRONMENT: IMPACT ON FLAGELLA EXPRESSION AND BACTERIAL VIRULENCEGwladys Sevrin, France; S. Massier; B. Chassaing; A. Agus; J. Denizot; J. Delmas; E. Billard; N. Barnich

09:30 – 09:42 OP156IL-10-INDEPENDENT PROTECTIVE ACTIVITIES OF HUMAN- DERIVED CLOSTRIDIUM STRAINS IN EXPERIMENTAL COLITISAkihiko Oka, USA; Y. Mishima; G. Bongers; A. Baltus; J. Herzog; B. Liu; S. Fukuda; K. Atarashi; K. Honda; D. Marshall; M. Hasse; L. San; R. B. Sartor

09:42 – 09:54 OP157FAECAL MICROBIOTA IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE BEFORE AND AFTER THERAPY.Christine Olbjørn, Norway; M. C. Småstuen; E. Thiis-Evensen; B. Nakstad; C. Casén; M. H. Vatn; G. Perminow

Free Paper Session08:30 – 10:00 Room E1Symptom patterns in functional GI disordersChairs: Lesley Houghton, United Kingdom

Giles Major, United Kingdom

08:30 – 08:42 IP334State-of-the-art introductionLesley Houghton, United Kingdom

08:42 – 08:54 OP158ABDOMINAL DISTENTION SYMPTOMS WITHOUT FUNCTIONAL DYSPEPSIA OR IRRITABLE BOWEL SYN-DROME ARE PERSISTENT: 10 YEAR FOLLOW-UP OF THE KALIXANDA STUDY.Jukka Ronkainen, Finland; P. Aro; L. Agréus; S.-E. Johansson; M. M. Walker; N. J. Talley

08:54 – 09:06 OP159THE PREVALENCE OF ROME IV FUNCTIONAL DYSPEPSIA AND ITS IMPACT ON HEALTH IMPAIRMENT; RESULTS FROM A THREE-COUNTRY GENERAL POPULATION STUDYImran Aziz, Sweden; O. S. Palsson; H. Törnblom; A. Sperber; W. E. Whitehead; M. Simrén

09:06 – 09:18 OP160ROME III VERSUS ROME IV CRITERIA FOR IRRITABLE BOWEL SYNDROME: A COMPARISON OF CLINICAL CHARACTERISTICS IN A LARGE COHORT STUDYLisa Vork, The Netherlands; Z. Z. R. M. Weerts; Z. Mujagic; J. Kruimel; M. Hesselink; D. Keszthelyi; D. M. Jonkers; A. A. M. Masclee

09:18 – 09:30 OP161FACTOR ANALYSIS DEFINES DISTINCT UPPER AND LOWER SYMPTOM GROUPINGS COMPATIBLE WITH ROME IV IN A POPULATION-BASED STUDYEgbert Clevers, Belgium; W. E. Whitehead; O. S. Palsson; H. Törnblom; L. Van Oudenhove; J. Tack; M. Simrén


72




09:18 – 09:30 OP173CAN ARTIFICIAL INTELLIGENCE FOR ENDOCYTOSCOPY PROVIDES FULLY AUTOMATED DIAGNOSIS OF HISTO-LOGICAL HEALING IN ULCERATIVE COLITIS ?Yasuharu Maeda, Japan; S.-E. Kudo; Y. Mori; M. Misawa; K. Wakamura; S. Sasanuma; N. Ogata; Y. Ogawa; K. Takeda; K. Ichimasa; T. Hayashi; T. Kudo; F. Ishida; K. Ohtsuka

09:30 – 09:42 OP174A PILOT INTERNATIONAL MULTICENTER RANDOMIZED CONTROLLED TRIAL OF CHROMOENDOSCOPY VERSUS AUTOFLUORESCENCE IMAGING FOR NEOPLASIA DETECTION IN PATIENTS WITH LONGSTANDING ULCER-ATIVE COLITIS (FIND-UC)Jasper Vleugels, The Netherlands; J. E. East; M. D. Rutter; L. K. Wanders; K. Ragunath; C. J. Rees; C. Y. Ponsioen; S. Samuel; F. Butt; T. Kuiper; S. van Eeden; E. Dekker

09:42 – 09:54 OP175MULTICENTRE EUROPEAN EVALUATION OF A NOVEL TECHNOLOGY (BLUE LIGHT IMAGING) IN THE OPTICAL DIAGNOSIS OF SMALL COLORECTAL POLYPSSharmila Subramaniam, United Kingdom; K. Kandiah; P. Aepli; G. Wurm Johansson; E. J. Schoon; M. Stefanovic; P. Bhandari

Free Paper Session08:30 – 10:00 Room B5New insights in microbiota: Gut and liver aspectsChairs: Mária Papp, Hungary


08:30 – 08:42 IP337State-of-the-art introductionMária Papp, Hungary

08:42 – 08:54 OP176GUT MICROBIOTA INVOLVES IN NON-ALCOHOLIC FATTY LIVER DISEASE VIA AFFECTING INTRA-HEPATIC CD4+ T LYMPHOCYTELin Su, China; Z. Wu; J. Tan; J. Xu; Y. Song; Y. L. Liu

08:54 – 09:06 OP177METHYL DONOR MOLECULES SUPPLEMENTATION IMPAIRS E. COLI COLONISATION BACTERIA BY MODU-LATING IGA PATHWAYElodie Gimier, France; A. Agus; N. Barnich; J. Denizot

09:06 – 09:18 OP178COMMD10 NEGATIVELY REGULATES LY6CHI MONO-CYTE-DRIVEN INFLAMMATION AND PROMOTES BACTE-RIAL CLEARANCE BY KUPFFER CELLS DURING SEPSISNathan Gluck, Israel; S. Ben-Shlomo; O. Mouhadeb; C. Varol

09:30 – 09:42 OP168THE RISK FOR POST-ERCP PANCREATITIS AFTER IN-ADVERTENT PANCREATIC DUCT CANNULATION CAN BE PREVENTED BY TEMPORARY PANCREATIC STENTING. A MULTICENTRE, PROSPECTIVE, RANDOMIZED TRIAL.Veit Phillip, Germany; A. Pukitis; A. Epstein; A. Hapfelmeier; D. Haf; M. Schwab; J. Rosendahl; A. Hofmeister; I. E. Demir; A. Weber; H. Algül

09:42 – 09:54 OP169EXOCRINE PANCREATIC INSUFFICIENCY AFTER ACUTE PANCREATITIS: SYSTEMIC REVIEW AND META-ANALYSIS D. De la Iglesia-García; W. Huang; I. Baston Rey; J. Lariño Noia; J. Iglesias-Garcia; P. Szatmary; Q. M. Nunes; R. Mukherjee; J. Enrique Dominguez-Muñoz, Spain; R. Sutton

Free Paper Session08:30 – 10:00 Room E3Progress in endoscopic diagnosisChairs: Tomas Hucl, Czech Republic

Alexandre Oliveira Ferreira, Portugal

08:30 – 08:42 IP336State-of-the-art introductionTomas Hucl, Czech Republic

08:42 – 08:54 OP170TERMINOLOGY AND DESCRIPTION OF VASCULAR LESIONS IN SMALL BOWEL CAPSULE ENDOSCOPY: AN INTERNATIONAL DELPHI CONSENSUS STATEMENT.Romain Leenhardt, France; C. LI; A. Koulaouzidis; F. Cavallaro; F. Cholet; R. Eliakim; I. Fernández-Urién; U. Kopylov; M. Mcalindon; A. Németh; J. N. Plevris; G. Rahmi; E. Rondonotti; J. C. Saurin; G. E. Tontini; E. Toth; D. E. Yung; P. Marteau; X. Dray

08:54 – 09:06 OP171A PROSPECTIVE MULTICENTER SINGLE-BLIND RANDOMIZED CONTROLLED TRIAL COMPARING FNA AND FNB IN THE DIAGNOSIS OF SOLID MASSESA PRO-SPECTIVE MULTICENTER SINGLE-BLIND RANDOMIZED CONTROLLED TRIAL COMPARING FNA AND FNB IN THE DIAGNOSIS OF SOLID MASSESQian Chen, China; B. Cheng; G. Wang; T. Jiang; L. Dou; J. Wang; Y. Li; Y. Zhang; B. Sun; H. Shan; Z. Deng; G. Xu; X. Yang

09:06 – 09:18 OP172RANDOMIZED TRIAL COMPARING THE 22 GAUGE FRANSEEN BIOPSY AND 22 GAUGE ASPIRA-TION NEEDLES FOR EUS-GUIDED SAMPLING OF SOLID PANCREATIC MASS LESIONSJi Young Bang, USA; S. Hebert-Magee; U. Navaneethan; M. Hasan; R. Hawes; S. Varadarajulu


73


Tues

day,

Oct

ober

31,

201

7


Live Endoscopy10:30 – 12:00 Hall 6Live endoscopyChairs: Mario Dinis-Ribeiro, Portugal

Tomas Hucl, Czech Republic Christian Gerges, Germany


Symposium10:30 – 12:00 Room C1Perianal fistulising Crohn's disease: From pathophysi-ology to managementChairs: Antonino Spinelli, Italy

Matthieu Allez, France

10:30 – 10:52 IP344Pathophysiology of anal fistulaBritta Siegmund, Germany, #B. Siegmund#, Germany

Tandem Talks10:52 – 11:02 IP345Imaging assessment: MRI and ultrasoundFrancesca Maccioni, Italy

11:02 – 11:12 IP346Surgical strategiesJanindra Warusavitarne, United Kingdom

11:12 – 11:34 IP347Medical therapy: Biologics and stem cellsJulian Panés, Spain

11:34 – 11:46 OP182ANTI-TNF THERAPY FOR RECTOVAGINAL FISTULAS COMPLICATING CROHN'S DISEASE: A GETAID STUDYGuillaume Le Baut, France; P. Seksik; G. Bouguen; A. Amiot; D. Laharie; R. Altwegg; F. Mathurin; C. Trang; L. Vuitton; M. Simon; C. Gilletta De Saint Joseph; L. Caillo; E. Del Tedesco; L. Plastaras; A. Aubourg; L. Peyrin-Biroulet; S. Viennot

11:46 – 11:58 OP183HIGHER INFLIXIMAB AND ADALIMUMAB SERUM LEV-ELS CORRELATE WITH PERIANAL FISTULA CLOSURE IN CROHN’S DISEASE PATIENTSAnne Strik, The Netherlands; M. Lowenberg; C. Y. Ponsioen; C. J. Buskens; W. A. Bemelman; G. R. D'Haens

09:18 – 09:30 OP179IMPROVED HEMODYNAMIC AND LIVER FUNCTION MARKERS IN BILE-DUCT LIGATED RATS AFTER ADMIN-ISTRATION OF B. PSEUDOCATENULATUM CECT7765Isabel Gomez-Hurtado, Spain; P. Zapater; K. Portune; J. M. Gonzalez-Navajas; Y. Sanz; R. Frances

09:30 – 09:42 OP180THE ROLE OF B LYMPHOCYTES WITHIN MESENTERIC AD-IPOSE TISSUE IN NON-ALCOHOLIC FATTY LIVER DISEASEZhe Wu, China; F. Zhang; J. Tan; J. Xu; Y. Song; Y. L. Liu

09:42 – 09:54 OP181METABOLOMICS: IN THE SEARCH FOR NEW BIO-MARKERS OF DECOMPENSATION AND INFECTION IN PATIENTS WITH CIRRHOSISPetra Fischer, Romania; C. Moraru; A. Bugariu; C.-A. Grigoras; O. Farcau; H. Stefanescu; M. Tantau; C. Socaciu; B. D. Procopet

Symposium08:30 – 10:00 HotspotLaryngopharyngeal reflux (LPR)Chair: Daniel Sifrim, United Kingdom

08:30 – 08:33 IP338IntroductionDaniel Sifrim, United Kingdom

08:33 – 08:38 IP339LPR doesn't existAndré Smout, The Netherlands


08:53 – 08:58 IP340LPR can be confidently diagnosedRadu Tutuian, Switzerland


09:13 – 09:18 IP341If a PPI doesn't work, reflux testing is uselessFrank Zerbib, France


09:33 – 09:38 IP342Fundoplication is an option in resistant casesSerhat Bor, Turkey


09:53 – 09:56 IP343ConclusionDaniel Sifrim, United Kingdom


74




Symposium10:30 – 12:00 Room F2Optimising the diagnosis of IBSChairs: Robin Spiller, United Kingdom

Daniel Pohl, Switzerland

Debate10:30 – 10:40 IP357Symptom-based criteria: Will Rome IV optimise the diagnosis of IBS? ProFermin Mearín Manrique, Spain

10:40 – 10:50 IP358Symptom-based criteria: Will Rome IV optimise the diagnosis of IBS? ConAlexander Charles Ford, United Kingdom

10:50 – 11:12 IP359Psychological markers: How can they be used in the clinic?Lukas Van Oudenhove, Belgium

11:12 – 11:34 IP360Biological markers: Ready for primetime?Daisy Mae Jonkers, The Netherlands

11:34 – 11:56 IP361Future directionsLin Chang, USA

Symposium10:30 – 12:00 Room F1From guidelines to clinical practice: Colorectal cancerChairs: Eric Van Cutsem, Belgium

Yasmijn van Herwaarden, The Netherlands

Tandem Talks10:30 – 10:40 IP362Early rectal cancer: Clinical caseMihai Ciocirlan, Romania

10:40 – 10:50 IP363Early rectal cancer: GuidelinesRob Glynne-Jones, United Kingdom


Tandem Talks11:00 – 11:10 IP364Borderline resectable liver metastasis: Clinical caseBernard Nordlinger, France

11:10 – 11:20 IP365Borderline resectable liver metastasis: GuidelinesEric Van Cutsem, Belgium

Symposium10:30 – 12:00 Room C2Treating patients with acute cholecystitis and cholangitisChairs: Lars Aabakken, Norway

Tom Hemming Karlsen, Norway

10:30 – 10:42 IP348Case presentation: Part IMostafa Ibrahim, Belgium

10:42 – 11:04 IP349The role of endoscopy: When to drain?Marcel Tantau, Romania

11:04 – 11:26 IP350The role of surgery: When to operate?David Fuks, France

11:26 – 11:48 IP351The role of interventional radiology: The era of mini-mal invasive approachesAndrea Phillips, United Kingdom

11:48 – 12:00 IP352Case presentation: Part IIMostafa Ibrahim, Belgium

Symposium10:30 – 12:00 Room F3Therapy update: Evidence for the efficacy of probiotics?Chairs: Niek J. De Wit, The Netherlands

Max Nieuwdorp, The Netherlands

10:30 – 10:52 IP353Health claims for probioticsHenk van Loveren, The Netherlands

10:52 – 11:14 IP354Antibiotic-associated diarrhea and clostridum difficile infectionGianluca Ianiro, Italy

11:14 – 11:36 IP355Acute gastroenteritisHania Szajewska, Poland

11:36 – 11:58 IP356IBSPali Hungin, United Kingdom


75


Tues

day,

Oct

ober

31,

201

7


10:52 – 11:14 IP374When does the pathologist come in?Karoline Lackner, Austria

11:14 – 11:36 IP375Nutrition and the liverShira Zelber-Sagi, Israel

11:36 – 11:58 IP376Drugs versus life-style interventionsElisabetta Bugianesi, Italy

Free Paper Session10:30 – 12:00 Room A3Long-term management in IBD with biologicsChairs: Joline de Groof, The Netherlands

Tim Raine, United Kingdom

10:30 – 10:42 IP377State-of-the-art introductionTim Raine, United Kingdom

10:42 – 10:42 OP184EFFICACY OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A POST-HOC ANALYSIS OF THE OBSERV-IBD COHORT OF THE GETAIDSara Tadbiri, France; M. Serrero; L. Peyrin-Biroulet; J. Filippi; B. Pariente; X. Roblin; A. Buisson; C. Stefanescu; C. Trang; R. Altwegg; P. Marteau; T. Vaysse; A. Bourrier; S. Nancey; D. Laharie; M. Allez; G. Savoye; J. Moreau; C. Gagniere; L. Vuitton; Y. Bouhnik; A. Amiot

10:42 – 10:42 OP185HISTOLOGICAL FEATURES OF JOINT AND COLONIC INFLAMMATION IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH ANTI-TNFA ªS. Alivernini; Daniela Pugliese, Italy; B. Tolusso; L. Petricca; L. Bui; L. Guidi; G. L. Rapaccini; F. Federico; G. Ferraccioli; A. Armuzzi; E. Gremese

10:42 – 10:42 OP186LONG-TERM EFFICACY AND SAFETY OF USTEKINUM-AB IN REFRACTORY CROHN’S DISEASE PATIENTS: A MULTICENTER RETROSPECTIVE EXPERIENCEPauline Wils, France; Y. Bouhnik; P. Michetti; B. Flourie; H. Brixi; A. Bourrier; M. Allez; B. Duclos; J.-C. Grimaud; A. Buisson; A. Amiot; M. Fumery; X. Roblin; L. Peyrin-Biroulet; J. Filippi; G. Bouguen; V. Abitbol; B. Coffin; M. Simon; D. Laharie; B. Pariente


Tandem Talks11:30 – 11:40 IP366Stage two colon cancer: Clinical caseMonique van Leerdam, The Netherlands

11:40 – 11:50 IP367Stage two colon cancer: GuidelinesMichel Ducreux, France


Symposium10:30 – 12:00 Room A2Evidence-based approach to achalasiaChairs: Albert Jan Bredenoord, The Netherlands

Thomas Rösch, Germany

Debate10:30 – 10:40 IP368High-resolution manometry is mandatory in all casesSabine Roman, France

10:40 – 10:50 IP369Conventional manometry or no manometry at all may sufficeRadu Tutuian, Switzerland

10:50 – 11:12 IP370Treatment of therapy-naive achalasiaGuy E. Boeckxstaens, Belgium

11:12 – 11:34 IP371Management of complex cases and therapeutic fail-ures: Endoscopic approachHaruhiro Inoue, Japan

11:34 – 11:56 IP372Management of complex cases and therapeutic fail-ures: Surgical approachMario Costantini, Italy

Symposium10:30 – 12:00 Room A1Lifestyle-related liver disease: Risks and managementChairs: Dina Tiniakos, United Kingdom

Vlad Ratziu, France

10:30 – 10:52 IP373What should the clinician worry about?Helen Reeves, United Kingdom


76




11:06 – 11:18 OP192SAFETY OF THE SIX-SHOOTER MULTIBAND MUCO-SECTOMY DEVICE FOR ENDOSCOPIC RESECTION IN BARRETT’S ESOPHAGUS IN 4327 RESECTIONS: A RET-ROSPECTIVE INTERNATIONAL MULTICENTER STUDY.Kamar Belghazi, The Netherlands; M. A. Everson; R. Haidry; P. Kandel; L. K. Mejia; M. J. Bourke; F. Bahin; B. L. A. M. Weusten; G. G. Ginsberg; G. Ma; A. D. Koch; R. V. Milano; S. Seewald; K. Ragunath; R. Bisschops; J. J. G. H. M. Bergman; R. E. Pouw

11:18 – 11:30 OP193ENDOSCOPIC SUBMUCOSAL DISSECTION FOR BAR-RETT’S EARLY NEOPLASIA: A SYSTEMATIC REVIEW AND META-ANALYSISDennis Yang, USA; F. Zou; S. Xiong; J. J. Forde; P. V. Draganov

11:30 – 11:42 OP194NEUTROPHIL LYMPHOCYTE RATIO AS PREDICTIVE MARKER OF SURVIVAL IN ESOPHAGEAL CANCER: SYSTEMATIC REVIEW AND META-ANALYSISGiovannI Pirozzolo, Italy; S. S. Gisbertz; C. Castoro; M. I. van Berge Henegouwen; M. Scarpa

11:42 – 11:54 OP195THE OPTIMAL TIME INTERVAL BETWEEN NEOADJU-VANT CHEMORADIOTHERAPY AND ESOPHAGECTOMY: A NATIONWIDE STUDYLeonie van der Werf, The Netherlands; J. Dikken; E. van der Willik; M. I. van Berge Henegouwen; V. E. P. P. Lemmens; G. A. P. Nieuwenhuijzen; B. P. L. Wijnhoven; on behalf of the Dutch Upper GI Cancer Audit group

Translational Basic Science10:30 – 12:00 Room B3Genetics of pancreatic disease and lessons for clinical practiceChairs: Julia Mayerle, Germany

Marco J. Bruno, The Netherlands

10:30 – 10:52 IP379Cystic fibrosis transmembrane conductance regulator (CFTR): Its physiological role and in the pathogenesis of pancreatitisPeter Hegyi, Hungary

10:52 – 11:14 IP380CFTR gene mutations in pancreatitis and treatment optionsDavid C. Whitcomb, USA

11:14 – 11:36 IP381Rising Star: Genetic susceptibility to acute and chronic pancreatitis ªVinciane Rebours, France

10:42 – 10:42 OP187USEFULNESS OF COMBINATION THERAPY WITH ADALI-MUMAB AND IMMUNOMODULATORS IN PATIENTS WITH CROHN’S DISEASE: A LARGE, MULTI-CENTRE COHORT STUDYHiroki Tanaka, Japan; N. Kamata; A. Yamada; T. Fujii; K. Endo; T. Yoshino; S. Bamba; T. Sugaya; T. Kawaguchi; M. Ishii; S. Shinzaki; Y. Toya; Y. Yanai; Y. Yokoyama; J. Umeno; T. Okada; T. Kobayashi; M. Nojima; T. Hibi

10:42 – 10:42 OP188SPACING OF INFLIXIMAB THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES IN CLINICAL REMIS-SION: PRELIMINARY RESULTS OF A RETROSPECTIVE MULTICENTRE FRENCH NATIONAL COHORTGaspard Dufour, France; B. Pariente; R. Altwegg; L. Caillo; J.-C. Valats; M. Bismuth; J.-F. Bourgaux; L. Peyrin-Biroulet; P. Desreumaux; P. Pouderoux; P. Blanc; G. Pineton de Chambrun

10:42 – 10:42 OP189HIGHER RATE OF CORTICORESISTANCE AND CORTI-CODEPENDENCE IN ELDERLY-ONSET UC PATIENTS DIAGNOSED <70 YEARS COMPARED TO ≥70 YEARS OF AGE: A POPULATION-BASED STUDYD. Duricova; H. Sarter; M. Fumery; A. Leroyer; C. Charpentier; Benjamin Pariente, France; L. Armengol-Debeir; L. Peyrin-Biroulet; C. Gower-Rousseau; G. Savoye

Free Paper Session10:30 – 12:00 Room B2Evidence-based management of Barrett's and oe-sophageal adenocarcinomaChairs: Jan Bornschein, Germany

Marnix Jansen, United Kingdom

10:30 – 10:42 IP378State-of-the-art introductionJan Bornschein, Germany

10:42 – 10:54 OP190INCIDENCE OF MALIGNANT PROGRESSION IN PER-SISTENT NONDYSPLASTIC BARRETT'S ESOPHAGUS – A DUTCH NATIONWIDE COHORT STUDYYonne Peters, The Netherlands; J. Honing; W. Kievit; C. Kestens; W. Pestman; I. D. Nagtegaal; P. D. Siersema

10:54 – 11:06 OP191MULTICENTER FEASIBILITY STUDY OF COMBINED INJECTION AND ARGON PLASMA COAGULATION (HY-BRID-APC) IN THE ABLATION THERAPY OF NEOPLAS-TIC BARRETT ESOPHAGUSThomas Rösch, Germany; H. Manner; A. May; M. Knabe; G. Schachschal; H. Ehlken; H. Neuhaus; T. Beyna; J. J. G. H. M. Bergman; B. L. A. M. Weusten; O. Pech; S. Faiss; M. Anders; C. Ell


77


Tues

day,

Oct

ober

31,

201

7


11:06 – 11:18 OP198HELICOBACTER PYLORI ERADICATION THERAPY WITH VONOPRAZAN WAS MORE EFFECTIVE COMPARED TO PROTON PUMP INHIBITORS, AND THE EFFECT WAS NOT DISTURBED IN THE PATIENTS WITH LIFE STYLE-RELATED DISEASESHiroyoshi Endo, Japan; Y. Takara; T. Matsunaga; H. Hidaka; S. Shirai; R. Shimoda; R. Iwakiri; K. Fujimoto

11:18 – 11:30 OP199OPTIMIZED 14-DAY SEQUENTIAL VERSUS 10-DAY BIS-MUTH QUADRUPLE THERAPY CONTAINING HIGH DOSE ESOMEPRAZOLE IN THE FIRST-LINE TREATMENT OF HELICOBACTER PYLORI –A MULTICENTER RANDOM-IZED TRIAL Jyh-Ming Liou, Taiwan; Y.-J. Fang; C.-C. Chen; M.-J. Bair; J.-T. Lin; M.-S. Wu

11:30 – 11:42 OP200THE ABUNDANCE OF ANTIBIOTIC RESISTANCE GENES IN HUMAN GUTS AFTER H. PYLORI ERADICATION THERAPY ªS. Y. Malanin; D. D. Safina; D. R. Khusnutdinova; I. Y. Vasilyev; Tatiana Grigoryeva, Russian Federation; M. N. Siniagina; M. I. Markelova; E. A. Boulygina; S. R. Abdulkhakov; R. A. Abdulkhakov; V. M. Chernov

11:42 – 11:54 OP201PAN-EUROPEAN REGISTRY ON H. PYLORI MANAGE-MENT (HP-EUREG): BACTERIAL RESISTANCE OF 2,241 H. PYLORI ISOLATES.Adrian Gerald McNicholl, Spain; O. P. Nyssen; D. S. Bordin; B. Tepeš; M. Á. Perez Aisa; B. Vaira; M. Caldas Álvarez; L. Bujanda Fernández de Piérola; M. Castro Fernández; F. Lerang; M. Leja; L. Rodrigo; T. Rokkas; L. Kupcinskas; J. Perez-Lasala; L. Jonaitis; O. Shvets; A. Gasbarrini; H. Şimşek; A. Axon; G. M. Buzás; J. C. L. Machado; Y. Niv; L. Boyanova; A. Goldis; V. Lamy; M. Katicic; K. Przytulski; C. Beglinger; M. Venerito; P. Bytzer; L. Capelle; T. Milosavljevic; L. Veijola; J. Molina Infante; L. Vologzhanina; G. Fadeenko; I. Ariño; G. Fiorini; M. Ramas; M. Garcia Donday; F. Megraud; C. O'Morain; J. P. Gisbert

Symposium10:30 – 12:00 Room E1Intestinal ultrasound: How and when?Chairs: Odd Helge Gilja, Norway

Giovanni Maconi, Italy

10:30 – 10:52 IP388The new European guidelines on intestinal ultrasoundOdd Helge Gilja, Norway

10:52 – 11:14 IP389What is the prognostic value of ultrasound in IBD?Giovanni Maconi, Italy

11:36 – 11:58 IP382Update on the genetic basis of familial pancreatic cancerBill Greenhalf, United Kingdom

Today's Science, Tomorrow's Medicine10:30 – 12:00 Room E4Gut microbiota and digestive disordersChairs: Alessio Aghemo, Italy

Franck Carbonnel, France

10:30 – 10:52 IP383Gastric disordersMarcis Leja, Latvia

10:52 – 11:14 IP384IBDHarry Sokol, France

11:14 – 11:36 IP385IBSMagnus Simrén, Sweden

11:36 – 11:58 IP386Liver and metabolic syndromeHerbert Tilg, Austria

Free Paper Session10:30 – 12:00 Room 7.1H. pylori: Treatment and antibiotic resistanceChairs: Giuseppe Losurdo, Italy

Juozas Kupcinskas, Lithuania

10:30 – 10:42 IP387State-of-the-art introductionJuozas Kupcinskas, Lithuania

10:42 – 10:54 OP196HELICOBACTER PYLORI ERADICATION AND THE RISK OF GASTRIC CANCER: A POPULATION-BASED COHORT STUDYEva Doorakkers, Sweden; J. Lagergren; L. Engstrand; N. Brusselaers

10:54 – 11:06 OP197PAN-EUROPEAN REGISTRY ON H. PYLORI MANAGE-MENT (HP-EUREG): FIRST-LINE TREATMENTS AND INTERIM ANALYSIS OF 20,000 PATIENTSAdrian Gerald McNicholl, Spain; O. P. Nyssen; D. S. Bordin; B. Tepeš; M. Á. Perez Aisa; B. Vaira; M. Caldas Álvarez; L. Bujanda Fernández de Piérola; M. Castro Fernández; F. Lerang; M. Leja; L. Rodrigo; T. Rokkas; L. Kupcinskas; J. Perez-Lasala; L. Virginijus Jonaitis; O. Shvets; A. Gasbarrini; H. Şimşek; A. Axon; G. M. Buzás; J. C. L. Machado; Y. Niv; J. Molina Infante; L. Boyanova; A. Goldis; V. Lamy; M. Katicic; K. Przytulski; C. Beglinger; M. Venerito; P. Bytzer; L. Capelle; T. Milosavljevic; L. Veijola; L. Vologzhanina; G. Fadeenko; I. Ariño; G. Fiorini; M. Caldas; M. Ramas; M. Garcia Donday; F. Megraud; C. O'Morain; J. P. Gisbert


78




11:42 – 11:54 OP207UTILITY TO ENDOSCOPIC SUBMUCOSAL DISSECTION IN THE COLORECTAL TUMORS NEAR OR WITHIN DIVER-TICULUM: CASE SERIESVictoria Alejandra Jimenez-Garcia, Japan; M. Yamada; H. Ikematsu; S. Abe; T. Sakamoto; T. Nakajima; T. Matsuda; Y. Saito

Free Paper Session10:30 – 12:00 Room E3Mechanisms of carcinogenesis in the pancreasChairs: Albrecht Neesse, Germany

Corinne Bousquet, France

10:30 – 10:42 IP393State-of-the-art introductionAlbrecht Neesse, Germany

10:42 – 10:54 OP208ENHANCED EXPRESSION OF K-RAS PROTEIN IN PANCREAS PROMOTES DEVELOPMENT OF CIGARETTE SMOKE INDUCED CHRONIC PANCREATITIS IN MICE.Jaroslaw Daniluk, Poland; U. Daniluk; J. Reszec; A. Dabrowski

10:54 – 11:06 OP209EXPRESSION OF TN ANTIGEN CAUSES CHRONIC PAN-CREATITIS IN A TRANSGENIC MOUSE MODELBaris Mercanoglu, Germany; K.-F. Karstens; C. Güngör; J. R. Izbicki; M. Bockhorn; G. Wolters-Eisfeld

11:06 – 11:18 OP210LIPOXIN A4 INHIBITS PANCREATIC STELLATE CELL DIFFER-ENTIATION INTO PANCREATIC TUMOR STROMAL MYOFI-BROBLASTS AND PANCREATIC TUMOR GROWTH IN VIVOM. Heinrich; Jonas Schnittert, The Netherlands; J. Prakash

11:18 – 11:30 OP211PROTEIN FACTORS PRESENTED IN SERUM OF PAN-CREATIC CANCER PATIENTS ENHANCES THE MOTILITY OF CANCER CELLS – A NOVEL VIEW OF PANCREATIC CANCER CELL METASTASIS. ªAgata Poniewierska-Baran, Poland; K. Dąbkowski; T. Starzynska; M. Z. Ratajczak

11:30 – 11:42 OP212ATM-DEFICIENCY GENERATES GENOMIC INSTABILITY IN PANCREATIC DUCTAL ADENOCARCINOMA AND SEN-SITIZES TOWARD THERAPEUTIC DNA-DAMAGELukas Perkhofer, Germany; A. Schmitt; E. Hessmann; D. A. A. Ruess; M. Lesina; A. Neese; B. Sipos; T. Seufferlein; H. C. Reinhardt; P.-O. Frappart; A. Kleger

11:42 – 11:54 OP213COMBINED INHIBITION OF HISTONE DEACETYLASES AND SIRTUIN 1 LEADS TO PARTIAL REDIFFERENTIATION OF DUCTAL NEOPLASIA TOWARDS A MORE ACINAR PHENO-TYPE IN MOUSE PANCREATIC TUMOR ORGANOIDSS. ZHANG; Xiaoping Zou, China

11:14 – 11:36 IP390Ultrasound in appendicitis and diverticulitis: A must or an option?Klaus Dirks, Germany

11:36 – 11:58 IP391Any added value of elastography and contrast-en-hanced ultrasound in Crohns disease?Kim Nylund, Norway

Free Paper Session10:30 – 12:00 Room E2Diverticular disease: From bench to bedsideChairs: Anton Emmanuel, United Kingdom

Nicolas Cenac, France

10:30 – 10:42 IP392State-of-the-art introductionAnton Emmanuel, United Kingdom

10:42 – 10:54 OP202CALCITONIN GENE-RELATED PEPTIDE INNERVATING ENTERIC PLEXUSES IS DOWNREGULATED IN DIVERTIC-ULAR DISEASE: IMPLICATIONS FOR PATHOGENESIS ªJaune Ieva Lukosiene, Lithuania; A. G. Pauza; K. Rysevaite-Kyguoliene; J. Kupcinskas; Z. Saladzinskas; A. Tamelis; N. Pauziene

10:54 – 11:06 OP203IMMUNE ACTIVATION AND NERVE SPROUTING IN THE COLONIC MUCOSA OF PATIENTS WITH DIVERTICULAR DISEASE.Maria Raffaella Barbaro, Italy; C. Cremon; D. Fuschi; E. Scaioli; G. Marasco; M. Carapelle; E. Benatti; E. Capelli; A. Colecchia; D. Festi; V. Stanghellini; G. Barbara

11:06 – 11:18 OP204PROLONGED RECURRENT ABDOMINAL PAIN IS AS-SOCIATED WITH ON-GOING UNDERLYING MUCOSAL INFLAMMATION IN PATIENTS WHO HAD AN EPISODE OF ACUTE COMPLICATED DIVERTICULITSAdi Lahat, Israel; D. Necula; M. Yavzori; O. Picard; R. Eliakim; S. Ben-Horin

11:18 – 11:30 OP205INCIDENCE OF COMPLICATED DIVERTICULAR DISEASE (ABSCESS AND PERFORATION): A POPULATION BASED COHORT STUDY FROM ENGLANDH. E. Otete; C. J. Crooks; J. West; David Humes, United Kingdom

11:30 – 11:42 OP206COLONIC DIVERTICULA ARE NOT ASSOCIATED WITH MUCOSAL INFLAMMATION OR CHRONIC GASTROIN-TESTINAL SYMPTOMSAnne Peery, USA; T. Keku; C. Addamo; A. McCoy; C. Martin; J. Galanko; R. Sandler


79


Tues

day,

Oct

ober

31,

201

7


Free Paper Session10:30 – 12:00 HotspotAbstracts on Fire: Predicting and optimising IBD outcomeChairs: Walter Reinisch, Austria

Catherine Reenaers, Belgium

10:30 – 10:40 OP220ENRICHMENT OF CIRCULATING DOUBLE POSITIVE INTERLEUKIN-17 PRODUCING FOXP3+ CD4+ T CELL SUBSETS ARE ASSOCIATED WITH A HIGHER RISK OF FURTHER RELAPSE IN CROHN’S DISEASE IN REMISSION: AN OBSERVATIONAL, PROSPECTIVE MUL-TICENTER STUDYGilles Boschetti, France; B. Flourie; X. Roblin; S. Paul; J. Bienvenu; G. Bommelaer; A. Buisson; E. Del Tedesco; C. Josson; S. Legastelois; S. Nancey

10:40 – 10:50 OP221INFLIXIMAB TROUGH LEVELS ABOVE 7 μG/ML IN INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB: BETTER CONTROL OF INFLAMMATION WITHOUT INCREASED RISK OF INFECTION David Drobne, Slovenia; T. Kurent; S. Golob; P. Svegl; P. Rajar; S. Terzic; M. Kozelj; G. Novak; N. Smrekar; S. Plut; A. Smid; N. Sever; L. Strnisa; J. Brecelj; D. Urlep; J. Osredkar; M. Homan; R. Orel; B. Stabuc; I. Ferkolj

10:50 – 11:00 OP222AN UPDATED ANALYSIS OF IN VITRO CYTOKINE INHIBI-TION PROFILES OF A NUMBER OF JANUS KINASE INHIB-ITORS AT CLINICALLY MEANINGFUL CONCENTRATIONSMartin Dowty, USA; T. H. Lin; L. Wang; J. M. Jussif; L. Li; E. Moy; J.-B. Telliez

11:00 – 11:10 OP223IDENTIFICATION OF GENETIC SIGNATURES AND IMMUNE MECHANISMS THAT DEFINE THERAPEUTIC RESPONSE AND FAILURE TO ANTI-INTEGRIN THERAPY WITH VEDOLIZUMAB IN IBD PATIENTSTimo Rath, Germany; U. Billmeier; F. Ferrazzii; M. Vieth; A. Ekici; M. F. Neurath; R. Atreya

11:10 – 11:20 OP224EXPANSION OF IL-23 RECEPTOR BEARING TNFR2+ T CELLS DRIVES RESISTANCE TO ANTI-TNF THERAPY IN CROHN`S DISEASEHeike Schmitt, Germany; U. Billmeier; W. Dieterich; T. Rath; S. Hirschmann; C. Neufert; K. Hildner; M. J. Waldner; J. Mudter; T. Münster; M. F. Neurath; R. Atreya

Free Paper Session10:30 – 12:00 Room B5Microbiology and immunology of the small intestineChairs: Ashley Blackshaw, United Kingdom

Johannes Roksund Hov, Norway

10:30 – 10:42 IP394State-of-the-art introductionAshley Blackshaw, United Kingdom

10:42 – 10:54 OP214VERIFICATION OF IMMUNOGLOBULIN A REGULATION OF MICROFLORA AND PROTECTION OF INTESTINAL MUCOSANaoya Tsugawa, Japan; T. Nagaishi; T. Watabe; N. Jose; A. Hosoya; Y. Kojima; T. Adachi; R. S. Blumberg; M. Watanabe

10:54 – 11:06 OP215MONOCYTE-DERIVED MACROPHAGES RESTORE GUT MOTILITY IN POSTOPERATIVE ILEUS BY LIMITING ENTERIC NEURONAL DAMAGEM. Stakenborg; G. Farro; G. Goverse; V. De Simone; P. J. Gomez-Pinilla; Z. Lisowski; D. Laoui; J. Van Ginderachter; D. A. Hume; G. E. Boeckxstaens; Gianluca Matteoli, Belgium

11:06 – 11:18 OP216VONOPRAZAN, A NOVEL ACTIVE POTASSIUM-COM-PETITIVE ACID BLOCKER, AND RABEPRAZOLE INDUCE SMALL INTESTINAL DYSBIOSIS AND EXACERBATE THE NON-STEROIDAL ANTI-INFLAMMATORY DRUG-IN-DUCED SMALL INTESTINAL ENTEROPATHYYuji Nadatani, Japan; T. Watanabe; N. Sugimura; K. Otani; K. Taira; S. hosomi; Y. Nagami; F. Tanaka; N. Kamata; H. Yamagami; T. Tanigawa; M. Shiba; Y. Fujiwara

11:18 – 11:30 OP217COMPOSITION OF MUCOSA-ASSOCIATED MICROBIOME ALONG THE ENTIRE GASTROINTESTINAL TRACT IN HUMANSFanny E. R. Vuik, The Netherlands; G. M. Fuhler; S. R. Konstantinov; J. Dicksved; L. Engstrand; A. Van De Winkel; M. C. W. Spaander; E. J. Kuipers; M. P. Peppelenbosch

11:30 – 11:42 OP218HYPOXIA DISRUPTS INTESTINAL BARRIER VIA REG-ULATING NHE8-TIGHT JUNCTION IN SEVERE ACUTE PANCREATITIS RAT MODELSXiao Li, China; C. Geng; X. Lei; C. Wang

11:42 – 11:54 OP219MODULATION OF THE ENDOCANNABINOID SYSTEM BY FATTY ACID AMIDE HYDROLASE, MONO- AND DIA-CYLGLYCEROL LIPASE INHIBITORS AS AN ATTRACTIVE TARGET FOR SECRETORY DIARRHEA THERAPYA. Wasilewski; A. Misicka; M. Sacharczuk; Jakub Fichna, Poland


80




Round Table Discussion12:45 – 13:45 Room A3Autoimmune pancreatitis: Diagnostic and therapeutic challengesChair: Thomas M. Gress, GermanyExperts: Luca Frulloni, Italy

Thomas M. Gress, Germany Julia Mayerle, Germany Vinciane Rebours, France

Round Table Discussion12:45 – 13:45 Room B2Management of malignant dysphagiaChair: Mark Ivo van Berge Henegouwen, The Neth-

erlandsExperts: Riccardo Rosati, Italy

Peter D. Siersema, The Netherlands Eric Van Cutsem, Belgium Mark Ivo van Berge Henegouwen, The Netherlands

Round Table Discussion12:45 – 13:45 Room B3Use and abuse of GI function testsChair: Mark Fox, SwitzerlandExperts: Fernando Azpiroz, Spain

Mark Fox, Switzerland Jutta Keller, Germany Stuart Taylor, United Kingdom

Symposium12:45 – 13:30 HotspotThe role of academia in drug developmentChairs: Michael Manns, Germany

Magnus Simrén, Sweden

12:45 – 13:00 IP395Breaking down borders between public and private research

13:00 – 13:15 IP396How to turn a biotech company into big pharmaJohn C. Martin, USA

13:15 – 13:30 IP397Role of academia in drug development: View of the regulatory authorityJoachim Musaus, United Kingdom

11:20 – 11:30 OP225SUPERIOR ENDOSCOPIC AND DEEP REMISSION OUT-COMES IN ADULTS WITH MODERATE TO SEVERE CROHN'S DISEASE MANAGED WITH TREAT TO TARGET APPROACH VERSUS CLINICAL SYMPTOMS: DATA FROM CALMJean-Frederic Colombel, USA; R. Panaccione; P. Bossuyt; M. Lukas; F. Baert; T. Vanásek; A. Danalıoğlu; G. Novacek; A. Armuzzi; X. Hebuterne; S. Travis; S. Danese; W. Reinisch; W. J. Sandborn; P. Rutgeerts; D. Hommes; S. Schreiber; E. Neimark; B. Huang; Q. Zhou; J. Petersson; K. Wallace; A. M. Robinson; R. Thakkar; G. R. D'Haens

11:30 – 11:40 OP226EFFICACY AND SAFETY OF A BRIDGING STRATEGY WITH CALCINEURIN INHIBITORS TO VEDOLIZUMAB IN PATIENTS WITH SEVERE ULCERATIVE COLITISG. Pellet; C. Stefanescu; F. Carbonnel; L. Peyrin-Biroulet; X. Roblin; C. Allimant; M. Nachury; S. Nancey; J. Filippi; R. Altwegg; H. Brixi; G. Fotsing Makougang; S. Shili; David Laharie, France

11:40 – 11:50 OP227A TREAT TO TARGET APPROACH DECREASES THE RATE OF CD-RELATED ADVERSE OUTCOMES VERSUS A CLINICAL APPROACH IN PATIENTS WITH MODERATE TO SEVERELY ACTIVE CROHN'S DISEASE: DATA FROM CALMJean-Frederic Colombel, USA; R. Panaccione; P. Bossuyt; F. Baert; T. Vanásek; A. Danalıoğlu; G. Novacek; A. Armuzzi; X. Hebuterne; S. Travis; S. Danese; W. Reinisch; W. J. Sandborn; P. Rutgeerts; D. Hommes; S. Schreiber; E. Neimark; B. Huang; Q. Zhou; W. J. Lee; J. Petersson; K. Wallace; A. M. Robinson; R. B. Thakkar; G. D'Haens

11:50 – 12:00 OP228PROFILE TRIAL: PREDICTING OUTCOMES FOR CROHN’S DISEASE USING A MOLECULAR BIOMARKERJ. C. Lee; D. Biasci; Nurulamin Noor, United Kingdom; E. F. McKinney; T. Ahmad; N. R. Lewis; A. Hart; P. A. Lyons; M. Parkes; K. G. Smith

Round Table Discussion12:45 – 13:45 Room A2Therapy-resistent reflux symptoms: What can we offer to the patient?Chair: André Smout, The NetherlandsExperts: Pali Hungin, United Kingdom

Sabine Roman, France André Smout, The Netherlands Giovanni Zaninotto, United Kingdom


81


Tues

day,

Oct

ober

31,

201

7


Symposium14:00 – 15:30 Room C2Proctology made easyChairs: Dieter Hahnloser, Switzerland

Roger Leicester, United Kingdom

14:00 – 14:22 IP403HemorrhoidsAlexander Herold, Germany

14:22 – 14:44 IP404Anal fissureMonica Millan, Spain

14:44 – 15:06 IP405Anal wartsDesmond C. Winter, Ireland

15:06 – 15:28 IP406Perianal abscessIbrahim Ethem Gecim, Turkey

Symposium14:00 – 15:30 Room F3Therapy update: Faecal incontinenceChairs: Emma Carrington, United Kingdom

José Maria Remes-Troche, Mexico

14:00 – 14:22 IP407Diagnostic work-up: What is the preferred strategy?Mark Scott, United Kingdom

14:22 – 14:44 IP408Conservative treatmentHenriette Heinrich, United Kingdom

14:44 – 15:06 IP409Behavioural treatmentSatish Rao, USA

15:06 – 15:28 IP410Surgical treatment optionsCharles H. Knowles, United Kingdom

Career Chat13:00 – 14:00 Young GI LoungeTop advice from female leaders and their fellowsChairs: Rebecca Clare Fitzgerald, United Kingdom

Monika Maria Widlak, United KingdomExperts: Marianna Arvanitakis, Belgium

Siwan Thomas-Gibson, United Kingdom Severine Vermeire, Belgium

Live Endoscopy14:00 – 15:30 Hall 6Live endoscopyChairs: Guido Costamagna, Italy

Jacques Deviere, Belgium Christian Gerges, Germany


Symposium14:00 – 15:30 Room C1Management of dysplasia in ulcerative colitisChairs: Willem A. Bemelman, The Netherlands

Britta Siegmund, Germany

Tandem Talks14:00 – 14:10 IP398Endoscopic diagnosisTomas Hucl, Czech Republic

14:10 – 14:20 IP399Histopathological diagnosisMichael Vieth, Germany

14:20 – 14:30 IP400Endoscopic therapy and resectionBrian P. Saunders, United Kingdom

14:30 – 14:40 IP401Surgical therapyAntonino Spinelli, Italy

14:40 – 15:02 IP402Surveillance strategies after ileal pouchIris Dotan, Israel



82




15:06 – 15:28 IP417Pancreatic cancerMichel Ducreux, France

Symposium14:00 – 15:30 Room A2Malignant colorectal polyp: What to do?Chairs: Gabriela Möslein, Germany

Ian Jenkins, United Kingdom

14:00 – 14:22 IP418Clinically relevant information from the pathologistIris D. Nagtegaal, The Netherlands

Debates14:22 – 14:32 IP419Malignant colon polyp: Endoscopy or surgery? EndoscopyMichael Bretthauer, Norway

14:32 – 14:42 IP420Malignant colon polyp: Endoscopy or surgery? SurgeryEloy Espin Basany, Spain

14:42 – 14:52 IP421Malignant rectal polyp: Endoscopy or surgery or chemo-radiotherapy? Endoscopy and chemoradiotherapyMarc Giovannini, France

14:52 – 15:02 IP422Malignant rectal polyp: Endoscopy or surgery or chemoradiotherapy? SurgeryRoel Hompes, United Kingdom

15:02 – 15:14 OP231WATER EXCHANGE SIGNIFICANTLY IMPROVED ADENO-MA DETECTION RATE AND RELATED MEASURES AND COLON CLEANLINESS IN PROPOFOL-SEDATED PATIENTSFelix Leung, USA; M. Koo; Y.-H. Hsieh; C.-W. Tseng; C.-T. Hu; L. Zhang; T. Dong; H. Jia; Y. Pan

15:14 – 15:26 OP232COLONIC POST POLYPECTOMY BLEEDING IN PATIENTS ON NEW ORAL ANTI-COAGULANT – A CASE CONTROL STUDY.Long Yan Kelvin Lam, Hong Kong PRC; T. Y. T. Lam; J. Y. L. Ching; S. H. Wong; S. C. C. Ng; F. K. L. Chan

Symposium14:00 – 15:30 Room A1The role of the GI microenvironment in IBSChairs: Giovanni Barbara, Italy

Daisy Mae Jonkers, The Netherlands

14:00 – 14:22 IP423Bile acidsJulian Walters, United Kingdom

Symposium14:00 – 15:30 Room F2How to manage early gastric cancer?Chairs: Mario Dinis-Ribeiro, Portugal

Mark Ivo van Berge Henegouwen, The Netherlands

14:00 – 14:22 IP411Endoscopic diagnosis and stagingFabian Emura, Colombia

14:22 – 14:44 IP412Update on endoscopic treatmentHelmut Messmann, Germany

14:44 – 15:06 IP413Minimally invasive surgical and hyprid techniquesSuzanne S. Gisbertz, The Netherlands

15:06 – 15:18 OP229LYMPHATIC INVASION MAY BE MOST RELEVANT TO NODAL METASTASES IN EARLY-STAGE GASTRIC CAN-CERS: A RETROSPECTIVE ANALYSIS IN 65 CASESTeppei Akimoto, Japan; O. Goto; N. Ueki; H. Kawakubo; H. Noda; G. Ikeda; K. Higuchi; Y. Mitsunaga; H. Yamawaki; Y. Kodaka; A. Nakayama; M. Kato; A. Fujimoto; Y. Ochiai; T. Maehata; K. Suda; T. Uraoka; T. Kawagoe; S. Futagami; I. Fujita; M. Kaise; Y. Kitagawa; K. Iwakiri; N. Yahagi

15:18 – 15:30 OP230CLINICAL CHARACTERISTICS AND MANAGEMENT OF PATIENTS WITH GASTRIC PRECANCEROUS LESIONS IN FRANCE: A LARGE 15-YEAR SINGLE CENTER RETRO-SPECTIVE STUDY.Matthieu Péron, France; N. Chapelle; A. Bourget; J.-F. Mosnier; S. Bruley Des Varannes; Y. Touchefeu; E. Coron; E. Cauchin; T. Matysiak Budnik

Symposium14:00 – 15:30 Room F1From guidelines to clinical practice: Pancreatic diseasesChairs: Rodger A. Liddle, USA

Philippe Lévy, France

14:00 – 14:22 IP414Acute pancreatitisDjuna L. Cahen, The Netherlands

14:22 – 14:44 IP415Chronic pancreatitisDavid C. Whitcomb, USA

14:44 – 15:06 IP416Pancreatic cystic tumoursMarco Del Chiaro, Sweden


83


Tues

day,

Oct

ober

31,

201

7


14:48 – 15:00 OP236EFFICACY OF HEPATITIS B VIRUS VACCINATION IN NEWBORNS EXPOSED TO ANTI-TNF ALPHA IN UTEROAlison de Lima-Karagiannis, The Netherlands; S. Kanis; J. C. Escher; C. J. van der Woude

15:00 – 15:12 OP237STRUCTURE AND BIOLOGICAL ACTIVITY OF INFLIX-IMAB PRODUCTSChangsoo Lee, Republic of Korea; M. Jeong; J. Lee; S. Seo; S. Cho; W. Zhang; O. Jaquez

15:12 – 15:24 OP238BODY WEIGHT AND RAPID CLEARANCE DETERMINE EARLY FORMATION OF ANTI-DRUG ANTIBODIES AGAINST INFLIXIMAB.Walter Reinisch, Austria; A. Eser; S. Schreiber; H. C. Kwon; D. R. Mould

Translational Basic Science14:00 – 15:30 Room B3Which GI diseases are inherited?Chairs: Carla Oliveira, Portugal

Bill Greenhalf, United Kingdom

14:00 – 14:22 IP428When to refer a GI patient to a geneticist?Marc Tischkowitz, United Kingdom

14:22 – 14:44 IP429Genetics and gastric cancerCarla Oliveira, Portugal

14:44 – 15:06 IP430Genetics and colon cancerEmad El-Omar, Australia

15:06 – 15:28 IP431The genetics of IBD: Status quo and beyondVito Annese, Italy

Today's Science, Tomorrow's Medicine14:00 – 15:30 Room E4How to modulate the microbiome?Chairs: Sibylle Koletzko, Germany

Ed Kuijper, The Netherlands

14:00 – 14:22 IP432Diet and prebioticsJan Tack, Belgium

14:22 – 14:44 IP433AntibioticsJasmohan S. Bajaj, USA

14:22 – 14:44 IP424MicrobiotaMuriel Derrien, France

14:44 – 15:06 IP425FoodShanti Lynne Eswaran, USA

15:06 – 15:28 IP426GasFernando Azpiroz, Spain

Free Paper Session14:00 – 15:30 Room A3Late breaking abstracts III

Free Paper Session14:00 – 15:30 Room B2Impacts of biologics in IBDChairs: Pascal Juillerat, Switzerland

Julien Kirchgesner, France

14:00 – 14:12 IP427State-of-the-art introductionJulien Kirchgesner, France

14:12 – 14:24 OP233MRI IMPROVEMENT AFTER ANTI-TNF THERAPY IS PRE-DICTIVE OF SUSTAINED CLINICAL REMISSION AND IS A POTENTIAL THERAPEUTIC TARGET IN CROHN’S DISEASEAnthony Buisson, France; L. Messadeg; G. Bouguen; F. GOUTORBE; J.-M. Reimund; M. Goutte; C. Sautel; A.-L. Boucher; I. Ticlete; C. Duron; J. Scanzi; M. Reymond; C. Allimant; M. Dapoigny; G. Bommelaer; B. Pereira; C. Hordonneau

14:24 – 14:36 OP234EFFICACY OF ENDOSCOPIC PLACEMENT OF A DRUG-ELUTING PLATFORM WITH INFLIXIMAB FOR THE TREATMENT OF MUCOSAL LESIONS IN A RAT MODEL OF EXPERIMENTAL COLITIS.Ramon Bartolí, Spain; I. Bon; J. Boix; V. Moreno de Vega; N. D. De la Ossa; I. Marín; V. Lorenzo-Zúñiga

14:36 – 14:48 OP235FINAL RESULTS ON EFFICACY AND SAFETY OF BIOSIM-ILAR INFLIXIMAB AFTER ONE-YEAR: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORTK. B. Gecse; Z. Vegh; Z. Kurti; M. Rutka; K. Farkas; P. A. Golovics; B. D. Lovasz; Lorant Gonczi, Hungary; J. Banai; L. Bene; B. Gasztonyi; T. Kristof; L. Lakatos; P. Miheller; F. Nagy; K. Palatka; M. Papp; A. Patai; A. Salamon; T. Szamosi; Z. Szepes; G. T. Toth; A. Vincze; T. Molnar; P. L. Lakatos


84




15:12 – 15:24 OP244IMPLEMENTATION OF AN OPTICAL DIAGNOSIS STRAT-EGY FOR DIMINUTIVE POLYPS INCLUDING SESSILE SERRATED LESIONS: TRAINING AND LONG-TERM QUALITY ASSURANCEJasper Vleugels, The Netherlands; M. G. W. Dijkgraaf; Y. Hazewinkel; P. Fockens; E. Dekker; O. B. O. T. DIS-COUNT study group

Symposium14:00 – 15:30 Room E1From fibrosis to cirrhosis: Diagnostic challenges and novel therapiesChairs: Dominique Thabut, France

Alexandre Louvet, France

Debate14:00 – 14:10 IP437Staging of liver disease: Non-invasive methods are the gold-standardLaurent Castera, France

14:10 – 14:20 IP438Staging of liver disease: Biopsies are still neededKaroline Lackner, Austria

14:20 – 14:42 IP439Novel therapeutic optionsFrank Tacke, Germany

14:42 – 15:04 IP440Regression of liver cirrhosis: Is this really possible?Maria Buti, Spain

15:04 – 15:26 IP441Rising Star: The role of stabilin-1 in liver fibrogenesis and repair ªShishir Shetty, United Kingdom

Free Paper Session14:00 – 15:30 Room E2H. pylori: From pathophysiology to the clinicChairs: Jose Carlos L. Machado, Portugal

Chella Van der Post, The Netherlands

14:00 – 14:12 IP442State-of-the-art introductionJose Carlos L. Machado, Portugal

14:12 – 14:24 OP245LONG-TERM EFFECTS OF H. PYLORI ERADICATION ON MOLECULAR ALTERATIONS RELATED TO GASTRIC CARCINOGENESISJiro Watari, Japan; Y. Michigami; C. Ito; K. Hara; T. Yamasaki; T. Okugawa; T. Kono; K. Tozawa; T. Tomita; Y. Ohda; T. Oshima; H. Fukui; H. Miwa

14:44 – 15:06 IP434Faecal microbiota transplantation (FMT)Giovanni Cammarota, Italy

15:06 – 15:28 IP435How to optimise banking for faecal microbiota trans-plantation (FMT)Josbert Keller, The Netherlands

Free Paper Session14:00 – 15:30 Room 7.1Optimising your colonoscopy practiceChairs: Bjorn Rembacken, United Kingdom

Fatih Aslan, Turkey

14:00 – 14:12 IP436State-of-the-art introductionBjorn Rembacken, United Kingdom

14:12 – 14:24 OP239RELATED FACTORS TO THE QUALITY OF COLON CLEANSINGCarolina Mangas, Spain; E. Santana Rocamora; A. Suárez González; I. Portillo Villares; A. Seoane; M. Ponce; P. Diez; E. Quintero Carrion; M. Herraiz; M. Pellisé Urquiza; Á. Ferrández Arenas; V. Hernández; Á. E. Pizarro Moreno; R. Jover

14:24 – 14:36 OP240IMPROVEMENT OF COLONOSCOPY PREPARATION BY AN AUTOMATED 4-DAY PATIENT GUIDANCE BY SMS; RESULTS FROM THE PERICLES-II STUDYBenjamin Walter, Germany; P. Klare; K. Strehle; J. Aschenbeck; L. Ludwig; N. Dikopoulos; B. Neu; S. Delius

14:36 – 14:48 OP241A RANDOMIZED CONTROLLED TRIAL COMPARING WA-TER ASSISTED AND AIR INSUFFLATION COLONOSCOPY WITHOUT SEDATIONRichard Azevedo, Portugal; C. Leitão; H. Ribeiro; J. Pinto; F. Pereira; A. Caldeira; R. Sousa; E. Pereira; J. Barros; A. Banhudo

14:48 – 15:00 OP242NEW GENERATION FULL-SPECTRUM VERSUS STANDARD FORWARD-VIEWING COLONOSCOPY: A MULTICENTER, RANDOMIZED CONTROLLED, TANDEM COLONOSCOPY TRIALKinichi Hotta, Japan; T. Kudo; Y. Saito; H. Ikematsu; Y. Takeuchi; M. Shimatani; K. Kawakami; N. Tamai; K. Yoshimura; H. Ishikawa; K. Imai; Y. Mori; T. Matsuda; S.-E. Kudo

15:00 – 15:12 OP243PERFORMANCE COMPARISON OF FULL-SPECTRUM VERSUS FORWARD-VIEWING COLONSCOPY: A RAN-DOMIZED CONTROLLED TRIAL.Martin Geyer, Switzerland; L. Dominik; F. Bannwart


85


Tues

day,

Oct

ober

31,

201

7


14:36 – 14:48 OP253SURVEILLANCE FOR PANCREATIC CANCER IN HIGH-RISK INDIVIDUALS: FIRST-ROUND SCREENING RESULTS OF A MULTICENTRIC ITALIAN PROGRAMSalvatore Paiella, Italy; G. Capurso; G. Butturini; R. Pezzilli; S. Carrara; M. Falconi; M. Signoretti; M. Di Leo; I. Frigerio; C. Bassi; A. Zerbi

14:48 – 15:00 OP254THE ROLE OF CYSTIC PRECURSOR LESIONS IN THE DEVELOPMENT OF PANCREATIC DUCTAL ADENOCARCI-NOMA IN CDKN2A-P16-LEIDEN MUTATION CARRIERSIsaura Ibrahim, The Netherlands; M. Wasser; Y. Wu; A. Inderson; W. De Vos Tot Nederveen Cappel; H. Morreau; F. Hes; R. A. Veenendaal; H. Putter; S. Feshtali; A. van Mil; N. Gruis; R. Tollenaar; W. Bergman; B. Bonsing; H. Vasen

15:00 – 15:12 OP255CHARACTERIZATION OF GENETIC ALTERATIONS IN PANCREATIC CANCER HIGH RISK POPULATIONGuy Rosner, Israel; E. Scapa; E. Santo; M. Ben-Yehoyada

15:12 – 15:24 OP256DETECTION OF PANCREATIC CANCER BY URINE ELEC-TRIC NOSE ANALYSIS, A PROOF-OF-CONCEPT STUDY, 80 CASESSamuli Nissinen, Finland; A. Roine; L. Hokkinen; T. Rantanen; N. Oksala

Free Paper Session14:00 – 15:30 Room B5Carcinogenesis and tumour progression in GI cancerChairs: Ian Tomlinson, United Kingdom

Albrecht Neesse, Germany

14:00 – 14:12 IP444State-of-the-art introductionIan Tomlinson, United Kingdom

14:12 – 14:24 OP257HINOS PROMOTES A CD24+CD133+ LIVER CANCER STEM CELL PHENOTYPE AND TUMOR PROGRESSION THROUGH A TACE/ADAM17 DEPENDENT NOTCH SIG-NALING PATHWAYRonghua Wang, China

14:24 – 14:36 OP258AUTOPHAGY INHIBITS PROTUMORAL EFFECTS INDUCED BY COLIBACTIN-PRODUCING COLORECTAL CANCER-ASSOCIATED ESCHERICHIA COLICécily Lucas, France; G. Dalmasso; M. Bonnet; P. Sauvanet; D. Pezet; N. Barnich; P. Rosenstiel; R. Bonnet; H. T. T. Nguyen

14:24 – 14:36 OP246CLINICAL CHARACTERISTICS OF HELICOBACTER PYLO-RI NAÏVE NON-CARDIAC GASTRIC ADENOCARCINOMA.Sho Suzuki, Japan; N. Uedo; M. Arao; T. Iwatsubo; H. Nakahira; M. Kato; Y. Tounai; K. Hamada; Y. Yamasaki; N. Matsuura; S. Sichijo; T. Kanesaka; S. Yamamoto; T. Akasaka; N. Hanaoka; Y. Takeuchi; K. Higashino; R. Ishihara; Y. Tomita; H. Iishi

14:36 – 14:48 OP247EPIGENETIC SILENCING OF AN AUTOPHAGY GENE BY HELICOBACTER PYLORI FACILITATES CARCINOGENIC TRANSFORMATION OF GASTRIC EPITHELIAL CELLS ªJibran Sualeh Muhammad, Pakistan; S. Nanjo; T. Ando; S. Yamashita; T. Ushijima; T. Sugiyama

14:48 – 15:00 OP248THE EPITHELIAL-MESENCHYMAL TRANSITION PRO-CESS OF NORMAL EPITHELIUM INFECTED BY HELICO-BACTER PYLORI. ROLE OF FIBROBLASTS AND CANCER ASSOCIATED PROTEINSGracjana Krzysiek-Maczka, Poland; A. Ptak-Belowska; A. Targosz; M. Strzalka; U. Szczyrk; T. Brzozowski

15:00 – 15:12 OP249HELICOBACTER PYLORI INFECTION IS AN INDE-PENDENT RISK FACTOR OF EARLY AND ADVANCED COLORECTAL NEOPLASMSo Jung Lee, Republic of Korea; S. H. Kim; T. J. Kim; E. R. Kim; S. N. Hong; D. K. Chang; Y. H. Kim

15:12 – 15:24 OP250HELICOBACTER PYLORI INFECTION ALLEVIATES THE AL-LERGIC SYMPTOMS OF ATOPIC DERMATITIS IN A MOUSE MODEL VIA GENERATION OF CD4+CD25+FOXP3+ T CELLSQian Xue, China; W. J. tong; X. Li

Free Paper Session14:00 – 15:30 Room E3Pancreatic cancer: Risk factors and screeningChairs: Stefano Crippa, Italy

Jonas Rosendahl, Germany

14:00 – 14:12 IP443State-of-the-art introductionJonas Rosendahl, Germany

14:12 – 14:24 OP251INCREASING MORTALITY FROM PANCREATIC CANCER IN PORTUGAL – AN EPIDEMIOLOGICAL ANALYSIS OF 25 YEARSPedro Marques Da Costa, Portugal; R. T. Marinho; H. Cortez-Pinto; L. Costa; J. Velosa

14:24 – 14:36 OP252ADHERENCE TO FOOD GUIDELINES OF THE WORLD CANCER RESEARCH FUND & AMERICAN INSTITUTE FOR CANCER RESEARCH AND PANCREATIC CANCER RISKJesse Fest, The Netherlands; R. Ruiter; M. A. Ikram; C. H. J. van Eijck; J. C. Kiefte-de Jong; B. H. Stricker


86





Jaime Bosch, SpainElisabetta Bugianesi Vlad Ratziu, FranceHelen Reeves, United Kingdom

14:45 – 15:00 IP447Trial presentation: A placebo-controlled trial of obeti-cholic acid in primary biliary cholangitisJoost P. H. Drenth, The Netherlands

15:00 – 15:15 IP448Critical reviewTom Hemming Karlsen, Norway


Joost P. H. Drenth, The NetherlandsTom Hemming Karlsen, NorwayMarco Marzioni, ItalyMichael Trauner, Austria

Symposium15:45 – 17:15 Hall 6Multidisciplinary management of complicated luminal Crohn's diseaseChairs: Tine Jess, Denmark


15:45 – 16:07 IP449Imaging of complicated luminal Crohn's diseaseStuart Taylor, United Kingdom

Tandem Talks16:07 – 16:17 IP450Management of ileal abscess: Medical therapy or surgery? Gastroenterologist's viewSeverine Vermeire, Belgium

16:17 – 16:27 IP451Management of ileal abscess: Medical therapy or surgery? Surgeon's viewAndré D'Hoore, Belgium

16:27 – 16:37 IP452Management of symptomatic ileal stricture: Gastroen-terologist's viewYoram Bouhnik, France

16:37 – 16:47 IP453Management of symptomatic ileal stricture: Surgeon's viewYves Panis, France

14:36 – 14:48 OP259INTERPLAY BETWEEN CD80 SIGNALLING AND MIS-MATCH REPAIR GENES EXPRESSION IN THE EARLY STAGES OF COLONIC CARCINOGENESISAndromachi Kotsafti, Italy; M. Scarpa; M. Fassan; S. Morgan; A. Porzionato; C. Marchiori; P. BRUN; I. Angriman; M. Rugge; C. Castoro; I. Castagliuolo; M. Scarpa

14:48 – 15:00 OP260BETA-6-INTEGRIN SERVES AS A NOVEL SERUM TUMOR MARKER AND THERAPEUTIC TARGET FOR COLORECTAL CARCINOMAS. Bengs; E. Becker; M. R. Spalinger; T. Raselli; S. Kasper; S. Lang; K. Atrott; C. Mamie; N. Britzen-Laurent; L. von Boehmer; A. K. R. Knuth; A. Tuomisto; M. J. Mäkinen; P. Hruz; M. Turina; A. Rickenbacher; H. Petrowsky; A. Weber; P. Frei; S. Vavricka; M. Halama; R. S. Croner; J. Christoph; G. Jenkins; D. Sheppard; M. Stürzl; M. Fried; G. Rogler; Michael Scharl, Switzerland

15:00 – 15:12 OP261RESPONSIBLE GENES FOR CHARACTERISTICS OF THE INDUCED CANCER STEM-LIKE SPHERE CELLS OF HEPA-TOCELLULAR CARCINOMARyouichi Tsunedomi, Japan; K. Yoshimura; M. Nishiyama; S. Matsukuma; S. Kanekiyo; Y. Tokumitsu; S. Tomochika; Y. Tokuhisa; M. Iida; K. Sakamoto; N. Suzuki; S. Takeda; S. Yamamoto; S. Yoshino; S. Hazama; T. Ueno; H. Nagano

15:12 – 15:24 OP262IN VIVO EFFICACY OF LOCAL THERAPY WITH ADHESIVE WAFER CONTAINING ANTICANCER DRUG IN AN OR-THOTOPIC PANCREATIC CANCER MOUSE MODELEunhye Lee, Republic of Korea; J. H. Maeng; Y. H. Nan; K. Kim; S. Jeong; D. H. Lee

Symposium14:00 – 15:30 HotspotClinical trials revisited: New drugs in liver diseasesChair: Heiner Wedemeyer, Germany

14:00 – 14:15 IP445Trial presentation: Elafibranor, an agonist of the peroxisome proliferator-activated receptor-α and -δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worseningVlad Ratziu, France

14:15 – 14:30 IP446Critical reviewJaime Bosch, Spain


87


Tues

day,

Oct

ober

31,

201

7


Symposium15:45 – 17:15 Room C2East meets West: Oesophageal cancerChairs: Hironori Yamamoto, Japan

Riccardo Rosati, Italy

15:45 – 16:07 IP459Epidemiology and risk factorsIsabelle Soerjomataram, France

16:07 – 16:29 IP460Neo-adjuvant treatmentTeresa Macarulla, Spain

Tandem Talks16:29 – 16:39 IP461Endoscopic treatment: EastNaoyuki Yamaguchi, Japan

16:39 – 16:49 IP462Endoscopic treatment: WestMichael B Wallace, USA

Tandem Talks16:49 – 16:59 IP463Surgical treatment: EastHaruhiro Inoue, Japan

16:59 – 17:09 IP464Surgical treatment: WestMark Ivo van Berge Henegouwen, The Netherlands

Symposium15:45 – 17:15 Room F3Therapy update: Nutritional therapy in gastroenterologyChairs: Antonio Gasbarrini, Italy

Herbert Tilg, Austria

15:45 – 16:07 IP465Pre-operative nutritional interventionsAndré Van Gossum, Belgium

16:07 – 16:29 IP466Acute pancreatitis: From nil by mouth to early feedingStephan Bischoff, Germany

16:29 – 16:51 IP467Nutritional interventions and cancerFrancisca Joly, France

16:51 – 17:13 IP468Intestinal failureLoris Pironi, Italy

16:47 – 16:59 OP263PATIENT-REPORTED OUTCOMES WITH UPADACITINIB IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: PHASE 2 RESULTS FROM CELEST STUDYLaurent Peyrin-Biroulet, France; E. Louis; E. V. Loftus Jr; N. Tundia; M. Fuldeore; A. Lacerda; J. Enejosa; A. Pangan

16:59 – 17:11 OP264FECAL MICROBIOTA TRANSPLANT FOR CROHN’S DISEASE: A PROSPECTIVE, RANDOMIZED STUDY IN CHINESE POPULATIONZhenyu Yang, China; X. Wang; C. bu

Symposium15:45 – 17:15 Room C1Case finding and surveillance of Barrett's oesophagusChairs: Jacques J. Bergman, The Netherlands

Cord Langner, Austria

Tandem Talks15:45 – 15:55 IP454Screening for Barrett's: Biomarkers and risk factorsJesper Lagergren, Sweden

15:55 – 16:05 IP455Screening for Barrett's: EndoscopyMarcia Irene Canto, USA

16:05 – 16:17 OP265A NOVEL, INTERACTIVE WEB-BASED EDUCATION-AL TOOL IMPROVES DETECTION AND DELINEATION OF BARRETT’S OESOPHAGUS RELATED NEOPLASIA (BORN): THE BORN PROJECT.Jacques J. Bergman, The Netherlands; O. Pech; K. Ragunath; D. Armstrong; G. Tytgat; J. Dent; L. Lundell; M. Vieth; P. Sharma

16:17 – 16:29 OP266MANAGEMENT OF PATIENTS WITH BARRETT’S OE-SOPHAGUS: A COST-EFFECTIVENESS ANALYSISAmir-Houshang Omidvari, The Netherlands; S. Kroep; I. Lansdorp-Vogelaar; A. Ali; W. D. Hazelton; E. Richmond; C. Y. Kong; J. H. Rubenstein; G. Luebeck; C. Hur; J. Inadomi

Debate16:29 – 16:39 IP456Suspected Barrett's epithelium: Endoscopy is enoughRaf Bisschops, Belgium

16:39 – 16:49 IP457Suspected Barrett's epithelium: Histopathology is necessaryMarnix Jansen, United Kingdom

16:49 – 17:11 IP458Surveillance of known Barrett's: A rational approachOliver Pech, Germany


88




16:07 – 16:29 IP478Disorders of oesophageal motilityMark Fox, Switzerland

16:29 – 16:51 IP479Gastro-oesophageal reflux diseaseEdoardo Savarino, Italy

Debate16:51 – 17:01 IP480High-resolution manometry is pivotal in the assess-ment of defecation disordersSatish Rao, USA

17:01 – 17:11 IP481High-resolution manometry is not essential in the assessment of defecation disordersEmma Carrington, United Kingdom

Symposium15:45 – 17:15 Room A1Update on diverticular diseaseChairs: Ronan O'Connell, Ireland

Julian Walters, United Kingdom

15:45 – 16:07 IP482Definition, epidemiology and risk factorsAnne Peery, USA

16:07 – 16:29 IP483Pathophysiology: What is new?Giovanni Barbara, Italy

16:29 – 16:51 IP484Management of symptomatic uncomplicated divertic-ular diseaseRobin Spiller, United Kingdom

16:51 – 17:13 IP485When to operate in recurrent uncomplicated diverticulitis?Desmond C. Winter, Ireland

Free Paper Session15:45 – 17:15 Room A3Potential future targets in IBDChairs: Charlotte Hedin, Sweden

Subrata Ghosh, Canada

15:45 – 15:57 IP486State-of-the-art introductionCharlotte Hedin, Sweden

15:57 – 16:09 OP267MIR-9 INHIBITS GROWTH OF INTESTINAL EPITHELIAL CELLS AND PROMOTES EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CROHN’ S DISEASE AND MURINE COLITISYe Zhao, China; R. Shi

Symposium15:45 – 17:15 Room F2Common mistakes in biliary obstruction managementChairs: Stefan Seewald, Switzerland

Geoffroy Vanbiervliet, France

15:45 – 16:07 IP469Pitfalls in the diagnostic work upDaniel Bléro, Belgium

16:07 – 16:29 IP470How to prevent and manage infectionsJörg Albert, Germany

16:29 – 16:51 IP471How to optimise endoscopic managementAndrea Tringali, Italy

16:51 – 17:13 IP472When to call the surgeon?Olivier Farges, France

Symposium15:45 – 17:15 Room F1From guidelines to clinical practice: Upper GI bleedingChairs: Peter D. Siersema, The Netherlands

Paul Fockens, The Netherlands

15:45 – 16:07 IP473Non variceal upper GI bleeding: European guidelinesIan Gralnek, Israel

16:07 – 16:29 IP474The patient with portal hypertensionMostafa Ibrahim, Belgium

16:29 – 16:51 IP475The place of capsule endoscopy and enteroscopyAndrea May, Germany

16:51 – 17:13 IP476The patient on anticoagulant therapyCesare Hassan, Italy

Symposium15:45 – 17:15 Room A2Improved testing for upper and lower GI dysmotilityChairs: Sabine Roman, France

Anton Emmanuel, United Kingdom

15:45 – 16:07 IP477Swallowing disordersNathalie Rommel, Belgium


89


Tues

day,

Oct

ober

31,

201

7


16:09 – 16:21 OP274VARIATION BETWEEN PATHOLOGICAL MEASUREMENT AND ENDOSCOPIC ESTIMATED SIZE OF COLONIC POLYPSCatarina Atalaia Martins, Portugal; P. Marcos; S. Barbeiro; A. Fernandes; A. Santos; L. Eliseu; C. Gonçalves; I. Cotrim; H. Vasconcelos

16:21 – 16:33 OP275SHOULD WE RESECT AND DISCARD SMALL AND DIMINUTIVE POLYPS? S. Mifsud; E. L. Schembri; M. Muscat; Pierre Ellul, Malta

16:33 – 16:45 OP276APPROPRIATE INTERVALS TO LOOK FOR LOCAL RECURRENCE AFTER ENDOSCOPIC TREATMENT OF COLORECTAL NEOPLASMS.Yoriaki Komeda, Japan; H. Kashida; T. Sakurai; T. Nagai; S. Matsui; M. Kudo

16:45 – 16:57 OP277OPTICAL DIAGNOSIS OF T1 COLORECTAL CANCER AMONGST ACCREDITED ENDOSCOPISTS IN A NATION-WIDE BOWEL CANCER SCREENING PROGRAMJasper Vleugels, The Netherlands; L. Koens; Y. Hazewinkel; P. Fockens; E. Dekker; O. B. O. T. DISCOUNT study group

16:57 – 17:09 OP278TIME TO POLYPECTOMY COMPETENCY IN THE UK: RETROSPECTIVE ANALYSIS OF 1633 DOPYS FROM 131 TRAINEESArun Rajendran, United Kingdom; S. Thomas-Gibson; P. Bassett; R. Rameshshanker; P. Dunckley; N. Sevdalis; A. Haycock

Translational Basic Science15:45 – 17:15 Room B3Emerging biomarkers in GI cancer medicineChairs: Rebecca Clare Fitzgerald, United Kingdom

Massimo Rugge, Italy

15:45 – 16:07 IP488The biomarker roadmapMassimiliano di Pietro, United Kingdom

16:07 – 16:29 IP489Upper GI cancerKausilia K. Krishnadath, The Netherlands

16:29 – 16:51 IP490Lower GI cancerVictor Moreno, Spain

16:51 – 17:03 OP279NOVEL COMBINATION OF CIRCULATING MICRORNAS FOR DETECTION OF EARLY GASTRIC CANCERSeiichiro Abe, Japan; J. Matsuzaki; K. Sudo; I. Oda; H. Katai; K. Kato; J. Kawauchi; S. Takizawa; H. Sakamoto; F. Takeshita; S. Niida; Y. Saito; T. Ochiya

16:09 – 16:21 OP268TARGETING NAD IMMUNOMETABOLISM AS NOVEL THERAPEUTIC STRATEGY IN IBDRomana Gerner, Austria; V. Klepsch; K. Arnhard; T. E. Adolph; S. Macheiner; C. Grander; N. Hermann-Kleiter; H. Oberacher; G. Baier; H. Tilg; A. R. Moschen

16:21 – 16:33 OP269BALANCING JAK/STAT-SIGNALING WITH TOFACITINIB IN MONOCYTES OF HEALTHY CONTROLS AND IBD PATIENTS ªFriederike Cordes, Germany; E. Lenker; T. Weinhage; D. Bettenworth; G. Varga; D. Foell

16:33 – 16:45 OP270CHROMOFUNGIN, CGA47-66 DERIVED PEPTIDE, PRO-MOTES ALTERNATIVELY ACTIVATED MACROPHAGES, SUPPRESSES CLASSICALLY ACTIVATED MACROPHAGES AND IMPROVES EPITHELIAL BARRIER FUNCTIONS DURING COLITIS ªNour Eissa, Canada; L. Kermarrec; C. N. Bernstein; J.-E. Ghia

16:45 – 16:57 OP271A ROLE FOR THE NADPH OXIDASES NOX1 AND P22PHOX IN VEOIBDS. Lipinski; Florian Tran, Germany; B. Petersen; S. Stengel; M. Barann; M. Jentzsch; A. Franke; S. Schreiber; P. Rosenstiel

16:57 – 17:09 OP272A NOVEL ORAL DOMAIN ANTIBODY TO TUMOUR NECROSIS FACTOR (TNF), ENGINEERED TO BE STABLE TO INTESTINAL PROTEASES, RESULTS IN HIGH CON-CENTRATIONS OF ACTIVE COMPOUND DETECTED IN FAECES OF CROHN’S PATIENTS AFTER ORAL DOSINGJ. Robinson; S. Crowe; M. West; T. Carlton; L. Maggiore; G. Whale; J. Ritter; P. Irving; Suhail Nurbhai, United Kingdom

Free Paper Session15:45 – 17:15 Room B2Quality assurance in colonoscopy: Room for improve-ment?Chairs: Michal Filip Kaminski, Poland

Ana Wilson, United Kingdom

15:45 – 15:57 IP487State-of-the-art introductionMichal Filip Kaminski, Poland

15:57 – 16:09 OP273SUSTAINED CHANGE IN COLONOSCOPY PRACTICE 3 YEARS AFTER INTRODUCTION OF QUALITY IMPROVE-MENT IN COLONOSCOPY (QIC) BUNDLELaura Jane Neilson, United Kingdom; J. E. East; P. T. Rajasekhar; S. Dunn; R. Bevan; S. Paremal; S. Esmaily; C. J. Rees


90




16:21 – 16:33 OP283EFFECT OF LACTOBACILLUS PARACASEI CNCM I-1572 ON SYMPTOMS, GUT MICROBIOTA, SHORT CHAIN FATTY ACIDS, AND IMMUNE ACTIVATION IN PATIENTS WITH IRRITABLE BOWEL SYNDROME: A RANDOMIZED CLINICAL TRIAL.Cesare Cremon, Italy; S. Guglielmetti; A. M. Castellazzi; W. Fiore; M. Bellini; M. Cicala; M. R. Barbaro; L. Bellacosa; V. Stanghellini; G. Barbara

16:33 – 16:45 OP284PATIENT-REPORTED OUTCOMES WITH NALDEMEDINE LONG-TERM TREATMENT OF OPIOID-INDUCED CONSTIPA-TION (OIC) IN SUBJECTS WITH CHRONIC NON-CANCER PAINJan Tack, Belgium; M. Camilleri; B. Cai; T. Yamada; J. C. Arjona Ferreira

16:45 – 16:57 OP285RANDOMIZED CLINICAL TRIAL OF FOUR TREATMENTS FOR FAECAL INCONTINENCE AMONG ADULT COMMUNI-TY-DWELLING WOMEN: ASSESSMENT OF INDIVIDUAL EFFICACY OF ANORECTAL PHYSIOLOGY, THE IMPACT ON CLINICAL SEVERITY AND ON QUALITY OF LIFELluís Mundet, Spain; L. Rofes; O. Ortega; P. Clavé

16:57 – 17:09 OP286THE EFFECT OF ZESPRI GREEN KIWIFRUIT ON DIGES-TIVE FUNCTIONS IN CONSTIPATED PATIENTS: A MULTI-CENTRE, RANDOMIZED, CONTROLLED, SINGLE-BLIND, CROSS-OVER STUDYCesare Cremon, Italy; J. Ansell; I. Pagano; B. Kuhn-Sherlock; L. Drummond; M. R. Barbaro; E. Capelli; L. Belacosa; V. Stanghellini; G. Barbara

Symposium15:45 – 17:15 Room E1EU funding: What UEG can offerChairs: Michael Manns, Germany

Arthur Kaser, United Kingdom

Introduction

15:45 – 15:50 IP496Importance of research coordination in European digestive healthMichael Manns, Germany

15:50 – 16:05 IP497Funding opportunities for digestive health research in Horizon 2020Rebecca Breuer, Germany

Case studies and role models in digestive health research

16:05 – 16:20 IP498Leading a Horizon 2020 research consortiumPhilip Rosenstiel, Germany

16:20 – 16:35 IP499Winning a Marie-Curie fellowshipMarkus Tschurtschenthaler, Germany

17:03 – 17:15 OP280CIRCULATING TUMOR DNA FOR MONITORING COLORECTAL CANCER – RELATIONSHIP TO TISSUE METHYLATION, CANCER CHARACTERISTICS AND COM-PLETENESS OF RESECTIONGraeme Young, Australia; E. Symonds; D. Murray; S. Pedersen; S. Byrne; P. Rabbitt; R. Baker

Today's Science, Tomorrow's Medicine15:45 – 17:15 Room E4Microbiota: Future directionsChairs: Mirjana Rajilic-Stojanovic, Serbia

Muriel Derrien, France

15:45 – 16:07 IP491Rising Star: Clinical implication of gut microbiome in primary sclerosing cholangitis (PSC) ªJohannes Roksund Hov, Norway

16:07 – 16:29 IP492"Omics" in clinical practice: Between dreams and real needsMirjana Rajilic-Stojanovic, Serbia

16:29 – 16:51 IP493Next-generation probioticsMax Nieuwdorp, The Netherlands

16:51 – 17:13 IP494The future of FMT: Indications, techniques, regulatory issuesGianluca Ianiro, Italy

Free Paper Session15:45 – 17:15 Room 7.1Randomised controlled trials in functional lower GI disordersChairs: Philippe Van Hootegem, Belgium

Daniel Keszthelyi, The Netherlands

15:45 – 15:57 IP495State-of-the-art introductionDaniel Keszthelyi, The Netherlands

15:57 – 16:09 OP281PRELIMINARY RESULTS OF A RANDOMISED CON-TROLLED TRIAL ON HYPNOTHERAPY FOR IRRITABLE BOWEL SYNDROME (THE IMAGINE STUDY).Carla Flik, The Netherlands; Y. R. van Rood; W. Laan; A. Smout; B. L. A. M. Weusten; P. Whorwell; N. J. De Wit

16:09 – 16:21 OP282INDIVIDUAL VERSUS GROUP HYPNOTHERAPY FOR IBS: A RANDOMIZED CONTROLLED TRIALJenny Lövdahl, Sweden; O. S. Palsson; G. Ringström; H. Törnblom; M. Simrén


91


Tues

day,

Oct

ober

31,

201

7


16:45 – 16:57 OP291CLINICAL EFFECT AND SAFETY OF ENDOSCOPIC RADIOF-REQUENCY ABLATION FOR UNRESECTABLE EXTRAHE-PATIC CHOLANGIOCARCINOMA-A PROSPECTIVE STUDYJianfeng Yang, China; Y. zhou; Q. Lou; W. Gu; X. Zhang

16:57 – 17:09 OP292PREDNISONE DOSAGE AND CHANCE OF REMISSION IN PATIENTS WITH AUTOIMMUNE HEPATITIS: AN INTER-NATIONAL MULTICENTER COHORT STUDYSimon Pape, The Netherlands; T. J. Gevers; I. F. Mustafajev; F. F. van den Brand; C. M. van Nieuwkerk; G. Bouma; J. M. Vrolijk; J. Hartl; A. W. Lohse; C. Schramm; J. P. H. Drenth

Free Paper Session15:45 – 17:15 Room E3From prevention to therapy of oesophago-gastric cancerChairs: Juozas Kupcinskas, Lithuania

Jurjen Boonstra, The Netherlands

15:45 – 15:57 IP503State-of-the-art introductionJurjen Boonstra, The Netherlands

15:57 – 16:09 OP293LONG-TERM ASPIRIN AND RISK OF GASTRIC CANCER AFTER H. PYLORI ERADICATION: A POPULATION-BASED STUDY WITH PROPENSITY SCORE ANALYSISKa Shing Cheung, Hong Kong PRC; A. Y. Wong; E. W. Chan; L. Chen; I. C. Wong; W. K. Leung

16:09 – 16:21 OP294GASTRIC INTESTINAL METAPLASIA IS SIGNIFICANTLY ASSOCIATED WITH POST ENDOSCOPY NON-CAR-DIA GASTRIC CANCERYifat Snir, Israel; A. Vilkin; R. Gingold Belfer; D. Boltin; O. Sneh Arbib; I. Feldhamer; Y. Niv; I. Dotan; Z. Levi

16:21 – 16:33 OP295ROLE OF MIR-20B-5P, MIR-451A-5P AND MIR-1468-5P IN GASTRIC CANCERGreta Streleckiene, Lithuania; J. Kupcinskas; S. Juzenas; R. Gedgaudas; V. Salteniene; A. Link; M. Leja; G. Kiudelis; L. Jonaitis; R. Lukosevicius; R. Inciuraite; G. Hemmrich-Stanisak; M. Hübenthal; A. Franke; P. Malfertheiner; L. Kupcinskas; J. Skieceviciene

16:33 – 16:45 OP296AMOTL1 IS INVOLVED IN HIPPO PATHWAY BY PROMOT-ING YAP1 NUCLEAR LOCALIZATION TO DRIVE GASTRIC CARCINOGENESISYuhang Zhou, Hong Kong PRC; T. HUANG; J. Zhang; C. C. Wong; Y. Dong; A. S. L. Cheng; J. Yu; K. F. To; W. Kang

16:35 – 16:50 IP500Applying for an ERC grantHarry Sokol, France

16:50 – 17:00Discussion and questions from the audience

UEG as facilitator for European digestive health research

17:00 – 17:10 IP501How UEG can support your application to EU fundingArthur Kaser, United Kingdom

17:10 – 17:15Discussion and questions from the audience

Free Paper Session15:45 – 17:15 Room E2Autoimmune and cholestatic liver diseases: NoveltiesChairs: Olivier Chazouillères, France

Ewa Wunsch, Poland

15:45 – 15:57 IP502State-of-the-art introductionOlivier Chazouillères, France

15:57 – 16:09 OP287SURROGATE MARKERS FOR DISEASE PROGRESSION AND RISK FOR BILIARY NEOPLASIA IN PRIMARY SCLE-ROSING CHOLANGITIS Martti A. Färkkila, Finland; H. Mustonen; K. Jokelainen; J. Arola; H. Alfthan

16:09 – 16:21 OP288DURABLE RESPONSE IN THE MARKERS OF CHOLESTASIS THROUGH 24 MONTHS OF OPEN-LABEL EXTENSION STUDY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITISMichael Trauner, Austria; F. Nevens; P. Andreone; G. Mazzella; S. Strasser; P. Invernizzi; J. P. H. Drenth; P. Pockros; J. Regula; A. Floreani; S. Hohenester; V. Luketic; M. Shiffman; K. van Erpecum; V. Vargas; C. Vincent; B. Hansen; C. Bowlus; L. MacConell; E. Smoot Malecha; D. Shapiro

16:21 – 16:33 OP289DIFFERENTIAL EFFECTS OF FXR OR TGR5 ACTIVATION IN CHOLANGIOCARCINOMA PROGRESSIONO. Erice; I. Labiano; A. Arbelaiz; A. Santos-Laso; P. Munoz-Garrido; A. Caro-Maldonado; N. Martin-Martin; A. Carracedo; E. Lozano; J. J. Marin; C. J. O'Rourke; J. B. Andersen; J. Llop; V. Gomez-Vallejo; D. Padro; A. Martin; M. Marzioni; L. Adorini; M. Trauner; L. Bujanda Fernández de Piérola; M. J. Perugorría; Jesus M. Banales, Spain

16:33 – 16:45 OP290THE ROLE OF PNPLA3 (RS738409 C>G P.I148M) ALLELE DOSE ON BILE ACID COMPOSITION IN PRIMARY SCLE-ROSING CHOLANGITIS (PSC)Martti A. Färkkila, Finland; A. Tenca; H. Kautiainen


92




16:33 – 16:45 OP302SEMAPHORIN-3E PLAYS A ROLE IN TIGHT JUNCTION EPITHELIAL BARRIER MAINTENANCE IN PATIENTS WITH ACTIVE ULCERATIVE COLITISLaetitia Kermarrec, Canada; N. Eissa; C. N. Bernstein; J.-E. Ghia

16:45 – 16:57 OP303ENDOPLASMIC RETICULUM STRESS INCREASES TRYPSIN-3 ACTIVITY IN ENTEROCYTES AND ALTERS BARRIER FUNCTION.Nuria Sola Tapias, France; A. Denadai-Souza; C. Rolland-Fourcade; C. Blanpied; G. Dietrich; C. Bonnart; A. Edir; C. Rolland; C. Deraison; N. Vergnolle; F. Barreau

16:57 – 17:09 OP304INTESTINAL EPITHELIAL BARRIER DYSFUNCTION IN PATIENTS WITH CHRONIC INTESTINAL PSEUDO-OB-STRUCTIONElisa Boschetti, Italy; V. Bertakis; T. M. P. B. Karunaratne; A. Accarino; C. Malagelada; F. Azpiroz; R. Cogliandro; E. Bonora; P. CLAVENZANI; U. Volta; G. Caio; A. Gori; V. Stanghellini; R. De Giorgio

Symposium15:45 – 17:15 E-Poster Lounge 1How to submit a good paperChairs: Johan Burisch, Denmark

Madalina Ilie, Romania

15:45 – 16:00 IP505How to write a good research abstractLukas Van Oudenhove, Belgium

16:00 – 16:15 IP506Evidence Based Medicine: What can it do for you?Hania Szajewska, Poland

16:15 – 16:30 IP507How to choose a journal for your paperC. Janneke van der Woude, The Netherlands

16:30 – 16:45 IP508How to write a good discussionEmad El-Omar, Australia


16:45 – 16:57 OP297PERIOPERATIVE CHEMOTHERAPY WITH DOCETAXEL, OXALIPLATIN AND FLUOROURACIL/LEUCOVORIN (FLOT) VERSUS EPIRUBICIN, CISPLATIN AND FLUORO-URACIL OR CAPECITABINE (ECF/ECX) FOR RESECTABLE GASTRIC OR GEJ ADENOCARCINOMA (FLOT4-AIO): A RANDOMIZED PHASE 3 TRIAL.Nils Homann, Germany; H. Schmalenberg; H.-G. Kopp; G. M. Haag; K. B. Luley; W. Schmiegel; G. Folprecht; S. Probst; N. Prasnikar; P. Thuss-Patience; W. Fischbach; J. Trojan; M. Koenigsmann; C. Pauligk; T. O. Goetze; T. W. Kraus; A. Battmann; S. P. Moenig; W. Bechstein; T. Gaiser; A. Tannapfel; E. Jäger; M. Schuler; U. Lindig; M. Pohl; S. Kasper; R. D. Hofheinz; S.-E. Al-Batran

16:57 – 17:09 OP298TUMOR ASSOCIATED MACROPHAGES AS NOVEL TARGETS FOR IMMUNOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA Silvia Calpe, The Netherlands; S. Hoefnagel; S. Bouchmal; C. del Sancho-Serra; D. Straub; K. K. Krishnadath

Free Paper Session15:45 – 17:15 Room B5Nerves & barrier function in health & diseaseChairs: Roberto De Giorgio, Italy

Johanna Sundin, Sweden

15:45 – 15:57 IP504State-of-the-art introductionRoberto De Giorgio, Italy

15:57 – 16:09 OP299ESTROGEN RECEPTOR BETA STIMULATION CONTROLS ENTERIC NEURON AND GLIAL CELL PROLIFERATION IN VITRO AND IN VIVOFrancesca D'Errico, Belgium; G. Goverse; Y. Dai; W. Wu; E. Labeeuw; P. J. Gomez-Pinilla; M. Stakenborg; M. Warner; A. Di Leo; J.-Å. Gustafsson; G. Matteoli

16:09 – 16:21 OP300CD90+ SUBPOPULATION OF FIBROBLASTS AS A MES-ENCHYMAL STEM CELL NICHE IN THE COLONOlga Karpus, The Netherlands; B. F. Westendorp; J. J. Koster; S. Meisner; V. Muncan; M. E. Wildenberg; G. R. van den Brink

16:21 – 16:33 OP301INDIAN HEDGEHOG SUPPRESSES A STROMAL CELL DRIVEN INTESTINAL IMMUNE RESPONSEB. Florien Westendorp, The Netherlands; N. V. J. A. Büller; O. N. Karpus; W. A. van Dop; J. J. Koster; R. Versteeg; P. J. Koelink; C. Snel; S. Meisner; J. J. T. H. Roelofs; A. Uhmann; E. Ver Loren van Themaat; J. Heijmans; H. Hahn; V. Muncan; M. E. Wildenberg; G. R. van den Brink


93


Tues

day,

Oct

ober

31,

201

7


16:25 – 16:35 OP309SQLE DRIVES HEPATOCARCINOGENESIS AND IS A THERA- PEUTIC TARGET IN NONALCOHOLIC FATTY LIVER DIS-EASE-ASSOCIATED HEPATOCELLULAR CARCINOMA ªDabin Liu, Hong Kong PRC; C. C. Wong; H. Chen; L. Fu; L. Zhao; C. Li; J. JY Sung; J. Yu

16:35 – 16:45 OP310A XENOTRANSPLANTATION APPROACH USING HUMAN PLURIPOTENT STEM CELL-DERIVED PANCREATIC ORGANOIDSMeike Hohwieler, Germany; Z. Xiaofeng; P. C. Hermann; L. Perkhofer; T. Seufferlein; B. Böhm; Y. Ali; A. Kleger

16:45 – 16:55 OP311FEASIBILITY OF WHOLE EXOME SEQUENCING AND GENOMIC PROFILING OF PANCREAS TUMOR TISSUE OBTAINED WITH A NOVEL FORK-TIPPED EUS GUIDED FINE NEEDLE CORE BIOPSYPujan Kandel, USA; A. Nassar; G. Tranesh; C. Graddy; R. Bingham; B. Brahmbhatt; V. Gomez; M. Raimondo; T. Woodward; M. B. Wallace

16:55 – 17:05 OP312USEFULNESS OF COMPLEMENTARY PANCREATIC JUICE CYTOLOGY IN AVOIDING UNNECESSARY SURGERY FOR PANCREATIC INTRA-DUCTAL PAPILLARY MUCINOUS NEOPLASMMohammed Tag-Adeen, Japan; E. Ozawa; K. Ogihara; S. Iwatsu; Y. Akazawa; K. Ohnita; T. Adachi; Y. Sumida; K. Nakao

17:05 – 17:15 OP313COMPARISON OF AMERICAN GASTROENTEROLOGI-CAL ASSOCIATION, INTERNATIONAL ASSOCIATION OF PANCREATOLOGY, AND AMERICAN COLLEGE OF RA-DIOLOGY GUIDELINES FOR DIAGNOSIS OF MALIGNANT PANCREATIC CYSTSMeir Mizrahi, USA; T. Kent; K. J. Mortele; J. Moser; J. Tseng; M. Callery; J. Cohen; T. Berzin; D. Pleskow; M. Sawhney

Free Paper Session15:45 – 17:15 HotspotAbstracts on Fire: Hepatobiliary and pancreatic ma-lignancies: From bench to bedsideChairs: Marcello Fabio Maida, Italy

Eithne Costello-Goldring, United Kingdom

15:45 – 15:55 OP305PREOPERATIVE ENDOSCOPIC VERSUS PERCUTANEOUS TRANSHEPATIC BILIARY DRAINAGE IN RESECTABLE PERIHILAR CHOLANGIOCARCINOMA: A MULTICENTER RANDOMIZED CONTROLLED TRIALEva Roos, The Netherlands; R. J. S. Coelen; J. K. Wiggers; E. A. J. Rauws; O. M. van Delden; B. Groot Koerkamp; J. N. M. IJzermans; C. H. J. van Eijck; J. de Jonge; R. J. Porte; C. I. Buis; C. H. Dejong; V. van Woerden; D. J. Gouma; M. G. H. Besselink; O. R. C. Busch; M. G. W. Dijkgraaf; T. M. van Gulik

15:55 – 16:05 OP306IMPACT OF THE PREOPERATIVE GD-EOB-DTPA-EN-HANCED MRI ON PROGNOSIS AFTER HEPATECTOMY IN THE PATIENTS WITH HEPATOCELLULAR CARCINOMAMasaharu Tada, Japan; E. Hatano; T. Okada; Y. Asano; N. Uyama; K. Suzumura; I. Nakamura; Y. Kondo; S. Hai; H. Sueoka; H. Iwama; A. Kurimoto; R. Ito; H. Nishida; K. Iida; J. Fujimoto

16:05 – 16:15 OP307SAFETY AND EFFICACY OF TAE AND SIRT IN NET PATIENTS.Linde van Veenendaal, The Netherlands; A. Braat; M. Meier; K. Samsom; W. Verbeek; M. Vriens; G. Valk; W. Prevoo; M. Lam; M. Tesselaar

16:15 – 16:25 OP308GEMCITABINE AND PLATINUM BASED CHEMOTHERAPY FOR THE FIRST LINE TREATMENT OF HEPATOCHOL-ANGIOCARCINOMA : AN AGEO MULTICENTER RETRO-SPECTIVE STUDYMaeva Salimon, France; C. Prieux-Klotz; D. Tougeron; T. Lecomte; M. Caulet; T. Matysiak Budnik; V. Hautefeuille; M. Tiako-Meyo; A. Zaanan; Y. Touchefeu

Wednesday, November 1, 2017

94


Wednesday, N

ovember 1, 2017


Symposium08:30 – 10:00 Room F1Resolving the enigma of coeliac diseaseChairs: Katri Kaukinen, Finland

Michael Schumann, Germany

08:30 – 08:52 IP517Gluten immune response and enteropathyFrits Koning, The Netherlands

08:52 – 09:14 IP518The role of genes in coeliac diseaseSebo Withoff, The Netherlands

09:14 – 09:36 IP519Environmental factors other than glutenDaniel Agardh, Sweden

09:36 – 09:58 IP520Extraintestinal manifestation and associated autoim-mune disordersKnut E. A. Lundin, Norway

Symposium08:30 – 10:00 Room A2Quality in endoscopy: How to use and interpret per-formance measures?Chairs: Matthew David Rutter, United Kingdom

Helmut Neumann, Germany

08:30 – 08:52 IP521Why performance measures are importantRaf Bisschops, Belgium

Tandem Talks08:52 – 09:02 IP522What are the ESGE/UEG endoscopy performance mea-sures? Upper GI and small bowelCristiano Spada, Italy

09:02 – 09:12 IP523What are the ESGE/UEG endoscopy performance mea-sures? Lower GI and pancreatobiliaryDirk Domagk, Germany

09:12 – 09:34 IP524Endoscopy service performance measuresRoland Valori, United Kingdom

09:34 – 09:56 IP525Top tips for implementing performance measures and how to maximise their impactSiwan Thomas-Gibson, United Kingdom

Scientific Programme by DayWednesday, November 1, 2017

Symposium08:30 – 10:00 Hall 6Update on new treatments in IBDChairs: Iris Dotan, Israel

Siew Chien Ng, Hong Kong PRC

08:30 – 08:52 IP509Inhibition of cell migration: Vedolizumab and beyondRaja Atreya, Germany

08:52 – 09:14 IP510Targetting of 12/23 and IL17 pathways: Benefits and limitsAlexander R. Moschen, Austria

09:14 – 09:36 IP511Targetting cell activation: Small molecules and anti-bodiesMatthieu Allez, France

09:36 – 09:58 IP512Hematopietic and mesenchymal stem cellsJulian Panés, Spain

Advances in Clinical GI & Hepatology08:30 – 10:00 Room F2New therapeutic options for functional GI disordersChairs: Guy E. Boeckxstaens, Belgium

Robin Spiller, United Kingdom

08:30 – 08:52 IP513Functional dyspepsiaJan Tack, Belgium

08:52 – 09:14 IP514Irritable bowel syndromeLin Chang, USA

09:14 – 09:36 IP515Functional heartburn and chest painDaniel Sifrim, United Kingdom

09:36 – 09:58 IP516Functional anorectal disordersHenriette Heinrich, United Kingdom


95


Wed

nesd

ay, N

ovem

ber

1, 2

017


Symposium08:30 – 10:00 Room A1Pancreato-biliary EUS: How to do it better?Chairs: Marc Giovannini, France

Jeanin E. van Hooft, The Netherlands

08:30 – 08:52 IP526Seeing is believing: Can elastography and contrast enhancement help?Pierre Eisendrath, Belgium

08:52 – 09:14 IP527Tissue is the issue: How to improve tissue samplingMariana Milashka, France

09:14 – 09:36 IP528Ten mistakes to avoid when performing EUS-guided drainageUlrike Denzer, Germany

09:36 – 09:48 OP314LONG TERM OUTCOMES AND RE-INTERVENTION OF EUS-GUIDED BILIARY DRAINAGE FOR MALIGNANT BILIARY OBSTRUCTIONYousuke Nakai, Japan; H. Isayama; Y. Ito; H. Yagioka; N. Sasahira; N. Yamamoto; S. Matsubara; H. Kogure; S. Mizuno; N. Takahara; T. Hamada; K. Saito; R. Hakuta; K. Ishigaki; T. Takeda; T. Sato; T. Nakamura; M. Tada; K. Koike

09:48 – 10:00 OP315EUS-GUIDED RADIOFREQUENCY ABLATION (RFA) FOR PANCREATIC NEUROENDOCRINE TUMOR (NET) AND PRE-MALIGNANT INTRADUCTAL PANCREATIC MUCINOUS TUMOR (IPMN) : FIRST RESULTS OF PRO-SPECTIVE MULTICENTER STUDYMarc Barthet, France; M. Giovannini; N. Lesavre; B. Napoléon; C. Boustiere; S. Koch; M. Gasmi; J.-M. Gonzalez

Symposium08:30 – 10:00 Room A3Viral hepatitis: Moving towards eliminationChairs: Alessio Aghemo, Italy

Soo Aleman, Sweden

08:30 – 08:52 IP529How to identify asymptomatic viral hepatitis carriers?Charles Helsper, The Netherlands

08:52 – 09:14 IP530Nucleos(t)ide analog (NUC) treatment of hepatitis B: Can we stop therapy?Markus Cornberg, Germany

09:14 – 09:36 IP531Hepatitis C virus therapy: Still unmet needs?Alessio Aghemo, Italy

09:36 – 09:58 IP532Long-term surveillance of patients after viral clearanceMaria Reig, Spain

Symposium08:30 – 10:00 Room B2Submucosal endoscopy: Indications, techniques and outcomesChairs: Guido Costamagna, Italy

Haruhiro Inoue, Japan

08:30 – 08:52 IP533Peroral oesophageal endoscopic myotomyAlbert Jan Bredenoord, The Netherlands

08:52 – 09:14 IP534Peroral endoscopic myotomy of the pylorusGeoffroy Vanbiervliet, France

09:14 – 09:26 OP316LIFE AFTER PERORAL ENDOSCOPIC MYOTOMY (POEM): QUALITY OF LIFE AND ITS ASSOCIATION WITH ECK-ARDT SCORE Y. Perbtani; J. Suarez; L. Mramba; D. Yang; Peter Draganov, USA

09:26 – 09:38 OP317TECHNICAL FEASIBILITY OF ENDOSCOPIC SUBMUCO-SAL DISSECTION FOR LOCAL FAILURE AFTER CHEMO-RADIOTHERAPY OR RADIOTHERAPY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA.Keiichiro Nakajo, Japan; T. Yano; Y. Yoda; K. Hori; K. Takashima; K. Shinmura; Y. Ohno; H. Ikematsu

09:38 – 10:00 IP535Resection of submucosal tumoursPing-Hong Zhou, China

Translational Basic Science08:30 – 10:00 Room B3Intestinal failure: Understanding the cause and treat-ment optionsChairs: André Van Gossum, Belgium

Francisca Joly, France

08:30 – 08:52 IP536Diagnostic assesment of intestinal failureGeert Wanten, The Netherlands

08:52 – 09:14 IP537Physiology of nutrient absorptionKimberley K. Buhman, USA


96


Wednesday, N

ovember 1, 2017


09:30 – 09:42 OP322SIGNIFICANT REDUCTION OF POSTINTERVENTION-AL HAEMORRHAGE AFTER RESECTION OF LARGE DUODENAL ADENOMAS BY THE USE OF A HEMOSTATIC POWDER?Till Mueller, Germany; M. Knabe; J. Wetzka; C. Ell; A. May

09:42 – 09:54 OP323EFFECT OF PROPHYLACTIC CLIP APPLICATION FOR THE PREVENTION OF POSTPOLYPECTOMY BLEEDING IN LARGE PEDUNCULATED COLONIC POLYPS: A RANDOM-IZED, CONTROLLED MULTICENTER TRIALJeong-Seon Ji, Republic of Korea; K.-M. Lee; S.-W. Lee; D. B. Kim; T.-G. Gweon; H. Choi

Free Paper Session08:30 – 10:00 Room 7.1Long-term complications in IBDChairs: Alessandro Armuzzi, Italy

Marianne Rebecca Spalinger, Switzerland

08:30 – 08:42 IP541State-of-the-art introductionAlessandro Armuzzi, Italy

08:42 – 08:54 OP324THE RISK OF PROXIMAL DISEASE EXTENSION IN PA-TIENTS WITH LIMITED ULCERATIVE COLITIS IN A PRO-SPECTIVE EUROPEAN POPULATION-BASED INCEPTION COHORT – THE ECCO-EPICOM COHORT ªJohan Burisch, Denmark; J. Halfvarson; L. Kupcinskas; V. Hernández; I. Kaimakliotis; D. Valpiani; N. Pedersen; D. Duricova; L. Kievit; J. F. Dahlerup; M. Fumery; R. Salupere; N. Arebi; K. R. Nielsen; M. Giannotta; P. Oksanen; K. H. Katsanos; Z. Vegh; P. Ellul; D. Schwartz; S. Čuković-Čavka; R. D’Inca; S. Turcan; F. Magro; A. Goldis; E. Langholz; P. L. Lakatos; P. Munkholm

08:54 – 09:06 OP325EARLY FIBROSTENOSIS IN CROHN’S DISEASE IS AS-SOCIATED WITH MULTIPLE SUSCEPTIBILITY LOCI ON IMMUNOCHIP ANALYSISTom Holvoet, Belgium; P. Bossuyt; I. Cleynen; I. De Kock; P. Hindryckx; S. Vermeire; D. Laukens; M. De Vos

09:06 – 09:18 OP326THE ROLE OF THE IKBA GENE FAMILY MEMBER NFKBIZ IN COLITIS ASSOCIATED CANCERGo Ito, Germany; D. Esser; J. Kuiper; R. Sheibani; S. Schreiber; P. Rosenstiel

09:18 – 09:30 OP327RORGAMMA-T-EXPRESSING TREGS DRIVE GROWTH OF COLITIS-ASSOCIATED COLORECTAL CANCER BY CON-TROLLING IL6 EXPRESSION OF DENDRITIC CELLSAngela Rizzo, Italy; M. Di Giovangiulio; E. Franzè; H.-J. Fehling; R. Carsetti; E. Giorda; G. Monteleone; M. C. Fantini

09:14 – 09:36 IP538Current management of intestinal failureTim Vanuytsel, Belgium

09:36 – 09:58 IP539Building a better human intestineMichael A. Helmrath, USA

Free Paper Session08:30 – 10:00 Room E4Endoscopic management of GI bleeding: What is new?Chairs: Edward Despott, United Kingdom

Madalina Ilie, Romania

08:30 – 08:42 IP540State-of-the-art introductionEdward Despott, United Kingdom

08:42 – 08:54 OP318MULTICENTRE RANDOMISED CONTROLLED TRIAL COM-PARING THE EFFICACY AND SAFETY OF ADDING EARLY HEMOSTATIC POWDER APPLICATION TO ENDOSCOPIC AND MEDICAL TREATMENT IN THE MANAGEMENT OF ACUTE VARICEAL BLEEDING IN CIRRHOTIC PATIENTS.Mostafa Ibrahim, Belgium; A. El-Mikkawy; M. Abdel Hamid; H. Abdalla; A. Lemmers; I. Mostafa; J. Devière

08:54 – 09:06 OP319HIGH EFFICACY OF OTSC AS FIRST-LINE ENDOSCOPIC TREATMENT IN PATIENTS WITH GASTROINTESTINAL BLEEDING: AN ITALIAN MULTICENTRIC EXPERIENCE IN A LARGE COHORT OF PATIENTS.Santi Mangiafico, Italy; S. Russo; M. Lupo; A. Caruso; G. Grande; F. P. Zito; H. Bertani; R. Conigliaro; A. Pisani; B. Germaná; G. Galloro; L. Pasquale; B. Mangiavillano; G. Bassotti; M. Mutignani; R. Manta

09:06 – 09:18 OP320NEW USE OF LOW-DOSE ASPIRIN AND RISK OF UPPER AND LOWER GASTROINTESTINAL BLEEDING: ASSOCI-ATIONS BY CASE-FATALITY, HOSPITALISATION STATUS, BLEEDING LOCATION, ASPIRIN DOSE AND DURATION IN A LARGE OBSERVATIONAL STUDY IN THE UNITED KINGDOML. Cea Soriano; M. Soriano-Gabarró; A. Lanas; Luis Alberto García Rodríguez, Spain

09:18 – 09:30 OP321THE EFFICACY OF POLYGLYCOLIC ACID SHEETS AND FIBRIN GLUE FOR PREVENTING BLEEDING AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR GASTRIC NEOPLASMS (PAGER BUSTER TRIAL): INTENTION TO TREAT ANALYSIS OF A PROSPECTIVE MULTICENTER RANDOMIZED CONTROLLED TRIALYosuke Kataoka, Japan; Y. Tsuji; K. Hirasawa; K. Takimoto; T. Wada; S. Mochizuki; K. Ohata; K. Niimi; S. Ono; S. Kodashima; N. Yamamichi; M. Fujishiro; K. Koike


97


Wed

nesd

ay, N

ovem

ber

1, 2

017


08:42 – 08:54 OP330THE UBIQUITIN-LIKE PROTEIN UBIQUITIN D IS UP-REGULATED BY SYNERGY OF NOTCH AND PRO-IN-FLAMMATORY CYTOKINES IN THE INFLAMED INTESTI-NAL EPITHELIA OF IBD PATIENTS.Ami Kawamoto, Japan; G. Ito; T. Nakata; S. Fujii; K. Suzuki; F. Ishibashi; H. Shimizu; S. Nagata; S. Anzai; R. Kuno; K. Kuwabara; M. Kawai; J. Takahashi; M. Hama; K. Tsuchiya; T. Nakamura; R. Okamoto; M. Watanabe

08:54 – 09:06 OP331WNT5B UP-REGULATION IN THE MUCOSA OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE COULD CONTRIB-UTE TO THE REGENERATION OF INTESTINAL EPITHELIUMIsabella Dotti, Spain; E. Ferrer-Picón; N. Planell; E. H. van Herk; M. Cuatrecasas; J. Panés; A. Salas

09:06 – 09:18 OP332NOVEL HUMAN GUT XENOGRAFT MOUSE MODEL FOR INTESTINAL FISTULAS ªRamona Sonja Bruckner, Switzerland; N. Marsiano; E. Nissim-Eliraz; E. Nir; M. Leutenegger; C. Gottier; S. Lang; M. R. Spalinger; G. Rogler; S. Yagel; M. Scharl; N. Y. Shpigel

09:18 – 09:30 OP333REPROGRAMMED ATOH1+ INTESTINAL EPITHELIAL CELLS CONTRIBUTE TO REGENERATE DAMAGED CO-LONIC MUCOSA IN DSS-INDUCED COLITIS ªFumiaki Ishibashi, Japan; H. Shimizu; A. Kawamoto; G. Ito; T. Nakata; S. Fujii; K. Suzuki; R. Kuno; S. Anzai; K. Kuwabara; M. Kawai; J. Takahashi; M. Hama; S. Nagata; K. Tsuchiya; T. Nakamura; R. Okamoto; M. Watanabe

09:30 – 09:42 OP334THE ROLE OF PH-SENSING RECEPTOR TDAG8 (GPR65) IN INTESTINAL INFLAMMATIONI. Tcymbarevich; Jesus Cosin Roger, Switzerland; S. M. Richards; K. Baebler; M. R. Spalinger; G. Russo; K. Atrott; I. Frey-Wagner; C. A. Wagner; B. Misselwitz; K. Seuwen; G. Rogler; C. de Vallière

09:42 – 09:54 OP335PRO-INFLAMMATORY HUMAN CD11C+ MACROPHAGES, BUT NOT THEIR TOLEROGENIC CD11CDIM OR CD11C- COUNTERPARTS, ARE EXPANDED IN THE INFLAMED MUCOSA FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE. David Bernardo, Spain; I. Mora-Gutierrez; A. C. Marín; A. Montalban-Arques; S. Fernandez-tome; A. Diaz-Guerra; R. Caminero-Fernandez; S. Casabona; P. Miranda; F. Casals; M. Caldas Álvarez; M. Jimenez; F. de la Morena; C. Santander; M. Chaparro; J. P. Gisbert

09:30 – 09:42 OP328NEW METHYLATION BIOMARKER PANEL FOR EARLY DIAGNOSTIC OF DYSPLASIA OR CANCER IN HIGH RISK INFLAMMATORY BOWEL DISEASE PATIENTSDaniel Azuara Garcia, Spain; S. Aussó; F. Rodriguez Moranta; J. Guardiola; X. Sanjuan; T. Lobaton; J. Boadas; E. Guinó; V. Moreno; G. Capella; J. de Oca

09:42 – 09:54 OP329INCIDENT CANCER IN INFLAMMATORY BOWEL DISEASE IN A PROSPECTIVE MULTICENTER NESTED CASE-CONTROL IG-IBD STUDYLivia Biancone, Italy; A. Armuzzi; M. L. Scribano; F. Castiglione; R. D'inca; C. Papi; M. Vecchi; G. Riegler; F. Mocciaro; A. Ruffa; B. Neri; S. Festa; W. Fries; P. Alvisi; M. Daperno; G. Meucci; L. guidi; L. Spina; S. Renna; E. calabrese; F. Rogai; S. Ardizzone; A. Rossi; A. Orlando; F. Pallone

Symposium08:30 – 10:00 Room E1Update on gastric precancerous conditions and lesionsChairs: Fatima Carneiro, Portugal

Emad El-Omar, Australia

08:30 – 08:52 IP542Time for a new classification of gastritis?Peter Malfertheiner, Germany

08:52 – 09:14 IP543Is there a place for subtyping intestinal metaplasia?Maria Blanca Piazuelo, USA

Debate09:14 – 09:24 IP544Targeted biopsies suffice: The endoscopist's viewMario Dinis-Ribeiro, Portugal

09:24 – 09:34 IP545Random biopsies are required: The pathologist's viewMassimo Rugge, Italy

09:34 – 09:56 IP546Guidelines on management of precancerous lesions: Where do we stand?Ernst J. Kuipers, The Netherlands

Free Paper Session08:30 – 10:00 Room E2Pathogenesis of IBDChairs: Andreas Sturm, Germany

Mathieu Uzzan, France

08:30 – 08:42 IP547State-of-the-art introductionAndreas Sturm, Germany


98


Wednesday, N

ovember 1, 2017


Symposium08:30 – 10:00 HotspotControversies around serrated colorectal lesionsChair: James Edward East, United Kingdom

08:30 – 08:33 IP549IntroductionJames Edward East, United Kingdom

08:33 – 08:38 IP550With proper technique and equipment you detect all serrated lesionsMichael Bretthauer, Norway,


08:53 – 08:58 IP551All serrated lesions need sub-classificationIris D. Nagtegaal, The Netherlands


09:13 – 09:18 IP552All serrated lesions should be endoscopically removedMichal Filip Kaminski, Poland


09:33 – 09:38 IP553Short surveillance intervals are needed for patients with serrated lesionsCesare Hassan, Italy


09:53 – 09:56 IP554ConclusionJames Edward East, United Kingdom

Symposium10:30 – 12:00 Hall 6Diagnostic and therapeutic challenges in pancreatologyChairs: Peter Hegyi, Hungary


10:30 – 10:52 IP555Drug-induced pancreatitisLuca Frulloni, Italy

Debate10:52 – 11:02 IP556Diagnosis and definition of early chronic pancreatitis: Is EUS all we need? ProMaria Chiara Petrone, Italy

Free Paper Session08:30 – 10:00 Room E3Can colonic polyps be diagnosed in real time?Chairs: Michael B. Wallace, USA

Bjorn Rembacken, United Kingdom

08:30 – 08:42 IP548State-of-the-art introductionMichael B. Wallace, USA

08:42 – 08:54 OP336DOES CHROMOENDOSCOPY REDUCE COLORECTAL NEO-PLASIA DURING SURVEILLANCE IN LYNCH SYNDROME? A RANDOMIZED TRIAL Jasmijn Haanstra, The Netherlands; E. Dekker; A. Cats; F. M. Nagengast; J. Hardwick; S. Vanhoutvin; W. De Vos Tot Nederveen Cappel; H. Vasen; J. Kleibeuker; J. J. Koornstra

08:54 – 09:06 OP337LEAVING COLORECTAL POLYPS IN PLACE CAN BE ACHIEVED WITH HIGH ACCURACY USING BLUE LIGHT IMAGING (BLI)Helmut Neumann, Germany; H. Neumann Sen; F. Thieringer; F. Rahman; G. E. Tontini; P. R. Galle

09:06 – 09:18 OP338A STUDY ON DIAGNOSTIC ABILITY TO DISTINGUISH BETWEEN ADENOMAS AND INVASIVE COLORECTAL CANCERS USING COMPUTER-AIDED ENDOCYTOSCOPYKenichi Takeda, Japan; S.-E. Kudo; Y. Mori; M. Misawa; S. Kataoka; Y. maeda; Y. Ogawa; K. Ichimasa; T. Kudo; K. Wakamura; T. Baba; E. Hidaka; F. Ishida; H. Inoue; M. Oda; K. Mori

09:18 – 09:30 OP339ENDOSCOPIC AND MOLECULAR CHARACTERISTICS IN COLORECTAL SERRATED LESIONS REPRESENT SUB-CLASSES OF THE SERRATED NEOPLASIA PATHWAYHironori Aoki, Japan; E. Yamamoto; H.-O. Yamano; H.-O. Matsushita; K. Yoshikawa; R. Takagi; E. Harada; Y. Tanaka; T. Harada; T. Sugai; H. Suzuki

09:30 – 09:42 OP340CLASSIFICATION OF CELL NUCLEI MORPHOLOGY OF EC FINDINGS IN COLORECTAL ENDOCYTOSCOPYKenichi Suzuki, Japan; S.-E. Kudo; T. Kudo; Y. Mori; K. Wakamura; M. Misawa; Y. Ogawa; Y. maeda; K. Takeda; H. Nakamura; T. Hayashi; T. Baba; F. Ishida

09:42 – 09:54 OP341COMPUTER-AIDED DIAGNOSTIC SYSTEM USING ARTIFICIAL INTELLIGENCE FOR PREDICTING THE NBI INTERNATIONAL COLORECTAL ENDOSCOPIC CLASSIFI-CATION OF COLORECTAL TUMORSJeong-Sik Byeon, Republic of Korea; E. M. Song; S. H. Lee; K. J. Change; S. W. Hwang; S. H. Park; D.-H. Yang; B. D. Ye; S.-J. Myung; S.-K. Yang; B. H. Park; N. K. Kim; J. B. Seo


99


Wed

nesd

ay, N

ovem

ber

1, 2

017


10:36 – 10:42 VC02TEMPORARY BILIARY METAL STENT PLACEMENT IN THE CYSTIC DUCT AS AN AID TO CHOLANGIOSCOPY-GUIDED LASER LITHOTRIPSY OF MIRIZZI SYNDROME (MS).Ramon Sanchez-Ocana, Spain; M. Jimenez-Palacios; P. Gil-Simon; C. De la Serna-Higuera; M. Perez-Miranda

10:42 – 10:49 VC03METACHRONOUS DEPLOYMENT OF FOUR PLASTIC AND FOUR METALLIC STENTS IN THE PATIENT WITH HILAR BILE DUCT CARCINOMA SUCCESSFULLY ACHIEVED ONLY VIA ENDOSCOPIC PROCEDURE.Hirofumi Kawamoto, Japan

10:49 – 10:55 VC04CHRONIC TRACHEOESOPHAGEAL FISTULA SUCCESS-FULLY TREATED USING AMPLATZER SEPTAL OCCLUDERMichele Amata, Italy; C. Gandolfo; L. De Monte; A. Granata; D. Ligresti; L. Barresi; I. Tarantino; M. Traina

10:55 – 11:01 VC05A NOVEL SCISSOR AND LOOP TECHNIQUE FOR ENDO-SCOPIC RESECTION AND CLOSURE OF ESD DEFECTS: A VIDEO ABSTRACT ON THE RESECTION OF A GASTRIC SUBMUCOSAL TUMOURKesavan Kandiah, United Kingdom; S. Subramaniam; D. Poller; A. Higginson; P. Bhandari

11:01 – 11:07 VC06RENDEZVOUS BILIARY RECANALIZATION OF COMPLETE BILIARY OBSTRUCTION WITH DIRECT PERORAL AND PERCUTANEOUS TRANSHEPATIC CHOLANGIOSCOPYMajidah Bukhari, USA; Y. Haito-Chavez; S. Ngamruengphong; O. I. Brewer Gutierrez; Y.-I. Chen; M. A. Khashab

11:07 – 11:13 VC07EUS GUIDED CONTINUOUS CATHETER THROMBOLYSIS OF PORTAL VENOUS SYSTEMMalay Sharma, India; S. Jindal; P. somani; K. Sampath; V. V. Mahesh

11:13 – 11:19 VC08PER RECTAL ENDOSCOPIC MYOTOMY (PREM) FOR PEDIATRIC HIRSCHSPRUNG’S DISEASE Amol Bapaye, India; M. R. Mahadik; R. Pujari; S. Date; N. Dubale; T. K. Bharadwaj; S. G. Vare; J. A. Bapaye

11:19 – 11:26 VC09COMBINED LAPAROSCOPIC AND ENDOSCOPIC FULL THICKNESS RESECTION APPROACH FOR GASTRO-IN-TESTINAL STROMAL TUMOR (GIST). SERIES OF 3 CASES WITH VIDEO.Jean-Michel Gonzalez, France; L. Beyer; S. Berdah; M. Barthet

11:02 – 11:12 IP557Diagnosis and definition of early chronic pancreatitis: Is EUS all we need? ConCelso Matos, Belgium

Tandem Talks11:12 – 11:22 IP558Pancreatic duct stones in chronic pancreatitis: Inter-ventional treatmentJacques Deviere, Belgium

11:22 – 11:32 IP559Pancreatic duct stones in chronic pancreatitis: When does surgery come in?Ross Carter, United Kingdom

11:32 – 11:54 IP560Screening for pancreatic cancer in chronic pancreatitis: Should we do it at all and how?Maiken Thyregod Joergensen, Denmark

Advances in Clinical GI & Hepatology10:30 – 12:00 Room F2Organic-functional overlap syndromes: Continuum or distinct diseases?Chairs: Umberto Volta, Italy

Albert Jan Bredenoord, The Netherlands

10:30 – 10:52 IP561Eosinophilic oesophagitis, GORD or both?Javier Molina Infante, Spain

10:52 – 11:14 IP562Non-coeliac gluten sensitivity or IBS?Katri Kaukinen, Finland

11:14 – 11:36 IP563IBS-like symptoms in IBD in remissionMagnus Simrén, Sweden

11:36 – 11:58 IP564Painful diverticuli or IBS?Giovanni Barbara, Italy

Video Case Session10:30 – 12:00 Room F1Video Case SessionChairs: Lars Aabakken, Norway

Helmut Neumann, Germany

10:30 – 10:36 VC01SUBMUCOSAL TUNNELING ENDOSCOPIC RESECTION OF A LARGE OESOPHAGEAL LEIOMYOMAMayenaaz Sidhu, Australia; D. J. Tate; M. J. Bourke


100


Wednesday, N

ovember 1, 2017


Symposium10:30 – 12:00 Room A3Management of advanced liver cirrhosisChairs: Dominique Thabut, France

Patrizia Burra, Italy

10:30 – 10:52 IP574Prevention and treatment of encephalopathyJohn Vierling, USA

10:52 – 11:14 IP575Nutritional therapy: Between evidence and common senseClaire Francoz, France

11:14 – 11:36 IP576Primary and secondary prevention of variceal bleedingJuan Carlos Garcia Pagan, Spain

11:36 – 11:58 IP577Hepatorenal syndromeThomas Reiberger, Austria

Symposium10:30 – 12:00 Room B2Long-term adverse effects of bariatric surgeryChairs: Ramon Vilallonga, Spain

Robert Hawes, USA

10:30 – 10:52 IP578Dysphagia after restrictive proceduresEdoardo Savarino, Italy

10:52 – 11:14 IP579GORD and dumpingMario Morino, Italy

11:14 – 11:36 IP580Nutrient deficienciesLoris Pironi, Italy

11:36 – 11:58 IP581The role of endoscopy in long-term follow-upTodd H. Baron, USA

Translational Basic Science10:30 – 12:00 Room B3Microbiota in liver diseaseChairs: Stephan Bischoff, Germany

Max Nieuwdorp, The Netherlands

10:30 – 10:52 IP582Role of microbiota in liver inflammation and fibrosisAntonio Gasbarrini, Italy

11:26 – 11:34 VC10TRACTION STRATEGY WITH CLIPS AND RUBBER BAND ALLOWS COMPLETE EN BLOC ENDOSCOPIC SUBMUCO-SAL DISSECTION OF LATERALLY SPREADING TUMORS INVADING THE APPENDIX.Mathieu Pioche, France; J. Jacques; J. Rivory; J. C. Saurin; R. Legros; T. Ponchon

Symposium10:30 – 12:00 Room A2Patient education in IBDChairs: Matthieu Allez, France

Britta Siegmund, Germany

10:30 – 10:52 IP565How to communicate at the time of diagnosisAlessandro Armuzzi, Italy

10:52 – 11:14 IP566How to improve adherence: Apps, e-health, etc.Pierre Michetti, Switzerland

11:14 – 11:36 IP567How to develop an educational programJacques Moreau, France

Tandem Talks11:36 – 11:46 IP568Patient empowerment: The patient´s perspectiveLuisa Avedano, Belgium

11:46 – 11:56 IP569Patient empowerment: The physician´s perspectiveSubrata Ghosh, Canada

Symposium10:30 – 12:00 Room A1Endoscopic resection of the difficult polypChairs: Michael John Bourke, Australia

Ana Wilson, United Kingdom

10:30 – 10:52 IP570Endoscopic mucosal resection (EMR)Thierry Ponchon, France

10:52 – 11:14 IP571Endoscopic submucosal dissection (ESD)Hironori Yamamoto, Japan

11:14 – 11:36 IP572Full-thickness resectionAlanna Ebigbo, Germany

11:36 – 11:58 IP573Combined endoscopic-laparoscopic resectionDieter Hahnloser, Switzerland


101


Wed

nesd

ay, N

ovem

ber

1, 2

017


11:18 – 11:30 OP347ESSENTIAL ROLE OF INTERLEUIKIN-33-INDUCED INNATE LYMPHOID CELLS IN DEVELOPMENT OF EOSIN-OPHILIC ESOPHAGITIS IN MICENaoki Oshima, Japan; S. Ishihara; H. Sonoyama; N. Yamashita; N. Fukuba; Y. Mishima; I. Moriyama; K. Kawashima; N. Ishimura; Y. Kinoshita

11:30 – 11:42 OP348EFFICACY AND SAFETY OF BUDESONIDE ORODISPERS-IBLE TABLETS IN ACTIVE EOSINOPHILIC OESOPHAGI-TIS: RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PIVOTAL, EUROPEAN MULTI-CENRE TRIAL (EOS-1)Alex Straumann, Switzerland; A. J. Lucendo Villarin; S. Miehlke; M. Vieth; C. Schlag; U. von Arnim; J. Molina-Infante; D. Hartmann; A. J. Bredenoord; C. Ciriza de Los Rios; S. Schubert; S. Brueckner; A. Madisch; J. Hayat; J. Tack; A. Schoepfer; R. Greinwald; R. Mueller; S. Attwood

11:42 – 11:54 OP349LONG-TERM TREATMENT OF EOSINOPHILIC OESOPHA-GITIS WITH SWALLOWED TOPICAL CORTICOSTEROIDS: DEVELOPMENT AND EVALUATION OF A THERAPEUTIC CONCEPTThomas Greuter, Switzerland; C. Bussmann; E. Safroneeva; A. Schoepfer; L. Biedermann; S. Vavricka; A. Straumann

Free Paper Session10:30 – 12:00 Room 7.1Safety and long-term outcomes with biologics in IBDChairs: Johan Burisch, Denmark

Laurent Beaugerie, France

10:30 – 10:42 IP586State-of-the-art introductionLaurent Beaugerie, France

10:42 – 10:54 OP350PYRAMID REGISTRY: LONG-TERM SAFETY OF ADALIM-UMAB BY AGE IN PATIENTS WITH CROHN’S DISEASEJean-Frederic Colombel, USA; G. D'Haens; W. Reinisch; E. V. Loftus Jr; R. Panaccione; J. Satsangi; G. Alperovich; S. Berg; J. Kalabic; M. Bereswill; J. Petersson; A. M. Robinson

10:54 – 11:06 OP351EXPOSURE TO COMBINATION THERAPY WITH THIOPU-RINES AND ANTI-TNF AGENTS IS ASSOCIATED WITH REDUCED INCIDENCE OF ACUTE ARTERIAL EVENTS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A NATIONWIDE FRENCH COHORT STUDY.Julien Kirchgesner, France; N. N. Andersen; F. Carrat; M. Schwarzinger; T. Jess; L. Beaugerie

10:52 – 11:14 IP583Role of microbiota in liver cancerAntonio Moschetta, Italy

11:14 – 11:36 IP584The paradoxical effect of antibiotics on microbiotaJasmohan S. Bajaj, USA

11:36 – 11:48 OP342LONG TERM PROTON PUMP INHIBITOR USE INCREAS-ES INTESTINAL DYSBIOSIS, GUT PERMEABILITY, INFLAMMATION AND MORTALITY IN PATIENTS WITH LIVER CIRRHOSISAngela Horvath, Austria; F. Rainer; M. Bashir; B. Leber; B. Schmerboeck; H. Grønbæk; H. J. Møller; T. Madl; A. Groselj-Strele; P. Fickert; P. Stiegler; V. Stadlbauer

11:48 – 12:00 OP343CO-ADMINISTRATION OF PROBIOTIC WITH OMEGA-3 FATTY ACIDS IN NAFLD MANAGEMENT: EVIDENCE FROM ANIMALS TO RANDOMIZED CLINICAL STUDIES ªNazarii Kobyliak, Ukraine; T. Falalyeyeva; G. Mykhalchyshyn; O. Dynnyk; D. Kyriienko; I. Komisarenko

Free Paper Session10:30 – 12:00 Room E4Hot topics in GORD and EoEChairs: Martin Ďuriček, Slovak Republic

Stephan Miehlke, Germany

10:30 – 10:42 IP585State-of-the-art introductionStephan Miehlke, Germany

10:42 – 10:54 OP344ORAL ALGINATE SOLUTION REDUCES SENSITIVITY TO ESOPHAGEAL ACID PERFUSION IN PATIENTS WITH HEARTBURN. INTERIM REPORT OF A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDYJoanne Li Shen Ooi, United Kingdom; P. Woodland; D. Sifrim

10:54 – 11:06 OP345SYMPTOM ASSOCIATION PROBABILITY DETERMINES THE OUTCOME OF BACLOFEN THERAPY IN REFRACTO-RY GASTRO-OESOPHAGEAL REFLUX DISEASEAns Pauwels, Belgium; E. Deloose; V. Boecxstaens; C. Broers; T. Vanuytsel; J. Tack

11:06 – 11:18 OP346GASTRO-ESOPHAGEAL REFLUX AFTER PERORAL ENDO-SCOPIC MYOTOMY AS COMPARED WITH HELLER’S MY-OTOMY: A SYSTEMATIC REVIEW WITH META-ANALYSIS.Alessandro Repici, Italy; L. Fuccio; R. Maselli; F. Mazza; L. Correale; D. Mandolesi; C. Bellisario; A. Sethi; M. Kashab; T. Rösch; C. Hassan


102


Wednesday, N

ovember 1, 2017


11:36 – 11:48 OP356THE CONTRIBUTION OF LYMPHOTOXIN TO PANCREATIC CARCINOGENESIS – FROM PANINS TO TUMOR DEVEL-OPMENTGitta Maria Seleznik, Switzerland; T. Reding; C. Waschkies; D. Lenggenhager; A. Gupta; E. Diamantis; A. Perren; M. Heikenwälder; R. Graf

11:48 – 12:00 OP357RELA/NF-κB CONTROLLED ONCO-IMMUNO CROSSTALK IN PANCREATIC CANCER – ROLE OF CCL20 AND CX3CL1 IN APOPTOSIS RESISTANCEClaudia Geismann, Germany; F. Grohmann; S. Schreiber; A. Arlt

Free Paper Session10:30 – 12:00 Room E2Endoluminal and transluminal interventions in the upper GI tractChairs: Geoffroy Vanbiervliet, France

Myriam Delhaye, Belgium

10:30 – 10:42 IP590State-of-the-art introductionGeoffroy Vanbiervliet, France

10:42 – 10:54 OP358ENDOLUMINAL AND INTRACAVITAL VACUUM COM-BINED WITH STENT-OVER-SPONGE (SOS) TREATMENT FOR FOREGUT PERFORATIONS AND LEAKSPiero V Valli, Switzerland; J. Mertens; A. Kroeger; P. M. Schneider; C. Gutschow; C. Gubler; P. Bauerfeind

10:54 – 11:06 OP359INTRADUCTAL BILIARY OR PANCREATIC ABLATION DURING ENDOSCOPIC AMPULLECTOMY MAY REDUCE THE LONG-TERM RECURRENCE RATE. ªEnrique Perez-Cuadrado-Robles, Belgium; H. Piessevaux; T. Moreels; R. Yeung; T. Aouattah; A. Jouret-Mourin; M. Komuta; P. H. Deprez

11:06 – 11:18 OP360EFFECT OF SUBMUCOSAL INJECTION IN ENDOSCOPIC PAPILLECTOMY OF AMPULLARY TUMOR: A PROPENSI-TY ANALYSISKwang Hyun Chung, Republic of Korea; S. H. Lee; J. H. Choi; J. W. Kang; J. K. Ryu; Y.-T. Kim

11:18 – 11:30 OP361EUS-GUIDED GASTROENTEROSTOMY: A LARGE MULTICENTER STUDY COMPARING THE DIRECT AND BALLOON-ASSISTED TECHNIQUESY.-I. Chen; R. Kunda; A. C. Storm; C. C. Thompson; J. Nieto; A. A. Siddiqui; T. James; M. A. Bukhari; O. I. Brewer Gutierrez; M. I. Canto; V. K. Singh; T. H. Baron; Mouen A. Khashab, USA

11:06 – 11:18 OP352PYRAMID REGISTRY: LONG-TERM SAFETY AND EFFEC-TIVENESS OF ADALIMUMAB BY BASELINE IMMUNO-MODULATOR USE IN PATIENTS WITH CROHN’S DISEASEWalter Reinisch, Austria; R. Panaccione; G. R. D'Haens; E. V. Loftus Jr; J. Satsangi; J.-F. Colombel; G. Alperovich; S. Berg; J. Kalabic; M. Bereswill; J. Petersson; A. M. Robinson

11:18 – 11:30 OP353INTEGRATED SAFETY ANALYSES OF TOFACITINIB IN ULCERATIVE COLITIS CLINICAL TRIALSWilliam Sandborn, USA; J. Panés; G. D’Haens; B. E. Sands; C. Su; M. Moscariello; T. V. Jones; R. Pedersen; G. Friedman; N. Lawendy; G. Chan

11:30 – 11:42 OP354LONG-TERM HEALTH OUTCOMES OF 1000 CHILDREN BORN TO MOTHERS WITH INFLAMMATORY BOWEL DISEASE IN THE ANTI-TNF ERAShannon Kanis, The Netherlands; S. Modderman; J. C. Escher; R. Beukers; K. H. N. (. de Boer; A. Bodelier; A. Depla; G. Dijkstra; A.-B. Van Dijk; L. P. L. Gilissen; F. Hoentjen; J. M. Jansen; J. Kuijvenhoven; N. Mahmmod; R. Mallant; A. E. Van Der Meulen – De Jong; A. Noruzi; B. Oldenburg; L. E. Oostenbrug; R. J. Ouwendijk; M. J. Pierik; M. Romberg Camps; W. J. Thijs; R. West; A. Lima; C. J. van der Woude

11:42 – 11:54 OP355SAFETY OF HERPES ZOSTER VACCINATION AMONG IN-FLAMMATORY BOWEL DISEASE PATIENTS BEING TREATED WITH ANTI-TNF MEDICATIONSC. Trivedi; Y. Shah; Nabeel Khan, USA

Symposium10:30 – 12:00 Room E1Therapeutic approaches targeting the tumour envi-ronment in pancreatic cancer: Hope or hype?Chairs: Caroline Verbeke, Norway

Eike Gallmeier, Germany

10:30 – 10:52 IP587Stromal targets in human pancreatic ductal adenocar-cinomaEithne Costello-Goldring, United Kingdom

10:52 – 11:14 IP588Pharmacological targeting of dysregulated pathways in cancer associated fibroblastsCorinne Bousquet, France

11:14 – 11:36 IP589Rising Star: Stromal remodelling in vivo-therapeutic and biological implications ªAlbrecht Neesse, Germany


103


Wed

nesd

ay, N

ovem

ber

1, 2

017


11:30 – 11:42 OP368FAECAL MICROBIOTA TRANSFER IN IRRITABLE BOWEL SYNDROME – CLINICAL OUTCOMES OF A RANDOMISED PLACEBO-CONTROLLED TRIAL ªSavanne Holster, Sweden; D. Repsilber; R. J. Brummer; J. König

11:42 – 11:54 OP369INTRODUCTION OF MOLECULAR STOOL TESTING FOR PATIENTS WITH GASTROENTERITIS IS ASSOCIATED WITH INCREASED INCIDENCE AND ANTIBIOTIC TREAT-MENT OF BLASTOCYSTIS AND DIENTAMOEBAAlwin Schierenberg, The Netherlands; P. C. J. Bruijning-Verhagen; M. D. Nipshagen; J. Kusters; S. van Delft; M. J. M. Bonten; N. J. De Wit

Free Paper Session10:30 – 12:00 HotspotAbstracts on Fire: Diagnosis and treatment of upper GI diseases in children and adultsChairs: Anne Christin Meyer-Gerspach, Switzerland

Michael Farthing, United Kingdom

10:30 – 10:40 OP370THE RESULTS OF ENDOSCOPIC AND SURGICAL TREAT-MENT FOR ACHALASIA IN ENGLAND BETWEEN 2005 AND 2016Phil Harvey, United Kingdom; B. Coupland; J. Mytton; F. Evison; P. Patel; N. Trudgill

10:40 – 10:50 OP371Spectrum of histopathologic patterns among achalasia subtypesNao Nakajima, Japan; H. Sato; K. Takahashi; G. Hasegawa; K.-I. Mizuno; S. Hashimoto; Y. Sato; S. Terai

10:50 – 11:00 OP372THE TAUROLIDINE-CITRATE-HEPARIN CATHETER LOCK REDUCES CATHETER-RELATED BLOODSTREAM INFEC-TIONS IN INTESTINAL FAILURE PATIENTS RECEIVING HOME PARENTERAL SUPPORT: A RANDOMISED AND PLACEBO-CONTROLLED TRIAL.Siri Tribler, Denmark; C. F. Brandt; A. H. Petersen; J. H. Petersen; K. A. Fuglsang; M. Staun; P. Brøbech; C. E. Moser; P. B. Jeppesen

11:00 – 11:10 OP373REDUCING FODMAP CONTENT IN THE BREASTFEED-ING MOTHER’S DIET ALLEVIATES THE SYMPTOMS OF INFANTILE COLIC: A RANDOMISED CONTROLLED DOUBLE-BLIND CROSSOVER STUDYMarina Iacovou, Australia; P. R. Gibson; J. G. Muir

11:30 – 11:42 OP362MINIMALLY INVASIVE SURGERY VERSUS ENDOSCO-PY RANDOMIZED (MISER) TRIAL FOR NECROTIZING PANCREATITISJi Young Bang, USA; J. P. Arnoletti; B. A. Holt; U. Navaneethan; M. Hasan; C. M. Wilcox; R. Hawes; S. Varadarajulu

11:42 – 11:54 OP363LUMEN APPOSING METAL STENTS ARE COST-EFFECTIVE WHEN COMPARED WITH PLASTIC STENTS IN THE MAN-AGEMENT OF PANCREATIC WALLED-OFF NECROSISO. I. Brewer Gutierrez; Y. I. Chen; A. Barkun; V. Adam; Lea Fayad, USA; G. Bai; V. K. Singh; M. A. Bukhari; O. Sanaei; B. J. Elmunzer; T. H. Baron; S. Ngamruengphong; M. I. Canto; A. Repici; M. A. Khashab

Free Paper Session10:30 – 12:00 Room E3Bugs in lower GI diseasesChairs: Giovanni Cammarota, Italy

Charlotte Hedin, Sweden

10:30 – 10:42 IP591State-of-the-art introductionGiovanni Cammarota, Italy

10:42 – 10:54 OP364EVALUATION OF MULTIPLEX PCR FOR DIAGNOSIS OF GASTROINTESTINAL TUBERCULOSIS ªN. Berry; Sarthak Malik, India; K. Sharma; S. K. Sinha; N. Dhaka; R. Kochhar; K. Vaiphei

10:54 – 11:06 OP3651-DAY OR 5-DAY FECAL SAMPLES, WHICH ONE IS MORE BENEFICIAL TO BE USED FOR DNA-BASED GUT MICROBIOTA STUDYT. Su; Shujie Chen, China

11:06 – 11:18 OP366THE IN-HOSPITAL MORTALITY RATE FOR CLOSTRIDI-UM DIFFICILE INFECTION HAS DECREASED OVER THE PAST DECADE IN THE UNITED STATES: A NATIONWIDE ANALYSISPaul Thomas Kroener, USA; P. Jirapinyo; M. S. Abougergi; C. C. Thompson

11:18 – 11:30 OP367SINGLE-INFUSION FECAL MICROBIOTA TRANSPLAN-TATION IS NOT EFFECTIVE IN TREATING SEVERE CLOSTRIDIUM DIFFICILE INFECTION Gianluca Ianiro, Italy; L. Masucci; C. Simonelli; M. Sanguinetti; A. Gasbarrini; G. Cammarota


104


Wednesday, N

ovember 1, 2017


Round Table Discussion12:45 – 13:45 Room A2Management of severe acute colitisChair: Iris Dotan, IsraelExperts: Willem A. Bemelman, The Netherlands

Franck Carbonnel, France Iris Dotan, Israel Geert D'Haens, The Netherlands

Round Table Discussion12:45 – 13:45 Room A3Endoscopic management of complications following upper GI surgeryChair: Todd H. Baron, USAExperts: Todd H. Baron, USA

Andrea May, Germany Alessandro Repici, Italy Riccardo Rosati, Italy

Round Table Discussion12:45 – 13:45 Room B2Diagnostic and therapeutic approach to patients with anal bloodlossChair: Roger Leicester, United KingdomExperts: Alexander Herold, Germany

Ian Jenkins, United Kingdom Roger Leicester, United Kingdom Monica Millan, Spain

Round Table Discussion12:45 – 13:45 Room B3Infectious complications of liver cirrhosisChair: Claire Francoz, FranceExperts: Claire Francoz, France

Thomas Reiberger, Austria Frank Tacke, Germany Jonel Trebicka, Germany

11:10 – 11:20 OP374COMPARISON OF TWO STRATEGIES FOR PREVENTION OF REBLEEDING AMONG CHILDREN WITH PEPTIC ULCEROana Belei, Romania; L. Olariu; C. Jinca; T. Marcovici; O. Marginean

11:20 – 11:30 OP375EXPLOITING THE MECHANISM OF GASTROPROTECTION BY ADIPONECTIN IN MICE FED A HIGH FAT DIET AND CHALLENGED BY ETHANOL. RELEVANCE TO ETHANOL CONSUMPTION IN HUMAN OBESITY.A. Szlachcic; J. Majka; M. Magierowski; D. Wojcik; M. Surmiak; K. Magierowska; S. Kwiecien; G. Ginter; Tomasz Brzozowski, Poland

11:30 – 11:40 OP376PAN-EUROPEAN REGISTRY ON H. PYLORI MANAGE-MENT (HP-EUREG): INTERIM ANALYSIS OF 4,417 SECOND-LINE TREATMENTSA. G. McNicholl; Olga P. Nyssen, Spain; D. S. Bordin; B. Tepeš; M. Á. Perez Aisa; B. Vaira; M. Caldas Álvarez; L. Bujanda Fernández de Piérola; M. Castro Fernández; F. Lerang; M. Leja; L. Rodrigo; T. Rokkas; L. Kupcinskas; J. Perez-Lasala; L. Jonaitis; O. Shvets; A. Gasbarrini; H. Şimşek; A. Axon; G. M. Buzás; J. C. L. Machado; Y. Niv; L. Boyanova; A. Goldis; V. Lamy; M. Katicic; K. Przytulski; C. Beglinger; M. Venerito; P. Bytzer; L. Capelle; T. Milosavljevic; L. Veijola; J. Molina Infante; L. Vologzhanina; G. Fadeenko; I. Ariño; G. Fiorini; M. Ramas; M. Garcia Donday; F. Megraud; C. O'Morain; J. P. Gisbert

11:40 – 11:50 OP377CAPSULE ENDOSCOPY IN INTESTINAL LYMPHAGIECTA-SIA: A NOVEL ENDOSCOPIC CLASSIFICATION AND ITS CLINICAL CORRELATIONKuiliang Liu, China; W. Shen; J. Wu

11:50 – 12:00 OP378LONG-TERM OUTCOMES OF PATIENTS WITH EARLY GASTRIC CANCER DIAGNOSED AS PATHOLOGICAL EXTRA-INDICATED LESION AFTER ENDOSCOPIC SUB-MUCOSAL DISSECTIONKenji Ishido, Japan; T. Yano; S. Tanabe; T. Wada; M. Azuma; C. Katada; W. Koizumi


105


Wed

nesd

ay, N

ovem

ber

1, 2

017


Symposium14:00 – 15:30 Hall 6IBD: What's new in 2017?Chairs: C. Janneke van der Woude, The Netherlands

Julian Panés, Spain

14:00 – 14:22 IP601MicrobiotaHarry Sokol, France

14:22 – 14:44 IP602PathophysiologyArthur Kaser, United Kingdom

14:44 – 15:06 IP603New drugsRaja Atreya, Germany

15:06 – 15:28 IP604SurgeryWillem A. Bemelman, The Netherlands

Advances in Clinical GI & Hepatology14:00 – 15:30 Room F2Treatment of GORD beyond acid inhibitionChairs: Frank Zerbib, France

Serhat Bor, Turkey

14:00 – 14:22 IP605What is wrong with PPI-nonresponders?Daniel Sifrim, United Kingdom

14:22 – 14:44 IP606Laparoscopic fundoplicationMario Costantini, Italy

14:44 – 15:06 IP607Endoscopic anti-reflux proceduresNicole Bouvy, The Netherlands

15:06 – 15:28 IP608Magnets, pacemakers and other new approachesStephen Attwood, United Kingdom

Symposium12:30 – 13:30 Hotspot25th UEG Week Anniversary Session: Major advances in gastroenterology and hepatology over the last 25 yearsChair: Michael Farthing, United Kingdom

12:30 – 12:35 IP592Introduction by the UEG PresidentMichael Manns, Germany

12:35 – 12:40 IP593IBD and biologics: A happy marriage!Julian Panés, Spain

12:40 – 12:45 IP594Hepatitis C virus: Discovery and extinctionMichael Manns, Germany

12:45 – 12:50 IP595H. pylori: The Nobel bugJohn Atherton, United Kingdom

12:50 – 12:55 IP596Endoscopy: A technical revolutionPaul Fockens, The Netherlands

12:55 – 13:00 IP597Treating diarrhoea in children: A global life-saverSibylle Koletzko, Germany

13:00 – 13:05 IP598GI oncology: A successful multidisciplinary endeavourThomas Seufferlein, Germany

13:05 – 13:10 IP599Gastroesophageal reflux disease: Reducing acid and complicationsRebecca Clare Fitzgerald, United Kingdom

13:10 – 13:15 IP600Laparoscopic surgery: A diagnostic and therapeutic success story!Mario Morino, Italy


“Looking into the crystal ball: The future in gastroen-terology and hepatology looks bright!”


106


Wednesday, N

ovember 1, 2017


Symposium14:00 – 15:30 Room A1Pancreatology: What's new in 2017?Chairs: Vinciane Rebours, France

Thomas Seufferlein, Germany

14:00 – 14:22 IP617Rising Star: Management of acute pancreatitis: Nothing is what it seems ªEnrique de-Madaria, Spain

14:22 – 14:44 IP618Chronic pancreatitisDavid C. Whitcomb, USA

14:44 – 15:06 IP619Neuroendocrine pancreatic tumoursGabriele Capurso, Italy

15:06 – 15:28 IP620Pancreatic cancerEike Gallmeier, Germany

Symposium14:00 – 15:30 Room A3H. pylori: What's new in 2017?Chairs: Emad El-Omar, Australia

John Atherton, United Kingdom

14:00 – 14:22 IP621What’s new in ‘omics’ and pathogenesis?Jose Carlos L. Machado, Portugal

14:22 – 14:44 IP622What’s new in diagnostics?Francis Megraud, France

14:44 – 15:06 IP623What’s new in treatment?Xavier Calvet Calvo, Spain

15:06 – 15:28 IP624The way to the vaccinePeter Malfertheiner, Germany

Symposium14:00 – 15:30 Room F1Endoscopy: What's new in 2017?Chairs: Lars Aabakken, Norway

Thierry Ponchon, France

14:00 – 14:22 IP609Upper GIMario Dinis-Ribeiro, Portugal

14:22 – 14:44 IP610Lower GIBrian P. Saunders, United Kingdom

14:44 – 15:06 IP611ERCPIoannis Papanikolaou, Greece

15:06 – 15:28 IP612EUSMaria Chiara Petrone, Italy

Symposium14:00 – 15:30 Room A2Hepatology: What's new in 2017?Chairs: Dominique Thabut, France

Olivier Rosmorduc, France

14:00 – 14:22 IP613Viral hepatitisHeiner Wedemeyer, Germany

14:22 – 14:44 IP614Autoimmune and cholestatic diseasesMarco Marzioni, Italy

14:44 – 15:06 IP615CirrhosisJonel Trebicka, Germany

15:06 – 15:28 IP616Hepatocellular carcinomaAlejandro Forner, Spain


107


Wed

nesd

ay, N

ovem

ber

1, 2

017


Symposium14:00 – 15:30 Room E4Upper GI cancer: What's new in 2017?Chairs: Tamara Matysiak Budnik, France

Ernst J. Kuipers, The Netherlands

14:00 – 14:22 IP633New TNM classificationFatima Carneiro, Portugal

14:22 – 14:44 IP634Early diagnosis in primary careGregory Rubin, United Kingdom

14:44 – 15:06 IP635Progress in neo-adjuvant treatmentTamara Matysiak Budnik, France

Tandem Talks15:06 – 15:16 IP636 Endoscopic treatmentFabian Emura, Colombia

15:16 – 15:26 IP637 Surgical treatmentRiccardo Rosati, Italy

Symposium14:00 – 15:30 Room E1Diagnostic tools for GI diseases: What's new in 2017?Chairs: Marianna Arvanitakis, Belgium

Joost P. H. Drenth, The Netherlands

14:00 – 14:22 IP638 RadiologyAndrew Plumb, United Kingdom

14:22 – 14:44 IP639 EndoscopyMarco J. Bruno, The Netherlands

14:44 – 15:06 IP640 HistopathologyCord Langner, Austria

15:06 – 15:28 IP641BiomarkersRebecca Clare Fitzgerald, United Kingdom

Symposium14:00 – 15:30 Room B2Colorectal cancer: What's new in 2017?Chairs: Rob Glynne-Jones, United Kingdom

André D'Hoore, Belgium

14:00 – 14:22 IP625Molecular classification of colorectal cancerRodrigo Dienstmann, Spain

14:22 – 14:44 IP626Liquid biopsyFederica Di Nicolantonio, Italy

14:44 – 15:06 IP627Organ sparing treatment for rectal cancerRodrigo Perez, Brazil

15:06 – 15:28 IP628Immunotherapy in colorectal cancerRamon Salazar, Spain

Symposium14:00 – 15:30 Room B3Neurogastroenterology and motility: What's new in 2017?Chairs: Lesley Houghton, United Kingdom

Guillaume Gourcerol, France

14:00 – 14:22 IP629Basic neurogastroenterologyGary M. Mawe, USA

14:22 – 14:44 IP630Brain-gut interactionsAsbjørn Drewes, Denmark

14:44 – 15:06 IP631Disease mechansimsNathalie Vergnolle, France

15:06 – 15:28 IP632Diagnostic testsGuillaume Gourcerol, France

View the programme schedule directly in the UEG Week App (www.ueg.eu/app) and on www.ueg.eu/week

Visit the Scientific Centre in Hall 7, hosting all possibilities to present your abstract

Poster Exhibition

Clinical Cases

Poster of Excellence

Poster in the Spotlight

Abstracts on Fire

17_04_Inserat_UEGWEEK_FP_ScientificCentre_160x220mm_RZ.indd 1 14.09.17 11:42

Poster Sessionsby Day

Overview Icons

Poster in the Spotlight

Poster of Excellence

Clinical Case Session

Posters are displayed from Monday, October 30 until Wednesday, November 1 in the poster exhibition in Hall 7. The posters are changed daily and are at display during the following times:


Four Poster Champ Sessions run in parallel from Mon-day until Wednesday from 12:30 – 13:30. 2-minutes pre-sentations of the highest scoring posters will be given at the e-poster terminals in the poster exhibition, followed by 3-minutes Q&As from the chairs.

Poster Champs are awarded in the following categories:

1. Upper gastrointestinal diseases2. Lower gastrointestinal diseases3. Liver, biliary and pancreatic diseases4. Surgery, endoscopy and imaging

Poster Champ sessions are open to all delegates. All UEG Week 2017 attendees are kindly invited to join these sessions and the Poster Champ award ceremony held in E-Poster Lounge I at 13:45 every day.

Posters in the Spotlight will be presented additionally in dedicated sessions held daily in the E-Poster Lounge I and II.


Poster Sessions

E-Posters will be published onwww.ueg.eu/week/24-7

Visit the E-PosterTerminals & PosterChamp Sessions

Find posters also electronically on the e-poster terminals in the UEG Week Scientific Centre (Hall 7).

Additionally 4 Poster Champ Sessions run in parallel each day from 12:30 – 13:30 in the poster exhibition and a Poster Champ will be selected out of the Posters of Excellence in each category.

Poster Sessions by DayMonday, October 30, 2017

Posters in the Spotlight10:30 – 12:00 E-Poster Lounge 1Therapeutic observations in IBDChairs: James Lindsay, United Kingdom

Krisztina Barbara Gecse, The Netherlands

P0405DIRECT INTESTINAL PH-TRANSIT ASSESSMENT IN PATIENTS WITH ULCERATIVE COLITIS AS A STRATEGY FOR PREDICTING SUCCESS OF REGIONAL DELIVERY OF TOPICALLY-ACTING DRUGS

P0376CELL THERAPY FOR PERIANAL CROHN'S DISEASE

P0407COMPARATIVE EFFICACY AND SAFETY OF TOFACITINIB AND BIOLOGICS AS INDUCTION THERAPY FOR MOD-ERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

P0374CHANGES IN THERAPEUTIC STRATEGY AND OUTCOMES IN NEWLY DIAGNOSED PATIENT WITH CROHN'S DISEASE IN THE BIOLOGICAL ERA IN HUNGARY: A NA-TIONWIDE STUDY BASED ON THE NATIONAL HEALTH INSURANCE FUND DATABASE

P0396INTEGTRATING PSYCHOLOGICAL SUPPORT INTO ROUTINE CARE FOR PEOPLE WITH INFLAMMATORY BOWEL DISEASE.

P0399ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR ULCERATIVE COLITIS: A DOUBLE-BLIND, RAN-DOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY

Posters in the Spotlight10:30 – 12:00 E-Poster Lounge 2Basic science models to understand human diseaseChairs: Nathalie Vergnolle, France

Gary M Mawe, USA

P0312THE EFFECTS OF GLIAL -DERIVED NEUROTROPHIC FACTOR PRODUCED BY ENTERIC GLIAL CELLS ON DEN-DRITIC CELL AND ITS ROLES IN DEXTRAN SULPHATE SODIUM INDUCED COLITIS

P0300REGULATORY B CELLS CONTRIBUTE TO THE ALLEVI-ATION OF COLITIS INDUCED BY DEXTRAN SULPHATE SODIUM AFTER H.PYLORI INFECTION

Poster Sessions : UEG Week Final Programme

111


Mon

day,

Oct

ober

30,

201

7

Poster in the Spotlight Poster of Excellence Clinical Case Session

P0512REAL-LIFE ANALYSIS OF FREQUENCY, LOCATIONS AND BLEEDING SOURCES IN UNSELECTED EMERGENCY PATIENTS DURING NON-VITAMIN K ANTICOAGULANT (NOAC) THERAPY AND COMPARISON TO CONTROLLED APPROVAL STUDIES

P0529RELEVANCE OF SLEEP DISTURBANCE TO FUNCTIONAL GASTROINTESTINAL SYMPTOMS, CLINICAL CHARAC-TERISTICS, AND PSYCHOLOGICAL DISTRESS

P0534A PHASE 1 STUDY TO ASSESS THE PHARMACOKINET-ICS, SAFETY, AND TOLERABILITY OF SINGLE DOSE APT-1011 ADMINSTERED UNDER FED OR FASTED CONDITIONS OR AT BEDTIME IN A RANDOMISED THREE-WAY, CROSSOVER DESIGN

P0643FEATURES OF CHRONIC GASTRITIS CAUSED BY CO-INFECTION OF HELICOBACTER PYLORI AND EP-STEIN-BARR VIRUS IN PEDIATRIC PATIENTS

P0519ESOPHAGEAL REFLUX BURDEN IN RELATIONSHIP TO ESOPHAGOGASTRIC JUNCTION (EGJ) AND ESOPHAGEAL BODY FUNCTION ON HIGH RESOLUTION MANOMETRY (HRM)

P0531DETERMINANT FACTORS OF QUALITY OF LIFE IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS

Poster Champ Session12:30 – 13:30 Scientific Centre: Terminal 2Poster Champ Session: Liver, biliary and pancreatic diseasesChairs: Albrecht Neesse, Germany


P0004THE PROTECTIVE EFFECTS OF GROUP 3 INNATE LYM-PHOID CELLS ON HEPATITIS B VIRUS RELATED LIVER FIBROSIS COULD BE IMPAIRED BY TH17 CELLS

P0063EPIGENETIC INACTIVATION OF METALLOTHIONEIN 1G IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

P0037RIFAXIMIN-? IS ASSOCIATED WITH REDUCTIONS IN EMERGENCY DEPARTMENT RESOURCE USE IN UK PATIENTS WITH HEPATIC ENCEPHALOPATHY: REAL WORLD EVIDENCE FROM THE IMPRESS STUDY

P0333ORMDL PROTEINS: CRITICAL REGULATORS OF FINE-TUNING OF THE UNFOLDED PROTEIN RESPONSE IN INTESTINAL INFLAMMATION

P0473POTENTIAL REGULATORY EFFECTS OF CORTICOTRO-PIN-RELEASING FACTOR ON TIGHT JUNCTION-RE-LATED INTESTINAL EPITHELIAL PERMEABILITY ARE PARTIALLY MEDIATED THROUGH CK8 UPREGULATION

P0005EFFECTS OF INTERNAL AND EXTERNAL BILIARY DRAINAGE ON THE EXPRESSION OF INTESTINAL BILE ACID RECEPTOR AND TLR4/NOD2 IN MICE WITH OB-STRUCTIVE JAUNDICE

P0097EXPDF IMPACTS PANCREATIC DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELL DERIVED PANCRE-ATIC ORGANOIDS

Poster Champ Session12:30 – 13:30 Scientific Centre: Terminal 1Poster Champ Session: Upper gastrointestinal diseasesChairs: Niek J. De Wit, The Netherlands

Fatima Carneiro, Portugal

P0627FOOD-DERIVED MICRORNA AND INFLUENCE ON THE FECAL MICRORNA EXPRESSION

P0555A DEDICATED BARRETT'S OESOPHAGUS ENDOSCO-PY LIST IMPROVES THE ACCURACY OF ENDOSCOPIC REPORTING AND QUALITY OF BIOPSIES

P0497THE ONCOGENIC MIR-491-5P/MIR-875-5P-NOTCH3-PHLDB2 AXIS IN GASTRIC TUMORIGENESIS

P0597EFFICACY OF THREE-IN-ONE CAPSULE BISMUTH QUA-DRUPLE THERAPY FOR HELICOBACTER PYLORI ERAD-ICATION IN CLINICAL PRACTICE IN A MULTINATIONAL PATIENT POPULATION

P0521MOTILITY PATTERNS AFTER PER-ORAL ENDOSCOPIC MYOTOMY (POEM) IN PATIENTS WITH ACHALASIA

P0603ROLE OF POLYMORPHISMS IN TLR1 AND PRKAA1 GENES IN THE DEVELOPMENT OF ATROPHIC GASTRITIS AND GASTRIC CANCER


112

UEG Week Final Programme : Poster Sessions



P0470A NEW SCORING MODEL FOR PREDICTING ADVANCED COLORECTAL NEOPLASIA IN ASYMPTOMATIC SCREEN-ING POPULATION AND COMPARISON WITH THE MODI-FIED ASIA-PACIFIC COLORECTAL SCREENING SCORE

P0446MITOCHONDRIAL GLUTAMATE TRANSPORTER (SLC25A22) MEDIATES DNA AND HISTONE HYPER-METHYLATION AND PROMOTES THE TUMORIGENICITY OF KRAS-MUTANT COLORECTAL CANCER

P0320EPIDEMIOLOGY OF MICROSCOPIC COLITIS IN NOTTING-HAM: A CONTEMPORARY COHORT STUDY

P0436WORLD ENDOSCOPY ORGANISATION CONSENSUS STATEMENTS ON POST-COLONOSCOPY/POST-IMAGING COLORECTAL CANCER

P0481THE DIAGNOSTIC VALUE OF BALLOON EXPLUSION TEST AND COLON TRANSIT TEST AND AGREEMENT WITH FINDINGS FROM HIGH RESOLUATION ANORECTAL MA-NOMETRYIN PATIENTS WITH DYSSYNERGIA DEFECATION

P0469LONG-TERM COLONOSCOPIC SURVEILLANCE BETWEEN PATIENTS WITH UNRESECTED DIMINUTIVE POLYPS AND THOSE WITH COLORECTAL ADENOMAS > 5MM IN SIZE RESECTED AT INITIAL COLONOSCOPY

P0360DOUBLE-BALLOON ENDOSCOPIC EVALUATION OF FECAL CALPROTECTIN AS A BIOMARKER FOR SMALL INTESTINAL INFLAMMATION IN CROHN'S DISEASE

P0408CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH C. DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE: BEZLOTOXUMAB VERSUS PLACEBO

P0428THE PROPHYLACTIC CLIP APPLICATION BEFORE SNARE POLYPECTOMY DECREASES IMMEDIATE POST-POLYP-ECTOMY BLEEDING IN LARGE PEDUNCULATED POLYPS.

P0451THE POSSIBILITIES OF APPLICATION OF METABOLIC PROFILES OF BLOOD SERUM AND RED BLOOD CELLS IN DIAGNOSING OF COLORECTAL CANCER

P0416ALTERED INTESTINAL EXPRESSION PROFILES OF ANTI-MICROBIAL GENES IN IRRITABLE BOWEL SYN-DROME ARE LINKED TO BACTERIAL COMPOSITION AND IMMUNE ACTIVATION

P0083ERCP WITH SHORT-TYPE SINGLE BALLOON ENTEROSCOPE IN PATIENTS WITH SURGICALLY ALTERED PATIENTS

P0057OPTIMAL NUMBER OF MEASUREMENTS IN REAL-TIME SHEAR WAVE ELASTOGRAPHY TO ASSESS LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION

P0125CONCOMITANT PANCREATIC CANCERS ARISING ADJA-CENT TO INDEX INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS SHARE IDENTICAL KRAS MUTATIONS AND ARE ASSOCIATED WITH A FAVORABLE PROGNOSIS.

P0007THE EMERGING ROLE OF ZBP-89 IN SENSITIZING HEPATIC CANCER STEM CELLS TO SORAFENIB

P0104EARLY OR LATE CHOLECYSTECTOMY IN MILD GALLSTONE PANCREATITIS? RESULTS FROM RANDOMIZED TRIAL

P0116AUTOIMMUNE PANCREATITIS CLASSIFIED AS NOT-OTHERWISE SPECIFIED (NOS) ACCORDING TO THE INTERNATIONAL CONSENSUS DIAGNOSTIC CRITERIA: CLINICAL FEATURES AND OUTCOMES IN 47 PATIENTS.

P0121GALECTIN-1 EXPRESSED IN PANCREATIC STELLATE CELLS PROMOTES TUMOR PROGRESSION IN PAN-CREATIC CANCER VIA UPREGULATION OF SDF-1 AND ACTIVATION OF NF-?B

P0129VERIFICATION OF INTERNATIONAL CONSENSUS GUIDELINES 2012 – SURGICAL INDICATION FOR BRANCH DUCT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE PANCREAS (BD-IPMN) WITH WOR-RISOME FEATURES

P0017THE ROLE OF GENETIC FACTORS IN NON-OBESE NASH PATIENTS

Poster Champ Session12:30 – 13:30 Scientific Centre: Terminal 3Poster Champ Session: Lower gastrointestinal diseasesChairs: Yasmijn van Herwaarden, The Netherlands


P0367INCIDENTAL FINDINGS AT CT ENTEROGRAPHY IN PATIENTS WITH CROHN'S DISEASE: CLINICAL SIGNIFI-CANCE AND IMPACT ON TARGETED THERAPY


113


Mon

day,

Oct

ober

30,

201

7


P0233INCIDENCE AND RISK FACTORS FOR PANCREATITIS IN EMERGENCY ENDOSCOPIC RETROGRADE CHOLAN-GIOPANCREATOGRAPHY: A PROSPECTIVE MULTI-CENTER STUDY

P0252RANDOMIZED TRIAL COMPARING THE LUMEN-APPOS-ING METAL STENTS (LAMS) AND PLASTIC STENTS FOR EUS-GUIDED DRAINAGE OF WALLED-OFF NECROSIS (WON)

Posters in the Spotlight14:00 – 15:30 E-Poster Lounge 1Upper GI dysmotility: Understanding the symptoms and providing effective therapyChairs: Nathalie Rommel, Belgium

Guillaume Gourcerol, France

P0527CHRONIC POSTSTROKE OROPHARYNGEAL DYSPHAGIA IS ASSOCIATED WITH IMPAIRED CORTICAL ACTIVATION TO PHARYNGEAL SENSORY INPUTS.

P0522WHAT IS THE EFFECT OF MYOTOMY SITE ON PER-ORAL ENDOSCOPIC MYOTOMY? COMPARISON OF ANTERIOR AND POSTERIOR MYOTOMY

P0528PERCUTANEOUS ENDOSCOPIC GASTROSTOMY WITH JEJUNAL EXTENSION FOR GASTROPARESIS: THE ULTI-MATE SOLUTION?

P0516INFLUENCE OF PRUCALOPRIDE ON SECONDARY PERISTALSIS IN REFLUX PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY

P0518PER-ORAL ENDOSCOPIC MYOTOMY IN TREATMENT NAÏVE VERSUS PRIOR TREATMENT FAILURE CASES – OUTCOME IN OVER 500 PATIENTS

P0640OUTCOMES OF PER-ORAL ENDOSCOPIC MYOTOMY IN CHILDREN WITH ACHALASIA CARDIA

Poster Champ Session12:30 – 13:30 Scientific Centre: Terminal 4Poster Champ Session: Surgery, endsocopy and imagingChairs: Mariana Milashka, France

Myriam Delhaye, Belgium

P0293EARLY VERSUS DELAYED CLOSURE OF TEMPORARY LOOP ILEOSTOMY AFTER COLORECTAL SURGERIES: A PROSPECTIVE RANDOMIZED STUDY

P0271LONG-TERM OUTCOMES OF ENDOSCOPIC ULTRA-SOUND-GUIDED RIGHT INTRAHEPATIC DUCT DRAIN-AGE WITH TRANSMURAL COVERED METAL STENT.

P0262SINGLE INCISION LAPAROSCOPIC ASSISTED DOUBLE BALLOON ENTEROSCOPY: A NOVEL TECHNIQUE TO MANAGE SMALL BOWEL PATHOLOGY

P0203VASCULAR AND PIT-PATTERN ANALYSIS ACCORD-ING TO KUDO, SANO AND NICE CLASSIFICATIONS SIGNIFICANTLY IMPROVES AFTER AN IMAGE-BASED TRAINING PROGRAM

P0275PROSPECTIVE RANDOMIZED STUDY FOR EFFICACY OF AN DOUBLE BARE STENT COMPARED A DOUBLE COVERED STENT IN MALIGNANT COLORECTAL OB-STRUCTION

P0259EUS-GUIDED RADIOFREQUENCY ABLATION OF DIFFI-CULT SITES IN THE LIVER: A PRECLINICAL STUDY.

P0225PERIOPERATIVE MANAGEMENT OF ORAL ANTICOAG-ULANTS WITHOUT HEPARIN BRIDGING THERAPY FOR PATIENTS UNDERGOING ENDOSCOPIC SURGERY: A PILOT STUDY

P0242EXPERT VALIDATION OF A NOVEL MECHANICAL CUT-TING PAPILLA

P0244VISUALIZATION OF INTRA-AMPULLARY CHOLEDO-CHOCELE WITH CONTRAST MEDIUM FOR EVALUATING TECHNICAL DIFFICULTY IN ERCP

P0258THE SUCCESS RATE OF DOUBLE BALLOON ENDOSCOPIC CHOLANGIOGRAPHY IN PATIENTS WHO UNDERWENT THEIR INITIAL SURGERY AS INFANT IS SIGNIFICANTLY LOWER THAN OTHER PATIENTS


114




P0002NATURAL KILLER CELLS MAY BE THE KEY FACTOR FOR THE AMELIORATION OF THE LIVER FIBROSIS AFTER MESENCHYMAL CELL TRANSPLANTATIONMunkhtsetseg Banzragch, Turkey; T. Akkoc; N. Zibandeh; M. U. Ugurlu; T. Akkoc; D. Genc; C. A. Celikel; D. G. Duman

P0003SERPINB3 INVOLVEMENT IN THE STIMULATION OF MACROPHAGE ACTIVATION MARKER SCD163 IN HCV INFECTED PATIENTSAndrea Martini, Italy; A. Cappon; A. Biasiolo; C. Turato; P. Pontisso

P0004 THE PROTECTIVE EFFECTS OF GROUP 3 INNATE LYM-PHOID CELLS ON HEPATITIS B VIRUS RELATED LIVER FIBROSIS COULD BE IMPAIRED BY TH17 CELLSSi-Qi Wang, China; W. Ma; L.-S. Cheng; W. Jiang

P0005 EFFECTS OF INTERNAL AND EXTERNAL BILIARY DRAINAGE ON THE EXPRESSION OF INTESTINAL BILE ACID RECEPTOR AND TLR4/NOD2 IN MICE WITH OB-STRUCTIVE JAUNDICES. Li; Shaohua Shen, China; T. Zhang; W. LI

P0006ALTERED SMALL INTESTINAL MICROBIOTA TOWARD FAMILY LACTOBACILLACEAE IN MIR-21 KNOCKOUT MICEA. Santos; M. B. Afonso; P. M. Rodrigues; R. S. Ramiro; I. Gordo; Rui Castro, Portugal; C. M. P. Rodrigues

P0007 THE EMERGING ROLE OF ZBP-89 IN SENSITIZING HEPATIC CANCER STEM CELLS TO SORAFENIBNuozhou Wang, Hong Kong PRC; Y. Liu; J. Ren; J. Yu; R. Ho; P. B. Lai; G. G. Chen

Microbiology

P0008PROTECTIVE EFFECT OF AKKERMANSIA MUCINIPHI-LA AGAINST IMMUNE-MEDIATED LIVER INJURY IN A MOUSE MODELW. Wu; D. Shi; D. Fang; Xingkang He, China; L. Li

P0009CLINICAL OBSERVATION ON THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER WITH PROBIOTICSWei Wang, China

P0010FAECALIBACTERIUM ASSOCIATED WITH GUT-PERMEA-BILITY IN NONALCOHOLIC FATTY LIVER DISEASETakaomi Kessoku, Japan; K. Imajo; Y. Honda; T. Kato; Y. Ogawa; W. Tomeno; T. Higurashi; M. Yoneda; M. Shimakawa; Y. Tanaka; T. Kawahara; S. Saito; H. Usuda; K. Wada; A. Nakajima

Posters in the Spotlight14:00 – 15:30 E-Poster Lounge 2Colorectal neoplasia: Improving detection and outcomeChairs: Rob Glynne-Jones, United Kingdom


P0456 CORRELATION OF ELECTRICAL AND VISCOELASTIC PARAMETERS OF ERYTHROCYTES WITH FATTY ACID COMPOSITION OF THEIR MEMBRANES AND SERUM IN PATIENTS WITH COLORECTAL CANCERIana Prudnikova, Russian Federation

P0438INCIDENCE OF FECAL OCCULT BLOOD TEST INTERVAL CANCERS IN COLORECTAL CANCER SCREENING; A SYSTEMATIC REVIEW AND META-ANALYSISEls Wieten, The Netherlands

P0467WAIT-AND-SEE STRATEGY IN LOW RECTAL CANCERJoão Cortez-Pinto, Portugal

P0184ACHIEVING ADEQUATE LEVEL BOWEL PREPARA-TION WITH EVENING/MORNING OR MORNING-ONLY SPLIT-DOSING REGIMENS OF NER1006 VERSUS STAN-DARD 2L PEG WITH ASCORBATE: POST HOC ANALYSIS OF A PHASE 3 TRIALRaf Bisschops, Belgium

P0176PREDICTORS OF ADENOMA DETECTION AT COLONOS-COPY AFTER BOWEL SCOPE SURVEILLANCE: RESULTS FROM A UK PILOT SCREENING CENTREKeith Siau, United Kingdom

P0209REAL TIME MORPHOLOGIC CHANGE ON NUCLEUS & MITOCHONDRIA OF COLON CANCER CELL BY IRRE-VERSIBLE ELECTROPORATION: DETECTED BY PROBE BASED MULTIPHOTON MICROSCOPYSeong Ji Choi, Republic of Korea

Poster Session09:00 – 17:00 Hall 7Liver and Biliary I

Molecular biology, inflammation and fibrosis

P0001ALTERATIONS OF THE NO-CGMP PATHWAY IN THIOAC-ETAMIDE-INDUCED LIVER FIBROSIS/CIRRHOSIS IN RATSDenise Schaffner, Germany; A. Lazaro; I. Merfort; P. Hasselblatt; P. Deibert; W. Kreisel


115


Mon

day,

Oct

ober

30,

201

7


P0019INVESTIGATION OF THE RELATIONSHIP BETWEEN THE THICKNESS OF THE INTIMA-MEDIA COMPLEX OF COM-MON CAROTID ARTERIES AND PATHOLOGICAL CHANG-ES IN THE LIVER IN PATIENTS WITH ABDOMINAL OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE.Ekaterina Chernetcova, Russian Federation; N. Denisov; V. Grinevich; Y. Kravchuk; K. Ivashkin; L. Kornouchova

P0020OVEREXPRESSION OF HEPASSOCIN IN DIABETIC PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE MAY FACILITATE INCREASED HEPATIC LIPID ACCUMU-LATION.Sherief Abd-Elsalam, Egypt; S. Khodeir; S. Abou Saif; G. Abdelmoemen

P0021Mesenteric adipose tissue protects against non-alco-holic fatty liver disease by improving intestinal barrierZ. Wu; J. Tan; F. Zhang; Jun Xu, China; Y. Song; Y. L. Liu

P0022DIAGNOSTIC ACCURACY OF SHEAR WAVE ULTRA-SOUND ELASTOGRAPHY FOR EARLY DETECTION OF NON ALCOHOLIC STEATOHEPATITIS AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS.Asmaa Gameel, Egypt; E. M. Elhadidy; A. A. Mousa; M. M. Elrakhawy

P0023WITHDRAWN

P0024A NOVEL TOOL FOR THE NON-INVASIVE QUANTITATIVE ASSESSMENT OF HEPATIC STEATOSIS USING B-MODE IMAGE-GUIDED ULTRASOUND ATTENUATION IMAG-ING: A PROSPECTIVE STUDYYudai Fujiwara, Japan; H. Kuroda; T. Abe; Y. Mikami; T. Oguri; S. Noguchi; N. Kamiyama; Y. Takikawa

Cirrhosis and complications: Basic aspects

P0025SERUM FERRITIN SPECIFICITY IN PREDICTING EARLY MORTALITY OF PATIENTS WITH ALCOHOLIC LIVER CIRRHOSISI. Valantiene; Andrius Kederys, Lithuania; J. Kupcinskas; J. Kondrackiene; J. Šumskienė; V. Petrenkiene; L. Kupcinskas

P0026PLASMA RETICULON 4 PROTEIN IS ASSOCIATED WITH PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSISSigita Gelman, Lithuania; V. Salteniene; A. Pranculis; L. Kupcinskas

P0011GUT MICROBIOTA COMPOSITION IN EXPERIMENTAL MOUSE MODELS OF NON-ALCOHOLIC FATTY LIVER DISEASEBangzhou Zhang, China; L. Fan; J. Ren

Metabolic/genetic disorders

P0012PREVALENCE OF METABOLIC SYNDROME AND LIVER STEATOSIS IN A PROSPECTIVE MULTICENTER STUDY OF PATIENTS REFERRED FOR HYPERFERRITINEMIAAgustin Castiella Eguzkiza, Spain; E. Zapata; I. Urreta; L. Zubiaurre; P. Otazua; J. M. Alustiza; E. Salvador; G. Letamendi; B. Arrizabalaga; L. Mendibil; J. I. Emparanza

P0013LIVER IRON CONCENTRATION IN PATIENTS REFERRED FOR HYPERFERRITINEMIA. MULTICENTRE ANALYSIS OF THE DIFFERENT GROUPS ACCORDING TO HFE MU-TATIONS AND TRANSFERRIN SATURATION INDEX.Agustin Castiella Eguzkiza, Spain; E. Zapata; I. Urreta; L. Zubiaurre; P. Otazua; J. M. Alustiza; M. D. De Juan; E. Salvador; G. Letamendi; B. Arrizabalaga; A. iribarren; L. Mendibil; J. I. Emparanza

P0014LIVER IRON CONCENTRATION IN THE METABOLIC SYN-DROME WITH HYPERFERRITINEMIA (DYSMETABOLIC HYPERFERRITINEMIA). RESULTS FROM A PROSPEC-TIVE COHORT OF 312 PATIENTS.Agustin Castiella Eguzkiza, Spain; E. Zapata; I. Urreta; L. Zubiaurre; P. Otazua; J. M. Alustiza; E. Salvador; G. Letamendi; B. Arrizabalaga; L. Mendibil; J. I. Emparanza

P0015INTERLEUKIN-25 PROTECTS AGAINST HIGH-FAT DIET-INDUCED HEPATIC STEATOSIS IN MICE BY INDUC-ING IL-25 AND M2A KUPFFER CELL PRODUCTIONAn-Jiang Wang, China; X.-L. Zheng; B.-M. Li; H.-Y. Xiao; J.-B. Hong; X. Zhu

P0016LONG TERM BENEFIT OF STATINS USED FOR TREAT-MENT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)A.-I. Suceveanu; Adrian Suceveanu, Romania; I. R. Parepa; D. Catrinoiu; F. Voinea; L. Mazilu

P0017 THE ROLE OF GENETIC FACTORS IN NON-OBESE NASH PATIENTSFehmi Ates, Turkey

P0018EVALUATION OF THE RELATIONSHIP OF LEVELS OF C-REACTIVE PROTEIN AND HOMOCYSTEIN IN PATIENTS WITH ABDOMINAL OBESITY AND PATHOLOGICAL CHANGES IN THE LIVER DEFINED BY BIOPROGNOSTIC TEST STEATOSCREEN.Ekaterina Chernetcova, Russian Federation; N. Denisov


116




P0036HAEMOSTASIS IN PORTAL VEIN IN CIRRHOSIS: ROLE OF LOCAL ENDOTHELIAL DAMAGES. Shalaby; P. Simioni; E. Campello; S. Gavasso; A. Zanetto; F. D'Amico; E. Gringeri; U. Cillo; M. Battistel; Patrizia Burra, Italy; M. Senzolo

P0037 RIFAXIMIN-Α IS ASSOCIATED WITH REDUCTIONS IN EMERGENCY DEPARTMENT RESOURCE USE IN UK PATIENTS WITH HEPATIC ENCEPHALOPATHY: REAL WORLD EVIDENCE FROM THE IMPRESS STUDYM. Hudson; Paola Di Maggio, United Kingdom; R. Cipelli; R. Aspinall

P0038PREDICTING FACTORS FOR HOSPITAL READMISSON AF-TER THE FIRST EPISODE OF HEPATIC ENCEPHALOPATHYMarco Silva, Portugal; A. Peixoto; H. Cardoso; S. Lopes; G. Macedo

P0039SAFETY, EFFICACY AND RISK OF COMPLICATIONS FOR CIRRHOTIC HCV PATIENTS WITH THROMBOCYTOPENIA AND HYPOALBUMINEMIA TREATED WITH OMBITAS-VIR/PARITAPREVIR/R+DASABUVIR+RIBAVIRIN – A REAL LIFE COHORTCarmen-Cristina Ester, Romania; L. Gheorghe; S. Iacob; C. Cijevschi; A.-V. Trifan; C. Stanciu; I. Sporea; R. Sirli; M. Curescu; C. Brisc; A. Goldis; V. Arama; F. A. Caruntu; I. Rogoveanu; A. Seicean; I. SIMIONOV; R. Vadan; I. Pirvulescu; C. Pietrareanu; R. A. Iacob; C. Gheorghe; M. Diculescu

P0040WITHDRAWN

P0041REAL WORLD IMPACT OF RIFAXIMIN-Α USE IN HE-PATIC ENCEPHALOPATHY PATIENTS WITH ADVANCED LIVER DISEASE OR CONTINUED ALCOHOL MISUSE: A POST-HOC ANALYSIS OF THE IMPRESS STUDYM. Hudson; Paola Di Maggio, United Kingdom; R. Cipelli; R. Aspinall

P0042BACTERIAL INFECTION IN PATIENTS WITH DECOM-PENSATED CIRRHOSIS – A PREDICTOR OF LONG-TERM MORTALITY INDEPENDENT OF DISEASE´S SEVERITY Mafalda Sousa, Portugal; S. Fernandes; J. Silva; A. Ponte; J. Rodrigues; J. C. Silva; L. Proença; J. Carvalho

P0043A PROPORTIONALLY GREATER ELEVATION IN LIVER TRANSPLANT CANDIDACY IN PATIENTS WITH NAFLD AND PORTAL VEIN THROMBOSISMetin Basaranoglu, Turkey

P0027MICRORNAS IN ASCITES AS POTENTIAL BIOMARKERS FOR PERITONEAL CARCINOMATOSIS AND PERITONITISP. Schindler; J. Kupcinskas; S. Juzenas; J. Skieceviciene; V. Salteniene; C. Schulz; J. Weigt; P. Malfertheiner; Alexander Link, Germany

P0028ALTERATIONS IN GUT VASCULAR BARRIER IN EXPERI-MENTAL PORTAL HYPERTENSIONMarcel Sorribas Olivera, Switzerland; I. Spadoni; M. Rescigno; R. Wiest

P0029INHIBITION OF CYCLOOXYGENASE-2 AMELIORATES SPLENOMEGALY IN CIRRHOTIC RATSC. Tang; L. Zhang; Shihang Tang, China; X. Jia; J. Gao

P0030EPITHELIAL BARRIER DESTABILIZATION AND REGULA-TION OF P53 – A POSSIBLE BACTERIAL DEFENSE MECH-ANISM IN SPONTANEOUS BACTERIAL PERITONITIS?Marika Haderer, Germany; L. Wächter; E. Aschenbrenner; K. Pollinger; J. Middendorf; S. Schlosser; C. Kunst; M. Müller-Schilling

P0031INTESTINAL EPITHELIAL BARRIER IN EXPERIMENTAL LIVER CIRRHOSIS – A ROLE FOR BILE SALTS IN THE MUCUS LAYERM. Sorribas Olivera; Y. Noser; A. Albillos; Reiner Wiest, Switzerland

P0032CAPSAICIN AND SULFORAPHANE PREVENT THE AD-VANCEMENT OF LIVER FIBROSIS IN AN EXPERIMENTAL MODEL OF LIVER CIRRHOSISEdgar Mendivil, Mexico; A. Sandoval-Rodriguez; A. Dominguez-Rosales; L. Zuñiga-Ramos; J. Armendariz-Borunda

Cirrhosis and complications: Clinical aspects

P0033DIAGNOSIS OF GASTRIC VARICES BY ENDOSCOPIC ULTRASONOGRAPHY USING COLOR DOPPLER Takahiro Sato, Japan

P0034PORTAL HYPERTENSIVE COLOPATHY BUT NOT ILEOPA-THY IS COMMON IN EGYPTIANS WITH LIVER CIRRHOSIS A. Farag; Mohamed-Naguib Wifi, Egypt; M. Fawzi; A. Nageeb; M. Alboraie

P0035PREDICTIVE FACTORS FOR THE DEVELOPMENT OF ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH GASTROINTESTINAL BLEEDINGC. Cojocariu; Stefan Chiriac, Romania; A.-V. Trifan; C. Stanciu


117


Mon

day,

Oct

ober

30,

201

7


P0051RED BLOOD CELL DISTRIBUTION WIDTH (RDW) AS NON INVASIVE PREDICTOR OF LIVER FIBROSIS IN CHRONIC HEPATITIS C PATIENTS GENOTYPE 4.Mahmoud El-Bendary, Egypt; K. Farid; D. El-Barber; M. Elnagar

P0052CANCER INCIDENCE IN VARIOUS ORGANS OTHER THAN THE LIVER FOLLOWING DIRECT-ACTING ANTIVIRAL (DAA) THERAPY FOR HEPATITIS CBunji Endoh, Japan; N. Esaka; S. Katsushima; K. Chikugo; S. Nakano; T. Shimogama; S. Iwamoto; K. Kasahara; T. Komeda

P0053OPTIMIZATION OF DIRECT ANTI-VIRAL AGENT TREAT-MENT SCHEDULE: FOCUS ON HCV GENOTYPE 3R. Granata; Filomena Morisco, Italy; S. Camera; A. Ippolito; M. Milella; F. Conti; C. Masetti; A. Smedile; P. Tundo; T. Santantonio; M. R. Valvano; A. Termite; P. Gatti; V. Messina; A. Iacobellis; M. Librandi; N. Caporaso; A. Andriulli

P0054IS THERE AN INCREASE IN THE INCIDENCE OF HEPA-TOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS WITH HEPATITIS C TREATED WITH THE DIRECT-ACTING ANTIVIRALS?Joana C. Branco, Portugal; R. Carvalho; S. Alberto; A. Martins

Immunology, autoimmune liver disease

P0055MIRNA-506 PROMOTES PRIMARY BILIARY CHOL-ANGITIS-LIKE FEATURES IN CHOLANGIOCYTES AND IMMUNE ACTIVATIONO. Erice; P. Munoz-Garrido; J. Vaquero; M. J. Perugorría; M. G. Fernandez-Barrena; E. Saez; A. Santos-Laso; A. Arbelaiz; R. Jimenez-Agüero; J. Fernandez-Irigoyen; E. Santamaria; V. Torrano; A. Carracedo; M. Ananthanarayanan; M. Marzioni; J. Prieto; U. H. W. Beuers; R. Elferink; N. LaRusso; L. Bujanda Fernández de Piérola; J. J. Marin; Jesus M. Banales, Spain

Imaging, radiology (incl. interventional radiology)

P0056CLINICAL EXPERIENCE IN THE USE OF TRANSJUGULAR LIVER BIOPSY WITH TRU-CUT NEEDLE: A RETROSPEC-TIVE EVALUATION OF 265 CASESArmando Peixoto, Portugal; M. Silva; A. L. Santos; P. Costa-Moreira; I. Pita; S. Rodrigues; S. Lopes; G. Macedo

P0044RISK FACTORS AND PREDICTIVE MODEL FOR THE DEVELOPMENT OF MULTIDRUG RESISTANT BACTERIAL INFECTIONS AND THE IMPACT ON PROGNOSIS IN HOSPITALIZED DECOMPENSATED LIVER CIRRHOSIS PATIENTSRui Morais, Portugal; S. Rodrigues; H. Cardoso; M. Silva; A. Peixoto; E. Moniz; A. L. Santos; I. Pita; R. Liberal; R. Gaspar; E. Rodrigues-Pinto; G. Macedo

Viral hepatitis C: Clinical aspects

P0045EFFECT OF TREATMENT OF CHRONIC HEPATITIS C WITH SOFOSBUVIR AND DACLATASVIR IN PATIENTS OLDER THAN 60 YEARSKarim Elnoemany, Egypt; M. Badr

P0046EGY FIBRO-MARK: A PANEL OF ACCURATE LABORATO-RY PARAMETERS FOR THE IDENTIFICATION HEPATIC FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS CDalia Omran, Egypt; A. M. Attallah; M. Omran; R. Zayed; S. Saif; A. Farid; M. Hassany; A. Yosry

P0047EXTRACELLULAR MATRIX PROTEINS CIRCULAT-ING LEVELS SUBSTANTIATE THE EFFECT OF IL-28B RS12979860 T ALLELE ON FIBROSIS STAGE OF CHRONIC HEPATITIS C TYPE 4Dalia Omran, Egypt; A. M. Attallah; M. Omran; R. Zayed; R. El Essawey; S. Saif; A. Farid; M. Hassany; A. Yosry

P0048REAL-WORLD EFFECTIVENESS OF FIVE DIFFERENT DIRECT ACTING ANTIVIRAL REGIMENS FOR TREAT-MENT OF CHRONIC HEPATITIS C WITH NORMAL LIVER ENZYMES: SINGLE CENTER EGYPTIAN EXPERIENCEM. El Kassas; Mohamed Alboraie, Egypt; M. Salah; A. Eltahan; Y. Abdellatif; I. Kabbash; A. Fouad; M. Eltabbakh; Z. Ali-Eldin; M.-N. Wifi; M. El-Serafy; K. Elsaeed; Y. Elshazly; W. Doss

P0049THE SAFETY AND EFFICACY OF THE COMBINATION OF DACLATASVIR, ASUNAPREVIR, AND BECLABUVIR IN THE TREATMENT OF CHRONIC HEPATITIS C VIRUS GENOTYPE 1 INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS.Ali Mahmoud Ahmed, Egypt; M. F. Doheim; O. M. Mattar; N. A. Sherif; D. H. Truong; P. T. L. Hoa; K. Hirayama; N. T. Huy

P0050GENETIC EPIDEMIOLOGY OF HCV INFECTION IN UPPER &LOWER EGYPT: A MULTICENTRE FAMILY BASED STUDYMahmoud El-Bendary, Egypt; M. Neamatallah; E. Kamel; H. Elalfy; T. Besheer; H. Elsayed; Y. Ellazeik; A. A. Elmorsy; M. El-Setouhy; A.-H. Eladl; G. Esmat;


118




P0065CUX1 CONTROLS ENDOPLASMIC RETICULUM STRESS AND AUTOPHAGY RELATED CELL DEATHGiulia Metzger, Germany; P. Di Fazio; D. Bartsch; T. M. Gress; T. T. Wissniowski

P0066CUX1 CONFERS RESISTANCE TO APOPTOTIC CELL DEATH IN LIVER CANCER CELLSElena Hofmann, Germany; P. Di Fazio; D. Bartsch; T. M. Gress; T. T. Wissniowski

P0067SERUM SQUAMOUS CELL CARCINOMA ANTIGEN LEVEL IN CIRRHOTIC CHRONIC HEPATITIS C PATIENTS WITH AND WITHOUT HEPATOCELLULAR CARCINOMAWalid Ellakany, Egypt

Liver neoplasia: Clinical

P0068HEPATOCELLULAR CARCINOMA MULTIDISCIPLINARY CLINIC – CAIRO UNIVERSITY (HMC-CU) SCORE; A NEW SIMPLE SCORE FOR EARLY DIAGNOSIS OF HCCA. Omar; Dalia Omran, Egypt; M. Mahmoud; T. El Baz; E. Medhat; A. Hosny; A. Salah; H. Shousha

P0069MULTIPLE BIPOLAR RADIOFREQUENCY ABLATION IN TREATMENT OF MEDIUM TO LARGE HEPATOMAS – EXPERIENCE IN A REGIONAL HOSPITALPo-Jen Hsieh, Taiwan; C.-L. Yen

P0070RECENT TRENDS IN HEPATOCELLULAR ADENOMAS: CLINICAL FEATURES, DIAGNOSIS AND OUTCOMESMarco Silva, Portugal; A. Peixoto; R. Coelho; H. Cardoso; G. Macedo

P0071LASER ABLATION IS SUPERIOR TO TACE IN LARGE SIZED HEPATOCELLULAR CARCINOMA: A CASE–CON-TROL STUDYSilvia Camera, Italy; G. G. Di Costanzo; R. Tortora; M. Guarino; V. Cossiga; A. Vitiello; G. Cordone; N. Caporaso; F. Morisco; I. L. C. Italian Liver Cancer Group

P0072ENDOSCOPIC ULTRASOUND GUIDED BIOPSY FOR LIVER MASS USING CORE BIOPSY NEEDLEH. K. Chon; Tae Hyeon Kim, Republic of Korea; K. H. Choi

P0073COMPARISON OF METHODS TO ESTIMATE LIVER FUNCTION IN NEWLY-DIAGNOSED HEPATOCELLULAR CARCINOMA PATIENTS WITH ASCITESYoungSun Ko, Republic of Korea

P0057 OPTIMAL NUMBER OF MEASUREMENTS IN REAL-TIME SHEAR WAVE ELASTOGRAPHY TO ASSESS LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTIONHiroshi Numao, Japan; K. Shimaya; M. Ryoma; S. Igarashi; K. Hasui; K. Kanazawa; M. Munakata; N. Hanabata

P0058APPARENT DIFFUSION COEFFICIENT IN EVALUATING THERAPEUTIC EFFICACY AFTER RADIOFREQUENCY ABLATION FOR HEPATOCELLULAR CARCINOMA: PROM-ISING RESULTSE. Emara; R. Mousa; M. Ghalab; Mohamed Hassan Emara Elzanan, Egypt; M. Balbaa; M. Talaat

P0059NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IMPACT ON RESULTS OF SHEAR WAVE ELASTOGRAPHY FOR HEPATIC FIBROSIS STAGING Alexey Katrich, Russian Federation; A. Okhotina; O. Ponkina; N. Ryabin

P0060FEASIBILITY AND REPRODUCIBILITY OF NON-INVASIVE LIVER AND PANCREATIC STIFFNESS ASSESSMENT IN A COHORT OF PATIENTS WITH ALCOHOL-RELATED LIVER DISEASEClara Benedetta Conti, Italy; N. Weiler; M. Fraquelli; G. Casazza; D. Conte; M. Colombo; S. Zeuzem; M. Friedrich-Rust

Liver neoplasia: Basic

P0061EXOSOMIC MIR-224 REGULATED TUMOR INVASION AND MIGRATION THROUGH IL-6/STAT3 PATHWAY IN HEPATOCELLULAR CARCINOMAFangmei An, China; D. Chen; Q. Zhan; M. Xia; X. Wu

P0062 ªEXPRESSION ANALYSIS OF LIVER-SPECIFIC CIRCULAT-ING MICRORNAS IN HCV-INDUCED HEPATOCELLULAR CARCINOMA IN EGYPTIAN PATIENTSLobna Mourad, Egypt; E. El-Ahwany; M. Zoheiry; H. Abu-Taleb; M. Hassan; A. Abdel Rehim; M. Hassan; S. Zada

P0063 EPIGENETIC INACTIVATION OF METALLOTHIONEIN 1G IN PATIENTS WITH HEPATOCELLULAR CARCINOMAXiaoxing LI, China; N. Zhang; L. XU; G. Zhao

P0064THE FXR RECEPTOR PATHWAY IN HEPATOCELLULAR ADENOMA AND FOCAL NODULAR HYPERPLASIA, A PRELIMINARY EXPERIENCEBelle van Rosmalen, The Netherlands; M. Visentin; J. Verheij; M. Bieze; B. Stieger; T. M. van Gulik


119


Mon

day,

Oct

ober

30,

201

7


P0082ALCOHOL CONSUMPTION CAN REDUCE THE RISK OF GALLSTONE DISEASE: A SYSTEMATIC REVIEW WITH DOSE-RESPONSE META-ANALYSIS OF CASE-CONTROL AND COHORT STUDIES.Byung Hyo Cha, United Arab Emirates; M.-J. Jang

P0083 ERCP WITH SHORT-TYPE SINGLE BALLOON ENTERO-SCOPE IN PATIENTS WITH SURGICALLY ALTERED PATIENTSMitsuhiro Kida, Japan; H. Yamauchi; Y. Kawaguchi; E. Miyata; R. Hasegawa; T. Kaneko; K. Okuwaki; T. Iwai; H. Kikuchi; H. Imaizumi; W. Koizumi

P0084CHOLECYSTECTOMY FOLLOWING ENDOSCOPIC RET-ROGRADE CHOLANGIOPANCREATOGRAPHY AND DUCT CLEARANCE FOR CHOLEDOCHOLITHIASIS; A SINGLE CENTRE EXPERIENCE FROM UNITED KINGDOM.Fahd Rana, United Kingdom; D. Majumdar; P. Sambaiah; D. Craig; J. Greenaway; V. Mitra

Biliary neoplasia: Clinical

P0085THE DEVELOPMENT OF MULTI-LAYER DRUG ELUTING MEMBRANE USING ULTRASONIC SPRAY COATING TECHNIQUEJin-Seok Park, Republic of Korea; D. H. Lee

P0086THE ANTI-TUMOR EFFECT OF PACLITAXEL, GEMCIT-ABINE AND MITOMYCIN C ELUTING MEMBRANE IN ANIMAL MODELJin-Seok Park, Republic of Korea; D. H. Lee; S. Jeong

P0087ADVANCES IN CYTOLOGY FOR THE EARLY DIAGNOSIS OF PANCREATICO-BILIARY MALIGNANCYChristopher Meredith, Australia; P. Irandoost; P. Baird

P0088IMPACT OF PALLIATIVE BILIARY DRAINAGE BETWEEN METAL STENT AND PLASTIC STENT ON SURVIVAL RATE IN UNRESECTABLE DISTAL MALIGNANT BILIARY STRICTURE IN SOUTH OF THAILANDTanawat Pattarapuntakul, Thailand; B. Ovartlanporn; N. Netinatsunton

P0089PROGNOSTIC VALUE OF EARLY CA19-9 RESPONSE DURING CHEMOTHERAPY IN PATIENTS WITH AD-VANCED OR RECURRENT BILIARY TRACT CANCER Naminatsu Takahara, Japan; Y. Nakai; K. Saito; T. Nakamura; T. Sato; T. Takeda; R. Uchino; S. Mizuno; H. Kogure; S. Matsubara; M. Tada; H. Isayama; K. Koike

P0074DIAGNOSTIC AND PROGNOSTIC ROLE OF SQUAMOUS CELL CARCINOMA ANTIGEN IN HEPATOCELLULAR CAR-CINOMA: SEROLOGICAL AND TISSUE DETERMINATIONFilippo Pelizzaro, Italy; L. Ferrara; R. Cardin; M. Piciocchi; G. Peserico; P. Todesca; A. Imondi; C. Pozzan; F. Farinati

P0075ADHERENCE TO BARCELONA CLINIC LIVER CANCER GUIDELINES IN FIELD-PRACTICE: RESULTS OF PRO-GETTO EPATOCARCINOMA CAMPANIA.F. Morisco; Maria Guarino, Italy; A. Vitiello; R. Tortora; G. de Stefano; C. Coppola; A. Salomone Megna; F. Izzo; G. Nardone; L. E. Adinolfi; G. D'Adamo; G. B. Gaeta; V. Messina; P. Guido; G. Francica; V. De Girolamo; N. Coppola; M. Persico; G. G. Di Costanzo

Liver health services research

P0076A QUESTIONNAIRE SURVEY ON QUALITY OF LIFE WITH ANXIETY AND DEPRESSION SELF-RATING IN PATIENTS OF LIVER CIRRHOSISYuanyuan Zhang, China; X. Li; N. Cui; Y. L. Liu

P0077THE IMPORTANCE OF INDIVIDUAL CORRECTION OF EATING BEHAVIOR IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASEYana Nikiforova, Ukraine

P0078NON-GOVERNMENTAL HCV SCREENING IN A VILLAGE IN NILE DELTA IN DAAS ERA IN EGYPTAhmed Sadek, Egypt; A. Salem; W. Wafy; A. Abdelfattah

P0079EARLY DIAGNOSTICS OF NAFLD: ANALYSIS OF RISK FACTORS AND SCREENING USING ELASTOMETRY. ASSOTIATION BETWEEN THE PREVALENCE STEATOSIS AND COMPONENT COMPOSITION OF THE BODY.Igor Bakulin, Russian Federation; L. Belousova; L. Evdokimova; M. Serkova; S. Ivanov; D. Korostelev

Cholestasis and gallstones: Clinical

P0080SALVAGE TECHNIQUE USING A MICRO GUIDEWIRE FOR DIFFICULT BILIARY CANNULATION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHYAkihiro Mori, Japan; S. Ito; S. Hayashi; T. Shibuya; M. Sawada; H. Hachiya; T. Yumura; N. Ohashi

P0081ERCP IN VERY ELDERLY PATIENTS AGE 85 OR OLDER.Mohammad Taghi Ayoubi Khajekini, Italy; F. Castellino; N. Leone; M. Berrutti; G. Sansoè; L. Framarin; A. Repici


120




P0097 EXPDF IMPACTS PANCREATIC DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELL DERIVED PANCRE-ATIC ORGANOIDSM. Breunig; M. Hohwieler; T. Seufferlein; Alexander Kleger, Germany

P0098MELATONIN METABOLITE; N1-ACETYL-N2-FORMYL-5- METHOXYKYNURAMINE STIMULATES PANCREATIC EN-ZYME SECRETION VIA CCK RELEASE. STUDY ON THE RATS.Jolanta Maria Jaworek, Poland

P0099INVESTIGATION OF THE FUNCTION OF TRPM2 IN MOUSE PANCREATIC ACINAR CELLSJúlia Fanczal, Hungary; P. Biró; T. Madacsy; P. Hegyi; J. Maléth

P0100INVESTIGATION OF THE PANCREATIC DUCTAL ION SE-CRETION IN PANCREATIC DUCTAL ORGANOID CULTURESRéka Molnár, Hungary; L. Alsardi; J. Fanczal; T. Madacsy; P. Hegyi; J. Maléth

P0101INVESTIGATION OF THE ORAI1 MEDIATED CA2+ ENTRY IN MOUSE PANCREATIC DUCTAL CELLSMarietta Görög, Hungary; A. Grassalkovich; A. Balázs; P. Pallagi; P. Hegyi; J. Maléth

Pancreatitis, acute

P0102ACUTE PANCREATITIS OF UNKNOWN ORIGIN AND IDIOPATHIC JUVENILE PANCREATITIS IN SWEDENMiroslav Vujasinovic, Sweden; F. Lindgren; S. Haas; R. Valente; S. Ghazi; N. Kartalis; R. Pozzi; M. Del Chiaro; P. Bauer; C. Verbeke; H. Witt; U. Arnelo; J.-M. Löhr

P0103THE FACTORS FOR PREDICTING HOSPITAL MORTALITY IN EARLY STAGE OF SEVERE ACUTE PANCREATITIS.Masayasu Horibe, Japan; M. Sasaki; M. Sanui; H. Sawano; T. Goto; T. Ikeura; T. Hamada; E. Iwasaki; T. Kanai; T. Mayumi

P0104 EARLY OR LATE CHOLECYSTECTOMY IN MILD GALLSTONE PANCREATITIS? RESULTS FROM RANDOMIZED TRIALRozh Noel, Sweden; U. Arnelo; L. Enochsson; G. Sandblom

P0105COMPARISON OF PREDICTIVE SYSTEMS TO PREDICT DEATH, SEVERE AND MILD ACUTE PANCREATITIS AC-CORDING TO THE REVISED ATLANTA CLASSIFICATIONRubén Pique Becerra, Spain; F. J. García Alonso; F. García Durán; M. Hernández Tejero; A. Granja Navacerrada; P. Bernal Checa; P. Bernal Checa; F. Bermejo

P0090BILIARY DRAINAGE IN PATIENTS WITH UNRESECTABLE PERIHILAR CHOLANGIOCARCINOMA HAS A VERY HIGH COMPLICATION AND FAILURE RATE.Marcia Gaspersz, The Netherlands; J. L. A. van Vugt; E. Roos; R. J. S. Coelen; J. Vugts; E. Belt; J. de Jonge; W. Polak; J. W. Poley; F. E. J. A. Willemssen; L. Hol; T. M. van Gulik; J. N. M. IJzermans; B. Groot Koerkamp

P0091BRUSH CYTOLOGY GUIDED BY ENDOSCOPIC RETRO-GRADE CHOLANGIOPANCREATOGRAPHY OF BILIARY STRICTURESArmando Peixoto, Portugal; P. Pereira; M. Silva; F. Vilas-Boas; E. Rodrigues-Pinto; P. Moutinho-Ribeiro; J. Lopes; G. Macedo

P0092WITHDRAWN

P0093UNILATERAL VERSUS BILATERAL STENT-IN-STENT PLACEMENT OF METAL STENTS FOR MALIGNANT HILAR BILIARY OBSTRUCTIONHaruka Toyonaga, Japan; Y. Taniguchi; T. Inokuma

Biliary health services research

P0094CLINICAL ASSESSMENT OF THE SAFETY AND EFFICACY OF A NOVEL BIODEGRADABLE STENT IN PATIENTS WITH BILIARY OBSTRUCTION: A PILOT STUDY Hairol Othman, Malaysia; N. Y. Yaacob; E. J. Roslan; R. Jarmin; Z. Mohamed

Poster Session09:00 – 17:00 Hall 7Pancreas I

Cell biology/secretion/enzymology/physiology

P0095TOLL-LIKE RECEPTOR 5 IS ESSENTIAL FOR THE ACTI-VATION OF LIVER AND PANCREATIC STELLATE CELLSIsabell Böhm, Germany; D. Bartsch; T. M. Gress; M. Buchholz; T. T. Wissniowski; P. Di Fazio

P0096THE IMPAIRED FUNCTION OF THE PLASMA MEMBRANE CA2+ PUMP RESULTS IN CA2+ OVERLOAD AND CELL DAM-AGE IN CFTR KNOCK OUT PANCREATIC DUCTAL CELLSTamara Madacsy, Hungary; J. Fanczal; A. Schmidt; P. Pallagi; Z. Rakonczay; P. Hegyi; Z. Rázga; M. A. Gray; M. Hohwieler; A. Kleger; J. Maléth


121


Mon

day,

Oct

ober

30,

201

7


P0115LONGER CANNULATION TIME AND PANCREATIC GUIDEWIRE DURING ERCP CAN BE A GOOD CANDIDATE FOR PROPHYLACTIC PANCREATIC STENT TO PREVENT POST-ERCP PANCREATITIS: A MATCHED PROPENSITY ANALYSISShiro Hayashi, Japan; T. Nishida; R. Tomita; Y. Higaki; H. Shimakoshi; A. Shimoda; N. Osugi; A. Sugimoto; K. Takahashi; D. Nakamatsu; K. Mukai; T. Matsubara; M. Yamamoto; K. Fukui; M. Inada

Pancreatitis, chronic (including hereditary disorders)

P0116 AUTOIMMUNE PANCREATITIS CLASSIFIED AS NOT-OTHERWISE SPECIFIED (NOS) ACCORDING TO THE INTERNATIONAL CONSENSUS DIAGNOSTIC CRITERIA: CLINICAL FEATURES AND OUTCOMES IN 47 PATIENTS.N. de Pretis; A. Brandolese; L. Brozzi; F. Vieceli; A. Amodio; Martina Ruffini, Italy; S. Crinò; A. Gabbrielli; L. Frulloni

P0117698 CASES OF PANCREATIC DISEASES TREATED BY EPDBD (ENDOSCOPIC PANCREATIC DUCT BALLOON DILATION) – ITS USEFULNESS AND SAFETYTadao Tsuji, Japan

P0118ENDOSCOPIC ULTRASOUND AS A PREDICTOR AND GUIDE TO SUCCESSFUL ENDOTHERAPY IN CHRONIC PANCREATITISMalay Sharma, India; P. Somani

P0119UTILITY OF SERUM APOPTOSIS INHIBITOR OF MACRO-PHAGE FOR DIFFERENTIATING IGG4-RELATED DISEASE FROM MALIGNANT DISEASEShiroh Tanoue, Japan; S. Hashimoto; S. Arima; Y. Nasu; F. Sasaki; S. Kanmura; A. Ido

P0120ENDOSONOGRAPHY FOR SUSPECTED PANCREATIC NEOPLAMS: OUTCOME AND FOLLOW-UP OF PAN-CREATIC LESIONS IN THE SETTING OF A NORMAL OR INFLAMED PANCREASFrancesco Vitali, Germany; D. Strobel; S. Heinrich; L. Frulloni; L. Pfeifer; R. S. Goertz; M. F. Neurath; D. Wildner

Pancreatic cancer: Basic

P0121 GALECTIN-1 EXPRESSED IN PANCREATIC STELLATE CELLS PROMOTES TUMOR PROGRESSION IN PAN-CREATIC CANCER VIA UPREGULATION OF SDF-1 AND ACTIVATION OF NF-ΚBT. Yu; Dong Qian, China

P0106PANCREATIC DUCT ASCARIASISPiyush Somani, India; M. Sharma

P0107LARGE VOLUME FLUID RESUSCITATION IN PATIENTS WITH SEVERE ACUTE PANCREATITIS IS ASSOCIATED WITH REDUCED MORTALITY: A MULTI-CENTRE RETRO-SPECTIVE STUDYTakahiro Yamashita, Japan; M. Horibe; M. Sanui; M. Sasaki; H. Sawano; T. Goto; T. Ikeura; T. Hamada; T. Oda; T. Mayumi

P0108SERUM PHOSPHATE AS A PROGNOSTIC FACTOR IN POST-ENDOSCOPIC RETROGRADE CHOLANGIOPAN-CREATOGRAPHY PANCREATITISYoung Hoon Choi, Republic of Korea; D. K. Jang; Y.-T. Kim; J. K. Ryu; W. H. Paik; J. W. Kang; J. H. Choi; S. H. Lee

P0109BISAP AND RANSON AS PREDICTORS OF SEVERE ACUTE PANCREATITIS AND MORTALITY IN A EUROPE-AN COHORT.Francisco Valverde López, Spain; E. Fernández-Fernández; R. Jiménez-Rosales; A. M. Matas-Cobos; E. Ortega-Suazo; E. Redondo-Cerezo

P0110POST-ENDOSCOPIC RETROGRADE CHOLANGIOPAN-CREATOGRAPHY PANCREATITIS: MORBIDITY AND PREDICTORS OF SEVERITYEhab El-Hanafy, Egypt; A. El Nakeeb

P0111LACTATE AND OTHER BIOMARKERS AS PREDICTORS OF SEVERE ACUTE PANCREATITIS IN A EUROPEAN COHORT.Francisco Valverde López, Spain; E. Fernández-Fernández; F. Vadillo-Calles; A. M. Matas-Cobos; P. Abellán-Alfocea; E. Redondo-Cerezo

P0112COTTON VS. REVISED ATLANTA CRITERIA TO DEFINE SEVERITY OF POST-ERCP PANCREATITISXavier Smeets, The Netherlands; A. C. Tan; J. P. H. Drenth; E. Van Geenen

P0113RISKS FACTORS AND OUTCOMES OF INFECTED PAN-CREATIC NECROSIS: RESULTS FROM A COHORT OF 148 PATIENTS ADMITTED IN ICU FOR SEVERE ACUTE PANCREATITIS.Charlotte Garret, France; M. Péron; A. Le Thuaut; M. Le Rhun; C. Guitton; J. Gournay; J. Reignier; E. Coron

P0114EARLY PREDICTORS AND OUTCOMES OF FLUID SE-QUESTRATION IN ACUTE PANCREATITISSundeep Goyal, India


122




P0130USE OF A NOVEL THROUGH-THE-NEEDLE MICRO-BI-OPSY FORCEPS IN DIAGNOSING PANCREATIC CYSTS – A MULTICENTER FEASIBILITY STUDYBojan Kovacevic, Denmark; J. G. Karstensen; R. F. Havre; K. D.-C. Pham; M. Giovannini; E. Dabizzi; P. G. Arcidiacono; E. Vazquez Sequeiros; P. Klausen; C. V. Rift; J. P. Hasselby; A. Toxværd; E. Kalaitzakis; C. P. Hansen; P. Vilmann

P0131PANCREATIC DUCTAL CYTOLOGY: AN UNDERUSED DIAGNOSTIC TOOLArmando Peixoto, Portugal; P. Pereira; E. Rodrigues-Pinto; F. Vilas-Boas; J. Lopes; G. Macedo

P0132ANALYSIS OF PROGNOSTIC FACTORS IN PANCREATIC ME-TASTASES, A MULTICENTER RETROSPECTIVE ANALYSISTakashi Ito, Japan; R. Takada; S. Omoto; M. Tsuda; D. Masuda; H. Kato; H. Ishii; I. Moriyama; K. Tanaka; H. Kawamoto; S. Yazumi

P0133LUNG METASTASIS IN PANCREATIC CANCER: SHOULD STAGING CHEST CT BE ROUTINELY PERFORMED?Shailendra Singh, USA; B. Rao; S. Umar; M. Chowdhry; A. Kulkarni; K. Farah; S. Morrissey; M. Dhawan; S. Thakkar

P0134VALUE OF EUS IN EARLY DETECTION OF TUMOR LE-SION IN THE REMNANT PANCREASHirotsugu Maruyama, Japan; A. Shimizu; T. Minami; N. Hirano; K. Hanada

P0135PATIENTS WITH INTRADUCTAL PAPILLARY MUCIONOUS NEOPLASMS OF PANCREAS (IPMNS) ARE AT INCREASED RISK OF RENAL CELL CARCINOMA, PROSTATE, COL-ORECTAL AND BREAST CANCER: A SINGLE CENTER ITALIAN EXPERIENCENikola Panic, Italy; M. Bulajic; F. Macchini; S. Solito; S. Boccia; E. Leoncini; D. Berretti; S. Pevere; S. Vadala; M. Marino; E. Pinese; M. Zilli

P0136CLINICAL CHARACTERISTICS OF SECOND PRIMARY PANCREATIC CANCERJung Hyun Jo, Republic of Korea; I. R. Cho; H. S. Lee; M. J. Chung; S. Bang; S. W. Park; S. Y. Song; J.-B. Chung; J. Y. Park

P0137ADEQUACY ASSESSMENT OF EUS-FNAB SAMPLES OF PANCREATIC CANCER FOR “PRECISION MEDICINE”: A COMPARISON OF 22-GAUGE AND 25-GAUGE NEEDLESNaohiko Yoshizawa, Japan; R. Yamada; H. Miura; T. Takeuchi; T. Harada; H. Inoue; H. Okuse; T. Sakuno; M. Nakamura; Y. Hamada; M. Katsurahara; K. Tanaka; N. Horiki; Y. Takei

P0122WHOLE-GENOME SEQUENCING OF PANCREATIC TUMOR BY NEXT-GENERATION SEQUENCING USING EUS-FNA SPECIMENSMiho Matsukawa, Japan; M. Nishimura; Y. Fujii

P0123PTPN11 DRIVES TUMOR DEVELOPMENT AND DEFINES A NOVEL THERAPEUTIC TARGET IN KRAS-MUTANT CANCERSDietrich Alexander Ruess, Germany; G. J. Heynen; K. Ciecielski; H. Algül

P0124CIRCHIPK3 PROMOTES PANCREATIC CARCINOMA CELLS BXPC3 PROLIFERATION BY TARGETING MIR-124/IL6R/STAT3 PATHWAYGenwen Chen, China; Y. Zhang; J. Sun

P0125 CONCOMITANT PANCREATIC CANCERS ARISING ADJA-CENT TO INDEX INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS SHARE IDENTICAL KRAS MUTATIONS AND ARE ASSOCIATED WITH A FAVORABLE PROGNOSIS.Yuko Omori, Japan; Y. Ono; M. Tanino; H. Karasaki; T. Shinohara; S. Tanaka; H. Maguchi; Y. Mizukami

P0126POLYMORPHISM OF TP53 GENE, LEVELS OF INSULIN AND PROINFLAMMATORY CYTOKINES IN PATIENTS WITH PANCREATIC CANCERT. I. Romanova; Irina Grigoreva, Russian Federation; V. N. Maximov; O. V. Efimova; Y. I. Ragino; T. S. Suvorova; N. L. Tov

P0127VALIDATION OF SERUM/PLASMA METABOLOMIC BIOMARKERS AGAINST PANCREATIC CANCER BY QUANTITATIVE TARGETED GC/MS/MSTakashi Kobayashi, Japan; Y. Hirata; M. Yoshida; S. Nishiumi; K. Honda

Pancreatic cancer: Clinical

P0128COMBINED HISTO-CYTOLOGICAL ANALYSIS OF EUS-FNA SAMPLES FROM SOLID LESIONS USING STANDARD FNA NEEDLES GIVES BETTER DIAGNOSTIC YIELD AND ACCURACYAshwini Banerjee, United Kingdom; A. Cairns; L. Sanni; B. Paranandi; M. Huggett

P0129 VERIFICATION OF INTERNATIONAL CONSENSUS GUIDE-LINES 2012 – SURGICAL INDICATION FOR BRANCH DUCT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE PANCREAS (BD-IPMN) WITH WORRISOME FEATURESYasuhiro Shimizu, Japan; H. Yamaue; H. Maguchi; S. Hirono; S. Hijioka; K. Hara; T. Sano; Y. Senda; S. Natsume; A. Yanagisawa


123


Mon

day,

Oct

ober

30,

201

7


P0146CONSCIOUS SEDATION FOR ENDOSCOPIC SUBMUCOSAL RESSECTION BY USING DEXMEDETOMIDINE Masaya Esaki, Japan; M. Hattori; I. Matsuzaki; K. Hirose; C. Izumi; M. Yoshikawa; H. Yamauchi; S. Nakazawa

P0147DIAGNOSTIC ACCURACY OF BLUE LASER IMAGING WITH MAGNIFYING ENDOSCOPY FOR INVASION DEPTH OF SU-PERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA.Tomohiro Ueda, Japan; O. Dohi; K. Ogita; S. Takayama; K. Terasaki; T. Nakano; N. Iwai; T. Okayama; N. Yoshida; K. Katada; K. Kamada; K. Uchiyama; O. Handa; T. Ishikawa; T. Takagi; H. Konishi; Y. Naito; Y. Itoh

P0148IMPACT OF NEEDLE-BASED CONFOCAL LASER EN-DOMICROSCOPY (NCLE) IN IMPROVING DIAGNOSIS OF PANCREATIC CYSTIC NEOPLASMS: SINGLE CENTER EXPERIENCEF. Shariati; E. Verter; M. Lucas; C. Molina; J. Adams; Virendra Joshi, USA

P0149FULL-SPECTRUM ENDOSCOPY FOR UPPER GASTROIN-TESTINAL SCREENING INCLUDING PRECISE OBSERVA-TION OF THE AMPULLA OF VATER AND THE ANAL SIDE OF THE PYLORIC RINGHyuga Yamada, Japan; T. Shibata; T. Kawamura; N. Horiguchi; M. Okubo; T. Tahara; M. Nagasaka; Y. Nakagawa; N. Ohmiya

P0150PREDICTIVE FACTORS OF PROCEDURAL DIFFICULTIES IN ENDOSCOPIC SUBMUCOSAL DISSECTION OF EAR-LY-STAGE GASTRIC CANCERHyuga Yamada, Japan; T. Shibata; T. Kawamura; N. Horiguchi; M. Okubo; T. Tahara; M. Nagasaka; Y. Nakagawa; N. Ohmiya

P0151LOCATION FEATURES OF EARLY GASTRIC CANCER TREATED WITH ENDOSCOPIC SUBMUCOSAL DISSECTIONCheol Woong Choi, Republic of Korea; D. H. Kang; H. W. Kim; S. J. Kim; J. S. Lee; C. W. Yeo; S. H. Choi; H. J. Kim; J. H. Ko

P0152A STUDY OF THE RECOGNITION OF ENDOSCOPIC IM-AGES BY MACHINE LEARNING WITH CONVOLUTIONAL NEURAL NETWORK AND DEEP LEARNING Ryoichi Yamakawa, Japan; M. Harada; K. Kawauchi; S. Nuzuki; M. Iwata

Poster Session09:00 – 17:00 Hall 7Endoscopy and Imaging I

Endoscopy, upper GI

P0138FEASIBILITY OF GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION WITH CONTINUOUS LOW-DOSE ASPIRIN FOR PATIENTS ON DUAL ANTIPLATELET THERAPYHideaki Harada, Japan; S. Suehiro; D. Murakami; R. Nakahara; T. Ujihara; T. Shimizu; Y. Katsuyama; K. Hayasaka

P0139OUTCOMES OF PERORAL ENDOSCOPIC MYOTOMY FOR TREATMENT OF ESOPHAGEAL ACHALASIA WITH A MEDIAN FOLLOW-UP OF 4 YEARSQuan-Lin Li, China; Q.-N. Wu; X.-C. Zhang; P.-H. Zhou

P0140PATIENTS WITH CHRONIC GASTROINTESTINAL ISCHEMIA HAVE AN ALTERED SUBLINGUAL MICROCIRCULATIONJihan Harki, The Netherlands; M. Suker; M. S. Tovar Doncel; L. J. D. van Dijk; D. van Noord; C. H. J. van Eijck; M. J. Bruno; E. J. Kuipers; C. Ince

P0141CONVENTIONAL NARROW BAND IMAGING HAS GOOD CORRELATION WITH OLGA STAGING OF GASTRITISA. Gawish; A. Elbahrawy; S. Mabrouk; Mohamed Abdellah, Egypt; M. El Fayoumie; A. Aboelfotoh; M. Eldahshan; F. Al Ghamry

P0142SAFETY ADVANTAGE OF THE NEW DEVICE (SPLASH-M KNIFE®) FOR ENDOSCOPIC SUBMUCOSAL DISSECTION OF EARLY GASTRIC CANCERMitsuru Esaki, Japan; K. Hayashi; S. Suzuki; C. Kusano; S. Itonaga; S. Abe; Y. Hayashi; A. Yokoyama; T. Hosokawa; H. Ogino; H. Akiho; T. Gotoda

P0143INTUBATION FAILURE DURING GASTROSCOPY – INCI-DENCE, PREDICTORS AND FOLLOW-UP FINDINGSKeith Siau, United Kingdom; J. Li; N. C. Fisher; C. J. J. Mulder; S. Ishaq

P0144DIAGNOSTIC CAPABILITY OF ENDOSCOPY FOR HELICO-BACTER PYLORI INFECTIONYoshii Shinji, Japan; K. Mabe; M. Kato; N. Sakamoto

P0145A RETROSPECTIVE AUDIT OF OUTCOMES AND CUR-RENT CLINICAL PRACTICE POST- BALLOON TAMPON-ADE FOR ACUTE SEVERE VARICEAL BLEEDING: HAVE THINGS IMPROVED OVER TIME?Charlotte Keung, Australia; A. Jackson; M. Swan


124




P0161ENDOSCOPIC GRADING FOR GASTRIC INTESTINAL META-PLASIA (EGGIM): A MULTICENTRE VALIDATION STUDYGianluca Esposito, Italy; P. Pimentel-Nunes; S. Angeletti; R. Castro; D. Libanio; G. Galli; E. Lahner; E. Di Giulio; B. Annibale; M. Dinis-Ribeiro

P0162PERCUTANEOUS TRANSESOPHAGEAL GASTROTUBING (PTEG) IN THE DECOMPRESSION TREATMENT FROM THE GASTROINTESTINAL TRACT AS THE IDEAL PALLIATIVE CARE FOR THE PATIENTS WITH MALIGNANT DISEASEMasato Murakami, Japan; K. Nishino; T. Okamoto; S. Murakami; K. Mori; B. Murakami; M. Azuma; S. Tanabe; M. Kida; W. Koizumi

P0163COMPARISON OF PERCUTANEOUS ENDOSCOPIC VERSUS RADIOLOGIC GASTROSTOMY IN TERMS OF INDICATIONS, EFFICACY, COMPLICATIONS; A RETROSPECTIVE ANALYSISDenise Strijbos, The Netherland; D. Keszthelyi; L. P. L. Gilissen; M. W. de Haan; C. van der Leij; R. de Ridder; J. Kruimel; J. Conchillo; A. A. M. Masclee

P0164WITHDRAWN

P0165COMPREHENSIVE EVALUATION OF THE LEARNING CURVE FOR PERORAL ENDOSCOPIC MYOTOMY: LES-SONS FROM 1346 PATIENTSZu-Qiang Liu, China; X.-C. Zhang; Q.-L. Li; P.-H. Zhou

P0166CLINICAL CURATIVE EFFECT ANALYSIS OF 162 GASTRIC STRO-MAL TUMORS RESECTED BY ENDOSCOPIC TREATMENTSLi Liu, China; W. Liu; Z. Fan

P0167GASTROENTEROLOGY REGISTRAR OF THE WEEK: A SOLUTION FOR AUGIB ENDOSCOPY TRAINING?Shivkumar Budihal, United Kingdom; P. Wurm

P0168HIGH PERCENTAGE OF VISIBLE LESIONS IN PATIENTS WITH BARRETT’S ESOPHAGUS REFERRED WITH DYS-PLASIA IN RANDOM BIOPSIES.Irma Noordzij, The Netherlands; W. L. Curvers; I. van Lijnschoten; C. J. Huysentruyt; E. J. Schoon

P0169ENDOSCOPIC MANAGEMENT OF BENIGN ESO-RESPI-RATORY FISTULASAntoine Debourdeau, France; J.-M. Gonzalez; A. Benezech; M. Barthet

P0170CLINICAL UTILITY OF NARROW BAND IMAGING MAGNIFYING ENDOSCOPY FOR MM/SM1 ESOPHAGEAL SQUAMOUS CELL CARCINOMAMasazumi Inoue, Japan; T. Omori; K. Nastu; K. Aiura

P0153CONVENTIONAL VERSUS TRACTION-ASSISTED ENDO-SCOPIC SUBMUCOSAL DISSECTION FOR GASTRIC NEO-PLASMS (CONNECT-G): A MULTICENTER, RANDOMIZED CONTROLLED TRIALSho Suzuki, Japan; M. Yoshida; K. Takizawa; Y. Koike; S. Nonaka; Y. Yamasaki; T. Minagawa; C. Sato; C. Takeuchi; K. Watanabe; K. Miura; H. Morimoto; T. Yano; K. Sudo; K. Mori; T. Gotoda; H. Ono

P0154MACHINE LEARNING-BASED AUTOMATIC DETECTION SYSTEM FOR DEMARCATION LINE OF GASTRIC CANCER WITH NBI IMAGESNaoya Ishida, Japan; N. Yagi; H. Kitae; A. Tomie; H. Ichikawa; S. Hiwa; T. Hiroyasu

P0155ENDOSCOPIC TREATMENT OF FISTULAS AFTER SLEEVE GASTRECTOMY: ASSESSMENT FOR SWITCHING TOWARDS INTERNAL DRAINAGE IN A REFERENCE CENTERDiane Lorenzo, France; T. Guilbaud; J.-M. Gonzalez; A. Benezech; S. Berdah; T. Bège; M. Barthet

P0156CLOSURE BY USING OVER-THE-SCOPE CLIPS AFTER ENDOSCOPIC FULL-THICKNESS RESECTIONJintao Guo, China

P0157EFFICACY OF ORAL MIXTURE OF HYDROCORTISONE SODIUM SUCCINATE AND ALUMINUM PHOSPHATE GEL FOR THE PREVENTION OF STRICTURE AFTER ≥2/3 CIRCUMFERENTIAL ENDOSCOPIC SUBMUCOSAL DIS-SECTION (ESD) FOR ESOPHAGEAL CANCER---A SINGLE CENTER PILOT STUDY FROM CHINAYonghui Huang, China; X. Yan; H. Chang; Y. Zhang; W. Yao; K. Li

P0158LONG-TERM OUTCOMES OF COLD POLYPECTOMY FOR NONAMPULLARY DUODENAL ADENOMASDaisuke Maruoka, Japan; M. Arai; N. Akizue; K. Okimoto; T. Matsumura; T. Nakagawa; T. Katsuno; N. Kato

P0159ENDOSCOPIC TREATMENT OF BOERHAAVE SYNDROME: A SURPRISINGLY QUICK HEALINGGeorgios Sakizlis, Greece; D. Karagiannis

P0160ARTIFICIAL INTELLIGENCE DIAGNOSIS OF HELICO-BACTER PYLORI INFECTION USING LINKED COLOR IMAGINGHirotaka Nakashima, Japan; H. Kawahira; H. Kawachi; N. Sakaki


125


Mon

day,

Oct

ober

30,

201

7


P0178COLONOSCOPIC POLYPECTOMY PRACTICE AMONGST SPANISH CLINICAL GASTROENTEROLOGISTS. RESULTS OF A NATIONAL SURVEY FROM THE SPANISH ENDOS-COPY SOCIETY ENDOSCOPIC RESECTION GROUP.Carla Jerusalen Gargallo Puyuelo, Spain; E. Albéniz Arbizu; M. Fraile González; C. Guarner Argente; M. Pellisé Urquiza; M. A. Alvarez; F. Ramos; M. Rodriguez Tellez; D. Martínez-Ares; J. Santiago; A. Sanchez Yague; F. Gonzalez Huix; J. Merlo

P0179ASSESSMENT OF TRAINING NEEDS AND DEVELOPMENT OF A SIMULATION BASED TRAINING PROGRAMME FOR SEMI-AUTOMATED ROBOTIC COLONOSCOPYM. Kopczynska; R. Hopps; S. Smits; N. Warren; S. Goddard; X. Ye; Sunil Dolwani, United Kingdom

P0180WHITE OPAQUE SUBSTANCE, A NEW OPTICAL MARKER ON MAGNIFYING ENDOSCOPY: USEFULNESS IN DIAG-NOSING COLORECTAL EPITHELIAL NEOPLASMSKazutomo Yamasaki, Japan; T. Hisabe; K. Yao; H. Ishihara; T. Ueki; T. Matsui; H. Tanabe; A. Iwashita

P0181WITHDRAWN

P0182NARROW BAND IMAGING OPTICAL DIAGNOSIS OF SMALL COLORECTAL POLYPS. LEARNING CURVE AND SUBSEQUENT DIAGNOSTIC ACCURACY IN UNEXPERI-ENCED EVALUATORSFrancisco Javier Garcia-Alonso, Spain; I. Manzano Santamaría; A. Guardiola Arévalo; A. Bermejo; M. Molinero García; S. Sevo Spahiu; L. García Martín; I. Gómez-Pastrana; I. Carrascosa del Álamo; G. Martínez Izquierdo; M. J. Motta Molina; A. Gutiérrez Martín; M. Alguacil Cuéllar; A. Zubillaga de Diego; F. J. Parra Villanueva; P. Plaza Roig; M. J. Reyes Larriba; A. Posada Restrepo; F. Bermejo

P0183HIGH CLEANSING EFFICACY OF NER1006 ALSO IN THE ELDERLY: POST HOC SUBGROUP ANALYSIS OF RAN-DOMISED PHASE 3 TRIALSRodrigo Jover, Spain; R. Ng Kwet Shing; P. Uebel

P0184 ACHIEVING ADEQUATE LEVEL BOWEL PREPARA-TION WITH EVENING/MORNING OR MORNING-ONLY SPLIT-DOSING REGIMENS OF NER1006 VERSUS STAN-DARD 2L PEG WITH ASCORBATE: POST HOC ANALYSIS OF A PHASE 3 TRIALRaf Bisschops, Belgium; L. Clayton

P0171PER-ORAL ENDOSCOPIC PYLOROMYOTOMY (POEP) IN THE TREATMENT OF REFRACTORY GASTROPARESIS – A SINGLE CENTRE EXPERIENCERastislav Hustak, Czech Republic; Z. Vackova; J. Spicak; L. Jurgoš; J. Martinek

P0172BLUE LIGHT IMAGING FOR BARRETT'S NEOPLASIA CLASSIFICATION (BLINC): THE DEVELOPMENT AND VALIDATION OF A NEW ENDOSCOPIC CLASSIFICATION SYSTEM TO IDENTIFY BARRETT'S NEOPLASIASharmila Subramaniam, United Kingdom; K. Kandiah; F. Chedgy; R. Bhattacharyya; P. Basford; G. Longcroft-Wheaton; P. Bhandari

P0173TREATMENT OF MULTIPLE GASTROINTESTINAL SUBMUCOSAL TUMORS BY SUBMUCOSAL TUNNELING ENDOSCOPIC RESECTIONJingzheng Liu, China; W. Qin; Y. Huang; Z. Ren; P. Zhou

P0174COMPARISON OF THE LINKED COLOR IMAGING (LCI) TECHNOLOGY AND CHROMOENDOSCOPY WITH ACETIC ACID FOR DIAGNOSIS OF BARRETT’S ESOPHAGUSHelmut Neumann, Germany; H. Neumann Sen; P. Grimminger; F. Corvinus; F. Rahman; F. Thieringer; G. E. Tontini; P. R. Galle

Endoscopy, colon

P0175ALBERTA FAMILY PRACTICE ELECTRONIC ENDOSCOPY STUDY (AFPEE)Michael Kolber, Canada; L. Green; N. Olivier; R. Torrie; O. Babenko

P0176 PREDICTORS OF ADENOMA DETECTION AT COLONOS-COPY AFTER BOWEL SCOPE SURVEILLANCE: RESULTS FROM A UK PILOT SCREENING CENTREA. Yew; Keith Siau, United Kingdom; S. Jewes; A. Veitch; S. Ishaq; M. Brookes; B. McKaig; A. Veitch; S. Shetty; A. Murugananthan

P0177COLD SNARE POLYPECTOMY WITH SUBMUCOSAL PRE-LIFT VERSUS ENDOSCOPIC MUCOSAL RESECTION FOR 6-10MM COLORECTAL POLYPS: A RANDOMIZED NON-INFERIORITY TRIAL.V. Papastergiou; M. Fragkaki; I. Dimas; A. Mpitouli; E. Vardas; A. Theodoropoulou; N. Mathou; A. Giannakopoulos; K. Karmiris; D. Apessou; L. Giannikaki; G. Chlouverakis; K. Paraskeva; Grigorios Paspatis, Greece


126




P0193EFFICACY OF CIMETROPIUM BROMIDE ON POLYP DETECTION DURING COLONOSCOPIC WITHDRAWAL: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CON-TROLLED, CLINICAL TRIALDae Hwan Kang, Republic of Korea; H. W. Kim; C. W. Choi; S. J. Kim; J. S. Lee; H. S. Nam; S. H. Choi; B. J. Kwon; C. W. Yeo

P0194ADHERENCE TO EUROPEAN SOCIETY OF GASTROEN-TEROLOGY ENDOSCOPY (ESGE) POLYPECTOMY GUIDE-LINES: AN IRISH EXPERIENCE.Neil O'Morain, Ireland; V. parihar; O. O'Dwyer; P. Maheshwari; L. Kumar; S. Fennessy; N. Breslin; B. Ryan; D. McNamara

P0195WOMEN AWAKE FASTER THAN MEN AFTER EEG MONI-TORED PROPOFOL SEDATION – FIRST PROSPECTIVE OB-SERVATIONAL STUDY OF GENDER DIFFERENCES IN PROPO-FOL DOSES AND RECOVERY TIMES FOR COLONOSCOPYAndrea Riphaus, Germany; M. Slottje; J. Bulla; C. Keil; C. Mentzel; V. Limbach; B. Schultz; C. Unzicker

P0196EFFECT OF PREOPERATIVE COLONOSCOPIC TATTOOING USING BOTH SIDE INJECTION OF INDOCYANINE GREEN FOR IMPROVEMENT OF LYMPH NODE HARVEST IN COLORECTAL CANCERHyung Wook Kim, Republic of Korea; J. S. Lee; D. H. Kang; C. W. Choi; S. J. Kim; H. S. Nam; D. G. Ryu; C. W. Yeo; S. H. Choi; B. J. Kwon

P0197THE EFFICACY OF COLD SNARE POLYPECTOMY IN ACHIEVING COMPLETE RESECTION OF SUBCENTI-METRE COLORECTAL POLYPS: A MULTICENTRE RAN-DOMISED CONTROLLED TRIAL (CRESCENT STUDY)Takuji Kawamura, Japan; Y. Takeuchi; S. Asai; I. Yokota; E. Akamine; M. Kato; T. Akamatsu; K. Tada; Y. Komeda; M. Iwatate; K. Kawakami; M. Nishikawa; D. Watanabe; A. Yamauchi; N. Fukata; M. Shimatani; M. Ooi; K. Fujita; Y. Sano; H. Kashida; S. Hirose; H. Iwagami; N. Uedo; S. Teramukai; K. Tanaka

P0198EFFICACY OF PLATELET-RICH PLASMA (PRP) ON EN-DOSCOPIC RESECTION TECHNIQUES: CLINICAL STUDY IN 15 PATIENTSVicente Lorenzo-Zúñiga García, Spain; V. Moreno de Vega; I. Marín; N. Caballero; R. Bartolí; I. Bon; J. Boix

P0199INTERVENTIONS AND COSTS ASSOCIATED WITH SIVA-DEFINED ADVERSE EVENTS DURING PROCEDUR-AL SEDATION IN FIVE COUNTRIESRhodri Saunders, Germany; J. Davis; R. Weissbrod; D. Whitaker; P. Kranke; J. R. Lightdale

P0185ASSESSMENT OF COLONOSCOPY QUALITY IN CLINICAL PRACTICE COMPARED WITH EUROPEAN SOCIETY OF GASTROINTESTINAL ENDOSCOPY PERFORMANCE INDICATORSErvin Toth, Sweden; R. Jover; C. Spada; A. Agrawal; P. Amaro; L. Brink; W. Fischbach; M. Hünger; A. Ono; L. Petruzziello; A. Naidoo; J. F. Riemann

P0186SEDATION IN GASTROINTESTINAL ENDOSCOPY: CUR-RENT PRACTICES OF GREEK GASTROENTEROLOGISTS Adonis Protopapas, Greece; E. Stournaras; G. Neokosmidis; A. Protopapas

P0187QUALITY MEASURE IN COLONOSCOPY: IMPLEMENTA-TION OF COLONOSCOPY QUALITY MONITORING IN A BELGIAN UNIVERSITY HOSPITAL.Sohaib Ouazzani, Belgium; A. Lemmers; F. Martinez; M. Delhaye; M. Arvanitakis; O. Le Moine; P. Demetter; J. Deviere; P. Eisendrath

P0188LARGE RECTAL ADENOMAS - EMR VERSUS ESD: WHAT IS THE BEST APPROACH?Hubertus Heinrich Nietsch, Germany

P0189COMPUTED TOMOGRAPHY COLONOGRAPHY VERSUS COLONOSCOPY FOR THE DIAGNOSIS OF COLORECTAL CANCER: A SYSTEMATIC REVIEW AND META-ANALYSISRalph Duarte, Brazil; W. M. Bernardo; C. M. Sakai; G. L. R. Silva; H. G. Guedes; R. Kuga; E. Ide; R. K. Ishida; P. Sakai; E. G. H. de Moura

P0190AUTOMATED POLYP DETECTION FOR COLONOSCOPY USING DEEP LEARNING TECHNOLOGY: PRELIMINARY RESULTS.Masashi Misawa, Japan; S.-E. Kudo; Y. Mori; K. Takeda; K. Ichimasa; Y. maeda; Y. Ogawa; S. Kataoka; H. Nakamura; T. Ishigaki; Y. Yagawa; S. Matsudaira; N. Toyoshima; N. Ogata; T. Kudo; T. Hayashi; K. Wakamura; T. Baba; F. Ishida; H. Itoh; H. Roth; M. Oda; K. Mori

P0191MOTORIZED SPIRAL COLONOSCOPY (MSC) – A FIRST FEASIBILITY TRIALTorsten Beyna, Germany; M. Schneider; D. Pullmann; H. Neuhaus

P0192TREATMENT OUTCOMES OF COLD FORCEPS POLYP-ECTOMY FOR PATIENTS WITH DIMINUTIVE POLYPS: A PROSPECTIVE FOLLOW-UP STUDYHiroshi Hasegawa, Japan; S. Bamba; H. Ban; H. Imaeda; A. Nishida; O. Inatomi; M. Sasaki; M. Sugimoto; A. Andoh


127


Mon

day,

Oct

ober

30,

201

7


P0208AN INNOVATIVE 3D COLONOSCOPE SHAPE IMAGING SYSTEM BASED ON FIBER BRAG GRATING ARRAYI. K. Yoo; B. Keum; Woojung Kim, Republic of Korea; S. J. Choi; G. Min; S. H. Kim; J. M. Lee; H. S. Choi; E. S. Kim; Y. T. Jeen; H. J. Chun; H. S. Lee; C. D. Kim; J. M. Lee; J. Kim; M. S. Jang; S. Yang

P0209 REAL TIME MORPHOLOGIC CHANGE ON NUCLEUS & MITOCHONDRIA OF COLON CANCER CELL BY IRRE-VERSIBLE ELECTROPORATION: DETECTED BY PROBE BASED MULTIPHOTON MICROSCOPYI. K. Yoo; B. Keum; W. Kim; Seong Ji Choi, Republic of Korea; G. Min; J. M. Lee; S. H. Kim; J. M. Lee; H. S. Choi; E. S. Kim; Y. T. Jeen; H. J. Chun; H. S. Lee; C. D. Kim

P0210WITHDRAWN

P0211LARGE (>30MM) POLYP ENDOSCOPIC MUCOSAL RESEC-TION: OUTCOMES AND PREDICTORS OF SUCCESSKeith Siau, United Kingdom; E. Karunadasa; A. Kawesha; S. Ishaq

P0212PROSPECTIVE RANDOMIZED CONTROLLED TRIAL COM-PARING EFFICACY OF 1-L PEG-ASC WITH PRUCALO-PRIDE AND 2-L PEG-ASC FOR BOWEL PREPARATIONSeong Ji Choi, Republic of Korea; Y. T. Jeen; G. Min; W. Kim; J. M. Lee; I. K. Yoo; S. H. Kim; J. M. Lee; H. S. Choi; E. S. Kim; B. Keum; H. S. Lee; H. J. Chun; C. D. Kim

P0213IMPROVING SURVEILLANCE FOLLOW UP RATES AFTER COLONOSCOPY ENDOSCOPIC MUCOSAL RESECTION: A QUALITY IMPROVEMENT PROJECTMonia Werlang, USA; P. Kandel; I. Ahn; B. Brahmbhatt; M. Raimondo; E. Bouras; T. Woodward; M. B. Wallace; V. Gomez

P0214META-ANALYSIS SUGGESTS: INSPECT TWICE TO IN-CREASE RIGHT COLON ADENOMA DETECTION RATEKonstantinos Triantafyllou, Greece; P. Gkolfakis; G. Tziatzios; G. D. Dimitriadis

P0215ENDOSCOPIC FULL-THICKNESS RESECTION FOR T1 EARLY RECTAL CANCER: A CASE SERIES (WITH VIDEO).S. Vavassori; Paola Soriani, Italy; G. E. Tontini; H. Neumann; G. De Nucci; D. De Toma; B. Bruni; L. Pastorelli; M. Vecchi; P. Lagoussis

P0200COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION (CR-ESD), KNIFE-ASSISTED SNARE RESECTION (KAR) AND RECURRENCE RATE: A WESTERN EUROPEAN EXPERIENCE IN SPAIN.José Marín-Gabriel, Spain; J. B. Díaz Tasende; P. Cancelas-Navia; S. Rodríguez-Muñoz; A. J. Del Po-zo-García; M. Alonso-Riaño; Y. Rodríguez-Gil; C. Ibarrola-de Andrés; G. Castellano-Tortajada

P0201ASSOCIATION BETWEEN SIZE, LOCATION AND HISTO-LOGICAL CHARACTERISTICS OF COLORECTAL LATERAL-LY SPREADING TUMORS.F. L. Mota; J. F. Loureiro; Lucas Da Costa, Brazil

P0202SAFE AND SUCCESSFUL RESECTION OF DIFFICULT GI LESIONS USING A NOVEL SINGLE-STEP FULL-THICK-NESS RESECTION DEVICE (FTRD)Piero V Valli, Switzerland; J. Mertens; P. Bauerfeind

P0203 VASCULAR AND PIT-PATTERN ANALYSIS ACCORD-ING TO KUDO, SANO AND NICE CLASSIFICATIONS SIGNIFICANTLY IMPROVES AFTER AN IMAGE-BASED TRAINING PROGRAMFederico Desideri, Italy; G. Esposito; S. Angeletti; F. Iacopini; M. Haefner; E. Di Giulio

P0204YIELD OF 2ND SURVEILLANCE COLONOSCOPY IN “IN-TERMEDIATE RISK” PATIENTS. COULD SURVEILLANCE INTERVALS BE REFINED?M. Balakrishnan; B. Adeoti; S. Cerys; S. Catnach; A. King; B. Macfarlane; Jonathan Landy, United Kingdom

P0205SAFETY OF COLD SNARE COLON POLYPECTOMY IN PATIENTS ON ANTITHROMBOTIC MEDICATIONMio Matsumoto, Japan

P0206OPTICAL ENHANCEMENT FOR THE IN VIVO PREDIC-TION OF COLORECTAL POLYP HISTOLOGYEntcho Klenske, Germany; C. Neufert; A. Nägel; S. Zopf; M. F. Neurath; T. Rath

P0207BLUE LASER IMAGING OPTICAL DIAGNOSIS OF COL-ORECTAL POLYPS: ACCURACY OF THE NICE, SANO AND WASP CLASSIFICATIONSSophie Ribiere, France; J. Dreanic; M. Barret; M. Camus; M. Dior; B. Brieau; S. Leblanc; F. Prat; R. Coriat; S. Chaussade


128




P0223RESECT AND DISCARD/DIAGNOSE AND DISREGARD STRATEGY FOR COLONIC POLYPS: ARE WE READY TO START IT?Richard Azevedo, Portugal; J. Pinto; H. Ribeiro; F. Pereira; C. Leitão; A. Caldeira; E. Pereira; R. Sousa; J. Barros; A. Banhudo

P0224THE EFFICACY AND SAFETY OF JUMBO FORCEPS BI-OPSY USING NARROW-BAND IMAGING ENDOSCOPY IN PATIENTS WITH DIMINUTIVE POLYPSTakuya Yamada, Japan; T. Kuwai; T. Toyokawa; H. Iwase; T. Kudo; N. Esaka; H. Ota; H. Yamashita; Y. Hosoda; N. Watanabe; N. Harada

P0225 PERIOPERATIVE MANAGEMENT OF ORAL ANTICOAG-ULANTS WITHOUT HEPARIN BRIDGING THERAPY FOR PATIENTS UNDERGOING ENDOSCOPIC SURGERY: A PILOT STUDYShouko Ono, Japan; M. Kato; M. Kato; K. Matsuda; M. Tsuda; S. Abiko; S. Miyamoto; K. Yamamoto; T. Kudo; Y. Shimizu; N. Sakamoto

P0226ENDOSCOPIC FEATURE OF DEPRESSED TYPE COLOREC-TAL NEOPLASMA IN MAGNIFYING ENDOSCOPY AND ENDOCYTOSCOPYShinei Kudo, Japan; K. Mochizuki; T. Okumura; S. Matsudaira; Y. Kouyama; K. Ichimasa; N. Toyoshima; Y. Mori; M. Misawa; N. Ogata; T. Kudo; T. Hisayuki; T. Hayashi; K. Wakamura; E. Hidaka; T. Baba; S. Hamatani; F. Ishida

P0227COLONOSCOPY INDICATION INFLUENCE ON THE COM-PLIANCE OF QUALITY INDICATORSCarolina Mangas, Spain; E. Santana Rocamora; A. Suárez González; I. Portillo Villares; A. Seoane; M. Ponce; P. Diez; E. Quintero Carrion; M. Herraiz; M. Pellisé Urquiza; Á. Ferrández Arenas; V. Hernández; Á. E. Pizarro Moreno; R. Jover

Endoscopy, ERCP

P0228THERAPEUTIC ERCP USING A SHORT SINGLE-BALL-LOON ENTEROSCOPE IN PATIENTS WITH SURGICALLY ALTERED ANATOMYKaori Masu, Japan; K. Ito; T. Ohira; S. Koshita; Y. Kanno; T. Ogawa

P0229USEFULNESS OF SPYGLASS PERORAL CHOLANGIOS-COPY FOR THE DIAGNOSIS AND TREATMENT OF BILE-DUCT DISORDERS: EXPERIENCE FROM A LARGE-VOL-UME CENTERXiaowei Tang, China; D. Zhang; C. Xu; X. Zhang

P0216UNTUTORED LEARNING CURVE ANALYSIS FOR COL-ORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION: PREDICTIVE FACTORS FOR COMPLEX TECHNIQUEF. Ramos-Zabala; Jorge Vásquez-Guerrero, Spain; A. Alzina-Pérez; M. García-Mayor; A. Domínguez-Pino; J. M. Cárdenas-Rebollo; F. J. Pérez-Rodríguez; J. Rodríguez-Pascual; L. Moreno-Almazán

P0217PERSISTENT PAIN AFTER COLONIC ENDOSCOPIC MUCOSAL RESECTION: PREDICTORS, A MANAGEMENT ALGORITHM AND OUTCOMESLobke Desomer, Australia; D. J. Tate; H. Awadie; L. Pillay; G. Ahlenstiel; M. J. Bourke

P0218QUALITY OF SINGLE SESSION COLONOSCOPIC EXAM-INATIONS INTENDING TO REMOVE ALL NEOPLASTIC POLYPS USING COLD POLYPECTOMY IN OUTPATIENT SETTING: RESULTS FROM CLINICAL PRACTICE DATA OF SINGLE CANCER CENTER HOSPITAL IN JAPANKinichi Hotta, Japan; K. Imai; S. Ito; Y. Kishida; M. Yoshida; N. Kawata; N. Kakushima; K. Takizawa; M. Tanaka; H. ishiwatari; H. Matsubayashi; H. Ono

P0219META-ANALYSIS AND OWN EXPERIENCE IN THE TREATMENT OF RECTO-UROGENITAL FISTULA USING THE OVER-THE-SCOPE CLIP (OTSC)Martin Raithel, Germany; M. Vetter; A. Braun; T. Vasilakis; A. F. Hagel

P0220QUALITY INDICATORS FULFILLMENT AT QUALISCOPIA STUDYCarolina Mangas, Spain; E. Santana Rocamora; A. Suárez González; I. Portillo Villares; A. Seoane; M. Ponce; P. Diez; E. Quintero Carrion; M. Herraiz; M. Pellisé Urquiza; Á. Ferrández Arenas; V. Hernández; Á. E. Pizarro Moreno; R. Jover

P0221ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) IN THE COLORECTUM: FEASIBILITY IN AN EUROPEAN SINGLE CENTER CASE SERIES.Regina Maria Lackermeier, Germany; M. Meiborg; S. Schürle; C. Aubele; E. Tsegai-Eh; M. Edelmann; H.-R. Kitterer; S. Leykauf; M. Hack; G. Kleber

P0222CLINICAL USABILITY QUANTIFICATION OF A REAL-TIME POLYP DETECTION METHOD IN VIDEOCOLONOSCOPYQ. Angermann; J. Bernal; C. Sánchez-Montes; M. Hammami; G. Fernández-Esparrach; O. Romain; J. Sánchez; X. Dray; Aymeric Histace, France


129


Mon

day,

Oct

ober

30,

201

7


P0237ENDOSCOPIC PANCREATIC SPHINCTEROTOMY COM-BINED WITH PANCREATIC DUCT STENT CAN EFFEC-TIVELY PREVENT RECURRENCE OF ACUTE RECURRENT PANCREATITIS CAUSED BY BILIARY MICROLITHIASIS --- A SINGLE-CENTER STUDY FROM BEIJING, CHINA.Yonghui Huang, China; X. Yan; W. Liu; Y. Zhang; W. Yao; K. Li

P0238OUTCOME OF ENDOSCOPIC RETROGRADE CHOLAN-GIOPANCREATOGRAPHY IN PATIENTS WITH PERIAMP-ULLARY DIVERTICULUMMuhammad Asif Baig, Pakistan; M. Salih; N. H. Shah; M. Fatima

P0239COMPARISON OF DIGITAL VS FIBEROPTIC CHOLANGIOS-COPY IN PATIENTS REQUIRING EVALUATION OF BILE DUCT DISEASE OR TREATMENT OF BILIARY STONES.I. D. Dimas; E. Vardas; M. Fragkaki; A. Mpitouli; E. Voudoukis; A. Theodoropoulou; Grigorios Paspatis, Greece

P0240EMERGENCY ENDOSCOPIC RETROGRADE CHOLAN-GIOPANCREATOGRAPHY IN SUPER-ELDERLY PATIENTS WITH SEVERE ACUTE CHOLANGITIS: CAN WE PER-FORM THE PROCEDURE SAFELY?Shuhei Shintani, Japan; T. Imai; Y. Yokota; Y. Sato; H. Inoue; H. Tanabe; H. Bamba; Y. Komai; O. Inatomi; A. Andoh

P0241EFFICACY AND SAFETY OF ENDOBILIARY RADIOFRE-QUENCY ABLATION FOR THE ERADICATION OF RESID-UAL NEOPLASIA AFTER ENDOSCOPIC AMPULLECTOMY. RESULTS OF A MULTICENTER PROSPECTIVE STUDYMarine Camus, France; B. Napoléon; A. Vienne; M. Le Rhun; S. Leblanc; M. Barret; N. Kaddour; F. Robin; S. Chaussade; F. Prat

P0242 EXPERT VALIDATION OF A NOVEL MECHANICAL CUT-TING PAPILLASophia van der Wiel, The Netherlands; A. D. Koch; M. J. Bruno

P0243MEDICO-LEGAL CLAIMS IN GASTROINTESTINAL ENDOSCOPY: DOES PROCEDURE RISK RELATE TO SUC-CESSFUL OUTCOMES?Shivkumar Budihal, United Kingdom; J. F Mayberry

P0244 VISUALIZATION OF INTRA-AMPULLARY CHOLEDO-CHOCELE WITH CONTRAST MEDIUM FOR EVALUATING TECHNICAL DIFFICULTY IN ERCPNoriyuki Nishino, Japan

P0230DIAGNOSTIC AND THERAPEUTIC ENDOSCOPIC RETRO-GRADE CHOLANGIOPANCREATOGRAPHY (ERCP) IN IN-FANT AND CHILDREN: A LARGE RETROSPECTIVE STUDYXiaowei Tang, China; D. Zhang; C. Xu; X. Zhang

P0231ENDOSCOPIC RETROGRADE CHOLANGIOPANCREA-TOGRAPHY IN PATIENTS WITH SURGICALLY ALTERED GASTROINTESTINAL ANATOMY: 11 YEARS’ EXPERIENCE AT A LARGE CENTER IN CHINAXiaowei Tang, China; D. Zhang; C. Xu; X. Zhang

P0232IMPACT OF HIGH DEFINITION, NEAR FOCUS-IMAG-ING AND SYDNEY RECURRENCE TOOL (SERT) AFTER COLORECTAL ENDOSCOPIC MUCOSAL RESECTION: A PROPENSITY SCORE ANALYSIS.Daniela Guerrero Vinsard, USA; R. Lennon; P. Kandel; L. K. Mejia; R. Bingham; T. Woodward; V. Gomez; M. Raimondo; E. Bouras; M. B. Wallace

P0233 INCIDENCE AND RISK FACTORS FOR PANCREATITIS IN EMERGENCY ENDOSCOPIC RETROGRADE CHOLAN-GIOPANCREATOGRAPHY: A PROSPECTIVE MULTI-CENTER STUDYNakai Yoshitaka, Japan; K. Kusumoto; Y. Itokawa; B. Endoh; K. Chikugo; A. Suzuki; T. Kawakami; T. Suzuki; O. Inatomi; S. Bamba; T. Kusaka; H. Kokuryu; Y. Mizumoto; K. Tanaka

P0234WALLED-OFF NECROSIS (WON): OUTCOMES OF AN ALGORITHMIC APPROACH TO NECROSECTOMYJi Young Bang, USA; U. Navaneethan; M. Hasan; R. Hawes; S. Varadarajulu

P0235ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOG-RAPHY IN THE MANAGEMENT OF PANCREAS DIVISUM ASSOCIATED WITH RECURRENT ACUTE PANCREATITIS IN CHILDREN: EXPERIENCE FROM A SINGLE CENTER IN CHINAG.-X. Cui; J. Yang; X. Tang; J. Yang; Xiaofeng Zhang, China

P0236ENDOSCOPIC BILIARY SPHINCTEROTOMY IN MALIG-NANT BILIARY OBSTRUCTION: IS IT INDICATED IN CASE OF STENT PLACEMENT? A META-ANALYSISBenedetto Mangiavillano, Italy; A. Montale; L. Frazzoni; M. Bianchetti; A. Repici; L. Fuccio


130




P0251A PROSPECTIVE COMPARATIVE STUDY OF EFFICACY OF EUS GUIDED FNA VERSUS ERCP GUIDED BRUSH CYTOLOGY IN ATTAINMENT OF HISTOPATHOLOGY OF DISTAL CBD MASSES. Pankaj N. Desai, India; M. Kabrawala

P0252 RANDOMIZED TRIAL COMPARING THE LUMEN-APPOSING METAL STENTS (LAMS) AND PLASTIC STENTS FOR EUS- GUIDED DRAINAGE OF WALLED-OFF NECROSIS (WON)Ji Young Bang, USA; M. Hasan; U. Navaneethan; R. Hawes; S. Varadarajulu

P0253TRANS AORTIC ENDOSCOPIC ULTRASOUND GUIDED FNA IN THE DIAGNOSIS OF LUNG CANCERS AND MEDI-ASTINAL LYMPH NODESPiyush Somani, India; M. Sharma

P0254ULTRASOUND-GUIDED ENDOSCOPIC TRANSGASTRIC DRAINAGE OF PANCREATIC FLUID COLLECTIONSMarco Silva, Portugal; S. Lopes; A. Peixoto; F. Vilas-Boas; P. Moutinho-Ribeiro; G. Macedo

P0255ENDOSCOPIC ULTRASOUND-GUIDED TISSUE SAMPLING WITH A NEW 20G BIOPSY NEEDLE FOR THE CHARACTER-IZATION OF GASTROINTESTINAL SUBEPITHELIAL LESIONSFilippo Antonini, Italy; G. Delconte; L. Fuccio; G. De Nucci;C. Fabbri; E. Armellini; L. Frazzoni; A. Fornelli; A. Magarotto; E. Mandelli; P. Occhipinti; E. Masci; G. Manes; G. Macarri

P0256COMPARISON OF NATURAL COURSE VERSUS EUS-GUIDED ETHANOL ABLATION FOR PANCREATIC CYSTIC LESIONSJ. H. Choi; Sang Hyub Lee, Republic of Korea; Y. H. Choi; J. W. Kang; W. H. Paik; D.-W. Ahn; J. K. Ryu; Y.-T. Kim

P0257RANDOMIZED TRIAL COMPARING THE FRANSEEN AND FORK-TIP NEEDLES FOR EUS-GUIDED FINE NEEDLE BIOPSY Ji Young Bang, USA; S. Hebert-Magee; M. Hasan; U. Navaneethan; R. Hawes; S. Varadarajulu

Enteroscopy

P0258 THE SUCCESS RATE OF DOUBLE BALLOON ENDOSCOPIC CHOLANGIOGRAPHY IN PATIENTS WHO UNDERWENT THEIR INITIAL SURGERY AS INFANT IS SIGNIFICANTLY LOWER THAN OTHER PATIENTS Kensuke Yokoyama, Japan; T. Yano; J. Ushio; K. Tamada; A. K. Lefor; H. Yamamoto

P0259 EUS-GUIDED RADIOFREQUENCY ABLATION OF DIFFI-CULT SITES IN THE LIVER: A PRECLINICAL STUDY.Nuta Junya, Japan; T. Tamura; M. Itonaga; R. Shimizu; Y. Ida; M. Kitano

P0245ENDOTHERAPIES FOR DUCT-TO-DUCT BILIARY ANAS-TOMOTIC STRICTURE AFTER LIVER TRANSPLANTATION (BASALT STUDY GROUP): INTERIM ANALYSIS AND MEDIUM-TERM OUTCOMES OF A RETROSPECTIVE NATIONWIDE ITALIAN SURVEY.P. Cantù; I. Parzanese; R. Rosa; G. Santi; F. Barbaro; E. Forti; G. Lombardi; E. Nadal; V. Boarino; A. Pisani; A. Di Sario; H. Bertani; M. Bulajic; D. Ghinolfi; T. Staiano; D. Ligresti; L. Barresi; G. Catalano; A. Baldan; A. Cerofolini; L. De Carlis; M. Monteleone; A. Tringali; G. Costamagna; M. Mutignani; A. Fantin; A. Merighi; S. Traini; R. Conigliaro; M. Zilli; F. Filipponi; E. Masci; I. Tarantino; M. Traina; M. Salizzoni; P. Ravelli; L. Rodella; V. Mazzaferro; M. F. Donato; U. Maggi; L. Caccamo; G. Paone; P. Reggiani; G. E. Rossi; D. Conte; Roberto Penagini, Italy

Endosonography

P0246COMPARATIVE EVALUATION OF TWO PORCINE EX-VIVO MODELS FOR TRAINING IN ENDOSCOPIC ULTRA-SOUND-GUIDED DRAINAGE OF PANCREATIC FLUID COLLECTIONS Frederick Moryoussef, France; S. Leblanc; A. Bertucat; A. Laquière; E. Coron; L. Mangialavoria; J. C. Duchmann; Y. Le Baleur; F. Prat

P0247A COMPARATIVE STUDY OF SUCTION METHODS DURING ENDOSCOPIC ULTRASOUND-GUIDED FINE-NEEDLE ASPIRATION (CONVENTIONAL SUCTION VERSUS CAPIL-LARY SUCTION)Keisuke Yamakita, Japan; Y. Kitano; H. Iwamoto; K. Takahashi; K. Wada; S. Otake; Y. Ota; Y. Tamaki; M. Okada; K. Aso; Y. Makino

P0248A PROSPECTIVE COMPARISON OF EUS-GUIDED TISSUE ACQUISITION USING A 25G-GAUGE CORE BIOPSY NEE-DLE WITHOUT AND WITH A STYLET FOR INTRAABDOM-INAL SOLID MASS LESIONSJin-Hong Kim, Republic of Korea; M. J. Yang; J. C. Hwang; B. M. Yoo

P0249DIAGNOSTIC EFFICACY OF ENDOSCOPIC ULTRA-SOUND-GUIDED FINE-NEEDLE ASPIRATION FOR A PANCREATIC MASS USING THE CELL BLOCK METHOD WITHOUT RAPID ON-SITE CYTOLOGYKaori Masu, Japan; K. Ito; Y. Noda; S. Koshita; Y. Kanno; T. Ogawa; T. Sawai

P0250A COMPARATIVE STUDY BETWEEN EUS-GUIDED BILIARY DRAINAGE AND PERCUTANEOUS BILIARY DRAINAGE IN PATIENTS WITH MALIGNANT BILIARY OBSTRUCTION AND FAILED ERCPLei Lu, China; J. Yang; H. Jin; X. Tang; J. Yang; X. Zhang


131


Mon

day,

Oct

ober

30,

201

7


P0267EVALUATION OF A NEW PAN ENTERIC CAPSULE SYS-TEM IN PATIENTS WITH SUSPECTED OR ESTABLISHED INFLAMMATORY BOWEL DISEASE – ASSESSING THE SYSTEM FUNCTIONALITY TO VISUALIZE AND ASSESS THE SMALL AND LARGE BOWELSRami Eliakim, Israel; C. Spada; I. Fernández-Urién Sainz; H. Yanai; A. Lahat; Y. Ron; S. Pecere; G. Costamagna; A. Schwartz; I. Eyal; A. Lapidus; S. N. Adler

Biliary and pancreatic stenting

P0268THE UTILITY OF A NOVEL TRANSPAPILLARY DILATION TECHNIQUE WITH A DIATHERMIC CATHETER FOR SEVERE MAIN PANCREATIC DUCT STRICTURE DUE TO CHRONIC PANCREATITISShin Kato, Japan; M. Kuwatani; R. Sugiura; I. Sano; K. Kawakubo; N. Sakamoto

P0269CLINICAL OUTCOMES OF BILIARY DRAINAGE DURING NEOADJUVANT CHEMOTHERAPY/ CHEMORADIOTHER-APY IN MULTICENTER PANCREATIC CANCER STUDIES: METAL STENT VERSUS PLASTIC STENTMasaki Kuwatani, Japan; T. Nakamura; T. Hayashi; Y. Kimura; M. Ono; K. Yamakita; T. Goto; K. Takahashi; M. Motoya; H. MAGUCHI; S. Hirano; N. Sakamoto

P0270OUTCOME OF ENDOSCOPIC REINTERVENTION FOR MALIGNANT HILAR OBSTRUCTION TREATED BY STENT-IN-STENT DEPLOYMENTDae Hwan Kang, Republic of Korea; H. W. Kim; C. W. Choi; S. J. Kim; J. S. Lee; C. W. Yeo; H. S. Nam; S. H. Choi; J. H. Ko; B. J. Kwon; D. G. Ryu

P0271 LONG-TERM OUTCOMES OF ENDOSCOPIC ULTRA-SOUND-GUIDED RIGHT INTRAHEPATIC DUCT DRAIN-AGE WITH TRANSMURAL COVERED METAL STENT.Dong Hui Cho, Republic of Korea; D. H. Park; D. Oh; T. J. Song; S. S. Lee; D. W. Seo; S. K. Lee; M.-H. Kim

P0272UTILITY OF EUS-GUIDED HEPATICOGASTROSTOMY WITH ANTEGRADE STENTING FOR MALIGNANT BILI-ARY OBSTRUCTION OF ERCP INABILITYHajime Imai, Japan; M. Takenaka; M. Kudo

P0273EUS-GUIDED GALLBLADDER DRAINAGE REDUCES LATE ADVERSE EVENT AND NEED FOR RE-INTERVENTION COMPARED WITH PERCUTANEOUS CHOLECYSTOSTOMY IN PATENTS WHO ARE NOT ELIGIBLE FOR SURGERYDong Hui Cho, Republic of Korea; S. S. Lee; D. Oh; T. J. Song; D. H. Park; D. W. Seo; S. K. Lee; M.-H. Kim

P0260CYANOACRYLATE INJECTION THERAPY OF SMALL BOWEL VARICES BY DOUBLE-BALLOON ENTEROSCOPY (DBE): A TERTIARY CENTRE EXPERIENCEAlberto Murino, United Kingdom; N. Koukias; E. Vlachou; K. Planche; D. Patch; E. J. Despott

P0261MAGNIFYING NARROW-BAND IMAGING FINDINGS EFFICACY FOR INFLAMMATORY ACTIVITY EVALUATION IN SMALL INTESTINAL CROHN’S DISEASE WHEN USING NEWLY DEVELOPED MAGNIFYING ENTEROSCOPY: A PILOT STUDY.Noriyuki Ogata, Japan; K. Ohtsuka; S. Sasanuma; M. Misawa; Y. Mori; T. Kudo; T. Hisayuki; T. Hayashi; K. Wakamura; S.-E. Kudo

P0262 SINGLE INCISION LAPAROSCOPIC ASSISTED DOUBLE BALLOON ENTEROSCOPY: A NOVEL TECHNIQUE TO MANAGE SMALL BOWEL PATHOLOGYIoannis Stasinos, United Kingdom; N. Kamperidis; R. Rameshshanker; A. Murino; C. Fraser; J. Warusavitarne; A. Humphries

Capsule endoscopy

P0263GASTRIC EMPTYING IN CROHN’S DISEASE – EVALUA-TION BY SMALL BOWEL CAPSULE ENDOSCOPYAna Maria Singeap, Romania; A.-V. Trifan; S. Chiriac; I. Girleanu; T. Cuciureanu; C. Stanciu

P0264META-ANALYSIS SHOWS THAT PURGATIVE PREPA-RATION INCREASES SMALL BOWEL VIDEO CAPSULE ENDOSCOPY DIAGNOSTIC YIELD AND IMPROVES THE QUALITY OF SMALL BOWEL MUCOSA VISUALIZATIONP. Gkolfakis; G. Tziatzios; G. D. Dimitriadis; Konstantinos Triantafyllou, Greece

P0265INTER-OBSERVER AGREEMENT IN BROTZ CLEANING SCALES FOR CAPSULE ENDOSCOPYMafalda Sousa, Portugal; R. Pinho; A. Ponte; J. Silva; J. Rodrigues; J. C. Silva; A. Rodrigues; L. Proença; J. Carvalho

P0266PILOT STUDY OF THE EFFECTS OF IMAGE QUALITY ON LESION VISUALISATION IN SMALL BOWEL CAPSULE ENDOSCOPYDiana Yung, United Kingdom; X. Dray; E. Toth; E. Rondonotti; R. Sidhu; U. Kopylov; M. Mcalindon; M. Pennazio; J. N. Plevris; A. Koulaouzidis


132




P0281OUTCOMES OF PATIENTS UNDERGOING PLACEMENT OF FULLY COVERED SELF EXPANDING METAL STENTS FOR MALIGNANT OESOPHAGEAL STRICTURESMartin Everson, United Kingdom; C. Magee; P. Galloway; A. Nelson; R. Sweis; M. Banks; S. Bown; D. Graham; L. Lovat; R. Haidry

Poster Session09:00 – 17:00 Hall 7Surgery I

Oesophagus / stomach / duodenum

P0282COMBINED RESECTION IN ESOPHAGEAL CANCER: MYTH OR REALITY.Dmitry Rusanov, Russian Federation; K. Pavelets; M. Antipova; M. Protchenkov; M. Pavelets; U. Drozd; A. Sokolova; G. Florovsky

P0283INFLUENCE OF CONTINUOUS ADMINISTRATION OF LOW-DOSE ASPIRIN FOR INTRAOPERATIVE BLEEDING ON GASTRIC ENDOSCOPIC GASTRIC DISSECTION: A PROPENSITY SCORE MATCHING ANALYSISYohei Horikawa, Japan; N. Mimori; H. Mizutamari; Y. Kato; S. Fushimi; S. Okubo; S. Sato

P0284WEEKDAY OF CANCER SURGERY IN RELATION TO PROGNOSISPernilla Lagergren, Sweden; F. Mattsson; J. Lagergren

P0285IMPACT OF POSTOPERATIVE COMPLICATIONS AND PERIOPERATIVE ONCOLOGICAL TREATMENTS FOR GASTRIC CANCER PATIENTS AFTER GASTRECTOMYSatoshi Kamiya, Sweden; F. Klevebro; I. Rouvelas; M. Lindblad; L. Lundell; M. Nilsson

P0286ENDOSCOPIC PAPILLECTOMY OF DUODENAL PAPIL-LARY TUMOR: A REPORT OF 75 CASESZikai Wang, China; E. Linghu; F. Cai; Y. Yang; G. Sun; M. Li; S. Li; X. Wang; J. Meng; H. Du; J. Zhu; W. Li

Small bowel / colorectal and anal

P0287PROPHYLACTIC COLECTOMY WITH EXTENDED INDI-CATION OF RECTAL PRESERVATION IN RELATED APC FAMILIAL ADENOMATOUS POLYPOSIS: SYSTEMATIC ADENOMA TREATMENT DRAMATICALLY CHANGES THE NATURAL HISTORY OF POLYPOSISArnaud Pasquer, France; G. Poncet; M. Pioche; J. Rivory; O. Vinet; N. Benech; J. C. Saurin

P0274ENDOSCOPIC TREATMENT OF ANASTOMOTIC BILIARY STRICTURES IN PATIENTS WITH LIVING DONOR LIVER TRANSPLANTATION: MULTIPLE PLASTIC STENTS VS FULLY COVERED SELF-EXPANDABLE METALLIC STENTSA. T. Eminler; Erkan Parlak, Turkey; A. S. Koksal; B. Toka; M. I. Uslan

Enteral dilatation and stenting (oesophagus, stomach, duodenum, colon)

P0275 PROSPECTIVE RANDOMIZED STUDY FOR EFFICACY OF AN DOUBLE BARE STENT COMPARED A DOUBLE COV-ERED STENT IN MALIGNANT COLORECTAL OBSTRUCTIONAlexandr Vodoleev, Russian Federation; V. Duvanskiy; V. Malyuga

P0276THE FEASIBILITY OF NEW ENDOSCOPIC GASTROIN-TESTINAL BYPASS STENT FOR WEIGHT REDUCTION: EXPERIMENTAL STUDYS. J. Choi; Chang Duck Kim, Republic of Korea; W. Kim; G. Min; J. M. Lee; I. K. Yoo; S. H. Kim; J. M. Lee; H. S. Choi; E. S. Kim; B. Keum; Y. T. Jeen; H. J. Chun; H. S. Lee

P0277LONG TERM EFFICACY OF AN ENDOSCOPIC DILATION PROGRAM ON POST-RADIATION AND ANASTOMOTIC FARINGO-ESOPHAGIC STRICTURESDiana Martins, Portugal; S. Pires; C. Camila Dias; P. Pimentel-Nunes; R. Silva; M. Dinis-Ribeiro

P0278OUTCOME AFTER THE USE OF SX-ELLA DANIS BLEED-ING STENTS FOR REFRACTORY VARICEAL BLEEDING – A VIENNA MULTICENTER EXPERIENCENikolaus Pfisterer, Austria; T. Pachofszky; W. Dolak; M. Schöniger-Hekele; B. Schuster; B. Tribl; M. Mandorfer; P. Schwabl; F. Riedl; T. Bucsics; K. König; L. Kramer; M. Gschwantler; C. Madl; M. Trauner; T. Reiberger

P0279A NOVEL METHOD WITH SELF-EXPANDABLE METALLIC STENT FASTENED WITH CLIP AND LOOP FOR THE TREATMENT OF ANASTOMOTIC STRICTURE AFTER SUBTOTAL GASTRECTOMYJoon Koo Kang, Republic of Korea; S. G. LIm; K. M. Lee; S. J. Shin; B. M. Yoo; J.-H. Kim; C.-K. Noh

P0280EFFICACY AND TOLERABILITY OF BIODEGRADABLE STENTS FOR RECURRENT BENIGN OESOPHAGEAL STRICTURES: THE LEEDS EXPERIENCENicolas Rabb, United Kingdom; H. Procter; N. Burr; V. Appleby; S. Everett


133


Mon

day,

Oct

ober

30,

201

7


P0296LAPAROSCOPIC COMPLETE LATERAL LYMPH NODE DISSECTION FOR LOW RECTAL CANCERTakashi Kinoshita, Japan; K. Komori; T. Oshiro; A. Ouchi; Y. Shimizu

P0297TRANSGASTRIC-NOTES SIGMOID RESECTION IN AN ANI-MAL SURVIVAL MODEL USING THE ANUBIS-SYSTEMJoern Bernhardt, Germany; H. Steffen; P. Koehler; S. Schneider-Koriath; K. Ludwig

P0298ASCITES, COMPLEX ADNEXAL MASSES AND RAISED CA-125 IN POST-MENOPAUSAL WOMEN: OVARIAN CANCER OR TUBERCULOSIS?Sonda Jardak, Tunisia; H. Kchir; N. Maamouri; H. Chaabouni; N. Ben Mami

Poster Session09:00 – 17:00 Hall 7IBD I

Basic/pathogenesis/pathology

P0299INSULINLIKE GROWTH FACTOR IGF-I AND INFLAM-MATORY RESPONSE IN THE COLONIC MUCOSA IN ULCERATIVE COLITISVladimir Pavlenko, Russian Federation; F. Urusova; G. Eseneeva; A. Pavlenko; N. Korablina

P0300 REGULATORY B CELLS CONTRIBUTE TO THE ALLEVI-ATION OF COLITIS INDUCED BY DEXTRAN SULPHATE SODIUM AFTER H.PYLORI INFECTIONXia Li, China; N. Wang; Q. Xue; J. Tan; J. Wang

P0301FUNGAL COMPOSTION AND FUNGI-BACTERIA COR-RELATION IN IBD PATIENTS WITH DIFFERENT TREAT-MENT STRATEGIESJun Xu, China; Z. Wu; Y. Song; N. Wu; F. Zhang; H. X. Ren; N. Chen; Y. L. Liu

P0302INVESTIGATING THE MICROBIOME IN A PHASE 1B STUDY OF ANDECALIXIMAB IN ULCERATIVE COLITISBrandon LaMere, USA; E. R. Wendt; B. Kanwar; S. V. Lynch

P0303MUCOSAL CYTOKINE PROFILE IN INFLAMMATORY BOWEL DISEASE PATIENTS: A LASER CAPTURE MICRO-DISSECTION APPROACHGiuseppe Mazzarella, Italy; V. Rotondi Aufiero; P. Marena; A. Venezia; R. Melina; N. Giardullo; B. Perugini; F. S. Taccone; S. Iaquinto; G. Iacomino; G. Iaquinto

P0288ANAL PROBLEMS DURING PREGNANCY AND POSTPAR-TUM: A PROSPECTIVE COHORT STUDY.Kymentie Ferdinande, Belgium; Y. Dorreman; K. Roelens; W. Ceelen; D. De Looze

P0289SURGICAL TREATMENT OF DIVERTICULITIS AND ITS COMPLICATIONS: A SYSTEMATIC REVIEW AND ME-TA-ANALYSIS OF RANDOMIZED CONTROL TRIALS.Ali Mahmoud Ahmed, Egypt; A. T. Moahammed; O. M. Mattar; E. M. Mohamed; E. A. Faraag; A. M. AlSafadi; N. T. Huy; K. Hirayama

P0290 ªNLR AND PLR IN DIAGNOSING SYNCHRONOUS LIVER AND LYMPH NODE METASTASES IN PATIENTS WITH CRC Milica Stojkovic Lalosevic, Serbia; A. Pavlovic Markovic; V. Markovic; I. Dimitrijevic; M. Stojkovic; S. Kiurski; Z. Krivokapic

P0291DEVELOPING AND VALIDATING OF RAMATHIBODI APPENDICITIS SCORE (RAMA-AS) FOR DIAGNOSIS OF APPENDICITIS IN SUSPECTED APPENDICITIS PATIENTSChumpon Wilasrusmee, Thailand; B. Siribumrungwong; S. Phuwapraisirisan; N. Poprom; A. Thakkinstian

P0292IS HAEMORRHOIDECTOMY SAFE IN PATIENTS WITH ULCERATIVE COLITIS?Seong-Dae Lee, Republic of Korea; Y. S. Choi; E.-J. Lee; J. B. Lee; D. S. Lee; E. G. Youk; D. H. Lee; D. S. Kim

P0293 EARLY VERSUS DELAYED CLOSURE OF TEMPORARY LOOP ILEOSTOMY AFTER COLORECTAL SURGERIES: A PROSPECTIVE RANDOMIZED STUDYSiva Gavini, India; V. Vutukuru; D. Annareddy; C. Chandramaliteeswaran; V. Dasari; N. Pagadala

Laparoscopic techniques

P0294FULL-SCALE INTRODUCTION OF RADICAL LAPARO-SCOPIC SURGERY FOR INGUINAL HERNIA EMPLOYING THE TRANSABDMINAL PREPERITONEAL (TAPP) REPAIR AND EARLY OUTCOMESTakuya Saito, Japan; T. Sano; S. Komatsu; T. Arikawa; S. Ishiguro; K. Komaya

P0295EFFECTIVENESS OF PURE LAPAROSCOPIC LEFT COL-ECTOMY WITH PRIMARY ANASTOMOSIS AND LOOP ILEOSTOMY FOR THE TREATMENT OF COMPLICATED HINCHEY 3 DIVERTICULITISFrancesco Roscio, Italy; A. De Luca; I. Scandroglio


134




P0312 THE EFFECTS OF GLIAL -DERIVED NEUROTROPHIC FACTOR PRODUCED BY ENTERIC GLIAL CELLS ON DEN-DRITIC CELL AND ITS ROLES IN DEXTRAN SULPHATE SODIUM INDUCED COLITISYu Huan, China

P0313DETERMINANTS OF REDUCED GENETIC CAPACITY FOR BUTYRATE SYNTHESIS BY THE GUT MICROBIOME IN CROHN’S DISEASE AND ULCERATIVE COLITISEmilio Laserna-Mendieta, Ireland; A. G. Clooney; J. F. Carretero-Gomez; J. Nolan; C. Hill; C. G. Gahan; S. A. Joyce; C. Moran; D. Sheehan; F. Shanahan; M. J. Claesson

P0314A COMBINED ADMINISTRATION OF AMPICILLIN AND VANCOMYCIN INDUCES MILD COLITIS WITH DECREASED DIVERSITY OF GUT MICROBIOTA AND PERTURBATION OF GLUTAMINE AND SHORT CHAIN FATTY ACID METABOLISMS.Akira Sonoda, Japan; N. Sachi; Y. Gendo; T. Ozaki; N. Kamiyama; S. Hidano; K. Mizukami; T. Okimoto; K. Murakami; T. Kobayashi

P0315ANTI-INFLAMMATORY EFFECTS OF G PROTEIN-COU-PLED RECEPTOR 18 – A NOVEL POTENTIAL THERAPEU-TIC TARGET IN INFLAMMATORY BOWEL DISEASEAdam Fabisiak, Poland; N. Fabisiak; M. Zielińska; A. Mokrowiecka; E. Malecka-Panas; R. Kordek; K. Kieć-Kononowicz; J. Fichna

P0316THE MECHANISM OF PROTECTIVE ROLE OF D3 DOPA-MINE RECEPTORS IN PATHOGENESIS OF ULCERATIVE COLITISA. Prysiazhniuk; T. Dovbynchuk; Y. Holota; I. Vareniuk; L. Garmanchuk; Ganna Tolstanova, Ukraine

P0317INFLAMMATION AT DISTAL ILEOCAECAL RESECTION MARGINS INCREASE THE RISK OF POSTOPERATIVE CROHN’S RECURRENCEKarin Wasmann, The Netherlands; J. van Amesfoort; L. Koens; W. A. Bemelman; C. J. Buskens

P0318APPLICATION OF NEW SINGLE NUCLEOTIDE POLYMOR-PHISMS TO THE IDENTIFICATION OF ADHERENT-INVA-SIVE E. COLI (AIEC)Carla Camprubí-Font, Spain; M. Lopez-Siles; M. Ferrer-Guixeras; L. Niubo-Carulla; C. Abellà-Ametller; L. J. Garcia-Gil; M. Martinez-Medina

P0304ALTERATIONS IN THE MUCOSA-ASSOCIATED FUNGAL MICROBIOTA IN PATIENTS WITH ULCERATIVE COLITIS Xinyun Qiu, China; H. Zhang

P0305CD16 POSITIVE CELLS, EXPRESSING WNT LIGANDS, AC-CUMULATE IN THE MUCOSA AND MEDIATE INTESTINAL FIBROSIS.Dolores Ortiz Masia, Spain; P. Salvador; D. Macias-Ceja; S. Coll-Puig; L. Gisbert-Ferrándiz; C. Hernández; S. Calatayud; M. D. Barrachina

P0306CHARACTERIZATION OF GUT MICROBIOME ASSOCI-ATED WITH IMPROVEMENT OF ULCERATIVE COLITIS AFTER ANTIBIOTIC COMBINATION THERAPY USING FECAL METAGENOMIC ANALYSISKimitoshi Kato, Japan; T. Sekizuka; T. Sugiyama; Y. Ishii; M. Kuroda; T. Ohkusa

P0307GLP-1 EXPRESSING ENTEROENDOCRINE CELL NUMBERS ARE REDUCED AT THE SITE OF ACTIVE DISEASE IN VAR-IOUS MOUSE MODELS OF INTESTINAL INFLAMMATIONEva Rath, Germany; N. Waldschmitt; M. Ahmed; S. Khaloian Sarnaghi; M. Schaubeck; G. Hörmannsperger; J. Planchais; H. Sokol; D. Haller

P0308 ªACTIVE ULCERATIVE COLITIS IS CHARACTERIZED BY THE FORMATION OF THROMBOGENIC TISSUE FAC-TOR-EXPRESSING NEUTROPHIL EXTRACELLULAR TRAPSI. Angelidou; A. Mitsios; Akrivi Chrysanthopoulou, Greece; K. Kambas; A. Arampatzioglou; E. Dellaporta; S. Arelaki; V. Dalla; K. Ritis; G. Kouklakis; P. Skendros

P0309IMPAIRED MITOCHONDRIAL PROTEOSTASIS IS ASSO-CIATED WITH MITOCHONDRIAL DYSFUNCTION AND INDUCES PHENOTYPIC TRANSITION OF LGR5+ STEM CELLS INTO PANETH CELLSSevana Khaloian Sarnaghi, Germany; E. Rath; N. Waldschmitt; I. Gosch; E. Berger; D. Haller

P0310METABONOMIC PROFILING OF ULCERATIVE COLITIS PATIENTS; RESULTS FROM AN INCEPTION COHORT TIME SERIES ANALYSISRavi Misra, United Kingdom; M. Sarafian; N. S. Ding; E. Holmes; O. Faiz; N. Arebi

P0311BASELINE CLINICAL AND ENDOSCOPIC FEATURES OF ULCERATIVE COLITIS PATIENTS ARE RELEVANT GUIDE FOR SELECTING RESPONDERS TO SELECTIVE DEPLETION OF MYELOID LINEAGE LEUCOCYTES AS REMISSION INDUCTION THERAPYTomotaka Tanaka, Japan; M. Akagi; H. Goishi; T. Iiboshi; T. Kajihara; T. Miura


135


Mon

day,

Oct

ober

30,

201

7


P0326OPIATE USE IN INFLAMMATORY BOWEL DISEASE. PRE-SCRIPTION TRENDS AND MORTALITY IN AN ENGLISH PRIMARY CARE COHORT FROM 1990-2014.Nick Burr, United Kingdom; C. Smith; R. West; M. A. Hull; V. Subramanian

P0327PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE AN INCREASE RISK OF PERIODONTITIS COR-RELATED WITH DISEASE ACTIVITYO. Fumery; C. Yzet; K. Agossa; J. Braux; J. Loreau; F. Brazier; S. Dapke; B. Devauchelle; S. Testelin; E. Nguyen-Khac; J.-L. Dupas; Mathurin Fumery, France

Genetics

P0328DETECTION OF MUTATIONS IN NOD2/CARD15 GENE IN ARAB PATIENTS WITH CROHN’S DISEASE Iqbal Siddique, Kuwait; I. Khan; R. Sulaiman; N. Kadungothayil; M. Al-Tarrah; A. S. Mustafa

P0329GENETIC ASSOCIATIONS OF INFLAMMATORY BOWEL DISEASE IN SRI LANKA: A CASE-CONTROL STUDY OF PHENOTYPES AND SELECTED GENETIC POLYMORPHISMSMadunil Niriella, Sri Lanka; K. S. Kodisinghe; A. P. De Silva; N. Rajapakshe; S. D. Nanayakkara; D. P. Luke; T. M. De Silva; N. M. Navarathne; U. Kalubovila; R. S. Kumarasena; V. H. Dissanayake; R. W. Jayasekara; H. J. de Silva

P0330VDR GENE BSM I POLYMORPHISM AND ULCERATIVE COLITISDaria Kuznetsova, Russian Federation; A. Razumov; M. Merzlyakov; G. Vavin

P0331GENETIC AND SEROLOGICAL PROFILE AS MARKERS OF DISEASE SUSCEPTIBILITY IN SIBLINGS OF CHILDREN WITH INFLAMMATORY BOWEL DISEASEGiulia D'Arcangelo, Italy; M. Bramuzzo; G. Catassi; C. Romano; E. Miele; G. Morabito; S. Pellegrino; C. Cuzzupè; C. Strisciuglio; S. Martelossi; S. Cucchiara; M. Aloi

P0332ROLE OF DNMT3A IN INTESTINAL EPITHELIAL CELLSAntonella Fazio, Germany; J. Kuiper; A. Sinha; R. Sheibani-Tezerji; P. Rosenstiel

P0333 ORMDL PROTEINS: CRITICAL REGULATORS OF FINE-TUNING OF THE UNFOLDED PROTEIN RESPONSE IN INTESTINAL INFLAMMATIONM. Jentzsch; M. Falk-Paulsen; A. Luzius; Stephanie Stengel, Germany; J. Kuiper; B. Messner; F. Tran; K. Aden; P. Rosenstiel

P0319LIPOSOMAL FORMULATION AS A NEW DRUG DELIVERY SYSTEM FOR CROHN’S DISEASE – VALIDATION IN THE MOUSE MODEL OF TNBS-INDUCED COLITISJulia Krajewska, Poland; P. Pietruszka; D. Tomczyk; J. Fichna

Aetiology/epidemiology

P0320 EPIDEMIOLOGY OF MICROSCOPIC COLITIS IN NOTTING-HAM: A CONTEMPORARY COHORT STUDYNina Lewis, United Kingdom; T. Archer; P. Kaye

P0321EXTRA-INTESTINAL MANIFESTATIONS AT DIAGNOSIS IN PAEDIATRIC- AND ELDERLY-ONSET ULCERATIVE COLITIS ARE ASSOCIATED WITH A MORE SEVERE DIS-EASE OUTCOME: A POPULATION-BASED STUDYD. Duricova; A. Leroyer; G. Savoye; H. Sarter; B. Pariente; D. Aoucheta; L. Armengol-Debeir; D. Ley; D. Turck; L. Peyrin-Biroulet; C. Gower-Rousseau; Mathurin Fumery, France

P0322LONG-TERM NATURAL HISTORY OF MICROSCOPIC COLITIS: A POPULATION-BASED STUDYJulien Loreau, France; D. Duricova; C. Gower-Rousseau; G. Savoye; H. Sarter; C. Yzet; M. Kohut; F. Brazier; D. Chatelain; E. Nguyen-Khac; J.-L. Dupas; M. Fumery

P0323IBD-INFO QUESTIONNAIRE: A MULTICENTER FRENCH UP-TO-DATE SURVEY OF PATIENT KNOWLEDGE IN INFLAMMATORY BOWEL DISEASEPauline Danion, France; A. Buisson; X. Roblin; N. Mathieu; A.-L. Charlois; N. Williet; E. Del Tedesco; B. Flourie; S. Nancey; G. Boschetti

P0324IMPACT OF PRIMARY SCLEROSING CHOLANGITIS ON THE DISEASE COURSE IN PATIENTS WITH INFLAMMA-TORY BOWEL DISEASE – EVIDENCE FROM A LARGE RETROSPECTIVE STUDY WITH MATCHED COHORTSFriederike Cordes, Germany; T. Laumeyer; M. Brückner; T. M. Nowacki; J. Gerß; T. Kucharzik; D. Bettenworth

P0325UNCHANGED SURGERY AND HOSPITALIZATION RATES IN AN EAST-WEST EUROPEAN INCEPTION COHORT DE-SPITE DIFFERENCES IN USE OF BIOLOGICALS – 5-YEAR FOLLOW-UP OF THE ECCO-EPICOM COHORTJohan Burisch, Denmark; E. Langholz; A. Goldis; R. D’Inca; L. Kupcinskas; V. Hernández; D. Valpiani; D. Duricova; Z. Vegh; L. Kievit; I. Kaimakliotis; J. F. Dahlerup; R. Salupere; J. Halfvarson; K. R. Nielsen; M. Giannotta; K. H. Katsanos; N. Pedersen; P. Ellul; M. Fumery; D. Schwartz; S. Turcan; S. Čuković-Čavka; P. Oksanen; F. Magro; N. Arebi; P. L. Lakatos; P. Munkholm


136




P0341CONCORDANCE OF STOOL FREQUENCY AND ABDOM-INAL PAIN MEASURES WITH SIMPLE ENDOSCOPIC SCORE FOR CROHN'S DISEASEJames Lewis, USA; P. Rutgeerts; G. D'Haens; J.-F. Colombel; W. Sandborn; W. Reinisch; J. Butler; J. F. Maa; A. M. Robinson

P0342DECREASED CD8+CD28+/CD8+CD28- T CELLS’ RATIO CAN PREDICT THE POOR OUTCOME SENSITIVELY FOR PATIENTS WITH COMPLICATED CROHN’S DISEASES.-X. Dai; H.-X. Gu; Q.-Y. Lin; Y.-K. Wu; X.-Y. Wang; S.-Z. Huang; T.-S. Xing; M.-H. Chen; Q.-F. Zhang; Zhong-Wen Zheng, China; W. Sha

P0343BOWEL PREPARATION QUALITY OF NER1006 VERSUS STANDARD 2L PEG WITH ASCORBATE AS ASSESSED BY COLONOSCOPISTS AT SITE: A POST HOC ANALYSIS FROM A RANDOMISED CONTROLLED TRIALJonathan Manning, United Kingdom; L. Clayton; V. Lorenzo-Zúñiga García

P0344BOWEL PREPARATION QUALITY OF NER1006 VERSUS ORAL TRISULFATE SOLUTION AS ASSESSED BY COLO-NOSCOPISTS AT SITE: A POST HOC ANALYSIS FROM A RANDOMISED CONTROLLED TRIALRichard Ng Kwet Shing, United Kingdom; P. Bekal

P0345BOWEL PREPARATION QUALITY OF NER1006 VERSUS SODIUM PICOSULFATE + MAGNESIUM CITRATE AS ASSESSED BY COLONOSCOPISTS AT SITE: A POST HOC ANALYSIS FROM A RANDOMISED CONTROLLED TRIALStephen Lewis, United Kingdom; J. P. H. Drenth; C. Santander; C. Pediconi; B. Amlani; A. Repici

P0346LOW VITAMIN D LEVELS ARE RELATED TO CLINICAL ACTIVITY, MUCOSAL INFLAMMATION, AND INTESTINAL FIBROSTENOSIS IN CROHN’S DISEASE.Tsunaki Sawada, Japan; O. Watanabe; M. Nakamura; T. Yamamura; M. Matsushita; M. Saito; R. matsuura; Y. Mizutani; Y. Niwa; E. Ishikawa; G. Uchida; H. Otsuka; H. Suzuki; T. Nishikawa; T. Ishida; T. Kuno; S. Hattori; K. Yamada; T. Ishikawa; K. Furukawa; K. Funasaka; E. Ohno; R. Miyahara; H. Kawashima; H. Goto; Y. Hirooka

P0347PATIENT SATISFACTION WITH HOME MONITORING OF DISEASE ACTIVITY AND FECAL CALPROTECTIN IN ADULT PATIENTS WITH INFLAMMATORY BOWEL DIS-EASE- INTERIM ANALYSIS OF 68 PATIENTSPetra Weimers, Denmark; D. Marker; D. V. Ankersen; J. Burisch; P. Munkholm

Diagnosis and monitoring

P0334THE USE OF LÉMANN SCORE TO EVALUATE THE DAM-AGE TO THE DIGESTIVE TRACT CAUSED BY CROHN’S DISEASE IN AN EGYPTIAN COHORTHussein Saad, Egypt; O. E. Salem; M. A. Salem; M. E. Ibrahim; S. M. El Kady

P0335FINAL RESULTS ON IMMUNOGENICITY PROFILE AND PRE-DICTORS OF ADA DEVELOPMENT OF BIOSIMILAR INFLIX-IMAB DURING THE FIRST 12 MONTHS OF THE THERAPY: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORTPetra Anna Golovics, Hungary; B. D. Lovasz; Z. Kurti; M. Rutka; Z. Vegh; K. B. Gecse; K. Farkas; J. Banai; L. Bene; L. Gonczi; B. Gasztonyi; T. Kristof; L. Lakatos; P. Miheller; K. Palatka; A. Patai; M. Papp; A. Salamon; T. Szamosi; Z. Szepes; G. T. Toth; A. Vincze; E. Biro; T. Molnar; P. L. Lakatos

P0336RECONSIDERING THE PROGNOSTIC VALUE OF TRADI-TIONAL SEROLOGIC ANTIBODIES IN CROHN’S DISEASE – IMMUNOGLOBULIN CLASSES TO TAKE THE CENTRE STAGENora Sipeki, Hungary; B. Suga; G. L. Norman; Z. Shums; G. L. Veres; P. L. Lakatos; P. Antal-Szalmas; M. Papp

P0337UTILITY OF MAGNETIC RESONANCE EVALUATION FOR SMALL BOWEL ENDOSCOPIC HEALING IN PATIENTS WITH CROHN’S DISEASEKento Takenaka, Japan; K. Ohtsuka; Y. Kitazume; T. Fujii; K. Matsuoka; M. Kimura; M. Nagahori; M. Watanabe

P0338USEFULNESS OF DOUBLE BALLOON ENDOSCOPY IN DI-AGNOSIS AND TREATMENT OF SMALL BOWEL CROHN'S DISEASEAli Madian, Egypt; M. Matsuura; A. Elbahrawy; H. Nakase; T. Chiba; M. N. Rafat

P0339AGE AND SMOKING KEY TO ADHERENCE IN INFLAM-MATORY BOWEL DISEASE: LOW ADHERENCE CAN SERIOUSLY LIMIT DRUG EFFECTIVENESS IN YOUNGSCarla Jerusalen Gargallo Puyuelo, Spain; P. Alarcon; E. Alfambra; T. Arroyo Villarino; J. M. Nerin de la Puerta; A. Lué; F. Gomollon

P0340IS THE CDMRIS USEFUL TO MONITOR PATIENTS WITH CROHN’S DISEASE BY MAGNETIC RESONANCE IMAGING?Catherine Le Berre, France; M. Tahora; C. Trang; M. Flamant; P. Hallouin; S. Bruley Des Varannes; A. Bourreille; E. Frampas


137


Mon

day,

Oct

ober

30,

201

7


P0355ROLE FOR THERAPEUTIC DRUG MONITORING IN ASSESSING SECONDARY LOSS OF RESPONSE TO MAIN-TENANCE ANTI-TNFA THERAPY IN INFLAMMATORY BOWEL DISEASE.Donal Tighe, Ireland; R. Hession; A. Naqeem; S. Smith; A. O'Connor; N. Breslin; B. Ryan; D. McNamara

P0356COMPARATIVE ACCURACY OF BOWEL ULTRASOUND VERSUS MAGNETIC RESONANCE ENTEROGRAPHY AND COLONOSCOPY IN ASSESSING DISEASE ACTIVITY AND COMPLICATIONS AND INFLUENCING THE DECI-SION-MAKING PROCESS IN CROHN’S DISEASEMariangela Allocca, Italy; G. Fiorino; C. Bonifacio; F. Furfaro; D. Gilardi; S. Radice; L. Peyrin-Biroulet; S. Danese

P0357DIAGNOSTIC DELAY IN PATIENTS WITH INFLAMMATO-RY BOWEL DISEASE – A STUDY OF THE AUSTRIAN IBD STUDY GROUP (ATISG)Gottfried Novacek, Austria; H. P. Gröchenig; T. Haas; H. H. Wenzl; P. Steiner; R. Koch; T. Feichtenschlager; G. Eckhardt; A. Mayer; A. Kirchgatterer; O. Ludwiczek; R. Platzer; P. Papay; J. Gartner; H. Fuchssteiner; W. Miehsler; P.-G. Peters; G. Reicht; H. Vogelsang; C. Dejaco; T. Waldhör

P0358IDENTIFICATION OF NON-INVASIVE BIOMARKERS TO DETECT ILEAL CEACAM-6 OVEREXPRESSION AND ADHERENT AND INVASIVE E. COLI (AIEC) INFECTION IN CROHN’S DISEASE PATIENTS: RESULTS FROM THE CEALIVE MULTICENTER STUDYEmilie Vazeille, France; X. Hebuterne; M. Fumery; B. Pariente; S. nancey; P. SEKSIK; L. Peyrin-Biroulet; M. Allez; A. Dubois; N. Ballet; J. Filippi; J.-L. Dupas; M. Nachury; G. Boschetti; M. Goutte; G. Bommelaer; B. Pereira; N. Barnich; A. Buisson

P0359INCREASED LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH ULCERATIVE COLITIS IN REMISSIONMagdalena Panek-Jeziorna, Poland; M. Jasinska; B. Marczak-Karpina; A. Mulak

P0360 DOUBLE-BALLOON ENDOSCOPIC EVALUATION OF FECAL CALPROTECTIN AS A BIOMARKER FOR SMALL INTESTINAL INFLAMMATION IN CROHN’S DISEASERinzaburo Matsuura, Japan; O. Watanabe; M. Nakamura; T. Yamamura; M. Matsushita; M. Saito; Y. Mizutani; T. Sawada; Y. Niwa; E. Ishikawa; G. Uchida; H. Otsuka; H. Suzuki; T. Nishikawa; T. Ishida; T. Kuno; S. Hattori; K. Yamada; T. Ishikawa; K. Furukawa; K. Funasaka; E. Ohno; H. Kawashima; R. Miyahara; Y. Hirooka; H. Goto

P0348SKELETAL MUSCLE ATROPHY IS A PREDICTIVE FACTOR FOR INTESTINAL RESECTION IN PATIENTS WITH CROHN'S DISEASEShigeki Bamba, Japan; M. Sasaki; A. Takaoka; A. Nishida; O. Inatomi; M. Sugimoto; A. Andoh

P0349A PROSPECTIVE STUDY TO PREDICT A MILD COURSE OF CROHN’S DISEASE AN INTERIM ANALYSIS OF THE PROGNOS STUDYWolfgang Kruis, Germany; L. Leifeld; N. Hoepffner; M. Hoesl; P. Jessen; M. Mroß; T. Klugmann; S. Ceplis-Kastner; B. Reimers; B. Bokemeyer

P0350USEFULNESS OF REPEATING TESTING FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH IN-FLAMMATORY BOWEL DISEASE (IBD). CORRELATION BETWEEN TUBERCULIN SKIN TEST (TST)/BOOSTER AND QUANTIFERON-TB (QFT) Ana María Fuentes Coronel, Spain; P. Fradejas Salazar; C. López Ramos; C. Ochoa Sangrador; G. Rascarachi; L. Julian Gómez; C. Bailador; E. Martín; P. Conde; M. García; F. Fernández; R. Castillo; S. Rodríguez

P0351MAGNETIC RESONANCE ENTEROGRAPHY GLOBAL SCORE ALLOWS FOR ACCURATE QUANTIFICATION OF SMALL BOWEL INFLAMMATION IN CROHN’S DISEASE- A COMPARISON WITH CAPSULE ENDOSCOPYE. Klang; M. M. Amitai; A. Lahat; D. Yablecovitch; S. Neuman; N. Levhar; N. Rozendorn; B. Avidan; S. Ben-horin; R. Eliakim; Uri Kopylov, Israel

P0352WHICH ONE IS BETTER FOR ASSESSMENT OF ESTAB-LISHED CROHN’S DISEASE BY CAPSULE ENDOSCOPY: THE LEWIS SCORE OR THE CAPSULE ENDOSCOPY CROHN'S DISEASE ACTIVITY INDEX?D. Yablecovitch; A. Lahat; S. Neuman; N. Levhar; B. Avidan; S. Ben-Horin; R. Eliakim; Uri Kopylov, Israel

P0353CONCORDANCE BETWEEN TUBERCULIN SKIN TEST AND INTERFERON GAMMA RELEASE ASSAY FOR LA-TENT TUBERCULOSIS SCREENING IN INFLAMMATORY BOWEL DISEASE (META-ANALYSIS).Saad Alrajhi, Canada; P. Germain; W. Afif; M. Martel

P0354THIOPURINE MAINTENANCE THERAPY FOR IBD: WHICH IS THE BEST METHOD TO MEASURE MEDICA-TION ADHERENCE?Alvin Ochieng, United Kingdom; V. George; C. Selinger


138




P0369BOWEL ULTRASOUND IS USEFUL IN DISEASE MON-ITORING OF ULCERATIVE COLITIS PATIENTS: FIRST ANALYSIS FROM THE TRUST&UC STUDY IN GERMANYChristian Maaser, Germany; F. Petersen; U. Helwig; A. Rössler; D. Lang; S. Rath; T. Kucharzik; on behalf of the TRUST&UC study group

P0370THE GUT MICROBIOME IN IBD IS CHARACTERIZED BY IMPAIRED METABOLIC COOPERATIVITY AND CAN BE RESTORED UPON ANTI-TNFα THERAPYKonrad Aden, Germany; A. Rehman; W. H. Pan; S. Waschina; J. Zimmermann; J. Bethge; A. Franke; S. Nikolaus; J. O. Schröder; R. Zeuner; C. Kaleta; S. Schreiber; P. Rosenstiel

P0371SELF-MONITORING OF THE COLONIC INFLAMMATORY BOWEL DISEASE BY A RAPID HOME BASED FEACAL CALPROTECTIN TEST AND A SYMPTOM QUESTIONNAIREAnna-Maija Puolanne, Finland; M. A. A. Färkkila; K.-L. Kolho

P0372CLINICAL CHARACTERISTICS IN ULCERATIVE COLITIS PATIENTS WITH COLITIS ASSOCIATED DYSPLASIA/CAN-CER AND SPORADIC TUMOR Makoto Mutaguchi, Japan; M. Naganuma; Y. Iwao; T. Fukuda; S. Sugimoto; K. Nanki; S. Mizuno; H. Ogata; T. Kanai

Treatment-medical

P0373CAN WE PREDICT THE LACK OF RESPONSE TO CYC-LOSPORINE AS SECOND LINE THERAPY IN PATIENTS WITH ACUTE SEVERE COLITIS REFRACTORY TO CORTI-COSTEROIDS?Hammami Aya, Tunisia; B. S. Aida; H. Bassem; J. Hanen; E. Nour; B. M. Imed; A. Salem; B. Ahlem; K. Mehdi; J. Ali

P0374 CHANGES IN THERAPEUTIC STRATEGY AND OUTCOMES IN NEWLY DIAGNOSED PATIENT WITH CROHN’S DISEASE IN THE BIOLOGICAL ERA IN HUNGARY: A NA-TIONWIDE STUDY BASED ON THE NATIONAL HEALTH INSURANCE FUND DATABASEZsuzsanna Kurti, Hungary; L. Gonczi; Z. Vegh; P. A. Golovics; P. Fadgyas-Freyler; J. Gimesi-Orszagh; G. Korponai; B. D. Lovasz; K. B. Gecse; P. L. Lakatos

P0375RELATIVE FREQUENCY OF RELAPSES IN PATIENTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE TREATED WITH MESENCHYMAL STROMAL CELLS – 5 YEARS OF FOLLOW UPO. Knyazev; A. Kagramanova; Nina Fadeeva, Russian Federation; A. Lishchinskaya; I. Ruchkina; A. Konoplyannikov; A. Parfenov

P0361CLINICIANS’ ATTITUDES TO PHOTO PROTECTION IN INFLAMMATORY BOWEL DISEASE PATIENTS ON IMMU-NOSUPPRESSIONCatriona Gallagher, Ireland; M. Hussey; D. Tighe; A. Ridge; M. Kennedy; Y. Bailey; D. Kevans; A. M. Tobin; D. McNamara

P0362HOME MONITORING OF DISEASE ACTIVITY AND FECAL CALPROTECTIN IN ADULT PATIENTS WITH INFLAMMATO-RY BOWEL DISEASE – INTERIM ANALYSIS OF 68 PATIENTSDorit Ankersen, Denmark; D. Marker; P. Weimers; J. Burisch; P. Munkholm

P0363S100A4 PROTEIN IN INFLAMMATORY BOWEL DISEASE: RESULTS OF A SINGLE CENTRE PROSPECTIVE STUDYP. Moravkova; Darina Kohoutova, Czech Republic; J. Vavrova; J. Bures

P0364SEVERE VITAMIN D DEFICIT IN ACTIVE INFLAMMATO-RY BOWEL DISEASEG. Burrelli Scotti; M. T. Afferri; A. De Carolis; V. Vaiarello; V. Fassino; S. Minisola; Piero Vernia, Italy

P0365MAGNETIC RESONANCE OF THE SMALL BOWEL WITH EARLY (70S) AND LATE (7MINS) PHASE POST GADOLIN-IUM IMAGING TO IDENTIFY FIBROSIS IN STRICTURING SMALL BOWEL CROHN’S DISEASE.Roisin Stack, Ireland; C. O'Brien; T. Nuzum; S. Cummins; N. O'Morain; A. O'Connor; N. Breslin; B. Ryan; I. Murphy; D. McNamara

P0366GASTRODUODENAL INVOLVEMENT IN PATIENTS WITH CROHN'S DISEASE – UPPER ENDOSCOPY ONLY IN SYMPTOMATIC PATIENTS?Mafalda Sousa, Portugal; L. Proença; J. Silva; A. Ponte; J. Rodrigues; J. C. Silva; J. Carvalho

P0367 ª INCIDENTAL FINDINGS AT CT ENTEROGRAPHY IN PATIENTS WITH CROHN'S DISEASE: CLINICAL SIGNIFI-CANCE AND IMPACT ON TARGETED THERAPYRui Morais, Portugal; S. Lopes; I. Pita; F. Magro; G. Macedo

P0368CLINICAL SIGNIFICANCE OF ASYMPTOMATIC CLOS-TRIDIUM DIFFICILE CARRIAGE IN PATIENTS ON IMMU-NOMODULATOR FOR INFLAMMATORY BOWEL DISEASE Siu Tong Law, Hong Kong PRC; W. M. Yip; K. K. Li


139


Mon

day,

Oct

ober

30,

201

7


P0384ARE STEROIDS STILL USEFUL IN THOSE INFLAMMATORY BOWEL DISEASE PATIENTS UNDER IMMUNOSUPPRES-SION? A RETROSPECTIVE POPULATION-BASED STUDYL. Arias García; G. Hontoria Bautista; E. Badia Aranda; F. Saez-Royuela Gonzalo; F. Gomollon; Beatriz Sicília Aladrén, Spain

P0385ADALIMUMAB LONG-TERM EFFECTIVENESS IN ADALI-MUMAB-NAIVE PATIENTS WITH CROHN'S DISEASE: FINAL DATA FROM PYRAMID REGISTRYEdward Loftus Jr, USA; G. D'Haens; W. Reinisch; J. Satsangi; R. Panaccione; S. Berg; G. Alperovich; M. Bereswill; J. Kalabic; M. Skup; J. Petersson; A. M. Robinson

P0386EFFECT OF ADALIMUMAB ON CLINICAL AND HEALTH-RELATED QUALITY OF LIFE OUTCOMES BY DISEASE SEVERITY AND PRIOR TUMOUR NECROSIS FACTOR INHIBITOR USE IN PATIENTS WITH ULCER-ATIVE COLITIS IN A CLINICAL PRACTICE SETTING: SUBGROUP ANALYSES FROM INSPIRADASimon Travis, United Kingdom; B. G. Feagan; L. Peyrin-Biroulet; R. Panaccione; S. Danese; J. Petersson; A. Lazar; A. M. Robinson; N. Chen; M. Skup; W.-J. Lee

P0387SUBCUTANEOUS ADMINISTRATION OF A NOVEL FORMULATION OF CT-P13 (INFLIXIMAB BIOSIMILAR) IS SAFE AND ACHIEVES PROJECTED THERAPEUTIC DRUG LEVELS: A PHASE I STUDY IN HEALTHY SUBJECTSR. Westhovens; D. H. Yoo; S. Schreiber; W. Reinish; S. Ben-Horin; B. D. Ye; J. W. Kim; Sang Joon Lee, Republic of Korea; Y. J. Jung; J. H. Suh; S. Kim; D. H. Kwak

P0388REAL-WORLD HEALTHCARE UTILISATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE NEWLY TREATED WITH VEDOLIZUMAB AND ANTI-TUMOUR NECROSIS FACTOR AGENTSMark Osterman, USA; A. Afzali; X. Song; N. Shi; M. Skup; W.-J. Lee

P0389SAFETY OF ANTI-TNF TREATMENT IN ELDERLY PA-TIENTS WITH INFLAMMATORY BOWEL DISEASELuís Maia, Portugal; P. Lago; Â. Rodrigues; M. S. Rodrigues; C. Caetano; D. Ferreira; M. Rocha; I. Pedroto

P0390SWITCHING FROM REFERENCE INFLIXIMAB TO CT-P13 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: 12 MONTHS RESULTSMaria Fernanda Guerra Veloz, Spain; F. Argüelles Arias; R. Perea Amarillo; L. Castro Laria; B. Maldonado Pérez; D. Chaaro; A. Benítez Roldan; V. Merino; G. Ramirez; A. Caunedo Álvarez; M. Romero Gómez

P0376 CELL THERAPY FOR PERIANAL CROHN'S DISEASEO. Knyazev; A. Kagramanova; N. Fadeeva; A. Lishchinskaya; Nikita Belyakov, Russian Federation; A. Konoplyannikov; A. Parfenov

P0377DYNAMICS OF PROINFLAMMATORY CYTOKINES IN PATIENTS WITH CROHN'S DISEASE TREATED WITH MESENCHYMAL STROMAL CELLS OF BONE MARROW AND AZATHIOPRINEO. Knyazev; Nina Fadeeva, Russian Federation; K. Noskova; A. Kagramanova; A. Konoplyannikov; R. Gudkova; E. Dobrolyubova; A. Parfenov

P0378EFFICACY AND SAFETY OF RECTAL 5-AMINOSALICYLIC ACID VERSUS CORTICOSTEROIDS IN ACTIVE DISTAL ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSISXiaojing Zhao, China; H. Zhang

P0379A PROTEASE-STABILISED ORAL DOMAIN ANTIBODY TO TNF DELIVERS HIGH CONCENTRATIONS OF ACTIVE COM-POUND IN ILEAL FLUID OF SUBJECTS WITH AN ILEOSTOMYJ. Robinson; S. Crowe; G. Whale; K. Roberts; M. West; J. Ritter; P. Irving; Suhail Nurbhai, United Kingdom

P0380ULCERATIVE COLITIS (UC) WITH IBS – LIKE DISOR-DERS: PARTICULAR QUALITIES OF CLINICAL MANIFES-TATIONS AND MEDICAL THERAPY.Ekaterina Dobrolyubova, Russian Federation; I. Ruchkina; A. Parfenov; O. Knyazev

P0381A PROSPECTIVE RANDOMISED STUDY: ELECTROACU-PUNCTURE VS. SHAM PROCEDURE FOR THE TREAT-MENT OF FATIGUE IN PATIENTS WITH QUIESCENT INFLAMMATORY BOWEL DIASEDiana Horta, Spain; M. Sanchez-Lloansi; A. Lira; A. Villoria; M. Teggiachi; D. Garcia; T. Torres; M. Calatayud; A. Figuerola; X. Calvet

P0382EFFICACY AND SAFETY OF GOLIMUMAB IN CROHN’S DISEASE : A FRENCH NATIONAL RETROSPECTIVE STUDYChloé Martineau, France; B. Flourie; P. Wils; T. Vaysse; R. Altwegg; A. Buisson; A. Amiot; G. Pineton de Chambrun; V. Abitbol; M. Fumery; X. Hebuterne; S. Viennot; D. Laharie; L. Beaugerie; S. Nancey; H. Sokol

P0383BIOLOGICS AND BIOSIMILARS: WHAT MATTERS TO PHYSICIANS?A. Molinari; A. Loaiza-Bonilla; David Charles, USA


140




P0398PREDICTIVE FACTORS OF RESPONSE TO GRANULOCYTE – MONOCYTE APHERESIS IN INFLAMMATORY BOWEL DISEASEIago Rodríguez – Lago, Spain; J. M. Benítez-Cantero; V. García-Sánchez; L. Sempere; A. Gutiérrez; I. Galdona; A. Rodríguez-Pescador; E. Fernández; I. Lafuente; A. Loroño; J. L. Cabriada

P0399 ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR ULCERATIVE COLITIS: A DOUBLE-BLIND, RAN-DOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDYWilliam J. Sandborn, USA; B. R. Bhandari; C. Randall; Z. Younes; T. Romańczyk; H. Chai; M. McKevitt; S. Zhao; B. Kanwar; J. Sundy; S. Keshav; S. Danese

P0400ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR CROHN’S DISEASE: A DOUBLE-BLIND, RANDOM-IZED, PLACEBO-CONTROLLED, PHASE 2 STUDYStefan Schreiber, Germany; C. Siegel; K. Friedenberg; U. Seidler; B. R. Bhandari; Z. Younes; K. Wang; M. McKevitt; S. Zhao; B. Kanwar; J. Sundy; S. D. Lee; E. V. Loftus Jr

P0401TUBERCULIN SKIN TEST CONVERSION RATE IN IN-FLAMMATORY BOWEL DISEASE PATIENTS RECEIVING ANTI-TNF ALPHA AGENTSM. Fragkaki; A. Mpitouli; I. Dimas; Grigorios Paspatis, Greece; K. Karmiris

P0402THE TEMPORAL EVOLUTION OF IMMUNOGENICITY IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH ADALIMUMABBella Ungar, Israel; T. Engel; D. Yablecovich; A. Lahat; A. Lang; B. Avidan; O. Har-Noy; N. Levhar; L. Selinger; S. Neuman; O. Haj Natour; M. Yavzori; E. Fudim; O. Picard; U. Kopylov; Y. Chowers; T. Naftali; E. Broide; E. Shachar; R. Eliakim; S. Ben-Horin

P0403GOLIMUMAB IN ULCERATIVE COLITIS. REAL-LIFE PRO-SPECTIVE COHORT STUDY FROM A SINGLE REFERRAL CENTRE OF MIDDLE ITALYLaurino Grossi, Italy; V. Vecchione; S. Cocciolillo; R. Tavani; M. Di Berardino; A. Sepe; C. Di Giacomo; N. Russo; V. D'Addetta; L. Marzio

P0404FIVE-YEAR SAFETY DATA FROM THE OBSERVATION-AL POSTMARKETING ULCERATIVE COLITIS STUDY, A EUROPEAN REGISTRY FOR ADULTS WITH ULCERATIVE COLITIS TREATED WITH ORIGINATOR INFLIXIMAB OR STANDARD THERAPYJulian Panés, Spain; J. Lindsay; N. Teich; S. Lindgren; J.-F. Colombel; F. Cornillie; H. A. Flynn; S. Huyck; P. Stryszak; R. Yao; G. Philip; W. Reinisch

P0391CLINICAL RESPONSE TO VEDOLIZUMAB IN IBD PA-TIENTS IS ASSOCIATED WITH THE CONCOMITANT USE OF IMMUNOMODULATORSIoanna Parisi, United Kingdom; R. Vega; L. Whitley; S. Bloom; S. McCartney

P0392CORRELATION OF RELATIONSHIP BETWEEN INFLIX-IMAB AND ADALIMUMAB TROUGH AND ANTIBODY LEVELS WITH CLINICAL RESPONSE RATES AT COMPLE-TION OF INDUCTION THERAPYDonal Tighe, Ireland; S. Smith; A. O'Connor; B. Ryan; N. Breslin; D. McNamara

P0393BUDESONIDE IS SUPERIOR TO MESALAZINE AND PLACEBO FOR INDUCTION OF REMISSION IN LYMPHOCYTIC COLITISStephan Miehlke, Germany; D. Aust; E. Mihaly; P. Armerding; G. Boehm; O. K. Bonderup; F. Fernández-Bañares; J. Kupcinskas; L. K. Munck; K.-U. Rehbehn; T. Nacak; R. Greinwald; A. Münch

P0394PREGNANCY OUTCOMES IN THE TOFACITINIB ULCER-ATIVE COLITIS OCTAVE STUDIESU. Mahadevan; Daniel C. Baumgart, Germany; M. C. Dubinsky; N. Lawendy; G. Friedman; G. G. Konijeti; H. P. Gröchenig; T. V. Jones; A. Marren; A. J. Thorpe; C. Nduaka; C. Su

P0395SAFETY AND EFFICACY OF GRANULOCYTE AND MONO-CYTE ADSORPTIVE APHERESIS IN 363 PATIENTS WITH INFLAMMATORY BOWEL DISEASE WHO HAVE SPECIAL SITUATIONS: AN INTERIM ANALYSIS OF A POST-MAR-KETING SURVEILLANCE STUDYSatoshi Motoya, Japan; H. Tanaka; T. Shibuya; T. Osada; H. Hongo; T. Kimura; D. Saito; A. Sakuraba; C. Mizuno; A. Ito; T. Kobayashi; D. Abukawa; S. Kokuma; E. Hosoi

P0396 INTEGTRATING PSYCHOLOGICAL SUPPORT INTO ROU-TINE CARE FOR PEOPLE WITH INFLAMMATORY BOWEL DISEASE.T. Lores; Charlotte Goess, Australia; C. Hrycek; R. Grafton; J. Hughes; L. Cronin; A. Mikocka-Walus; A. Chur-Hansen; A. L. Burke; K. L. Collins; J. M. Andrews

P0397LONG-TERM EFFICACY, SAFETY, AND IMMUNOGENIC-ITY DATA FROM A PHASE III CONFIRMATORY STUDY COMPARING GP2017, A PROPOSED BIOSIMILAR, WITH REFERENCE ADALIMUMABA. Blauvelt; J.-P. Lacour; J. F. Fowler; E. Schuck; Julia Jauch-Lembach, Germany; A. Balfour; C. L. Leonardi


141


Mon

day,

Oct

ober

30,

201

7


P0413RESPONSE AND REMISSION AFTER 16 WEEKS OF USTEKINUMAB– AN ALL PATIENTS ANALYSIS FROM THE UNITI CROHN’S STUDIESJean-Fred Colombel, USA; S. Sloan; C. Gasink; L.-L. Gao; D. Jacobstein; S. D. Lee; S. R. Targan

P0414REAL-WORLD PATTERNS OF TREATMENT DISCONTIN-UATION, FLARES, AND HOSPITALISATIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS WITHIN 12 MONTHS OF INITIATION OF VEDOLIZUMAB OR INFLIXIMABHaridarshan Patel, United Kingdom; M. Raluy Callado; A. Berger; R. Curtis; M. J. Khalid

Poster Session09:00 – 17:00 Hall 7Other Lower GI Disorders I

Lower GI Immunology, immunity, inflammation (NOT IBD)

P0415OXIDATIVE STRESS ENHANCES THE ANTIGEN PRESENTING FUNCTION OF COLONIC EPITHELIAL CELLS BY INDUCING CD80 IN THE EARLY STAGES OF COLONIC CARCINOGENESISChiara Marchiori, Italy; A. Kotsafti; I. Angriman; C. Castoro; A. Porzionato; P. BRUN; M. Scarpa; I. Castagliuolo; M. Scarpa

P0416 ALTERED INTESTINAL EXPRESSION PROFILES OF ANTI-MICROBIAL GENES IN IRRITABLE BOWEL SYN-DROME ARE LINKED TO BACTERIAL COMPOSITION AND IMMUNE ACTIVATIONJohanna Sundin, Sweden; S. M. P. Bennet; M. K. Magnusson; J. Tap; M. Derrien; B. Le Nevé; J. Doré; H. Törnblom; M. Simrén; L. Öhman

P0417THE EXPOSURE OF ANTIBIOTICS IS ASSOCIATED WITH INCREASED RISK OF COLORECTAL CANCER- A SYSTEM-ATIC REVIEW AND META-ANALYSISXingkang He, China; W. wu; Y. Ding; L. Sun

P0418EFFECT OF INTERNAL AND EXTERNAL BILIARY DRAIN-AGE ON INTESTINAL MUCOSAL BARRIER FUNCTION IN BILIARY OBSTRUCTION RATSShuling Li, China; X. Su; K. Luo; C. Ge; W. Li

P0419COMPARATIVE EFFECT OF XYLOGLYCAN ASSOCIATIONS WITH COMPOUNDS FROM ANIMAL OR ALGAE ORIGIN ON LPS-INDUCED ENTERITIS IN RATSHelene Eutamene, France; C. Harkat; V. Theodorou

P0405 DIRECT INTESTINAL PH-TRANSIT ASSESSMENT IN PATIENTS WITH ULCERATIVE COLITIS AS A STRATEGY FOR PREDICTING SUCCESS OF REGIONAL DELIVERY OF TOPICALLY-ACTING DRUGSCk Yao, Australia; R. E. Burgell; K. M. Taylor; M. G. Ward; J. S. Barrett; J. G. Muir; P. R. Gibson

P0406HIGHER EXPOSURE TO GOLIMUMAB IS ASSOCIATED WITH ENDOSCOPIC RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE GO-KINETIC TRIALSophie Berends, The Netherlands; A. Strik; R. Mathot; G. R. D'Haens; M. Lowenberg

P0407 COMPARATIVE EFFICACY AND SAFETY OF TOFACITINIB AND BIOLOGICS AS INDUCTION THERAPY FOR MOD-ERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSISDavid Rubin, USA; A. O. Ashaye; Y. Zhang; Y. Xu; K. Fahrbach; L. A. Chen; A. Manuchehri; C. Kayhan; J. Woolcott; J. C. Cappelleri

P0408 CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH C. DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE: BEZLOTOXUMAB VERSUS PLACEBOCiaran Kelly, USA; M. Wilcox; H. Glerup; N. Aboo; K. Eves; D. Mary Beth

P0409SIMILAR TRIAL - EFFICACY OF INFLIXIMAB-BIOSIM-ILAR COMPARED TO INFLIXIMAB-BIOLOGICAL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN REMISSION – A RANDOMIZED, CONTROLLED, DOUBLE BLIND, PHASE 4 NONINFERIORITY TRIALAdrian Volkers, The Netherlands; J. M. Jansen

P0410WITHDRAWN

P0411ENCAPSULATED FECAL MICROBIOTA TRANSFER IN PATIENTS WITH CHRONIC, ANTIBIOTIC–REFRACTORY POUCHITISA. Steube; M. Vital; A. Sturm; C. Buening; Andreas Stallmach, Germany; D. Pieper

P0412HISTOLOGIC MEASURES OF MUCOSAL HEALING COR-RELATE WITH ENDOSCOPIC MEASURES OF DISEASE ACTIVITY AT BASELINE AND FOLLOWING INDUCTION THERAPY WITH THE JAK1 INHIBITOR FILGOTINIB IN AC-TIVE CROHN’S DISEASE: RESULTS FROM FITZROY STUDYWalter Reinisch, Austria; G. R. D'Haens; G. De Hertogh; A. Van der Aa; J. Zhang; C. Tasset; C. Yun; A. Serone; B. G. Feagan; W. J. Sandborn; S. Vermeire


142




P0427INCREASING INCIDENCE OF CLOSTRIDIUM DIFFICILE INFECTION AND THE USE OF PROTON-PUMP INHIB-ITORS: RESULTS FROM A TERRITORY-WIDE POPULA-TION STUDY IN HONG KONGSunny Wong, Hong Kong PRC; J. Ho; R. Dai; L. Y. K. Lam; S. C. C. Ng; J. C. Wu; J. J. Y. Sung; W. Wu

Lower GI bleeding

P0428 THE PROPHYLACTIC CLIP APPLICATION BEFORE SNARE POLYPECTOMY DECREASES IMMEDIATE POST-POLYP-ECTOMY BLEEDING IN LARGE PEDUNCULATED POLYPS.Jae Seung Soh, Republic of Korea; S. H. Park; Y. Song; K.-J. Kim

P0429DOES CONTINUATION OF WARFARIN BECOME A PERIPROCEDURAL ALTERNATIVE METHOD TO HEPARIN REPLACEMENT IN COLONIC POLYPECTOMY / ENDO-SCOPIC MUCOSAL RESECTION?Itaru Saito, Japan; S. Ono; Y. Takeda; K. Takemura; H. Doyama; Y. Tsuji; K. Niimi; S. Kodashima; N. Yamamichi; M. Fujishiro; K. Koike

P0430EFFECTS OF HEPARIN BRIDGING THERAPY ON POST-POL-YPECTOMY BLEEDING AND THROMBOEMBOLIC RISKS IN PATIENT UNDERGOING COLONOSCOPIC POLYPECTOMYNoriyuki Hayashi, Japan; H. Kataoka; T. Katano; K. Ozeki; Y. okamoto; T. Mizoshita; T. Shimura; E. Kubota; S. Tanida; T. Joh

P0431ARTERIOSCLEROSIS IS A SIGNIFICANT CONTRIBUTOR TO COLON DIVERTICULUM RECURRENT BLEEDINGTaiki Aoyama, Japan; S. Nagata; T. Sakamoto; Y. Shimohara; H. Tamari; Y. Ogawa; K. Shigita; N. Asayama; A. Fukumoto; S. Mukai

P0432EARLY VERSUS STANDARD COLONOSCOPY – A RAN-DOMIZED CONTROLLED TRIAL IN PATIENTS WITH ACUTE LOWER GASTRO-INTESTINAL BLEEDING: RESULTS OF THE BLEED STUDYInge van Rongen, The Netherlands; B. Thomassen; L. Perk

P0433THE COMPARISON OF DIRECT ORAL ANTICOAGULANTS (DOAC) AND WARFARIN FOR ANTICOAGULATION IN THE PATIENTS WITH GASTROINTESTINAL BLEEDINGKentaro Kojima, Japan; N. Toda; J. Arai; K. Kurokawa; C. Shibata; S. Kurosaki; K. Funato; M. Kondo; T. Ohki; M. Seki; K. Tagawa

Lower GI infections

P0420RISK FACTORS ASSOCIATED WITH RECURRENCE OF CLOSTRIDIUM DIFFICILE INFECTION IN THE ELDERLYMin Su You, Republic of Korea; D. H. Lee

P0421CLINICAL CHARACTERISTICS OF CYTOMEGALOVIRUS COLITIS: 15 YEAR-EXPERIENCE IN A TERTIARY MEDI-CAL CENTERPuo-Hsien Le, Taiwan; R.-C. Wu; C.-T. Chiu; C.-J. Kuo; M.-Y. Su; C.-J. Lin; J.-T. Hsu

P0422FIRST CASE SERIES OF FECAL MICROBIOTA TRANS-PLANTATION FOR RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN BALTIC COUNTRIESRolandas Gedgaudas, Lithuania; M. Urba; V. Petkevicius; L. Jonaitis; G. Kiudelis; L. Kupcinskas; J. Kupcinskas

P0423A RANDOMISED CONTROLLED TRIAL OF RIFAXIMIN TO PREVENT RELAPSE OF CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHOEA AFTER RESOLUTION WITH STANDARD THERAPY Giles Major, United Kingdom; L. Bradshaw; N. Boota; K. Sprange; A. Jawhari; M. Diggle; A. Montgomery; R. Spiller

P0424A SYSTEMATIC REVIEW AND META-ANALYSIS OF IN-HOS-PITAL DELAY BEFORE SURGERY AS A RISK FACTOR FOR COMPLICATIONS IN PATIENTS WITH ACUTE APPENDICITIS.Stefan van Dijk, The Netherlands; A. Van Dijk; M. G. W. Dijkgraaf; M. A. Boermeester

P0425VANCOMYCIN FOLLOWED BY FECAL MICROBIOTA TRANSPLANTATION VERSUS VANCOMYCIN FOR INITIAL CLOSTRIDIUM DIFFICILE INFECTION: AN OPEN-LABEL RANDOMISED CONTROLLED TRIALSiew Chien Ng, Hong Kong PRC; S. H. Wong; R. N. Lui; K. Cheung; J. Y. L. Ching; W. Tang; M. Kyaw; Z. Tao; K. T. Ho; M. Ip; P. Chan; F. K. L. Chan; J. J. Y. Sung; J. C. Wu; L. Y. K. Lam

P0426A 10-YEAR REVIEW OF ABDOMINAL TUBERCULOSIS EXPERIENCE IN A MULTI-ETHNIC SECONDARY CARE POPULATIONU. Shivaji; T. Critchlow; S. Pathmakanthan; S. Ghosh; M. Iacucci; N. Sharma; R. Cooney; T. Iqbal; P. Glynn; Neeraj Bhala, United Kingdom


143


Mon

day,

Oct

ober

30,

201

7


P0443COLORECTAL CANCER AND DYSLIPIDAEMIA: CAUSE OR CONFOUNDING? A MENDELIAN RANDOMIZATION STUDYGemma Ibáñez, Spain; A. Díez-Villanueva; M. Riera-Ponsati; E. Guinó; B. Pérez-Gómez; M. Bustamante; V. Martin; J. Llorca; P. Amiano; E. Ardanaz; A. Tardón; J. J. Jimenez-Moleon; R. Peiró; J. Alguacil; C. Navarro; P. Pablo Fernández Navarro; A. Espinosa; V. Verónica Dávila-Batista; A. J. Molina; C. Palazuelos; G. Castaño-Vinyals; N. Aragonés; M. Kogevinas; M. Pollán; V. Moreno

P0444LINC00152 LONG NON-CODING RNA FACILITATES CELL PROLIFERATION IN SW480 COLON CARCINOMA CELLS THROUGH REGULATION OF CELL CYCLE AND WNT SIGNALING PATHWAYOrsolya Galamb, Hungary; B. K. Bartak; A. Kalmár; A. Sebestyén; T. Dankó; C. Tolnai-Kriston; G. Valcz; K. Szigeti; Z. B. Nagy; G. Barna; Z. Tulassay; P. Igaz; B. Molnar

P0445GENETIC PROFILE OF POLYPS AND RISK OF ADVANCED METACHRONOUS LESIONSOscar Murcia, Spain; M. Juárez; E. Hernández-Illán; M. Rodríguez-Soler; C. Egoavil; C. Alenda; A. Martínez-García; C. Mangas; M. Giner-Calabuig; M. Alustiza; J. R. Aparicio; F. A. Ruiz; J. F. Martínez; J. A. Casellas; J. L. Soto; P. Zapater; R. Jover

P0446 MITOCHONDRIAL GLUTAMATE TRANSPORTER (SLC25A22) MEDIATES DNA AND HISTONE HYPER-METHYLATION AND PROMOTES THE TUMORIGENICITY OF KRAS-MUTANT COLORECTAL CANCERChi Chun Wong, Hong Kong PRC; J.-L. Wu; J. Xu; W. Kang; Y. Qian; H. Chen; X. Li; Z. Cai; J. Jao-yiu Sung; J. Yu

P0447FOLLISTATIN-LIKE PROTEIN 1 SUSTAINS COLON CAN-CER CELL GROWTH AND SURVIVALGerolamo Bevivino, Italy; V. De Simone; R. Izzo; M. Di Giovangiulio; S. Sedda; E. Franzè; A. Rizzo; P. Rossi; C. Stolfi; G. Monteleone

P0448TP53 MUTATION ACQUIRES HIGHER MALIGNANT PO-TENTIAL IN HUMAN COLON CANCER CELLSSho Watanabe, Japan; K. Tsuchiya; T. Shirasaki; S. Hibiya; S. Ooshima; T. Nakamura; M. Watanabe; R. Nishimura; R. Okamoto

P0449PROTECTIVE EFFECT OF OPIOID RECEPTOR ACTIVA-TION IN THE DEVELOPMENT OF COLITIS-ASSOCIATED COLORECTAL CANCER IN MICEAgata Jarmuz, Poland; D. Jacenik; H. Zatorski; R. Kordek; W. M. Krajewska; J. Fichna; M. Zielińska

Lower GI malignant disease-epidemiology

P0434WITHDRAWN

P0435INCREASED INCIDENCE OF OVARIAN CANCER FOLLOW-ING COLORECTAL CANCER: A KOREAN NATIONWIDE COHORT STUDYDong Woo Shin, Republic of Korea; D. H. Lee; H. S. Kim

P0436 WORLD ENDOSCOPY ORGANISATION CONSENSUS STATEMENTS ON POST-COLONOSCOPY/POST-IMAGING COLORECTAL CANCERIosif Beintaris, United Kingdom; S. Sanduleanu; H. M. Chiu; D. Corley; M. Cuatrecasas; E. Dekker; A. Forsberg; U. Haug; M. F. Kaminski; T. Matsuda; G. A. Meijer; E. Morris; A. Plumb; L. Rabeneck; D. Robertson; R. Schoen; H. Singh; J. Tinmouth; R. Valori; G. Young; M. D. Rutter

P0437EXCESS RISK OF SECOND PRIMARY CANCERS IN YOUNG-ONSET COLORECTAL CANCER SURVIVORSXingkang He, China; W. wu; L. Sun; Y. Ding; J. Si

P0438 INCIDENCE OF FECAL OCCULT BLOOD TEST INTERVAL CANCERS IN COLORECTAL CANCER SCREENING; A SYSTEMATIC REVIEW AND META-ANALYSISEls Wieten, The Netherlands; E. Schreuders; E. J. Grobbee; D. Nieboer; I. Lansdorp-Vogelaar; M. J. Bruno; E. J. Kuipers; M. C. W. Spaander

P0439MEASURES OF BODY COMPISITION AND GENDER DIFFERENCES IN RISK FOR COLORECTAL CANCER – A POPULATION-BASED COHORT STUDYAnna Forsberg, Sweden; F. Sköldberg; P. Thelin Schmidt; A. Carlsson; K. Önnerhag; H. Hagström; A. Andreasson

Lower GI malignant disease, pathogenesis

P0440TH17 CELLS INDUCE EPITHELIAL-MESENCHYMAL TRANSITION VIA IL-17/PI3K/AKT/SNAIL PATHWAY IN COLORECTAL CANCERQuan-Lin Li, China; X.-Y. Xu; P.-H. Zhou

P0441MICRORNA EXPRESSION PROFILE IN RECTAL CANCERJan Král, Czech Republic; V. Rusnakova; L. Langerova; V. Korenkova; P. Vodicka; J. Spicak; J. Slyskova

P0442MUSCARINIC-3 RECEPTOR TARGETED MIRNAS ARE INVOLVED IN BILE ACID INDUCED PROLIFERATION ON H508 COLON CANCER CELL LINEFatih Tekin, Turkey; C. Aktan; N. Oruc; O. Ozutemiz


144




P0458POST INVESTIGATION COLORECTAL CANCER RATES INCLUDING POST COLONOSCOPY COLORECTAL CANCER RATES IN A DISTRICT GENERAL HOSPITAL: THE POOLE EXPERIENCE MARCH 2015 TO FEBRUARY 2017.Sally Davina Parry, United Kingdom; T. Deacy; E. J. Williams

P0459RISK OF DETECTION OF GASTROINTESTINAL NEO-PLASMS AND DEATH IN SYMPTOMATIC PATIENTS WITH A POSITIVE FECAL IMMUNOCHEMICAL TEST WITHOUT COLORECTAL CANCERNoel Pin, Spain; M. J. Iglesias; D. Remedios; P. Vega; J. Cubiella

Lower GI malignant disease, management

P0460LONG-TERM OUTCOMES OF TRANSANAL COLORECTAL TUBE PLACEMENT FOR DISTAL STAGE II/III COLOREC-TAL CANCER WITH ACUTE COLORECTAL OBSTRUCTIONTomonori Yamada, Japan; Y. Okuda; R. Yamaguchi; E. Sakamoto; Y. Hirata; T. Shimura

P0461FACTORS ASSOCIATED WITH THE TECHNICAL DIF-FICULTY OF DOUBLE-WIRE WOVEN UNCOVERED SELF-EXPANDABLE METALLIC STENT PLACEMENT FOR MALIGNANT COLORECTAL OBSTRUCTIONKenji Tominaga, Japan; I. Maetani; S. Yoshida; H. Isayama; T. Yamada; Y. Sumida; R. Kyo; T. Kuwai; M. Tomita; Y. Kushiyama; M. Kikkawa; S. Saito; Y. Saida

P0462PROGNOSIS AND CLINICOPATHOLOGICAL FACTORS OF PATIENTS WHO SELECTED THE FOLLOW-UP OPTION AMONG HIGH-RISK T1 COLORECTAL CANCER PATIENTS AFTER ENDOSCOPIC RESECTION BASED ON JAPANESE CLINICAL PRACTICE GUIDELINE: A RETROSPECTIVE OBSERVATIONAL STUDY.Yoshitaka Nishikawa, Japan; T. Horimatsu; S. Minamiguchi; H. Seno; Y. Sakai; T. Nakayama

P0463LONG-TERM OUTCOMES AFTER TREATMENT FOR T1 CARCINOMA OF LATERALLY SPREADING TUMORS: – A MULTICENTER RETROSPECTIVE STUDY OF HIROSHIMA GI ENDOSCOPY RESEARCH GROUP- Ken Yamashita, Japan; S. Tanaka; S. Oka; S. Nagata; T. Kuwai; A. Furudoi; T. Tamura; M. Kunihiro; H. Okanobu; K. Nakadoi; H. Kanao; M. Higashiyama; Y. Tamaru; F. Shimamoto; K. Chayama

Lower GI malignant disease, diagnosis/histopathology

P0450INCREASED HMGB1 EXPRESSION CORRELATES WITH HIGHER EXPRESSION OF C-IAP2 AND PERK IN COL-ORECTAL CANCERWenjia Zhang, China; M. Xia; F. an; Q. Zhan; W. Tian

P0451 THE POSSIBILITIES OF APPLICATION OF METABOLIC PROFILES OF BLOOD SERUM AND RED BLOOD CELLS IN DIAGNOSING OF COLORECTAL CANCERMargarita Kruchinina, Russian Federation; A. A. Gromov; Y. I. Prudnikova; S. A. Kurilovich; V. N. Kruchinin; M. V. Shashkov; A. S. Sokolova; S. E. Peltec

P0452THE MICRORNAS EXPRESSION PROFILES OF MULTIPLE COLORECTAL TUMORSYoshihito Nakagawa, Japan; Y. Akao; T. Tahara; T. Shibata; M. Nagasaka; N. Ohmiya

P0453UTILITY OF MEAN PLATELET VOLUME, PLATELETCRIT, PLATELET-LYMPHOCYTE RATIO AND NEUTROPHIL-LYM-PHOCYTE RATIO IN THE DIFFERENTIATION OF COLON CANCER AND COLONIC POLYPS IN OLDER PATIENTSFatih Karakaya, Turkey; Ç. Kalkan; I. Soykan

P0454IMPROVING THE SELECTION OF COMPLETE RESPOND-ERS FOR WATCHFUL WAITING AFTER CHEMORA-DIOTHERAPY FOR RECTAL CANCER: WHAT CAN WE LEARN FROM THE ‘MISSED’ PATHOLOGIC COMPLETE RESPONDERS AFTER SURGERY?Doenja M. Lambregts, The Netherlands; M. Maas; M. van der Sande; B. Hupkens; M. Martens; F. Bakers; R. G. H. Beets-Tan; S. O. Breukink; G. L. Beets

P0455RADIOMICS AS A NOVEL TOOL FOR PRE-TREATMENT RESPONSE PREDICTION IN RECTAL CANCERJ. J. M. van Griethuysen; S. Trebeschi; Doenja M. Lambregts, The Netherlands; M. Lahaye; F. Bakers; R. F. A. Vliegen; E. Voest; G. L. Beets; R. G. H. Beets-Tan; H. J. W. L. Aerts

P0456 CORRELATION OF ELECTRICAL AND VISCOELASTIC PARAMETERS OF ERYTHROCYTES WITH FATTY ACID COMPOSITION OF THEIR MEMBRANES AND SERUM IN PATIENTS WITH COLORECTAL CANCERIana Prudnikova, Russian Federation

P0457CLINICOPATHOLOGICAL STUDY OF LATERALLY SPREAD-ING TUMORS OF THE COLORECTUM.Masahiro Iwabuchi, Japan; M. Sugimura; S. Toda; K. Ukai


145


Mon

day,

Oct

ober

30,

201

7


IBS /Lower GI motility: Brain-gut and gut-brain axes, neuro-hormonal, neural-immune and visceral sensitivity

P0471ASSOCIATION BETWEEN PARAMETERS OF THE REC-TOANAL INHIBITORY REFLEX AND THRESHOLD FOR FIRST RECTAL SENSATION ESTABLISHED BY HIGH-RES-OLUTION ANORECTAL MANOMETRY (HRAM) AND ITS SIGNIFICANCE FOR FECAL INCONTINECE DIAGNOSTICSOlga Storonova, Russian Federation; A. Trukhmanov; V. T. Ivashkin

P0472AVOIDANT COPING AND SOMATIZATION PARTLY EXPLAIN THE RELATIONSHIP BETWEEN NEUROTICISM AND GASTROINTESTINAL SYMPTOM BURDENMichael P. Jones, Australia; A. P. Beath; A. Ejova; P. Mahoney; J. M. Koch

P0473 POTENTIAL REGULATORY EFFECTS OF CORTICOTRO-PIN-RELEASING FACTOR ON TIGHT JUNCTION-RE-LATED INTESTINAL EPITHELIAL PERMEABILITY ARE PARTIALLY MEDIATED THROUGH CK8 UPREGULATIONYue Hu, China; B. Lv

P0474REGULATING EFFECTS OF TONGXIE-YAOFANG FOR-MULA ON COLONIC EPITHELIAL SECRETION IN RATS WITH DIARREHEA-PREDOMINANT IRRITABLE BOWEL SYNDROMEY. Cheng; Zhan Qiang, China; Z. Q. Lin; S. Jing; L. X. Ling

P0475DIOSMECTITE CHRONIC TREATMENT SUPPRESSES GUT VISCERAL HYPERSENSITIVITY AND INTESTINAL TRANSIT ACCELERATION INDUCED BY CHRONIC STRESS IN RAT.Helene Eutamene, France; C. Beaufrand; H. Mathiex-Fortunet; V. Theodorou

P0476METABOLOMIC SIGNATURE OF THE POSTPRANDIAL EXPERIENCECarolina Malagelada, Spain; T. Pribic; N. Cañellas; J. Gomez; N. Amigo; B. Ciccantelli; A. Accarino; J. R. Malagelada; F. Azpiroz

P0477NEGATIVE EFFECTS OF BIFIDOBACTERIUM BIFIDUS ON THE RAT WITH COLONIC VISCERAL HYPERSENSITIVITY INDUCED BY ACETIC ACID PERFUSIONX. Wang; Weifang Zhang, China; K. Wang; L. Zhang; Q. Sun; L. Duan

Lower GI motility disorders: Clinical

P0478EFFECTS OF PREBIOTICS AND SYNBIOTICS ON FUNC-TIONAL CONSTIPATION Ting Yu, China; L. Lin

P0464ASSESSMENT OF THE EFFECTS OF A PACLI-TAXEL-ELUTING SELF-EXPANDING METAL STENT ON NAÏVE PORCINE BILIARY TISSUEJohn Favreau, USA; G. Haber; S. Alkaade; M. Arain; T. H. Baron; S. Branch; P. V. Draganov; J. H. Lee; D. K. Mullady; B. T. Petersen; R. J. Shah; S. Sherman; D. Amos; R. Bennett; J. Hemerick; S. Dassner; A. Foss; D. Ross; A. Pearlman; J. Saunders; M. Rivera-Bermudez; C. O. Clerc; L. Swanson; J. Scutti

P0465COMPLETE ENDOSCOPIC MUCOSAL RESECTION OF MALIGNANT COLONIC SESSILE POLYPS AND CLINICAL OUTCOME OF 51 CASES.M. Fragkaki; E. Chliara; I. Dimas; A. Mpitouli; E. Vardas; A. Theodoropoulou; K. Karmiris; E. Voudoukis; L. Giannikaki; Grigorios Paspatis, Greece

P0466IMPACT OF EVALUATION OF PRECISION CHEMOTHER-APY FOR COLORECTAL CANCER (CRC) BASED ON COL-LAGEN GEL DROPLET-EMBEDDED DRUG SENSITIVITY TEST (CD-DST).Takumi Ochiai, Japan; K. Nishimura; T. Watanabe; M. Kitajima; A. Nakatani; K. Nagayasu; N. Sakuyama; T. Sato; K. Kishine; Y. Abe; C. Hara; K. Fujiwara; I. Nagaoka

P0467 WAIT-AND-SEE STRATEGY IN LOW RECTAL CANCERJoão Cortez-Pinto, Portugal; R. Oom; I. Rosa; C. Travancinha; G. Fernandez; I. Marques; I. Miguel; J. Freire; J. Pereira da Silva; J. Venâncio; L. d´Orey; L. Mirones; M. Limbert; P. Chaves; P. Pereira; R. Fonseca; R. Barroca; T. Ferreira; T. Marques; A. Dias Pereira

P0468LONG-TERM COLONOSCOPIC SURVEILLANCE BE-TWEEN PATIENTS AFTER SURGICAL RESECTIONS OF COLORECTAL INVASIVE CANCER AND THOSE AFTER ENDOSCOPIC RESECTIONS OF COLORECTAL ADENOMA AND INTRAMUCOSAL CANCER Seiji Kimura, Japan; M. Tanaka

P0469 LONG-TERM COLONOSCOPIC SURVEILLANCE BETWEEN PATIENTS WITH UNRESECTED DIMINUTIVE POLYPS AND THOSE WITH COLORECTAL ADENOMAS > 5MM IN SIZE RESECTED AT INITIAL COLONOSCOPY Seiji Kimura, Japan; M. Tanaka

P0470 A NEW SCORING MODEL FOR PREDICTING ADVANCED COLORECTAL NEOPLASIA IN ASYMPTOMATIC SCREEN-ING POPULATION AND COMPARISON WITH THE MODI-FIED ASIA-PACIFIC COLORECTAL SCREENING SCOREMasau Sekiguchi, Japan; T. Matsuda; Y. Kakugawa; M. Matsumoto; Y. Saito


146




Diverticular disease

P0488DIVERTICULITIS IN THE SIGMOID COLON HAS THE HIGHEST RISK FOR INTESTINAL COMPLICATION OF COLONIC DIVERTICULITIS IN JAPANESE PATIENTSHiroshi Takayama, Japan; Y. Shimodate; A. Doi; N. Nishimura; H. Mouri; K. Matsueda; H. Yamamoto; M. Mizuno

P0489A VARIANT OF COL3A1 (RS3134646) IS ASSOCIATED WITH RISK OF DEVELOPING DIVERTICULOSIS IN CAU-CASIAN MALESM. C. Reichert; Juozas Kupcinskas, Lithuania; M. Krawczyk; C. Jüngst; B. Appenrodt; S. N. Weber; V. Zimmer; A. Tamelis; J. I. Lukosiene; N. Pauziene; G. Kiudelis; L. Jonaitis; C. Schramm; T. Goeser; M. Glanemann; L. Kupcinskas; F. Lammert

P0490THE USE OF ENDOSCOPIC CLASSIFICATION “DICA” MAY HAVE A SIGNIFICANT COST-SAVING ON THE BURDEN OF DIVERTICULAR DISEASE OF THE COLONA. Tursi; W. Elisei; M. Picchio; G. Nasi; A. M. Mastromatteo; F. Di Mario; E. Di Rosa; M. A. Brandimarte; C. Cassieri; P. G. Lecca; Giovanni Brandimarte, Italy

P0491NATURAL HISTORY OF SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE: A 13-YEAR PROSPECTIVE STUDYA. Tursi; S. Scida; C. Miraglia; C. Scarpignato; M. Franceschi; W. Elisei; M. Picchio; G. Brandimarte; Francesco Di Mario, Italy

P0492IMPACT OF TREATMENTS ON FECAL MICROBIOTA AND FECAL METABOLIC PROFILING IN SYMPTOMATIC UN-COMPLICATED DIVERTICULAR DISEASE OF THE COLONAntonio Tursi, Italy; P. Mastromarino; D. Capobianco; W. Elisei; L. Laghi; C.-L. Zhu; M. Picchio; G. Giorgetti; F. Fabiocchi; F. Di Mario; G. Brandimarte

P04935-YEARS ITALIAN REGISTER OF DIVERTICULOSIS AND DIVERTICULAR DISEASE (REMAD): A LOW PROGRES-SION RATE OF DISEASE DURING THE FIRST YEAR OF FOLLOW-UPMarilia Carabotti, Italy; R. Cuomo; G. Barbara; F. Pace; P. Andreozzi; R. Benini; B. Annibale

P0494CLINICAL FEATURES ASSOCIATED WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE AND DI-VERTICULITIS PATIENTS: RESULTS FROM THE ITALIAN REGISTER OF DIVERTICULAR DISEASE (REMAD)Marilia Carabotti, Italy; R. Cuomo; G. Barbara; F. Pace; P. Andreozzi; R. Benini; B. Annibale

P0479EFFICACY AND PREDICTORS FOR BIOFEEDBACK THER-APEUTIC OUTCOME IN PATIENTS WITH DYSSYNERGIC DEFECATIONTing Yu, China; L. Lin

P0480THE PREVALENCE OF DELAYED OROCECAL TRANSIT TIME AND SMALL INTESTINAL BACTERIAL OVERGROWTH IN PATIENTS WITH FUNCTIONAL CONSTIPATIONTing Yu, China

P0481 THE DIAGNOSTIC VALUE OF BALLOON EXPLUSION TEST AND COLON TRANSIT TEST AND AGREEMENT WITH FINDINGS FROM HIGH RESOLUATION ANORECTAL MA-NOMETRYIN PATIENTS WITH DYSSYNERGIA DEFECATIONTing Yu, China

P0482DA-9701 IMPROVES COLONIC TRANSIT TIME AND SYMPTOMS IN PATIENTS WITH FUNCTIONAL CONSTI-PATION: A PROSPECTIVE STUDYS.-Y. Kim; Hyun Sun Woo, Republic of Korea; S. H. Choi; D. K. Park; K. A. Kwon; J.-W. Chung; Y. J. Kim; J. H. Kim; S. J. Kim; K. O. Kim

Irritable bowel syndrome: Classification and diagnosis

P0483INDEPENDENT VALIDATION OF THE ROME IV CRITERIA FOR IRRITABLE BOWEL SYNDROME REVEALS THEIR MODEST PERFORMANCE AND RESTRICTIVE NATURE.Orla Craig, United Kingdom; C. Black; L. Houghton; A. C. Ford

P0484WHAT DETERMINES WHETHER INDIVIDUALS WITH IRRITABLE BOWEL SYNDROME IN THE GENERAL POP-ULATION SEEK MEDICAL CARE FOR THEIR DISORDER?Navkiran Jossan, Sweden; H. Törnblom; M. Simrén; I. Aziz; O. S. Palsson; A. Sperber; W. E. Whitehead

P0485PERFORMANCE OF A DIAGNOSTIC ALGORITHM FOR FUNCTIONAL GASTROINTESTINAL DISORDERS.Ecushla Linedale, Australia; A. Mikocka-Walus; P. R. Gibson; J. M. Andrews

P0486SCOTTISH GUT MOTILITY DISORDER CLINIC: REVIEW OF ACTIVITY OVER 1 YEAR PERIOD.Francesca Moroni, United Kingdom; M. P. Eugenicos

P0487ALTERED EXPRESSION OF MEMBRANE TRANSPORTERS IN COLONIC MUCOSA OF PATIENTS WITH IRRITABLE BOWEL SYNDROME (IBS) AND POST-INFECTIOUS (PI)-IBS COMPARED TO HEALTHY SUBJECTS Rebecca Wall, Sweden; T. M. Marques; H. Edebol-Carlman; J. Sundin; R. Vumma; I. Rangel; R. J. Brummer


147


Mon

day,

Oct

ober

30,

201

7


P0502THE OBESTATIN/G PROTEIN-COUPLED RECEPTOR 39 SYSTEM REGULATES PEPSINOGEN I SECRETION IN HUMAN STOMACHB. Otero-Alen; S. Leal-López; L. S. Estevez-Perez; M. Otero-Alen; J. Baltar-Boileve; J. Enrique Dominguez-Muñoz, Spain; R. Gallego-Gomez; T. Garcia-Caballero; J. P. Perez-Camiña; Y. Pazos-Randulfe

P0503SERUM EXOSOMAL MIRNAS EXPRESSION AS NOVEL BIOMARKERS FOR DETECTION OF ESOPHAGEAL ADE-NOCARCINOMAHan Chen, China

Upper GI and small intestinal bleeding

P0504COMPARATIVE STUDY BETWEEN THE EFFICACY OF REBAMIPIDE, SUCRALFATE AND PANTOPRAZOLE IN TREATMENT OF POST BANDING VARICEAL ULCERSM. Yousry; A. A. Wahib; Gamal Soliman, Egypt

P0505MULTICENTRE EVALUATION OF FIRST-LINE ENDOSCOPIC TREATMENT WITH THE OTSC IN ACUTE NON-VARICEAL UPPER GASTROINTESTINAL BLEEDING AND COMPARISON WITH THE ROCKALL COHORT – THE FLETROCK-STUDYEdris Wedi, Germany; A. Fischer; J. Hochberger; C. Jung; H.-J. Richter-Schrag

P0506A NEW PREDICTION RULE FOR UPPER GASTROINTES-TINAL BLEEDING USING THE GLASGOW BLATCHFORD SCORE AND CT NUMBER Mari Tsudome, Japan; K. Fujita; A. Sugahara

P0507FIBRIN GLUE CAN PREVENT BLEEDING AFTER ENDO-SCOPIC SUBMUCOSAL DISSECTION.Lianzhen Yu, China; Y. Wang

P0508WITHDRAWN

P0509A COMPARATIVE STUDY OF THERAPEUTIC EFFECT BY VONOPRAZAN AND ESOMEPRAZOLE ON BLEEDING AF-TER GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTIONYuhei Sakata, Japan; T. Yamazaki; Y. Yasui; K. Yamamoto; M. Suo; A. Kimura; A. Nakata; M. Yamamura; T. Suekane; T. Nakai; E. Sasaki; K. Sano; K. Watanabe; Y. Kawasaki; K. Kioka; H. Nebiki

P0495FEATURES OF ABDOMINAL PAIN MAY DISTINGUISH PATIENTS WITH PREVIOUS DIVERTICULITIS FROM PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICOLAR DISEASE: RESULTS FROM THE ITALIAN REGISTER OF DIVERTICULAR DISEASE (REMAD).Paolo Andreozzi, Italy; B. Annibale; G. Barbara; F. Pace; M. Carabotti; C. Cremon; R. Benini; R. Cuomo

P0496MUSCULAR INFLAMMATORY STATE AND PHENOTYP-IC SWITCH IN DIVERTICULOSIS AND COMPLICATED DIVERTICULAR DISEASEL. Pallotta; A. Scirocco; A. Ignazzi; M. A. Maselli; M. Carabotti; A. Cicenia; G. De Toma; F. Pezzolla; E. S. Corazziari; Carola Severi, Italy

Poster Session09:00 – 17:00 Hall 7Oesophageal, Gastric and Duodenal Disorders I

Cell/molecular biology/pathology

P0497 THE ONCOGENIC MIR-491-5P/MIR-875-5P-NOTCH3-PHLDB2 AXIS IN GASTRIC TUMORIGENESISTingting Huang, Hong Kong PRC; Y. Zhou; J. Zhang; C. C. Wong; Y. Dong; A. S. L. Cheng; J. Yu; K. F. To; W. Kang

P0498FOXF2 SUPPRESSES WNT SIGNALING PATHWAY IN GASTRIC CARCINOGENESIS THROUGH TRANSCRIP-TIONALLY UPREGULATING E3 LIGASE IRF2BPL AND PROMOTING β-CATENIN DEGRADATIONYujuan Dong, Hong Kong PRC; A. Higashimori; Y. Zhang; S. S. M. Ng; T. Arakawa; F. K. L. Chan; J. J. Y. Sung; J. Yu

P0499CLINICOPATHOLOGICAL AND COMPREHENSIVE ANALYSIS BY NEXT GENERATION SEQUENCING IN GASTRIC ADENO-CARCINOMA WITH ENTEROBLASTIC DIFFERENTIATIONYoichi Akazawa, Japan; T. Saito; T. Hayashi; Y. Yanai; S. Tsuyama; K. Akaike; T. Murakami; T. Yao

P0500CO-OCCURRENCE OF MODERATE RISK ALLELES IN THE GERMLINE OF FAMILIAL INTESTINAL GASTRIC CANCER SYNDROMEJoana Carvalho, Portugal; C. São José; H. Pinheiro; P. Oliveira; J. Senz; S. Hansford; A. S. Valente; D. Lemos; V. Pascale; F. Roviello; D. Huntsman; C. Oliveira

P0501PREVENTION OF STENOSIS WITH ENDOSCOPIC TRANS-PLANTATION OF CULTURED AUTOLOGOUS ORAL MU-COSAL EPITHELIAL CELL SHEETS AFTER ESOPHAGEAL ENDOSCOPIC SUBMUCOSAL DISSECTIONDaisuke Murakami, Japan; H. Harada; S. Suehiro; T. Ohki; M. Yamato


148




P0517EFFECTS OF PRIOR JEJUNAL FEEDING ON GASTRIC EMPTYING AND SYMPTOMS IN PATIENTS WITH DIA-BETIC GASTROPARESIS (J4G STUDY): A RANDOMIZED, DOUBLE BLIND CONTROLLED CLINICAL TRIALHelen Parker, United Kingdom; L. Carneiro; C. L. Hoad; E. Tucker; J. R. White; L. Marciani; P. Mansell; T. Gazis; M. M. Walker; B. Scurry; M. Fox

P0518 PER-ORAL ENDOSCOPIC MYOTOMY IN TREATMENT NAÏVE VERSUS PRIOR TREATMENT FAILURE CASES –OUTCOME IN OVER 500 PATIENTS Zaheer Nabi, India; M. Ramchandani; R. Chavan; S. Darisetty; R. Kalapala; D. N. Reddy

P0519 ESOPHAGEAL REFLUX BURDEN IN RELATIONSHIP TO ESOPHAGOGASTRIC JUNCTION (EGJ) AND ESOPHAGEAL BODY FUNCTION ON HIGH RESOLUTION MANOMETRY (HRM)Arvind Rengarajan, USA; S. Roman; E. Savarino; R. Yadlapati; M. Tye; F. Mion; J. Pandolfino; C. P. Gyawali

P0520MEASURING THE ACTIVE AND PASSIVE CHARACTERIS-TICS OF CONTRACTILE SMOOTH MUSCLE IN PORCINE INTESTINE MODELG. Min; W. Kim; S. J. Choi; I. K. Yoo; S. H. Kim; J. M. Lee; H. S. Choi; E. S. Kim; B. Keum; Hong Sik Lee, Republic of Korea; H. J. Chun; C. D. Kim; Y. T. Jeen

P0521 ª MOTILITY PATTERNS AFTER PER-ORAL ENDOSCOPIC MYOTOMY (POEM) IN PATIENTS WITH ACHALASIAZuzana Vackova, Czech Republic; J. Krajciova; L. Zdrhova; P. Loudova; P. Stirand; T. Hucl; J. Spicak; J. Martinek

P0522 WHAT IS THE EFFECT OF MYOTOMY SITE ON PER-ORAL ENDOSCOPIC MYOTOMY? COMPARISON OF ANTERIOR AND POSTERIOR MYOTOMYFatih Aslan, Turkey; Z. Akpinar; D. A. Yurtlu; C. Cekic; B. Unsal; S. Bor

P0523LONG – TERM RESULTS OF PERORAL ENDOSCOPIC MYOTOMY (POEM) FOR ACHALASIAZuzana Rabekova, Czech Republic; Z. Vackova; V. Lanska; J. Spicak; P. Stirand; T. Hucl; E. Kieslichova; J. Martinek

Functional upper GI disorders: Clinical

P0524BEER EFFECTS ON POSTPRANDIAL DIGESTIVE SYMP-TOMS AND GASTROESOPHAGIC PHYSIOLOGYBlanca Serrano Falcón, Spain; M. Megía Sánchez; A. Ruiz de León; E. Rey

P0525WITHDRAWN

P0510OUTCOMES FROM AN INTERNATIONAL MULTICENTRE REGISTRY OF PATIENTS WITH GASTROINTESTINAL BLEEDING UNDERGOING ENDOSCOPIC TREATMENT WITH HEMOSPRAYDurayd Alzoubaidi, United Kingdom; S. Gulati; A. Murino; L. H. Eusebi; D. Graham; A. Haji; J. J. G. H. M. Bergman; M. Goetz; E. J. Despott; M. Banks; B. Hayee; R. Haidry

P0511RISK FACTORS OF GASTROINTESTINAL BLEEDING IN PATIENTS RECEIVED DUAL ANTIPLATELET THERAPYWorapoth Yingyongthawat, Thailand; A. Pulsombat

P0512 REAL-LIFE ANALYSIS OF FREQUENCY, LOCATIONS AND BLEEDING SOURCES IN UNSELECTED EMERGENCY PATIENTS DURING NON-VITAMIN K ANTICOAGULANT (NOAC) THERAPY AND COMPARISON TO CONTROLLED APPROVAL STUDIESMartin Raithel, Germany; H. Albrecht; L. S. Maass; S. Peter; A. K. Kluger; M. F. Neurath; A. F. Hagel

Functional upper GI disorders: Basic

P0513REDUCED INTERSTITIAL CELLS OF CAJAL DENSITY AND INCREASED INTRAEPITHELIAL LYMPHOCYTES ARE AS-SOCIATED WITH DEVELOPMENT OF SMALL INTESTINAL BACTERIAL OVERGROWTH IN POST-INFECTIOUS IBS MOUSE MODELBinrui Chen, China; L. Du; H. He; S. Zhu; J. J. Kim; N. Dai

P0514CLINICAL CHARACTERISTICS OF FUNCTIONAL DYSPEP-SIA PATIENTS DEPENDING ON WHETHER THEY ARE CHEMOSENSITIVE OR NOTV. Hammer; Katharina Hammer, Austria; M. Führer; J. Hammer

P0515NUCLEAR LORICRIN AND A DYSREGULATION OF BARRIER PROTEINS OBSERVED IN GASTRO-OESOPHAGEAL REFLUX DISEASE AFFECTED OESOPHAGEAL EPITHELIUM Lisa McGinty, United Kingdom; J. Ooi; P. Woodland; D. Kelsell; D. Blaydon

Upper GI motility disorders: Clinical

P0516 INFLUENCE OF PRUCALOPRIDE ON SECONDARY PERISTALSIS IN REFLUX PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITYChien-Lin Chen, Taiwan; W.-Y. Lei; C.-H. Yi; T.-T. Liu; J.-S. Hung


149


Mon

day,

Oct

ober

30,

201

7


P0534 A PHASE 1 STUDY TO ASSESS THE PHARMACOKINET-ICS, SAFETY, AND TOLERABILITY OF SINGLE DOSE APT-1011 ADMINSTERED UNDER FED OR FASTED CONDITIONS OR AT BEDTIME IN A RANDOMISED THREE-WAY, CROSSOVER DESIGNG. M. Comer; Brian Meltzer, USA

P0535EOSINOPHILLIC ESOPHAGITIS: RATIONALISING THERAPYMartin Everson, United Kingdom; I. Parisi; S. Mankodi; A. Shah; D. Grant; M. Rodriguez-Justo; M. R. Novelli; R. Sweis

P0536ESOMEPRAZOLE, RABEPRAZOLE AND PANTOPRAZOLE ARE EQUALLY EFFECTIVE IN INDUCING ENDOSCOPIC AND HISTOLOGIC REMISSION IN PATIENTS WITH PROTON PUMP INHIBITOR-RESPONSE ESOPHAGEAL EOSINOPHILIAM. Della Coletta; S. Tolone; N. de Bortoli; O. Bartolo; G. Bodini; E. Marabotto; P. Zentilin; A. Mauro; R. Penagini; V. Savarino; Edoardo Savarino, Italy

Reflux disease, diagnosis

P0537THE « GARD (GASTRO-ESOPHAGEAL ANTI-REFLUX DEVICE»: A NEW ENDOSCOPIC MEDICAL DEVICE TO DIAGNOSE, MANAGE AND TREAT GERD.Norman Godin, Switzerland

P0538SYMPTOM PATTERNS AND TYPES OF GASTROESOPHA-GEAL REFLUXES SIGNIFICANTLY DIFFER IN GROUPS OF EROSIVE ESOPHAGITIS AND NON-EROSIVE FORM OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) PATIENTS.Mariya Konovalova, Russian Federation; S. Morozov; V. Isakov

P0539LARYNGEAL DISORDERS AND CHRONIC COUGH IN ADULTS WITH AND WITHOUT EROSIVE ESOPHAGITIS: A CASE-CONTROL STUDY IN ALBANIABledar Kraja, Albania; I. Këlliçi; I. Mone; F. Kraja; S. Prifti; G. Burazeri

P0540ASSESSMENT OF EXHALED BREATH CONDENSATE FOR NON-INVASIVE DIAGNOSIS OF GASTROESOPHAGEAL REFLUX DISEASE IN CORRELATION WITH MII-PH AND PEPTESTStefan Konecny, Czech Republic; J. Dolina; M. Doubkova; J. Skrickova; D. Kindlova; E. Pokojova; P. Durc; J. Lacna; M. Gregus; F. Foret; P. Kuban

P0526DUODENAL PATHOLOGY IN PATIENTS WITH RUMINA-TION SYNDROME – EOSINOPHILIA AND INTRAEPITHE-LIAL LYMPHOCYTOSISMagnus Halland, USA; N. J. Talley; J. A. Murray; R. Cameron; M. M. Walker

P0527 CHRONIC POSTSTROKE OROPHARYNGEAL DYSPHAGIA IS ASSOCIATED WITH IMPAIRED CORTICAL ACTIVATION TO PHARYNGEAL SENSORY INPUTS.Omar Ortega, Spain; C. Cabib; N. Vilardell; L. Mundet; P. Clavé; L. Rofes

P0528 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY WITH JEJUNAL EXTENSION FOR GASTROPARESIS: THE ULTI-MATE SOLUTION?Denise Strijbos, The Netherlands; D. Keszthelyi; J. Kruimel; L. P. L. Gilissen; R. de Ridder; J. Conchillo; A. A. M. Masclee

P0529 RELEVANCE OF SLEEP DISTURBANCE TO FUNCTIONAL GASTROINTESTINAL SYMPTOMS, CLINICAL CHARAC-TERISTICS, AND PSYCHOLOGICAL DISTRESS Wei-Yi Lei, Taiwan; C.-L. CHEN; S.-H. Wen; C.-H. Yi; T.-T. Liu; J.-S. Hung

P0530ESOPHAGEAL SYMPTOMS ARE COMMON AND RELATED TO OTHER FUNCTIONAL GASTROINTESTINAL DISOR-DERS (FGIDS) IN A WESTERN POPULATIONAxel Josefsson, Sweden; O. S. Palsson; M. Simrén; A. Sperber; H. Törnblom; W. E. Whitehead

Eosinophilic oesophagitis

P0531 DETERMINANT FACTORS OF QUALITY OF LIFE IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITISAlfredo J Lucendo Villarin, Spain; L. Arias-González; J. Molina-Infante; Á. Arias

P0532THE ASSOCIATION BETWEEN ATOPIC MANIFESTATIONS AND EOSINOPHILIC ESOPHAGITIS: A SYSTEMATIC REVIEW AND META-ANALYSISAlfredo J Lucendo Villarin, Spain; J. González-Cervera; Á. Arias; O. Redondo-González; I. T. Terreehorst; M. M. Cano-Mollinedo

P0533WITHDRAWN


150




Barrett's oesophagus: Basic

P0548THE EFFECT OF SPECIFIC REFLUXATE COMPONENTS ON BILE RECEPTOR SIGNALING AND DEVELOPMENT OF METAPLASTIC BARRETT-LIKE GLANDS IN MICE.D. Straub; L. Mari; S. van de Graaf; Kausilia K. Krishnadath, The Netherlands

P0549REMODELING BARRETT’S METAPLASIA IN A NOVEL IN VIVO HUMANORGANOID MODELAna Correia, The Netherlands; M. Read; S. Calpe; N. Clemons; D. Liu; C. Duong; W. Phillips; K. Kausilia Krishnadath

P0550GASTRIC CARDIA GLANDS MANIFEST APPARENT BROAD DIFFERENTIATION POTENTIAL, AS EVIDENCED BY HOXA13 EXPRESSION, IMPLICATIONS FOR THE ORIGIN OF BARRETT’S ESOPHAGUSVincent Janmaat, The Netherlands; M. J. M. Smits; M. J. Bruno; M. C. W. Spaander; M. P. Peppelenbosch

P0551ACTIVE HUMAN PAPILLOMAVIRUS INVOLVEMENT IN BARRETT’S DYSPLASIA AND OESOPHAGEAL AD-ENOCARCINOMA IS CHARACTERIZED BY WILD-TYPE P53 AND ABERRATIONS OF THE RETINOBLASTOMA PROTEIN PATHWAY Shan Rajendra, Australia; T. Yang; W. Xuan; P. Sharma; D. Pavey; C. S. Lee; S. Le; J. Collins; B. Wang

P0552CHARACTERIZING DIPEPTIDYL PEPTIDASE SPECIFIC ACTIVITY IN HUMAN BARRETT’S OESOPHAGUS AND IN A PANEL OF OESOPHAGEAL METAPLASIA, DYSPLASIA AND CANCER CELL LINESS. Jaenisch; D. J. Hussey; D. Watson; C. A. Abbott; M. Squire; Roger Yazbeck, Australia

P0553AN ANTI-INFLAMMATORY ENVIRONMENT CHARAC-TERISES BARRETT'S OESOPHAGUS ASSOCIATED ADE-NOCARCINOMAS AND INFLUENCES PATIENT SURVIVALKarl-Frederick Karstens, Germany; J. Kempski; A. Giannou; S. Steurer; G. Wolters-Eisfeld; T. Rösch; J. R. Izbicki; A. W. Lohse; N. Gagliani; S. Huber

P0554DIFFERENT GLAND PHENOTYPES ARE CLONALLY RELATED IN BARRETT'S EOSOPHAGUS AND GLAND PHENOTYPIC DIVERSITY IS INCREASED IN PATIENTS WHO HAVE PROGRESSED TO DYSPLASIA.J. Evans; E. Carlotti; M. Rodriguez-Justo; S. L. Preston; N. Wright; T. Graham; M. Jansen; Stuart McDonald, United Kingdom

P0541GASTRIN 17 MEASUREMENTS IN SINGLING OUT PATIENTS WITH DIFFERENT PATTERNS OF REFLUXATE: A PILOT STUDY USING IMPEDANCE-PH AS REFERENCE STANDARDMarco Della Coletta, Italy; E. Savarino; N. de Bortoli; S. Speroni; S. Landi; S. Grillo; A. Bertelè; N. Dal Bò; F. Di Mario

Reflux disease, treatment

P0542ANTI REFLUX MUCOSECTOMY (ARMS) FOR REFRACTORY GASTRO ESOPHAGEAL REFLUX DISEASE (GERD) – ARE WE THERE YET?Rahul Shah, India; A. P. MAYDEO; V. Dhir

P0543A RANDOMISED, DOUBLE-BLIND, PLACEBO-CON-TROLLED, MULTICENTRE 26-WEEK STUDY ON THE EFFECTS OF DEXLANSOPRAZOLE AND ESOMEPRAZOLE ON BONE HOMEOSTASIS IN HEALTHY POSTMENOPAUS-AL WOMENK. E. Hansen; J. W. Nieves; S. Nudurupati; D. C. Metz; Maria Perez, USA

P0544ALGINATE EFFECT ON POSTPRANDIAL REFLUXES AND PH OF STOMACH CONTENT: RESULTS OF PH-IMPED-ANCE MONITORING COMBINED WITH STOMACH PH MONITORING IN REFLUX PATIENTS I. Paliy; S. Zaika; Oleh Ksenchyn, Ukraine

P0545EFFICACY OF S-PANTOPRAZOLE 10 MG IN THE SYMP-TOM CONTROL OF NON-EROSIVE REFLUX DISEASE: A PHASE III PLACEBO-CONTROLLED TRIALMyung-Gyu Choi, Republic of Korea; Y. K. Cho; Y.-T. Bak; P.-L. Rhee; S. G. Kim; H.-Y. Jung; S. Y. Seol

P0546TAILORED THERAPY GUIDED BY MULTICHANNEL INTRALUMINAL IMPEDANCE PH MONITORING FOR REFRACTORY NON EROSIVE REFLUX DISEASE: PRE-LIMINARY EXPERIENCEN. Ranaldo; Giuseppe Losurdo, Italy; A. Morelli; A. Iannone; M. Barone; M. Principi; E. Ierardi; A. Di Leo

Reflux disease, complications

P0547STW5 MODULATES TIGHT-JUNCTION GENE AND PROTEIN EXPRESSIONS IN REFLUX-ESOPHAGITIS – POSSIBLE RELEVANCE FOR TUMORIGENESISH. Abdel-Aziz; Gudrun Ulrich-Merzenich, Germany; A. Shcherbakova; O. Kelber


151


Mon

day,

Oct

ober

30,

201

7


P0563RISK FACTORS FOR THE DEVELOPMENT OF DYSPLAS-TIC SQUAMOUS EPITHELIUM IN THE ESOPHAGUSChikatoshi Katada, Japan; T. Yokoyama; T. Yano; I. Oda; Y. Shimizu; S. Tanabe; H. Doyama; T. Koike; K. Takizawa; M. Hirao; H. Okada; T. Yoshii; K. Konishi; T. Yamanouchi; T. Tsuda; T. Omori; N. Kobayashi; H. Ishikawa; A. Yokoyama; M. Muto

P0564EVALUATION OF THE RISK OF METACHRONOUS SQUA-MOUS CELL CARCINOMA OF THE OESOPHAGUS AND THE HEAD AND NECK AFTER ENDOSCOPIC RESECTION FOR SQUAMOUS CELL CARCINOMA OF THE ESOPH-AGUS BASED ON THE GENETIC POLYMORPHISMS OF ADH1B AND ALDH2.Satoshi Abiko, Japan; Y. Shimizu; T. Mizushima; M. Kato; K. Matsuda; S. Miyamoto; M. Tsuda; K. Yamamoto; S. Ono; T. Kudo; N. Sakamoto

P0565IS IT FEASIBLE TO TREAT ESOPHAGEAL SQUAMOUS CELL CARCINOMA WITH CLINICAL DEPTH OF MM/SM1 BY ENDOSCOPIC RESECTION?Ken Namikawa, Japan; T. Yoshio; A. Ishiyama; T. Tsuchida; J. Fujisaki

P0566TRIAMCINOLONE INJECTION AND SHIELDING WITH POLYGLYCOLIC ACID SHEETS AND FIBRIN GLUE FOR THE PREVENTION OF POSTOPERATIVE STRICTURE AFTER ESOPHAGEAL ENDOSCOPIC SUBMUCOSAL DISSECTION: A RETROSPECTIVE COMPARISON OF TWO PILOT STUDIES AND A HISTORICAL COHORTYoshiki Sakaguchi, Japan; Y. Tsuji; Y. Kataoka; I. Saito; K. Niimi; S. Ono; S. Kodashima; M. Fujishiro; K. Koike

P0567MULTICENTRIC ASSESSMENT OF THE ENDOSCOPIC MANAGEMENT OF SUPERFICIAL ESOPHAGEAL SQUA-MOUS-CELL CARCINOMA IN WESTERN POPULATION.Arthur Berger, France; G. Rahmi; G. Perrod; M. Pioche; J.-M. Canard; E. Cesbron Métivier; J. Boursier; E. Samaha; A. Vienne; V. Lepilliez; C. Cellier

P0568CURATIVE CONDITIONS AFTER ENDOSCOPIC RESEC-TION FOR MM/SM1 OESOPHAGEAL SQUAMOUS CELL CARCINOMA BASED ON LONG-TERM OUTCOMESTakeshi Mizumoto, Japan; S. Oka; S. Tanaka; T. Hiyama; K. Kuroki; M. Kurihara; Y. Yoshihuku; Y. Sanomura; Y. Urabe; K. Chayama

Barrett's oesophagus: Clinical

P0555 A DEDICATED BARRETT’S OESOPHAGUS ENDOSCO-PY LIST IMPROVES THE ACCURACY OF ENDOSCOPIC REPORTING AND QUALITY OF BIOPSIESHannah Al-Hasani, United Kingdom; T. Sharp; S. M. Ha; L. Matsuka; N. Siddique

P0556ADHERENCE TO QUALITY INDICATORS AND SURVEIL-LANCE GUIDELINES IN THE MANAGEMENT OF BAR-RETT’S ESOPHAGUS: A RETROSPECTIVE ANALYSISD. Westerveld; V. Khullar; M. B. Riverso; Y. Perbtani; M. Agarwal; J. J. Forde; J. Chakraborty; T. S. Brar; F. Ayoub; A. Gupte; C. E. Forsmark; P. V. Draganov; Dennis Yang, USA

P0557EXPRESSION OF TGF-B AND CD-44 IN AGE SPECIFIC SUBGROUP OF PATIENTS WITH ADENOCARCINOMA OF GASTRIC CARDIA Nazar Lukavetskyy, Ukraine; T. Fetsych

P0558BARRETT’S OESOPHAGUS PROFILE AND OUTCOMES IN A LARGE COHORTNir Bar, Israel; N. Fliss Isacov; M. Nisim; R. Kariv

P0559THE EFFICACY OF ENDOSCOPIC MUCOSAL RESECTION IN MANAGING EARLY NEOPLASIA IN BARRETT’S OE-SOPHAGUS, EXPERIENCES OF A TERTIARY REFERRAL CENTER IN THE UKBalint Eross, United Kingdom; C. Clisby; B. Foria; C. Gordon

P0560ADHERENCE TO BARRETT’S ESOPHAGUS SURVEILLANCE GUIDELINES: A SYSTEMATIC REVIEW AND META-ANALYSISCarlijn Roumans, The Netherlands; E. W. Steyerberg; D. Rizopoulos; I. Lansdorp-Vogelaar; M. C. W. Spaander; M. J. Bruno

Oesophageal neoplasia: Clinical

P0561LONG-TERM OUTCOMES OF ENDOSCOPIC RESECTION VERSUS SURGICAL RESECTION FOR MM-SM1 ESOPHA-GUS SQUAMOUS CELL CARCINOMA.Kenji Yamauchi, Japan; M. Iwamuro; Y. Obayashi; Y. Baba; H. Sakae; T. Gotoda; Y. Kouno; H. Kanzaki; S. Kawano; Y. Kawahara; H. Okada

P0562ESOPHAGEAL REFLUX DISEASE AND ESOPHAGEAL SQUAMOUS CELL CANCER IN PATIENTS WITH FANCONI ANEMIA UNDERGOING ENDOSCOPIC SURVEILLANCEDavid Itskoviz, Israel; H. Tamary; T. Krasnov; N. Sahar; N. Zevit; O. Ben-Bassat; Y. Leibovici Wiseman; D. Boltin; Y. Goldberg; Z. Levi


152




P0576USEFULNESS OF OPERATIVE LINK ON GASTRITIS AS-SESSMENT (OLGA) AND OPERATIVE LINK ON GASTRIC INTESTINAL METAPLASIA (OLGIM) FOR DIAGNOSIS OF HELICOBACTER PYLORI-ASSOCIATED GASTRIC CANCER REGARDLESS OF TISSUE TYPE IN KOREAChangYong Yun, Republic of Korea; N. Kim; Y.-J. Hwang; H. Lee; M. Kwon; J. Lee; Y. J. Choi; H. Yoon; C. M. Shin; Y. S. Park; D. H. Lee

P0577BODY MASS INDEX AND DIGESTIVE CANCER MOR-TALITY IN THE KOREAN GENERAL POPULATION : A NATIONWIDE COHORT STUDYPumsoo Kim, Republic of Korea; Y. J. Kim; M. K. Baeg; S. H. Jeong; S.-W. Yi

P0578RISK FACTORS FOR LYMPH NODE METASTASIS OF ULCERATIVE TYPE INTRAMUCOSAL EGCTaewan Kim, Republic of Korea; T. J. Kim; H. Lee; J. H. Lee; J. J. Kim

P0579THE FEASIBILITY STUDY USING KUMC ROBOTIC MA-NIPULATOR IN ENDOSCOPIC SUBMUCOSAL DISSECTIONG. Min; S. J. Choi; W. Kim; J. M. Lee; I. K. Yoo; S. H. Kim; J. M. Lee; Hyuk Soon Choi, Republic of Korea; E. S. Kim; B. Keum; H. S. Lee; H. J. Chun; C. D. Kim; Y. T. Jeen

P0580DEVELOPMENT OF NOVEL ENDOSCOPIC IRREVERSIBLE ELECTROPORATION ABLATION DEVICEG. Min; S. J. Choi; W. Kim; I. K. Yoo; S. H. Kim; J. M. Lee; Hyuk Soon Choi, Republic of Korea; E. S. Kim; B. Keum; H. S. Lee; H. J. Chun; C. D. Kim; Y. T. Jeen

P0581DIAGNOSIS OF MICROVASCULAR PATTERN IS MORE IMPORTANT THAN MICROSURFACE PATTERN TO DELINEATE GASTRIC CANCERS DETECTED AFTER H. PYLORI ERADICATION BY MAGNIFYING ENDOSCOPY.Takehiro Iwasaki, Japan; K. Uchita; K. Kojima; S. Iwamura

P0582ENDOSCOPIC SMALL CAPACITY FORCEPS INCREASE THE PATHOLOGICAL DIAGNOSIS OF GASTRIC INDEFI-NITE NEOPLASIAYasumasa Matsuo, Japan; H. Yasuda; M. Kato; H. Kiyokawa; M. Ozawa; Y. Sato; Y. Ikeda; M. Yamashita; T. Fujino; H. Yamamoto; M. Takagi; F. Itoh

Gastroduodenal neoplasia: Clinical

P0569ENDOSCOPIC SUBMUCOSAL DISSECTION COMPARED TO LAPAROSCOPIC GASTRECTOMY FOR TREATMENT OF EARLY GASTRIC CANCER – A PROSPECTIVE RANDOM-IZED TRIALPhilip Wai Yan Chiu, Hong Kong PRC; A. Y. Teoh; E. Ng; V. Wong; H. C. Yip; J. C. Wu; S. Liu; S. K. Wong; F. K. L. Chan; J. JY Sung; J. Y. Lau

P0570PREVALENCE OF PRE-MALIGNANT LESIONS IN BIOP-SIES TAKEN FROM GASTRIC MUCOSA ENDOSCOPICALLY NORMAL OR WITH GASTRITISVictor Yep-Gamarra, Peru; P. Rojas-Perez; A. Aldave; C. Rodriguez-Ulloa; C. Díaz-Veléz; H. Mariños; H. Calvo; J. Pelaez; G. Flores-Trujillo

P0571CORRELATION BETWEEN THE COMBINATION OF HELICOBACTER PYLORI ANTIBODY AND PEPSINOGEN AND OLGA/OLGIM STAGING FOR RISK ASSESSMENT OF GASTRIC PRECANCEROUS LESIONSXiaoteng Wang, China; B. Lv; Z. Ji

P0572ENDOSCOPIC MUCOSAL RESECTION FOR SPORADIC NON AMPULLARY DUODENAL ADENOMA (SDA) : CAN WE REDUCE THE RISK OF RECURRENCE AND COMPLI-CATIONS IN TERTIARY CENTERS?Solene Hoibian, France; E. Bories; F. Caillol; C. Pesenti; J. P. Ratone; J.-M. Gonzalez; M. Giovannini; M. Barthet

P0573CAN BE THE PATIENT WITH NON-CURATIVE ESD FOR EARLY GASTRIC CANCER RESCUED BY SURGERY AFTER RECURRENCE?Kohei Takizawa, Japan; W. Hatta; T. Gotoda; N. Kawata; M. Nakagawa; A. Takahashi; M. Esaki; A. Mitoro; S. Yamada; K. Tanaka; M. Matsuda; J. Takada; Y. Yoshifuku; H. Ito; K. Ohnita; R. Shimoda; S. Hoteya; T. Oyama; T. Shimosegawa

P0574BLEEDING AFTER ENDOSCOPIC RESECTION FOR EARLY GASTRIC LESIONS IN PATIENTS ON ANTITHROMBOTIC THERAPYTomoyuki Nagai, Japan; S. Matsui; H. Kashida; Y. Komeda; T. Sakurai; M. Kudo

P0575FACTORS AFFECTING CURATIVE ENDOSCOPIC RESEC-TION OF EARLY GASTRIC CANCER IN THE ENVIRON-MENT OF POPULATION-BASED SCREENINGYoon Gwon Mun, Republic of Korea; H. H. Lee; D. H. Kang; J. M. Park; K. Y. Song; M.-G. Choi


153


Mon

day,

Oct

ober

30,

201

7


Poster Session09:00 – 17:00 Hall 7H. Pylori I

Epidemiology/natural history

P0590HELICOBACTER PYLORI INFECTION ASSOCIATED WITH NONALCOHOLIC FATTY LIVER DISEASE: A LARGE-SCALE COHORT STUDYTaewan Kim, Republic of Korea; T. J. Kim; H. Lee; J. J. Kim

P0591HELICOBACTER PYLORI INFECTION STATUS IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTSSeiya Kato, Japan; T. Yamada; Y. Fujii; A. Shoji; R. Kiyota; K. Shinkai; T. Tashiro; A. Ishihara; T. Iwasaki; S. Tanaka; H. Hasegawa; Y. Sakakibara; S. Nakazuru; H. Ishida; E. Mita

P0592HELICOBACTER PYLORI INFECTION REDUCES THE RISK OF BARRETT’S OESOPHAGUS AND IT IS INDEPENDENT FROM THE GEOGRAPHICAL LOCATION, A META-ANALYSISBalint Eross, Hungary; N. Farkas; K. Márta; P. Hegyi

P0593THE IMPACT OF HELICOBACTER PYLORI ON MORTALI-TY AND OTHER OUTCOMES IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: A NATIONWIDE ANALYSISPaul Thomas Kroener, USA; M. S. Abougergi; V. Popov; C. C. Thompson

Treatment

P0594ERADICATION THERAPY FOR HELICOBACTER PYLORI – AN IMPORTANT TOOL TO IMPROVE THE HEART FUNC-TION IN PATIENTS WITH CORONARY HEART DISEASE.Andra-Iulia Suceveanu, Romania; A. P. Suceveanu; I. R. Parepa; F. F. Voinea; D. Catrinoiu; L. Mazilu

P0595RANDOMIZED CONTROLLED STUDY OF A NOVEL TRI-PLE NITAZOXANIDE (NTZ) CONTAINING THERAPEUTIC REGIMEN VERSUS THE TRADITIONAL REGIMEN FOR ERADICATION OF HELICOBACTER PYLORI INFECTION.Sherief Abd-Elsalam, Egypt; M. A. H. Shehata; H. Elmesseri; R. Talaat

P0596PREVIOUS INTAKE OF MACROLIDES PREDICTS FAILURE TO ERADICATE HELICOBACTER PYLORI WITH CLARI-THROMYCIN-CONTAINING REGIMENS.P. Muñoz-Gómez; A. Jordán-Castro; M. Abanades-Tercero; J. Blanco-González; Julio Valle-Muñoz, Spain

Gastroduodenal neoplasia: Basic

P0583THE ROLE OF STRESS AND NITROSAMINES IN THE DE-VELOPMENT OF GASTRIC CANCER: A NEW MODEL OF ADENOCARCINOMA FORMATION WITH METASTASES IN RATSAlexandr Khorovodov, Russian Federation; I. Agranovich; N. Shushunova; N. Navolokin; A. Telegin; A. Shnitenkova; M. Sagatova; I. Trishkina; M. Ulanova; E. Borisova; O. Semyachkina-Glushkovskaya

P0584WITHDRAWN

P0585RELEVANCE OF PTGS1 AND PTGS2 GENE POLYMOR-PHISMS TO GASTRIC CANCER RISK AND PHENOTYPE IN CAUCASIANS.María Asunción García-González, Spain; L. Bujanda Fernández de Piérola; E. Quintero Carrion; M. Strunk; F. Sopeña-Biarge; S. Santolaria; R. Benito; E. Piazuelo; C. Thomson; Á. Pérez-Aísa; M. Badía; D. Nicolás-Pérez; E. Hijona; J. Espinel; R. Campo; M. Pellisé; M. Manzano; F. Geijo; F. González-Huix; M. Zaballa; J. Espinós; L. Titó; L. Barranco; Á. Lanas

P0586GASTRIC JUICE FREE AMINO ACID PROFILING AS A METHOD FOR DISCOVERING POTENTIAL BIOMARKERS OF GASTRIC CANCERJian Liu, China; Y. L. Zhou; R. S. Lin; Y. Xue; E. X. Yan; M. L. Meng; J. B. Suo; J. J. Lu

P0587THE ASSOCIATION BETWEEN MMP-2/9 AND TYPE IV COLLAGEN AND THE LEVELS OF AROMATIC AMINO AC-IDS IN GASTRIC JUICE OF GASTRIC CANCER PATIENTSJian Liu, China; Y. L. Zhou; R. S. Lin; Z. Jin; J. Y. Han; Y. Xue; E. X. Yan; M. L. Meng

P0588MISSING RATE OF GASTRIC CANCER DURING UPPER GASTROINTESTINAL ENDOSCOPY AND INFLUENCE ON THE NATURAL HISTORY OF THE DISEASERosario Salmoral, Spain; J. Rodriguez-Sanchez; F. Martín Dávila; B. López Viedma; P. Olivencia Palomar; E. De la Santa Belda; J. Olmedo Camacho

P0589INTERFERENCE OF PG2 TATA BOX REGION WITH THE SERUM PG2 LEVEL IN GASTRIC CANCER V. De Re; R. Magris; M. De Zorzi; S. Maiero; L. Caggiari; M. Fornasarig; O. Repetto; E. Buscarini; F. Di Mario; Renato Cannizzaro, Italy


154




P0604ASSOCIATION BETWEEN GASTRIC ADENOCARCINOMA OF THE FUNDIC GLAND TYPE AND H.PYLORI INFECTIONMayu Matsueda, Japan; H. Kinugasa; K. Miyahara; M. Nakagawa

Poster Session09:00 – 17:00 Hall 7Small Intestinal I

Coeliac disease (adult)

P0605MUCIN EXPRESSION IN THE SMALL BOWEL OF CELIAC DISEASE – A SYSTEMATIC REVIEW AND META-ANALYSISYaron Niv, Israel; R. Shamir

P0606HEPATIC ABNORMALITIES ASSOCIATED WITH CELIAC DISEASE Dalila Tagzout, Algeria; A. Tebaibia; N. Oumnia; N. Benfenatki

P0607CELIAC DISEASE ASSOCIATED WITH VASCULAR THROMBOSISDalila Tagzout, Algeria; A. Tebaibia; N. Oumnia; N. Benfenatki

P0608DIFFERENT PROFILES OF TLR 2,4, 7 AND 9 MRNA IN PBMC AND BIOPSY SPECIMENS OF PATIENTS WITH CELIAC DISEASE H. Ghasiyari; Mohammad Rostami-Nejad, Iran; D. Amani; M. A. Pourhosseingholi; E. Aghamohammadi; K. Rostami; H. Asadzadeh; M. R. Zali

P0609STUDY OF BONE DENSITY IN CELIAC DISEASEA. Ravaux; G. Malamut; Christophe Cellier, France

P0610GLUTEN-FRIENDLY BREAD (GFB) INCREASES GUT MUCUS PRODUCTION AND MONOLAYER PERMEABILI-TY IN VITRO.G. Corona; M. Henderson; T. Bergillos-Meca; M. Roul; D. Musaico; C. Lamacchia; Adele Costabile, United Kingdom

P0611IMMUNOHISTOCHEMICAL LYMPHOCYTE PATTERN OF NON CELIAC GLUTEN SENSITIVITY MAY SUPPORT THE INVOLVEMENT OF INNATE IMMUNITYGiuseppe Losurdo, Italy; F. Pezzuto; C. Covelli; F. Fortarezza; A. Marra; A. Iannone; A. Amoruso; M. Barone; M. Principi; E. Ierardi; A. Di Leo

P0597 EFFICACY OF THREE-IN-ONE CAPSULE BISMUTH QUA-DRUPLE THERAPY FOR HELICOBACTER PYLORI ERAD-ICATION IN CLINICAL PRACTICE IN A MULTINATIONAL PATIENT POPULATIONStephan Miehlke, Germany; D. Frederking; T. Guenther; E. Glocker; B. Eisele; V. Andresen; S. Schroeder; A. Morgner

P0598ERADICATION OF HELICOBACTER PYLORI INFECTION WITH A COMBINATION FORMULATION OF BISMUTH, METRONIDAZOLE AND TETRACYCLINE WITH ESOME-PRAZOLE: A REAL-LIFE STUDYElena Pérez Arellano, Spain; M. I. Rodriguez Garcia; A. B. Galera; E. De La Morena

P0599COST EFFECTIVENESS OF HELICOBACTER PYLORI POPULATION SCREENING: ECONOMIC EVALUATION ALONGSIDE A RANDOMIZED CONTROLLED TRAIL WITH 13-YEARS FOLLOW-UP (THE HEP-FYN STUDY)Maria Bomme Høgh, Denmark; C. Kronborg; J. M. Hansen; M. Wildner-Christensen; J. Hallas; O. B. Schaffalitzky de Muckadell

P0600A SEVEN DAY TRIPLE THERAPY CONTAINING A PO-TASSIUM-COMPETITIVE ACID BLOCKER COMPARED WITH PROTON PUMP INHIBITORS, AMOXICILLIN AND CLARITHROMYCIN FOR FIRST-LINE HELICOBACTER PYLORI ERADICATION IN JAPAN: A SINGLE CLINIC RETROSPECTIVE STUDYSadamoto Yojiro, Japan

P0601AN OPEN-LABEL, RANDOMIZED CONTROLLED TRIAL OF VONOPRAZAN VERSUS ESOMEPRAZOLE AS PART OF FIRST-LINE TRIPLE THERAPY FOR HELICOBACTER PYLORI INFECTIONHiroyuki Tamaki, Japan; M. Morita; A. Omura; T. Noda; A. Kubo; C. Ogawa; T. Matsunaka; M. Shibatoge

P0602THE IMPACT OF AMOXICILLIN RESISTANCE ON THE EF-FICACY OF AMOXICILLIN-CONTAINING REGIMENS FOR HELICOBACTER PYLORI ERADICATION- A POST-HOC ANALYSIS OF FIVE RANDOMIZED TRIALS Jyh-Ming Liou, Taiwan; M.-J. Chen; J.-T. Lin; M.-S. Wu

H. pylori-associated malignancy

P0603 ROLE OF POLYMORPHISMS IN TLR1 AND PRKAA1 GENES IN THE DEVELOPMENT OF ATROPHIC GASTRITIS AND GASTRIC CANCERVytenis Petkevicius, Lithuania; G. Dargiene; M. Leja; A. Link; L. Jonaitis; G. Kiudelis; G. Streleckiene; J. Skieceviciene; L. Kupcinskas; P. Malfertheiner; J. Kupcinskas


155


Mon

day,

Oct

ober

30,

201

7


Poster Session09:00 – 17:00 Hall 7Nutrition I

Obesity

P0620THERAPEUTIC ACTION OF KETOGENIC ENTERAL NUTRITION IN OBESE AND OVERWEIGHT PATIENTS: A RETROSPECTIVE INTERVENTIONAL STUDYCinzia Papadia, United Kingdom; P. Basset; G. Cappello; R. Shidrawi

P0621ANALYSIS OF LONG-TERM WEIGHT REGAIN IN OBESE PATIENTS TREATED WITH INTRAGASTRIC BALLOON Bruno Sander, Brazil; M. Galvao Neto; J. I. B. Scarparo; E. Grecco; T. F. Souza; M. P. Sander; D. S. Paiva; L. R. Alberti; V. N. Arantes

P0622LONG TERM EFFECT OF DUODENAL-JEUJENAL BYPASS LINEAR IMPLANTATION ON WEIGHT REDUCTION AND GLYCEMIC CONTROLSigal Fishman, Israel; L. Mlynarsky; L. Ben-Haim; J. Rutenberg; M. Shnell; E. Santo

P0623SYNBIOTIC (INULIN, LACTOBACILLUS, BIFIDOBACTE-RIUM AND SACCHAROMYCES BOULARDII) IMPROVES FATTY LIVER DISEASE BY VIRTUE OF ITS ACTION ON LIPID PROFILES, LEPTIN, ADIPONECTIN, AND INFLAM-MATORY BIOMARKERS T. M. M. Falalyeyeva; Nazarii Kobyliak, Ukraine; O. Tsyryuk; I. Prybytko; T. Beregova; L. Ostapchenko

P0624IMPROVED EMPLOYEMENT OF INTRAGASTRIC BAL-LOON FOR WEIGHT LOSS: A PRELIMINARY ANALYSISS. H. Kim; Hoon Jai Chun, Republic of Korea; H. S. Choi; E. S. Kim; B. Keum; Y. T. Jeen; H. S. Lee; C. D. Kim

P0625IS RE-IMPLANTATION OF THE DUODENAL-JEJUNAL BYPASS LINER VIABLE?S. Guenthert; A. Dienethal; Jürgen Stein, Germany

P0626THE COMPARATIVE EFFICACY OF OBESITY TREAT-MENTS IN YOUNG PEOPLE – A SYSTEMATIC REVIEW AND META ANALYSISSubothini Selvendran, United Kingdom; N. Penney; N. Aggarwal; A. Darzi; S. Purkayastha

P0612FUNCTIONAL DYSPEPSIA SYMPTOMS ARE STRONGLY ASSOCIATED WITH COELIAC DISEASE: RESULTS FROM A POPULATION-BASED STUDY Michael Potter, Australia; M. M. Walker; M. P. P. Jones; N. Koloski; G. Brogan; S. Keely; N. J. Talley

P0613MALE GENDER AND UNDERWEIGHT ARE ASSOCIATED WITH OSTEOPOROSIS IN PATIENTS WITH NEW DIAG-NOSIS OF COELIAC DISEASEGloria Galli, Italy; E. Lahner; L. Conti; G. Esposito; M. C. Sacchi; E. Di Giulio; B. Annibale

P0614SELF-REPORTED WHEAT SENSITIVITY IN AN AUSTRA-LIAN POPULATION STUDYMichael Potter, Australia; M. M. Walker; M. P. P. Jones; N. Koloski; G. Brogan; S. Keely; N. J. Talley

Malabsorption syndromes and food enteropathies (adult)

P0615INSUFFICIENCY OF THE SMALL INTESTINAL ENZYMES MAY BE ONE OF THE CAUSES OF FUNCTIONAL BOWEL DISEASE.Olga Akhmadullina, Russian Federation; A. Parfenov; N. Belostotsky; E. Sabelnikova; S. Bykova; S. Khomeriki

P0616WHEAT PROTEIN ALLERGY OR SENSITIZATION TO WHEAT PROTEIN IN A CELIAC POPULATION. C. Caruso; V. Gerardi; A. Armuzzi; L. Guidi; A. Papa; S. Ennas; A. Romano; G. Rapaccini; Italo De Vitis, Italy

P0617A QUESTIONNAIRE BASED SYMPTOM EVALUATION STUDY IN 381 PATIENTS DIAGNOSED WITH BILE ACID MALABSORPTION BY SEHCAT FROM 2003 TO 2016Helene Rask Clausen, Denmark; B. Damsgaard; J. F. Dahlerup; J. Agnholt; S. P. Jørgensen; K. Krogh

P0618EFFICACY OF PERCUTANEOUS ENDOSCOPIC GAS-TRO-JEJUNOSTOMY (PEG-J) DECOMPRESSION THERAPY FOR PATIENTS WITH CHRONIC INTESTINAL PSEU-DO-OBSTRUCTION (CIPO)Hidenori Ohkubo, Japan; T. Higurashi; J. Arimoto; A. Nakajima

P0619DIFFERENT ORAL GLUTEN LOADS INDUCE AN INFLAM-MATORY AND ANTIOXIDANT RESPONSE IN HEALTHY VOLUNTEERSM. Di Stefano; Irene Benedetti, Italy; E. V. Pesatori; G. F. Manfredi; M. Deamici; M. Bergonzi; E. Pagani; C. Torre; G. Testa; B. Valvo; E. Miceli; G. L. Marseglia; G. R. Corazza


156




Enteral and parenteral nutrition

P0635USE OF ALTERNATIVE LIPID EMULSION IN NON-CRITI-CALLY ILL PATIENTS IN ACUTE HOSPITAL SETTINGEnnaliza Salazar, Singapore; P. Ghosh; V. Tan; T. Pang; B. Y. Poh; L. B. Tan; K. L. Loy; J. N. C. Chong; D. H. L. Ng; K. L. Ling; Y. T. Wang

P0636COMPLICATIONS AND EARLY MORTALITY IN PERCUTA-NEOUS ENDOSCOPIC GASTROSTOMY PLACEMENT IN LOMBARDY: A MULTICENTER PROSPECTIVE STUDYAndrea Anderloni, Italy; F. Barzaghi; G. Meucci; R. Marino; L. Amato; M. Frigerio; V. Saladino; A. Toldi; G. Manfredi; A. E. Redaelli; M. Feliziani; G. De Roberto; F. Boni; G. Scacchi; D. Mosca; M. Devani; M. Arena; M. Massidda; P. Zanoni; C. Ciscato; V. Casini; P. Beretta; E. Forti; R. Salerno; V. Caramia; G. Lollo; M. Bianchetti; C. Tomba; M. Di Leo; A. Repici; M. Soncini; G. Maconi; G. Manes; R. Gullotta

P0637MEDICAL REGISTRAR REPORTING OF CHEST XRAYS FOR NASOGASTRIC TUBE POSITION: HOW CAN IT BE MADE SAFER?Maeve Tierney, United Kingdom; Z. Leach; C. Sibley; C. Rutter; C. Pither; T. Smith

P0638MICRONUTRIENT MONITORING IN HOME PARENTERAL NUTRITION PATIENTS: AN AUDIT OF PRACTICE IN A REGIONAL REFERRAL CENTREMaeve Tierney, United Kingdom; L. Bakewell; E. Buse; C. Rutter; C. Pither; T. Smith

P0639CLINICAL NUTRITION – ARE WE IGNORANT OR NEGLIGENT?Tau Ming Aaron Gan, Singapore; R. Asokkumar; E. Salazar

Poster Session09:00 – 17:00 Hall 7Paediatric: Upper GI

Paediatric oesophageal disorders

P0640 OUTCOMES OF PER-ORAL ENDOSCOPIC MYOTOMY IN CHILDREN WITH ACHALASIA CARDIAZaheer Nabi, India; M. Ramchandani; R. Chavan; R. Kalapala; D. N. Reddy; S. Darisetty

Nutrients and gut function

P0627 FOOD-DERIVED MICRORNA AND INFLUENCE ON THE FECAL MICRORNA EXPRESSIONJ. Link; C. Langner; A. Canbay; P. Malfertheiner; Alexander Link, Germany

P0628NEUROMEDIN U BLOCKS GASTRIC EMPTYING THROUGH VAGAL-DEPENDENT MECHANISMS AND IMPROVES ORAL GLUCOSE TOLERANCEAnne-Charlotte Jarry, France; N. Merah; M.-N. Fiamma; L. Bodineau; A. Bado; J. Le Beyec; M. Le Gall

P0629LOW FODMAP DIET & PREBIOTIC GALACTOOLIGOSAC-CHARIDES IMPROVE IRRITABLE BOWEL SYNDROME SYMPTOMS AND RESPONSE TO LOW FODMAP DIET IS PREDICTED BY URINE METABOLOME, STOOL SHORT-CHAIN FATTY ACIDS AND VOLATILE ORGANIC COM-POUNDS: A RANDOMISED CONTROLLED TRIALB. Wilson; R. Hough; T. Kanno; M. Rossi; G. Parkes; Q. Aziz; S. Anderson; Peter Irving, United Kingdom; M. Lomer; A. J. Mason; C. S. J. Probert; K. Whelan

P0630THE ANALYSIS OF PROTEIN CONSUMPTION PATTERNS IN PATIENTS WITH SIBOVladimir Pilipenko, Russian Federation; V. Isakov; A. Vlasova

P0631LOW FODMAP DIET IMPROVES SYMPTOMS AND QUAL-ITY OF LIFE IN PATIENTS WITH RADIATION INDUCED SMALL BOWEL DISEASE: A PILOT STUDYTrine Larsen, Norway; T. Hausken; S. O. Ystad; N. Hovdenak; B. Mueller; G. A. Lied

P0632DIET SUPPLEMENTED WITH MEDIUM- AND LONG-CHAIN FATTY ACIDS DOES NOT AFFECT LOWER GI MOTILITY AND VISCERAL PAIN IN RATSPaula Mosinska, Poland; M. Martin-Ruiz; R. Abalo; J. Fichna

P0633INTESTINAL ADAPTATIONS AFTER SUBTOTAL PANCRE-ATECTOMY IN MICE MAY CONTRIBUTE TO POSTPRAN-DIAL HYPERGLUCAGONEMIAAnne-Charlotte Jarry, France; G. Guillemain; J. Le Beyec; A. Bado; J.-F. Gauthier; B. Blondeau; J.-P. Riveline; M. Le Gall

P0634QUALITY, VIABILITY AND COMPOSITION OF THE MUL-TISPECIES PROBIOTIC VSL#3Diego Mora, Italy; S. Colombo; G. Della Scala; G. Gargari; S. Arioli; W. M. de Vos


157


Mon

day,

Oct

ober

30,

201

7


P0650WITHDRAWN

Malabsorption syndromes, food enteropathies and other small intestinal disorders (paediatric)

P0651META-ANALYSIS: PROTON PUMP INHIBITORS MOD-ERATELY INCREASE THE RISK OF SMALL INTESTINAL BACTERIAL OVERGROWTH Tingting Su, China; S. Chen

P0652CLINICAL SIGNIFICANCE OF TRANSFORMING GROWTH FAC-TOR – β1 AND TUMOR NECROSIS FACTOR – α IN CHILDREN WITH FOOD PROTEIN INDUCED ENTEROCOLITIS SYNDROME. Oltinoy Kamilova, Uzbekistan; A. N. Aripov; S. S. Sultankhodjaeva; S. I. Geller; D. X. Dustmuxamedova; Z. S. Xudoyorova; M. Rustamova

Paediatric nutrition

P0653THE ROLE OF GTS1 & GTM1 GENE POLYMORPHISMS IN NEWBORNS’ OBESITY RISKCristina Oana Marginean, Romania; C. Marginean; L. E. Melit; C. Banescu; M. O. Marginean

P0654SARCOPENIA IN CHILDREN WITH INTESTINAL TRANS-PLANTATIONR. Hegarty; J. Hind; Dhamyanthi Thangarajah, United Kingdom

P0655GENETIC PREDISPOSITION TO PRIMARY LACTOSE INTOLERANCE AND ITS INFLUENCE ON CHILDREN’S QUALITY OF LIFE AND DAIRY INTAKECorina Pienar, Romania; E. Seclaman; M. Lazarescu; R. Costachescu; S. A. Popescu; I. Sporea; I. Ciuca; L. Pop

Poster Session09:00 – 17:00 Hall 7Clinical Cases I

Liver / Biliary / Pancreas

CC001HEPATIC GLYCOGENOSIS ASSOCIATED WITH TYPE 1 DIA-BETES MELLITUS – A RARE ENTITY IN THE 21ST CENTURYMarta Patita, Portugal; R. Barosa; G. Nunes; H. Coelho; M. J. Brito; A. Alves de Matos; J. Fonseca; C. Fonseca

CC002CASE OF PORPHIRIA ACUTE INTERMITTENT. ENTITY OF DIFFICULT DIAGNOSIS.J. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain

Paediatric H. pylori

P0641HIGH RATE OF HELICOBACTER PYLORI ANTIBIOTIC RESISTANCE IN ARMENIAN CHILDREN WITH GASTRO-DUODENAL DISEASET. Shahinyan; Gayane Amaryan, Armenia; M. Hovsepyan; C. Braegger

P0642GASTRIC MICROBIOTA OF CHILDREN WITH CHRONIC GASTRITISElena Kornienko, Russian Federation; N. Parolova; P. Zykov

P0643 FEATURES OF CHRONIC GASTRITIS CAUSED BY CO-INFECTION OF HELICOBACTER PYLORI AND EP-STEIN-BARR VIRUS IN PEDIATRIC PATIENTSEugeny Spivak, Russian Federation; R. Levit

P0644HELICOBACTER PYLORI INFECTION AND SPECIFIC IM-MUNOGLOBULIN E ANTIBODIES TO FOOD ALLERGENS IN SYMPTOMATIC CHILDREN ADMITTED IN A DIGES-TIVE ENDOSCOPY UNIT.Victoria Hurduc, Romania; B. Luiza; P. Doina

P0645CURRENT STATUS OF THE FIRST AND SECOND LINE THERAPY FOR HELICOBACTER PYLORI INFECTION IN SYMPTOMATIC CHILDREN: A SINGLE CENTER STUDYVictoria Hurduc, Romania; B. Luiza; P. Doina

Coeliac disease (paediatric)

P0646GUT MICROBIOTA ALTERATIONS UNDER OLIGOFRUC-TOSE-ENRICHED INULIN ADMINISTRATION IN PAEDI-ATRIC COELIAC DISEASE PATIENTS ON A GLUTEN-FREE DIET:A RANDOMIZED CONTROLLED TRIALUrszula Krupa-Kozak, Poland; N. Drabińska; L. H. Markiewicz; E. Jarocka-Cyrta

P0647WITHDRAWN

P0648EVALUATING GLUTEN IMMUNOGENIC PEPTIDES AS NON-INVASIVE MARKER OF GLUTEN-FREE DIET AD-HERENCE IN PAEDIATRIC CELIAC DISEASEAlfonso Rodriguez-Herrera, Spain; I. Comino; V. Segura; J. Diaz; A. Muñoz-Suano; A. Cebolla; C. Sousa; The DELIAC Group

P0649INTUSSUSCEPTION IN CHILDREN WITH NEWLY DIAG-NOSED CELIAC DISEASE: PREVALENCE AND NATURAL HISTORYUjjal Poddar, India; V. V. Borkar; A. Thakral; J. Agarwal; A. Srivastava; S. K. Yachha; S. Kumar


158




CC013DIGITAL CHOLANGIOSCOPY FOR THE DIAGNOSIS OF A RARE CAUSE OF PAINLESS JAUNDICEBjoern Lewerenz, Germany; W. Schepp

CC014PANCREATIC METASTASIS IN AN EPIDERMOID LUNG NEOPLASIAIsabel Leyre Pinazo Martínez, Spain; J. Mostazo Torres; M. Vilchez Jaimez

CC015INCIDENTALOMA: DIAGNOSIS OF AMPULOMA AFTER EXTENSION STUDY OF CA UTERINE.J. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martínez, Spai

CC016A COMPRESSIVE SEROUS CYSTADENOCARCINOMA OF THE PANCREAS REVEALED BY A DIGESTIVE HEMOR-RHAGE: ABOUT AN EXCEPTIONAL CASEChu Mohammed Zakaria, Morocco; I. Zahi; W. Khannoussi; E. M. amine; G. Kharrasse

CC017A CASE OF NON FUNCTIONAL PANCREATIC PARAGAN-GLIOMAStefano Rizza, Italy; L. Venezia; P. Cortegoso Valdivia; C. G. De Angelis

Surgery / Endoscopy / Imaging

CC018SPONTANEOUS CHOLEDOCHO DUODENAL FISTULA WITH TUBERCULOUS DUODENAL ULCERATION: A RARE CAUSE OF UPPER GASTROINTESTINAL BLEEDINGPatrícia Santos, Portugal; C. Freitas; M. Moura; L. Meireles; M. Camacho; A. Sá; A. Valente; J. Velosa

CC019GASTRIC OUTLET OBSTRUCTION DUE TO DISPLACE-MENT OF AN INTRAGASTRIC BALLOON DEVICEPedro Marques Da Costa, Portugal; M. Verdelho Machado; A. O. Ferreira; A. Marques; L. Carrilho Ribeiro; J. Velosa

CC020THE FIRST CASE OF ENDOSONOGRAPHY BIOPSY FOR LEIOMYOMA OF INFRARENAL INFERIOR VENA CAVATatiana Silina, Russian Federation; A. V. Chizhikov; N. Y. Mishakina; K. V. Kirsanov; V. I. Vladimirova; A. P. Raksha; T. N. Starostina; A. V. Sazhin

Lower GI

CC021MUCINOUS ADENOCARCINOMA OF PERIANAL FISTULA IN A PATIENT WITH ULCERATIVE COLITISVlasta Orsic Fric, Croatia; V. Borzan; B. Borzan

CC003A CASE OF GENOTYPE-4 ACUTE HEPATITIS E IN KOREANKyoung Min Sohn, Republic of Korea; I.-S. Choi; G. Y. Jeong; Y. J. Jeon

CC004ELEVATED LIVER ENZYMES IN A PATIENT RECEIVING ANTIRETROVIRAL THERAPY – A DIAGOSTIC CHALLENGEMarta Patita, Portugal; R. Barosa; G. Nunes; D. Gonçalves; M. J. Aleixo; M. J. Brito; C. Fonseca

CC005A RARE CASE OF HYPERSENSITIVITY CHOLESTASIS Ravindra Lakshman Satarasinghe, Sri Lanka; B. M. Dayananda; K. Weerasinghe

CC006AN UNUSUAL FINDING ON LIVER BIOPSY – GIANT CELL HEPATITISThomas Garvey, United Kingdom; D. Galloway; A. Winstanley; A. O'Brien; D. Joshi

CC007LIVER TRANSPLANTATION FOR MALIGNANT MUCI-NOUS CYSTIC NEOPLASM OF THE LIVER: THE FIRST PUBLISHED CASEPeter Macinga, Czech Republic; J. Mendl; L. Bajer; E. Sticova; J. Fronek; P. Trunecka; J. Spicak; T. Hucl

CC008A HEPATOCELLULAR CARCINOMA WITH GUIL-LAIN-BARRE SYNDROME IN A YOUNG ADULTKhellaf Amalou, Algeria; F. Belghanem; D. Kezzoula; F. Yahiaoui; A. Bousseloub

CC009LIVER NODULE AND ELEVATED ALPHA-FETOPROTEIN: BEYOND THE HEPATOCELLULAR CARCINOMAMarta Gravito-Soares, Portugal; E. Soares; D. Gomes; R. Ferreira; M. A. Cipriano; L. Tomé

CC010DUODENAL BULB INVASION BY AN HEPATOCELLULAR CARCINOMA MIMICS ACUTE CHOLECYSTITIS WITH CHOLECYSTODUODENAL FISTULA.Pedro Marques Da Costa, Portugal; J. Lopes; R. Luís; E. Vitorino; I. Leite; J. Coutinho; L. Carrilho Ribeiro; J. Velosa

CC011DIFFUSE HEPATOCELLULAR CARCINOMA IN A HIV-INFECTED PATIENT – COMPLETE RESPONSE TO SORAFENIBGonçalo Nunes, Portugall; R. Barosa; M. Patita; M. J. Aleixo; M. Ramalho; J. Fonseca; C. Fonseca

CC012ENDOBILIARY RADIOFREQUENCY ABLATION OF MA-LIGNANT BILIARY OBSTRUCTION: A SINGLE-CENTRE EXPERIENCEHairol Othman, Malaysia; M. F. Che Ani; Z. Zuhdi; R. Jarmin; A. Azman


159


Mon

day,

Oct

ober

30,

201

7


Upper GI

CC032LYMPHOCYTIC OESOPHAGITIS – EMERGING CLINICAL ENTITYAyman Bannaga, United Kingdom; R. Iriarte; B. Disney

CC033MASSIVE GASTRIC POLYPOSIS – DIAGNOSTIC CHALLENGEJoana Castela, Portugal; G. Esteves; R. Casaca; P. Chaves; C. Albuquerque; I. Claro; A. Dias Pereira

CC034BAFFLING CAUSE OF UPPER GASTROINTESTINAL BLEEDAmit Soni, India; N. S. Malhi

CC035ACUTE GASTROINTESTINAL BLEEDING CAUSED BY GASTRITIS CYSTICA PROFUNDA IN AN UNOPERATED STOMACH – A CHALLENGING CASEJoana Rita Carvalho, Portugal; L. C. Meireles; I. Goulart; A. C. Quadros; P. M. dos Santos; F. Serejo; C. Ferreira; J. Velosa

CC036ESOPHAGEAL RUPTURE (BOERHAAVE SYNDROME) AS A FIRST CLINICAL EVENT IN YOUNG ADULTMaria Stafylidou, Greece; A. Gagalis; P. Saripoulos; A. Kalambakas; G. Tzatzagou

CC037LUPUS ENTERITIS AS AN INITIAL PRESENTATION OF SYSTEMIC LUPUS ERYTHEMATOSUSPatrícia Santos, Portugal; S. Fernandes; L. Correia; H. Cortez Pinto; J. Velosa

CC038A TALE OF TWO LYMPHOMASVikrant Parihar, Ireland; P. Crotty; D. McNamara

CC039JEJUNAL VARICEAL BLEEDING SUCCESSFULLY TREATED WITH TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT: A CASE REPORTFabiana Capuano, Italy; C. Cusumano; N. Passigato; D. Costa; S. Di Stefano; C. Perini; G. Vettori; A. Colecchia; L. Frulloni

CC040NEUROMUSCULAR AND VASCULAR HAMARTOMA AS A RARE CAUSE OF RECURRENT GASTROINTESTINAL BLEEDINGMarta Patita, Portugal; J. Félix; M. Allen; M. M. Mafra; L. Gargaté; P. Pinto Marques

CC041AN OCCULT CAUSE OF OBSCURE GASTROINTESTINAL BLEEDINGRui Morais, Portugal; R. Coelho; A. Andrade; A. C. Nunes; M. Marques; H. Cardoso; C. Fernandes; R. Melo; G. Macedo

CC022TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPA-THY WITH GASTROINTESTINAL ONSET: PRESENTATION OF TWO CASESRadislav Nakov, Bulgaria; S. Sarafov; V. Nakov; M. Gospodinova; L. Tankova; V. Gerova; A. Borizanova; T. Todorov; A. Kirov; A. Todorova; I. Tournev; B. Vladimirov

CC023IMPACTED RING CAUSING COLONIC OBSTRUCTION : A CASE REPORTS.-J. Boo; H. S. Jang; S. T. Kim; S. J. Ko; S.-Y. Na; S. U. Jeong; Eun Kwang Choi, Republic of Korea; H. U. Kim; B.-C. Song

CC024A RARE CASE WITH RECURRENT DIARRHEA: GOOD SYNDROMEV. Asoglu; H. Goze; A. R. Soylu; Hüseyin Tezel, Turkey; G. Ünsal; H. Ümit

CC025A RARE CASE PRESENTING WITH ABDOMINAL PAIN: EOSINOPHILIC GASTROENTERITISV. Asoglu; S. Orman; A. R. Soylu; G. Ünsal; Hüseyin Tezel, Turkey; H. Ümit

CC026EXCLUSIVE ABDOMINAL LYMPHADENOMEGALY: A RARE PRESENTATION OF SARCOIDOSISAbadia Matoso, Brazil; M. Simão Ferreira; L. E. Zumpano

CC027UNUSUAL PRESENTATION OF A DIGESTIVE MANTLE CELL LYMPHOMA.Khellaf Amalou, Algeria; D. Kezzoula; F. Belghanem; S. Bouchnafa; F. Yahiaoui; A. Bousseloub

CC028LIVER ABSCESS AS THE FIRST MANIFESTATION OF RECTAL ADENOCARCINOMA WITHOUT METASTASISAdam Nagy, Hungary; A. V. Patai; A. Kocsis; T. Micsik; H. Székely; J. Lohinszky; V. Lehoczki; B. Molnar; P. Igaz

CC029SYNCHRONOUS MULTIPLE LYMPHOMATOUS POLYPOSIS AND ADENOCARCINOMA IN THE COLON : A CASE REPORTS.-J. Boo; Hoe Soo Jang, Republic of Korea; S. T. Kim; S. J. Ko

CC030AN UNUSUAL CAUSE OF ANORECTAL DISCHARGERafaela Loureiro, Portugal; V. Pavão Borges; C. Bernardes; J. Saiote

CC031A CASE OF DOUBLE TROUBLE: DIARRHEA IN A PATIENT WITH DIFFUSE LARGE B CELL LYMPHOMA Harshal Mandavdhare, India; R. Agarwala; R. Nada; G. Prakash; V. Suri; V. Sharma


Poster Sessions by DayTuesday, October 31, 2017

Posters in the Spotlight10:30 – 12:00 E-Poster Lounge 1Pancreatic and biliary neoplasia: Basic and clinical observationsChairs: Marco Del Chiaro, Sweden

Eike Gallmeier, Germany

P0788HENT1 & DPD EXPRESSION IN EUS-FNAB SAMPLES OF PANCREATIC DUCTAL ADENOCARCINOMA: TECHNICAL FEASIBILITY AND PROGNOSTIC SIGNIFICANCE OF GEMCITABINE+S1-BASED CHEMORADIOTHERAPY

P0784PRESENTATION SYMPTOMS AND RISK FACTORS ARE AS-SOCIATED WITH DIAGNOSTIC DELAY AND DISEASE STAGE BUT NOT WITH PROGNOSIS OF PANCREATIC CANCER.

P0793RAPID ON SITE EVALUATION (ROSE): AN ESSENTIAL TOOL IN ECHO-ENDOSCOPIC (EUS) STUDY OF SOLID LESIONS OF THE PANCREAS

P0749THE OUTCOMES OF ERCP FOR THE PALLIATION OF MALIG-NANT JAUNDICE IN ENGLAND BETWEEN 2001 AND 2015

P0770IMAGING IN CHRONIC PANCREATITIS – DATA FROM THE SCANDINAVIAN BALTIC PANCREAS CLUB DATABASE

Posters in the Spotlight10:30 – 12:00 E-Poster Lounge 2Advances in the management of functional GI disordersChairs: Henriette Heinrich, United Kingdom

Imran Aziz, Sweden

P1178GASTRIC PERORAL ENDOSCOPIC MYOTOMY (G-POEM) AS TREATMENT FOR FUNCTIONAL DELAYED GASTRIC EMPTYING: INITIAL ASIAN EXPERIENCE

P1191THE MUCOSAL INTEGRITY IN PHENOTYPES OF GAS-TROESOPHAGEAL REFLUX DISEASE AND FUNCTIONAL HEARTBURN

P1204LOW-FODMAP DIET RESULTED EFFECTIVE IN RE-DUCING SYMPTOM PERCEPTION IN PATIENTS WITH FUNCTIONAL HEARTBURN

Poster Sessions

E-Posters will be published on www.ueg.eu/week/24-7

Up to 6 posters featuring hot topic research will be presented in the Posters in the Spotlight Sessions at the e-poster terminal in the E-Poster Lounges in Hall 7. A following discussion is led by two moderators and experts in the field. At the end of each session, the Oral Free Paper Prize will be awarded to the best presenter.

Focus on original research: Posters in the Spotlight

17_09_Inserat_UEGWEEK_FP_posters_75_75x220mm_RZ.indd 1 11.09.17 16:11


161


Tues

day,

Oct

ober

31,

201

7


P1137HEALTHCARE PROFESSIONALS FAIL TO PROVIDE ADE-QUATE COUNSELLING AND SUPPORT ABOUT OPIOID-IN-DUCED CONSTIPATION TO STRONG-OPIOID USERS

P1140EFFECT OF FAECAL MICROBIOTA TRANSPLANTATION ON GUT BACTERIAL FERMENTATION PRODUCTS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME

P1149ORAL ?-GALACTOSIDASE IMPROVES GASTROINTESTI-NAL TOLERANCE TO A DIET HIGH IN GALACTO-OLIGO-SACCHARIDES: ADJUNCT THERAPY TO A LOW FODMAP DIET IN IRRITABLE BOWEL SYNDROME

Poster Champ Session12:30 – 13:30 Scientific Centre: Terminal 1Poster Champ Session: Upper gastrointestinal diseasesChairs: Jan Bornschein, Germany

Jose Carlos L. Machado, Portugal

P1157A CASE-CONTROL STUDY ON THE RISK OF UPPER GASTROINTESTINAL MUCOSAL INJURIES IN SUBJECTS PRESCRIBED NSAIDS AND ANTI-THROMBOTIC DRUGS USING THE LARGE ORGANIZED DATABASE OF CLAIMS IN JAPAN (APPROXIMATELY 3.7 MILLION OF POPULA-TION ON AN ACCUMULATED BASIS)

P1171THE NORMATIVE VALUES OF A NEW 36 CHANNELS WATER PERFUSION ESOPHAGEAL MOTILITY CATHETER

P1172LOW-VOLUME MULTIPLE RAPID SWALLOW BETTER DISTINGUISH PERISTALTIC ESOPHAGEAL RESERVE COMPARED TO HIGH-VOLUME RAPID DRINKING TEST

P1190A LESS COMPETENT OESOPHAGO-GASTRIC JUNCTION IS ASSOCIATED WITH OESOPHAGEAL ACID HYPERSEN-SITIVITY EVEN IN HEALTHY CONTROLS

P1217SAFETY AND EFFICACY OF CHEMORADIOTHERAPY AFTER ENDOSCOPIC RESECTION IN PATIENTS WITH SU-PERFICIAL ESOPHAGEAL SQUAMOUS-CELL CARCINOMA.

P1221ENDOSCOPIC CRYOBALOON ABLATION IS SAFE, WELL-TOLERATED AND HIGHLY EFFECTIVE IN THE ERADI-CATION OF ESOPHAGEAL SQUAMOUS CELL NEOPLASIA.

P1240HOXC10 IS UPREGULATED IN HUMAN GASTRIC CANCER AND PROMOTES CELL G1-S TRANSFORMATION AND PROLIFERATION THROUGH DIRECT TRANSCRIPTIONAL REPRESSION OF P21

P1245FUNDING DISPARITIES IN DIGESTIVE CANCER RE-SEARCH IN THE UNITED STATES

P1253THE TRANSITION OF HELICOBACTER PYLORI ERADICA-TION IN OUR INSTITUTION

P1256COMPARISON OF HELICOBACTER PYLORI ERADICATION RATES :VONOPRAZAN VS. PROTON PUMP INHIBITOR

P1275CELIAC DISEASE AND POSITIVE IGA TISSUE TRANS-GLUTAMINASE IN PATIENTS WITH DISTAL RADIUS AND ANKLE FRACTURE: A CASE-CONTROL STUDY

P1300INTRAGASTRIC BALLOON: A LARGE BRAZILIAN MULTI-CENTRIC STUDY OVER 10,000 CASES AND 20 YEARS OF EXPERIENCE

Poster Champ Session12:30 – 13:30 Scientific Centre: Terminal 2Poster Champ Session: Liver, biliary and pancreatic diseasesChairs: Corinne Bousquet, France

Stefano Crippa, Italy

P0664STEM CELL TRANSPLANTATION IMPROVES SURVIVAL, QUALITY OF LIFE AND SYNTHETIC FUNCTIONS OF THE LIVER IN PATIENTS WITH END STAGE LIVER DISEASE

P0778AUTOPHAGY IS ESSENTIAL FOR PANCREATIC CANCER DEVELOPMENT IN A NEW HUMANIZED GENETICAL-LY-MODIFIED ADULT MOUSE MODEL

P0665PERIPHERAL BLOOD MONONUCLEAR CELL TRANS-PLANTATION STIMULATES HEPATOCYTES PROLIFERA-TION IN PATIENTS WITH ALCOHOLIC LIVER CIRRHOSIS

P0689NESTED CASE-CONTROL STUDY FOR RISK FACTORS OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSIS

P0753DEVELOPMENT OF AUTOIMMUNE PANCREATITIS IS INDE-PENDENT OF P21 MEDIATED PANCREATIC INFLAMMATION

P0785PLASMA DNA GENOTYPING USING DIGITAL PCR FOR SURVEILLANCE OF PANCREATIC CANCER IN HIGH-RISK INDIVIDUALS


162




P0669ROLE OF BISPHENOL A AS AN ENVIRONMENTAL FAC-TOR IN THE PROMOTION OF NON-ALCOHOLIC FATTY LIVER DISEASE: IN VITRO AND IN VIVO STUDY

P0674AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE IS A RISK FACTOR TO HAVE A LARGER LIVER VOLUME COMPARED WITH PATIENTS WITH COMBINED POLY-CYSTIC LIVER DISEASE AND AUTOSOMAL POLYCYSTIC KIDNEY DISEASE: RESULTS OF THE PLD REGISTRY

P0731A PROPOSAL FOR MODIFICATION OF BARCELONA CLINIC LIVER CANCER SYSTEM FOR HEPATOCELLULAR CARCINOMA STAGING BASED ON KOREAN MULTI-CENTER REGISTRY DATABASE

P0690SEPSIS-3 CRITERIA ARE MORE ACCURATE THAN SIRS CRITERIA IN PREDICTING IN-HOSPITAL MORTALITY IN PATIENTS WITH CIRRHOSIS AND BACTERIAL INFECTIONS

P0742SYSTEMATIC REVIEW AND META-ANALYSIS OF TRANS-ABDOMINAL AND ENDOSCOPIC ULTRASOUND FOR GALLBLADDER POLYPS

P0672IDENTIFICATION AND IN SILICO CHARACTERIZATION OF SIX NOVEL GANAB MUTATIONS IN POLYCYSTIC LIVER DISEASE.

Poster Champ Session12:30 – 13:30 Scientific Centre: Terminal 3Poster Champ Session: Lower gastrointestinal diseasesChairs: Laurence Egan, Ireland

Ian Jenkins, United Kingdom

P0956PATHOBIONT-FREE MICROBIOTA PROTECTS AGAINST GUT INFLAMMATION INDUCED BY AN INNATE IMMUNE DEFI-CIENCY OR DIETARY PERTURBANT OF THE MICROBIOTA

P0967FIRST ANALYSIS FROM UK IBD TWIN BIOBANK; 16S RRNA GENE SEQUENCING IDENTIFIES REDUCED DI-VERSITY IN ACTIVE IBD AND TAXA ASSOCIATED WITH ACTIVE DISEASE PHENOTYPE TO LEVEL OF SPECIES

P0974DISTINCT GUT MICROBIOTA PROFILES IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND UL-CERATIVE COLITIS

P0982COLORECTAL CANCER IN INFLAMMATORY BOWEL DIS-EASE: RISK FACTORS IN A PROSPECTIVE MULTICENTER NESTED CASE-CONTROL IG-IBD STUDY

P0990RISK OF SERIOUS INFECTION IN HEALTHCARE WORKER WITH INFLAMMATORY BOWEL DISEASE: A CASE-CON-TROL STUDY OF THE GETAID

P0995THE DIAGNOSTIC UTILITY OF LINKED-COLOR IMAGING IN THE EVALUATION OF MUCOSAL INFLAMMATION IN PATIENTS WITH ULCERATIVE COLITIS

P1003FAECAL CALPROTECTIN AND MAGNETIC RESONANCE IMAGING ARE RELIABLE TOOL TO DETECT ENDOSCOPIC POSTOPERATIVE RECURRENCE IN CROHN'S DISEASE

P1012MMP3 (METALLOPROTEINASE 3): A NEW MARKER FOR ASSESSING LOSS OF RESPONSE TO INFLIXIMAB IN IBD

P1030INDIRECT TREATMENT COMPARISON OF USTEKINUM-AB VERSUS OTHER BIOLOGICS IN MODERATE-TO-SE-VERE CROHN'S DISEASE PATIENTS HAVING FAILED ANTI-TNF THERAPY? A 1-YEAR TREATMENT SEQUENCE ANALYSIS INCLUDING DELAYED RESPONDERS

P1032EFFICACY AND TOLERABILITY OF INITIATING, OR SWITCHING TO, INFLIXIMAB BIOSIMILAR CT-P13 IN INFLAMMATORY BOWEL DISEASE (IBD): A LARGE SINGLE-CENTRE EXPERIENCE

P1058A UNITED STATES CLAIMS DATABASE ANALYSIS COM-PARING SAFETY, MEDICAL RESOURCE UTILIZATION, AND TREATMENT COSTS ASSOCIATED WITH THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE BY DRUG CLASS

Poster Champ Session12:30 – 13:30 Scientific Centre: Terminal 4Poster Champ Session: Surgery, endsocopy and imagingChairs: Sandra van Brunschot, The Netherlands

Jörg Albert, Germany

P0944PARADIGM SHIFT? SHOULD A LYMPHADENECTOMY ROUTINELY BE PERFORMED ALSO AMONG GALLBLAD-DER CANCER PATIENTS WITH T1A DISEASE?

P0921COLON CAPSULE ENDOSCOPY MAY REDUCE COLONOS-COPY MISS RATE – A MULTICENTER STUDY


163


Tues

day,

Oct

ober

31,

201

7


Posters in the Spotlight14:00 – 15:30 E-Poster Lounge 1Optimising our diagnostic tools in gastroenterology and hepatologyChairs: Stuart Taylor, United Kingdom

Oliver Pech, Germany

P1115PROSPECTIVE COMPARISON OF THE NOVEL FULL SPECTRUM ENDOSCOPY (FUSE) AND ADVANCED HIGH DEFINITION-WHITE LIGHT ENDOSCOPY FOR DETEC-TION OF POLYPS IN ROUTINE PRACTICE

P1005VALUE OF 75SEHCAT IN THE DIAGNOSIS OF BILE ACID MALABSORPTION IN CROHN´S DISEASE WITH CHRON-IC DIARRHOEA

P0714UTILITY OF A NEW FUNCTION IN 3D SIM-NAVIGATOR: ELECTRIC FIELD, WHICH INDICATES THE PREDICTED ABLATIVE AREA

P0713STAGING HEPATIC STEATOSIS IN NONALCOHOLIC FATTY LIVER DISEASE BY QUANTITATIVE CONVENTIONAL ULTRA-SOUND IMAGING, VALIDATED WITH HISTOPATHOLOGY

P0920COLON CAPSULE ENDOSCOPY: HOW DOES INADEQUATE PROCEDURE CLEANSING CORRELATE WITH PROCE-DURE ACCURACY?

P0846DEVELOPMENT OF A NEW ENDOSCOPIC CLASSIFICA-TION AND FIRST INTERNATIONAL VALIDATION (FACILE GROUP) OF COLONIC LESIONS USING ADVANCED IMAGING MODALITIES IN IBD PATIENTS

Posters in the Spotlight14:00 – 15:30 E-Poster Lounge 2How to improve the success rate in therapeutic endoscopy?Chairs: Stefan Seewald, Switzerland

Mostafa Ibrahim, Belgium

P0859NON-GRANULAR LATERALLY SPREADING COLONIC LESIONS ?20MM (LSL) ARE SMALLER AND MORE COMMONLY MULTIPLE THAN GRANULAR LSL; IMPLI-CATIONS OF A COLONIC MUCOSAL PHENOTYPE' FOR PRACTITIONERS OF ENDOSCOPIC RESECTION

P0862THE SMSA POLYP SCORE RELIABLY PREDICTS ROBUST ENDPOINTS OF ENDOSCOPIC MUCOSAL RESECTION OF COLORECTAL LATERALLY SPREADING LESIONS.

P0910DETERMINATION OF INTRACYSTIC GLUCOSE CON-CENTRATIONS IN THE DIFFERENTIAL DIAGNOSIS OF PANCREATIC CYSTS: A PROSPECTIVE STUDY.

P0895PROSPECTIVE STUDY OF EARLY PRECUT VS. UTMOST PRECUT WITH PANCREATIC STENT IN INITIAL PANCRE-ATIC DUCT CANNULATION

P0924ENDOSCOPIC ULTRASONOGRAPHY-GUIDED BILIARY DRAINAGE WITHOUT DILATION DEVICE USING A THIN DELIVERY-SYSTEM STENT: A PRECLINICAL STUDY

P0794ESOPHAGEAL FISTULA HEALING BY MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLES IN A THERMO-RESPONSIVE GEL: A PRE-CLINICAL PORCINE STUDY

P0796IMPROVEMENT IN HEPATIC TRANSAMINASES OVER 12 MONTHS AFTER SINGLE PROCEDURE DUODENAL MU-COSAL RESURFACING IN TYPE 2 DIABETES PATIENTS

P0919A NOVEL CAPSULE TECHNOLOGY PLATFORM FOR SPE-CIFIC LOCALIZED COLON DRUG DELIVERY

P0946EFFECT OF TRICLOSAN-COATED SUTURE USE ON THE INCIDENCE OF SUPERFICIAL INCISIONAL SURGICAL SITE INFECTIONS AFTER GASTROENTEROLOGIC SURGERY: A PROPENSITY SCORE MATCHING RETROSPECTIVE STUDY

P0948NOVEL ENDOSCOPIC REPAIR TECHNIQUE FOR GAS-TROINTESTINAL LEAKS AND PERFORATIONS USING NEGATIVE PRESSURE THERAPY WITH OPEN-PORE POLYURETHANE-FOAM AND FILM DRAINAGE

P0820USEFULNESS OF LINKED COLOR IMAGING (LCI) FOR RECOGNITION OF EARLY GASTRIC CANCER AND GAS-TRIC ADENOMA

P0824ENDOSCOPIC SUBMUCOSAL TUNNEL DISSECTION FOR LESSER GASTRIC CURVATURE SUPERFICIAL NEOPLASMS


164




P0661DISSECTING AUTOPHAGY IN A NAFL/NASH MOUSE AND HUMAN MODELSophia Polte, Germany; T. T. Wissniowski; T. M. Gress; D. Bartsch; K. Okamoto; T. Matono; T. Stiewe; M. Wanzel; P. Di Fazio

P0662MODULATION OF MITOCHONDRIAL DYNAMICS BY MIRNAS IN NAFLDAndré Lopes Simão, Portugal; M. B. Afonso; P. M. Rodrigues; A. J. Amaral; M. Gama-Carvalho; A. Zorzano; C. M. P. Rodrigues; R. E. Castro

Regeneration, stem cells and nutrition

P0663 ªGRANULOCYTE COLONY STIMULATING FACTOR IN DECOMPENSATED LIVER DISEASE – OUR EXPERIENCE IN A TERTIARY HOSPITAL IN NEPALSabin Thapaliya, Nepal

P0664 TITLE: STEM CELL TRANSPLANTATION IMPROVES SUR-VIVAL, QUALITY OF LIFE AND SYNTHETIC FUNCTIONS OF THE LIVER IN PATIENTS WITH END STAGE LIVER DISEASEM. Albadry; M.-E. Amer; W. A. E. Mostafa; H. A. Bayomi; A. El Shafie; Mohamed Alboraie, Egypt

P0665 PERIPHERAL BLOOD MONONUCLEAR CELL TRANS-PLANTATION STIMULATES HEPATOCYTES PROLIFERA-TION IN PATIENTS WITH ALCOHOLIC LIVER CIRRHOSISGuzel R. Burganova, Russian Federation; S. R. Abdulkhakov; I. M. Gazizov; A. A. Gumerova; M. A. Titova; R. Deev; A. P. Kiyasov


P0666ASSOCIATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME IN APPARENTLY HEALTHY KOREAN ADULTSKyoung Min Sohn, Republic of Korea; Y. J. Jeon

P0667LEAN-NAFLD IS THE STRONGEST PREDICTOR OF FU-TURE OBESITY AMONG URBAN ADULT SRI LANKANS: RESULTS FROM A PROSPECTIVE, COMMUNITY COHORT FOLLOW-UP STUDYMadunil Niriella, Sri Lanka; S. T. De Silva; A. Kasthuriratna; A. G. Ranasinghe; A. S. Dassanayake; A. P. De Silva; A. Pathmeswaran; A. R. Wickramasinghe; N. Kato; H. J. de Silva

P0668THE USE OF THE FATTY LIVER INDEX TO DETERMINE THE PREVALENCE OF FATTY LIVER DISEASE (HEPATIC STEATOSIS) IN AN IRISH POPULATIONLaura Reynolds, Ireland; L. Rabbitt; C. Goulding

P0890MOST ADVANCED ENDOSCOPY TRAINEES DO NOT MEET COMPETENCE FOR NATIVE PAPILLAE CANNU-LATION IN ERCP: RESULTS FROM A PROSPECTIVE MULTICENTER STUDY

P0896POST-ERCP BLEEDING IN THE ERA OF MULTIPLE ANTI-PLATELET AGENTS

P0926EFFICACY OF SELF-EXPANDABLE METALLIC STENT PLACE-MENT IN THE MANAGEMENT OF ANASTOMOTIC STRIC-TURE AFTER ORTHOTOPIC LIVER TRANSPLANTATION

P0930CLINICAL FAILURE IN COLONIC STENTING FOR MALIG-NANT LARGE BOWEL OBSTRUCTION: OUTCOMES AND RISK FACTORS IN 172 PROCEDURES

Poster Session09:00 – 17:00 Hall 7Liver & Biliary II


P0656HYPOXIA CAUSES HEPATIC STELLATE CELLS ACTIVA-TION IN THE ABSENCE OF CUX1Eva Becker, Germany; P. Di Fazio; J. Hänze; T. M. Gress; D. Bartsch; T. T. Wissniowski

P0657HEPATIC FIBROBLAST GROWTH FACTOR-21 AND OMENTIN-1 MRNA LEVELS IN MORBIDLY OBESE WOM-EN WITH NON-ALCOHOLIC FATTY LIVER DISEASEM. Kukla; Marek Waluga, Poland; M. Żorniak; M. Kajor; Ł. Liszka; M. Dyaczyński; G. Kowalski; R. J. Buldak; M. Hartleb

P0658LOUREIRIN B INHIBITS THE PROLIFERATION OF HEPATIC STELLATE CELLS VIA DOWN-REGULATING FRIZZLED-4Zhengji Song, China

P0659MACROPHAGE CONTRIBUTES TO STEATOHEPATITIS THROUGH MEDIATING INFLAMMATORY CYTOKINES, AUTOPHAGY AND THE CROSSTALK WITH HEPATOCYTESJennie Ka Ching Lau, Hong Kong PRC; X. Zhang; E. S. Chu; J. Yu

P0660NEWLY SYNTHESIZED BILE ACID DERIVATIVES PRE-VENT LIVER STEATOSIS IN VITRO THROUGH TARGET-ING OF NR1 SUBFAMILY NUCLEAR RECEPTORSH. M. D. S. Brito; M. Batista; M. Silva; J. Salvador; Rui Castro, Portugal; C. M. P. Rodrigues


165


Tues

day,

Oct

ober

31,

201

7


P0676DEVELOPMENT AND VALIDATION OF AN AUTOMATED SYSTEM FOR ASSESSMENT OF LIVER STEATOSIS AND FIBROSIS IN ROUTINE HISTOLOGICAL IMAGES FROM PATIENTS WITH NAFLDRoberta Forlano, United Kingdom; B. H. Mullish; J. Maurice; N. Giannakeas; N. Angkathunyakul; J. Lloyd; A. Tzallas; M. Tsipouras; M. Yee; S. Taylor-Robinson; R. D. Goldin; M. Thursz; P. Manousou

P0677THE IMPORTANCE OF FIBROSIS SCORES AND TRAN-SIENT ELASTOGRAPHY IN NAFLD EVOLUTIONDaniela Neagoe, Romania; A. Amzolini; G. Ianosi; M. Popescu; A. Farmazon; S. Ianosi; A. Turculeanu

P0678EFFECTS OF UDCA AND STATIN COMBINATIONS ON LIPID PROFILE IN NAFLD PATIENTSSergey Vyalov, Russian Federation

Hepatotoxicity/alcohol

P0679EFFECT OF GRANULOCYTE COLONY-STIMULATING FAC-TOR (G-CSF) ON MORTALITY AND COMPLICATIONS VIZ. SEPSIS, ENCEPHALOPATHY, HEPATORENAL SYNDROME, AND GASTROINTESTINAL BLEED IN SEVERE ALCOHOLIC HEPATITIS- A RANDOMIZED CONTROLLED STUDY.Abhinav Sharma, India

P0680ALCOHOLIC LIVER DISEASE/NON ALCOHOLIC FATTY LIVER DISEASE INDEX(ANI): HOW TO DISTINGUISH ALCOHOLIC FROM NON ALCOHOLIC LIVER DISEASE WITHOUT HISTOLOGY Rui Gaspar, Portugal; J. Santos-Antunes; S. Rodrigues; F. Carneiro; G. Macedo

P0681TO DRINK OR NOT TO DRINK? A PROSPECTIVE COHORT STUDY ON THE EFFECTS OF ONE MONTH ALCOHOL ABSTINENCE IN MODERATE DRINKERSIsabelle Munsterman, The Netherlands; M. Groefsema; G. Weijers; W. Klein; D. W. Swinkels; J. P. H. Drenth; A. Schellekens; E. Tjwa

P0682PROBIOTICS REDUCE ETHANOL-INDUCED HEPATIC INJURY BY MODULATING GUT MICROBIOTA AND IN-TESTINAL BARRIER INTEGRITY IN MICEYu Zhang, China; G. Chen; J. Sun

P0683THE OVERWEIGHT ROLE IN THE OCCURRENCE OF HEPATOTOXIC REACTIONS DURING CHEMOTHERAPY OF ACUTE LEUKEMIAIgor Skrypnyk, Ukraine; G. Maslova

P0669 ROLE OF BISPHENOL A AS AN ENVIRONMENTAL FAC-TOR IN THE PROMOTION OF NON-ALCOHOLIC FATTY LIVER DISEASE: IN VITRO AND IN VIVO STUDYMarcello Dallio, Italy; A. G. Gravina; M. Masarone; S. Errico; C. Nicolucci; R. Di Sarno; C. Tuccillo; D. Sgambato; M. Romano; M. Persico; N. Diano; C. Loguercio; A. Federico

P0670ASSESSMENT OF FATTY PANCREAS IN PATIENTS WITH NON–ALCOHOLIC FATTY LIVER DISEASETamara Alempijevic, Serbia; S. Dragasevic; S. Zgradic; M. Stojkovic Lalosevic; B. Milicic; D. Popovic; T. Milosavljevic

P0671SERUM THYROID STIMULATING HORMONE IS INDE-PENDENTLY ASSOCIATED WITH HEPATIC STEATOSIS AND STEATOHEPATITIS IN EUTHYROID SUBJECTS Ahad Eshraghian, Iran; S. Nikeghbalian; B. Geramizadeh; S. Ali Malek-Hosseini

P0672 IDENTIFICATION AND IN SILICO CHARACTERIZATION OF SIX NOVEL GANAB MUTATIONS IN POLYCYSTIC LIVER DISEASE.Liyanne van de Laarschot, The Netherlands; R. H. M. te Morsche; A. Hoisschen; W. R. Cnossen; H. Venselaar; J. M. Banales; J. P. H. Drenth

P0673DIFFERENCES BETWEEN BY-PASS AND SLEEVE GASTREC-TOMY ON CLINICAL AND LABORATORY STATUS 6 AND 12 MONTHS AFTER INTERVENTION IN BARIATRIC SUBJECTSDaniele Macor, Italy; S. Palmisano; F. Masutti; V. Lanzlotti; R. Patti; R. M. Buonocore; C. Abazia; N. De Manzini; L. S. Croce'; C. Tiribelli

P0674 AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE IS A RISK FACTOR TO HAVE A LARGER LIVER VOLUME COMPARED WITH PATIENTS WITH COMBINED POLY-CYSTIC LIVER DISEASE AND AUTOSOMAL POLYCYSTIC KIDNEY DISEASE: RESULTS OF THE PLD REGISTRYRené van Aerts, The Netherlands; M. de Jong; W. Kievit; F. Nevens; H. Kim; C. Ahn; J. P. H. Drenth

P0675CARDIOVASCULAR RISK DEVELOPMENT MODEL FOR THE (ATYPICAL) PATIENT WITH NON-ALCOHOLIC FATTY LIVER DISEASEMihai Alexandru Munteanu, Romania; G. Nagy; M. Gordan; S. Valean; P. A. Mircea


166




P0693CARVEDILOL VERSUS PROPRANOLOL EFFECT IN THE PRIMARY PROPHYLAXIS OF VARICEAL BLEEDING IN CIRRHOTIC PATIENTS WITH PORTAL VEIN THROMBOSISIrina Girleanu, Romania; A.-V. Trifan; C. Cojocariu; A. M. Singeap; C. Sfarti; O. Stoica; S. Chiriac; T. Cuciureanu; C. Stanciu

P0694ASSESSMENT OF PROGNOSTIC PERFORMANCE OF ALBI, CHILD-PUGH AND MELD SCORES IN PATIENTS WITH LIVER CIRRHOSIS COMPLICATED WITH ACUTE UPPER GASTROINTESTINAL BLEEDINGSofia Xavier, Portugal; R. Villas-Boas; P. Boal Carvalho; J. Magalhães; C. Marinho; J. Cotter

P0695PROTON PUMP INHIBITORS IN CIRRHOTIC PATIENTS: IT’S URGENT TO RETHINK THEIR USE!Tiago Cúrdia Gonçalves, Portugal; S. Monteiro; S. Xavier; M. Barbosa; P. Boal Carvalho; J. Magalhães; C. Marinho; J. Cotter

P0696WITHDRAWN

P0697CRITICAL FLICKER FREQUENCY TEST PREDICTS THE FIRST EPISODE OF OVERT HEPATIC ENCEPHALOPATHY IN PATIENTS WITH COMPENSATED LIVER CIRRHOSISEndrit Shahini, Italy; M. Barone; A. Iannone; M. T. Viggiani; V. Corvace; M. Principi; A. Di Leo

P0698OMNIPRESENCE OF LIVER FIBROSIS, BUT PORTAL HYPER-TENSION ONLY IN SELECTED ADULT FONTAN PATIENTSIsabelle Munsterman, The Netherlands; T. Duijnhouwer; R. van Kimmenade; C. Bronkhorst; J. P. H. Drenth; A. van Dijk; E. Tjwa

P0699A RANDOMIZED DOUBLE BLIND CONTROLLED TRIAL ON THE EFFECT OF LACTOBACILLUS RHAMNOSUS GG IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHYEndrit Shahini, Italy; M. Barone; A. Iannone; M. T. Viggiani; V. Corvace; M. Principi; A. Di Leo

Viral hepatitis: Basic aspects

P0700ASSOCIATIONS OF GENETIC POLYMORPHISM OF TOLL- LIKE RECEPTOR 3(TLR-3) AND SEX- LINKED TOLL- LIKE RECEPTOR 7 (TLR-7) ALLELES WITH THE HEPATITIS C VIRUS INFECTION OUTCOME IN EGYPTIAN POPULA-TION :A MULTICENTRE FAMILY BASED STUDYMahmoud El-Bendary, Egypt; M. Neamatallah; H. Elalfy; T. Besheer; A. Elkholy; M. El-Diasty; M. Elsareef; M. Zahran; B. El-Aarag; M. El-Setouhy; A.-H. Eladl; G. Esmat;

P0684RESEARCH ON FERROPTOSIS IN HEPATOCYTE INJURY INDUCED BY ALCOHOLIC.Y. Wu; Ting Liu, China; G. Zhang

P0685AMANITA PHALLOIDES HEPATOTOXICITY: 20-YEAR EXPE-RIENCE IN A GASTROENTEROLOGY INTENSIVE CARE UNITCatarina Atalaia Martins, Portugal; J. Carvalheiro; R. Ferreira; P. Amaro; M. Ferreira; L. Tomé

P0686BINGE DRINKING AMONG YOUNG STUDENTS IS A RISK FACTOR FOR THE DEVELOPMENT OF ALCOHOL USE DIS-ORDER: RESULTS FROM A CROSS-SECTIONAL STUDY.G. Addolorato; Gabriele Vassallo, Italy; G. Antonelli; M. Antonelli; C. Tarli; A. Mirijello; C. Mosoni; M. M. Rando; L. Sestito; M. Barbara; M. F. Maida; C. Cammà; A. Gasbarrini

P0687LOW LYSOPHOSPHATIDYLCHOLINE LEVELS MAY PRE-DICT SEVERE ALCOHOLIC HEPATITISP. Fischer; Adelina Horhat, Romania; C. Hebristean; B. D. Procopet; M. Tantau; C. Socaciu; H. Stefanescu


P0688APPLICATION OF THE ICA-AKI CRITERIA IN THE DIAG-NOSIS OF ACUTE KIDNEY INJURY IN PATIENTS WITH ACUTE DECOMPENSATION OF CIRRHOSISRichard Azevedo, Portugal; J. Pinto; H. Ribeiro; F. Pereira; C. Leitão; A. Caldeira; E. Pereira; R. Sousa; A. Banhudo

P0689 NESTED CASE-CONTROL STUDY FOR RISK FACTORS OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH LIVER CIRRHOSISLan Ting Yuan, Taiwan; S.-K. Chuah; S.-C. Yang; C.-M. Liang; C.-K. Wu; W.-C. Tai; T.-H. Hung; S.-H. Nguang; J.-W. Wang; K.-L. Tseng; M.-K. Ku; P.-I. Hsu; D.-C. Wu; C.-N. Hsu

P0690 SEPSIS-3 CRITERIA ARE MORE ACCURATE THAN SIRS CRITERIA IN PREDICTING IN-HOSPITAL MORTALITY IN PATIENTS WITH CIRRHOSIS AND BACTERIAL INFECTIONSSalvatore Piano, Italy; M. Tonon; G. Chies; A. Romano; E. Vettore; M. Stanco; C. Pilutti; A. Brocca; P. Angeli

P0691A SUBCLINICAL HIGH TRICUSPID REGURGITATION PRESSURE GRADIENT IS A RISK FACTOR FOR SURVIV-AL AFTER LIVING DONOR LIVER TRANSPLANTATIONAtsushi Ohyama, Japan; A. Takaki; Y. Umeda; T. Yasunaka; R. Yoshida; D. Nobuoka; F. Ikeda; H. Okada; H. Onishi; H. Shiraha; S. Nakamura; T. Yagi

P0692WITHDRAWN


167


Tues

day,

Oct

ober

31,

201

7


P0708EFFICACY AND SAFETY OF SOFOSBUVIR AND RIBAVIRIN IN HCV POSITIVE PATIENTS WITH RENAL IMPAIRMENTMuhammad Osama Butt, Pakistan

P0709CHRONIC HEPATITIS C A MAJOR HEALTH – RELATED QUALITY OF LIFE BURDEN IN COMPANSATED CIR-RHOTIC PATIENTS.Tudor Cuciureanu, Romania; A. M. Singeap; I. Girleanu; S. Chiriac; A.-V. Trifan

P0710SOFOSBUVIR IN COMBINATION WITH RIBAVIRIN IN GENOTYPE 3 HEPATIITS C PATIENTS WITH CIRRHOSIS. AN EXPERIENCE FROM TERTIARY CARE HOSPITALAli Langhah, Pakistan

P0711RECURRENCE OF HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH COMPENSATED LIVER CIRRHOSIS AND HCC TREATED WITH PARITAPREVIR/ OMBITASVIR /RITONAVIR, DASABUVIR WITH RIBAVIRIN: A NATION-AL COHORT STUDYDoina Proca, Romania; C. M. Preda; C.-R. Baicus; C. P. Popescu; M. Manuc; C. S. Pop; T. Voiosu; E. Ceausu; M. Diculescu; A. Oproiu


P0712SHEAR WAVE ELASTOGRAPHY FOR THE DIAGNOSIS OF ESOPHAGOGASTRIC VARICESHiroko Iijima, Japan; T. Nishimura; C. Nakano; T. Aoki; Y. Miyamoto; N. Ishii; Y. Yuri; K. Hasegawa; R. Takata; K. Yo; A. Ishii; T. Takashima; Y. Sakai; N. Aizawa; N. Ikeda; H. Nishikawa; Y. Iwata; H. Enomoto; S. Nishiguchi; J. Fujimoto

P0713 STAGING HEPATIC STEATOSIS IN NONALCOHOLIC FATTY LIVER DISEASE BY QUANTITATIVE CONVENTIONAL ULTRA-SOUND IMAGING, VALIDATED WITH HISTOPATHOLOGYG. Weijers; Isabelle Munsterman, The Netherlands; A. Meel – van den Abeelen; J. M. Thijssen; J. P. H. Drenth; E. Tjwa; C. de Korte

P0714 UTILITY OF A NEW FUNCTION IN 3D SIM-NAVIGATOR: ELECTRIC FIELD, WHICH INDICATES THE PREDICTED ABLATIVE AREAAzusa Sakamoto, Japan; T. Kimura; T. Matsumae; G. Tanke; H. Yoshida; M. Taki; M. Fukuhara; S. Henmi; T. Yamashina; Y. Sawai; S. Saito; N. Nishijima; A. Nasu; H. Komekado; M. Asada; T. Tsumura; T. Maruo; R. Kita; Y. Osaki

P0701ACTIVATED HEPATIC STELLATE CELLS CAN DIRECTLY INDUCE PATHOGENIC TH17 CELLS IN CHRONIC HEPATI-TIS B VIRUS INFECTIONYun Liu, China; W. Jiang


P0702EFFICACY AND SAFETY OF DIRECT ACTING ANTIVIRAL DRUGS IN EARLY TREATMENT OF HCV GENOTYPE 4 POST-LIVING DONOR LIVER TRANSPLANTATIONEhab Fawzy, Egypt; A. M. Moussa; I. M. Fawzy; M. Elbadry

P0703OPTIMIZATION OF DAA TREATMENT SCHEDULE: FOCUS ON HCV GENOTYPE 3F. Morisco; R. Granata; S. Camera; Federica Morando, Italy; A. Ippolito; M. Milella; F. Conti; C. Masetti; A. Smedile; P. Tundo; T. Santantonio; M. R. Valvano; A. Termite; P. Gatti; V. Messina; A. Iacobellis; M. Librandi; N. Caporaso; A. Andriulli

P0704IMPROVEMENT OF LIVER STIFFNESS VALUES MEASURED BY TRANSITION ELASTOGRAPHY AFTER CHRONIC HEPA-TITIS C TREATMENT WITH DIRECT ACTION ANTIVIRALS AND EVOLUTIVE CORRELATION OF THROMBOCYTOPENIA AND PRESENCE OF ESOPHAGEAL VARICESMiguel Perez Ferrer, Spain; I. Maestro Prada; A. McGee; J. L. Castro Urda; L. A. Castillo Hererra; C. Garcia Ramos

P07058 VERSUS 12 WEEKS OF LEDIPASVIR/SOFOSBUVIR REGIMEN IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 INFECTIONJoana Rita Carvalho, Portugal; P. Alexandrino; F. Serejo; R. T. Marinho; F. Ramalho; B. Rodrigues; P. Ferreira; M. S. Dias; H. Cortez-Pinto; C. Baldaia; A. J. Pedro; L. X. de Brito; L. Carrilho Ribeiro; N. Fatela; J. Velosa

P0706CLINICAL FEATURES OF PATIENTS DEVELOPING HCC AFTER ACHIEVING SVR WITH DAA AGAINST CHRONIC HEPATITIS CKoji Ishida, Japan; T. Nakatani; Y. Motokawa; F. Tomooka; A. Shibamoto; Y. Fujimoto; Y. Aihara; S. Nagamatu; M. Uejima; H. Matuo; E. Kikuchi

P0707EARLY OCCURRENCE OF HEPATOCELLULAR CARCINO-MA IN PATIENTS WITH HEPATITIS C VIRUS TREATED WITH DIRECT-ACTING ANTIVIRALSSeikan Hai, Japan; E. Hatano; T. Okada; Y. Asano; N. Uyama; K. Suzumura; M. Tada; I. Nakamura; K. Iida; H. Sueoka; H. Iwama; A. Kurimoto; R. Ito; H. Nishida; J. Fujimoto


168





P0724MICROWAVE VERSUS RADIOFREQUENCY THERMAL ABLATION OF HEPATOCELLULAR ADENOMA : SAFETY AND EFFICACY.H. El Alfy; T. Besheer; K. Farid; A. Mohammed El Sayed Ahmed El Nakib; A. El Shabrawi; A. Elbadrawy; A. El morsy; K. Zalata; Mahmoud Abd el_Aziz, Egypt

P0725METABOLIC DISORDERS ACROSS HEPATOCELLULAR CARCINOMA IN ITALY.F. Morisco; M. Guarino; M. R. Valvano; Valentina Cossiga, Italy; F. Farinati; E. G. Giannini; F. Ciccarese; F. Piscaglia; G. L. Rapaccini; M. Di Marco; E. Caturelli; M. Zoli; F. Borzio; R. Sacco; C. Cammà; M. Felder; L. Benvengù; A. Gasbarrini; G. Svegliati Baroni; F. G. Foschi; G. Missale; A. Masotto; R. Virdone; N. Caporaso; F. Trevisani

P0726LIVER VOLUME AS A PREDICTOR OF RISK FOR HEPA-TOCELLULAR CARCINOMA IN CHRONIC HEPATITIS C PATIENTSNamkyu Kang, Republic of Korea; J. W. Chung; J.-W. Kim

P0727HAND AND FOOT SYNDROME AS A PREDICTOR OF OUTCOME IN PATIENTS WITH HEPATOCELLULAR CAR-CINOMA TREATED WITH SORAFENIBMasanori Ochi, Japan; A. Okawara; N. Kakinoki; T. Kamoshida; S. Hirai

P0728WITHDRAWN

P0729UNUSUAL METASTASIS OF HEPATOCELLULAR CARCINOMAIbtissam Nakhcha, Morocco; I. Benelbarhdadi; F. Z. Ajana

P0730EPIDEMIOLOGICAL STUDY OF HISTOLOGICALLY PROVEN ADVANCED HEPATOCHOLANGIOCARCINOMA : AN AGEO MULTICENTER RETROSPECTIVE STUDY IN FRANCEMaeva Salimon, France; C. Prieux-Klotz; D. Tougeron; T. Lecomte; M. Caulet; T. Matysiak Budnik; V. Hautefeuille; M. Tiako-Meyo; A. Zaanan; Y. Touchefeu

P0731 A PROPOSAL FOR MODIFICATION OF BARCELONA CLINIC LIVER CANCER SYSTEM FOR HEPATOCELLULAR CARCINOMA STAGING BASED ON KOREAN MULTI-CENTER REGISTRY DATABASEJaeyoun Cheong, Republic of Korea; H. Cho

P0732HEPATIC LYMPHOMAS: A RARE ENTITY Rui Gaspar, Portugal; A. Andrade; J. Santos-Antunes; R. Liberal; F. Carneiro; G. Macedo

P0715ATTENUATION COEFFICIENT MEASUREMENT (ACM) AS NOVEL REAL TIME ULTRASOUND ALTERNATIVE TO CAP (FIBROSCAN)O. Dynnyk; N. Marunchyn; Nazarii Kobyliak, Ukraine; O. Fedusenko; V. Gurianov

P0716HOW DIFFERENT IS THE PERFORMANCE OF CEUS IN CIRRHOTIC VS. NON-CIRRHOTIC PATIENTS?Tudor Moga, Romania; C. S. Ivascu; C. G. Foncea; D. Gherhardt; R. Sirli; S. A. Popescu; M. Danila; I. Sporea

Liver neoplasia: Basic

P0717CUX1 IN LIVER CANCER: EXPERIMENTAL STUDY IN HYPOXIA MODELSophie Blümel, Germany; T. T. Wissniowski; J. Hänze; T. M. Gress; D. Bartsch; P. Di Fazio

P0718S-ADENOSYLMETHIONINE AFFECTS CELL CYCLE PATH-WAYS AND SUPRESSES PROLIFERATION IN LIVER CELLSLu Yan, China; G. Zhang; Y. Chen

P0719BRG1 PROMOTES HEPATOCARCINOGENESIS BY MODULAT-ING CYCLINB, D, E AND MATRIX METALLOPROTEINASE 7Benedikt Kaufmann, Germany; B. Wang; M. Lu; N. Hüser; H. Friess; G. von Figura; D. Hartmann

P0720PROGNOSTIC ROLE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN HEPATOCELLULAR CARCINOMA (HCC)Nour Elleuch, Tunisia; S. jardak; A. Sabbek; A. Ben Slama; H. Jaziri; E. Hammami; B. Ahlem; K. Mehdi; J. Ali

P0721REIC/DKK-3 PROTEIN CONCENTRATION INDUCE THE POSITIVE EFFECT TO THE MORTALITY OF HEPATOCEL-LULAR CARCINOMAAtsushi Ohyama, Japan; D. Uchida; H. Shiraha; H. Sawahara; H. Kato; H. Okada

P0722SURGICAL OUTCOME OF PATIENTS WITH FIBROLAMEL-LAR HEPATOCELLULAR CARCINOMA. DOES IT DIFFERS FROM COMMON HEPATOCELLULAR CARCINOMA ?Ehab El-Hanafy, Egypt

P0723WITHDRAWN


169


Tues

day,

Oct

ober

31,

201

7



P0740KML001, AN ORAL ARSENIC COMPOUND, AS PALLIA-TIVE CHEMOTHERAPY IN ADVANCED BILIARY TRACT CANCERS AFTER FAILURE OF GEMCITABINE BASED CHEMOTHERAPYJung Hyun Jo, Republic of Korea; I. R. Cho; H. S. Lee; M. J. Chung; J. Y. Park; S. Bang; S. W. Park; J.-B. Chung; S. Y. Song

P0741ENDOSCOPIC DRAINAGE OF MALIGNANT STENOSIS OF THE BILIARY CONFLUENCE : HOW MANY SEGMENTS SHOULD BE DRAINED TO IMPROVE THE PATIENT SURVIVAL?Fabrice Caillol, France; E. Bories; C. Zemmour; C. Pesenti; J. P. Ratone; M. Giovannini

P0742 SYSTEMATIC REVIEW AND META-ANALYSIS OF TRANS-ABDOMINAL AND ENDOSCOPIC ULTRASOUND FOR GALLBLADDER POLYPSSarah Wennmacker, The Netherlands; M. P. Lamberts; M. Di Martino; J. P. H. Drenth; K. S. Gurusamy; C. J. H. M. van Laarhoven

P0743DIAGNOSTIC VALUE OF CONTRAST-ENHANCED ULTRA-SONOGRAPHY IN HIGH MECHANICAL INDEX CONTRAST MODE FOR POLYPOID LESIONS OF THE GALLBLADDERHaruo Miwa, Japan; K. Numata; A. Hirotani; K. Sanga; Y. Gouda; K. Irie; T. Ishii; T. Kaneko; K. Sugimori; S. Maeda

P0744ASSOCIATION OF CIRCULATING ADIPONECTIN LEVELS AND TUMOR STAGE IN BILIARY TRACT CANCERAida Saray, Bosnia And Herzegovina; B. Gogov; N. Zubcevic; D. Prohic; A. Mehmedović; A. Puhalović

P0745PRETREATMENT BODY MASS INDEX AND WEIGHT CHANGE DURING INITIAL PERIOD OF CHEMOTHERAPY AFFECT SURVIVAL OUTCOME IN ADVANCED BILIARY TRACT CANCER PATIENTSJinwoo Kang, Republic of Korea; S. H. Lee; Y. H. Choi; J. H. Choi; J. K. Ryu; Y.-T. Kim

P0746THROUGH THE CATHETER BIOPSY METHOD FOR BILI-ARY CARCINOMAToru Okuzono, Japan

P0747THE DEVELOPMENT OF A RISK SCORE TO PREDICT ADVERSE OUTCOMES OF EXPLORATORY SURGERY IN PERIHILAR CHOLANGIOCARCINOMAMarcia Gaspersz, The Netherlands; S. Buettner; J. L. A. van Vugt; R. J. S. Coelen; J. Vugts; E. Belt; J. de Jonge; W. Polak; F. E. J. A. Willemssen; T. M. van Gulik; J. N. M. IJzermans; B. Groot Koerkamp

Bile acids, transport, cholestasis, gallstones: Basic

P0733USE OF BILE ACIDS AS A REGULATOR OF GUT MICROBIOTA.Kihyun Ryu, Republic of Korea; Y. Choi; H. Koo; K. Song; S. Kim; T. Lee; K. Huh; Y. Kang; M. Kang; S. Han; J. Jeong

P0734MIRNA-21 IS OVEREXPRESSED IN PRIMARY BILIARY CHOLANGITIS AND MEDIATES LIVER INJURY AND NECROPTOSIS IN EXPERIMENTAL CHOLESTASISM. B. B. Afonso; P. M. Rodrigues; André Simão, Portugal; M. M. Gaspar; T. Carvalho; P. Borralho; J. M. Banales; R. E. Castro; C. M. P. Rodrigues


P0735IS COMPLETE STONE REMOVAL FOR CHOLEDOCHOLI-THIASIS ALWAYS NECESSARY IN EXTREMELY ELDERLY PATIENTS?Naoko Okuda, Japan; S. Sugimoto; H. Nakamura; H. Hisada; T. Temma; Y. Hashimoto; S. Hayashi; T. Ito; M. Takami; M. Yamamura; J. Oyamada; A. Kamei

P0736THE EVALUATION OF TRANSPAPILLARY ENDOSCOPIC GALLBLADDER DRAINAGE WITH THE USE OF INTRA-DUCTAL ULTRASONOGRAPHYKenji Hayasaka, Japan; T. Ujihara; R. Nakahara; D. Murakami; T. Shimizu; S. Suehiro; Y. Katsuyama; H. Harada

P0737THE RENDEZVOUS PROCEDURE FOR THE MANAGE-MENT OF BILE DUCT INJURIES AFTER CHOLECYS-TECTOMY: SHORT AND LONG TERM OUTCOMES AND PREDICTORS FOR SUCCESS.Anne Marthe Schreuder, The Netherlands; K. A. Booij; P. R. de Reuver; O. M. van Delden; K. P. van Lienden; M. G. H. Besselink; O. R. C. Busch; D. J. Gouma; E. A. J. Rauws; T. M. van Gulik

P0738CHOLECYSTECTOMY AFTER ERCP CLEARANCE OF COM-MON BILE DUCT STONES: DOES TIMING MATTERS?. A PROSPECTIVE RANDOMIZED STUDYEhab Atif, Egypt; E. A. Elhanafy; A. Elnakeeb

P0739TRANSRECTAL GALLBLADDER PRESERVING CHOLECYS-TOLITHOTOMY AND POLYPECTOMY BY PURE NOTESBingrong Liu, China


170




P0754GRANULOCYTES DRIVE PANCREATITIS IN A NOVEL MODEL OF INTERLEUKIN-17A-INDUCED PANCREATITIS VIA PEPTIDYL ARGININE DEIMINASE-DEPENDENT EXTRACELLULAR TRAP FORMATIONMoritz Leppkes, Germany; C. Maueröder; S. Hirth; C. Günther; S. Nowecki; U. Billmeier; S. Paulus; M. Biermann; L. E. Munoz; M. Hoffmann; D. Wildner; A. L. Croxford; A. Waisman; D. E. Jenne; J. Mayerle; M. M. Lerch; G. Schett; S. Wirtz; M. F. Neurath; M. Herrmann; C. Becker

P0755MITOCHONDRIAL FUNCTION AND DISTRIBUTION IN PANCREATIC DUCTAL EPITHELIAL CELLSEmese Tóth, Hungary; J. Maléth; R. Erdős; Z. Rázga; L. Tretter; G. Horváth; Z. Rakonczay; P. Hegyi

Pancreatitis, acute

P0756RELATIONSHIP BETWEEN NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN-CONTAINING PROTEIN 2 VARIANTS AND SEVERITY OF ACUTE PANCREATITISMuhsin Murat Muhip Harputluoglu, Turkey; M. Ozbek; B. Otlu; U. Demirel; M. Aladag; M. A. Erdogan; Y. Atayan; B. Barut; B. Sarici; O. Yener

P0757DETERMINANTS OF SEVERITY IN ACUTE PANCREATITIS - A NATION-WIDE PROSPECTIVE MULTICENTER STUDYHanna Sternby, Sweden; F. Bolado; H. J. Canaval-Zuleta; C. Marra-López; A. I. Hernando-Alonso; A. del-Val-Antonana; G. García-Rayado; R. Rivera Irigoin; F. J. Grau-Garcia; L. Oms; J. Millastre-Bocos; I. Pasqual-Moreno; D. Martínez-Ares; J. A. Rodriguez-Oballe; A. Lopez-Serrano; M. Ruiz-Rebollo; A. Viejo-Almanzor; P. Zapater; E. de-Madaria

P0758A LUMEN APPOSING METAL STENT WITH ANTI-REFLUX VALVE FOR ENDOSCOPIC ULTRASOUND-GUIDED DRAIN-AGE OF PSEUDOCYST AND WALLED-OFF NECROSIS.In Rae Cho, Republic of Korea; M. J. Chung; J. H. Jo; H. S. Lee; J. Y. Park; S. Bang; S. W. Park; S. Y. Song; J.-B. Chung

P0759THE PREDICTORS OF STEP UP APPROACH USING ENDOSCOPIC ULTRASOUND-GUIDED TRANSMURAL DRAINAGE FOR WALLED-OFF NECROSISHideyuki Shiomi, Japan; A. Sakai; T. Ezaki; T. Nakagawa; T. Kobayashi; Y. Shiomi; A. Masuda; Y. Okabe; T. Azuma

P0760THE ANALYSIS OF CLINICAL FEATURES AND RISK FACTOR OF RECURRENCE AFTER THE FIRST ATTACK OF ACUTE PANCREATITISN. Gao; C. Jiao; C. Ma; M. Li; Weichang Chen, China

P0748A NEW PROGNOSTIC MODEL FOR PATIENTS WITH PERIHILAR CHOLANGIOCARCINOMAJ. L. A. van Vugt; Marcia Gaspersz, The Netherlands; R. J. S. Coelen; E. Roos; J. de Jonge; W. Polak; O. R. C. Busch; M. G. H. Besselink; C. Y. Nio; F. E. J. A. Willemssen; J. N. M. IJzermans; D. van Klaveren; T. M. van Gulik; B. Groot Koerkamp

P0749 THE OUTCOMES OF ERCP FOR THE PALLIATION OF MALIG-NANT JAUNDICE IN ENGLAND BETWEEN 2001 AND 2015Phil Harvey, United Kingdom; S. Baldwin; J. Mytton; F. Evison; P. Patel; N. Trudgill

Poster Session09:00 – 17:00 Hall 7Paediatric: Liver, Biliary and Pancreas

Paediatric liver disease

P0750EARLY DEVELOPMENT OF NONALCOHOLIC FATTY LIVER DISEASE IN GENETICALLY PREDISPOSED CHILDREN WITH OVERWEIGHT AND OBESITY DOES NOT COINCIDE WITH METABOLIC DERANGEMENTSKylie Karnebeek, The Netherlands; J. Plat; A. Vreugdenhil

P0751TWO-DIMENSIONAL SHEAR WAVE ELASTOGRAPHY IN CHILDREN: WHAT IS THE NUMBER OF LIVER STIFF-NESS MEASUREMENTS NEEDED FOR A HIGH QUALITY EVALUATION?Corina Pienar, Romania; P.-I. Velea; D. Gherhardt; I. Ciuca; C. Paul; O. Belei; S. A. Popescu; I. Sporea

Poster Session09:00 – 17:00 Hall 7Pancreas II

Pancreatitis, experimental

P0752PERCUTANEOUS EMBOLIZATION OF VISCERAL ARTERY PSEUDO-ANEURYSMS – A TERTIARY CENTER EXPERIENCE Radhika Chavan, India; J. Singh; Z. Nabi; R. Kalapala; D. N. Reddy

P0753 DEVELOPMENT OF AUTOIMMUNE PANCREATITIS IS INDEPENDENT OF P21 MEDIATED PANCREATIC INFLAMMATIONG. M. Seleznik; T. Reding; L. Peter; Anurag Gupta, Switzerland; S. Sonda; C. Verbeke; E. Dejardin; M. Heikenwälder; R. Graf


171


Tues

day,

Oct

ober

31,

201

7


P0769APOLIPOPROTEIN B AND A-I RATIO PREDICTS SEVERE ACUTE PANCREATITISJae-Woo Kim, Republic of Korea; K. J. Lee


P0770 IMAGING IN CHRONIC PANCREATITIS – DATA FROM THE SCANDINAVIAN BALTIC PANCREAS CLUB DATABASETrond Engjom, Norway; F. G. Erchinger; E. Tjora; G. Dimcevski

P0771OSTEOPATHY IS COMMON IN PATIENTS WITH CHRONIC PANCREATITIS, BUT IS NOT RELATED WITH VITAMIN D AND FECAL ELASTASE LEVELS (P-BONE STUDY).Serena Stigliano, Italy; A. Waldthaler; E. Martínez-Moneo; S. Robinson; M. Malvik; A. Hedstrom; A. Kaczka; M. Scholdei; G. Delle Fave; P. Simon; G. Capurso

P0772NATURAL HISTORY OF PANCREATITIS ASSOCIATED WITH SPINK1 MUTATIONSNelly Muller, France; O. Hentic; F. Maire; P. Ruszniewski; P. Lévy; V. Rebours

P0773EXOCRINE FUNCTION, NUTRITION AND ENZYME TREATMENT IN THE SCANDINAVIAN BALTIC PANCREAS CLUB DATABASE – PRELIMINARY DATAFriedemann Georg Erchinger, Norway; T. Engjom; E. Tjora; G. Dimcevski

P0774FLUID AND HCO3- SECRETION AND CFTR ACTIVITY IS INHIBITED BY CIGARETTE SMOKE EXTRACT IN GUINEA PIG PANCREATIC DUCTAL CELLSDavid Talas, Hungary; P. Pallagi; V. Venglovecz; E. Gál; K. Tóth; A. Schnúr; J. Maléth; D. Csupor; Z. Rakonczay; P. Hegyi


P0775HISTOLOGICAL DIAGNOSIS WITH RAPID ON-SITE EVALU-ATION IN ENDOSCOPIC ULTRASOUND-GUIDED FINE-NEE-DLE ASPIRATION OF PANCREATIC SOLID LESIONSTakashi Hirayama, Japan; K. Hara; N. Mizuno; S. Hijioka; T. Kuwahara; N. Okuno; Y. Niwa

P0776 WITHDRAWN

P0777THE NOVEL ROLE OF GASTROKINE, A GASTRIC TUMOR SUPPRESSOR PROTEIN, IN PANCREATIC CARCINOGENESISSabrina Steiner, Switzerland; G. M. Seleznik; T. Reding; A. Gupta; D. Lenggenhager; M. Heikenwälder; R. Graf

P0761CROSSTALK BETWEEN INFLAMMATION AND COAGULA-TION IN PANCREATITIS-INDUCED ACUTE RENAL FAILURESerhii Chuklin, Ukraine; S. Chooklin; B. Pidhirnyy

P0762A NEW IL13/IFNγ RATIO PREDICTS SEVERITY IN ACUTE PANCREATITISA. Rodriguez-Nicolas; A. Martinez-Chamorro; M. P. Jimenez-Gamiz; A. M. Matas-Cobos; F. Ruiz-Cabello; Eduardo Redondo-Cerezo, Spain

P0763CORRELATION BETWEEN POST-ERCP SERUM AMYLASE LEVELS AND CT FINDINGS IN ERCP-INDUCED PANCREATI-TIS: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDYOsamu Inatomi, Japan; S. Bamba; Y. Nakai; K. Kusumoto; B. Endoh; A. Suzuki; T. Suzuki; T. Kawakami; S. Oota; A. Inoue; Y. Itokawa; K. Chikugo; A. Andoh; Y. Mizumoto; K. Tanaka

P0764CLINICAL EFFIACY AND SAFETY OF EUS-GUIDED LU-MEN-APPOSING METAL STENT ASSISTED PANCREATIC WALL-OFF NECROSIS DRAINAGE : A REAL-LIFE EXPE-RIENCE IN A TERTIARY HOSPITAL Siu Tong Law, Hong Kong PRC; C. De La Serna Higuera; M. Perez-Miranda; P. Gil

P0765RECTAL INDOMETHACIN IS PROTECTIVE AGAINST POST-ERCP PANCREATITIS IN HIGH-RISK AND AVER-AGE-RISK POPULATION: A SYSTEMATIC REVIEW AND META-ANALYSISXingkang He, China; W. Wu; Y. Ding; W. Zheng; L. Sun; J. Si

P0766THE IMPACT OF THE SPECIALISTIC GASTROENTERO-LOGIC UNIT ON THE OUTCOME OF ACUTE PANCREATITIS (AP) IN THE VENETO REGION (NORTH-EAST OF ITALY)Lucas Giovanni Cavallaro, Italy; B. Germaná; A. Giacomin; L. Frulloni; A. Gabbrielli; F. Farinati; M. Saia

P0767COMPARISON OF CLINICAL COURSE AND OUTCOME OF ACUTE PANCREATITIS, RECURRENT ACUTE PANCRE-ATITIS, ACUTE ON CHRONIC PANCREATITIS.N. Berry; Dibya Sharma, India; J. Samanta; N. Dhaka; S. K. Sinha; R. Kochhar; R. Prasada; V. Gupta; T. Yadav

P0768ACUTE PANCREATITIS IN PATIENTS WITH IPMNS: RETROSPECTIVE STUDY OF 346 PATIENTS OBSERVED FROM 2009 TO 2016Lorenzo Brozzi, Italy; A. Amodio; F. De Marchi; R. Teresa Marzia; I. Breoni; P. Campagnola; S. F. Crinó; A. Gabbrielli; L. Frulloni


172




P0786TREATMENT EFFICACY AND ADVERSE EVENTS OF GEMCITABINE PLUS NAB-PACLITAXEL USED FOR METASTATIC PANCREATIC CANCER : A RETROSPECTIVE COHORT STUDYIn Rae Cho, Republic of Korea; J. H. Jo; H. S. Lee; M. J. Chung; J. Y. Park; S. W. Park; S. Y. Song; J.-B. Chung; S. Bang

P0787IMPACT OF PREOPERATIVE EUS-FNA ON PERITONE-AL RECURRENCE AND SURVIVAL IN PATIENTS WITH PANCREATIC CANCERSun Hwa Kim, Republic of Korea; S. J. Lee; K. H. Lee; J. K. Lee; K. T. Lee; J. K. Park

P0788 HENT1 & DPD EXPRESSION IN EUS-FNAB SAMPLES OF PANCREATIC DUCTAL ADENOCARCINOMA: TECHNICAL FEASIBILITY AND PROGNOSTIC SIGNIFICANCE OF GEMCITABINE+S1-BASED CHEMORADIOTHERAPYReiko Yamada, Japan; S. Isaji; H. Inoue; A. Hayasaki; Y. Murata; M. Kishiwada; H. Miura; T. Takeuchi; T. Harada; N. Yoshizawa; H. Okuse; T. Sakuno; M. Nakamura; M. Katsurahara; Y. Hamada; K. Tanaka; N. Horiki; Y. Takei

P0789EVALUATION OF THE EFFICACY OF ENDOSCOPIC SPHINCTEROTOMY IN THE TREATMENT OF SYMP-TOMATIC IPMN WITHOUT WORRISOME FEATURES. A MULTICENTER FRENCH RESTROSPECTIVE STUDYJean-Michel Gonzalez, France; D. Lorenzo; J. P. Ratone; A. Culetto; P. Lévy; M. Giovannini; M. Barthet

P0790STATIN USE DECREASES THE RISK OF PANCREATIC CANCER OCCURRENCE: A META-ANALYSISLivia Archibugi, Italy; P. G. Arcidiacono; G. Delle Fave; G. Capurso

P0791AN IMPROVED DIGITAL POLYMERASE CHAIN REACTION PROTOCOL TO CAPTURE LOW-COPY KRAS MUTATIONS IN PLASMA CELL-FREE DNA BY RESOLVING “SUBSAM-PLING” ISSUESYusuke Ono, Japan; A. Sugitani; H. Karasaki; M. Ogata; R. Nozaki; J. Sasajima; Y. Mizukami

P0792ANALYSIS OF CLINICAL PREDICTIVE FACTORS AFFECT-ING THE OUTCOME OF 2ND LINE CHEMOTHERAPY FOR THE PATIENT OF ADVANCED PANCREATIC CANCERJeung Eun Lee, Republic of Korea; H. S. Lee; M. J. Chung; J. Y. Park; S. Bang; S. W. Park; S. Y. Song

P0778 AUTOPHAGY IS ESSENTIAL FOR PANCREATIC CANCER DEVELOPMENT IN A NEW HUMANIZED GENETICAL-LY-MODIFIED ADULT MOUSE MODELC. Tang; Xintong Jia, China; R. Luo; Q. Tu; X. Zhao

P0779HIPEC IN GI CANCERS. IS HYPERTHERMIA FRIEND OR FOE?V. Cesna; A. Sukovas; S. Paskauskas; G. Barauskas; Z. Dambrauskas; Antanas Gulbinas, Lithuania

P0780CACHEXIA INVOLVEMENT IN THE LOCAL SPREAD OF PANCREATIC DUCTAL ADENOCARCINOMAL. Petrusel; R. Suharoschi; I. Rusu; C. Pojoga; R. Seicean; Andrada Seicean, Romania

P0781THE INTRACELLULAR CYTOSKELETON MARKER IS OVER-EXPRESSED IN PANCREATIC DUCTAL ADENOCARCINOMAL. Petrusel; R. Suharoschi; T. Zaharie; I. Rusu; C. Pojoga; R. Seicean; Andrada Seicean, Romania


P0782QUALITY OF LIFE DURING CHEMOTHERAPY IN JAP-ANESE PATIENTS WITH UNRESECTABLE ADVANCED PANCREATIC CANCERKaoru Shibayama, Japan; F. Koga; S. Nakashita; N. Oza; T. Otsuka; N. Ureshino; Y. Kawaguchi

P0783C-REACTIVE PROTEIN (CRP) LEVEL IS AN INDICA-TOR OF THE THERAPEUTIC EFFECT OF TREATMENT RESPONSE TO ENDOSCOPIC ULTRASOUND-GUIDED CELIAC NEUROLYSIS (EUS-CPN) IN PATIENTS WITH PANCREATIC CANCER (PC) PAINGen Kimura, Japan; Y. Hashimoto; K. Umemoto; K. Watanabe; M. Sasaki; H. Takahashi; H. Imaoka; I. Oono; S. Mitsunaga; M. Ikeda

P0784 PRESENTATION SYMPTOMS AND RISK FACTORS ARE AS-SOCIATED WITH DIAGNOSTIC DELAY AND DISEASE STAGE BUT NOT WITH PROGNOSIS OF PANCREATIC CANCER.G. Capurso; C. Stornello; Livia Archibugi, Italy; S. Stigliano; M. Signoretti; M. Milella; V. Barucca; C. Capalbo; G. Delle Fave

P0785 PLASMA DNA GENOTYPING USING DIGITAL PCR FOR SURVEILLANCE OF PANCREATIC CANCER IN HIGH-RISK INDIVIDUALSYusuke Mizukami, Japan; Y. Ono; H. Karasaki; K. Koizumi; T. Okada; J. Sasajima; M. Yamada; S. Asahara; K. Kawakubo; H. Maguchi


173


Tues

day,

Oct

ober

31,

201

7


P0800THE EFFECT OF VONOPRAZAN FOR ENDOSCOPIC SUBMUCOSAL DISSECTION-INDUCED ULCERATION AND POSTOPERATIVE BLEEDING.Go Ikeda, Japan; N. Ueki; S. Futagami; S. Agawa; H. Noda; K. Higuchi; T. Akimoto; Y. Maruki; H. Yamawaki; Y. Kodaka; T. Kawagoe; K. Miyake; M. Kaise; K. Iwakiri

P0801INFLUENCE OF ANTITHROMBOTIC THERAPY ON DE-LAYED BLEEDING AFTER GASTRIC ESD: A RETROSPEC-TIVE ANALYSIS IN 665 CASESHiroto Noda, Japan; N. Ueki; T. Akimoto; G. Ikeda; K. Higuchi; S. Agawa; Y. Maruki; H. Yamawaki; Y. Kodaka; T. Kawagoe; K. Miyake; S. Futagami; K. Iwakiri

P0802LOW DOSE ASPIRIN DELAYS THE ULCER HEALING AND INCREASES THE RISK OF POSTOPERATIVE BLEEDING AFTER GASTRIC ENDOSCOPIC SUBMUCOSAL DISSEC-TION THROUGH THE DUODENOGASTRIC REFLUXNobue Ueki, Japan; S. Futagami; T. Akimoto; S. Agawa; G. Ikeda; H. Noda; K. Higuchi; Y. Maruki; H. Yamawaki; Y. Kodaka; T. Kawagoe; K. Miyake; M. Kaise; K. Iwakiri

P0803NARROW-BAND IMAGING (NBI) ENDOSCOPY WITH DUAL FOCUS MAGNIFICATION FOR CHARACTERIZATION OF GASTRIC NON-NEOPLASTIC AND NEOPLASTIC LESIONSRoman Kuvaev, Russian Federation; S. Kashin; A. Aleshicheva; E. Kraynova; A. Nadezhin; E. Nikonov

P0804TRANSPLANTATION OF AUTOLOGOUS ESOPHAGUS MUCOSA TO PREVENT STRICTURE AFTER CIRCUMFER-ENTIAL ENDOSCOPIC SUBMUCOSAL DISSECTION OF EARLY SQUAMOUS CELLLiao ZhongLi, China; F. ChaoQiang; Y. Xin; P. Xue; Z. Xia; Y. Jin; X. Xia; B. JianYing

P0805ENDOSCOPIC CLOSURE OF POST-SURGICAL FISTULAS OR PERFORATIONS WITH OVER-THE-SCOPE-CLIPPatrícia Santos, Portugal; D. Reis; C. Noronha Ferreira; J. Lopes; L. Carrilho Ribeiro; J. Velosa

P0806A PROSPECTIVE STUDY USING A NEW DEVICE FOR ENDOSCOPIC RESECTION OF EARLY NEOPLASIA IN BARRETT’S ESOPHAGUSRoos Pouw, The Netherlands; T. Beyna; K. Belghazi; A. D. Koch; E. J. Schoon; R. Haidry; B. L. A. M. Weusten; R. Bisschops; N. J. Shaheen; M. B. Wallace; N. E. Marcon; K. Wang; C. Leggett; J. Ortiz Fernandez-Sordo; K. Ragunath; M. di Pietro; O. Pech; H. Neuhaus; J. J. G. H. M. Bergman

P0793 RAPID ON SITE EVALUATION (ROSE): AN ESSENTIAL TOOL IN ECHO-ENDOSCOPIC (EUS) STUDY OF SOLID LESIONS OF THE PANCREAS Rui Gaspar, Portugal; P. Moutinho-Ribeiro; V. Magno Pereira; M. Silva; A. Peixoto; S. Lopes; F. Vilas-Boas; H. Barroca; J. Lopes; F. Carneiro; G. Macedo

Poster Session09:00 – 17:00 Hall 7Endoscopy and Imaging II

Endoscopy, upper GI

P0794 ESOPHAGEAL FISTULA HEALING BY MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLES IN A THERMO-RESPONSIVE GEL: A PRE-CLINICAL PORCINE STUDYA. A K Silva; S. Perretta; G. Perrod; L. Pidial; V. Lindner; C. Wilhelm; B. Dallemagne; F. gazeau; C. Cellier; O. Clément; Gabriel Rahmi, France

P0795REAL-TIME MULTIPHOTON MORPHOLOGICAL IMAGING FOR DIAGNOSING GASTRIC ATYPICAL HYPERPLASIA AND ADENOCARCINOMAK. He; L. Zhao; M. Wang; X. Wang; L. Liu; Zhining Fan, China

P0796 IMPROVEMENT IN HEPATIC TRANSAMINASES OVER 12 MONTHS AFTER SINGLE PROCEDURE DUODENAL MU-COSAL RESURFACING IN TYPE 2 DIABETES PATIENTSAnnieke van Baar, The Netherlands; M. Nieuwdorp; L. Crenier; R. Batterham; F. Holleman; P. Vignolo; G. Costamagna; J. Deviere; R. Haidry; L. Rodríguez; M. Galvao Neto; J. J. G. H. M. Bergman; G. Mingrone

P0797UPPER GASTROINTESTINAL ENDOSCOPIC FINDINGS IN ASYMPTOMATIC HEALTHY INDIVIDUALS WITH NORMAL AND DECREASED SERUM PEPSINOGENS FROM THE GISTAR PILOT STUDYIlze Kikuste, Latvia; J. Young Park; R. Murillo; S. Parshutin; I. Polaka; A. Kirsners; R. Herrero; M. Leja

P0798REBAMIPIDE SOLUTION AS A NOVEL SUBMUCOSAL INJECTION PROMOTES HEALING SPEED AND QUALITY OF ESD-INDUCED ULCER BY SUPRESSING FIBROSIS.Ai Fujimoto, Japan; T. Nishizawa; M. Shimoda; O. Goto; Y. Ochiai; T. Maehata; T. Akimoto; Y. Mitsunaga; M. Kato; A. Nakayama; M. Sasaki; T. Uraoka; N. Yahagi

P0799EFFECT OF ILAPRAZOLE ON THE HEALING OF ENDOSCOPIC SUBMUCOSAL DISSECTION-INDUCED GASTRIC ULCER: IN-TERIM ANALYSIS OF RANDOMIZED, MULTICENTER STUDYC. S. Bang; Woon Geon Shin, Republic of Korea; G. H. Baik; H. Y. Kim; S.-H. Kae; H. J. Jang; M. H. Choi


174




P0815PREDICTIVE RISK MODEL FOR POST-ENDOSCOPIC SUB-MUCOSAL DISSECTION ULCER BLEEDING OF STOMACHYeon Hwa Choe, Republic of Korea; S. K. Shin; E. H. Kim; Y. C. Lee; S. K. Lee; J. Park

P0816USEFULNESS OF DUAL RED IMAGING IN ESOPHAGEAL AND GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTION.Tomoaki Yamasaki, Japan; K. Yamamoto; Y. Yasui; Y. Sakata; M. Suo; T. Ochiai; A. Kimura; A. Nakata; M. Yamamura; N. Hirata; T. Suekane; E. Sasaki; K. Sano; K. Watanabe; H. Nebiki

P0817EFFICACY OF BLUE LIGHT IMAGING USING LED LIGHT SOURCE FOR DIAGNOSIS OF EARLY GASTRIC CANCEROsamu Dohi, Japan; Y. Naito; S. Takayama; K. Ogita; K. Terasaki; T. nakano; N. Iwai; T. ueda; T. Okayama; N. Yoshida; K. Kamada; K. Uchiyama; T. Ishikawa; T. Takagi; O. Handa; H. Konishi; Y. Itoh

P0818RISK FACTORS OF COMPLICATION RELATED TO ENDO-SCOPIC MANAGEMENT OF FOREIGN BODIES IN THE ESOPHAGUS: A PROSPECTIVE STUDY IN 595 CASES FROM MULTIPLE CENTERS IN CHINAL. Wang; Liangjing Wang, China

P0819BIOPSY STRATEGIES FOR ENDOSCOPICS SCREENING OF PRE-MALIGNANT GASTRIC LESIONS Zhang Meng, China

P0820 USEFULNESS OF LINKED COLOR IMAGING (LCI) FOR RECOGNITION OF EARLY GASTRIC CANCER AND GAS-TRIC ADENOMANobuaki Yagi, Japan; H. kitae; A. Tomie; T. Yasuda; T. Omatsu; Y. Nakahata; T. Kurobe; A. Obora; T. Kojima

P0821GASTROINTESTINAL STROMAL TUMORS SHOULD BE RESECTED EVEN IN A SMALL SIZE – A RETROSPECTIVE ANALYSIS IN 33 CASESOsamu Goto, Japan; T. Akimoto; Y. Mitsunaga; A. Fujimoto; Y. Ochiai; T. Maehata; H. Kawakubo; H. Takeuchi; Y. Kitagawa; N. Yahagi

P0822LONG-TERM OUTCOMES OF PERORAL ENDOSCOPIC MYOTO-MY FOR ACHALASIA IN PATIENTS OLDER THAN 70 YEARSJunyu Zhu, China; Q.-L. Li; P.-H. Zhou

P0823POST-POEM ESOPHAGITIS – REAL REFLUX ESOPHAGI-TIS OR JUST A HEALING PROCESS?Denisa Erhartova, Czech Republic; J. Krajciova; Z. Vackova; Z. Rabekova; P. Stirand; T. Hucl; J. Spicak; J. Martinek

P0807COST–EFFECTIVE ANALYSIS COMPARING STANDARD BIOP-SY VS. DIGITAL BIOPSY BY CONFOCAL ENDOMICROSCOPYCarlos Robles-Medranda, Ecuador; M. Valero; J. Ospina; M. Puga-Tejada; H. Alvarado-Escobar; M. Soria; H. Pitanga-Lukashok

P0808GASTRIC PER-ORAL ENDOSCOPIC PYLOROMYOTO-MY (G-POEM) IN THE TREATMENT OF REFRACTORY GASTROPARESIS: EXPERIENCE OF THE FIRST 9 CASES IN A MEXICO.Oscar Hernandez Mondragon, Mexico; R. Palos Cuellar; G. Blanco Velasco; J. M. Blancas-Valencia; M. L. Hernandez Reyes

P0809ENDOSCOPIC MANAGEMENT OF FOREIGN BODIES IN THE UPPER GASTROINTESTINAL TRACT: A RETRO-SPECTIVE STUDY OF 1294 CASESChong Geng, China; X. Li; X. Lei; C. Wang

P0810CLINICAL OUTCOMES AFTER ENDOSCOPIC RESECTION FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA COM-PARING THE CASES WITH MM AND SM1 INVASION.S. Yoshimizu; Toshiyuki Yoshio, Japan; K. Namikawa; A. Ishiyama; T. Tsuchida; J. Fujisaki

P0811GASTRIC ESD IN AN ANIMAL SURVIVAL MODEL USING THE ANUBIS-SYSTEMJoern Bernhardt, Germany; H. Steffen; P. Koehler; S. Schneider-Koriath; K. Ludwig

P0812USEFULNESS OF NARROW BAND IMAGING WITH MAGNIFYING ENDOSCOPY AS A SCREENING TEST FOR GASTRIC CANCERTatsuo Morinushi, Japan

P0813DIAGNOSTIC LIMITATIONS OF MAGNIFYING ENDOSCO-PY WITH NARROW BAND IMAGING (ME-NBI) IN EARLY GASTRIC CANCERKohei Matsumoto, Japan; H. Ueyama; K. Matsumoto; Y. Akazawa; H. Komori; M. Hojo; A. Nagahara; T. Yao; S. Watanabe

P0814BEST PRACTICE IN PLACEMENT OF PERCUTANEOUS ENDOSCOPIC GASTROSTOMY WITH JEJUNAL EXTEN-SION TUBE FOR CONTINUOUS INFUSION OF LEVODOPA CARBIDOPA INTESTINAL GEL IN THE TREATMENT OF ADVANCED PARKINSON'S DISEASE: THE ROLE OF GASTROENTEROLOGISTAntonietta Gerarda Gravina, Italy; I. Apicella; V. M. Ormando; M. R. Amato; M. I. Russo; M. Romano; P. Esposito


175


Tues

day,

Oct

ober

31,

201

7


P0832DIFFERENCES IN DISTRIBUTION OF SIZE, SHAPE AND SERRATED HISTOLOGY OF COLORECTAL ADENOMAS BETWEEN ENDOSCOPISTS WITH LOW (<20%) AND HIGH (≥20%) ADENOMA DETECTION RATEDaniela Penz, Austria; E. Waldmann; A. Hinterberger; B. Majcher; A. Dokladanska; A. Szymanska; M. Trauner; M. Ferlitsch

P0833PREDICTIVE FACTORS FOR TECHNICALLY DIFFICULT ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD). IMPLI-CATIONS FOR CASE SELECTION: A SPANISH PROSPEC-TIVE MULTICENTER COHORT STUDY.José Marín-Gabriel, Spain; F. Ramos-Zabala; F. Mugica; A. Herreros de Tejada; E. Albéniz Arbizu; J. De la Peña Garcia; O. Nogales Rincón; A. Sanchez Yague; M. G. Fernández-Esparrach; C. Dolz Abadia; A. Alvarez Delgado; H. Cortés-Pérez; C. Guarner Argente; A. J. Del Pozo-García; J. B. Díaz Tasende

P0834EPOCH-MAKING TECHNIQUE OF FULL-THICKNESS RESEC-TION FOR THE COLORECTAL TUMOR BY USING LAPAROS-COPY ENDOSCOPY COOPERATIVE SURGERY (LECS) Yoshiro Tamegai, Japan; Y. Fukunaga; A. Chino; S. Saito; J. Fujisaki; M. Ueno

P0835WITHDRAWN

P0836HIGH INCIDENCE OF MINOR ADVERSE EVENTS AFTER ENDOSCOPIC MUCOSAL RESECTION OR SUBMUCOSAL DISSECTION FOR COLORECTAL NEOPLASMSYelim Song, Republic of Korea; J.-S. Byeon; K.-J. Kim; D.-H. Yang; S. W. Hwang; E. M. Song; S. H. Park

P0837DEVELOPING PATIENT REPORTED EXPERIENCE MEASURES FOR GI ENDOSCOPY: RESULTS OF PATIENT INTERVIEWSLaura Jane Neilson, United Kingdom; L. Sharp; J. Patterson; P. Hewitson; C. von Wagner; C. J. Rees

P0838RANDOMIZED CONTROLLED TRIAL OF ABDOMINAL VI-BRATION STIMULATION AND WALKING EXERCISE FOR BOWEL CLEANSING PRIOR TO COLONOSCOPYChoong-Kyun Noh, Republic of Korea; J. K. Kang; K. M. Lee; S. J. Shin; S. G. LIm; K. J. Lee

P0839COMPARATIVE STUDY OF ELECTRICAL AND RHEO-LOGICAL PROPERTIES OF DIFFERENT SOLUTIONS TO PERFORM SUBMUCOSAL INJECTIONIgnacio Bon, Spain; V. Lorenzo-Zúñiga; V. Moreno de Vega; A. Rodríguez; N. D. De la Ossa; I. Marín; J. Boix; R. Bartolí

P0824 ENDOSCOPIC SUBMUCOSAL TUNNEL DISSECTION FOR LESSER GASTRIC CURVATURE SUPERFICIAL NEOPLASMSD. Shi; Rui Li, China; W. chen; X. Wang; C. Ma; D. Zhang

P0825PROPOFOL SEDATION DURING GASTROINTESTINAL ENDOSCOPY INDUCES EUPHORIA IN A LARGE SUBSET OF PATIENTS.Thorsten Brechmann, Germany; C. Maier; M. Kaisler; J. Vollert; W. Schmiegel; S. Pak; N. Scherbaum; F. Rist; A. Riphaus

P0826ENDOSCOPIC SUBMUCOSAL DISSECTION FOR UPPER GI SUBMUCOSAL TUMOURSHalim Awadie, Australia; D. J. Tate; A. Klein; L. Desomer; M. Ma; S. Heitman; N. J. Burgess; E. Y. T. Lee; V. Kwan; M. J. Bourke

P0827COMPARING APPROACHES TO SELF-EXPANDING ME-TALLIC STENTS INSERTIONLeanne Mooney, United Kingdom; N. Church; R. Sinha; C. Basquill

P0828CAUSTIC INJURIES OF THE SUPERIOR GASTROINTESTI-NAL TRACT: 15 YEARS OF EXPERIENCEMarta Rocha, Portugal; T. Moreira; M. Salgado; L. Maia; S. Barrias; I. Pedroto

P0829NOVEL IMAGE ENHANCEMENT TECHNOLOGY USING LINKED COLOR IMAGING WITH ACETIC ACID INDI-GOCARMINE MIXTURE FOR DIAGNOSIS OF EARLY GASTRIC NEOPLASMYoshiro Kawahara, Japan; H. Kanzaki; S. Kawano; M. Iwamuro; Y. Kono; T. Gotoda; H. Sakae; Y. Baba; Y. Obayashi; Y. Okamoto; H. Okada

P0830THE SAFETY AND EFFECTIVENESS OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC NEO-PLASMS IN PATIENTS AGED 85 YEARS OR OLDERYuki Sumida, Japan; T. Kuwai; K. Tao; S. Funaki; Y. Miyasako; T. Takasago; T. Nishimura; R. Miura; H. Imagawa; T. Yamaguchi; A. Yamaguchi; H. Kouno; H. Kohno; S. Ishaq

Endoscopy, colon

P0831RESULTS FROM THE FIRST UK VIRTUAL COMPLEX POLYP MDMAmit Chattree, United Kingdom; M. Rutter


176




P0848THE ROLE OF PROBE CONFOCAL LASER ENDOMI-CROSCOPY WITH IMAGE ENHANCED ENDOSCOPY IN CHARACTERISATION AND ENDOSCOPIC RESECTION OF DYSPLASTIC LESIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS. Marietta Iacucci, United Kingdom; X. Gui; S. Ghosh

P0849THE SAFETY AND EFFECTIVENESS OF COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION USING A SCISSORS-TYPE KNIFE IN ELDERLY PATIENTSToshio Kuwai, Japan; T. Yamaguchi; H. Imagawa; S. Funaki; K. Tao; R. Miura; T. Takasago; Y. Sumida; Y. Miyasako; A. Yamaguchi; H. Kouno; H. Kohno; S. Ishaq

P0850QUALITY IN COLONOSCOPY; HAVE YOU REALLY GOT TO THE CAECUM?Shivkumar Budihal, United Kingdom

P0851DETECTION AND CHARACTERIZATION OF SSA/PS DURING SURVEILLANCE COLONOSCOPY IN LONG STAND-ING IBD USING ADVANCED ENDOSCOPIC TECHNIQUES. Marietta Iacucci, United Kingdom; O. Akinola; R. Panaccione; G. G. Kaplan; X. Gui; S. Urbanski; S. Ghosh

P0852IN VIVO HISTOLOGICAL PREDICTION OF COLORECTAL POLYPS USING FICE TECHNOLOGYJoão Cortez-Pinto, Portugal; J. Moleiro; I. Marques; R. Barosa; J. Castela; J. Pereira da Silva; S. Faias; S. Mão de Ferro; P. Lage; A. Dias Pereira

P0853POLYP DETECTION RATES IN COLONOSCOPIES PER-FORMED UNDER GENERAL ANAESTHETIC COMPARED TO CONVENTIONAL SEDATIONBen Perren, United Kingdom; A. S. Bancil; A. G. Lim; P. Youd; S. J. Moodie; P. Patel

P0854PATIENT AND PHYSICIANS RELATED FACTORS ASSO-CIATED WITH A HIGH ADENOMA DETECTION RATE IN ROUTINE COLONOSCOPY.Maryan Cavicchi, France; G. Tharsis; P. Burtin; P. Cattan; F. Venezia; G. Tordjman; A. Gillet; J. Samama; K. Nahon-Uzan; D. Karsenti

P0855EFFICIENCY OF COLONOSCOPY IN CASE OF POSITIVE FECAL IMMUNOCHEMICAL TEST: ONE-YEAR EXPE-RIENCE AND RESULTS ON 391 PATIENTS IN ROUTINE PRACTICE IN FRANCE.Maryan Cavicchi, France; G. Tharsis; P. Burtin; P. Cattan; F. Venezia; G. Tordjman; A. Gillet; J. Samama; K. Nahon-Uzan; D. Karsenti

P0840PATIENT SATISFACTION RELATED TO QUALITY OF INFORMATION GIVEN THROUGHOUT COLONOSCOPYSara Sjöblom, Sweden; S. Jakobsson; J. Ryhlander; M. Simrén; P.-O. Stotzer; G. Ringström

P0841THE INCIDENCE OF SYNCHRONOUS ADVANCED NEO-PLASIA OF RECTAL LATERALLY SPREADING TUMORS WITH A SKIRTShozo Osera, Japan; T. Shinohara; A. Kudo; T. Yamada; T. Momoi; H. Fukushima; M. Furutake; A. Tomori; T. Hisa

P0842EVALUATION OF MUCOSAL HEALING WITH SHIELDS BASED ON DIFFERENT HYDROGELS IN A RAT MODEL OF THERMAL INJURYIgnacio Bon, Spain; R. Bartolí; V. Moreno de Vega; J. Boix; N. D. De la Ossa; I. Marín; V. Lorenzo-Zúñiga

P0843EFFICACY OF ENDOSCOPIC PLACEMENT OF A DRUG- ELUTING PLATFORM WITH DIFFERENT ANTITUMORAL AGENTS TO EVALUATE ACUTE NECROSIS IN AN AZOXY-METHANE-INDUCED COLONIC TUMOURS IN RATS.Ramon Bartolí, Spain; I. Bon; V. Moreno de Vega; J. Boix; N. D. De la Ossa; I. Marín; V. Lorenzo-Zúñiga

P0844A THREE-DIMENSIONAL IMAGING SYSTEM IMPROVES THE ENDOSCOPIC VISIBILITY OF NON-POLYPOID COL-ORECTAL NEOPLASMSTomoaki Matsumura, Japan; D. Maruoka; K. Okimoto; N. Akizue; T. Nakagawa; H. Ishigami; M. Arai; N. Kato

P0845PAIN DURING COLONOSCOPY: DIFFERENCES BETWEEN PATIENTS’ EXPERIENCES AND CAREGIVERS’ ASSESSMENTJessica Ryhlander, Sweden; G. Ringström; M. Simrén; S. Sjöblom; P.-O. Stotzer; S. Jakobsson

P0846 DEVELOPMENT OF A NEW ENDOSCOPIC CLASSIFICA-TION AND FIRST INTERNATIONAL VALIDATION (FACILE GROUP) OF COLONIC LESIONS USING ADVANCED IMAGING MODALITIES IN IBD PATIENTS Marietta Iacucci, United Kingdom; K. McQuaid; T. Uraoka; T. Matsumoto; V. Subramanian; Y. Iwao; M. Lowerison; B. C. Lethebe; S. Sanduleanu; S. Ghosh; R. Kiesslich

P0847GENDER DIFFERENCES IN ACCEPTANCE OF COLOREC-TAL CANCER SCREENING: PAIN AS THE EXPLENATIONBenedicte Kirkøen, Norway; P. Berstad; E. Botteri; E. Dalén; J. A. Nilsen; G. Hoff; T. de Lange; T. Bernklev


177


Tues

day,

Oct

ober

31,

201

7


P0864AUTOLOGOUS BLOOD, A NOVEL AGENT FOR PRE-OPERATIVE COLONIC LOCALIZATION: A SAFETY AND EFFICACY COMPARISON STUDYE. J. Kim; J.-W. Chung; S.-Y. Kim; J. H. Kim; Y. J. Kim; Kyung Oh Kim, Republic of Korea; K. A. Kwon; D. K. Park; S. W. Park; J.-H. Baek

P0865SUBMUCOSAL INVASION IN COLORECTAL LATERAL-LY SPREADING TUMORS (LST) AND ABILITY OF THE ENDOSCOPIST FOR CANCER DETECTIONHeithem Soliman, France; B. Brieau; M.-A. Guillaumot; S. Leblanc; R. coriat; F. Prat; S. Chaussade

P0866ETHNIC VARIATION OF COLONIC POLYPS: FINDINGS FROM AN INTERNATIONAL HOSPITAL FOR MEDICAL TOURISM IN THAILANDS. Techapaitoon; V. Permpoon; Krit Pongpirul, USA

P0867ARE WE READY FOR COLONIC ESD IN FRANCE?Jérémie Jacques, France; J. Albouys; A. Charissoux; J. Rivory; D. Sautereau; T. Ponchon; R. Legros; M. Pioche

P0868RISK OF COLORECTAL NEOPLASM IN PATIENTS WITH ACROMEGALY -A CASE-CONTROL STUDY- Yorinari Ochiai, Japan; T. Iizuka; N. Inoshita; S. Yamada; S. Hoteya

P0869COMPARISON OF WHITE LIGHT COLONOSCOPY AND A NOVEL ROBOTIC COLONOSCOPE IN THE ASSESSMENT OF ULCERATIVE COLITIS S. Pallotta; E. Tumino; G. Manes; S. Ardizzone; R. Sacco; Francesca Iannuzzi, Italy; R. de Franchis

P0870WHAT IS THE CONCORDANCE FOR THE DIAGNOSIS OF LATERALLY SPREADING-TYPE LESIONS (LST) AMONGST WESTERN AND JAPANESE EXPERT ENDOSCOPISTS?Bairavi Manorahan, United Kingdom; A. Jimenez; S. Sansone; M. Yamada; M. San Juan; N. Gonzalez; E. Albéniz Arbizu; M. A. Bianco; R. Bisschops; K. Homma; H. Ikematsu; Y. Morita; T. Uraoka; K. Ragunath; A. Parra-Blanco

P0856WITHDRAWN

P0857TWO LITERS OF POLYETHYLENE GLYCOL (PEG) WITH 15 MG OF BISACODYL VERSUS 4 LITERS OF PEG FOR BOWEL PREPARATION TO COLONOSCOPY. PROSPEC-TIVE RANDOMIZED STUDY. PRELIMINARY RESULTSEl Mekkaoui Amine, Morocco; Z. Abdelkrim; E. M. Aziz; W. Khannoussi; G. Kharrasse; Z. Ismaili

P0858COLONOSCOPY ON THE LEFT, RIGHT?Irina Mocanu, Portugal; A. Laranjo; S. Pires; N. Veloso; L. Gonçalves; R. Godinho; I. Medeiros

P0859 NON-GRANULAR LATERALLY SPREADING COLONIC LESIONS ≥20MM (LSL) ARE SMALLER AND MORE COMMONLY MULTIPLE THAN GRANULAR LSL; IMPLI-CATIONS OF A ‘COLONIC MUCOSAL PHENOTYPE’ FOR PRACTITIONERS OF ENDOSCOPIC RESECTIONDavid Tate, Australia; H. Awadie; L. Desomer; M. Sidhu; K. Goodrick; N. G. Burgess; M. J. Bourke

P0860WIDE-FIELD PIECEMEAL COLD SNARE POLYPECTOMY OF LARGE SESSILE SERRATED POLYPS WITHOUT A SUBMUCOSAL INJECTION IS SAFEDavid Tate, Australia; H. Awadie; F. Bahin; L. Desomer; R. Lee; S. Heitman; K. Goodrick; M. J. Bourke

P0861THE PROSPECTIVE OBSERVATION STUDY FOR OVER 10MM COLORECTAL LESIONS ENDOSCOPICALLY RE-SECTED USING BIPOLAR SNAREHiroshi Nakamura, Japan; H. Ikematsu; N. Okamoto; R. Ito; D. Sato; T. Minamide; Y. Yamamoto; K. Takashima; T. Hombu; K. Nakajo; T. Kadota; Y. Yoda; K. Hori; Y. Oono; T. Yano

P0862 THE SMSA POLYP SCORE RELIABLY PREDICTS ROBUST ENDPOINTS OF ENDOSCOPIC MUCOSAL RESECTION OF COLORECTAL LATERALLY SPREADING LESIONS.Mayenaaz Sidhu, Australia; D. J. Tate; L. Desomer; G. Brown; A. Moss; S. Raftopoulos; S. Zanati; R. Singh; S. Williams; E. lee; M. J. Bourke

P0863USE OF ACETIC ACID FOR EVALUATING SESSILE SER-RATED ADENOMA/POLYP: A PILOT STUDYShunsuke Yamamoto, Sweden; M. Shafazand


178




P0877EQUAL ADENOMA DETECTION RATE IN COLONOSCO-PIES OF PATIENTS WITH SPINAL CORD INJURY AND CONTROLS – A CASE-CONTROL STUDY.A. Blanco Belver; M. Aach; W. Schmiegel; T. A. Schildhauer; R. Meindl; Thorsten Brechmann, Germany

P0878RISK FACTORS AND PRACTICAL CONSEQUENCES OF COLORECTAL ESD CONVERSION TO EMR AT A WESTERN REFERRAL CENTER IN DAILY PRACTICE.Enrique Perez-Cuadrado-Robles, Belgium; H. Piessevaux; T. Moreels; P. H. Deprez

P0879CONTRIBUTION OF COLONOSCOPY IN ELDERLY PA-TIENTS OLDER THAN 70 YEARSAmine El Mekkaoui, Morocco; A. Taiymi; A. Zazour; W. Khannoussi; G. Kharrasse; Z. Ismaili

P0880ENDOSCOPIC CLOSURE OF ACUTE IATROGENIC PERFORATIONS OF THE GASTROINTESTINAL TRACT AND PREDICTORS OF NEED FOR EARLY SURGERY: A SYSTEMATIC REVIEW AND META-ANALYSISAhmed Gabr, United Kingdom; N. Ammar; M. El Houssine; M. Rutter

P0881REAL-TIME HISTOLOGICAL CHARACTERIZATION OF COLORECTAL POLYPS – THE IMPACT OF TRAININGJoana Castela, Portugal; J. Cortez-Pinto; S. Mão de Ferro; I. Rosa; S. Ferreira; J. Pereira da Silva; I. Claro; S. Faias; P. Lage; A. Dias Pereira

P0882“O-RING SIGN” AS A NOVEL COLONOSCOPIC FINDING WITH NARROW-BAND IMAGING FOR DETECTING DEPRESSED-TYPE COLORECTAL LESIONSTakahiro Fujii, Japan

P0883THE LEARNING CURVE FOR COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) BETWEEN EXPERT AND TRAINEE ENDOSCOPISTNaohiko Akimoto, Japan; K. Mitsui; T. Teramoto; S. Fujimori; K. Iwakiri

Endoscopy, ERCP

P0884LARGE BALLOON DILATATION VERSUS MECHANICAL LITHOTRIPSY AFTER ENDOSCOPIC SPHINCTEROTOMY IN MANAGEMENT OF LARGE COMMON BILE DUCT STONES AMONG CIRRHOTIC PATIENTSM. I. Radwan; Mohamed Hassan Emara Elzanan, Egypt; I. M. Ibrahim; M. E. Morsy

P0871CLINICAL USEFULNESS OF THE SMSA DIFFICULTY SCORE AND COMPARISON WITH A SUBJECTIVE SCORE FOR THE MANAGEMENT OF LARGE NON-PEDUNCU-LATED COLORECTAL LESIONS. A MULTICENTER STUDY FROM THE SPANISH ENDOSCOPY SOCIETY ENDOSCOP-IC RESECTION GROUP.Eduardo Albéniz Arbizu, Spain; M. Fraile González; C. Guarner Argente; D. Martínez-Ares; B. Ibañez Beroiz; A. Herreros de Tejada; J. Santiago; M. A. Alvarez; X. Bessa Casserras; M. Rullan; O. Nogales Rincón; F. Ramos-Zabala; E. Valdivielso Cortazar; R. Pardeiro Pertega; P. Alonso; J. Cobian; F. Mugica; C. J. Gargallo Puyuelo; A. Elosua; J. de la Peña; J. G. Martinez-Cara; E. Redondo Cerezo; M. Pellisé Urquiza; L. Rivero Sánchez; A. Huerta; J. Gonzalez Santiago; A. Alvarez Delgado; J. Espinós; A. Repiso Ortega; F. J. Navajas; J. Carbo Perseguer; J. Merlo; M. Rodriguez Tellez; V. A. Jimenez-Garcia; F. Sabado; E. Saperas Franch; P. Huelin Alvarez; M. Concepcion-Martin; Spanish Endoscopy Society Endoscopic Resection Group members

P0872NARROW BAND IMAGING GUIDED BIOPSY IMPROVES THE YIELD OF HISTOLOGY FOR THE DIAGNOSIS OF GASTROINTESTINAL TUBERCULOSIS (GITB)N. Berry; Saroj Sinha, India; S. Malik; R. Kochhar; K. Vaiphei; K. Sharma; N. Dhaka; A. Koshi

P0873EFFICACY AND SAFETY OF ENDOSCOPIC RESECTION OF LARGE COLORECTAL ADENOMAS – CLINICAL EXPERI-ENCE OF A TERTIARY REFERRAL CENTERL. Mlynarsky; S. Zelber-Sagi; E. Miller; Revital Kariv, Israel

P0874COLORECTAL MUCOSAL DEFECT CLOSURE FOLLOWING ENDOSCOPIC MUCOSAL RESECTION: A SYSTEMATIC REVIEW AND META-ANALYSISCarolina Palmela, Portugal; P. Marques Da Costa; A. O. Ferreira

P0875RECTAL ESD IN VERY OLD PATIENTS (>80 YEARS) : A FRENCH MULTICENTER RETROSPECTIVE STUDYRomain Legros, France; J. Albouys; M.-A. Guillaumot; V. Lepilliez; S. Chaussade; M. Pioche; S. Leblanc; M. Barret; F. Prat; J. Rivory; D. Sautereau; T. Ponchon; J. Jacques

P0876COLONOSCOPY SPLIT-DOSE PROTOCOL IMPLEMENTA-TION: A SINGLE-CENTRE EXPERIENCECarolina Palmela, Portugal; C. Gomes; M. P. Costa Santos; M. Rocha; S. Pereira; D. Tavares; R. Ribeiro; A. O. Ferreira; E. Barjas; M. Cravo


179


Tues

day,

Oct

ober

31,

201

7


P0892CONFIRMATION OF THE EFFECT OF AN ANTAGONIST TO CONSCIOUS SEDATION ON THE PREVENTION OF ASPIRATION PNEUMONIA AFTER ENDOSCOPIC RETRO-GRADE CHOLANGIOPANCREATOGRAPHYYoko Taya, Japan; M. Kuwatani; K. Sakurai; R. Sasaki; S. Tsunematsu; M. Matsumoto; U. Baba; Y. Tsukamoto; S. Muto; T. Kimura

P0893PREVENTION OF POST-ERCP PANCREATITIS: RESULTS OF AN AGGRESSIVE HYDRATION PROTOCOLPedro Marcos, Portugal; C. Atalaia-Martins; S. Barbeiro; I. Cotrim; C. Gonçalves; L. Eliseu; H. Vasconcelos

P0894ERCP CYTOLOGY YIELD – DOES THE BRUSH MATTER?Irina Mocanu, Portugal; A. Laranjo; S. Pires; N. Veloso; L. Gonçalves; R. Godinho; I. Medeiros

P0895 PROSPECTIVE STUDY OF EARLY PRECUT VS. UTMOST PRECUT WITH PANCREATIC STENT IN INITIAL PANCRE-ATIC DUCT CANNULATIONEun Taek Park, Republic of Korea; B. C. Yun; S. U. Lee; B. H. Han

P0896 POST-ERCP BLEEDING IN THE ERA OF MULTIPLE ANTI-PLATELET AGENTSHyoung-Chul Oh, Republic of Korea; I. El Hajj; J. Easler; E. Fogel; J. Watkins; L. McHenry; G. Lehman; J. S. Choi; H. Kang; S. Sherman

P0897PROSPECTIVE COMPARISON OF DIGITAL SPYGLASS DIRECT VISUALIZATION SYSTEM VS DIRECT PERORAL CHOLANGIOSCOPY USING A MULTIBENDING ENDO-SCOPE AS A SINGLE-OPERATOR CHOLANGIOSCOPY FOR MANAGING BILIARY LESIONSYun Nah Lee, Republic of Korea; J. H. Moon; H. J. Choi; H. K. Kim; T. H. Lee; H. W. Lee; M. H. Choi; S.-W. Cha; Y. D. Cho; S.-H. Park

P0898WITHDRAWN

P0899THE DILEMMA OF MANAGMENT BORDERLINE COM-MON BILE DUCT STONE. DOES STONE SIZE MATTER? : A PROSPECTIVE RANDOMIZED STUDY.Ehab Abdellatif, Egypt; E. Elhanafy; A. Elnakeeb

P0900PROSPECTIVE STUDY ON METHODS AND SUCCESS OF BILIARY CANNULATION OF 458 VIRGIN PAPILLAS – QUALITY ASSURANCE OF ERCP AT OUR DEPARTMENTÁ. Orbán-Szilágyi; K. Lorinczy; K. Rábai; M. Horváth; F. Zsigmond; Tibor Gyökeres, Hungary

P0885SAFETY AND EFFICACY OF ENDOSCOPIST-DIRECTED BAL-ANCED PROPOFOL SEDATION (BPS) DURING ENDOSCOPIC RETROGRADE CHOLANGIO-PANCREATOGRAPHY (ERCP)Alon Lapidus, Israel; I. M. Gralnek; A. Suissa; A. Klein; K. A. Yassin; I. Khamaysi

P0886A NOVEL METHOD OF PREVENTING DUODENOBILIARY REFLUX BY MEANS OF SUSPENDED OVERLENGTH BILI-ARY STENTS IN PATIENTS WITH BILIARY STRICTUREYonghui Huang, China; X. Yan; H. Chang; Y. Zhang; W. Yao; K. Li

P0887DUODENOSCOPES AND LINEAR ECHOENDOSCOPES ARE CONTAMINATED WITH DIGESTIVE TRACT BACTERIA: NATIONWIDE PERSISTENT HIGH PREVALENCE IN THE THE NETHERLANDSArjan Rauwers, The Netherlands; A. F. Voor in ’t holt; W. De Groot; J. G. Buijs; B. E. Hansen; M. C. Vos; M. J. Bruno

P0888TECHNICAL EVOLUTION OF A NEWLY-DEVELOPED DIGITAL CHOLANGIO/PANCREATO-SCOPY (SPYGLASS DS) FOR PREOPERATIVE EVALUATION OF PANCREATO-BILIARY NEOPLASMKei Ito, Japan; S. Koshita; T. Ogawa; Y. Kanno; K. Masu; H. Kusunose; T. Sakai; T. Murabayashi; S. Hasegawa; F. Kozakai; Y. Noda

P0889ACUTE PANCREATITIS AND HYPERAMYLASAEMY DEVELOPMENT AFTER ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPY – CHALLENGES AND PREVENTIONPlamen Petrov, Bulgaria; B. Petrov; T. Vukova

P0890 MOST ADVANCED ENDOSCOPY TRAINEES DO NOT MEET COMPETENCE FOR NATIVE PAPILLAE CANNU-LATION IN ERCP: RESULTS FROM A PROSPECTIVE MULTICENTER STUDY Sachin Wani, USA; M. Hall; V. Simon; S. Han; D. Early; R. Keswani

P0891SIMILAR POST-ERCP PANCREATITIS RATES IN ENDOS-COPIST- VS ASSISTANT-CONTROLLED WIRE-GUIDED BILE DUCT CANNULATION: A SINGLE CENTRE OBSER-VATIONAL STUDYMaxworth Hu, United Kingdom; A. Bhagwat; M. Hayat


180




P0908ACCURACY OF ENDOSCOPIC ULTRASOUND IN GASTRIC ADENOCARCINOMA PATIENT SELECTION FOR NEOAD-JUVANT THERAPYJuliana Costa, Portugal; J. B. Soares; B. Gonçalves; S. Carvalho; R. Gonçalves

P0909IS IT USEFULL TO REPEAT ENDOSCOPIC ULTRASOUND WITH FINE NEEDLE ASPIRATION OF PANCREATIC CYS-TIC LESIONS? A RETROSPECTIVE STUDYSandra Faias, Portugal; J. Pereira Silva; I. Marques; R. Fonseca; A. Dias Pereira

P0910 DETERMINATION OF INTRACYSTIC GLUCOSE CON-CENTRATIONS IN THE DIFFERENTIAL DIAGNOSIS OF PANCREATIC CYSTS: A PROSPECTIVE STUDY.A. Cantamessa; M. Bruno; S. Gaia; G. Saracco; Claudio De Angelis, Italy

P0911WITHDRAWN

P0912UTILITY OF LIQUID BASED CYTOLOGY IN EUS-FNA SAMPLES FOR THE PANCREATIC LESIONSYusuke Ishida, Japan; Y. Okabe; T. Taira; T. Sakaue; M. Fukahori; M. Yasumoto; T. Ushijima; Y. Naito; O. Tsuruta; T. Torimura

P0913ANTIBIOTIC PROPHYLAXIS AFTER PANCREATIC CYST PUNCTURE – LESS IS MORE? ONE-TIME VERSUS EX-TENDED CIPROFLOXACIN PROTOCOL. Irina Mocanu, Portugal; R. Barosa; M. Patita; G. Nunes; P. Pinto Marques

P0914EUS-GUIDED FNA IN THE STUDY OF THE ADRENAL GLAND: NATIONAL RETROSPECTIVE MULTICENTER STUDYAlbert Martin-Cardona, Spain; G. Fernández-Esparrach; J. C. Súbtil Íñigo; J. Iglesias Garcia; M. Garcia-Guix; A. Barturen Barroso; A. Z. Gimeno García; J. Miguel Esteban; A. Pardo Balteiro; A. J. Velasco Guardado; E. Vazquez Sequeiros; C. Loras Alaustrey; B. Martinez Moreno; A. Castellot; C. Huertas Nadal; M. Martínez Lapiedra; A. Sanchez Yague; Á. Terán Lantarón; V. Jair Morales; M. T. Betes Ibáñez; D. de la Iglesia Garcia; C. Sánchez-Montes; M. D. Lozano Escario; J. Lariño Noia; A. Gines; J. B. Gornals

P0915RELIABILITY OF GIST'S PRE-TREATMENT RISK AS-SESSMENT CLASSIFICATION WITH EUS-FNB BY USING DESIGNED CORE NEEDLESRoberto Grassia, Italy; P. Capone; F. Cereatti; E. Iiritano; K. Vjero; M. Martinotti; G. Tanzi; F. Buffoli

P0901RISK FACTORS FOR POST-ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS: A PROSPECTIVE MULTICENTER STUDYAzumi Suzuki, Japan; B. Endoh; K. Chikugo; T. Kawakami; T. Suzuki; N. Yoshitaka; K. Kusumoto; Y. Itokawa; O. Inatomi; S. Bamba; K. Uno; Y. Mizumoto; K. Tanaka

P0902USEFULNESS OF AMY MEASUREMENTS AT 2 HOURS AFTER ENDOSCOPIC RETROGRADE CHOLANGIOPAN-CREATOGRAPHY IN PREDICTING THE SEVERITY OF POST-ERCP PANCREATITIS, MULTICENTER PROSPEC-TIVE STUDY, SOSUI.Kawakami Takumi, Japan; T. Suzuki; H. Sato; N. Yoshida; Y. Nakai; K. Kusumoto; Y. Itokawa; A. Suzuki; B. Endoh; K. Chikugo; O. Inatomi; S. Bamba; Y. Mizumoto; K. Tanaka

Endosonography

P0903ENDOSCOPIC ULTRASOUND-BASED TRANSDUODENAL CHOLECYSTOLITHOTOMY VIA DOUBLE-FLANGED FULLY COVERED METAL STENT WITH HOT STENT DELIVERYSiyu Sun, China

P0904QUANTITATIVE ENDOSCOPIC ULTRASOUND ELASTOG-RAPHY IN THE DIFFERENTIAL DIAGNOSIS OF PANCRE-ATIC SOLID TUMORSHelena Ribeiro, Portugal; C. Leitão; J. Pinto; R. Azevedo; F. Pereira; R. Sousa; A. I. L. Pires Caldeira; E. Pereira; A. Banhudo

P0905IS ENDOSCOPIC ULTRASONOGRAPHY EXAMINATION USEFUL BEFORE ENDOSCOPIC SUBMUCOSAL DIS-SECTION IN PATIENTS OF SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA?Yin Yi Chu, Taiwan; S. C. Ng; J. M. Lien; C. T. Chiu

P0906COMPARISON OF DIAGNOSTIC PERFORMANCES FOR THE EVALUATION OF SUSPECTED MALIGNANT BILIARY STRICTURE AMONG SAME SESSION EUS-AND ER-CP-GUIDED TISSUE SAMPLINGSeong Jae Yeo, Republic of Korea; C. M. Cho; M. K. Jung; A. N. Seo; H. I. Bae

P0907PREVALENCE OF POSTERIOR MEDIASTINAL LYMPHADENOPATHIES IN PATIENTS UNDERGOING ENDOSCOPIC ULTRASONOGRAPHY FOR NON-MALIG-NANT INDICATIONS: A PORTUGUESE SINGLE-CENTRE PROSPECTIVE STUDYJoana Veloso do Carmo, Portugal; S. C. Marques; M. Bispo; C. Chagas


181


Tues

day,

Oct

ober

31,

201

7


P0923EFFICIENCY OF PANCREATIC STENTS IN DIFFICULT CAN-NULATION – A RETROSPECTIVE SINGLE – CENTER STUDYVasile Sandru, Romania; M. Ilie; O. M. Plotogea; E. Rinja; I. Moroi; B. Ungureanu; G. Constantinescu

P0924 ENDOSCOPIC ULTRASONOGRAPHY-GUIDED BILIARY DRAINAGE WITHOUT DILATION DEVICE USING A THIN DELIVERY-SYSTEM STENT: A PRECLINICAL STUDYItonaga Masahiro, Japan; M. Kitano; Y. Kawaji; H. Abe; T. Tamura; N. Junya; K. Hatamaru; H. IMAI; S. Omoto; K. Yamao; K. Minaga; K. Kamata; T. Miyata; M. Takenaka; M. Kudo

P0925TREATMENT WITH FULLY-COVERED METAL STENTS OF POST-SPHINCTEROTOMY EARLY AND LATE BLEEDINGP. Gambitta; S. Pallotta; A. D'Alessandro; F. Iannuzzi; E. Bareggi; Alessandro Ballerini, Italy

P0926 EFFICACY OF SELF-EXPANDABLE METALLIC STENT PLACEMENT IN THE MANAGEMENT OF ANASTOMOTIC STRICTURE AFTER ORTHOTOPIC LIVER TRANSPLANTATIONSunguk Jang, USA; M. Parsi; R. Lopez; A. Bhatt; J. J. Vargo

P0927“DISCONNECTED PANCREATIC DUCT” FOLLOWING EUS GUIDED DRAINAGE OF PANCREATIC FLUID COLLECTION – IS IT CLINICALLY RELEVANT? LONG-TERM FOLLOW UP FROM A LARGE VOLUME TERTIARY CARE CENTRE.Sundeep Lakhtakia, India; J. Basha; P. Pal; R. Gupta; M. Ramchandani; S. Kumar; R. Kalapala; M. Tandan; Z. Nabi; P. M. Reddy; G. V. Rao; D. N. Reddy

P0928FULLY COVERED SELF-EXPANDABLE METAL STENT IN THE MANAGEMENT OF DUODENAL RETROPERITONE-AL PERFORATIONS DURING ERCP: A SINGLE CENTER EXPERIENCEM. Pizzicannella; G. Andrisani; M. Martino; R. Rea; M. Pandolfi; Francesco Maria Di Matteo, Italy


P0929EFFICACY AND ONCOLOGIC SAFTY OF ENDOSCOPIC DUODENAL STENTING IN PATIENTS WITH ADVANCED PANCREATIC CANCERTakashi Sakuno, Japan; H. Inoue; R. Yamada; T. Harada; M. Nakamura; M. Katsurahara; Y. Hamada; K. Tanaka; N. Horiki; Y. Takei

P0916TECHNICAL FEASIBILITY AND SAFETY OF ENDO-SCOPIC ULTRASOUND (EUS)-GUIDED FIDUCIAL MARKER PLACEMENT USING A NOVEL SYSTEM WITH PRE-LOADED 22-GAUGE NEEDLES IN PANCREATIC CANCER PATIENTS Eun Ji Shin, USA; S.-H. Kim; M. A. Khashab; M. I. Canto

Capsule endoscopy

P0917DEVELOPMENT AND VALIDATION OF A HIGHLY SENSI-TIVE AND SPECIFIC AUTOMATED ALGORITHM TO EVAL-UATE THE ABUNDANCE OF BUBBLES IN SMALL BOWEL CAPSULE ENDOSCOPY Olivia Pietri, France; G. Rezgui; A. Histace; M. Camus; I. Nion-Larmurier; E. Abou Ali; C. Li; A. Becq; O. Romain; U. Chaput; P. Marteau; C. Florent; X. Dray

P0918AGE AND GASTRIC EMPTYING TIME ARE PREDICTIVE FACTORS FOR INCOMPLETE CAPSULE ENDOSCOPY: RESULTS OF A MULTIVARIATE ANALYSIS IN A LARGE STUDY POPULATION.E. Macías; Ignacio Fernández-Urién Sainz, Spain; J. F. Juanmartiñena; I. Elizalde; A. Borda; G. Ezpeleta; J. J. Vila

P0919 A NOVEL CAPSULE TECHNOLOGY PLATFORM FOR SPE-CIFIC LOCALIZED COLON DRUG DELIVERYNadir Arber, Israel; H. Elizabeth; S. Doron; G. Nathan; J.-D. Maayan; L. Jesse; M. Alaa; S. Benny; G. Ian; R. Tova; L. Evgenya

P0920 COLON CAPSULE ENDOSCOPY: HOW DOES INADEQUATE PROCEDURE CLEANSING CORRELATE WITH PROCE-DURE ACCURACY?Shay Perek, Israel; S. Farkash; N. Schwartz

P0921 COLON CAPSULE ENDOSCOPY MAY REDUCE COLONOS-COPY MISS RATE – A MULTICENTER STUDYShay Perek, Israel; N. Schwartz

Biliary and pancreatic stenting

P0922ENDOSCOPIC MANAGEMENT OF POSTOPERATIVE PAN-CREATIC FISTULAS AFTER DISTAL PANCREATECTOMY OR ENUCLEATIONMarine Camus, France; S. Chaouch; S. Leblanc; S. Gaujoux; F. Paye; P. Balladur; J. C. Vaillant; F. Menegaux; P. P. Massault; M. Barret; R. coriat; S. Chaussade; B. Dousset; F. Prat


182




P0937PREDICTORS OF POSTOPERATIVE LYMPHOPAENIA AFTER SURGERY FOR ESOPHAGEAL AND ESOPHA-GO-GASTRIC JUNCTION CANCEROttavia De Simoni, Italy; S. Mocellin; P. Moroni; L. M. Saadeh; F. Cavallin; R. Alfieri; M. Cagol; C. Castoro; M. Scarpa

P0938FLEXIBLE ENDOSCOPIC TREATMENT FOR ZENKER’S DIVERTICULUM OF HIGH ANESTHETIC RISK PATIENTS WITH THE SB KNIFE. TERTIARY CENTRE CENTRE EXPERIENCESauid Ishaq, United Kingdom; A. Antonello; A. Aziz; L. Priestnall; T. Kuwai; S. Kong; F. Walji; K. Siau; A. Gait; C. J. J. Mulder

P0939INCREASING LYMPH NODE RETRIEVAL IN ESOPHAGEC-TOMY, OUTCOMES OF THE DUTCH UPPER GASTROIN-TESTINAL CANCER AUDITLeonie van der Werf, The Netherlands; J. Dikken; M. I. van Berge Henegouwen; V. E. P. P. Lemmens; G. A. P. Nieuwenhuijzen; B. P. L. Wijnhoven; on behalf of the Dutch Upper GI Cancer Audit group

P0940COLONIC INTERPOSITION AFTER OESOPHAGECTOMY IN ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE INFLUENCE OF CONDUIT CHOICE AND ROUTE ON OUTCOMEJade Brown, United Kingdom; D. Chan; W. Lewis; G. Clark; G. Blackshaw; A. Foliaki

Hepatobiliary / pancreas / spleen

P0941THE ROLE OF LIVER RESECTION AFTER CHEMO-THERAPY FOR SYNCHRONOUS COLORECTAL LIVER METASTASISAkira Ouchi, Japan; Y. Shimizu; K. Komori; Y. Senda; T. Kinoshita; S. Natsume; T. Ooshiro

P0942SURGICAL OUTCOME OF HEPATOPANCREATODUODENEC-TOMY ASSOCIATED WITH HEMIHEPATECTOMY OR MORE EXTENDED LIVER RESECTION FOR BILIARY CANCERSTsuyoshi Sano, Japan; K. Komaya; T. Arikawa; T. Saito; S. Ishiguro; S. Komatsu; Y. Senda; S. Natsume; Y. Shimizu; M. Esaki; K. Shimada

P0943PERIOPERATIVE ADMINISTRATION OF BROAD-SPEC-TRUM ANTIBIOTICS COVERING ENTEROBACTERIACEAE DECREASE THE INCIDENCE OF SURGICAL SITE INFEC-TION FOLLOWING PANCREATODUODENECTOMYKimitaka Tanaka, Japan; Y. Nakanishi; T. Asano; T. Noji; T. Nakamura; T. Tsuchikawa; K. Okamura; T. Shichinohe; S. Hirano

P0930 CLINICAL FAILURE IN COLONIC STENTING FOR MALIG-NANT LARGE BOWEL OBSTRUCTION: OUTCOMES AND RISK FACTORS IN 172 PROCEDURESRei Ishibashi, Japan; S. Yoshida; A. Narita; T. Shimpoh; N. Takahara; A. Nakada; M. Tsuboi; M. Hata; Y. Nakai; Y. Hirata; K. Koike

P0931THE CLINICAL EFFICACY OF MITOMYCIN-C INJECTION THERAPY IN REFRACTORY BENIGN ESOPHAGEAL STENOSIS: A PRELIMINARY STUDYSun Gyo Lim, Republic of Korea; J.-H. Kim; K. M. Lee

P0932TREATMENT WITH MULTIPLE REABSORBABLE STENTS OF COMPLETE AND PARTIAL LOWER GI ANASTOMOSIS DEHISCENCE AND STENOSISP. Gambitta; S. Pallotta; F. Iannuzzi; E. Bareggi; Alessandro Ballerini, Italy; A. D'Alessandro

P0933EVALUATION OF FACTORS ASSOCIATED TO A SUCCESS-FUL DILATION IN POST-ESD STRICTURESEnrique Perez-Cuadrado-Robles, Belgium; H. Piessevaux; T. Moreels; R. C. P. Yeung; E. Danse; P. H. Deprez

P0934EFFECTIVENESS OF REPEATED DILATIONS IN THE MANAGEMENT OF ESOPHAGEAL BENIGN STRICTURESAlban Benezech, France; A. Debourdeau; J.-M. Gonzalez; M. Barthet

P0935EFFICACY AND SAFETY OF NEWLY DEVELOPED ENDOSCOPIC COLONIC STENTS WITH AN INCREASED EXPANDABLE FORCE: A RETROSPECTIVE COMPARISON WITH CONVENTIONAL COLONIC STENTSTomoyuki Nishimura, Japan; T. Kuwai; H. Kohno; H. Kouno; A. Yamaguchi; T. Yamaguchi; H. Imagawa; Y. Miyasako; Y. Sumida; T. Takasago; R. Miura; K. Tao; S. Funaki; S. Ishaq

Poster Session09:00 – 17:00 Hall 7Surgery II


P0936PERORAL ENDOSCOPIC MYOTOMY FOR THE CASES IN WHICH HELLER-DOR OPERATION WERE INEFFECTIVEHironari Shiwaku, Japan; K. Yamashita; N. Kore-eda; T. Ohmiya; H. Okada; F. Yoshimura; S. Nimura; H. Inoue; S. Hasegawa


183


Tues

day,

Oct

ober

31,

201

7


Laparoscopic techniques

P0951COMPARATIVE EVALUATION OF LAPAROSCOPIC SINGLE-PORT (SILS) CHOLECYSTECTOMY AND LAPARO-SCOPIC FOUR-PORT CHOLECYSTECTOMYAftandil Alekberzade, Russian Federation; N. Krylov; E. Lipnitsky

P0952LAPAROSCOPIC SURGERY’S 100 MOST INFLUENTIAL MANUSCRIPTS: A BIBLIOMETRIC ANALYSISKatie Mellor, United Kingdom; A. Powell; W. Lewis

P0953BASELINE CHARACTERISTICS IN LAPAROSCOPIC SIMU-LATOR PERFORMANCENinos Oussi, Sweden; P. Renman; E. Georgiou; L. Enochsson

P0954PERITONEAL TUBERCULOSIS: EPIDEMIOLOGICAL DATA, CLINICAL AND EVOLUTIVE ASPECTS ACCORDING TO THE EXPERIENCE OF A TUNISIAN CENTERWafa Ben Ameur, Tunisia; J. Hanen; E. Hammami; E. Nour; M. Kssia; B. Ahlem; A. Salem; A. Ben Slama; J. Ali

P0955ABDOMINAL TUBERCULOSIS: A RETROSPECTIVE SERIES OF 150 CASESSonda Jardak, Tunisia; H. Kchir; N. Maamouri; H. Chaabouni; N. Ben Mami

Poster Session09:00 – 17:00 Hall 7IBD II


P0956 PATHOBIONT-FREE MICROBIOTA PROTECTS AGAINST GUT INFLAMMATION INDUCED BY AN INNATE IMMUNE DEFI-CIENCY OR DIETARY PERTURBANT OF THE MICROBIOTABenoit Chassaing, USA; A. T. Gewirtz

P0957WITHDRAWN

P0958ISOLATION AND CHARACTERIZATION OF LAMINA PROPRIA MONONUCLEAR CELLS FROM HUMAN COLONIC MUCOSASanja Musladin, Croatia; I. Zlatar; L. Pribolšan; K. Ilić; P. Nikolić; M. Antolić; S. Čužić; G. Aralica; L. Patrlj; R. Kliček; M. Bosnar; V. Eraković Haber

P0959FACTORS ASSOCIATED WITH DISABILITY IN INFLAMMATORY BOWEL DISEASE: OUTPATIENT CROSS–SECTIONAL STUDYJuliana Costa, Portugal; D. Matos; J. B. Soares; R. Costa; B. Arroja; R. Gonçalves

P0944 PARADIGM SHIFT? SHOULD A LYMPHADENECTOMY ROUTINELY BE PERFORMED ALSO AMONG GALLBLAD-DER CANCER PATIENTS WITH T1A DISEASE?N. Köhn; R. Warschkow; D. Nussbaum; D. Candinas; B. Gloor; B. Schmied; D. Blazer; Mathias Worni, Switzerland

P0945RECTAL SWAB CULTURE CAN DIRECT ANTIMICROBIAL PROPHYLAXIS AND PREDICT THE RISK OF INFECTIOUS COMPLICATIONS AFTER PANCREATICODUODENECTOMY.M. De Pastena; Salvatore Paiella, Italy; D. Ciprani; G. Marchegiani; A. M. Azzini; E. Concia; R. Salvia; C. Bassi

Postoperative complications

P0946 EFFECT OF TRICLOSAN-COATED SUTURE USE ON THE INCIDENCE OF SUPERFICIAL INCISIONAL SURGICAL SITE INFECTIONS AFTER GASTROENTEROLOGIC SURGERY: A PROPENSITY SCORE MATCHING RETROSPECTIVE STUDYKanefumi Yamashita, Japan; S. Takeno; S. Hoshino; H. Shiwaku; S. Hasegawa

P0947COMPARISON OF POSTOPERATIVE CONDITIONS BETWEEN ESOPHAGOGASTROSTOMY WITH THE DOU-BLE-FLAP TECHNIQUE AND THAT WITH A CIRCULAR STAPLER IN LAPAROSCOPIC PROXIMAL GASTRECTOMYMasato Hayashi, Japan; H. Kawakubo; S. Mayanagi; K. Fukuda; R. Nakamura; K. Suda; N. Wada; Y. Kitagawa

P0948 NOVEL ENDOSCOPIC REPAIR TECHNIQUE FOR GAS-TROINTESTINAL LEAKS AND PERFORATIONS USING NEGATIVE PRESSURE THERAPY WITH OPEN-PORE POLYURETHANE-FOAM AND FILM DRAINAGEGunnar Loske, Germany; F. Rucktaeschel; T. Schorsch; C. T. Mueller

P0949INFLUENCE OF THE HYBRID METHOD OF DETOXICA-TION ON BLOOD CLARIFICATION EFFECTIVENESS AT PATIENTS WITH THE MULTIORGAN FAILUREKhasan Khalikulov, Uzbekistan; B. A. Saidkhanov; D. B. Saidkhanova

P0950CARDIAC SEPTAL DEFFECT OCCLUDER DEVICE FOR ENDOSCOPIC TREATMENT OF GASTRO-CUTANEOUS AND GASTRO-PULMONARY LEAKS AFTER BARIATRIC SURGERYAlberto J. Baptista, Venezuela; W. Bandel; A. Gelrud; A. Salinas; L. C. Sabagh; A. Ospina; M. A. Guzman; J. F. Piñerúa Gonsálvez; H. Rass; A. Oropeza; M. Antor


184




P0968CD4+ T CELLS OF IBD PATIENTS ARE CHARACTERIZED BY AN INCREASED EXPRESSION OF THE NUCLEOTIDE RECEPTOR P2Y2, WHICH IMPACTS RELEVANTLY ON PRO-INFLAMMATORY SIGNALING CASCADES.J. Panteleev-Ivlev; S. Zundler; R. Atreya; M. F. Neurath; Imke Atreya, Germany

P0969HIF-1α STABILIZATION THROUGH HYDROXYLASE INHIBITION AMELIORATES DSS-INDUCED COLITIS AND INDUCES AUTOPHAGYJesus Cosin Roger, Switzerland; S. Simmen; H. Melhem; K. Atrott; I. Frey-Wagner; M. Hausmann; C. De Valliere; M. R. Spalinger; P. Spielmann; R. H. Wenger; J. Zeitz; S. Vavricka; G. Rogler; P. A. Ruiz

P0970PROTECTIVE EFFECT AND ACTION MECHANISM OF APOCYNIN IN IBD MOUSE MODELSeung-Joo Nam, Republic of Korea; S.-I. Kim; W. Chun; J. M. Park; S. C. Park; D. H. Choi; C. D. Kang; S. J. Lee

P0971THE USE OF RAPID EVAPORATIVE IONISATION MASS SPECTROMETRY (REIMS) IN FAECAL SAMPLES TO IDENTIFY INFLAMMATORY BOWEL DISEASESam Tristan Richmond Powles, United Kingdom; L. W. L. Chong; S. J. Cameron; L. C. Hicks; Z. Takats; H. R. T. Williams; T. R. Orchard

P0972THE PATHOGENIC MECHANISM OF ARYL HYDROCAR-BON RECEPTOR MEDIATED ABNORMAL DIFFERENTIA-TION OF INTESTINAL ILC3/ILC1 IN CROHN'S DISEASEXiaojing Zhao, China; H. Zhang

P0973PREVALENCE AND GENETIC DIFFERENCES IN ADHE-SION-RELATED GENES AMONG COMMENSAL AND ADHERENT-INVASIVE E. COLI STRAINSCarla Camprubí-Font, Spain; A. Segú-Roig; N. Maeso-Sánchez; M. López-Siles; M. Martinez-Medina

P0974 DISTINCT GUT MICROBIOTA PROFILES IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND UL-CERATIVE COLITISLukas Bajer, Czech Republic; M. Kverka; M. Kostovcik; P. Macinga; J. Dvorak; Z. Stehlikova; J. Brezina; J. Spicak; P. Drastich

P0975WITHDRAWN

P0976HYPOXIA INDUCIBLE FACTOR (HIF)-1 ACCELERATES EPITHE-LIAL WOUND HEALING THROUGH INTEGRIN REGULATIONB. J. Goggins; K. Minahan; D. Knight; J. Horvat; M. M. Walker; Simon Keely, Australia

P0960BIOLOGIC THERAPY REDUCES T CELL ACTIVATION IN PATIENTS WITH CROHN'S DISEASE.Leticia Garcia, Brazil; A. E. Z. Carvalho; E. A. Rosseto; C. C. V. Nora; F. S. Flaquer; C. L. P. Mangueira; L. V. Rizzo; K. I. L. de Carvalho

P0961CHANGES OF THE MUCOSAL COLON MICROFLORA ARE CAUSE OF INFLAMMATION AT THE PATIENTS WITH ULCERATIVE COLITISArtem Kasianov, Russian Federation; A. Fedotova; M. Logacheva; K. Klimina; A. Zhurov; I. Ruchkina; A. Parfenov; O. Knyazev; N. Fadeeva

P0962COLONIC INFLAMMATION DELAYS DEVELOPMENT OF STREPTOZOTOCIN-INDUCED DIABETES IN MICE THROUGH MODULATION OF ENDOGENOUS INCRETIN SYSTEMHubert Zatorski, Poland; M. Sałaga; M. Zielińska; J. Fichna

P0963EOSINOPHILS-ASSOCIATED CYTOKINES AS INFLAMMA-TORY BOWEL DISEASE BIOMARKERSKatarzyna Neubauer, Poland; M. Matusiewicz; I. Bednarz-Misa; S. Górska; A. Gamian; M. Krzystek-Korpacka

P0964MACROPAHGE IL10 SIGNALING IS REQUIRED FOR THE THERAPEUTIC EFFECT OF ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASEPim Koelink, The Netherlands; F. M. Bloemendaal; L. Westera; A. B. van 't Wout; A. K. Gloudemans; B. Li; T. L. Geiger; M. E. Wildenberg; G. R. van den Brink

P0965LONG-TERM CONSEQUENCES OF ANTIBIOTIC THERAPY: ROLE OF SCFAS AND INTESTINAL BARRIER INTEGRITYYuliia Holota, Ukraine; A. Bazan; V. Stetska; N. Dziubenko; T. Dovbynchuk; T. Chervinska; L. Zakordonets; T. Serhiychuk; I. Kaji; G. Tolstanova

P0966THE ROLE OF TLR2-MEDIATED TREG/TH17 IMBALANCE IN THE PATHOGENESIS OF ULCERATIVE COLITISY. F. Xie; J. Y. Hao; Y. H. Pang; Y. H. Ma; Z. R. Li; X. Q. He; Xin Juan Liu, China

P0967 FIRST ANALYSIS FROM UK IBD TWIN BIOBANK; 16S RRNA GENE SEQUENCING IDENTIFIES REDUCED DI-VERSITY IN ACTIVE IBD AND TAXA ASSOCIATED WITH ACTIVE DISEASE PHENOTYPE TO LEVEL OF SPECIESH. Gordon; Marcus Harbord, United Kingdom; J. Marchesi; W. Blad; T. R. Orchard; J. McDonald


185


Tues

day,

Oct

ober

31,

201

7


P0983EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE IN SPAIN: INTERIM ANALYSIS OF THE NATIONWIDE EPIDEMIBD STUDY OF GETECCUMaria Chaparro, Spain; J. L. Cabriada; M. J. Casanova; D. Ceballos; M. Esteve; H. Fernández Rosaenz; M. Barreiro-de Acosta; V. García-Sánchez; D. Ginard; F. Gomollon; R. Lorente Poyatos; P. Nos; S. Riestra Menéndez; M. Rivero Tirado; P. Robledo Andrés; C. Rodríguez; B. Sicília Aladrén; E. A. Torrella Cortes; F. Rodríguez-Artalejo; J. P. Gisbert; On behalf of the EpidemIBD group

P0984IMPACT OF ANORECTAL COMPLAINTS ON QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DIS-EASE – A SURVEY OF THE DUTCH NATIONAL CROHN’S AND COLITIS ORGANISATION.Paul Vollebregt, The Netherlands; A. A. van Bodegraven; M. L. Markus-de Kwaadsteniet; D. van der Horst; R. J. Felt-Bersma

P0985CURRENT UNDERSTANDING OF POUCH MICROBIOTA IN HEALTH AND DISEASE; A SYSTEMATIC REVIEWJonathan Segal, United Kingdom; S. Oke; G. Hold; A. Hart

P0986LIVE-VACCINES AND BREASTFEEDING IN NEWBORN EXPOSED IN UTERO TO ANTI TNF: A MULTICENTER FRENCH STUDY IN INFLAMMATORY BOWEL DISEASESihem Bendaoud, France; S. Nahon; L. Beaugerie; J.-M. Gornet; B. Pariente; L. Peyrin-Biroulet; V. Abitbol; M. Boualit; R. Altwegg; A. Buisson; C. Baudry; L. Plastaras; F. Heluwaert; M. Amil; M. Antoni; K. Bideau; V. Quentin; G. Pineton de Chambrun; R. Faroux; F. Skinazi; C. LOCHER; E. Cuillerier; A. Boureille; A. Aubourg; I. Rosa; M. Simon


P0987OUTCOME OF ENDOSCOPIC ALLY RESECTED DYSPLASIC LESIONS IN ULCERATIVE COLITIS Houria Saoula, Algeria; A. F. Boutaleb; H. Mahiou; M. Aissaoui; Y. Zmiri; N. Hamidouche; R. Osmane; Y. Aissat; A. Mitiche; L. Gamar; K. Belhocine; N. Bounab; T. Boucekkine; L. Kecili; S. Berkane; Z. Amir; M. Nakmouche

P0988CYTOMEGALOVIRUS INFECTION IS ASSOCIATED WITH A POOR OUTCOME IN PATIENTS WITH ULCERATIVE COLITIS TREATED BY VEDOLIZUMABXavier Roblin, France; L. Brichet; S. Pillet; E. del Tedesco; J. M. Phelip; B. Pozzetto; N. Williet

P0977EFFECTS OF TIME ON URINARY METABOLIC SIGNA-TURES IN INFLAMMATORY BOWEL DISEASELucy Hicks, United Kingdom; S. T. R. Powles; L. W. L. Chong; J. Swann; E. Holmes; H. R. T. Williams; T. R. Orchard

P0978BACTERIAL TRANSLOCATION CONTINUES IN ULCER-ATIVE COLITIS DESPITE MUCOSAL HEALING AND CONTINUED CLINICAL REMISSIONAlan Steel, United Kingdom


P0979EFFECT OF FIBER AND FAT CONSUMPTION ON DISEASE ACTIVITY AND QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASEIoanna Pefkianaki, Greece; I. Mouzas; I. Koutroubakis

P0980PROGRESSION IN CROHN’S DISEASE BEHAVIOUR IN A PROSPECTIVE EUROPEAN POPULATION-BASED INCEP-TION COHORT – THE ECCO-EPICOM COHORTJohan Burisch, Denmark; A. Goldis; F. Magro; S. Turcan; R. D’Inca; S. Čuković-Čavka; D. Schwartz; P. Ellul; Z. Vegh; P. Oksanen; M. Giannotta; K. R. Nielsen; N. Arebi; R. Salupere; M. Fumery; J. F. Dahlerup; D. Christodoulou; L. Kievit; D. Duricova; N. Pedersen; D. Valpiani; I. Kaimakliotis; V. Hernández; L. Kupcinskas; J. Halfvarson; E. Langholz; P. L. Lakatos; P. Munkholm

P0981CHANGES IN GUT MICROBIOTA COMPOSITION CORRELATE WITH SHORT TERM CHANGES IN FACEAL CALPROTECTIN AND CRP IN PATIENTS WITH CROHN’S DISEASEDerek Chan, United Kingdom; D. Kumar; M. Mendall

P0982 COLORECTAL CANCER IN INFLAMMATORY BOWEL DIS-EASE: RISK FACTORS IN A PROSPECTIVE MULTICENTER NESTED CASE-CONTROL IG-IBD STUDYLivia Biancone, Italy; A. Armuzzi; M. L. Scribano; R. D'inca; C. Papi; L. Spina; L. Guidi; F. Moccisro; P. Alvisi; A. Ruffa; B. Neri; W. Fries; G. Riegler; M. Daperno; F. Castiglione; S. Renna; S. Festa; E. Calabrese; G. Meucci; F. Rogai; S. Ardizzone; A. Rossi; A. Orlando; F. Pallone


186




P0997EVALUATION OF LISA-TRACKER IMMUNOASSAY INFLIXIMAB AND ANTI-INFLIXIMAB FOR THE THERA-PEUTIC DRUG MONITORING OF SB2.A.-E. Berger; A. Haccourt; J. Salameh; X. Roblin; Stéphane Paul, France

P0998THE MEASURE OF TROUGH LEVELS OF INFLIXIMAB IS LINKED TO THERAPEUTIC RESPONSE IN IBD PATIENTS.Xavier Roblin, France; A.-E. Berger; G. Boschetti; B. Flourie; S. Nancey; S. Paul

P0999SMOKING STATUS INFLUENCES FECAL VOLATILE OR-GANIC COMPOUNDS COMPOSITIONJ. de Swart; N. van Gaal; D. J. C. Berkhout; Sofie Bosch, The Netherlands; T. G. J. de Meij; K. H. N. de Boer

P1000CLOSTRIDIUM DIFFICILE INFECTION AND IBD PATIENTS IN ONE CLINICAL CENTERAntonia Atanassova, Bulgaria; A. Georgieva

P1001DEVELOPMENT OF A NEW SCORE PREDICTIVE OF SUSTAINED CLINICAL REMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE UNDER INFLIX-IMAB-AZATHIOPRINE COMBOTHERAPY.B. Sivard; N. Williet; J.-M. Phelip; E. Del Tedesco; S. Paul; Xavier Roblin, France

P1002LOWER GI SYMPTOMS IN YOUNG PATIENTS: CAN SYMP-TOMS AND NON-INVASIVE TESTS BE USED SYSTEMATI-CALLY TO AVOID UNNECESSARY COLONOSCOPIES?Alaa Alakkari, Ireland; B. Ryan

P1003 FAECAL CALPROTECTIN AND MAGNETIC RESONANCE IMAGING ARE RELIABLE TOOL TO DETECT ENDOSCOPIC POSTOPERATIVE RECURRENCE IN CROHN’S DISEASEAnthony Buisson, France; P. Baillet; G. Cadiot; M. Goutte; F. Goutorbe; H. Brixi; C. Hoeffel; C. Allimant; M. Reymond; H. Obritin-Guilhen; G. Bommelaer; B. Pereira; C. Hordonneau

P1004SMALL BOWEL PREPARATION IN PATIENTS WITH CROHN'S DISEASE: THE POLYETHYLENE-GLYCOL IS NO LONGER USEFULLudovic Lagin, France; A. Bourreille; M. Flamant; M. Freyssinet; C. Le Berre; S. Bruley Des Varannes; C. Trang

P1005 VALUE OF 75SEHCAT IN THE DIAGNOSIS OF BILE ACID MALABSORPTION IN CROHN´S DISEASE WITH CHRON-IC DIARRHOEA Beatriz Gros, Spain; L. Mena; J. M. Benítez-Cantero; E. Carmona; E. Iglesias-Flores; F. R. Maza; R. Medina; V. García-Sánchez

P0989F-CALPROTECTIN USE IN INFLAMMATORY BOWEL DIS-EASE IS CHARACTERISED BY IMPROVED DIAGNOSTIC ACCURACY, LESS PATIENT HARM AND DECREASED COSTS, COMPARED WITH CONVENTIONAL SEROLOG-ICAL MARKERS AND COLONOSCOPY. THE SPANISH SCENARIO.Barbara Mascialino, Sweden; A. A. Vora

P0990 RISK OF SERIOUS INFECTION IN HEALTHCARE WORKER WITH INFLAMMATORY BOWEL DISEASE: A CASE-CON-TROL STUDY OF THE GETAIDCharlotte Gagniere, France; A. Bourrier; P. Seksik; J.-M. Gornet; O. Dewit; S. Nancey; R. Altwegg; V. Abitbol; D. Laharie; C. Reenaers; A. Buisson; M. Nachury; S. Viennot; L. Vuitton; C. Stefanescu; P. Marteau; G. Bouguen; J. Cosnes; A. Amiot

P0991CORRELATION BETWEEN INFLAMMATORY BIOMARK-ERS AND ENDOSCOPIC SCORES IN ULCERATIVE COLI-TIS: THUS EXTENSION MAKES THE DIFFERENCE?Cátia Arieira, Portugal; F. Dias de Castro; M. J. Moreira; J. Cotter

P0992IBD – IS IT A RISK FACTOR FOR THE DIAGNOSIS OF HEPATIC STEATOSIS?Cátia Arieira, Portugal; S. Monteiro; S. Xavier; F. Dias de Castro; J. Magalhães; M. J. Moreira; J. Cotter

P0993BONE HEALTH IN CROHN'S DISEASE IN THE ERA OF TNF-ALPHA INHIBITORSShahrad Hakimian, USA; J. Kheder; D. Cave; B. Hyatt

P0994THE AVAILABILITY OF INFLIXIMAB TROUGH LEVELS IN IBD PATIENTS ON MAINTENANCE THERAPY DEEPLY IMPACTS THERAPEUTIC DECISION-MAKINGTriana Lobaton, Spain; F. Cañete; A. Teniente; E. Cabré; M. Mañosa; E. Martínez; E. Domènech

P0995 THE DIAGNOSTIC UTILITY OF LINKED-COLOR IMAGING IN THE EVALUATION OF MUCOSAL INFLAMMATION IN PATIENTS WITH ULCERATIVE COLITISHitomi Hamamoto, Japan; S. Kanmura; S. Arima; Y. Nasu; S. Tanoue; F. Sasaki; S. Hashimoto; A. Ido

P0996WHAT SITUATIONS PRODUCE PSYCHOLOGICAL MALAISE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE? PERCEPTIONS FROM PHYSICIANS AND PATIENTS. THE ENMENTE PROJECTManuel Barreiro-de Acosta, Spain; A. Panadero; M. Cañas; L. Carmona; Y. Modino; J. Guardiola; L. Cea-Calvo; B. Juliá De Páramo; C. Romero; M. Gobbo; I. Marín-Jiménez


187


Tues

day,

Oct

ober

31,

201

7


P1014PERFORMANCE OF THE BÜHLMANN QUANTUM BLUE® ADALIMUMAB RAPID TEST DEDICATED FOR THERA-PEUTIC DRUG MONITORING OF SERUM ADALIMUMAB TROUGH LEVELST. Schuster; M. Wieser; S. Kräuchi; R. Sokoll; F. Bantleon; J. Weber; Michael Schneider, Switzerland; A. P. Abel

P1015ADALIMUMAB TROUGH LEVELS AND ANTI-ADALIM-UMAB ANTIBODIES CORRELATE WITH CLINICAL AND ENDOSCOPIC ACTIVITY IN CROHN’S DISEASE PATIENTS.Gaia Pellegatta, Italy; S. Lo Pumo; G. Bodini; I. Baldissarro; E. G. Giannini; V. Savarino; A. Jain; E. Savarino

P1016ULTRASONOGRAPHIC RESPONSE TO ANTI-TNFS IS ASSO-CIATED WITH BETTER OUTCOMES IN CROHN’S DISEASEEmma Calabrese, Italy; F. Zorzi; E. Lolli; S. Onali; M. C. Fantini; L. Biancone; G. Monteleone

P1017CONTINUOUS MONITORING WITH THE TELEMEDICINE TOOL MYIBDCOACH SHOWS AN ASSOCIATION BETWEEN NOVEL STRESS AND INFLAMMATORY BOWEL DISEASE FLARESDion Wintjens, The Netherlands; M. de Jong; A. E. Van Der Meulen – De Jong; M. Romberg Camps; M. Becx; M. H. Verwey; B. Winkens; A. A. M. Masclee; D. M. Jonkers; M. J. Pierik

P1018STRAIN ELASTOGRAPHY AND DIFFERENTIAL DIAGNO-SIS OF INFLAMMATORY AND FIBROTIC STRICTURES IN CROHN’S DISEASELarisa Orlova, Russian Federation; T. V. Samsonova; I. Khalif; M. Shapina; P. Evgrafov

P1019THE INFLAMMATORY BOWEL DISEASE DISABILITY IN-DEX IN INFLAMMATORY BOWEL DISEASE : RELATION-SHIP WITH DISEASE CHARACTERISTICS AND QUALITY OF LIFE IN A COHORT OF SICILIAN PATIENTSG. C. Morreale; E. Gianquinto; V. Calvaruso; M. G. Cilluffo; B. Scrivo; Maria Cappello, Italy

P1020DIPEPTIDYL PEPTIDASE 4 (DPP-4): A BIOMARKER OF DISEASE ACTIVITY AND PROGNOSIS IN INFLAMMATO-RY BOWEL DISEASEPedro Pinto-Lopes, Portugal; J. Afonso; G. Macedo; F. Magro

P1021ROLE OF PET-CT TO ASSESS DISEASE ACTIVITY IN UL-CERATIVE COLITIS AND ITS CORRELATION WITH CLINI-CAL CRITERIA, ENDOSCOPY AND FECAL BIOMARKERSNeha Berry, India; S. K. Sinha; A. Bhattacharya; K. Prasad; C. Vaishnavi; K. Vaiphei; J. Samanta; R. Prasada; N. Dhaka; R. Kochhar

P1006CLINICAL USEFULNESS OF ENDOSCOPIC ASSESSMENT IN ULCERATIVE COLITIS USING LINKED COLOR IMAG-ING: A PRELIMINARY PILOT STUDY WITH 10 PATIENTS Kohei Yamanouchi, Japan; R. Iwakiri; R. Shimoda; Y. Sakata; N. Tsuruoka; S. Shirai; K. Yamamoto; K. Akutagawa; T. Noda; H. Endo; K. Fujimoto

P1007THE ROLE OF SENSE OF COHERENCE IN DETERMINING HEALTH RELATED QUALITY OF LIFE AND DISABILITY IN INFLAMMATORY BOWEL DISEASEGary Wild, Canada; M. Vitagliano; I. Albanese; K. Shirlow

P1008FAECAL AMINO ACID PROFILES AS NOVEL NON-INVA-SIVE BIOMARKERS FOR THE DETECTION OF PAEDIAT-RIC INFLAMMATORY BOWEL DISEASE: A METABOLOM-IC APROACH.Sofie Bosch, The Netherlands; N. van Gaal; R. Zuurbier; E. Struijs; A. Bakkali; K. H. N. (. de Boer; T. G. J. de Meij

P1009INFLIXIMAB TROUGH LEVELS AND ANTIBODIES TO INFLIXIMAB IN ASSOCIATION WITH DISEASE ACTIVITY AND MUCOSAL HEALING IN PATIENTS WITH INFLAM-MATORY BOWEL DISEASEEleni Orfanoudaki, Greece; M. Gazouli; K. Foteinogiannopoulou; E. Theodoraki; E. Legaki; I. Koutroubakis

P1010COMPARATIVE INVESTIGATION OF ENTEROBACTERIA BUSH IN ULCERATIVE COLITIS PATIENTS, AND THEIR CON-SANGUINEOUS, AND NON-CONSANGUINEOUS RELATIVESKatsuyuki Fukuda, Japan

P1011EVALUATION OF PET-MRI AND FECAL BIOMARKERS TO MONITOR DISEASE ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS.Jost Langhorst, Germany; J. H. Boone; A. K. Koch; A. Rueffer; G. Dobos; K. Beiderwellen; T. Lauenstein; Y. Li; L. Umutlu

P1012 MMP3 (METALLOPROTEINASE 3): A NEW MARKER FOR ASSESSING LOSS OF RESPONSE TO INFLIXIMAB IN IBDBrigida Barberio, Italy; R. D'inca; L. Digiglio; S. Facchin; M. Piciocchi; R. Cardin; M. G. Vettorato; M. Dalla Gasperina; A. Rigo; G. C. Sturniolo

P1013USEFULNESS OF A MULTIDISCIPLINARY APPROACH COMBINING BOTH RHEUMATOLOGY AND GASTROEN-TEROLOGY FOR THE ASSESSMENT AND TREATMENT OF INFLAMMATORY BOWEL DISEASE PATIENTSManuel Barreiro-de Acosta, Spain; E. Pérez-Pampín; R. Ferreiro Iglesias; R. Mejuto; A. Mera; J. E. Dominguez-Muñoz


188




P1029MOLECULAR SURROGATES OF HISTOLOGIC ACTIVITY IN CROHN’S DISEASECalixte Monast, USA; K. Li; E. Myshkin; C. Brodmerkel; J. Friedman; F. Baribaud

P1030 INDIRECT TREATMENT COMPARISON OF USTEKINUM-AB VERSUS OTHER BIOLOGICS IN MODERATE-TO-SE-VERE CROHN'S DISEASE PATIENTS HAVING FAILED AN-TI-TNF THERAPY – A 1-YEAR TREATMENT SEQUENCE ANALYSIS INCLUDING DELAYED RESPONDERSLaura Mesana, United Kingdom; M. Pacou; D. Naessens; S. Sloan; A. Gauthier

P1031INDIRECT TREATMENT COMPARISON OF USTEKINUM-AB VERSUS OTHER BIOLOGICS IN MODERATE-TO-SE-VERE CROHN'S DISEASE PATIENTS HAVING FAILED CONVENTIONAL THERAPY – A 1-YEAR TREATMENT SE-QUENCE ANALYSIS INCLUDING DELAYED RESPONDERSLaura Mesana, United Kingdom; M. Pacou; D. Naessens; S. Sloan; A. Gauthier

P1032 EFFICACY AND TOLERABILITY OF INITIATING, OR SWITCHING TO, INFLIXIMAB BIOSIMILAR CT-P13 IN INFLAMMATORY BOWEL DISEASE (IBD): A LARGE SINGLE-CENTRE EXPERIENCERagu Prakash Ratnakumaran, United Kingdom; N. To; D. Gracie; C. Selinger; T. Clark; N. Carey; G. Dowson; K. Leigh; L. Bourner; A. C. Ford; P. J. Hamlin

P1033SAFETY AND EFFICACY OF HELICOBACTER PYLORI ERADICATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASEShinichiro Shinzaki, Japan; T. Fujii; S. Bamba; T. Kobayashi; H. Tanaka; T. Yoshino; A. Yamada; N. Kamata; T. Hibi

P1034EFFECTIVENESS OF IMMUNOSUPPRESSORS IN CROHN'S DISEASELinda Kecili, Algeria; N. Kaddache; L. Si Salah; A. Rebiha; S. Khouitar; K. Soualah; H. Bellimi; F. Ihaddadene; R. Benbaya; K. Bouchaoui; A. Tata; B. Bahaz; T. Boucekkine; S. Berkane

P1035EVALUATION OF PHARMACOKINETIC PROFILES OF SB2 AS A BIOSIMILAR OF REFERENCE INFLIXIMABD. Shin; J. W. Kang; S. Park; Y. Lee; Sora Lee, Republic of Korea

P1036INFLIXIMAB DOSE BANDING SHORTENS LENGTH OF STAY OF INFLAMMATORY BOWEL DISEASE PATIENTS Julien Ollivier, France; F. Poullenot; A. Berroneau; S. Djabarouti; F. Xuereb; F. Zerbib; D. Laharie; D. Breilh

P1022CLINICAL PERSPECTIVE ON DRUG MONITORING WITH AN INFLIXIMAB RAPID QUANTIFICATION ASSAYF. Magro; Joana Afonso, Portugal; S. Lopes; R. Coelho; R. Gonçalves; P. Caldeira; P. Lago; M. H. Tavares Sousa; J. Ramos; A. R. Gonçalves; P. Ministro; I. Rosa; T. Meira; A. Andrade; J. B. Soares; D. Carvalho; P. Sousa; A. Vieira; C. Camila Dias

P1023THE IMPACT OF AN INFLAMMATORY BOWEL DISEASE EDUCATION CLINIC ON PATIENT OUTCOMES AND RESOURCE UTILISATIONWei On, United Kingdom; B. Collins; H. Stanley; A. Westhoff; S. Tynan; D. McClements; V. Theis; J. McLindon; R. Chandy; A. Bassi

P1024EMERGING ROLE OF IL-33/ST2 LEVELS IN PREDICT-ING MUCOSAL RESPONSE TO ANTI-TNF THERAPY IN ULCERATIVE COLITIS.Loris Riccardo Lopetuso, Italy; V. Petito; C. Graziani; T. T. Pizarro; F. Scaldaferri; A. Gasbarrini

P1025INFLIXIMAB TROUGH LEVELS IN THE INDUCTION PHASE ARE ASSOCIATED WITH PROLONGED REMIS-SION IN CROHN´S DISEASE PATIENTS.María Dolores Martín-Arranz, Spain; M. Jaquotot Herranz; E. Martín-Arranz; A. Martínez Feito; M. Díaz-Almirón; C. Suárez Ferrer; J. Poza Cordon; S. Gómez Senent; L. García Ramirez; M. P. Aracelia; D. Pascual-Salcedo

P1026CORRELATION BETWEEN CLINICAL, ENDOSCOPIC AND HISTOLOGICAL ACTIVITY IN INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE STUDYBenedetto Neri, Italy; A. Ruffa; S. Romeo; E. Grasso; F. Zorzi; G. Palmieri; L. Biancone

Treatment-medical

P1027THE RELATIONSHIP BETWEEN SERUM INFLIXIMAB AND ADALIMUMAB CONCENTRATIONS AND THEIR CORRE-SPONDING ANTI-DRUG ANTIBODY LEVELS: ANALYSIS OF OVER 50,000 PATIENT RESULTS USING LAB DEVEL-OPED CHEMILUMINESCENT IMMUNOASSAYSKelly Chun, USA; J. Yang

P1028REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMABM. Raluy Callado; R. Carroll; R. Curtis; M. J. Khalid; Haridarshan Patel, United Kingdom


189


Tues

day,

Oct

ober

31,

201

7


P1045CLINCAL EFFECTIVENESS OF GOLIMUMAB IN CROHN’S DISEASE – AN OBSERVATIONAL STUDY BASED ON THE SWEDISH NATIONAL QUALITY REGISTRY FOR INFLAM-MATORY BOWEL DISEASESara Rundquist, Sweden; C. Eriksson; L. Nilsson; L. Angelison; S. Jäghult; J. Björk; O. Grip; H. Hjortswang; H. Strid; P. Karlén; S. Montgomery; J. Halfvarson

P1046EARLY IMPROVEMENT IN QUALITY OF LIFE IN PA-TIENTS WITH LUMINAL CROHN´S DISEASE TREATED WITH ADALIMUMAB. DATA FROM RAPIDA TRIALFrancesc Casellas, Spain; M. Barreiro-de Acosta; M. Esteve; L. Castro-Laria; R. Vicente; D. Ceballos; A. Echarri; M. Martín-Arranz; D. Busquets; J. Llaó; M. Navarro-Llavat; J. Huguet; F. Argüelles-Arias; J. Boudet; L. Rodríguez-San Pedro; G. Díaz; R. Casado; I. Marín-Jiménez

P1047EVALUATION OF QUALITY OF LIFE IN IBD PATIENTS TREATED WITH ANTI-TNFα THERAPYGreta Lorenzon, Italy; R. Caccaro; G. Girardin; B. Barberio; A. Rigo; E. Savarino; G. C. Sturniolo; R. D'inca

P1048ENDOSCOPIC AND HISTOLOGIC FINDINGS CORRELATE WITH FREE INFLIXIMAB FOUND IN UNINFLAMED TISSUE IN IBD PATIENTSHaggai Bar-Yoseph, Israel; A. Blatt; S. Pressman; S. Gerassy; B. Ungar; S. Ben-Horin; Y. Chowers

P1049WITHDRAWN

P1050LONG-TERM OUTCOMES OF MAINTENANCE ANTIBI-OTIC THERAPY IN CHRONIC ANTIBIOTIC-DEPENDENT POUCHITISStephanie Poo, United Kingdom; J. Segal; S. McLaughlin; O. Faiz; S. Clark; A. Hart

P1051ANTIBODIES TO INFLIXIMAB OCCUR THROUGHOUT TREATMENT BUT DEVELOPMENT IS DELAYED BY IM-MUNOSUPPRESSION.Robert Downey, United Kingdomm; G. S. Z. Tun; K. Swallow; G. Wild; A. Wright; K. Robinson; L. Marshall; R. Sargur; M. F. Hale; A. J. Lobo

P1052A DRUG-RESISTANT ASSAY CAN BETTER DIRECT THE NEED FOR ADALIMUMAB DOSE-ESCALATION AFTER INDUCTION THERAPY IN ANTI-TNF NAÏVE PATIENTS WITH CROHN’S DISEASEGitte Moors, Belgium; B. Verstockt; S. Bian; S. Tops; V. Ballet; G. Van Assche; S. Vermeire; A. Gils; M. Ferrante

P1037RAPIDITY OF ONSET OF RESPONSE TO ADALIMUM-AB (ADA) IN LUMINAL CROHN´S DISEASE (CD). DATA FROM RAPIDA TRIALIgnacio Marín-Jiménez, Spain; F. Casellas; M. Esteve; L. Castro-Laria; S. García-López; D. Ceballos; A. Echarri; M. Martín-Arranz; D. Busquets; J. Llaó; M. Navarro-Llavat; J. Huguet; F. Argüelles-Arias; R. Vicente; L. Rodríguez-San Pedro; G. Díaz; R. Casado; M. Barreiro-de Acosta

P1038HIGH DOSE INTRAVENOUS IRON ISOMALTOSIDE IN PATIENTS WITH GASTROINTESTINAL DISEASESR. Derman; J. F. Dahlerup; Walter Reinisch, Austria

P1039EFFICACY AND SAFETY OF GOLIMUMAB IN ULCER-ATIVE COLITIS. PRELIMINARY DATA FROM A MULTI-CENTER ITALIAN STUDYFabrizio Bossa, Italy; M. R. Valvano; C. Giuseppe; A. Lauria; N. Buccianti; E. Vinci; E. Shaini; M. Mendolaro; L. Grossi; S. Mazzuoli; A. Rispo; G. Pranzo; L. Sebkova; A. Tursi; A. Miranda; M. Patturelli; R. Spagnuolo; C. Ricciardelli; C. Sgarro; P. Paese; G. Inserra; A. Azzarone; W. Fries; A. C. Privitera; M. Principi; M. Cappello; A. Andriulli

P1040OUTCOMES OF PATIENTS IN REMISSION WITH INFLAM-MATORY BOWEL DISEASE WITH UNDETECTABLE IN-FLIXIMAB TROUGH LEVELS AND POSITIVE ANTIBODIES TO INFLIXIMAB.Gloria Shwe Zin Tun, United Kingdom; R. W. Downey; K. Robinson; A. Wright; L. Marshall; M. F. Hale; A. J. Lobo

P1041PHARMACOKINETIC SIMILARITY OF ABP 710 TO INFLIX-IMAB: RESULTS FROM A RANDOMISED, SINGLE-BLIND, SINGLE-DOSE, PARALLEL-GROUP STUDY IN HEALTHY SUBJECTS Vincent Chow, USA; N. Zhang; P. Kaur; A. Kaliyaperumal; E. Krishnan

P1042EPIDEMIOLOGY AND BURDEN OF COMPLEX PERIANAL FISTULAS IN PATIENTS WITH CROHN DISEASE– A SYSTEMATIC LITERATURE REVIEWJ. Panés; Haridarshan Patel, United Kingdom; E. Rupniewska; S. Khan; D. Bojic; M. J. Khalid; W. Reinisch

P1043VITAMIN D IS RELATED TO THE EFFECTS OF ANTI-TNF TREATMENT IN CROHN´S DISEASE PATIENTSMauro Bafutto, Brazil; M. B. G. Costa; K. T. P. E. Silva; J. P. V. Costa; C. C. S. O. Reviglio; E. C. Oliveira; J. R. Filho

P1044WITHDRAWN


190




P1060TREATMENT EXPERIENCE WITH TOPICAL PRODUCTS FOR ULCERATIVE COLITIS – THE PATIENT´S PERSPEC-TIVE IN EUROPE AND THE USAT. Bayrhoffer; A. Thompson; Thomas Knittel, Sweden

P1061SELF-MANAGEMENT IN INFLAMMATORY BOWEL DIS-EASE: A PERSPECTIVE OF NURSES AND PHYSICIANSSiepke van den Burg, The Netherlands; N. M. S. Peek; A. E. Van Der Meulen – De Jong; J. P. W. Maljaars

P1062DISTINCT PATTERNS OF SHORT CHAIN FATTY ACIDS IN PATIENTS WITH ULCERATIVE COLITIS EXPERIENCING A FLARE DURING TREATMENT WITH MESALAMINE OR A HERBAL COMBINATION OF MYRRH, CHAMOMILE FLOWERS AND COFFEE CHARCOALJost Langhorst, Germany; A. K. Koch; A. Rueffer; G. Dobos

P1063GRANULOCYTE-MONOCYTE APHERESIS (GMA) IN DIF-FICULT- TO-TREAT INFLAMMATORY BOWEL DISEASE (IBD). A SINGLE-CENTER REAL-LIFE EXPERIENCE.Alessandro Caroli, Italy; F. Lamboglia; I. Franceschet; C. Pozzan; D. Checchin; F. Bortoluzzi; R. Cappuccio; A. Vitalba

P1064SYNERGISTIC AND ADDITIVE EFFECTS OF MYRRH, CHAMOMILE AND COFFEE CHARCOAL – COMPONENTS OF A TRADITIONAL HERBAL MEDICINE ENHANCE AN-TISPASMODIC AND CYTOKINE/CHEMOKINE-INHIBITING ACTIVITY OF THE HERBAL COMBINATIONCica Vissiennon, Germany; S. Paulo; D. Hammoud; K.-H. Goos; K. Nieber; J. Arnhold

P1065ARE TROUGH LEVELS OF ANTI-TNF DRUGS RELATED WITH TREATMENT FAILURE AND DURATION OF TREATMENT?J. González-López; Manuel Barreiro-de Acosta, Spain; C. Llamas; J. E. Dominguez-Muñoz; J. M. Giráldez-Montero; R. Ferreiro Iglesias; M. J. Lamas-Díaz

P1066IMMUNOSUPPRESSIVE CO-TREATMENT WITH INFLIX-IMAB AND ADALIMUMAB IS NOT SUPERIOR TO ANTI-TNF MONOTHERAPY TO PREVENT TREATMENT FAILURE AND TREATMENT DISCONTINUATION IN ULCERATIVE COLITIS.S. Vieujean; E. Louis; Catherine Reenaers, Belgium

P1067EFFICACY AND SAFETY OF ADALIMUMAB AFTER INFLIX-IMAB FAILURE IN PEDIATRIC ULCERATIVE COLITIS: A RE-AL-LIFE EXPERIENCE FROM THE SIGENP-IBD REGISTRYMarina Aloi, Italy; M. Bramuzzo; S. Arrigo; C. Romano; D. Iacorte; S. Gatti; M. T. Illiceto; F. Zucconi; D. Dilillo; G. Zuin; D. Knafelz; A. Ravelli; G. D'Arcangelo; P. Alvisi

P1053ADHERENCE TO MAINTENANCE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEFORE AND AFTER THE INTRODUCTION OF THE SHARED MEDICA-TION RECORDKlaus Roelsgaard, Denmark

P1054CLINICAL EFFICACY AND SAFETY OF GOLIMUMAB IN BIOLOGIC NAÏVE AND EXPERIENCED PATIENTS WITH ACTIVE ULCERATIVE COLITIS NON-RESPONDER OR INTOLERANT TO CONVENTIONAL THERAPIES.Beatrice Orlandini, Italy; E. Capoferro; S. Bagnoli; G. Dragoni; A. Geccherle; F. Rogai

P1055ENDOSCOPIC FOLLOW-UP AND THERAPEUTIC ATTITUDE AFTER ILEOCOLONIC RESECTION IN A NATIONWIDE SPANISH COHORT OF CROHN’S DISEASE PATIENTS. PRACTICROHN STUDYM Barreiro-de Acosta, Spain; V. García-Sánchez; A. Gutiérrez; M. D. Martín Arranz; L. Cea-Calvo; C. Romero; B. Juliá De Páramo; E. Domènech

P1056ETROLIZUMAB TREATMENT IMPROVES HISTOLOGICAL ACTIVITY AS ASSESSED BY BOTH THE ROBARTS HISTO-PATHOLOGY AND NANCY HISTOLOGICAL INDICESL. Peyrin-Biroulet; B. G. Feagan; G. de Hertogh; D. T. Rubin; R. Maciuca; J. McBride; Udaysankar Arulmani, USA; A. Scherl

P1057GO-COLITIS: EFFICACY AND QUALITY OF LIFE DURING GOLIMUMAB MAINTENANCE IN UK PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITISD. R. Gaya; P. Irving; S. Sebastian; P. J. Hamlin; C. Wheeler; A. Rose; G. Gillespie; Chris Probert, United Kingdom

P1058 A UNITED STATES CLAIMS DATABASE ANALYSIS COM-PARING SAFETY, MEDICAL RESOURCE UTILIZATION, AND TREATMENT COSTS ASSOCIATED WITH THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE BY DRUG CLASSG. H. Long; A. Tatro; Young Oh, USA; S. R. Reddy; A. N. Ananthakrishnan

P1059CAN EARLY DRUG AND ANTI-INFLIXIMAB-ANTIBODY LEVELS PREDICT PRIMARY NON RESPONSE TO INFLIX-IMAB THERAPY?H. Bar-Yoseph; Y. Chowers; N. Levhar; L. Selinger; U. Manor; M. Yavzori; E. Fudim; O. Picard; U. Kopylov; R. Eliakim; S. Ben-Horin; Bella Ungar, Israel


191


Tues

day,

Oct

ober

31,

201

7


P1075REMISSION INDUCTION IN CORTICOSTEROID NAÏVE CHILDREN AND ADOLESCENTS WITH ULCERATIVE COLITIS BY ADSORPTIVE LEUCOCYTAPHERESIS AS MONOTHERAPY OR IN COMBINATION WITH A LOW DOSE PREDNISOLONE AFTER FAILURE OF FIRST-LINE MEDICATIONSTomotaka Tanaka, Japan; M. Akagi; T. Iiboshi; H. Goishi; T. Kajihara; T. Miura

P1076EARLY SCREENING FOR INFLAMMATORY BOWEL DIS-EASE IN CHILDREN WITH AUTOIMMUNE LIVER DISEASEDhamyanthi Thangarajah, United Kingdom; E. Cernat; B. Vadamalayan; D. Hadzic; M. Samyn

P1077CLINICAL AND LABORATORY VARIABLES THAT PREDICT CLINICAL AND ENDOSCOPIC REMISSION IN CHILDREN WITH CROHN’S DISEASE TREATED WITH INFLIXIMABGiulia D'Arcangelo, Italy; S. Oliva; F. Tarani; F. Viola; F. Civitelli; S. Cucchiara; M. Aloi

Poster Session09:00 – 17:00 Hall 7Other Lower GI Disorders II

Lower GI bleeding

P1078THALIDOMIDE FOR THE TREATMENT OF REFRACTORY GAS-TROINTESTINAL BLEEDING CAUSED BY ANGIODYSPLASIASXia Wang, China; Q. Wang; H. Huang; W. Lu

P1079NEWLY DEVELOPED ENDOSCOPIC DETACHABLE SNARE LIGATION THERAPY FOR COLONIC DEVERTICULAR HEMORRHAGE: A MULTICENTER PHASE II TRIALKatsumasa Kobayashi, Japan; T. Narasaka; D. Akutsu; M. Nishi; M. Wakayama; Y. Hiroshima; S. Endo; T. Mamiya; S. Hirai; K. Ikezawa; H. Ishida; M. Hirose; T. Yamada; H. Suzuki; T. Kaneko; Y. Mizokami; I. Hyodo

P1080RISK FACTORS FOR EARLY AND LATE RE-BLEEDING IN PATIENTS WITH COLONIC DIVERTICULAR BLEEDINGYoshinori Sato, Japan; H. Yasuda; S. Nakatsu; M. Yamashita; Y. Matsuo; H. Yamamoto; F. Itoh

P1081ACUTE LOWER GASTROINTESTINAL BLEEDING – IS NOBLADS THE ANSWER?Sofia Xavier, Portugal; J. Magalhães; J. Cotter

P1082COLORECTAL CANCERS (CRCS) DEPENDING ON THE SCREENING INTERVAL IN IBARAKI, JAPANYoko Saitoh, Japan; H. H. Suzuki; I. Hyodo

P1068LOW FODMAP DIET IMPROVE DISEASE ACTIVITY AND QUALITY OF LIFE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASEGiorgia Bodini, Italy; E. G. Giannini; V. Savarino; M. Crespi; S. Lo Pumo; C. Zanella; I. Baldissarro; E. Savarino

Poster Session09:00 – 17:00 Hall 7Paediatric: Lower GI

Paediatric and adolescent IBD

P1069SUBCUTANEOUS USTEKINUMAB PROVIDED CLINICAL AND BIOLOGICAL BENEFIT FOR 9/12 REFRACTORY PEDIATRIC CROHN'S DISEASEChristine Martinez-Vinson, France; J.-P. Hugot; M. Bellaiche; J. Viala

P1070TROUGH LEVELS TO INFLIXIMAB AT W6 ARE PREDICTIVE OF REMISSION AT W14, IN PEDIATRIC CROHN DISEASE.Christine Martinez-Vinson, France; O. Courbette; C. Aupiais; J. Viala; J.-P. Hugot

P1071INFLIXIMAB INDUCED PSORIASIS IN A COHORT OF CHILDREN WITH INFLAMMATORY BOWEL DISEASE : A 12 YEARS FOLLOW-UP STUDY.Christine Martinez-Vinson, France; O. Courbette; C. Aupiais; J. Viala; J.-P. Hugot

P1072PLATELET ABNORMALITIES AND ANEMIA IN PAEDIAT-RIC IBD: ARE THEY LINKED?Martina Votto, Italy; F. Viviano; F. Viola

P1073RELATIONSHIP BETWEEN CLINICAL COURSE OF ULCERATIVE COLITIS (UC) DURING PREGNANCY AND OUTCOMES OF PREGNANCY: A RETROSPECTIVE EVAL-UATION STUDYAyumi Ito, Japan; O. Teppei; T. Katutishi

P1074USE OF STEROIDS IN ADULTS AND ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE IN THE BIOLOGICS ERAIoanna Parisi, United Kingdom; L. Whitley; C. Murray; F. Kiparissi; F. Rahman; S. Mehta; E. Seward; D. Graham; H. Kwok; S. McCartney


192




P1090ETHNIC VARIATION IN ADENOMA DETECTION IN THE UK FLEXIBLE SIGMOIDOSCOPY BOWEL CANCER SCREENING PROGRAMME Dennis Lim, United Kingdom; S. Mellor; S. Szarvas-Jones; D. Bools; H. Whitsey; B. Miri; A. Mapiye; P. Wurm; R. J. Robinson


P1091DEAD BOX POLYPEPTIDE 27 PROMOTES TUMORIGENICI-TY IN COLORECTAL CANCER THROUGH ACTIVATING NU-CLEAR FACTOR KAPPA B PATHWAY AND ITS EXPRESSION IS ASSOCIATED WITH POOR SURVIVAL IN PATIENTSHuarong Chen, Hong Kong PRC; J. Tang; C. C. Wong; J. Fang; J. J. Y. Sung; J. Yu

P1092CLINICOPATHOLOGICAL STUDY OF SERRATED LESIONS OF THE COLORECTUM.Mikako Sugimura, Japan; M. Iwabuchi; K. Ukai

P1093IN SITU DETECTION OF MIGRATING COLORECTAL CANCER CELL-RELEASED LARGE EXTRACELLULAR EXOSOME CLUSTERSG. Valcz; E. I. Buzás; T. Krenács; Arpad V. Patai, Hungary; Á. Nagy; L. Homolya; G. Török; Z. Szállási; K. Dede; S. Spisák; Z. Tulassay; P. Igaz; B. Molnar

P1094ALTERED ARGININE METABOLISM IN HYPERPROLIF-ERATIVE INTESTINAL EPITHELIAL CELLS: A POTENTIAL ROLE IN TUMORIGENESIS AND WOUND HEALING.Jonathan van der Meer, The Netherlands; W. L. Smit; B. J. Meijer; C. N. Spaan; T. B. M. Hakvoort; M. A. Boermeester; G. R. van den Brink; V. Muncan

P1095ENHANCED COLONIC TUMORIGENESIS IN TLR4-DE-FICIENT MICE IS ASSOCIATED TO IMPAIRMENT OF ANTIGEN PRESENTATION BY EPITHELIAL CELLSMelania Scarpa, Italy; I. Castagliuolo; C. Marchiori; S. Morgan; A. Kotsafti; P. BRUN; A. Porzionato; I. Angriman; C. Castoro; M. Scarpa

P1096ENDOSCOPIC FOLLOW UP CAN SELECT PATIENTS FOR MULTI-GENE TESTING IN ATTENUATED ADENOMATOUS POLYPOSIS WITH NO APC OR MUTYH IDENTIFIED MUTATIONS.Renato Cannizzaro, Italy; R. Magris; G. Cini; M. Quaia; S. Maiero; E. Canton; A. Viel; M. Fornasarig

P1097GLOBAL DNA HYPOMETHYLATION ALONG THE COL-ORECTAL NORMAL-ADENOMA-CANCER SEQUENCEKrisztina Szigeti, Hungary; O. Galamb; A. Kalmár; G. Valcz; E. Markus; Z. Tulassay; B. Wichmann; P. Igaz; B. Molnar

P1083ANALYSIS OF THE CONCENTRATION OF FIT FOR COL-ORECTAL CANCERS FROM THE SCREENING (2000-2014) IN IBARAKI, JAPANYoko Saitoh, Japan; I. Hyodo; H. Suzuki; M. Kaneko


P1084COLONOSCOPY SURVEILLANCE DETECTS A HIGH PREVALENCE OF ADVANCED COLORECTAL NEOPLASIA AND SERRATED POLYPOSIS SYNDROME IN HODGKIN LYMPHOMA SURVIVORSLisanne Rigter, The Netherlands; M. C. W. Spaander; B. M. Aleman; T. M. Bisseling; L. M. G. Moons; A. Cats; P. J. Lugtenburg; C. P. Janus; E. J. Petersen; J. M. Roesink; R. W. van der Maazen; P. Snaebjornsson; E. J. Kuipers; M. J. Bruno; E. Dekker; G. A. Meijer; J. P. de Boer; F. E. van Leeuwen; M. E. van Leerdam

P1085INCIDNCE OF PROSTATE CANCER IN COLORECTAL CANCER PATIENTS: NATIONWIDE RETROSPECTIVE COHORT STUDYHyun Soo Kim, Republic of Korea; D. H. Lee; K. D. Han; D. W. Shin; Y. J. Choi; H. Yoon; N. Kim

P1086SITE AND STAGE DISTRIBUTION OF SCREEN DETECTED AND CLINICALLY DETECTED COLORECTAL CANCERS IN THE THE NETHERLANDSEsther Toes-Zoutendijk, The Netherlands; A. Kooyker; M. A. Elferink; V. Lemmens; M. E. van Leerdam; I. Lansdorp-Vogelaar

P1087LOCATION AND SEX PREDOMINANCE OF MISMATCH REPAIR DEFICIENT COLORECTAL CANCER IN IVORY COAST DIFFER FROM ITS EUROPEAN COUNTERPARTLucie Bienfait, Belgium; B. Doukoure; N. D'Haene; I. Salmon; P. Demetter; L. Verset

P1088ROUTINE MOLECULAR ANALYSIS FOR LYNCH SYN-DROME IN PATIENTS WITH ADVANCED ADENOMA OR COLORECTAL CANCER WITHIN A NATIONAL SCREENING PROGRAM FOR COLORECTAL CANCER.Anne Goverde, The Netherlands; W. NM Dinjens; M. J. Bruno; R. M. W. Hofstra; M. Doukas; M. M. van der Weiden; H. J. Dubbink; A. Wagner; M. C. W. Spaander

P1089COLORECTAL CANCER SCREENING PROGRAMS AND THE RATE OF SURGICAL ONCOLOGY PROCEDURES IN THE VENETO REGION (ITALY): ARE FOLLOW-UP COLO-NOSCOPIES REALLY NEEDED?E. Rosa-Rizzotto; M. Saia; Diego Caroli, Italy; G. Ennio; B. Germaná; F. Monica; P. Pilati; F. De Lazzari


193


Tues

day,

Oct

ober

31,

201

7


P1105ENDOSCOPIC OBSERVATIONS OF MICROSURFACE STRUCTURES MAY REFLECT MOLECULAR SUBCLONES IN COLORECTAL TUMORSEiichiro Yamamoto, Japan; H. Aoki; H. Yamano; H. Suzuki; H. Nakase

P1106THE DIAGNOSTIC VALUE OF HYPOXIA INDUCED EXO-CELLULAR VESICLES IN COLORECTAL CANCER PATIENT PLASMAA. Abols; Daiga Santare, Latvia; R. Toleikiene; E. Zandberga; R. Vangravs; M. Takatalo-Laine; M. Palviainen; P. Siljander; M. Leja; A. Line

P1107THE GENESIS STUDY: GENETIC BIOPSY FOR PREDIC-TION OF SURVEILLANCE INTERVALS AFTER ENDO-SCOPIC RESECTION OF COLONIC POLYPSA. W. Berger; K. Raedler; C. Langner; L. Ludwig; N. Dikopoulos; K. F. Becker; J. Slotta-Huspenina; M. Quante; D. Schwerdel; L. Perkhofer; A. Kleger; E. Zizer; F. Oswald; T. Seufferlein; Alexander Meining, Germany

P1108QUANTITY, FRAGMENT LENGTH AND GLOBAL DNA METHYLATION LEVEL ALTERATIONS OF CIRCULATING CELL-FREE DNA IN COLORECTAL ADENOMA, CANCER AND INFLAMMATORY BOWEL DISEASESEszter Markus, Hungary; A. Kalmár; O. Galamb; K. Szigeti; B. K. Bartak; Z. B. Nagy; B. Wichmann; Z. Tulassay; P. Igaz; B. Molnar

P1109ANALYSIS OF SFRP1, SFRP2, SDC2 AND PRIMA1 PROMOTER METHYLATION IN CELL-FREE PLASMA DNA FOR NON-INVASIVE DETECTION OF COLORECTAL ADENOMA AND CANCERBarbara Kinga Bartak, Hungary; A. Kalmár; B. Péterfia; A. V. Patai; O. Galamb; G. Valcz; B. Wichmann; Z. B. Nagy; E. Markus; K. Szigeti; Á. Nagy; Z. Tulassay; P. Igaz; B. Molnar

P1110URINE-NMR METABOLOMICS FOR SCREENING OF ADVANCED COLORECTAL ADENOMA AND EARLY STAGE COLORECTAL CANCEREun-Ran Kim, Republic of Korea; H. N. Kwon; S. H. Kim; N. Y. Paik; S.-N. Hong; T. J. Kim; D. K. Chang; J. J. Kim; S. H. Park; Y.-H. Kim

P1111VALIDATION OF THE UTILITY OF A FAECAL IMMU-NOCHEMICAL TEST FOR HAEMOGLOBIN (FIT) IN PATIENTS PRESENTING TO PRIMARY CARE WITH NEW BOWEL SYMPTOMSJayne Digby, United Kingdom; J. A. Strachan; C. G. Fraser; R. Steele; C. Mowat

P1098CIRCULATING MIRNA CHANGES IN HUMAN COLOREC-TAL CANCER DEVELOPMENT AND IN ANIMAL MODELZsofia Brigitta Nagy, Hungary; B. K. Bartak; A. Kalmár; B. Wichmann; O. Galamb; E. Markus; K. Szigeti; Á. Nagy; P. Igaz; Z. Tulassay; B. Molnar

P1099RHOA: THE KEY SIGNALING PATHWAY OF MICROR-NA-126 IN SUPPRESSING THE EPITHELIAL-MESENCHY-MAL TRANSITION, PROLIFERATION, MIGRATION AND INVASION OF COLORECTAL CANCER CELLSM.-Y. Huang; W. Yuan; S. Wu; Zhaohua Shen, China; Z. Yang; Y. Quan; C. Zhu; K. Tang; X. Wang

P1100DNA METHYLATION CHANGES PRECEDE AND CON-TRIBUTE TO SPORADIC MUTATIONS IN COLORECTAL ADENOMA AND CANCER DEVELOPMENT THROUGH INDUCED GENOMIC INSTABILITYBela Molnar, Hungary; O. Galamb; B. Péterfia; B. Wichmann; A. Kalmár; Z. B. Nagy; B. K. Bartak; K. Szigeti; E. Markus; Z. Tulassay

P1101MIR-126 REGULATES TUMOR GROWTH AND METASTA-SIS IN COLORECTAL CANCER BY RECRUITING TUMOR ASSOCIATED MACROPHAGES THROUGH PARACRINE SIGNALING OF CXCL12Shuai Wu, China; Z. shen; M.-Y. Huang; W. Yuan; Y. Quan; C. Zhu; Z. Yang; X. Wang


P1102THE EFFICACY OF NEXT-GENERATION OF IMAGE ENHANCED COLONOSCOPY (BLUE LASER IMAGING) IN THE DETECTION OF COLONIC LESIONS : A PILOT STUDYRyo Shimoda, Japan; Y. Sakata; N. Tsuruoka; S. Shirai; T. Noda; H. Endo; K. Akutagawa; R. Iwakiri; K. Fujimoto

P1103COLORECTAL CANCER SCREENING COLONOSCOPY – ABSENT DISTAL POLYPS IN ADVANCED PROXIMAL NEOPLASIARajan Patel, United Kingdom; M. Hussein; L. Polak; A. Kumar; S. Samanta

P1104STUDIES ON CLINICOPATHOLOGICAL CHARACTER-ISTICS AND THE LONG-TERM PROGNOSIS OF DE-PRESSED-TYPE COLORECTAL CARCINOMAS.Shinei Kudo, Japan; T. Kurata; K. Ichimasa; Y. Kouyama; S. Matsudaira; N. Toyoshima; Y. Mori; M. Misawa; N. Ogata; T. Kudo; T. Hisayuki; T. Hayashi; K. Wakamura; E. Hidaka; T. Baba; F. Ishida


194




P1119LOCAL RECURRENCE AFTER ENDOSCOPIC MUCOSAL RESECTION FOR HIGH-RISK LESIONS: MAY WE BETTER PLAN THE ENDOSCOPIC FOLLOW-UP ACCORDING TO PROCEDURAL, MORPHOLOGICAL AND HISTOLOGICAL CHARACTERISTICS?Cinzia Quondamcarlo, Italy; C. Lucidi; R. Lapenta

P1120TREATMENT STRATEGY FOR LOCAL RECURRENCES AFTER ENDOSCOPIC RESECTION OF COLORECTAL NEOPLASMSSayo Ito, Japan; K. Hotta; K. Imai; Y. Yamaguchi; Y. Kishida; K. Takizawa; N. Kakushima; M. Tanaka; N. Kawata; M. Yoshida; H. ishiwatari; H. Matsubayashi; H. Ono

P1121A COMPARATIVE STUDY ON EFFICACY OF CHEMO-THERAPY AFTER ENDOSCOPIC COLONIC STENTING VS. THAT AFTER COLONIC SURGERY IN THE MANAGEMENT OF OBSTRUCTIVE COLORECTAL CANCERNorihiro Hanabata, Japan; Y. Sasaki; K. Kanazawa; S. Igarashi; K. Hasui; K. Shimaya; H. Numao; M. Munakata; S. Fukuda

P1122A NEW MANEUVER TO PLACE A THROUGH-THE-SCOPE STENT IN A MALIGNANT COLONIC STRICTURE INAC-CESSIBLE WITH A STANDARD-CALIBER COLONOSCOPE: "OVER-THE-CATHETER" COLONOSCOPE REPLACEMENT TECHNIQUEYoichiro Iboshi, Japan; Y. Sumida; N. Harada; H. Tsuru; M. Tomonori; M. Wada; T. Osoegawa; M. Nakamuta; E. Ihara

P1123RESULT OF THE FIRST ROUND OF THE COLORECTAL CANCER SCREENING PROGRAMME IN THE BALEARIC ISLANDS (SPAIN)Monica Florido, Spain; M. Novella; M. Heredia; E. Miro; C. Sanchez-Contador; J. Gelabert; S. P. Ortega; E. Y. Iyo; J. Reyes; P. Garcia-Cortes; J. A. Lucero; Z. Salman; C. Rodriguez; A. Ruiz; M. J. Garcia

IBS/Lower GI motility: Transmitters/signals/receptors/enteric nervous system

P1124ADVANCED GLYCATION END PRODUCTS IMPAIR CA2+ HANDLING IN COLON SMOOTH MUSCLE CELLS VIA CAMP/PKA PATHWAYTing Yu, China; L. Lin

P1125ENTEROENDOCRINE, MUSASHI 1, AND NEUROGENIN 3 CELLS IN THE LARGE INTESTINE OF THAI PATIENTS WITH IRRITABLE BOWEL SYNDROMEMagdy El-Salhy, Norway; T. Patcharatrakul; J. G. Hatlebakk; T. Hausken; O. H. Gilja; S. Gonlachanvit

P1112NEW FECAL IMMUNOASSAY TEST (FIT) FOR THE COLORECTAL CANCER SCREENING IN ILE DE FRANCE: IMPACT OF AGE, GENDER AND HEMOGLOBIN LEVELS. Bercier; A. Liautaud; A. Kaufmanis; C. Vincelet; A. Bernoux; H. Aithadad; H. Delattre; G. Lemab; A. Koivogui; T. Letrung; Z. Brixie; Iradj Sobhani, France


P1113ARTIFICIAL INTELLIGENCE CAN PREDICT THE PRESENCE OF LYMPH NODE METASTASIS IN T1 COLORECTAL CANCERKatsuro Ichimasa, Japan; S.-E. Kudo; Y. Mori; M. Misawa; S. Matsudaira; Y. Kouyama; T. Baba; K. Wakamura; T. Hayashi; T. Hisayuki; T. Kudo; N. Toyoshima; H. Nakamura; T. Ishigaki; Y. Yagawa; K. Takeda; Y. Maeda; Y. Ogawa; S. Hamatani; H. Miyachi; F. Ishida

P1114RISK FACTORS OF ADVANCED METACHRONOUS NEOPLASM IN COLONOSCOPIC SURVEILLANCE AFTER COLON CANCER RESECTIONKwangwoo Nam, Republic of Korea; J. E. Shin; K. B. Bang; H. D. Shin; H. Namgung; D. G. Park

P1115 PROSPECTIVE COMPARISON OF THE NOVEL FULL SPECTRUM ENDOSCOPY (FUSE) AND ADVANCED HIGH DEFINITION-WHITE LIGHT ENDOSCOPY FOR DETEC-TION OF POLYPS IN ROUTINE PRACTICEAlvaro Martinez- Alcala García, Spain; F. J. Martínez-Alcala; C. Martínez- Alcalá; K. Thakar; R. Madero; K. Mönkemüller; F. Martínez Alcalá

P1116UNDERWATER ENDOSCOPIC MUCOSAL RESECTION FOR NON-PENDULATED COLORECTAL LESIONS. IS THE DISTAL CAP REALLY NECESSARY?L. H. Lenz Tolentino; Caterina Pennacchi, Brazil; J. F. de Oliveira; E. Q. Mendonça; M. Minata; E. Gonzalez; G. de Paulo; S. Geiger; M. Sorbello; M. Simas de Lima; F. Kawaguti; B. D. C. Martins; E. R. Baba; A. V. Safatle-Ribeiro; C. C. Gusmon; R. Uemura; A. Tellian; F. Rolim; C. Hashimoto; U. Ribeiro Jr.; F. Maluf-Filho

P1117ADENOMA DETECTION RATE INFLUENCES RISK PRE-DICTION OF METACHRONOUS ADVANCED COLORECTAL NEOPLASIA IN LOW-RISK PATIENTSSun Hwa Kim, Republic of Korea; S. J. Lee; T. J. Kim; E. R. Kim; S. N. Hong; D. K. Chang; Y.-H. Kim

P1118EXPERIENCE OF PER ANAL ENDOSCOPIC MYECTOMY (PAEM)Takashi Toyonaga, Japan; Y. Ohara; S. Tanaka; H. Takihara; S. Baba; F. Kawara; T. Ishida; Y. Morita; E. Umegaki


195


Tues

day,

Oct

ober

31,

201

7


P1135TRANS-ABDOMINAL INTERFERENTIAL ELECTRICAL STIMULATION IS EFFECTIVE IN MANAGING REFRACTORY LOWER GASTROINTESTINAL DYSMOTILITY DISORDERS.Judith Moore, Australia; P. R. Gibson; R. E. Burgell

P1136YH12852, A NOVEL AND HIGHLY SELECTIVE 5-HY-DROXYTRYPTAMINE 4 RECEPTOR AGONIST, INCREASES STOOL FREQUENCY IN HEALTHY VOLUNTEERS AND PATIENTS WITH FUNCTIONAL CONSTIPATION: RESULTS OF A RANDOMIZED DOUBLE-BLIND PLACEBO/AC-TIVE-CONTROLLED PHASE 1/2A TRIALS. J. Moon; H. G. Yoo; Seoungoh Lee, Republic of Korea; S. B. Jang; M. K. Kim; H. Na; H. Lee

P1137 HEALTHCARE PROFESSIONALS FAIL TO PROVIDE ADE-QUATE COUNSELLING AND SUPPORT ABOUT OPIOID-IN-DUCED CONSTIPATION TO STRONG-OPIOID USERSViola Andresen, Germany; V. Banerji; G. Hall; A. Lass; A. V. Emmanuel

P1138THREE-DIMENSIONAL HIGH-RESOLUTION ANORECTAL MANOMETRY IN CHILDREN AFTER SURGERY FOR ANORECTAL DISORDERSMarcin Banasiuk, Poland; A. Banaszkiewicz; M. Dziekiewicz; A. Kamiński; P. Albrecht

Irritable bowel syndrome: Treatment

P1139UK CLINICAL EXPERIENCE AT 52 WEEKS WITH LIN-ACLOTIDE FOR IRRITABLE BOWEL SYNDROME WITH CONSTIPATIONAnton Emmanuel, United Kingdom; J. McLaughlin; Y. Yiannakou; S. McLain-Smith

P1140 EFFECT OF FAECAL MICROBIOTA TRANSPLANTATION ON GUT BACTERIAL FERMENTATION PRODUCTS IN PATIENTS WITH IRRITABLE BOWEL SYNDROMETarek Mazzawi, Norway; J. Valeur; T. Hausken; M. El-Salhy; J. G. Hatlebakk; G. A. Lied

P1141HEALTHCARE RESOURCE USE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH DIARRHOEA BASED ON A SURVEY OF PHYSICIANS IN THE UNITED KINGDOMAnne Marciniak, United Kingdom; D. Collomb; S. Baker; R. Goosey

P1126SUBJECT GLOBAL SATISFACTION SCORE TO ASSESS OVERALL EFFECT OF NALDEMEDINE COMPARED WITH PLACEBO ON CONSTIPATION AND ABDOMINAL SYMP-TOMS IN SUBJECTS WITH CHRONIC NON-CANCER PAIN AND OPIOID-INDUCED CONSTIPATIONJan Tack, Belgium; M. Camilleri; B. Cai; T. Yamada; J. C. Arjona Ferreira

P1127IBEROGAST PREVENTS CHANGES IN INTESTINAL PERME-ABILITY INDUCED BY PSYCHOLOGICAL STRESS IN MICE.P. Aubert; J. Chevalier; T. Durand; A. Bessard; O. Kelber; H. Abdel-Aziz; Michel Neunlist, France

P1128WITHDRAWN

P1129ALTERING SPHINGOSINE-1-PHOSPHATE WITH AGING INDUCES MOTILITY DYSFUNCTION OF COLON SMOOTH MUSCLE BY BKCA UPREGULATION IN RATSShen Xiaoxue, China

P1130DIABETES-RELATED ALTERATIONS IN THE EXPRES-SION OF THE INFLAMMATORY CYTOKINES, TUMOR NECROSIS FACTOR ALPHA AND INTERLEUKIN 6 IN THE MYENTERIC GANGLIA AND ITS MICROENVIRONMENT OF DIFFERENT INTESTINAL SEGMENTSLalitha Chandrakumar, Hungary; D. Mezei; B. P. Barta; Z. Szalai; N. Bódi; M. Bagyánszki

P1131ROLE OF SEMAPHORIN 3A IN THE POSTNATAL DEVEL-OPMENT OF THE ENTERIC NERVOUS SYSTEMJacques Gonzales, France; C. Le Berre; E. Dikkongue; M. Neunlist; H. Boudin


P1132A POPULATION-BASED STUDY ON BOWEL HABITS IN A POR-TUGUESE COMMUNITY: PREVALENCE OF CONSTIPATIONMarco Silva, Portugal; S. Gomes; J. Silva; M. Fazendeiro; M. Ribeiro; A. Peixoto; R. Gaspar; R. Morais; J. A. Sarmento; G. Macedo

P1133DIAGNOSTIC DISCORDANCE BETWEEN TESTS OF EVAC-UATION : A PROSPECTIVE STUDYDan Carter, Israel; E. Bardan; M. Beer-Gabel

P1134DIAGNOSTIC USE OF ENDOSCOPIC FULL-THICKNESS WALL RESECTION (EFTR) IN PATIENTS WITH SYMPTOMS OF CHRONIC INTESTINAL PSEUDO-OBSTRUCTION (CIPO)Piero V Valli, Switzerland; D. Pohl; M. Fried; R. Caduff; P. Bauerfeind


196




Ano-rectal disorders other than IBD or motility-related

P1150A SYSTEMATIC REVIEW AND META-ANALYSIS TO DETERMINE WHETHER BALLOON EXPULSION TESTING MIGHT BE AN APPROPRIATE INITIAL OFFICE-BASED TEST FOR DYSSYNERGIC DEFECATIONEric Shah, USA; J. Farida; W. D. Chey

P1151PREVALENCE OF ANAL SQUAMOUS INTRAEPITHELIAL LESIONS IN LIVER TRANSPLANTED PATIENTS. Andreia Albuquerque, Portugal; H. Pessegueiro Miranda; J. Lopes; J. Gandara; S. Rodrigues; R. Gaspar; R. Morais; R. Ramalho; E. Rodrigues-Pinto; H. Cardoso; H. Barroca; C. Camila Dias; F. Carneiro; G. Macedo

Poster Session09:00 – 17:00 Hall 7Oesophageal, Gastric and Duodenal Disorders II

Immunity and inflammation (not H. pylori)

P1152IMMUNOHISTOCHEMICAL EXPRESSION OF DIAMINE OXIDASE IN THE UPPER GASTROINTESTINAL TRACT OF PATIENTS WITH GASTROINTESTINALLY MEDIATED FOOD ALLERGYThomas Vasilakis, Germany; R. J. Rieker; J. Heinrich; A. Missbichler; A. F. Hagel; J. Kressel; M. Raithel

P1153PREVALENCE OF ATROPHIC GASTRITIS IN GENERAL POPULATION: A GASTROPANEL®- BASED STUDY, COM-PARED WITH OLGA HISTOLOGICAL CLASSIFICATIONFrancesco Di Mario, Italy; S. Grillo; S. Cesario; C. Miraglia; S. Scida; S. Landi; P. Crafa; R. Cannizzaro; G. grande; V. Corrente; M. Franceschi; M. Riccò; L. Franzoni; C. Scarpignato; M. Rugge

P1154IMPROVEMENT OF SYMPTOMS IN PATIENTS AFFECTED BY CHRONIC ATROPHIC GASTRITIS: A TWO-YEAR PRO-SPECTIVE STUDY BY USING L-CYSTEINEG. Masciangelo; L. Franzoni; C. Miraglia; P. Crafa; S. Scida; M. Franceschi; R. Cannizzaro; N. Dal Bò; C. Scarpignato; M. Rugge; Francesco Di Mario, Italy

P1155PROGNOSTIC SIGNIFICANCE OF SERUM INFLAMMATO-RY MARKERS IN GASTRIC CANCERArfon Powell, United Kingdom; D. Parkinson; N. Patel; C. Brown; W. Lewis

P1142RANDOMISED PLACEBO CONTROLLED ESCITALOPRAM INTERVENTION IN IBS WITH PANIC DISORDER: EVALUA-TION BY GSRS AND BY EXPERIENCE SAMPLING METHODLisa Vork, The Netherlands; M. Drukker; Z. Mujagic; D. Keszthelyi; J. van Os; A. A. M. Masclee; C. Leue; J. Kruimel

P1143LINACLOTIDE ACCELERATES COLONIC TRANSIT AND IMPROVES COLONIC CONTRACTILITY IN IBS WITH CONSTIPATION Adam Farmer, United Kingdom; A. R. Hobson

P1144RELATIONSHIP BETWEEN RIFAXIMIN THERAPY AND SEHCAT TEST IN PATIENTS WITH DIARRHEA-PREDOM-INANT IRRITABLE BOWEL SYNDROME OR FUNCTIONAL DIARRHEA.Alexandra Ruiz Cerulla, Spain; S. Maisterra; C. Arajol; P. Gilabert; K. Serra; O. Puig; P. Notta; F. Rodriguez-Moranta; L. Rodriguez-Alonso; E. Sanchez-Pastor; J. Guardiola

P1145FECAL MICROBIOTA TRANSPLANTATION FOR PATIENTS WITH POST-INFECTIOUS OR ANTIBIOTIC-INDUCED IRRITABLE BOWEL SYNDROME: RESULTS FROM A PROSPECTIVE PILOT STUDYYvette van Beurden, The Netherlands; A. E. Budding; E. M. Terveer; J. J. Keller; E. J. Kuijper; C. M. J. E. Vandenbroucke-Grauls; C. J. J. Mulder

P1146CONSECUTIVE WEEKS OF INADEQUATE RELIEF: A POST HOC ANALYSIS OF THE POOLED ELUXADOLINE PHASE 3 STUDIES IN PATIENTS WITH IRRITABLE BOWEL SYNDROMED. Collomb; A. Marciniak; Y. Mo; D. A. Andrae; Gwen Wiseman, United Kingdom

P1147CLINICAL RESPONSE AND DISCONTINUATION OVER TIME IN PHASE 3 TRIALS OF ELUXADOLINE FOR IRRI-TABLE BOWEL SYNDROME WITH DIARRHOEAAnne Marciniak, United Kingdom; R. T. Carson; J. L. Abel; D. A. Andrae; K. Fust; D. Becker

P1148THE LOW FODMAP DIET REDUCES CAECAL FERMENTA-TION COMPARED TO TRADITIONAL DIETARY ADVICE: A RANDOMISED CONTROLLED TRIAL Adam Farmer, United Kingdom; N. Saini; A. R. Hobson

P1149 ORAL A-GALACTOSIDASE IMPROVES GASTROINTESTI-NAL TOLERANCE TO A DIET HIGH IN GALACTO-OLIGO-SACCHARIDES: ADJUNCT THERAPY TO A LOW FODMAP DIET IN IRRITABLE BOWEL SYNDROMECaroline Tuck, Australia; K. M. Taylor; J. S. Barrett; P. R. Gibson; J. G. Muir


197


Tues

day,

Oct

ober

31,

201

7


P1164PREDICTORS OF LIFE THREATENING MUCOSAL ULCER-ATION AFTER VARICEAL SCLEROTHERAPYAmr Hanafy, Egypt

Community dyspepsia

P1165IMPACT OF SLEEP DISORDER IN PATIENTS WITH FUNC-TIONAL DYSPEPSIAKyuchan Huh, Republic of Korea; J. K. Park; K. W. Jung; C. M. Shin; J. W. Kim

P1166PREVALENCE OF DYSPEPSIA IN INDIVIDUALS WITH GASTRO-OESOPHAGEAL REFLUX-TYPE SYMPTOMS IN THE COMMUNITY: A META-ANALYSISL. H. Eusebi; Ragu Prakash Ratnakumaran, United Kingdom; M. L. Artesiani; F. Bazzoli; A. C. Ford

Upper GI nerve-gut and motility: Brain-gut and gut-brain axes, neuro-hormonal, neural-immune and visceral sensitivity

P1167PSYCHOSOCIAL PREDICTORS OF LATER GASTROINTES-TINAL SYMPTOMSMichael P. Jones, Australia; N. Koloski; L. Van Oudenhove; A. Ejova; N. J. Talley

P1168AN INCREASED PREVALANCE OF NEURODEGENERA-TIVE/DEMYELINATING PROCESS IN PATIENTS WITH ESOPHAGEAL ACHALASIA – A PROSPECTIVE STUDYMartin Jerie, Czech Republic; Z. Vackova; H. Svecová; E. Meluzinova; J. Krajciova; Z. Vojtech; J. Spicak; J. Vymazal; J. Martinek

P1169HIGH RESTING PARASYMPATHETIC CARDIAC VAGAL TONE CONFERS A UNIQUE FUNCTIONAL BRAIN NET-WORK DURING ACUTE OESOPHAGEAL PAINJames Ruffle, United Kingdom; S. J. Coen; V. Giampietro; S. C. R. Williams; A. D. Farmer; Q. Aziz


P1170RAPID DRINK CHALLENGE (RDC) TEST DURING OE-SOPHAGEAL HIGH RESOLUTION MANOMETRY (HRM) IN PATIENTS WITH OESOPHAGO-GASTRIC JUNCTION OUTFLOW OBSTRUCTIONDario Biasutto, France; F. Mion; A. Garros; S. Roman

P1171 ª THE NORMATIVE VALUES OF A NEW 36 CHANNELS WATER PERFUSION ESOPHAGEAL MOTILITY CATHETERS. Bor; Sezgi Kipcak, Turkey


P1156ANALYSIS OF REBLEEDING PATIENTS IN UPPER GASTRO- INTESTINAL BLEEDING IN A SINGLE CENTER SERIESR. Jiménez-Rosales; E. Ortega-Suazo; P. Abellán-Alfocea; F. Valverde López; J. G. Martinez-Cara; Eduardo Redondo Cerezo, Spain

P1157 A CASE-CONTROL STUDY ON THE RISK OF UPPER GASTROINTESTINAL MUCOSAL INJURIES IN SUBJECTS PRESCRIBED NSAIDS AND ANTI-THROMBOTIC DRUGS USING THE LARGE ORGANIZED DATABASE OF CLAIMS IN JAPAN (APPROXIMATELY 3.7 MILLION OF POPULA-TION ON AN ACCUMULATED BASIS)Nobuyuki Sugisaki, Japan; R. Iwakiri; K. Fujimoto

P1158GASTROINTESTINAL BLEEDING UNDER ANTICOAG-ULATION THERAPY: SYSTEMATIC REVIEW OF THE REBLEEDING RISK, ITS REVERSIBILITY PROFILE AND RISK STRATIFICATION TO SELECT PATIENTS FOR LEFT ATRIAL APPENDAGE OCCLUSION.Alia Hadefi, Belgium; A. Aminian; A. Bondue; J. Devière; A. Lemmers

P1159AN AUDIT INTO THE MANAGEMENT OF BLEEDING PEP-TIC ULCER DISEASEKeith Siau, United Kingdom; A. Vijayasingam

P1160COMPARISON OF SCORING SYSTEMS FOR NON-VAR-ICEAL UPPER GI BLEEDING; FOCUS ON THE SIMPLE PREDICTION SYSTEM, AIMS65Min Seong Kim, Republic of Korea; J. Choi; W. C. Shin

P1161COMPARISON OF RISK-SCORING SYSTEMS IN PRE-DICTING NEEDS OF INTERVENTION AND CLINICAL OUTCOMES OF UPPER GASTROINTESTINAL BLEEDINGMarie Ooi, Australia; W. Low; R. Bryant; N. Q. Nguyen

P1162STEROID ADMINISTRATION IS AN INDEPENDENT RISK FACTOR FOR REBLEEDING IN HEMORRHAGIC DUODE-NAL ULCER WITH A DOSE-RESPONSE RELATIONWaku Hatta, Japan; Y. Kondo; T. Koike; T. Kanno; N. Ara; K. Asanuma; N. Asano; A. Imatani; T. Shimosegawa

P1163EFFICACY AND SAFETY OF BIO-INSERT MINERAL SMECTITE IN CONTROLLING GASTROINTESTINAL HEM-ORRHAGE: AN ANIMAL PILOT STUDYJ. Wang; L. Zhao; M. Wang; L. Liu; Z. Fan; Xiang Wang, China


198




P1180DO THE ENDOSCOPIC FINDINGS OF GASTRITIS BRING THE FD SYMPTOMS?Yuji Shimada, Japan; S. Sato; K. tomishima; Y. Kanemitsu; H. Tsuzura; A. Murata; N. Amano; S. Sato; T. Genda; K. Iijima; M. Kusano; A. Nagahara

P1181IMPACT OF EPIGASTRIC PAIN SYNDROME ACCOMPANY-ING PANCREATIC ENZYME ABNORMALITIES EXHIBITED RAPID EARLY PHASE OF GASTRIC EMPTYING AND EAR-LY CHRONIC PANCREATITIS USING ENDOSONOGRAPHY Kumiko Kirita, Japan; S. Futagami; S. Agawa; G. Ikeda; H. Noda; K. Higuchi; T. Akimoto; Y. Maruki; H. Yamawaki; Y. Kodaka; N. Ueki; T. Kawagoe; K. Iwakiri

P1182ENDOSCOPIC AUTOLOGOUS TRANSPLANTATION OF ESOPHAGEAL MUCOSA FOR TREATING THE REFRACTO-RY CAUSTIC ESOPHAGEAL STRICTUREK. He; L. Zhao; S. Bu; L. Liu; M. Wang; X. Wang; Zhining Fan, China

P1183FUNCTIONAL DYSPEPSIA IS STRONGLY ASSOCIATED WITH OBSTRUCTIVE SLEEP APNOEA – A CASE CON-TROL STUDYRashid Lui, Hong Kong PRC; P. Cheong; C. K. Cheung; Y. Chan; K. Yuen; F. Fang; J. C. Wu

P1184INDIVIDUAL ASSESSMENT OF GASTRIC ACID PRO-DUCTION BY MEANS OF A NON-INVASIVE TEST: RE-LATIONSHIP BETWEEN MAXIMAL ACID OUTPUT AND PEPSINOGEN I LEVELSF. Di Mario; S. Scida; Chiara Miraglia, Italy; L. Franzoni; M. Franceschi; A. Bertelè; R. Cannizzaro; N. Dal Bò; E. Savarino; N. de Bortoli; M. Rugge; C. Scarpignato

Reflux disease, epidemiology

P1185THE DISCREPANCY BETWEEN THE ACID REGURGITA-TION SYMPTOMS AND ENDOSCOPIC GERD GRADE IN DIABETES MELLITUS PATIENTS.Kosuke Sakitani, Japan; N. Suzuki

P1186SARCOPENIA AS A LEADING RISK FACTOR FOR EROSIVE ESOPHAGITIS: A LARGE-SCALE CROSS-SECTIONAL STUDYTaewan Kim, Republic of Korea; T. J. Kim; H. Lee; J. J. Kim

P1187FOOD RATE (FREQUENCY AND TIME SPENT IN EATING) IN PATIENTS WITH MORBID OBESITY. DIFFERENCES AND SIMILARITIES BETWEEN MEN AND WOMEN.J. Perez de la Serna; A. Ruiz de León; Sonia Ayllón Cano, Spain; C. Sevilla Mantilla; A. Sánchez Pernaute; E. Rey; B. Merchan Gomez

P1172 LOW-VOLUME MULTIPLE RAPID SWALLOW BETTER DISTINGUISH PERISTALTIC ESOPHAGEAL RESERVE COMPARED TO HIGH-VOLUME RAPID DRINKING TESTIrene Martinucci, Italy; N. de Bortoli; S. Tolone; M. Furnari; M. Frazzoni; L. Frazzoni; L. Fuccio; M. Bellini; V. Savarino; R. Penagini; S. Marchi; E. Savarino

P1173HIGH-VOLUME RAPID DRINKING TEST BETTER DISTIN-GUSH ESOPHAGEAL BODY INHIBITION COMPARED TO LOW-VOLUME MULTIPLE RAPID SWALLOWSIrene Martinucci, Italy; N. de Bortoli; S. Tolone; M. Furnari; M. Frazzoni; L. Frazzoni; L. Fuccio; M. Bellini; V. Savarino; R. Penagini; S. Marchi; E. Savarino

P1174ESOPHAGEAL BOLUS FLOW METRICS ON PRESSURE FLOW ANALYSIS (PFA) OF ESOPHAGEAL HIGH RESO-LUTION IMPEDANCE MANOMETRY (HRIM) IN GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD)Stephen Hasak, USA; A. Manolakis; R. Badillo; A. Ding; A. Pauwels; J. Tack; N. Rommel; T. Omari; C. P. Gyawali

P1175PROVOCATIVE TESTING INCREASES THE DIAGNOSTIC YIELD OF HIGH RESOLUTION OESOPHAGEAL MANOME-TRY IN PATIENTS WITH OESOPHAGEAL DIVERTICULA.Fabien Wuestenberghs, Belgium; C. A. Melchior; A. M. Leroi; G. Gourcerol

P1176 EVALUATION OF ESOPHAGOGASTRIC JUNCTION CONTRACTILITY AFTER DIFFERENT TREATMENTS FOR ACHALASIASalvatore Tolone, Italy; E. Savarino; N. de Bortoli; M. Frazzoni; M. Furnari; L. Frazzoni; V. Savarino; L. Docimo; L. Swanström

P1177MULTIPLE RAPID SWALLOWING IN JACKHAMMER ESOPHAGUS PATIENTS: EVIDENCE FOR ALTERED NEU-RAL CONTROL.Aurelio Mauro, Italy; S. Tolone; E. Savarino; N. de Bortoli; M. Franchina; R. Penagini


P1178 GASTRIC PERORAL ENDOSCOPIC MYOTOMY (G-POEM) AS TREATMENT FOR FUNCTIONAL DELAYED GASTRIC EMPTYING: INITIAL ASIAN EXPERIENCE Mingyan Cai, China; J. Xu; P.-H. Zhou

P1179EFFECTIVENESS OF CAP-ASSISTED DEVICE IN THE ENDOSCOPIC MANAGEMENT OF FOOD BOLUS OB-STRUCTION IN THE UPPER ESOPHAGUS.Marie Ooi, Australia; E. J. Young; N. Q. Nguyen


199


Tues

day,

Oct

ober

31,

201

7


P1196GASTRIN-17 AS A NON-INVASIVE MARKER OF EARLY GERD RELAPSE: A PROSPECTIVE ONE-YEAR STUDYFrancesco Di Mario, Italy; S. Speroni; S. Scida; C. Miraglia; V. Corrente; M. Franceschi; E. Savarino; N. de Bortoli; A. Tursi; G. Brandimarte; L. Franzoni; C. Scarpignato

P1197THE DIAGNOSTIC VALUE OF ESOPHAGEAL MUCOSAL AND BASELINE IMPEDANCE MEASUREMENTS IN PA-TIENTS WITH GASTROESOPHAGEAL REFLUX DISEASESezgi Kipcak, Turkey; P. Ergun; S. Bor

P1198ENDOSCOPIC-HISTOPATHOLOGIC ESOPHAGEAL FIND-INGS IN ATROPHIC BODY GASTRITIS PATIENTS WITH GASTRO-ESOPHAGEAL REFLUX SYMPTOMSMarilia Carabotti, Italy; G. Esposito; E. Lahner; E. Pilozzi; G. Galli; G. Ranazzi; E. Di Giulio; B. Annibale

P1199CLINICAL PRESENTATION RISK FACTORS AND ENDO-SCOPICAL FEATURES IN GERD: A COMPARATIVE STUDY BETWEEN GERD AND DYSPEPTIC SUBJECTS ON A SAM-PLE OF 2300 PEOPLE IN A PRIMARY CARE SETTINGFrancesco Di Mario, Italy; T. B. Tene Fokam; S. Landi; S. Cesario; S. Grillo; S. Scida; C. Miraglia; E. Savarino; N. de Bortoli; L. Franzoni; G. grande; C. Scarpignato


P1200REAL-WORLD RESPONSE OF PATIENTS WITH GASTRO-ESOPHAGEAL REFLUX DISEASE TO EMPIRICAL TREATMENT WITH PROTON PUMP INHIBITORS: A MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY IN CHINAB. Lu; L. Zhang; J. Wang; B. Wang; X. Zou; J. Qian; D. Chen; X. Wang; B. Wu; Duowu Zou, China

P1201WIRELESS ELECTRICAL STIMULATION FOR MANAGING GASTROESOPHAGEAL REFLUX DISEASE IN THE RABBIT MODELM. Wang; L. Zhao; L. Liu; X. Wang; Zhining Fan, China

P1202SYSTEMATIC REVIEW AND META-ANALYSIS OF OUT-COMES AFTER LAPAROSCOPIC ANTI-REFLUX SURGERY RELATED TO OBESITYTarig Abdelrahman, United Kingdom; A. Latif; D. Chan; N. Patel; C. Brown; W. Lewis; T. Havard; X. Escofet

P1203GASTROESOPHAGEAL REFLUX DISEASE REFRACTORY TO PROTON PUMP INHIBITOR THERAPY. INCOMPLETE ACID INHIBITION OR DIAGNOSTIC ERROR?Julio Perez de la Serna, Spain; A. Ruiz de León; C. Sevilla Mantilla; A. Zataraín Valles; O. N. López García; E. Rey; B. Merchan Gomez

P1188ONE DRINK CAN INCREASE A RISK FOR ESOPHAGEAL, STOMACH AND COLORECTAL CANCER IN A COHORT OF 23,323,730 KOREAN ADULTSYoon Jin Choi, Republic of Korea; D. H. Lee

Reflux disease, pathogenesis

P1189THE INFLUENCES OF VISCERAL FAT AREA ON THE SITES OF ESOPHAGEAL MUCOSAL BREAKS AND SYMP-TOM SEVERITIES IN SUBJECTS WITH GASTROESOPHA-GEAL REFLUX DISEASESE. Cho; Jae Hak Kim, Republic of Korea

P1190 A LESS COMPETENT OESOPHAGO-GASTRIC JUNCTION IS ASSOCIATED WITH OESOPHAGEAL ACID HYPERSEN-SITIVITY EVEN IN HEALTHY CONTROLSChristian Lottrup, Denmark; A. L. Krarup; P. Ejstrud; B. P. McMahon; A. M. Drewes

P1191 THE MUCOSAL INTEGRITY IN PHENOTYPES OF GAS-TROESOPHAGEAL REFLUX DISEASE AND FUNCTIONAL HEARTBURNPelin Ergun, Turkey; S. Kipcak; S. Bor

P1192PEPSIN AND PH LEVELS OF HUMAN GASTRIC JUICES IN GASTROESOPHAGEAL REFLUX DISEASE SUBGROUPS AND FUNCTIONAL HEARTBURNPelin Ergun, Turkey; S. Kipcak; P. Dettmar; A. Woodcock; S. Bor

P1193NON INVASIVE DIAGNOSIS OF UPPER GI DISEASES IN A PRIMARY CARE SETTING: A STUDY ON 1,900 PATIENTSF. Di Mario; S. Cesario; Simone Grillo, Italy; S. Landi; G. Baldassarre; R. Cannizzaro; P. Crafa; M. Riccò; L. Franzoni; C. Miraglia; S. Scida; C. Scarpignato; M. Rugge; M. F. Roberti

P1194CHANGES IN ANTHROPOMETRIC AND METABOLIC PA-RAMETERS RELATED TO GASTROESOPHAGEAL REFLUX DISEASE IN NON-OBESE CASESS. Yavuz; Özlem Gül Utku, Turkey; A. Gungunes; N. Dindar Badem; B. Ergul; D. Oğuz


P1195PROXIMAL ESOPHAGEAL BASELINE IMPEDANCE LEV-ELS ARE ABLE TO DISCRIMINATE BETWEEN SCLERO-DERMA PATIENTS WITH AND WITHOUT ESOPHAGEAL INVOLVEMENTMarco Della Coletta, Italy; P. Zentilin; E. Marabotto; S. Tolone; N. de Bortoli; G. Bodini; V. Savarino; E. Savarino


200




P1211IDENTIFICATION OF THREE DISTINCT BIOLOGICAL SUBTYPES IN ESOPHAGEAL AND JUNCTIONAL ADENO-CARCINOMA BY RNA SEQUENCINGSanne Hoefnagel, The Netherlands; B. Scicluna; S. Calpe; C. del Sancho-Serra; K. K. Krishnadath

P1212CLINICAL VALUE OF LONG NONCODING RNA TRPM2-AS EXPRESSION IN ESOPHAGEAL SQUAMOUS CELL CARCINOMAHairong Xu, China; G. Yao; L. Lin

P1213ROLE OF CD80 EXPRESSION IN INFLAMMATORY-RE-LATED ESOPHAGEAL CARCINOGENESISMelania Scarpa, Italy; L. Dall'Olmo; M. Fassan; A. Porzionato; A. Kotsafti; V. Macchi; R. Alfieri; S. Realdon; M. Rugge; I. Castagliuolo; C. Castoro; M. Scarpa

P1214TUMOR MICROENVIRONMENT IN ESOPHAGEAL ADE-NOCARCINOMA: NUCLEAR P53 OVER-EXPRESSION IS ASSOCIATED TO WORSE DISEASE FREE SURVIVALAndromachi Kotsafti, Italy; M. Fassan; L. M. Saadeh; V. Guzzardo; M. Scarpa; F. Cavallin; M. Agostini; M. Cagol; R. Alfieri; M. Rugge; I. Castagliuolo; C. Castoro; M. Scarpa

P1215PHARMACOLOGICAL INHIBITION OF MONOCARBOXYL-ATE TRANSPORTER 1 INDUCES APOPTOSIS IN META-STATIC ESOPHAGEAL ADENOCARCINOMA CELLSEduardo Chueca Lapuente, Spain; A. Valero Torres; S. Arechavaleta Tabuenca; M. Á. Sáenz; M. A. García-González; C. Hörndler; A. Lanas; E. Piazuelo


P1216THE PREDICTIVE FACTOR FOR PERFORATION IN ESOPHAGEAL ESDYasuaki Nagami, Japan; M. Ominami; M. Shiba; S. Fukunaga; F. Tanaka; N. Kamata; H. Yamagami; T. Tanigawa; T. Watanabe; Y. Fujiwara

P1217 SAFETY AND EFFICACY OF CHEMORADIOTHERAPY AFTER ENDOSCOPIC RESECTION IN PATIENTS WITH SU-PERFICIAL ESOPHAGEAL SQUAMOUS-CELL CARCINOMA.Takuya Wada, Japan; C. Katada; M. Azuma; T. Yano; S. Tanabe; W. Koizumi; H. Moriya; K. Yamashita; S. Komori; K. Ishido

P1218SAFETY, EFFICACY AND OUTCOME OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR THE TREATMENT OF EARLY BARRETT’S NEOPLASIAMasami Omae, Sweden; M. Konradsson; P. Elbe; M. Nilsson; M. Lindblad; I. Rouvelas; F. Baldaque-Silva

P1204 LOW-FODMAP DIET RESULTED EFFECTIVE IN RE-DUCING SYMPTOM PERCEPTION IN PATIENTS WITH FUNCTIONAL HEARTBURNIrene Martinucci, Italy; E. Savarino; G. Guidi; K. Nardi; S. Tolone; M. Frazzoni; L. Fuccio; L. Frazzoni; M. Bellini; V. Savarino; S. Marchi; N. de Bortoli


P1205GENDER DIFFERENCES IN NEOPLASTIC PROGRESSION IN BARRETT'S ESOPHAGUS: A MULTICENTER PRO-SPECTIVE COHORT STUDYCarlijn Roumans, The Netherlands; A. Treling; D. Rizopoulos; E. W. Steyerberg; M. J. Bruno; M. C. W. Spaander

P1206SINGLE SESSION FOCAL CRYOBALLOON ABLATION THERAPY IS SAFE AND EFFECTIVE IN THE TREATMENT OF DYSPLASTIC BARRETT’S ESOPHAGUSSanne van Munster, The Netherlands; A. Overwater; J. J. G. H. M. Bergman; B. L. A. M. Weusten

P1207CRYOBALLOON ABLATION OF DYSPLASTIC BARRETT’S ESOPHAGUS CAUSES SHORTER DURATION AND LESS SEVERE POST-PROCEDURAL PAIN AS COMPARED TO RADIOFREQUENCY ABLATIONSanne van Munster, The Netherlands; A. Overwater; J. J. G. H. M. Bergman; B. L. A. M. Weusten

P1208COMPARATIVE OUTCOMES OF RADIOFREQUENCY ABLATION FOR BARRETT’S OESOPHAGUS WITH DIF-FERENT BASELINE HISTOLOGYWei Keith Tan, United Kingdom; A. Rattan; T. Nuckcheddy; B. Alias; V. Sujendran; M. di Pietro

P1209IS IT REASONABLE TO PROPOSE AN ENDOSCOPIC MU-COSAL RESECTION FOR BARRET’S OESOPHAGUS WITH HIGH GRADE DYSPLASIA ON THE BIOPSIES ?Jean-Michel Gonzalez, France; J.-P. Casanova; A. Benezech; E. Bories; S. Garcia; M. Giovannini; M. Barthet

Oesophageal neoplasia: Basic

P1210CD4+ AND CD8+ LYMPHOCYTE RATE AND PDL-1 LEU-KOCYTE EXPRESSION ARE PREDICTIVE OF CLINICAL COMPLETE RESPONSE AFTER NEOADJUVANT CHEMO-RADIOTHERAPY FOR SQUAMOUS CELL CANCER OF THE THORACIC OESOPHAGUSM. Fassan; F. Cavallin; V. Guzzardo; Andromachi Kotsafti, Italy; R. Alfieri; M. Cagol; M. Scarpa; V. Chiarion Sileni; I. Castagliuolo; M. Rugge; C. Castoro; M. Scarpa


201


Tues

day,

Oct

ober

31,

201

7


P1226IRON DEFICIENCY ANEMIA – ARE THERE ANY PREDIC-TORS OF GASTROINTESTINAL MALIGNANCY?Sofia Xavier, Portugal; J. Magalhães; J. Cotter

P1227IMPROVEMENT OF DETECTION RATE OF EARLY GAS-TRIC CANCER BY A TRAIN-THE-TRAINER (TTT) COURSE IN CHINA: A PROSPECTIVE CONTROLLED STUDYJian-Wei Hu, China; M.-Y. Cai; Q. Shi; B.-Q. Zhu; Y. Huang; W. Qin; Z. Ren; J.-Z. Liu; J.-J. Lian; Z. Zhang; P.-H. Zhou; K. Yao

P1228COMPARISON OF ENDOSCOPIC SUBMUCOSAL DIS-SECTION AND SURGERY FOR THE TREATMENT OF EARLY GASTRIC CANCER: SINGLE CENTER LONG TERM OUTCOME STUDYHye in Jung, Republic of Korea; S. J. Kim; I. T. So; J. H. Choi; Y. J. Lee; H. J. Lee; K. B. Cho; K. S. Park; S. W. Ryu; Y. G. Son; J. Y. Lee

P1229HEMATOLOGISTS SHOULD ORDER ENDOSCOPIC EXAMINATION TO EXPERTS OF ENDOSCOPY IN CASE OF ENDOSCOPIC CHECK-UP OF GASTROINTESTINAL MALIGNANT LYMPHOMA. Takuji Yamasaki, Japan; T. Sakurai; J. Mitobe; M. Mitsunaga; M. Saruta

P1230SURVIVAL BENEFITS OF GASTRECTOMY IN PATIENTS WITH STAGE IV GASTRIC CANCER: A POPULA-TION-BASED STUDYXingkang He, China; W. wu; Y. Ding; Z. Jin; L. Sun; J. Si

P1231DEVELOPMENT OF AND EXPERIENCE WITH AN INSU-LATED SCISSORS-TYPE KNIFE (SB KNIFE)Makoto Kobayashi, Japan

P1232GASTROINTESTINAL LYMPHOMASRui Gaspar, Portugal; A. Andrade; J. Santos-Antunes; R. Liberal; F. Carneiro; G. Macedo

P1233THE EFFECT OF OBESITY ON EARLY GASTRIC CANCER IN PATIENTS UNDERGOING ENDOSCOPIC TREATMENTSun Jin, Republic of Korea; S. Y. Nam; S. W. Jeon; Y.-H. Kwon; H. S. Lee

P1234COMPARATIVE STUDY OF THE ENDOSCOPIC ULTRA-SONOGRAPHY-GUIDED FINE-NEEDLE ASPIRATION VS MUCOSAL-INCISION ASSISTED BIOPSY FOR THE HISTOLOGICAL DIAGNOSIS OF GASTROINTESTINAL SUBEPITHELIAL TUMORS.Takashi Osoegawa, Japan; N. Harada; E. Ihara; Y. Iboshi; Y. Sumida; M. Nakamuta; Y. Ogawa

P1219ENDOSCOPIC EVALUATION AT THE PRIMARY SITE OF CT1 ESOPHAGEAL CANCER AFTER PROTON BEAM THERAPY AND CLINICAL RESULTS OF SALVAGE ENDO-SCOPIC THERAPY FOR LOCAL RECURRENCEDaiki Satou, Japan; A. Motegi; T. Kojima; H. Bando; K. Hori; T. Kadota; Y. Yoda; K. Shinmura; Y. Oono; H. Ikematsu; S. Zenda; T. Akimoto; T. Yano

P1220CLINICAL OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR SUPERFICIAL ESOPHAGEAL NEO-PLASMS OF PATIENTS WITH HEAD AND NECK CANCERJ. F. D. Oliveira; E. Q. Mendonça; B. D. C. Martins; F. Kawaguti; M. S. de Lima; S. Geiger; Caterina Pennacchi, Brazil; C. C. Gusmon; R. Uemura; E. R. Baba; A. V. Safatle-Ribeiro; L. H. Lenz Tolentino; G. de Paulo; M. Sorbello; M. Minata; R. N. Moura; U. Ribeiro Jr.; F. Maluf-Filho

P1221 ENDOSCOPIC CRYOBALOON ABLATION IS SAFE, WELL- TOLERATED AND HIGHLY EFFECTIVE IN THE ERADICATION OF ESOPHAGEAL SQUAMOUS CELL NEOPLASIA.Ke Yan, China; S. van Munster; C. Jian; L. Fugang; Z. Deli; W. Li; S. He; Y. Zhang; D. Lizhou; Y. Liu; L. Xudong; L. Xue; L. Ning; S. Dawsey; J. J. G. H. M. Bergman; B. L. A. M. Weusten; G. Wang

P1222THE ENDOSCOPIC TREATMENT STRATEGY FOR SUPER-FICIAL ESOPHAGEAL CANCERNaoyuki Yamaguchi, Japan

P1223DIAGNOSIS OF TUMORS IN THE CERVICAL AND UPPER THORACIC ESOPHAGUS: EFFICACY OF ENDOSCOPIC ULTRASONOGRAPHY USING A JELLY-FILLING METHOD WITH WATER-SOLUBLE LUBRICATING JELLY Noriko Matsuura, Japan; N. Hanaoka; R. Ishihara; S. Yamamoto; T. Akasaka; Y. Takeuchi; K. Higashino; N. Uedo; H. Iishi


P1224OPTIMAL SURGERY TIME AFTER ENDOSCOPIC RESECTION IN EARLY GASTRIC CANCER : LONG-TERM FOLLOW-UP STUDY FOR SURGICAL AND ONCOLOGICAL SAFETYJae Hwang Cha, Republic of Korea; J.-H. Kim; S. H. Choi; D. H. Jung; J. J. Park; Y. H. Youn; H. Park; H.-I. Kim; J.-H. Cheong; W. J. Hyung; S. H. Noh

P1225THE POINT TO DISTINGUISH EARLY GASTRIC CANCER FROM DEPRESSION TYPE OF GASTRIC INTESTINAL METAPLASIA.Toshiyuki Wakatsuki, Japan; S. Furutachi; H. Yamashita


202




Upper GI / Intestinal health services research

P1243FLYING OFF COURSE WITH A 2WW DIRECT ACCESS TO TEST PILOT: NOTTINGHAM'S EXPERIENCE OF THE SUS-PECTED UPPER GASTRO-INTESTINAL CANCER PATH-WAY CHANGE WITH GP VETTING AND OGD BOOKINGNina Lewis, United Kingdom; J. Catton; E. James

P1244WHAT IS THE YIELD OF ROUTINE D2 BIOPSIES IN THOSE PRESENTING WITH WEIGHT LOSS AT GASTROSCOPY?Mehmet Yalchin, United Kingdom; S. Zonoozi; M. Hussein; N. Jayasooriya; K. Besherdas

P1245 FUNDING DISPARITIES IN DIGESTIVE CANCER RE-SEARCH IN THE UNITED STATESPeter Liang, USA; K. O'Connell; M. Du

Poster Session09:00 – 17:00 Hall 7H. Pylori II

Pathogenesis: Microbial factors

P1246HELICOBACTER PYLORI ERADICATION MODULATES AB-ERRANT CPG ISLAND HYPERMETHYLATION IN GASTRIC CARCINOGENESISJeongmin Choi, Republic of Korea; S. G. Kim; B. G. Kim; S.-J. Koh; J. W. Kim; K. L. Lee

Pathogenesis: Host factors/immunology/inflammation

P1247CURCUMIN DOWNREGULATES INTERLEUKIN (IL)-17 BY INCREASING THE EXPRESSION OF INDOLEAMINE 2,3-DIOXYGENASE (IDO) IN HELICOBACTER PYLORI-IN-FECTED HUMAN GASTRIC MUCOSATiziana Larussa, Italy; R. Liparoti; S. Gervasi; E. Suraci; R. Marasco; M. Imeneo; F. Luzza

P1248ALTERATIONS IN SALIVARY MICROBIOTA IN SUBJECTS WITH HELICOBACTER PYLORI-ASSOCIATED GASTRITISWai Keung Leung, Hong Kong PRC; K. S. Lau; T. S. Tong; K.-M. Chu; P. C. Sham

P1249EFFECT OF ALCOHOL DRINKING ON SEROCONVSERSION IN HELICOBACTER PYLORI-SERONEGATIVE KOREANSJi Hye Kim, Republic of Korea; S.-Y. Lee; H. G. Kwon; S. P. Lee; J. H. Kim; I.-K. Sung; H. S. Park; C. S. Shim

P1235CLINICAL TRENDS AND BURDEN OF DEATH IN GASTRIC CANCER: A SIX YEARS SURVEYPellegrino Crafa, Italy; S. Landi; S. Grillo; M. Franceschi; A. Noto; S. Scida; C. Miraglia; L. Franzoni; V. Corrente; R. Cannizzaro; G. M. Cavestro; M. Rugge; F. Di Mario; P. Caruana; C. Mancini


P1236GASTRIC ADENOCARCINOMA OF FUNDIC GLAND TYPE: CANCER GENOMIC DATAHiroya Ueyama, Japan; T. Hayashi; T. Saito; Y. Akazawa; H. Komori; K. Matsumoto; K. Matsumoto; M. Hojo; A. Nagahara; T. Yao; S. Watanabe

P1237LNCRNA-HOTAIR INDUCES THE UBIQUITINATION OF RUNX3 IN GASTRIC CANCERShujie Chen, China; M. Xue; L. Chen; L. Wang

P1238CAB39L FUNCTIONS AS A TUMOUR SUPPRESSOR IN GASTRIC CANCER THROUGH LKB1-MEDIATED AMPK ACTIVATIONWeilin Li, Hong Kong PRC; C. C. Wong; Y. Dong; J. Xu; Y. Qian; W. Kang; P. W. Y. Chiu; E. Ng; J. Yu

P1239FUNCTIONAL CHARACTERIZATION AND CLINICAL SIG-NIFICANCE OF PKNOX2, A NOVEL TUMOR SUPPRESSOR IN GASTRIC CANCERLi Zhang, Hong Kong PRC; C. C. Wong; W. Li; J. Xu; L. Cao; J. Yu

P1240 HOXC10 IS UPREGULATED IN HUMAN GASTRIC CANCER AND PROMOTES CELL G1-S TRANSFORMATION AND PROLIFERATION THROUGH DIRECT TRANSCRIPTIONAL REPRESSION OF P21Liangjing Wang, China; Z. Jin; S. Chen; S. Lai; X. He; J. Si

P1241RECOVERY OF GASTRIC FUNCTION IN CHRONIC ATRO-PHIC GASTRITIS BY USING L-CYSTEINE: A 3 YEARS STUDY Francesco Di Mario, Italy; L. Franzoni; S. Grillo; S. Landi; C. Miraglia; S. Scida; M. Riccò; G. Grande; M. Franceschi; M. P. Panozzo; A. Antico; R. Cannizzaro; G. M. Cavestro; M. Rugge; C. Scarpignato

P1242ANDROGEN RECEPTOR DIRECTLY REGULATES CELL CYCLE-RELATED KINASE TO PROMOTE GASTROCAR-CINOGENESISGuijun Zhao, China; X. LI; L. XU; N. Zhang


203


Tues

day,

Oct

ober

31,

201

7


P1258MAY PROBIOTICS MONOTHERAPY ERADICATE HE-LICOBACTER PYLORI? A SYSTEMATIC REVIEW WITH POOLED-DATA ANALYSISGiuseppe Losurdo, Italy; R. Cubisino; M. Barone; M. Principi; E. Ierardi; A. Di Leo

P1259EFFECTIVENESS AND SAFETY OF PYLERA® IN PATIENTS INFECTED BY HELICOBACTER PYLORI: A LARGE, PROSPECTIVE, REAL LIFE STUDYA. Tursi; M. Franceschi; L. Allegretta; E. Savarino; R. De Bastiani; W. Elisei; G. Baldassarre; A. Ferronato; S. Scida; C. Miraglia; A. Penna; C. Licci; G. L. Rizzo; P. Giuseppe; C. Cassieri; G. Brandimarte; M. Picchio; Francesco Di Mario, Italy

P1260COMPARISON OF CLARITHROMYCIN- AND LEVOFLOX-ACIN-CONTAINING TRIPLE THERAPIES FOR FIRST LINE HELICOBACTER PYLORI ERADICATION IN IRANH. Fakheri; A. Sadoogh; Sepehr Tirgar Fakheri, Iran

P1261EFFICACY AND TOLERABILITY OF REBAMIPIDE IN TRI-PLE THERAPY FOR ERADICATION OF HELICOBACTER PYLORI: A RANDOMIZED CLINICAL TRIALSergey Vyalov, Russian Federation

Poster Session09:00 – 17:00 Hall 7Small Intestinal II

Small intestinal immunology, immunity and inflammation

P1262OBSERVER AGREEMENT FOR DIAGNOSIS OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION WITH MICROVILLI ATROPHY IN THE TERMINAL ILEUM Yuusaku Sugihara, Japan; S. Hiraoka; N. Fujii; S. Takashima; Y. Yamasaki; D. Takei; T. Inokuchi; M. Takahara; Y. Morito; S. Takahashi; K. Kuwaki; K. Harada; T. Tanaka; H. Okada

P1263EPIGALLOCATECHIN-3-GALLATE FROM GREEN TEA AMELIORATE 5-FLUROURACIL-INDUCED INTESTINAL MUCOSITISJ. M. Lee; G. Min; W. Kim; S. J. Choi; I. K. Yoo; S. H. Kim; J. M. Lee; H. S. Choi; E. S. Kim; B. Keum; H. J. Chun; H. S. Lee; Yoon Tae Jeen, Republic of Korea; C. D. Kim; K. C. Yoon

P1264INCREASED SUSCEPTIBILITY TO ENTEROPATHOGEN-IC BACTERIA BY PROTON PUMP INHIBITORS IN THE MURINE MODEL OF FOOD POISONINGEiichiro Yasutomi, Japan; N. Hoshi; J. Inoue; S. Adachi; T. Otsuka; D. Watanabe; Y. Ku; H. Yamairi; M. Ooi; S. Fukuda; M. Yoshida; T. Azuma

P1250AUTOIMMUNE GASTRITIS WITH PREVIOUS O CON-CURRENT H. PYLORI INFECTION PRESENTS DISTINCT FUNCTIONAL AND MORPHOLOGICAL FEATURES.Gemma Maddalo, Italy; V. Pilotto; C. Orlando; M. Pizzi; M. Fassan; D. Basso; M. Rugge; F. Farinati

P1251THE INVESTIGATION OF MIR-155, MIR-21, MIR-146A AND MIR-223 EXPRESSIONS IN HELICOBACTER PYLORİ POSITIVE AND NEGATIVE INDIVIDUALSN. Uyar Alpaslan; Enver Ucbilek, Turkey; İ. Ö. Barlas; O. Sezgin; S. Yaraş

P1252INTERLEUKIN LEVEL IN PATIENTS INFECTED WITH CAGA(+) AND CAGA(-) STRAINS OF HELICOBACTER PYLORIN. V. Baryshnikova; Yury P. Uspenskiy, Russian Federation; A. Suvorov

Treatment

P1253 THE TRANSITION OF HELICOBACTER PYLORI ERADICA-TION IN OUR INSTITUTIONMasayoshi Ono, Japan; T. Kitagataya; Y. Shimoda; J. Ito; T. Kudo; K. Hatanaka; Y. Yamamoto; H. Naruse

P1254ERADICATION OF H. PYLORI INFECTION IN PATIENTS NAÏVE TO TREATMENT USING CONCOMITANT THERAPY OR BISMUTH QUADRUPLE THERAPY (THREE-IN-ONE PILL): A REAL LIFE OBSERVATIONAL STUDYAntonietta Gerarda Gravina, Italy; G. Nardone; A. Miranda; D. Sgambato; A. Rocco; G. Visciola; D. Compare; M. Dallio; L. Granata; M. R. Romito; M. Martorano; C. Mucherino; P. Rocco; A. Federico; C. Loguercio; M. Romano

P1255CYP3A5 GENOTYPE STATUS AFFECTS OUTCOME OF FIRST-LINE VONOPRAZAN-CONTAINED HELICOBACTER PYLORI ERADICATION THERAPYMitsushige Sugimoto, Japan; H. Ban; A. Otsuki; H. Itoi; O. Inatomi; A. Andoh

P1256 COMPARISON OF HELICOBACTER PYLORI ERADICATION RATES :VONOPRAZAN VS. PROTON PUMP INHIBITORNaoko Kozawa, Japan; T. Mochida; A. Igarashi; C. Kamitsuma; J. Tsuchiya; M. Ike; K. Yasuda; M. Kaneshiro; H. Ikemiyagi; Y. Fukami; K. Yoshino; S. Sakita

P1257CAN TWO WEEK BISMUTH BASED QUADRUPLE THER-APY FOR RESISTANT H.PYLORI INFECTION STILL BE USED IN THE UK?Hugh Logan-Ellis, United Kingdom; L. Bensaid; R. P. H. Logan


204




P1273SYSTEMATIC REVIEW AND META-ANALYSIS: PREV-ALENCE OF SMALL INTESTINAL BACTERIAL OVER-GROWTH IN CHRONIC LIVER DISEASEAyesha Shah, Australia; P. Ghasemi; E. Shanahan; G. MacDonald; L. Fletcher; M. Morrison; M. P. P. Jones; G. Holtmann

P1274IS THERE AN ASSOCIATION BETWEEN ENTERIC METH-ANE (CH4) PRODUCTION AND SYMPTOMS IN PATIENTS WITH UNEXPLAINED GI SYMPTOMS?Ayesha Shah, Australia; P. Ghasemi; M. Morrison; L. Fletcher; G. Holtmann; T. Hansen


P1275 CELIAC DISEASE AND POSITIVE IGA TISSUE TRANS-GLUTAMINASE IN PATIENTS WITH DISTAL RADIUS AND ANKLE FRACTURE: A CASE-CONTROL STUDYAnja Hjelle, Norway; P. F. Mielnik; G. S. Tell; K. E. A. Lundin; R. M. Nilsen; E. Apalset

P1276INTERLEUKIN 1BETA, CLAUDIN AND OCCLUDIN CON-CENTRATIONS IN SERUM AND AUTONOMIC NERVOUS SYSTEM ACTIVITY AMONG NEUROLOGICAL ASYMP-TOMATIC CELIAC DISEASE PATIENTS – PILOT STUDYMalgorzata Zwolinska-Wcislo, Poland; M. Przybylska-Feluś; A. Furgała; B. Brzozowski; O. Kaczmarczyk; K. Gil; T. Mach

P1277WIDE HETEROGENEITY AND HIGH MORTALITY IN UNDEFINED AND NON-COELIAC REFRACTORY SPRUE: A RETROSPECTIVE EVALUATION OF 7 CASESAnnalisa Schiepatti, Italy; F. Biagi; M. Zuffada; G. Maiorano; G. R. Corazza

P1278 ªEVERYDAY LIFE RESTRICTIONS CAUSED BY LONG-TERM TREATED CELIAC DISEASE: PREVALENCE AND ASSOCIATED FACTORSLaura Kivelä, Finland; S. Alin; S. Kröger; K. Kaukinen; K. Kurppa

P1279SYSTEMATIC REVIEW OF THE ECONOMIC BURDEN OF COELIAC DISEASE T. Boulanger; Aliki Taylor, United Kingdom; D. A. Leffler; E. S. Mearns; M. Gerber

P1265EXPRESSION OF AMINO ACID TRANSPORTERS IN ANTITUMOR AGENT-INDUCED GASTROINTESTINAL MUCOSAL INJURIESMasaru Kodo, Japan; R. Kawashima; W. Koizumi; T. Ichikawa

P1266A MUCOUS DEPENDENT MECHANISM OF ACETYL SAL-ICYLIC ACID- INDUCED SMALL INTESTINAL MUCOSAL INJURY IN RATS.Yosuke Suyama, Japan; O. Handa; S. Takayama; R. Mukai; A. Majima; Y. Onozawa; A. Fukui; T. Okayama; K. Kamada; K. Katada; K. Uchiyama; T. Ishikawa; T. Takagi; Y. Naito; Y. Itoh

P1267ANTIBIOTIC-INDUCED DYSBIOSIS IN THE MOUSE SMALL INTESTINE PROMOTES ALLERGIC SENSITISATIONG. Burns; B. J. Goggins; K. Minahan; P. Foster; N. J. Talley; M. M. Walker; J. Horvat; Simon Keely, Australia

P1268PREBIOTIC EFFECTS ON HEALTHY AND CHEMOTHERA-PY-INDUCED SMALL BOWEL INJURY IN RATSRoger Yazbeck, Australia; R. J. Lindsay; M. S. Geier; R. N. Butler; S. Jaenisch; G. S. Howarth

P1269THE RELATION OF CHEMOKINE RECEPTOR CXCR3 AND GUT-HOMING MARKERS ON SMALL INTESTINAL LAM-INA PROPRIA T-LYMPHOCYTES IN CROHN’S DISEASE PATIENTS.Anh Do, Australia; A. Shah; E. Shanahan; P. Gashemi; T. Hansen; N. Koloski; S. Keelly; N. J. Talley; G. Holtmann

Microbiology

P1270METHODOLOGICAL QUALITY OF CLINICAL PRACTICE GUIDELINES ON PROBIOTICS IN ACUTE GASTROENTRITIS IN CHILDREN USING THE APPRAISAL OF GUIDELINES FOR RESEARCH & EVALUATION II INSTRUMENT (AGREEII)Aldo Maruy Saito, Peru; J. C. Herrera Rodriguez; R. Rojas Galarza

P1271COMBINATION OF TWO IN VITRO MODELS TO STUDY THE IMPACT OF CHRONIC CO-EXPOSURE OF A PESTICIDE WITH A PREBIOTIC ON THE INTESTINAL ENVIRONMENTMarina Requile, France; D. O. Gonzalez Alvarez; S. Delanaud; L. Rhazi; V. Bach; F. Depeint; H. Khorsi-Cauet

P1272THE DIET FEATURES OF DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME PATIENTS WITH SMALL INTESTINAL BOWEL OVERGROWTHH. Wei; Z. Liu; K. Wang; W. Zheng; Liping Duan, China


205


Tues

day,

Oct

ober

31,

201

7


P1287LACTULOSE, LACTOSE AND FRUCTOSE INGESTION INDUCES SPECIFIC PATTERNS OF GASTROINTESTINAL SYMPTOMS IN CHINESE SUBJECTS WITH FUNCTIONAL DYSPEPSIA AND IRRITABLE BOWEL SYMPTOMS. Victoria Tan, Hong Kong PRC; N. H. S. Chu; C. K. Yao; P. R. Gibson

P1288PATIENTS WITH SHORT BOWEL SYNDROME STRATI-FIED BY DIAGNOSIS: POST HOC ANALYSIS OF TEDU-GLUTIDE ON FLUID COMPOSITE EFFECTPalle Bekker Jeppesen, Denmark; S. M. Gabe; K. Iyer; U.-F. Pape; D. L. Seidner; H.-M. Lee; C. Olivier

P1289RESULTS OF A POST HOC ANALYSIS OF BASELINE CHARACTERISTICS AND CLINICAL RESPONSE TO TEDU-GLUTIDE IN PATIENTS WITH SHORT BOWEL SYNDROME BASED ON RESIDUAL BOWEL ANATOMYPalle Bekker Jeppesen, Denmark; S. M. Gabe; D. L. Seidner; H.-M. Lee; C. Olivier

Small intestinal neoplasia

P1290GENE EXPRESSION PROFILING OF SUPERFICIAL SPORAD-IC NON-AMPULLARY DUODENAL EPITHELIAL TUMORSYoshiki Sakaguchi, Japan; N. Yamamichi; S. Tomida; C. Takeuchi; Y. Takahashi; N. Kageyama-Yahara; M. Fujishiro; K. Koike

P1291WITHDRAWN

P1292USE OF 3D COMPUTED TOMOGRAPHIC ENTEROCLYSIS TO OBTAIN INFORMATION ON THE LENGTH OF THE SMALL INTESTINE AND ON THE SIZE, SHAPE, LOCA-TION OF INTESTINAL NEOPLASIASToshiyuki Yoshikawa, Japan; K. Ohno; T. Kurokami

P1293INK TATTOOING FOR BALLOON-ASSISTED ENTEROSCO-PY – TIME WELL SPENT?Christoph Römmele, Germany; A. Ebigbo; H. Messmann; S. Gölder

P1294THE ROLE OF CAPSULE ENDOSCOPY IN THE DETECTION OF SMALL BOWEL TUMOURS IN A LOW RISK POPULA-TION; A SINGLE CENTRE EXPERIENCEMary Hussey, Ireland; G. Holleran; T. Nuzum; S. Crowther; D. McNamara

P1280PNPLA3 RS738409 POLYMORPHISM PREDICTS THE DE-VELOPMENT AND THE SEVERITY OF HEPATIC STEATO-SIS, BUT NOT METABOLIC SYNDROME, IN PATIENTS WITH CELIAC DISEASENicola Imperatore, Italy; R. Tortora; A. Rispo; A. Alisi; A. Crudele; F. Ferretti; V. Nobili; L. Miele; N. Gerbino; V. Di Martino; N. Caporaso; F. Morisco

P1281PROTON PUMP INHIBITORS AS RISK FACTOR FOR MET-ABOLIC SYNDROME AND HEPATIC STEATOSIS IN PA-TIENTS WITH CELIAC DISEASE ON GLUTEN FREE-DIETNicola Imperatore, Italy; R. Tortora; A. Testa; N. Gerbino; M. Di Palma; V. Di Martino; N. Caporaso; A. Rispo

P1282HOW MANY HOURS DO STABLE COELIAC PATIENTS TAKE UP IN GASTROENTEROLOGY OUT-PATIENT CLINICS?Mehmet Yalchin, United Kingdom; R. Eckersley; T. Coysh; S. Mann

P1283MONITORING PATIENTS WITH COELIAC DISEASE: WHO ACTUALLY NEEDS A DEXA SCAN?Mehmet Yalchin, United Kingdom; R. Eckersley; T. Coysh; S. Mann

P1284CELIAC DISEASE AND ADHERENCE TO THE GLU-TEN-FREE DIET: A 30-YEAR FOLLOW UP STUDYFederica Branchi, Italy; M. Bravo; L. Norsa; F. Ferretti; M. T. Bardella; D. Conte; L. Elli

Malabsorption syndromes and food enteropathies (adult)

P1285PATIENTS WITH SHORT BOWEL SYNDROME STRATI-FIED BY BASELINE PARENTERAL SUPPORT VOLUME: POST HOC ANALYSIS OF THE CLINICAL EFFECT OF TEDUGLUTIDEPalle Bekker Jeppesen, Denmark; S. M. Gabe; D. L. Seidner; H.-M. Lee; C. Olivier

P1286POST HOC ANALYSIS OF THE RELATIONSHIP BETWEEN PLASMA CITRULLINE AND PARENTERAL SUPPORT NEEDS IN PATIENTS WITH SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE RECEIVING TEDUGLUTIDEPalle Bekker Jeppesen, Denmark; S. M. Gabe; D. L. Seidner; H.-M. Lee; C. Olivier


206





P1303THE EFFECT OF A CONTROLLED GLUTEN CHALLENGE IN PATIENTS WITH SUSPECTED NON-COELIAC GLUTEN SENSITIVITY: A RANDOMIZED, DOUBLE-BLIND PLACE-BO-CONTROLLED CHALLENGEHanna Dale, Norway; J. G. Hatlebakk; N. Hovdenak; S. O. Ystad; G. A. Lied

P1304THE ROLE OF BILE ACIDS AND GUT MICROBIOTA IN CORONARY ARTERY DISEASE: RESULTS OF THE MABAC STUDY IN HUMAN (MICROBIOTA ATHEROMA AND BILE ACID IN CORONARY DISEASE)Henri Duboc, France; C. Chong Nguyen; D. Rainteau; H. Sokol; L. Humbert; P. SEKSIK; B. Coffin; O. Varenne; A. Bado; D. Duboc

P1305LOW FODMAP DIET: REINTRODUCTION PHASE DOES NOT MODIFY EFFICACY, BUT BEWARE OF REAL TRIGGER FOODS! Massimo Bellini, Italy; A. Rossi; D. Gambaccini; D. Menicucci; L. Bazzichi; B. Fani; R. Sellitri; M. G. Mumolo; N. de Bortoli; L. Ceccarelli; M. Mosca; S. Marchi

P1306EXPRESSION OF THE FRUCTOSE TRANSPORTER GLUT5 IN PATIENTS WITH FRUCTOSE MALABSORPTION.Pia Staubach, Germany; S. Krüger; A. K. Koch; J. Langhorst; C. Röcken; U. Helwig

P1307BETTER RESPONSE TO LOW FODMAP DIET IN JH NEGATIVE PATIENTS WITH DISORDERS OF GUT-BRAIN INTERACTIONValeria Schindler, Switzerland; A. Zweig; A. Becker; J. Zeitz; D. Runggaldier; M. Fried; D. Pohl

P1308CHANGES IN GASTROINTESTINAL SYMPTOMS, SMALL INTESTINAL BACTERIA, AND DUODENAL PHYSIOLOGY FOLLOWING A LOW FIBER, HIGH SUGAR DIETGeorge Saffouri, USA; B. Schmidt; E. J. Battaglioli; Y. Bhattarai; J. Cho; H. Lekatz; M. Grover; G. Farrugia; P. Kashyap

P1309STRESS AND STRESS-RELATED PEPTIDE AMPLIFY THE ANOREXIC ACTIONS OF CHOLECYSTOKININNaomi Yamaguchi, Japan; E. Hosomi; M. Ochiai; S. Ro; K. Chieko; K. Maezawa; S. Nagoshi; K. Takayama; K. Yakabi

P1310PEPTIDE TYROSINE-TYROSINE (PYY) ENHANCES EFFECTS OF CHOLECYSTOKININ (CCK) ON GASTRIC MOTILITY AND FOOD INTAKE IN RATS.Eriko Hosomi, Japan; N. Yamaguchi; K. Maezawa; M. Ochiai; S. Ro; K. Chieko; K. Takayama; K. Yakabi

Poster Session09:00 – 17:00 Hall 7Nutrition II

Obesity

P1295VITAMIN D PREVENTS HEPATIC STEATOSIS AND CAR-DIOVASCULAR DAMAGE IN A RAT MODEL OF FATTY WESTERN DIETG. Mazzone; C. Morisco; Vincenzo Lembo, Italy; G. D'Argenio; M. D'Armiento; A. Rossi; C. Del Giudice; N. Caporaso; F. Morisco

P1296WITHDRAWN

P1297ELIPSE BALLOON SYSTEM: OUR EXPERIENCE. A PRE-LIMINARY STUDYEleonora Avallone, Italy; M. A. Vitale; A. De Cesare; G. Villotti; R. Urgesi; M. C. Di Paolo; L. Pallotta; M. G. Graziani

P1298NUTRITIONAL STATUS EVALUATION TOOL IS NOT USED AND NUTRITIONAL SUPPORT CONSULTATION IS RARELY REQUESTED BY THE TREATING PHYSICIAN IN A TERTIARY GREEK HOSPITAL G. Vlachonikolou; L. Bounou; S. Kalousios; A. Theodorou-Kanakari; E. A. Mavroeidi; M. Roma; A. Kasti; G. D. Dimitriadis; Konstantinos Triantafyllou, Greece

P1299CHANGE OF VITAMIN D AND BONE MINERAL DENSITY AFTER BARIATRIC SURGERY IN CHINESE POPULATIONMing-Lun Han, Taiwan; W.-J. Lee

P1300 INTRAGASTRIC BALLOON: A LARGE BRAZILIAN MULTI-CENTRIC STUDY OVER 10,000 CASES AND 20 YEARS OF EXPERIENCEBruno Sander, Brazil; C. Marchesini; D. S. Paiva; J. Schemberk Jr.; G. Baretta; G. Cairo Nunes; J. I. B. Scarparo; E. Grecco; T. F. Souza; M. Galvao Neto

P1301WEIGHT REGAIN AFTER BARIATRIC SURGERY – ARGON PLASMA COAGULATION FOR GASTROJEJUNAL ANASTO-MOSIS DECREASEBruno Sander, Brazil; D. S. Paiva; M. P. Sander; M. Galvao Neto; G. Baretta; E. Grecco; T. F. Souza; J. I. B. Scarparo

P1302EXCESS WEIGHT IN THE ELDERLY: A BRAZILIAN EXPERI-ENCE WITH THE INTRAGASTRIC BALLOON TREATMENTRicardo Jose Fittipaldi Fernandez, Brazil; E. Usuy; M. Galvao Neto; C. F. Diestel; S. Barrichello; A. F. Teixeira


207


Tues

day,

Oct

ober

31,

201

7


CC089TRANSVERSE MYELITIS ON THE BACKGROUND OF HEPATITIS C RESPONDING TO TREATMENT OF THE VIRUS – A CASE REPORTH. Khan; Prayman Sattianayagam, United Kingdom

CC090A RARE CAUSE OF FULMINANT ACUTE LIVER FAILURE IN A YOUNG ADULTGonçalo Alexandrino, Portugal; S. Bernardo; P. Marcelino

CC091ADULT CAVERNOUS HEMANGIOMA MISDIAGNOSED RADIOLOGICALLY AS ATYPICAL HEPATOCELLULAR CARCINOMA :CASE REPORT.H. El Alfy; K. Farid; M. Elegezy; A. El Nakib; Ahmed Ibrahim, Egypt; M. Abd El Wahab; K. Zalata; A. Abd El Rahman; M. El-Bendary; M. El Bendary

CC092WHEN STONES DECIDE TO ROLLAna-Maria Bucalau, Belgium; M. Arvanitakis; M. Pezzullo; M. Zalcman; E. Coppens; D. Blero; N. Nayer; J. Carro Valdes; P. Loi

CC093FISHING FOR A CAUSE OF OBSTRUCTIVE JAUNDICEWee Khoon Ng, Singapore; R. S. Tang; J. Y. Lau

Poster Session15:45 – 17:15 E-Poster Lounge 2Exemplary Clinical Cases IIIChairs: Christopher John Hawkey, United Kingdom

CC094METASTATIC CROHN'S DISEASE WITH OROFACIAL INVOLVEMENTRui Morais, Portugal; F. Magro; R. Silva; G. Macedo

CC095CROHN’S DISEASE AND ACQUIRED VON WILLEBRAND SYNDROME: A RARE DANGEROUS AFFAIR OR AN UNDERDIAGNOSED ASSOCIATION?Roberto Grassia, Italy; P. Capone; F. Pasin; S. Testa; G. P. Coppeta; F. Cereatti; E. Iiritano; K. Vjero; F. Buffoli

CC096A VERY RARE FORM OF PRESENTATION OF CROHN’S DISEASE – A CASE OF DIAGNOSTIC CHALLENGEJoana Rita Carvalho, Portugal; I. Goulart; J. Tavares; P. M. dos Santos; F. Serejo; C. Ferreira; J. Velosa

CC097RESOLUTION OF ULCERATIVE COLITIS RELATED EXTRAINTESTINAL PULMONARY MANIFESTATION BY ANTI-TNF THERAPYSarah Fischer, Germany; J. Köhler; M. F. Neurath; R. Atreya

Poster Session09:00 – 10:00 E-Poster Lounge 1Exemplary Clinical Cases IChairs: Tomer Adar, USA


CC082THE UTILITY OF AN UPPER OESOPHAGEAL SPHINCTER ASSIST DEVICE ON TREATMENT OF RECURRENT ASPI-RATION PNEUMONIA AFTER ESOPHAGECTOMYDharma Sunjaya, USA; M. Halland

CC083PRIMARY FOLLICULAR LYMPHOMA OF THE DUODE-NUM: THERAPEUTIC APROACH WITH ENDOSCOPIC MUCOSAL RESECTIONDiana Martins, Portugal; J. Pinho; P. Sousa; R. Cardoso; R. Araújo; E. Cancela; A. Castanheira; P. Ministro; A. Silva

CC08414.6 X 8 CM SUCCESSFUL WIDESPREAD ENDOSCOPIC SUB-MUCOSAL DISSECTION (ESD) AND PROTECTIVE VACUUM SPONGE IMPLANTATION FOR SPARING OF WHIPPLE’S RESECTION IN IN THE SECOND AND THIRD DUODENUM Malte Hofmeyer, Germany; J. Hochberger

CC085A CASE OF EBV-POSITIVE EARLY LYMPHOEPITHELI-OMA-LIKE GASTRIC CARCINOMA (LELGC) RESECTED BY ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD), INITIALLY DIAGNOSED AS A STROMAL TUMOUR.L. Shuwen; S. Zhan; D. Shi; Rui Li, China; W. Chen

CC086PNEUMATOSIS CYSTOIDES INTESTINALIS. A CASUAL ENDOSCOPIC FINDINGPilar Ibarrola Arevalo, Spain; B. Agudo Castillo; M. Magaz Martínez; B. Oliva del Rio; L. E. Abreu García

CC087SUCCESSFUL DETECTION, CYTOLOGICAL DIAGNOSIS AND LOCAL ETHANOL ABLATION TREATMENT OF A SYMPTOMATIC 6 MM INSULINOMA IN THE PANCREAT-IC HEAD BY ENDOSONOGRAPHY (EUS)Dirk Brenke, Germany; T. Topalidis; L. Goßner

Poster Session09:00 – 10:00 E-Poster Lounge 2Exemplary Clinical Cases IIChairs: Maria Chiara Petrone, Italy

Frank Tacke, Germany

CC088YELLOWISH SPUTUM: WHAT IS YOUR DIAGNOSIS ?Laura Bromberg, Belgium; M. bruyneel; A. Peeters; G. Dapri


208




CC044A RARE CASE OF JAUNDICE: HEPATIC LEPTOSPIROSIS, OBSTRUCTIVE POLYP OF DUODENAL PAPILLA IN A PATIENT WITH CHRONIC HEPATITIS BBoroka Horeanga, Romania; C. A. Dutei; M. Barbu; O. E. Balas; I. A. Husar-Sburlan; M. Ciocirlan; M. Manuc; C. M. Preda; M. Diculescu

CC045FAILURE OF PROPER ASSESSMENT OF FIBROSIS STAGE BEFORE DAAS IN THOSE WITH CONCURRENT HBV INFECTION MAY END UP WITH LIVER TRANSPLANTA-TION: A CASE STUDYAhmed Kamal, Egypt

CC046LATE HEPATITIS B VIRUS REACTIVATION AFTER RITUX-IMAB – HOW LONG SHOULD WE KEEP SURVEILLANCE?Joana Castela, Portugal; S. Mão de Ferro; A. Dias Pereira

CC047REVERSION OF A PREVIOUS SEROCONVERSION OF HBV AFTER RENAL TRANSPLANTSahar Hassany, Egypt; W. Hassan

CC048REACTIVATION OF PAST HBV INFECTION AFTER SUC-CESFULL HCV TREATMENT WITH SOFOSBUVIR-LEDIP-ASVIR IN A HCV/HIV COINFECTED PATIENT. Dina Chaaro, Spain; B. Maldonado Pérez; P. Cordero Ruiz; M. F. Guerra Veloz; I. Carmona Soria; A. Caunedo Álvarez

CC049THERAPEUTIC APHERESIS IN A PATIENT WITH THYRO-TOXICOSIS WITH SEVERE HEPATIC COMPLICATIONS AND LIVER CIRRHOSIS FROM CHRONIC HEPATITIS B INFECTIONEverly Faith Ramos, Philippines; G. C. Floro; D. Bernardo; D. Gauiran

CC050ACUTE LIVER FAILURE SECONDARY TO DIFFUSE LIVER INFILTRATION BY OESOPHAGEAL SQUAMOUS CELL CAR-CINOMA – AN UNEXPECTED AND RARE MANIFESTATION.Pedro Marques Da Costa, Portugal; S. Fernandes; M. Verdelho Machado; C. Baldaia; A. Valente; R. Palma; A. Costa e Silva; J. Velosa

CC051ACUTE SICKLE CELL INTRAHEPATIC CHOLESTASIS- A RARE CAUSE OF ACUTE LIVER FAILURE Sonia Bernardo, Portugal; A. Cristino; N. Fatela; R. T. Marinho; S. Pina; A. Figueiredo; G. Alexandrino; R. Perdigoto; E. Mateus; A. Morbey; M. Mendes; H. Glória; E. Barroso; H. C. Pinto; J. Velosa

CC098A COMPLEX CASE OF FEVER IN A PATIENT UNDER ANTI-TNF THERAPYJoana Veloso do Carmo, Portugal; J. Rodrigues; L. Carvalho; M. Túlio; M. Bispo; C. Chagas

CC099LABIAL ULCER IN A PATIENT WITH CROHN’S DISEASE – AN UNEXPECTED DIAGNOSISMarco Silva, Portugal; M. Silva; A. Peixoto; S. Lopes; S. Magina; C. Lisboa; F. Magro; G. Macedo

CC100HEPATOSPLENIC T CELL LYMPHOMA : A RARE COM-PLICATION OF MONOTHERAPY WITH AZATIOPRINE IN CHRON’S DISEASE Joana Carvão, Portugal; V. Magno Pereira; C. Sousa Andrade; H. Morna; F. Jacinto; M. Cordeiro; M. Pires; L. Jasmins

CC101SEVERE SMALL INTESTINAL BLEEDING SECONDARY TO DIFFUSE IMMUNE MEDIATED ENTERITIS AFTER SUBTOTAL COLECTOMY FOR STEROID REFRACTORY ULCERATIVE COLITISRangarajan Purushothaman, Singapore; S. C. Kong; P. W. Chan; S. W. Chuah; K. H. Lim; L. T. Choong; B. H. Tan; S. J. Mesenas; G. S. Tan; B. J. Schwender

CC102AN UNUSUAL CAUSE OF CHRONIC DIARRHOEA Joyce Mak, Hong Kong PRC; Y. T. Hui; T. W. J. Lam; W. H. Li; K. H. Kwok

Poster Session09:00 – 17:00 Hall 7Clinical Cases II


CC042NOVEL HUMAN LEUCOCYTE ANTIGEN ASSOCIATION WITH AMOXICILLIN/CLAVULANATE-INDUCED FULMI-NANT HEPATIC FAILUREKalaiyarasi Kaliyaperumal, Singapore; W. Griffiths; G. Aithal; A. Duckworth

CC043A CASE REPORT OF USTEKINUMAB- INDUCED ACUTE LIVER INJURYRosa Lovero, Italy; G. Losurdo; M. Mastromauro; N. M. Castellaneta; A. Mongelli; A. Gentile; A. Di Leo


209


Tues

day,

Oct

ober

31,

201

7


CC061BLEEDING HEPATIC CYST – AN UNUSUAL COMPLICA-TION OF COLONOSCOPY L. Mlynarsky; I. Nachmany; Rafael Bruck, Israel

CC062ESOPHAGEAL STENTS IN AORTOESOPHAGEAL FISTU-LAS – ANECDOTAL EXPERIENCES OR NEW ARMAMEN-TARIUM?Eduardo Rodrigues-Pinto, Portugal; P. Pereira; F. Vilas-Boas; A. Peixoto; M. Silva; G. Macedo

Lower GI

CC063RAPIDLY GROWING HAMARTOMA OF THE COLON IN AN ADULT WITH ULCERATIVE COLITISMamoru Ito, Japan; M. Yoshioka; M. Kaneto; S. Yabe; S. Saito; M. Fujii; S. Ishiyama; A. Fujiwara; J. Nasu; J. Shiode; K. Yamamoto

CC064RENAL TRANSPLANT IN SECONDARY AMYLOIDOSIS AS-SOCIATED WITH CLINICALLY INDOLENT CROHN'S DISEASECarlos Bernardes, Portugal; D. F. B. Carvalho; R. Loureiro; S. Santos; J. Saiote; J. Ramos

CC065MIXED ADENONEUROENDOCRINE CARCINOMA OF THE RECTUM IN A PATIENT WITH ULCERATIVE COLITISRui Gaspar, Portugal; J. Santos-Antunes; M. Marques; R. Liberal; D. Melo; P. Pereira; S. Lopes; G. Macedo

CC066C3 GLOMERULOPATHY AS AN EXTRA-INTESTINAL MANIFESTATION OF ULCERATIVE COLITIS – A RARE ASSOCIATIONPedro Marques Da Costa, Portugal; N. Rodrigues; H. Silva; L. Correia; L. Correia; H. Cortez-Pinto; J. Velosa

CC067ABIOTROPHIA DEFECTIVA: A RARE GUT PATHOGEN RESULTING ENDOCARDITIS IN INFLAMMATORY BOWEL DISEASEYu Jun Wong, Singapore; B. J. Schwender

CC068RARE CAUSE IN THE DIFFERENTIAL DIAGNOSIS OF ULERATIVE COLITISMarco Silva, Portugal; A. Peixoto; H. Cardoso; G. Macedo

CC069COLIC LEUKOCYTOCLASTIC VASCULITIS – CORTICOID RESPONSIVE COLITISJoão Carlos Silva, Portugal; A. P. Silva; J. Silva; A. Ponte; J. Rodrigues; M. Sousa; R. Pinho; G. Lage; A. Furtado; J. Carvalho

CC052ATYPICAL FUNGAL INFECTION BY BIPOLARIS AND CURVULARIA IN POST LIVER TRANSPLANT PATIENT: A CASE REPORT Menahil Fatima, Pakistan; M. A. Baig; N. H. Shah; F. S. Dar

CC053A RARE CASE OF RECURRENT VARICEAL BLEEDING DUE TO NON-CIRRHOTIC PORTAL HYPERTENSION (NCPH) IN BEHÇET'S DISEASEA. Hinkson; Selena Dixon, United Kingdom; S. Moreea

CC054A RARE CAUSE OF AN ABDOMINAL MASS IN A PA-TIENT WITH ACUTE NECROTIZING PANCREATITISJoana C. Branco, Portugal; L. Lourenço; A. Oliveira; L. Santos; D. Horta; J. Reis

CC055INFREQUEN CAUSE OF ACUTE PANCREATITIS. CURET-TAGEJ. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain

CC056ACUTE PANCREATITIS OF INFREQUENT ETIOLOGY: ANAFILÁCTIC SHOCK AFTER KIWI'S INGESTIONJ. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain

CC057A PATIENT WITH COLLOID CARCINOMA OF THE PAN-CREAS FOLLOWED FOR 13 YEARS PREOPERATIVELY AND ALIVE 10 YEARS AFTER TOTAL PANCREATECTOMYYoshihiro Hamada, Japan; D. Kato

CC058PANCREATOBLASTOMA: AN UNUSUAL DIAGNOSIS IN A YOUNG ADULT PATIENTGonçalo Nunes, Portugal; D. Gonçalves; R. Barosa; M. Patita; P. Pinto Marques; M. J. Brito; A. Tomaz; J. Fonseca

CC059A CASE OF MIXED ADENONEUROENDOCRINE CARCI-NOMA OF THE PANCREASFabiana Capuano, Italy; A. Amodio; P. Campagnola; S. F. Crinó; A. Brandolese; T. M. Rogger; A. Gabbrielli; L. Frulloni


CC060ATTEMPT AT ENDOSCOPIC REMOVAL OF A LESION MIMICKING APPENDIX ORIFICE CAUSED BY INGESTION OF MULTIPLE MAGNETSeung Jun Gim, Republic of Korea; H. H. Lee; H. K. Chang


210




CC076HAEMORRHAGE DUE TO CYTOMEGALOVIRUS OESOPH-AGITIS AND DUODENITISLuís Maia, Portugal; A. Castro; T. Moreira; T. Araujo; S. Barrias; R. Küttner Magalhães; P. S. Salgueiro; R. Marcos-Pinto; M. Rocha; M. Salgado; I. Pedroto

CC077LATE MESH MIGRATION AFTER NISSEN FUNDUPLI-CATION MIMICKING A GASTRIC NEOPLASM UNDER ECHOENDOSCOPIC VIEWFelipe Martínez-Alcala, Spain; A. Martinez- Alcala García; C. Martínez- Alcalá; F. Martínez Alcalá

CC078DILATION FOR DIAGNOSE. A RARE CAUSE OF ESOPHA-GEAL STENOSISJosue Umana, Honduras; J. Suazo; R. Zelaya; F. Ramirez; V. Portillo; S. Portillo

CC079INTESTINAL PSEUDOPOLYPS IN A PATIENT WITH CROHN'S DISEASE AND RENAL TRANSPLANT – AN UNEXPECTED DIAGNOSISMarco Silva, Portugal; A. Peixoto; A. C. R. Nunes; E. Rios; G. Macedo

CC080THERE IS SOMETHING FISHY WITH THIS PANNICULITISLaura Mans, Belgium; A.-M. Bucalau; A. Hadefi; M. Zalcman; P. Demetter; P. Eisendrath; A. Buggenhout; J. Deviere; M. Arvanitakis; M. Fernandez Y Viesca

CC081STRONGYLOIDIASIS - A CHALLENGING DIAGNOSISCarolina Simões, Portugal; D. Neves; A. C. Quadros; N. Fatela; A. Pereira; E. Vitorino; L. Carrilho Ribeiro; J. Velosa

CC070SHOULD MESALAZINE PREVENT ISCHEMIC COLITIS?Deborah Costa, Italy; C. Perini; F. Capuano; S. Di Stefano; G. Vettori; C. Cusumano; L. Frulloni

CC071INTESTINAL LYMPHANGIECTASIA IN THE ADULT IN CAPSULA STUDY ENDOSCOPIC IN RELATION TO CHRONIC DIARRHEA STUDYJ. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain

CC072ISCHEMIC COLITIS DUE TO VENOUS COMPROMISE.Sergey Skridlevskiy, Russian Federation; V. Veselov; V. Veselov; S. Achkasov; I. Nazarov; O. Mainovskaya; I. Semenova; L. Orlova; Y. Vaganov

Upper GI

CC073THE OTHER SIDE OF THE COIN IN EOSINOPHILIC GAS-TROENTERITIS: A RARE FORM OF PRESENTATION OF THIS UNCOMMON GASTROINTESTINAL ENTITYElisa Soares, Portugal; I. Cunha; M. Gravito-Soares; S. Mendes; L. Tomé

CC074MÉNÉTRIER´S DISEASE: A CASE OF SUCCESSFUL TREATMENT USING LONG-ACTING OCTREOTIDEGonçalo Nunes, Portugal; R. Barosa; M. Patita; P. Pinto Marques; D. Gonçalves; C. Fonseca; A. Alves de Matos; J. Fonseca

CC075SECONDARY ESOPHAGITIS TO THE VARICELA-ZÓSTER VIRUS ON A MALE IMMUNOCOMPETENT YOUNGJ. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain

Find out more, visit www.ueg.eu/awards-grants

We give your ideas green light!UEG provides a great collection of awards, fellowships and prizes to encourage research.

16_08_Inserat_UEGWEEK_FP_awards_grants_136x62mm_RZ.indd 1 13.09.16 15:06


211


Wed

nesd

ay, N

ovem

ber

1, 2

017


Posters in the Spotlight10:30 – 12:00 E-Poster Lounge 1Bugs and viruses causing GI diseasesChair: Tamara Matysiak Budnik, France

Francis Megraud, France

P1908COMPARISON OF THE EFFICACY BETWEEN BISMUTH AND ALTERNATING RIFAXIMIN ON SECOND-LINE QUADRUPLE REGIMEN OF HELICOBACTER PYLORI ERADICATION.

P1917MANAGEMENT OF HELICOBACTER PYLORI INFECTION AT PRIMARY CARE LEVEL. THE IMPLEMENTATION OF SPE-CIFIC COUNSELLING IMPROVES ERADICATION RATES.

P1907HIGH DOSE CAM WITH VONOPRAZAN (P-CAB) PLUS AMX TRIPLE THERAPY REGIMEN IS THE STRONGEST H.PYLORI ERADICATION THERAPY EVEN IF CAM RESISTANCE.

P1635ANAL CANAL HUMAN PAPILLOMAVIRUS (HPV) INFEC-TION IN MEN AND WOMEN UNDERGOING COLONOSCO-PY: PREVALENCE AND RISK FACTORS, HIGH BURDEN IN CROHN'S DISEASE PATIENTS.

P1725ASSOCIATION OF FUSOBACTERIUM NUCLEATUM IN ORAL CAVITY AND COLORECTAL CARCINOMAS

P1610FECAL MICROBIAL DYSBIOSIS IN CHINESE PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Posters in the Spotlight10:30 – 12:00 E-Poster Lounge 2Progress in our understanding of colorectal inflam-mation and neoplasiaChairs: Victor Moreno, Spain

Arthur Kaser, United Kingdom

P1616THE IMPACT OF THE RS8005161 POLYMORPHISM ON G PROTEIN-COUPLED RECEPTOR GPR65 (TDAG8) PH-AS-SOCIATED SIGNALING IN INTESTINAL INFLAMMATION

P1618CD16 POSITIVE CELLS EXPRESS TGF? AND MEDIATES MURINE INTESTINAL FIBROSIS

Poster Sessions by DayWednesday, November 1, 2017

Posters in the Spotlight08:30 – 10:00 E-Poster Lounge 1Detecting and removing colonic lesionsChairs: Roger Leicester, United Kingdom

Brian P. Saunders, United Kingdom

P1530WHAT IMPROVED AND WHAT REMAINS TO BE ACHIEVED IN ORDER TO COMPLY WITH THE NEW REC-OMMENDATIONS OF POLYPECTOMY BY THE EUROPEAN SOCIETY OF GASTROINTESTINAL ENDOSCOPY

P1528MANAGEMENT OF RESECTION OF LARGE COLONIC LESIONS IN A REAL-LIFE SETTING: THE SCALP STUDY.

P1529ENDOSCOPIC REMOVAL OF HIGH-RISK COLORECTAL ADENOMAS: SAFE AND EFFECTIVE?

P1534THE INFLUENCE OF THE REAL FOLLOW-UP TIMES DURING A COLORECTAL CANCER SCREENING PRO-GRAM IN DAILY PRACTICE

Posters in the Spotlight08:30 – 10:00 E-Poster Lounge 2Clinical observations in oesophageal cancerChairs: Teresa Macarulla, Spain

Thomas Seufferlein, Germany

P1866OUTCOMES OF TREATMENT OF PATIENTS WITH EARLY-STAGE ADENOCARCINOMA OF THE ESOPHAGUS WITH INCIPIENT SUBMUCOSAL INVASION, RETRO-SPECTIVE ANALYSIS OF 19 CASES FROM A TERTIARY REFERRAL CENTER IN THE UK

P1870OUTCOME OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR SUPERFICIAL PHARYNGEAL SQUAMOUS CELL CARCINOMA

P1868CLINICAL OUTCOMES OF ENDOSCOPIC RESECTION FOR ACHALASIA-ASSOCIATED SUPERFICIAL ESOPHAGEAL CANCER


212


Wednesday, N

ovember 1, 2017


P1845THE LOCATION OF OESOPHAGEAL MUCOSAL AFFERENT NERVES ARE MORE SUPERFICIAL IN PATIENTS WITH NERD THAN IN HEALTHY VOLUNTEERS AND PATIENTS WITH BARRETT'S OESOPHAGUS

P1846BELCHING PATTERNS IN PATIENTS WITH ISOLATED PATHOLOGICAL UPRIGHT REFLUX AND PATHOLOGICAL BIPOSITIONAL REFLUX

P1928USEFULNESS OF BULB BIOPSY SAMPLES IN CELIAC DISEASE DIAGNOSIS IN ADULTS

P1940VALIDATION OF A SCORE CHART TO PREDICT THE RISK OF CHRONIC MESENTERIC ISCHEMIA: A DISCRIMINA-TIVE AND USEFUL TOOL IN CLINICAL DECISION-MAKING

P1959TAUROLIDINE PREVENTS CATHETER-RELATED BLOOD-STREAM INFECTIONS IN PATIENTS ON HOME PAREN-TERAL NUTRITION – A RANDOMIZED CONTROLLED TRIAL

Poster Champ Session12:30 – 13:30 Scientific Centre: Terminal 2Poster Champ Session: Liver, biliary and pancreatic diseasesChairs: Asbjørn Drewes, Denmark

Alessio Aghemo, Italy

P1399DIGITAL, SINGLE-OPERATOR CHOLANGIOPANCRE-ATOSCOPY IN THE DIAGNOSIS AND MANAGEMENT OF PANCREATOBILIARY DISORDERS: RESULTS FROM THE MULTICENTER CZECH AND SLOVAK NATIONAL DATABASE

P1418LONG-TERM OUTCOMES OF A FULLY COVERED SELF-EXPANDABLE METAL STENT WITH ANTIMIGRA-TION PROPERTIES FOR EUS-GUIDED PANCREATIC DUCT DRAINAGE

P1317BMP1-3 IN LIVER FIBROSIS

P1374EFFECT OF FIBROBLAST GROWTH FACTOR-2 AND ITS RECEPTOR GENE POLYMORPHISMS ON SURVIVAL IN PATIENTS WITH HEPATITIS B VIRUS-ASSOCIATED HEPATOCELLULAR CARCINOMA

P1369HOW OFTEN DO WE FIND STEATOSIS AND SEVERE FIBROSIS IN TYPE 2 DIABETES MELLITIUS PATIENTS

P1619GTS-21, ?7 NICOTINIC ACETYLCHOLINE RECEPTOR AGO-NIST, ATTENUATE DSS-INDUCED COLITIS BY IMPROV-ING INTESTINAL MUCOSAL BARRIER FUNCTION

P1623ZIP7 INDUCES DISRUPTION OF THE INTESTINAL BAR-RIER THROUGH ACTIVATION OF ENDOPLASMIC RETIC-ULUM STRESS IN INFLAMMATORY BOWEL DISEASE

P1753COLORECTAL CANCER CELLS INDUCE NEUROGENESIS IN THE ENTERIC NERVOUS SYSTEM OF THE TUMOR MI-CROENVIRONMENT VIA A NGF-DEPENDENT PATHWAY

P1729BACTERIOCIN PRODUCTION BY MUCOSAL BACTERIA IN COLORECTAL NEOPLASIA

Poster Champ Session12:30 – 13:30Scientific Centre: Terminal 1Poster Champ Session: Upper gastrointestinal diseasesChairs: Pali Hungin, United Kingdom

Ernst J. Kuipers, The Netherlands

P1811CLINICAL FEATURES OF DELAYED BLEEDING AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR GASTRIC NEOPLASMS IN HIGH-RISK AND LOW-RISK PATIENTS

P1818EFFECTS OF FAECAL MICROBIOTA TRANSPLANTATION ON NEUROGENIN 3, MUSAHSI 1 AND ENTEROENDO-CRINE CELLS IN THE DUODENUM OF PATIENTS WITH IRRITABLE BOWEL SYNDROME

P1819THE EFFECT OF ESOPHAGEAL ACID EXPOSURE ON NMDA RECEPTOR SUBUNITS EXPRESSION AND D-SER-INE IN PREFRONTAL CORTEX AND HIPPOCAMPUS

P1837HIGH-RESOLUTION ESOPHAGEAL MANOMETRY: EVAL-UATION OF NEW SYSTEMS FOR THE ACQUISITION AND ANALYSIS.

P1838PROTON PUMP INHIBITOR THERAPY IMPROVES ESOPH-AGEAL SYMPTOMS BY RESTORING A NORMAL ESOPH-AGEAL PERISTALSIS IN PATIENTS WITH PROTON PUMP INHIBITOR-RESPONSE ESOPHAGEAL EOSINOPHILIA

P1843SYSTEMATIC ANALYSIS OF SUBEPITHELIAL EOSIN-OPHIL COUNTS INCREASES DIAGNOSTIC YIELD IN ADULTS WITH EOSINOPHILIC ESOPHAGITIS


213


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1631ILEAL SULFOMUCINS PREDICT CLINICAL RECURRENCE AFTER ILEO-COLONIC RESECTION FOR CROHN'S DIS-EASE: A PROSPECTIVE STUDY AT 5 YEARS

P1660SIMPLIFIED MR ENTEROCOLONOGRAPHY CLASSIFICA-TION BASED ON ENDOSCOPIC FINDINGS FOR ACTIVITY ASSESSMENT OF CROHN'S DISEASE

P1674THE DIAGNOSTIC VALUE OF MIRNA-320A AS A BIO-MARKER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

P1679THE ADDITION OF AN IMMUNOSUPPRESSANT IS AN EFFECTIVE OPTIMIZATION STRATEGY AFTER LOSS OF RESPONSE TO ANTI-TNF ALPHA MONOTHERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TWO-YEAR STUDY

P1698ENDOSCOPIC SUBMUCOSAL DISSECTION OF ULCER-ATIVE COLITIS-ASSOCIATED DYSPLASIA: A SINGLE CENTER BASED EXPERIENCE

P1704POST-MARKETING SAFETY EXPERIENCE OF VEDOL-IZUMAB IN PATIENTS WITH PRE-EXISTING VIRAL HEPATITIS

P1711REAL-LIFE STUDY (GORE-UC) EVALUATING THE EF-FECTIVENESS OF GOLIMUMAB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN INTERIM ANALYSIS FROM ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE (IG-IBD)

Poster Champ Session12:30 – 13:30 Scientific Centre: Terminal 4Poster Champ Session: Surgery, endsocopy and imagingChairs: Ioannis Papanikolaou, Greece

Maria Chiara Petrone, Italy

P1575DEDICATED DIFFUSION WEIGHTED MR IMAGING FOR STAGING PERITONEAL METASTASES IN COLORECTAL CANCER; AN ACCURATE PREOPERATIVE SELECTION TOOL FOR CYTOREDUCTION SURGERY (CRS/HIPEC) CANDIDATES

P1506HIGH LEVELS OF "PRESUMED POLYP MISS RATE" AT 1 AND 3 YEARS FOLLOWING INDEX SCREENING COLO-NOSCOPY: NO ROOM FOR COMPLACENCY.

P1326METABOLOMICS IDENTIFIES PROGRESSIVE NAFLD

P1383THE EVOLUTION OF ESOPHAGEAL VARICES IN NON CIRRHOTIC PORTAL HYPERTENSION CAUSED BY POR-TAL VEIN THROMBOSIS

P1323LONG-TERM COPPER EXPOSURE OF HEPATIC CELLS LACKING FUNCTIONAL ATP7B

P1321AUTOMATED RAPID DETECTION SYSTEM USING THE QUENCHING PROBE METHOD FOR DETECTING RS738409 POLYMORPHISM IN PNPLA3 IN NONALCO-HOLIC FATTY LIVER DISEASE

P1389THE IMPACT OF BARIATRIC SURGERY ON ACUTE CHOLANGITIS MORTALITY AND OTHER OUTCOMES: A NATIONWIDE ANALYSIS

P1423TRYPTOPHAN DEGRADATION AS AN ALTERNATIVE ENERGY SOURCE IN PANCREATIC CANCER

Poster Champ Session12:30 – 13:30 Scientific Centre: Terminal 3Poster Champ Session: Lower gastrointestinal dis-easesChairs: Arthur Kaser, United Kingdom

Ibrahim Ethem Gecim, Turkey

P1795THE RISK PREDICTIVE VALUES OF ACG CLASSIFICATION IN A COHORT OF ISCHEMIC COLITIS – REFINING THE DEFINITION OF MILD DISEASE

P1772EFFICACY AND SAFETY OF TWELVE CHEMOPREVEN-TIVE REGIMENS FOR THE RECURRENCE OF COLOREC-TAL ADENOMAS: A NETWORK META-ANALYSIS

P1665GLYCEMIC CONTROL AND INSULIN RESISTANCE IN PATIENT WITH INFLAMMATORY BOWEL DISEASE – PRELIMENARY RESULTS FROM THE POLIBD STUDY.

P1779LOW UPTAKE OF PSYCHOLOGICAL THERAPIES AMONG PATIENTS WITH IRRITABLE BOWEL SYNDROME IN SECONDARY CARE.

P1626PROSTACYCLIN REVERSES COLITIS THROUGH THE DOWN REGULATION OF INTESTINAL EPITHELIAL PERMEABILITY


214


Wednesday, N

ovember 1, 2017


Poster Session09:00 – 14:00 Hall 7Liver and Biliary III


P1311REGULATION OF MICRORNAS BY P53 FAMILY MEMBERS IN HEPATOCELLULAR CARCINOMARafael Hermelink, Germany; M. Bender; L. Kaser; E. Aschenbrenner; K. Pollinger; C. Kunst; M. Müller-Schilling

P1312IGFBP2 IS REGULATED BY THE P53 FAMILY OF TRAN-SCRIPTION FACTORS IN HEPATOCELLULAR CARCINOMADana Gschwind, Germany; M. Lohse; E. Aschenbrenner; K. Pollinger; S. Schlosser; C. Kunst; M. Müller-Schilling

P1313HOW TO IMPROVE THE RELIABILITY OF LIVER FIBRO-SIS EVALUATION USING 2D-SWE.GEFelix Bende, Romania; I. Sporea; R. Sirli; M. Danila; S. A. Popescu

P1314MONITORING OF LIVER FUNCTION IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE IN COMBINA-TION WITH METABOLIC SYNDROMEKrystyna Kvit, Ukraine; E. Sklyarov; N. Kurlyak; A. Bochar

P1315IDENTIFICATION OF P73 AS A NOVEL TRANSACTIVA-TOR OF IGFBP4 GENE EXPRESSION IN HEPATOCELLU-LAR CARCINOMAD. Gschwind; Sebastian Heckel, Germany; E. Aschenbrenner; K. Pollinger; S. Schlosser; C. Kunst; M. Müller-Schilling

P1316NONALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH 2 TYPE DIABETES MELLITUS AND CORONARY HEART DISEASE AGAINST THE BACKGROUND OF MET-ABOLIC SYNDROME. HOW TO DIAGNOSE?Krystyna Kvit, Ukraine; E. Sklyarov; N. Kurlyak; A. Bochar

P1317 BMP1-3 IN LIVER FIBROSISI. Grgurevic; Lovorka Grgurevic, Croatia; S. Vukicevic; I. Erjavec; I. Dumic Cule


P1318LIVER TRANSIENT ELASTOGRAPHY IN NON-ALCOHOL-IC FATTY LIVER DISEASE: IS THERE ANY PREDICTIVE ROLE IN THE DEVELOPMENT OF COLORECTAL POLYPS?Marta Gravito-Soares, Portugal; E. Gravito-Soares; D. Gomes; A. Simão; L. Tomé

P1499MULTIPLE COLORECTAL ADENOMAS WITHOUT APC OR MUTYH GERMLINE MUTATION: A HETEROGENEOUS SUBGROUP OF PATIENTS

P1535CLINICAL OUTCOME OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF MALIGNANT NON-PEDUNCULATED COLORECTAL LESIONS

P1573HOW MANY CAPSULE ENDOSCOPY STUDIES CAN BE READ IN A GIVEN SESSION BEFORE ACCURACY IS AFFECTED?

P1456THE VALUE OF ENDOSCOPIC FULL-THICKNESS RESEC-TION FOR GASTRIC AND DUODENAL SUBMUCOSAL TUMORS ORIGINATING FROM THE MUSCULARIS PROPRIA LAYER

P1462CAP ASSISTED UPPER ENDOSCOPY VERSUS SIDE-VIEWING ENDOSCOPE FOR EXAMINATION OF THE MAJOR DUODENAL PAPILLA: A RANDOMIZED, BLIND-ED, CONTROLLED, NON-INFERIORITY CROSSOVER STUDY (CAPPA-II STUDY)

P1480TRENDS IN CERTIFICATION FOR GASTROINTESTINAL ENDOSCOPY AND VARIATIONS BETWEEN TRAINEE SPECIALTIES: RESULTS FROM THE UK TRAINEE EN-DOSCOPY DATABASE

P1451EXPOSURE TO ENDOTHERAPY FOR UPPER GASTROIN-TESTINAL BLEEDING AT THE POINT OF GASTROSCOPY CERTIFICATION – IS IT SUFFICIENT?

P1487COMPARISON BETWEEN AN ASYMMETRIC (SMALL DOSE IN THE MORNING) AND A SYMMETRIC SPLIT-DOSE REGIMEN OF POLYETHYLENE GLYCOL PLUS BI-SACODYL FOR BOWEL PREPARATION FOR SCREENING COLONOSCOPY: A RANDOMIZED NON-INFERIORITY CLINICAL TRIAL

P1517OUTCOMES OF ENDOSCOPIC RESECTION OF RECUR-RENT COLORECTAL LESIONS TREATED AT A UK TERTIA-RY REFERRAL CENTRE


215


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1327CHRONIC RENAL FAILURE IS ASSOCIATED WITH THE DEVELOPMENT OF NAFLD/NASHSonja Gehring, Germany; P. Di Fazio; T. M. Gress; T. T. Wissniowski

P1328NONINVASIVE DIAGNOSICS OF NONALCOHOLIC FATTY LIVER IN PATIENTS WITH TYPE 2 DIABETES MELLITUSKrystyna Kvit, Ukraine; E. Sklyarov; A. Bochar

P1329NON-OBESE FATTY LIVER DISEASE IN TYPE 2 DIABETES:NOVEL CONDITION OR SIMILAR TO TYPICAL NAFLD STATE?N. Kobyliak; Natalia Bosak, Ukraine; G. Mykhalchyshyn; D. Kyriienko; O. Dynnyk

P1330CHARACTERIZATION OF LEAN INDIVIDUALS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: RESULTS OF A COHORT STUDYAhad Eshraghian, Iran; M. R. Fattahi; R. Niknam; S. A. Taghavi


P1331ASSESSING BAVENO VI CRITERIA WITH A NEW POINT-SHEAR WAVE ELASTOGRAPHY TECHNIQUE: THE BAVELASTPQ STUDYMatteo Garcovich, Italy; G. Gibiino; E. DI Stasio; B. E. Annicchiarico; E. Carli; M. E. Ainora; L. Riccardi; M. E. Riccioni; M. Pompili; M. Siciliano; A. Gasbarrini; M. A. Zocco

P1332PROTON PUMP INHIBITORS INTAKE NOT ASSOCIATED WITH HEPATIC ENCEPHALOPATHY IN CIRRHOTIC PATIENTSCristina Teixeira, Portugal; A. Antunes; E. Dantas; A. M. Vaz; P. Queirós; A. L. Alves; B. Peixe; I. Cremers; H. Guerreiro; A. P. Oliveira

P1333CLINICAL IMPACT OF MULTIDRUG-RESISTANT BACTE-RIAL INFECTIONS IN LIVER CIRRHOSISAna Catarina Cunha, Portugal; A. G. Antunes; A. M. Vaz; P. Queirós; T. Gago; J. Roseira; A. R. Clara; M. S. Eusébio; B. Peixe; H. Guerreiro

P1334STATIN THERAPY IN THE REDUCTION OF PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALSJose Guillain Cataluna, Philippines; J. G. Cervantes

P1319‘SUBTRACTED ADULTHOOD MASS INDEX’ (SAMI)- A NEW INDEX TO PREDICT NAFLD RISK IN NON-OBESE INDIVIDUALSAta Kıyak, Turkey; S. Elibol; M. Saruc; Ö. Saygılı; N. Tözün

P1320CHARACTERIZATION OF CISPLATIN RESISTANCE IN HEPATOMA CELL LINESSarah Guttmann, Germany; G. Chandhok; S. Reinartz Groba; C. Niemietz; V. Sauer; G. Ciarimboli; U. Karst; A. Zibert; H. Schmidt

P1321 AUTOMATED RAPID DETECTION SYSTEM USING THE QUENCHING PROBE METHOD FOR DETECTING RS738409 POLYMORPHISM IN PNPLA3 IN NONALCO-HOLIC FATTY LIVER DISEASEYasunori Kawaguchi, Japan; A. Nakamura; K. Shibayama; F. Koga; S. Nakashita; D. Mori

P1322EFFECT OF ORLISTAT ON TOTAL LIVER FAT QUANTIFI-CATION BY NOVEL MAGNETIC RESONANCE IMAGING IN OBESE PATIENTS WITH NON-ALCOHOLIC STEATO-HEPATITIS: INTERIM ANALYSIS OF A PROSPECTIVE, RANDOMIZED, SINGLE CENTER, OPEN-LABEL TRIALJ. Ye; W. Yanqin; H. Xuan; Zhong Bihui, China

P1323 LONG-TERM COPPER EXPOSURE OF HEPATIC CELLS LACKING FUNCTIONAL ATP7BSarah Guttmann, Germany; S. Reinartz Groba; C. Niemietz; P. Ballmaier; R. Muhmann; V. Sauer; A. Zibert; H. Schmidt

P1324THE NONALCOHOLIC FAT LIVER DISEASE FIBROSIS SCORE IN PREDICTING FIBROSIS IN MORBIDLY OBESE PATIENTS BEFORE BARIATRIC SURGERYR. G. Silva Junior; Thicianie Fauve Andrade Cavalcante, Brazil; W. R. Freitas Júnior; A. Vieira; L. A. Szutan

P1325COMPARISON OF FIBROSCAN® AND FATTY LIVER INDEX (FLI) TO SCREEN FOR FATTY LIVER DISEASE IN A LARGE CO-HORT OF EMPLOYEES: WHERE IS THE OPTIMAL CUT OFF? Manuela Teufelhart, Austria; C. Rabitsch; B. Mehl; R. Winker; B. Meyer; T.-M. Scherzer

P1326 METABOLOMICS IDENTIFIES PROGRESSIVE NAFLDDana Crisan, Romania; M. Grigorescu; A. Suciu; H. Stefanescu; F. Romanciuc; C. Socaciu; L. Avram; V. Donca; C. Radu


216


Wednesday, N

ovember 1, 2017


Viral hepatitis B: Clinical aspects

P1343 WITHDRAWN

P1344LONGITUDINAL MONITORING OF LIVER STIFFNESS BY ACOUSTIC RADIATION FORCE IMPULSE IMAGING IN PATIENTS WITH CHRONIC HEPATITIS B RECEIVING ENTECAVIRShengdi Wu, China; H. Ding; L. Liu; N. Xu; W. Jiang

P1345CHRONIC HEPATITIS B VIRUS INACTIVE CARRIERS – IMPACT OF METABOLIC DISORDERS IN STEATOSIS ASSESSED BY FIBROSCANSofia Xavier, Portugal; S. Monteiro; C. Arieira; J. Magalhães; C. Marinho; J. Cotter

P1346ANTIVIRAL EFFICACY OF UNANI HERBS (SAUSSUREA LAPPA AND ARTEMISIA ABSINTHIUM) IN CHRONIC HEPATITIS BShabnam Ansari, India; M. A. Siddiqui; S. Malhotra; M. Maaz

P1347QUANTIFICATION OF SERUM HBSAG IS A HELPFUL MARKER TO OPTIMIZE THE MANAGEMENT OF ANTI-VIRAL NUC THERAPY IN CHRONIC HBEAG-NEGATIVE HEPATITIS B.M. Guarino; M. Masarone; G. Portella; Anna Sessa, Italy; R. Bonavolta; N. Caporaso; F. Morisco

P1348IMPROVEMENTS IN CHRONIC HEPATITIS B PATIENTS AND THE ALTERATION IN GUT MICROBIOTA AFTER FECAL MICROBIOTA TRANSPLANTATIONChuanxing Xiao, China; B. Zhang; J. Ren

P1349EFFICACY OF PEGYLATED INTERFERON ALFA-2A ADD-ON THERAPY VERSUS NUCLEOSIDE ANALOGUE MONOTHERAPY IN TREATMENT-EXPERIENCED CHRONIC HEPATITIS B PA-TIENTS: A RANDOMISED, CONTROLLED, OPEN-LABEL TRIALXuan Hu, China; J. Ye; W. Yanqin; R. Li; C. Shao; Z. Bihui


P1350HEPATITIS C IN LEBANON: BURDEN OF THE DISEASE AND VALUE OF COMPREHENSIVE SCREENING AND TREATMENTAntoine Abou Rached, Lebanon; S. Abi Kheir; J. Saba; S. Assaf; G. Kassis; Y. S. Gonzales; O. Ethgen

P1335IN HOW MANY PATIENTS WE WILL MISDIAGNOSE ES-OFAGEAL VARICES BY USING THE BAVENO VI CRITERIA?Simona Alina Popescu, Romania; R. Lupusoru; R. Sirli; M. Danila; L. Gheorghe; A. Seicean; A.-V. Trifan; M. Curescu; A. Goldis; L. D. Sandulescu; C. Cijevschi Prelipcean; C. Stanciu; C. Brisc; S. Iacob; I. Sporea

P1336COMBINED RADIOLOGIC-BLOOD PARAMETERS AND BLOOD DERIVED NON-INVASIVE FIBROSIS SCORES IN PREDICTING OUTCOMES IN CHRONIC HEPATITIS C Ragesh Babu Thandassery, Qatar; H. Wani; S. Al Kaabi; M. Khanna

P1337A SMART APPROACH TO THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHYTatiana Nuzum, Ireland; M. Hussey; T. Khanna; E. MacGregor; J. Olaniyi; C. Tersaruolo; N. Breslin; D. McNamara

P1338MULTISPECIES PROBIOTIC ENRICHES THE MICROBI-OME WITH LACTOBACILLUS AND LACTOCOCCUS AND REDUCES ENTEROCOCCUS ABUNDANCE IN PATIENTS WITH LIVER CIRRHOSIS: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALAngela Horvath, Austria; M. Durdevic; B. Leber; B. Schmerboeck; F. Rainer; P. Douschan; E. Krones; W. Spindelboeck; F. Durchschein; G. Zollner; R. Stauber; P. Fickert; P. Stiegler; V. Stadlbauer

P1339THE IMPACT OF DIABETES MELLITUS ON SHORT-TERM AND LONG-TERM OUTCOMES AFTER LIVER TRANS-PLANTATIONAhad Eshraghian, Iran; S. Nikeghbalian; M. R. Fattahi; S. Ali Malek-Hosseini

P1340VALIDATION OF THE BAVENO VI CRITERIA ON A CO-HORT OF CIRRHOTIC PATIENTSIulia Maria Ratiu, Romania; R. Lupusoru; N. Baltes; C. Pienar; I. Sporea

P1341MORTALITY PREDICTING MODEL IN LIVER CIRRHOSIS PATIENTSRaluca Lupusoru, Romania; I. Sporea; S. A. Popescu; A.-M. Stepan; A. Pascaru; M. Danila; A. Barbulescu; I. M. Ratiu; B. Miutescu; R. Sirli

P1342BARIATRIC SURGERY IS ASSOCIATED WITH INCREASED RISK OF DEVELOPING ACUTE LIVER INJURY: A NATION-WIDE ANALYSISPaul Thomas Kroener, USA; P. K. Wander; V. Popov; C. C. Thompson


217


Wed

nesd

ay, N

ovem

ber

1, 2

017


Acute liver failure, transplantation/surgery

P1359IS AN ACUTE LIVER FAILURE REALLY ALWAYS AN ACUTE LIVER FAILURE? PRE-EXISTING LIVER DISEASE IS COMMON IN PATIENTS WITH ALF DIAGNOSISAline Gottlieb, Germany; J. P. Sowa; M. Kottmann; P. Manka; L. Bechmann; A. Canbay

P1360EFFECTS OF PREOPERATIVE TRANSARTERIAL CHEMO-EMBOLIZATION ON PATIENTS’ SHORT TERM PROGNO-SIS AFTER LIVER TRANSPLANTATION.Di Ma, China

P1361IMPORTANCE OF INTERFERON-GAMMA RELEASE ASSAYS IN EVALUATING CANDIDATES FOR LIVER TRANSPLANTA-TION IN A COUNTRY ENDEMIC FOR TUBERCULOSISM. C. Lita; C.-C. Ester; S. Iacob; C. Pietrareanu; Razvan Cerban, Romania; C. Gheorghe; L. S. Gheorghe

P1362A NATIONAL STUDY OF CANCER DIAGNOSES IN IRISH LIVER TRANSPLANT RECIPIENTS WITH PRIMARY SCLE-ROSING CHOLANGITIS Susanne O'Reilly, Ireland; K. Hartery; M. Walshe; S. Deady; E. O'Leary; G. A. Doherty; D. Houlihan; G. Cullen; H. Mulcahy; J. Sheridan

P1363OUTCOME OF LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS IN CONTEXT OF HLA-DR MISMATCH: SINGLE CENTRE EXPERIENCEPavel Drastich, Czech Republic; L. Bajer; A. Slavcev; M. Benes; P. Trunecka; J. Spicak

P1364GRAFT DYSFUNCTION IN POST-LIVER TRANSPLANTATION: UTILITY OF TRANSIENT ELASTOGRAPHY BY FIBROSCAN®Elisa Soares, Portugal; M. Gravito-Soares; D. Gomes; A. Simão; E. Furtado; L. Tomé

P1365NEW-ONSET DIABETES AFTER TRANSPLANT (NODAT): INCIDENCE, RISK ANALYSIS AND IMPACT ON SURVIVAL-NEW-ONSET DIABETES AFTER TRANSPLANT (NODAT): INCIDENCE, RISK ANALYSIS AND IMPACT ON SURVIVALYasir Abbas, Pakistan; K. Nawaz; M. Salih; N. Ullah; S. Saadat

P1366VITAMIN B12 AS A PROGNOSTIC MARKER IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILUREVera Anapaz, Portugal; M. V. Machado; C. Baldaia; A. Valente

P1351HEPATITIS C TREATMENT IN HEMODIALYSIS PATIENTS: THE EFFICACY AND SAFETY OF DIRECT-ACTING ANTI-VIRALS IN THE REAL LIFE.Liliana Carvalho, Portugal; J. Rodrigues; M. A. Túlio; T. Bana e Costa; L. Lebre; C. Chagas

P1352HEPATITIS C TREATMENT IN RENAL TRANSPLANTA-TION: THE EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRALS IN THE REAL LIFE.Liliana Carvalho, Portugal; J. Rodrigues; M. A. Túlio; T. Bana e Costa; L. Lebre; C. Chagas

P1353WHAT HAPPENED WITH LIVER STIFFNESS VALUES ASSESSED BY MEANS OF TRANSIENT ELASTOGRAPHY IN PATIENTS WITH HCV LIVER CIRRHOSIS AFTER DAA TREATMENTIoan Sporea, Romania; R. Lupusoru; S. A. Popescu; A. Lazar; R. Mare; L. Gheorghe; S. Iacob; R. Sirli

P1354ACHIEVING SVR AFTER DAA THERAPY FOR HCV DE-CREASES THE ACCURACY OF BAVENO VI CLASSIFICA-TION OF HIGH-RISK VARICES IN CIRRHOTIC PATIENTSMagda Rotaru, Romania; H. Stefanescu; A. Suciu; R. Sav; E. Pop; M. Lupsor; B. D. Procopet; A. Seicean; M. Tantau; Z. Sparchez; C. Radu

P1355 ªMONOCYTE CHEMOATTRACTANT PROTEIN -1 CONCEN-TRATIONS IN SERUM DEPEND ON OVERWEIGHT IN CHRONIC HEPATITIS C PATIENTS AND INCREASE AFTER SUSTAINED VIROLOGIC RESPONSEIvan Valkov, Bulgaria; T. Velikova; K. Tumangelova-Yuzeir; D. Kyurkchiev; K. Antonov

P1356HLA –A02, HLA- A03 AND HLA-B15: A NEW RISK FOR HEPATIC STEATOSIS IN EGYPTIAN CHRONIC HEPATITIS C PATIENTSRaghda Farag, Egypt; M. M. Arafa; H. Elalfy; A. F. Ainin; Y. A. Mossad

P1357THE VALUE OF 2D-SWE.GE FOR THE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH HCV COMPENSAT-ED CHRONIC HEPATOPATHIESFelix Bende, Romania; I. Sporea; S. A. Popescu; R. Sirli; M. Danila; R. Mare; A.-M. Stepan

P1358DE NOVO HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CIRRHOSIS AFTER TREATMENT WITH DIRECT ANTIVIRAL AGENTSP. Ruiz; Laura Deiss Pascual, Spain; L. Buendia; I. Erdozain; I. Esain; S. Blanco; A. Baranda; F. Menendez


218


Wednesday, N

ovember 1, 2017


P1375EXTRAHEPATIC HEPATOCELLULAR CARCINOMA ME-TASTASIS: IMPORTANCE OF AN EARLY DIAGNOSIS AND TARGETED THERAPYRui Morais, Portugal; H. Cardoso; S. Rodrigues; R. Coelho; R. Liberal; P. Pereira; A. Albuquerque; R. Gonçalves; S. Lopes; A. M. Horta e Vale; G. Macedo

P1376MANAGEMENT OF INTERMEDIATE STAGE HEPATOCEL-LULAR CARCINOMAAkihiro Deguchi, Japan

P1377HEPATOCELLULAR CARCINOMA RECURRENCE RATE IN HCV INFECTED PATIENTS TREATED WITH DIRECT ANTI-VIRAL AGENTS. A SINGLE CENTER EXPERIENCEG. G. Di Costanzo; R. Granata; M. Guarracino; M. Sanduzzi Zamparelli; M. Guarino; G. Cordone; G. D'Adamo; Raffaella Tortora, Italy

P1378PATTERN OF DISTANT EXTRAHEPATIC METASTASES IN PRIMARY LIVER CANCER: A SEER-BASED STUDYWenrui Wu, China; X. He; L. Li; D. Fang; D. Shi; Y. Li; J. Ye; F. Guo

P1379TIME-DEPENDENT EFFECT OF ALFA-FETOPROTEIN AND DISEASE CONTROL ON PATIENTS’ SURVIVAL IN BCLC C STAGE HEPATOCELLULAR CARCINOMAFrancesca Romana Ponziani, Italy; I. Spinelli; E. Rinninella; L. Cerrito; A. Saviano; M. Garcovich; B. E. Annicchiarico; M. Siciliano; L. Riccardi; M. A. Zocco; N. De Matthaeis; M. Biolato; F. Giuliante; R. Iezzi; A. M. De Gaetano; M. Basso; L. Miele; A. Avolio; F. Vecchio; G. L. Rapaccini; A. Grieco; A. Gasbarrini; M. Pompili

P1380WITHDRAWN

Vascular diseases of the liver, bile duct or pancreas

P1381INTRAHEPATIC PORTAL HYPERTENSION WITHOUT CIR-RHOSIS: EXPERIENCE OF A MORROCAN UNIVERSITY CENTER (33 CASES)Ibtissam Nakhcha, Morocco; I. Benelbarhdadi; F. Z. Ajana

P1382CONSERVATIVE MANAGEMENT OF EXTERNAL BILIARY FISTULAS COMPLICATING SURGERY OF HYDATID CYST OF THE LIVEROussama Baraket, Tunisia; K. Ayed; W. Triki; M. A. Lahmidi; A. Itami; I. Abbassi; S. Bouchoucha

P1367OUTCOMES OF LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMAAhad Eshraghian, Iran; S. Nikeghbalian; S. Ali Malek-Hosseini; B. Geramizadeh


P1368THE ASSESSMENT OF THE ADC PREDICTIVE VALUE IN SURVIVAL OUTCOMES OF PATIENTS UNDERGOING RADIOFREQUENCY ABLATION FOR METASTATIC COL-ORECTAL CANCER LIVER TUMORS.Oliwia Kozak, Poland; T. Nowicki; J. M. Pienkowska; E. Izycka-Swieszewska; D. Zadrozny; E. Szurowska

P1369 ª HOW OFTEN DO WE FIND STEATOSIS AND SEVERE FIBROSIS IN TYPE 2 DIABETES MELLITIUS PATIENTSI. Sporea; Ruxandra Mare, Romania; R. Sirli; S. A. Popescu; S. Nistorescu; A. Sima; R. Timar

P1370LEARNING CURVE EVALUATION USING ELASTPQRuxandra Mare, Romania; I. Sporea; S. A. Popescu; R. Sirli; C. Pienar

P1371ENHANCEMENT PATTERN OF HEPATOCELLULAR CARCI-NOMA ON CONTRAST ENHANCED ULTRASOUND EXAM-INATION IN PATIENTS WITH CHRONIC LIVER DISEASEMirela Danila, Romania; I. Sporea; R. Sirli; A. Popescu; T. V. Moga; A.-M. Stepan

P1372DIAGNOSTIC ACCURACY OF CONTRAST-ENHANCED ULTRASOUND ALGORITHM (ACR CEUS LI-RADSV 2016) FOR THE DIAGNOSIS OF HEPATOCELLULAR CARCINO-MA IN PATIENTS WITH CHRONIC LIVER DISEASEAna-Maria Stepan, Romania; M. Danila; R. Sirli; S. A. Popescu; T. V. Moga; C. S. Ivascu; C. Pienar; I. Sporea


P1373DICKKOPF-1: AS A SERUM BIOMARKER FOR PREDICTION OF HEPATOCELLULAR CARCINOMA TREATMENT RESPONSE.Ahmed Sharaf, Egypt; E.-S. G. El-Badrawy; N. A. Khalifa

P1374 EFFECT OF FIBROBLAST GROWTH FACTOR-2 AND ITS RECEPTOR GENE POLYMORPHISMS ON SURVIVAL IN PATIENTS WITH HEPATITIS B VIRUS–ASSOCIATED HEPATOCELLULAR CARCINOMAJaeyoun Cheong, Republic of Korea


219


Wed

nesd

ay, N

ovem

ber

1, 2

017


Biliary neoplasia: Basic

P1390WITHDRAWN

P1391PATHOLOGICAL, CLINICAL AND RADIOLOGICAL CHAR-ACTERISTICS OF NEOPLASTIC AND NONNEOPLASTIC GALLBLADDER POLYPSSarah Wennmacker, The Netherlands; A. Van Dijk; J. Reassens; N. Hasami; J. P. H. Drenth; C. J. H. M. van Laarhoven; P. de Reuver; I. D. Nagtegaal

P1392METFORMIN INDUCES APOPTOSIS AND MODULATES PROLIFERATION IN THE BILE DUCT CANCER CELLS.Jin Lee, Republic of Korea; J. H. Jung; D. H. Koh; S. W. Park; H. J. Jang; M. H. Choi; S.-H. Kae

P1393DEREGULATIONS IN BASE EXCISION REPAIR (BER) PATH- WAY AND RESULTING OXIDATIVE STRESS AS KEY MODU-LATOR OF GALL BLADDER ANOMALIES AND PROGRESSION TO CARCINOGENESIS: A NORTHEAST INDIA BASED STUDYSujoy Bose, India; N. Singh; D. Tiwari; R. Sultana; R. Borkotoky; A. K. Saikia; N. N. Das; S. N. Kazim

P1394THE DEVELOPMENT OF NON-INVASIVE MOLECU-LAR DIAGNOSIS OF GALLBLADDER CANCER BY BILE JUICE-LIQUID BIOPSYHideaki Kinugasa, Japan; K. Nouso; S. Ako; K. Matsumoto; H. Kato; H. Okada

P1395EFFICACY OF INTRADUCTAL RADIOFREQUENCY ABLA-TION USING A NOVEL ENDOLUMINAL RADIOFREQUEN-CY ABLATION CATHETER IN A SWINE MODELHyung-Keun Kim, Republic of Korea; O.-R. Shin; B.-S. Jeon; H.-H. Choi; S.-W. Kim; S.-S. Kim; H.-S. Chae


P1396PREDICTIVE MODEL FOR THE NEOPLASTIC POTENTIAL OF GALLBLADDER POLYPSJong Kyun Lee, Republic of Korea

P1397COMPARISONS OUTCOMES FOR CONTROLLED PHOTO-DYNAMIC THERAPY IN HIGH GRADE UNRESECTABLE HILAR CHOLANGIOCARCINOMAEen Taek Park, Republic of Korea; B. C. Yun; S. U. Lee; B. H. Han

P1398IGG4-ASSOCIATED CHOLANGITIS MIMICKING PERIHILAR CHOLANGIOCARCINOMA: A PERSISTENT DILEMMA.Lowiek Hubers, The Netherlands; E. Roos; R. J. S. Coelen; J. Verheij; U. H. W. Beuers; T. M. van Gulik

P1383 THE EVOLUTION OF ESOPHAGEAL VARICES IN NON CIRRHOTIC PORTAL HYPERTENSION CAUSED BY POR-TAL VEIN THROMBOSIS Imane Benelbarhdadi, Morocco; K. loubaris; H. Boutallaka; F. Z. Ajana


P1384EVALUATION OF COMMON BILE DUCT CLEARANCE AFTER ENDOSCOPIC MANAGEMENT OF DIFFICULT BIL-IARY STONES BY DIRECT PERORAL CHOLANGIOSCOPY: PRELIMINARY RESULTS OF A PILOT STUDY.Andrea Anderloni, Italy; A. Fugazza; F. Auriemma; R. Maselli; S. Carrara; M. Di Leo; E. Ferrara; P. A. Galtieri; R. Semeraro; G. Lollo; G. Amvrosiadis; A. Repici

P1385LONG-TERM OUTCOMES OF PATIENTS WITH ACUTE CALCULOUS CHOLECYSTITIS AFTER SUCCESSFUL REMOVAL OF GALLBLADDER STONES WITH PERCUTA-NEOUS TRANSHEPATIC CHOLANGIOSCOPY: A DECADE EXPERIENCE AT A SINGLE TERTIARY CENTERSeok-Ho Dong, Republic of Korea; C. H. Oh; J. R. Moon

P1386SINGLE DEVICE TECHNIQUE FOR ENDOSCOPIC TREAT-MENT OF BILE DUCT STONESManabu Sen-yo, Japan; S. Kaino; S. Amano; S. Shinoda; I. Sakaida

P1387ACCURACY OF ASGE CRITERIA IN THE IDENTIFICATION OF PATIENTS WITH SUSPECTED CHOLEDOCHOLITHIASISCláudia Macedo, Portugal; N. Almeida; D. Gomes; E. Camacho; S. Mendes; L. Tomé; A. M. Ferreira

P1388DOES FIBRIN GLUE APPLIED ON THE CHOLANGIOTOMY IN LAPAROSCOPIC COMMON BILE DUCT EXPLORATION RE-DUCE THE RISK OF BILE LEAKAGE? A RANDOMIZED STUDYBahman Darkahi, Sweden; G. Sandblom; T. Nordén

P1389 THE IMPACT OF BARIATRIC SURGERY ON ACUTE CHOLANGITIS MORTALITY AND OTHER OUTCOMES: A NATIONWIDE ANALYSISPaul Thomas Kroener, USA; M. S. Abougergi; V. Popov; C. C. Thompson


220


Wednesday, N

ovember 1, 2017


Poster Session09:00 – 14:00 Hall 7Pancreas III

Pancreatitis, acute

P1405INCREASED MORTALITY AMONG PATIENTS WITH ACUTE PANCREATITIS FROM THE MEDITERRANEAN REGION COMPARED WITH THE REST OF SPAINGuillermo García-Rayado, Spain; F. Bolado; H. J. Canaval-Zuleta; C. Marra-López; A. I. Hernando-Alonso; A. del-Val-Antonana; H. Sternby; R. Rivera Irigoin; F. J. Grau-Garcia; L. Oms; J. Millastre-Bocos; I. Pascual-Moreno; D. Martínez-Ares; J. A. Rodriguez-Oballe; A. Lopez-Serrano; M. Ruiz-Rebollo; A. Viejo-Almanzor; P. Zapater; E. de-Madaria

P14061-DEOXY-SPHINGOLIPIDS, NOVEL BIOMARKERS OF DIABE-TES, ARE CYTOTOXIC FOR EXOCRINE PANCREATIC CELLSRong Chen, Switzerland; T. Hornemann; W. Yu; S. Camargo; R. Graf; S. Sonda

P1407ROLE OF THROMBOPHILIA IN SPLANCHNIC VENOUS THROMBOSIS IN ACUTE PANCREATITISSobur Uddin Ahmed, India; S. S. Rana; J. Ahluwalia; M. Kang; R. Sharma; D. K. Bhasin

P1408EVALUATION OF A PROTOCOL OF AN ENDOSCOPIC ULTRASOUND TRANSMURAL DRAINAGE OF INFECTED PANCREATIC NECROSIS (IPN) WITH LOCAL ANTIBIO-THERAPY THROUGH NASOCYSTIC CATHETERJ. Lariño Noia; J. López-Díaz; Daniel De la Iglesia-García, Spain; J. Iglesias-Garcia; R. Mejuto-Fernández; F. Macias-Garcia; A. Álvarez-Castro; A. Mckenzie-Ballesteros; S. García-Rodríguez; J. Díaz-Gutiérrez; J. E. Dominguez-Muñoz

P1409EUS-GUIDED PANCREATIC FLUID COLLECTION DRAINAGE WITH LUMEN-APPOSING METAL STENTS OR PLASTIC DOUBLE PIGTAIL STENTS: A MULTI-FACTORIAL ANALYSISNan Ge, China; S. Sun

P1410EARLY ACHIEVABLE SEVERITY (EASY) INDEX FOR SIM-PLE AND ACCURATE EXPEDITE RISK STRATIFICATION IN ACUTE PANCREATITISBalázs Kui, Hungary; S. Gódi; J. Bajor; I. Török; M. Macaria; H. Farkas; A. Mickevicius; V. Sallinen; E. R. Maldonado; M. Papp; G. Kovács; P. Sarlós; S. Galeev; B. Nemeth; A. Vincze; P. Pencik; I. Ozola-Zalite; A. Pukitis; A. Litvin; I. Kovalskaya; J. Czimmer; T. Huszár; M. Ihász; G. Pár; I. Hritz; T. Molnár; D. Illés; A. Szentesi; L. Lakatos; G. Capruso; A. V. Patai; E. Stilidi; G. Peserico; K. Zadorozhna; E. Sonmez; A. Tüzün Ince; S. Vishalkumar; M. Horibe; P. Hegyi

P1399 ª DIGITAL, SINGLE-OPERATOR CHOLANGIOPANCREATOS-COPY IN THE DIAGNOSIS AND MANAGEMENT OF PAN-CREATOBILIARY DISORDERS: RESULTS FROM THE MUL-TICENTER CZECH AND SLOVAK NATIONAL DATABASERastislav Hustak, Slovak Republic; J. Král; F. Neumann; V. Nosek; E. Skanderova; J. Usak; O. Urban; B. Bunganic; M. Zavoral; O. Shonova; P. Vitek; J. Spicak; J. Martinek

P1400DISTINCT PROGNOSTIC VALUE AND BIOLOGICAL CHARACTERISTICS OF OSTEOPONTIN IN INTRAHEPATIC CHOLANGIOCARCINOMAKaiqian Zhou, China; F.-Y. Chen; C. Zhou; L.-S. Cheng; Z. Wang

P1401PANCREATIC STENT PLACEMENT AFTER ENDOSCOPIC RESECTION OF AMPULLARY TUMORS IS MANDATORYPietro Gambitta, Italy; F. Iannuzzi; S. Pallotta; A. Ballerini; A. D'Alessandro; E. Bareggi; P. Fontana

P1402SERUM LEVELS OF HEAVY METALS IN CHOLANGIOCAR-CINOMA PATIENTS FROM THE NILE DELTA REGION OF EGYPT :A SINGLE CENTRE STUDYM. Abdel-Wahab; M. El-Bendary; Mahmoud Abdel-Wahab, Egypt; S. Abed; A. S. Shehatta; M. Salah; A.-H. El-Gilany

P1403SELF-EXPANDLE METAL STENT ARE SUPERIOR TO PLASTIC STENT FOR PREOPERATIVE BILIARY DRAINAGE IN RESECTABLE MALIGNANT DISTAL BILIARY STRIC-TURE: A SYSTEMATIC REVIEW AND META-ANALYSISAlberto Tringali, Italy; M. Cintolo; L. Cristoferi; E. Forti; F. Pugliese; L. Dioscoridi; R. Manta; M. Mutignani

P1404THE EFFICACY AND SAFETY OF PREOPERATIVE BILIARY DRAINAGE IN PATIENTS WITH OBSTRUCTIVE JAUNDICE: A SYSTEMATIC REVIEW AND META-ANALYSIS.Alberto Tringali, Italy; M. Cintolo; L. Cristoferi; E. Forti; F. Pugliese; L. Dioscoridi; M. Mutignani


221


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1419MONITORING AND OPTIMIZATION OF PANCREATIC ENZYME REPLACEMENT THERAPY IN PATIENTS WITH PANCREATIC EXOCRINE INSUFFICIENCYMila Kovacheva-Slavova, Bulgaria; S. Siminkovitch; J. Genov; B. Golemanov; R. Mitova; P. Gecov; D. Svinarov; B. Vladimirov


P1420HUR MEDIATED POST-TRANSCRIPTIONAL REGULATION OF HO-1 AND INHIBITORS OF APOPTOSIS PROTEINS IS ASSOCIATED WITH THE POOR CLINICAL OUTCOMES AMONG PATIENTS WITH PANCREATIC CANCERZilvinas Dambrauskas, Lithuania; A. Gulbinas; A. Jakštaite; A. Urboniene

P1421HYPOXIA INDUCED HIF1A-MEDIATED DIFFERENTIAL O-GALNAC GLYCOSYLATION DIRECTLY REGULATES SIGNALING PATHWAYS IN PANCREATIC CANCER.B. Mercanoglu; B. T. Hofmann; C. Güngör; J. R. Izbicki; M. Bockhorn; Gerrit Wolters-Eisfeld, Germany

P1422THE EXPRESSION AND FUNCTION OF MIR-195 IN PAN-CREATIC CANCERTHE EXPRESSION AND FUNCTION OF MIR-195 IN PANCREATIC CANCERY. Zhang; Qiang Zhan, China

P1423 TRYPTOPHAN DEGRADATION AS AN ALTERNATIVE ENERGY SOURCE IN PANCREATIC CANCERCenap Guengoer, Germany; C. Kondziella; B. Mercanoglu; G. Wolters-Eisfeld; J. R. Izbicki; M. Bockhorn

P1424INTEGRIN α11 IS SPECIFICALLY EXPRESSED IN PANCREAT-IC TUMOR STROMA AND A KEY TARGET IN REGULATION OF PANCREATIC TUMOR STROMAL MYOFIBROBLASTSJonas Schnittert, The Netherlands; R. Bansal; G. Storm; A. Östman; J. Prakash

P1425EFFECT OF ACOUSTIC CAVITATION ON A THREE-DI-MENSIONAL CULTURE MODEL OF PANCREATIC ADENO-CARCINOMA.Benoit Bordacahar, France; M. Camus; E. Abou Ali; J. L. Mestas; M. Lafond; I. Suarez; A. Gomes; V. Lobjois; F. Batteux; C. Lafon; F. Prat

P1426PATHOLOGICAL EVALUATION AND REPORTING OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS OF THE PANCREAS: THE CORRELATION AND ANALYZES OF THE HISPATHOTOLOGIC PATTERNSCarolin Nava, Brazil; R. Coudry; M. C. Cesar Machado; L. Meirelles; M. D. C. Gonçalves; G. Ferreira Paduani; J. G. Guerra; J. C. Ardengh

P1411EVALUATION OF LOCAL INSTILLATION OF ANTIBIOTICS IN WALLED-OFF PANCREATIC NECROSISMikkel Werge, Denmark; S. Roug; E. Feldager; J. D. Knudsen; L. L. Gluud; S. Novovic; P. N. Schmidt

P1412CORONARY DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE ARE NOT ASSOCIATED WITH WORSE OUTCOME IN ACUTE PANCREATITISJoana Rita Carvalho, Portugal; P. Santos; S. Fernandes; M. Moura; T. Antunes; J. Velosa

P1413WORSE OUTCOMES IN ACUTE PANCREATITIS IN PA-TIENTS WITH TYPE-2 DIABETES MELLITUSPatrícia Santos, Portugal; J. R. Carvalho; S. Fernandes; M. Moura; T. Antunes; J. Velosa

P1414ACUTE PANCREATITIS IN LIVER TRANSPLANT RECIPI-ENTS: INCIDENCE AND OUTCOMEPeter Macinga, Czech Republic; K. Poc; P. Trunecka; J. Spicak; T. Hucl


P1415THE IMPACT OF BILIARY SLUDGE TO DEVELOPMENT OF PAIN AND EFFICACY OF HYMECROMONE IN CHRONIC BILIARY PANCREATITISAlexey Okhlobystin, Russian Federation; N. Ponkratova; O. Okhlobystina; S. Nasonova; M. Tatarkina; S. A. Budzinsky; V. Ivashkin

P1416RETROSPECTIVE ANALYSIS OF EXOCRINE PANCRE-ATIC FUNCTIONALITY IN PATIENTS WITH CHRONIC PANCREATITISAlessandro Brandolese, Italy; A. Amodio; M. C. Conti Bellocchi; S. Di Stefano; P. Campagnola; N. de Pretis; L. Bernardoni; S. F. Crinó; A. Gabbrielli; L. Frulloni

P1417‘PAINLESS’ CHRONIC PANCREATITIS: EPIDEMIOLOGICAL, CLINICAL AND RADIOLOGICAL CHARACTERIZATIONClaudia Perini, Italy; A. Amodio; L. Bernardoni; A. Gabbrielli; S. F. Crinó; P. Campagnola; D. Costa; F. Capuano; V. Framba; L. Frulloni

P1418 LONG-TERM OUTCOMES OF A FULLY COVERED SELF-EX-PANDABLE METAL STENT WITH ANTIMIGRATION PROP-ERTIES FOR EUS-GUIDED PANCREATIC DUCT DRAINAGEDong-Wook Oh, Republic of Korea; D. H. Park; D. H. Cho; T. J. Song; S. S. Lee; D.-W. Seo; S. K. Lee; M.-H. Kim


222


Wednesday, N

ovember 1, 2017


P1434A 5- YEAR TERTIARY CENTRE EXPERIENCE OF ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION FOR DIAGNOSIS OF SOLID PANCREATIC MASS LESIONS Thomas Skouras, United Kingdom; L. Bonnett`; M. Swaminathan; R. Mcgalliard; A. Metussin; J. Evans; S. Sarkar; T. Giles; A. Cullen; K. Brougham; J. Sheard

P1435CLINICAL IMPACT OF GNAS AND KRAS MOLECULAR ALTERATIONS ADDED TO CEA AND CYTOLOGY IN PAN-CREATIC CYSTIC FLUID OBTAINED BY EUS-FNASandra Faias, Portugal; M. Duarte; C. Albuquerque; R. Roque; J. Pereira da Silva; R. Fonseca; A. Dias Pereira

P1436KRAS MUTATION ASSAY ON EUS FNA SPECIMENS FROM PACIENTS WITH PANCREATIC MASSMartin Laclav, Czech Republic; B. Bunganic; T. Halkova; L. Benesova; B. Belsanova; E. Traboulsi; S. Suchanek; M. Minarik; M. Zavoral

P1437DO BILIARY STENTS REDUCE THE DIAGNOSTIC PER-FORMANCE OF EUS BIOPSY IN PATIENTS WITH A MASS IN THE HEAD OF PANCREAS?Noor Bekkali, United Kingdom; M. Nayar; L. Thornton; S. J. Johnson; B. Haugk; A. Darne; J. S. Leeds; R. Charnley; K. Oppong

P1438SOLID-PSEUDOPAPILLARY NEOPLASM OF THE PANCREAS (SPN) DOES NOT CONTRAINDICATE EUS PONCTION: ABOUT A RETROSPECTIVE SERIES OF FIFTY PATIENTS WITH PREOPERATIVE EUS-FNA (THE SPN G.R.A.P.H.E. SERIES)David Karsenti, France; S. Koch; L. Poincloux; U. Chaput; G. Vanbiervliet; F. Cholet; M. Wangermez; P. Ah-Soune; P. Bichard; Y. Le Baleur; J. Privat; E. Coron; C. Subtil; M. Palazzo

Endocrine tumours of the pancreas

P1439DIAGNOSIS OF PANCREATIC NEUROENDOCRINE TUMOURS USING SUREPATH CYTOLOGY AND IMMU-NOHISTOCHEMISTRY WITHOUT NEED FOR EXCISION BIOPSY.Christopher Meredith, Australia; H. Dixson; P. Irandoost; P. Baird

P1440EFFECTS OF IGF2BPS ON GROWTH AND PROLIFERATION IN NEUROENDOCRINE PANCREATIC TUMOR CELL LINESLars Nietfeld, Germany; F. Sperling; K. Theuerkorn; H. Griesmann; S. Krug; S. Hüttelmaier; P. Michl


P1427EVALUATION OF LONG TERM SURVIVAL OF CHEMORA-DIOTHERAPY WITH GEMCITABINE AND S-1 COMPARED WITH CHEMOTHERAPY ALONE IN THE CASES WITH LOCALLY ADVANCED PANCREATIC CANCERKo Tomishima, Japan; S. Ishii; T. Fujisawa; S. Takahashi; A. Suzuki; R. Kanazawa; H. Saito; H. Isayama; K. Sasai; S. Kawasaki

P1428HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) THER-APY FOR UNRESECTABLE PANCREATIC CANCERAtsushi Sofuni, Japan; Y. Asai; M. Fujita; T. Tsuchiya; S. Tsuji; R. Tanaka; R. Tonozuka; M. Honjo; S. Mukai; K. Yamamoto; Y. Matsunami; K. Kamada; T. Itoi

P1429EUS AND CT SCAN ACCURACY IN ESTABLISHING THE T STAGE IN PANCREATIC CANCER BASED ON THE UPCOMING TNM 8TH EDITIONLivia Archibugi, Italy; M. C. Petrone; S. Crippa; E. Dabizzi; A. Mariani; R. Nicoletti; C. Doglioni; G. Capurso; M. Falconi; P. G. Arcidiacono

P1430 RISK FACTORS AND SURVIVAL IN PANCREATIC ADENOCARCINOMALivia Petrusel, Romania; V. L. Drug; M. Bilibou; C. Cainap; C. Pojoga; R. Seicean; A. Seicean

P1431PREVALENCE STRATIFICATION OF MALIGNANCY IN RESECTED INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS INVOLVING MAIN DUCT: IS THE 10 MM WIRSUNG DIAMETER AN ADEQUATE CUTOFF? Tiago Cúrdia Gonçalves, Portugal; C. Montironi; M. Cuatrecasas; J. R. Ayuso; S. Sanchez; H. de Leon; C. Sanchez; G. Fernández-Esparrach; A. Gines; X. Molero; C. Marinho; J. Cotter; E. Vaquero

P1432CLINICAL SIGNIFICANCE OF CHEMOTHERAPY FOR EL-DERLY UNRESECTABLE PANCREATIC CANCER PATIENTSSeiji Kaino, Japan; M. Sen-yo; S. Shinoda; S. Amano; I. Sakaida

P1433THE USE OF A NEW CORE NEEDLE IN THE ENDOSCOPIC ULTRASOUND ASSISTED TISSUE SAMPLING FOR PANCREATIC SOLID MASSES: A MULTICENTRE PRO-SPECTIVE STUDY.Silvia Carrara, Italy; M. Di Leo; L. Bernardoni; D. Rahal; G. Donato; M. Massidda; A. Anderloni; S. Crinò; E. Manfrin; M. Ballare; L. Poliani; F. Auriemma; A. Fugazza; P. Occhipinti; A. Gabbrielli; A. Repici


223


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1449LONG-TERM OUTCOMES OF EARLY GASTRIC CANCER WITH LATERAL MARGIN POSITIVE AFTER ENDOSCOPIC RESECTIONHyung-Kil Kim, Republic of Korea; D.-H. Yang; J.-S. Park; B. W. Bang; Y. W. Shin

P1450EFFICACY OF THE FORCED COAGULATION MODE WITH LOW HIGH-FREQUENCY POWER SETTING DURING ENDOSCOPIC SUBMUCOSAL DISSECTIONTsukasa Ishida, Japan; T. Toyonaga; Y. Ohara; R. Ariyoshi; F. Kawara; S. Tanaka; Y. Morita; E. Umegaki; N. Hoshi; T. Azuma

P1451 EXPOSURE TO ENDOTHERAPY FOR UPPER GASTROIN-TESTINAL BLEEDING AT THE POINT OF GASTROSCOPY CERTIFICATION – IS IT SUFFICIENT? Keith Siau, United Kingdom; P. Dunckley; J. Anderson; I. Beales; R. Broughton; M. Feeney; A. Haycock; N. Hawkes; R. Valori; C. Wells; S. Thomas-Gibson; B. McKaig

P1452ELECTRONIC CHROMOENDOSCOPY WITH MAGNIFICA-TION IN THE DETECTION OF DYSPLASIA IN BARRETT'S ESOPHAGUSC. Carames; Juan Carlos Carames, Mexico; M.-M. Xu; M. Carames; M. Gaidhane; M. Kahaleh

P1453DOES ‘INVISIBLE’ DYSPLASIA IN BARRETT’S OESOPHA-GUS REALLY EXIST?A. Antonello; D. Nucci; D. Arcidiacono; T. Morbin; M. Fassan; M. Häfner; M. Rugge; Stefano Realdon, Italy

P1454SAFETY, EFFICACY AND CLOSURE TECHNIQUES OF ENDOSCOPIC FULL THICKNESS RESECTION-INITIAL CLINICAL EXPERIENCEA. Bapaye; Tarun Bharadwaj, India; M. R. Mahadik; S. G. Vare; R. pujari; S. date; N. dubale; J. A. Bapaye; A. Kulkarni

P1455PROPHYLAXIS OF VARICEAL BLEEDING IN CIRRHOTIC PATIENTS: EFFICACY AND SAFETY OF ENDOSCOPIC VARICEAL LIGATION IN A TERTIARY CENTREElisa Soares, Portugal; M. Gravito-Soares; A. Henriques; N. Almeida; L. Tomé

P1456 THE VALUE OF ENDOSCOPIC FULL-THICKNESS RESEC-TION FOR GASTRIC AND DUODENAL SUBMUCOSAL TUMORS ORIGINATING FROM THE MUSCULARIS PROPRIA LAYERMei-Dong Xu, China; C. Zhang; Q.-L. Li

P1441CONCOMITANT NEUROENDOCRINE TUMOR OF THE PANCREAS AND INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM: IS THERE SOMETHING BEYOND? Ludovica Venezia, Italy; P. Cortegoso Valdivia; C. G. De Angelis

P1442EFFECTS OF LOW-DOSES ASPIRIN ON CLINICAL OUT-COME AND DISEASE PROGRESSION IN PATIENTS WITH GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE TUMORS: RESULTS OF A MULTICENTRIC RETROSPEC-TIVE STUDY.S. Massironi; S. Pusceddu; Federica Cavalcoli, Italy; A. Zilli; G. Tamagno; D. Femia; N. Prinzi; C. Ciafardini; D. Conte

P1443PANCREATIC LESIONS IN VON HIPPEL-LINDAU SYN-DROME: CLINICAL AND EPIDEMIOLOGICAL DATA FROM A SINGLE CENTERL. Venezia; Pablo Cortegoso Valdivia, Italy; C. G. De Angelis

P1444IMPACT OF TUMOUR SIZE ON THE PROBABILITY OF METASTASIS AND SURVIVAL IN PATIENTS WITH PANCREATIC NEUROENDOCRINE TUMOURS (PNETS): A POPULATION BASED STUDYYangyang Liu, China; B. Ye; X. He; S. Chen; J. Pan; L. Wang; H. Shi

P1445THE LARGEST FAMILY IN TURKEY WITH MULTIPLE EN-DOCRINE NEOPLASIA-TYPE 1 AND A NOVEL MUTATIONAlş Çetin, Turkey; D. G. Duman

P1446PROGNOSTIC VALUE OF THE DIFFERENT PRE-TREAT-MENT BIOMARKERS FOR PATIENTS WITH NEUROEN-DOCRINE TUMORSRaluca Roxana Grigorescu, Romania; C. Gheorghe; I. M. Stanel; A. Croitoru; I. Dinu; V. Croitoru

P1447FUNCTIONAL RELEVANCE OF THE OVEREXPRESSION OF PLAC8 IN NEUROENDOCRINE PANCREATIC TUMORSMarina Hutzler, Germany; M. Haijat; H. Schmidt; R. Lawlor; A. Scarpa; T. M. Gress; M. Buchholz

Poster Session09:00 – 14:00 Hall 7Endoscopy and Imaging III

Endoscopy, upper GI

P1448CLINICAL OUTCOMES OF SUPERFICIAL LARYNGOPHA-RYNGEAL CANCER WITH LYMPHO-VASCULAR INVASION AFTER ENDOSCOPIC LARYNGO-PHARYNGEAL SURGERYHIroki Ishida, Japan; R. Nakamura; T. Omori; S. Mayanagi; K. Fukuda; K. Suda; N. Wada; H. Kawakubo; Y. Kitagawa


224


Wednesday, N

ovember 1, 2017


P1466PER ORAL ENDOSCOPIC MYOTOMY: UPDATED RESULTS FROM A UNITED KINGDOM CASE SERIESShraddha Gulati, United Kingdom; A. Emmanuel; H. Inoue; A. Haji; B. Hayee

P1467NEW CHALLENGE FOR SAFER ENDOSCOPIC SUBMUCO-SAL DISSECTION USING CO2 LASERYoshinori Morita, Japan; R. Ariyoshi

P1468LONG TERM OUTCOME OF ACUTE CORROSIVE INGES-TION: A PROSPECTIVE SINGLE CENTER STUDYSudipta Dhar Chowdhury, India; B. Kumar C; R. T. Kurien; S. K. Ghatak; D. Sreekar

P1469PROBE-BASED CONFOCAL LASER ENDOMICROSCOPY (PCLE) FOR IN VIVO DIAGNOSIS OF ESOPHAGEAL AND GASTRIC LESIONS – RESULTS OF A PROSPECTIVE, CONTROLLED, CROSS-OVER STUDYMarek Kollar, Czech Republic; J. Krajciova; J. Maluskova; M. Kment; Z. Vackova; J. Spicak; J. Martinek

P1470COMPARING RISK SCORING SYSTEMS FOR NON-VARI-CEAL UPPER DIGESTIVE BLEEDING IN THE GASTROEN-TEROLOGY DEPARTMENTDaniela Lazar, Romania; I. Sporea; D. Tornea; L. Girboni; R. Lupusoru; I. Romosan; A. Goldis

P1471PERCUTANEOUS ENDOSCOPIC GASTROSTOMY: A SAFE PROCEDURE EVEN IN CANCER PATIENTSJuliana Pinho, Portugal; J. Lage; D. Libanio; S. Ferraz; N. Silva; M. Dinis-Ribeiro; C. Brandão

P1472A PROSPECTIVE, SINGLE-CENTER, CROSS-OVER CON-TROLLED TRIAL OF CONFOCAL LASER ENDOMICROS-COPY ASSESSMENT OF PERSISTENT OR RECURRENT INTESTINAL METAPLASIA AND RECURRENCE OF NEOPLASIA AFTER ENDOSCOPIC TREATMENT OF BAR-RETT'S ESOPHAGUS RELATED NEOPLASIA (BORN)Jana Krajciova, Czech Republic; M. Kollar; J. Maluskova; M. Kment; Z. Vackova; J. Spicak; J. Martinek

P1473FLEXIBLE ENDOSCOPIC SEPTUM DIVISION (FESD) OF ZENKER'S DIVERTICULUM: OUTCOMES FROM A SINGLE TERTIARY CENTER USING A NEW SYMPTOMS SCORE.Roberta Maselli, Italy; G. Lollo; M. Di Leo; R. Nicoletti; E. Finati; P. A. galtieri; L. Poliani; F. Auriemma; R. Semeraro; A. Fugazza; E. C. Ferrara; A. Anderloni; S. Carrara; A. Repici

P1474HOW ACCURATE ARE THE SYMPTOMS IN PATIENTS WITH FOOD IMPACTION AND FOREIGN BODIES INGESTION?Ana Laranjo, Portugal; I. Mocanu; M. M. Carvalho; S. Pires; N. Veloso; L. Gonçalves; R. Godinho; I. Medeiros

P1457BLUE LIGHT IMAGING AND LINKED COLOR IMAGING FOR DETECTION AND CHARACTERISATION OF CHRONIC GASTRITISJochen Weigt, Germany; A. Link; A. Canbay; P. Malfertheiner

P1458LONG-TERM OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION(ESD) FOR RELATIVE INDICATION GROUP OF EARLY ESOPHAGEAL SQUAMOUS CELL CARCINOMA(EE-SCC) IN AGED PATIENTS Z. Qi; Y. Zhong; Ping-Hong Zhou, China

P1459RETROSPECTIVE ANALYSIS ON SUSPICION OF FOREIGN BODY INGESTION AND FOOD IMPACTION ON GASTRO-ENTEROLOGY EMERGENCIES.Joao Correia de Sousa, Portugal; D. Libanio; P. Lago; R. Marcos-Pinto; I. Pedroto

P1460LEARNING CURVE FOR ENDOSCOPIC SUBMUCOSAL DISSECTION OF GASTRIC NEOPLASMS; LOW-VOLUME SINGLE CENTER EXPERIENCESeong Taeg Kim, Republic of Korea; T. H. Kim; S.-Y. Na

P1461COMPARATIVE STUDY OF ESD AND SURGICAL RESEC-TION FOR GASTRIC SETS ORIGINATED FROM MUSCU-LARISPROPRIAChang Beom Ryu, Republic of Korea; M. S. Lee; J. Y. Bae

P1462 CAP ASSISTED UPPER ENDOSCOPY VERSUS SIDE-VIEWING ENDOSCOPE FOR EXAMINATION OF THE MAJOR DUODE-NAL PAPILLA: A RANDOMIZED, BLINDED, CONTROLLED, NON-INFERIORITY CROSSOVER STUDY (CAPPA-II STUDY)Mohamed Abdelhafez, Germany; V. Phillip; A. Hapfelmeier; M. Elnegouly; M. Dollhopf; A. El Magid Kassem; P. Klare; M. Bajbouj; R. M. Schmid; S. Delius; F. Eckel Florian

P1463(IN)ACCURACY OF CAMBRIDGE PROTOCOL FOR PATIENTS HARBOURING CHD1 MUTATION: A CONSECUTIVE SERIESRui Castro, Portugal; D. Libânio Monteiro; T. Pinto-Pais; M. Dinis-Ribeiro; C. Brandão

P1464SINGLE CENTER CLINICAL EXPERIENCE WITH A RE-CENTLY DEVELOPED FULL-THICKNESS ENDOSCOPIC CLIP A. Bapaye; S. G. Vare; M. R. Mahadik; Tarun Bharadwaj, India; R. Pujari; S. Date; N. Dubale; J. A. Bapaye; A. Kulkarni

P1465ENDOSCOPIC AMPULLECTOMY OUTCOMES IN A TER-TIARY ENDOSCOPY DEPARTMENTM. Tantau; A. Varciu; M. Voicu; Bogdan Miutescu, Romania; V. Ioana; C. Lidia; T. Alina


225


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1483 WITHDRAWN

P1484PROTECTIVE VACUUM SPONGE IMPLANTATION AND CONTINUOUS EVACUATION OF BILE AND PANCREATIC JUICE FOR PREVENTION OF SECONDARY PERFORA-TION AFTER PRIMARY SUCCESSFUL ENDOSCOPIC RESECTION OF WIDESPREAD D2/D3 DUODENAL AND PAPILLARY ADENOMATAJürgen Hochberger, Germany; M. Loss; C. von Heymann; C. Jung; E. Wedi; M. Hofmeyer

Endoscopy, colon

P1485ENDOSCOPIC CLOSURE OF ACUTE PERFORATIONS OF THE GASTROINTESTINAL TRACT IN ANIMAL MODELS: A SYSTEMATIC REVIEW AND META-ANALYSISAhmed Gabr, United Kingdom; N. Ammar; M. El Houssine; M. Rutter

P1486RISK FACTORS FOR COLORECTAL POLYP IN ASYMP-TOMATIC YOUNG ADULTS UNDER THE AGE OF 50Yusik Myung, Republic of Korea

P1487 COMPARISON BETWEEN AN ASYMMETRIC (SMALL DOSE IN THE MORNING) AND A SYMMETRIC SPLIT-DOSE REG-IMEN OF POLYETHYLENE GLYCOL PLUS BISACODYL FOR BOWEL PREPARATION FOR SCREENING COLONOSCOPY: A RANDOMIZED NON-INFERIORITY CLINICAL TRIALPaolo Andreozzi, Italy; C. Bezzio; G. De Nucci; S. Saibeni; M. Devani; I. Arena; R. Reati; E. Mandelli; D. Redaelli; D. Morganti; B. Omazzi; G. Manes

P1488SINGLE BALLOON OVERTUBE-GUIDED COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION; A NEW APPROACH TO MANAGEMENT OF COLORECTAL ENDO-SCOPIC SUBMUCOSAL DISSECTIONTadateru Maehata, Japan; Y. Ochiai; T. Akimoto; Y. Mitsunaga; Y. Kiguchi; A. Fujimoto; O. Goto; T. Nishizawa; T. Uraoka; N. Yahagi

P1489SEDATION IN COLORECTAL ESD: A SYSTEMATIC RE-VIEW OF WESTERN CLINICAL PRACTICEMileidis Esther San Juan Acosta, Spain; S. Beg; S. Sansone; K. Ragunath; B. Manorahan

P1490COMPUTER-AIDED POLYP MEASUREMENT OF 78 POLYPS DURING LIVE COLONOSCOPY (CAPME) : A PROSPECTIVE STUDY Christophe Allimant, France; O. Rouquette; S. Le Roux; B. Pereira; A. Abergel; A. Bartoli; C. Tilmant; L. Poincloux

P1475GASTROINTESTINAL ENDOSCOPY UNDER SEDATION IS ASSOCIATED WITH PNEUMONIA IN OLDER INPATIENTS – RESULTS OF A RETROSPECTIVE CASE-CONTROL STUDY.Christopher Kollmann, Germany; W. Schmiegel; T. Brechmann

P1476SYMPTOMATIC RESPONSE OF PYLORIC PNEUMATIC DIL-ATATION, BOTOX INJECTION OR COMBINATION THERAPY IN PATIENTS WITH GASTROPARESIS OR DELAYED GAS-TRIC EMPTYING POST-GASTRIC TRANSPOSITIONAbhinav Gupta, United Kingdom; M. A. Everson; R. Haidry; M. Banks; S. Bown; D. Graham; R. Ganatra; A. Ramasubramoni; L. Lovat; R. Sweis

P1477AN ANALYSIS OF COMPLICATIONS FOLLOWING ENDOSCO- PIC SUBMUCOSAL DISSECTION IN A WESTERN SETTING – MAKING THE CASE FOR A SHORTER LENGTH OF STAYSharmila Subramaniam, United Kingdom; K. Kandiah; G. Longcroft-Wheaton; P. Bhandari

P1478PREDICTIVE FACTORS AND MANAGEMENT OF REFRAC-TORY BENIGN OESOPHAGEAL STRICTURESMiguel Moura, Portugal; C. Simões; C. Noronha Ferreira; P. Santos; J. P. Freire; J. Lopes; L. Carrilho Ribeiro; J. Velosa

P1479LOCAL CORTICOSTEROIDS IMPROVE EARLY CLINICAL OUTCOMES IN PATIENTS UNDERGOING ENDOSCOPIC DILATION OF BENIGN OESOPHAGEAL STRICTURESMiguel Moura, Portugal; C. Simões; C. Noronha Ferreira; P. Santos; J. P. Freire; J. Lopes; L. Carrilho Ribeiro; J. Velosa

P1480 TRENDS IN CERTIFICATION FOR GASTROINTESTINAL ENDOSCOPY AND VARIATIONS BETWEEN TRAINEE SPECIALTIES: RESULTS FROM THE UK TRAINEE EN-DOSCOPY DATABASEKeith Siau, United Kingdom; R. Broughton; J. Anderson; I. Beales; M. Feeney; A. Haycock; N. Hawkes; G. Johnson; B. McKaig; R. Pullan; R. Valori; C. Wells; S. Thomas-Gibson; P. Dunckley

P1481EFFICIENCY AND SAFETY OF ENDOSCOPIC PAPILLECTO-MY FOR TREATMENT OF DUODENAL PAPILLA TUMORSY. Chu; Mei-Dong Xu, China; P.-H. Zhou; C. Zhang

P1482CHANGES IN SCORING OF DIRECT OBSERVATION OF PROCEDURAL SKILLS (DOPS) FORMS IN ENDOSCO-PY TRAINING AND THEIR IMPACT ON COMPETENCE ASSESSMENTKeith Siau, United Kingdom; P. Dunckley; A. Nevill; J. Anderson; I. Beales; R. Broughton; M. Feeney; A. Haycock; N. Hawkes; B. McKaig; S. Thomas-Gibson; R. Valori; C. Wells; G. Johnson


226


Wednesday, N

ovember 1, 2017


P1499 MULTIPLE COLORECTAL ADENOMAS WITHOUT APC OR MUTYH GERMLINE MUTATION: A HETEROGENEOUS SUBGROUP OF PATIENTSLupe Sanchez Mete, Italy; E. Mannisi; A. Martayan; M. Varanese; V. Stigliano

P1500EVALUATION THE RELATIONSHIP BETWEEN NUMBERS OF BIOPSIES PER CASE AND DEGREE OF FIBROSIS IN COLONJaekook Yang, Republic of Korea; Y. Jung; I.-K. Chung; Y. S. Cho; S. J. HAN; T. H. Lee; S.-H. Park; H. Cho; Y. Hwangbo; S.-J. Kim

P1501ADVANCED NEOPLASIA YIELD IN PATIENTS UNDERGO-ING COLONOSCOPY AFTER SCREENING FLEXIBLE SIG-MOIDOSCOPY: DOES THE DISTAL COLONIC PATHOLOGY PREDICTS THE YIELD IN PROXIMAL COLON?Rajaratnam Rameshshanker, United Kingdom; F. Purchiaroni; A. Crudeli; A. Rajendran; I. Stasinos; A. Wilson; S. Thomas-Gibson; A. Haycock; A. Humphries; N. Suzuki; B. P. Saunders

P1502LEARNING CURVE FOR OPTICAL DIAGNOSIS OF COL-ORECTAL POLYPS USING CUMULATIVE SUM ANALYSISRajaratnam Rameshshanker, United Kingdom; A. Wilson; S. Thomas-Gibson; N. Kamperidis; N. O'shea; B. P. Saunders

P1503THE CLINICAL VALUE OF ENDOSCOPIC FULL-THICKNESS RESECTION FOR THE TREATMENT OF COLORECTAL SUB-MUCOSAL TUMORS ORIGINATING FROM THE MUSCU-LARIS PROPRIA: A PROSPECTIVE SINGLE-CENTER STUDYMei-Dong Xu, China; C. Zhang; Q.-L. Li

P1504COLONIC ESD BY UTILIZING SHORT DOUBLE BALLOON ENDOSCOPE ~HOW TO TREAT DIFFICULT CASES IN COLONIC ESD~Shinichi Katsuki, Japan; T. Fujita; K. Takanashi; E. Waga

P1505WITHDRAWAL TIME MONITORING AND FULL-SPECTRUM ENDOSCOPY IMPROVE ADENOMA DETECTION RATE.Germana De Nucci, Italy; P. Andreozzi; C. Bezzio; R. Reati; D. Morganti; D. Redaelli; E. Mandelli; B. Omazzi; I. Arena; S. Saibeni; G. Manes

P1506 HIGH LEVELS OF “PRESUMED POLYP MISS RATE” AT 1 AND 3 YEARS FOLLOWING INDEX SCREENING COLO-NOSCOPY: NO ROOM FOR COMPLACENCY.Rajaratnam Rameshshanker, United Kingdom; F. Purchiaroni; A. Wilson; A. Rajendran; S. Thomas-Gibson; A. Humphries; A. Haycock; N. Suzuki; B. P. Saunders

P1491USING THE MULTI-ASSISTANT RATING SCALE (MARS) FOR ENDOSCOPIC NON-TECHNICAL SKILLS PERFOR-MANCE AUGMENTS USE OF STANDARD KEY PERFOR-MANCE MEASURES IN INDEPENDENT COLONOSCOPISTS.Neil Hawkes, United Kingdom; F. Kokwara; B. Davies; J. Cornish

P1492EARLY ECONOMIC MODELLING OF EMI-137 TO IM-PROVE THE DETECTION RATE OF POLYPS IN PATIENTS WITH INCREASED RISK OF COLORECTAL CANCERBethany Shinkins, United Kingdom; A. Smith; N. King; A. Davies; I. Wilson

P1493RANDOMIZED CLINICAL TRIAL EVALUATING THE EFFECT OF A VISUAL EDUCATIONAL BOOKLET ON THE PREPARA-TION OF COLONOSCOPIES IN HOSPITALIZED PATIENTS.Antonio Guardiola Arévalo, Spain; A. Granja Navacerrada; F. J. Garcia-Alonso; P. Bernal Checa; M. Hernández Tejero; D. Bonillo; E. M. Andrés Esteban; A. Algaba Garcia; F. Bermejo

P1494STUDY OF ULCERATIVE COLITIS COMPLICATED BY PRIMARY SCLEROSING CHOLANGITISShun Murasugi, Japan; A. Ito; H. Kambayashi; M. Yonezawa; T. Ohmori; K. Tokushige

P1495COMPETENCY OF ENDOSCOPIC NON-TECHNICAL SKILLS (ENTS) DURING ENDOSCOPY TRAININGKeith Siau, United Kingdom; P. Dunckley; J. Anderson; I. Beales; R. Broughton; M. Feeney; N. Hawkes; G. Johnson; B. McKaig; R. Valori; C. Wells; S. Thomas-Gibson; A. Haycock

P1496MAKING COLONOSCOPISTS MORE AWARE OF THEIR ENDOSCOPIC NON-TECHNICAL SKILLS – IMPROVING FEEDBACK FORMATS DERIVED FROM THE MULTI-AS-SISTANT RATING SCALE (MARS) TOOL.Neil Hawkes, United Kingdom; F. Kokwara; B. Davies; J. Cornish

P1497OUTCOMES OF ENDOSCOPIC RESECTION OF COMPLEX COLORECTAL LESIONS REFERRED TO A TERTIARY INSTITUTION AFTER FAILED ATTEMPTS AT RESECTION OR EXTENSIVE MANIPULATIONAndrew Emmanuel, United Kingdom; S. Gulati; M. Burt; B. Hayee; A. Haji

P1498NBI VERSUS BLI! WHICH MODALITY IS BETTER FOR OBSERVATION OF MUCOSAL BLOOD FLOW IN THE SMALL AND LARGE BOWEL USING NBI (NARROW BAND IMAGING) OR BLI (BLUE LASER IMAGING)?Mitsunori Yasuda, Japan; Y. Naito; Y. Itoh


227


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1515RISK OF HIGH GRADE DYSPLASIA AND SUBMUCOSAL INVASION IN DIFFERENT MORPHOLOGICAL SUB-TYPES OF LARGE COLORECTAL NEOPLASTIC LESIONS RESECT-ED AT A UK TERTIARY REFERRAL UNITAndrew Emmanuel, United Kingdom; S. Gulati; M. Burt; B. Hayee; A. Haji

P1516POLYP DETECTION INCREASES WITH COLONOSCOPY WITHDRAWAL TIMEKhaled Agar, Tunisia; L. Hamzaoui; M. Medhioub; B. Bouchabou; M. M. Azouz

P1517 OUTCOMES OF ENDOSCOPIC RESECTION OF RECUR-RENT COLORECTAL LESIONS TREATED AT A UK TERTIA-RY REFERRAL CENTREAndrew Emmanuel, United Kingdom; S. Gulati; M. Burt; B. Hayee; A. Haji

P1518THE EFFECTIVENESS OF NEW TECHNIQUE WITH SELF-EXPANDABLE METALLIC STENT INSERTION IN TREATING RIGHT-SIDED COLONIC OBSTRUCTIONChang Beom Ryu, Republic of Korea; M. S. Lee; J. Y. Bae

P1519ENDOSCOPIC FULL-THICKNESS RESECTION FOR CO-LONIC LESIONS. INITIAL EXPERIENCE IN 3 CENTERS OF CATALONIA.Hugo Uchima Koecklin, Spain; D. Barquero; A. Fernandez-Simon; A. Mata; C. Huertas Nadal; M. Figa; M. Hombrados; J. Espinós

P1520A META-ANALYSIS: CHROMOENDOSCOPY OR WHITE LIGHT ENDOSCOPY FOR NEOPLASIA DETECTION IN LYNCH SYNDROMEO. Har-Noy; D. E. Yung; A. Koulaouzidis; U. Kopylov; Lior Katz, Israel

P1521HOT AVULSION TECHNIQUE – A FIRST LINE APPROACH FOR TREATMENT OF VISIBLE RESIDUAL NEOPLASIA DURING ENDOSCOPIC MUCOSAL RESECTION OF COL-ORECTAL POLYPS?Juliana Pinho, Portugal; R. Castro; D. Libanio; P. Pimentel-Nunes; T. Pinto-Pais; M. Dinis-Ribeiro; R. P. Bastos

P1522QUALITY IN BOWEL CLEANSING, PERFORMANCE MEASURES AND PATIENTS SATISFACTION USING DIF-FERENT PURGATIVES IN SCREENING COLONOSCOPYElisabeth Waldmann, Austria; D. Penz; B. Majcher; A. Dokladanska; A. Hinterberger; H. Sinkovec; G. Heinze; M. Trauner; M. Ferlitsch

P1507IMPACT OF PERIODONTAL DISEASE ON PREVALENCE OF COLORECTAL NEOPLASIA IN PATIENTS UNDERGO-ING ROUTINE SCREENING COLONOSCOPYAngelika Dokladanska, Austria; P. Jeschek; E. Waldmann; D. Penz; B. Majcher; A. Hinterberger; G. Heinze; M. Ferlitsch

P1508OUTCOMES OF ENDOSCOPIC RESECTIONS OF LARGE NON-POLYPOID LESIONS IN INFLAMMATORY BOWEL DIS-EASE: A SINGLE UNITED KINGDOM CENTRE EXPERIENCEShraddha Gulati, United Kingdom; A. Emmanuel; M. Burt; P. Dubois; B. Hayee; A. Haji

P1509RESEARCH ON APPLICATION OF TRANSANAL TUBE DE-COMPRESSION FOR PREVENTION OF COMPLICATIONS IN COLORECTAL MUCOSAL LESIONS AFTER ESDL. Bing; Z. Qi; Yunshi Zhong, China

P1510OUTCOMES FOLLOWING UNDERWATER ENDOSCOPIC MUCOSAL RESECTION OF >10MM COLONIC POLYPS: A PROSPECTIVE DUAL-CENTRE STUDYKeith Siau, United Kingdom; A. Yusuf; N. Suzuki; S. Ishaq

P1511WATER-AIDED COLONOSCOPY – RESEARCH FOCUS IN THE PAST DECADE AND CURRENT CLINICAL PRACTICEFelix Leung, USA

P1512ENDOSCOPIC SUBMUCOSAL DISSECTION: RESULTS AND LEARNING CURVE OF A LARGE PROSPECTIVE SERIE OF 183 CASES IN THREE CENTERSM. Lopez Gomez; M. Hernández; C. E. González; J. Santiago; C. Bernardo; B. Conde; C. González-Lois; P. Matallanos; J. L. Calleja; L. E. Abreu García; Alberto Herreros de Tejada, Spain

P1513ENDOSCOPIC SUBMUCOSAL DISSECTION FOR COL-ORECTAL NEOPLASIA: THE EXPERIENCE OF A UK TERTIARY REFERRAL CENTREAndrew Emmanuel, United Kingdom; S. Gulati; M. Burt; B. Hayee; A. Haji

P1514RISK OF STENOSIS AND OUTCOMES FOLLOWING ENDOSCOPIC RESECTION OF LARGE COLORECTAL LE-SIONS INVOLVING MORE THAN 75% OF THE LUMINAL CIRCUMFERENCEAndrew Emmanuel, United Kingdom; S. Gulati; M. Burt; B. Hayee; A. Haji


228


Wednesday, N

ovember 1, 2017


P1531ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) OF SUPERFICIAL COLORECTAL NEOPLASMS AT THE ANAL CANAL AND ILEOCECAL VALVEFederico Iacopini, Italy; Y. Saito; T. Gotoda; C. Grossi; W. Elisei; F. Montagnese; P. Rigato; A. Cefaro; G. Costamagna

P1532SELF-EXPANDABLE METALLIC STENT IN THE OCCLU-SIVE COLORECTAL CANCER AS PALLIATIVE TREATMENTTânia Gago, Portugal; A. Antunes; A. M. Vaz; P. Queirós; J. Roseira; A. C. Cunha; A. Ramos; H. Guerreiro

P1533RISK FACTORS FOR ADENOMA RECURRENCE AFTER ENDOSCOPIC MUCOSAL RESECTION OF LARGE COL-ORECTAL POLYPSJuliana Pinho, Portugal; D. Martins; P. Sousa; R. Araújo; A. Castanheira; E. Cancela; R. Cardoso; P. Ministro; A. Silva

P1534 THE INFLUENCE OF THE REAL FOLLOW-UP TIMES DURING A COLORECTAL CANCER SCREENING PRO-GRAM IN DAILY PRACTICEEnrique Perez-Cuadrado-Robles, Belgium; B. Martínez-Andrés; E. A. Torrella Cortes; E. Pérez-Cuadrado-Martínez; F. Pérez-Riquelme

P1535 CLINICAL OUTCOME OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF MALIGNANT NON-PEDUNCULATED COLORECTAL LESIONSCarl-Fredrik Rönnow, Sweden; E. Toth; H. Thorlacius

P1536ENDOSCOPIC SUBMUCOSAL DISSECTION (ESD) VS HYBRID DISSECTION: WHICH TECHNIQUE TO FAVOR IN LARGE COLORECTAL LESIONS ?Marie-Anne Guillaumot, France; S. Leblanc; H. Soliman; B. Brieau; M. Barret; R. coriat; F. Prat; S. Chaussade

Endoscopy, ERCP

P1537TRENDS IN STATISTICS REGARDING ELECTIVE ERCP PROCEDURES IN THE VENETO REGION: A RETROSPEC-TIVE STUDY BASED ON ADMINISTRATIVE DATABASES.M. Saia; E. Rosa-Rizzotto; E. Guido; Diego Caroli, Italy; A. Frasson; B. Germaná; P. Pilati; F. De Lazzari

P1538EFFECT OF OBESITY, DYSLIPIDEMIA AND DIABETES MELLITUS ON THE RISK OF POST-ERCP PANCREATITISHajer Hassine, Tunisia; H. Elloumi; M. Sabbah; N. Bibani; D. Trad; D. Gargouri; A. Ouakaa; J. Kharrat

P1523DIFFERENCES BETWEEN BOWEL PREPARATION QUALI-TY OF SURVEILLANCE AND SCREENING COLONOSCOPYAnna Hinterberger, Austria; D. Penz; E. Waldmann; B. Majcher; A. Dokladanska; A. Szymanska; M. Trauner; M. Ferlitsch

P1524DIFFERENCES IN QUALITY OF BOWEL PREPARATION AT SCREENING COLONOSCOPIES IN PRIVATE PRACTICES AND HOSPITALSBarbara Majcher, Austria; D. Penz; E. Waldmann; A. Hinterberger; A. Dokladanska; A. Szymanska; M. Trauner; M. Ferlitsch

P1525RISK FACTORS FOR RESIDUAL NEOPLASIA AFTER ENDOSCOPIC MUCOSAL RESECTION OF LATERALLY SPREADING TUMORSNagyia Brogyuk, Czech Republic; T. Grega; M. Voska; O. Ngo; O. Majek; M. Zavoral; S. Suchanek

P1526ENDOSCOPIC SURVEILLANCE AFTER SURGERY ON FAMILIAL ADENOMATOUS POLYPOSIS PATIENTS: IT IS EFFECTIVE BUT INTERVALS CAN BE WIDENEDJuliana Pinho, Portugal; J. Lage; M. Dinis-Ribeiro; C. Brandão

P1527BOWEL PREPARATION FOR FLEXIBLE SIGMOIDOSCOPY: COMPARISON OF POLYETHYLENE GLYCOL ELECTRO-LYTE SOLUTION (PEG-ES) AND PHOSPHATE ENEMA IN 4,949 PATIENTS AT TWO UK HOSPITALSAbdulkani Yusuf, United Kingdom; S. Paranahewa; A. Jeevagan; P. Mayhead

P1528 MANAGEMENT OF RESECTION OF LARGE COLONIC LESIONS IN A REAL-LIFE SETTING: THE SCALP STUDY.Arnaldo Amato, Italy; F. Radaelli; V. Cennamo; E. Di Giulio; L. Fuccio; G. Manes; O. Tarantino; G. Fiori; M. De Bellis; A. Buda; F. Pigò; P. Cesaro; A. Anderloni; P. Occhipinti; G. Feliciangeli; P. Dulbecco; A. Musso; G. Gullotti; M. Giardini; B. Mangiavillano; S. Paggi; C. Hassan; A. Repici

P1529 ENDOSCOPIC REMOVAL OF HIGH-RISK COLORECTAL ADENOMAS: SAFE AND EFFECTIVE?Mariann Rutka, Hungary; K. Farkas; A. Fabian; R. Bor; A. Balint; Á. Milassin; Z. Szepes; T. Molnar

P1530 WHAT IMPROVED AND WHAT REMAINS TO BE ACHIEVED IN ORDER TO COMPLY WITH THE NEW REC-OMMENDATIONS OF POLYPECTOMY BY THE EUROPEAN SOCIETY OF GASTROINTESTINAL ENDOSCOPYJaime Rodrigues, Portugal; R. Pinho; L. Alberto; A. Rodrigues; L. Proença; T. Freitas; A. P. Silva; S. Fernandes; S. Leite; J. Silva; A. Ponte; M. Sousa; J. C. Silva; J. Carvalho


229


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1547DEVELOPMENT OF AN ERCP REGISTRY FOR QUALITY CONTROL AND BENCHMARKINGDániel Pécsi, Hungary; S. Gódi; F. Pakodi; P. Nagy; T. Molnár; P. Hegyi; A. Vincze

P1548DOUBLE-BALLON ENTEROSCOPY FOR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY IN PATIENTS WITH SURGICALLY ALTERED UPPER GAS-TROINTESTINAL ANATOMYCeline Ghaoui, France; E. Samaha; G. Rahmi; G. Perrod; H. Benosman; A. Vienne; C. Savale; S. Khater; L. Abbes; J.-B. Danset; G. Malamut; C. Cellier

P1549NEEDLE-KNIFE SPHINCTEROTOMY (NKS) VERSUS TRANSPANCREATIC SPHINCTEROTOMY (TPS) FOR DIF-FICULT BILIARY CANNULATION: A SYSTEMATIC REVIEW AND META-ANALYSISAlberto Tringali, Italy; M. Cintolo; L. Cristoferi; E. Forti; F. Pugliese; L. Dioscoridi; M. Mutignani

P1550TRANSPANCREATIC SPHINCTEROTOMY: A VALUABLE TECHNIQUE FOR GAINING CBD ACCESSShiran Esmaily, United Kingdom; M. Elzubier; D. Dwarakanath; V. Mitra; D. Majumdar; B. K. Chaudhury; J. Hancock

P1551ENDOSCOPIC REMOVAL OF BILE DUCT STONES – A RETROSPECTIVE SINGLE-CENTER STUDYGabriel Constantinescu, Romania; O. M. Plotogea; M. Ilie; B. Ungureanu; A. Constantinescu; I. Moroi; V. Sandru

P1552DICLOFENAC AND INDOMETHACIN IN THE PREVEN-TION OF POST-ERCP PANCREATITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF PROSPECTIVE CONTROLLED TRIALSArpad V. Patai, Hungary; N. Solymosi; L. Mohácsi; Á. Nagy; A. Patai

P1553RECTAL DICLOFENAC AND PANCREATITIS AFTER ENDO-SCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY Lourdes Del Olmo Martinez, Spain; B. Velayos; M. Ruiz-Rebollo

P1554WITHDRAWN

P1555A PILOT STUDY OF PROBE-BASED CONFOCAL LASER ENDOMICROSCOPY FOR COMPUTER-AIDED DIAGNOSIS OF BILE DUCT CANCER BY USING THE DEEP LEARNING TECHNOLOGYKoichi Furukawa, Japan; N. Yokoyama; H. Hashidate

P1539PLACE OF ENDOSCOPIC RETROGRADE CHOLAN-GIOPANCREATOGRAPHY (ERCP) IN THE MANAGEMENT OF HEPATIC HYDATID DISEASEHajer Hassine, Tunisia; M. Sabbah; N. Bibani; D. Trad; H. Elloumi; D. Gargouri; A. Ouakaa; J. Kharrat

P1540QUALITY INDICATORS AND POST OPERATIVE OUTCOME OF ERCP PERFORMED IN A LOW RESOURCE SETTING; CAN QUALITY INDICATORS FROM DEVELOPED SET-TINGS BE APPLIED?I. Kongala Liyanage; E. Thalagala; Supun Kulatunge, Sri Lanka; R. Peiris; N. Nawarathne

P1541USE OF MICROCATHETERS IN ECHOENDOSCOPY-GUIDED BILIOPANCREATIC RENDEZ-VOUS – INITIAL EXPERIENCEJoão Pinto, Portugal; C. Saldaña Dueñas; C. Leitão; I. Fernández-Urién Sainz; J. J. Vila

P1542ERCP AND PTCD IN BILIARY TRACT COMPLICATIONS AFTER LIVER TRANSPLANTATION: PREDICTORS OF LONG-TERM OUTCOMEM. Heinemann; Bita Tafrishi, Germany; S. Pischke; C. Spehr; A. W. Lohse; L. Fischer; T. Rösch; M. Sterneck; U. Denzer

P1543RESULTS OF THE FRENCH NATIONAL OBSERVATIONAL STUDY CONCERNING THE PRACTICE OF PROBE BASED CONFOCAL ENDOMICROSCOPY (CELLVIZIO®).Eid Mahfouz, France; G. Rahmi; L. Palazzo; R. Gincul; B. Napoléon; M. Giovannini; J. Moreau; M. Levy; G. Perrod; A. Vienne; E. Samaha; J.-M. Canard; F. Caillol; V. Lepilliez; T. Ponchon; E. Coron; C. Cellier

P1544ENDOSCOPIC RETROGRADE CHOLANGIOPANCREA-TOGRAPHY IN PATIENTS WITH SURGICALLY MODIFIED GASTRO-ENTERIC-BILIARY ANATOMY: RESULTS FROM A TERTIARY CENTERElisa Soares, Portugal; M. Gravito-Soares; N. Almeida; D. Gomes; E. Camacho; S. Mendes; R. Ferreira; L. Tomé

P1545NEWLY DEVELOPED BASKET FOR DIGITAL, SINGLE-OP-ERATOR CHOLANGIOSCOPY FOR MANAGEMENT OF RESIDUAL STONES AFTER LITHOTRIPSYJong Ho Moon, Republic of Korea; Y. N. Lee; H. J. Choi; H. W. Lee; T. H. Lee; M. H. Choi; S.-W. Cha; Y. D. Cho; S.-H. Park

P1546ASSOCIATION BETWEEN PREDICTIVE FACTORS AND RADIATION EXPOSURE DURING ENDOSCOPIC RETRO-GRADE CHOLANGIOPANCREATOGRAPHYSeok-Ho Dong, Republic of Korea; C. H. Oh; J. R. Moon


230


Wednesday, N

ovember 1, 2017


P1565THROMBOEMBOLIC DISEASE DIAGNOSED BY ENDOSCOP-IC ULTRASOUND IN PANCREATIC CANCER: A CASE SERIESCatarina Atalaia Martins, Portuga; P. Pinto-Marques; I. Mocanu; J. Cortez-Pinto; D. Serra

P1566THE ROLE OF EARLY ENDOSCOPIC ULTRASONOGRAPHY FOLLOWING TRANSABDOMINAL ULTRASONOGRAPHY IN PATIENTS WITH SUSPECTED BILIARY COLICBenedetto Mangiavillano, Italy; L. Frazzoni; R. Grassia; M. Flavia Savarese; M. Bianchetti; A. Repici; L. Fuccio

P1567BILIOPANCREATIC RADIOFREQUENCY ABLATION: COMPARISON OF THE THREE CURRENTLY AVAILABLE DEVICES IN A PIG MODEL.Maximilien Barret, France; S. Leblanc; B. Bordaçahar; A. Rouquette; S. Chaussade; F. Prat

P1568ENDOSCOPIC ULTRASOUND-GUIDED RENDEZVOUS FACILITATES BILIARY CANNULATION IN CASE OF INAC-CESSIBLE INTRA-DIVERTICULAR PAPILLADimitrios Kypraios, Greece; A. Malachias; L. Theodoropoulos; S. L. Hatzinicolaou; S. Stavrinidis; N. Saribegioglou; G. Sofianidis; K. Tsamakidis; D. Dimitroulopoulos; D. Xinopoulos

P1569A RANDOMIZED CONTROL TRIAL ASSESSING THE CON-TRAST ENHANCED GUIDED FINE NEEDLE ASPIRATION IN SOLID PANCREATIC NEOPLASMSAndrada Seicean, Romania; A. Samarghitan; I. Rusu; M. I. Gheorghiu; C. Pojoga; R. Seicean

Capsule endoscopy

P1570EARLY CAPSULE ENDOSCOPY PROVIDES BETTER BLEED-ING LOCALIZATION VALUE IN PATIENTS PRESENTING WITH NON-HEMATEMESIS GASTROINTESTINAL BLEED-ING WHEN COMPARED TO CLINICAL SYMPTOMS ALONESalmaan Jawaid, USA; N. Marya; A. Foley; C. Marshall; K. Bhattacharya; D. Cave

P1571MUCOSAL HEALING RATES INDUCED BY ADALIMUMAB IN ISOLATED SMALL BOWEL CROHN’S DISEASE: PRO-SPECTIVE EVALUATION BY CAPSULE ENDOSCOPYEyal Gal, Israel; O. Ben-Bassat; Z. Levi; G. M. Fraser; Y. Snir; H. Yanai; I. Dotan; I. Avni-Biron

P1572CORRELATION BETWEEN SMALL BOWEL MRI, FAECAL CALPROTECTIN AND CAPSULE ENDOSCOPY IN THE INVESTIGATION OF INFLAMMATORY BOWEL DISEASES. Vijayan; Diana Yung, United Kingdom; H. Suzuki; R. Makins; U. Kopylov; A. Levartovsky; B. J. F. Rosa; J. N. Plevris; A. Koulaouzidis

Endosonography

P1556COMPARISON OF EUS-GUIDED FINE NEEDLE BIOPSY TECHNIQUES FOR CORE TISSUE ACQUISITION AND DIAG-NOSTIC PERFORMANCES IN PANCREATIC SOLID LESIONSChang-Min Cho, Republic of Korea; S. J. Yeo; A. N. Seo; H. I. Bae

P1557WITHDRAWN

P1558WITHDRAWN

P1559WITHDRAWN

P1560EUS-GUIDED GALLBLADDER DRAINAGE FOR ACUTE-CHOLECYSTITIS WITH A SILICONE-COVERED NITINOL SHORT FLARED ENDS STENT: A CASE SERIES.R. Manta; Claudio Zulli, Italy; F. P. Zito; A. Zullo; E. Forti; A. Tringali; L. Dioscoridi; S. Russo; M. Lupo; A. Caruso; H. Bertani; R. Conigliaro; M. Mutignani

P1561 ªEFFICIENCY COMPARISON BETWEEN 22 G VERSUS 25G NEEDLES DURING ENDOSCOPIC ULTRASOUND FINE NEEDLE ASPIRATION FOR SOLID PANCREATIC MASSES ASSESSMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS BASED ON RCTS.H. G. Guedes; Ralph Duarte, Brazil; D. T. H. de Moura; S. Cheng; M. Coronel; M. E. L. dos Santos; S. E. Matuguma; D. M. Chaves; W. M. Bernardo; E. G. Hourneaux Moura

P1562OUTCOMES AND LEARNING CURVES OF EUS-GUIDED GALL-BLADDER DRAINAGE WITH LUMEN APPOSING STENTS.Anthony Teoh, Hong Kong PRC; S. M. Chan; H. C. Yip; V. Wong; P. W. Y. Chiu; E. Ng

P1563TECHNICAL FEASIBILITY STUDY OF EUS-GUIDED HYDRO-GEL MICROPARTICLE INJECTION INTO THE PANCREATIC HEAD-DUODENAL WALL INTERFACE IN A CADAVERIC MODELS.-H. Kim; K. Ding; A. Rao; L. Rosati; A. Narang; Eun Ji Shin, USA

P1564EX-VIVO RADIOFREQUENCY ABLATION OF PORCINE LIVER: A PRELIMINARY STUDY OF EFFICACY OF A NEW SYSTEMGemma Rossi, Italy; M. C. Petrone; E. Dabizzi; A. Mariani; S. G. G. Testoni; M. Traini; L. Archibugi; P. Magnoni; P. G. Arcidiacono


231


Wed

nesd

ay, N

ovem

ber

1, 2

017



P1581HOMEMADE FIXATION OF FULLY-COVERED SELF EX-PANDING METAL STENTCaterina Maria Pia Simioni Pennacchi, Brazil; E. H. G. dominguez; E. Q. Mendonça; J. F. D. Oliveira; B. D. C. Martins; G. de Paulo; F. Kawaguti; C. C. Gusmon; U. Ribeiro Jr.; R. A. A. sallum; F. Maluf-Filho

P1582CLINICAL OUTCOME WHEN USING SELF EXPANDING METAL STENT IN OBSTRUCTIVE COLORECTAL CANCER IN 248 PATIENTS; 7 YEARS EXPERIENCE FROM A TER-TIARY CENTER.Morteza Shafazand, Sweden; T. Radomski; L. Alkelin; N. Papachrysos

P1583ENDOSCOPIC TREATMENT OF ESOPHAGEAL FISTULASDenisa Bucur, Romania; D. Oprisanescu; G. Constantinescu; M. Ilie; V. Sandru; D. Tabacelia

P1584LONG-TERM OUTCOME OF ENDOSCOPIC TREATMENT OF SYMPTOMATIC ENTERIC STRICTURES IN CROHN'S DISEASEElisabeth Aichinger, Germany; M. Koch; K. Rothfuss; C. Schäfer; K. Grün; M. Schneider; J. Peveling-Oberhag; N. Lubomierski; J. Albert

P1585ENDOSCOPIC INTRALESIONAL STEROID INJECTION IS EFFECTIVE IN THE TREATMENT OF BENIGN REFRAC-TORY OESOPHAGEAL STRICTURE, A META-ANALYSISLászló Szapáry, Hungary; N. Farkas; K. Márta; P. Hegyi; B. Eross

P1586EFFICACY AND COMPLICATIONS IN PALLITVE OE-SOPHAGEAL STENTING, EXPERINCES OF A TERTIARY REFERRAL CENTER IN THE UKCharles Clisby, United Kingdom; C. Gordon; B. Eross

P1587LONG-TERM RESULTS: WHEN RE-STENOSIS COMES AFTER ESOPHAGEAL STENTING?Denis Gusev, Russian Federation; S. Kashin; N. Akhapkin

P1588SELF-EXPANDABLE METAL STENTS ARE A VALID OP-TION IN PATIENTS WITH LONG-TERM SURVIVAL FROM ADVANCED ESOPHAGEAL CANCEREduardo Rodrigues-Pinto, Portugal; P. Pereira; T. H. Baron; G. Macedo

P1573 HOW MANY CAPSULE ENDOSCOPY STUDIES CAN BE READ IN A GIVEN SESSION BEFORE ACCURACY IS AFFECTED?Sabina Beg, United Kingdom; R. Sidhu; T. R. Card; E. Wronska; K. Ragunath

P1574 ªFEASIBILITY OF SAME DAY COLON CAPSULE ENDOSCO-PY (CCE) IN PATIENTS WITH INCOMPLETE COLONOSCOPYMary Hussey, Ireland; G. Holleran; C. Tersaruolo; D. McNamara

Cross sectional imaging

P1575 DEDICATED DIFFUSION WEIGHTED MR IMAGING FOR STAGING PERITONEAL METASTASES IN COLORECTAL CAN-CER; AN ACCURATE PREOPERATIVE SELECTION TOOL FOR CYTOREDUCTION SURGERY (CRS/HIPEC) CANDIDATESI. Jansen; D. M. Lambregts; S. Chandrasegaram-Shanmuganathan; N. Kok; G. L. Beets; R. G. H. Beets-Tan; A. Aalbers; Max Lahaye, The Netherlands

P1576HISTOLOGICAL PREDICTION OF COLONIC POLYPS BY COMPUTER VISION. PRELIMINARY RESULTS.Cristina Sánchez-Montes, Spain; J. Sánchez; C. Rodríguez de Miguel; H. Córdova; J. Bernal; M. López-Cerón; J. LLach; G. Fernández-Esparrach

P1577COLORECTAL LATERALLY SPREADING TUMORS DE-TECTED AT CT COLONOGRAPHYMasahiro Iwabuchi, Japan; M. Sugimura; S. Toda; K. Ukai

P1578ANALYSIS OF CT COLONOGRAPHY MISS RATE OF LARGE NEOPLASTIC LESIONS DETERMINED BY COLO-NOSCOPY ON JAPANESE NATIONAL CT COLONOGRAPHY TRIAL (JANCT).Michiaki Hirayama, Japan; T. Takayama; R. Fujii; T. Minagawa; S. Ohiwa; K. Sakata; M. Yoshida; Y. Okagawa; H. Ihara; T. Sumiyoshi; Y. Tsuji; N. Yoshizaki; H. Kondo; K. Nagata

P1579DIFFUSION-WEIGHTED MAGNETIC RESONANCE FOR ASSESSING FIBROSIS IN CROHN’S DISEASEAntonino Caruso, Italy; M. Scarpa; G. Schifano; C. Mescoli; M. Rudatis; R. D'inca; G. C. Sturniolo; C. Lacognata; I. Angriman

P1580MOLECULAR IMAGING OF C-MET IN THE CLINICAL MANAGEMENT OF GASTROINTESTINAL CANCERSN. McDonald; C. Portal; Ian Wilson, United Kingdom


232


Wednesday, N

ovember 1, 2017


Hepatobiliary / pancreas / spleen

P1596A RELIABLE AND ACCURATE ALGORITHM TO QUANTIFY THE TUMOR STROMA QTS AMONG TUMOR ENTITIES: HIGH INFILTRATION OF CD3+ AND CD8+ LYMPHOCYTES CORRELATES WITH IMPROVED SURVIVAL IN HEPATOCEL-LULAR CARCINOMA AND PANCREATIC CANCERRainer Christoph Miksch, Germany; J. Hao; K. Dötzer; F. Schlüter; M. Weniger; S. Yin; S. Ormanns; J. G. D'Haese; M. Guba; J. Werner; B. Mayer; A. V. Bazhin; M. B. Schoenberg

P1597WITHDRAWN

P1598LIVER RESECTION IN OBESE PATIENTS WITH HEPATO-CELLULAR CARCINOMAHideaki Iwama, Japan; S. Hai; E. Hatano; T. Okada; Y. Asano; N. Uyama; K. Suzumura; M. Tada; J. Fujimoto

P1599TIMING OF ELECTIVE CHOLECYSTECTOMY AFTER ACUTE CHOLECYSTITIS – A POPULATION BASED STUDYAgnieszka Popowicz, Sweden; G. Sandblom

P1600MIXED REALITY SURGERY USING CT-BASED PATIENT-SPECIFIC IMMERSIVE 3D HOLOGRAMS ENHANCED SPATIAL AWARENESS IN HEPATO-PANCRE-ATO-BILIARY AND GASTROINTESTINAL SURGERYMaki Sugimoto, Japan

P1601WITHDRAWN

Postoperative complications

P1602EFFICACY OF DOUBLE PIGTAIL STENT FOR POST OESO- GASTRIC SURGICAL LEAKS NON LINKED TO BARIATRIC SURGERY: A PILOT BI-CENTRE RETROSPECTIVE STUDYJ. Jacques; Lauriane Pagnon, France; A. Taibi; R. Legros; T. Tabouret; T. Barrioz; M. Wangermez; S. Durand-Fontanier; S. Bouvier; M. Mathonnet; D. Valleix; A. Le-sidaner; H. Lepetit; V. Loustaud-Ratti; D. Sautereau

P1603ROUTINE USE OF POLYPROPYLENE MESH FOR PRO-PHYLAXIS OF ABDOMINAL COMPARTMENT SYNDROME FOR PATIENTS AFTER RUPTURED ABDOMINAL AORTIC ANEURYSM OPEN REPAIRING. RESULTS OF THREE YEARS FOLLOW-UP.Oksana Popova, Ukraine; O. Sergeev

Interventional radiology

P1589NOVEL PERCUTENOUS TECHNIQUES IN MANAGEMENT OF POST-CHOLECYSTECTOMY COMPLICATIONSMahmoud Ghalab, Egypt; A. A. Abd El Kerim; S. E. Hegab; O. S. El Aassar; M. H. Emara Elzanan; E. Emara; M. Sharaan

P1590WHAT IS THE ROLE OF ANGIOGRAPHY IN ACUTE CO-LONIC AND SMALL BOWEL BLEEDING?Rita Vale Rodrigues, Portugal; P. Amaro; M. Ferreira; M. Barros; P. Donato; L. Tomé

Poster Session09:00 – 14:00 Hall 7Surgery III


P1591PROGNOSTIC VALUE OF CARDIOPULMONARY EXERCISE TESTING FOR MORBIDITY RISK AND SURVIVAL AFTER OESOPHAGECTOMY FOR CANCERNeil Patel, United Kingdom; J. Wheat; C. Brown; A. Powell; T. Abdelrahman; R. Davies; I. Appadurai; W. Lewis

P1592PROPENSITY SCORE ANALYSIS OF 18-FDG PET/CT ENHANCED STAGING IN PATIENTS UNDERGOING SUR-GERY FOR OESOPHAGEAL CANCERNeil Patel, United Kingdom; K. Foley; D. Chan; C. Brown; A. Powell; T. Abdelrahman; P. Fielding; A. Roberts; W. Lewis

P1593PREDICTION OF LYMPH NODE METASTASIS FOR SUPERFICIAL ESOPHAGEAL CANCER WITH USING RAN-DOM FOREST ANALYSISMasashi Takeuchi, Japan; H. Kawakubo; K. Fukuda; R. Nakamura; K. Suda; N. Wada; Y. Kitagawa

P1594PROGNOSTIC SIGNIFICANCE OF CARDIORESPIRATO-RY FITNESS, BODY COMPOSITION ANALYSIS, AND SYSTEMIC INFLAMMATORY RESPONSE IN UPPER GASTROINTESTINAL CANCER Neil Patel, United Kingdom; P. Blake; J. Wheat; C. Brown; A. Powell; T. Abdelrahman; W. lewis

P1595COPING AND QUALITY OF LIFE AFTER ESOPHAGECTO-MY FOR CANCERE. Pinto; F. Cavallin; Luca Maria Saadeh, Italy; R. Alfieri; C. Caberlotto; M. C. Bellissimo; M. Cagol; C. Castoro; M. Scarpa


233


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1612OGR1 (GPR68) EXPRESSION IS INCREASED IN INTESTI-NAL INFLAMMATION AND CORRELATES WITH DISEASE ACTIVITY IN PATIENTS WITH IBDJ. Cosin Roger; Katharina Baebler, Switzerland; S. Bengs; S. Lang; M. Turina; A. Rickenbacher; M. Scharl; K. Seuwen; P. A. Ruiz-Castro; B. Misselwitz; G. Rogler; C. De Valliere

P1613MICROBIAL PROFILING OF NEWLY DIAGNOSED PATIENTS WITH ULCERATIVE COLITIS DIFFERS WITH ETHNICITY; RE-SULTS OF AN INCEPTION COHORT TIME SERIES ANALYSISRavi Misra, United Kingdom; A. Perdones-Montero; N. S. Ding; D. Rees; O. Faiz; J. Marchesi; N. Arebi

P1614VITAMIN D SUPPLEMENTATION REDUCES FAECAL CAL-PROTECTIN AND ALTERS INTESTINAL MICROBIOTA COM-POSITION IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS M. Garg; Philip Hendy, United Kingdom; S. Shaw; N. S. Ding; G. Hold; A. Hart

P1615SUPPRESSION OF PHOSPHOLIPASE A2 OF INTESTINAL MICROBIOTA AMELIORATES MUCOSAL INFLAMMATION IN A GENETIC MOUSE MODEL OF ULCERATIVE COLITISWolfgang Stremmel, Germany; S. Staffer; N. C. Stuhrmann; A. Gauss; N. Burger; D. Hornuss

P1616 THE IMPACT OF THE RS8005161 POLYMORPHISM ON G PROTEIN-COUPLED RECEPTOR GPR65 (TDAG8) PH-AS-SOCIATED SIGNALING IN INTESTINAL INFLAMMATIONI. Tcymbarevich; Katharina Baebler, Switzerland; J. Cosin Roger; N. Obialo; M. R. Spalinger; J. J. Eloranta; S. Lang; G. A. Kullak-Ublick; C. A. Wagner; M. Scharl; K. Seuwen; P. A. Ruiz-Castro; G. Rogler; B. Misselwitz; C. de Vallière

P1617B2-STRICTURING AND B3-PENETRATING PHENOTYPE IN CROHN’S DISEASE: CHARACTERIZATION OF MACRO-PHAGES POPULATION AND WNT SIGNALINGDolores Ortiz Masia, Spain; P. Salvador; D. Macias-Ceja; R. Alos; J. Hinojosa Del Val; F. Navarro-Vicente; J. Manyé; M. D. Barrachina; S. Calatayud

P1618 CD16 POSITIVE CELLS EXPRESS TGFβ AND MEDIATES MURINE INTESTINAL FIBROSISPedro Salvador, Spain; D. Ortiz-Masia; D. Macias-Ceja; L. Gisbert-Ferrándiz; C. Hernández; J. V. Esplugues; M. D. Barrachina; S. Calatayud

P1619 GTS-21, α7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST, ATTENUATE DSS-INDUCED COLITIS BY IM-PROVING INTESTINAL MUCOSAL BARRIER FUNCTIONYunjuan Zhu, China; H. Zhang

P1604ENDOSCOPIC PERORAL DRAINAGE (EPOD) OF PERITO-NEAL COLLECTIONS AND ABSCESSES SECONDARY TO BARIATRIC SURGERY LEAKS: THE PARADIGM SHIFT OF SEEING PERITONEUM AS AN ORGAN AMENABLE FOR FLEXIBLE ENDOSCOPES INTERVENTIONSAlberto J. Baptista, Venezuela; A. Salinas; M. A. Guzman; A. Gelrud; D. Ramirez; W. García; A. Oropeza; H. Rass; J. F. Piñerúa Gonsálvez

P1605CLINICAL ASSESSMENT OF THE FAILING TO REVERSE A DIVERTING ILEOSTOMYAleksandra Sobolewska-Włodarczyk, Poland; M. Wlodarczyk; J. Włodarczyk; P. Siwiński; J. Kasprzyk; A. Dziki; Ł. Dziki

P1606BODY COMPOSITION AS A PREDICTOR OF MORBI-MOR-TALITY FOLLOWING BILIOPANCREATIC CANCER SURGERYMaria Pia Costa Santos, Portugal; S. Velho; C. Cunha; F. Costa; L. Agostinho; R. Cruz; R. Maio; M. Cravo

Paediatric surgery

P1607GASTROSCHISIS: A 16-YEAR STUDYAna Maria Bradeanu, Romania; L. Balanescu; I. Nenciu

Poster Session09:00 – 14:00 Hall 7IBD III


P1608ASSESSING THE EFFECT OF ETHNICITY ON URINARY MET-ABOLIC PROFILES IN INFLAMMATORY BOWEL DISEASE.Lucy Hicks, United Kingdom; S. T. R. Powles; L. W. L. Chong; J. Swann; E. Holmes; H. R. T. Williams; T. R. Orchard

P1609EFFECTS OF ACUTE CHANGES IN FERMENTABLE FIBRE IN-TAKE ON REGIONAL COLONIC FERMENTATION AND TRAN-SIT IN PATIENTS WITH QUIESCENT ULCERATIVE COLITISCk Yao, Australia; R. E. Burgell; K. M. Taylor; M. G. Ward; J. S. Barrett; J. G. Muir; P. R. Gibson

P1610 FECAL MICROBIAL DYSBIOSIS IN CHINESE PATIENTS WITH INFLAMMATORY BOWEL DISEASEHaiqin Ma, China; H. Zhang

P1611HYPOXIA-MEDIATED IRON UPTAKE PREVENTS INFLAMMA-TORY GENE EXPRESSION IN THE INTESTINAL EPITHELIUM THROUGH THE REGULATION OF NF-κB BINDING ACTIVITYS. Simmen; J. Cosin Roger; C. De Valliere; M. Scharl; J. Zeitz; S. Vavricka; G. Rogler; Pedro Ruiz-Castro, Switzerland


234


Wednesday, N

ovember 1, 2017


P1629ANP32E IS INVOLVED IN THE STEROID-REFRACTORY ULCERATIVE COLITISVioleta Lorén, Spain; A. Garcia-Jaraquemada; J. E. Naves; J. Carmona; E. Cabré; M. Mañosa; J. Manyé; E. Domènech

P1630CO-HOUSING DSS TREATED MICE WITH HEALTHY MICE RESULTS IN FASTER NORMALIZATION OF THE INTESTI-NAL MICROBIOTA AND PROMOTES RECOVERYMarianne Rebecca Spalinger, Switzerland; L. Hering; C. Gottier; S. Lang; G. Rogler; M. Scharl


P1631 ILEAL SULFOMUCINS PREDICT CLINICAL RECURRENCE AFTER ILEO-COLONIC RESECTION FOR CROHN’S DIS-EASE: A PROSPECTIVE STUDY AT 5 YEARSLivia Biancone, Italy; M. Ascolani; C. Mescoli; G. Sica; G. Palmieri; S. Romeo; L. Albertoni; B. Neri; F. Pallone; M. Rugge

P1632IMMUNOGENICITY OF A QUADRIVALENT INFLUENZA VACCINE AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASEShimpei Shirai, Japan; Y. Sakata; K. Akutagawa; K. Yamanouchi; N. Tsuruoka; H. Endo; R. Shimoda; T. Noda; N. Sugisaki; R. Iwakiri; K. Fujimoto

P1633THE INCIDENCE OF INFLAMMATORY BOWEL DISEASE IN SEVEN ETHNICALLY DIVERSE URBAN POPULATIONS IN ENGLAND; RESULTS FROM THE UK INCEPTION COHORT EPIDEMIOLOGICAL STUDY (UNITE)Ravi Misra, United Kingdom; J. Limdi; R. Cooney; M. Brookes; E. Fogden; S. Pattni; N. Sharma; G. Young; J. Burisch; P. Munkholm; N. Arebi

P1634IBD-RELATED MALIGNANCIES AND MORTALITIES OBSERVED BETWEEN 2015-2016 – TWO YEARS’ RESULTS FROM THE PROSPECTIVE NATIONWIDE HUNGARIAN REGISTRYTamas Molnar, Hungary; M. Rutka; F. Nagy; P. Fritz; L. Lakatos; P. Miheller; Z. Erdélyi; T. Szamosi; E. Schäfer; A. Vincze; P. Sarlós; J. Banai; Á. Kovács; J. Novák; A. Salamon; A. Szepes; N. Szigeti; M. Juhász; K. Müllner; Z. Barta; O. Kadenczki; A. Gelley; K. Palatka; M. Papp; A. Zaránd; P. L. Lakatos; G. L. Veres; A. Fabian; A. Balint; R. Bor; Z. Szepes; K. Farkas

P1635 ANAL CANAL HUMAN PAPILLOMAVIRUS (HPV) INFEC-TION IN MEN AND WOMEN UNDERGOING COLONOSCO-PY: PREVALENCE AND RISK FACTORS, HIGH BURDEN IN CROHN’S DISEASE PATIENTS.Lucine Vuitton, France; E. Jacquin; A.-L. Parmentier; F. Fein; A.-C. Dupont-Gossart; L. Plastaras; S. Koch; J.-L. Pretet; C. Mougin; S. Valmary-Degano

P1620EXPRESSION OF WNT10B IN M2-MACROPHAGES FROM CROHN´S DISEASE PATIENTSDolores Ortiz Masia, Spain; D. Macias-Ceja; P. Salvador; D. Bernardo; F. Navarro-Vicente; R. Alos; L. Gisbert-Ferrándiz; C. Hernández; S. Calatayud; M. D. Barrachina

P1621ANAEMIA PREVALENCE AND TREATMENT APPROACH FOR INFLAMMATORY BOWEL DISEASEGoksel Bengi, Turkey; H. Keyvan; H. Akpınar

P1622SUCCINATE RECEPTOR (SUCNR1) MEDIATES INFLAM-MATION IN A MURINE MODEL OF COLITIS.Dulce Carolina Macias Ceja, Spain; D. Ortiz-Masia; P. Salvador; L. Gisbert-Ferrándiz; S. Coll-Puig; C. Hernández; J. V. Esplugues; S. Calatayud; M. D. Barrachina

P1623 ZIP7 INDUCES DISRUPTION OF THE INTESTINAL BAR-RIER THROUGH ACTIVATION OF ENDOPLASMIC RETIC-ULUM STRESS IN INFLAMMATORY BOWEL DISEASEJing Sun, China; Q. Zhan; F. An

P1624EFFECT OF T CELL ACTIVATION AND INFLAMMATION ON THE INTERACTION BETWEEN T CELLS AND ENTER-IC GLIAL CELLSI. Neveu; Julie Pabois, France; T. Durand; J. Gonzales; J. A. Gonzales; M. Neunlist; P. Naveilhan

P1625ENTERIC GLIAL CELLS REACTION TO INFLAMMATION IS LOST IN CROHN’S DISEASEMalvyne Rolli-Derkinderen, France; C. Pochard; T. clairembault; N. Cenac; A. Bourreille; M. Neunlist

P1626 PROSTACYCLIN REVERSES COLITIS THROUGH THE DOWN REGULATION OF INTESTINAL EPITHELIAL PERMEABILITYCamille Pochard, France; P. Aubert; C. Gesret; N. Cenac; A. Bourreille; G. Meurette; E. Coron; M. Neunlist; M. Rolli-Derkinderen

P16277α-HYDROXY-4-CHOLESTEN-3-ONE FOR DIAGNOSIS AND MANAGEMENT OF BILE ACID MALABSORPTION: FIRST YEAR CLINICAL EXPERIENCE.B. Friedli; F. Brunner; C. Prost; C. Bovet; D. Kröll; A. Macpherson; Pascal Juillerat, Switzerland

P1628THE ROLE OF SEVERAL CYTOKINES IN THE PATHOGEN-ESIS OF AUTOIMMUNE INFLAMMATION IN PATIENTS WITH ULCERATIVE COLITISAlina Valeeva, Russian Federation; R. A. Abdulkhakov; O. V. Skorokhodkina; S. R. Abdulkhakov; S. Khaiboullina; E. Martinova; A. Rizvanov


235


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1643CONTRAST-ENHANCED ULTRASOUND IS HELPFUL IN THERAPEUTIC DECISION MAKING IN PATIENTS WITH STRICTURING CROHN`S DISEASEZuzana Zelinkova, Slovak Republic; B. Kadleckova; D. Podmanicky

P1644FERTILITY AND PREGNANCY IN IBD – OUR EXPERIENCESEszter Schäfer, Hungary; K. Bursics; T. Szamosi; J. Banai; F. Zsigmond; T. Gyökeres; L. Herszényi

P1645DIAGNOSTIC DELAY AND PREDICTIVE FACTORS FOR CROHN'S DISEASE IN AN ALGERIAN POPULATION.Yacine Chelbi, Algeria; R. Boulares

P1646TUBERCULOSIS IN INFLAMMATORY BOWEL DISEASE UNDER TUMOUR NECROSIS FACTOR ALPHA ANTAGO-NIST – THE RISK BEYOND SCREENINGLiliana Carvalho, Portugal; M. A. Túlio; J. Carmo; J. Rodrigues; T. Bana e Costa; C. Chagas

P1647CAN A PATIENT RATE THE ACTIVITY OF THEIR CROHN´S DISEASE THROUGH A MOBILE APP? THE MEDICROHN STUDY. Ana Echarri Piudo, Spain; I. Vera Mendoza; J. Guardiola; V. Ollero; B. Castro; F. Gallego; M. Aguas; M. Chaparro; D. Ceballos; C. Arajol; P. Robledo Andrés; S. Riestra; I. Marín-Jiménez; P. Nos; S. García-López

P1648HISTOLOGICAL ASSESSMENT OF REMISSION IN UL-CERATIVE COLITIS: DISCREPANCIES BETWEEN DAILY PRACTICE AND EXPERT OPINIONPim Kranenburg, The Netherlands; T. E. H. Römkens; A. Van Tilburg; C. Bronkhorst; J. P. H. Drenth; I. D. Nagtegaal; F. Hoentjen

P1649EVALUATION OF MODIFIED MAYO ENDOSCOPIC SCORE AND DUBLIN, NEW ENDOSCOPIC SCORES THAT IN-CORPORATE ULCERATIVE COLITIS EXTENSION, IN THE PREDICTION OF RELAPSEJaime Rodrigues, Portugal; R. Pinho; S. Fernandes; J. Silva; A. Ponte; M. Sousa; J. C. Silva; S. Leite; T. Freitas; L. Proença; A. P. Silva; L. Alberto; A. Rodrigues; J. Carvalho

P1650USEFULNESS OF MAGNETIC RESONANCE ENTEROG-RAPHY ON MEDICAL DECISION-MAKING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) AFTER A 1 YEAR FOLLOW-UP: A MULTICENTER STUDY. L. Ramos; Alejandro Hernandez Camba, Spain; I. Rodríguez – Lago; M. Carrillo Palau; L. Cejas; A. Elorza; I. Alonso Abreu; M. Vela; A. Hidalgo; N. Alvarez-Builla; G. E. Rodriguez; M. Aduna; L. Diaz-Florez; Y. Rodriguez; C. Tardillo; D. Eiroa; J. A. Larena; M. S. Garrido; J. L. Cabriada; E. Quintero Carrion

P1636 ªGUT COLONIZATION WITH EXTENDED SPECTRUM BETA-LACTAMASE PRODUCING ENTEROBACTERIA MAY INCREASE DISEASE ACTIVITY IN INFLAMMATO-RY BOWEL DISEASES OUT-PATIENTS: PRELIMINARY STUDY RESULTSVita Skuja, Latvia; K. Pekarska; H. Dauvarte; E. Vasuka; L. Dobelniece; J. Malina; D. Rudzite; E. Lavrinovica; L. Piekuse; A. Kalcenaua; A. Krumina; A. Lejnieks; A. Derovs

P1637IS SMOKING CESSATION LINKED TO NEW ULCERATIVE COLITIS CASES? A RESTROSPECTIVE COHORT-BASED HYPOTHESIS.Maude Grueber, Switzerland; L. Biedermann; S. Vavricka; A. Schoepfer; A. Macpherson; P. Juillerat; C. Clair Willi; N. Fournier

P1638THE IMPACT OF INFLAMMATORY BOWEL DISEASE ON HARD TEETH TISSUES – PRELIMINARY RESULTS FROM POLIBD STUDYD. Piatek; I. Korona-Glowniak; A. Malm; S. Jarmakiewicz; S. Pudzianowski; A. Pekala; P. R. Kiela; Rafał Filip, Poland


P1639RESTING ENERGY EXPENDITURE IN WOMEN WITH CROHN’S DISEASE: A CROSS-SECTIONAL STUDYNicola Imperatore, Italy; I. Cioffi; R. Sammarco; A. Testa; A. Rispo; M. Marra; F. Contaldo; N. Caporaso; F. Castiglione; F. Pasanisi

P1640MAGNETIC RESONANCE CHOLANGIOGRAPHY ABNOR-MALITIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASEArthur Belle, France; A. Lopez; V. Laurent; C. Baumann; H. Rousseau; X. Orry; J.-P. Bronowicki; L. Peyrin-Biroulet

P1641TRUECOLOURS ULCERATIVE COLITIS (TCUC): WILL PA-TIENTS WITH UC COMPLETE DIGITAL QUESTIONNAIRES IN REAL-TIME?Alissa Walsh, United Kingdom; M. Peters; C. Hinds; V. Sexton; A. Kormilitzin; P. Seeva; G. Collins; S. Keshav; O. Brain; H. Uhlig; A. Simmons; J. Geddes; G. Goodwin; S. Travis

P1642BODY COMPOSITION AS A PREDICTOR FACTOR OF DIS-EASE OUTCOME IN INFLAMMATORY BOWEL DISEASE – RESULTS OF 3-YEAR FOLLOW UPAgnes Anna Csontos, Hungary; A. Molnár; R. Hencz; D. Piri; S. Dakó; T. Ferenci; E. Pálfi; P. Miheller


236


Wednesday, N

ovember 1, 2017


P1659DYSBIOSIS OF THE GUT MICROBIOTA IN RELATION TO DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASEPetr Ricanek, Norway; R. Kalla; Y. Ber; S. Vatn; M. K. Karlsson; L. Finnby; D. Bergemalm; A. Carstens; J. D. Söderholm; J. Jahnsen; F. Gomollon; J. Halfvarson; J. Satsangi; C. Casén; M. H. Vatn

P1660 SIMPLIFIED MR ENTEROCOLONOGRAPHY CLASSIFICA-TION BASED ON ENDOSCOPIC FINDINGS FOR ACTIVITY ASSESSMENT OF CROHN’S DISEASEToshimitsu Fujii, Japan; Y. Kitazume; K. Takenaka; M. Kimura; E. Saito; K. Matsuoka; M. Nagahori; K. Ohtsuka; M. Watanabe

P1661RISK FACTORS FOR METABOLIC SYNDROME AND ITS COMPONENTS IN INFLAMMATORY BOWEL DISEASEKonstantinos Efthymakis, Italy; M. Serio; M. Fioravante; A. Milano; F. Laterza; A. Bonitatibus; M. Neri

P1662C-REACTIVE PROTEIN / ALBUMIN RATIO IS A GOOD PREDICTOR OF RESPONSE TO INTRAVENOUS CORTICO-STEROIDS IN ACUTE SEVERE ULCERATIVE COLITISSara Monteiro, Portugal; T. Cúrdia Gonçalves; F. Dias de Castro; S. Leite; M. J. Moreira; J. Cotter

P1663INSUFFICIENT VARIATION OF MEDIUM CORPUSCU-LAR VOLUME (∆ MCV) IN INFLAMMATORY BOWEL DISEASE UNDER THYOPURINES PREDICTS DIFFICULTY IN ACHIEVING COMBINED DEEP REMISSION OUTCOME EVEN AFTER COMBINATION WITH ANTI-TNF – THE OTHER SIDE OF THE MCV FLOW STUDYJoana Roseira, Portugal; H. Tavares de Sousa; A. Marreiros; P. Queirós; A. M. Vaz; T. Gago; L. Contente; H. Guerreiro

P1664FECAL CALPROTECTIN PREDICTS SHORT-TERM RE-LAPSE IN INFLAMMATORY BOWEL DISEASE PATIENTS IN DEEP REMISSIONRadislav Nakov, Bulgaria; V. Nakov; V. Gerova; L. Tankova; T. Kundurzhiev; B. Vladimirov

P1665 GLYCEMIC CONTROL AND INSULIN RESISTANCE IN PATIENT WITH INFLAMMATORY BOWEL DISEASE – PRELIMENARY RESULTS FROM THE POLIBD STUDY.R. Filip; Joanna Sztembis, Poland; P. Kiela; A. Rybak

P1666THE ROLE OF MR IMAGING IN ASSESSMENT OF LE-MANN INDEX IN THE COURSE OF CROHN’S DISEASE.J. M. Pienkowska; Oliwia Kozak, Poland; T. Nowicki; E. Szurowska

P1651CORRELATION BETWEEN THE LÉMANN INDEX AND THE INFLAMMATORY BOWEL DISEASE- DISABILITY INDEX IN CROHN’S DISEASEClémentine Farré, France; M. Azahaf; M. Nachury; R. Gerard; J. Branche; P. Wils; P. Desreumaux; O. Ernst; B. Pariente

P1652COMPARISON OF CYTOKINES MRNA EXPRESSION IN INFLAMED AND NON-INFLAMED MUCOSA OF PA-TIENTS WITH INFLAMMATORY BOWEL DISEASEZuzana Lešková, Slovak Republic; A. Krajcovicova; K. Soltys; S. Stuchlik; I. Sturdik; T. Koller; M. Huorka; T. Hlavaty

P1653IMPACT OF THE BALLOON-ASSISTED ENDOSCOPY AND ENDOSCOPIC BALLOON DILATION THERAPY FOR THE SURGICAL RATE OF CROHN’S DISEASETakayoshi Nishimoto, Japan; K. Mitsui; M. Suzuki; A. Ehara; S. Tanaka; A. Tatsuguchi; S. Fujimori; K. Iwakiri

P1654THE RELATIONSHIP OF NEUTROPHILIC AND ENDOTHE-LIAL ACTIVITY MARKERS WITH THE DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE Salih Boga, Turkey; A. R. Koksal; H. Alkim; A. A. Ozagari; I. Sen; M. Sahin; C. Alkim

P1655MONITORING OF LABORATORY PARAMETERS DURING THIOPURINE MAINTENANCE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: AN UNNECES-SARY BURDEN?Joany Kreijne, The Netherlands; A. C. de Vries; G. Bouma; G. Dijkstra; R. West; M. J. Pierik; D. J. De Jong; N. K. H. de Boer; C. J. van der Woude

P1656ULTRASOUND ELASTICITY IMAGING PREDICTS THER-APEUTIC OUTCOMES IN PATIENTS WITH CROHN’S DISEASE TREATED WITH ANTI-TUMOR NECROSIS FACTOR ANTIBODIESStefania Orlando, Italy; M. Fraquelli; M. Coletta; F. Branchi; A. Magarotto; C. B. Conti; S. Mazza; D. Conte; G. Basilisco; F. Caprioli

P1657CLINICAL CHARACTERISTICS OF RECTAL-SPARING ULCERATIVE COLITISAyumi Ito, Japan; O. Teppei; T. Katutoshi

P1658EVALUATION OF COLONIC MUCOSA WITH FLEXIBLE SPECTRAL IMAGING COLOR ENHANCEMENT (FICE) IN PATIENTS WITH LONG TERM ULCERATIVE COLITIS DURING DYSPLASIA SCREENINGG. Bengi; Seda Kaya Özdinç, Turkey; H. Akpınar


237


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1675COST EFFECTIVENESS OF IBDOC FAECAL CALPROTEC-TIN AS A SURROGATE MARKER OF MUCOSAL HEALING POST INDUCTION OF BIOLOGICAL AGENTS IN INFLAM-MATORY BOWEL DISEASE Gafer El-Safi, Ireland; K. Sugrue; D. Fitzgerald; C. Byron; L. Barry; M. Farman; A. Alhanaee; M. Buckley; J. McCarthy

P1676DOSE OPTIMISATION OF INFLIXIMAB: COMPARATIVE STUDY OF A RAPID TEST AND A ESTABLISHED ELISA METHODAna Echarri Piudo, Spain; G. Molina; A. Lopez Insua; H. Ferreiro-Mazón; B. Fernandez Saya; J. Cid Fernandez; V. Ollero

P1677RISK FACTORS ASSOCIATED WITH A HIGH RISK OF COL-ORECTAL CANCER IN PATIENTS WITH ULCERATIVE COLI-TIS. PRELIMINARY RESULTS FROM THE IBSEN COHORT.Pasquale Klepp, Norway; M. C. Smaastuen; M. Hoivik; B. Mom; I. Study Group

P1678MANAGEMENT OF COMPLEX PERIANAL FISTULAE: WHEN TO SUSPECT INFLAMMATORY BOWEL DISEASE?Mariana Cardoso, Portugal; J. C. Branco; A. M. Oliveira; C. G. Rodrigues; L. Santos; C. Carneiro; J. Reis

Treatment-medical

P1679 THE ADDITION OF AN IMMUNOSUPPRESSANT IS AN EFFECTIVE OPTIMIZATION STRATEGY AFTER LOSS OF RESPONSE TO ANTI-TNF ALPHA MONOTHERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TWO-YEAR STUDYFabio Salvatore Macaluso, Italy; C. Sapienza; M. Ventimiglia; S. Renna; G. Rizzuto; R. Orlando; M. Di Pisa; M. Affronti; E. Orlando; M. Cottone; A. Orlando

P1680CORRELATION BETWEEN EXTRA-INTESTINAL MANI-FESTATIONS AND ANTI-DRUG ANTIBODIES DEVELOP-MENT IN CROHN’S DISEASE PATIENTS.Mattia Crespi, Italy; G. Bodini; E. G. Giannini; V. Savarino; A. Jain; E. Savarino

P1681THE PRESENCE OF IRRITABLE BOWEL SYN-DROME-TYPE SYMPTOMS IN MICROSCOPIC COLITIS IS ASSOCIATED WITH INCREASED PSYCHOLOGICAL COMORBIDITY AND IMPAIRED QUALITY OF LIFE.John Kane, United Kingdom; A. J. Irvine; Y. Derwa; O. Rotimi; A. C. Ford

P1682ANEMIA IN INFLAMMATORY BOWEL DISEASESSonia Bernardo, Portugal; J. R. Carvalho; S. Fernandes; A. Costa; L. Branco; A. R. Gonçalves; C. Baldaia; A. Valente; P. M. Santos; A. Oliveira; L. Correia; J. Velosa

P1667OPTICAL CHARACTERIZATION OF LESIONS IN IBD COLI-TIS: A SYSTEMATIC REVIEW AND META-ANALYSISRichard Lord, United Kingdom; N. Burr; N. Mohammed; V. Subramanian

P1668EVALUATION OF SEVERITY SCORE IN CROHN'S DISEASECatarina Gouveia, Portugal; M. P. Santos; C. Palmela; C. Gomes; J. Torres; C. Fidalgo; L. Glória; M. Cravo

P1669ENDOSCOPIC FINDINGS AND COLONOSCOPIC PERFORA-TION IN MICROSCOPIC COLITIS; A SYSTEMATIC REVIEW OF THE LITERATUREW. M. Marlicz; I. Łoniewski; K. Skonieczna-Żydecka; Diana Yung, United Kingdom; A. Koulaouzidis

P1670PREVALENCE AND QUANTITATIVE ASSESSMENT OF LIVER STEATOSIS IN INFLAMMATORY BOWEL DISEASE PATIENTSD. V. Balaban; Iulia Enache, Romania; B. Macadon; M. Patrasescu; G. C. Robu; A. Zoican; S. Bucurica; R. S. Costache; P. Nuta; F. Ionita Radu; M. Jinga

P1671INTESTINAL MICROBIOTA BIOMARKERS AS A NEW TOOL TO SUPPORT IRRITABLE BOWEL SYNDROME DIAGNOSTICSJoan Amoedo, Spain; L. Torrealba; S. Ramió-Pujol; L. Oliver; A. Bahí; M. Serrano; M. Malagón; D. Busquets; P. Gilabert; J. Guardiola; M. Serra-Pagès; J. Garcia-Gil; X. Aldeguer

P1672DISTINGUISH BETWEEN ULCERATIVE COLITIS AND CROHN DISEASE USING AN ELECTRONIC NOSE AND DATA MINING: PRELIMINARY STUDYJ. Pelegri-Sebastia; E. Climent; J. B. Talens; L. Torse; Ana Belen Beltran Niclos, Spain; T. Sogorb; P. Nos

P1673CZECH REGISTRY OF INFLAMMATORY BOWEL DISEASE PATIENTS ON BIOLOGICAL THERAPY: RESULTS FROM THE FIRST YEARMartin Bortlík, Czech Republic; P. Falt; P. Drastich; T. Douda; M. Konecny; V. Zboril; M. Lukas

P1674 THE DIAGNOSTIC VALUE OF MIRNA-320A AS A BIOMARK-ER IN PATIENTS WITH INFLAMMATORY BOWEL DISEASEFriederike Cordes, Germany; C. Ruhs; M. Brückner; T. M. Nowacki; F. Lenze; M. A. Schmidt; C. Cichon; D. Bettenworth


238


Wednesday, N

ovember 1, 2017


P1690C60 FULLERENES ATTENUATE THE INTENSITY OF COLON DAMAGE AND EXTRAINTESTINAL MANIFESTA-TIONS ON RAT ACUTE ULCERATIVE COLITIS MODELHalyna Kuznietsova, Ukraine; I. Byelinska; N. Dziubenko; O. Gurniak; O. Lynchak; Y. Prylutskyy; V. Rybalchenko

P1691EARLY CLINICAL REMISSION BY WEEK 2 PREDICTS GOOD SHORT- AND LONG-TERM EFFICACY OF TAC-ROLIMUS THERAPY IN PATIENTS WITH MODERATE TO SEVERE STEROID-REFRACTORY ULCERATIVE COLITISN. Oshima; Shunji Ishihara, Japan; K. Kawashima; H. Sonoyama; N. Yamashita; N. Fukuba; Y. Mishima; I. Moriyama; T. Yuki; Y. Kinoshita

P1692INFLIXIMAB (IFX) IN MODERATE TO SEVERE ULCER-ATIVE COLITIS (UC): COMPARISON BETWEEN SCHED-ULED TREATMENT STRATEGY AND BRIDGE STRATEGYAlicia Maria Sambuelli, Argentina; A. H. Gil; S. M. Negreira; M. I. Bellicoso; S. Goncalves; S. P. Huernos; P. R. Tirado; P. Chavero; A. Cabanne

P1693ILLNESS PERCEPTIONS, COPING STRATEGIES, OUTCOMES AND THEIR CHANGES OVER TIME IN IBD PATIENTS WITH ARTHROPATHIES: A 12-MONTH FOLLOW-UP STUDYSanne Van Erp, The Netherlands; M. van der Have; H. H. Fidder; D. van der Heijde; R. Wolterbeek; D. W. Hommes; A. A. Kaptein; A. E. Van Der Meulen – De Jong

P1694INFLIXIMAB BIOSIMILAR CT-P13 THERAPY IS EFFEC-TIVE IN MAINTAINING ENDOSCOPIC REMISSION IN ULCERATIVE COLITIS – RESULTS FROM MULTICENTRE OBSERVATIONAL COHORTKlaudia Farkas, Hungary; A. Balint; M. Rutka; M. Kolar; M. Bortlík; D. Duricova; V. Hruba; M. Lukas; K. Mitrova; K. Malickova; M. Lukas; Z. Szepes; F. Nagy; K. Palatka; S. Lovas; Z. Vegh; Z. Kurti; A. A. Csontos; P. Miheller; R. Bor; Á. Milassin; A. Fabian; P. L. Lakatos; T. Molnar

P1695THE USE OF ANTI-TNFS IN INDUCING CLINICAL RESPONSE AND REMISSION IN ULCERATIVE COLITIS: A COMPARATIVE ANALYSIS IN THE REAL LIFE EXPERI-ENCE OF A SINGLE REFERRAL CENTER Barbara Scrivo, Italy; M. G. Cilluffo; G. C. Morreale; V. Calvaruso; M. Mendolaro; A. Vitello; S. Peralta; M. Cappello

P1683TROUGH LEVELS AND ANTIBODIES TO USTEKINUMAB ARE NOT CORRELATED TO RESPONSE TO USTEKINUM-AB TREATMENT IN CROHN’S DISEASE PATIENTSClaire Painchart, France; S. Brabant; N. Duveau; P. Wils; M. Boualit; M. Nachury; J. Branche; R. Gerard; P. Desreumaux; M. Labalette; B. Pariente

P1684ECONOMIC IMPLICATIONS IN INFLAMMATORY BOWEL DISEASES: RESULTS FROM A RETROSPECTIVE ANAL-ISYS IN AN ITALIAN CENTREArianna Massella, Italy; A. Variola; R. Tessari; T. Zuppini; R. Ravasio; A. Geccherle

P1685THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD): PRELIMINARY DATA ON EFFICACY OF BIOLOGICAL THERAPYAmbrogio Orlando, Italy; F. S. Macaluso; W. Fries; A. C. Privitera; M. Cappello; S. Siringo; G. Inserra; A. Magnano; R. Di Mitri; N. Belluardo; G. Scarpulla; G. Magrì; A. Trovatello; A. Carroccio; S. Genova; C. Bertolami; R. Vassallo; C. Romano; S. Pellegrino; M. Citrano; S. Accomando; M. Ventimiglia; S. Renna; R. Orlando; G. Rizzuto; E. Vinci; M. Cottone

P1686SINGLE-CENTRE EXPERIENCE WITH BIOLOGICAL TREATMENT IN BUDESONIDE-REFRACTORY MICRO-SCOPIC COLITIS PATIENTSN. Daferera; S. Ignatova; Andreas Münch, Sweden

P1687BENEFICIAL EFFECT OF A LOW FODMAPS DIET IN DIFFERENT GASTROINTESTINAL DISORDERSAnna Testa, Italy; N. Imperatore; A. Rispo; M. Rea; R. Tortora; O. M. Nardone; L. Lucci; G. Accarino; N. Caporaso; F. Castiglione

P1688EFFICACY OF VEDOLIZUMAB ON INTESTINAL AND ARTICULAR SYMPTOMS: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)Fabio Salvatore Macaluso, Italy; R. Orlando; W. Fries; M. Scolaro; A. Magnano; D. Pluchino; M. Cappello; G. C. Morreale; S. Siringo; A. C. Privitera; C. Ferracane; N. Belluardo; N. Alberghina; M. Ventimiglia; S. Renna; M. Di Pisa; M. Cottone; A. Orlando

P1689POSITIVE PHARMACOKINETIC EFFECT OF AZATHI-OPRINE CO-MEDICATION ON INFLIXIMAB TROUGH LEVELS IS DOSE-DEPENDENTB. Kadleckova; K. Otottova; J. Lucenicova; P. Bozek; P. Mikus; Zuzana Zelinkova, Slovak Republic


239


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1704 POST-MARKETING SAFETY EXPERIENCE OF VEDOL-IZUMAB IN PATIENTS WITH PRE-EXISTING VIRAL HEPATITISD.-C. Wu; I. N. Hilmi; S. Adsul; A. Blake; Fatima Bhayat, United Kingdom

P1705AMINOSALICYLATES FOR MAINTENANCE THERAPY IN ULCERATIVE COLITIS: IS THE ADHERENCE REALLY IMPORTANT?D. Martí; Maria Pilar Ballester, Spain; M. Fullana; P. Navarro; M. M. Boscá; J. Tosca; F. Mora; M. Minguez

P1706DEVELOPMENT AND FEASIBILITY OF A WEB-BASED REGISTRY FOR MULTICENTRE SURVEILLANCE OF EFFECTIVENESS AND SAFETY OF NOVEL IBD-DRUGS IN THE THE NETHERLANDSVince Biemans, The Netherlands; C. J. van der Woude; G. Dijkstra; A. E. Van Der Meulen – De Jong; K. H. N. (. de Boer; C. Y. Ponsioen; B. Oldenburg; F. Hoentjen; M. J. Pierik

P1707SIX-YEAR EFFICACY AND SAFETY OF AZATHIOPRINE TREATMENT IN THE MAINTAINANCE OF STEROID-FREE REMISSION IN INFLAMMATORY BOWEL DISEASE PATIENTSClaudio Cassieri, Italy; R. Pica; E. V. Avallone; G. Brandimarte; M. Zippi; P. Crispino; D. De Nitto; G. P. Lecca; P. Vernia; P. Paoluzi; E. S. Corazziari

P1708CLINICAL EFFICACY AND SAFETY OF ANTI-TNF THERA-PY IN INFLAMMATORY BOWEL DISEASE IN THE ELDER-LY: A UK TERTIARY REFERRAL CENTRE EXPERIENCE Jonathan Digby-Bell, United Kingdom

P1709TACROLIMUS IN REFRACTORY ULCERATIVE COLITIS – 12 MONTH OUTCOME IN A SINGLE CENTRE UK DISTRICT HOSPITALNishani Jayasooriya, United Kingdom; L. Everson; S. Mann

P1710A REAL LIFE COMPARISON OF THE EFFICACY OF ADALIMUMAB VERSUS GOLIMUMAB IN MODER-ATE-TO-SEVERE ULCERATIVE COLITIS. A MULTICENTER EXPERIENCE FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)Sara Renna, Italy; F. Mocciaro; M. Ventimiglia; F. S. Macaluso; R. Orlando; M. Billeci; M. Cappello; M. Mendolaro; A. C. Privitera; C. Ferracane; W. Fries; V. Pisana; A. Magnano; D. Pluchino; G. Inserra; G. Scarpulla; S. Garufi; A. Carroccio; S. Siringo; R. Dimitri; M. Cottone; A. Orlando

P1696REAL WORLD SAFETY OF VEDOLIZUMAB IN INFLAM-MATORY BOWEL DISEASE: A META-ANALYSISStefan Schreiber, Germany; A. Dignass; L. Peyrin-Biroulet; M. Mosli; G. Hather; D. Demuth; A. Blake; R. Curtis; J. M. Khalid; E. V. Loftus Jr

P1697COST-UTILITY ANALYSES OF BIOLOGICS FOR REFRAC-TORY ULCERATIVE COLITISSophia Campbell Davies, Italy; C. Inserra; R. Salerno; A. Cassinotti; G. Muserra; M. Piacenza; S. Ardizzone

P1698 ENDOSCOPIC SUBMUCOSAL DISSECTION OF ULCER-ATIVE COLITIS-ASSOCIATED DYSPLASIA: A SINGLE CENTER BASED EXPERIENCEDong-Hoon Yang, Republic of Korea; S.-H. Lee; K. Chang; E. M. Song; S. W. Hwang; S. H. Park; B. D. Ye; J.-S. Byeon; S.-J. Myung; S.-K. Yang

P1699EVALUATION OF ADHERENCE TO INFLIXIMAB THERAPY IN IBD PATIENTSAriadna Clos, Spain; G. Corrales; F. Cañete; T. Lobaton; M. Larrain; L. Marin; M. Mañosa; E. Cabré; E. Domènech

P1700TNF-EXPRESSION OF MONOCYTES IS A PREDICTIVE MARKER FOR RESPONSE TO INFLIXIMAB TREATMENTDonata Lissner, Germany; B. Jessen; E. Sonnenberg; F. Schmidt; A. Kuehl; B. Siegmund

P1701EVALUATION OF CONCOMITANT CORTICOSTEROID AND VEDOLIZUMAB USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) IN REAL-LIFE CLINICAL PRACTICE T. Ylisaukko-oja; J. Aaltonen; S. Torvinen; A. Eberl; H. Nuutinen; T. Blomster; A. Jussila; M. Pajala; J. Jokelainen; S. Herrala; K. Tamminen; Taina Sipponen, Finland

P1702VEDOLIZUMAB TROUGH LEVELS PREDICT CLINICAL OUTCOMES IN INFLAMMATORY BOWEL DISEASEL. Guidi; Daniela Pugliese, Italy; T. Panici Tonucci; B. Tolusso; C. Felice; A. Papa; I. De Vitis; E. Gremese; A. Gasbarrini; G. L. Rapaccini; A. Armuzzi

P1703EFFICACY, SAFETY AND LONG-TERM OUTCOME OF EN-DOSCOPIC DILATION THERAPY FOR PRIMARY CROHN’S DISEASE STRICTURES OF THE UPPER GASTROINTES-TINAL TRACT – AN INTERNATIONAL MULTICENTER COMBINED ANALYSISDominik Bettenworth, Germany; M. M. Mücke; A. Singh; R. Lopez; M. Goetz; T. Matsui; J. G. Karstensen; N. S. Ding; T. B. Qui; J. Hampe; K. Matthes; P. V. Valli; G. Rogler; F. Rieder


240


Wednesday, N

ovember 1, 2017


P1717BASELINE CALPROTECTIN DOES NOT PREDICT RE-SPONSE TO BIOLOGICAL THERAPY IN ULCERATIVE COLITISD. Storey; Thomas Skouras, United Kingdom; A. Bond; S. Dodd; S. Subramanian

P1718EIGHT YEARS EXPERIENCE OF DRUG EFFICACY IN CROHN’S DISEASE PATIENTS: A PROSPECTIVE MULTI-CENTER REAL LIFE STUDYMichal Lodyga, Poland; P. Eder; M. Gawron-Kiszka; M. Hartleb; J. Kierkus; M. Klopocka; M. Kukulska; M. Grzymislawski; E. Malecka-Panas; E. Poniewierka; I. Smola; T. Rawa; J. Regula; G. Rydzewska

P1719EFFICACY OF VEDOLIZUMAB INDUCTION THERAPY IN PATIENTS WITH SEVERE, THERAPEUTIC RESISTANT INFLAMMATORY BOWEL DISEASERenáta Bor, Hungary; K. Farkas; P. Miheller; K. Palatka; T. Szamosi; P. L. Lakatos; K. B. Gecse; P. A. Golovics; A. Vincze; L. Lakner; M. Rutka; A. Balint; A. Fabian; Á. Milassin; Z. Szepes; T. Molnar

P1720WITHDRAWN

Treatment-surgical

P1721CLINICAL CHARACTERISTICS AND MANAGEMENT OF CROHN'S DISEASE IN PATIENTS WITH RESIDUAL DISEASE AFTER SURGERY COMPARED WITH CURATIVE SURGERY. RESULTS FROM PRACTICROHN STUDY.Eugeni Domènech, Spain; M. D. Martín Arranz; A. Gutiérrez; M. Iborra; V. García-Sánchez; M. Barreiro-de Acosta; L. Cea-Calvo; C. Romero; B. Juliá De Páramo

P1722SEVERITY OF BILE ACID MALABSORPTION COR-RELATES WITH LENGTH OF ILEAL RESECTION IN CROHN’S DISEASEThomas Skouras, United Kingdom; Y. Prasad; S. Dodd; S. Subramanian

Poster Session09:00 – 14:00 Hall 7Other Lower GI Disorders III

Microbiology

P1723A MICROBIAL SIGNATURE OF PSYCHOLOGICAL DIS-TRESS IN IRRITABLE BOWEL SYNDROMEJ. Peter; C. Fournier; L. Knoblich; B. Keip; Gabriele Moser, Austria

P1711 REAL-LIFE STUDY (GORE-UC) EVALUATING THE EF-FECTIVENESS OF GOLIMUMAB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN INTERIM ANALYSIS FROM ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE (IG-IBD)Daniela Pugliese, Italy; A. Variola; A. C. Privitera; M. Allocca; F. Bossa; M. Cappello; G. Lorenzon; S. Mazzuoli; M. Principi; R. Sablich; A. Ferronato; S. Festa; L. Moser; G. Tapete; G. Bodini; M. Di Girolamo; L. Grossi; F. Mocciaro; C. Ricci; S. Saibeni; R. Spagnuolo; E. Capoferro; A. Armuzzi

P1712PREVALENCE OF CIPROFLOXACIN RESISTANCE IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH GUT COLONIZATION WITH EXTENDED SPECTRUM BETA-LACTAMASE PRODUCING ENTEROBACTERIA ACCORDING TO BACTERIAL PLASMID GENESVita Skuja, Latvia; K. Pekarska; H. Dauvarte; E. Vasuka; L. Dobelniece; J. Malina; D. Rudzite; E. Lavrinovica; L. Piekuse; A. Kalcenaua; A. Krumina; A. Lejnieks; A. Derovs

P1713PATTERNS OF ANTI-TNF USE IN CROHN’S DISEASE PATIENTS IN FRANCE: RESULTS FROM AN ANALYSIS OF A FRENCH ADMINISTRATIVE DATABASE (GENERAL SAMPLE OF HEALTH INSURANCE BENEFICIARIES) AND HOSPITAL DISCHARGE DATA.Raphael Toueg, France; I. Bureau; C. Laurendeau; L. Lamarsalle; M. Allez

P1714PREDICTIVE FACTORS OF RESPONSE TO ANTI-TNF α TREATMENT OF COMPLEX ANO-PERINEAL FISTULAS IN CROHN’S DISEASE.Maroua Hafi, Tunisia; M. Fekih; A. Laabidi; N. Ben Mustapha; J. Boubaker; A. Filali

P1715COMPARISON OF ORIGINAL AND BIOSIMILAR INFLIX-IMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE AND MULTICENTRIC STUDY IN SPAINHelena Martínez Lozano, Spain; J. Miranda Bautista; K. Villa; Y. González-Lama; P. López Serrano; J. L. Pérez Calle; P. Pérez Galindo; D. Carpio López; V. Matallana; M. Calvo; M. I. Vera; I. Marín-Jiménez; L. Menchén Viso

P1716DOES SEVERE ENDOSCOPIC COLITIS PREDICT STEROID REFRACTORY DISEASE IN ACUTE SEVERE COLITIS?Fadoua Er-Rabie, Morocco; S. elmahjoubi; E. M. Amine; W. Khannoussi; Z. Ismaili; G. Kharrasse


241


Wed

nesd

ay, N

ovem

ber

1, 2

017


Lower GI bleeding

P1733THE EFFICACY OF SELECTIVE ARTERIAL EMBOLIZATION IN THE MANAGEMENT OF DIVERTICULAR BLEEDINGYuichi Fukami, Japan; S. Sakita; T. Mochida; C. Kamitsuma; A. Igarashi; J. Tsuchiya; K. Yasuda; M. Ike; N. Kozawa; M. Kaneshiro; H. Ikemiyagi; K. Yoshino; M. Watanabe

P1734ACCURACY OF THE NASOGASTRIC TUBE AND THE BUN/CREATININE RATIO FOR DISTINGUISHING BE-TWEEN UPPER AND LOWER SOURCES OF GASTROIN-TESTINAL BLEEDING. A SYSTEMATIC REVIEW.Salvador Machlab, Spain; E. Martinez-Bauer; P. Garcia-Iglesias; A. Lira; C. Marmol; G. Llibre; J. P. da Costa; M. Gallach; L. Melcarne; V. Puig-Divi; F. Junquera; R. Campo; E. Brullet; X. Calvet

P1735GLASGOW-BLACHFORD SCORE ACCURATELY PREDICTS THE NEED OF TRANSFUSION IN ACUTE LOWER GAS-TROINTESTINAL BLEEDING. A DIAGNOSTIC ACCURACY EVALUATION STUDY.Salvador Machlab, Spain; E. Martinez-Bauer; P. Garcia-Iglesias; A. Lira; C. Marmol; G. Llibre; J. P. da Costa; M. Gallach; L. Melcarne; V. Puig-Divi; F. Junquera; R. Campo; X. Calvet; E. Brullet

P1736ACUTE LOWER GASTROINTESTINAL BLEEDING IN PA-TIENTS TREATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS COMPARED WITH WARFARIN IN CLINICAL PRACTICE: CHARACTERISTICS AND CLINI-CAL OUTCOME. Georgia Diamantopoulou, Greece; C. Konstantakis; G. Theocharis; V. Theopistos; G. Skroubis; C. Triantos; V. Nikolopoulou; K. Thomopoulos

P1737NOBLADS – THE NEW RISK SCORE TO PREDICT THE SE-VERITY OF ACUTE LOWER GASTROINTESTINAL BLEEDINGMarta Patita, Portugal; G. Nunes; R. Barosa; L. Ramos; C. Fonseca

P1738WITHDRAWN

P1739ENDOSCOPIC MUCOSAL RESECTION OF COLORECTAL POLYP IN ANTICOAGULATED PATIENTSSayo Kobayashi, Japan; T. Nawa; K. Harada; H. Seki; Y. Noma; T. Ueki; H. Okada

P1724SACCHAROMYCES BOULARDII CNCM I-745 LOWERS FECAL CHOLIC ACID CONCENTRATIONS DURING ANTIBIOTHERAPY IN HEALTHY VOLUNTEERS: A NEW POTENTIAL MECHANISM IN THE PROTECTION AGAINST CLOSTRIDIUM DIFFICILE INFECTIONHenri Duboc, France; C. Chong Nguyen; T. Kabbani; D. Rainteau; L. Humbert; S. Dowd; L.-J. Palmieri; B. Coffin; K. Pallav; A. Bado; C. Kelly

P1725 ASSOCIATION OF FUSOBACTERIUM NUCLEATUM IN ORAL CAVITY AND COLORECTAL CARCINOMASYasuhiko Komiya, Japan; T. Higurashi; A. Nakajima

P1726WITHDRAWN

P1727HUMAN MILK OLIGOSACCHARIDES; A NEW STRATEGY AGAINST POST-ANTIBIOTIC CLOSTRIDIUM DIFFICILE INFECTION?Louise Vigsnaes, Denmark

P1728CHANGES IN GUT MICROBIATA ASSOCIATED WITH AGING IN OBESE INDIVIDUALSRina Tanaka, Japan; M. Matsuzaka; S. Nakaji; Y. Sasaki

P1729 BACTERIOCIN PRODUCTION BY MUCOSAL BACTERIA IN COLORECTAL NEOPLASIA Darina Kohoutova, Czech Republic; M. Forstlova; P. Moravkova; S. Rejchrt; D. Smajs; J. Bures

P1730CARBOXYLIC AND AMINO ACIDS MIXTURE IDENTICAL TO THE METABOLITES OF THE PROBIOTIC ESCHE-RICHIA COLI M17 INDUCES BACTERIOCIN SYNTHESIS IN PROBIOTIC LACTOBACILLUS HELVETICUS D75 AND D76 STRAINS AND ENHANCES THEIR ANTIMICROBIAL ACTIVITY AGAINST TEST PATHOGENST. Vakhitov; V. Toropov; O. Shalaeva; S. Sitkin; Evgeniy Tkachenko, Russian Federation

P1731LONG-TERM SAFETY AND EFFECT ON GASTROINTESTINAL SYMPTOMS OF FECAL MICROBIOTA TRANSPLANTATIONPerttu Arkkila, Finland; A. Hillamaa; J. Jalanka; E. Mattila; V.-J. Anttila; R. Satokari

P1732CLOSTRIDIUM DIFFICILE–ASSOCIATED DISEASE IN A PORTUGUESE HOSPITAL CENTERTânia Gago, Portugal; A. Antunes; A. M. Vaz; P. Queirós; J. Roseira; A. C. Cunha; A. Ramos; H. Guerreiro


242


Wednesday, N

ovember 1, 2017


P1748IMPACT OF COLIBACTIN-PRODUCING ESCHERICHIA COLI ON IMMUNE MICROENVIRONMENT IN PRECLINI-CAL COLORECTAL CANCER MODELSAmélie Lopes, France; A. H. Casse; J. Veziant; E. Cardamone; D. Pezet; N. Barnich; E. Miot-Noirault; S. Naimi; E. Billard; B. Dumas; M. Bonnet

P1749INVESTIGATING THE DIRECT INTERACTION BETWEEN CD24 AND β-CATENIN IN INTESTINAL TUMORIGENESISNadir Arber, Israel; A. Fokra; S. Shapira; D. Kazanov; F. Bedny; B. Eli; C. Varol

P1750YM155 AS AN INHIBITOR OF CANCER STEMNESS SI-MULTANEOUSLY INHIBITS AUTOPHOSPHORYLATION OF EGFR AND G9A-MEDIATED STEMNESS IN EGFR-POSI-TIVE CANCER CELLSC.-C. Cheng; Ai-Sheng Ho, Taiwan

P1751WITHDRAWN

P1752WITHDRAWN

P1753 COLORECTAL CANCER CELLS INDUCE NEUROGENESIS IN THE ENTERIC NERVOUS SYSTEM OF THE TUMOR MI-CROENVIRONMENT VIA A NGF-DEPENDENT PATHWAYFarouk Drissi, France; A. Bessard; M. Touvron; H. Boudin; F. Cossais; L. Van Landeghem; M. Neunlist; E. Duchalais

P1754FGF14 IS A FUNCTIONAL TUMOR SUPPRESSOR THROUGH INHIBTING AMPK/MTOR PATHWAY IN COL-ORECTAL CANCERLixia Xu, China; N. Zhang; L. Huang; X. LI; S. Peng; Z. Zeng; M. Chen

P1755CHARACTERISTICS OF HYPERMUTATOR IN DIGESTIVE SYSTEM CANCERS Hiroyuki Matsubayashi, Japan; H. Ishiwatari; N. Kawata; K. Takizawa; N. Kakushima; M. Tanaka; M. Yoshida; S. Ito; K. Imai; K. Hotta; H. Ono; Y. Kiyozumi; Y. Horiuchi; K. Urakami; M. Kusuhara

P1756UNBIASED ANALYSIS OF REGULATION OF TRAN-SCRIPTION FACTORS UPON ER STRESS IN THE LS174T COLORECTAL CANCER CELL LINE EXPOSES CTBP2 AS A POTENTIAL REGULATOR OF STEMNESSBartolomeus Meijer, The Netherlands; B. F. Westendorp; J. H. M. van der Meer; W. L. Smit; J. Heijmans; V. Muncan; G. R. van den Brink


P1740RISK OF COLORECTAL CANCER IN ASYMPTOMATIC INDIVIDUALS WHOSE FIRST DEGREE RELATIVES WERE AFFECTED BY CRC AT DIFFERENT AGES OF ONSET: A SYSTEMATIC REVIEW AND META-ANALYSIS OF 9.28 MILLION SUBJECTSJ. L. L. Huang; Martin Wong, Hong Kong PRC; C. Chan; J. Lin; W. W. Cheung; M. Liang; Y. Fang; C. Yu; D. Fung

P1741IS THERE ANY DIFFERENCE IN RISK OF COLORECTAL CANCER AMONG ASYMPTOMATIC SUBJECTS WHOSE SIBLINGS VS. PARENTS WERE AFFECTED? A SYSTEM-ATIC REVIEW AND META-ANALYSISJ. L. L. Huang; Martin Wong, Hong Kong PRC; C. Chan; J. Lin; W. W. Cheung; M. Liang; Y. Fang; D. Fung; C. Yu

P1742GILBERT SYNDROME IS NOT THAT INNOCENT!Nadir Arber, Israel; M. Menachem; L. Ari; G. Lior; B. Ezra; H. Gil; H. G. Amira; J.-D. Maayan; S. Shapira

P1743CHARACTERISTICS AND PREDICTORS OF INTERVAL CANCER: A CASE-CONTROL STUDYIdo Laish , Israel; J. Mizrahi; F. Konikoff

P1744THE RELATIONSHIP BETWEEN QUANTITATIVE FIT RESULTS AND NEOPLASTIC FINDINGSJerry Shane McGrath, Canada; M. Borgaonkar; D. Pace; S. Antle; S. Stone; E. Randell; J. Quinlan

P1745METABOLIC RISK FACTORS AND THEIR IMPACT IN COLORECTAL CANCER SCREENING: MULTICENTER PROSPECTIVE STUDYTomas Grega, Czech Republic; S. Suchanek; O. Majek; O. Ngo; P. Minarikova; B. Seifert; O. Shonova; K. Balihar; J. Cyrany; M. Benes; M. Zavoral

P1746PREVALENCE OF SERRATED POLYPOSIS SYNDROME IN AVERAGE-RISK SCREENING COLONOSCOPIES IN GERMANY.Christoph Schramm, Germany; K. S. Janhsen; J. Dinter; F. Kuetting; T. Goeser; H.-M. Steffen


P1747CONTRIBUTION OF GERMLINE MUTATIONS TO NON FAMILIAL EARLY ONSET CANCERSAlessandro Mannucci, Italy; F. Calabrese; R. A. Zuppardo; U. Elmore; F. Aleotti; M. Lemma; A. Tamburini; M. Reni; M. Ronzoni; V. Burgio; E. Mazza; M. G. Patricelli; A. Russo Raucci; R. Rosati; P. A. Testoni; G. M. Cavestro


243


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1765DIFFERENTIATION BETWEEN NEOPLASTIC AND NON-NEOPLASTIC DIMINUTIVE COLORECTAL POLYPS WITH FUJINON ELUXEO-BLI VERSUS FICE ELECTRONIC CHROMOENDOSCOPY WITH AND WITHOUT OPTICAL MAGNIFICATION – A RANDOMIZED PROSPECTIVE STUDYLaszlo Madacsy, Hungary; M. Szalai; L. Oczella; Z. Dubravcsik; P. Novak; K. Zsobrak; A. Szepes

P1766HOW FREQUENTLY DO SECONDARY CARE CLINICIANS MISS COLORECTAL CANCER?V. Theis; S. Priestley; A. Bassi; E. Berryman; I. Vasiliadou; Bethany Richards, United Kingdom; H. Parry

P1767ENDOCYTOSCOPIC VASCULAR PATTERN FOR COLOREC-TAL LESION IS HELPFUL IN PREDICTING PATHOLOGICAL DIAGNOSIS.Shinei Kudo, Japan; T. Watanabe; H. Nakamura; M. Misawa; K. Matsumoto; S. Kataoka; Y. maeda; S. Matsudaira; K. Ichimasa; S. Sasanuma; N. Toyoshima; Y. Mori; T. Kudo; T. Hisayuki; K. Wakamura; T. Hayashi; T. Baba; H. Miyachi; F. Ishida; H. Inoue


P1768CONSIDERATION OF RECTAL NEUROENDOCRINE TU-MOR IN OUR HOSPITALMitsuhiro Akita, Japan

P1769SELECTIVE ERADICATION OF K-RAS MUTATED CANCER CELLS BY DELIVERY OF BACTERIAL TOXINSNadir Arber, Israel; B. Ilana; D. Kazanov; S. Shapira

P1770USE OF A COMBINATION OF LENTIVIRUS PARTICLES AND A SPECIFIC PEPTIDE FOR ERADICATION OF CD24-EXPRESSINGNadir Arber, Israel; F. Eynat; L. Abraham; S. Shapira

P1771ILF3 STABILIZES AND ACTIVATES EGFR-MEDIATED G9A PATHWAY FOR MAINTAINING CANCER STEMNESS PROPERTY IN EGFR-POSITIVE CANCERSC.-C. Cheng; Ai-Sheng Ho, Taiwan

P1772 EFFICACY AND SAFETY OF TWELVE CHEMOPREVEN-TIVE REGIMENS FOR THE RECURRENCE OF COLOREC-TAL ADENOMAS: A NETWORK META-ANALYSISHan Chen, China

P1773COX-2 MEDIATES RESISTANCE TO EICOSAPENTAENOIC ACID IN COLORECTAL CANCER CELLS. Milene Volpato, United Kingdom; L. Coletta; M. A. Hull


P1757MICROBIOTA A NEW INDICATOR OF COLORECTAL CAN-CER (CRC) HETEROGENEITYIradj Sobhani, France; E. Bergstein; A. Ghozlane; S. Kennedy

P1758EPIGENETIC SILENCING OF SMOC1 IS ASSOCIATED WITH DEVELOPMENT OF COLORECTAL TRADITIONAL SERRATED ADENOMASHironori Aoki, Japan; E. Yamamoto; A. Takasawa; T. Niinuma; H.-O. Yamano; H.-O. Matsushita; T. Harada; T. Sugai; H. Suzuki

P1759DEVELOPMENT AND VALIDATION OF PREDICTIVE MODEL FOR PARTICIPATION IN COLORECTAL CANCER SCREENING IN KOREAJoo-Won Chung, Republic of Korea; J. J. Park; J. Y. Yoon

P1760CD24 PREDICTIVE LEVELS- A SIMPLE NOVEL BLOOD TEST FOR EARLY DETECTION OF VARIOUS MALIGNANCIESNadir Arber, Israel; S. Shapira; D. Kazanov; A. Fokra; Z. Sally; S. Zigdon; J.-D. Maayan; L. Ari; K. Roni; L. Alissa; I. Ofer; E. Liberman

P1761FACTORS ASSOCIATED WITH OPTIMIZING PREPARA-TION FOR COLONOSCUPOY USING SPLIT DOSE PICOLAX Elizabeth Half, Israel; R. Leiba; T. Hanania; I. Chermesh; E. Hag

P1762IMPROVED ADENOMA DETECTION WITH ELUXEO LINKED COLOR IMAGING (LCI) AS COMPARED TO CONVENTIONAL WHITE-LIGHT HIGH-DEFINITION COLONOSCOPY – A RANDOMIZED CONTROLLED TRIALMilán Szalai, Hungary; L. Oczella; Z. Dubravcsik; A. Szepes; L. Madacsy

P1763COMPREHENSIVE ANALYSIS OF LONG NON-CODING RNAS WITH CHARACTERISTIC EXPRESSION LEVEL AL-TERATION IN COLORECTAL ADENOMAS AND CANCERSAlexandra Kalmár, Hungary; Z. B. Nagy; O. Galamb; B. Wichmann; B. K. Bartak; G. Valcz; K. Szigeti; Z. Tulassay; P. Igaz; B. Molnar

P1764A1-ANTITRYPSIN (SERPIN-A1) AS A PUTATIVE BIO-MARKER FOR COLORECTAL CANCER D. Kypraios; Stamatia Lydia Hatzinicolaou, Greece; A. Malachias; L. Theodoropoulos; A. Vakrakou; G. Papachristopoulou; D. Dimitroulopoulos; M. Talieri; D. Xinopoulos


244


Wednesday, N

ovember 1, 2017


P1782PATHOPHYSIOLOGY ASSESSMENT OF FECAL INCONTI-NENCE AND RISK FACTORS ASSOCIATED. RESULTS OF A TEN YEARS RETROSPECTIVE STUDY.L. D'Alba; Emanuela Ribichini, Italy; R. Urgesi; M. A. Vitale; L. Pallotta; M. C. Di Paolo; G. Villotti; A. De Cesare; S. Cocca; P. Zaccari; M. G. Graziani

P1783RETROSPECTIVE STUDY: ROLE OF SEHCAT TEST IN THE DIAGNOSIS OF BILE ACID MALABSORPTION AS A CAUSE OF CHRONIC DIARRHOEA AND POTENTIAL RISK FACTORS ASSOCIATED.Claudia Barber Caselles, Spain; B. Lobo Alvarez; J. L. Mosquera; S. Aguade-Bruix; F. Azpiroz; J. Santos

Irritable bowel syndrome: Epidemiology

P1784INTAKE OF FERMENTABLE OLIGO-, DI- AND MO-NO-SACCHARIDES AND POLYOLS (FODMAPS) INCREAS-ES THE RISK OF IRRITABLE BOWEL SYNDROME (IBS) IN INDIVIDUALS EXPOSED TO PSYCHOSOCIAL STRESS IN THE COMMUNITY: RESULTS OF A LARGE, PROSPEC-TIVE, POPULATION BASED STUDYMark Fox, Switzerland; Y. Long; Y. Deng; H. Chu; X. Zheng; J. Yang; Y. Cong; Y. Yu; H. Liu; N. Dai

P1785CHARACTERIZING IBS PATIENTS WITH ANXIETY OR DEPRESSIONIrina Pontén, Sweden; M. Simrén; H. Törnblom

P1786THE ASSOCIATION BETWEEN IRRITABLE BOWEL SYN-DROME AND LACTOSE INTOLERANCEReşat Dabak, Turkey; T. Arslan Kucuk; S. Tuzun; H. Cetin; E. Ahıshalı; C. Dolapcıoglu

P1787WITHDRAWN

P1788THE PREVALENCE AND IMPACT OF OVERLAPPING ROME IV FUNCTIONAL GASTROINTESTINAL DISORDERS ON SOMATISATION, QUALITY OF LIFE, AND HEALTH-CARE UTILISATION: RESULTS FROM A THREE-COUNTRY GENERAL POPULATION STUDYImran Aziz, Sweden; O. S. Palsson; H. Törnblom; A. Sperber; W. E. Whitehead; M. Simrén

P1789WITHIN-PERSON CORRELATIONS BETWEEN GASTRO-INTESTINAL AND PSYCHOLOGICAL FEATURES OF THE IRRITABLE BOWEL SYNDROMEEgbert Clevers, Belgium; J. Tack; H. Törnblom; G. Ringström; L. Van Oudenhove; M. Simrén

P1774PROGNOSTIC ROLE OF GLASGOW PROGNOSTIC SCORE IN PATIENTS WITH COLORECTAL CANCER: EVIDENCE FROM POPULATION STUDIESYangyang Liu, China; X. He; J. Pan; S. Chen; L. Wang

P1775COST EFFECTIVENESS OF THE FIRST SURVEILLANCE COLONOSCOPY IN POPULATION WITH ADVANCED COLORECTAL POLYPS OR MULTIPLE POLYPS FROM COLORECTAL CANCER SCREENING PROGRAMLaura Carot, Spain; M. González; M. Batlle; A. Buron; X. Bessa Casserras; M. Andreu Garcia; A. Álvarez-Urturi

P1776OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR COLORECTAL LESIONS: A SINGLE EUROPEN CEN-TER EXPERIENCERoberta Maselli, Italy; P. A. Galtieri; L. Lamonaca; M. Di Leo; R. semeraro; L. Poliani; F. Auriemma; A. Fugazza; G. Lollo; G. amvrosiadis; E. C. Ferrara; A. Anderloni; S. Carrara; A. Repici

P1777POPULATION-BASED COLORECTAL CANCER SCREENING IN THE CZECH REPUBLIC – FIRST RESULTS OF THE NEW PROGRAM SETTINGSStepan Suchanek, Czech Republic; T. Grega; O. Majek; O. Ngo; B. Seifert; L. Dusek; M. Zavoral

P1778LONG-TERM OUTCOMES OF ENDOSCOPIC SUBMU-COSAL DISSECTION FOR EARLY CANCER AND HIGH GRADE DYSPLASIA IN COLORECTUMP.-H. Zhou; Tao Chen, China


P1779 LOW UPTAKE OF PSYCHOLOGICAL THERAPIES AMONG PATIENTS WITH IRRITABLE BOWEL SYNDROME IN SECONDARY CARE.Orla Craig, United Kingdom; C. Black; L. Houghton; A. C. Ford

P1780GUT SYMPTOMS AND TRANSIT DISTURBANCE IN PARKINSON’S DISEASE ARE PAN-ENTERIC BUT NOT UBIQUITOUS: A WIRELESS MOTILITY CAPSULE STUDYValentina Passananti, United Kingdom; N. Zarate Lopez; R. Sweis; A. V. Emmanuel

P1781OUTLET DYSFUNCTION IS PREVALENT IN SEVERE FUNCTIONAL BLOATING: PRELIMINARY REPORT FROM A MULTICENTER ITALIAN STUDYPaola Iovino, Italy; M. C. Neri; L. D'Alba; S. Gallotta; G. Chiarioni


245


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1798PATIENTS’ AND CLINICIANS’ VIEWS OF AND EXPERI-ENCE WITH A NOVEL CLINICAL PATHWAY FOR FUNC-TIONAL GASTROINTESTINAL DISORDERSEcushla Linedale, Australia; A. Mikocka-Walus; P. R. Gibson; J. M. Andrews

P1799ANNUAL FECAL IMMUNOLOGICAL TESTING IS LESS COSTLY THAN COLONOSCOPY EVERY 5 YEARS AND RE-DUCES MORTALITY IN FAMILIAL COLORECTAL CANCER SCREENING.David Nicolás Pérez, Spain; I. Castilla-Rodríguez; M. Salgado-Fernández; M. Ponce; J. M. Herrero-Rivas; T. Ocaña; M. P. Roncales; F. Sopeña-Biarge; J. Santiago; C. Alvarez Urturi; E. Andreu-García; O. Castaño-Fernández; P. Muñoz-Garrido; M. Rodríguez-Soler; M. Carrillo Palau; M. Llanos-Muñoz; N. González-López; J. Cubiella; F. Balaguer; L. Bujanda Fernández de Piérola; A. Lanas; A. Suárez González; A. Herreros de Tejada; R. Jover; X. Bessa Casserras; A. Gimeno Garcia; E. Quintero Carrion

P1800COMBINATION OF FOBT AND FECAL CALPROTECTIN MAY BE USEFUL FOR REDUCING UNNECESSARY COLO-NOSCOPIES IN SYMPTOMATIC PATIENTSCarlos Sostres, Spain; A. Lué; M. V. Barra Pardos; G. Hijos; A. Perales; J. J. Puente; A. Lanas; F. Gomollon

P1801CLINICAL PRACTICE, MONITORING, AND PATIENT SAFETY DURING PROCEDURAL SEDATION IN FIVE COUNTRIESR. Saunders; Jason Davis, Germany; R. Weissbrod; P. Kranke; J. R. Lightdale; D. Whitaker

P1802PERFORMANCE OF THE MOTUS PURE-VU SYSTEM – A NOVEL DEVICE FOR ACHIEVING ADEQUATE BOWEL PREP IN POORLY PREPPED PATIENTSP. D. Siersema; Kelly van Keulen, The Netherlands; H. Neumann; M. C. W. Spaander

P1803THE EUROPEAN SOCIETY OF GASTROINTESTINAL ENDOSCOPY KEY PERFORMANCE MEASURES FOR COLONOSCOPY IN THE POLISH COLORECTAL CANCER SCREENING PROGRAM.Marek Bugajski, Poland; P. Wieszczy; M. Rupinski; J. Regula; M. F. Kaminski

P1804WITHDRAWN

P1805VALIDATION OF THE “FAILURE TO PROVIDE ADEQUATE RELIEF” (F-PAR) SCALE IN A SPECIALIST CLINIC SETTING Valentina Passananti, United Kingdom; N. Zarate Lopez; A. V. Emmanuel

P1790IRRITABLE BOWEL SYNDROME WITH CONSTIPATION: IMPACT OF SYMPTOM SEVERITY ON HEALTH-RELATED QUALITY OF LIFE: A POST HOC ANALYSIS OF DATA FROM TWO PHASE 3 TRIALS OF LINACLOTIDEAnne Marciniak, United Kingdom; Y. Mo; J. Ma; J. L. Abel; R. T. Carson

P1791HEALTH CARE UTILIZATION FOR ROME IV IRRITABLE BOWEL SYNDROME; A THREE-COUNTRY SURVEY IN THE GENERAL POPULATIONNavkiran Jossan, Sweden; H. Törnblom; M. Simrén; I. Aziz; O. S. Palsson; W. E. Whitehead; A. Sperber

Lower GI vascular disorders

P1792ISCHAEMIC COLITIS AND VITAMIN K DEFICIENCY: A HYPOTHESISAchilleas Tsimperidis, Greece; I. A. Linardou; A. N. Kapsoritakis; A. K. Psychos; S. P. Potamianos

P1793WITHDRAWN

P1794ARTERIAL PH AND LACTATE HAVE SIGNIFICANT IMPACT ON THE OUTCOMES OF PATIENTS WITH ISCHEAMIC COLITISCarolina Simões, Portugal; V. Magno Pereira; M. Silva; J. Carvão; A. Oliveira; C. Baldaia; G. Serrão; L. Jasmins; J. Velosa

P1795 THE RISK PREDICTIVE VALUES OF ACG CLASSIFICATION IN A COHORT OF ISCHEMIC COLITIS – REFINING THE DEFINITION OF MILD DISEASEV. Magno Pereira; Carolina Simões, Portugal; M. Silva; J. Carvão; A. Oliveira; C. Baldaia; G. Serrão; L. Jasmins; J. Velosa

Lower GI health services research

P1796HOW COST AFFECTS THE TREATMENT CHOICE FOR IRRITABLE BOWEL SYNDROME WITH DIARRHEA PATIENTS: A COST-EFFECTIVENESS ANALYSIS OF TRI-CYCLIC AGENTS AND RIFAXIMINEric Shah, USA; E. Andraska; J. Li; S. Zhang; W. D. Chey

P1797PREDICTIVE FACTORS FOR BETTER OUTCOMES IN COLONOSCOPY-ASSOCIATED PERFORATIONByungsun Kim, Republic of Korea; S. Park; M. A. Yang; S. H. Yun; Y. Lee; J. W. Kim; J. Cho


246


Wednesday, N

ovember 1, 2017


P1812EFFICACY AND SAFETY OF FERRIC CARBOXYMALTOSE TREATMENT IN PATIENTS HOSPITALIZED FOR ACUTE GASTROINTESTINAL BLEEDING NOT ASSOCIATED WITH PORTAL HYPERTENSIONGisela Torres-Vicente, Spain; M. Planella-de Rubinat; R. Ballester-Clau; L. López-Barroso; T. Voltà-Pardo; M. Cucala-Ramos; J. M. Reñé-Espinet

P1813NOVEL EUS-GUIDED TREATMENT OF GASTRIC VARICES WITH A LIQUID NON-ADHESIVE NEUROVASCULAR EMBOLIZATION AGENT.Alberto J. Baptista, Venezuela; M. A. Guzman; H. Rass; J. F. Piñerúa Gonsálvez; E. Richards

P1814PEPTIC ULCER BLEEDING IN THE ELDERLY: CLINICAL OUTCOMES AND IN-HOSPITAL MORTALITY Daniela Matei, Romania; I. Groza; S. Pasca; D. Negrutiu; B. Furnea; C. Bocsan; C. Cruciat; A. Seicean; M. Tantau

P1815PREDICTIVE FACTORS FOR IN-HOSPITAL MORTALITY IN PATIENTS WITH PEPTIC ULCER BLEEDINGDaniela Matei, Romania; S. Pasca; I. Groza; D. Negrutiu; A. David; M. Nedal; M. Tantau

P1816ANAEMIA AND UPPER GI BLEEDING: A LOCAL EXPE-RIENCEMichael Ding, United Kingdom; R. Prawiradiradja; Z. Arastu; H. Sabri; M. Smith

Upper GI nerve- gut and motility: Transmitters/signals/receptors/enteric nervous system

P1817THE RELATIONS AMONG SERUM GHRELIN, MOTILIN, CIRCULATING ANTIMYENTERIC ANTIBODIES AND GAS-TRIC EMPTYING AND AUTONOMIC NERVOUS SYSTEM FUNCTION IN PATIENTS WITH AUTOIMMUNE GASTRITISÇ. Kalkan; Fatih Karakaya, Turkey; I. Soykan

P1818 EFFECTS OF FAECAL MICROBIOTA TRANSPLANTATION ON NEUROGENIN 3, MUSAHSI 1 AND ENTEROENDO-CRINE CELLS IN THE DUODENUM OF PATIENTS WITH IRRITABLE BOWEL SYNDROMETarek Mazzawi, Norway; M. El-Salhy; G. A. Lied; T. Hausken

P1819 THE EFFECT OF ESOPHAGEAL ACID EXPOSURE ON NMDA RECEPTOR SUBUNITS EXPRESSION AND D-SER-INE IN PREFRONTAL CORTEX AND HIPPOCAMPUSWeifang Zhang, China; L. Duan; K. Wang; X. Wang

P1806ADHERENCE WITH TRANSANAL IRRIGATION USING THE NAVINA™ SYSTEM IS ASSOCIATED WITH PERSON-ALITY TRAITS EVEN WHEN THERE IS IMPAIRED HAND FUNCTIONValentina Passananti, United Kingdom; J. Storrie; N. Zarate Lopez; A. V. Emmanuel

Poster Session09:00 – 14:00 Hall 7Oesophageal, Gastric and Duodenal Disorders III

Microbiology

P1807THE DUODENAL MUCOSA RETAINS A DIVERSE MICRO-BIOTA FOLLOWING BOWEL PREPARATIONErin Shanahan, Australia; A. Shah; A. Do; P. Ghasemi; T. Hansen; N. Koloski; M. Morrison; G. Holtmann


P1808PERFORMANCE OF GLASGOW-BLACTHFORD, ROCKALL AND AIMS65 SCORES TO PREDICT OUTCOMES AND TO IDENTIFY THE LOW-RISK GROUP AFTER UPPER GI BLEEDING IN PATIENTS WITH CANCER.Matheus Franco, Brazil; S. Jang; B. D. C. Martins; T. Stevens; V. Jairath; R. Lopez; J. J. Vargo; A. Barkun; F. Maluf-Filho

P1809THE EFFECTS OF ANTICOAGULANTS ON THE CLINICAL OUTCOME OF ENDOSCOPIC TREATMENTKen Namikawa, Japan; T. Yoshio; H. Tomita; T. Yamada; J. Fujisaki

P1810ENDOSCOPIC ALLPICATION OF MUCOADHESIVE POW-DER (NEXPOWDER®) FOR HEMOSTASIS IN PATIENTS WITH GASTROINTESTINAL BLEEDINGByoung Wook Bang, Republic of Korea; K. S. Kwon; H. K. Kim; Y. W. Shin; S. J. Hong; J.-S. Park; J. H. Moon; J. J. Hwang

P1811 CLINICAL FEATURES OF DELAYED BLEEDING AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR GASTRIC NEOPLASMS IN HIGH-RISK AND LOW-RISK PATIENTSTakuya Inoue, Japan; Y. maegawa; S. Ito; T. Shimizu; Y. Yokoyama; S. Tawara; S. Ishii; Y. Haruna; T. Yakushijin; A. Inoue


247


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1828SUBGROUP ANALYSES OF CLINICAL TRIALS ON A HERBAL MEDICINE IN FD, STW 5J. Müller; Olaf Kelber, Germany; B. Vinson; C. Fink; S. Rabini; K. Kraft; M. A. Storr

P1829THE TREATMENT OF ACHALASIA IN PATIENTS WITH OE-SOPHAGEAL VARICES: AN INTERNATIONAL CASE SERIESCormac Magee, United Kingdom; R. Holloway; C. P. Gyawali; S. Roman; M. Pioche; E. Savarino; F. Quader; N. Zarate Lopez; A. J. Bredenoord; R. Sweis

P1830THE NATURAL HISTORY OF ACHALASIA: EVIDENCE OF A CONTINUUM – THE PATTERN-EVOLUTIVE STAGING THEORYR. Salvador; G. Voltarel; E. Pesenti; E. Savarino; G. Capovilla; A. Perazzolo; L. Nicoletti; S. Merigliano; Mario Costantini, Italy


P1831ROLE OF A SERUM BIOMARKERS PANEL (GASTRO-PANEL®) IN NON-INVASIVE DIAGNOSIS OF UPPER GI DISEASE: DATA BY A PRIMARY CARE POPULATION OF NORTH-EST ITALYG. Baldassarre; M. Franceschi; M. P. Panozzo; Francesco Tomba, Italy; A. Ferronato; S. Grillo; D. Sella; M. Santacatterina; A. Antico; F. Di Mario

P1832SUSTAINED TREATMENT EFFECTS OF MENTHACARIN ON SYMPTOMS AND QUALITY OF LIFE IN PATIENTS WITH FUNCTIONAL DYSPEPSIA 8 WEEKS AFTER THE END OF A 4-WEEK PLACEBO-CONTROLLED TRIALGerald J. Holtmann, Australia; B. Stracke

P1833IMPROVEMENT OF APPROPRIATENESS OF PROTON PUMP INHIBITOR (PPI) – THERAPY PRESCRIPTION WITH USE OF SEROLOGICAL MARKERS (GASTROPANEL) IN A PRIMARY CARE POPULATION M. Franceschi; M. P. Panozzo; A. Ferronato; Francesco Tomba, Italy; D. Sella; S. Landi; A. Antico; F. Di Mario; G. Baldassarre

P1834DUODENAL ACID PERFUSION INCREASES DUODENAL PERMEABILITY AND ACTIVATES THE DUODENOGAS-TRIC REFLEX, INDEPENDENTLY FROM MAST CELL ACTIVATIONHanne Vanheel, Belgium; R. Farré; D. Beeckmans; M. Vicario; J. Tack; T. Vanuytsel

P18201.8. UPPER GI NERVE- GUT AND MOTILITY: TRANSMIT-TERS/SIGNALS/RECEPTORS/ENTERIC NERVOUS SYSTEMLin Jia, China; L. Yao; C. Dong-Yun; L. Wei-Dong; X. Jian


P1821DIAGNOSTIC YIELD OF PROVOCATIVE TESTS ON ESOPHAGEAL HIGH RESOLUTION MANOMETRY (HRM)Stephen Hasak, USA; S. A. Basit; V. Naravadi; A. Lazarescu; C. P. Gyawali

P1822THE INCIDENCE AND PREVALENCE OF ACHALASIA IN ENGLAND IN TWO NATIONAL DATABASESPhil Harvey, United Kingdom; T. Thomas; J. Chandan; B. Coupland; J. Mytton; N. Bhala; P. Patel; K. Nirantharakumar; N. Trudgill

P1823ACHALASIA DESPITE NORMAL INTEGRATED RELAX-ATION PRESSURE WITH 5ML WATER SWALLOWSS. Sanagapalli; M. Duffy; A. V. Emmanuel; A. Raeburn; M. Banks; R. Haidry; L. Lovat; Rami Sweis, United Kingdom

P1824200ML RAPID DRINK CHALLENGE DURING HIGH RESO-LUTION MANOMETRY PREDICTS OESOPHAGOGASTRIC JUNCTION OBSTRUCTION IN DYSPHAGIA, AND IS COR-RELATED WITH SYMPTOM SEVERITY IN ACHALASIAShirley Gabieta-Sonmez, United Kingdom; P. Woodland; J. Arguero; J. L. S. Ooi; K. Nakagawa; E. Glasinovic; E. Yazaki; D. Sifrim

P1825THE TIMED BARIUM ESOPHAGRAM SURFACE AREA CORRELATES WITH SYMPTOM IMPROVEMENT BETTER THAN COLUMN HEIGHT FOLLOWING TREATMENT IN ACHALASIA.S. Sanagapalli; J. Maynard; A. Plumb; A. V. Emmanuel; A. Raeburn; M. Banks; R. Haidry; L. Lovat; Rami Sweis, United Kingdom

P1826NUTRIENTS ENHANCE BELCHING AND REDUCE INTESTI-NAL PROPULSION OF GASTRIC GAS IN HEALTHY HUMANSElba Noemi Caballero De Garcia, Spain; B. Benslaiman Seyid-Jebari; J. Serra Pueyo

P1827MODIFICATIONS OF THE ECKARDT SCORE PARAME-TERS AFTER PERORAL ENDOSCOPIC MYOTOMYMaximilien Barret, France; S. Leblanc; M. Gaudric; M.-A. Guillaumot; A. Oudjit; M. Dhooge; V. Abitbol; A. Chryssostalis; R. Coriat; S. Chaussade; F. Prat


248


Wednesday, N

ovember 1, 2017


P1842TREATMENT SATISFACTION OF ADULT EOSINOPHILIC ESOPHAGITIS PATIENTSEkaterina Safroneeva, Switzerland; D. Hafner; C. Kuehni; M. Zwahlen; S. Trelle; A. Straumann; A. Schoepfer

P1843 SYSTEMATIC ANALYSIS OF SUBEPITHELIAL EOSIN-OPHIL COUNTS INCREASES DIAGNOSTIC YIELD IN ADULTS WITH EOSINOPHILIC ESOPHAGITISAlain Schoepfer, Switzerland; A. Simko; C. Bussmann; E. Safroneeva; M. Zwahlen; T. Greuter; L. Biedermann; S. Vavricka; S. Godat; A. Reinhard; C. Saner; H. Maye; C. Sempoux; C. Brunel; C. Blanchard; D. Simon; H.-U. Simon; A. Straumann

Reflux disease, pathogenesis

P1844GASTROESOPHAGEAL REFLUX DISEASE PATIENTS REFLUXATE TYPE INFLUENCE ON MACROPHAGE PHENOTYPESvetlana Lyamina, Russian Federation; S. Kalish; A. Paraskevova; O. Storonova; S. Pirogov; A. Ponomarev; D. Rumyantseva; A. S. Troukhmanov; V. T. Ivashkin; I. Maev; I. Malyshev

P1845 THE LOCATION OF OESOPHAGEAL MUCOSAL AFFERENT NERVES ARE MORE SUPERFICIAL IN PATIENTS WITH NERD THAN IN HEALTHY VOLUNTEERS AND PATIENTS WITH BARRETT’S OESOPHAGUSPhilip Woodland, United Kingdom; J. L. S. Ooi; F. Grassi; C. Lee; J. Evans; N. Koukias; C. Triantos; S. A. C. McDonald; M. Peiris; R. Aktar; A. Blackshaw; D. Sifrim

P1846 BELCHING PATTERNS IN PATIENTS WITH ISOLATED PATHOLOGICAL UPRIGHT REFLUX AND PATHOLOGICAL BIPOSITIONAL REFLUX José Maria Conchillo, The Netherlands; J. T. W. Snijkers; J. Santos Fernandez; A. A. M. Masclee

P1847IS REFLUX DURING NAPS WORSE THAN DURING NIGHT-TIME SLEEP?Carlos Teruel Sánchez-Vegazo, Spain; M. J. De Higes Ruiz; A. Albillos

P1848TREATMENT WITH PROTON PUMP INHIBITORS (PPI) DOES NOT REDUCE ACIDIC LARYNGOPHARYNGEAL REFLUX (LPR) DESPITE REDUCING DISTAL ACIDIC GASTROESOPHAGEAL REFLUX AND IMPROVING SYMP-TOMS IN PATIENTS WITH LPR. Peter Banovcin, Slovak Republic; M. Ďuriček; T. Haličková; R. Hyrdel; M. Kollarik

P1835APPROPRIATE USE OF PPI IN THE ELDERLY: EVALUA-TION OF ACID SECRETION AND ATROPHIC GASTRITIS BY MEANS OF A NON-INVASIVE TESTM. Franceschi; Silvia Speroni, Italy; R. De Bastiani; A. Antico; M. P. Panozzo; G. Baldassarre; S. Scida; C. Miraglia; L. Franzoni; V. Corrente; M. Rugge; F. Di Mario; C. Scarpignato; A. PILOTTO

P1836THE PSYCHOLOGICAL CHARACTERISTICS OF REFLUX HYPERSENSITIVITY-A PILOT STUDY BASED ON SCL-90 QUESTIONNAIRE AND 24 HOUR PH-IMPEDANCE MONITORINGK. Wang; Z. Xu; Z. Xia; Y. Ge; Liping Duan, China

P1837 HIGH-RESOLUTION ESOPHAGEAL MANOMETRY: EVAL-UATION OF NEW SYSTEMS FOR THE ACQUISITION AND ANALYSIS.G. Capovilla; A. Costantini; G. Voltarel; E. Pesenti; A. Perazzolo; L. Nicoletti; R. Salvador; Mario Costantini, Italy

Eosinophilic oesophagitis

P1838 PROTON PUMP INHIBITOR THERAPY IMPROVES ESOPH-AGEAL SYMPTOMS BY RESTORING A NORMAL ESOPH-AGEAL PERISTALSIS IN PATIENTS WITH PROTON PUMP INHIBITOR-RESPONSE ESOPHAGEAL EOSINOPHILIAM. Della Coletta; N. de Bortoli; O. Bartolo; S. Tolone; G. Bodini; E. Marabotto; P. Zentilin; A. Mauro; R. Penagini; V. Savarino; Edoardo Savarino, Italy

P1839EOSINOPHILIC ESOPHAGITIS: MANAGEMENT IN THE DAILY CLINICAL DUTCH PRACTICEBram Vermeulen, The Netherlands; A. Bogte; P. D. Siersema

P1840IGG4 EXPRESSION IS ELEVATED IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS COMPARED TO PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASESimon Weidlich, Germany; S. Nennstiel; K. Brockow; M. Jesinghaus; J. Slotta-Huspenina; M. Bajbouj; R. M. Schmid; C. Schlag

P1841SYSTEMATIC REVIEW: HEALTH-RELATED QUALITY OF LIFE IN CHILDREN AND ADULTS WITH EOSINOPHILIC ESOPHAGITIS: MEASURE INSTRUMENTS AND DETER-MINANT FACTORSAlfredo J Lucendo Villarin, Spain; L. Arias-González; J. Molina-Infante; Á. Arias


249


Wed

nesd

ay, N

ovem

ber

1, 2

017



P1856DIET IS MORE EFFECTIVE THAN ANTACIDS IN RELIEV-ING REFLUX SYMPTOMS IN MILD GERD.Manuele Furnari, Italy; S. Cento; S. Tolone; M. Frazzoni; E. Savarino; L. Frazzoni; E. Marabotto; G. Bodini; V. Savarino; N. De Bortoli; S. Marchi; P. Minale

P1857INTERIM RESULTS OF A PROSPECTIVE MULTI CENTER REGISTRY OF LOWER OESOPHAGEAL SPHINCTER STIM-ULATION FOR GORD: THE LESS -GORD REGISTRYJoachim Labenz, Germany; A. Leodolter; J. Pedersen; A. Nieponice; R. Weise; N. Bouvy; S. Schoppmann; C. Gutt; A. Madisch

P1858ANTI-REFLUX MUCOSECTOMY (ARMS) FOR REFRACTO-RY GERD – INITIAL CLINICAL EXPERIENCE Amol Bapaye, India; M. R. Mahadik; R. Pujari; T. K. Bharadwaj; S. G. Vare; N. Dubale; S. Date; J. A. Bapaye

P1859EFFECTIVENESS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN PATIENTS WITH NON-EROSIVE REFLUX DISEASE: A RANDOMIZED TRIALIryna Biriuchenko, Ukraine; N. Bondarenko; A. Svintsitskyy

P1860QUALITY OF ESOPHAGEAL MUCOSAL HEALING IN ERO-SIVE REFLUX DISEASE: A RANDOMIZED COMPARATIVE TRIAL WITH LANSOPRAZOLE ALONE OR COMBINED WITH REBAMIPIDEKyung-Ho Song, Republic of Korea; Y. C. Lee; S. J. Hong; S. W. Jeon


P1861LONG-TERM RESULTS OF RADIOFREQUENCY ABLATION (RFA) IN PATIENTS WITH BARRETT'S ESOPHAGUS RELATED NEOPLASIAJana Krajciova, Czech Republic; J. Maluskova; M. Kollar; Z. Vackova; J. Spicak; J. Martinek

P1862METHODS OF MEASURING BARRETT’S MUCOSAL THICKNESS WITH VOLUMETRIC LASER ENDOMICROS-COPY (VLE), AS A BIOMARKER TO GUIDE TO TREAT-MENT CHOICEIris Levink, USA; G. Tearney; H. C. Wolfsen; S. Schlachter; P. D. Siersema; M. B. Wallace

P1863SEVEN-YEAR PROSPECTIVE FOLLOW-UP RESULTS OF RA-DIOFREQUENCY ABLATION FOR BARRETT’S ESOPHAGUS WITH HIGH-GRADE DYSPLASIA AND EARLY CANCER.Kamar Belghazi, The Netherlands; B. L. A. M. Weusten; S. L. Meijer; J. J. G. H. M. Bergman; R. E. Pouw

P1849EFFECT OF L-MENTHOL ON ESOPHAGEAL PERISTALTIS AND LOWER ESOPHAGEAL SPHINCTER IN HEALTHY VOLUNTEERSPeter Banovcin, Slovak Republic; M. Ďuriček; P. Lipták; R. Hyrdel; M. Kollarik

P1850ANALYSIS OF THE RELATIONSHIP BETWEEN GLOBUS PERCEPTION AND ACIDIC LARYNGOPHARYNGEAL REFLUX BY DUAL PHARYNGEAL AND ESOPHAGEAL 24-HOUR PH/IMPEDANCE MONITORING.Lenka Bubernáková, Slovak Republic; M. Ďuriček; P. Banovcin; R. Hyrdel


P1851GASTRIN-17 AS A NON-INVASIVE MARKER FOR GERD: A PROSPECTIVE STUDY ON SAMPLE OF 777 CONSECU-TIVE PATIENTSG. Masciangelo; Francesco Di Mario, Italy; L. Franzoni; M. Franceschi; S. Landi; T. B. Tene Fokam; S. Grillo; S. Scida; E. Savarino; N. de Bortoli; C. Miraglia; A. Bertelè; V. Corrente; C. Scarpignato

P1852HIGH RESOLUTION MANOMETRY SHOULD BE CONSID-ERED THE BEST TEST TO DIAGNOSE SLIDING HIATAL HERNIAIrene Martinucci, Italy; N. de Bortoli; E. Savarino; S. Tolone; E. Marabotto; M. Frazzoni; L. Frazzoni; M. Bellini; V. Savarino; S. Marchi

P1853HIGH RESOLUTION MANOMETRY CAN BE PREDICTIVE OF GERD AS CONFIRMED BY IMPEDANCE-PH MONI-TORING: DEVELOPMENT AND INTERNAL VALIDATION OF A PREDICTIVE MODEL.Salvatore Tolone, Italy; L. Frazzoni; E. Savarino; M. Frazzoni; N. de Bortoli; I. Martinucci; G. Bodini; M. Furnari; R. Penagini; A. Mauro; V. Savarino; L. Docimo

P1854GORD PATIENTS ARE FREQUENTLY DISSATISFIED ON LONG-TERM PPI: EXPLORING THE REASON(S) AND MAN-AGEMENT IN ROUTINE CLINICAL CARE (LOPA II STUDY)Joachim Labenz, Germany; G. Labenz; M. Müller; D. Stephan; F. Willeke

P1855PREVALENCE AND PATHOPHYSIOLOGY OF GAS-TRO-ESOPHAGEAL REFLUX DISEASE IN PATIENTS WITH AUTOIMMUNE GASTRITISGemma Maddalo, Italy; V. Pilotto; E. Savarino; C. Orlando; M. Fassan; D. Basso; M. Rugge; F. Farinati


250


Wednesday, N

ovember 1, 2017


P1872EXPLORATORY STUDY OF PREDICTIVE BIOMARKER FOR DEFINITIVE CHEMORADIOTHERAPY USING BIOPSY SPECIMENS OF PATIENTS WITH ESOPHAGEAL SQUA-MOUS CELL CARCINOMA.Kenji Takashima, Japan; T. Yano; M. Takahashi; Y. Yoda; K. Hori; M. Komatsu; T. Kojima; H. Daiko; K. Minashi; M. Muto; H. Sasaki; S. Fujii

P1873ENDOSCOPIC TREATMENT OF PATIENTS WITH HIGH-RISK EARLY ESOPHAGEAL CANCERMarek Kollar, Czech Republic; J. Krajciova; J. Maluskova; E. Honsova; A. Pazdro; T. Harustiak; D. Kodetova; Z. Vackova; J. Spicak; J. Martinek

P1874DIAGNOSTIC ACCURACY OF ENDOSCOPIC ULTRASO-NOGRAPHY FOR ESOPHAGEAL SUBMUCOSAL GLAND DUCT INVOLVEMENT ACCOMPANIED BY EARLY ESOPH-AGEAL CANCERY. Jie; Lv Ying, China

P1875PRETREATMENT NEUTROPHIL TO LYMPHOCYTE RATIO IS NOT A PREDICTOR OF RESPONSE TO NEOADJUVANT THERAPY IN ESOPHAGEAL CANCERGiovannI Pirozzolo, Italy; S. S. Gisbertz; O. De Simoni; A. Slaman; C. Castoro; M. Scarpa; M. I. van Berge Henegouwen

Acid peptic disease (includes NSAIDS, but NOT H. pylori), epidemiology

P1876CAN THE USE OF A COMPUTER DECISION SUPPORT SYSTEM PREVENT COMPLICATED ULCER AMONG PATIENTS TREATED WITH NSAID OR ASPIRIN? A RAN-DOMISED CONTROLLED CLUSTER TRIAL IN GENERAL PRACTICE.Johanna Martina Petersen, Denmark; D. E. Jarbøl; J. Hallas; M. R. Munch; O. B. Schaffalitzky de Muckadell; J. M. Hansen

Acid peptic disease (includes NSAIDS, but NOT H. pylori), pathogenesis

P1877ACCELERATION OF HEALING OF PREEXISTING GASTRIC ULCERS BY CARBON MONOXIDE RELEASING MOLECULE -2 (CORM-2). INVOLVEMENT OF HEME OXYGENASE, OXIDATIVE STRESS AND PROINFLAMMATORY MARKERST. Brzozowski; Katarzyna Magierowska, Poland; S. Kwiecien; M. Magierowski; M. Hubalewska-Mazgaj; D. Wojcik; R. Pajdo; A. Chmura

P1864ACTION IS REQUIRED TO IMPROVE UNDERSTANDING AND REDUCE ANXIETY LEVELS AMONGST PATIENTS IN THE BARRETT’S SURVEILLANCE PROGRAMME.Vinay Sehgal, United Kingdom; A. Kumar; D. S. Kalsi; P. Jegatheesvaran; J. Walton; J. Sadeghian; S. Murray

P1865BARRETT’S ESOPHAGUS IS ASSOCIATED WITH TOTAL SERUM ADIPONECTIN IN WOMEN, BUT NOT WITH OTHER INFLAMMATORY OR METABOLIC BIOMARKERSManol Jovani, USA; Y. Cao; D. Feskanich; B. C. Jacobson; A. T. Chan

P1866 OUTCOMES OF TREATMENT OF PATIENTS WITH EARLY-STAGE ADENOCARCINOMA OF THE ESOPHAGUS WITH INCIPIENT SUBMUCOSAL INVASION, RETRO-SPECTIVE ANALYSIS OF 19 CASES FROM A TERTIARY REFERRAL CENTER IN THE UKBalint Eross, United Kingdom; C. Clisby; C. Gordon


P1867THE USE OF ENDOCYSTOSCOPY FOR THE EARLY DE-TECTION OF ESOPHAGEAL NEOPLASMShannon Chan, Hong Kong PRC; P. W. Y. Chiu; A. Y. B. Teoh; H. C. Yip; V. Wong; E. Ng; J. Y. Lau

P1868 CLINICAL OUTCOMES OF ENDOSCOPIC RESECTION FOR ACHALASIA-ASSOCIATED SUPERFICIAL ESOPHAGEAL CANCERYohei Nishikawa, Japan; K. Goda; S. Kono; K. Sumi; M. Ominami; Y. Ikebuchi; I. Haruo; M. Onimaru; H. Ito; H. Inoue

P1869USEFULNESS OF TRIAMCINOLONE INJECTION TO PREVENT STRICTURE AFTER CIRCUMFERENTIAL ESOPHAGEAL ESD FOR SCC AND EACTsuneo Oyama, Japan; A. Takahashi

P1870 OUTCOME OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR SUPERFICIAL PHARYNGEAL SQUAMOUS CELL CARCINOMAT. Oyama; Akiko Takahashi, Japan

P1871SHOULD ANTITHROMBOTIC AGENTS BE DISCONTINUED PRIOR TO ESOPHAGEAL ENDOSCOPIC SUBMUCOSAL DISSECTION?Noboru Kawata, Japan; M. Tanaka; K. Takizawa; N. Kakushima; M. Yoshida; S. Ito; K. Imai; K. Hotta; H. Ishiwatari; H. Matsubayashi; H. Ono


251


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1885SHORT-TERM OUTCOME OF ENDOSCOPIC SUBMU-COSAL DISSECTION FOR EARLY GASTRIC CANCER IN ELDERLY PATIENTS AND LONG-TERM OUTCOME AFTER NON-CURATIVE RESECTIONHiroya Sakaguchi, Japan; Y. Ohara; T. Toyonaga; H. Kaku; K. Matsuoka; T. Sako; R. Ariyoshi; H. Abe; F. Kawara; S. Tanaka; T. Ishida; Y. Morita; E. Umegaki

P1886GASTRIC INTESTINAL METAPLASIA OUTCOMES: RE-SULTS FROM A 17 YEAR TERTIARY CENTRE UPPER GI SURVEILLANCE PROGRAMME IN IRELAND Mairead Mc Nally, Ireland; I. Cretu; A. O'Connor

P1887DIFFERENT RELATIONSHIP BETWEEN STAGE OF GASTRIC CANCER AND GENOTYPE OF TGFB1 BASED ON FIRST-DEGREE RELATIVE OF GASTRIC CANCERMingu Kwon, Republic of Korea; N. Kim; C. Yun; Y. J. Hwang;Y. J. Choi; H. Yoon; C. M. Shin; Y. S. Park; D. H. Lee

P1888GASTRIC ADENOCARCINOMA AND PROXIMAL POLYPO-SIS OF THE STOMACH. A GENETIC STUDY OF A NEWLY DIAGNOSED FAMILYIlja Tachecí, Czech Republic; M. Podhola; M. Leško; M. Minarik; L. Benesova; M. Kopáčová; S. Rejchrt; J. Bures

P1889ENDOSCOPIC TREATMENT FOR LATERAL SPREADING SU-PERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMAHirofumi Kawakubo, Japan; T. Omori; K. Suda; R. Nakamura; N. Wada; N. Yahagi; Y. Kitagawa

P1890DIAGNOSTIC ACCURACY OF ENDOSCOPIC ULTRASONOG- RAPHY FOR ESOPHAGEAL SUBMUCOSAL GLAND DUCT IN-VOLVEMENT ACCOMPANIED BY EARLY ESOPHAGEAL CANCERY. Jie; Lv Ying, China

P1891PEPSINOGENS AND GASTRIN-17 FOR IDENTIFICATION OF GASTRIC CANCER PRECURSOR LESIONS: THE RE-SULTS FROM THE GISTAR PILOT STUDYC. Robles; D. Rudzite; I. Polaka; L. Tzivian; Ilze Kikuste, Latvia; A. Vanags; S. Isajevs; I. Liepniece-Karele; S. Parshutin; J. Young Park; R. Murillo; R. Herrero; M. Leja


P1892MIR-211 INHIBITS PROLIFERATION AND MIGRATION OF GASTRIC CANCER CELLS BY TARGETING FOXC1Xingkang He, China; Y. Ding; Z. Jin; L. Sun; J. Si

Acid peptic disease (includes NSAIDS, but NOT H. pylori), diagnosis and treatment

P1878PROTON PUMP INHIBITORS INAPPROPRIATE USE IN PATIENTS ADMITTED IN A TERTIARY GREEK HOSPITAL CREATES SIGNIFICANT DIRECT COSTS BURDEN AND EXPOSURE OF PATIENTS TO THE RISK OF UPPER GAS-TROINTESTINAL COMPLICATIONSG. Vlachonicolou; L. Bounou; A. Theodorou-Kanakari; S. Kalousios; M. Roma; E. A. Mavroeidi; G. D. Dimitriadis; Konstantinos Triantafyllou, Greece

P1879CONTINUOUS INCREASE IN PREVALENCE OF FUNDIC GLAND POLYPS WITH THE LENGTH OF PROTON PUMP IN-HIBITORS USE. IS THERE ANY CLINICAL CONSEQUENCE?Radek Kroupa, Czech Republic; M. Dastych; S. Konecny; J. Dolina


P1880ENDOSCOPIC RESECTION OF ADVANCED AMPULLARY ADENOMAS: A SINGLE-CENTER 14 YEAR RETROSPEC-TIVE COHORT STUDYSophia van der Wiel, The Netherlands; J. W. Poley; M. J. Bruno; A. D. Koch

P1881FACTORS ASSOCIATED WITH TECHNICAL DIFFICULTY OF ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER WHICH MET EXPANDED INDICATION CRITERIA; POST HOC ANALYSIS USING DATA OF MULTI-INSTITUTIONAL PROSPECTIVE CONFIRMATORY TRIAL. (JCOG0607)Tomonori Yano, Japan; N. Hasuike; H. Ono; N. Boku; G. Ogawa; J. MIzusawa; I. Oda; H. Doyama; S. Hori; H. Iishi; K. Takizawa; H. Fukuda; M. Muto

P1882COMPARATIVE EFFECTIVENESS OF NOVEL FINE-NEE-DLE BIOPSY DEVICE VS CONVENTIONAL FINE-NEEDLE ASPIRATION FOR ENDOSCOPIC ULTRASOUND DIAGNO-SIS OF GASTRIC SUBMUCOSAL LESIONSMeir Mizrahi, USA; E. U. Yee; I. Nasser; J. Cohen; J. Sheridan; R. Chuttani; T. Berzin; M. Sawhney; D. Pleskow

P1883A COMPARISON OF SUBMUCOSAL TUNNELING ENDO-SCOPIC RESECTION AND ENDOSCOPIC FULL-THICKNESS RESECTION FOR GASTRIC FUNDUS SUBMUCOSAL TUMORSTianying Duan, China; Y. Tan; X. Wang; L. Liang; D. Liu

P1884COMPARISON OF THE DIAGNOSTIC YIELDS OF ENDO-SCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION FOR DUODENAL AND GASTRIC SUBEPITHELIAL LESIONS.Kenji Nakamura, Japan


252


Wednesday, N

ovember 1, 2017


Poster Session09:00 – 14:00 Hall 7H. Pylori III

Diagnosis

P1900THE VALIDITY OF BREATH COLLECTION BAGS USING THE NOVEL BREATHID®HP LAB SYSTEM: A MULTI-CENTER CLINICAL STUDY IN 257 SUBJECTSHaim Shirin, Israel; J. Gonzalez; S. Hazan; G. Gottlieb; K. Friedenberg; D. Gatof; R. Ganeshappa; S. Delgado; D. Abramowitz; R. Hardi; A. Coates; M. Haq; N. Mehta; B. Jones; S. Moss

P1901MACHINE-LEARNING-BASED AUTOMATIC DIAGNOSIS SYSTEM FOR HELICOBACTER PYLORI INFECTION USING LINKED COLOR IMAGINGYuto Okada, Japan; N. Yagi; H. Ichikawa; H. Kitae; A. Tomie; S. Hiwa; T. Hiroyasu

P1902HELICOBACTER PYLORI DETECTION BY γ-GLUTAMYL-TRANSPEPTIDASE-ACTIVATED FLUORESCENT PROBETaro Akashi, Japan; K. Matsushima; T. Kanda; M. Nakano; M. Kamiya; Y. Akazawa; K. Ohnita; F. Takeshima; K. Nakao; Y. Urano; H. Isomoto

P1903SEROLOGICAL CHANGES AFTER EQUIVOCAL HELICO-BACTER PYLORI-SEROLOGY TEST FINDINGS DEPEND ON THE GASTRIC SECRETING ABILITYJi Hye Kim, Republic of Korea; S.-Y. Lee; S. P. Lee; J. H. Kim; I.-K. Sung; H. S. Park; C. S. Shim

P1904WE CAN JUDGE THE EXISTENCE OF PRESENT OR PAST H.PYLORI INFECTION WITH ONLY ONE ENDOSCOPIC CARDIAC IMAGES (WHALE SHARK SIGN: WSS). Takuji Yamasaki, Japan; T. Sakurai; J. Mitobe; M. Mitsunaga; Y. Amano; Y. Tokai; M. Saruta

P1905SERUM PEPSINOGEN II AS A NON-INVASIVE MARKER FOR DIAGNOSIS OF HELICOBACTER PYLORI INFECTION: A PROSPECTIVE STUDY IN A COHORT OF DYSPEPTIC PATIENTSFrancesco Di Mario, Italy; C. Miraglia; S. Scida; A. Violi; M. Franceschi; G. Baldassarre; M. Rugge; P. Crafa; A. Tursi; G. Brandimarte; L. Franzoni; N. Dal Bò; R. Cannizzaro; C. Scarpignato

P1906CAN THE UREA BREATH TEST PREDICT HELICOBACTER PYLORI ERADICATION?Denise Brennan, Ireland; C. Dalton; P. Murray; J. O'Toole; H. Temperley; C. O'Morain; S. Smith; D. McNamara

P1893CONGENITAL OR METAPLASTIC: EVALUATION OF GASTROESOPHAGEAL NEO-JUNCTIONS TO ASSESS CARDIAC TYPE EPITHELIUM ORIGINJoana Castela, Portugal; D. Vinha Pereira; S. Mão de Ferro; R. Casaca; R. Fonseca; P. Chaves; A. Dias Pereira

P1894ENDOSCOPIC MUCOSAL RESECTION OF NON-AMPUL-LARY SPORADIC DUODENAL ADENOMAS: LONG TERM RESULTS.G. Valerii; A. Tringali; I. Boskoski; P. Familiari; Vincenzo Bove, Italy; R. Landi; V. Perri; G. Costamagna

P1895CROSSTALK BETWEEN THE G PROTEIN-COUPLED RECEPTOR 39 AND RECEPTOR TYROSINE KINASES IN HUMAN GASTRIC CANCERS. Leal-López; B. Otero-Alen; C. S. Seonae-Mosteiro; L. S. Estevez-Perez; T. Garcia-Caballero; R. Gallego-Gomez; J. Enrique Dominguez-Muñoz, Spain; J. P. Perez-Camiña; Y. Pazos-Randulfe

P1896INDOMETHACIN INDUCES LYSOSOMAL DYSFUNCTION IN GASTRIC CANCER CELLS AND INCREASES THEIR SENSITIVITY TO CYTOTOXIC DRUGS J. Vallecillo-Hernández; Laura Gisbert-Ferrándiz, Spain; P. Salvador; D. Ortiz-Masia; D. C. Macias-Ceja; M. D. Barrachina; S. Calatayud; C. Hernández

P1897HOXD10 METHYLATION IN PLASMA WAS POTENTIALLY SERVED AS BIOMARKER OF GASTRIC CANCER AND PRECANCEROUS LESIONSL. Wang; Liangjing Wang, China; M. Luo

P1898ACETYLCHOLINE INDUCES CANCER STEM CELL- LIKE PHE-NOTYPE IN GASTRIC CANCER CELLS OF DIFFUSE TYPEP. H. Nguyen; Y. Touchefeu; E. Duchalais; T. Durand; P. Aubert; P. Girot; M. Peron; S. Bruley des Varannes; C. Varon; M. Neunlist; Tamara Matysiak Budnik, France

P1899SYSTEMATIC REVIEW AND META-ANALYSIS OF THE PROGNOSTIC SIGNIFICANCE OF CPG ISLAND METHYLA-TOR PHENOTYPE IN GASTRIC CANCERArfon Powell, United Kingdom; S. Soul; N. Patel; C. Brown; W. Lewis


253


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1915‘CONCOMITANT’ OR ‘SEQUENTIAL’ THERAPY FOR THE ERADICATION OF HELICOBACTER PYLORI: WHICH REGIMEN COMES FIRST IN MOROCCO? Adil Ait Errami, Morocco; Z. Samlani; S. Oubaha; K. Krati

P1916PROSPECTIVE COMPARATIVE STUDY OF TWO FIRST-LINE REGIMENS FOR HELICOBACTER PYLORI ERADICATION: 14-DAYS NON-BISMUTH QUADRUPLE OPTIMIZED CONCOMI-TANT THERAPY VERSUS 10-DAYS BISMUTH-CONTAINING QUADRUPLE THERAPY USING A THREE-IN-ONE CAPSULE.Javier Alcedo, Spain; M. Gracia; P. García-Cámara; C. Palacín; S. Frago; I. Aured; L. Luzón; S. Gallego; C. Jimeno-Ayllón; D. Pérez-Milián; D. Villafranca

P1917 MANAGEMENT OF HELICOBACTER PYLORI INFECTION AT PRIMARY CARE LEVEL. THE IMPLEMENTATION OF SPE-CIFIC COUNSELLING IMPROVES ERADICATION RATES.Viviana Laredo, Spain; T. Arroyo Villarino; E. Alfaro; C. Sostres; A. Lanas

Poster Session09:00 – 14:00 Hall 7Small Intestinal III

Enterocyte biology/pathology and nutrient/water transport/electrolyte transport

P1918VALPROATE AND CHIR 99201 AMELIORATES RADIATION INDUCED INTESTINAL EPITHELIAL INJURY IN MOUSE MODELYounjoo Kim, Republic of Korea; J. S. Shin


P1919PREVALENCE OF CELIAC DISEASE AMONG RELATIVES IN ALGERIAFadila Lounes, Algeria; N. Aliarous; S. Salah; K. Belanteur; M. G. Mokhtech; Z. C. Amir; D. Hannoun; R. Ouldgougam; Y. Chikhi; S. Cheraitia; F. Asselah; H. Asselah; M. Lahcene

P1920LONG-TERM HEALTH AND LIFESTYLE OUTCOMES IN ADULT CELIAC DISEASE PATIENTS DIAGNOSED IN CHILDHOOD BECAUSE OF CLINICAL SUSPICION OR BY SCREENINGLaura Kivelä, Finland; S. Alin; S. Kröger; K. Kaukinen; K. Kurppa

P1921REVIEW OF SERVICE PROVISION OF NATIONAL IN-STITUTE FOR HEALTH AND CARE EXCELLENCE (NICE) RECOMMENDED QUALITY STANDARDS FOR COELIAC DISEASE AT A BIG DISTRICT GENERAL HOSPITALFaisal Kamran Shaikh, United Kingdom; D. Vani; M. Sprakes; F. Greenhalgh

Treatment

P1907 HIGH DOSE CAM WITH VONOPRAZAN (P-CAB) PLUS AMX TRIPLE THERAPY REGIMEN IS THE STRONGEST H.PYLORI ERADICATION THERAPY EVEN IF CAM RESISTANCE. Takuji Yamasaki, Japan; T. Sakurai; J. Mitobe; M. Mitsunaga; Y. Amano; Y. Tokai; M. Chibai; M. Saruta

P1908 COMPARISON OF THE EFFICACY BETWEEN BISMUTH AND ALTERNATING RIFAXIMIN ON SECOND-LINE QUADRUPLE REGIMEN OF HELICOBACTER PYLORI ERADICATION.Junseok Park, Republic of Korea; J. S. Lee; J.-O. Kim; S. J. Hong; H. G. Kim; T. H. Lee; S. R. Jeon; J.-H. Cho

P1909COMPARISON OF 10-DAY STANDARD TRIPLE THER-APY AND LEVOFLOXACIN BASED THERAPY FOR HELICOBACTER PYLORI ERADICATION: RANDOMIZED CONTROLLED TRIALMin Kyu Kang, Republic of Korea; S.-H. Lee; M. C. Kim; K. H. KIM; K. O. Kim; B. I. Jang; T.-N. Kim

P1910TREATMENT OF HELICOBACTER PYLORI INFECTION: WILL TAILORING THERAPY FIRST TIME OVERCOME INCREASING FAILURE OF STANDARD TRIPLE THERAPY?Denise Brennan, Ireland; M. Hussey; D. Tighe; C. O'Morain; S. Smith; D. McNamara

P1911TREATING HELICOBACTER PYLORI INFECTION SECOND TIME ROUND: IS TAILORING THERAPY BASED ON AN-TIMICROBIAL SUSCEPTIBILITY THE BEST OPTION?Denise Brennan, Ireland; M. Hussey; D. Tighe; C. O'Morain; S. Smith; D. McNamara

P1912ARE PROBIOTICS USEFUL AS ADJUVANTS IN ERADICA-TION THERAPY OF HELICOBACTER PYLORI INFECTION?Marta Gravito-Soares, Portugal; E. Gravito-Soares; D. Gomes; N. Almeida; L. Tomé

P1913THE IMPACT OF CLOSTRIDIUM BUTYRICUM MIYAIRI-588 ON HELICOBACTER PYLORI ERADICATION THERAPYShun Takayama, Japan; O. Handa; R. Mukai; Y. Suyama; A. Majima; Y. Onozawa; O. Dohi; T. Okayama; N. Yoshida; K. Kamada; K. Katada; K. Uchiyama; T. Ishikawa; T. Takagi; H. Konishi; Y. Naito; Y. Itoh

P1914 ªTHE EFFECTS OF SACCHAROMYCES BOULARDII SUPPLE-MENTATION ON HELICOBACTER PYLORI ERADICATION RATE AND SIDE EFFECTS DURING SEQUENTIAL THERA-PY : A PROSPECTIVE RANDOMISED CONTROLLED STUDYHanae Boutallaka, Morocco; H. Seddik; K. Loubaris; F. Nejjari; S. Berrag; I. Elkoti; A. Benkirane


254


Wednesday, N

ovember 1, 2017


Small intestinal bleeding

P1931MANAGEMENT OF OCCULT OBSCURE GASTROINTESTINAL BLEEDING PATIENTS BASED ON LONG-TERM OUTCOMESSayoko Kunihara, Japan; S. Oka; S. Tanaka; A. Tsuboi; I. Otani; K. Chayama

P1932A PILOT STUDY EXPLORING THE VALUE OF FAECAL IMMUNOCHEMICAL TEST (FIT) WHEN INVESTIGATING ANAEMIA OR OCCULT GASTROINTESTINAL BLEEDING WITH SMALL BOWEL CAPSULE ENDOSCOPYDonal Tighe, Ireland; C. Judge; P. Walsh; M. Kelly; A. O'Connor; N. Breslin; B. Ryan; G. Boran; D. McNamara

P1933VIDEO CAPSULE ENDOSCOPY IN THE ASSESSMENT OF PORTAL HYPERTENSIVE ENTEROPATHY.Yasir Al-Azzawi, USA; M. Mahmoud; L. Spaho; J. Kheder; D. Cave

P1934MULTICENTER PROSPECTIVE CASE-CROSSOVER STUDY ON THE ASSOCIATION BETWEEN OVERT SMALL-BOWEL BLEEDING AND DRUGS USING CAPSULE ENDOSCOPY DATABASE IN JAPANNaoki Ohmiya, Japan; S. Fujimori; M. Nakamura; A. Yamada; K. Maki; S. Oka; M. Esaki; A. Nakajima; T. Matsumoto; S. Tanaka; H. Goto; C. Sakamoto

P1935META-ANALYSIS REVEALS SIMILAR REBLEEDING RATES AMONG EASTERN AND WESTERN POPULATIONS UP TO FIVE YEARS AFTER INDEX VIDEO CAPSULE ENDOSCOPY EXAMINATION FOR OBSCURE GASTROINTESTINAL BLEEDINGG. Tziatzios; P. Gkolfakis; G. D. Dimitriadis; Konstantinos Triantafyllou, Greece

P1936LONGTERM OUTCOMES AFTER NEGATIVE DOUBLE- BALLOON ENTEROSCOPY FOR SUSPECTED OVERT SMALL BOWEL BLEEDING (OBSCURE-OVERT GASTRO-INTESTINAL BLEEDING)Rintaro Hashimoto, Japan; T. Matsuda; M. Nakahori

P1937DOES DISCONTINUATION OF ANTITHROMBOTIC AGENTS AFFECT DIAGNOSTIC YIELD OF SMALL BOWEL CAPSULE ENDOSCOPY IN PATIENTS WITH OBSCURE GASTROINTESTINAL BLEEDING?Toshio Watanabe, Japan; S. Shimada; Y. Nadatani; K. Otani; F. Tanaka; Y. Nagami; N. Kamata; H. Yamagami; T. Tanigawa; M. Shibatoge; T. Miyazaki; S. Nakamura; Y. Fujiwara

P1938EFFICACY OF REBAMIPIDE TO PREVENT LOW-DOSE ASPIRIN-INDUCED SMALL INTESTINAL INJURYSergey Vyalov, Russian Federation

P1922SERUM MICROBIAL MARKERS IN NONRESPONSIVE CELIAC DISEASELiisa Viitasalo, Finland; K. Kurppa; H. Huhtala; M. Mäki; K. Kaukinen; S. Iltanen

P1923CORRELATION BETWEEN OXIDATIVE STRESS AND DUODENAL ATROPHY IN CELIAC DISEASEFrancesca Ferretti, Italy; F. Branchi; L. Roncoroni; S. Moretti; A. Vezzoli; S. Mrakic-Sposta; V. Lombardo; D. Conte; L. Elli

P1924CIRCULATING EXTRACELLULAR VESICLES, A NOVEL MECHANISM OF ENDOCRINE CELLULAR CROSS-TALK, ARE INCREASED IN NEWLY DIAGNOSED CELIAC DIS-EASE PATIENTSKonstantinos Efthymakis, Italy; G. Bologna; P. Lanuti; C. Pipino; A. Milano; F. Laterza; P. Simeone; A. Bonitatibus; A. Pandolfi; M. Marchisio; S. Miscia; M. Neri

P1925COELIAC DISEASE AND REPRODUCTIVE DISORDERS : IS THERE ANY CORRELATIONHanae Boutallaka, Morocco; I. benelbarhdadi; F. Z. Ajana

P1926SEVERITY OF MUCOSAL DAMAGE AND TISSUE TRANS-GLUTAMINASE ANTIBODY LEVELS CORRELATE WELL IN ADULT CELIAC DISEASE IRRESPECTIVE OF CLINICAL FEATURES R. Maxim; Anca-Victorita Trifan, Romania; A. Plesa; S. C. Oana Cristina; I. Ciortescu; I. Girleanu; C. Stanciu

P1927ASSOCIATION OF CELIAC DISEASE AND PATENT FORA-MEN OVALEMesut Sezikli, Turkey; G. Dindar; D. Karacimen; S. B. Acikgoz

P1928 USEFULNESS OF BULB BIOPSY SAMPLES IN CELIAC DISEASE DIAGNOSIS IN ADULTSDaniel Vasile Balaban, Romania; A. Popp; J. Taavela; K. Laurila; M. Mäki; M. Jinga

P1929PROSPECTIVE MULTI-CENTER-STUDY TO EVALUATE A FINGER PRICK-BASED POINT-OF-CARE-TEST (POCT) FOR DIAGNOSIS OF COELIAC DISEASE.P. H. Tangermann; F. Branchi; W. Spitz; U. Möhler; J. Aschenbeck; S. Schubert; A. Schroeder; F. Heller; S. Trenkel; M. Schmitt; B. Siegmund; C. Bojarski; Michael Schumann, Germany

P1930QUALITY STANDARDS IN COELIAC DISEASE: A RETRO-SPECTIVE EVALUATION IN A SINGLE SPECIALIST CLINICMichael FitzPatrick, United Kingdom; S. Nichols; E. Soilleux; S. Travis


255


Wed

nesd

ay, N

ovem

ber

1, 2

017


P1946INTRAGASTRIC BALLOON: A CRITICAL VIEW IN NON ELECTIVE BARIATRIC SURGERY PATIENTSRicardo Jose Fittipaldi Fernandez, Brazil; E. Usuy; C. F. Diestel; S. Barrichello; A. F. Teixeira; M. Galvao Neto

P1947SPATZ3® ADJUSTABLE INTRAGASTRIC BALLOON TREAT-MENT: A BRAZILIAN MULTICENTRIC EXPERIENCE Ricardo Jose Fittipaldi Fernandez, Brazil; C. F. Diestel; M. Galvao Neto; A. F. Teixeira; E. Usuy; S. Barrichello

P1948VOMITING FREQUENCY AFTER INTRAGASTRIC BAL-LOON PLACEMENT AND INTRAVENOUS HYDRATION REQUIREMENTSérgio Barrichello, Brazil; R. J. F. Fernandez; E. Usuy; A. F. Teixeira; M. Galvao Neto; T. F. Souza; E. Grecco

P1949BODY MASS IMPROVEMENT AND METABOLIC CHANGE RATE AFTER INTRAGASTRIC BALLOON TREATMENT. Sérgio Barrichello, Brazil; R. J. F. Fernandez; E. Usuy; T. F. Souza; M. Galvao Neto; A. F. Teixeira; E. Grecco

P1950A LARGE BRAZILIAN EXPERIENCE WITH THE INTRA-GASTRIC BALLOON TREATMENT IN HIGH VOLUME OF PATIENTS CENTERSRicardo Jose Fittipaldi Fernandez, Brazil; C. F. Diestel; M. Galvao Neto


P1951FRUCTO-OLIGOSACCHARIDE EXACERBATES STRESS-INDUCED VISCERAL HYPERALGESIA AND GUT INFLAMMATION IN A MURINE MODELBinrui Chen, China; L. Du; H. He; J. J. Kim; N. Dai

P1952GENOMIC ANALYSIS OF THE MULTISPECIES PROBIOTIC PRODUCT VSL#3Diego Mora, Italy; W. M. de Vos; F. P. Douillard

P1953RAISING PUBLIC AWARENESS OF GASTROINTESTINAL DISEASES: AN INNOVATIVE STRATEGY FOR A NATION-AL CAMPAIGNL. Franzoni; P. Crafa; A. Bertelè; V. Corrente; S. Grillo; S. Landi; C. Miraglia; S. Scida; Francesco Di Mario, Italy

P1954ALTERED PLASMA PROFILE AND URINE EXRECTION OF AMINO ACIDS IN COELIAC DISEASE CHILDREN AFTER ADMINISTRATION OF OLIGOFRUCTOSE-ENRICHED INULIN INTO GLUTEN-FREE DIET – RESULTS OF RAN-DOMIZED, PLACEBO-CONTROLLED PILOT TRIALNatalia Drabińska, Poland; E. Jarocka-Cyrta; U. Krupa-Kozak

P1939CAPSOCAM SV-1 VERSUS PILLCAM SB 3 IN THE DE-TECTION OF OBSCURE GASTROINTESTINAL BLEEDING: RESULTS OF A PROSPECTIVE RANDOMIZED COMPARA-TIVE MULTI-CENTER STUDYLilli Zwinger, Germany; B. Siegmund; A. Stroux; A. Adler; W. Veltzke-Schlieker; R. Wentrup; C. Jürgensen; B. Wiedenmann; F. Wiedbrauck; S. Hollerbach; T. Liceni; C. Bojarski

Vascular disorders

P1940 VALIDATION OF A SCORE CHART TO PREDICT THE RISK OF CHRONIC MESENTERIC ISCHEMIA: A DISCRIMINA-TIVE AND USEFUL TOOL IN CLINICAL DECISION-MAKINGLouisa van Dijk, The Netherlands; D. van Noord; R. H. Geelkerken; S. A. Berendsen; A. C. de Vries; A. Moelker; H. J. M. Verhagen; J. J. Kolkman; M. J. Bruno; on behalf of the Dutch Mesenteric Ischemia Study group (DMIS)

P1941LONG-TERM SYMPTOM RELIEF AFTER REVASCULAR-IZATION IN PATIENTS WITH SINGLE ARTERY CHRONIC MESENTERIC ISCHEMIALouisa van Dijk, The Netherlands; L. M. G. Moons; D. van Noord; A. Moelker; H. J. M. Verhagen; M. J. Bruno; E. V. Rouwet

P1942UNDERUTILIZATION OF ENDOSCOPIC ARGON PLASMA COAGULATION FOR TREATMENT OF BLEEDING GAS-TROINTESTINAL ANGIODYSPLASIAS: AN INTERNA-TIONAL MULTICENTRE COHORT STUDYKarina Grooteman, The Netherlands; M. Matheeuwsen; G. Holleran; E. Van Geenen; D. McNamara; J. P. H. Drenth

P1943DIGESTIVE INVOLVEMENT IN SYSTEMIC DISEASES: A UNIVERSITY HOSPITAL EXPERIENCEWafaa Khannoussi, Morocco; K. Chhita; H. Bachir; G. Kharrasse; A. El Mekkaoui; S. Hamaz; H. B. Alaoui; K. Serraj; Z. Ismaili

Poster Session09:00 – 14:00 Hall 7Nutrition III

Obesity

P1944CHANGES IN LEVELS OF VITAMIN D IN OBESE PA-TIENTS SUBMITTED TO BARIATRIC SURGERY Ana Vaz, Portugal; R. Guerreiro; D. Sousa; P. Queirós; T. Gago; J. Roseira; H. Guerreiro

P1945 WITHDRAWN


256


Wednesday, N

ovember 1, 2017


P1963COMPARING RISKS OF ADVERSE EVENTS ASSOCIATED WITH PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (PEG) PLACEMENT BETWEEN THE MODIFIED INTRO-DUCER TECHNIQUE AND THE OVERTUBE ASSISTED PULL TECHNIQUE. Hiroaki Matsui, Japan; H. Inomata; H. Horiuchi; N. Tamai; K. Sumiyama

Poster Session09:00 – 14:00 Hall 7Clinical Cases III


CC103FOLLICULAR LYMPHOMA IN A CIRRHOTIC PATIENT – WHEN ASCITIC FLUID IS THE ONLY CLUERichard Azevedo, Portugal; H. Ribeiro; J. Pinto; F. Pereira; C. Leitão; A. Caldeira; R. Sousa; E. Pereira; A. Banhudo

CC104IDIOPATHIC CHYLOUS ASCITES IN A PATIENT WITH HIV INFECTION – RESPONSE TO TOTAL PARENTERAL NUTRITION AND OCTREOTIDE THERAPYGonçalo Nunes, Portugal; R. Barosa; M. Patita; A. Gomes; J. Botas; H. Coelho; J. Fonseca; C. Fonseca

CC105RAPID-ONSET AND RECURRENT HEPATIC ENCEPHA-LOPATHY AFTER SPLENECTOMY: A CASE REPORTLinjie Guo, China

CC106A RARE CAUSE OF ACUTE-ON-CHRONIC LIVER FAILURE IN A PATIENT WITH SECONDARY BUDD-CHIARI SYN-DROME DUE TO HEPATOCELLULAR CARCINOMAOana Farcau, Romania; A.-M. Fit; F. Andreea; I. Rusu; P. Fischer; L. Dina; H. Stefanescu; M. Tantau; B. D. Procopet

CC107A CASE REPORT WITH (HEPATIC?) ENCEPHALOPATHYFrancesca Ponziani, Italy; C. Mosoni; G. Addolorato; A. Gasbarrini; G. Gasbarrini

CC108A CHALLENGING AND UNCOMMON DIAGNOSIS OF LONG-EVOLUTION ASCITESMarta Gravito-Soares, Portugal; E. Soares; J. Pina-Cabral; J. Almeida; E. Fraga; L. Tomé

CC109A RARE CAUSE OF HIGH INTESTINAL OBSTRUCTIONE.-C. Salloum-Cojocariu; M. Chiorascu; L. Stirbu; V. Fotea; Irina Girleanu, Romania

P1955LONG-TERM TRENDS IN HEMATOLOGICAL AND NUTRI-TIONAL STATUS AFTER GASTRECTOMY FOR GASTRIC CANCER.Ji-Hyun Kim, Republic of Korea

P1956EVOLUTION OF REPRODUCTIVE DISORDERS RELATED TO CELIAC DISEASE UNDER GLUTEN -FREE DIETAyoub Aomari, Morocco; M. firwana; A. Amjahdi; I. Benelbarhdadi

P1957ROLE OF VAGAL AFFERENTS ON HIGH FAT DIET INDUCED ALTERATIONS IN RAT BEHAVIOUR AND GUT MOTILITY Yonca Öztürk, Turkey; B. Akgün; O. Çetin; H. Ö. Karataş; B. Güney; Z. N. Özdemir Kumral; D. Özbeyli; S. Arabacı Çetin; H. Zortul; İ. Peker; F. Arıcıoğlu; C. Erzik; B. Çağlayan Yeğen; N. Imeryüz

Enteral and parenteral nutrition

P1958OPTIMAL NUTRITIONAL ROUTE FOLLOWING TOTAL GASTRECTOMY: A SYSTEMATIC REVIEW AND ME-TA-ANALYSIS OF RANDOMIZED CONTROLLED TRIALSShubhangi Govil, United Kingdom; D. Chan; T. Abdelrahman; A. Foliaki; W. Lewis; G. Clark; G. Blackshaw

P1959 TAUROLIDINE PREVENTS CATHETER-RELATED BLOOD-STREAM INFECTIONS IN PATIENTS ON HOME PARENTER-AL NUTRITION – A RANDOMIZED CONTROLLED TRIALYannick Wouters, The Netherlands; M. Theilla; P. Singer; S. Tribler; P. B. Jeppesen; L. Pironi; L. Vinter-Jensen; H. H. Rasmussen; F. Rahman; G. Wanten

P1960REPAIR OF DAMAGED CENTRAL VENOUS CATHETERS SUBSTANTIALLY PROLONGS DEVICE SURVIVAL IN PATIENTS ON HOME PARENTERAL NUTRITIONYannick Wouters, The Netherlands; R. Vissers; W. Kievit; G. Wanten

P1961LONG-TERM CLINICAL OUTCOMES OF PATIENTS ON HOME PARENTERAL NUTRITION USING TAUROLIDINE CATHETER LOCKSYannick Wouters, The Netherlands; B. Roosenboom; W. Kievit; G. Wanten

P1962INTESTINAL DYSBIOSIS IN PATIENTS WITH SHORT BOWEL SYNDROME DEPENDENT ON TOTAL PARENTER-AL NUTRITION IS REFLECTED BY ALTERED METABO-LOME IN FAECESLukas Bajer, Czech Republic; M. Kostovcik; J. Hradecky; T. David; P. Wohl; J. Spicak; P. Drastich; M. Cahova


257


Wed

nesd

ay, N

ovem

ber

1, 2

017



CC120EXTRAHEPATIC BILIARY CYSTADENOMA PRESENTING WITH ASCENDING CHOLANGITIS AND OBSTRUCTIVE JAUNDICE: A CASE REPORT.Tanawat Pattarapuntakul, Thailand; B. – Ovartlanporn

CC121AGENESIS OF THE MAJOR DUODENAL PAPILLA?João Pinto, Spain; C. Saldaña Dueñas; C. Leitão; E. Albéniz Arbizu; J. J. Vila

Lower GI

CC122SUCCESSFUL TREATMENT OF REFRACTORY INTESTINAL ULCER IN PATIENTS WITH MYELODYSPLASTIC SYNDROME.Shinichiro Henmi, Japan; Y. Osaki; T. Maruo

CC123ANTI-TNFα ANTIBODY THERAPY IS EFFECTIVE FOR EOSINOPHILIC GASTRITIS ASSOCIATED WITH ULCER-ATIVE COLITIS.Masao Yoshioka, Japan; M. Ito; M. Kaneto; S. Yabe; S. Saito; M. Fujii; S. Ishiyama; A. Fujiwara; J. Nasu; J. Shiode

CC124MANAGEMENT OF CROHN'S DISEASE IN YOUNG PA-TIENT WITH SEVERE MALNUTRITIONVeronika Shcherbakha, Russian Federation; O. Okhlobystina; A. Stepanov; P. Pavlov; O. S. Shifrin; V. T. Ivashkin

CC125CROHN'S DISEASE: A CLINICAL MANIFESTATION OF COMMON VARIABLE IMMUNODEFICIENCYCátia Arieira, Portugal; F. Dias de Castro; M. J. Moreira; J. Cotter

CC126A RARE CAUSE OF CHRONIC BLOODY DIARRHOEALuís Maia, Portugal; Â. Rodrigues; T. Moreira; M. Loforte; M. França; R. Maia; M. Rocha; I. Pedroto

CC127LOWER GASTROINTESTINAL BLEED: LIVER RAMS INTO GUT !!!Amit Soni, India; N. S. Malhi

CC128HEMATEMESIS AND HEMATOCHEZIA IN A YOUNG MAN: A SURPRISING CAUSEXinyi Liu, China; Y. Zhang; J. Gao; G. Zhang; Z. Wang; Y. Liu

CC129INFECTIOUS CAUSE OF ISCHEMIC COLITIS: TAKING OF AMPHETAMINES IN YOUNG PATIENT.J. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain

CC110ACUTE HEPATITIS CAUSED BY GENOTYPE 4 HCV PRE-SENTED WITH A PICTURE OF THROMBOTIC THROMBO-CYTOPENIC PURPURAAhmed Kamal, Egypt

CC111DIRECT ACTING ANTIVIRALS INDUCED GRAFT INJURY AFTER LIVER TRANSPLANTIva Košuta, Croatia; A. Skrtic; S. Gasparov; A. Mrzljak

CC112LIVER ABSCESS CAUSED BY A FISHBONEFlávio Pereira, Portugal; D. Oliveira; N. Devesa; P. Casanova

CC113SECONDARY HEPATIC METASTASIS TO CARCINOMA OF ECRINAL GLANDS IN A UMBILICAL HERNIA.J. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain

CC114HIGH DIGESTIVE OBSTRUCTION SECONDARY TO BOUV-ERET'S SYNDROME.J. Mostazo Torres; M. Vilchez Jaimez; Isabel Leyre Pinazo Martinez, Spain

CC115SUCCESSFUL CLOSURE OF CHOLECYSTO-COLONIC FISTU-LA USING A ENDOSCOPIC DETACHABLE SNARE LIGATIONJi Hye Kim, Republic of Korea; C. S. Shim

CC116UNUSUAL FOREIGN BODY IN THE COMMON BILE DUCTYakhlef Aissat, Algeria; H. Mahiou; M. Nakmouche; H. Saoula; A. F. Boutaleb; Y. Zmiri; R. Osmane; M. Aissaoui; A. Mitiche; N. Hamidouche; D. Nacima

CC117A CASE OF OBSTRUCTIVE JAUNDICE SECONDARY TO HEPATIC HILAR LYMPHADENITIS CAUSED BY INVASIVE TRICHOSPORONOSISC. Tang; Linhao Zhang, China; Y. Tai; H. Tong

CC118CHOLECYSTOGASTRIC FISTULA MASQUERADING AS MALIGNANT GASTRIC OUTLET OBSTRUCTIONSajan Nagpal, USA; A. M. Egan; M. Halland

CC119SPLENIC ARTERY PSEUDOANEURYSM AS A COMPLICA-TION OF PANCREATIC PSEUDOCYSTSPatrícia Santos, Portugal; D. Reis; J. Martins; P. Moura dos Santos; F. Serejo; J. Velosa


258


Wednesday, N

ovember 1, 2017


CC137GASTRIC KAPOSI SARCOMA AFTER RENAL TRANS-PLANTATION: SIROLIMUS INDUCED REMISSIONSara Santos, Portugal; C. Bernardes; R. V. Loureiro; V. P. Borges; P. Russo; D. Carvalho; J. Saiote; F. Remédio; M. Mendes

CC138ANAPLASTIC LARGE CELL LYMPHOMA ALK NEGATIVE: AN UNCOMMON DIAGNOSIS Rui Gaspar, Portugal; A. C. Nunes; G. Macedo

CC139GASTRIC MYELOID SARCOMAPedro Marcos, Portugal; C. Atalaia-Martins; S. Barbeiro; L. Eliseu; I. Cotrim; F. Silva; C. Amado; M. F. Cunha; A. Fernandes; A. Santos; C. Gonçalves; H. Vasconcelos

CC140GLOMIC TUMOR OF THE STOMACH – A CASE REPORTRafaela Loureiro, Portugal; S. Santos; C. Bernardes; V. Pavão Borges; M. Oliveira; D. F. B. Carvalho; J. S. Fonseca; G. Ramos; A. M. Carvalho

CC141CIRCUMFERENTIAL PYLORUS MUCOSECTOMY BY EN-DOSCOPIC SUBMUCOSAL DISSECTION FOR TREATMENT OF GASTRIC ADENOCARCINOMALiliana Carvalho, Portugal; J. Rodrigues; I. Carina; P. Barreiro; C. Chagas

CC142EARLY GASTRIC CANCER WITH GOOD RESPONSE AF-TER RECTAL CANCER CHEMOTHERAPYE. Q. Mendonça; Caterina Pennacchi, Brazil; J. F. de Oliveira; A. V. Safatle-Ribeiro; B. D. C. Martins; C. C. Gusmon; E. R. Baba; F. Kawaguti; L. H. Lenz Tolentino; G. de Paulo; M. Sorbello; R. S. Uemura; S. Geiger; M. Simas de Lima; U. Ribeiro Jr.; F. Maluf-Filho

CC130A RARE ASSOCIATION OF TWO DISEASESSonia Bernardo, Portugal; M. Moura; A. R. Gonçalves; E. Sousa; L. Correia; J. Velosa

Upper GI

CC131ADENOCARCINOMA ARISING FROM A GASTRIC DUPLI-CATION CYSTBrian Chan, Canada; F. Tse

CC132GANGLIOCYTIC PARAGANGLIOMA OF THE DUODENAL BULB: AN UNCOMMON LOCALIZATION.S. Rizza; P. Cortegoso Valdivia; L. Venezia; Claudio Giovanni De Angelis, Italy

CC133A CASE OF BRUNNER GLAND ADENOMA, WHICH EX-HIBITED DRAMATIC MACROSCOPIC METAMORPHOSIS WITHOUT CANCERATIONKenji Sasaki, Japan; N. Takano; N. Iwama; T. Masuda

CC134SMALL LYMPHOCYTIC LYMPHOMA CAUSING GASTTRIC OUTLET OBSTRUCTION – CHALLENGES IN DIAGNOSIS AND MANAGEMENTPedro Marques Da Costa, Portugal; C. Ferreira; I. Távora; H. Cortez-Pinto; J. Velosa

CC135A RARE CAUSE OF GASTRIC METASTASISCarolina Simões, Portugal; J. Monteiro; L. Carrilho Ribeiro; J. Velosa

CC136A CASE OF GASTRIC CYSTIC PROFUNDA ACCOMPANIED BY EARLY GASTRIC CANCER AND SYNCHRONOUS MUL-TIPLE GASTRIC NEUROENDOCRINE TUMOURSHangbin Jin, China; J. Yang; W. Gu; X. Zhang

Standards & Guidelines

Education

How can we support your

career?

Mentoring Programme

Guided Poster Tours

Visiting Fellowship Programme

Online Library

Online Courses

Classroom Courses

Postgraduate Teaching

at UEG Week

Research Prize

Travel Grants for UEG Week

International Scholarship

Award

Research & Science

Mentoring

Grants

Participation in other UEG Committees

Young GI Lounge at UEG

Week

JobCorner

Networking Events

Young Talent Group

Networking & Exchange

Rising Star Award

Poster Prizes

Your work presented in the spotlightAbstract based

Awards

Recognition

Journal Best Paper Award

Find out more, visit www.ueg.eu

17_09_Inserat_UEGWEEK_FP_SupportYourCareer_160x220mm_RZ.indd 1 14.09.17 11:37

www.ueg.eu/week/programme/hands-on

Get ready for practice in Hall 8.0

Surgical Learning AreaSurgical hands-on training

and educational modeling in GI Surgery in sync with associated disciplines

ESGE Lecture Theatre Meet and learn from

leading experts

ESGE eLibrary Learning Centre

View latest ESGE releases

ESGE Learning Area

ESGE hands-on training in cooperation with ESGENA

Take the opportunity to hone your endoscopy skills

– check the programme for session details


→ Meet with ultrasonography experts → Take part in a 2-day basic

and advanced course of ultrasonography with real-time video clips

Sat – Tue 9:00 – 18:00Wed 9:00 – 14:00

17_09_Inserat_UEGWEEK_FP_handson_160x220mm_RZ.indd 1 14.09.17 11:38

ESGE Learning Area

For all delegates of UEG Week whose focus is on en-doscopy the ESGE Learning Area is without a doubt the first and best place to meet and mingle. Again this year, accomplished doctors and nurses will volunteer their time and expertise to support the ESGE mission: To pro-mote good endoscopy, to show the basics as well as the latest developments, to support training and to offer small-group teaching activities to everyone with a real interest in the how and why of current endoscopy. The ESGE Learning Area provides a unique and ideal plat-form for live encounter and interaction among aspiring endoscopists and renowned experts in the field.

Please come and be a part of it!

262

Saturday, October 28, 2017• EMR • Hemostasis (injection, clipping, varices ligation)• Polypectomy/colonoscopy• ERCP

Session 1 14:00 – 15:30Session 2 16:00 – 17:30

Sunday, October 29, 2017• EMR • Hemostasis (injection, clipping, varices ligation)• Polypectomy/colonoscopy• ERCP

Session 1 11:00 – 12:30Session 2 14:00 – 15:30Session 3 16:00 – 17:30

Monday, October 30, 2017• EMR • Hemostasis (injection, clipping, varices ligation)• Polypectomy/colonoscopy• ERCP• FNA – fine needle aspiration• EUS – endoscopic ultrasound• Paediatric endoscopy – (Dilation, PEG, Bleeding)

Session 1 10:30 – 12:00Session 2 12:30 – 14:00Session 3 14:30 – 16:00

Hands-on Training CentreTest your skills and experience the latest technology. The 90-minute training sessions in the Hands-on The-atre offer unique access to state-of-the-art endoscopic equipment and accessories. Participants will have the opportunity to look, learn, ask questions and perform techniques themselves under personal doctor and nurse tutoring. In cooperation with ESGENA, the aim of this activity is to increase the awareness of diagnostic and therapeutic techniques and to offer delegates the possibility of checking their skills. Basic and advanced training is offered. The paediatric stations on Monday are limited to doctors working in child medicine.

RegistrationThere is limited availability of tickets for the training sessions from Saturday to Monday. Please go to the ESGE desk in the Learning Area and secure your tick-et (starting on Saturday at 9:00). Participation will be on a first-come, first-served basis. To maintain a high standard of teaching each workstation is limited to a maximum of eight participants.

Endoscopic training on GI simulators is available on a walk-in basis throughout UEG Week as are the hands-on sessions on Tuesday and Wednesday.

UEG Week Final Programme : ESGE Learning Area

ESGE Learning Area Hall 8.0

263

ESGE E-learning Stations

The ESGE E-learning Stations offer UEG Week delegates the opportunity to view the latest training material on video screens with headphone sound transmission.

The ESGE teaching units presented at the Learning Area are otherwise only available to ESGE members via the ESGE website. If you are not already a member of ESGE, this is your chance to catch a glimpse of one of the many benefits ESGE provides when you join.

The ESGE teaching units are complemented by selected video submissions from ASGE and JGES. Any time you are in the Learning Area take a seat, grab a headphone and tune in to the topic of your interest.

ESGE Lecture Theatre

In the ESGE Lecture Theatre highly qualified and well-known endoscopists have been invited to present their views and experience with current endoscopic proce-dures and techniques. Their counterparts in discussion are equally well known, in several cases more senior specialists whose role it is to moderate the talk and per-haps critically question the case at hand. The number of participants is limited to 70 in order to ensure a small-fo-rum atmosphere where active participation is possible.

Special highlights in the Lecture Theatre include a mini symposium entitled ‘How do I ensure the quality of my endoscopy?’ and an introduction of different research projects that are currently being conducted by ESGE.


10:30 – 11:00 When do I do ERCP in acute pancreatitis? G. Paspatis, Greece T. Marek, Poland

12:30 – 13:00 How do I treat a recurrent polyp in the colon? L. Fuccio, Italy H. Messmann, Germany

14:00 – 14:30 What POEM do I do and why: anterior or posterior? J. Martinek, Czech Republic T. Rösch, Germany

16:30 – 17:00 When and how do I treat early esophageal or gastric neoplasia with endoscopy M. Pioche, France M. Dinis-Ribeiro, Portugal

Tuesday, October 31, 2017No registration required

09:30 – 11:00• Colonoscopy – the basics• Modern clip (OTSC) treatment for bleeding, fistulae

and perforations• Barrx RFA procedure for the treatment of dysplastic

Barrett’s oesophagus• Hemostatic Technology

11:30 – 13:00• Stone Management: See the difference using cholan-

gioscopy in the treatment of stone disease• Therapy in the colon• Therapy in the oesophagus• ESD, Advanced Therapeutic Techniques

14:00 – 15:30• Hemostatic Technology • EUS anatomy and diagnostics• Modern clip (OTSC) treatment for bleeding, fistulae

and perforations

16:00 – 17:30• The emerging role of EUS FNB vs FNA – disease states

and procedural advances• Therapy in the colon• Therapy in the oesophagus• Barrx RFA procedure for the treatment of dysplastic

Barrett’s oesophagus• ESD, Advanced Therapeutic Techniques

Wednesday, November 1, 2017No registration required

09:30 – 11:00• Hot Axios: Practice placing a LAMS in a simulated

pseudocyst• Therapy in the colon• Therapy in the oesophagus• Barrx RFA procedure for the treatment of dysplastic

Barrett’s oesophagus

11:30 – 13:00• Modern clip (OTSC) treatment for bleeding, fistulae

and perforations• FNA – fine need aspiration• Hemostatic Technology

ESGE Learning Area : UEG Week Final Programme

264

15:00 – 15:30 How do I do surveillance endoscopy in IBD patients? Z. Zelinkova, Slovakia E. Despott, United Kingdom

16:00 – 18:00 Opportunities for research in GI endoscopy Funding opportunities for GI endoscopy in H2010 Grey areas for research in GI endoscopy Upper GI Working Group research proposals Lower GI Working Group research proposals Small Bowel Working Group research proposals ERCP-EUS Working Group research proposals J. Riese, Spain L. Fuccio, Italy O. Pech, Germany R. Jover, Spain A. Koulaouzidis, United Kingdom P.A. Testoni, Italy


10:30 – 11:00 How do I find and treat serrated polyps? M. Pellise, Spain J. Regula, Poland

11:30 – 12:00 How do I detect dyspasia in Barrett's oesophagus? J. de Groof, The Netherlands A. Meining, Germany


10:30 – 11:00 How do I treat pancreatic cysts and tumors with EUS? O. Mosteanu, Romania E. Santo, Israel

12:30 – 14:00 ESGE GENERAL ASSEMBLY15:00 – 17:00 Mini Symposium: How do I ensure

quality in my endoscopy? Performance measures for upper GI endoscopy Performance measures for lower GI endoscopy Performance measures for ERCP and EUS Performance measures for small bowel and endoscopy M. Rutter, United Kingdom R. Bisshops, Belgium M. Kaminski, Poland D. Domagk, Germany C. Spada, Italy R. Valori, United Kingdom


10:00 – 10:30 What endoscopy can I offer to my overweight patients? M. Ibrahim, Belgium P. Eisendrath, Belgium

14:00 – 14:30 How do I manage biliary cancer by endoscopy? I. Hritz, Hungary S. Lakhtakia, India

UEG Week Final Programme : ESGE Learning Area

ESGE Learning Area 2016

The Ultrasound Learning Area promotes the role of a major diagnostic and interventional tool in gastroen-terology: Clinical ultrasonography in the hands of the gastroenterologist. The Ultrasound Learning Area offers individual hands-on training, a basic and an advanced course on ultrasonography for the gastroenterologist, which are designed for both, the beginner and the ex-perienced and lectures in abdominal ultrasonography in the topics Interventional US (INVUS), Elastography and Contrast Enhanced US (CEUS) presented by expert gastroenterologists.

Course directorsDieter Nuernberg, Neuruppin, GermanyOdd Helge Gilja, Bergen, NorwayIoan Sporea, Timisoara, Romania


Faculty membersKlaus Dirks, Winnenden, Germany Gabriele Hanenberg, Düren, GermanyChristian Jenssen, Strausberg-Wriezen, GermanyHorst Kinkel, Düren, GermanyGiovanni Maconi, Milano, Italy Thomas Mueller, Reutlingen, GermanyKim Nylund, Bergen, NorwayAlina Popescu,Timisoara, RomaniaAdrian Saftoiu, Craiova, RomaniaZeno Sparchez, Cluij, RomaniaStefan Uebel, Hitachi Co., GermanyJonas Valentinas, Vilnius, LithuaniaRune Wilkens, Copenhagen, Denmark

ULA

266

Moderation: A. Popescu, H. Kinkel

11:00 – 11:15 Examination of liver I. Sporea

11:15 – 11:30 Examination of gall bladder and bile duct H. Kinkel

11:30 – 12:30 Hands-on Training: Focus liver and biliary system Faculty

12:30 – 12:45 Physics and technique – setting up the machine and small introduction to technical details S. Uebel

12:45 – 13:00 Examination of pancreas J. Valentinas



Basic CoursePart I 09:00 – 16:00Basics and introduction in abdominal ultrasound examinationsModeration: I. Sporea, T. Mueller

09:00 – 09:10 Introduction and aims of the course I. Sporea

09:10 – 09:25 The view in the body – examination technique and Sonoanatomy A. Popescu

09:25 – 09:40 Abdominal vessels – landmarks T. Mueller

09:40 – 10:30 Hands-on Training: Focus abdominal vessels Faculty

10.30 – 11:00 Coffee Break

UEG Week Final Programme : Ultrasound Learning Area

Ultrasound Learning AreaRoom B1 in Hall 8.0

Programme Overview

Ultrasonography for the Gastroenterologist

SaturdayOctober 28, 2017

SundayOctober 29, 2017

MondayOctober 30, 2017

TuesdayOctober 31, 2017

WednesdayNovember 1, 2017

09:00 PART I09:00 – 16:00Basic Course

PART II09:00 – 16:00Advanced Course

Hands-on Training C09:00 – 11:30

Hands-on Training E09:00 – 11:30

PART V09:00 – 11:00Morning SessionCEUS10:00

11:00 Hands-on Training G11:00 – 14:00PART III

11:30 – 14:00Noon LecturesINVUS

PART IV11:30 – 14:00Noon LecturesElastography

12:00

13:00

14:00

Hands-on Training D14:30 – 18:00

Hands-on Training F14:30 – 18:0015:00

16:00 Hands-on Training A16:00 – 18:00

Hands-on Training B16:00 – 18:00

17:00

267

11:40 – 12:25 Hands-on Training: Liver segments, abdominal vessels Faculty

12:25 – 12:45 Pathology of gastrointestinal tract R. Wilkens

12:45 – 13:00 Better examination (tips and tricks) – live demonstration – how to find the appendix? G. Maconi


Moderation: O. H. Gilja, D. Nuernberg

14:00 – 14:15 Bile duct pathology: Causes of obstruction Z. Sparchez

14:15 – 14:30 Pancreas pathology – inflammatory changes O. H. Gilja

14:30 – 15:15 Hands-on Training: Focus pancreas and bowel Faculty

15:15 – 15:30 Other abdominal and retroperitoneal pathology interesting for gastroenter-ologists D. Nuernberg

15:30 – 15:55 Interesting cases – (video demonstration) Faculty

15:55 – 16:00 Closing remarks, certificates O. H. Gilja, D. Nuernberg

Hands-on Training B16:00 – 18:00Ultrasonography for the gastroenterologist


Hands-on Training C09:00 – 11:30Ultrasonography for the gastroenterologist

PART III 11:30 – 14:00Ultrasound Learning Area – noon lectures: Interventional ultrasound in gastroenterologyModeration: D. Nuernberg, T. Mueller

11:30 – 12:00 INVUS guidelines – special points C. Jenssen

12:00 – 12:30 Update Hygiene regime – recommen-dations of DEGUM T. Mueller

Moderation: A. Popescu, K. Nylund

14:00 – 14:15 Examination of (abdominal) lymph nodes R. Wilkens

14:15 – 15:00 Hands-on Training: Focus pancreas and retroperitoneum Faculty

15:00 – 15:15 Where to check for free fluid and gas? A. Popescu

15:15 – 15:30 First look at stomach and bowel – typical positions K. Nylund

15:30 – 15:55 Live demonstration and QUIZZ G. Hanenberg, H. Kinkel, A. Popescu

15:55 – 16:00 Closing remarks for the first day A. Popescu, I. Sporea

Hands-on Training A16:00 – 18:00Ultrasonography for the gastroenterologist


Advanced Course Part II 09:00 – 16:00 Pathology and special topics in abdominal ultrasound examinationsModeration: D. Nuernberg, I. Sporea

09:00 – 09:05 Introduction and aims of the course D. Nuernberg

09:05 – 09:20 Gall bladder pathology: Stones and tumours K. Dirks

09:20 – 09:35 Pancreas pathology – focal lesions C. Jenssen

09:35 – 09:50 Liver pathology: Diffuse changes I. Sporea

09:50 – 10:30 Hands-on Training: Bile duct, liver and portal system Faculty


Moderation: C. Jenssen, T. Mueller

11:00 – 11:10 Better examination (tips and tricks) – live demonstration D. Nuernberg

11:10 – 11:25 Focal liver lesions H. Kinkel

11:25 – 11:40 Pathology of abdominal vessels T. Mueller

Ultrasound Learning Area : UEG Week Final Programme

268

UEG Week Final Programme : Ultrasound Learning Area

Hands-on Training F14:30 – 18:00Ultrasonography for the gastroenterologist


PART V 09:00 – 11:00Ultrasound Learning Area – morning session: Contrast enhanced ultrasound (CEUS) in gastroenterologyModeration: H. Kinkel, D. Nuernberg

09:00 – 09:30 What is CEUS? How does it work? H. Kinkel

09:30 – 10:00 CEUS for benign lesions D. Nuernberg

10:00 – 10:30 CEUS for malign lesions I. Sporea

10:30 – 11:00 CEUS and interventions (abscess drainage) in IBD G. Maconi

11:00 – 11:300 EUS and CEUS C. Jenssen

Hands-on Training G11:00 – 14:00Ultrasonography for the gastroenterologist

12:30 – 13:00 Drainage of liquid collections Z. Sparchez

13:00 – 13:30 Biliary interventions D. Nuernberg

13:30 – 14:00 EUS interventions A. Saftoiu

Hands-on Training D14:30 – 18:00Ultrasonography for the gastroenterologist


Hands-on Training E09:00 – 11:30Ultrasonography for the gastroenterologist

PART IV 11:30 – 14:00Ultrasound Learning Area – noon lectures: Ultrasonography and elastography in gastroenterologyModeration: I. Sporea, A. Saftoiu

11:30 – 12:00 Classification of elastographic meth-ods and actual Guidelines T. Mueller

12:00 – 12:30 Transient Elastography (TE) for the liver A. Popescu

12:30 – 13:00 Point Shear Wave Elasticity (SWE) and 2D SWE of the liver I. Sporea

13:00 – 13:30 Elastography in CED K. Nylund

13:30 – 14:00 Others applications of elastography in gastroenterology A. Saftoiu

Organised and supported by EFSUMB and ISCUS Supported by Hitachi Co., GE Co. and Bracco

Building on last year’s success, the UEG Surgical block welcomes delegates to this second offering in hands-on training and educational modeling for surgeons in GI Surgery and associated disciplines.

There will be 3 courses on offer to experience live hands-on training and demonstrations involving both simulation and anatomical models.

Colorectal Laparoscopic skills (LSS Grade 2), Trans Anal Microsurgery and Introduction into basic Laparoscopic skills. (Conditions apply)

In addition, there will be the general education area with activities such as case based discussions, meet the expert and video sessions.

The purpose of the area is to broaden the awareness within the GI community for the surgical perspective within GI Care and vice versa and attract attendees to gain a broader insight in surgical education and hands on training procedures.


Faculty membersM. Adham, FranceA. Arezzo, ItalyJ. Izbicki, GermanyJ. Jakimowicz, The NetherlandsI. Jenkins, United Kingdom M. Morino, ItalyM. van Berge Henegouwen, The NetherlandsY. Vashist, SwitzerlandP. Ignatavicius, LithuaniaO. Aziz, United KingdomC. Thorn, United Kingdom

270

UEG Week Final Programme : Surgical Learning Area

Information desk | Simulation demonstrations | Running videos09:00 – 12:00 General Area

Course One: Laparoscopic surgical skills grade 2 colorectal surgery hands-on course09:15 – 17:30 Room E6

Programme09:15 Welcome, introduction & course outline09:30 Baseline evaluation, suturing, knot tying

assessment and peer assessment11:00 Expert session: interactive clinical based

discussion: Safe use of tissue energisers Safe use of tissue approximation and stapling

13:30 Expert session: interactive clinical based discussion: Set-up for left hemicolectomy Step by step left hemicolectomy Critical steps in left hemicolectomy

14:00 Practical: bowel anastomosis Suturing anas-tomosis – side to side and end to end

16:30 Expert session: interactive discussions on case scenarios and video clips of left hemicolectomy

17:00 Closure of day

Simulation demonstrations | Running videos14:00 – 18:00 General Area

Basic laparoscopic skills course14:00 – 17:00 General Area

14:00 – 14:30 Introductory lecture14:30 – 16:00 Practical skills training16:30 – 17:00 Practical skills assessment

Surgical Learning AreaHall 8.0 Saturday, October 28, 2017

Simulation demonstrations | Running videos 09:00 – 12:30 General Area

Basic laparoscopic skills course: Part I09:00 – 12:00 General Area


TEO/TEM Theory and Discussion09:00 – 11:00 Room E5

09:00 Anatomical hints for transrectal excision (Arolfo)09:10 Indications and Results for local excision of

rectal lesions (Morino)09:30 The instrumentation: Evolution, present

standard, future development (Allaix)09:40 The technique: Tips and tricks (Arezzo)09:50 General or spinal anesthesia? (Morino)

TEO/TEM hands-on instructionHands-on 6 stations, 30 min per candidate11:00 – 12:00 Room E5

Course One: Laparoscopic surgical skills grade 2 col-orectal surgery hands-on course09:00 – 17:00 Room E6

Programme09:00 Introduction & course outline day 209:30 Expert session: interactive clinical based

discussion: Set-up and steps of right hemicolectomy Step by step right hemicolectomy Critical steps in right hemicolectomy

11:00 Expert session: interactive clinical based discussion on right hemicolectomy: Case scenarios

11:30 Laparoscopic bowel suturing and assessment, peer assessment and self assessment session 1


General Information for Saturday and Sunday | Coffee Breaks: 10:30 – 11:00 and 15:30 – 16:00 | Lunch Break: 13:00 – 14:00

271

13:30 Testing session: Complications in colon surgery: case scenarios: tips & tricks of trouble shouting

15:30 Laparoscopic bowel suturing assessment, peer assessment and self assessment session 2

16:30 Closure of day 2


Basic laparoscopic skills course: Part II14:00 – 17:00 General Area




Basic laparoscopic surgical skills: Part I09:00 – 12:00 General Area


TEO/TEM Theory and discussion09:00 – 11:00 Room E5

09:00 Anatomical hints for transrectal excision (Arolfo)

09:10 Indications and Results for local excision of rectal lesions (Morino)

09:30 The instrumentation: Evolution, present standard, future development (Allaix)

09:40 The technique: Tips and tricks (Arezzo)09:50 General or spinal anesthesia? (Morino)


Surgical Learning Area : UEG Week Final Programme


General Information for Monday | Coffee Breaks: 10:00 – 10:30 and 15:30 – 15:45 | Lunch Break: 12:00 – 14:00

272

UEG Week Final Programme : Surgical Learning Area


Basic laparoscopic skills course: Part I09:00 – 12:00 General Area



Course Two: Laparoscopic surgical skills grade 2 colorectal surgery hands-on course09:00 – 17:00 Room E6

Programme09:00 Introduction & course outline day 209:30 Expert session: interactive clinical based

discussion: Set-up and steps of right hemicolectomy Step by step right hemicolectomy Critical steps in right hemicolectomy

11:00 Expert session: interactive clinical based discussion on right hemicolectomy: Case scenarios

11:30 Laparoscopic bowel suturing and assessment, peer assessment and self assessment session 1

13:30 Testing session: Complications in colon surgery: case scenarios: tips & tricks of trouble shouting

15:30 Laparoscopic bowel suturing assessment, peer assessment and self assessment session 2

16:30 Closure of day 2

Course Two: Laparoscopic surgical skills grade 2 colorectal surgery hands-on course09:15 – 17:30 Room E6

Programme09:15 Welcome, introduction & course outline09:30 Baseline evaluation, suturing, knot tying

assessment and peer assessment11:00 Expert session: interactive clinical based

discussion: Safe use of tissue energisers Safe use of tissue approximation and stapling

13:30 Expert session: interactive clinical based discussion: Set-up for left hemicolectomy Step by step left hemicolectomy Critical steps in left hemicolectomy

14:00 Practical: bowel anastomosis Suturing anas-tomosis – side to side and end to end

16:30 Expert session: interactive discussions on case scenarios and video clips of left hemicolectomy

17:00 Closure of day






General Information for Monday and Tuesday | Coffee Breaks: 10:00 – 10:30 and 15:30 – 15:45 | Lunch Break: 12:00 – 14:00

Surgical Learning AreaHall 8.0 Monday, October 30, 2017

273

Surgical Learning Area : UEG Week Final Programme





The Surgical Learning Area is run courtesy of:

And kindly supported by:



Basic laparoscopic skills course09:00 – 12:00 General Area



Course Two: Laparoscopic surgical skills grade 2 colorectal surgery hands-on courseDetailed assessment, evaluation and discussion09:00 – 14:00 Room E6

General Information for Tuesday | Coffee Breaks: 10:00 – 10:30 and 15:30 – 15:45 | Lunch Break: 12:00 – 14:00

General Information for Wednesday | Coffee Break: 10:00 – 10:30 | Lunch Break: 12:00 – 14:00

Find out more, visit the UEG Booth in Hall 8.0or www.ueg.eu/education

Education from every angleOur classroom courses offer hands-on trainingin a range of medical specialities, with activitiesincluding case-based sessions, small-groupdiscussions, workshops and lectures as well as networking events.

Classroom Courses Young Investigators

MeetingMarch 16–18, 2018

Vienna, Austria

Evidence Based Medicine Course

October 20–21, 2018Vienna, Austria

Summer School May 24–27, 2018

Prague, Czech Republic

Basic Science Course

June 27–29, 2018Leuven, Belgium

17_09_Inserat_UEGWEEK_FP_ClassroomCourses_160x220mm_RZ.indd 1 14.09.17 15:29

Evidence Based Medicine Course

276

Programme Overview

Module AClinical questions: From clinical practice to answerable questionsExercises based on patient histories

Module BSearch literature databases: From the question to po-tentially relevant evidenceInteractive lecture, hands-on exercise on the computer

Module CCritical appraisal: From the papers to critically ap-praised new knowledgeSmall group work, interactive lectures

Module DEBM transfer: From critically appraised new knowledge to changed practice & from learning to teaching EBM skillsSmall group work, theory input and video analysis

Please note that this meeting takes place outside of the core scientific programme and attendance is by invita-tion only.

This course, designed for junior and senior physicians alike, aims to teach Evidence Based Medicine (EBM) principles and how they can be applied in daily clinical work.

The course combines interdisciplinary clinical cases with questions of diagnosis and therapy, and identifies opportunities to integrate EBM into clinical practice. Delegates will be guided by tutors and stimulated with short input lectures, they will work in break-out groups and discuss the results achieved.

Faculty membersAlexander Ford (Leeds, United Kingdom)Sanjiv Mahadeva (Kuala Lumpur, Malaysia)Leonardo Eusebi (Bologna, Italy)Gavin Johnson (London, United Kingdom) John Kane (Leeds, United Kingdom)Anne Lund Krarup (Aalborg, Denmark) Björn Lindkvist (Gothenburg, Sweden)Andre Mihaljevic (Heidelberg, Germany)

UEG Week Final Programme : Evidence Based Medicine Course

Evidence Based Medicine CourseSaturday and Sunday, October 28–29, 2017

Apply for the upcoming Evidence BasedMedicine Course, taking place at UEG WeekVienna 2018!

Application deadline: July 13, 2018

The ʻUEG Evidence Based Medicine Courseʼ is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. The 'UEG Evidence Based Medicine Course' is designated for a maximum of 11 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

21st ESGENA Conference

Hosted by the Spanish Society of Endoscopy Nurses and Associates (AEEED) and the Spanish Society of Digestive Disease Nurses (AEEPD)

In Conjunction with the 25th United European Gastro- enterology Week

Further information: www.esgena.org

278

UEG Week Final Programme : 21stESGENA Conference

programme of UEG Week ensures that the ESGENA con-ference will be an exceptional educational event.

In 2017 the UEG celebrates its 25th anniversary in Barce-lona, offering interesting and interactive learning for-mats which emphasise the multidisciplinary approach.

Enjoy the warm Spanish hospitality of Barcelona, com-bined with the multicultural atmosphere of an interna-tional meeting.

We welcome you to the 21st ESGENA Conference and 25th UEG Week in October 2017 in Barcelona.

Jadranka BrljakPresident of ESGENA

Enriqueta Hernández-Soto President of AEEED

Guillermo José Garcia SolaPresident of AEEPD

Dear colleague,

On behalf of ESGENA, the Spanish Society of Endos-copy Nurses and Associates (AEEED) and the Spanish Society of Digestive Disease Nurses (AEEPD) it is our great pleasure to welcome you to the 21st ESGENA Con-ference, which is being held during the 25th United Eu-ropean Gastroenterology Week, October 28–30, 2017, in Barcelona, Spain.

Following past meetings in 2010 and 2015, this is the third time that the medical and nursing community of gastroenterology and endoscopy will meet in Barcelona.

After celebrating its 20th anniversary in 2016, ESGENA will continue its established structures while also ini-tiating new formats of interactive learning. Recent suc-cesses have already connected countries and have laid the foundation for new future projects.

The three day ESGENA conference is not only an oppor-tunity to meet colleagues from throughout Europe, but also from North and South America, Africa, Asia and Aus-tralia. The exchange with nurses from all over the world combined with the opportunity to attend the medical

21st ESGENA ConferenceWord of Welcome

279

21th ESGENA Conference : UEG Week Final Programme

Programme Overview


Lecture Halls Room B2 Room B3 Room E4 Room B5 ESGE Learning Area

09:0

0 –

16:0

0

UEG Week Postgraduate Teaching Programme

09:0

0 –

10:3

0


11:0

0 –

13:0

0


14:0

0 –

15:3

0

Workshop 1Stop the bleed-ing: What is the best device in which situation?

Organised by Olympus Europa

Workshop 2Controlling the Procedure: The Nurses Role in ERCP and Infec-tion Prevention

Organised by Boston Scientific

Workshop 3Endoscope repro-cessing: Trends, current stan-dards, process innovations

Organised by BHT & Dr. Weigert

Workshop 4Actualización enreprocesamiento de Duodenos-copiosy controlde calidadDuodenoscopere-processing and-quality control update Organised byAEEED & OlympusSpain

Workshop 5Hands–on training on biosimulators: • Upper GI

bleeding • ERCP• Colonoscopy


16:0

0 –

17:3

0

Workshop 6Future endoscope reprocessing – A closer view into room concepts

Organised byOlympus

Workshop 7Actualización en hemostasia, técni-casmecánicasUpdate on hemo-stasis, mechani-cal techniques

Organised byAEEED & Boston Scientific Spain

Workshop 8 The Complete Cir-cle of Protection

Organised byCantel

Workshop 9Electrosurgery – Prevention of complication

Organised by Erbe

Workshop 10Hands–on training on biosimulators• Upper GI

bleeding • ERCP• Colonoscopy

17:3

0 –

19:0

0

ESGENA Annual General Assembly

280

UEG Week Final Programme : 21st ESGENA Conference


Room B2 Room B3 Poster Area ESGE Learning Area

09:0

0 –

10:3

0 Session 1Free Paper I

Session 2Liver transplantation

10:30 – 11:00 Coffee Break Poster Round I

11:0

0 –

12:3

0 Session 3Free Paper II

Session 4Education

Workshop 11Hands-on training on bio simulators • Upper GI Bleeding • ERCP


12:3

0 –

15:0

0 Lunch Session 1GE Endoscopy

Lunch Session 2Hygiene and infection control

Poster Round II Workshop 12Hands-on training on bio simulators: • ERCP • Colonoscopy

15:0

0 –

16:3

0 Session 5Management

Session 6Endoscopic techniques


17:0

0 –

18:0

0 Session 7Colo rectal cancer screening

Session 8When unforeseen happens …


Room A2

08:30 – 10:00Best Free Paper and Best Poster Award

ESGENA Plenary Session: Controversial discussions in endoscopy Invitation to next conferences


10:30 – 12:00Visit of exhibition

ESGE Learning AreaUEG Week sessions



ESGE Learning AreaUEG Week sessions



ESGE Learning AreaUEG Week aessions

281


This workshop will :• Highlight the importance of teamwork during an

ERCP procedure while using single use devices• Provide an update on infection risks in endoscopy

units and tips on how to provide quality control during cleaning and disinfection of reusable material

• Offer hands-on experience with our RX biliary devices as well as our new infection prevention line of products

Workshop 314:00 – 15:30 Room B3

Endoscope reprocessing: Trends, current standards, process innovationsThis workshop is organised by Chemische Werke Dr. Weigert and BHT

Workshop language: English

Chairs: Thomas Brümmer, Germany Stefan Stülpnagel, Germany

Aims & ContentPart 1: Process chemistry: overview – trends – active substances – Cleaning & disinfection processesThe individual steps for a safe reprocessing of endo-scopes are defined by national and international recom-mendations. Different active substances and processes have been established for manual and automated re-processing of endoscopes. This part of the workshop will answer the following questions:• What are the different active substances for manual

and WD (washer disinfector) reprocessing?• How good is the cleaning performance of different

active substances and how is it tested?• What impact do different process chemicals have on

treatment processes?

Presentations:Different active substances in the cleaning and disinfec-tion of flexible endoscopesMarkus Kamer, Germany

Part 2: Process improvements in endoscope reprocess-ing: simpler – safer – faster – more cost-effectiveAutomated reprocessing with WD (washer disinfectors) has become standard practice. This part of the work-shop works out what has to be taken into account to make reprocessing procedures more hygienic – simpler,


Stop the bleeding: What is the best device in which situation?This workshop is organised by OLYMPUS EUROPA SE & CO. KG


Chairs: Jens Niehaus, Germany Karina Yacoub, Germany

Aims & ContentThis workshop is all about hemostasis. You will learn about different endoscopic cases and their specific pro-cedures. In addition, there will be tips and tricks use-ful for the nurse’s daily work. During this workshop, we will offer the opportunity to improve your skills of choosing and handling the right device to stop the bleeding. It includes a hands-on training within the broad range of the hemostasis-area under supervision and support of highly experienced tutors.

After the theoretical part, an intensive hands-on will follow, where you may gain further knowledge and handling-skills about the following techniques in he-mostasis:• Diathermy • Injection • Looping • Clipping


Controlling the Procedure: The Nurses Role in ERCP and Infection PreventionThis workshop is organised by Boston Scientific


Chair: Marc Ellrichmann, Germany

Aims & ContentThe goal of this workshop is to highlight the nurses role during an ERCP procedure from start to finish. You will learn about various tips and techniques for pre-proce-dure, during the procedure as well as post procedure to reduce risks to the patient.

Scientific ProgrammeSaturday, October 28, 2017

282

UEG Week Final Programme : 21th ESGENA Conference

faster and cheaper. There are numerous innovations and process optimisations available:• Simpler: There are numerous approaches, which fa-

cilitate the process, e.g. documentation.• Safer: Technical solutions for enhanced safety in au-

tomated endoscope reprocessing.• Faster: Often endoscopists must wait for endoscopes.

Find out how you can speed up the process incl. drying.• Low cost: The cost of reprocessing is high – especially

concerning consumption of chemicals, consequential costs, damaged endoscopes and endoscope purchas-es. The workshop looks at possibilities to save costs

Presentations:Process improvements in endoscope reprocessing: Simpler – safer – faster – more cost-effectiveStefan Stülpnagel, Germany

Workshop 414:00 – 15:30 B5

Actualización en reproceso de duodenoscopios, material endoscópico y control de calidad / Update in duodenoscope reprocess, endoscopy material and quality controlThis workshop is organised by AEED and OLYMPUS EUROPA SE & CO. KG

Workshop language: Spanish

Chairs: Montserrat Medina, Spain Silvia Carnicer, Spain

Objetivo y Contenido / Aims & ContentActualización de conocimientos y desarrollo de las habi-lidades para fomentar las buenas prácticas en el reproc-esamiento de materiales y equipos de las unidades de endoscopia digestiva. Conocer las mejoras en el reprocesa-miento de los endoscopios y material reutilizable y los mét-odos de limpieza y esterilización disponibles. El contenido, actualización sobre riesgos de infección de las unidades de endoscopia digestiva. Limpieza y desinfección de material reutilizable y control de calidad.

Workshops:• Material reutilizable y desechable usado en departa-

mentos de endoscopia• Reprocesamiento de los nuevos endoscopios (duode-

noscopios)

Knowledge update and Development of skills to pro-mote good practices in the reprocessing of materials and equipment of digestive endoscopy units. To know the improvements in the reprocessing of endoscopes and reusable material and the available methods of cleaning and sterilization available The content, update on risks of infection of digestive endoscopy units. Cleaning and disinfection of reusable material and quality control.Workshops:

• Reusable material and single us common in Endosco-py department

• New generation scope reprocessing steps (duodenos-copes)

Workshop 514:00 – 15:30 ESGE Learning Area

Hands-on training on bio simulators This workshop is organised by ESGENA


Chairs: Eric Pflimlin, Switzerland Michael Ortmann, Switzerland

Aims and ContentHands-on training on bio simulators (pig models) under the supervision of highly experienced tutors: Participants will have the opportunity to perform endo-scopic techniques on the following topics: • OGD with Injection techniques, ligation, clipping, APC • Colonoscopy with polypectomy, EMR and APC • ERCP with stone extraction and stenting

As participation will be limited, registration will be treated on a first-come, first-served basis: Tickets will be available onsite only – at the entrance of the ESGE Learning Area.

283

El Objetivo del taller es: • Actualizar las técnicas hemostásicas• Describir cómo aplicar las técnicas mecánicas de he-

mostasia y conocer diferentes dispositivos de hemosta-sia mecánica

Endoscopic hemostasis, is safe and effective, reduces the recurrence rate, the need for surgery and mortality in upper GI Bleeding. In low digestive bleeding, iatrogenic (mainly Polypectomy) is one of the most frequent causes. Mechanical techniques, coupled with another method of endoscopic hemostasis, contribute to enhance the effica-cy and safety of the treatment of digestive bleeding.

The aim of the workshop is: • Update the hemostasis techniques • Describe how to apply the mechanical techniques

of hemostasis and to know different devices of me-chanical hemostasis.

Workshop 816:00 – 17:30 Room E4

The ‘Complete Circle of Protection’ This workshop is organised by CANTEL


Chair: Cheri Ackert-Burr, The Netherlands

Aims & Content Delivering the ‘Complete Circle of Protection’, a full-val-ue, proactive partnership dedicated to helping you re-move risk, streamline operational efficiencies and opti-mize your success.This part of the workshop focuses on the 4 stages of an endoscopes journey and looks at how you can maximize efficiency and improve patient safety at each stage.• Procedure: Defendo, amplifeye and Endo Stratus –

improving patient safety and outcomes • Manual clean: Scope Buddy – reducing the manual

process and improving the process• Reprocessing: Pass-Through machines – improving

process flow with CLEAN and DIRTY sides• Dry & store: Cleanascope carts & Endodry – protect-

ing the scope and ensuring clear identification of clean & dirty


Future endoscope reprocessing – A closer view into room concepts This workshop is organised by OLYMPUS EUROPA SE & CO. KG


Chairs: Holger, Biering, Germany Reinhard Blum, Germany

Aims & Content During the last 15 years, reprocessing of flexible endo-scopes has become an important and accepted discipline within the area of medical GI endoscopy. During that time, the workflow of endoscopes between patient examinations has become more and more standardised, automated en-doscope reprocessing machines (WD) are state-of-the-art in almost every endoscopy unit. International and national guidelines have been updated or newly released, focusing on patient and user safety. In this context, guidelines often recommend to clearly separate contaminated from clean steps in the reprocessing workflow, optimally by creating separate zones or even rooms for reprocessing.

This workshop will:• inform about relevant guidelines dealing with repro-

cessing room and workflow design• provide an overview of aspects to be considered for

set-up of endoscope reprocessing rooms• give examples of latest endoscope reprocessing room

designs• allow to practically experience how to set-up suit-

able reprocessing rooms based on real examples


Actualización en hemostasia, técnicas mecánicasUpdate on hemostasis, mechanical techniquesThis workshop is organised by AEEED and Boston Scientific

Workshop language: Spanish

Chairs: Alicia Sánchez Rubio, Spain Laura Moreno Salas, Spain

Objetivo y Contenido / Aims & ContentLa hemostasia endoscópica, es seguras y eficaz, reduce la tasa de recidiva, la necesidad de la cirugía y la mortali-dad en la HDA. En la HDB, la yatrogenia (principalmente la polipectomía) es una de las causas más frecuentes. Las técnicas mecánicas, sumadas a otro método de hemostasia endoscópica, contribuyen a potenciar la eficacia y seguri-dad del tratamiento de la hemorragia digestiva.


284


Scientific ProgrammeSunday, October 29, 2017

Session 109:00 – 10:30 Room B2

Free Paper I Chairs: Irene Dunkley, United Kingdom

Montse Victor, Spain Wendy Waagenes, Denmark Gerlinde Weilguny, Austria

09:00 – 09:15Welcome Jayne Tillett, United Kingdom

09:15 – 09:30 Nursing need theory potentially applied in gastrointes-tinal endoscopy setting Giulia Marika Futura Beorchia, Roberta Mattiola, Italy

09:30 – 09:45A ‘Debriefing’ method to improve gastroenterology nursing practicesRuhama Podoler, Ian M. Gralnek, Israel

09:45 – 10:00The quality of life of patients with inflammatory bowel diseases treated by biological therapyMarija Zubčić, Croatia

10:00 – 10:15Straight to scope – should iron deficiency anaemia re-ferrals go automatically to scope?Dominique McGinlay, Naismith G, United Kingdom

10:15 – 10:30Review of the number of endoscope repairs and loans re-quired after implementation of a new tip protection deviceEsther McBurney, United Kingdom


Electrosurgery – Prevention of complication This workshop is organised by ERBE Elektromedizin GmbH


Chairs: Thomas Beck, Germany Björn Fehrke, Switzerland

Aims and ContentElectrosurgery is a technology which is widely used during endoscopic procedures. It allows to cut and co-agulate using electric current. A broad range of differ-ent modes, effects and settings is possible, depending on the planned procedure. With argon plasma coagula-tion (APC) tissue can be devitalized and bleedings can be treated. Elevation can be achieved with the use of a waterjet device.

The aim of the workshop is: • To update on principles of electrosurgery• To get a deeper understanding of the use of electro-

surgery and APC in endoscopic procedures• Practical demonstration of settings for different appli-

cations like Polypectomy, EMR, ESD, Papilloectomy, etc.• How to achieve maximum safety for the patient and

how to prevent adverse events and complications


Hands-on training on bio simulators This workshop is organised by ESGENA


Chair: Eric Pflimlin, Switzerland Michael Ortmann, Switzerland

Aims and ContentHands-on training on bio simulators (pig models) under the supervision of highly experienced tutors: Participants will have the opportunity to perform endo-scopic techniques on the following topics: • OGD with Injection techniques, ligation, clipping, APC • Colonoscopy with polypectomy, EMR and APC • ERCP with stone extraction and stenting

As participation will be limited, registration will be treated on a first-come, first-served basis. Tickets will be available onsite only – at the entrance of the ESGE Learning Area.

285

P-4 Gastroenterology nurse administered dexmedeto-midine for ESD.Chaya Baruchi, Galina Garberg, Dganit Daniel Avdar, Israel


Free Paper IIChairs: Irene Dunkley, United Kingdom

Montse Victor, Spain Wendy Waagenes, Denmark Gerlinde Weilguny, Austria

11:00 – 11:15Awake! The effects of unsedated colonoscopy on ade-noma detection rateJane Magtoto, Jay Lardizabal, William Karnes USA

11:15 – 11:30Gastrostomy tube tract length: Does it change with the child's growth?Rachel Leshem-Namedar, Yael Adler Batia Weiss, Israel

11:30 – 11:45High incidence of minor adverse events after endoscop-ic mucosal resection or submucosal dissection for col-orectal tumorsYe Lim Song, Kyung-Jo Kim, Jeong-Sik Byeon, Ji Hye Kim, Yeo Ok Kim, Dong-Hoon Yang, Sang Hyoung Park, Sung Wook Hwang, Eun Mi Song, South Korea

11:45 – 12:00Endoluminal vacuum therapy in anastomotic leakages at rectal level.Pedro Luis Del Mazo Tomé, Alejandro Toledo Soriano, Cristina Viñuela Lobo, María Del Mar Gutiérrez García, Aida Longoria Argüelles, Spain

12:00 – 12:15The role of endoscopy nurse in removal foreign bodies from the upper gastrointestinal tract in childrenMirela Kubicz, Livia Dumitra, Valentina Vulpe, Cornelia Tudor

12:15 – 12:30 Digital, direct pancreatoscopy in chronic pancreatitis can change patient management – A case reportPetra Holzky-Haselbach, Sandra Krüger, Alexander Arlt, H. Aselmann, T. Becker, Mark Ellrichmann, Germany



Liver transplantation Chairs: Jadranka Brljak, Croatia

Eva Ramon Abal, Spain

09:00 – 09:10Welcome Jadranka Brljak, Croatia

09:10 – 09:30How to make liver transplantation a success? Jasna Brezak, Croatia

09:30 – 09:50Acute care of patient after liver transplantation Anna Aliberch, Spain

09:50 – 10:10Psychological aspects in the care of liver transplant patients Vlatka Rafaj, Croatia

10:10 – 10:30Complications after liver transplantation – the endoscop-ic approach Jacques Deviere, Belgium

Poster Round I10:30 – 11:00 ESGENA Poster area in front of Room E4 Chairs: Joan Skovlund Christensen, Denmark

Fanny Durand, France Minerva Galvez-Martin, Spain Jayne Tillett, United Kingdom

Sedation P-1 The role of nurse conducted informed consent in digestive endoscopy. A case-control studyAdriana-Sidela Leca, Valeria-Danuta Mihnea, Institute of Gastroenterology and Hepatology, Iasi, Romania

P-2 Assessing the postal consent for upper gastroduo-denal endoscopy Ama Badu, Natalia Cambon Bonet, Sarah Gibbings and Roxana Lupu, United Kingdom

P-3 Conventional sedation with midazolam and sufen-tanil is safe and feasible for endoscopic treatment of walled-off pancreatic necrosisSisse Rysgaard, Camilla Ramvold, Palle Nordblad Schmidt, Lise Lotte Gluud, Srdan Novovic, Denmark

286


Poster Round II13:30 – 15:00 ESGENA Poster area in front of Room E4 Chairs: Joan Slovlund Christensen, Denmark

Fanny Durand, France Minerva Galvez-Martin, Spain Jayne Tillett, United Kingdom

Upper GIT

P-5 Foreign bodies in the upper gastrointestinal tractMladenka Buić Gržeta, Boris Kopić, Katarina Matošević, Kristina Bego, Merima Salešević, Croatia

P-6 The comparison of pre-procedural anxiety for EsophagogastroduodenoscopySunghee Cho, South Korea

P-7 The role of the endoscopic nurse in the manage-ment of patient with acute pancreatitis undergoing to endoscopic necrosectomyGiulia Provenzano, Italy

P-8 Workload related to histological analysis in gas-troscopyCinzia Rivara, Daniela Carretto Teresa Iannone, Italy

Service & quality assurance

P-11 Comparison of sugared Polyethylene Glycol solu-tion versus Polyethylene Glycol solution for colonoscopy Ok Yeon Cho, Mi Yeong Kim, Ki Young Sung, Sun Hee Nam, Jun Won Chung, South Korea

P-10 Divided dose different day and same day drug use comparison in colon cleaning Tacettin Güngör, Mahmut Atas, F. Şentürk, S.Özarabaci, M.Türkbeyler, D.Sevindik, Mahmut Caneken Agil Ağakişiyev, M. C. Savaş, Turkey

P-11 Pressure on abdomen and position change during colonoscopy: A routine procedure?Tacettin Güngör, Mahmut Caneken, Mahmut Ataş, M. Sait Dağ,Nimet Yilmaz, Hakan Çam, Agil Agakişiyev, Turkey

P-12 Improvement Activities for Reducing Colonic Per-foration in ColonoscopyNalae Jo, South Korea

P-13 Screening for colorectal cancer: nursing interven-tion in intestinal preparation prior to colonoscopy.María Elena de la Torre, Nuria Rivas, María del Mar Pascual, María Jesús García, Spain


Education – Different approaches in Europe Chairs: Helen Griffiths, United Kingdom

Marjon de Pater, The Netherlands

11:00 – 11:15What kind of staff is needed in Endoscopy Ulrike Beilenhoff, Germany

11:15 – 11:35 What kind of specialist education and training is needed in Endoscopy? Experience from Estonia Siiri Maasen, Estonia

11:35 – 11:55 Endoscopy diploma at university – the French experience Fanny Durand and Mikael Mochet, France

11:55 – 12:15 E-Learning, Apps and YouTube innovate communication and training – what makes sense? What infrastructure is needed? José Manuel Martínez Gonzalez, Spain

12:15 – 12:30 Nursing Education – Combining Real & Virtual Training (Boston Scientific)NN


Hands-on training on bio simulators This workshop is organised by ESGENAChairs: Eric Pflimlin, Switzerland

Michael Ortmann, Switzerland

Hands-on training on bio simulators (pig models) un-der the supervision of highly experienced tutors. Partic-ipants will have the opportunity to perform endoscopic techniques on the following topics: • Upper GI Bleeding • ERCP As participation will be limited, registration will be treated on a first-come, first-served basis. Ticket will be available onsite only – at the entrance of the ESGE Learning Area.

287


Education & management

P-23 A new era for GI endoscopy nursing in MalaysiaRosalin Maria P.Sulit, Malaysia

P-24 Do you prescribe professional health apps?Antonio Torrejón, Octavi Rodríguez, Miguel A. Mayer, Spain

P-25 Design and implementation of a scientific update app for healthcare professionalsLorena Villa, Octavi Rodríguez, Antonio Torrejón, Spain

P-26 Transforming skills in practice. The experience of the European Endoscopy Training Center.Fabio Grilli, Anna Di Gemma, Cinzia Rivara, Davide Cordioli, Guido Costamagna, Italy

P-27 Development of Web-based Job Training Program for Nurses in Gastrointestinal Endoscopy Unit Kwon EunJu, Jung EunJu, Lee HangMi, Kim BoKoung, KIm YoungHui, Lee YoHan, Jung KwuyIm, South Korea

P-28 The experience of a nurse-operated referral center for Video-capsule EndoscopyOsnat Kalnizki, Inna Brin,Jorge Liechtmann, Israel

Lunch Session 112:30 – 15:00 Room B2

Endoscopic techniques This lunch session is organised by ESGENA

Chairs: Sylvia Lahey, The Netherlands Daniela Burtea, Romania

12:30 – 12:40Personal protection equipment – the forgotten topic for health care workers in endoscopy (Boston Scientific) Andrea Sochart, Germany

12:40-12:50Advantages of the OTSC® System in the treatment of UGIB (ovesco Endoscopy AG) Antonio Caputo, Germany

12:50-13:00Endoscopic tissue ablation – Techniques and instru-ments (Miro-tech Europe) Andreas Jung, Germany

P-14 Challenges of nursing and treatment management in a case of active ulcerative colitis with an uncommon extraintestinal manifestationCarmen Dirzu, Nicoleta Melinte, Carol Stanciu, Cristina Muzica, Oana Stoica, Stefan Chiriac, Anca Trifan, Romania

P-15 The influence of biological therapy on the quality of life of patients with inflammatory bowel diseaseŽeljka Pušeljić, Lidija Tomas, Maja Čebohin, Croatia

P-16 The role of the nurse in the endoscopic treatment with hemorrhoidal rubber bands ligationMartín Arias MC, García Zafra B, Pérez Oltra A, Ráez Frías RM, Vilar García M. Spain

Liver

P-17 Investigation of the information levels of patients about complications of chronic HBV – HCV diseasesTacettin Güngör, Nurevşan Kuşdoğan, Esra Ekiciler, Bahadır Edizer, A .Emre Yildirim, M.Taner Gülşen, Turkey

P-18 Challenges of nutritional intervention in patients with liver cirrhosis in a tertiary care center from north-eastern Romania: the perspective of the nurseAna Maria Rotaru, Valeria Dănuța, Carol Stanciu, Cristina Muzica, Irina Girleanu, Stefan Chiriac, Anca Trifan, Romania

P-19 Hepatitis B Virus (HBV) Transmission from 202 Con-firmed Viraemic Patients to Gastrointestinal Endoscopes and Current Infection Prevention Procedure EvaluationYatao Liu, Lihua Zhou, Qiong Deng, Yunchao Yang, Xiaodan Shao, China

Hygiene

P-20 Digital manual for adequate disinfection of flexible endoscopesAnna-Karin Olsson, Violetta Engelbrektsson, Sweden

P-21 The situation and quality control in the endoscopes reprocessing in ChinaXi Huijun, China

P-22 Development and application of an instrument for cleaning endoscopes and the effect of an enzymatic cleaner on removal of biofilm from endoscopes and the level of job satisfactionInJa Yoon, South Korea

288


Hands-on training with the companies Chairs: Eric Pflimlin, Switzerland

Michael Ortmann, Switzerland

Hands-on training on bio simulators (pig models) un-der the supervision of highly experienced tutors. Participants will have the opportunity to perform en-doscopic techniques on the following topics: • Colonoscopy • ERCP As participation will be limited, registration will be treated on a first-come, first-served basis. Ticket will be available onsite only – at the entrance of the ESGE Learning Area.


Management – which structure is needed?Chairs: Enriqueta Hernandez-Soto, Spain

Yuri Guriel, Israel

15:00 – 15:20 Optimising the workflow in Endoscopy Marjon de Pater, The Netherlands

15:20 – 15:40Implementation of checklists in daily routine – benefits & difficulties Peter Sirsema, The Netherlands 15:40 – 16:00How to assess and measure competence of the nurse assisting with endoscopic procedures?Laura Dwyer, United Kingdom

16:00 – 16:15How to calculate staff in Endoscopy – different ap-proachesUlrike Beilenhoff, Germany

16:15 – 16:30Building a comprehensive approach to medical device hygiene and infection control (Pentax) Hudson Garrett Jr., USA

13:00-13:10Electrosurgery in Endoscopy – How confident are you? (Olympus Europa SE & Co. KG) Philipp Grzeskowiak, Germany

13:10-13:20Novelties in reprocessing of duodenoscopes (KARL STORZ GmbH & Co. KG) Guido Merk, Germany 13:30-15:00Hands-on training with the companies Lunch Session 212:30 – 15:00 Room B3

Hygiene and infection control This lunch session is organised by ESGENA

Chairs: Björn Fehrke, Switzerland Maja Ilijevska, Macedonia

12:30-12:40Evolution of a total green automated system for effec-tive and safe endoscope reprocessing (CBC Europe)Monica Cimbro, Italy

12:40-12:50One Connection System = more safety, less cross con-tamination & faster reprocessing (Steelco) Monica Menin Ostani, Italy

12:50-13:00Ensure the hygiene control of your endoscope reprocess-ing eco system to guarantee patient safety (Soluscope)David Derrien, France

13:00-13:10Efficacy of endoscope reprocessing; what we know and what we can do about it (Pulthru)Rodolphe Hervé, United Kingdom

13:10-13:20A step further in perfection for endoscopy pre – clean-ing Ultrazonic Nancy Steenbakkers, Belgium

13:30 – 15:00Hands-on training with the companies


289


17:40 – 18:00The nurses role in colo rectal cancer screening Mireia Díaz Centeno, Spain

18:20 – 18:30 EMR, ESD – which technique for which polyp and which location? Michal Kaminski, Poland


When unforeseen happens …Chairs: Christine Petersen, The Netherlands

Patricia Burga, Italy

17:00 – 17:20How to treat bleeding and perforation – benefits and limitations of traditional and new techniquesHrvoje Ivecovic, Croatia

17:20 – 17:40Foreign body removal – routine and obscure cases in endoscopy Alexander Dechêne, Germany

17:40 – 18:00Stentmisplacement during and after the procedure – how to solve the problem Radu Tutuian, Switzerland

18:00 – 18:20‘I have a dream’: Nepal after the earthquake – back to normal life Michael Ortmann, Switzerland

18.20 – 18.30 Discussion

Sessions 615:00 – 16:30 Room B3

Endoscopic techniquesChairs: Siiri Maasen, Estonia

Lidia Gorchs, Spain

15:00-15:20Endoscopic faecal transplantation – different ways of application Salvador Machlab, Spain

15:20-15:40Endoscopic treatments for obesity – benefits and lim-itations Alba Lira, Spain

15:40-16:00 New techniques for treatment of pancreatic cystsNadan Rustemovic, Croatia

16:00-16:15 ERCP training for nurses – a model solution (Cook Medical)Ivo Boškoski, Italy

16:15-16:30Forthcoming Olympus innovations in Endoscopy (OLYM-PUS EUROPA)Rüdiger, Tamm, Germany


Colorectal cancer screeningChairs: Ingrid Karström, Sweden

Päivi Muranen, Finland

17:20 – 17:20Surveillance Colonoscopy – are we scoping the right people at the right time? Irene Dunkley, United Kingdom

17:20 – 17:40Who is qualified to perform screening colonoscopies? Experience from Scandinavia Helle Roy Tilgaard, Denmark

290


09:10 – 09:30 Medico-legal aspects of nursing in endoscopyEnriqueta Hernandez-Soto, Spain

The main responsibility of the endoscopy team is to of-fer a quality service, guaranteeing the patient’s safe-ty. Yearly about 1,000 endoscopies are performed per procedure room and the entire endoscopy team is re-sponsible for being prepared to carry out them. Each component has its share of responsibility, yet the nurs-es are the professional of the team that will be most time beside patients, while supporting technically the endoscopy. What can be done to legitimize the legal di-mension of endoscopy, which provides a lawful security acceptable to nurses?

09:30 – 09:50 Advanced roles for nurses – a mini-doctor or a maxi nurse? Helen Griffiths, United Kingsdom

Due to shortages of doctors many former medical tasks are delegated to nurses. This raises many questions: how will staff for these tasks identified, what training is needed, how is the quality of care assured (Quality Assurance), who takes the medico-legal responsibility for both nursing and delegated medical practice, and where are the boundaries between nursing and med-ical practice.

09:50 – 10:00Invitation to the next ESGENA Conference 2018 in Vienna Gerlinde Weilguny, Austria

Scientific ProgrammeMonday, October 30, 2017

Session 908:30 – 10:00 Room A2

Controversial discussions in endoscopy Chairs: Jadranka Brljak, Croatia

Enriqueta Hernandez-Soto, Spain

08:30 – 08:50Best Free Paper and Best Poster Awards PENTAX Medical supports the ESGENA Free Paper and Poster Award

The winner of the best free papers – oral presentation and the best poster presentations – will be announced. Presenting authors are requested to attend this session. • Jadranka Brljak, Croatia • Enriqueta Hernandez-Soto

08:50 – 09:10New techniques – easy and quick to perform! Does the endoscopist still need the qualified nurse? Marjon de Pater, The Netherlands

Nurses have two roles during endoscopic examinations: Patient Care with monitoring, and technical assistance for the procedures. The patient care role has become complexer over the years, but technical assistance has changed from mainly taking biopsies and occasional polypectomy in the early seventies to complex assis-tance during therapeutic ERCP. New procedures where the endoscopist handles accessories him/herself po-tentially changes the role of the assistant again. The question therefore arises – do we still need qualified endoscopy nurses for the technical assistance.

Common Interest Group Meetings

292


17:30 – 19:00 B5Faecal Microbiota Transplantation in Clinical Practice(Gut Microbiota & Health Section, ESNM, ECCO, ESPGHAN, EASL)

Loss of species diversity and microbial gene richness in the gut microbiome is commonly reported in individu-als affected by chronic non-communicable diseases. Maintaining gut microbiota diversity is a novel clinical target for health promotion and disease prevention. Functional foods and microbiota transplantation are useful tools for improving host-microbial symbiosis.

17:30 – 19:30 E2Water-aided colonoscopy (WAC) – consensus meeting(International WATER (Water Assisted Techniques Endoscopic

proceduRes) – working group)

Chair: Felix Leung Co-Chair: Chris Mulder

Distinction between water immersion (WI) and water exchange (WE) is importantSergio Cadoni, Italy

Underwater polypectomy Sauid Ishaq, United Kingdom

Where are we now and where are we going?Felix Leung, USA


10:00 – 12:00 B5Healthy Stomach InitiativeUpon invitation only

(HSI)

The non-profit HSI, a group of GI specialists from 35 countries aiming to bring awareness to doctors & the general population on stomach health and preventive care. The HSI has been endorsed by the WGO, EAGEN, EHMSG and many National Societies, private & athlete endorsors.

13:00 – 16:00 B5Annual meeting of the ESscD theme: intestinal biop-sies in diagnosing Celiac DiseaseUpon invitation only

(ESscD)

Discussion: What is the role of biopsy in adult and paediatric celiac disease?

Working group: 2020–2025 Renaming RCD II to pr-EATL

CIG Meeting including: a) report from the board b) election: president-elect, board member (pae-

diatrician) c) budget matters

16:00 – 17:30 E2PRO-MC collaboration – building a European registry for microscopic colitis(EMCG)

In July 2016, the ‘PRO-MC COLLABORATION: ESTABLISH-MENT OF A PROSPECTIVE REGISTRY FOR MICROSCOPIC COLITIS IN EUROPE – A UEG LINK AWARD PROJECT’ has started. The ultimate aim is to improve knowledge on MC across Europe. We want to inform about the progress and give interested colleagues the chance to participate in this project.

17:00 – 19:00 B5Normal values for esophageal pH impedance monitoring(ESNM)

UEG Week Final Programme : Common Interest Group Meetings

Common Interest Group Meetings

Business Meetings

Several business meetings – association, board and committee meetings for elected (UEG) leadership – will take place during UEG Week 2017. Please note that attendance is by invitation only.

294

UEG Week Final Programme : Business Meetings

Business MeetingsPlease note that attendance is by invitation only.

UEG Friday, October 27, 201716:00 – 20:00 Council Meeting UEG Meeting Room 1

Saturday, October 28, 201708:00 – 11:30 UEG Journal Management Board Meeting UEG Meeting Room 115:15 – 16:15 National Societies Committee Meeting UEG Meeting Room 216:30 – 18:30 Public Affairs Committee Meeting UEG Meeting Room 316:30 – 17:00 Scientific Committee: Best of UEG Week Team for DDW UEG Meeting Room 116:30 – 18:00 Standards & Guidelines Task Force Meeting UEG Meeting Room 2

Sunday, October 29, 201712:30 – 14:15 UEG Journal Editorial Board Meeting UEG Meeting Room 113:00 – 15:00 National Societies Forum Room A216:00 – 19:00 Meeting of Members Room A217:30 – 19:00 Scientific Committee – PGT Programme Committee UEG Meeting Room 2

Monday, October 30, 201712:00 – 13:30 Press Briefing UEG Meeting Room 214:30 – 15:30 UEG - EBGH Meeting UEG Meeting Room 116:00 – 17:30 Research Board Meeting UEG Meeting Room 116:00 – 18:00 Scientific Committee - Group Coordinators' Meeting Room 7.1217:00 – 18:30 Equality & Diversity Task Force Meeting UEG Meeting Room 317:15 – 18:00 Meeting with Friends of YTG UEG Meeting Room 2

Tuesday, October 31, 201712:00 – 13:30 Press Briefing UEG Meeting Room 2

Wednesday, November 1, 201708:00 – 10:00 Young Talent Group Meeting UEG Meeting Room 110:30 – 11:45 Industry Debrief Meeting Room B5

EAGEN Saturday, October 28, 201713:00 – 18:00 EAGEN Board Meeting Room 7.8

fEMGA Sunday, October 29, 201714:00 – 15:45 fEMGA/Medical Block Association Meeting Room 7.12

IAPWG Sunday, October 29, 201715:00 – 18:00 IAPWG Consensus Meeting Room 7.8

ISPM/EUREOS Sunday, October 29, 201712:00 – 14:00 EUREOS Update 2017 Room 7.8

UEG Press BriefingMonday, October 17, 2016 12:15 – 13:30 UEG Meeting Room 3Tuesday, October 18, 2016 12:15 – 13:30 UEG Meeting Room 3

Industry SponsoredSymposia

The programme of industry sponsored symposia is not affiliated with UEG and as of September 12, 2017.

296

UEG Week Final Programme : Industry Sponsored Symposia

Industry Sponsored Symposium16:15 – 17:45 A1A Novel Approach to Prevent Recurrent Clostridium difficile Infection (CDI) in High-Risk Patients(MSD)Chair: Mark Wilcox, United Kingdom

Welcome and Introduction Mark Wilcox, United Kingdom

Epidemiology and Patients at High Risk of Recurrent CDIJavier Cobo, Spain

Antitoxin Mechanism of Action for Prevention of Recurrent CDICiaran Kelly, USA

Bezlotoxumab for the Prevention of Recurrent CDIMark Wilcox, United Kingdom

Clinical and Economic Consequences of Recurrent CDIFrederic Barbut, France

Q&A and Closing Remarks Mark Wilcox, United Kingdom

Industry Sponsored Symposium16:15 – 17:45 F1Optimising infliximab therapy in IBD patients: Data, Dilemmas and Debates(Pfizer)Chair: Iris Dotan, Israel

Welcome and Introduction Iris Dotan, Israel

Biosimilar infliximab in IBD: Digesting the dataSilvio Danese, Italy

Optimising patient outcomes with infliximab: A virtual clinic2 challenging patient cases presented byKrisztina Gecse, NetherlandsStephan Vavricka, Switzerland

Take home messages for our clinical practiceIris Dotan, Israel

Industry Sponsored SymposiaSunday, October 29, 2017

Industry Sponsored Symposium16:15 – 17:45 A3How will we manage Crohn’s disease – in 2027?(Boehringer Ingelheim Pharma GmbH & Co KG)Chair: Stefan Schreiber, Germany

Introduction

Presentation and moderated panel discussion on each of the following:

• How will scientific advances influence Crohn’s disease management in 2027?

• Personalised medicine: what will the Crohn’s disease patients of 2027 expect from their health experts?

• The role of lifestyle interventions in the management of Crohn’s disease

Close

Industry Sponsored Symposium16:15 – 17:45 F2Bridging the gap in Crohn’s disease: from clinical evidence to daily practice (Janssen)Chairs: Séverine Vermeire, Belgium

Laurent Peyrin-Biroulet, France

Welcome and opening of the meeting Séverine Vermeire, Belgium

Targeting the IL-12/23 pathway Laurent Peyrin-Biroulet, France

Challenging questions in clinical practice Séverine Vermeire, BelgiumLaurent Peyrin-Biroulet, FranceJames Lindsay, United Kingdom

Conclusions and closure Séverine Vermeire, Belgium

297

STW-5: clinical experience in everyday practiceTatyana Lapina, Russia

Open discussion

Industry Sponsored Symposium18:00 – 19:30 F1Managing the Complexities of UC: Aligning Patient and Physician Goals(Pfizer)Chair: Laurent Peyrin-Biroulet, France

Welcome, Introduction, and Patient VignetteLaurent Peyrin-Biroulet, France

Better Understanding the Patient Perspective David T. Rubin, USA

Physician Perspective of the Complexities of UC ManagementGerhard Rogler, Switzerland

Aligning the Two Perspectives Laurent Peyrin-Biroulet, France

Question-and-Answer SessionPanel

Industry Sponsored Symposium18:00 – 19:30 C1Mission: Rapid Action and Lasting Remission – Focus on Disease Progression in Ulcerative Colitis(Takeda Pharmaceuticals International AG)Chair: William J. Sandborn, USA

Welcome and Introduction William J. Sandborn, USA

Mission Assigned: Rapid Onset and Lasting Remission in Ulcerative Colitis William J. Sandborn, USA

Q&A All Faculty

Mission Assessed: Challenges and Strategies to Achieve Early, Lasting Remission Geert D'Haens, The Netherlands

Q&A All Faculty

Mission: Remission — Optimising Rapid Onset and Long-term Outcomes With Gut-Selective Therapy Remo Panaccione, Canada

Q&A All Faculty

Panel Discussion William J. Sandborn, USA

Industry Sponsored Symposium18:00 – 19:30 E4Management of Diverticular Disease in the Third Millennium – Questions & Answers(Alfasigma S.p.A)Chair: Carmelo Scarpignato, Italy

What is the Clinical Picture of Diverticular Disease?Lisa L. Strate, USA

How Is the Gut Microbiota Altered in Patients with Diverticular Disease?Giovanni Barbara, Italy

What are the Aims of Treatment?Angel Lanas, Spain

Is There a Role for Diet and Nutraceuticals?Lisa L. Strate, USA

Which Drugs Are Effective?Angel Lanas, Spain

How Do Effective Drugs Work?Giovanni Barbara, Italy

Take Home MessagesCarmelo Scarpignato, Italy

Industry Sponsored Symposium18:00 – 19:30 A1Biosimilars: Experts Discuss Real World Considerations(Amgen Inc.)Chair: Simon Travis, United Kingdom

Roundtable Discussion: Addressing Questions in the Evolving Biosimilar LandscapeDaniel Hommes, USA Walter Reinisch, Austria

Industry Sponsored Symposium18:00 – 19:30 E1Functional digestive disorders and STW-5: passing the exam of evidence based medicine(Bayer Consumer Health)Chairs: Fermín Mearin, Spain

Alexander Trukhmanov, Russia

Introduction. Functional dyspepsia and irritable bowel syndrome: complex disorders with complex treatmentsFermín Mearin, Spain

FD and IBS pathophysiology: beyond ROME IVVincenzo Stanghellini, Italy

STW-5 mechanisms of action in FD and IBS: The origin of multi-targetHans-Dieter Allescher, Germany

Clinical evidence of the efficacy of STW-5 in FD and IBSPeter Malfertheiner, Germany

Industry Sponsored Symposia : UEG Week Final Programme

298


Industry Sponsored Symposium17:45 – 19:15 F2IBS – hard to ignore: Time to take a different view Innovations and advances in patient care(Allergan Pharmaceuticals International Ltd)Chair: Fermín Mearin, Spain

Welcome and Introduction Fermín Mearin, Spain

Changing the narrative in IBS: New perspectives for clinicians and patientsFermín Mearin, Spain Maura Corsetti, United Kingdom

New treatments in IBS: Translating clinical evidence into real-life benefits for patientsBill Chey, USA

Managing IBS in an era of rapid innovation: A case-based approachAll; led by Fermín Mearin, Spain

Summary and closeFermín Mearin, Spain

Industry Sponsored Symposium17:45 – 19:15 F1Role of detection and characterization in advanced endoscopy(FUJIFILM)Chairs: Alessandro Repici, Italy

Hironori Yamamoto, Japan

Welcome and Introduction Alessandro Repici, ItalyHironori Yamamoto, Japan

Role of BLI in the diagnosis of Barretts neoplasiaRaf Bisschops, Belgium

Predicting polyp histology with BLI: Keep it BASIC!Cesare Hassan, Italy

Linked Color Imaging (LCI) – A new tool for detection of early neoplasiaHironori Yamamoto, Japan

How to make ESD safe & efficient in the westPradeep Bhandari, United Kingdom

Closing remarksAlessandro Repici, ItalyHironori Yamamoto, Japan

Industry Sponsored SymposiaMonday, October 30, 2017

Industry Sponsored Symposium07:00 – 08:00 E4Biosimilars for IBD: Patient Concerns for Now and Later(Samsung Bioepis)Chair: Geert D'Haens, The Netherlands

Welcome and IntroductionGeert D'Haens, The Netherlands

Patients' View on BiosimilarsGeert D'Haens, The Netherlands

The Physician's Story to the Patient: How to Optimize the DialogueFraser Cummings, United Kingdom

Addressing Scientific Questions Regarding BiosimilarsKrisztina Gecse, The Netherlands

Panel Discussion and Q&AAll

Industry Sponsored Symposium17:45 – 19:15 C2Keep CALM and Treat to Target in IBD(AbbVie)Chair: Jean-Frédéric Colombel, USA

Welcome to ‘Keep CALM and Treat to Target in IBD’ Jean-Frédéric Colombel, USA

In Focus: Importance of early diagnosis and treating to target in IBD Benjamin Pariente, France

News update: CALM study results Jean-Frédéric Colombel, USA

Treating to target in IBD – At what cost? Geert D’Haens, The Netherlands

Discussion and audience Q&A Faculty

Close Jean-Frédéric Colombel, USA

299


Industry Sponsored SymposiaTuesday, October 31, 2017

Industry Sponsored Symposium07:00 – 08:00 A1How is the Future of the IBD Landscape Evolving?(Celgene Corporation)Chair: Geert D’Haens, The Netherlands

Improving Patient Care and Management: What Unmet Needs do we Still Need to Address? William Sandborn, USA

Beyond the Biologics: What do Future Therapies Hold? Silvio Danese, Italy

Industry Sponsored Symposium07:00 – 08:00 A3Probiotics effects in gut health: between art and science(Ferring International Center S.A.)

Probiotics: understanding their beneficial effects – from FAO/WHO to WGO Practice GuidelinesFrancisco Guarner, Spain

Evidence-based use of Probiotics – from IBD to IBS and Liver DiseasesGiovanni Barbara, Italy

Towards next generation ProbioticsHarry Sokol, France

Industry Sponsored Symposium07:00 – 08:00 F1Changing perspectives in Primary Biliary Cholangitis (PBC)(Intercept Pharmaceutical Europe Ltd)Chair: Albert Parés, Spain

The impact of the new European guidelines on the management of PBCGuilherme Macedo, Portugal

Recent advances in PBC management: Looking beyond current therapeutic options Fredrik Nevens, Belgium

Industry Sponsored Symposium17:45 – 19:15 F3Pharmacological and clinical perspectives: The evo-lution of the treatment landscape and personalised medicine approaches for management of UC(Pfizer)Chair: Silvio Danese, Italy

Welcome and Introductions Silvio Danese, Italy

Clinical Implications of the Evolving Treatment Land-scape in UCPeter Irving, United Kingdom

Emerging Therapies Targeting Mechanisms of UC Pathogenesis Silvio Danese, Italy

The Pharmacologist’s Perspective on Current and Emerging Treatment Options in UC Diane Mould, USA

Audience Q&A All

Industry Sponsored Symposium17:45 – 19:15 C1Targeting Mucosal Healing: Optimising Results With Early, Appropriate Therapy in Crohn’s Disease(Takeda Pharmaceuticals International AG)Chair: Julián Panés, Spain

Welcome and Introduction Julián Panés, Spain

The Case for Early Intervention in Crohn’s Disease Julián Panés, Spain

Close-up on Endoscopic Healing as a Treatment Goal: What Do We Need to Know? Laurent Peyrin-Biroulet, France

Meeting Evolving Treatment Goals With Gut-Selective Therapy Charlie Lees, Scotland

Putting Knowledge Into Practice: Approach to Patient Cases Julián Panés and Faculty

Summary and Concluding Remarks Julián Panés, Spain

300


Industry Sponsored Symposium17:45 – 19:15 F2Going Above and Beyond: A Full Spectrum of Innovation for Personalized, Convenient, and Affordable Treatment(CELLTRION HEALTHCARE)Chair: Stefan Schreiber, Germany

Exclusive to CT-P13: An Accumulation of Clinical Evidence Stefan Schreiber, Germany

A Leap beyond Evidence to the Next Stage_ Personalized Treatment Walter Reinisch, Austria

A Leap beyond Evidence to the Next Stage_ Convenient Treatment Stefan Schreiber, Germany

A Leap beyond Evidence to the Next Stage_ Affordable TreatmentLászló Gulácsi, Hungary

Panel Discussion All

Industry Sponsored Symposium17:45 – 19:15 A2Time to Get Ulcerative Colitis Under Tight Control(MSD)Chair: Laurent Peyrin-Biroulet, France

Welcome and Introduction Laurent Peyrin-Biroulet, France

The Disease Burden in UC Edouard Louis, Belgium

Q&A

Can We Change the Natural Course of UC?Laurent Peyrin-Biroulet, France

Q&A

Patient Empowerment and Remote Monitoring in UCPierre Michetti, Switzerland

Q&A

Panel Discussion Laurent Peyrin-Biroulet, France

Industry Sponsored Symposium17:45 – 19:15 C1Addressing common challenges in IBD – practical approaches and best practice sharing(AbbVie)Chairs: Remo Panaccione, Canada


Welcome and Introduction Remo Panaccione, Canada

Challenge presentation and faculty discussionFaculty

Addressing day-to-day challenges in IBD managementFaculty

Challenge 1: Beyond the bowel – Extra-intestinal man-ifestations of IBDVito Annese, UAE

Challenge 2: Monitoring/tight control/treat-to-target – Who, what, how and when?Remo Panaccione, Canada

Video Case Study: Ireland – Managing IBD under special circumstancesGlen Doherty, Ireland

Challenge 3: Moving from paediatrics to adult careJames Lindsay, United Kingdom

Challenge 4: TDM – Ready for prime time?Iris Dotan, Israel

Audience Q&A Chairs and faculty

Key takeaways James Lindsay, United Kingdom

301


Industry Sponsored Symposium17:45 – 19:15 A3Bowel preparation quality, ADR and patient experi-ence: Are low volume PEG-based preparations the vital link?(Norgine)Chair: Cesare Hassan, Italy

IntroductionsCesare Hassan, Italy

Setting up success through effective bowel preparationRalf Kiesslich, Germany

Key performance measures and the relationship with patient-related outcomesMichaeł F. Kamiński, Poland

Low volume PEG-based preparations: What do the data show?Cesare Hassan, Italy

Panel discussion: Low volume PEG-based preparations in relation to improving outcomes for colonoscopy – what can we learn?Cesare Hassan, Italy

Summary and closeCesare Hassan, Italy

Industry Sponsored Symposium17:45 – 19:15 A1Optimizing the management of acid-related disorders – from diagnosis to treatment(Takeda Pharmaceuticals International AG)Chair: David Metz, USA

Welcome David Metz, USA

How to make a conclusive diagnosis of GERD in 2017 Daniel Sifrim, United Kingdom

The evolving treatment landscape: risk/benefit ratio of PPIs David Metz, USA

Beyond PPIs: first clinical experiences with P-CABs Ken Haruma, Japan

Audience Q&A Faculty

Meeting summary and close David Metz,USA

Prof. Fermín Mearin, Barcelona, Spain.Introduction: Functional dyspepsia and irritable bowel syndrome: Complex disorders with complex treatments

Prof. Peter Malfertheiner, Magdeburg, Germany. Clinical evidence of the efficacy of STW-5 in FD and IBS

Ass. Prof. Tatyana Lapina, Moscow, Russia. STW-5: Clinical experience in everyday practice

Prof. Hans-Dieter Allescher, Garmisch-Partenkirchen, Germany. STW-5 mechanisms of action in FD and IBS: The origin of multi-target

Prof. Vincenzo Stanghellini, Bologna, Italy.FD and IBS pathophysiology: Beyond ROME IV

Bayer Meets the Media: “Harvesting the benefi ts of evidence-based phytomedicine”, 30th October 2017, 7:15 p.m., Hotel SB Plaza Europa, Barcelona:

[email protected]

29th October 2017, 6 p.m., Room E1

FUNCTIONAL DIGESTIVE DISORDERS AND STW-5: PASSING THE EXAM OF

EVIDENCE BASED MEDICINE

INDUSTRY SPONSORED SYMPOSIUM

This symposium is not affiliated with UEGL.ES.MA.08.2017.3195

1708_8787_Bayer_STW_5_Global_Anzeige_Symposium_UEG_Week_66 x 190mm_ISO_V2.indd 107.09.17 14:29

Optimising Infliximab Therapy

in IBD patients

Data, D i lemm

as

and Debates

Managing the Complexities of UC: Aligning Patient and Physician Goals

18:00 to 19:30

Chair and Moderator

Laurent Peyrin-Biroulet, MD, PhD l Vandoeuvre-lès-Nancy, France

Patient Perspective on the Burden of UC

David T. Rubin, MD l Chicago, Illinois, United States

Physician Perspective on the Complexities of UC Management

Gerhard Rogler, MD, PhD l Zürich, Switzerland

Panel Discussion: Aligning the Two Perspectives

Chair and Moderator

Iris Dotan, MD l Petah Tivka, Israel

Biosimilar Infl iximab in IBD: Digesting the Data

Silvio Danese, MD, PhD l Milan, Italy

Optimising Patient Outcomes with Infl iximab: A Virtual Clinic – 2 Challenging Cases

Krisztina Gecse, MD, PhD l Amsterdam, Netherlands

Stephan Vavricka, MD l Zürich, Switzerland

Este medicamento está sujeto a seguimiento adicional, es prioritaria la notifi cación de sospechas de reacciones adversas asociadas a este medicamento. This medicinal product is subject to additional monitoring, any suspected adverse reactions should be reported.

Optimising Infl iximab Therapy in IBD Patients: Data, Dilemmas and DebatesAn Interactive Patient Case-Led Session

16:15 to 17:45

These symposia are not a� liated with UEG. These programmes are funded and organised by Pfi zer Inc.

Full Summary of Product Characteristics is available at the booth (42). Ficha técnica de Infl ectra disponible en el stand (42)

Join Us for Two Informative Sessions Highlighting Emerging Trends in IBD

— Sunday, 29 October 2017 —Fira de Barcelona • Gran Via North Entrance – Hall 8 • Room F1 • Barcelona, Spain • Food and beverages will be provided.

PP-IFA-ESP-0169 September 2017 © 2017 Pfizer Inc. All rights reserved.

Congress Information

Congress VenueFira de Barcelona – Gran Via VenueNorth Entrance – Hall 8Carrer del Foc, 3508038 Barcelona, Spain

Congress Registration CounterAll congress material and documentation is available at the counters located in the Entrance Foyer.

Opening Hours Friday October 27 14:00 – 18:00 Saturday October 28 07:30 – 18:00 Sunday October 29 07:30 – 18:00 Monday October 30 07:00 – 18:00 Tuesday October 31 07:00 – 18:00 Wednesday November 1 07:00 – 16:00

During these opening hours the congress registration desk can be reached at: T +43 676 845 880 704.

304

Barcelona’s public transportation system includes met-ro and bus (TMB), local train (FGC), tram (TRAM) and regional trains (Rodalies de Catalunya).

However, using the AEROBUS from/to the airport re-quires the purchase of a separate ticket.

Please see page 309 for a metro map of Barcelona.

From the airport:At Terminal 1 or 2, take the metro line L9 Sud and stop at station ‘Fira’. From the metro station ‘Fira’ it is 6-8 minutes walking distance to Fira Gran Via – North En-trance Hall 8 for UEG Week.

From the city:Take the metro lines L1, L3 or L5 and change to met-ro line L9 Sud (direction to airport) as follows: When on metro line L1, you can change to metro line L9 Sud at station ‘Torrassa’, when on metro line L3, you can change to line L9 Sud at station ‘Zona Universitaria’ and when using metro line L5, you can change at station ‘Collblanc’. Then take the metro line L9 Sud (direction to airport) and stop at station "Fira’. From the metro station ‘Fira’ it is 6-8 minutes walking distance to Fira Gran Via – North Entrance Hall 8 for UEG Week.

TaxiA taxi stand is located in front of the North Entrance – Hall 8. Taxis can be called day and night at the telephone numbers: TAXI CLASS Phone: +34 933 07 07 07TAXI MÉS Phone: +34 933 30 03 00RADIO TAXI Phone: +34 933 03 30 33

AbstractsThe abstracts of UEG Week Barcelona 2017 will be avail-able online in the UEG Education library and on the UEG website.

Congress News and WebsiteThe UEG Week website, UEG Week 2017 Congress App and our social media channels will provide an overview of sessions and data presented each day and ‘what not to miss’ the following day along with hot topics and snapshots of the congress. For more information, visit the UEG Week website (www.ueg.eu/week)

UEG Week Final Programme : Congress Information

RegistrationOnsite registration does not necessarily entitle the par-ticipants to receive all congress material. Registration will be handled upon a first-come, first-served basis, priority will be given to pre-registered delegates.

Congress LanguageThe official language of UEG Week is English. No simultaneous translation will be provided.

Name BadgesParticipants are requested to wear their name badge at all times during the congress. The colours of the name badges have the following significance:

Delegate of UEG Week Faculty, Officers, Organisers of UEG Week Delegate of Postgraduate Teaching Programme

Delegate of UEG Week and Postgraduate Teaching Programme

Delegate of ESGENA Exhibitor Press Congress Staff Guest/Common Interest Group/Business Meeting

YGN Young GI Network

Kindly note that when your badge is being scanned at ex-hibition booths or during industry sponsored symposia, as previously agreed by you, personal data, comprising of full name, address (institute/company, department, address) and email address is being passed on to the respective UEG sponsors/exhibitors for the purpose of providing marketing and information material relating to the field of digestive health as well as information on scientific events.

How to get aroundWe ask all of our visitors to think of the environment and use public transport wherever possible.

Public Transportation TicketAll registered UEG Week and ESGENA delegates benefit from unlimited use of the Barcelona public transporta-tion system valid for 3 days once activated. Public trans-portation tickets will be handed out at the congress material counter.

Congress Information

305

UEG Members VillageMeet representatives of UEG’s Member Societies in Hall 8.0.

UEG Young GI LoungeJoin the Young GI Network in Hall 8.0. For more info please see page 21.

Speakers CentreThe Speakers Centre is located in the Entrance Foyer. Speakers are asked to hand in their CD-ROM or USB stick, containing the Power-Point Presentation (IBM format or compatible, no multisession) or video prefer-ably one day before their presentation but at the latest 3 hours prior to the presentation. The presentation will be transferred to the central congress server and will be available afterwards on a special congress notebook in the hall of the presentation. Due to time and technical reasons we kindly ask the speakers not to use their own notebook. In the Speakers Centre there are several PCs where speakers can also work on their slides in a quiet area. Technical staff will be happy to assist.

Opening Hours Friday October 27 14:00 – 18:00 Saturday October 28 07:30 – 18:00 Sunday October 29 07:30 – 18:00 Monday October 30 07:00 – 18:00 Tuesday October 31 07:00 – 18:00 Wednesday November 1 07:00 – 14:00

Internet Centre and WiFiThe Internet Centre with several terminals is located on the walkway to Halls 6/7.

Opening Hours Saturday October 28 08:30 – 17:00 Sunday October 29 08:30 – 17:00 Monday October 30 08:30 – 17:00 Tuesday October 31 08:30 – 17:00 Wednesday November 1 08:30 – 15:00

WiFi is available throughout the venue. #UEGWifi by Pfizer_5Ghz #UEGWifi by Pfizer_2.4GhzPassword: uegweek17

Live streaming of SessionsBe part of UEG Week and view 50% of all sessions of Europe’s largest GI meeting wherever you are!

UEG will connect everyone to its annual meeting via live stream on the UEG Week Live website. Lean back and get updated on relevant GI and liver topics free of charge, and connect with the community via the UEG Week So-cial Wall. Simply sign in to myUEG. For more informa-tion, please visit live.ueg.eu

UEG Week 2017 AppGet the UEG Week 2017 congress app for your smartphone and experience the congress at your fingertips! Send questions during ses-

sions via the Q&A tool or quickly find your way through the most up-to-date congress schedule. Cast your vote in interactive sessions via the app. Have a look at floor plans and browse the exhibition and company profiles. Just take the congress with you!

The app is free of charge for iPhone/iPad and Android smartphone users. The Q&A tool is available in the fol-lowing session rooms: Hall 6, C1, C2, F1, F2, F3, A1, A2

The UEG Week 2017 App is available at:

Programme ChangesUEG cannot assume liability for any changes in the conference programme due to external or unforeseen circumstances.

Meet UEGFind out more about the work we do at the UEG Booth in Hall 8.0.

Opening Hours Saturday October 28 07:30 – 18:00 Sunday October 29 07:30 – 18:00 Monday October 30 07:00 – 18:00 Tuesday October 31 07:00 – 18:00 Wednesday November 1 07:30 – 14:00

Congress Information : UEG Week Final Programme

306

Week 2017 Congress App as well as on the UEG website www.ueg.eu/week.

Please note that according to the EU Directive 2001/83/EC promotional material related to prescription-only med-icines must be distributed or provided exclusively to healthcare professionals who are authorised to pre-scribe or dispense them.

Opening Hours Monday October 30 09:00 – 17:00 Tuesday October 31 09:00 – 17:00 Wednesday November 1 09:00 – 14:00

Press CentreThe Press Centre is located at the end of the walkway to-wards Halls 6 and 7. It is open from 08:00 – 18:00 (Sun-Tue, October 29-31) and 08:00 – 16:00 (Wed, November 1).All press/media representatives are invited to attend the press briefings in UEG Meeting Room 2 (Foyer Halls 6/7):

Press BriefingsMonday October 30 12:15 – 13:30Tuesday October 31 12:15 – 13:30

Local and international speakers will be available to answer questions.

The Press Centre is managed by the press agency Spink.The agency’s staff is pleased to provide more detailed information related to press activities during UEG WeekBarcelona 2017.

Silent RoomThere is a room set apart for prayer. It is a quiet place where delegates may withdraw to seek divine strength and guidance. The silent room is located in Room 7.6 (Foyer Halls 6/7).

Coffee Breaks and LunchPGT Programme and ESGENA Conference (Sat – Sun)Coffee and a light sandwich snack are provided in the catering areas Hall 8.0 and Foyer Halls 6/7 for PGT Pro-gramme and ESGENA Conference delegates on Satur-day, October 28 and on Sunday, October 29.

PGT Catering Times Saturday, October 28 and Sunday, October 29 Coffee Break 10:30 – 11:00 Lunch 13:00 – 14:00

Poster ExhibitionPosters are displayed from Monday, October 30 until Wednesday, November 1 in the scientific centre in Hall 7. The posters are changed daily and are at display during the following times:


The poster presenters are asked to put up and remove their poster on the day of presentation according to the schedule below:

Hanging: On the day of display 08:00 – 09:00. Removal: On the day of display 17:00 – 17:30 (Mon-Tue) and 14:00 – 14:30 (Wed).

Posters that have not been removed by the respective time will be disposed of. Poster material to put up the poster is available at the poster service desk in the post-er exhibition area.

If you have submitted a poster for printing for UEG Week 2017 through the CTI poster printing service, please pick up your poster at the poster service desk in the poster area:


E-PostersE-posters will be available in the scientific centre in Hall 7. All poster presenters have been invited to upload their poster prior to UEG Week. All uploaded e-posters can be searched for and viewed electronically on the 6 terminals in the poster area throughout Monday, Oc-tober 30 to Wednesday, November 1 during the above mentioned display times.

Technical ExhibitionUEG Week is accompanied by a major technical exhibi-tion taking place in Hall 8.1. This provides an excellent opportunity for physicians, pharmacists, pharmacy as-sistants, nurse practitioners, physician assistants to in-teract with the industry and familiarise themselves with the latest advances in technology and pharmacology.

For further information and floor plans please see the list of exhibitors on page 313 and following, in the UEG

UEG Week Final Programme : Congress Information

307

Emergency and First AidIn case of emergency please contact our staff. The First Aid Room is located in Room 7.7 (Foyer Halls 6/7). The attentive staff there will be pleased to help.

SmokingThe Fira Barcelona is a non-smoking venue. Smoking is prohibited within the congress venue.

Photos, Filming and Recording of Scientific SessionsIt is strictly forbidden to film, take photos or record any oral or poster presentation of UEG Week without the consent of the organiser (in-cluding smart phones, mobile devices, etc).

Please note that numerous sessions will be recorded and published at www.ueg.eu/education/library im-mediately after the congress and will be available for all congress delegates. This archive will also include all abstracts, e-posters and the syllabus of the Postgradu-ate Teaching Programme.

Insurance / LiabilityUEG does not accept any liability for damages and/or losses of any kind which may be incurred by the con-gress participants, during either the official activities or official UEG networking events. Delegates attend the congress at their own risk. Participants are advised to take out insurance against loss, accidents or damage that could be incurred during the congress.

SafetyAs in all major cities and congress venues, people should always keep an eye on their personal belong-ings. Please be aware of pickpocketing and bag-snatch-ing and make sure to take off your name badge and congress bag when you go sightseeing in downtown Barcelona. Wearing the name and bag identifies you as a tourist which might attract pickpockets.

ESGENA Catering Times Saturday, October 28 Coffee Break 10:30 – 11:00 // 15:30 – 16:00 Lunch 13:00 – 14:00 Sunday, October 29 Coffee Break 10:30 – 11:00 // 16:30 – 17:00 Lunch 13:00 – 14:00

UEG Week Programme (Mon – Wed)Coffee as well as a light sandwich snack are served free of charge to all registered UEG Week participants in the designated catering stations located within the exhibi-tion area in Hall 8.1 and in the poster exhibition area in Hall 7.

UEG Week Catering Times Monday, October 30 and Tuesday, October 31 Coffee Break 10:00 – 10:30 // 15:30 – 15:45 Lunch 12:00 – 14:00 Wednesday, November 1 Coffee Break 10:00 – 10:30 Lunch 12:00 – 14:00

Throughout the venue there will be water dispensers and catering kiosks to buy refreshments and snacks.

Networking AreasThe perfect meeting point to network with colleagues are our designated networking areas in the exhibition area in Hall 8.1, in Hall 7. or at the UEG Booth in Hall 8.0 where we provide charging stations for your mobile devices. The live endoscopy will also be transmitted to the networking areas on Tuesday.

Congress delegates below 40 are also invited to meet other young fellows in the Young GI Lounge in Hall 8.0 where they can form new collaborations, surf the net, charge their devices and join our social media activities!

CloakroomThe cloakrooms are located in the Entrance Foyer next to the registration counters and can be used free of charge from Saturday, October 28 through to Wednesday, No-vember 1. Participants can also store their luggage there.

Congress Information : UEG Week Final Programme

www.AmgenBiosimilarSymposium.com

Experts Discuss Real World Considerations

BIOSIMILARS

Faculty

Sunday, 29 October 201718:00–19:30Fira de BarcelonaGran Via North EntranceHall 8 – Room A1

Agenda 17:45–18:00 Registration

18:00–18:05 Opening Remarks and Objectives18:05–19:30 Experts Discuss Real World Considerations

Objectives• Discuss key questions involved in evaluating a data

package for a biosimilar• Highlight study design approaches for biosimilar

clinical trials• Clarify extrapolation, immunogenicity, and other

considerations for biosimilar use in IBD

This symposium is not affiliated with UEG.

© 2017 Amgen Inc. All rights reserved. Not for reproduction.

Daniel Hommes, MD, PhDProfessor of Medicine

David Geffen School of Medicine of UCLALos Angeles, California, USA

Walter Reinisch, MDAssociate Professor of Gastroenterology

Medical University ViennaVienna, Austria

Simon Travis, DPhil, FRCPProfessor of Clinical Gastroenterology, University of Oxford

Consultant Gastroenterologist, John Radcliffe HospitalOxford, United Kingdom

I7-423 Program Guide Ad_v6.indd 1 9/8/17 12:59 PM

309

Public Transportation : UEG Week Final Programme

310

Allergan Pharmaceuticals International Ltd

Boehringer Ingelheim Pharma GmbH & Co KG

CELLTRION HEALTHCARE

MSD

AbbVie

FUJIFILM

Janssen

UEG Week Final Programme : Acknowledgements

Acknowledgements(in alphabetical oder)

UEG gratefully acknowledges the support of the following companies:

3D Matrix EMEA B.V3D Systems SimbionixACTIAL FARMACEUTICA SRLAlfasigma S.p.A Alton (Shanghai) Medical Instruments co., LtdamgAmgenAnkon ANREI MEDICALApollo EndosurgeryBayer Consumer Health BCM Co., LtdBedfont Scientific Beijing Richen-Force HoldingsBHT Hygienetechnik GmbHBiocodex BioGaia

Biohit OyjBiomedalBoston Scientific BÜHLMANN Laboratories AGCALPRO ASCantelCapsoVisionCasen Recordati S.LCBC GroupCelgene Corporation Changzhou Dahua Group/CitecChoyang MedicalCook Medical Creo Medical Ltd.Dr. Falk Pharma GmbHDr. Henke Medical Training & EducationELLA-CS

General Sponsors and Exhibitors

Premium Partners

Major Partners

Olympus Europa SE & Co. KG

Pfizer

Takeda Pharmaceuticals International AG

MEDTRONIC

Norgine

PENTAX EUROPE GmbH

Shire International GmbH

311

Micro-Tech-Europe GmbHMTW-EndoskopieNEXTBIOMEDICAL Co.,Ltd. NIKKISONiso Biomed srlNoventureOvesco Endoscopy AGOxford University PressOy Medix Biochemica AbPeter Pflugbeil GmbH Medizinische Instrumente PrecisionBiotics LtdProbiotics International Ltd (Protexin)Prometheus Laboratories Inc.R-BiopharmReckitt BenckiserRobarts Clinical Trials B.V.Samsung BioepisSandhill ScientificSandoz BiopharmaceuticalsShangxian Minimal Invasive Inc. SHENZHEN ZHONGHE HEADWAY BIO-SCI & TECH CO., LTDShionogi Europe LtdSMART Medical Systems Ltd.SOFAR SPASOLUSCOPESonoScape Medical Corp.Standard Sci-Tech Inc.STEELCO SPASTERISSUMITOMO BAKELITE CO., LTD.Surgical Science Sweden ABTaewoong Medical Co., LtdTEAC Europe GmbHThe LancetThe Standard Co., LtdTillotts Pharma AGTristelUS EndoscopyVital Therapies, Inc.W.L. Gore & Associates GmbHWalz Elektronik Wassenburg Medical B.V.WILSON INSTRUMENTS (SHA) CO., LTDWilson Therapeutics ABWisepress LtdZhuji Pengtian Medical Instrument Co.,Ltd

EMcision International Inc.EMED SP. Z O. O. SP. K.EndoAid Ltd.EndoClot Plus, Inc.Endoscopic Ultrasound JournalEndoscopy / ESGE - ThiemeEndoSim Europe GmbHEndoticsErbe Elektromedizin GmbHEurospital ExalenzF. Hoffmann La RocheFerring PharmaceuticalsFinemedix Co., LtdFischer Analysen Instrumente GmbHGE Healthcare Genetic Analysis ASGI SupplyGilead SciencesGrifolsHangzhou AGS MedTech Co., Ltd. Huger Medical Instrument Co., LtdImmundiagnostik AGINFAI GMBHInnovex Medical Co. Ltd. Insitumed GmbHIntercept Pharmaceutical Europe LtdIntromedic Co., Ltd. invendo medical GmbHJiangsu ATE Medical Technology Co., LtdJinshan Science & Technology Karger PublishersKARL STORZ GMBH & CO. KGLA LETTRE DE L'HEPATO-GASTROENTEROLOGUELABORIELeo Medical Co., Ltd.Life Partners EuropeLumendiM.I. Tech Ltd.Mauna Kea TechnologiesMayoly SpindlerMederi Therapeutics Inc.MedifyMedi-Globe GmbH/ Endo-Flex GmbHMEDITALIA S.A.S.Mednovamedwork GmbH

Acknowledgements : UEG Week Final Programme

General Sponsors and Exhibitors

THANK YOU

FOR YOUR

SUPPORT!

IMPORTANT: Please refer to the package insert for complete instructions, contraindications, warnings and precautions.

© 2017 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. ™* Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company. 17-uegw-program-advertisement-en-2000212

TAKING GIANT STRIDES FORWARDin helping to diagnose and monitor gastrointestinal diseases

Barrx™ 360 Express RFA Balloon Catheter

PillCam™ SB 3 System Advanced imaging and visualization of the small bowel with capsule endoscopy

The Beacon™ EUS delivery system features interchangeable FNA and FNB needles.

Scan the QR code to download your FREE guide to Barrx™ Radiofrequency Ablation

P0496 - A4 advert-EE_v4_hr 1 13/09/17 09:52

List of Exhibitors and Exhibition Floor Plans

Technical ExhibitionUEG Week is accompanied by a major technical exhibi-tion taking place in Hall 8.1.

Opening Hours Monday October 30 09:00 – 17:00 Tuesday October 31 09:00 – 17:00 Wednesday November 1 09:00 – 14:00

314

General Exhibitors Booth No.

UEG Week Final Programme : List of Exhibitors and Exhibition Floor Plan

List of Exhibitors(in alphabetical oder)

Major Partners Booth No.

Allergan Pharmaceuticals International Ltd 37Boehringer Ingelheim Pharma GmbH & Co KG 55CELLTRION HEALTHCARE 92MEDTRONIC 24MSD 60Norgine 56PENTAX EUROPE GmbH 111Shire International GmbH 94Shire International GmbH 40

Premium Partners Booth No.

AbbVie 36AbbVie 48FUJIFILM 43Janssen 59Janssen 58OLYMPUS Europa SE & Co. KG 81Pfizer 41Pfizer 42TAKEDA Pharmaceuticals International AG 82TAKEDA Pharmaceuticals International AG 93

3D Matrix EMEA B.V 1253D Systems Simbionix 87ACTIAL FARMACEUTICA SRL 71Alfasigma S.p.A 54Alton (Shanghai) Medical Instruments co., Ltd 53amg 105Ankon 63ANREI MEDICAL 119Apollo Endosurgery 2BCM Co., Ltd 97Bedfont Scientific Ltd. 45Beijing Richen-Force Holdings 120BHT Hygienetechnik GmbH 98Biocodex 121BioGaia 88Biohit Oyj 17Biomedal 66Boston Scientific 23BÜHLMANN Laboratories AG 64CALPRO AS 103Cantel 80CapsoVision 117Casen Recordati S.L 52CBC Group 15Celgene Corporation 112Changzhou Dahua Group/Citec 65Choyang Medical 139Cook Medical 85Creo Medical Ltd. 14Dr. Falk Pharma GmbH 86Dr. Henke Medical Training & Education 116ELLA-CS 130

EMcision International Inc. 100EMED SP. Z O. O. SP. K. 3EndoAid Ltd. 135EndoClot Plus, Inc. 18Endoscopic Ultrasound Journal 8Endoscopy / ESGE - Thieme 9EndoSim Europe GmbH 76Endotics 110Erbe Elektromedizin GmbH 61Eurospital 127Exalenz 31F. Hoffmann La Roche 108Finemedix Co., Ltd 140Fischer Analysen Instrumente GmbH 114GE Healthcare 132Genetic Analysis AS 90GI Supply 32Gilead Sciences 35Grifols 126Hangzhou AGS MedTech Co., Ltd. 26HITACHI Medical System / PENTAX EUROPE GmbH 111Huger Medical Instrument Co., Ltd 67Immundiagnostik AG 134INFAI GMBH 44Innovex Medical Co. Ltd. 133Insitumed GmbH 27Intercept Pharmaceutical Europe Ltd 115Intromedic Co., Ltd. 49invendo medical GmbH 77Jiangsu ATE Medical Technology Co., Ltd 33Jinshan Science & Technology 74Karger Publishers 7

General Exhibitors Booth No.

315

The Standard Co., Ltd 104Tristel 96US Endoscopy 25Vital Therapies, Inc. 51W.L. Gore & Associates GmbH 106Walz Elektronik 70Wassenburg Medical B.V. 99WILSON INSTRUMENTS (SHA) CO., LTD 79Wilson Therapeutics AB 29Wisepress 118Zhuji Pengtian Medical Instrument Co.,Ltd 73

Members Village - Hall 8.0 Booth No.

EAES MV06EAGEN MV12EASL MV01ECCO MV14EDS MV13EFISDS MV05EHMSG MV09EPC MV02ESCP MV07ESDO MV04ESGAR MV10ESGE MV11ESNM MV03ESPCG MV08

Association & Future Events Area – Hall 8.0 Booth No.

4th Athens International Symposium 2018 AFA10Asociación Mexicana de Hepatología AFA12EFCCA AFA14Egypt Gastro Hep Congress AFA09Ehlers-Danlos Society AFA15ENDO LIVE ROMA 2018 AFA07European Section and Board of Gastroenterology and Hepatology - ESBGH AFA05GEEW AFA06International Society for Diseases of the Esophagus - ISDE AFA11Portuguese Society of Gastroenterology - SPG AFA01Rome Foundation AFA08Sage AFA13Turkish Society of Gastroenterology AFA02World Endoscopy Organization - WEO AFA03World Gastroenterology Organisation - WGO AFA04

KARL STORZ GMBH & CO. KG 47LA LETTRE DE L'HEPATO-GASTROENTEROLOGUE 16LABORIE 62Leo Medical Co., Ltd. 28Life Partners Europe 109Lumendi 123M.I. Tech Ltd. 57Mauna Kea Technologies 89Mayoly Spindler 91Mederi Therapeutics Inc. 34Medify 136Medi-Globe GmbH/ Endo-Flex GmbH 39MEDITALIA S.A.S. 19Medix Biochemica 129Mednova 38medwork GmbH 46Micro-Tech-Europe GmbH 69MTW-Endoskopie 131NEXTBIOMEDICAL Co.,Ltd. 68NIKKISO 10Niso Biomed srl 1Noventure 13Ovesco Endoscopy AG 124Oxford University Press 5Peter Pflugbeil GmbH Medizinische Instrumente 70aPrecisionBiotics Ltd 20Probiotics International Ltd (Protexin) 72Prometheus Laboratories Inc. 128R-Biopharm 113Reckitt Benckiser 84Robarts Clinical Trials B.V. 12Sandhill Scientific 21Sandoz Biopharmaceuticals 50Shangxian Minimal Invasive Inc. 122SHENZHEN ZHONGHE HEADWAY BIO-SCI & TECH CO., LTD 138Shionogi Europe Ltd 137SMART Medical Systems Ltd. 75SOFAR SPA 107SOLUSCOPE 22SonoScape Medical Corp. 83Standard Sci-Tech Inc. 11STEELCO SPA 101STERIS 4SUMITOMO BAKELITE CO., LTD. 78Surgical Science 102Taewoong Medical Co., Ltd 95TEAC Europe GmbH 30The Lancet 6

List of Exhibitors and Exhibition Floor Plan : UEG Week Final Programme

General Exhibitors Booth No.General Exhibitors Booth No.

316

UEG Week Final Programme : List of Exhibitors and Exhibition Floor Plan

Esca

lato

rs to

Reg

istra

tion

Area

and

Sess

ion

Room

s in

Hal

l 8.0

Cate

ring

Kio

skCa

teri

ng K

iosk

Cate

ring En

tran

ce to

Hal

l 8.1

Entr

ance

to H

all 8

.1

Mee

ting

Room

s8.

1 –

8.30

Exhi

bitio

n

to H

alls

6/7

UEG

Wee

k H

otsp

otE-

Post

er L

oung

esPo

ster

Exh

ibiti

on

Hall

8.1

UEG

Mee

ting

Room

1

cc

Cate

ring

Kio

sk

Net

wor

king

& L

ive

Stre

amin

g Ar

ea

cCa

teri

ng K

iosk

Cate

ring

Ki

osk

c

Exhi

bito

r Se

rvic

e De

skFr

eigh

t Fo

rwar

ding

UEG

O�

ce

Pres

sCe

ntre

Inte

rnet

Cent

reEs

cala

tors

to

Hal

ls 6

/7

Catering

Hall

8.1

Entrance to Hall 8.1

Cate

ring

c

7070

a71

7273

69

68 67 66 656463

62 61

60 59

5857

5453

52

51

5550

5649

81

75

7477 76

7879

80

84 8385

82

4842

47 46

4544

43

3635

3130

3229

3328

273425

3837

26

243940

41

9392

9411

1

109

110

107

108

95

9610

1

9710

0

9899

8788 89 90

91

86

103

104

102

105

106

117

118

116

120119

121

126

125

124

123

122

127

133

128

129 13

0132

134

135

136

137

138

139

140

115

114

113

112

131

2311

10

22

21 2019

1312 14

9 8 7 6 5 4 3 2 116

15

1718

Prem

ium

Par

tner

s /

Maj

or P

artn

ers

Gen

eral

Exh

ibito

rs

Hall 8.1

List of Reviewers

318

UEG Week Final Programme : Letter of Thanks

This high volume and high standard confirm that UEG Week is the most important forum at which to present your best research.

We have received 95 video cases which were formally evaluated by the Scientific Committee for presentation in Barcelona. As in previous years, late breaking abstracts have been scored by the Scientific Committee for presen-tation in Vienna. The quality of reviewing this year was excellent, but if you have any further (positive or nega-tive) comments, please do let us know! Finally, but most importantly, thanks to all investigators both within and outside Europe who have submitted their research to the meeting, and who are clearly contributing to making the 25th UEG Week Barcelona 2017 such a great success!

Magnus SimrénChair, UEG Scientific

Dear Colleagues,

On behalf of the UEG Scientific Committee, I would like to take this opportunity to thank you most sincerely for your contribution as an abstract reviewer for the original programme of the 25th UEG Week Barcelona 2017. The abstract reviewing process has been again very import-ant this year with a number of innovations introduced to improve especially the poster abstract presentations.

I know just how much time and effort reviewing ab-stracts takes, but without your expertise we would not have the quality that I believe we have achieved in the free paper and poster sessions, and UEG Week would not be the top international digestive diseases meeting that it has become today. Thank you! We received a number of 3,438 abstracts in total for UEG Week Barcelona 2017. In total, 2,341 abstracts were accepted, giving an accep-tance rate of 68,13%. 378 abstracts will be delivered as oral presentations and 1,963 as posters.

I am even more pleased to tell you that standards have again reached a very high level and we can expect to be exposed to most interesting research and great presentations.

Letter of Thanks

319

Del Chiaro, MarcoDelhaye, MyriamDelladetsima, JohannaDepoortere, IngeDeprez, Pierre HenriDeviere, Jacquesdi Pietro, MassimilianoDignass, AxelDinis-Ribeiro, MarioDorta, GianDrenth, Joost P.H.Drewes, AsbjørnDziki, Adam

EEisendrath, PierreEl-Omar, EmadEliakim, RamiEmmanuel, AntonEnck, PaulEnsari, ArzuEsmat, Gamal

FFärkkila, Martti A.Ferenci, PeterFerrante, MarcFerreira, Rui M.Fewtrell, MaryFichna, JakubFitzgerald, Rebecca ClareFloreani, AnnarosaFockens, PaulFord, Alexander CharlesFox, MarkFrancoz, ClaireFriess, HelmutFroehlich, FlorianFujishiro, Mitsuhiro

GGangl, AlfredGasbarrini, AntonioGemilyan, ManikGhaneh, Paula

AAabakken, LarsAbraldes, JuanAcalovschi, MonicaAdamina, MichelAdar, TomerAdham, MustaphaAdolph, Timon ErikAghemo, AlessioAgréus, LarsAlbano, EmanueleAlgül, HanaAllez, MatthieuAlmasio, Piero LuigiAlmeida, RaquelAndresen, ViolaAnnibale, BrunoArlt, AlexanderArmengol-miro, Jose RamonArvanitakis, MariannaAtherton, JohnAzpiroz, Fernando

BBaert, FilipBahr, Matthias J.Balaguer, FrancescBarbu, Sorin TraianBasoli, AntonioBaumgart, Daniel C.Bazzoli, FrancoBeaugerie, LaurentBeglinger, ChristophBeldi, GuidoBenamouzig, RobertBendtsen, FlemmingBergquist, AnnikaBiancone, LiviaBiesiekierski, JessicaBinder, Henry J.Binek, JanekBisschops, RafBöcker, UlrichBoeckxstaens, Guy E.Boermeester, Marja A.

List of Reviewers : UEG Week Final Programme

List of Reviewers

Bor, SerhatBories, ErwanBornschein, JanBouhnik, YoramBourreille, ArnaudBredenoord, Albert JanBruno, Marco J.Bures, JanBurisch, JohanBurra, PatriziaBuscarini, ElisabettaBytzer, Peter

CCaca, KarelCapurso, GabrieleCardenas, AndresCarneiro, FatimaCarter, RossCaseiro Alves, FilipeCastiella Eguzkiza, AgustinCastro, RuiCastro, ValeriaCellier, ChristopheChamaillard, MathiasChmiela, MagdalenaCholongitas, EvangelosColombel, Jean-FredericCorsetti, MauraCortez-Pinto, HelenaCostamagna, GuidoCottone, MarioCravo, MariliaCremers, Isabelle

DD'Haese, Jan Goestade Franchis, RobertoDe Giorgio, Robertode Knegt, Robert J.De Palma, GiovanniDe Wit, Niek J.de-Madaria, EnriqueDejaco, ClemensDekker, Evelien

Ghia, Jean-EricGiangregorio, FrancescoGionchetti, PaoloGiovannini, MarcGisbertz, Suzanne S.Goetz, MartinGomes de Sousa, RitaGraf, RolfGraziadei, IvoGress, Thomas M.Grgurevic, IvicaGrundy, David

HHaddad, FouadHahnloser, DieterHalfvarson, JonasHammad, EssamHammer, Heinz FlorianHandra-Luca, AdrianaHassan, CesareHatakeyama, MasanoriHavre, Roald FleslandHegyi, PeterHeieck, FrankHelmberger, ThomasHerszényi, LászlóHofer, HaraldHojsak, IvaHolleran, GrainneHovde, ØisteinHuberty, VincentHytiroglou, Prodromos

IIacopini, GiampaoloIaniro, GianlucaIbrahim, MostafaIlan, YaronIlie, MadalinaIrving, Peter

JJackson, SimonJansen, Peter L. M.Jenkins, Ian

320

Ricciardiello, LuigiRiis, Lene BuhlRisio, MauroRodrigues, Cecília Maria PereiraRogler, GerhardRokkas, TheodoreRoman, SabineRomano, MarcoRonkainen, JukkaRösch, ThomasRosendahl, JonasRossini, Francesco PaoloRubin, GregoryRudler, MarikaRusso, Francesco PaoloRuszniewski, Philippe

SSalaga, MaciejSalupere, RiinaSanders, David SurendranSantos, JavierSarnelli, GiovanniSavarino, EdoardoSavarino, VincenzoScharl, MichaelSchemann, MichaelSchöfl, RainerSchölmerich, JürgenSchoon, Erik JanSchreiber, StefanSchrumpf, ErikSeifert, BohumilSekiguchi, MasauSerag Zakaria, KhaledSerra, JordiSeufferlein, ThomasShamir, RaananSheridan, James P.Shirin, HaimSiegmund, BrittaSiersema, Peter D.Sifrim, DanielSimrén, MagnusSingh, BaljitSiveke, Jens T.Smout, AndréSokol, HarrySookoian, SilviaSpada, CristianoSpiller, Robin

OO'Morain, ColmOdes, ShmuelOhlsson, BodilÖhman, LenaOkolicsanyi, LajosOliveira, CarlaOliveira, ClaudiaÖresland, Tom

PPace, FabioPalsson, Olafur S.Papadopoulou, AlexandraPapanikolaou, IoannisPapatheodoridis, GeorgiosPár, AlajosParola, MaurizioPech, OliverPeck-Radosavljevic, MarkusPedersen, NataliaPeeters, HaraldPenagini, RobertoPereira, StephenPerez Gisbert, Francisco JavierPérez-Miranda, ManuelPetrosillo, NicolaPeyrin-Biroulet, LaurentPlentz, RubenPohl, DanielPokrotnieks, JurisPrifti, SkerdiPüspök, Andreas

QQuante, MichaelQuintero Carrion, Enrique

RRacz, IstvanRagunath, KrishRakonczay, ZoltanRamadori, GiulianoRautou, Pierre-EmmanuelRebours, VincianeReenaers, CatherineRegula, JaroslawReif, ShimonRicart Gomez, Elena

KKaragiannis, JohnKaukinen, KatriKelly, PaulKeszthelyi, DanielKida, MitsuhiroKleger, AlexanderKnowles, Charles H.Koletzko, BertholdKoletzko, SibylleKolho, Kaija-LeenaKoning, FritsKori, MichalKorponay-Szabo, Ilma RitaKramer, LudwigKrishnadath, Kausilia K.Kuipers, Ernst J.Kurppa, Kalle

LLackner, KarolineLaghi, AndreaLaharie, DavidLakatos, Peter LászlóLamarque, DominiqueLambregts, Doenja M.Langner, CordLaukkarinen, JohannaLeedham, SimonLeicester, RogerLeja, MarcisLemmers, ArnaudLennon, Anne MarieLeroi, Anne MarieLévy, PhilippeLindberg, GregerLindley, KeithLindsay, JamesLöhr, MatthiasLopes, Ana IsabelLouis, HubertLouis, EdouardLügering, AndreasLugli, AlessandroLundin, Knut E.A.Luzza, Francesco

MMaaroos, Heidi-IngridMaaser, ChristianMachado, Jose Carlos L.

UEG Week Final Programme : List of Reviewers

Machado, Mariana Luisa Moutinho VerdelhoMakristathis, AthanasiosMalagelada, Juan RamonMalagelada, CarolinaManns, MichaelManolakopoulos, SpiliosMantzaris, GerassimosMarinho, Rui TatoMarquardt, Jens UweMarteau, PhilippeMarti-Bonmati, LuisMartinek, JanMasclee, AdMcalindon, MarkMcColl, Kenneth E. L.McLaughlin, JohnMearín Manrique, FerminMegraud, FrancisMeier, PeterMeining, AlexanderMeisner, SorenMenu, YvesMichetti, PierreMichl, PatrickMilashka, MarianaMilosavljevic, TomicaMion, FrancoisMoehler, MarkusMoeller, SoerenMorino, MarioMoschen, Alexander R.Mulder, Chris J.J.Muñoz Navas, MiguelMurray, CharlesMusso, AlessandroMyrelid, Pär

NNakajima, TakeshiNardone, GerardoNaylor, GregoryNeesse, AlbrechtNess-Jensen, EivindNeuberger, JamesNeufert, ClemensNeuhaus, HorstNeunlist, MichelNg, Siew ChienNielsen, Ole HaagenNowakowska-Dulawa, Ewa

321

Tomazic, AlesTomlinson, IanTörnblom, HansTorres, JoanaTözün, NurdanTrifan, Anca-VictoritaTroncone, RiccardoTrovato, Cristina MariaTrukhmanov, AlexanderTsochatzis, EmmanuelTulassay, ZsoltTurner, DanTutuian, Radu

UUranues, SelmanUraoka, Toshio

VVaira, BerardinoValantinas, JonasVálek, Vlastimil

List of Reviewers : UEG Week Final Programme

Spinelli, AntoninoSporea, IoanStaiano, AnnamariaStallmach, AndreasStauber, RudolfStengel, AndreasStieger, BrunoStoyanova, DanielaSung, Joseph Jao YiuSyn, Wing-Kin

TTack, JanTacke, FrankTamori, AkihiroTargarona, EduardoTaylor, StuartThabut, DominiqueTheodorou, VassiliaThorlacius, HenrikTilg, HerbertTiniakos, Dina

van Berge Henegouwen, Mark IvoVan Cutsem, Ericvan der Woude, C. Jannekevan Eijck, Casper H.J.van Herwaarden, YasmijnVan Hootegem, PhilippeVan Kemseke, CatherineVan Laethem, Jean-Lucvan Leerdam, MoniqueVan Oudenhove, LukasVeereman, GigiVeres, Gabor LaszloVermeire, SeverineVilmann, PeterVinter-Jensen, LarsVlachogiannakos, JohnVogel, ArndtVogel, Wolfgangvon Hahn, ThomasVucelic, Boris

WWalker, MarjorieWatson, AlastairWelsch, ChristophWhitehead, William E.Wilder-Smith, CliveWittenburg, HenningWolthuis, Albert

YYamaoka, YoshioYao, Kenshi

ZZachou, KalliopiZaninotto, GiovanniZeissig, SebastianZelinkova, ZuzanaZerbib, FrankZins, Marc

Dedicated guides will show you around their themed selection. The best opportunity to interact with the presenters!Open to all delegates, no registration is required.

Meet us at the poster service desk on Mon–Wed at 12:30

Don’t wander alone – join our

Guided Poster Tours

Join us for a scientific symposium at UEG WEEK BARCELONA 2017

Funded and sponsored by Pfizer. This symposium is not affiliated with UEG

Date of Preparation: September 2017PP-GIP-EUR-1030

PHARMACOLOGICAL AND CLINICAL PERSPECTIVES: The evolution of the treatment landscape and personalised

medicine approaches for management of UC

Clinical Implications of the Evolving Treatment Landscape in UC Peter Irving, MA, MD, FRCP Guy’s and St. Thomas’ Hospitals | London, United Kingdom

Emerging Therapies Targeting Mechanisms of UC PathogenesisSilvio Danese, MD, PhD—Chair Humanitas Research Hospital | Milan, Italy

The Pharmacologist’s Perspective on Current and Emerging Treatment Options in UCDiane Mould, PhD (Pharmaceutics and Pharmaceutical Chemistry), FCP, FAAPSProjections Research, Inc. | Pennsylvania, United States

Refreshments will be provided

Monday, 30 October | 17:45–19:15 | Fira de Barcelona Gran Via North Entrance – Hall 8 | Room F3

2085-17YXELJ_UEGW_2017_FullPage_Ad_R05.indd 1 9/11/17 2:11 PM

Index of Authorsand Co-Authors

324

UEG Week Final Programme : Index of Authors and Co-Authors

AA K Silva, A............................. 173Aabakken, L. ..........37, 74, 99, 106Aach, M. ................................ 178Aalbers, A. .............................231Aaltonen, J. ........................... 239Aasbrenn, M. ..........................52Abalo, R. ................................156Abanades-Tercero, M. .............153Abazia, C. ...............................165Abbas, Y. ................................ 217Abbassi, I. ..............................218Abbes, L. ............................... 229Abbott, C. A. ...........................150Abd El Kerim, A. A. ................ 232Abd El Rahman, A. ................ 207Abd El Wahab, M. .................. 207Abd el_Aziz, M. .......................168Abd-Elsalam, S. ......... 52, 115, 153Abdalla, H. ..............................96Abdel Hamid, M. .....................96Abdel Rehim, A. ..................... 118Abdel-Aziz, H. .................150, 195Abdel-Wahab, M. .................. 220Abdelfattah, A. ....................... 119Abdelhafez, M. ...................... 224Abdelkrim, Z. ......................... 177Abdellah, M. .......................... 123Abdellatif, E. .......................... 179Abdellatif, Y. ............................117Abdelmoemen, G. .................. 115Abdelrahman, T. ...... 199, 232, 256Abdulkhakov, R. A. ............77, 234Abdulkhakov, S. R. ......77, 164, 234Abe, H............................. 181, 251Abe, S. .................78, 89, 123, 220Abe, T. .............................. 61, 115Abe, Y. ...................................145Abed, S. ................................ 220Abel, A. P. .............................. 187Abel, J. L. ....................... 196, 245Abellà-Ametller, C. .................134Abellán-Alfocea, P. ...........121, 197Abergel, A. ............................ 225Abi Kheir, S. ...........................216Abiko, S. .................... 53, 128, 151Abitbol, V. .....75, 139, 185-186, 247Aboelfotoh, A. ........................ 123Abols, A. ................................193Aboo, N. ................................ 141Abou Ali, E. ......................181, 221Abou Rached, A......................216Abou Saif, S. .......................... 115Abougergi, M. S. ..71, 103, 153, 219

Abraham, L. .......................... 243Abramowich, D........................69Abramowitz, D. ..................... 252Abreu García, L. E. ...........207, 227Abu-Taleb, H. ......................... 118Abukawa, D. ...........................140Accarino, A. ...................... 92, 145Accarino, G. .......................... 238Accomando, S. ...................... 238Achkasov, S. ...........................210Acikgoz, S. B. ........................ 254Adachi, S. ............................. 203Adachi, T. ...........................79, 93Adair, R. A...............................59Adam, V. ................................103Adams, J. ............................... 123Adar, T. ............................ 63, 207Addamo, C. ............................. 78Addolorato, G. ................ 166, 256Adedokun, O. J. ....................... 47Aden, K. .......................... 135, 138Adeoti, B. ............................... 127Adinolfi, L. E. ......................... 119Adler, A. ................................ 255Adler, D. G. ............................. 62Adler, S. N. ............................. 131Adolph, T. E. ............................89Adorini, L. ............................... 91Adsul, S. ............................... 239Aduna, M. ............................. 235Aepli, P. .................................. 72Aerts, H. J. W. L. .....................144Afferri, M. T. ...........................138Affronti, M..............................237Afif, W. ................................... 137Afonso, J. .........................187-188Afonso, M. B. ........... 114, 164, 169Afzali, A. ................................ 139Agar, K. ..................................227Agardh, D. ...............................94Agarwal, J. ............................. 157Agarwal, M. ........................... 151Agarwala, R. ..........................159Agawa, S. ........................ 173, 198Aggarwal, N. ..........................155Aghamohammadi, E. ..............154Aghemo, A. .......39, 42, 77, 95, 212Agnholt, J. ..............................155Agossa, K. ..............................135Agostinho, L. ..........................233Agostini, M. ..........................200Agranovich, I. .........................153Agrawal, A. ............................126Agréus, L..................49, 53, 61, 71

Aguade-Bruix, S. ................... 244Aguas, M. ............................. 235Agudo Castillo, B. .................. 207Aguirre, E. .............................. 63Agus, A. .............................. 71-72Ah-Soune, P. ......................... 222Ahıshalı, E. ........................... 244Ahlem, B. ................. 138, 168, 183Ahlenstiel, G. .........................128Ahluwalia, J. ......................... 220Ahmad, T. ...............................80Ahmed, A. M. ................... 117, 133Ahmed, M. .............................134Ahmed, S. ...............................50Ahmed, S. U. ......................... 220Ahn, C. ...................................165Ahn, D.-W. .............................130Ahn, I..................................... 127Ahuja, N. K.............................. 62Aichinger, E. ...........................231Aida, B. S. ..............................138Aihara, Y. ............................... 167Ainin, A. F. ............................. 217Ainora, M. E. ..........................215Aissaoui, M. ....................185, 257Aissat, Y. .........................185, 257Ait errami, A. ........................ 253Aithadad, H. ...........................194Aithal, G. .............................. 208Aiura, K..................................124Aizawa, N. ............................. 167Ajana, F. Z. .........168, 218-219, 254Akagi, M. .........................134, 191Akaike, K. ............................... 147Akamatsu, T. ..........................126Akamine, E. ...........................126Akao, Y. ..................................144Akasaka, T. .......................85, 201Akashi, T. .............................. 252Akazawa, Y. .. 93, 147, 174, 202, 252Akgün, B. .............................. 256Akhapkin, N. ..........................231Akhmadullina, O. ...................155Akiho, H. ................................ 123Akimoto, N. ............................ 178Akimoto, T. .................82, 173-174,

198, 201, 225Akinola, O. ............................. 176Akita, M ................................ 243Akizue, N. ....................... 124, 176Akkoc, T. ................................ 114Ako, S. ...................................219Akpınar, H. ..................... 234, 236Akpinar, Z. .............................148

Aktan, C. ................................143Aktar, R. ................................ 248Akutagawa, K. .......... 187, 193, 234Akutsu, D. .............................. 191Al Abbas, A. I. .........................52Al Ghamry, F. .......................... 123Al Hajjar, N. ............................64Al Kaabi, S. ............................216Al-Azzawi, Y. ......................... 254Al-Batran, S.-E. .......................92Al-Hasani, H........................... 151Al-Tarrah, M. ..........................135Alaa, M. ................................. 181Aladag, M. ............................. 170Alakkari, A. ............................186Alami, R. .................................52Alaoui, H. B........................... 255Alarcon, P. ..............................136Albadry, M. ............................164Albanese, I. ............................ 187Albéniz Arbizu, E. ........... 125, 175,

177-178, 257Alberghina, N. ....................... 238Albers, D. ................................ 53Albert, J. ..............66, 88, 162, 231Alberti, L. R. ...........................155Alberto, L. ................228, 234-235Alberto, S. ...............................117Albertoni, L. .......................... 234Albillos, A. ......................116, 248Alboraie, M. ............... 116-117, 164Albouys, J. ...................53, 177-178Albrecht, H. ............................148Albrecht, P. .............................195Albuquerque, A. .............. 196, 218Albuquerque, C. ..............159, 222Alcedo, J. .............................. 253Aldave, A. ..............................152Aldeguer, X. ...........................237Aleixo, M. J. ............................158Alekberzade, A. ......................183Aleman, B. M. ........................192Aleman, S. ........................ 38, 95Alempijevic, T. ........................165Alenda, C. ..............................143Aleotti, F................................ 242Aleshicheva, A. ....................... 173Alexandrino, G. ...............207-208Alexandrino, P. ....................... 167Alfambra, E. ...........................136Alfaro, E. ...........................71, 253Alfaro-Almajano, E. ..................71Alferink, L. J. M. ......................48Alfieri, R. ................ 182, 200, 232

Index of Authors and Co-Authors

Index of Authors and Co-Authors : UEG Week Final Programme

325

Arampatzioglou, A..................134Aranda, R. ...........................47, 61Arantes, V. N. .........................155Arao, M. ..................................85Arastu, Z. .............................. 246Arau, B. ..................................56Araújo, R........................ 207, 228Araujo, T. ...............................210Arbelaiz, A. ........................91, 117Arber, N. .................. 181, 242-243Archer, T. ................................135Archibugi, L. ...... 59, 172, 222, 230Arcidiacono, D. ...................... 223Arcidiacono, P. G. ............122, 172,

222, 230Ardanaz, E. ............................143Ardengh, J. C. .........................221Ardizzone, S. ........97, 177, 185, 239Arebi, N. ................... 96, 134-135,

185, 233-234Arechavaleta Tabuenca, S. .....200Arelaki, S. ..............................134Arena, I. ..........................225-226Arena, M. ...............................156Arévalo-Rodríguez, M. .............56Argüelles-Arias, F. ..................189Arguero, J. ....................... 69, 247Ari, L. ......... 139, 149, 242-243, 248Arias García, L. ....................... 139Arias-González, L. .......... 149, 248Arias, Á. ......................... 149, 248Aridi, H. D. ........................ 52, 62Arieira, C.................. 186, 216, 257Arikawa, T. ...................... 133, 182Arima, S. ......................... 121, 186Arimoto, J. .............................155Ariño, I. ............................77, 104Arioli, S. .................................156Aripov, A. N. ........................... 157Ariyoshi, R. .............. 223-224, 251Arıcıoğlu, F. ........................... 256Arjona Ferreira, J. C. .........90, 195Arkkila, P. ...............................241Arlt, A. ...................................102Armellini, E. ...........................130Armendariz-Borunda, J........... 116Armengol-Debeir, L. ..........76, 135Armerding, P. .........................140Armstrong, D. .......................... 87Armuzzi, A. ........... 49, 53, 60, 75,

80, 96-97, 100, 155, 185, 239-240

Arnelo, U. ..............................120Arnhard, K. .............................89Arnheim Dahlström, L..............49Arnhold, J. .............................190Arnoletti, J. P. .........................103Aro, P. ......................................71Arola, J.................................... 91Arrigo, S. ...............................190

Andrews, J. M.....64, 140, 146, 245Andrisani, G. .......................... 181Andriulli, A. ...............117, 167, 189Angeletti, S. .................... 124, 127Angeli, P. ...............................166Angelidou, I. ..........................134Angelison, L. ..........................189Angermann, Q. .......................128Angkathunyakul, N. ................165Angriman, I. ........ 86, 141, 192, 231Ankersen, D. V. ................ 136, 138Annareddy, D. ........................ 133Annese, V. .................... 54, 67, 83Annibale, B. ............. 124, 146-147,

155, 199Annicchiarico, B. E. ......... 215, 218Ansari, S. ...............................216Ansell, J. .................................90Antal-Szalmas, P. ..............61, 136Antico, A. ................. 113, 128, 142,

202, 241, 247-248Antipova, M. ........................... 132Antle, S. ................................ 242Antolić, M. .............................183Antonelli, G. ...........................166Antonelli, M. ..........................166Antonello, A. ...................182, 223Antoni, M. ..............................185Antonini, F..............................130Antonov, K.............................. 217Antor, M. ................................183Anttila, V.-J.............................241Antunes, A. G. ..........215, 228, 241Antunes, T. .............................221Anzai, S. ................................. 97Aoki, H. ..................... 98, 193, 243Aoki, T. ................................... 167Aomari, A. ............................ 256Aouattah, T.............................102Aoucheta, D. ..........................135Aoyama, T. ....................... 69, 142Apalset, E. ............................. 204Aparicio, J. R. .........................143Apessou, D. ............................125Apicella, I. .............................. 174Appadurai, I. ......................... 232Appenrodt, B..........................146Appleby, V. ............................. 132Ara, N. ......................143, 155, 197Arabacı Çetin, S. .................... 256Aracelia, M. P. ........................188Arafa, M. M. ........................... 217Aragonés, N. ..........................143Arai, J. ...................................142Arai, M. .................... 124, 145, 176Arain, M. ................................145Arajol, C. .........................196, 235Arakawa, T. ............................ 147Aralica, G. ..............................183Arama, V. ............................... 116

Amani, D. ...............................154Amano, N. ..............................198Amano, S. .......................219, 222Amano, Y.........................252-253Amaral, A. J. ...........................164Amaro, M. ...............................52Amaro, P. .................126, 166, 232Amaryan, G. ........................... 157Amata, M. ...............................99Amato, A. .............................. 228Amato, L. ...............................156Amato, M. R. .......................... 174Amer, M.-E.............................164Amiano, P. .............................143Amigo, N................................145Amil, M. .................................185Amine, E. M. ............ 158, 177, 240Aminian, A. ............................ 197Amiot, A. ..............73, 75, 139, 186Amir, Z. C. ...................... 185, 253Amira, H. G. .......................... 242Amjahdi, A. ........................... 256Amlani, B. ..............................136Ammar, N. ......................178, 225Amodio, A. ......... 121, 171, 209, 221Amoedo, J. .............................237Amoruso, A. ...........................154Amos, D. ................................145Amrani, N. ..............................54Amvrosiadis, G. .............. 219, 244Amzolini, A. ...........................165An, F. ............. 59, 95, 111, 118, 127,

139, 144, 148, 157, 161, 164, 187, 200, 211, 228, 233-234, 242, 256-257

An, W. .............................. 52, 187Ananthakrishnan, A. N............190Ananthanarayanan, M. ............117Anapaz, V. L. .......................... 217Anderloni, A. ........... 156, 219, 222,

224, 228, 244Anders, M. .............................. 76Andersen, J. B. ........................ 91Andersen, N. N. ...................... 101Anderson, J. .............223, 225-226Anderson, R. ..................... 56, 64Anderson, S. ..........................156Ando, T. ..................................85Andoh, A. ..... 126, 129, 137, 171, 203Andrade, A. ....... 159, 168, 188, 201Andrae, D. A. ..........................196Andraska, E. .......................... 245Andreasson, A. .......................143Andreea, F. ............................ 256Andreone, P. ........................... 91Andreozzi, P. ...... 146-147, 225-226Andrés Esteban, E. M. ............ 226Andresen, V. ............... 71, 154, 195Andreu-García, E. .................. 245Andreu Garcia, M. ................. 244

Alfthan, H................................ 91Algaba Garcia, A.................... 226Alguacil, J. .............................143Alguacil Cuéllar, M. ................125Algül, H. ...........................72, 122Alhanaee, A. ..........................237Ali, A. ..............................87, 205Ali, J......................... 138, 168, 183Ali, Y. ...................................... 93Ali-Eldin, Z. ............................117Ali Malek-Hosseini, S. ...... 65, 165,

216, 218Aliarous, N. ........................... 253Alias, B. ................................200Alin, S. ...........................204, 253Alina, T. ................................ 224Alisi, A. ................................. 205Alissa, L. ............................... 243Alivernini, S. ........................... 75Alkaade, S. .............................145Alkelin, L. ...............................231Alkim, C. ............................... 236Alkim, H. ............................... 236Allegretta, L. ......................... 203Allen, M. ................................159Allez, M. ...........35, 40, 47, 63, 73,

75, 94, 100, 137, 240Allimant, C. ......... 80, 83, 186, 225Allocca, M. ...................... 137, 240Alm, E. .................................... 70Almeida, J. ............................ 256Almeida, N. .......219, 223, 229, 253Aloi, M. ..................... 135, 190-191Alonso, P. ............................... 178Alonso Abreu, I. .................... 235Alonso Cotoner, C. ................... 57Alonso-Riaño, M. ................... 127Alos, R. ........................... 233-234Alperovich, G. ........... 101-102, 139Alrajhi, S. ............................... 137AlSafadi, A. M. ....................... 133Alsardi, L. ..............................120Altwegg, R. .................. 73, 75-76,

80, 139, 185-186Alustiza, J. M. ......................... 115Alustiza, M. ................ 63, 115, 143Alvarado-Escobar, H. .........49, 174Alvarez, M. A. .................. 125, 178Alvarez-Builla, N. .................. 235Álvarez-Castro, A. ............. 71, 220Alvarez Delgado, A. ..........175, 178Álvarez-Urturi, A. .................. 244Alvarez Urturi, C. ..............63, 245Alves, A. L. .............................215Alves de Matos, A. ........... 157, 210Alvisi, P. .....................97, 185, 190Alzina-Pérez, A. ......................128Alzoubaidi, D. ........................148Amado, C. ............................. 258Amalou, K. ...................... 158-159

326


Bancil, A. S. ........................... 176Bandel, W. .............................183Bando, H. ...............................201Banerjee, A. K. .......................122Banerji, V. .........................71, 195Banescu, C. ............................ 157Bang, B. W. .................... 223, 246Bang, C. S. ............................. 173Bang, J. Y. ............72, 103, 129-130Bang, K. B. .............................194Bang, S. ........ 122, 169-170, 172-173Banhudo, A. ............. 84, 128, 166,

180, 256Banks, M. .......... 132, 148, 225, 247Bannaga, A. ...........................159Banno, S. ................................ 53Bannwart, F.............................84Banovcin, P. ..............69, 248-249Bansal, R. .........................61, 221Bantleon, F. ............................ 187Banzragch, M. ........................ 114Bapaye, A........... 99, 223-224, 249Bapaye, J. A........ 99, 223-224, 249Baptista, A. J. .......... 183, 233, 246Bar-Yoseph, H. ................ 189-190Bar, N. ..............54, 57, 59, 61, 63,

70-72, 82, 85, 88, 99, 110, 137, 150-151, 242, 249

Baraket, O. .............................218Baranda, A. ............................ 217Barann, M. ..............................89Barauskas, G. ......................... 172Barbara, G. ...... 59, 63, 70, 78, 82,

88, 90, 99, 146-147Barbara, M. ............................166Barbaro, F. .............................130Barbaro, M. R............... 70, 78, 90Barbeiro, S. ............... 89, 179, 258Barber Caselles, C. ................ 244Barberio, B. .................... 187, 189Barbosa, M. ...........................166Barbu, M............................... 208Barbulescu, A. ........................216Bardan, E. ..............................195Bardella, M. T. ....................... 205Bareggi, E. ................181-182, 220Baretta, G. ............................ 206Baribaud, F. ...........................188Barjas, E. ............................... 178Barkun, A. ...................... 103, 246Barlas, İ. Ö. ........................... 203Barna, G. ...............................143Barnich, N. .. 57, 71-72, 85, 137, 242Baron, T. H. ........49, 100, 102-104,

145, 231Barone, M. ........150, 154, 166, 203Barosa, R. ......... 157-158, 176, 180,

209-210, 241, 256Barquero, D. ..........................227Barra Pardos, M. V. ................ 245

Bai, G. ............................. 89, 103Baicus, C.-R. .......................... 167Baier, G. ..................................89Baig, M. A. ..................... 129, 209Baik, G. H............................... 173Bailador, C. ............................ 137Bailey, Y. ................................138Baillet, P. ...............................186Bair, M.-J. ............................... 77Baird, P. .......................... 119, 222Bajaj, J. S. ................... 51, 83, 101Bajbouj, M. ....................224, 248Bajer, L. ............ 158, 184, 217, 256Bajor, J. ................................. 220Bak, Y.-T. ................................150Baker, R. .................................90Baker, S. ................................195Bakers, F. ...............................144Bakewell, L. ...........................156Bakkali, A. ............................. 187Bakulin, I. .............................. 119Balaban, D. V. .................237, 254Balaguer, F. ......................63, 245Balakrishnan, M. .................... 127Balanescu, L. ..........................233Balas, O. E. ........................... 208Balázs, A. ...............................120Balbaa, M. ............................. 118Baldaia, C. .. 167, 208, 217, 237, 245Baldan, A. ..............................130Baldaque-Silva, F...................200Baldassarre, G. .............. 199, 203,

247-248, 252Baldissarro, I. ................... 187, 191Baldwin, S. ............................ 170Balfour, A. ..............................140Balihar, K. ............................. 242Balint, A...........228, 234, 238, 240Balladur, P. ............................ 181Ballare, M. ............................ 222Ballerini, A. ...............181-182, 220Ballester, M. P. ...................... 239Ballester-Clau, R. .................. 246Ballet, N. ............................... 137Ballet, V. ................................189Ballmaier, P. ...........................215Balmana, J. ............................. 63Balogh, B. ............................... 61Baltar-Boileve, J. .................... 147Baltes, N. ...............................216Baltus, A. .................................71Bamba, H. ..............................129Bamba, S. ...........76, 126, 129, 137,

171, 180, 188Ban, H. ...............61, 126, 201, 203Bana e Costa, T. ............... 217, 235Banai, J. ..............83, 136, 234-235Banales, J. M. ....... 91, 117, 165, 169Banasiuk, M. ..........................195Banaszkiewicz, A. ...................195

Avni-Biron, I. ........................ 230Avolio, A. ...............................218Avram, L. ...............................215Awadie, H. ...........69, 128, 175, 177Axon, A. ...................... 46, 77, 104Ay, C. ...................................... 51Aya, H. ...................................138Ayed, K. .................................218Ayllón Cano, S. .......................198Ayoub, F. ................................ 151Ayoubi Khajekini, M. T. ........... 119Ayuso, J. R............................. 222Azahaf, M. ............................. 236Azevedo, R. ..................... 84, 128,

166, 180, 256Aziz, A. .........64, 71, 160, 182, 244Aziz, E. M. .............................. 177Aziz, I. .... 64, 71, 146, 160, 244-245Aziz, Q. ........................... 156, 197Azman, A. ..............................158Azouz, M. M. ..........................227Azpiroz, F. ..............57, 65, 80, 83,

92, 145, 244Azuara Garcia, D. ..................... 97Azuma, M. .............. 104, 124, 200Azuma, T. .................170, 203, 223Azzarone, A. ...........................189Azzini, A. M. ...........................183

BBaba, E. R. .............. 194, 201, 258Baba, S. .................................194Baba, T...................... 46, 98, 126,

128, 193-194, 243Baba, U. ................................. 179Baba, Y.............................151, 175Babenko, O. ...........................125Bach, S. .................................. 41Bach, V.................................. 204Bachir, H. .............................. 255Bäckhed, F. ..............................50Badawi, R. ..............................52Badia Aranda, E. .................... 139Badía, M. ...............................153Badillo, R. ..............................198Bado, A. .................. 156, 206, 241Badr, M. ..................................117Bae, H. I. ........................ 180, 230Bae, J. Y. ........................ 224, 227Baebler, K. ........................97, 233Baeg, M. K. ............................152Baek, J.-H. ............................. 177Baert, F. .......................49, 55, 80Bafutto, M. ....................... 49, 189Bagnoli, S. .............................190Bagyánszki, M. .......................195Bahaz, B. ...............................188Bahí, A. ..................................237Bahin, F. ........................... 76, 177

Arrizabalaga, B. ..................... 115Arroja, B. ...............................183Arroyo Villarino, T. ...........136, 253Arslan Kucuk, T. ..................... 244Artesiani, M. L. ....................... 197Arulmani, U. ..........................190Arumugam, M. .................. 50, 63Arvanitakis, M. ........35-36, 54-55,

81, 107, 126, 207, 210Asada, M................................ 167Asadzadeh, H. ........................154Asahara, S.............................. 172Asai, S. ..................................126Asai, Y. .................................. 222Asakura, H. ............................. 61Asano, N. ............................... 197Asano, T. ................................182Asano, Y. ....................93, 167, 232Asanuma, K............................ 197Asayama, N. ..................... 69, 142Aschenbeck, J. ................. 84, 254Aschenbrenner, E. ........... 116, 214Ascolani, M. .......................... 234Ashall, B. ................................58Ashaye, A. O. .......................... 141Aslan, F. ...........................84, 148Aso, K. ...................................130Asoglu, V................................159Asokkumar, R. ........................156Aspinall, R. ............................ 116Assaf, S. .................................216Asselah, F. ............................. 253Asselah, H. ............................ 253Atalaia Martins, C. .....89, 166, 230Atanassova, A. ........................186Atarashi, K. ..............................71Atayan, Y. ............................... 170Ates, F. ................................... 115Athanasiadou, E. .....................49Atherton, J. ................ 37, 105-106Atif, E. ....................................169Atreya, I. ................................184Atreya, R. .......... 47, 55, 60-61, 79,

94, 105, 184, 207Atrott, K. .....................86, 97, 184Attallah, A. M. .........................117Attwell, A. ............................... 62Attwood, S. ...... 37, 47, 67, 101, 105Aubele, C. ..............................128Aubert, P. ................ 195, 234, 252Aubourg, A. ..................... 73, 185Aupiais, C. ............................. 191Aured, I................................. 253Auricchio, R. ...........................64Auriemma, F..... 219, 222, 224, 244Aussó, S. ................................. 97Aust, D. ..................................140Avallone, E. V. ................ 206, 239Avedano, L. ........................... 100Avidan, B. ........................137, 140


327

Berg, S. ..................... 101-102, 139Berg, T. .......................39, 46, 154Bergamin, I. ............................52Bergemalm, D. ...................... 236Berger, A. ............................... 141Berger, A. ............................... 151Berger, A. W. ..........................193Berger, A.-E. ..........................186Berger, E. ...............................134Bergillos-Meca, T. ...................154Bergman, J. J. G. H. M. .. 39, 54, 67, 76, 87,

148, 173, 200-201, 249Bergman, W. ...........................85Bergonzi, M. ............... 64-65, 155Bergstein, E. ......................... 243Berkane, S. .....................185, 188Berkhout, D. J. C. ....................186Bermejo, A. ............................125Bermejo, F. ...............120, 125, 226Bernal, J. ......................... 128, 231Bernal Checa, P. ............. 120, 226Bernardes, C. .......... 159, 209, 258Bernardo, C. ...........................227Bernardo, D. .............97, 208, 234Bernardo, S. ......207-208, 237, 258Bernardo, W. M. ............. 126, 230Bernardoni, L. ................. 221-222Bernhardt, J. ....................133, 174Bernklev, T. ............................ 176Bernoux, A. ............................194Bernstein, C. N. ................. 89, 92Berntsen, N. L. ........................59Berrag, S. .............................. 253Berretti, D. .............................122Berroneau, A..........................188Berrutti, M. ............................ 119Berry, N. .............103, 171, 178, 187Berryman, E. ......................... 243Berstad, P. .............................. 176Bertakis, V. ..............................92Bertani, H. ................96, 130, 230Bertelè, A......... 150, 198, 249, 255Bertolami, C. ......................... 238Bertucat, A. ............................130Berzin, T........................... 93, 251Besheer, T. ................ 117, 166, 168Besherdas, K. ........................ 202Bessa Casserras, X. ...........63, 178,

244-245Bessard, A. ..................... 195, 242Besselink, M. G. H. ...... 37, 46, 66,

71, 93, 169-170Betes Ibáñez, M. T. ................ 180Bethge, J. ...............................138Bettenworth, D. ...89, 135, 237, 239Beuers, U. H. W. ............... 117, 219Beukers, R. ............................102Bevan, R. ................................89Bevivino, G. ............................143

Belostotsky, N.........................155Belousova, L. .......................... 119Belsanova, B. ........................ 222Belt, E. ..................... 120, 169, 237Beltran Niclos, A. B. ...............237Belyakov, N. ........................... 139Bemelman, W. A. .............. 73, 81,

104-105, 134Ben Ameur, W. .......................183Ben-Bassat, O. ................ 151, 230Ben-Haim, L. ..........................155Ben-Horin, S. ...... 78, 137, 139-140,

189-190Ben Mami, N. .................. 133, 183Ben Mustapha, N. .................. 240Ben-Shlomo, S. ....................... 72Ben Shoham, A. ......................56Ben Slama, A. ................. 168, 183Ben-Yehoyada, M. ...................85Benatti, E. ............................... 78Benbaya, R.............................188Bendaoud, S. .........................185Bende, F. ......................... 214, 217Bender, M. .............................214Bender, P. ..................... 67, 73, 81Bene, L. ........ 56, 83, 136, 222, 251Benech, N. ............................. 132Benedetti, I. ................ 64-65, 155Benedikt, K. ............................64Benelbarhdadi, I. .....168, 218-219,

254, 256Benes, M....................52, 217, 242Benesic, A. ..............................59Benesova, L. ....................222, 251Benezech, A. ........... 124, 182, 200Benfenatki, N. ........................154Bengi, G. ........................ 234, 236Bengs, S...........................86, 233Benini, R. .........................146-147Benítez-Cantero, J. M. ......140, 186Benítez Roldan, A. .................. 139Benito, R. ...............................153Benkirane, A. ........................ 253Bennet, S. M. P. ...................... 141Bennett, R. .............................145Benny, S. ................................ 181Benosman, H. ....................... 229Bensaid, L. ............................ 203Benslaiman Seyid-Jebari, B. ................................ 65, 247Benson, A. ..............................69Benvengù, L. ..........................168Ber, Y. ................................... 236Bercier, S. ..............................194Berdah, S. ........................ 99, 124Beregova, T. ...........................155Berends, S. ............................ 141Berendsen, S. A. .................... 255Bereswill, M. ............. 101-102, 139Beretta, P. ..............................156

Battistel, M. ........................... 116Battmann, A. ...........................92Baudry, C. ..............................185Bauer, P. ............ 102, 120, 127, 195Bauerfeind, P. ...........102, 127, 195Baumann, C. ......................... 235Baumeler, S. ...........................52Baumgaertner, I. .....................50Baumgart, D. C. ......................140Bayomi, H. A. .........................164Bayrhoffer, T. ..........................190Bazan, A. ...............................184Bazhin, A. V........................... 232Bazzichi, L. ............................ 206Bazzoli, F. ............................... 197Beales, I. ..................223, 225-226Beath, A. P. ............................145Beaufrand, C. .........................145Beaugerie, L. ....... 54, 101, 139, 185Bech Johannesen, T. ................58Bechmann, L. ......................... 217Bechstein, W. ..........................92Becker, A. .............................. 206Becker, B. ................................52Becker, C. ......................... 70, 170Becker, D. ...............................196Becker, E. .........................86, 164Becker, K. F. ............................193Becq, A. ................................. 181Becx, M. ................................. 187Bednarz-Misa, I. .....................184Bedny, F. ............................... 242Beeckmans, D. .......................247Beer, S. ...................................46Beer-Gabel, M........................195Beets, G. L................. 50, 144, 231Beets-Tan, R. G. H. .... 50, 144, 231Beg, S. ............................225, 231Bège, T. ..................................124Beglinger, C. ............... 52, 77, 104Beiderwellen, K. .................... 187Beintaris, I. ............................143Bekal, P. .................................136Bekkali, N. .............................. 62Bekkali, N. L. ......................... 222Belacosa, L. .............................90Belanteur, K. ......................... 253Belei, O. .......................... 104, 170Belghanem, F. ................. 158-159Belghazi, K. ................76, 173, 249Belhocine, K. ..........................185Bellacosa, L. ............................90Bellaiche, M. .......................... 191Belle, A. ................................ 235Bellicoso, M. I. ...................... 238Bellimi, H...............................188Bellini, M. ..90, 198, 200, 206, 249Bellisario, C. .......................... 101Bellissimo, M. C. ................... 232Belluardo, N.......................... 238

Barrachina, M. D. ............ 134, 233-234, 252Barranco, L. ...........................153Barreau, F. ..............................92Barreiro, P. ............................ 258Barreiro-de Acosta, M. .......... 185-187, 189-190, 240Barresi, L. ........................ 99, 130Barret, M. ............53, 62, 127, 129,

178, 181, 228, 230, 247Barrett, J. S. ............. 141, 196, 233Barrias, S. ....................... 175, 210Barrichello, S. ................206, 255Barrioz, T. ............................. 232Barrison, I. ..............................65Barroca, H. ...................... 173, 196Barroca, R. .............................145Barros, J. .......................... 84, 128Barros, M. ............................. 232Barroso, E. ..................... 180, 208Barry, L. .................................237Barta, B. P. .............................195Barta, Z. ............................... 234Bartak, B. K. ............. 143, 193, 243Barthet, M......... 40, 48, 67, 73, 81,

95, 99, 124, 152, 172, 182, 200

Bartneck, M. ........................... 61Bartoli, A. ............................. 225Bartolí, R. ............83, 126, 175-176Bartolo, O. ..................... 149, 248Bartsch, D. .........118, 120, 164, 168Barturen Barroso, A. ............. 180Barucca, V. ............................. 172Barut, B. ................................ 170Baryshnikova, N. V. ............... 203Barzaghi, F. ............................156Basaranoglu, M. ..................... 116Basford, P. ..............................125Basha, J. ................................ 181Bashir, M. .............................. 101Basilisco, G. .......................... 236Basit, S. A. .............................247Basquill, C. ............................ 175Bassem, H. .............................138Basset, P. ......................... 89, 155Bassett, P. ...............................89Bassi, A. ....................58, 188, 243Bassi, C. ........................... 85, 183Basso, D. ........................203, 249Basso, M. ...............................218Bassotti, G...............................96Baston Rey, I. .......................... 72Bastos, R. P. ...........................227Bastuji-Garin, S. ......................50Batista, M. .............................164Batlle, M. .............................. 244Battaglioli, E. J. ..................... 206Batterham, R. ......................... 173Batteux, F. ..............................221

328


Boubaker, J. .......................... 240Boucekkine, T. .................185, 188Bouchabou, B. .......................227Bouchaoui, K..........................188Boucher, A.-L. ......................... 83Bouchmal, S. ...........................92Bouchnafa, S. .........................159Bouchoucha, S. ......................218Boudet, J. ...............................189Boudin, H. ..................... 195, 242Bouguen, G. ...........73, 75, 83, 186Bouhnik, Y. ................... 43, 75, 86Boulanger, T. ......................... 204Boulares, R. .......................... 235Boulygina, E. A. ....................... 77Bouma, G. ...................64, 91, 236Bounab, N. .............................185Bounou, L. ..................... 206, 251Bouras, E. ........................127, 129Boureille, A. ...........................185Bourgaux, J.-F. ........................ 76Bourget, A...............................82Bourke, M. J. .... 52, 62, 68-69, 76,

99-100, 128, 175, 177Bourner, L. .............................188Bourreille, A. ...........136, 186, 234Bourrier, A. ...................... 75, 186Boursier, J. ............................. 151Bousquet, C. .............. 78, 102, 161Bousseloub, A. ................ 158-159Boustiere, C. ...........................95Boutaleb, A. F. .................185, 257Boutallaka, H. .......... 219, 253-254Bouvier, S.............................. 232Bouvy, N. ....................... 105, 249Bove, V. ................................. 252Bovet, C. ............................... 234Bowlus, C. ............................... 91Bown, S. .........................132, 225Boyanova, L.......................77, 104Bozek, P. ............................... 238Braat, A. ................................. 93Brabant, S. ............................ 238Brachman, Y. ...........................69Bradeanu, A. M. .....................233Bradshaw, L. ..........................142Braegger, C. ........................... 157Brahmbhatt, B...................93, 127Brain, O. ............................... 235Bramuzzo, M. .................. 135, 190Branch, S. ..............................145Branche, J. ..................... 236, 238Branchi, F. ...............205, 236, 254Branco, J. C. ...........................237Branco, L. ...............................237Brandão, C. .................... 224, 228Brandimarte, G. .............146, 199,

203, 239, 252Brandimarte, M. A. .................146Brandolese, A........... 121, 209, 221

Bond, A........................... 197, 240Bondarenko, N. ..................... 249Bonder, M.-J. .......................... 70Bonderup, O. K. ......................140Bondue, A. ............................. 197Bongers, G. ..............................71Boni, F. ..................................156Bonifacio, C. ........................... 137Bonillo, D. ............................. 226Bonitatibus, A. ............... 236, 254Bonnart, C. .............................92Bonnet, M. .......................85, 242Bonnet, R. ...............................85Bonnett`, L. ........................... 222Bonora, E. ...............................92Bonsing, B. .............................85Bonten, M. J. M. .....................103Boo, S.-J. ...............................159Booij, K. A. .............................169Bools, D. ................................192Boone, J. H. ............................ 187Boonstra, J. ............................. 91Boota, N. ...............................142Bor, R. ......219, 228, 234, 238, 240Bor, S. .............52, 73, 77, 104-105,

148, 197, 199Boran, G. .............................. 254Borda, A. ............................... 181Bordaçahar, B. .......... 62, 221, 230Bordin, D. S. ......................77, 104Borgaonkar, M. ..................... 242Borges, V. P. .......................... 258Borgwardt, S. ..........................52Bories, E. ........... 62, 152, 169, 200Borisova, E. ............................153Borizanova, A. ........................159Borkar, V. V. ........................... 157Borkotoky, R. ..........................219Bornschein, J. .............. 62, 76, 161Borralho, P. ............................169Borrelli, O. ..............................65Bortlík, M. ....................... 237-238Bortoluzzi, F. ..........................190Borzan, B. ..............................158Borzan, V. ..............................158Borzio, F. ................................168Bosak, N. ...............................215Boscá, M. M. ......................... 239Bosch, J. ............................ 38, 86Bosch, S. .................... 92, 186-187Boschetti, E. .......................79, 92Boschetti, G..........79, 135, 137, 186Bose, S...................................219Boskoski, I............................. 252Bosnar, M. .............................183Bossa, F. ......................... 189, 240Bossuyt, P...............49, 55, 80, 96Botas, J. ................................ 256Botteri, E................................ 176Boualit, M. ..................... 185, 238

Blake, A. ............................... 239Blake, P. ................................ 232Blanc, P. .................................. 76Blancas-Valencia, J. M. ........... 174Blanchard, C. ........................ 248Blanco Belver, A. .................... 178Blanco Velasco, G. .................. 174Blanco-González, J. ................153Blanco, S. ............................... 217Blanpied, C. ............................92Blatt, A. .................................189Blauvelt, A. ............................140Blaydon, D. ............................148Blazer, D. ...............................183Bleijenberg, A. ........................50Blero, D. ............................... 207Bléro, D. ........................... 66, 88Bloemendaal, F. M. ................184Blomster, T. ........................... 239Blondeau, B. ..........................156Bloom, S. ......................... 61, 140Blumberg, R. S. ....................... 79Blümel, S. ..............................168Boadas, J................................. 97Boal Carvalho, P. ....................166Boarino, V. .............................130Boccia, S. ...............................122Bochar, A. ........................214-215Böcher, W. O. .......................... 47Bockhorn, M................ 46, 78, 221Bocsan, C. ............................. 246Boda, K. .................................. 53Bodelier, A. ............................102Bódi, N. .................................195Bodineau, L. ...........................156Bodini, G. ......... 149, 187, 191, 199,

237, 240, 248-249Boeckxstaens, G. E. .......... 50, 70,

75, 79, 94Boecxstaens, V. ...................... 101Boehm, G. ..............................140Boermeester, M. A. ...... 41, 53, 59,

142, 192Boga, S. ................................ 236Bogie, R. .................................69Bogte, A. ............................... 248Böhm, B.................................. 93Böhm, I. T. .............................120Boix, J. .................83, 126, 175-176Bojarski, C.......................254-255Bojic, D. .................................189Bokemeyer, B. ........................ 137Boku, N. .................................251Bolado, F. ........................170, 220Bologna, G. ........................... 254Boltin, D............................ 91, 151Bomme Høgh, M. ...................154Bommelaer, G. ......79, 83, 137, 186Bon, I. ............ 36, 83, 126, 175-176Bonavolta, R. .........................216

Beydogan, H. ..........................49Beyer, L. ..................................99Beyna, T. ...........36, 40, 42, 67, 73,

76, 81, 126, 173Bezzio, C. ........................225-226Bhagwat, A. ........................... 179Bhala, N. .........................142, 247Bhandari, B. R. ......................140Bhandari, P. ... 53, 72, 99, 125, 225Bharadwaj, ......................... T. K.Bhasin, D. K. ......................... 220Bhatt, A. ..........................181, 187Bhattacharya, A. ..................... 187Bhattacharya, K. .................... 230Bhattacharyya, R. ...................125Bhattarai, Y. .......................... 206Bhayat, F. .............................. 239Biagi, F. ................................. 204Bian, S. ..................................189Bianchetti, M............129, 156, 230Bianco, M. A. ......................... 177Biancone, L. ..97, 185, 187-188, 234Biasci, D. .................................80Biasiolo, A. ............................ 114Biasutto, D. ............................ 197Bibani, N. .......................228-229Bichard, P. ............................. 222Bideau, K. ..............................185Biedermann, L. ........101, 235, 248Bielich, A. ............................... 53Biemans, V. B. C. ................... 239Bienfait, L. .............................192Bienvenu, J. ............................ 79Bieri, O. ..................................52Biermann, M. ......................... 170Biesiekierski, J. ........................65Bieze, M. ................................ 118Bihui, Z. ...........................215-216Bilibou, M. ............................ 222Billard, E. ......................... 71, 242Billeci, M. ............................. 239Billiauws, L. ............................42Billmeier, U. ......................79, 170Bing, L. ..................................227Bingham, R. ..................... 93, 129Biolato, M. .............................218Biriuchenko, I. ....................... 249Biro, E. ..................................136Biró, P. ...................................120Bischoff, S. ....................... 87, 100Bismuth, M. ............................ 76Bispo, M. ....................... 180, 208Bisschops, R. ..........54, 76, 87, 94,

114, 125, 173, 177Bisseling, T. M. .......................192Björk, J. ..................................189Black, C. ......................... 146, 244Blackshaw, A. ............. 70, 79, 248Blackshaw, G.................. 182, 256Blad, W. .................................184


329

Caccamo, L. ............................130Caccaro, R. .............................189Cadiot, G. ...............................186Cadoni, S. ...............................52Caduff, R. ...............................195Caetano, C. ............................. 139Caggiari, L. .............................153Çağlayan Yeğen, B. ................ 256Cagol, M. ................ 182, 200, 232Cahen, D. L. ....................... 36, 82Cahova, M. ............................ 256Cai, B. ..............................90, 195Cai, F. ....................... 132, 152, 229Cai, M. ............................198, 201Cai, Z. ....................................143Caillo, L. ............................. 73, 76Caillol, F. .................. 152, 169, 229Cainap, C. ............................. 222Caio, G. ...................................92Cairns, A. ...............................122Cairo Nunes, G. ..................... 206Calabrese, E. .............. 97, 185, 187Calabrese, F. .......................... 242Calatayud, M. ......................... 139Calatayud, S. ..... 134, 233-234, 252Caldas, M. ............................... 77Caldas Álvarez, M .........77, 97, 104Caldeira, A. ........84, 128, 166, 256Caldeira, P. .............................188Calleja, J. L. ............................227Callery, M. ............................... 93Calpe, S. .................. 92, 150, 200Calvaruso, V. ................... 187, 238Calvet, X. .............62, 106, 139, 241Calvo, H. ................................152Calvo, M. ............................... 240Camacho, E. ....................219, 229Camacho, M. ..........................158Camargo, S. .......................... 220Camera, S. ................. 117-118, 167Cameron, R. ...........................149Cameron, S. J. ........................184Camila Dias, C. ......... 132, 188, 196Camilleri, M. .............. 65, 90, 195Caminero, A. ...........................56Caminero-Fernandez, R. .......... 97Cammà, C. ......................166, 168Cammarota, G. ................. 84, 103Campagnola, P. .........171, 209, 221Campbell Davies, S. ............... 239Campello, E. ........................... 116Campo, R. ....................... 153, 241Camprubí-Font, C. ........... 134, 184Camus, M. ...........127, 129, 181, 221Canard, J.-M. ................... 151, 229Cañas, M. ...............................186Canaval-Zuleta, H. J. ........170, 220Canbay, A. ................ 156, 217, 224Cancela, E. ..................... 207, 228Cancelas-Navia, P. .................. 127

Bulajic, M. ...................... 122, 130Buldak, R. J. ...........................164Bulla, J. ..................................126Büller, N. V. J. A. ......................92Bunganic, B. .................. 220, 222Buonocore, R. M.....................165Burazeri, G. ............................149Burdyga, G. .............................52Bureau, I. .............................. 240Bures, J. ................... 138, 241, 251Burganova, G. R. ....................164Burgell, R. E. ............ 141, 195, 233Burger, N. ..............................233Burgess, N. G. ........................ 177Burgess, N. J. ......................... 175Burgio, V. .............................. 242Burisch, J. ............ 60, 92, 96, 101,

135-136, 138, 185, 234Burke, A. L. ............................140Burns, G................................ 204Buron, A. .............................. 244Burr, N. .....................132, 135, 237Burra, P. ............... 54, 61, 100, 116Burrelli Scotti, G. ....................138Bursics, K. ............................. 235Burt, M. .......................... 226-227Burtin, P. ................................ 176Buscarini, E. ...........................153Busch, O. R. C. ........... 93, 169-170Buse, E. .................................156Buskens, C. J. ...............67, 73, 134Busquets, D. .................... 189, 237Bussmann, C. ..................101, 248Bustamante, M. ......................143Buti, M. ............................. 39, 84Butler, J. .................................136Butler, R. N. .......................... 204Butt, F. .................................... 72Butt, M. O. T. .......................... 167Butturini, G. ............................85Buxbaum, J. L. ......................... 62Buzás, E. I. .............................192Buzás, G. M. ......................77, 104Byelinska, I. .......................... 238Byeon, J.-S. ............... 98, 175, 239Bykova, S. ..............................155Byrne, S. .................................90Byron, C. ................................237Bytzer, P. ..................... 58, 77, 104

CC. Branco, J. ..............117, 209, 237Caballero, N. ............. 65, 126, 247Cabanne, A. .......................... 238Caberlotto, C. ........................ 232Cabib, C. ................................149Cabré, E. ................. 186, 234, 239Cabriada, J. L. ...........140, 185, 235Caca, K. ....................53, 67, 73, 81

Brueckner, S. .......................... 101Bruijning-Verhagen, P. C. J.................................103Bruins, M. J. ............................56Bruley Des Varannes, S. .................. 82, 136, 186, 252Brullet, E................................241Brummer, R. J. .......... 56, 103, 146Brun, P. ......................86, 141, 192Brunel, C. .............................. 248Brunet, J. ................................ 63Brunetti, F. ..............................50Bruni, B. ................................ 127Brunner, F. ............................ 234Bruno, M............................... 180Bruno, M. J.............49, 71, 76, 107,

123, 129, 143, 150-151, 179, 192, 200, 251, 255

Bruns, T. ................................. 61Brusselaers, N. ........................ 77Bruyneel, M. ......................... 207Bryant, R................................ 197Brzozowski, B. ....................... 204Brzozowski, T. .......... 85, 104, 250Bu, C.............. 87, 89, 93, 101, 135,

141, 169-170, 248Bu, S. ........49, 71, 97, 166, 169, 171,

198, 205, 231, 237, 250-251Bubernáková, L. .................... 249Bucalau, A.-M. ................207, 210Buccianti, N. ..........................189Buchen, B. .............................. 70Buchholtz, M.-L. ......................59Buchholz, M. ...................120, 223Buckley, M. ............................237Bucsics, T. .............................. 132Bucur, D. ................................231Bucurica, S. ............................237Buda, A. ...........................55, 228Budding, A. E. ........................196Budihal, S. ................124, 129, 176Budzinsky, S. A. ......................221Buendia, L. ............................ 217Buening, C. ............................ 141Buettner, S. ............................169Buffoli, F. ....................... 180, 207Bugajski, M. .......................... 245Bugariu, A. ........................64, 73Buggenhout, A. ......................210Bugianesi, E. ................48, 75, 86Buhman, K. K. .........................95Bui, L. ..................................... 75Buijs, J. G. .............................. 179Buis, C. I. ................................ 93Buisson, A. ............75, 79, 83, 135,

137, 139, 185-186Bujanda Fernández de Piérola, L. ........... 63, 77, 91,

104, 117, 153, 245Bukhari, M. A. ...... 62, 99, 102-103

Brandt, C. F. ...........................103Brar, T. S. ............................... 151Braun, A. ...............................128Braux, J. .................................135Braverman, M. ........................69Bravo, M. .............................. 205Brazier, F. ...............................135Brecelj, J. ................................ 79Brechmann, T. .......... 175, 178, 225Bredenoord, A. J. .......... 37, 67, 75,

95, 99, 101, 247Breidert, M. ............................ 53Breilh, D. ...............................188Brenke, D. ............................. 207Brennan, D. .....................252-253Brenner, H. .............................50Breoni, I. .................................171Bresciani, M. ......................64-65Breslin, N. ................ 126, 137-138,

140, 216, 254Bretthauer, M. ..............58, 82, 98Breuer, R.................................90Breukink, S. O. .......................144Breunig, M. ............................120Brewer Gutierrez, O. I. ...... 62, 99,

102-103Brezina, J. ..............................184Brichet, L. ..............................185Bridonneau, C. ........................ 57Brieau, B................... 127, 177, 228Brind, J. ..................................65Brink, L. .................................126Brisc, C. .......................... 116, 216Brito, H. M. D. S. ....................164Brito, M. J. ............... 157-158, 209Britzen-Laurent, N. ..................86Brixi, H. ..................... 75, 80, 186Brixie, Z. ................................194Brøbech, P. .............................103Brocca, A. ..............................166Brockow, K. ........................... 248Brodmerkel, C. .......................188Broers, C. ............................... 101Brogan, G. .............................155Brogyuk, N. ........................... 228Broide, E. ...............................140Bromberg, L. ......................... 207Bronkhorst, C. ................ 166, 235Bronowicki, J.-P. .................... 235Bronzwaer, M. .........................50Brookes, M. .....................125, 234Brougham, K. ........................ 222Broughton, R............223, 225-226Brown, C. ..........196, 199, 232, 252Brown, G. .............................. 177Brown, J. ................................182Brozzi, L. .......................... 121, 171Bruck, R. ............................... 209Brückner, M. ................... 135, 237Bruckner, R. S. ........................ 97

330


Cebolla, A. ....................... 56, 157Ceccarelli, L. .......................... 206Ceelen, W. .............................. 133Cefaro, A. .............................. 228Cejas, L. ................................ 235Cekic, C. .................................148Celikel, C. A. ........................... 114Cellier, C. ........... 151, 154, 173, 229Cenac, N. ..............50, 70, 78, 234Cennamo, V. .......................... 228Cento, S. ............................... 249Ceplis-Kastner, S. .................... 137Cerban, R. .............................. 217Cereatti, F. ...................... 180, 207Cernat, E. ............................... 191Cerofolini, A. ..........................130Cerrito, L. ...............................218Cervantes, J. G. .......................215Cerys, S. ................................. 127Cesar Machado, M. C. .............221Cesario, S. .......................196, 199Cesaro, P. .............................. 228Cesbron Métivier, E. ................ 151Cesna, V. ................................ 172Çetin, A. ................................ 223Cetin, H. ................................ 244Çetin, O. ................................ 256Cha, B. H. ............................... 119Cha, J. H. ................................201Cha, S.-W. ....................... 179, 229Chaabouni, H. ................. 133, 183Chaaro, D. ...................... 139, 208Chae, H.-S. .............................219Chagas, C. ............... 180, 208, 217,

235, 258Chai, H. ...........................109, 140Chakraborty, J. ........................ 151Chamaillard, M........................ 57Chan, A. T.............................. 250Chan, B. ................................ 258Chan, C. .................... 63, 133, 242Chan, D. .....182, 185, 199, 232, 256Chan, E. W. ........................46, 91Chan, F. C. ............................... 63Chan, F. K. L. ....... 82, 142, 147, 152Chan, G. .....................70, 102, 215Chan, H.-H. .............................59Chan, P. ..................................142Chan, P. W. ............................ 208Chan, S. M. ....................230, 250Chan, Y. ..................................198Chandan, J. ............................247Chandhok, G. .........................215Chandrakumar, L. ...................195Chandramaliteeswaran, C. ...... 133Chandrasegaram- Shanmuganathan, S. .........231Chandy, R. ..............................188Chang, D. K. ...............85, 193-194Chang, H. ............ 39, 124, 169, 179

Casellas, F. ....................... 49, 189Casellas, J. A. .........................143Casén, C. ...........................71, 236Casini, V. ................................156Casse, A. H. ........................... 242Cassieri, C. .............. 146, 203, 239Cassinotti, A. ......................... 239Castagliuolo, I. ... 86, 141, 192, 200Castanheira, A. ............... 207, 228Castaño-Fernández, O. .......... 245Castaño-Vinyals, G..................143Castela, J. ... 159, 176, 178, 208, 252Castelijn, D. A. R......................64Castellaneta, N. M. ................ 208Castellano-Tortajada, G. ......... 127Castellazzi, A. M. .....................90Castellino, F. ........................... 119Castellot, A. ........................... 180Castells, A. .............................. 63Castera, L. ....................38, 48, 84Castiella Eguzkiza, A. .............. 115Castiglione, F. ..... 97, 185, 235, 238Castilla-Rodríguez, I. ............. 245Castillejo, A. ............................ 63Castillejo, G. ............................64Castillo Hererra, L. A. .............. 167Castillo, R. .............................. 137Castoro, C. ........... 76, 86, 141, 182,

192, 200, 232, 250Castro Fernández, M. .........77, 104Castro Laria, L. ................ 139, 189Castro Urda, J. L. ..................... 167Castro, A. ...............................210Castro, B. .............................. 235Castro, R. ........................ 124, 227Castro, R. E. ...... 114, 164, 169, 224Catalano, G. ...........................130Cataluna, J. G. E. ....................215Catassi, G. ..............................135Catnach, S. ............................. 127Catrinoiu, D. .....................115, 153Cats, A. ............................ 98, 192Cattan, P. .......................... 50, 176Catton, J. ............................... 202Caturelli, E. ............................168Cauchin, E. ..............................82Caulet, M. ........................ 93, 168Caunedo Álvarez, A. ....... 139, 208Cavalcante, T. F. A. ..................215Cavalcoli, F. ........................... 223Cavallaro, F.............................. 72Cavallaro, L. G. G. ....................171Cavallin, F................ 182, 200, 232Cave, D. ................... 186, 230, 254Cavestro, G. M. ............... 202, 242Cavicchi, M. ...................... 50, 176Cea Soriano, L. ........................96Cea-Calvo, L. ........... 186, 190, 240Ceausu, E. .............................. 167Ceballos, D. ..............185, 189, 235

Carmona, E. ...........................186Carmona, J. ........................... 234Carmona, L. ............................186Carneiro, C. ............................237Carneiro, F. ...........97, 107, 111, 165,

168, 173, 196, 201Carneiro, L. ............................148Caro-Maldonado, A. ................ 91Caroli, A. ........................ 190, 245Caroli, D. .................. 138, 192, 228Carot, L. ................................ 244Carpio López, D. .................... 240Carracedo, A. .....................91, 117Carrara, S. ................ 85, 219, 222,

224, 244Carrascosa del Álamo, I. .........125Carrat, F. ................................ 101Carretero-Gomez, J. F. .............134Carriere, J. ............................... 57Carrilho Ribeiro, L. ... 158, 167, 173,

210, 225, 258Carrillo Palau, M. ......63, 235, 245Carrington, E. ...............60, 81, 88Carro Valdes, J. ...................... 207Carroccio, A. ....................238-239Carroll, R. ..............................188Carsetti, R. ..............................96Carson, R. T. ................... 196, 245Carstens, A. ........................... 236Carter, D. ................................195Carter, R. ................ 36, 53, 60, 99Caruana, P. ............................ 202Caruntu, F. A. ......................... 116Caruso, A. ............ 62, 96, 230-231Caruso, C. ..............................155Carvalheiro, J. ........................166Carvalho, A. E. Z. ....................184Carvalho, A. M....................... 258Carvalho, D. ............ 184, 188, 258Carvalho, D. F. B. ............209, 258Carvalho, J. ...............116, 131, 138,

147, 209, 228, 235Carvalho, J. R. .................159, 167,

207, 221, 237Carvalho, L. ...... 208, 217, 235, 258Carvalho, M. ............. 52, 224, 258Carvalho, M. M. ..................... 224Carvalho, R. .............. 117, 221, 237Carvalho, S. ........................... 180Carvalho, T. ..159, 167, 169, 207, 221Carvão, J. .......................208, 245Casabona, S. ........................... 97Casaca, R. .......................159, 252Casado, R. ..............................189Casals, F. ................................. 97Casanova, J.-P. .......................200Casanova, M. J. .......................185Casanova, P. ................... 200, 257Casazza, G. ............................. 118Caselitz, M. ............................. 53

Candinas, D. ...........................183Cañellas, N. ............................145Cañete, F. ....................... 186, 239Cannizzaro, R. ......... 153, 192, 196,

198-199, 202, 252Cano-Mollinedo, M. M. ...........149Cantamessa, A. ...................... 180Canto, M. I. .... 54, 87, 102-103, 181Canton, E. ..............................192Cantù, P..................................130Cao, C. .................................... 61Cao, L. ................................... 202Cao, Y. ................................... 250Capalbo, C. ............................. 172Capella, G. .........................63, 97Capelle, L. .........................77, 104Capelli, E. .................... 70, 78, 90Capobianco, D. .......................146Capoferro, E. .................. 190, 240Capone, P. ...................... 180, 207Caporaso, N. .............. 64, 117-118,

167-168, 205-206, 216, 235, 238

Capovilla, G. ....................247-248Cappelleri, J. C. ...................... 141Cappello, G. ...........................155Cappello, M. ...... 187, 189, 238-240Cappon, A. ............................. 114Cappuccio, R. .........................190Caprioli, F. ............................. 236Capruso, G. ........................... 220Capuano, F. ....... 159, 209-210, 221Capurso, G. ..........59, 68, 85, 106,

171-172, 222Carabotti, M. ............. 146-147, 199Carames, C. ........................... 223Carames, J. C. ........................ 223Carames, M. .......................... 223Caramia, V. .............................156Carapelle, M. ......................70, 78Carballal, S. ............................ 63Carbo Perseguer, J. ................. 178Carbonnel, F. ....36, 54, 77, 80, 104Card, T. R. ..............................231Cardamone, E........................ 242Cárdenas-Jaén, K. ............... 59, 71Cárdenas-Rebollo, J. M. ..........128Cardin, R. .........................119, 187Cardoso, H. ...............116-118, 159,

196, 209, 218Cardoso, M. F. ........................237Cardoso, R. .................... 207, 228Carey, N. ................................188Carina, I. ............................... 258Carli, E. ..................................215Carlotti, E. ..............................150Carlsson, A. ............................143Carlton, T. ...............................89Carmo, J. .........................234-235Carmona Soria, I. .................. 208


331

Church, N. .............................. 175Chuttani, R. ............................251Ciacci, C. ........................... 39, 59Ciafardini, C. ......................... 223Ciarimboli, G. .........................215Cicala, M. ................................90Ciccantelli, B. .........................145Ciccarese, F. ............................168Cicenia, A. .............................. 147Cichon, C. ...............................237Cid Fernandez, J. ....................237Cid Gómez, L. .......................... 63Ciecielski, K. ...........................122Cijevschi, C. ..................... 116, 216Cillo, U. .................................. 116Cilluffo, M. G. .................. 187, 238Cini, G. ...................................192Cintolo, M. ..................... 220, 229Ciocirlan, M. ............... 68, 74, 208Cioffi, I. ................................. 235Ciortescu, I. ........................... 254Cipelli, R. ............................... 116Ciprani, D. ..............................183Cipriano, M. A. .......................158Ciriza de Los Rios, C................ 101Ciscato, C. ..............................156Citrano, M. ............................ 238Ciuca, I. ............................157, 170Civitelli, F. .............................. 191Claesson, M. J. ........................134Clair Willi, C. ......................... 235Clairembault, T. ..................... 234Clara, A. R. .............................215Clark, G. ......................... 182, 256Clark, S. .................................189Clark, T. ..................................188Clarke, G. ................................56Claro, I. ........................... 159, 178Clausen, H. R..........................155Clavé, P. ...........................90, 149Clavenzani, P. ..........................92Clayton, L. ....................... 125, 136Clément, O. ............................ 173Clemons, N. ...........................150Clerc, C. O. .............................145Clevers, E. ........................ 71, 244Cleynen, I. ...............................96Climent, E. .............................237Clisby, C. .................. 151, 231, 250Clooney, A. G. .........................134Clos, A. ...........................142, 239Cnossen, W. R. .......................165Coates, A. .............................. 252Cobian, J. ............................... 178Cocca, S. ............................... 244Cocciolillo, S. ..........................140Coelen, R. J. S.................. 93, 120,

169-170, 219Coelho, H. ....................... 157, 256Coelho, R. ..........118, 159, 188, 218

Choi, C. W. ................ 123, 126, 131Choi, D. H. ..............................184Choi, E. K. ..............................159Choi, H. ........ 96, 102, 118, 121, 123,

126, 130-131, 146, 169, 173, 179, 184, 201, 219, 229

Choi, H. J. ........................ 179, 229Choi, H. S. ................ 127, 132, 148,

152, 155, 203Choi, H.-H. .............................219Choi, I.-S. ...............................158Choi, J. ...............114, 127, 132, 148,

152, 179, 192, 197, 202-203, 229, 251

Choi, J. H. .... 102, 121, 130, 169, 201Choi, J. S. ............................... 179Choi, K. H. .............................. 118Choi, M. H. ......... 173, 179, 219, 229Choi, M.-G. ..................... 150, 152Choi, S. H. ... 123, 126, 131, 146, 201Choi, S. J. ..................114, 127, 132,

148, 152, 203Choi, Y.............................150, 169Choi, Y. H. .................121, 130, 169Choi, Y. J.............152, 192, 199, 251Choi, Y. S. ............................... 133Cholet, F. .......................... 72, 222Chon, H. K. ............................. 118Chong, J. N. C. ........................156Chong, L. W. L. ......... 184-185, 233Chong Nguyen, C. ........... 206, 241Chooklin, S. .............................171Choong, L. T. ......................... 208Chow, V. .................................189Chowdhry, M. .........................122Chowers, Y. .............. 140, 189-190Christodoulou, D. ...................185Christoph, J. ............................86Chrysanthopoulou, A. .............134Chryssostalis, A. .....................247Chu, E. S. ...............................164Chu, H. ........................... 143, 244Chu, K.-M.............................. 202Chu, N. H. S........................... 205Chu, Y. ........................... 180, 225Chu, Y. Y. ............................... 180Chuah, S. W. ......................... 208Chuah, S.-K. ...........................166Chueca Lapuente, E. ..............200Chuklin, S................................171Chun, H. J. ................ 127, 132, 148,

152, 155, 203Chun, K. Y...............................188Chun, W. ............ 146, 168, 177, 184Chung, I.-K. ........................... 226Chung, J.-B. ........122, 169-170, 172Chung, J.-W. ..............146, 177, 243Chung, K. H. ...........................102Chung, M. J. ........122, 169-170, 172Chur-Hansen, A. .....................140

Cheng, J.-S. .............................59Cheng, L.-S. ....................114, 220Cheng, S. ........... 59, 114, 220, 230Cheng, Y. ................................145Cheong, J. .......................168, 218Cheong, J.-H. ..........................201Cheong, P. ..............................198Cheraitia, S. .......................... 253Chermesh, I. .......................... 243Chernetcova, E........................ 115Chernov, V. M. ......................... 77Chervinska, T. .........................184Chess, G. .................................52Cheung, C. K. .........................198Cheung, K. .............................142Cheung, K. S.......................46, 91Cheung, W. W. ....................... 242Chevalier, J. ............................195Chey, W. D. ..................... 196, 245Chhita, K. .............................. 255Chiarion Sileni, V. ..................200Chiarioni, G. .......................... 244Chiba, T. .................................136Chibai, M. ............................. 253Chieko, K. .............................. 206Chies, G. ................................166Chikhi, Y. ............................... 253Chikugo, K. .......... 117, 129, 171, 180Ching, J. Y. L. .................... 82, 142Chino, A. ................................ 175Chiorascu, M. ........................ 256Chiriac, S. ........... 116, 131, 166-167Chiu, C. T. ........................142, 180Chiu, H. M. .............................143Chiu, P. W. Y. .... 152, 202, 230, 250Chizhikov, A. V. .......................158Chliara, E. ..............................145Chlouverakis, G. .....................125Chmielewska, A. ......................64Chmura, A. ............................ 250Cho, C.-M. ............................. 230Cho, D. H. .................. 131, 184, 221Cho, E. ................54, 169, 199, 219Cho, H. ..........56, 96, 102, 118, 121,

123, 126, 130-131, 146, 168-169, 173, 179, 184, 201,

219, 221, 226, 229, 253Cho, I. R. .............122, 169-170, 172Cho, J. ......... 114, 127, 132, 148, 152,

179, 192, 197, 203, 206, 229, 245, 251

Cho, J.-H. .............................. 253Cho, K. B. ...............................201Cho, S. ...83, 127, 132-133, 148, 155,

158, 171, 179, 183, 203, 226Cho, Y. D.......................... 179, 229Cho, Y. K. ................................150Cho, Y. S. .........................133, 226Choe, B.-H. .............................56Choe, Y. H......................... 56, 174

Chang, H. K. .......................... 209Chang, K. ............85, 193-194, 239Chang, L. ..........46, 60, 74, 94, 132Change, K. J. ...........................98ChaoQiang, F. ......................... 173Chaouch, S. ............................ 181Chaparro, M. ............. 97, 185, 235Chapelle, N. ............................82Chaput, U. ....................... 181, 222Charissoux, A. ........................ 177Charles, D. ....................... 59, 139Charlois, A.-L. ........................135Charnley, R............................ 222Charpentier, C. ........................ 76Chassaing, B. .......... 57, 70-71, 183Chatelain, D. ..........................135Chattree, A. ............................ 175Chaudhari, H. ..........................69Chaudhury, B. K. ................... 229Chaussade, S. .......53, 62, 127, 129,

177-178, 181, 228, 230, 247

Chavan, R. ................ 148, 156, 170Chavero, P. ............................ 238Chaves, D. M. ........................ 230Chaves, P. .................145, 159, 252Chayama, K. ........53, 144, 151, 254Chazouillères, O. ................53, 91Che Ani, M. F. .........................158Checchin, D. ...........................190Chedgy, F. ...............................125Chelbi, Y. ............................... 235Chen, B. .................... 72, 148, 255Chen, C.-C. .... 77, 148-149, 242-243Chen, D. .......................... 118, 199Chen, F.-Y. ............................. 220Chen, G. .......................... 122, 165Chen, G. G. ............................. 114Chen, H. ....................93, 136, 143,

147, 192, 243Chen, J. ....................... 52, 57, 154Chen, J.-M. ..............................46Chen, L. .........46, 91, 147, 149, 202Chen, L. A. ............................. 141Chen, M. ..........................46, 242Chen, M.-H. ...........................136Chen, M.-J. .............................154Chen, N. ...... 133, 139, 170, 192, 220Chen, Q. .................................. 72Chen, R. ......................... 192, 220Chen, S. ..............59, 103, 114, 157,

202, 220, 223, 230, 244Chen, T. ................................. 244Chen, W. .................. 170, 175, 207Chen, W.-C. .............................59Chen, Y. I. ......................... 62, 103Chen, Y.-I. ...................62, 99, 102Cheng, A. S. L. ................... 91, 147Cheng, B. ................................ 72Cheng, C.-C. ....................242-243

332


Cusumano, C. .................. 159, 210Čužić, S. .................................183Cuzzupè, C. ............................135Cyrany, J. ............................... 242Czimmer, J. ............................ 220

DD'Arcangelo, G. ......... 135, 190-191D'Errico, F. ...............................92D'Haens, G. R. ......... 43, 47, 67, 73,

80, 102, 104, 141D'Hoore, A. .................56, 86, 107D’Haens, G. .......................47, 102D’Heygere, F. ...........................55D'Inca, R. ................... 96, 97, 135,

185, 187, 189, 231D´Orey, L. ...............................145Da Costa, G. ............................ 57Da Costa, J. P. .........................241Da Costa, L. S. N. .................... 127Dabak, R. .............................. 244Dabizzi, E. ................122, 222, 230Dąbkowski, K........................... 78Dabrowski, A. .......................... 78Dacal Rivas, A. ........................ 63Daferera, N............................ 238Dagorn, J.-C. ........................... 57Dahal-Koirala, S. .....................56Dahan, K. ................................58Dahlerup, J. F. ................. 96, 135,

155, 185, 189Dai, N. ..............148, 157, 244, 255Dai, R.....................................142Dai, S.-X. ................................136Dai, Y. .....................................92Daiko, H. ............................... 250Dakó, S. ................................ 235Dakour Aridi, H. ...................... 62Dal Bò, N. .........150, 196, 198, 252Dale, H. F. ............................. 206Dalén, E. ................................ 176Dalla, V. .................................134Dalla Gasperina, M. ................ 187Dallemagne, B. ...................... 173Dallio, M. ....................... 165, 203Dalmasso, G. ......................57, 85Dalton, C. .............................. 252Daly, K. ...................................52Dambrauskas, Z. ..............172, 221Damsgaard, B. .......................155Danalıoğlu, A. ................... 49, 80Danese, S. ............80, 137, 139-140Dang, Y. .................................. 57Danila, M. .......... 168, 214, 216-218Daniluk, J. ............................... 78Daniluk, U. .............................. 78Danion, P. ..............................135Dankó, T. ................................143Danse, E. ................................182

Cozijnsen, M. A. ......................56Crafa, P. ..... 196, 199, 202, 252, 255Craig, D. ................................. 119Craig, O. ......................... 146, 244Cravo, M................... 178, 233, 237Cremers, I. ..................54, 65, 215Cremon, C. .............70, 78, 90, 147Crenier, L. .............................. 173Crespi, M......................... 191, 237Crespo, P. ................................64Cretu, I. ..................................251Crinò, S. ....... 171, 121, 209, 221-222Crippa, S. .............68, 85, 161, 222Crisan, D. ...............................215Crispino, P. ............................ 239Cristino, A. ............................ 208Cristoferi, L..................... 220, 229Critchlow, T. ...........................142Croitoru, A. ........................... 223Croitoru, V. ............................ 223Croner, R. S. ............................86Cronin, L. ...............................140Crooks, C. J. ............................. 78Crotty, P. .................................159Crowe, S. ......................... 89, 139Crowe, S. E. .............................54Crowther, S. .......................... 205Croxford, A. L. ........................ 170Cruciat, C. ............................. 246Crudele, A. ............................ 205Crudeli, A. ............................. 226Cruz, R. ..................................233Csontos, A. A. ................. 235, 238Csupor, D. ...............................171Cuatrecasas, M. ..........97, 143, 222Cubiella, J. ..................... 144, 245Cubisino, R............................ 203Cucala-Ramos, M. ................. 246Cucchiara, S. ....................135, 191Cuciureanu, T. ............131, 166-167Cuenca Alarcón, F. ...................65Cui, G.-X. ...............................129Cui, N..................................... 119Cuillerier, E. ...........................185Cuk, K. ....................................50Čuković-Čavka, S. ....... 96, 135, 185Culetto, A. .............................. 172Cullen, A. .............................. 222Cullen, G. ............................... 217Cummins, S. ...........................138Cunha, A. C. .............215, 228, 241Cunha, C. .................228, 233, 241Cunha, I. ................................210Cunha, M. F. .......................... 258Cuomo, R. ........................146-147Cúrdia Gonçalves, T. ....................... 166, 222, 236Curescu, M. ..................... 116, 216Curtis, R. .................. 141, 188, 239Curvers, W. L. .........................124

Coron, E. ................... 82, 121, 130, 137, 222, 229, 234

Corona, G. ..............................154Coronel, M. ........................... 230Corral, J. E. ..............................52Corrales, G. ........................... 239Correale, L.............................. 101Correia de Sousa, J. T. ............ 224Correia, A. ...................... 150, 224Correia, L. .........159, 209, 237, 258Corrente, V. .............196, 199, 202,

248-249, 255Cortegoso Valdivia, P. ....................... 158, 223, 258Cortés-Pérez, H. ...................... 175Cortez Pinto, H. .....42, 61, 85, 159,

167, 209, 258Cortez-Pinto, J. ............... 114, 145,

176, 178, 230Corvace, V. .............................166Corvinus, F. ............................125Cosin Roger, J. ............97, 184, 233Cosnes, J. ...............................186Cossais, F. ............................. 242Cossiga, V. ....................... 118, 168Costa, A. .......... 208, 210, 237, 248Costa, D............ 42, 55, 57, 60, 81,

85, 95, 118-119, 127, 158-159, 178, 208-210,

218, 221, 241, 258Costa, F. .................................233Costa, J. M. ......................180, 183Costa, J. P. V............................189Costa, L. ........................... 85, 154Costa, M. B. G. .......................189Costa, R............................157, 183Costa e Silva, A. ..................... 208Costa-Moreira, P. .....................117Costa Santos, M. P. ................. 178Costabile, A. ...........................154Costache, R. S. .......................237Costachescu, R. ...................... 157Costamagna, G. ........... 55, 60, 81,

95, 130-131, 173, 228, 252

Costantini, A.......................... 248Costantini, M. ......75, 105, 247-248Costello-Goldring, E. ........ 93, 102Cotrim, I. ................... 89, 179, 258Cotter, J. ............166, 186, 191, 201,

216, 222, 236, 257Cottone, M. ..................... 237-239Coudry, R. ..............................221Coulie, P. ................................. 63Coupé, V. M. H.........................50Coupland, B. ...................103, 247Courbette, O. .......................... 191Coutinho, J. ............................158Covelli, C. ...............................154Coysh, T. ............................... 205

Coen, S. J. .............................. 197Coffin, B. ................... 75, 206, 241Cogliandro, R. .........................92Cohen, J. .......................... 93, 251Cojocariu, C. .................... 116, 166Colecchia, A. .................... 78, 159Coletta, L. ..................69, 149-150,

199, 243, 248Coletta, M. ............................ 236Coll-Puig, S. ....................134, 234Collij, V. .................................. 70Collins, B. ..............................188Collins, G. ............................. 235Collins, J.................................150Collins, K. L. ...........................140Collomb, D. ..................... 195-196Colombel, J.-F. ........ 47, 49, 61, 80,

101-102, 136, 140-141Colombo, M............................ 118Colombo, S. ............................156Comer, G. M. ..........................149Comino, I. .............................. 157Compare, D. .......................... 203Concepcion-Martin, M. ........... 178Conchillo, J. ..............124, 149, 248Concia, E. ...............................183Conde, B. ...............................227Conde, P. ................................ 137Cong, Y. ................................. 244Conigliaro, R. ..............62, 69, 96,

130, 230Conio, M. ................................ 62Constantinescu, A. ................. 229Constantinescu, G. .... 181, 229, 231Contaldo, F. ........................... 235Conte, D. ................. 118, 130, 205,

223, 236, 254Contente, L. ........................... 236Conti Bellocchi, M. C. ..............221Conti, C. B. ...................... 118, 236Conti, F. ............................ 117, 167Conti, L. .................................155Cooney, R. .......................142, 234Cooreman, M. P. ......................64Coppens, E. ........................... 207Coppeta, G. P. ........................ 207Coppola, C.............................. 119Coppola, N. ............................ 119Corazza, G. R. ............64, 155, 204Corazziari, E. S. ............... 147, 239Cordeiro, M. .......................... 208Cordero Ruiz, P. ..................... 208Cordes, F. ...................89, 135, 237Cordone, G. ..................... 118, 218Córdova, H. ............................231Coriat, R. ...... 127, 177, 181, 228, 247Corley, D. ...............................143Cornberg, M. ......................61, 95Cornillie, F. .............................140Cornish, J. ............................. 226


333

Derrien, M. ........... 56, 83, 90, 141Derwa, Y. ...............................237Desai, P. N. .............................130Desideri, F. ............................. 127Desomer, L. ..........69, 128, 175, 177Despott, E. J. ................ 37, 41, 96,

131, 148Desreumaux, P. .........76, 236, 238Dettmar, P. .............................199Devani, M........................156, 225Devauchelle, B. ......................135Devesa Medina, M. J. ..........64-65Devesa, N. ..............................257Deviere, J. .........60, 67, 81, 96, 99,

126, 173, 197, 210Dewit, O. ..................... 47, 55, 186Dhaka, N. ............103, 171, 178, 187Dhar Chowdhury, S. ............... 224Dhawan, M. ..................... 58, 122Dhir, V. ...................................150Dhooge, M. ............................247Di Berardino, M. .....................140Di Costanzo, G. G. .......118-119, 218Di Fazio, P. ..................... 118, 120,

164, 168, 215Di Fede, G. .........................64-65Di Giacomo, C. .......................140Di Giovangiulio, M. ........... 96, 143Di Girolamo, M. ..................... 240Di Giulio, E. .....................124, 127,

155, 199, 228Di Leo, A. ................. 92, 150, 154,

166, 203, 208Di Leo, M.................. 85, 156, 219,

222, 224, 244Di Lorenzo, C. ..................... 47, 55Di Maggio, P. .......................... 116Di Marco, M. ..........................168Di Mario, F. ...... 146, 150, 153, 196,

198-199, 202-203, 247-249, 252, 255

Di Martino, M. ........................169Di Martino, V. ........................ 205Di Matteo, F. M. ...................... 181Di Mitri, R. ............................ 238Di Nicolantonio, F. .................. 107Di Palma, M. ......................... 205Di Paolo, M. C.................206, 244Di Pietro, M. ........ 69, 89, 173, 200Di Pisa, M........................ 237-238Di Rosa, E. .............................146Di Sario, A. .............................130Di Sarno, R. ............................165DI Stasio, E. ............................215Di Stefano, M. ............. 64-65, 155Di Stefano, S............. 159, 210, 221Diamantis, E. ..........................102Diamantopoulou, G. ...............241Diano, N.................................165Dias de Castro, F. ......186, 236, 257

De Wit, N. J. .......... 74, 90, 103, 111De Zorzi, M. ...........................153De-Madaria, E. .............59-60, 71,

106, 170, 220Deacy, T..................................144Deady, S. ................................ 217Deamici, M. ...................... 65, 155Debourdeau, A. ............... 124, 182Dede, K. .................................192Deev, R. .................................164Deguchi, A. ............................218Deibert, P. .............................. 114Deiss Pascual, L. ..................... 217Dejaco, C. ............................... 137Dejardin, E. ............................ 170Dejong, C. H. ........................... 93Dekker, E. ...............39, 50, 68, 72,

84, 89, 98, 143, 192Del Chiaro, M. ..... 64, 82, 120, 160Del Giudice, C........................ 206Del Olmo Martinez, L. ............ 229Del Pozo-García, A. J. ........ 127, 175Del Sancho-Serra, C. ....... 92, 200Del Tedesco, E. ........... 73, 79, 135,

185-186Del-Val-Antonana, A. .......170, 220Delacre, M............................... 57Delanaud, S. ......................... 204Delattre, H..............................194Delconte, G. ...........................130Delgado, M. D. P. .....................49Delgado, S. ........................... 252Delhaye, M. ......... 36, 102, 113, 126Deli, Z. ...................................201Delius, S. .........................84, 224Della Coletta, M. ........69, 149-150,

199, 248Della Scala, G. ........................156Dellaporta, E. .........................134Delle Fave, G. ....................171-172Delmas, J. ...........................57, 71Deloose, E. ....................... 65, 101Demetter, P............... 126, 192, 210Demir, I. E. .............................. 72Demirel, U.............................. 170Demuth, D. ............................ 239Denadai-Souza, A. ...................92Deng, Y. ................................ 244Deng, Z. .................................. 72Denisov, N. ............................. 115Denizot, J. ........................... 71-72Dent, J. .................................... 87Denys, A.................................. 51Denzer, U. .................. 53, 95, 229Depeint, F. ............................. 204Depla, A. ................................102Deprez, P. H. ............54, 67, 73, 81Deraison, C. ............................92Derman, R..............................189Derovs, A. ......................235, 240

De Jonge, J. ......... 93, 120, 169-170De Juan, M. D. ........................ 115De Kleine, R. H. J. ....................59De Kock, I. ...............................96De Korte, C. ............................ 167De la Iglesia Garcia, D. ......................... 72, 180, 220De La Morena, E. ....................154De la Morena, F. ...................... 97De la Ossa, N. D. ..........83, 175-176De la Peña, J. ....................175, 178De la Santa Belda, E. ..............153De La Serna Higuera, C. ..... 99, 171De Lange, T. ........................... 176De Lazzari, F. ...................192, 228De Leon, H. ........................... 222De Lima-Karagiannis, A. .......... 83De Lima, M. S. ........................201De Looze, D. ........................... 133De Luca, A. ............................. 133De Luca, L. .............................. 62De Manzini, N. .......................165De Marchi, F. ...........................171De Matthaeis, N. .....................218De Meij, T. G. J..................186-187De Meijer, V. E. ........................59De Monte, L. ............................99De Moura, D. T. H. ................. 230De Moura, E. G. H. ..................126De Nitto, D. ........................... 239De Nucci, G. ....... 127, 130, 225-226De Oca, J. ................................ 97De Oliveira, J. F. .............. 194, 258De Pastena, M. .......................183De Paulo, G. ......194, 201, 231, 258De Pretis, N. .....................121, 221De Re, V. ................................153De Reuver, P. ................... 169, 219De Ridder, L. ...........................56De Ridder, R. ............. 69, 124, 149De Roberto, G. .......................156De Silva, A. P. .................. 135, 164De Silva, H. J. .................. 135, 164De Silva, S. T...........................164De Silva, T. M. ........................135De Simone, V. ....................79, 143De Simoni, O. ................. 182, 250De Stefano, G. ........................ 119De Swart, J. ............................186De Toma, D. ............................ 127De Toma, G. ........................... 147De Torres, I.............................. 57De Valliere, C. ............97, 184, 233De Vitis, I. .......................155, 239De Vos Tot Nederveen Cappel, W. .................... 85, 98De Vos, M. ...................36, 49, 54,

96, 156, 255De Vos, W. M. ................. 156, 255De Vries, A. C. ................ 236, 255

Danset, J.-B. .......................... 229Dantas, E. ..............................215Daperno, M. ......................97, 185Dapke, S.................................135Dapoigny, M. ........................... 83Dapri, G. ............................... 207Dar, F. S. ................................ 209Dargiene, G. ...........................154Darisetty, S. .....................148, 156Darkahi, B. .............................219Darne, A. .............................. 222Darwish Murad, S. ...................48Darzi, A. .................................155Das, N. N................................219Dasari, V. ............................... 133Dassanayake, A. S. ..................164Dassner, S. .............................145Dastych, M. ............................251Date, S. .............. 99, 223-224, 249Dauvarte, H. ...................235, 240Daveson, A. J. ..........................64David, A. .........................139, 246David, T. ...........................78, 256Davies, A. .............................. 226Davies, B. .............................. 226Davies, R. .............................. 232Davis, H. M. ............................. 47Davis, J. .......................... 126, 245Davis, M. ............................ 47, 49Dawsey, S. ..............................201Dayananda, B. M. ...................158De Angelis, C. ... 158, 180, 223, 258De Bastiani, R. ...............203, 248De Bellis, M. ......................... 228De Boer, J. P. ..........................192De Boer, K. H. N. .......59, 186, 236De Bortoli, N. ............69, 149-150,

198-200, 206, 248-249

De Brito, L. X. ......................... 167De Buck Van Overstraeten, A. .......................................56De Carlis, L. ............................130De Carolis, A. .........................138de Carvalho, K. I. L. ................184De Ceglie, A. ........................... 62De Cesare, A. ..................206, 244De Falco, L. .............................64de Franchis, R. ....................... 177De Gaetano, A. M. ..................218De Giorgio, R. ......... 50, 63, 70, 92De Girolamo, V. ...................... 119De Groof, J. ............................. 75De Groot, W............................ 179De Haan, M. W. ......................124De Hertogh, G. ................ 141, 190De Higes Ruiz, M. J. ............... 248De Jong, D. ..............................64De Jong, D. J. ......................... 236De Jong, M. ................49, 165, 187

334


Dulbecco, P. ........................... 228Duman, D. G. .................. 114, 223Dumas, B. ............................. 242Dumic Cule, I. .........................214Dunckley, P. ........ 89, 223, 225-226Dunn, S. ..................................89Duong, C. ...............................150Dupas, J.-L. ......................135, 137Dupont-Gossart, A.-C. ........... 234Durand-Fontanier, S. ............. 232Durand-Zaleski, I. ....................50Durand, T. ............... 195, 234, 252Durc, P. ..................................149Durchschein, F. .......................216Durdevic, M. ...........................216Ďuriček, M. ........ 69, 101, 248-249Duricova, D....76, 96, 135, 185, 238Duron, C. ................................ 83Dusek, L. ............................... 244Dustmuxamedova, D. X. .......... 157Dutei, C. A. ............................ 208Duvanskiy, V. .......................... 132Duveau, N. ............................ 238Dvorak, J. ...............................184Dwarakanath, D. .................... 229Dwyer, L. K. ............................. 62Dyaczyński, M. ........................164Dynnyk, O. .................101, 168, 215Dziekiewicz, M. ......................195Dziki, A. .................................233Dziki, Ł. ..................................233Dziubenko, N. ................. 184, 238Dzuris, J. J. ..............................56

EEarly, D. ................................. 179Easler, J. ................................. 179East, J. E. ................ 68, 72, 89, 98Eberl, A. ................................ 239Eberl, G................................... 57Ebigbo, A. ................ 48, 100, 205Echarri, A. ..............................189Echarri Piudo, A. .............235, 237Eckel, F. ................................. 224Eckersley, R. .......................... 205Eckhardt, G. ........................... 137Edebol-Carlman, H. ................146Edelmann, M..........................128Eder, P................................... 240Edir, A. ....................................92Ee, H. ......................................64Efimova, O. V. .........................122Efthymakis, K. ................ 236, 254Egan, A. M. ............................257Egan, L. .......................54, 63, 162Egoavil, C. ..............................143Ehara, A. ............................... 236Ehlken, H. ............................... 76Eiroa, D. ................................ 235

Doukas, M. .............................192Doukoure, B. ..........................192Douschan, P. ..........................216Dousset, B. ............................. 181Dovbynchuk, T. ................ 134, 184Dowd, S. ................................241Downey, R. W. ........................189Dowson, G. ............................188Dowty, M. E. ............................ 79Doyama, H. .... 51, 58, 142, 151, 251Drabińska, N. .................. 157, 255Draganov, P. ..........75, 95, 145, 151Dragasevic, S. .........................165Dragoi, D. ................................59Dragoni, G..............................190Drastich, P. ... 52, 184, 217, 237, 256Dray, X. ................ 72, 128, 131, 181Dreanic, J. .............................. 127Drenth, J. P. H. ...46, 58, 71, 86, 91,

107, 121, 136, 165-167, 169, 219, 235, 255

Drewes, A. M........37, 107, 199, 212Drissi, F. ................................ 242Drobne, D................................ 79Drozd, U. ................................ 132Drug, V. L. ............................. 222Drukker, M. ............................196Drummond, L. .........................90Drvarov, O. .............................. 61Du, H. ...........52, 76, 132, 155, 158,

173, 181-182, 185, 207, 212, 231, 246-247, 255, 258

Du, L. .........57, 59, 62, 72, 99, 129, 135, 137, 145, 148, 169, 178-179, 218-219, 229,

244, 246, 255, 257Du, M. ..................... 133, 202, 216,

222, 247, 256Duan, L. ......57, 145, 204, 246, 248Duan, T. .................................251Duarte Rojo, A..........................71Duarte, M. ............................. 222Duarte, R. B. .................. 126, 230Dubale, N. .......... 99, 223-224, 249Dubbink, H. J. .........................192Dubinsky, M. C. ......................140Duboc, D. .............................. 206Duboc, H. ....................... 206, 241Dubois, A. .............................. 137Dubois, P. ...............................227Dubravcsik, Z. ....................... 243Duchalais, E. .................. 242, 252Duchmann, J. C. .....................130Duckworth, A. ....................... 208Duclos, B. ............................... 75Ducreux, M.............. 38, 51, 75, 82Duffy, M. ................................247Dufour, G. ............................... 76Dufour, J.-F. ....................... 38, 42Duijnhouwer, T. ......................166

Dixson, H. ............................. 222Djabarouti, S. .........................188Do, A. ........ 39, 58, 60, 69, 82, 89,

92, 113, 116, 123, 128, 132, 139, 146-147, 162, 165, 168, 175, 188-189, 204, 217, 227-228, 246

Dobelniece, L. ................235, 240Dobos, G. ........................ 187, 190Dobrolyubova, E. .................... 139Docimo, L. .................69, 198, 249Dodd, S. ................................ 240Doglioni, C. ........................... 222Doheim, M. F. ..........................117Doherty, G. A. ......................... 217Dohi, O. ................... 123, 174, 253Doi, A. ............................. 69, 146Doina, P. ................................ 157Dokladanska, A. ........175, 227-228Dolak, W. ............................... 132Dolapcıoglu, C. ...................... 244Dolin, P. ..................................49Dolina, J. ......................... 149, 251Dollhopf, M. .......................... 224Dolwani, S. ............................125Dolz Abadia, C. ....................... 175Domagk, D. L. ..........................94Domènech, E. ..........186, 190, 234,

239-240Domínguez-Flores, R. ..............56Dominguez-Muñoz, J. E. ...................71-72, 147, 187,

190, 220, 252Domínguez-Pino, A. ...............128Dominguez-Rosales, A. .......... 116Dominguez, E. H. G. ...............231Dominik, L. .............................84Donato, G. ............................. 222Donato, M. F. ..........................130Donato, P. ............................. 232Donca, V. ................................215Dong-Yun, C. ..........................247Dong, J. ...................................52Dong, S.-H. .....................219, 229Dong, T. ..................................82Dong, Y. ..................... 91, 147, 202Doorakkers, E. ......................... 77Doré, J.............................. 50, 141Doron, S. ................................ 181Dorreman, Y. .......................... 133Dos Santos, M. E. L. ............... 230Dos Santos, P. M. .............159, 207Doss, W. ..................................117Dotan, I. .......................43, 81, 91,

94, 104, 230Dotti, I. ................................... 97Dötzer, K. .............................. 232Dou, L. .................................... 72Doubkova, M. .........................149Douda, T. ...............................237Douillard, F. P. ....................... 255

Dias Pereira, A. .. 145, 159, 176, 178, 180, 208, 222, 252

Dias, M. S............................... 167Díaz Tasende, J. B. ............ 127, 175Díaz-Almirón, M. ....................188Diaz-Florez, L. ....................... 235Diaz-Guerra, A. ....................... 97Díaz-Gutiérrez, J. ................... 220Díaz-Veléz, C. .........................152Díaz, G. ..................................189Diaz, J. ................................... 157Dicksved, J............................... 79Diculescu, M. ............116, 167, 208Dienethal, A. ..........................155Dienstmann, R. ...................... 107Diestel, C. F. ...................206, 255Dieterich, W. ........................... 79Dietrich, G. ..............................92Díez-Villanueva, A. .................143Diez, P. ............................. 84, 128Digby-Bell, J. ......................... 239Digby, J. .................................193Diggle, M. ..............................142Digiglio, L. ............................. 187Dignass, A. ............................ 239Dijkgraaf, M. G. W. ..... 84, 93, 142Dijkstra, G. ......... 70, 102, 236, 239Dikken, J. ......................... 76, 182Dikkongue, E. .........................195Dikopoulos, N................... 84, 193Dilillo, D. ................................190DiMaio, C. J. ............................ 62Dimas, I. ........... 125, 129, 140, 145Dimcevski, G. ..........................171Dimitri, R. ............................. 239Dimitriadis, G. D. ............. 127, 131,

206, 251, 254Dimitrijevic, I. ........................ 133Dimitroulopoulos, D. ..62, 230, 243Dina, L. ................................. 256Dindar Badem, N. ..................199Dindar, G. ............................. 254Ding, A...................................198Ding, H. .................................216Ding, K. ................................. 230Ding, M. ................................ 246Ding, N. ............. 70, 134, 233, 239Ding, Y. ........ 141, 143, 171, 201, 251Dinis-Ribeiro, M. .... 37, 46, 73, 82,

97, 106, 124, 132, 224, 227-228

Dino, P. ................................... 70Dinter, J. ........................... 61, 242Dinu, I................................... 223Dior, M. .................................. 127Dioscoridi, L. ........... 220, 229-230Dirks, K. .................................. 78Disney, B. ...............................159Dissanayake, V. H. ..................135Dixon, S. ............................... 209


335

FFabbri, C. ...............................130Fabian, A. ........228, 234, 238, 240Fabiocchi, F. ...........................146Fabisiak, A. ............................134Fabisiak, N. ............................134Facchin, S............................... 187Fadeenko, G. .....................77, 104Fadeeva, N. ............... 138-139, 184Fadgyas-Freyler, P. ..................138Fahrbach, K. ........................... 141Faias, S. .............176, 178, 180, 222Faiss, S. .................................. 76Faiz, O. ..................... 134, 189, 233Fakheri, H. ............................ 203Falalyeyeva, T. ................. 101, 155Falconi, M. .......................85, 222Falk-Paulsen, M. .....................135Falt, P. ....................................237Familiari, P. ........................... 252Fan, L. .................................... 115Fan, Z. ................124, 173, 197-199Fanczal, J. ..............................120Fang, D. .......................... 114, 218Fang, F. ..................................198Fang, J. ............................. 77, 192Fang, Y. ................................. 242Fang, Y.-J. ............................... 77Fani, B. ................................. 206Fantin, A. ...............................130Fantini, M. C..................... 96, 187Faraag, E. A. .......................... 133Farag, A. ................................ 116Farag, R. ................................ 217Farah, K. .......................... 58, 122Farcau, O.......................... 73, 256Farges, O. ................................88Farid, A. ..................................117Farid, K. .................... 117, 168, 207Farida, J. ................................196Farinati, F. ... 119, 168, 171, 203, 249Farkas, H. .............................. 220Farkas, K. ................. 83, 136, 228,

234, 238, 240Farkas, N. ........................ 153, 231Farkash, S. ............................. 181Färkkila, M. A. A. ...............91, 138Farman, M. ............................237Farmazon, A. ..........................165Farmer, A. D. ....................196-197Faroux, R. ..............................185Farré, C. ................................ 236Farré, R. .................................247Farro, G. ................................. 79Farrugia, G. ...................... 57, 206Farthing, M. ....................103, 105Fassan, M. ..86, 200, 203, 223, 249Fassino, V. ..............................138Fatela, N. ................. 167, 208, 210Fatima, M. ...................... 129, 209

Erdogan, M. A. ....................... 170Erdős, R. ................................ 170Erdozain, I. ............................ 217Ergul, B. .................................199Ergun, P. ................................199Erhardt, A. .............................. 53Erhartova, D. .......................... 174Erice, O. .............................91, 117Eriksson, C. ............................189Erjavec, I. ...............................214Erler, N. S. ...............................48Ernst, O. ..........................212, 236Eross, B..............151, 153, 231, 250Errico, S. ................................165Erzik, C. ................................ 256Esain, I................................... 217Esaka, N. .......................... 117, 128Esaki, M. ........... 123, 152, 182, 254Escher, J. C. .................56, 83, 102Escofet, X. ..............................199Eseneeva, G. .......................... 133Eser, A. ................................... 83Eshraghian, A.................. 65, 165,

215-216, 218Esmaily, S. .......................89, 229Esmat, G. ......................... 117, 166Espin Basany, E. ......................82Espinel, J. ...............................153Espinós, J. .................153, 178, 227Espinosa, A. ...........................143Esplugues, J. V. ................ 233-234Esposito, G. ........ 124, 127, 155, 199Esposito, P. ............................. 174Esser, D. ..................................96Esteban, R. .............................. 39Ester, C.-C. ....................... 116, 217Esteve, M. ................. 56, 185, 189Esteves, G. .............................159Estevez-Perez, L. S. .......... 147, 252Eswaran, S. L. ...............47, 53, 83Ethgen, O. ..............................216Ette, E. ....................................50Eugenicos, M. P. .....................146Eusebi, L. H. .................... 148, 197Eusébio, M. S. ........................215Eutamene, H. .................. 141, 145Evans, J. .................. 150, 222, 248Evdokimova, L. ....................... 119Everett, S................................ 132Everson, L. ............................ 239Everson, M. A. .....76, 132, 149, 225Eves, K. .................................. 141Evgenya, L. ............................. 181Evgrafov, P. ............................. 187Evison, F. ......................... 103, 170Eyal, I. ................................... 131Eynat, F. ................................ 243Ezaki, T. ................................. 170Ezpeleta, G. ............................ 181Ezra, B. ................................. 242

Ellakany, W. I.......................... 118Ellazeik, Y. ...............................117Elleuch, N. .............................168Elli, L. ............................205, 254Elloumi, H. ......................228-229Ellul, P. ................89, 96, 135, 185Elmahjoubi, S........................ 240Elmesseri, H. ..........................153Elmore, U. ............................. 242Elmorsy, A. A. ..........................117Elmunzer, B. J................... 62, 103Elnagar, M. .............................117Elnakeeb, A. .................... 169, 179Elnegouly, M. ........................ 224Elnoemany, K. .........................117Eloranta, J. J. ..........................233Elorza, A. .............................. 235Elosua, A................................ 178Elrakhawy, M. M. .................... 115Elsaeed, K. ..............................117Elsareef, M. ............................166Elsayed, H. ..............................117Elshazly, Y. ..............................117Eltabbakh, M. ..........................117Eltahan, A. ..............................117Elwan, N. ................................52Elzubier, M. ........................... 229Emara Elzanan, M. H. ....................118, 178, 232Emara, E. ........................ 118, 232Eminler, A. T. .......................... 132Emmanuel, A. ..........224, 226-227Emmanuel, A. V. ...........40, 71, 78,

88, 195, 244-247Emparanza, J. I. ...................... 115Emura, F......................58, 82, 107Enache, I. ...............................237Endo, H. .......67, 69, 77, 79, 97, 151,

163, 176-177, 187, 193-194, 198, 201, 222, 227, 234

Endo, K. .................................. 76Endo, S. ........... 75, 87-88, 91, 125,

152, 178, 191, 224Endoh, B. ............ 117, 129, 171, 180Enejosa, J. .......................... 47, 87Engel, T. .................................140Engelen, S. M. .........................50Engjom, T. ...............................171Engsbro, A. L. ..........................58Engstrand, L. ...................... 77, 79Ennas, S. ................................155Ennio, G. ................................192Enochsson, L. .................. 120, 183Enomoto, H. ........................... 167Epshtein, J. ..............................69Epstein, A. .............................. 72Er-Rabie, F. ........................... 240Eraković Haber, V. ...................183Erchinger, F. G. ........................171Erdélyi, Z. ............................. 234

Eisele, B. ................................154Eisendrath, P. ...... 60, 95, 126, 210Eissa, N. ............................ 89, 92Ejova, A........................... 145, 197Ejstrud, P. ...............................199Ekici, A. ................................... 79El Aassar, O. S. ...................... 232El-Aarag, B. ...........................166El-Ahwany, E. ......................... 118El Alfy, H. ........................168, 207El Baz, T. ................................ 118El-Badrawy, E.-S. G. ...............218El-Barber, D. ...........................117El-Bendary, M. ... 117, 166, 207, 220El-Diasty, M. ...........................166El Essawey, R. .........................117El Fayoumie, M. ..................... 123El-Gilany, A.-H. ..................... 220El Hajj, I. ................................ 179El-Hanafy, E. ................... 121, 168El Houssine, M. ...............178, 225El Kady, S. M. .........................136El Kassas, M. ...........................117El Magid Kassem, A. .............. 224El Mekkaoui, A. ...............178, 255El-Mikkawy, A. ........................96El Morsy, A. ............................168El Nakeeb, A. ......................... 121El Nakib, A. ........................... 207El-Omar, E. .......37, 83, 92, 97, 106El-Safi, G................................237El-Salhy, M. .............. 194-195, 246El-Serafy, M. ...........................117El-Setouhy, M. .................. 117, 166El Shabrawi, A........................168El Shafie, A. ...........................164Eladl, A.-H. ...................... 117, 166Elalfy, H. ....................117, 166, 217Elbadrawy, A. .........................168Elbadry, M. ............................ 167Elbahrawy, A. .................. 123, 136Elbe, P. ..................................200Eldahshan, M. ........................ 123Elegezy, M. ............................ 207Elferink, M. A. ........................192Elferink, R. ..............................117Elfert, A. .................................52Elhadidy, E. M. ....................... 115Elhanafy, E. ..................... 169, 179Eli, B. .................................... 242Eliakim, R. .................. 72, 78, 131,

137, 140, 190Elibol, S. ................................215Elisei, W. ................. 146, 203, 228Eliseu, L. ................... 89, 179, 258Elizabeth, H............................ 181Elizalde, I. .............................. 181Elkholy, A. ..............................166Elkoti, I. ................................ 253Ell, C. ................................ 76, 96

336


Foss, A. ..................................145Foster, P. ............................... 204Fotea, V. ................................ 256Foteinogiannopoulou, K. ........ 187Fotsing Makougang, G. ............80Fouad, A. ................................117Fournier, C. ........................... 240Fournier, N. ........................... 235Fowler, J. F. ............................140Fox, M. .... 40, 60, 80, 88, 148, 244Fradejas Salazar, P. ................. 137Fraga, E. ............................... 256Fragkaki, M. ...... 125, 129, 140, 145Frago, S. ............................... 253Fraile González, M. .......... 125, 178Framarin, L. ........................... 119Framba, V. .............................221Frampas, E. ............................136França, M. ..............................257Frances, R. .............................. 73Franceschet, I. ........................190Franceschi, M. ................146, 196,

198-199, 202-203, 247-249, 252

Franchimont, D................... 47, 55Franchina, M. .........................198Francica, G. ............................ 119Franco, M. C. ......................... 246Franco, O. H. ...........................48Francoz, C. ................38, 100, 104Franke, A. ................... 89, 91, 138Franke, L. ................................ 70Franzè, E. ......................... 96, 143Franzoni, L. ...... 196, 198-199, 202,

248-249, 252, 255Frappart, P.-O. ......................... 78Fraquelli, M. ................... 118, 236Fraser, C. ................................ 131Fraser, C. G. ...........................193Fraser, G. M. ......................... 230Frasson, A. ............................ 228Frazzoni, L. ............... 69, 129-130,

198, 200, 230, 249Frazzoni, M. ...... 69, 198, 200, 249Frederking, D. ........................154Frei, P. .............................86, 225Freire, J. .................................145Freire, J. P. ............................ 225Freitas, C. ...............................158Freitas, T. ....................... 228, 235Freitas Júnior, W. R. ................215Frey-Wagner, I. .................97, 184Freyssinet, M. .........................186Fried, M. ............ 86, 118, 195, 206Friedenberg, K. .............. 140, 252Friedli, B. .............................. 234Friedman, G. ........ 56, 61, 102, 140Friedman, J. ...........................188Friedrich-Rust, M. .................. 118Frieling, T. ............................... 53

Fischer, A. ..................53, 147, 207Fischer, L. .............................. 229Fischer, P. .................. 73, 166, 256Fischer, S. ............................. 207Fisher, N. C. ........................... 123Fishman, S. ............................155Fit, A.-M. .............................. 256Fitzel, G. ................................. 53Fitzgerald, D. ..........................237Fitzgerald, R. C. .... 81, 89, 105, 107FitzPatrick, M. ....................... 254Flamant, M. .................... 136, 186Flaquer, F. S. ..........................184Flavia Savarese, M. ................ 230Fletcher, L. ............................ 204Flik, C. ....................................90Fliss Isacov, N. ........................ 151Floquet, E. .............................. 57Floreani, A. .................. 53, 68, 91Florent, C. .............................. 181Flores-Trujillo, G. ....................152Florido, M. .............................194Floro, G. C. ............................ 208Florovsky, G............................ 132Flourie, B. ...... 75, 79, 135, 139, 186Flynn, H. A. ............................140Fockens, P. ............42, 46, 60, 84,

88-89, 105Foell, D. ..................................89Fogden, E. ............................. 234Fogel, E.................................. 179Fokra, A. .........................242-243Foley, A. ................................ 230Foley, K. ................................ 232Foliaki, A........................ 182, 256Folprecht, G. ...........................92Foncea, C. G. ..........................168Fondevila, C. ...........................38Fonseca, C. .. 157-158, 210, 241, 256Fonseca, J....157-158, 209-210, 256Fonseca, J. S. ......................... 258Fonseca, R. ...... 145, 180, 222, 252Fontaine, F. .............................55Fontana, P. ............................ 220Ford, A. C. ........59, 67, 70, 74, 146,

188, 197, 237, 244Forde, J. J. ......................... 76, 151Foret, F. ..................................149Foria, B. ................................. 151Forlano, R. .............................165Fornasarig, M. ................. 153, 192Fornelli, A. .............................130Forner, A. .........................54, 106Forsberg, A. ...........................143Forsmark, C. E. ....................... 151Forstlova, M. ..........................241Fortarezza, F. ..........................154Fortea, M. ............................... 57Forti, E. ...... 130, 156, 220, 229-230Foschi, F. G. ............................168

Fernandez Y Viesca, M. ...........210Ferracane, C. ...................238-239Ferraccioli, G. .......................... 75Ferrández Arenas, Á. ........ 84, 128Ferrante, M. ........... 47, 55-56, 189Ferrara, E. ............... 219, 224, 244Ferrara, L. .............................. 119Ferraz, S. .............................. 224Ferrazzii, F. .............................. 79Ferreira Paduani, G. ...............221Ferreira, A. M. ........................219Ferreira, A. O.............. 72, 158, 178Ferreira, C. ...............159, 207, 258Ferreira, D. ............................. 139Ferreira, M. .............. 166, 219, 232Ferreira, P. ............................. 167Ferreira, R. ......... 72, 158, 166, 229Ferreira, S. ............................. 178Ferreira, T. .............................145Ferreiro Iglesias, R. ......... 187, 190Ferreiro-Mazón, H. .................237Ferrer-Guixeras, M. ................134Ferrer-Picón, E. ....................... 97Ferretti, F. ......................205, 254Ferronato, A. ........... 203, 240, 247Feshtali, S. ..............................85Feskanich, D. ......................... 250Fest, J......................................85Festa, S. .................... 97, 185, 240Festen, E. A. M. ....................... 70Festi, D.................................... 78Fetsych, T. .............................. 151Fiamma, M.-N. .......................156Fichna, J. ....................79, 134-135,

143, 156, 184Fickert, P. ........................ 101, 216Fidalgo, C. ..............................237Fidder, H. H. .......................... 238Fiedorek, F. T. ..........................65Fielding, P. ............................ 232Figa, M. .................................227Figueiredo, A. ....................... 208Figuerola, A. .......................... 139Filali, A. ................................ 240Filho, J. R. ..............................189Filiberti, R. .............................. 62Filip, R. ...........................235-236Filippi, J. ..................... 75, 80, 137Filipponi, F. ............................130Finati, E. ............................... 224Fink, C. ..................................247Finnby, L. .............................. 236Fioravante, M. ....................... 236Fiore, W. .................................90Fiori, G.................77, 104, 137, 228Fiorini, G. ..........................77, 104Fiorino, G. .............................. 137Firwana, M. .......................... 256Fisas, D. .................................. 63Fischbach, W. ................... 92, 126

Fattahi, M. R. ............. 65, 215-216Favreau, J. T............................145Fawzi, M. ............................... 116Fawzy, E. F. ............................. 167Fawzy, I. M. ............................ 167Fayad, L. .......................... 62, 103Fazendeiro, M. .......................195Fazio, A. .................................135Feagan, B.....................47, 56, 61,

139, 141, 190Federico, A. .................... 165, 203Federico, F. .............................. 75Fedotova, A. ...........................184Fedusenko, O. ........................168Feeney, M. ...............223, 225-226Fehling, H.-J. ...........................96Feichtenschlager, T. ................ 137Fein, F. .................................. 234Fekih, M. ............................... 240Feldager, E. ............................221Felder, M................................168Feldhamer, I. ........................... 91Felice, C. ............................... 239Feliciangeli, G. ...................... 228Félix, J. ...................................159Feliziani, M. ...........................156Fellermann, K. ........................ 53Felt-Bersma, R. J. ...................185Femia, D. .............................. 223Fennessy, S. ...........................126Ferdinande, K......................... 133Férec, C. ..................................46Ferenci, T. ............................. 235Ferkolj, I. ................................ 79Ferlitsch, A. ............................. 51Ferlitsch, M. ..............175, 227-228Fernandes, A. ...................89, 258Fernandes, C. .........................159Fernandes, S. .......... 116, 159, 208,

221, 228, 235, 237Fernández, E. .................. 121, 140Fernández, F. ....................137, 140Fernandez, G. ................... 117, 145Fernandez, R. J. F............206, 255Fernández-Bañares, F. ......56, 140Fernandez-Barrena, M. G. .......117Fernández-Esparrach, G. ...........128, 175, 180, 222, 231Fernández-Esparrach, M. G. ... 175Fernández-Fernández, E. ........ 121Fernandez-Irigoyen, J. .............117Fernández-Laso, A. B................71Fernández Rosaenz, H. ...........185Fernandez Saya, B. .................237Fernandez-Simon, A. ..............227Fernandez-Tome, S. ................. 97Fernández-Urién Sainz, I. .......................... 131, 181, 229Fernández-Urién, I. .......... 72, 131,

181, 229


337

Gargallo Puyuelo, C. J. ......................125, 136, 178Gargari, G. .............................156Gargaté, L. .............................159Gargouri, D. ....................228-229Garmanchuk, L. ......................134Garret, C. ............................... 121Garrido, M. S. ........................ 235Garros, A. .............................. 197Gartner, J. .............................. 137Garufi, S................................ 239Garvey, T. ...............................158Garzon-Benavides, M. ............. 63Gasbarrini, A. ..........37, 50, 59, 77,

87, 100, 103-104, 166, 168, 188, 215,

218, 239, 256Gasbarrini, G. ........................ 256Gashemi, P. ........................... 204Gasink, C. .......................... 47, 141Gasmi, M. ...............................95Gaspar, M. M. .........................169Gaspar, R. ..........117, 165, 168, 173,

195-196, 201, 209, 258Gasparov, S. ...........................257Gaspersz, M. .............120, 169-170Gasztonyi, B. .................... 83, 136Gatof, D. ................................ 252Gatti, P. ............................ 117, 167Gatti, S. ..................................190Gaudric, M. ............................247Gauiran, D............................. 208Gaujoux, S. ............................ 181Gauss, A. ................................233Gauthier, A. ............................188Gauthier, J.-F. .........................156Gavasso, S. ............................. 116Gavini, S. ............................... 133Gawish, A. ............................. 123Gawron-Kiszka, M. ................ 240Gaya, D. R. ....................... 61, 190Gazeau, F. .............................. 173Gazis, T. .................................148Gazizov, I. M. ..........................164Gazouli, M. ............................ 187Ge, C. .......... 57, 59, 77-79, 117, 141,

144, 167, 234, 253Ge, N. ..........36-38, 51, 55-56, 58,

61-62, 64, 66-68, 71, 76, 82, 88-89, 92-94, 98-99, 102,

105-106, 118, 125, 138, 143, 155, 161-162, 168, 171-172, 174-175, 178, 184, 190, 195, 205, 211, 215, 220-

221, 225, 251, 254Ge, Y. ............48, 60, 88, 104, 134,

193, 214, 226, 248Geccherle, A. .................. 190, 238Gecim, I. ...........................81, 213Gecim, I. E. .......................81, 213Gecov, P. ................................221

Gallego, S. ............................ 253Galli, G. ................... 124, 155, 199Gallittu, P. ...............................52Gallmeier, E. ............102, 106, 160Galloro, G. ..............................96Gallotta, S. ............................ 244Galloway, D. ...........................158Galloway, P............................. 132Galtieri, P. A. ........... 219, 224, 244Galvao Neto, M. .............. 155, 173,

206, 255Gama-Carvalho, M. ................164Gamar, L. ...............................185Gambaccini, D. ...................... 206Gambitta, P. ..............181-182, 220Gameel, A. ............................. 115Gamian, A. .............................184Gan, T. M. A. ..........................156Ganatra, R. ............................ 225Gandara, J. .............................196Gandolfo, C. ............................99Ganeshappa, R. ..................... 252Gao, J. ............................. 116, 257Gao, L.-L. .......................... 47, 141Gao, N. .................................. 170Garau Colom, C. ...................... 63Garcia, D. .................. 65, 139, 247Garcia, L. D.............................184García, M. ................ 128, 137, 220Garcia, M. J. ...........................194Garcia, S. ..............................200García, W. ..............................233García Alonso, F. J. ..................120Garcia Donday, M. .............77, 104García Durán, F. ......................120García Martín, L......................125Garcia Pagan, J. C. ................. 100García Ramirez, L. ..................188Garcia Ramos, C. .................... 167García Rodríguez, L. A. ............96Garcia-Alonso, F. J. ..........125, 226García-Arribas, D. ....................65Garcia-Caballero, T. ......... 147, 252García-Cámara, P. .................. 253Garcia-Cortes, P. .....................194Garcia-Gil, J. ................... 134, 237García-González, M. A. ... 153, 200Garcia-Guix, M. ..................... 180Garcia-Iglesias, P. ...................241Garcia-Jaraquemada, A. ........ 234García-López, S. ............. 189, 235García-Mayor, M. ....................128García-Puig, R. ........................56García-Rayado, G. ......71, 170, 220García-Rodríguez, S............... 220García-Sánchez, V. ... 140, 185-186,

190, 240Garcovich, M. .................. 215, 218Gardiner, P. J. ..........................59Garg, M. ...........................58, 233

Fukui, K. ................................ 121Fukumoto, A. ................... 69, 142Fukunaga, S. .........................200Fukunaga, Y............................ 175Fukushima, H. ........................ 176Fuldeore, M. ........................... 87Fullana, M. ............................ 239Fumery, M............. 75-76, 96, 135,

137, 139, 185Fumery, O. .............................135Fumihito, H. ............................58Funaki, S. .................. 175-176, 182Funasaka, K. .................... 136-137Funato, K. ..............................142Fung, D. ................................ 242Furfaro, F. .............................. 137Furgała, A. ............................ 204Furnari, M. ................69, 198, 249Furnea, B. ............................. 246Furtado, A. ............................ 209Furtado, E. ............................. 217Furudoi, A. ....................... 53, 144Furukawa, K. ............. 136-137, 229Furutachi, S............................201Furutake, M............................ 176Fuschi, D. ...........................70, 78Fushimi, S. ............................. 132Fust, K. ..................................196Futagami, S. ...............82, 173, 198

G Gabbrielli, A. ................... 121, 171,

209, 221-222Gabe, S. M. ........................... 205Gabieta-Sonmez, S. ................247Gabr, A. ............... 64-65, 178, 225Gabriele, A. ........................64-65Gaeta, G. B. ............................ 119Gagalis, A. .............................159Gagliani, N. ............................150Gagniere, C. ................50, 75, 186Gago, T. .... 215, 228, 236, 241, 255Gahan, C. G. ...........................134Gaia, S. ................................. 180Gaidhane, M. ........................ 223Gaiser, T. .................................92Gait, A. ..................................182Gal, E. .......... 49, 131, 171, 230, 240Galamb, O. ......... 143, 192-193, 243Galanko, J. .............................. 78Galdona, I. .............................140Galeev, S. .............................. 220Galera, A. B............................154Gallach, M..............................241Gallagher, C. ..........................138Gallart, M. .............................. 57Galle, P. R. ................. 55, 98, 125Gallego-Gomez, R. .......... 147, 252Gallego, F. ............................. 235

Fries, W.....................97, 185, 189, 238-239

Friess, H. ................................168Frigerio, I. ...............................85Frigerio, M. ............................156Fritz, P. .................................. 234Fritzer-Szekeres, M. ................. 51Fronek, J. ...............................158Frulloni, L. .......... 80, 98, 121, 159,

171, 209-210, 221Fu, J. ............... 51, 70, 93, 151, 167,

174-175, 232, 246Fu, L. .................... 69-70, 93, 101,

129-130, 198, 200-201, 228, 230, 249

Fuccio, L. .............69, 101, 129-130, 198, 200, 228, 230

Fuchssteiner, H. ...................... 137Fudim, E. ........................140, 190Fuentes Coronel, A. M. ........... 137Fugang, L. ..............................201Fugazza, A. ...... 219, 222, 224, 244Fuglsang, K. A. .......................103Fuhler, G. M. ........................... 79Führer, M. ..............................148Fujii, M. ......................... 209, 257Fujii, N. ................................. 203Fujii, R. ........................... 178, 231Fujii, S. .....................97, 236, 250Fujii, T. ......... 76, 136, 178, 188, 236Fujii, Y............................. 122, 153Fujimori, S. ..............178, 236, 254Fujimoto, A. ... 53, 82, 173-174, 225Fujimoto, J. ................93, 167, 232Fujimoto, K. .. 77, 187, 193, 197, 234Fujimoto, Y. ............................ 167Fujino, T. .........................152, 243Fujisaki, J. ......51, 151, 174-175, 246Fujisawa, T. ......................58, 222Fujishiro, M................ 51, 96, 142,

151, 205Fujita, I. ..................................82Fujita, K. ......................... 126, 147Fujita, M. .............................. 222Fujita, T. ................................ 226Fujiwara, A. ............. 115, 209, 257Fujiwara, K.............................145Fujiwara, Y. ........ 79, 115, 200, 254Fukahori, M. ......................... 180Fukami, Y. ...................... 203, 241Fukata, N. ..............................126Fuks, D. ..............................49, 74Fukuba, N. ......................101, 238Fukuda, H. .............................251Fukuda, K. ......... 183, 187, 223, 232Fukuda, S. ..................71, 194, 203Fukuda, T. ..............................138Fukuhara, M. .......................... 167Fukui, A. ............................... 204Fukui, H. .................................84

338


Gonçalves, M. D. C. .................221Gonçalves, R. ..........180, 183, 188,

218, 237, 258Goncalves, S. ......................... 238Gonczi, L. ...................83, 136, 138Gonlachanvit, S. .....................194Gonzales, J. .................... 195, 234Gonzales, J. A. ....................... 234Gonzales, Y. S. ........................216Gonzalez Alvarez, D. O. .......... 204Gonzalez Huix, F. ....................125Gonzalez Santiago, J. .............. 178Gonzalez Suarez, B. .................56González-Castro, A. M. ............ 57González-Cervera, J. ...............149González-Huix, F.....................153González-Lama, Y. ................. 240González-Lois, C. ....................227González-López, J. ..................190González-López, N. ................ 245Gonzalez-Navajas, J. M. ........... 73González, C. ..................... 56, 227González, C. E. .......................227Gonzalez, E. ....... 99, 172, 194, 200Gonzalez, J.-M. ....95, 99, 124, 152,

172, 182, 200González, M. .................... 57, 244Gonzalez, N. ......................56, 177Goodrick, K. ......................69, 177Goodwin, G. .......................... 235Goos, K.-H. ............................190Goosey, R. ..............................195Gooszen, J. .............................. 41Gordan, M. .............................165Gordo, I. ................................ 114Gordon, C. ................ 151, 231, 250Gordon, H. .............................184Gori, A. ...................................92Gornals, J. B. ......................... 180Gornet, J.-M. ................... 185-186Görög, M. ...............................120Górska, S. ..............................184Gosch, I. .................................134Gospodinova, M. ....................159Goßner, L. ............................. 207Goto, H. .................... 136-137, 254Goto, O. ...............82, 173-174, 225Goto, T. .............. 120-121, 123-124,

131, 151-152, 175, 228Gotoda, T. .......... 123-124, 151-152,

175, 228Gottesdiener, K. .......................65Gottier, C. ......................... 97, 234Gottlieb, A. ............................. 217Gottlieb, G............................. 252Gouda, Y. ...............................169Goulart, I. .......................159, 207Goulding, C. ...........................164Gouma, D. J. ..................... 93, 169Gourcerol, G. ........39, 107, 113, 198

Glanemann, M. ......................146Glasinovic, E. ................... 69, 247Glerup, H. .............................. 141Glocker, E. ..............................154Gloor, B. ................................183Glória, H. .............................. 208Glória, L. ................................237Gloudemans, A. K. ..................184Gluck, N. ............................69, 72Gluud, L. L. ............................221Glynn, P. ................................142Glynne-Jones, R. ... 38, 74, 107, 114Gobbo, M. ..............................186Goda, K. ................................ 250Godat, S. ............................... 248Goddard, S. ............................125Godfrey, E. ..............................59Gódi, S. .......................... 220, 229Godin, N. ...............................149Godinho, R. ............... 177, 179, 224Goertz, R. S. ........................... 121Goeser, T. ....................... 146, 242Goess, C. ................................140Goetz, M. .................. 69, 148, 239Goetze, T. O. ............................92Goggins, B. J. ................. 184, 204Gogov, B. ...............................169Goishi, H. .........................134, 191Goldberg, Y. ........................... 151Gölder, S. .............................. 205Goldin, R. D. ..........................165Goldis, A. .............77, 96, 104, 116,

135, 185, 216, 224Goldsmith, J. D. .......................56Goldstein, K. E. .................. 56, 64Goldsworthy, M. A. ..................59Golemanov, B. ........................221Golob, S. ................................. 79Golovics, P. A...... 83, 136, 138, 240Gomes, A. .......................221, 256Gomes, C. ....................... 178, 237Gomes, D. ................158, 214, 217,

219, 229, 253Gomes, S. ..............................195Gomez, A. .............63-65, 198-199Gomez, J. .................... 79, 92, 145Gomez, V. .............. 91, 93, 127, 129Gomez-Hurtado, I.................... 73Gómez-Pastrana, I. .................125Gomez-Pinilla, P. J. .............79, 92Gómez Senent, S. ...................188Gomez-Vallejo, V. .................... 91Gomollon, F. .............136, 139, 185,

236, 245Gonçalves, A. R. .............183, 188,

237, 258Gonçalves, B. ........................ 180Gonçalves, C. .......89, 179, 221, 258Gonçalves, D. ........... 158, 209-210Gonçalves, L. ............. 177, 179, 224

Giacomin, A. ...........................171Giampietro, V. ........................ 197Giannakeas, N. .......................165Giannakopoulos, A. ................125Giannikaki, L. .................. 125, 145Giannini, E. G. .... 168, 187, 191, 237Giannotta, M. ............ 96, 135, 185Giannou, A. ............................150Gianquinto, E. ........................ 187Giardini, M. ........................... 228Giardullo, N. .......................... 133Gibiino, G. .............................215Gibson, P. R. ...47, 67, 103, 141, 146,

195-196, 205, 233, 245Gies, A. ...................................50Gil-Simon, P. ...........................99Gil, A. H. ........................ 238, 242Gil, H. ..................... 194, 238, 242Gil, K. ................................... 204Gil, P. .................. 99, 171, 196, 237Gilabert, P. ...................... 196, 237Gilardi, D. .............................. 137Giles, T. ................................. 222Gilissen, L. P. L. ........ 102, 124, 149Gilja, O. H. ........................77, 194Gillespie, G. ..................... 61, 190Gillet, A. .......................... 50, 176Gilletta De Saint Joseph, C. ...... 73Gils, A. .............................64, 189Gim, S. J. ............................... 209Gimeno Garcia, A. ................. 245Gimeno García, A. Z. ............. 180Gimesi-Orszagh, J. ..................138Gimier, E. ................................ 72Ginard, D. ..............................185Gincul, R. .............................. 229Giner-Calabuig, M. ........... 63, 143Gines, A. ........................ 180, 222Gingold Belfer, R. .................... 91Gini, A. ...................................50Ginsberg, G. G. ........................ 76Ginter, G. .............................. 104Giorda, E. ................................96Giorgetti, G. ...........................146Giouleme, O. ...........................49Giovannini, M....... 49, 82, 95, 122,

152, 169, 172, 200, 229Giráldez-Montero, J. M. ..........190Girardin, G. ............................189Girboni, L. ............................. 224Girleanu, I. .. 131, 166-167, 254, 256Girot, P. ................................. 252Gisbert-Ferrándiz, L. ..............134,

233-234, 252Gisbert, J. P. ..........77, 97, 104, 185Gisbertz, S. S. ............. 76, 82, 250Giuliante, F. ............................218Giuseppe, C. ...........................189Giuseppe, P. .......................... 203Gkolfakis, P. ............... 127, 131, 254

Gecse, K. B. ............54, 61, 70, 83, 110, 136, 138, 240

Geddes, J. ............................. 235Gedgaudas, R. ...................91, 142Geelkerken, R. H. .................. 255Gehring, S. .............................215Geier, M. S. ........................... 204Geiger, S. ................ 194, 201, 258Geiger, T. L. ............................184Geijo, F...................................153Geismann, C. ..........................102Gelabert, J. .............................194Geller, S. I. ............................. 157Gelley, A. .............................. 234Gelman, S. ............................. 115Gelrud, A. .......................183, 233Genc, D. ................................. 114Genda, T.................................198Gendo, Y. ...............................134Geng, C. ............................79, 174Genov, J. ................................221Genova, S. ............................. 238Gentile, A. ............................. 208George, V. .............................. 137Georgieva, A. .........................186Georgiou, E. ...........................183Geramizadeh, B...............165, 218Gerard, R. ...................... 236, 238Gerardi, V. ..............................155Gerassy, S. .............................189Gerber, M. ............................. 204Gerbes, A. L. ...........................59Gerbino, N. ..................... 64, 205Gerges, C. ................42, 67, 73, 81Germain, P. ............................ 137Germaná, B. ........ 96, 171, 192, 228Gerner, R. R. ...........................89Gerova, V. .......................159, 236Gerß, J. ..................................135Gervasi, S. ............................. 202Gesret, C. .............................. 234Gevers, T. J. ............................. 91Gewirtz, A. T................ 57, 70, 183Geyer, M. ................................84Ghalab, M. ...................... 118, 232Ghaoui, C. ............................. 229Ghasemi, P. ....................204, 246Ghasiyari, H. ..........................154Ghatak, S. K. ......................... 224Ghazi, S. ................................120Gheorghe, C. ............. 116, 217, 223Gheorghe, L. ..............116, 216-217Gheorghiu, M. I. .................... 230Gherhardt, D. .................. 168, 170Ghia, J.-E. ......................... 89, 92Ghinolfi, D. .............................130Ghosh, P. ................................156Ghosh, S. ................ 47, 49, 61, 67,

88, 100, 142, 176Ghozlane, A. ......................... 243


339

Ha, S. M. ......................... 151, 252Haag, G. M. .............................92Haanstra, J. .............................98Haas, S. .................................120Haas, T. .................................. 137Haber, G. ................................145Haccourt, A. ...........................186Hachiya, H. ............................. 119Hack, M..................................128Hadefi, A. ........................ 197, 210Haderer, M. ............................ 116Hadzic, D. ............................... 191Haefner, M. ............................ 127Haf, D. .............................. 72, 248Hafi, M. ................................. 240Hafner, D. .............................. 248Häfner, M. ............................. 223Hag, E. .................................. 243Hagel, A. F. ............... 128, 148, 196Hagström, H. ..........................143Hahn, H. .................................92Hahnloser, D. ........ 38, 53, 81, 100Hai, S. ........................93, 167, 232Haidry, R. ..................76, 132, 148,

173, 225, 247Haijat, M. .............................. 223Haito-Chavez, Y. ................ 62, 99Haj Natour, O. ........................140Hajek, P. ..................................69Haji, A. ............. 148, 224, 226-227Hakimian, S. ..........................186Hakuta, R. ...............................95Hakvoort, T. B. M. ...................192Halama, M. .............................86Hale, M. F. ..............................189Half, E. .................................. 243Halfvarson, J............. 96, 135, 185,

189, 236Haličková, T. .....................69, 248Halkova, T. ............................ 222Hall, D...............................47, 134Hall, G. .............................71, 195Hall, M. .................... 179, 207, 257Halland, M. .............. 149, 207, 257Hallas, J. ........................ 154, 250Haller, D. .......................... 50, 134Hallouin, P. ............................136Hällström, P.............................49Hama, M. ..........................97, 186Hamada, K. .............................85Hamada, T. ................. 95, 120-121Hamada, Y. .........122, 172, 181, 209Hamamoto, H. ........................186Hamatani, S. ...................128, 194Hamaz, S............................... 255Hamidouche, N. ..............185, 257Hamlin, P. J. ......... 61, 70, 188, 190Hammami, E. .................. 168, 183Hammami, M. ........................128Hammer, H. F. ................... 39, 65

Gui, X. ................................... 176Guidi, G. ...............................200Guidi, L. .........75, 97, 155, 185, 239Guido, E. ............................... 228Guido, P. ................................ 119Guilbaud, T. ...........................124Guillaumot, M.-A. ............ 53, 62,

177-178, 228, 247Guillemain, G. ........................156Guinó, E. ...........................97, 143Guitton, C. .............................. 121Gül Utku, Ö. ...........................199Gulati, A. ................................58Gulati, S. ........... 148, 224, 226-227Gulbinas, A. .....................172, 221Gullotta, R..............................156Gullotti, G. ............................ 228Gumerova, A. A. .....................164Güney, B. .............................. 256Güngör, C. ................... 46, 78, 221Gungunes, A. .........................199Günther, C. ..................55, 70, 170Guo, F. ...................................218Guo, J.....................................124Guo, L. .................................. 256Gupta, A. ............102, 170-171, 225Gupta, R................................. 181Gupta, V. .................................171Gupte, A................................. 151Gurianov, V.............................168Gurniak, O. ............................ 238Gurry, T. .................................. 70Gurusamy, K. S. ......................169Gusev, D. ................................231Gusmon, C. C. ...194, 201, 231, 258Gustafsson, J.-Å. ......................92Gutberlet, K. ............................ 53Gutiérrez, A. ..... 125, 140, 190, 240Gutierrez, J. P. .........................52Gutiérrez Galiana, E. A. ...........49Gutiérrez Martín, A. ................125Gutschow, C. ..........................102Gutt, C. ................................. 249Guttmann, S. ..........................215Guzman, M. A. ........ 183, 233, 246Guzzardo, V. ..........................200Gweon, T.-G. ...........................96Gyawali, C. P. ..... 69, 148, 198, 247Gyimesi, J. ...............................64Gyökeres, T. ..................... 179, 235

HH., L. ...... 51, 57, 59, 62, 74, 76, 80,

85, 87, 92, 95-96, 98, 101, 117, 120, 139, 146, 148, 151, 157-159,

163-164, 167, 173-174, 181, 192, 194, 196-197,201, 206, 208, 212,

216, 218-219, 227, 230-231, 234-236, 241-242, 244, 256, 258

Griffiths, W. ........................... 208Grigoras, C.-A. ........................ 73Grigorescu, M. ........................215Grigorescu, R. R. R. ............... 223Grigoreva, I. N. .......................122Grigoryeva, T. V. ...................... 77Grillo, S............150, 196, 199, 202,

247, 249, 255Grimaud, J.-C. ......................... 75Grimminger, P. .......................125Grinevich, V. ........................... 115Gringeri, E. ............................ 116Grip, O. ..................................189Grobbee, E. J. .........................143Gröchenig, H. P.................137, 140Groefsema, M. ........................165Grohmann, F. .........................102Gromov, A. A. .........................144Gronaas Farup, P. ....................52Grønbæk, H. ........................... 101Groot Koerkamp, B. ......... 93, 120,

169-170Grooteman, K. .................. 71, 255Gros, B. ..................................186Groselj-Strele, A. .................... 101Gross, S. A. .............................69Grossi, C. .............................. 228Grossi, L. ................. 140, 189, 240Grover, M. ........................ 57, 206Groza, I. ................................ 246Grueber, M. ........................... 235Gruis, N. .................................85Grün, K. .................................231Grzymislawski, M. ................. 240Gschwantler, M. ..................... 132Gschwind, D. ..........................214Gu, H.-X. ................................136Gu, W. .............................. 91, 258Guagnozzi, D. .......................... 57Guardiola Arévalo, A. ......125, 226Guardiola, J. .....................97, 186,

196, 235, 237Guarino, M. ................ 42, 118-119,

168, 216, 218Guarner Argente, C. ...125, 175, 178Guarracino, M. .......................218Guba, M. ............................... 232Gubler, C. ...............................102Gudkova, R. ............................ 139Guedes, H. G. ................. 126, 230Guengoer, C. ..........................221Guenther, T. ...........................154Guenthert, S. ..........................155Guerra Veloz, M. F. ......... 139, 208Guerra, J. G. ...........................221Guerreiro, H. ...........215, 228, 236,

241, 255Guerreiro, R. ......................... 255Guerrero Vinsard, D. ...............129Guglielmetti, S. .......................90

Gournay, J. ............................. 121Goutorbe, F. ..................... 83, 186Goutte, M. .................. 83, 137, 186Gouveia, C. .............................237Goverde, A. ............................192Goverse, G. ........................79, 92Govil, S. ................................ 256Gower-Rousseau, C. ..........76, 135Goyal, S. ................................ 121Goze, H. .................................159Gracia, M. ............................. 253Gracie, D. ...............................188Gracie, D. J. ............................. 70Graddy, C. ............................... 93Graf, R. ....... 102, 140, 170-171, 220Grafton, R. .............................140Graham, D..........132, 148, 191, 225Graham, T. .............................150Gralnek, I. M. ....37, 41, 48, 88, 179Granata, A. ..............................99Granata, L. ............................ 203Granata, R. ................. 117, 167, 218Grande, G. ......... 96, 196, 199, 202Grander, C. ..............................89Granja Navacerrada, A. ... 120, 226Grant, D. ................................149Grassalkovich, A. ....................120Grassi, F. ............................... 248Grassia, R. ............... 180, 207, 230Grasso, E. ...............................188Grau-Garcia, F. J. .............170, 220Graur, F. ..................................64Gravina, A. G. ........... 165, 174, 203Gravito-Soares, E. ............214, 253Gravito-Soares, M. ... 158, 210, 214,

217, 223, 229, 253, 256

Gray, M. A. .............................120Graziani, C. ............................188Graziani, M. G. ...............206, 244Grecco, E. ................ 155, 206, 255Green, J.................................. 119Green, L. ......................77, 83, 125Greenaway, J. ......................... 119Greenhalf, B. ...................... 77, 83Greenhalgh, F. ....................... 253Grega, T. .................228, 242, 244Gregory, M. H. ......................... 62Gregus, M. .............................149Greinwald, R. .................. 101, 140Gremese, E....................... 75, 239Gress, T. M. .......... 66, 68, 80, 118,

120, 164, 168, 215, 223Greuter, M. ..............................50Greuter, T. .......................101, 248Grgurevic, I. ...........................214Grgurevic, L. ...........................214Grieco, A. ...............................218Griesmann, H. ....................... 222Griffiths, A. M. .........................56

340


Hermann, P. C. ........................ 93Hermelink, R. .........................214Hermsen, S. A. B. ....................58Hernandez Camba, A. ............ 235Hernandez Mondragon, O. V. .. 174Hernandez Reyes, M. L. .......... 174Hernández Tejero, M. ..... 120, 226Hernández-Illán, E. ................143Hernández, C. ... 134, 233-234, 252Hernández, L. .......................... 57Hernández, M. ......... 120, 226-227Hernández, V. ............ 84, 96, 128,

135, 185Hernando-Alonso, A. I. ....170, 220Herold, A. ........................ 81, 104Herraiz, M. ..................63, 84, 128Herrala, S. ............................. 239Herrera Rodriguez, J. C. ......... 204Herrero-Rivas, J. M. ............... 245Herrero, R. ...................... 173, 251Herreros de Tejada, A. .....175, 178,

227, 245Herrmann, M. ........................ 170Hershcovici, T. .........................69Herszényi, L. .......................... 235Herzog, J. .................................71Hes, F. .....................................85Hesselink, M. ...........................71Hession, R. ............................. 137Hessmann, E. .......................... 78Hewitson, P. ........................... 175Heynen, G. J. ..........................122Hibi, T. ........................ 61, 76, 188Hibiya, S. ...............................143Hicks, L. C. ............... 184-185, 233Hidaka, E. ................. 98, 128, 193Hidaka, H. ............................... 77Hidalgo, A. ............................ 235Hidano, S. ..............................134Higaki, Y. ................................ 121Higashi, R. .............................. 53Higashimori, A. ...................... 147Higashino, K.....................85, 201Higashiyama, M. .............. 53, 144Higginson, A. ..........................99Higuchi, K. .................82, 173, 198Higueras Nafría, J. ...................65Higurashi, T. ........ 63, 114, 155, 241Hijioka, S. ........................ 122, 171Hijona, E. ...............................153Hijos, G. ................................ 245Hildner, K. ............................... 79Hill, C.....................................134Hillamaa, A. ...........................241Hilmi, I. N. ............................ 239Hind, J. .................................. 157Hindryckx, P. ...........................96Hinds, C. ............................... 235Hinkson, A. ........................... 209Hinojosa Del Val, J. .................233

Hayashi, T. ........... 46, 72, 98, 126, 128, 131, 147, 183, 193-194, 202, 243

Hayashi, Y. ....................... 68, 123Hayat, J. ................................. 101Hayat, M. ............................... 179Haycock, A. ........ 89, 223, 225-226Hayee, B. .......... 148, 224, 226-227Hazama, S. ..............................86Hazan, S. .............................. 252Hazelton, W. D. ........................ 87Hazewinkel, Y. ................... 84, 89He, H. ..........50, 148, 151, 153-154,

158, 166, 173, 190, 222, 255He, K. .............................. 173, 198He, S. ............ 69, 72, 121, 130, 158,

167-168, 175, 177, 201, 239He, X. ............ 52, 80, 114, 137, 139,

141, 143, 171, 201-202, 218, 223, 244, 251

He, X. Q. ................................184Hebert-Magee, S. ..............72, 130Hebristean, C. ........................166Hebuterne, X. ............. 80, 137, 139Heckel, S. ...............................214Hedin, C. .....................63, 88, 103Hedstrom, A. ...........................171Hegab, S. E. .......................... 232Hegarty, R. ............................. 157Hegyi, E. ......................46, 76, 98Hegyi, P. ........ 59, 76, 98, 120, 153,

170-171, 220, 229, 231Heijmans, J. .....................92, 242Heikenwälder, M. .......102, 170-171Heinemann, M. ..................... 229Heinrich, H. ................. 40, 57, 65,

81, 94, 160Heinrich, J. .............................196Heinrich, M. ............................ 78Heinrich, S. ............................ 121Heinze, G. ..............................227Heitman, S. ................ 69, 175, 177Heller, F................................. 254Helmrath, M. A. .......................96Helsper, C. ..............................95Heluwaert, F. ..........................185Helwig, U. ...................... 138, 206Hemerick, J. ...........................145Hemmrich-Stanisak, G. ............ 91Hencz, R. .............................. 235Hendel, J. ................................69Henderson, M. .......................154Hendy, P. .................... 40, 70, 233Henmi, S. ........................ 167, 257Henriques, A. ........................ 223Hentic, O. ................................171Heredia, M. ............................194Herichova, I. ............................ 47Hering, L. .............................. 234Hermann-Kleiter, N. ................89

Hartmann, D. ............ 64, 101, 168Haruna, Y. ............................. 246Haruo, I. ............................... 250Harustiak, T. .......................... 250Harvey, P. ................. 103, 170, 247Hasak, S. .........................198, 247Hasami, N. .............................219Hasan, M. ............72, 103, 129-130Hasegawa, G. .........................103Hasegawa, H. .................. 126, 153Hasegawa, K. ......................... 167Hasegawa, R. ......................... 119Hasegawa, S. ............ 179, 182-183Hashem, R. A. ......................... 61Hashidate, H. ........................ 229Hashimoto, C..........................194Hashimoto, R. ....................... 254Hashimoto, S. ............103, 121, 186Hashimoto, Y. .................. 169, 172Hassan, C. ................... 41, 48, 88,

98, 101, 228Hassan, M. ........................117-118Hassan, W. ............................ 208Hassany, M. .............................117Hassany, S. M. ....................... 208Hasse, M. .................................71Hasselblatt, P. ......................... 114Hasselby, J. P. .........................122Hassine, H. ......................228-229Hasui, K. ......................... 118, 194Hasuike, N. ............................251Hata, M. .................................182Hatamaru, K. .......................... 181Hatanaka, K. ......................... 203Hatano, E. ..................93, 167, 232Hatem, G.................................55Hather, G............................... 239Hatlebakk, J. G. ........ 194-195, 206Hatta, W. ......................... 152, 197Hattori, M. ............................. 123Hattori, S.......................... 136-137Hatzinicolaou, S. L. ....62, 230, 243Haug, U..................................143Haugk, B. .............................. 222Hauptmann, M. .......................64Hausken, T. ....... 156, 194-195, 246Hausmann, M. ........................184Hautefeuille, V. ................. 93, 168Havard, T. ...............................199Havre, R. F. .............................122Hawes, R. ...............49, 55, 64, 72,

100, 103, 129-130Hawkes, N. ...............223, 225-226Hawkey, C. J. .................... 41, 207Hayasaka, K..................... 123, 169Hayasaki, A. ........................... 172Hayashi, K. ...................... 123, 142Hayashi, M. ............................183Hayashi, N. ............................142Hayashi, S. ...........53, 119, 121, 169

Hammer, J. .............................148Hammer, K. ............................148Hammer, V. ............................148Hammoud, D. .........................190Hampe, J. .............................. 239Hamzaoui, L. ..........................227Han, B. H. ....................... 179, 219Han, J. Y. ................................153Han, K. D. ...............................192Han, M.-L. ............................. 206Han, S. ............ 47, 61, 147, 169, 179Han, S. J. ............................... 226Hanabata, N. ................... 118, 194Hanada, K. .............................122Hanafy, A. S............................ 197Hanania, T. ............................ 243Hanaoka, N. .....................85, 201Hanauer, S. .........................47, 61Hancock, J. ............................ 229Handa, O. .......... 123, 174, 204, 253Hanen, J. ......................... 138, 183Hann, A. .................................58Hannoun, D. .......................... 253Hansen, B. .............................. 91Hansen, B. E. ......................... 179Hansen, C. P. ..........................122Hansen, J. M................... 154, 250Hansen, K. E. ..........................150Hansen, T. ......................204, 246Hansford, S. ........................... 147Hänze, J. .........................164, 168Hao, J. ................................... 232Hao, J. Y. ................................184Hapfelmeier, A. ................ 72, 224Haq, M. ................................. 252Har-Noy, O. .....................140, 227Hara, C. ..................................145Hara, K. .. 84, 122-123, 171, 203, 241Harada, E. ...............................98Harada, H.................. 123, 147, 169Harada, K. ................123, 203, 241Harada, M. ............................. 123Harada, N. ............... 128, 194, 201Harada, T. .... 98, 122, 172, 181, 243Haraoka, S. .............................58Harbord, M. ...........................184Hardi, R. ............................... 252Hardwick, J..............................98Harkat, C. ............................... 141Harki, J. .................................. 123Harputluoglu, M. M. M. M........................ 170Harris, J. P. .............................. 62Harrison, P. ............................. 47Hart, A. ................. 40, 43, 70, 80,

185, 189, 233Hartery, K. .............................. 217Hartl, J. ................................... 91Hartleb, M. ..................... 164, 240Hartman, C..............................64


341

Huang, T. .......................... 91, 147Huang, W. ............................... 72Huang, Y. ................. 124-125, 129,

179, 193, 201Hubalewska-Mazgaj, M. ........ 250Hübenthal, M. ......................... 91Huber, S. ................................150Hubers, L. M. .........................219Hübner, G. .............................. 53Hucl, T. ................... 52, 72-73, 81,

148, 158, 174, 221Hudson, M. ............................ 116Huelin Alvarez, P. ................... 178Huelsen, A. ............................. 51Huernos, S. P. ........................ 238Huerta, A. .............................. 178Huertas Nadal, C. ............180, 227Huggett, M. ............................122Hughes, J. ..............................140Hugot, J.-P. ............................. 191Huguet, J. ...............................189Huh, K. ........................... 169, 197Huhtala, H. ............................ 254Hui, J. .....................................52Hui, Y. T. ................................ 208Hull, M. A. ......................135, 243Hulscher, J. B. F. ......................59Humbert, L. .................... 206, 241Hume, D. A. ............................ 79Humes, D. J. ............................ 78Humphries, A. ................. 131, 226Hung, J.-S. ...................... 148-149Hung, T.-H. ............................166Hünger, M. .............................126Hungin, P. ...................74, 80, 212Huntsman, D. ......................... 147Huorka, M. ............................ 236Hupkens, B. ...........................144Hur, C. .................................... 87Hurduc, V. .............................. 157Husar-Sburlan, I. A................ 208Hüser, N. ..........................64, 168Hussein, M. .....................193, 202Hussey, D. J. ...........................150Hussey, M. . 138, 205, 216, 231, 253Hustak, R. ...................... 125, 220Huszár, T. .............................. 220Hüttelmaier, S. ...................... 222Hutzler, M. ............................ 223Huy, N. T. ......................... 117, 133Huyck, S. ................................140Huysentruyt, C. J. ....................124Hwang, J. C. ...........................130Hwang, J. J. ........................... 246Hwang, S. W.............. 98, 175, 239Hwang, Y. J. ..................... 152, 251Hwangbo, Y. .......................... 226Hyams, J. S. .............................56Hyatt, B. .................................186Hyodo, I. .......................... 191-192

Horiuchi, H. ........................... 256Horiuchi, Y. ........................... 242Hörmannsperger, G. ...............134Hörndler, C. ...........................200Hornemann, T. ...................... 220Hornuss, D. ............................233Horta e Vale, A. M. .................218Horta, D. ........................ 139, 209Horvat, J. ........................ 184, 204Horvath, A. ...................... 101, 216Horváth, G.............................. 170Horváth, M. ............................ 179Hoshi, N. ........................ 203, 223Hoshino, S. ............................183Hosmer, A. .............................. 62Hosny, A. ................................ 118Hosoda, Y. ..............................128Hosoi, E. ................................140Hosokawa, T. .......................... 123Hosomi, E. ............................ 206Hosomi, S. .............................. 79Hosoya, A. ............................... 79Hoteya, S.................... 68, 152, 177Hotta, K. .....................51, 84, 128,

194, 242, 250Hou, J. ....................................52Hough, R................................156Houghton, L. .. 57, 71, 107, 146, 244Houlihan, D. ........................... 217Hourigan, L. ............................ 51Hourneaux Moura, E. G. ........ 230Hov, J. R. ...................... 57, 79, 90Hovdenak, N. ................. 156, 206Hovsepyan, M......................... 157Howarth, G. S. ....................... 204Hradecky, J. ........................... 256Hritz, I................................... 220Hruba, V. ............................... 238Hruz, P. ............................. 70, 86Hrycek, C. ...............................140Hsieh, P.-J. ............................. 118Hsieh, Y.-H. .............................82Hsu, C.-N. ..............................166Hsu, J.-T. ................................142Hsu, P.-I. .......................... 59, 166Hu, C.-T. ..................................82Hu, J.-W. ................................201Hu, M.......... 116, 122, 138, 179, 193,

202, 216, 236, 250, 253Hu, X. ....................................216Hu, Y. .........120, 125, 134, 145, 159,

193, 201, 231, 243Huan, Y. .............125, 134, 193, 201Huang, B. ...........................47, 80Huang, H................................ 191Huang, J. .................................52Huang, J. L. L. ........................ 242Huang, L. .........................59, 242Huang, M.-Y. ..........................193Huang, S.-Z. ...........................136

Hoffmann, M. ......................... 170Hofheinz, R. D. ........................92Hofmann, B. T. .......................221Hofmann, E. ........................... 118Hofmeister, A. ......................... 72Hofmeyer, M....................207, 225Hofstra, R. M. W. ....................192Högenauer, C. .................... 41, 61Hohenester, S. ......................... 91Hohwieler, M. .................. 93, 120Hoibian, S. .............................152Hoisschen, A. .........................165Hoivik, M................................237Hojo, M. ..........................174, 202Hokkinen, L. ............................85Hol, L. ....................................120Hold, G. ..........................185, 233Holleman, F. ........................... 173Hollenstein, M. ........................40Holler, B. ................................. 61Holleran, G.............. 205, 231, 255Hollerbach, S. ....................... 255Holloway, R. ...........................247Holmes, E. ..........70, 134, 185, 233Holota, Y. ........................ 134, 184Holster, S. ........................ 56, 103Holt, B. A. ..............................103Holtmann, G. ..................204, 246Holtmann, G. J. .......................247Holvoet, T. ...............................96Homan, M. .............................. 79Homann, N. ............................92Hombrados, M. ......................227Hombu, T. .............................. 177Homma, K. ............................. 177Hommes, D. .................... 80, 238Homolya, L. ............................192Hompes, R. .............................82Honda, K. .......................... 71, 122Honda, Y. ............................... 114Hong, J.-B. ............................. 115Hong, S. J. ...............246, 249, 253Hong, S. N............ 70, 85, 193-194Hongo, H. ...............................140Honing, J. ................................ 76Honjo, M. .............................. 222Honsova, E. ........................... 250Hontoria Bautista, G. .............. 139Hoorn, E. J. .............................48Hopps, R. ...............................125Hordonneau, C. ................ 83, 186Horeanga, B. C. ..................... 208Horhat, A. ........................64, 166Hori, K. ...............95, 177, 201, 250Hori, S. ........................... 120, 251Horibe, M. .................120-121, 220Horiguchi, N. .......................... 123Horikawa, Y. ........................... 132Horiki, N. .................. 122, 172, 181Horimatsu, T..................... 51, 144

Hinterberger, A..........175, 227-228Hiraga, Y. ................................ 53Hirai, H. W. ............................. 63Hirai, S............................ 168, 191Hirai, Y. ................................... 53Hirano, N. ..............................122Hirano, S. .........................131, 182Hirao, M. ................................ 151Hiraoka, S. ............................ 203Hirasawa, K. ............................96Hirata, N. ............................... 174Hirata, Y. .................. 122, 144, 182Hirayama, K. ..............117, 133, 231Hirayama, M. .........................231Hirayama, T. ............................171Hirono, S. ...............................122Hirooka, Y. ....................... 136-137Hirose, K. ............................... 123Hirose, M. .............................. 191Hirose, S. ...............................126Hiroshima, Y. .......................... 191Hirotani, A. ............................169Hiroyasu, T. .................... 124, 252Hirschmann, S. ................... 61, 79Hirth, S. ................................. 170Hisa, T. ................61, 125, 128, 131,

176, 193-194, 243Hisabe, T. ...............................125Hisada, H. ..............................169Hisamatsu, T. .......................... 61Hisayuki, T. ...128, 131, 193-194, 243Histace, A. ....................... 128, 181Hiwa, S. ......................... 124, 252Hiyama, T. .............................. 151Hjelle, A. M. .......................... 204Hjortswang, H. .......................189Hlavaty, T. ............................. 236Ho, A.-S. .........................242-243Ho, J. ...... 48, 52, 76, 142, 147, 184,

204, 207, 246-247, 249, 253Ho, K. T. .................................142Ho, R. ................58, 102, 114, 125,

156, 164, 167, 171, 196, 247Ho, S. .................39, 47, 56, 61-62,

68, 74, 79, 91-92, 95, 114, 120, 125, 136, 152, 177, 183,

196, 202, 204-205, 241, 245, 251, 255

Hoa, P. T. L. .............................117Hoad, C. L. .............................148Hobson, A. R. .........................196Hochberger, J. .......... 147, 207, 225Hodgson, D. C. ........................50Hoeffel, C. ..............................186Hoefnagel, S.................... 92, 200Hoentjen, F. ............. 102, 235, 239Hoepffner, N. .......................... 137Hoesl, M. ............................... 137Hoff, G. .................................. 176Hoffman, A. .............................69

342


Ismaili, Z............177-178, 240, 255Isomoto, H. ......................58, 252Israeli, E. ................................69Itakura, J. ................................69itami, A. .................................218Ito, A. .....48, 55, 140, 191, 226, 236Ito, C. ......................................84Ito, G.................................. 96-97Ito, H. ........122, 126, 152, 203, 250Ito, J. ..................................... 203Ito, K. ........................128, 130, 179Ito, M. ........ 130, 191, 209, 236, 257Ito, R. .................. 93, 167, 177, 209Ito, S. ..................51, 119, 123, 128,

194, 242, 246, 250Ito, T. ............ 51, 53, 122, 169, 222Ito, Y. ........... 95, 123, 129, 171, 174,

180, 194, 204, 226, 253Itoh, F. .............................152, 191Itoh, H. ..................................126Itoh, Y. .......123, 174, 204, 226, 253Itoi, H. .................................. 203Itoi, T. ........................ 48, 55, 222Itokawa, Y. ................129, 171, 180Itonaga, M. ............................130Itonaga, S............................... 123Itskoviz, D. .............................. 151Ivanov, S. ............................... 119Ivascu, C. S. .....................168, 218Ivashkin, K. ............................ 115Ivashkin, V. ........145, 221, 248, 257Iven, J. ....................................65Iwabuchi, M. ............ 144, 192, 231Iwagami, H. ...........................126Iwai, N. ........................... 123, 174Iwai, T. ................................... 119Iwakiri, K. .... 82, 173, 178, 198, 236Iwakiri, R. ..... 77, 187, 193, 197, 234Iwama, H. ..................93, 167, 232Iwama, N. ............................. 258Iwamoto, H. ...........................130Iwamoto, S. .............................117Iwamura, S. ...........................152Iwamuro, M. ....................151, 175Iwao, Y. ........................... 138, 176Iwasaki, E. .............................120Iwasaki, T. ........................152-153Iwase, H. ................................128Iwashita, A. ...................... 58, 125Iwata, M. ........................ 123, 126Iwata, Y. ................................. 167Iwatate, M. .............................126Iwatsu, S. ................................ 93Iwatsubo, T. ............................85Iyer, K. .................................. 205Iyo, E. Y. .................................194Izbicki, J. R. .......... 46, 78, 150, 221Izquierdo Rubio, S. .............64-65Izumi, C. ................................ 123Izycka-Swieszewska, E. ...........218

Inserra, G. ................ 189, 238-239Invernizzi, P. ............................ 91Ioana, V................................. 224Iolascon, A. .............................64Ionita Radu, F. ........................237Iovanna, J. L. ........................... 57Iovino, P. ............................... 244Iozzi, D. ...................................65Ip, M. .....................................142Ippolito, A. ....................... 117, 167Iqbal, T...................................142Irandoost, P. .................... 119, 222Irani, S. S. ............................... 62Iriarte, R. ...............................159Iribarren, A. ........................... 115Irie, K. ....................................169Irvine, A. J. .............................237Irving, P. ........61, 89, 139, 156, 190Isajevs, S. ...............................251Isaji, S.................................... 172Isakov, V. ......................... 149, 156Isayama, H. ... 58, 95, 119, 144, 222Ishaq, S. ..............69, 123, 125, 127,

175-176, 182, 227Ishibashi, F. ............................. 97Ishibashi, R. ...........................182Ishida, F. .............. 46, 72, 98, 126,

128, 193-194, 243Ishida, H. ..................153, 191, 223Ishida, K.............126, 167, 180, 223Ishida, N. ...............................124Ishida, R. K. ...........................126Ishida, T. ......136-137, 194, 223, 251Ishida, Y. .........................124, 180Ishido, K. ..................51, 104, 200Ishigaki, K. ..............................95Ishigaki, T........................126, 194Ishigami, H. ........................... 176Ishiguro, S. ..................... 133, 182Ishihara, A. ............................153Ishihara, H. ............................125Ishihara, R. ................ 53, 85, 201Ishihara, S. ......................101, 238Ishii, A. .................................. 167Ishii, H. ..................................122Ishii, M. .................................. 76Ishii, N. .................................. 167Ishii, S. .......................... 222, 246Ishii, T. ...................................169Ishii, Y. ...................................134Ishikawa, E. ..................... 136-137Ishikawa, H. ................58, 84, 151Ishikawa, S..............................58Ishikawa, T. ...............123, 136-137,

174, 204, 253Ishimura, N. ........................... 101Ishiwatari, H. ...................51, 128,

194, 242, 250Ishiyama, A. ..................... 151, 174Ishiyama, S. ................... 209, 257

Iiritano, E. ...................... 180, 207Iishi, H. ................53, 85, 201, 251Iizuka, T. ...........................68, 177IJspeert, J. ...............................50IJzermans, J. N. M. ........... 93, 120,

169-170Ike, M. ..................... 172, 203, 241Ikebuchi, Y. ........................... 250Ikeda, F. .................................166Ikeda, G. ....................82, 173, 198Ikeda, M. ................................ 172Ikeda, N. ................................ 167Ikeda, Y. .................................152Ikematsu, H. .... 78, 84, 95, 177, 201Ikemiyagi, H. .................. 203, 241Ikeura, T. .................... 62, 120-121Ikezawa, K.............................. 191Ikram, M. A. ...................... 48, 85Ilana, B. ................................ 243Ilić, K. ....................................183Ilie, M. .......... 92, 96, 181, 229, 231Illés, D. ................................. 220Illiceto, M. T. ..........................190Iltanen, S. ............................. 254Imaeda, H. .............................126Imagawa, H. .............. 175-176, 182Imai, H. ...................... 119, 131, 181Imai, K. . 51, 84, 128, 194, 242, 250Imai, T. ..................................129Imaizumi, H. .......................... 119Imajo, K. ................................ 114Imamura, K. ............................69Imaoka, H. ............................. 172Imatani, A. ............................. 197Imed, B. M. ............................138Imeneo, M. ........................... 202Imeryüz, N. ........................... 256Imhann, F. ............................... 70Imondi, A. .............................. 119Imperatore, N. ... 64, 205, 235, 238Inada, M. ............................... 121Inadomi, J. .............................. 87Inamdar, S. ............................. 62Inatomi, O. ............... 126, 129, 137,

171, 180, 203Ince, C.................................... 123Inciuraite, R. ........................... 91Inderson, A. ............................85Inokuchi, T. ........................... 203Inokuma, T. ............................120Inomata, H. ........................... 256Inoshita, N. ............................ 177Inoue, A. ......................... 171, 246Inoue, H. .......... 46, 48, 75, 87, 95,

98, 122, 129, 172, 181-182, 224, 243, 250

Inoue, J. ................................ 203Inoue, M. ...............................124Inoue, T. ................................ 246Inserra, C. ............................. 239

Hyrdel, R. ..................69, 248-249Hyung, W. J. ...........................201

IIacob, R. A. ............................ 116Iacob, S. .....................116, 216-217Iacobellis, A. .................... 117, 167Iacomino, G............................ 133Iacopini, F. ...................... 127, 228Iacorte, D. ..............................190Iacovou, M. ............................103Iacucci, M. ....................... 142, 176Ian, G. ............................. 165, 181Ianiro, G. ....................74, 90, 103Iannone, A. .............. 150, 154, 166Iannuzzi, F. ..........177, 181-182, 220Ianosi, G. ...............................165Ianosi, S. ................................165Iaquinto, G. ............................ 133Iaquinto, S. ............................ 133Ibañez Beroiz, B. .................... 178Ibáñez, G. ..............................143Ibarrola Arevalo, P. ................ 207Ibarrola-de Andrés, C. ............ 127Iborra, M. .............................. 240Iboshi, Y. .........................194, 201Ibrahim, A. ............................ 207Ibrahim, I. ...............................85Ibrahim, I. M. ......................... 178Ibrahim, M. ............ 41, 70, 74, 88,

96, 163, 178Ibrahim, M. E. ........................136Ichikawa, H. ................... 124, 252Ichikawa, T. ........................... 204Ichimasa, K. ......... 46, 72, 98, 126,

128, 193-194, 243Ida, Y. ....................................130Ide, E. ....................................126Ido, A. ............................. 121, 186Ierardi, E. .................150, 154, 203Iezzi, R. ..................................218Igarashi, A. .................... 203, 241Igarashi, S. ...................... 118, 194Igaz, P. ........ 143, 159, 192-193, 243Iglesias, M. J. .........................144Iglesias Garcia, J. ................... 180Iglesias-Garcia, J. ......... 71-72, 220Iglesias-Flores, E. ...................186Ignatova, S. ........................... 238Ignazzi, A. .............................. 147Ihaddadene, F. .......................188Ihara, E. ..........................194, 201Ihara, H. .................................231Ihász, M. ............................... 220Iiboshi, T. .........................134, 191Iida, K. ..............................93, 167Iida, M. ...................................86Iijima, H. ................................ 167Iijima, K. ......................... 167, 198


343

Jussif, J. M. .............................. 79Jussila, A. .............................. 239Justin, A. .................................59Juzenas, S. ........................ 91, 116JY Sung, J. ...................63, 93, 152

KKabbani, T. .............................241Kabbash, I. ..............................117Kabrawala, M. ........................130Kaczka, A. ...............................171Kaczmarczyk, O. .................... 204Kaddache, N. ..........................188Kaddour, N. ............................129Kadenczki, O. ........................ 234Kadleckova, B. ................ 235, 238Kadota, T. .........................177, 201Kadungothayil, N. ...................135Kae, S.-H. ........................ 173, 219Kageyama-Yahara, N. ............ 205Kagramanova, A. ..............138-139Kahaleh, M............................ 223Kaimakliotis, I. .......... 96, 135, 185Kaino, S. .........................219, 222Kaise, M. ...........................82, 173Kaisler, M. .............................. 175Kaji, I. ....................................184Kajihara, T. .......................134, 191Kajor, M. ................................164Kakinoki, N.............................168Kaku, H. .................................251Kakugawa, Y. ..........................145Kakushima, N. ..................51, 128,

194, 242, 250Kalabic, J. .................. 101-102, 139Kalaitzakis, E. .........................122Kalambakas, A. ......................159Kalapala, R......... 148, 156, 170, 181Kalcenaua, A. .................235, 240Kaleta, C. ...............................138Kalish, S. ............................... 248Kaliyaperumal, A. ...................189Kaliyaperumal, K. .................. 208Kalkan, Ç. ....................... 144, 246Kalla, R. ................................ 236Kalmár, A. .......... 143, 192-193, 243Kalousios, S. .................. 206, 251Kalsi, D. S. ............................. 250Kalubovila, U. .........................135Kamada, K. .................... 123, 174,

204, 222, 253Kamada, N. ............................. 57Kamal, A. ....................... 208, 257Kamata, K. ............................. 181Kamata, N. ... 76, 79, 188, 200, 254Kambas, K. .............................134Kambayashi, H. ..................... 226Kamei, A. ...............................169Kamel, E. ................................117

Jing, S. ...................................145Jinga, M. .........................237, 254Jirapinyo, P. ............................103Jo, J. H. ...............122, 169-170, 172Jochum, W...............................52Joergensen, M. T. .....................99Joh, T. ....................................142Johanns, J. .............................. 47Johansson, M. ......................... 63Johansson, S.-E. .......................71Johnson, G. .....................225-226Johnson, S. ..............................49Johnson, S. J. ......................... 222Jokelainen, J. ......................... 239Jokelainen, K. .......................... 91Joly, F. .......................... 42, 87, 95Jonaitis, L. ...................77, 91, 104,

142, 146, 154Jones, B. ............................... 252Jones, M. P. P. .... 145, 155, 197, 204Jones, T. V. ......................102, 140Jonkers, D. M. ..........49, 55, 70-71,

74, 82, 187Jordán-Castro, A. ....................153Jørgensen, S. P. ......................155Jose, N. ........................73, 79, 161Josefsson, A............................149Joshi, D. .................................158Joshi, V. .................................. 123Jossan, N. ....................... 146, 245Josson, C. ................................ 79Jouret-Mourin, A. ...................102Jovani, M. .............................. 250Jovanovic, I..............................52Jover, R. ...............63, 84, 125-126,

128, 143, 245Joyce, S. A. .............................134Juanmartiñena, J. F. ................ 181Juárez, M. ..............................143Judge, C. ............................... 254Juhász, M. ............................. 234Juillerat, P. ..... 36, 55, 83, 234-235Juliá De Páramo, B. ....................... 186, 190, 240Julian Gómez, L. ..................... 137Jung, C. ........................... 147, 225Jung, D. H. .............................201Jung, G.................................... 63Jung, H. I................................201Jung, H.-Y. ..............................150Jung, J. H................................219Jung, K. W. ............................. 197Jung, M. K. ............................ 180Jung, Y. .......................... 150, 226Jung, Y. J. ............................... 139Jüngst, C. ...............................146Junquera, F. ............................241Junya, N. ......................... 130, 181Jürgensen, C. ......................... 255Jurgoš, L.................................125

Jayanna, M. .............................69Jayasekara, R. W. ....................135Jayasooriya, N. ............... 202, 239Jaziri, H. .................................168Jeen, Y. T. ................. 127, 132, 148,

152, 155, 203Jeevagan, A. .......................... 228Jegatheesvaran, P. ................. 250Jenkins, G................................86Jenkins, I. .............35, 82, 104, 162Jenne, D. E. ............................ 170Jentzsch, M....................... 89, 135Jeon, B.-S...............................219Jeon, S. R. ............................. 253Jeon, S. W. ..................... 201, 249Jeon, Y. J..........................158, 164Jeong, G. Y. ............................158Jeong, J. .................................169Jeong, M. ................................ 83Jeong, S. ...........................86, 119Jeong, S. H. ............................152Jeong, S. U. ............................159Jeppesen, P. B. ........103, 205, 256Jerie, M. ................................. 197Jeschek, P. ..............................227Jesinghaus, M. ...................... 248Jess, T. ........................36, 86, 101Jesse, L................................... 181Jessen, B. .............................. 239Jessen, P. ................................ 137Jewes, S. ................................125Ji, J.-S. ....................................96Ji, Z. ............ 152-153, 201-202, 251Jia, H. ......................................82Jia, L. .....................................247Jia, X. ...................70, 116, 172, 247Jian, C. ...................................201Jian, X. ............................. 70, 247Jiang, B. ..................................49Jiang, T. ................................... 72Jiang, W. ................... 114, 167, 216Jiang, X. .................................. 70JianYing, B. ............................ 173Jiao, C. ................................... 170Jie, Y. ..............................250-251Jimenez, A. ...................... 177-178Jimenez, M. ........................97, 99Jimenez-Agüero, R. .................117Jimenez-Gamiz, M. P. ..............171Jimenez-Garcia, V. A. .........78, 178Jimenez-Moleon, J. J. ..............143Jimenez-Palacios, M. ...............99Jiménez-Rosales, R...........121, 197Jimeno-Ayllón, C. .................. 253Jin, H. ............................ 130, 258Jin, S. ........................ 99, 145, 201Jin, Y. ..................................... 173Jin, Z. .................153, 201-202, 251Jinca, C. ................................ 104Jindal, S. .................................99

Izzo, F. .................................... 119Izzo, R. ...................................143

JJacenik, D. ..............................143Jacinto, F. .............................. 208Jackson, A. ............................. 123Jacob, H. .................................69Jacobson, B. C. ...................... 250Jacobstein, D. .................... 47, 141Jacques, J. .....53, 100, 177-178, 232Jacquin, E. ............................. 234Jaenisch, S. .................... 150, 204Jäger, E. ..................................92Jäghult, S. ..............................189Jahnsen, J. ............................. 236Jain, A. ............................ 187, 237Jair Morales, V. ...................... 180Jairath, V. .............................. 246Jakobsson, S. .......................... 176Jakštaite, A. ............................221Jalanka, J................................241James, A. ................................ 61James, E. ............................... 202James, T. ................................102Jamoul, C. ............................... 47Jang, B. I. .............................. 253Jang, D. K. .............................. 121Jang, H. J. ........................ 173, 219Jang, H. S. ..............................159Jang, M. S. ............................. 127Jang, M.-J. .............................. 119Jang, S. .............. 127, 159, 181, 246Jang, S. B. ..............................195Janhsen, K. S. ........................ 242Jankipersadsing, S. .................. 70Janmaat, V. T. .........................150Jansen, I. ......................76, 87, 231Jansen, J. M. .................... 102, 141Jansen, M. ...... 76, 87, 102, 141, 150Janssen, H. L. A. ......................48Janus, C. P. .............................192Jao-yiu Sung, J. ......................143Jaquez, O. ............................... 83Jaquotot Herranz, M. ..............188Jaramillo, C. A. ........................49Jarbøl, D. E. ........................... 250Jardak, S. ................. 133, 168, 183Jarmakiewicz, S. .................... 235Jarmin, R. .......................120, 158Jarmuz, A. ..............................143Jarocka-Cyrta, E. .............. 157, 255Jarry, A.-C. .............................156Jasinska, M. ............................ 137Jasmins, L. .....................208, 245Jauch-Lembach, J. ..................140Jawaid, S. .............................. 230Jawhari, A. .............................142Jaworek, J. M. .........................120

344


Keszthelyi, D. .............. 71, 90, 124, 149, 196

Keum, B. .................. 127, 132, 148, 152, 155, 203

Keung, C. ............................... 123Kevans, D. ..............................138Keyvan, H. ............................. 234Kezzoula, D. .................... 158-159Kf Tsoi, K. ................................ 63Khaiboullina, S. ..................... 234Khalid, J. M. ..................... 61, 239Khalid, M. J. ..............141, 188-189Khalif, I. ................................. 187Khalifa, N. A. ..........................218Khalikulov, K. G. .....................183Khaloian Sarnaghi, S. .............134Khamaysi, I. ........................... 179Khan, H. ................................ 207Khan, I. ..................................135Khan, N. .................................102Khan, S. .................................189Khanna, M. ............................216Khanna, T. ..............................216Khannoussi, W. .........158, 177-178,

240, 255Kharrasse, G. .............158, 177-178,

240, 255Kharrat, J. .......................228-229Khashab, M. A. ................. 62, 99,

102-103, 181Khater, S. .............................. 229Kheder, J. ....................... 186, 254Khodeir, S. ............................. 115Khomeriki, S. .........................155Khorovodov, A. .......................153Khorsi-Cauet, H. .................... 204Khouitar, S. ............................188Khullar, V. .............................. 151Khusnutdinova, D. R. ............... 77Kida, M. .......................... 119, 124Kieć-Kononowicz, K. ...............134Kiefte-de Jong, J. C. ........... 48, 85Kiela, P. ...........................235-236Kierkus, J. .............................. 240Kieslichova, E. ........................148Kiesslich, R....................... 69, 176Kievit, L. .................... 96, 135, 185Kievit, W. .............. 71, 76, 165, 256Kiguchi, Y. ............................. 225Kikkawa, M. ...........................144Kikuchi, D. ...............................68Kikuchi, E. .............................. 167Kikuchi, H. ............................. 119Kikuste, I. ........................ 173, 251Kim, B. .............................96, 245Kim, B. G. ............................. 202Kim, C. D. ................. 127, 132, 148,

152, 155, 203Kim, D. B. ................................96Kim, D. S. ............................... 133

Kawagoe, T. ................82, 173, 198Kawaguchi, K. .........................58Kawaguchi, T. .......................... 76Kawaguchi, Y. ............ 119, 172, 215Kawaguti, F. ......194, 201, 231, 258Kawahara, T. .......................... 114Kawahara, Y. ....................151, 175Kawahira, H. ..........................124Kawai, M. ................................ 97Kawaji, Y. ............................... 181Kawakami, K. ................... 84, 126Kawakami, T. .............129, 171, 180Kawakubo, H. ............82, 174, 183,

223, 232, 251Kawakubo, K. ................... 131, 172Kawamoto, A. .......................... 97Kawamoto, H. .................. 99, 122Kawamura, T. .................. 123, 126Kawano, S. .......................151, 175Kawara, F. ................194, 223, 251Kawasaki, S. .......................... 222Kawasaki, Y. ........................... 147Kawashima, H. ................. 136-137Kawashima, K. ................101, 238Kawashima, R. ...................... 204Kawata, N. ................ 51, 128, 152,

194, 242, 250Kawauchi, J. ............................89Kawauchi, K. .......................... 123Kawesha, A. ........................... 127Kaya Özdinç, S. ...................... 236Kaye, P. ..................................135Kayhan, C. .............................. 141Kazanov, D. .....................242-243Kazim, S. N. ...........................219Kchir, H. .......................... 133, 183Kecili, L. ..........................185, 188Kederys, A. ............................. 115Keelly, S. ............................... 204Keely, S. .................. 155, 184, 204Keil, C. ...................................126Keip, B. ................................. 240Keku, T. ................................... 78Kelber, O. ................. 150, 195, 247Keller, J. ...... 37, 39, 59, 67, 80, 196Keller, J. J. ........................84, 196Këlliçi, I. .................................149Kelly, C. ........................... 141, 241Kelly, M. ................................ 254Kelsell, D. ...............................148Kempski, J. .............................150Kennedy, M. ...........................138Kennedy, S. ........................... 243Kent, T. .................................... 93Kermarrec, L...................... 89, 92Keshav, S. ....................... 140, 235Keshavarz, H. ..........................50Kessoku, T. ............................. 114Kestens, C. .............................. 76Keswani, R. ............................ 179

Karnebeek, K. ......................... 170Karpus, O. N. ...........................92Karsenti, D. ............... 50, 176, 222Karst, U. .................................215Karstens, K.-F. .................. 78, 150Karstensen, J. G. ........ 69, 122, 239Kartalis, N. .............................120Karunadasa, E. ....................... 127Karunaratne, T. M. P. B. ...........92Kasahara, K. ............................117Kaser, A. ............46-47, 70, 90-91,

105, 211, 213Kaser, L. .................................214Kashab, M. ............................. 101Kashida, H................. 89, 126, 152Kashin, S. .........................173, 231Kashyap, P. ....................... 57, 206Kasianov, A. ...........................184Kasper, S. .......................... 86, 92Kasprzyk, J. ............................233Kassis, G. ...............................216Kasthuriratna, A. ....................164Kasti, A. ................................ 206Katada, C. ...........51, 104, 151, 200Katada, K. ............... 123, 204, 253Katai, H. ..................................89Katano, T. ...............................142Kataoka, H. ............................142Kataoka, S. ................ 98, 126, 243Kataoka, Y. ........................96, 151Katicic, M. .........................77, 104Kato, D. ................................. 209Kato, H. ........ 65, 122, 134, 168, 219Kato, K. ............................ 89, 134Kato, M. ................51, 82, 85, 123,

126, 128, 151-152, 173Kato, N. .................... 124, 164, 176Kato, S. ............................131, 153Kato, T. ................................... 114Kato, Y. ............................ 132, 153Katrich, A. .............................. 118Katsanos, K. H. ................. 96, 135Katsoula, A. .............................49Katsuki, S. ............................. 226Katsuno, T. .............................124Katsurahara, M. ......... 122, 172, 181Katsushima, S. ........................117Katsuyama, Y. .................. 123, 169Katutishi, T. ............................ 191Katutoshi, T. .......................... 236Katz, L. H................................227Kaufmanis, A. .........................194Kaufmann, B. .........................168Kaukinen, K. ...........39, 61, 94, 99,

204, 253-254Kaul, V. ................................... 62Kaur, P. ..................................189Kausilia Krishnadath, K. ..........150Kautiainen, H. ......................... 91Kawachi, H. ............................124

Kamilova, O. T. ....................... 157Kamiński, A. ...........................195Kaminski, M. F. ............48, 68, 89,

98, 143, 245Kamitsuma, C. ................ 203, 241Kamiya, M. ............................ 252Kamiya, S. .............................. 132Kamiyama, N. ...................115, 134Kamoshida, T..........................168Kamperidis, N. ................ 131, 226Kanai, T. .....................61, 120, 138Kanao, H. ......................... 53, 144Kanazawa, K. .................. 118, 194Kanazawa, R. ........................ 222Kanda, T. ..........................58, 252Kandel, P. ..............76, 93, 127, 129Kandiah, K. .... 53, 72, 99, 125, 225Kandler, J. ..................... 67, 73, 81Kane, J. S. ..............................237Kanekiyo, S. ............................86Kaneko, M. ....................... 69, 192Kaneko, T. ................. 119, 169, 191Kanemitsu, Y. .........................198Kanesaka, T. .................53, 58, 85Kaneshiro, M. ................. 203, 241Kaneto, M. ..................... 209, 257Kang, B. ..................................56Kang, C. D. .............................184Kang, D. H. ......... 123, 126, 131, 152Kang, H. ............. 123, 126, 152, 179Kang, J. ..................................169Kang, J. K. ........................132, 175Kang, J. W. .........102, 121, 130, 188Kang, M. ........................ 169, 220Kang, M. K. ........................... 253Kang, N. .................................168Kang, W. .............91, 102, 121, 130,

143, 147, 188, 202Kang, Y. .................... 168-169, 253Kanis, S. ........................... 83, 102Kanmura, S. .................... 121, 186Kanno, T. ......................... 156, 197Kanno, Y. ...................128, 130, 179Kanwar, B. ...................... 133, 140Kanzaki, H. .......................151, 175Kao, J. Y. ..................................54Kaplan, G. G. .......................... 176Kapsoritakis, A. N. ................. 245Kaptein, A. A. ........................ 238Karacimen, D. ........................ 254Karagiannis, D. .......................124Karakaya, F. .................... 144, 246Karasaki, H. ......................122, 172Karashima, T. ..........................69Karataş, H. Ö. ........................ 256Kariv, R. ...........................151, 178Karlén, P. ...............................189Karlsen, T. H. .......... 59, 68, 74, 86Karlsson, M. K. ...................... 236Karmiris, K. .............. 125, 140, 145


345

Koehler, P. ........................133, 174Koelink, P. J. ..................... 92, 184Koenigsmann, M. ....................92Koens, L. .......................... 89, 134Koga, F. ........................... 172, 215Kogevinas, M. .........................143Kogure, H. .........................95, 119Koh, D. H. ...............................219Koh, S.-J. ............................... 202Köhler, J. ............................... 207Köhn, N. .................................183Kohno, H. .................. 175-176, 182Kohoutova, D. .................. 138, 241Kohut, M. ...............................135Koike, K. ...............95-96, 119, 142,

151, 182, 205Koike, T. ...........................151, 197Koike, Y. .................................124Koivogui, A.............................194Koizumi, K. ............................. 172Koizumi, W. ............. 104, 119, 124,

200, 204Kojima, K. ....................... 142, 152Kojima, T. .................174, 201, 250Kojima, Y. ................................ 79Kok, N. ...................................231Koksal, A. R. .......................... 236Koksal, A. S. ........................... 132Kokuma, S. .............................140Kokuryu, H. ............................129Kokwara, F. ........................... 226Kolar, M. ............................... 238Kolber, M. ..............................125Koletzko, S. ................. 47, 53, 56,

61, 64, 83, 105Kolho, K.-L. ............................138Kolkman, J. J.......................... 255Kollar, M. ...........69, 224, 248-250Kollarik, M. ...............69, 248-249Koller, T. ................................ 236Kollmann, C. M...................... 225Koloski, N. .........155, 197, 204, 246Komai, Y. ................................129Komatsu, M. .......................... 250Komatsu, S. ..................... 133, 182Komaya, K. ...................... 133, 182Komeda, T. ..............................117Komeda, Y. ................ 89, 126, 152Komekado, H. ......................... 167Komisarenko, I. ...................... 101Komiya, Y. ..............................241Komori, H........................174, 202Komori, K. ....................... 133, 182Komori, S. .............................200Komuta, M. ............................102Kondo, H. ...............................231Kondo, M. ..............................142Kondo, Y. ...........................93, 197Kondrackiene, J. ..................... 115Kondziella, C. .........................221

Kiyota, R. ...............................153Kiyozumi, Y. ........................... 242Kıyak, A..................................215Klang, E. ................................ 137Klare, P. ...........................84, 224Klausen, P. .............................122Kleber, G. ...............................128Kleger, A. ............. 78, 93, 120, 193Kleibeuker, J. ...........................98Klein, A. ...........................175, 179Klein, W. ................................165Klenske, E. ............................. 127Klepp, P. .................................237Klepsch, V. ..............................89Klevebro, F. ............................ 132Kliček, R. ................................183Klimina, K. .............................184Klopocka, M. ......................... 240Kluger, A. K. ...........................148Klugmann, T. .......................... 137Klünder, B. ..............................48Kment, M. ............................. 224Knabe, M. ......................... 76, 96Knafelz, D. ..............................190Knight, D. ..........................57, 184Knights, D. .............................. 57Knittel, T. ...............................190Knoblich, L. ........................... 240Knoester, I. ...............................71Knowles, C. H. ....................59, 81Knudsen, J. D..........................221Knuth, A. K. R. .........................86Knyazev, O. ................ 138-139, 184Ko, C. ................. 62, 208, 221, 241Ko, J. H. ............................123, 131Ko, S. J. ............................115, 159Ko, Y.................79, 82, 87, 93, 118,

124, 126, 128-129, 149, 151-152, 173, 175, 193-194,

197-198, 241Kobayashi, K. ......................... 191Kobayashi, M.................... 69, 201Kobayashi, N. ......................... 151Kobayashi, S. ................... 191, 241Kobayashi, T. ........61, 76, 122, 134,

140, 170, 188, 201Kobyliak, N. ........101, 155, 168, 215Koch, A. D. .......... 76, 129, 173, 251Koch, A. K. ...............187, 190, 206Koch, J. M. ..............................145Koch, M. .......................... 145, 231Koch, R. .. 70, 103, 137, 171, 178, 187Koch, S. .....................95, 222, 234Kochhar, R...........103, 171, 178, 187Kocsis, A. ...............................159Kodaka, Y. ..................82, 173, 198Kodashima, S. ............96, 142, 151Kodetova, D. .......................... 250Kodisinghe, K. S. ....................135Kodo, M. ............................... 204

Kim, T. ..............102, 121, 130, 140, 152-153, 159, 167,

169, 179, 198Kim, T. H. ........................ 118, 224Kim, T. J. ................... 85, 152-153,

193-194, 198Kim, T.-N. .............................. 253Kim, W. .........123, 126-127, 131-132,

139, 148, 152, 168, 172, 194, 197, 202-203, 219, 245

Kim, Y. ............... 131, 146, 173, 177, 202, 252-253, 257

Kim, Y. H. ................................85Kim, Y. J. ...................146, 152, 177Kim, Y.-H. ................... 70, 193-194Kim, Y.-T. ............ 102, 121, 130, 169Kimura, A. ........................ 147, 174Kimura, G. .............................. 172Kimura, M. ......................136, 236Kimura, S. ..............................145Kimura, T. ................. 140, 167, 179Kimura, Y. .............................. 131Kindlova, D. ............................149King, A. .................................. 127King, N. ................................. 226King, T.....................................64Kinoshita, S. ............................ 53Kinoshita, T. .................... 133, 182Kinoshita, Y. ....................101, 238Kinugasa, H. .................... 154, 219Kioka, K. ................................ 147Kiparissi, F. ............................. 191Kipcak, S. ........................ 197, 199Kirchgatterer, A. ..................... 137Kirchgesner, J. ...................83, 101Kirita, K. .................................198Kirkøen, B. ............................. 176Kirov, A. .................................159Kirsanov, K. V. ........................158Kirsners, A. ............................ 173Kirsten, H. ...............................46Kishida, Y. .......................128, 194Kishine, K. ..............................145Kishiwada, M. ........................ 172Kita, R. ................................... 167Kitae, H. ................... 124, 174, 252Kitagataya, T. ......................... 203Kitagawa, Y. ..............82, 174, 183,

223, 232, 251Kitajima, M. ...........................145Kitamoto, S. ............................ 57Kitano, M. ....................... 130, 181Kitano, Y. ................................130Kitazume, Y. ....................136, 236Kitterer, H.-R. .........................128Kiudelis, G. ......... 91, 142, 146, 154Kiurski, S. ............................... 133Kivelä, L. ........................204, 253Kiyasov, A. P. ..........................164Kiyokawa, H. ..........................152

Kim, E. H. ............................... 174Kim, E. J. .......................... 127, 177Kim, E. R. ...................85, 193-194Kim, E. S. ................. 127, 132, 148,

152, 155, 203Kim, H............ 70, 85, 127, 131-132,

146, 148, 152, 155, 165, 174, 177, 181-182, 193-194,

201-203, 221, 224, 230, 252-253

Kim, H. G. ............................. 253Kim, H. J................................. 123Kim, H. K. ........................179, 246Kim, H. S. ..................139, 143, 192Kim, H. U. ..............................159Kim, H. W. ................. 123, 126, 131Kim, H. Y. ............................... 173Kim, H.-I. ...............................201Kim, H.-K. .......................219, 223Kim, J. ............ 47, 85, 123, 126-127,

131, 142, 145-146, 148, 152-153, 175, 177, 193-194,

198, 201, 226, 255Kim, J. H.................. 202, 252, 257Kim, J. H................... 146, 177, 199,

202, 252, 257Kim, J. J. ................... 148, 152-153,

193, 198, 255Kim, J. W. .......... 139, 197, 202, 245Kim, J.-H. ................ 130, 132, 182,

201, 256Kim, J.-O. .............................. 253Kim, J.-W. ........................168, 171Kim, K. ..........86, 98, 179, 195, 246Kim, K. H. .............................. 253Kim, K. O. ..................146, 177, 253Kim, K.-J. ................... 47, 142, 175Kim, M. C. ............................. 253Kim, M. K. ..............................195Kim, M. S. .............................. 197Kim, M.-H. .......................131, 221Kim, N. .................... 127, 130, 152,

192, 197, 251, 253Kim, N. K........................... 86, 98Kim, P. ...................................152Kim, S. ............... 127, 132-133, 139,

143, 148, 152, 155, 169, 203, 219

Kim, S. G. ....................... 150, 202Kim, S. H. ........... 85, 127, 132, 148,

152, 155, 165, 172, 193-194, 203

Kim, S. J. ..... 123, 126, 131, 146, 201Kim, S. T. .........................159, 224Kim, S.-H. .......................181, 230Kim, S.-I.................................184Kim, S.-J. .............................. 226Kim, S.-S. ...............................219Kim, S.-W. ..............................219Kim, S.-Y. ........................ 146, 177

346


Kurata, T. ...............................193Kurent, T. ................................ 79Kurien, R. T. .......................... 224Kurihara, M. ........................... 151Kurilovich, S. A. ......................144Kurilshikov, A. ......................... 70Kurimoto, A. ......................93, 167Kurlyak, N. .............................214Kurobe, T................................ 174Kuroda, H. .............................. 115Kuroda, M. .............................134Kurokami, T. .......................... 205Kurokawa, K. ..........................142Kuroki, K. ............................... 151Kurosaki, S. ............................142Kurppa, K. ................... 53, 56, 61,

204, 253-254Kurti, Z. .......................... 83, 136,

138, 238Kurumi, H. ..............................58Kusaka, T. ...............................129Kusano, C. .............................. 123Kusano, M. .............................198Kushiyama, Y. .........................144Kushnir, V. ............................... 62Kusters, J. ...............................103Kusuhara, M. ......................... 242Kusumoto, K. .............129, 171, 180Kusunose, H. .......................... 179Küttner Magalhães, R. ............210Kuvaev, R. .............................. 173Kuwabara, K. ........................... 97Kuwahara, T. ...........................171Kuwai, T. .................. 53, 128, 144,

175-176, 182Kuwaki, K. ............................. 203Kuwatani, M. .................... 131, 179Kuznetsova, D. ........................135Kuznietsova, H. ...................... 238Kverka, M. ..............................184Kvit, K. .............................214-215Kwak, D. H. ............................ 139Kwan, V. ................................. 175Kwiecien, S. ................... 104, 250Kwok, H. .........................191, 208Kwok, K. H. ........................... 208Kwon, B. J. .......................126, 131Kwon, H. C. ............................. 83Kwon, H. G. ........................... 202Kwon, H. N. ............................193Kwon, K. A. ..................... 146, 177Kwon, K. S. ........................... 246Kwon, M. ........................ 152, 251Kwon, R. ................................. 62Kwon, Y.-H. ............................201Kyaw, M. ................................142Kyo, R. ...................................144Kypraios, D. ...............62, 230, 243Kyriienko, D. .................... 101, 215Kyurkchiev, D. ......................... 217

Krzysiek-Maczka, G. .................85Krzystek-Korpacka, M..............184Ksenchyn, O. ..........................150Kssia, M. ................................183Ku, M.-K. ...............................166Ku, Y. ........................53, 144, 203Kuban, P. ................................149Kubo, A. .................................154Kubosawa, Y. ........................... 53Kubota, E. ..............................142Kucharzik, T. ............... 61, 135, 138Kudo, A. ................................. 176Kudo, M. ..............89, 131, 152, 181Kudo, S. ................... 128, 193, 243Kudo, S.-E. ............ 46, 72, 84, 98,

126, 131, 194Kudo, T. ............46, 72, 84, 98, 113,

126-128, 131, 151, 193-194, 203, 243

Kuehl, A. ............................... 239Kuehni, C. ............................. 248Kuetting, F. ............................ 242Kuga, R. .................................126Kühbacher, T. .......................... 61Kuhn-Sherlock, B. ...................90Kui, B. ................................... 220Kuijper, E. ........................ 83, 196Kuijvenhoven, J. .....................102Kuiper, J. ......... 79, 96-97, 107, 123,

135, 143, 192, 212Kuiper, T. ................................. 72Kuipers, E. J. ........ 79, 97, 107, 123,

143, 192, 212Kukla, M.................................164Kukulska, M. ......................... 240Kulatunge, S. ......................... 229Kulkarni, A. .........58, 122, 223-224Kullak-Ublick, G. A. ................233Kumar C, B. ........................... 224Kumar, A. ....................... 193, 250Kumar, D. ...............................185Kumar, L. ...............................126Kumar, S. .................. 135, 157, 181Kumarasena, R. S. ..................135Kumbhari, V. ........................... 62Kumon, H. ...............................65Kumta, N. ................................ 62Kunda, R. ......................... 62, 102Kundurzhiev, T. ...................... 236Kunihara, S. .......................... 254Kunihiro, M. ..................... 53, 144Kuno, R. .................................. 97Kuno, T. ............................ 136-137Kunst, C. ......................... 116, 214Kuo, C.-J.................................142Kupcinskas, J. .... 77-78, 91, 115-116,

140, 142, 146, 154Kupcinskas, L. ....... 77, 91, 96, 104,

115, 135, 142, 146, 154, 185

Kovács, Á. ............................. 234Kovács, G. ............................. 220Kovacs, P. ................................46Kovalskaya, I. ........................ 220Kowalski, G. ...........................164Kowalski, T. ............................. 62Kozak, O. .........................218, 236Kozakai, F. .............................. 179Kozawa, N. ..................... 203, 241Kozelj, M. ................................ 79Kraft, K. ..................................247Kraja, B. .................................149Kraja, F. ..................................149Krajciova, J. .............. 148, 174, 197,

224, 249-250Krajcovicova, A. ..................... 236Krajewska, J. B. ......................135Krajewska, W. M. ....................143Král, J. .............................143, 220Kramer, L. .............................. 132Kranenburg, P. ...................... 235Kranke, P. ....................... 126, 245Krarup, A. L. ...........................199Krasnov, T. .............................. 151Krati, K. ................................. 253Kräuchi, S. ............................. 187Kraus, T. W. .............................92Kravchuk, Y. ............................ 115Krawczyk, M. ..........................146Kraynova, E. ........................... 173Krdzalic, J. ...............................50Kreijne, J. E. .......................... 236Kreisel, W. .............................. 114Krenács, T. .............................192Kressel, J. ...............................196Krishnadath, K. K. ............. 89, 92,

150, 200Krishnan, E. ...........................189Krishnan, K. ............................ 62Kristof, T. .......................... 83, 136Krivokapic, Z. ......................... 133Kroeger, A. .............................102Kroener, P. T. .............. 52, 71, 103,

153, 216, 219Kroep, S. ................................. 87Kröger, S. .......................204, 253Krogh, K. ................................155Kröll, D.................................. 234Kronborg, C. ...........................154Krones, E. ..............................216Kroupa, R. ..............................251Kruchinin, V. N. ......................144Kruchinina, M. V. ....................144Krug, S. ................................. 222Krüger, S. .............................. 206Kruimel, J. ........... 71, 124, 149, 196Kruis, W. ................................ 137Krumina, A. ....................235, 240Krupa-Kozak, U. .............. 157, 255Krylov, N. ...............................183

Konecny, M.............................237Konecny, S. ...................... 149, 251Kong, C. Y. ............................... 87Kong, S. .................................182Kong, S. C. ............................ 208Kongala Liyanage, I. .............. 229König, J. ........................... 56, 103König, K. ................................ 132Konijeti, G. G. .........................140Konikoff, F. ............................ 242Koning, F. ................................94Konishi, H. ............... 123, 174, 253Konishi, K. .............................. 151Kono, S. ................................ 250Kono, T. ...................................84Kono, Y. ........................... 149, 175Konoplyannikov, A. ...........138-139Konovalova, M. .......................149Konradsson, M. .....................200Konstantakis, C. ......................241Konstantinov, S. R. ................... 79Koo, H. ...................................169Koo, M. ............................. 52, 82Koornstra, J. J. .........................98Kooyker, A. ........................41, 192Kopáčová, M. ..........................251Kopczynska, M. .......................125Kopp, H.-G. .............................92Kopylov, U. ................. 72, 131, 137,

140, 190, 227, 230Korablina, N. .......................... 133Kordek, R. ....................... 134, 143Kore-eda, N............................182Korenkova, V. .........................143Kormilitzin, A. ....................... 235Kornienko, E. .......................... 157Kornouchova, L. ...................... 115Korona-Glowniak, I. .............. 235Korostelev, D. ......................... 119Korpela, T. ...............................59Korponai, G. ...........................138Korponay-Szabo, I. R. ..............64Koshi, A. ................................ 178Koshita, S. .................128, 130, 179Koster, J. J................................92Kostovcik, M. .................. 184, 256Košuta, I. ................................257Kothari, S. ............................... 62Kotsafti, A. ......... 86, 141, 192, 200Kottmann, M. ......................... 217Koukias, N. ...................... 131, 248Kouklakis, G. ..........................134Koulaouzidis, A. .........72, 131, 227,

230, 237Kouno, H. .................. 175-176, 182Kouno, Y. ................................ 151Koutroubakis, I. ............... 185, 187Kouyama, Y. ..............128, 193-194Kovacevic, B. ..........................122Kovacheva-Slavova, M. ...........221


347

Lee, J. S. ...... 123, 126, 131, 222, 253Lee, J. Y. .................................201Lee, K. H. ............................... 172Lee, K. J. ........................... 171, 175Lee, K. L. ............................... 202Lee, K. M. ..................132, 175, 182Lee, K. T. ................................ 172Lee, K.-M. ...............................96Lee, M. S. .................. 62, 224, 227Lee, R. .................. 51, 69, 177, 188Lee, S. ................... 62,70, 122-123,

126-127, 131-133, 150, 152, 155, 169-170, 172,

188, 195, 201, 203, 221-222, 224, 227, 253

Lee, S. D. ..........................140-141Lee, S. H. ...... 98, 102, 121, 130, 169Lee, S. J. ....... 85, 139, 172, 184, 194Lee, S. K. ................... 131, 174, 221Lee, S. P. ........................ 202, 252Lee, S. S. ..........................131, 221Lee, S. U. ......................... 179, 219Lee, S.-D. ............................... 133Lee, S.-H. ....................... 239, 253Lee, S.-W.................................96Lee, S.-Y. ........................ 202, 252Lee, T. ....................... 169, 172, 175Lee, T. H. ...........179, 226, 229, 253Lee, W. J. ........................... 49, 80Lee, W.-J. .................. 49, 139, 206Lee, Y. ............... 86, 188, 201-202,

245, 252Lee, Y. C. .........................174, 249Lee, Y. J. .................................201Lee, Y. N. ................... 62, 179, 229Leeds, J. S. ............................ 222Leenhardt, R. .......................... 72Leffler, D. A. .......................... 204Lefor, A. K. ....................... 68, 130Legaki, E. ............................... 187Legastelois, S. ......................... 79Leggett, C. .............................. 173Legros, R. ......53, 100, 177-178, 232Lehman, G. ............................ 179Lehoczki, V. ............................159Lei, W.-Y. ......................... 148-149Lei, X. ...............................79, 174Leiba, R. ................................ 243Leibovici Wiseman, Y. ............. 151Leicester, R. ................ 81, 104, 211Leifeld, L. ............................... 137Leigh, K. .................................188Leitão, C. ........... 84, 128, 166, 180,

229, 256-257Leite, I. ...................................158Leite, S. ....................228, 235-236Leitl, A. ...................................59Leja, M. ............ 37, 62, 77, 91, 104,

154, 173, 193, 251Lejnieks, A. ....................235, 240

Lazarescu, M. ......................... 157Lazaro, A. ............................... 114Le, P.-H. .................................142Le, S. ................. 53, 62, 70-72, 79,

122-123, 125-133, 147, 150, 152, 155, 169-172, 177-178,

181, 194, 201, 203, 221-222, 224-225, 227-228, 230, 235-236, 247, 252-253

Le Baleur, Y. ....................130, 222Le Baut, G. .............................. 73Le Berre, C. .............. 136, 186, 195Le Beyec, J..............................156Le Gall, M...............................156Le Moine, O. ...........................126Le Nevé, B. ............................. 141Le Rhun, M...................... 121, 129Le Roux, S. ............................ 225Le Thuaut, A. .......................... 121Le-sidaner, A. ........................ 232Leach, Z. ................................156Leal, S. ....................... 71, 147, 252Leal-López, S. .................. 147, 252Leber, B. ......................... 101, 216Leblanc, S. ................. 53, 62, 127,

129-130, 177-178, 181, 228, 230, 247

Lebre, L. ................................. 217Lecca, G. P. ......................146, 239Lecomte, T. ....................... 93, 168Lee, C. .........................70, 80, 83,

174, 248-249Lee, C. S. ................................150Lee, D. H. ..... 86, 119, 133, 142-143,

152, 192, 199, 251Lee, D. S. ................................ 133Lee, E. ...............................86, 177Lee, E. Y. T. ............................. 175Lee, E.-J. ................................ 133Lee, H. .......... 86, 98, 102, 119, 121,

132-133, 142-143, 145, 152-153, 169, 172, 179, 192,

195, 198-199, 209, 226, 229, 239, 251, 253

Lee, H. H. ....................... 152, 209Lee, H. J. ................................201Lee, H. S. ........... 122, 127, 132, 148,

152, 155, 169-170, 172, 201, 203

Lee, H. W. ........................ 179, 229Lee, H.-M. ............................. 205Lee, J. .............49, 80, 83, 133, 139,

152, 171-172, 175, 184, 194, 201, 206, 219

Lee, J. B. ................................ 133Lee, J. C. ..................................80Lee, J. E. ................................. 172Lee, J. H. ......................... 145, 152Lee, J. K. .......................... 172, 219Lee, J. M. ..... 127, 132, 148, 152, 203

Landi, R. ............................... 252Landi, S. ...........150, 196, 199, 202,

247, 249, 255Landman, C. ............................ 41Landy, J. ................................. 127Lang, A. .................................140Lang, D. .......................... 138, 176Lang, S. .......................86, 97, 187,

190, 233-234Langella, P. ............................. 57Langerova, L. ..........................143Langhah, A. A. ....................... 167Langholz, E. .............. 96, 135, 185Langhorst, J. .............187, 190, 206Langner, C. ......67, 87, 107, 156, 193Lansdorp-Vogelaar, I. ........50, 87,

143, 151, 192Lanska, V. ...............................148Lanuti, P. ............................... 254Lanzlotti, V. ............................165Laoui, D. ................................. 79Lapenta, R. .............................194Lapidus, A. ....................... 131, 179Laquière, A. ...........................130Larabi, A. ................................ 57Laranjo, A. .......... 52, 177, 179, 224Laredo, V. .............................. 253Larena, J. A. .......................... 235Lariño Noia, J. ....... 71-72, 180, 220Larmour, K. .............................65Larrain, M. ............................ 239Larsen, N. ........................ 58, 156Larsen, T. ...............................156Larussa, T. ............................. 202LaRusso, N. .............................117Lasch, K. ................................. 61Laserna-Mendieta, E. J............134Lass, A. .............................71, 195Laterza, F........................ 236, 254Latif, A. ..................................199Lau, J. K. C. ............................164Lau, J. Y. ...................152, 207, 250Lau, K. S. ............................... 202Lauenstein, T. ......................... 187Laukens, D. .............................96Laukkarinen, J. ........................58Laumen, H. .............................46Laumeyer, T. ...........................135Laurberg, S. ............................40Laurendeau, C. ...................... 240Laurent, V. ............................. 235Lauria, A. ...............................189Laurila, K. ............................. 254Lavrinovica, E. ................235, 240Law, S. T. .......................... 138, 171Lawendy, N. ...............61, 102, 140Lawlor, R. .............................. 223Lazar, A. ..............114, 139, 217, 247Lazar, D. ................................ 224Lazarescu, A. ..........................247

L Laabidi, A. ............................ 240Laan, W. ..................................90Labalette, M. ......................... 238Labeeuw, E. ............................92Labenz, G. ............................. 249Labenz, J. .............................. 249Labiano, I. ............................... 91Lacerda, A. .............................. 87Lacerda, A. P. ..................... 47-48Lackermeier, R. M. ..................128Lackner, K. ................... 38, 75, 84Laclav, M. .............................. 222Lacna, J. .................................149Lacognata, C...........................231Lacour, J.-P. ............................140Lafon, C. .................................221Lafond, M. ..............................221Lafuente, I. .............................140Lage, G. ................................ 209Lage, J. ................77, 132, 224, 228Lage, P. ............................176, 178Lagergren, J. ...........46, 77, 87, 132Lagergren, P. .......................... 132Laghi, L. .................................146Lagin, L. .................................186Lago, P. ..............127, 139, 188, 224Lagoussis, P. ........................... 127Laharie, D. .................. 73, 75, 80,

139, 186, 188Lahat, A. .............. 78, 131, 137, 140Lahaye, M. ...................... 144, 231Lahcene, M............................ 253Lahmidi, M. A.........................218Lahner, E. ................. 124, 155, 199Lai, P. B. ................................. 114Lai, S. ................................... 202Lakatos, L. ..... 83, 96, 135-136, 138,

185, 220, 234, 238, 240Lakatos, P. L. . 83, 96, 135-136, 138,

185, 234, 238, 240Lakhtakia, S. ........................... 181Lakner, L. .............................. 240Lam, L. Y. K. ..................... 82, 142Lam, M. ...............50, 93, 144, 231Lam, T. W. J. .......................... 208Lam, T. Y. T. .............................82Lamacchia, C. .........................154Lamarsalle, L. ........................ 240Lamas-Díaz, M. J. ...................190Lamas, B. ................................ 57Lamberts, M. P. ......................169Lamboglia, F. ..........................190Lambrecht, G. ..........................55Lambregts, D. M. ....... 50, 144, 231LaMere, B. ............................. 133Lammert, F. ............................146Lamonaca, L. ......................... 244Lamy, V. ............................77, 104Lanas, A. .... 96, 135, 200, 245, 253

348


Liu, T.-T. .......................... 148-149Liu, W. ............................ 124, 129Liu, X. ....................................257Liu, X. J. .................................184Liu, Y. ..................52, 114, 167, 201,

223, 244, 257Liu, Y. L. ..... 48, 72-73, 115, 119, 133Liu, Z. .......................52, 201, 204Liu, Z.-Q. ................................124Lizhou, D. ...............................201LLach, J. .................................231Llamas, C. ..............................190Llanos-Muñoz, M. .................. 245Llaó, J. ...................................189Llibre, G. ................................241Llop, J. .................................... 91Llorca, J. .................................143Llort, G.................................... 63Lloyd, J. ..................................165Lo Pumo, S. ...................... 187, 191Loaiza-Bonilla, A. ................... 139Lobaton, T. .................97, 186, 239Lobjois, V. ..............................221Lobo Alvarez, B. ............... 57, 244Lobo, A. J. ..............................189Locher, C. ...............................185Lodyga, M. ............................ 240Loforte, M. .............................257Loftus Jr, E. V. ........61, 87, 101-102,

139-140, 239Logacheva, M. ........................184Logan-Ellis, H. ....................... 203Logan, R. P. H. ....................... 203Loguercio, C. .................. 165, 203Lohinszky, J. ...........................159Löhr, J.-M. ..............................120Lohse, A. W. .............. 91, 150, 229Lohse, M. ...............................214Loi, P. .................................... 207Lojo, S. .....................................71Lolli, E. .................................. 187Lollo, G. ............156, 219, 224, 244Lombardi, G. ..........................130Lombardo, V. ......................... 254Lomer, M. ...............................156Long, G. H. .............................190Long, Y. .................... 101-102, 244Longcroft-Wheaton, G. .....125, 225Łoniewski, I. ...........................237Lopes, A. ............................... 242Lopes, J. .................. 120, 122, 158,

173, 196, 225Lopes, S. ...... 116-117, 130, 138, 173,

188, 208-209, 218Lopetuso, L. R. ........................188Lopez, A. .................. 63, 170, 220,

235, 237Lopez, R. ..................181, 239, 246López-Barroso, L. .................. 246López-Cerón, M. .....................231

Lima, A. .................................102Limbach, V. ............................126Limbert, M. ............................145Limdi, J. ................................ 234Lin, C.-J. .................................142Lin, H.-C..................................59Lin, J. ........ 140, 142, 156, 204, 242Lin, J.-T. ............................ 77, 154Lin, K.-H. ................................59Lin, L. .........................66, 70, 143,

145-146, 150, 156, 194, 200, 215, 222, 242, 245

Lin, Q.-Y. ................................136Lin, R. S. ................................153Lin, T. H. .................................. 79Lin, Z. Q. ................................145Linardou, I. A. ....................... 245Linas, I. ................................... 70Lindblad, M. ................... 132, 200Lindgren, F. ............................120Lindgren, S. ............................140Lindig, U. ................................92Lindley, K. ...............................65Lindner, V. .............................. 173Lindsay, J. ......36, 86, 110, 140, 204Lindsay, R. J........................... 204Line, A. ..................................193Linedale, E. C. ................ 146, 245Ling, K. L. ...............................156Ling, L. X. ...............................145Linghu, E. .............................. 132Link, A. ........ 91, 116, 154, 156, 224Link, J. ...................................156Lior, G. .................................. 242Liou, J.-M. ......................... 77, 154Liparoti, R. ............................ 202Lipinski, S. ..............................89Lipnitsky, E. ............................183Lipták, P. ............................... 249Lira, A. ............................ 139, 241Lisboa, C. .............................. 208Lishchinskaya, A. ..............138-139Lisowski, Z. ............................. 79Lissner, D. ............................. 239Lissoos, T. ................................49Liszka, Ł. ................................164Lita, M. C................................ 217Litvin, A................................. 220Liu, B. ......................... 52, 71, 169Liu, C. .....................................52Liu, D. ....................... 93, 150, 251Liu, F. ......................................52Liu, H. ................................... 244Liu, J. .............................. 125, 153Liu, J.-Z. .................................201Liu, K. ................................... 104Liu, L. ...............48, 72-73, 115, 119,

124, 133, 173, 197-199, 216Liu, S. ....................................152Liu, T. ....................... 148-149, 166

Li, J. ............59, 123, 140, 142, 156, 201, 204, 234, 242, 245

Li, K. ..... 65, 124, 129, 138, 179, 188Li, K. K. ..................................138Li, L. .............48, 66, 70, 72-74, 79,

114-115, 119, 124, 133, 136, 143, 145-146, 150, 156, 166,

173-174, 194, 197-200, 215-216, 218, 222-223, 226, 229,

242, 245, 251-252Li, M. ................. 115, 117, 132, 145,

166-167, 170, 180, 200, 242Li, Q.-L. .................... 123-124, 143,

174, 223, 226Li, R. ................52, 59, 61, 112, 117,

126, 141, 168, 175, 184, 191, 201-202, 207, 209,

216, 218, 245, 257Li, S. ........... 38, 52, 59, 77, 89, 91,

93, 112, 114-115, 118, 132, 140-142, 146, 152-155, 172,

203, 208-209, 217, 221, 227LI, W. ................ 114, 124, 129, 132,

141, 177, 201-202Li, W. H. ................................ 208Li, X. ........79, 85, 118-119, 133, 143,

145, 166, 174, 202, 242Li, Y. .............. 52, 72, 114, 136, 182,

187, 201, 218, 257Li, Z. ................... 52, 79, 201, 204Li, Z. R. ..................................184Lian, J.-J. ................................201Liang, C.-M. ...........................166Liang, H. .................................49Liang, L. .................................251Liang, M. ........................ 166, 242Liang, P. S. ............................ 202Liautaud, A. ...........................194Libânio Monteiro, D. .............. 224Libanio, D.................124, 224, 227Liberal, R. ................. 68, 117, 168,

201, 209, 218Liberman, E. .......................... 243Librandi, M. ..................... 117, 167Licci, C. ................................. 203Liceni, T. ................................ 255Lichtenstein, G. R. ................... 61Lichtner, P. ..............................46Liddle, R. A. .................54, 68, 82Lidia, C. ................................. 224Lied, G. A. ........ 156, 195, 206, 246Lien, J. M............................... 180Liepniece-Karele, I..................251Liggi, M. ..................................52Lightdale, J. R. ................ 126, 245Ligresti, D. ........................ 99, 130Lim, A. G. ............................... 176Lim, D. N. F. ............................192Lim, K. H. .............................. 208Lim, S. G. ..................132, 175, 182

Lekatz, H. ......................... 57, 206Lemab, G. ..............................194Lembo, V. .............................. 206Lemma, M. ............................ 242Lemmens, V. ...........................192Lemmens, V. E. P. P. .......... 76, 182Lemmers, A. ...............96, 126, 197Lemos, D. ............................... 147Lenggenhager, D. .............102, 171Lenker, E. ................................89Lennon, R. .............................129Lenz Tolentino, L. H. ................... 194, 201, 258Lenze, F. .................................237Leodolter, A. .......................... 249León, F. ...................................56Leonardi, C. L. ........................140Leoncini, E. ............................122Leone, N. ............................... 119Lepage, P................................. 63Lepetit, H. ............................. 232Lepilliez, V. .......... 53, 151, 178, 229Leppkes, M. ............................ 170Lerang, F. ..........................77, 104Lerch, M. M. ........... 36-37, 60, 170Leroi, A. M. ............................198Leroyer, A. .........................76, 135Lesavre, N. ..............................95Lesina, M. ............................... 78Leško, M. ................................251Lešková, Z. ............................ 236Letamendi, G. ......................... 115Lethebe, B. C. ......................... 176Letrung, T. ..............................194Leue, C. ..................................196Leung, F. W....................... 82, 227Leung, W. K. ................46, 91, 202Leutenegger, M. ...................... 97Levartovsky, A........................ 230Levesque, B. G. ........................ 47Levhar, N. ..................137, 140, 190Levi, Z. .......................91, 151, 230Levink, I. ............................... 249Levit, R. .................................. 157Levy, M. ................................. 229Lévy, P. .............82, 98, 111, 171-172Lewerenz, B. ..........................158Lewis, J. D. .............................136Lewis, N. R. ...............80, 135, 202Lewis, S. ................................136Lewis, W. .......... 182-183, 196, 199,

232, 252, 256Ley, D. ....................................135Leykauf, S. ..............................128Li, B. ................52, 71, 79, 115, 184LI, C. ....... 47, 52, 59, 61, 72-73, 93,

170, 181, 203, 208, 217, 224Li, G. ....................52, 68, 132, 161,

164, 174-176, 204, 242, 252, 257


349

Machado, M. V. ...................... 217Macheiner, S. ..........................89Machlab, S. ............................241Macías, E. .............................. 181Macias-Ceja, D. ........ 134, 233-234Macias-Garcia, F. ................... 220Macinga, P. .............. 158, 184, 221Maciuca, R. ............................190Maconi, G. ........................ 77, 156Macor, D. ...............................165Macpherson, A. ......... 70, 234-235Macutkiewicz, C. .....................59Madacsy, L. ........................... 243Madacsy, T. ............................120Maddalo, G. ...................203, 249Madero, R. .............................194Madian, A. .............................136Madisch, A. .....................101, 249Madl, C. ................................. 132Madl, T. .................................. 101Maeda, S. ...............................169Maeda, Y. .................... 46, 72, 98,

126, 194, 243Maegawa, Y. .......................... 246Maehata, T. ..........82, 173-174, 225Maekawa, T. ............................58Maeng, J. H. ............................86Maeso-Sánchez, N. .................184Maestro Prada, I. .................... 167Maetani, I. .............................144Maev, I. ................................. 248Maezawa, K. ......................... 206Mafra, M. M. ..........................159Magalhães, J. .......... 166, 186, 191,

201, 216Magarotto, A. ..................130, 236Magaz Martínez, M. ............... 207Magee, C. ........................ 132, 247Maggi, U. ...............................130Maggiore, L. ............................89Magierowska, K. ............. 104, 250Magierowski, M. ............. 104, 250Magina, S.............................. 208Magnano, A. ...................238-239Magno Pereira, V. .... 173, 208, 245Magnoni, P. ........................... 230Magnusson, M. K. ................... 141Magrì, G. ............................... 238Magris, R. ....................... 153, 192Magro, F. ............96, 135, 138, 185,

187-188, 207-208Maguchi, H. .............. 122, 131, 172Mahadevan, U. .......................140Mahadik, M. R. ... 99, 223-224, 249Mahajan, H. ............................69Mahesh, V. V. ..........................99Maheshwari, P. .......................126Mahfouz, E. ........................... 229Mahiou, H. ......................185, 257Mahmmod, N. ........................102

Ma, G. .......... 55, 76, 78, 81, 91-92, 116-118, 120, 122, 125, 130,

138, 143-144, 154, 156, 159, 165, 168, 173, 177-178, 181, 183, 187,192-197, 201, 204,

206-210, 218,225-226, 228-229, 231, 238, 242-243, 249, 258

Ma, H. ............... 37, 43, 46, 51, 62, 66, 69, 76, 86, 91, 96,

103, 122, 128-129, 131, 145, 151-152, 157-158, 160, 162, 164,

167, 169, 172, 178, 181-182, 184-185, 190, 194, 197, 206,

208, 214, 216, 224, 229, 233, 239, 241, 248, 250, 257

Ma, J. .......56, 89, 91, 104, 117, 120, 125, 148, 156, 165-166, 170-171,

174, 184, 186, 191, 194, 197, 201, 216, 220, 224, 233-235, 240,

245, 247, 249-250, 257Ma, M. ............. 49-50, 52, 56, 62,

64-65, 71, 91, 102, 104, 107, 117-118, 121-122, 124, 132-134,

136-137, 144-146, 149, 152-153, 156, 159, 165, 167, 171, 175,

179-181, 184, 186-187, 189, 196, 203, 207-209, 216, 220, 222, 229, 232, 234-235, 237, 239,

241, 248-250, 254-255Ma, W. ............................ 114, 190Ma, Y. H. .......................... 76, 184Maa, J. F. ................................136Maamouri, N. .................. 133, 183Maas, M. ..........................50, 144Maaser, C. .........................61, 138Maass, L. S. ............................148Maayan, J.-D. ........... 181, 242-243Maaz, M. ................................216Mabe, K. ................................ 123Mabrouk, S. ........................... 123Macadon, B. ...........................237Macaluso, F. S. ................ 237-239Macaria, M. ........................... 220Macarri, G. .............................130Macarulla, T. ..................... 87, 211Macchi, V. .............................200Macchia, L. ..............................69Maccioni, F. ........................60, 73MacConell, L. .......................... 91MacDonald, G. ...................... 204Macedo, C. .............................219Macedo, G. ......... 116-118, 120, 122,

130, 138, 159, 165, 168, 173, 187, 195-196, 201, 207-210, 218, 231, 258

Macfarlane, B. ........................ 127MacGregor, E..........................216Mach, T. ................................ 204Machado, J. C. L. ........ 77, 84, 104,

106, 161

Lucas, C. .................................85Lucas, M. ............................... 123Lucci, L. ................................. 238Lucendo Villarin, A. J. ....... 67, 101,

149, 248Lucenicova, J. ........................ 238Lucero, J. A. ............................194Luciani, A. ...............................50Lucidi, C. ................................194Ludwiczek, O. ......................... 137Ludwig, K. ........................133, 174Ludwig, L. ........................ 84, 193Lué, A. ............................136, 245Luebeck, G. ............................. 87Lugtenburg, P. J. .....................192Lui, R. N. .........................142, 198Luís, R....................................158Luiza, B. ................................. 157Lukas, M. .............49, 80, 237-238Lukavetskyy, N. ....................... 151Luke, D. P. ..............................135Luketic, V................................. 91Lukosevicius, R. ....................... 91Lukosiene, J. I. .................. 78, 146Luley, K. B. ..............................92Lundell, L. .........................87, 132Lundin, K. E. A. .... 39, 56, 94, 204Luo, K. ................................... 141Luo, M. ................................. 252Luo, R. ................................... 172Lupo, M. ..........................96, 230Lupsor, M. .............................. 217Lupusoru, R. ............. 216-217, 224Luzius, A. ...............................135Luzón, L. ............................... 253Luzza, F. ................................ 202Lv, B. ............................... 145, 152Lyamina, S. ........................... 248Lydersen, S. .............................52Lynch, S. V. ............................. 133Lynchak, O. ............................ 238Lyons, P. A. ..............................80

MMa, C. ..........54, 57, 59-61, 68, 73,

78-80, 86, 92, 97, 106, 117, 132, 143-144, 156-157, 166-167,

170, 175, 180-181, 192, 194, 198, 201-202, 206, 208, 210, 213,

216, 220, 222, 230-232, 241, 246, 252, 258

Ma, D. ........67, 71, 74, 101, 116, 119, 122, 125, 134, 136, 138, 141, 146, 150, 152-153, 157, 165,

168-171, 176, 178, 181, 183, 190, 196, 198-199, 202-205, 210,

217-218, 220, 228-229, 233-234, 239-240, 242-243,

247-249, 252, 255

López-Díaz, J. ........................ 220Lopez Fernandez, A. ................ 63López García, O. N. ........... 65, 199Lopez Gomez, M. ....................227Lopez Insua, A. .......................237López Ramos, C. ..................... 137Lopez-Serrano, A. ............170, 220López Serrano, P. ................... 240Lopez-Siles, M. ................ 134, 184López Viedma, B. ....................153Loras Alaustrey, C. ................. 180Lord, R. ..................................237Loreau, J. ...............................135Loren, D. ................ 47, 55, 62, 172Lorén, V. ................................ 234Lorente Poyatos, R. .................185Lorenzo-Zúñiga García, V. ............................... 126, 136Lorenzo-Zúñiga, V. .................... 83, 136, 175-176Lorenzo, D. ............47, 55, 124, 172Lorenzon, G. ................... 189, 240Lores, T. .................................140Lorinczy, K. ............................. 179Loroño, A. ..............................140Loske, G. ................................183Loss, M. ................................ 225Losurdo, G................. 77, 150, 154,

203, 208Lottrup, C. ..............................199Lou, Q. .................................... 91Loubaris, K. .....................219, 253Loudova, P. .............................148Louis, E. ................. 47, 55, 87, 190Lounes, F. .............................. 253Loureiro, J. F. .......................... 127Loureiro, R. ............. 159, 209, 258Lourenço, L. .......................... 209Loustaud-Ratti, V. .................. 232Louvet, A. ...........................61, 84Lovas, S. ................................ 238Lovasz, B. D. ...............83, 136, 138Lovat, L. ................... 132, 225, 247Lövdahl, J. ...............................90Lovero, R. .............................. 208Low, W. .................................. 197Lowenberg, M. .................. 73, 141Lowerison, M. ........................ 176Loy, K. L. ................................156Lozano Escario, M. D.............. 180Lozano, E. ........................ 91, 240Lu, B. ......................... 92, 157, 199Lu, J. J. ...................................153Lu, L................84-85, 87, 130, 132,

193, 201, 238, 253Lu, M. ...................49, 64, 80, 96,

123, 168, 217, 230, 237-238, 252

Lu, W. .................................... 191Lubomierski, N. ......................231

350


Martin, C. ........54, 57, 78, 80, 194, 201, 231, 246, 258

Martín, E. ............. 71, 125, 137, 171, 186, 188

Martin, J. C. .............................80Martin, S. ................................ 67Martin, V. ...............................143Martín Arranz, M. D. ....... 190, 240Martín Dávila, F. .....................153Martin de Carpi, J. ...................56Martín-Arranz, E. ...................188Martín-Arranz, M. ........... 188-189Martín-Arriero, S. .....................71Martin-Cardona, A................. 180Martin-Martin, N. .................... 91Martin-Ruiz, M. ......................156Martineau, C. ......................... 139Martinek, J. ....... 125, 148, 174, 197,

220, 224, 249-250Martinez, C. ............................ 57Martinez, E. ................ 63-64, 241Martínez, E. ................71, 171, 186Martinez, F. ............................126Martínez, J. F. .........................143Martínez Alcalá, F. ...........194, 210Martinez de Castro, E............... 63Martínez Feito, A. ...................188Martínez Izquierdo, G. ............125Martínez Lapiedra, M............. 180Martínez Lozano, H. ............... 240Martinez Moreno, B. .............. 180Martínez- Alcalá, C. .........194, 210Martinez-Alcala García, A. ...............................194, 210Martínez-Alcala, F. J. .......194, 210Martínez-Andrés, B. .............. 228Martínez-Ares, D. ........... 125, 170,

178, 220Martinez-Bauer, E. .................241Martinez-Cara, J. G. ..........178, 197Martinez-Chamorro, A. ............171Martínez-García, A. ................143Martinez-Medina, M. ....... 134, 184Martínez-Moneo, E. ............71, 171Martinez-Vinson, C. ................ 191Martini, A. ............................. 114Martino, M. ......................180-181Martinotti, M. ........................ 180Martinova, E.......................... 234Martins, A. ..............................117Martins, B. D. C. .............194, 201,

231, 246, 258Martins, D. ............... 132, 207, 228Martins, J. ..............................257Martinucci, I. ..... 69, 198, 200, 249Martorano, M. ....................... 203Maruki, Y. ........................ 173, 198Marunchyn, N. .......................168Maruo, T. ........................ 167, 257Maruoka, D. .................... 124, 176

Marescaux, J. ...........................46Marginean, C. ........................ 157Marginean, C. O. .................... 157Marginean, M. O. ................... 157Marginean, O. ................. 104, 157Mari, L. .....................96, 150, 239Mariani, A. ..................... 222, 230Marín-Gabriel, J. C. .......... 127, 175Marín-Jiménez, I. ...........186, 189,

235, 240Marín, A. C. ............................. 97Marín, I. .............. 83, 126, 175-176,

186, 189, 235, 240Marin, J. J. ..........................91, 117Marin, L. ............................... 239Marinho, C. .............. 166, 216, 222Marinho, R. T. ........... 85, 167, 208Marini, M. ............................... 62Marino, M. .............................122Marino, R. ..............................156Mariños, H. ............................152Markaki, A. .............................59Markelova, M. I. ...................... 77Marker, D. ....................... 136, 138Markiewicz, L. H. .................... 157Markovic, V. ........................... 133Markus-de Kwaadsteniet, M. L. .................................185Markus, E. ........................192-193Marlicz, W. M. ........................237Marmol, C. .............................241Maroto Castellanos, M. .......64-65Marques Da Costa, P. ....................42, 85, 158, 178,

208-209, 258Marques, A. ...........................158Marques, I. .............. 145, 176, 180Marques, M. ............ 146, 159, 209Marques, S. C. ....................... 180Marques, T. .................... 145, 159,

180, 209-210Marra-López, C. ...............170, 220Marra, A. ...............................154Marra, M. .............................. 235Marreiros, A. ......................... 236Marren, A. .............................140Marseglia, G. L. ................ 65, 155Marshall, C............................ 230Marshall, D. .............................71Marshall, L. ............................189Marsiano, N. ........................... 97Márta, K. ......................... 153, 231Martayan, A. ......................... 226Marteau, P. ...........72, 75, 181, 186Martel, M. .............................. 137Martelossi, S. .........................135Martens, M. ...........................144Martí, D. ..................125, 170, 178,

190, 220, 239-240Martin, A. ........ 67, 91, 117, 171, 210

Manes, G. ................ 130, 156, 177, 225-226, 228

Manfredi, G. ...........................156Manfredi, G. F. ............. 64-65, 155Manfrin, E. ............................ 222Mangas, C. ................ 84, 128, 143Mangiafico, S. .........................96Mangialavoria, L. ....................130Mangiavillano, B. ............. 62, 96,

129, 228, 230Mangueira, C. L. P. .................184Manka, P. ............................... 217Mankodi, S. ............................149Mann, S. .................. 49, 205, 239Manne, S. ...............................49Manner, H. .............................. 76Manning, J. ............................136Mannisi, E. ............................ 226Manns, M. ............. 39, 46, 49, 54,

80, 90, 105Mannucci, A. ......................... 242Manolakis, A. .........................198Manor, U. ...............................190Manorahan, B. ................ 177, 225Mañosa, M. ............. 186, 234, 239Manousou, P. .........................165Mans, L. .................................210Mansell, P. .............................148Manta, R. ................. 96, 220, 230Manuc, M. .......................167, 208Manuchehri, A. ...................... 141Manvar, A................................ 62Manyé, J. ......................... 233-234Manz, M. .......................... 52, 153Manzano Santamaría, I. ..........125Manzano, M. ..........................153Mão de Ferro, S. ..............176, 178,

208, 252Mapiye, A. ..............................192Marabotto, E. ........... 69, 149, 199,

248-249Marasco, G. ............................. 78Marasco, R. ........................... 202Marcelino, P. ......................... 207Marchegiani, G. ......................183Marchesi, J. .....................184, 233Marchesini, C. ....................... 206Marchi, S. ................69, 198, 200,

206, 249Marchiori, C. ..............86, 141, 192Marchisio, M. ........................ 254Marciani, L. ............................148Marciniak, A. ............ 195-196, 245Marcon, N. E. ......................... 173Marcos-Pinto, R. ............. 210, 224Marcos, P. ................. 89, 179, 258Marcovici, T. .......................... 104Marczak-Karpina, B. ............... 137Mare, R. ........................... 217-218Marena, P. .............................. 133

Mahmoud, M. .................118, 254Mahoney, P.............................145Maia, L. ..............139, 175, 210, 257Maia, R. .................................257Maida, M. F. ..................... 93, 166Maier, C. ................................ 175Maiero, S. ....................... 153, 192Mainovskaya, O. .....................210Maio, R. .................................233Maiorano, G. ......................... 204Maire, F. ..................................171Maisterra, S............................196Majcher, B.................175, 227-228Majek, O. ................228, 242, 244Majima, A. .....................204, 253Majka, J. ............................... 104Major, G. ..................... 52, 71, 142Majumdar, D. .................. 119, 229Mak, J. .................................. 208Maki, K. ................................ 254Mäki, M. ............................... 254Mäkinen, M. J. .........................86Makino, Y. ..............................130Makins, R. ............................. 230Malachias, A. ............62, 230, 243Malagelada, C. ................. 92, 145Malagelada, J. R. ....................145Malagón, M. ...........................237Malamut, G. ....................154, 229Malanin, S. Y. .......................... 77Maldonado Pérez, B. ...... 139, 208Maldonado, E. R. ................... 220Malecka-Panas, E. .......... 134, 240Maléth, J. ...................120, 170-171Malfertheiner, P. ...........62, 91, 97,

106, 116, 154, 156, 224

Malhi, N. S. ..................... 159, 257Malhotra, S. ...........................216Maliar, A. ................................69Malickova, K. ......................... 238Malik, S. ......................... 103, 178Malina, J. .......................235, 240Maljaars, J. P. W. ....................190Mallant, R. .............................102Malm, A. ............................... 235Maluf-Filho, F. ................194, 201,

231, 246, 258Maluskova, J. ........... 224, 249-250Malvik, M. ...............................171Malyshev, I. ........................... 248Malyuga, V. ............................ 132Mamie, C. ...............................86Mamiya, T. ............................. 191Mancini, C. ............................ 202Mandai, M. .............................65Mandavdhare, H. S. ................159Mandelli, E. ............. 130, 225-226Mandolesi, D. ......................... 101Mandorfer, M. ...................51, 132


351

Mehmedović, A. .....................169Mehta, N. .............................. 252Mehta, S. ............................... 191Meiborg, M. ...........................128Meier, B. ................................. 53Meier, M. ................................ 93Meijer, B. ..................59, 192, 242Meijer, G. A. .................... 143, 192Meijer, S. L. ........................... 249Meindl, R. .............................. 178Meining, A. ......51, 54, 58, 64, 193Meira, T. .................................188Meireles, L. ............................158Meireles, L. C. ........................159Meirelles, L. ...........................221Meisner, S. ..............................92Mejia, L. K. ....................... 76, 129Mejuto-Fernández, R. ............ 220Mejuto, R. ....................... 187, 220Melcarne, L. ...........................241Melchior, C. A. ........................198Melhem, H. ............................184Melina, R. .............................. 133Melit, L. E............................... 157Mellor, K. ...............................183Mellor, S. ...............................192Melo, D. ................................ 209Melo, R. .................................159Meltzer, B. A. .........................149Melum, E. ...............................59Meluzinova, E. ........................ 197Mena, L. .................................186Menachem, M. ...................... 242Menchén Viso, L. ................... 240Mendall, M. ...........................185Mendes, M. ....................208, 258Mendes, S. ...............210, 219, 229Mendibil, L. ............................ 115Mendivil, E. J. ......................... 116Mendl, J. ................................158Mendolaro, M. ......... 189, 238-239Mendonça, E. Q. .............194, 201,

231, 258Menegaux, F. .......................... 181Menendez, F. .......................... 217Meng, J. ................................. 132Meng, M. L. ............................153Meng, Z. ................................ 174Menicucci, D. ......................... 206Mentzel, C. .............................126Mera, A. ................................. 187Merah, N. ...............................156Mercanoglu, B. ............ 46, 78, 221Merchan Gomez, B. ...........64-65,

198-199Meredith, C. .................... 119, 222Merfort, I. .............................. 114Merighi, A. .............................130Merigliano, S..........................247Merino, V. .............................. 139

Maynard, J. ............................247Mayumi, T. ....................... 120-121Maza, F. R. .............................186Mazilu, L. .........................115, 153Mazza, E. ................ 195, 242, 246Mazza, F. ................................ 101Mazza, S. .............................. 236Mazzaferro, V. ........................130Mazzarella, G. ........................ 133Mazzawi, T. .................... 195, 246Mazzella, G. ............................ 91Mazzone, G. .......................... 206Mazzuoli, S. ................... 189, 240Mc Nally, M. ...........................251Mcalindon, M. ................... 72, 131McBride, J. .............................190McCallum, R. W. ......................65McCarthy, J. ............................237McCartney, S. .................. 140, 191McCarville, J. ...........................56McClements, D. ......................188McCoy, A. ................................ 78McDonald, J. ..........................184McDonald, N. .........................231McDonald, S. A. C. .......... 150, 248Mcgalliard, R. ........................ 222McGee, A. .............................. 167McGinty, L. A. .........................148McGrath, J. S. ........................ 242McHenry, L. ............................ 179McKaig, B.......................125, 223,

225-226Mckenzie-Ballesteros, A......... 220McKenzie, Y. ....................... 47, 55McKevitt, M. ...........................140McKinney, E. F. ........................80McLain-Smith, S. ....................195McLaughlin, J. ........................195McLaughlin, S. .......................189McLeod, D. ..............................69McLindon, J. ...........................188McMahon, B. P. ......................199McNamara, D. .......... 126, 137-138,

140, 159, 205, 216, 231, 252-255

McNicholl, A. G. ................77, 104McQuaid, K. ........................... 176Mearín Manrique, F. ...........55, 74Mearin Manrique, M. L. ...........64Mearns, E. S. ......................... 204Medeiros, I. ......... 52, 177, 179, 224Medhat, E. ............................. 118Medhioub, M..........................227Medina, R. .............................186Meester, R. G. S. ......................50Megía Sánchez, M. .................148Megraud, F. .................. 37, 62, 77,

104, 106, 211Mehdi, K. ........................ 138, 168Mehl, B. .................................215

Matsudaira, S. ................ 126, 128, 193-194, 243

Matsueda, K. .................... 69, 146Matsueda, M. .........................154Matsui, H. ............................. 256Matsui, S. ......................... 89, 152Matsui, T. .................. 58, 125, 239Matsuka, L. ............................ 151Matsukawa, M. .......................122Matsukuma, S. ........................86Matsumae, T........................... 167Matsumoto, K. .......... 58, 174, 202,

219, 243Matsumoto, M. .......... 127, 145, 179Matsumoto, T. .................176, 254Matsumura, T. ................. 124, 176Matsunaga, T. .......................... 77Matsunaka, T. .........................154Matsunami, Y. ....................... 222Matsuo, Y. ........................152, 191Matsuoka, K. ....... 61, 136, 236, 251Matsushima, K. ..................... 252Matsushita, H.-O. .............98, 243Matsushita, M. ................. 136-137Matsuura, M...........................136Matsuura, N. ....................85, 201Matsuura, R. .................... 136-137Matsuzaka, M. ........................241Matsuzaki, I............................ 123Matsuzaki, J. ...........................89Mattar, O. M. .................... 117, 133Matteoli, G. ........................79, 92Matthes, K. ............................ 239Mattila, E. ..............................241Mattsson, F. ............................ 132Matuguma, S. E. .................... 230Matuo, H. ............................... 167Matusiewicz, M. .....................184Matysiak Budnik, T. ...... 37, 51, 82,

93, 107, 168, 211, 252

Maueröder, C. ........................ 170Maurano, A. ............................ 62Maurice, J...............................165Mauro, A. ..........149, 198, 248-249Mavroeidi, E. A. .............. 206, 251Mawe, G. B. ..................... 56, 110Mawe, G. M...................... 56, 110Maxim, R. ............................. 254Maximov, V. N. .......................122May, A. ........... 48, 60, 76, 88, 96,

104, 137, 146Mayanagi, S. ...................183, 223Mayberry, J. ............................129Maydeo, A. P. .........................150Maye, H. ............................... 248Mayer, A. ............................... 137Mayer, B. .............................. 232Mayerle, J. ......... 36-37, 76, 80, 170Mayhead, P............................ 228

Maruy Saito, A. ...................... 204Maruyama, H. ........................122Mary Beth, D. ......................... 141Marya, N. .............................. 230Marzio, L. ...............................140Marzioni, M. ... 68, 86, 91, 106, 117Masahiro, I. ............................ 181Masarone, M. .................. 165, 216Masci, E. ................................130Mascialino, B. ........................186Masciangelo, G. .............. 196, 249Masclee, A. A. M. ....... 49, 71, 124,

149, 187, 196, 248Maselli, M. A. ......................... 147Maselli, R. .........101, 219, 224, 244Masetti, C. ........................ 117, 167Maslova, G. ............................165Mason, A. J. ...........................156Masotto, A. ............................168Massault, P. P. ........................ 181Massella, A. .......................... 238Massidda, M....................156, 222Massironi, S. ......................... 223Masson, E. ..............................46Mastromarino, P. ....................146Mastromatteo, A. M. ...............146Mastromauro, M. ................... 208Masu, K.....................128, 130, 179Masucci, L. .............................103Masuda, A. ............................. 170Masuda, D. .............................122Masuda, M. ............................. 62Masuda, T. ............................ 258Masutti, F. ..............................165Masuy, I. .................................65Mata, A. .................................227Matallana, V. ......................... 240Matallanos, P. ........................227Matalon, S. .............................69Matas-Cobos, A. M. .......... 121, 171Matei, D. ............................... 246Mateus, E. ............................. 208Matheeuwsen, M. .................. 255Mathieu, N. .......................97, 135Mathiex-Fortunet, H. ..............145Mathonnet, M. ...................... 232Mathot, R. .............................. 141Mathou, N. .............................125Mathurin, F. ............................ 73Matono, T. ..............................164Matos, C. ........................... 53, 99Matos, D. ..................157, 183, 210Matoso, A. G. B. .....................159Matsubara, S. ....................95, 119Matsubara, T. ......................... 121Matsubayashi, H. .......51, 128, 194,

242, 250Matsuda, K. ......................128, 151Matsuda, M. ...........................152Matsuda, T. ...78, 84, 143, 145, 254

352


Mois, E....................................64Mokhtech, M. G. .................... 253Mokrowiecka, A. .....................134Moleiro, J. .............................. 176Molero, X. ............................. 222Molina, A. J. ............... 77, 104, 143Molina, C. .............................. 123Molina, G. ..............................237Molina Infante, J. ....67, 77, 99, 101,

104, 149, 248Molinari, A. ............................ 139Molinero García, M. ................125Møller, H. J. ............................ 101Molnár, A. ............................. 235Molnar, B. ... 143, 159, 192-193, 243Molnár, R. ..............................120Molnar, T. ................. 83, 136, 228,

234, 238, 240Molnár, T. ....................... 220, 229Mom, B. .................................237Momoi, T. ............................... 176Monast, C. ..............................188Mone, I. .................................149Mongelli, A. .......................... 208Monica, F. ..............................192Moniz, E. .................................117Mönkemüller, K. ............... 52, 194Montagnese, F. ...................... 228Montalban-Arques, A. ............. 97Montale, A. ............................129Monteiro, J. ........................... 258Monteiro, S. ...... 166, 186, 216, 236Monteleone, G............96, 143, 187Monteleone, M. ......................130Montesano, L. .........................64Montgomery, A.......................142Montgomery, S. ......................189Montironi, C. ......................... 222Moodie, S. J............................ 176Moon, J. H. ...............179, 229, 246Moon, J. R. ......................219, 229Moon, S. J. .............................195Mooney, L. ............................. 175Moons, L. M. G. .............. 192, 255Moor, M. .................................52Moore, J. ................................195Moors, G. ...............................189Mora, D. ......................... 156, 255Mora, F. ................................. 239Mora-Gutierrez, I..................... 97Morabito, G. ...........................135Morais, R. .................117, 138, 159,

195-196, 207, 218Moran, A. W. ...........................52Moran, C. ...................55, 134, 167Morando, F. ............................ 167Moraru, C. ............................... 73Moravkova, P. .................. 138, 241Morbey, A. ............................ 208Morbin, T. ............................. 223

Miutescu, B. ....................216, 224Miwa, H. ..........................84, 169Miyachi, H. ..................... 194, 243Miyahara, K. ...........................154Miyahara, R. ..................... 136-137Miyake, K. .............................. 173Miyamoto, S. .........51, 62, 128, 151Miyamoto, Y. .......................... 167Miyaoka, M. ............................58Miyasako, Y. .............. 175-176, 182Miyata, E. ............................... 119Miyata, T. ............................... 181Miyazaki, T. ........................... 254Miyoshi, H. .............................. 62Mizokami, Y. ........................... 191Mizoshita, T. ...........................142Mizrahi, J. ............................. 242Mizrahi, M...................69, 93, 251Mizukami, K. ................... 134, 172Mizukami, Y. .....................122, 172Mizumoto, T. .......................... 151Mizumoto, Y. .............129, 171, 180Mizuno, C. ..............................140Mizuno, K.-I. ..........................103Mizuno, M. ....................... 69, 146Mizuno, N. ..............................171Mizuno, S. .................. 95, 119, 138MIzusawa, J. ...........................251Mizushima, T. ....................53, 151Mizutamari, H. ....................... 132Mizutani, Y. ...................... 136-137Mlynarsky, L. ............155, 178, 209Mo, Y. .............69, 72, 84, 98, 126,

128, 131, 167, 177, 186, 193-194, 196, 203, 223,

243, 245, 251Moahammed, A. T. ................. 133Mocanu, I. ........... 52, 177, 179-180,

224, 230Mocciaro, F. ................97, 239-240Moccisro, F. ............................185Mocellin, S. ............................182Mochida, T. .................... 203, 241Mochizuki, K. .........................128Mochizuki, S. ...........................96Modderman, S. ......................102Modino, Y. ..............................186Moehler, M. .......................38, 63Moelker, A. ............................ 255Moenig, S. P. ...........................92Moga, T. .................................168Moga, T. V. .............................218Mohácsi, L............................. 229Mohamed, E. M. ..................... 133Mohamed, M.-E. F. ..................48Mohamed, Z...........................120Mohammed El Sayed Ahmed El Nakib, A. ............168Mohammed, N. ......................237Möhler, U. ............................. 254

Min, G. ..................... 127, 132, 148, 152, 173, 203

Min, M. ...... 194, 201, 222, 239, 251Minaga, K. ............................. 181Minagawa, T. ................... 124, 231Minahan, K. ................... 184, 204Minale, P. .............................. 249Minami, T. ........................122, 177Minamide, T. .......................... 177Minamiguchi, S. .....................144Minarik, M. .....................222, 251Minarikova, P......................... 242Minashi, K. ............................ 250Minata, M. ......................194, 201Mingrone, G. .......................... 173Minguez, M. .......................... 239Minisola, S. ............................138Ministro, P. ...............188, 207, 228Mion, F. ........................... 148, 197Miot-Noirault, E. ................... 242Miraglia, C. ....... 146, 196, 198-199,

202-203, 248-249, 252, 255

Miranda Bautista, J. ............... 240Miranda, A. .................... 189, 203Miranda, P. .............................. 97Mircea, P. A. ...........................165Miri, B. ..................................192Mirijello, A. ............................166Miro, E. ..................................194Mirones, L. .............................145Misawa, M. .......... 46, 72, 98, 126,

128, 131, 193-194, 243Miscia, S. .............................. 254Mishakina, N. Y.......................158Mishima, Y. ................ 71, 101, 238Misicka, A. .............................. 79Misra, R. ............. 70, 134, 233-234Missale, G. .............................168Missbichler, A. ........................196Misselwitz, B. ....................97, 233Mita, E. ..................................153Mitiche, A. ......................185, 257Mitobe, J. .................201, 252-253Mitoro, A. ...............................152Mitova, R. ..............................221Mitra, V. .......................... 119, 229Mitre, M. .................................58Mitrova, K. ............................ 238Mitsios, A. ..............................134Mitsui, K. ........................178, 236Mitsunaga, M. ..........201, 252-253Mitsunaga, S. ......................... 172Mitsunaga, Y. .......82, 173-174, 225Mitsuyama, K. ......................... 61Miura, H...........................122, 172Miura, K. ................................124Miura, R. ................... 175-176, 182Miura, T. ..........................134, 191Miura, Y. .................................68

Merlin, D. ................................ 70Merlo, J. .......................... 125, 178Mertens, J. ................. 61, 102, 127Merzlyakov, M. .......................135Mesana, L. .............................188Mescoli, C. ......................231, 234Mesenas, S. J. ........................ 208Messadeg, L. ........................... 83Messina, V. ................. 117, 119, 167Messmann, H. ............64, 82, 205Messner, B. ............................135Mestas, J. L. ............................221Metselaar, H. J. ........................48Metussin, A. .......................... 222Metz, D. C. .............................150Metzger, G. ............................. 118Meucci, G. ..................97, 156, 185Meurette, G. .......................... 234Meyer-Gerspach, A. C. ...... 52, 103Meyer, B. ...............................215Mezei, D. ................................195Miceli, E. .......................... 64, 155Michel, M.-L. ........................... 57Michetti, P. .................. 67, 75, 100Michida, T. .........................51, 53Michigami, Y. ..........................84Michl, P. ...........................46, 222Mickevicius, A. ...................... 220Micsik, T. ................................159Middendorf, J. ........................ 116Miehlke, S. .......... 67, 101, 140, 154Miehsler, W. ........................... 137Miele, E. ................................135Miele, L. ......................... 205, 218Mielnik, P. F. .......................... 204Mifsud, S. ................................89Miguel Esteban, J. ................. 180Miguel, I. ...............................145Mihaly, E. ...............................140Miheller, P. .........83, 136, 234-235,

238, 240Mikami, K. ..............................58Mikami, Y. .............................. 115Mikocka-Walus, A. ... 140, 146, 245Mikolasevic, I. .........................64Miksch, R. C. ......................... 232Mikus, P. ............................... 238Milani, V. ................................55Milano, A. ...................... 236, 254Milano, R. V. ........................... 76Milashka, M. .....................95, 113Milassin, Á. .............228, 238, 240Milella, M. ................. 117, 167, 172Milicic, B. ...............................165Millan, M. ........................ 81, 104Millastre-Bocos, J. ......71, 170, 220Miller, E. ................................ 178Milosavljevic, T. ..........77, 104, 165Mimori, N. ............................. 132Mimura, T. ..............................65


353

Muto, M. ..............51, 151, 250-251Muto, S. ................................. 179Mykhalchyshyn, G. ........... 101, 215Myshkin, E. ............................188Mytton, J. ................. 103, 170, 247Myung, S.-J. .....................98, 239Myung, Y. .............................. 225

NNa, H. .........51, 65, 85-86, 89, 98,

102, 110, 126, 132, 136, 138, 153, 169, 177, 185, 193-195,

203, 241, 243, 246-247Na, S.-Y. ..........................159, 224Nabers, D. ...............................52Nabi, Z. .............. 148, 156, 170, 181Nacak, T. ................................140Nachmany, I. ......................... 209Nachury, M. ..............80, 137, 186,

236, 238Nacima, D. .............................257Nada, R. .................................159Nadal, E. ................................130Nadatani, Y. ..................... 79, 254Nadezhin, A. .......................... 173Naessens, D. ..........................188Naftali, T. ...............................140Nagahama, T. ..........................58Nagahara, A. ............ 174, 198, 202Nagahori, M. ...................136, 236Nagai, T. ..................... 79, 89, 152Nagaishi, T. ............................. 79Nagamatu, S. ......................... 167Nagami, Y. ............... 79, 200, 254Nagano, H. ..............................86Naganuma, M. ..................61, 138Nagaoka, I..............................145Nagasaka, M. .................. 123, 144Nagase, H. .............................. 51Nagata, K. ..............................231Nagata, S. ................... 53, 69, 97,

142, 144Nagayasu, K. ..........................145Nageeb, A. ............................. 116Nägel, A. .......................... 55, 127Nagengast, F. M. ......................98Nagoshi, S............................. 206Nagpal, S. J. S. .......................257Nagtegaal, I. D. ........... 76, 82, 98,

219, 235Nagy, A. .............159, 192-193, 229Nagy, F. .....................83, 234, 238Nagy, G. .................................165Nagy, P. ................................. 229Nagy, Z. B. ............... 143, 193, 243Nahon-Uzan, K. ................ 50, 176Nahon, S. ...............................185Naidoo, A. ..............................126Naimi, S. ............................... 242

Mulder, C. J. J. .................. 59, 64, 123, 182, 196

Mullady, D. K. .........................145Müller, J. ................................247Müller, M. ................ 116, 214, 249Muller, N. ................................171Müller-Schilling, M.......... 116, 214Mullish, B. H. .........................165Müllner, K. ............................ 234Mumolo, M. G. ...................... 206Mun, Y. G. ..............................152Munakata, M. .................. 118, 194Muncan, V. ................ 92, 192, 242Münch, A. ................. 67, 140, 238Munch, M. R. ........................ 250Munck, L. K. ...........................140Mundet, L. .......................90, 149Munkholm, P. ............ 96, 135-136,

138, 185, 234Munoz, L. E. ........................... 170Munoz-Garrido, P. .......91, 117, 245Muñoz-Gómez, P. ...................153Muñoz-Jurado, G. ....................49Muñoz-Suano, A. ............. 56, 157Münster, T. .............................. 79Munsterman, I. .................165-167Munteanu, M. A. ....................165Mura, D. .................... 52, 123, 169Murabayashi, T. ...................... 179Murakami, B. .........................124Murakami, D. ............ 123, 147, 169Murakami, K. .................. 134, 147Murakami, M. ...................51, 124Murakami, S...........................124Murakami, T. ................... 124, 147Murasugi, S. .......................... 226Murata, A. ..............................198Murata, Y. .............................. 172Murcia, O. ..............................143Murillo, R. ....................... 173, 251Murino, A. ....................... 131, 148Murphy, I. ..............................138Murray, C. .............................. 191Murray, D. ...............................90Murray, J. A. ...........................149Murray, P. .............................. 252Murray, S. ............................. 250Murugananthan, A. ................125Musaico, D. ............................154Musaus, J. ...............................80Muscat, M. ..............................89Muserra, G. ........................... 239Musladin, S. ...........................183Musso, A. .............................. 228Mustafa, A. S. .........................135Mustafajev, I. F. ....................... 91Mustonen, H. .......................... 91Mutaguchi, M. ........................138Mutignani, M. ..........96, 130, 220,

229-230

Mosinska, P. ...........................156Möslein, G. ....................... 58, 82Mosli, M. ............................... 239Mosnier, J.-F. ...........................82Mosoni, C. ...................... 166, 256Mosquera, J. L. ...................... 244Moss, A. ........................... 177, 217Moss, A. C. ..............................56Moss, S. ................................ 252Mossad, Y. A. .......................... 217Mössner, J. .........................46, 61Mostafa, I. ...............................96Mostafa, W. A. E. ....................164Mostazo Torres, J. ............157-158,

209-210, 257Mota, F. L. .............................. 127Motegi, A. ..............................201Motokawa, Y. .......................... 167Motoya, M. ............................. 131Motoya, S. ..............................140Motta Molina, M. J. .................125Mougin, C. ............................ 234Mouhadeb, O. ......................... 72Mould, D. R. ............................ 83Moura dos Santos, P. ..............257Moura, M. .........158, 221, 225, 258Moura, R. N. ..........................201Mourad, L. ............................. 118Mouri, H. ......................... 69, 146Mousa, A. A. .......................... 115Mousa, R................................ 118Moussa, A. M. ........................ 167Moutinho-Ribeiro, P. .........................120, 130, 173Mouzas, I. ..............................185Mowat, C. ..............................193Moy, E. .................................... 79Mpitouli, A. ....... 125, 129, 140, 145Mrakic-Sposta, S.................... 254Mramba, L. .............................95Mroß, M. ................................ 137Mrzljak, A. .............................257Mucherino, C. ........................ 203Mücke, M. M. ........................ 239Mudter, J. ...........................55, 79Mueller, B. .............................156Mueller, C. T. ..........................183Mueller, R. ............................. 101Mueller, T. ........................ 96, 183Mugica, F. ........................175, 178Muguruma, N. ......................... 51Muhmann, R. .........................215Muir, J. G. ...........103, 141, 196, 233Mujagic, Z. ................... 70-71, 196Mukai, K. ............................... 121Mukai, R. .......................204, 253Mukai, S.................... 69, 142, 222Mukherjee, R. ......................... 72Mulak, A. ............................... 137Mulcahy, H. ............................ 217

Moreau, J. ................. 75, 100, 229Moreea, S.............................. 209Moreels, T. ............... 102, 178, 182Moreira, L. .............................. 63Moreira, M. J. ...........186, 236, 257Moreira, T. ............... 175, 210, 257Morelli, A. ..............................150Moreno, C. .........................42, 61Moreno, L. ....................... 63, 128Moreno, V. ............83, 89, 97, 126,

143, 175-176, 211Moreno de Vega, V. ......... 83, 126,

175-176Moreno-Almazán, L. ...............128Moretti, S. ............................. 254Morgan, S. ....................... 86, 192Morganti, D. ....................225-226Morgner, A. ............................154Mori, A. ................................. 119Mori, D...................................215Mori, H. .............. 46, 53, 124, 200Mori, K. ...........46, 51, 98, 124, 126Mori, Y. ..... 46, 69, 72, 84, 98, 126,

128, 131, 177, 193-194, 203, 223, 243, 251

Morimitsu, Y. ...........................69Morimoto, H. ..........................124Morino, M. ...........52, 67, 100, 105Morinushi, T. .......................... 174Morisco, C. ............................ 206Morisco, F. ........... 117-119, 167-168,

205-206, 216Morita, M. ..............................154Morita, Y. .... 177, 194, 223-224, 251Morito, Y. .............................. 203Moriya, H. .............................200Moriyama, I. ............. 101, 122, 238Morna, H. .............................. 208Moroi, I. .......................... 181, 229Moroni, F................................146Moroni, P. ..............................182Morozov, S. ............................149Morreale, G. C. ................ 187, 238Morreau, H..............................85Morris, E. ...............................143Morrison, M. ..................204, 246Morrissey, S. .................... 58, 122Morsy, M. E. ........................... 178Mortele, K. J. ........................... 93Moryoussef, F. ........................130Mosca, D. ...............................156Mosca, M. ...................... 102, 206Moscariello, M. ......................102Moschen, A. R. ........47, 70, 89, 94Moschetta, A. ......................... 101Moser, C. E. ............................103Moser, G. .............................. 240Moser, J................................... 93Moser, L. ............................... 240Moshkowitz, M. .......................69

354


Nietfeld, L. ............................ 222Nieto, A. ................................. 57Nieto, J. ............................ 62, 102Nieto, L. ...................................71Nietsch, H. H. .........................126Nieuwdorp, M. ..... 74, 90, 100, 173Nieuwenhuijzen, G. A. P. .. 76, 182Nieves, J. W. ...........................150Niezychowski, W. .....................56Niida, S. ..................................89Niimi, K. ...............51, 96, 142, 151Niinuma, T. ........................... 243Nijeboer, P. .............................64Nikaido, M. ............................. 51Nikeghbalian, S. .................. 65, 165, 216, 218Nikiforova, Y. .......................... 119Niknam, R. .............................215Nikolaus, S. ............................138Nikolić, P. ...............................183Nikolopoulou, V. .....................241Nikonov, E. ............................. 173Nilsen, J. A. ............................ 176Nilsen, R. M. ......................... 204Nilsson, L. ..............................189Nilsson, M. ..................... 132, 200Nimura, S...............................182Ning, L. ..................................201Nio, C. Y. ................................ 170Nion-Larmurier, I. .................. 181Nipshagen, M. D. ....................103Nir, E. ..................................... 97Nirantharakumar, K. ...............247Niriella, M. A. .................. 135, 164Nishi, M. ............. 86, 122, 126, 191Nishida, A. .......................126, 137Nishida, H. ........................93, 167Nishida, T. .........................53, 121Nishiguchi, S. ......................... 167Nishijima, N. .......................... 167Nishikawa, H. ......................... 167Nishikawa, M. ........................126Nishikawa, T. .................... 136-137Nishikawa, Y. .................. 144, 250Nishimoto, T. ......................... 236Nishimura, K. .................. 145, 182Nishimura, M. ........................122Nishimura, N. ................... 69, 146Nishimura, R. .........................143Nishimura, T.............. 167, 175, 182Nishino, K. ...................... 124, 129Nishino, N. .............................129Nishiumi, S. ...........................122Nishiyama, M. .........................86Nishizawa, T. ................... 173, 225Nisim, M. ............................... 151Nissim-Eliraz, E. ...................... 97Nissinen, S. .............................85Nistorescu, S. .........................218Niubo-Carulla, L. ....................134

Negrutiu, D. .......................... 246Neilson, L. J. ..................... 89, 175Neimark, E. ....................... 49, 80Nejjari, F. .............................. 253Nelson, A. .............................. 132Németh, A. .............................. 72Nemeth, B. .......................59, 220Nenciu, I. ...............................233Nennstiel, S........................... 248Neokosmidis, G. .....................126Neri, B. ...............97, 185, 188, 234Neri, M. .................. 136, 236, 254Neri, M. C. ............................ 244Nerin de la Puerta, J. M. .........136Netinatsunton, N. ................... 119Neu, B. ...................................84Neubauer, K. ..........................184Neufert, C. ........................79, 127Neuhaus, H. ................. 39, 67, 73,

76, 81, 126, 173Neuman, S. ......................137, 140Neumann Sen, H. ............. 98, 125Neumann, F. .......................... 220Neumann, H. ..... 37, 55, 69-70, 94,

98-99, 125, 127, 245Neumann, U. P. ................. 55, 66Neunlist, M. ..... 195, 234, 242, 252Neurath, M. F. ... 47, 55, 61, 70, 79,

121, 127, 148, 170, 184, 207Neuweiler, J. ...........................52Nevens, F. .........................91, 165Neves, D. ................................210Neveu, I. ............................... 234Nevill, A. ............................... 225Ng Kwet Shing, R. ........... 125, 136Ng, D. H. L. .............................156Ng, E............. 36, 60, 94, 135, 142,

152, 202, 230, 250Ng, S. C. ................................ 180Ng, S. C. C. ...... 36, 60, 82, 94, 142Ng, S. S. M. ............................ 147Ng, W. K. ............................... 207Ngamruengphong, S. ..62, 99, 103Ngo, O. ...................228, 242, 244Nguang, S.-H. ........................166Nguyen-Khac, E. .....................135Nguyen, H. T. T. ..................57, 85Nguyen, N. Q. ...................197-198Nguyen, P. H. ........................ 252Nichols, S. ............................. 254Nicolás Pérez, D. .................... 245Nicoletti, L. ......................247-248Nicoletti, R. .................... 222, 224Nicolucci, C. ...........................165Nieber, K. ...............................190Nieboer, D. .............................143Nielsen, K. R. ............ 96, 135, 185Niemietz, C. ...........................215Nieponice, A. ........................ 249Niess, J. H. .............................. 70

Nam, S.-J. ..............................184Namgung, H. ..........................194Namikawa, K. ............151, 174, 246Nan, Y. H. ................................86Nanayakkara, S. D. .................135Nancey, S. ....................75, 79-80,

135, 137, 139, 186Nande, K. S. ............................56Nanjo, S. .................................85Nanki, K. ................................138Napoléon, B. ............. 95, 129, 229Naqeem, A. ............................ 137Narang, A. ............................ 230Narasaka, T. ........................... 191Naravadi, V. ............................247Nardi, K. ...............................200Nardone, G. .................... 119, 203Nardone, O. M. ...................... 238Narita, A. ...............................182Narita, T. ................................. 53Naruse, H. ............................. 203Nasi, G. ..................................146Nasonova, S. ..........................221Nassar, A. ................................ 93Nasser, I. ................................251Nastro, F. .................................64Nastu, K. ................................124Nasu, A. ................................. 167Nasu, J. .......................... 209, 257Nasu, Y. ......................65, 121, 186Nathan, G. ............................. 181Natividad, J. M. ....................... 57Natsume, S. .................... 122, 182Nava, C. D. .............................221Navajas, F. J. ........................... 178Navaneethan, U. ...72, 103, 129-130Navarathne, N. M. ..................135Navarro, C. .............................143Navarro, M. ...................... 63, 189Navarro, P. ............................ 239Navarro-Llavat, M. ..................189Navarro-Vicente, F. .......... 233-234Naveilhan, P. ......................... 234Naves, J. E. ............................ 234Navolokin, N. .........................153Nawa, T. .................................241Nawarathne, N. ..................... 229Nawaz, K. ............................... 217Nayar, M. .............................. 222Nayer, N. ............................... 207Nazarov, I. ..............................210Nduaka, C. ....................... 61, 140Neagoe, D. .............................165Neamatallah, M. .............. 117, 166Nebiki, H. ......................... 147, 174Necula, D. ............................... 78Nedal, M. .............................. 246Neese, A. ................................ 78Neesse, A. ............. 78, 85, 102, 111Negreira, S. M. ...................... 238

Naito, Y. .................. 123, 174, 180, 204, 226, 253

Nakad, A. ......................... 55, 182Nakada, A. .............................182Nakadoi, K. ...................... 53, 144Nakagawa, K. .........................247Nakagawa, M. ................. 152, 154Nakagawa, T.......124, 144, 170, 176Nakagawa, Y.................... 123, 144Nakahara, R. ................... 123, 169Nakahata, Y. ........................... 174Nakahira, H. ............................85Nakahori, M. ......................... 254Nakai, T. ................................. 147Nakai, Y. ........ 95, 119, 171, 180, 182Nakaji, S. ...............................241Nakajima, A. ............103, 114, 155,

241, 254Nakajima, N. ..........................103Nakajima, T. ............................ 78Nakajo, K. .........................95, 177Nakamatsu, D. ........................ 121Nakamura, A. .........................215Nakamura, H. ........... 98, 126, 169,

177, 194, 243Nakamura, I. .....................93, 167Nakamura, K. .........................251Nakamura, M. ...........122, 136-137,

172, 181, 254Nakamura, R. .... 183, 223, 232, 251Nakamura, S. ................. 166, 254Nakamura, T. ...............95, 97, 119,

131, 143, 182Nakamuta, M. .................194, 201Nakanishi, Y. ..........................182Nakano, C. ............................. 167Nakano, M. ........................... 252Nakano, S. ..............................117Nakano, T. ....................... 123, 174Nakao, K. .........................93, 252Nakase, H........................ 136, 193Nakashima, H. ........................124Nakashita, S. ................... 172, 215Nakata, A. ................. 145, 147, 174Nakata, T. .......................... 97, 167Nakatani, A. ...........................145Nakatani, T. ............................ 167Nakatsu, S. ............................. 191Nakayama, A. ....................82, 173Nakayama, T. ..........................144Nakazawa, S. ......................... 123Nakazuru, S............................153Nakhcha, I. ......................168, 218Nakmouche, M. ...............185, 257Nakov, R.................... 49, 159, 236Nakov, V. .........................159, 236Nakstad, B. ..............................71Nam, H. S. .......................126, 131Nam, K............................ 174, 194Nam, S. Y. ..............................201


355

Oliveira, C. .................83, 147, 189Oliveira, D. .............. 194, 201, 231,

257-258Oliveira, E. C. ................... 49, 189Oliveira, J. F. D. ..194, 201, 231, 258Oliveira, M. .....................237, 258Oliveira, P. ........................147, 215Olivencia Palomar, P. ..............153Oliver, L. .................................237Olivier, C. ....................... 106, 205Olivier, N. ...............................125Ollero, V. .........................235, 237Ollivier, J. ...............................188Olmedo Camacho, J. ...............153Olmos, C. ................................65Olson, A. .............................47, 61Omae, M. ..............................200Omar, A.................................. 118Omari, T. ................................198Omatsu, T. .............................. 174Omazzi, B. .......................225-226Omidvari, A.-H. ....................... 87Ominami, M. ................. 200, 250Omori, T. ............124, 151, 223, 251Omori, Y. ................................122Omoto, S. .........................122, 181Omran, D. .........................117-118Omran, M. ...............................117Oms, L. ...........................170, 220Omura, A. ..............................154On, W. .............................. 38, 188Onali, S. ................................. 187Onimaru, M. .......................... 250Onishi, H. ...............................166Önnerhag, K. ..........................143Ono, A. ..................................126Ono, H. .............. 51, 124, 128, 194,

203, 242, 250-251Ono, M. ........................... 131, 203Ono, S. ................ 96, 128, 142, 151Ono, Y. ........ 58, 122, 172, 204, 253Onozawa, Y. ...................204, 253Ooi, J..................101, 148, 247-248Ooi, M. ...............126, 197-198, 203Oom, R. .................................145Oono, I. .................................. 172Oono, Y. ...........................177, 201Ooshima, S. ............................143Ooshiro, T. ..............................182Oostenbrug, L. E. ....................102Oota, S. ...................................171Oppong, K. ............................ 222Oprisanescu, D. ......................231Oproiu, A. .............................. 167Orbán-Szilágyi, Á. .................. 179Orchard, T. R. ......36, 184-185, 233Orel, R. ................................... 79Orfanoudaki, E. ...................... 187Orlandini, B. ..........................190Orlando, A. ......... 97, 185, 237-239

Ohmiya, N. ...............123, 144, 254Ohmiya, T. ..............................182Ohmori, T. ............................. 226Ohnishi, S. .............................. 53Ohnita, K. .................. 93, 152, 252Ohno, E. ........................... 136-137Ohno, K. ................................ 205Ohno, Y. ..................................95Ohta, A. ..................................58Ohtsu, K. ........69, 72, 131, 136, 236Ohtsuka, K........... 72, 131, 136, 236Ohyama, A. .....................166, 168Oka, A. ..............................71, 168Oka, S. ................53, 144, 151, 254Okabe, Y. ......................... 170, 180Okada, H. ..... 53, 65, 151, 166, 168,

175, 182, 203, 219, 241Okada, M. ..............................130Okada, T. .....................76, 93, 167,

172, 232, 252Okada, Y. ............................... 252Okagawa, Y. ...........................231Okamoto, K. ...........................164Okamoto, N. ........................... 177Okamoto, R. ......................97, 143Okamoto, T. ............................124Okamoto, Y. ..................... 142, 175Okamura, K. ...........................182Okanobu, H. ..................... 53, 144Okawara, A. ...........................168Okayama, T........ 123, 174, 204, 253Okazaki, K. .............................. 62Oke, S. ...................................185Okhlobystin, A. .......................221Okhlobystina, O. ..............221, 257Okhotina, A. ........................... 118Okimoto, K. ..................... 124, 176Okimoto, T. .............................134Oksala, N. ...............................85Oksanen, P. ............... 96, 135, 185Okubo, M. .............................. 123Okubo, S. ............................... 132Okuda, N. ...............................169Okuda, Y. ................................144Okugawa, T. ............................84Okumura, T. ...........................128Okuno, N. ................................171Okuse, H. .........................122, 172Okuwaki, K. ............................ 119Okuzono, T. ............................169Olaniyi, J. ...............................216Olariu, L. ............................... 104Olbjørn, C.................................71Oldenburg, B. ..................102, 239Oleas-Narea, R. .......................49Oliva, S. ................................. 191Oliva del Rio, B...................... 207Oliveira, A. .............. 209, 237, 245Oliveira, A. M. ........................237Oliveira, A. P. ..........................215

Nuutinen, H. ......................... 239Nuzuki, S. .............................. 123Nuzum, T..................138, 205, 216Nylund, K. ............................... 78Nyssen, O. P. .....................77, 104

O O'Connell, R. ..................... 40, 88O'Morain, N..................... 126, 138O'Reilly, S. M. ......................... 217O´Brien Andersen, L. ...............58Oana Cristina, S. C. ................ 254Obayashi, Y.......................151, 175Oberacher, H. ..........................89Obialo, N................................233Obora, A. ............................... 174Obritin-Guilhen, H. .................186Ocaña, T. ..........................63, 245Occhipinti, P. ............130, 222, 228Ochi, M. .................. 145, 168, 206Ochiai, M. ...................... 145, 206Ochiai, T. ......................... 145, 174Ochiai, Y. .. 68, 82, 173-174, 177, 225Ochieng, A. ............................ 137Ochiya, T. ................................89Ochoa Sangrador, C. ............... 137Oczella, L. ............................. 243Oda, I. ........................89, 151, 251Oda, M. ...................... 46, 98, 126Oda, T. ................................... 121Ofer, I. ................................... 243Ogata, H. ................................138Ogata, M. ............................... 172Ogata, N. ....... 72, 126, 128, 131, 193Ogawa, C. ..............................154Ogawa, G. ..............................251Ogawa, T. ..................128, 130, 179Ogawa, Y. ........ 46, 69, 72, 98, 114,

126, 142, 194, 201Ogihara, K. ........................ 58, 93Ogino, H................................. 123Ogita, K. .......................... 123, 174Oguri, T. ................................. 115Oğuz, D. .................................199Oh, C. H. .........................219, 229Oh, D. .................................... 131Oh, D.-W. ...............................221Oh, H.-C. ................................ 179Oh, Y. .....84, 95, 190, 194, 223, 251Ohara, Y. ..................194, 223, 251Ohashi, N. .............................. 119Ohata, K. .................................96Ohda, Y. ..................................84Ohira, T. .................................128Ohiwa, S. ...............................231Ohki, T. ........................... 142, 147Ohkubo, H. .............................155Ohkusa, T. ..............................134Öhman, L. .............................. 141

Niv, Y. ....................77, 91, 104, 154Niwa, Y. ......................136-137, 171NM Dinjens, W. ......................192Nobili, V. ............................... 205Nobuoka, D. ...........................166Noda, H. ....................82, 173, 198Noda, T. .............. 69, 82, 154, 173,

187, 193, 234Noda, Y. .......................... 130, 179Noel, R...................................120Nogales Rincón, O. ...........175, 178Noguchi, S. ............................ 115Noh, C.-K. ........................132, 175Noh, S. H. ..............................201Noji, T. ...................................182Nojima, M. .............................. 76Nolan, J. .................................134Noma, Y. ................................241Nonaka, S. .............................124Noor, N. M. .............................80Noordzij, I. C. .........................124Nora, C. C. V. ..........................184Nordén, T. ..............................219Nordlinger, B. .................... 51, 74Norman, G. L. ....................61, 136Noronha Ferreira, C. ........ 173, 225Norsa, L. ............................... 205Noruzi, A. ...............................102Nos, P. .....................185, 235, 237Nosek, V. ............................... 220Noser, Y. ................................. 116Noskova, K. ............................ 139Noto, A. ................................ 202Notta, P. .................................196Nour, E............................ 138, 183Nouso, K. ...............................219Novacek, G. ................. 49, 80, 137Novak, G. ................................ 79Novák, J. ............................... 234Novak, P. ............................... 243Novella, M..............................194Novelli, M. R. .........................149Novovic, S. .............................221Nowacki, T. M. ................. 135, 237Nowecki, S. ............................ 170Nowicki, T. ......................218, 236Nozaki, R. .............................. 172Nucci, D. ..... 127, 130, 223, 225-226Nuckcheddy, T. ......................200Nudo, D. .................................64Nudurupati, S.........................150Numao, H. ...................... 118, 194Numata, K. .............................169Nunes, A. C. .............159, 210, 258Nunes, G. .................157-158, 180,

209-210, 241, 256Nunes, Q. M. ........................... 72Nurbhai, S. ...................... 89, 139Nussbaum, D. .........................183Nuta, P. ..................................237

356


Pariente, B. ........... 75-76, 135, 137, 185, 236, 238

Parihar, V. ....................... 126, 159Parisi, I. ....................140, 149, 191Park, B. H. ...............................98Park, D. G. ..............................194Park, D. H. ........................131, 221Park, D. K. ....................... 146, 177Park, E. T. ............................... 179Park, H. ........ 98, 131, 142, 175, 179,

193, 201, 221, 226, 229, 239Park, H. S. ...................... 202, 252Park, J. .............. 174, 201, 243, 253Park, J. J. ........................ 201, 243Park, J. K. .........................172, 197Park, J. M. ....................... 152, 184Park, J. Y. .............122, 169-170, 172Park, J.-S. ................. 119, 223, 246Park, K. S. ..............................201Park, S. ............ 152, 188, 201-202,

223, 245-246, 251-252Park, S. C. ..............................184Park, S. H. ....98, 142, 175, 193, 239Park, S.-H.................179, 226, 229Park, S. W. ............... 122, 169-170,

172, 177, 219Park, Y. S. ........................ 152, 251Parker, H. L.............................148Parkes, G. ...............................156Parkes, M. ...............................80Parkinson, D. ..........................196Parlak, E. ............................... 132Parmentier, A.-L. ................... 234Parniczky, A. ............................59Parodi, A. ................................ 62Parolova, N. ........................... 157Parry, H. ................................ 243Parry, S. D. .............................144Parra Villanueva, F. J. ..............125Parra-Blanco, A. ..................... 177Parshutin, S. ................... 173, 251Parsi, M. ................................ 181Parzanese, I. ..........................130Pasanisi, F. ............................ 235Pasca, S................................. 246Pascale, V. .............................. 147Pascaru, A. .............................216Paschos, P. ..............................49Pascual-Moreno, I. ................ 220Pascual-Salcedo, D. ................188Pasin, F. ................................ 207Paskauskas, S. ........................ 172Paspatis, G. ....... 125, 129, 140, 145Pasqual-Moreno, I. ................. 170Pasquale, L. .............................96Pasquer, A. ............................. 132Passananti, V. ................. 244-246Passigato, N. ..........................159Pastorelli, L. ........................... 127Patai, A. .................... 83, 136, 229

Palmieri, G. .................... 188, 234Palmieri, L.-J. .........................241Palmisano, S. .........................165Palos Cuellar, R. ..................... 174Palsson, O. S. ............. 71, 90, 146,

149, 244-245Palviainen, M. ........................193Pan, A. ....43, 46, 73, 77, 87, 94-95,

102, 105, 140, 156, 158, 163, 179, 181, 186, 209, 254

Pan, J. ..............47, 56, 69, 97, 102, 148, 184, 189, 223, 244

Pan, W. H. ..............................138Pan, Y. .....................................82Panaccione, R. .................. 49, 80,

101-102, 139, 176Panadero, A. ..........................186Pandolfi, A. ........................... 254Pandolfi, M. ........................... 181Pandolfino, J. ................... 69, 148Panek-Jeziorna, M. ................. 137Panés, J. ............43, 47, 56, 73, 94,

97, 102, 105, 140, 189Pang, T. ..................................156Pang, Y. H. ..............................184Pangan, A. ......................... 47, 87Panic, N. ................................122Panici Tonucci, T. ................... 239Panis, Y. .......................38, 43, 86Panozzo, M. P. ..........202, 247-248Panteleev-Ivlev, J. ...................184Paoluzi, P. ............................. 239Paone, G. ...............................130Papa, A. ..........................155, 239Papachristopoulou, G. ........... 243Papachristou, G. I. ....................71Papachrysos, N. ......................231Papadia, C. .............................155Papadopoulou, A. .................... 67Papanikolaou, I. ........ 42, 106, 213Papastergiou, V. .....................125Papatheodoridis, G. ........... 39, 64Papay, P.................................. 137Pape, S...............................46, 91Pape, U.-F. ............................ 205Papi, C. .............................97, 185Papp, M. ......................61, 72, 83,

136, 220, 234Pappalardo, B. ........................49Pár, G. ................................... 220Paranahewa, S. ..................... 228Paranandi, B. .........................122Paraskeva, K. ..........................125Paraskevova, A. ..................... 248Pardeiro Pertega, R. ............... 178Pardo Balteiro, A. .................. 180Pardo-Camacho, C. .................. 57Paremal, S. .............................89Parepa, I. R. .....................115, 153Parfenov, A......... 138-139, 155, 184

Ovartlanporn, B. ..................... 119Overbeek, L. I. H. .....................64Overwater, A. ........................200Oyama, A. ...............................65Oyama, T. ....................... 152, 250Oyamada, J.............................169Oza, N. ................................... 172Ozagari, A. A. ........................ 236Ozaki, T. .................................134Ozawa, E. ................................ 93Ozawa, M. ..............................152Ozbek, M. ............................... 170Özbeyli, D. ............................. 256Özdemir Kumral, Z. N. ........... 256Ozeki, K. .................................142Ozola-Zalite, I. ....................... 220Öztürk, Y................................ 256Ozutemiz, O. ...........................143

PPablo Fernández Navarro, P. ......................................143Pabois, J. ............................... 234Pace, D. ................................. 242Pace, F. .............................146-147Pachofszky, T. ......................... 132Pacou, M. ...............................188Padro, D. ................................. 91Padula, S. J. ............................. 47Paese, P..................................189Pagadala, N............................ 133Pagani, E. ......................... 64, 155Pagano, I. ................................90Paggi, S................................. 228Pagnon, L. ............................. 232Paiella, S. ......................... 85, 183Paik, N. Y. ...............................193Paik, W. H. .......................121, 130Painchart, C. ......................... 238Paiva, D. S. ..................... 155, 206Pajala, M. .............................. 239Pajdo, R. ............................... 250Pak, S...............................175, 217Pakodi, F. .............................. 229Pal, P. ........................ 120, 171, 181Palacín, C. ............................. 253Palatka, K. ...83, 136, 234, 238, 240Palazuelos, C. .........................143Palazzo, L. ............................. 229Palazzo, M. ............................ 222Pálfi, E. ................................. 235Paliy, I. ...................................150Pallagi, P. .........................120, 171Pallav, K. ................................241Pallone, F. ................. 97, 185, 234Pallotta, L. ............... 147, 206, 244Pallotta, S. ..........177, 181-182, 220Palma, R. .............................. 208Palmela, C. ...................... 178, 237

Orlando, C. .....................203, 249Orlando, E. .............................237Orlando, R....................... 237-239Orlando, S. ............................ 236Orlova, L. ........................ 187, 210Orman, S. ........................159, 232Ormando, V. M. ...................... 174Ormanns, S. .......................... 232Oropeza, A. .....................183, 233Orry, X. ................................. 235Orsic Fric, V. ...........................158Ortega, O. ........................90, 149Ortega, S. P. ...........................194Ortega-Suazo, E. ..............121, 197Orth-Höller, D. ......................... 70Ortiz Fernandez-Sordo, J. ....................................... 173Ortiz Masia, D. .......... 134, 233-234Oruc, N. .................................143Osada, T. ................................140Osaki, Y. .......................... 167, 257Osera, S. ................................ 176Oshima, N. ......................101, 238Oshima, T. ...............................84Oshiro, T. ............................... 133Osmane, R. .....................185, 257Osoegawa, T. ...................194, 201Ospina, A. ..............................183Ospina, J. ..........................49, 174Osredkar, J. ............................. 79Ostapchenko, L. ......................155Osterman, M. T. ...................... 139Östman, A. .............................221Osugi, N. ................................ 121Oswald, F. ..............................193Ota, H. ...................................128Ota, Y. ....................................130Otake, S. ................................130Otani, I. ................................. 254Otani, K. ........................... 79, 254Otazua, P. ............................... 115Otero-Alen, B. ................. 147, 252Otero-Alen, M. ....................... 147Otete, H. E. .............................. 78Othman, A. A. .........................48Othman, H. .....................120, 158Otlu, B. .................................. 170Otottova, K. ........................... 238Otsuka, H. ........................ 136-137Otsuka, T. ........................172, 203Otsuki, A. .............................. 203Ouakaa, A. ......................228-229Ouazzani, S. ...........................126Oubaha, S. ............................ 253Ouchi, A. ......................... 133, 182Oudjit, A. ...............................247Ouldgougam, R. .................... 253Oumnia, N. ............................154Oussi, N. ................................183Ouwendijk, R. J. .....................102


357

Petrov, P. ................................ 179Petrowsky, H. ..........................86Petrusel, L. ...................... 172, 222Petruzziello, L. ........................126Peveling-Oberhag, J. ...............231Pevere, S. ...............................122Peyrin-Biroulet, L. ...49, 73, 75-76,

80, 87, 135, 137, 139, 185, 190, 235, 239

Pezet, D. ...........................85, 242Pezzilli, R. ...............................85Pezzolla, F. ............................. 147Pezzullo, M. .......................... 207Pezzuto, F. ..............................154Pfeifer, L................................. 121Pfister, A. ................................ 70Pfisterer, N. ............................ 132Pham, K. D.-C. ........................122Pham, P................................... 57Phelip, J. M. .................... 185-186Philip, G. .........................140, 233Phillip, V. ......................... 72, 224Phillips, A. .............................. 74Phillips, W. .............................150Phuwapraisirisan, S. ............... 133Piacenza, M. .......................... 239Piano, S. ................................166Piatek, D. .............................. 235Piazuelo, E. .................... 153, 200Piazuelo, M. B. ........................ 97Pica, R. ................................. 239Picard, O. .................. 78, 140, 190Picchio, M. ..................... 146, 203Piciocchi, M. .....................119, 187Pico Sala, M. D. ....................... 63Pidhirnyy, B. ............................171Pidial, L. ................................ 173Piekuse, L. ......................235, 240Pienar, C. ......59, 157, 170, 216, 218Pienkowska, J. M. ............218, 236Pieper, D. ............................... 141Pierik, M. J. ..49, 102, 187, 236, 239Piessevaux, H. .......... 102, 178, 182Pietrareanu, C. ................. 116, 217Pietri, O.................................. 181Pietruszka, P. ..........................135Pigò, F. .................................. 228Pigrau Pastor, M. ..................... 57Pigrau, M. ............................... 57Pilati, P. ..........................192, 228Pilipenko, V. ...........................156Pillay, L. .................................128Pillet, S. .................................185Pilotto, A. .............................. 248Pilotto, V. .......................203, 249Pilozzi, E. ...............................199Pilutti, C. ................................166Pimentel-Nunes, P. ... 124, 132, 227Pin, N. .........51, 144, 224, 227-228Pina, S. ................................. 208

Pérez Galindo, P. ................... 240Pérez-Berezo, T. ...................... 57Perez-Camiña, J. P. .......... 147, 252Pérez-Cuadrado-Martínez, E. ..................................... 228Perez-Cuadrado-Robles, E. ................. 102, 178, 182, 228Pérez-Gómez, B. .....................143Perez-Lasala, J. ..................77, 104Pérez-Milián, D. .................... 253Perez-Miranda, M. ............. 99, 171Pérez-Pampín, E. .................... 187Pérez-Riquelme, F. ................ 228Pérez-Rodríguez, F. J...............128Perini, C. .................. 159, 210, 221Perk, L........................93, 142, 193Perkhofer, L. ................ 78, 93, 193Perminow, G. ...........................71Permpoon, V........................... 177Péron, M. ...................82, 121, 252Perren, A. ...............................102Perren, B. ............................... 176Perretta, S. ............................. 173Perri, V. ................................. 252Perrod, G. .................151, 173, 229Persico, M. ...................... 119, 165Perugini, B. ............................ 133Perugorría, M. J. .................91, 117Pesatori, E. V. .............. 64-65, 155Pesenti, C. ....................... 152, 169Pesenti, E. .......................247-248Peserico, G. ..................... 119, 220Pessegueiro Miranda, H. .........196Pestman, W. ............................ 76Peter, J. ................49, 80, 101-102,

139, 192, 240Peter, L. .......................55, 66, 170Peter, S. .................................148Péterfia, B. .............................193Peterli, R. ................................52Peters, A. ...........................49, 61Peters, M............................... 235Peters, P.-G. ........................... 137Peters, Y. ................................. 76Petersen, A.............................. 61Petersen, A. H. .......................103Petersen, B..............................89Petersen, B. T. .................. 62, 145Petersen, E. J. .........................192Petersen, F. ............................138Petersen, J. H. ........................103Petersen, J. M. ....................... 250Petersson, J. ... 49, 80, 101-102, 139Petito, V. ................................188Petkevicius, V. .................. 142, 154Petrenkiene, V. ....................... 115Petricca, L................................ 75Petrone, M. C. .................98, 106,

207, 213, 222, 230Petrov, B. ............................... 179

Peiris, R. ............................... 229Peiró, R. .................................143Peixe, B. .................................215Peixoto, A. .......... 116-118, 120, 122,

130, 173, 195, 208-210Pekala, A. .............................. 235Pekarska, K. ...................235, 240Peker, İ. ................................. 256Pelaez, J. ................................152Pelegri-Sebastia, J. .................237Pelizzaro, F. ............................ 119Pellegatta, G........................... 187Pellegrino, S. ...................135, 238Pellet, G. .................................80Pellisé Urquiza, M. ........... 63, 84,

125, 128, 178Pellisé, M. ..................63, 84, 125,

128, 153, 178Peltec, S. E. ............................144Penagini, R. ................... 130, 149,

198, 248-249Pencik, P. .............................. 220Penenberg, D. .....................47, 61Penez, L. ................................. 70Peng, S. ................................ 242Penna, A. .............................. 203Pennacchi, C. .....194, 201, 231, 258Pennazio, M. .......................... 131Penney, N. ..............................155Penz, D......................175, 227-228Peppelenbosch, M. P. ............................ 79, 150Perales, A. ............................. 245Peralta, S. ............................. 238Perazzolo, A. ...................247-248Perbtani, Y.........................95, 151Perdigao, F. ............................. 62Perdigoto, R. ......................... 208Perdones-Montero, A. ....... 70, 233Perea Amarillo, R. .................. 139Pereira, A. ......... 145, 159, 176, 178,

180, 208, 210, 222, 252Pereira, B. ........... 83, 137, 186, 225Pereira, E. ...84, 128, 166, 180, 256Pereira, F. ................. 84, 128, 166,

180, 256-257Pereira, P................. 120, 122, 145,

209, 218, 231Pereira, S. .............................. 178Pereira da Silva, J. .......... 145, 176,

178, 222Pereira Silva, J. ...................... 180Perek, S.................................. 181Perez, M. C. ............................150Perez, R. ...........................51, 107Pérez-Aísa, Á. ............. 77, 104, 153Pérez Arellano, E. ...................154Pérez Calle, J. L. ..................... 240Perez de la Serna, J.......... 198-199Perez Ferrer, M. ...................... 167

Patai, A. V. ............... 159, 192-193, 220, 229

Patch, D. ................................ 131Patcharatrakul, T. ....................194Patel, A. ........69, 141, 188-189, 193Patel, H. ....................141, 188-189Patel, N. ............196, 199, 232, 252Patel, P. ..............103, 170, 176, 247Patel, R. N. .............................193Paternostro, R. ........................ 51Pathmakanthan, S. .................142Pathmeswaran, A. ..................164Patita, M. ................. 157-159, 180,

209-210, 241, 256Patrasescu, M. ........................237Patricelli, M. G....................... 242Patrick, V. B. ............................ 62Patrlj, L. .................................183Pattarapuntakul, T. .......... 119, 257Patterson, J. ........................... 175Patti, R. ..................................165Pattni, S. ............................... 234Patturelli, M. ..........................189Paul, C. ............................ 92, 170Paul, S. ...............79, 170, 186, 190Pauligk, C. ...............................92Paulo, S. ................................190Paulus, S. ............................... 170Pauwels, A. ..................... 101, 198Pauza, A. G. ............................ 78Pauziene, N. ..................... 78, 146Pavão Borges, V. ............. 159, 258Pavelets, K.............................. 132Pavelets, M. ............................ 132Pavey, D. ................................150Pavlenko, A. ........................... 133Pavlenko, V. ............................ 133Pavlov, P. ................................257Pavlovic Markovic, A. .............. 133Paye, F.................................... 181Pazdro, A. ............................. 250Pazos-Randulfe, Y. ........... 147, 252Pearlman, A. ..........................145Pecere, S. ............................... 131Pech, O. .....58, 60, 76, 87, 163, 173Peck-Radosavljevic, M.............. 51Pécsi, D. ................................ 229Pedersen, J. ........................... 249Pedersen, N. ............. 96, 135, 185Pedersen, R. ...........................102Pedersen, S. ............................90Pediconi, C. ............................136Pedro, A. J. ............................. 167Pedroni, C. .........................64-65Pedroto, I. ...139, 175, 210, 224, 257Peek, N. M. S. .........................190Peery, A. ................. 59, 67, 78, 88Peeters, A. ............................ 207Pefkianaki, I. ..........................185Peiris, M. .............................. 248

358


Prohic, D. ...............................169Prost, C. ................................ 234Protchenkov, M. ...................... 132Protopapas, A.........................126Prudnikova, I. .................. 114, 144Prudnikova, Y. I. .....................144Prybytko, I. .............................155Prylutskyy, Y. ......................... 238Prysiazhniuk, A. .....................134Przybylska-Feluś, M. .............. 204Przytulski, K. .....................77, 104Psychos, A. K. ........................ 245Ptak-Belowska, A. ...................85Pudzianowski, S. ................... 235Puente, J. J. ........................... 245Puga-Tejada, M. ................49, 174Pugliese, D. ............... 75, 239-240Pugliese, F. ..................... 220, 229Puhalović, A. ..........................169Puig, O. ..................................196Puig-Divi, V. ...........................241Pujada, A. ............................... 70Pujari, R. ............ 99, 223-224, 249Pukitis, A.......................... 72, 220Pullan, R. .............................. 225Pullmann, D. ..........................126Pulsombat, A..........................148Puolanne, A.-M. .....................138Purchiaroni, F. ....................... 226Purkayastha, S. .......................155Purushothaman, R. ................ 208Pusceddu, S. ......................... 223Putter, H. .................................85

QQi, R. ......................................52Qi, X. ......................................52Qi, Z............................... 224, 227Qian, D. .................................. 121Qian, J. ...................................199Qian, Y. ...........................143, 202Qiang, Z. ................................145Qin, W. ............................125, 201Qiu, X. ...................................134Quader, F. ...............................247Quadros, A. C. ................. 159, 210Quaia, M. ...............................192Quan, Y. ............................57, 193Quante, M. .............................193Quehenberger, P. ..................... 51Queirós, P................215, 228, 236,

241, 255Quentin, V. .............................185Qui, T. B. ............................... 239Quinlan, J. ............................. 242Quintero Carrion, E. ......... 84, 128,

153, 235, 245Quirke, P. ................................ 70Quondamcarlo, C. ...................194

Porte, R. J. ............................... 93Portella, G. .............................216Portillo, S. ..............................210Portillo, V. ..............................210Portillo Villares, I. ............. 84, 128Portune, K. .............................. 73Porzionato, A. .... 86, 141, 192, 200Posada Restrepo, A.................125Posch, W. ................................ 70Potamianos, S. P. ................... 245Potter, M. ...............................155Pouderoux, P. .......................... 76Poulin, L. F. ............................. 57Poullenot, F. ...........................188Pourhosseingholi, M. A...........154Pouw, R. E. ................76, 173, 249Poves, C. ................................. 63Powell, A. .........183, 196, 232, 252Powles, S. T. R. ......... 184-185, 233Poza Cordon, J. .......................188Pozzan, C. ....................... 119, 190Pozzetto, B. ............................185Pozzi, R. .................................120Prakash, G................ 159, 188, 197Prakash, J. .........................78, 221Pranculis, A. ........................... 115Pranzo, G. ..............................189Prasad, K. .............................. 187Prasad, Y. .............................. 240Prasada, R........................ 171, 187Prasnikar, N. ...........................92Prat, F. .......... 53, 62, 127, 129-130,

177-178, 181, 221, 228, 230, 247

Prawiradiradja, R. ................. 246Preda, C. M. ....................167, 208Pressman, S. ..........................189Preston, S. L. ..........................150Pretet, J.-L. ............................ 234Prevoo, W. ............................... 93Pribic, T. ............................57, 145Pribolšan, L. ...........................183Priestley, S. ......................58, 243Priestnall, L. ...........................182Prieto, J. ..................................117Prieux-Klotz, C. ................. 93, 168Prifti, S. ..................................149Principi, M. ............. 150, 154, 166,

189, 203, 240Prinzi, N. ............................... 223Privat, J. ................................ 222Privitera, A. C. ..........189, 238-240Probert, C. .................61, 156, 190Probst, S. ................................92Proca, D. ................................ 167Procopet, B. D. ..................64, 73,

166, 217, 256Procter, H. .............................. 132Proença, L. ................116, 131, 138,

228, 235

Pochapin, M. B. .......................69Pochard, C............................. 234Pockros, P. ............................... 91Poddar, U. .............................. 157Podhola, M.............................251Podmanicky, D. ...................... 235Poh, B. Y. ...............................156Pohl, D. ....................... 39, 55, 74,

195, 206Pohl, M. ..................................92Poincloux, L. .................. 222, 225Pojoga, C..................172, 222, 230Pokojova, E. ...........................149Polak, L. .................................193Polak, W. ...................120, 169-170Polaka, I. ......................... 173, 251Polanco, I. ...............................64Poley, J. W. ...................... 120, 251Poliani, L. ................222, 224, 244Pollán, M. ..............................143Poller, D. .................................99Pollinger, K. .................... 116, 214Polte, S. C. H. .........................164Pomej, K. ................................ 51Pompili, M. ..................... 215, 218Ponce, M. ............ 63, 84, 128, 245Poncet, G. .............................. 132Ponchon, T. .....36, 48, 53, 67, 100,

106, 177-178, 229Pongpirul, K. .......................... 177Poniewierka, E. ..................... 240Poniewierska-Baran, A. ........... 78Ponkina, O. ............................ 118Ponkratova, N. ........................221Ponomarev, A. ....................... 248Ponsioen, C. Y...............72-73, 239Ponte, A. ...................116, 131, 138,

209, 228, 235Pontén, I. .............................. 244Pontisso, P. ............................. 114Ponziani, F. R. ................ 218, 256Poo, S. ...................................189Pop, C. S. ............................... 167Pop, E. ....................... 46, 52, 217,

233, 244Pop, L. ............................. 68, 157Popescu, A. .............. 157, 168, 170,

214, 216-218Popescu, C. P. ......................... 167Popescu, M. ...........................165Popescu, S. A. .......... 157, 168, 170,

214, 216-218Popov, V. ..............71, 153, 216, 219Popova, O. ............................. 232Popovic, D. .............................165Popowicz, A. ......................... 232Popp, A. ................................ 254Poprom, N.............................. 133Poropat, G. ..............................59Portal, C. ................................231

Pina-Cabral, J. ....................... 256Pinazo Martínez, I. L. ..............158Pineda, M. .............................. 63Piñerúa Gonsálvez, J. F. ..................... 183, 233, 246Pinese, E. ...............................122Pineton de Chambrun, G. ..........................76, 139, 185Pinheiro, H. ............................ 147Pinho, J. ............ 207, 224, 227-228Pinho, R. ...........131, 209, 228, 235Piñol, V. .................................. 63Pinto Marques, P. ...........159, 180,

209-210, 230Pinto-Lopes, P. ....................... 187Pinto-Pais, T. .................. 224, 227Pinto, E. ..........................159, 232Pinto, H. C. ............................ 208Pinto, J. .................... 84, 128, 166,

180, 229, 256-257Pioche, M. ........... 52-53, 100, 132,

151, 177-178, 247Pipino, C. .............................. 254Pique Becerra, R. ...................120Pires Caldeira, A. I. L. ............ 180Pires, M. ............................... 208Pires, S. .....................52, 132, 177,

179, 224Piri, D. .................................. 235Pirogov, S. ............................. 248Pironi, L. ................... 87, 100, 256Pirozzolo, G. .....................76, 250Pirvulescu, I. .......................... 116Pisana, V. .............................. 239Pisani, A. ......................... 96, 130Piscaglia, F. ............................168Pischke, S. ........................39, 229Pita, I. .............................. 117, 138Pitanga-Lukashok, H. .........49, 174Pither, C. ................................156Pizarro Moreno, Á. E....63, 84, 128Pizarro, T. T. ...........................188Pizzi, M. ..........................181, 203Pizzicannella, M. .................... 181Planchais, J. ......................57, 134Planche, K. ............................. 131Planell, N. ............................... 97Planella-de Rubinat, M. ......... 246Plastaras, L................ 73, 185, 234Plat, J. .................................... 170Platzer, R................................ 137Plaza Roig, P. .........................125Plesa, A................................. 254Pleskow, D. ...................... 93, 251Plevris, J. N. ............... 72, 131, 230Plotogea, O. M. ................ 181, 229Pluchino, D. ....................238-239Plumb, A. .......51, 60, 107, 143, 247Plut, S. .................................... 79Poc, K. ...................................221


359

Ribeiro Jr., U. ....194, 201, 231, 258Ribeiro, H. ...84, 128, 158, 166-167,

173, 180, 210, 225, 256, 258

Ribeiro, M. .............................195Ribeiro, R. .............................. 178Ribes Koninckx, C. ...................64Ribichini, E. .......................... 244Ribiere, S. .............................. 127Ricanek, P. ............................ 236Riccardi, L. ...................... 215, 218Ricci, C. .......................... 189, 240Ricciardelli, C. ........................189Ricciardiello, L. .................. 58, 66Riccioni, M. E. ........................215Riccò, M. ..................196, 199, 202Richard, M. L. .......................... 57Richards, B. .......................... 243Richards, E. ........................... 246Richards, S. M. ........................ 97Richmond, E............................ 87Richter-Schrag, H.-J. ............... 147Rickenbacher, A. ...............86, 233Ridge, A. ................................138Rieder, F. ............................... 239Riedl, F. .................................. 132Riegler, G. .........................97, 185Rieker, R. J. ............................196Riemann, J. F. .........................126Riera-Ponsati, M. ...................143Riestra Menéndez, S. ..............185Riestra, S. ...................... 185, 235Rift, C. V. ................................122Rigato, P................................ 228Rigo, A. ........................... 187, 189Rigter, L. S. ............................192Rimmani, H. H. .......................52Rindom Krogsgaard, L. ............58Ringström, G. ............90, 176, 244Rinja, E. ................................. 181Rinninella, E. .........................218Rios, E. ..................................210Riphaus, A. ..................... 126, 175Risnes, L. F. .............................56Rispo, A. .... 64, 189, 205, 235, 238Rist, F. .................................... 175Ritis, K. ..................................134Ritter, J. ............................ 89, 139Rivas, L. .................................. 63Riveline, J.-P. ..........................156Rivera Irigoin, R. .............170, 220Rivera-Bermudez, M. ..............145Rivero Sánchez, L. .............63, 178Rivero Tirado, M. ....................185Riverso, M. B. ......................... 151Rivière, P. ................................56Rivory, J. ....... 53, 100, 132, 177-178Rizopoulos, D. .................151, 200Rizvanov, A............................ 234Rizza, S. ......................... 158, 258

Reenaers, C. .............. 79, 186, 190Rees, C. J..................... 72, 89, 175Rees, D. .................................233Reeves, H. .............. 48, 54, 75, 86Reggiani, P. ............................130Regula, J. .......50, 63, 91, 240, 245Rehbehn, K.-U. ......................140Rehman, A. ............................138Reiberger, T. ........51, 100, 104, 132Reichert, M. C. .......................146Reicht, G. ............................... 137Reider, S. J. ............................. 70Reig, M. ............................ 55, 95Reignier, J. ............................. 121Reimers, B. ............................ 137Reims, H. M. ...........................56Reimund, J.-M......................... 83Reinartz Groba, S. ..................215Reinhard, A. .......................... 248Reinhardt, H. C. ....................... 78Reinisch, W. ................ 49, 56, 67,

79-80, 83, 101-102, 136, 139-141, 189

Reis, D. ........................... 173, 257Reis, J. ........................... 209, 237Rejchrt, S. ....................... 241, 251Rembacken, B. ................. 46, 84,

98, 114, 207Remédio, F. ........................... 258Remedios, D. ..........................144Remes-Troche, J. M. ............60, 81Ren, H. X................................ 133Ren, J. ........................114-115, 216Ren, Z. ............................125, 201Reñé-Espinet, J. M. ................ 246Rengarajan, A. ................. 69, 148Reni, M. ................................ 242Renman, P. .............................183Renna, S. ............ 97, 185, 237-239Repetto, O. .............................153Repici, A. ................... 37, 60, 101,

103-104, 119, 129, 136, 156, 219, 222, 224,

228, 230, 244Repiso Ortega, A. ................... 178Repp, M. ................................. 53Repsilber, D............................103Requile, M. ........................... 204Rescigno, M. .......................... 116Reszec, J. ................................ 78Reviglio, C. C. S. O. .................189Rey, E...... 64-65, 148, 174, 198-199Rey, J. W. .................................69Reyes Larriba, M. J. ................125Reyes, J. ..........................125, 194Reymond, M. .................... 83, 186Reynolds, L. ...........................164Rezgui, G. .............................. 181Rhazi, L. ................................ 204Rhee, P.-L. .............................150

Ramos, L. ........................235, 241 Ramos-Zabala, F. .......128, 175, 178Rana, F. .................................. 119Rana, S. S. ............................ 220Ranaldo, N. ............................150Ranasinghe, A. G. ...................164Ranazzi, G. .............................199Randall, C. .............................140Randell, E. ............................ 242Rando, M. M. .........................166Rangel, I. ...............................146Rantanen, T. ............................85Rao, A. .................................. 230Rao, B. ............................. 58, 122Rao, G. V. ............................... 181Rao, S. ................... 40, 59, 81, 88Rapaccini, G. ..........................155Rapaccini, G. L. .. 75, 168, 218, 239Rascarachi, G. ........................ 137Rasch, C. ................................. 53Raselli, T. ................................86Rasmussen, H. H. .................. 256Rass, H.................... 183, 233, 246Ratajczak, M. Z. ....................... 78Rath, E. ..................................134Rath, S. ..................................138Rath, T. ....................... 55, 79, 127Ratiu, I. M. .............................216Ratnakumaran, R. P. ........ 188, 197Ratone, J. P. ...............152, 169, 172Rattan, A. ..............................200Ratziu, V.......................48, 75, 86Rauwers, A. W. ....................... 179Rauws, E. A. J. .................. 93, 169Ravasio, R. ............................ 238Ravaux, A. ..............................154Ravelli, A. ..............................190Ravelli, P. ......................... 62, 130Rawa, T. ................................ 240Raza, A. .................................. 62Rázga, Z. ......................... 120, 170Razumov, A. ...........................135Rea, M. .......................... 150, 238Rea, R. ............... 181, 217, 225-226Read, M. ................................150Realdon, S. ....................200, 223Reassens, J. ............................219Reati, R. ..........................225-226Rebiha, A. ..............................188Rebours, V. .....66, 76, 80, 106, 171Redaelli, A. E. ........................156Redaelli, D. .....................225-226Reddy, D. N. ................49, 60, 69,

148, 156, 170, 181Reddy, P. M. ........................... 181Reddy, S. R. ............................190Redero Brioso, L. .....................64Reding, T. ...................102, 170-171Redondo Cerezo, E. ..........178, 197Redondo-González, O. ............149

RRábai, K. ................................ 179Rabb, N.................................. 132Rabbitt, L. ..............................164Rabbitt, P. ...............................90Rabekova, Z. ................... 148, 174Rabeneck, L. ...............54, 66, 143Rabini, S. ...............................247Rabitsch, C. ............................215Radaelli, F. ............................ 228Radice, S. ............................... 137Radomski, T............................231Radu, C. .......................... 215, 217Radulovic, K. ........................... 70Radwan, M. I.......................... 178Raeburn, A. ............................247Raedler, K. .............................193Rafat, M. N. ............................136Raftopoulos, S. ....................... 177Ragheb, A. .................... 67, 73, 81Ragino, Y. I. ............................122Ragunath, K. .... 40, 54, 64, 72, 76,

87, 173, 177, 225, 231Rahal, D. ............................... 222Rahman, F. ..........98, 125, 191, 256Rahmi, G. .............72, 151, 173, 229Rai, R. R..................................52Raijman, I. .............................. 62Raimondo, M. ............ 93, 127, 129Raine, T. .............................36, 75Rainer, F. ......................... 101, 216Rainteau, D. ................... 206, 241Raithel, M. ............... 128, 148, 196Rajapakshe, N. .......................135Rajar, P. .................................. 79Rajasekhar, P. T. ......................89Rajendra, S. ...........................150Rajendran, A. ...................89, 226Rajilic-Stojanovic, M. ... 50, 56, 90Rakonczay, Z. .............120, 170-171Raksha, A. P. ..........................158Raluy Callado, M. ............ 141, 188Ramalho, F. ............................ 167Ramalho, M. ..........................158Ramalho, R. ...........................196Ramas, M. .........................77, 104Ramasubramoni, A. ............... 225Ramchandani, M. ......148, 156, 181Rameshshanker, R. .....89, 131, 226Ramió-Pujol, S. ......................237Ramirez, D. ............................233Ramirez, F. .............................210Ramirez, G. ............................ 139Ramiro, R. S. .......................... 114Ramon y Cajal, T. ..................... 63Ramos, A. .......................228, 241Ramos, E. F. .......................... 208Ramos, F. ........... 125, 128, 175, 178Ramos, G. ............................. 258Ramos, J. ....................... 188, 209

360


Ruess, D. A. A....................78, 122Ruffa, A. .....................97, 185, 188Ruffert, C. ...............................46Ruffini, M. .............................. 121Ruffle, J. K. ............................. 197Rugge, M. ............ 86, 89, 97, 196,

198-200, 202-203, 223, 234, 248-249, 252

Ruhs, C. .................................237Ruiter, R. .................................85Ruiz, A. ............ 143, 148, 184, 194,

198-199, 233Ruiz, F. A. ...............................143Ruiz, P. A...................184, 217, 233Ruiz Cerulla, A. ......................196Ruiz-Cabello, F. .......................171Ruiz-Castro, P. A. ....................233Ruiz de León, A. ....... 148, 198-199Ruiz-Rebollo, M. ..... 170, 220, 229Rullan, M. .............................. 178Rumyantseva, D. .................... 248Rundquist, S. .........................189Rune Stensvold, C....................58Runggaldier, D. ..................... 206Rupinski, M. .......................... 245Rupniewska, E. ......................189Rusanov, D. ............................ 132Rusnakova, V. .........................143Russell, A. K. ...........................56Russell, R. K. ...........................56Russo Raucci, A. .................... 242Russo, G.................................. 97Russo, M. I. ............................ 174Russo, N. ...............................140Russo, P. ............................... 258Russo, S. ..........................96, 230Rustamova, M. ....................... 157Rusu, I. ....................172, 230, 256Ruszniewski, P. ........................171Rutenberg, J. ..........................155Rutgeerts, P. ............... 56, 80, 136Rutka, M. ................. 83, 136, 228,

234, 238, 240Rutter, C. ................................156Rutter, M. ...... 48, 94, 175, 178, 225Ryabin, N. .............................. 118Ryan, B. ................... 126, 137-138,

140, 186, 254Rybak, A. .........................65, 236Rybalchenko, V. ..................... 238Rydzewska, G. ....................... 240Ryffel, B. ................................. 57Ryhlander, J............................ 176Ryoma, M............................... 118Rysevaite-Kyguoliene, K. .......... 78Ryu, C. B. ....................... 224, 227Ryu, D. G. .........................126, 131Ryu, J. K. ............ 102, 121, 130, 169Ryu, K. ............... 102, 121, 130, 169Ryu, S. W. ..............................201

Rönnow, C.-F. ........................ 228Ronzoni, M............................ 242Roos, E. ..............93, 120, 170, 219Roosenboom, B. .................... 256Roque, R. .............................. 222Rosa, B. J. F. .......................... 230Rosa, I. ............. 145, 178, 185, 188Rosa, R. ..........................130, 242Rosa-Rizzotto, E. .............192, 228Rosati, L. ............................... 230Rosati, R. ...... 80, 87, 104, 107, 242Rösch, T. ...53, 75-76, 101, 150, 229Roscio, F. ................................ 133Rose, A. ........... 46, 61, 71, 85, 190Roseira, J. ......................215, 228,

236, 241, 255Rosenberg, L. ..........................56Rosendahl, J. ............ 46, 71-72, 85Rosenstiel, P. ...............85, 89-90,

96, 135, 138Rosinach, M. ...........................56Roslan, E. J.............................120Rosmorduc, O. .................55, 106Rosner, G. ...............................85Ross, D. ..................................145Rosseto, E. A. .........................184Rossi, A. .................... 97, 185, 206Rossi, G. ............................... 230Rossi, G. E. .............................130Rossi, M. ........................ 156, 230Rossi, P. .................................143Rössler, A. ..............................138Rostami-Nejad, M. .................154Rostami, K. ............................154Rotaru, M. I. ........................... 217Roth, H. .................................126Rothfuss, K. ............................231Rotimi, O................................237Rotondi Aufiero, V. ................. 133Rotondo, A. .............................65Rotter, I. ..................................59Roug, S. .................................221Roul, M. .................................154Roumans, C. A. M. ...........151, 200Rouquette, A. ........................ 230Rouquette, O. ........................ 225Rousseau, H. ......................... 235Rouvelas, I. .................... 132, 200Rouwet, E. V. ......................... 255Roviello, F. ............................. 147Rozendorn, N. ........................ 137Rubenstein, J. H. ..................... 87Rubin, D. T. ..................... 141, 190Rubin, G. ............................... 107Ruchkina, I. ............... 138-139, 184Rucktaeschel, F. ......................183Rudatis, M. ............................231Rudzite, D. .............. 235, 240, 251Rueffer, A. ....................... 187, 190Ruemmele, F. M. .....................56

Rodriguez Tellez, M. ........ 125, 178Rodríguez-Alcalde, D. .............. 63Rodriguez-Alonso, L. ..............196Rodríguez-Artalejo, F. .............185Rodríguez-Gil, Y. .................... 127Rodriguez-Herrera, A. ...... 56, 157Rodriguez-Justo, M. ......... 149-150Rodriguez-Moranta, F. ............196Rodríguez-Muñoz, S. .............. 127Rodriguez-Nicolas, A. ..............171Rodriguez-Oballe, J. A. ....170, 220Rodríguez-Pascual, J...............128Rodríguez-Pescador, A. ...........140Rodríguez-San Pedro, L. .........189Rodriguez-Sanchez, J..............153Rodríguez-Soler, M..........143, 245Rodriguez-Ulloa, C. ................152Roelens, K. ............................. 133Roelofs, J. J. T. H. .....................92Roelsgaard, K. ........................190Roesink, J. M. .........................192Rofes, L. ...........................90, 149Rogai, F. .....................97, 185, 190Rogger, T. M. ......................... 209Rogler, G. ...................86, 97, 184,

233-234, 239Rogoveanu, I. ......................... 116Roine, A. .................................85Rojas Galarza, R. ................... 204Rojas-Perez, P. .......................152Rokkas, T. ..........................77, 104Rolim, F. ................................194Rolland, C. ..............................92Rolland-Fourcade, C. ...............92Rolli-Derkinderen, M. ............ 234Roma, M. ...165, 174, 203, 206, 251Romain, O. ...................... 128, 181Roman, S. ........ 37, 40, 69, 75, 80,

88, 148, 197, 247Romanciuc, F. .........................215Romańczyk, T. ........................140Romano, A. ..................... 155, 166Romano, C. ..............135, 190, 238Romano, M. ............. 165, 174, 203Romanova, T. I. ......................122Romberg Camps, M. ........ 102, 187Romeo, S. ...................... 188, 234Romero, C. .............. 186, 190, 240Romero Gómez, M. ................. 139Romito, M. R. ........................ 203Römkens, T. E. H. .................. 235Rommel, N. .......... 40, 88, 113, 198Römmele, C. ......................... 205Romosan, I............................ 224Ron, Y. ................................... 131Roncales, M. P. ...................... 245Roncoroni, L. ......................... 254Rondonotti, E. ................... 72, 131Roni, K. ................................. 243Ronkainen, J. M. .......................71

Rizzo, A. ........................... 96, 143Rizzo, G. L. ............................ 203Rizzo, L. V. ..............................184Rizzuto, G........................ 237-238Ro, S. ........ 56, 60, 69, 116-117, 127,

137, 139, 148, 157, 165, 171, 188, 194, 196-197, 206,

218, 221, 234, 247Roberti, M. F. .........................199Roberts, A. ............................ 232Roberts, K. ............................. 139Robertson, D. .........................143Robin, F. ................................129Robinson, A. M. .......... 47, 49, 80,

101-102, 136, 139Robinson, J. ...............89, 139, 192Robinson, K. ..........................189Robinson, R. J. .......................192Robinson, S. ............................171Robledo Andrés, P. ......... 185, 235Robles-Diaz, G. ........................71Robles, C................................251Robles-Medranda, C. .........49, 174Roblin, X. ..75, 79-80, 135, 185-186Robu, G. C. .............................237Rocco, A. ............................... 203Rocco, P. ............................... 203Rocha, M................... 52, 139, 175,

178, 210, 257Rochberger, S. .........................69Röcken, C. ............................. 206Rodella, L. ..............................130Rodiño Janeiro, B. K. ............... 57Rodrigo, L. ........................77, 104Rodrigues, A. ...........131, 139, 228,

257, 235Rodrigues, B. ......................... 167Rodrigues, C. G. .....................237Rodrigues, C. M. P. ... 114, 164, 169Rodrigues, J. .............116, 131, 138,

208-209, 217, 235, 258

Rodrigues, J. P. ............... 228, 235Rodrigues, M. S. ..................... 139Rodrigues, N. ........................ 209Rodrigues, P. M. ....... 114, 164, 169Rodrigues, S.................... 117, 139,

165, 196, 218Rodrigues-Pinto, E. .. 117, 120, 122,

196, 209, 231Rodríguez, A. ...................140, 175Rodriguez, C. .... 152, 185, 194, 231Rodriguez, G. E. .................... 235Rodríguez, L. ................... 173, 189Rodríguez, S..................... 127, 137Rodriguez, Y. ......................... 235Rodríguez de Miguel, C. ......................................231Rodriguez Garcia, M. I. ...........154Rodriguez Moranta, F. .........63, 97


361

Sandulescu, L. D. ....................216Sanduzzi Zamparelli, M. .........218Saner, C. ............................... 248Sanga, K. ...............................169Sanguinetti, M. ......................103Sanjuan, X. ............................. 97Sanni, L. ................................122Sano, I. .................................. 131Sano, K. ........................... 147, 174Sano, T. .....................122, 133, 182Sano, Y. ............................126, 151Sanomura, Y. .......................... 151Sansoè, G. .............................. 119Sansone, S. ..................... 177, 225Santacatterina, M. ..................247Santamaria, E..........................117Santana Rocamora, E. ...... 84, 128Santander, C......................97, 136Santantonio, T. ................. 117, 167Santare, D. .............................193Santi, G. .................................130Santi, S. ..................................69Santiago, J. ........125, 178, 227, 245Santo, E. .......................... 85, 155Santolaria, S...........................153Santos, A. ...... 89, 91, 114, 117, 258Santos, J. ...................57, 165, 168,

201, 209, 244, 248Santos, L. ..................117, 209, 237Santos, M. P. ...................233, 237Santos, P. ................. 158-159, 173,

221, 225, 237, 257Santos, P. M. ..........................237Santos, S. .......................209, 258Santos-Antunes, J. ..........165, 168,

201, 209Santos Fernandez, J. .............. 248Santos-Laso, A. ..................91, 117Sanui, M. ......................... 120-121Sanz, Y. ................................... 73São José, C. ............................ 147Saoula, H. .......................185, 257Saperas Franch, E. .............63, 178Sapienza, C. ...........................237Saracco, G. ............................ 180Sarafian, M. ..................... 70, 134Sarafov, S. ..............................159Saray, A. ................................169Sargur, R. ...............................189Saribegioglou, N. .................. 230Sarici, B. ................................ 170Sarigianni, M. .........................49Saripoulos, P. .........................159Sarkar, A. ................................ 62Sarkar, S. .............................. 222Sarlós, P. ........................ 220, 234Sarmento, J. A. .......................195Sarna, V. K. .............................56Sarter, H. ..........................76, 135Sartor, R. B. .............................71

Salman, Z. .............................194Salmon, I. ..............................192Salmoral, R. ...........................153Salomone Megna, A. .............. 119Salteniene, V. ...............91, 115-116Salupere, R. .............. 96, 135, 185Salvador, E. ............................ 115Salvador, J. .............................164Salvador, P. ....... 134, 233-234, 252Salvador, R. ..............233, 247-248Salvia, R. ................................183Salvo Romero, E. ..................... 57Samaha, E. ...................... 151, 229Samama, J. ...................... 50, 176Samanta, J. ...................... 171, 187Samanta, S. ............................193Samarghitan, A. .................... 230Sambaiah, P. .......................... 119Sambuelli, A. M. ................... 238Sami, S. .................................. 41Samlani, Z. ........................... 253Sammarco, R. ........................ 235Sampath, K. ............................99Sampaziotis, F. ........................59Samsom, K. ............................. 93Samsonova, T. V...................... 187Samuel, S. .............................. 72Samyn, M. .............................. 191San Juan Acosta, M. E. ........... 225San Juan, M. .......................... 177San, L. .................71, 117, 122, 153,

181, 209, 237Sanaei, O. ........................ 62, 103Sanagapalli, S. .......................247Sanborn, W. J. ......................... 47Sánchez, A. B. ......................... 63Sanchez, C. .....................194, 222Sánchez, J. ...................... 128, 231Sanchez, S. ........................... 222Sánchez García, A. ................... 63Sanchez Mete, L. ................... 226Sánchez Pernaute, A. ..............198Sanchez Yague, A. .... 125, 175, 180Sanchez-Contador, C. ..............194Sanchez-Lloansi, M. ............... 139Sánchez-Montes, C. .. 128, 180, 231Sanchez-Ocana, R. ..................99Sanchez-Pastor, E. ..................196Sandblom, G. ........... 120, 219, 232Sandborn, W. ........ 47, 61, 102, 136Sandborn, W. J. ........... 47, 56, 80,

140-141Sander, B. Q. .................. 155, 206Sander, M. P. .................. 155, 206Sanders, D. S. ............... 39, 53, 64Sandler, R. .............................. 78Sandoval-Rodriguez, A. .......... 116Sandru, V. ................ 181, 229, 231Sands, B. E. ...................... 56, 102Sanduleanu, S. ...........69, 143, 176

Sakaguchi, Y. ............ 151, 205, 251Sakai, A. ................................ 170Sakai, C. M. ............................126Sakai, P. .................................126Sakai, T. ................................. 179Sakai, Y. .......................... 144, 167Sakaida, I. .......................219, 222Sakaki, N................................124Sakakibara, Y. .........................153Sakamoto, A. .......................... 167Sakamoto, C. ......................... 254Sakamoto, E. ..........................144Sakamoto, H...................... 68, 89Sakamoto, K. ...........................86Sakamoto, N. .................. 53, 123,

128, 131, 151Sakamoto, T. .................... 78, 142Sakao, M. ................................ 62Sakata, K. ...............................231Sakata, Y. .....147, 174, 187, 193, 234Sakaue, T. ............................. 180Sakemi, R................................69Sakita, S. ........................ 203, 241Sakitani, K..............................198Sakizlis, G. .............................124Sako, T. ..................................251Sakuno, T. ................. 122, 172, 181Sakuraba, A. ..........................140Sakurai, K. ............................. 179Sakurai, T. ....89, 152, 201, 252-253Sakuyama, N. .........................145Saladino, V. ............................156Saladzinskas, Z. ....................... 78Sałaga, M. ..............................184Salah, A. ................................ 118Salah, M. .........................117, 220Salah, S. ........................ 188, 253Salameh, J. ............................186Salamon, A. .............. 83, 136, 234Salas, A................................... 97Salazar, E. ..............................156Salazar, R. .............................. 107Salces, I. ................................. 63Saldaña Dueñas, C. ........ 229, 257Salem, A. ........... 119, 136, 138, 183Salem, M. A. ................... 136, 183Salem, O. E. ...........................136Salerno, R. ......................156, 239Salgado-Fernández, M. ......... 245Salgado, M. .............. 175, 210, 245Salgueiro, P. S. .......................210Saliakellis, E............................65Salih, M. ......................... 129, 217Salimon, M. ..................... 93, 168Salinas, A. .......................183, 233Salizzoni, M. ..........................130Sallinen, V. ............................ 220Salloum-Cojocariu, E.-C. ....... 256Sallum, R. A. A. ......................231Sally, Z. ................................. 243

SSá, A. ........................ 63, 158, 198Saad, H. M. ............................136Saadat, S. .............................. 217Saadeh, L. M. .......... 182, 200, 232Saba, J. ..................................216Sabado, F. .............................. 178Sabagh, L. C. ..........................183Sabbah, M. .....................228-229Sabbek, A. .............................168Sabelnikova, E. .......................155Sablich, R.............................. 240Sabri, H................................. 246Sacchi, M. C. ..........................155Sacco, R. ......................... 168, 177Sacharczuk, M. ........................ 79Sachi, N. ................................134Sadeghian, J. ......................... 250Sadek, A. ............................... 119Sadoogh, A. .......................... 203Sadr-Azodi, O. .........................59Saeb-Parsy, K. .........................59Sáenz, M. Á. ..........................200Saez-Royuela Gonzalo, F. ........ 139Saez, E. ...................................117Safadi, B. ................................52Safatle-Ribeiro, A. V. ................... 194, 201, 258Saffouri, G. ....................... 57, 206Safina, D. D. ............................ 77Safroneeva, E. .................101, 248Sagatova, M. ..........................153Sagawa, T................................ 51Sahar, N. ................................ 151Sahin-Toth, M. ................... 46, 59Sahin, M. ................... 46, 59, 236Saia, M. ....................171, 192, 228Saibeni, S................ 225-226, 240Saida, Y. .................................144Saidkhanov, B. A. ...................183Saidkhanova, D. B. .................183Saif, S. ....................................117Saiki, H. .............................51, 53Saikia, A. K.............................219Saini, N. .................................196Saiote, J. ................. 159, 209, 258Saito, D. .................................140Saito, E. ................................ 236Saito, H. ................................ 222Saito, I. ........................... 142, 151Saito, K. ............... 95, 119, 191-192Saito, M. .......................... 136-137Saito, S. ................... 114, 144, 167,

175, 209, 257Saito, T. ..............133, 147, 182, 202Saito, Y. ... 78, 84, 89, 133, 145, 228Saitoh, Y. .......................... 191-192Sakae, H. .........................151, 175Sakaguchi, H. .........................251Sakaguchi, M. .........................65

362


Seidler, U. .........................47, 140Seidner, D. L. ......................... 205Seifert, B. .......................242, 244Sejpal, D. V.............................. 62Seki, H. ..................................241Seki, M. .................................142Sekiguchi, M. .........................145Sekizuka, T. ............................134Seksik, P. ............. 73, 137, 186, 206Seleznik, G. M. ...........102, 170-171Selinger, C. .................47, 137, 188Selinger, L. ......................140, 190Sella, D. .................................247Sellitri, R. .............................. 206Seltsam, K. ..............................46Selvendran, S. S. ....................155Semela, D. ..............................52Semenova, I. ..........................210Semeraro, R. ........... 219, 224, 244Sempere, L. ............................140Sempoux, C. .......................... 248Semyachkina-Glushkovskaya, O. ......................................153Sen-yo, M. ......................219, 222Sen, I. .. 64, 112, 114, 204, 236, 252Senda, Y. ......................... 122, 182Seno, H. ........................... 51, 144Senz, J. .................................. 147Senzolo, M. ............................ 116Seo, A. N. ....................... 180, 230Seo, D. W. ........................131, 221Seo, J. B. .................................98Seo, S. .............................83, 252Seoane, A. ....................... 84, 128Seol, S. Y. ...............................150Seonae-Mosteiro, C. S. .......... 252Sepe, A. .................................140Serejo, F. ............ 159, 167, 207, 257Sergeev, O. ............................ 232Serhiychuk, T. .........................184Serio, M. ............................... 236Serkova, M. ............................ 119Serone, A. .............................. 141Serra Pueyo, J................... 65, 247Serra-Pagès, M. ......................237Serra, D................................. 230Serra, K. ......................... 196, 255Serra, M. .......................... 63, 237Serraj, K. ............................... 255Serrano Falcón, B. ..................148Serrano, M. ............................237Serrão, G............................... 245Serrero, M. .............................. 75Sessa, A. ................................216Sestito, L. ...............................166Sethi, A. ................................. 101Setia, A. ..................................52Setoyama, T. ............................ 51Seufferlein, T. ... 38, 51, 68, 78, 93,

105-106, 120, 193, 211

Schöniger-Hekele, M. ............. 132Schoon, E. J. ............... 72, 124, 173Schoppmann, S. .................... 249Schorsch, T. ............................183Schoufour, J. D.........................48Schramm, C. ........ 61, 91, 146, 242Schreiber, S. .......... 80, 83, 89, 96,

102, 138-140, 239Schreuder, A. M. .....................169Schreuders, E. ........................143Schröder, J. O. ........................138Schroeder, A. ........................ 254Schroeder, S. ..........................154Schrotz-King, P. .......................50Schubert, S. ....................101, 254Schuck, E. ..............................140Schuler, M. ..............................92Schultz, B. ..............................126Schulz, C. ............................... 116Schumacher, B. ....................... 53Schumann, M. .......56, 61, 94, 254Schuppan, D. ...........................56Schürle, S...............................128Schuster, B. ............................ 132Schuster, T. ............................. 187Schwab, M. ............................. 72Schwabl, P. .......................51, 132Schwartz, A. ........................... 131Schwartz, D. .............. 96, 135, 185Schwartz, N. ........................... 181Schwarzinger, M. .................... 101Schwender, B. J. ............. 208-209Schwerdel, D. .........................193Schwingel, G. ..........................52Scicluna, B. ...........................200Scida, S. ............146, 196, 198-199,

202-203, 248-249, 252, 255Scirocco, A. ............................ 147Scolaro, M. ............................ 238Scott, M. ................................. 81Scribano, M. L. ..................97, 185Scrivo, B.......................... 187, 238Scurry, B. ...............................148Scutti, J. .................................145Sebastian, S. .................... 61, 190Sebestyén, A. .........................143Sebkova, L. .............................189Secher, T. ................................ 57Seclaman, E. .......................... 157Sedda, S.................................143Seddik, H. ............................. 253Seeva, P. ............................... 235Seewald, S. ......55, 66, 76, 88, 163Segal, J. ..........................185, 189Segú-Roig, A. .........................184Segura, V. .............................. 157Sehgal, V. .............................. 250Seicean, A. ..........116, 172, 216-217,

222, 230, 246Seicean, R. ...............172, 222, 230

Scarpa, A. ............................. 223Scarpa, M. .....76, 86, 141, 182, 192,

200, 231-232, 250Scarparo, J. I. B. ............. 155, 206Scarpignato, C. ..146, 196, 198-199,

202, 248-249, 252Scarpulla, G. ...................238-239Scatton, O. .............................. 62Schachschal, G. ....................... 76Schäfer, C. ..............................231Schäfer, E. .......................234-235Schäfer, M. ..............................38Schaffalitzky de Muckadell, O. B. ........ 154, 250Schaffner, D. ........................... 114Scharl, M. ............ 86, 97, 233-234Schaubeck, M. ........................134Schellekens, A. .......................165Schemberk Jr., J. .................... 206Schembri, E. L. ........................89Schepp, W. .............................158Scherbaum, N. ....................... 175Scherl, A. ...............................190Scherzer, T.-M. .......................215Schett, G. ............................... 170Schiepatti, A. ......................... 204Schierenberg, A. .....................103Schifano, G. ............................231Schildhauer, T. A. ................... 178Schindler, P. ........................... 116Schindler, V. .......................... 206Schlachter, S. ........................ 249Schlag, C. ........................101, 248Schlitzer, A. ............................. 70Schlosser, S. .................... 116, 214Schlüter, F. ............................ 232Schmalenberg, H. ....................92Schmerboeck, B. ............. 101, 216Schmid, R. M..................224, 248Schmidt, A. ............... 53, 120, 237Schmidt, B. ...................... 57, 206Schmidt, F. ............................ 239Schmidt, M. A. .......................237Schmidt, P. N. .........................221Schmidt, S. ..............................58Schmied, B.............................183Schmiegel, W. .....92, 175, 178, 225Schmitt, A. .............................. 78Schmitt, H. .............................. 79Schmitt, M. ........................... 254Schneider, M. ..... 102, 126, 187, 231Schneider-Koriath, S. ........133, 174Schnittert, J. ......................78, 221Schnúr, A. ...............................171Schoen, R. ..............................143Schoenberg, M. B. ................. 232Schoepfer, A. ............101, 235, 248Scholdei, M. ............................171Scholz, D. ................................ 53Scholz, M. ...............................46

Saruc, M. ...............................215Saruta, M. ................201, 252-253Sasahira, N. ............................95Sasai, K. ................................ 222Sasajima, J. ............................ 172Sasaki, E. ......................... 147, 174Sasaki, F. ......................... 121, 186Sasaki, H. .............................. 250Sasaki, K. .............................. 258Sasaki, M. ................ 120-121, 126,

137, 172-173Sasaki, R. ............................... 179Sasaki, Y. .........................194, 241Sasanuma, S. ............. 72, 131, 243Satarasinghe, R. L. .................158Sato, C. ..................................124Sato, D. .................................. 177Sato, H. ...........................103, 180Sato, S. ........................... 132, 198Sato, T. .................95, 116, 119, 145Sato, Y. .......... 51, 103, 129, 152, 191Satokari, R. ............................241Satou, D. ................................201Satsangi, J. ......... 101-102, 139, 236Sattianayagam, P. .................. 207Sauer, V..................................215Saunders, B. P. ..................48, 81,

106, 211, 226Saunders, J. ...........................145Saunders, R. .................. 126, 245Saurin, J. C. ................72, 100, 132Sautel, C. ................................ 83Sautereau, D. .......53, 177-178, 232Sauvanet, P. ............................85Sav, R..................................... 217Savale, C. .............................. 229Savarino, E. .......... 68-69, 88, 100,

148-150, 187, 189, 191, 198-200, 203, 237,

247-249Savarino, V. .........69, 149, 187, 191,

198-200, 237, 248-249Saviano, A. .............................218Savoye, G. .................... 75-76, 135Sawada, M. ............................ 119Sawada, T. ....................... 136-137Sawahara, H. ...................65, 168Sawai, T. ................................130Sawai, Y. ................................ 167Sawano, H. ...................... 120-121Sawhney, M. .................... 93, 251Sawiak, S. ...............................59Saygılı, Ö................................215Sazhin, A. V. ...........................158Scacchi, G. .............................156Scaioli, E. ................................ 78Scaldaferri, F. ........ 57, 72, 112, 188Scandroglio, I. ........................ 133Scanzi, J. ................................. 83Scapa, E. .................................85


363

Siddique, I. ............................135Siddique, N. ........................... 151Siddiqui, A. A. .................. 62, 102Siddiqui, M. A. .......................216Sidhu, M. ..........................99, 177Sidhu, R. ..........................131, 231Siegel, C.................................140Siegmund, B. ........43, 73, 81, 100,

239, 254-255Siersema, P. D. ...... 55, 69, 76, 80,

88, 245, 248-249Sifrim, D. ..........47, 69, 73, 94, 101,

105, 247-248Signorelli, S. ........................... 62Signoretti, M. ................... 85, 172Silina, T. L. .............................158Siljander, P. ............................193Silva Junior, R. G. ...................215Silva, A. ......................... 207, 228Silva, A. P. ...............209, 228, 235Silva, F. ................................. 258Silva, G. L. R. ..........................126Silva, H. ................................ 209Silva, J................116, 131, 138, 195,

209, 228, 235Silva, J. C. ..................116, 131, 138,

209, 228, 235Silva, K. T. P. E. .......................189Silva, M. ...... 116-118, 120, 130, 164,

173, 195, 208-210, 245Silva, N. ................................ 224Silva, R. ............ 126, 132, 180, 207Silva, S. ...................................52Sima, A. .................................218Simantov, R. ............................69Simão, A. ........................ 214, 217Simão, A. L. .....................164, 169Simão Ferreira, M...................159Simas de Lima, M. .......... 194, 258Simeone, P. ........................... 254Siminkovitch, S. ......................221Simioni, P. .............................. 116Simionov, I. ............................ 116Simko, A. .............................. 248Simmen, S. .....................184, 233Simmons, A. ......................... 235Simões, C. ........210, 225, 245, 258Simon, D. ..................79, 143, 182,

248, 250Simon, H.-U. ......................... 248Simon, M. ................... 73, 75, 185Simon, P..................................171Simon, V. ............................... 179Simonelli, C. ..........................103Simrén, M. ........46, 71, 77, 80, 90,

99, 141, 146, 149, 176, 244-245

Şimşek, H. .........................77, 104Simsek, M. ..............................59Singeap, A. M. ............131, 166-167

Shimpoh, T. ............................182Shimura, T. .....................142, 144Shin, C. M. ................ 152, 197, 251Shin, D. ...........................188, 194Shin, D. W. ...................... 143, 192Shin, E. J. ........................181, 230Shin, H. D...............................194Shin, J. E. ...............................194Shin, J. S. .............................. 253Shin, O.-R. .............................219Shin, S. J. .........................132, 175Shin, S. K. .............................. 174Shin, W. C. ............................. 197Shin, W. G. ............................. 173Shin, Y. W. ...................... 223, 246Shinji, Y. ................................ 123Shinkai, K. .............................153Shinkins, B. ........................... 226Shinmura, K. ....................95, 201Shinoda, S. .....................219, 222Shinohara, T. ................... 122, 176Shinozaki, S. ...........................68Shintani, S. ............................129Shinzaki, S. ...................... 76, 188Shiode, J. ....................... 209, 257Shiomi, H. .............................. 170Shiomi, Y. ............................... 170Shiraha, H. ................ 65, 166, 168Shirai, S. ..............77, 187, 193, 234Shirasaki, T. ...........................143Shirazi-Beechey, S. P. ..............52Shirin, H. .........................69, 252Shirlow, K. ............................. 187Shivaji, U. ..............................142Shiwaku, H.......................182-183Shnell, M. ........................ 69, 155Shnitenkova, A. ......................153Shoji, A. .................................153Shonova, O. .................... 220, 242Shousha, H. ........................... 118Shpak, B. ................................69Shpigel, N. Y............................ 97Shums, Z. ..............................136Shushunova, N. ......................153Shutkever, O. ........................... 70Shuwen, L. ............................ 207Shvets, O. ..........................77, 104Si-Salah, L. ............................188Si, G. ................... 52, 82, 118, 162,

188, 207, 209, 215, 234Si, J. ................... 116, 131, 138, 143,

170-171, 195, 201-202, 209, 228, 235, 251

Siau, K. ..............114, 123, 125, 127, 182, 197, 223, 225-227

Sibley, C. ................................156Sica, G. ................................. 234Sichijo, S. ................................85Sicília Aladrén, B. ............ 139, 185Siciliano, M. .................... 215, 218

Shcherbakova, A. ....................150Sheard, J. .............................. 222Sheehan, D. ...........................134Shehata, M. A. H. ...................153Shehatta, A. S. ...................... 220Sheibani-Tezerji, R. ................135Sheibani, R. ..................... 96, 135Shen, S. ................................. 114Shen, W. ............................... 104Shen, Z. ............................57, 193Sheppard, D. ...........................86Sheridan, J. ......................217, 251Sherif, N. A. ............................117Sherman, S. ...............62, 145, 179Shetty, S. .......................... 84, 125Shi, D. ......................114, 175, 188,

194, 207, 218Shi, H.................... 65, 69, 97, 121,

166, 168, 183, 223Shi, N. ......................139, 151, 226Shi, Q. ....................................201Shi, R. .... 77, 88, 122, 130, 152, 155,

172, 182, 187-188, 219, 234Shiba, M. ...........79, 154, 200, 254Shibamoto, A. ........................ 167Shibata, C. .............................142Shibata, M. ............................. 51Shibata, T. ....................... 123, 144Shibatoge, M. ................. 154, 254Shibayama, K. ................. 172, 215Shibuya, T. ...................... 119, 140Shichinohe, T. ........................182Shidrawi, R. ...........................155Shiffman, M. ........................... 91Shifrin, O. S. ...........................257Shigita, K. ..............................142Shili, S. ...................................80Shim, C. S. .............. 202, 252, 257Shimada, K. ...........................182Shimada, S............................ 254Shimada, Y. ............................198Shimakawa, M. ...................... 114Shimakoshi, H. ....................... 121Shimamoto, F. ........................144Shimatani, M. ............ 62, 84, 126Shimaya, K. ..................... 118, 194Shimizu, A. ............................122Shimizu, H. ............................. 97Shimizu, R. ..................... 122, 130Shimizu, T. ...............123, 169, 246Shimizu, Y. ................53, 122, 128,

133, 151, 182Shimoda, A. ........................... 121Shimoda, M. .....................53, 173Shimoda, R. .. 77, 152, 187, 193, 234Shimoda, Y. ..............146, 193, 203Shimodate, Y. ................... 69, 146Shimogama, T. ........................117Shimohara, Y. ................... 69, 142Shimosegawa, T. ............. 152, 197

Seuwen, K. ........................97, 233Sevdalis, N. .............................89Sever, N. ................... 79, 103, 121,

170, 212, 218Severi, C................................. 147Sevilla Mantilla, C............ 198-199Sevo Spahiu, S. ......................125Sevrin, G. .................................71Seward, E. ............................. 191Sexton, V. .............................. 235Sezgin, O. .............................. 203Sezikli, M. ............................. 254Sfarti, C. .................................166Sgambato, D. ................. 165, 203Sgarro, C. ...............................189Sha, W. ..................................136Shachar, E. ....................... 69, 140Shafazand, M. .................. 177, 231Shah, A. ............ 62, 149, 204, 246Shah, E. D. ..................... 196, 245Shah, N. H. .................... 129, 209Shah, R. .................................150Shah, R. J. ........................ 62, 145Shah, Y. ..................................102Shaheen, N. J. ........................ 173Shahini, E. .............................166Shahinyan, T. ......................... 157Shaib, Y. ..................................52Shaikh, F. K. .......................... 253Shaini, E. ...............................189Shalaby, S. ............................. 116Shalaeva, O. ...........................241Sham, P. C. ............................ 202Shamir, R. ........................ 64, 154Shan, H. .................................. 72Shanahan, E. ..................204, 246Shanahan, F. ..........................134Shao, C. .................................216Shapina, M. ........................... 187Shapira, S. ......................242-243Shapiro, D. .............................. 91Sharaan, M. .......................... 232Sharaf, A. L. ...........................218Sharara, A. I. ...........................52Shariati, F. .............................. 123Sharkey, K. A. .................... 50, 70Sharma, A. ........... 52, 99, 121, 165Sharma, D. ..............................171Sharma, K. ...................... 103, 178Sharma, M. ................99, 121, 130Sharma, N. ......................142, 234Sharma, P..........................87, 150Sharma, R. ............................ 220Sharma, V. .............................159Sharp, L. ................................ 175Sharp, T. ................................ 151Shashkov, M. V. ......................144Shaw, S. .................................233Shayto, R. H. ...........................52Shcherbakha, V. S. ..................257

364


Spivak, E. ............................... 157Sporea, I. ...........116, 157, 168, 170,

214, 216-218, 224Sprakes, M. ........................... 253Sprange, K. ............................142Squire, M. ..............................150Sreekar, D. ............................ 224Srivastava, A. ......................... 157Stabuc, B. ............................... 79Stack, R. .................................138Stadlbauer, V. .................. 101, 216Staffer, S. ...............................233Stafylidou, M. .........................159Staiano, T. ..............................130Stakenborg, M. ...................79, 92Stålhammar, J. ........................49Stallmach, A. .......................... 141Stanciu, C. ... 116, 131, 166, 216, 254Stanco, M. ..............................166Stanel, I. M. .......................... 223Stanghellini, V. ....... 70, 78, 90, 92Stanley, H...............................188Starostina, T. N. ......................158Starzynska, T. .......................... 78Stasinos, I. ...................... 131, 226Staubach, P. .......................... 206Stauber, R. .............................216Staun, M. ...............................103Stavrinidis, S. ...................62, 230Steel, A. .................................185Steele, R. ...............................193Stefanescu, C. ............. 75, 80, 186Stefanescu, H. ............64, 73, 166,

215, 217, 256Stefanovic, M. ......................... 72Steffen, H. ........................133, 174Steffen, H.-M. ........................ 242Stehlikova, Z. .........................184Steijlen, P. ...............................49Stein, J. ..................................155Steiner, P. ............................... 137Steiner, S. ...............................171Steinert, A. .............................. 70Stengel, S. ...............................89Stengel, S. T. ..........................135Stepan, A.-M. ...................216-218Stepanov, A. ...........................257Stephan, D. ........................... 249Sternby, H. ......................170, 220Sterneck, M. .......................... 229Stetska, V. ..............................184Steube, A. .............................. 141Steurer, S. ..............................150Stevens, T. ............................. 246Steyerberg, E. W. .............151, 200Sticova, E. ..............................158Stieger, B. .............................. 118Stiegler, P. ....................... 101, 216Stiewe, T. ...............................164Stigaard, T. ..............................69

Soni, A. ........................... 159, 257Sonmez, E. ............................ 220Sonnenberg, E....................... 239Sonoda, A. .............................134Sonoyama, H. ..................101, 238Sopeña-Biarge, F. ............153, 245Sorbello, M. ............ 194, 201, 258Soria, M. .....................49, 96, 174Soriani, P. .............................. 127Soriano Izquierdo, A. ............... 63Soriano-Gabarró, M. ...............96Sorrentino, D. .................... 54, 63Sorribas Olivera, M. ................ 116Sostres, C. ...................... 245, 253Soto, J. L. ......................... 63, 143Sou, S. .............................69, 252Soualah, K. ............................188Soul, S. ................................. 252Sousa Andrade, C. ................. 208Sousa, C. ................... 56, 157, 208Sousa, D....................116, 131, 138,

224, 236, 255Sousa, E. ........................ 188, 258Sousa, M. ..................116, 131, 138,

209, 228, 235Sousa, P. ..................188, 207, 228Sousa, R......84, 128, 166, 180, 256Souza, T. F. .............. 155, 206, 255Sowa, J. P. .............................. 217Soykan, I. ....................... 144, 246Soylu, A. R. ............................159Spaan, C. N. ...........................192Spaander, M. C. W. .......37, 48, 79,

143, 150-151, 192, 200, 245

Spada, C. ................... 94, 126, 131Spadoni, I. ............................. 116Spagnuolo, R. ................ 189, 240Spaho, L. ............................... 254Spalinger, M. R....... 70, 86, 96-97,

184, 233-234Sparchez, Z. ........................... 217Spehr, C. ............................... 229Spence, S. C. ...........................65Sperber, A. ................ 71, 146, 149,

244-245Sperling, F. ............................ 222Speroni, S. .............. 150, 199, 248Spicak, J. .....52, 125, 143, 148, 158,

174, 184, 197, 217, 220-221, 224, 249-250, 256

Spiceland, C. M. ...................... 62Spielmann, P. .........................184Spiller, R. ...56, 60, 74, 88, 94, 142Spina, L. ............................97, 185Spindelboeck, W. ....................216Spinelli, A. ......................... 73, 81Spinelli, I. ..............................218Spisák, S. ...............................192Spitz, W. ............................... 254

Smith, C. ................................135Smith, K. G. .............................80Smith, M. .........................59, 246Smith, S. ............ 137, 140, 252-253Smith, T. ................................156Smits, M. J. M. ........................150Smits, S. ................................125Smola, I. ............................... 240Smoot Malecha, E.................... 91Smout, A. ................37, 73, 80, 90Smrekar, N. ............................. 79Snaebjornsson, P. ...................192Sneh Arbib, O. ......................... 91Snel, C. ...................................92Snijkers, J. T. W. .................... 248Snir, Y. ............................. 91, 230So, I. T. ...................................201Soaita, A. ................................ 47Soares, E. .................158, 210, 217,

223, 229, 256Soares, J. B. .............180, 183, 188Sobhani, I. ................50, 194, 243Sobolewska-Włodarczyk, A. ......................................233Socaciu, C. .................73, 166, 215Söderholm, J. D. .................... 236Soerjomataram, I. ................... 87Sofianidis, G. ....................62, 230Sofuni, A. .............................. 222Sogorb, T................................237Soh, J. S. ................................142Sohn, K. M. .....................158, 164Soilleux, E. ............................ 254Sokol, H. ............ 41, 46, 57, 77, 91,

105, 134, 139, 206Sokoll, R. ............................... 187Sokolova, A. ........................... 132Sokolova, A. S. .......................144Sola Tapias, N. ........................92Soliman, G. M. M. .................. 147Soliman, H. ..................... 177, 228Solito, S. ................................122Sollid, L. .................................56Soltys, K. ............................... 236Solymosi, N. .......................... 229Somani, P. ..................99, 121, 130Son, Y. G. ...............................201Soncini, M. .............................156Sonda, S. ........................170, 220Song, B.-C..............................159Song, E. M. ............... 98, 175, 239Song, K. .................................169Song, K.-H. ........................... 249Song, K. Y. ....................... 142, 152Song, S. Y. ...........122, 169-170, 172Song, T. J. .........................131, 221Song, X. ................................. 139Song, Y. .....48, 72-73, 115, 122, 133,

142, 152, 169-170, 172, 175Song, Z. .................................164

Singer, P. ............................... 256Singh, A. ............................... 239Singh, H. ................................143Singh, J. ................................. 170Singh, N. ................................219Singh, R. .................... 58, 122, 177Singh, S. .......................... 58, 122Singh, V. ................................. 62Singh, V. K. .................71, 102-103Sinha, A. ................................135Sinha, R. ................................ 175Sinha, S. K. .........103, 171, 178, 187Siniagina, M. N. ...................... 77Sinkovec, H. ...........................227Sipeki, N. ..........................61, 136Sipos, B. ................................. 78Sipponen, T. .......................... 239Siribumrungwong, B. ............. 133Siringo, S. .......................238-239Sirli, R. ........116, 168, 214, 216-218Sitkin, S. ................................241Sivard, B. ...............................186Siwiński, P. .............................233Six, A. ..................................... 57Sjöblom, S. ............................ 176Skanderova, E. ...................... 220Skendros, P. ...........................134Skieceviciene, J. .......... 91, 116, 154Skinazi, F. ...............................185Sklyarov, E. ......................214-215Skodje, G. I. ............................56Sköldberg, F. ..........................143Skolnick, B. E. ......................... 47Skonieczna-Żydecka, K. ...........237Skorokhodkina, O. V. .............. 234Skouras, T. ..................... 222, 240Skrickova, J. ............................149Skridlevskiy, S. .......................210Skroubis, G. ...........................241Skrtic, A. ................................257Skrypnyk, I. ............................165Skuja, V. .........................235, 240Skup, M. .......................... 49, 139Slaman, A. ............................ 250Slavcev, A. .............................. 217Sloan, S. ......................... 141, 188Sloth, S. ..................................69Slotta-Huspenina, J. ....... 193, 248Slottje, M. ..............................126Slyskova, J. .............................143Smaastuen, M. C. ...................237Smajs, D. ...............................241Småstuen, M. C. .......................71Smecuol, E. ........................49, 61Smedile, A. ...................... 117, 167Smeets, X. ......................... 71, 121Smid, A. .................................. 79Smit, W. L. ..................... 192, 242Smith, A. ............................... 226Smith, A. M. ............................59


365

Szurowska, E. ..................218, 236Szutan, L. A. ...........................215Szymanska, A. .................175, 228

TTaavela, J. ............................. 254Tabacelia, D. ..........................231Tabouret, T. ........................... 232Taccone, F. S. .......................... 133Tachecí, I. ...............................251Tack, J. ..............39, 59, 65, 71, 83,

90, 94, 101, 195, 198, 244, 247

Tacke, F. ......... 48, 61, 84, 104, 207Tada, K. ..................................126Tada, M. ......... 93, 95, 119, 167, 232Tadbiri, S. ............................... 75Tafrishi, B. ............................ 229Tag-Adeen, M.......................... 93Tagawa, K. .............................142Taghavi, S. A. ................... 65, 215Tagzout, D. .............................154Tahara, T. ........................ 123, 144Tahora, M...............................136Tai, W.-C. ...............................166Tai, Y. ............................... 59, 257Taibi, A. ................................ 232Taira, K. .................................. 79Taira, T. ................................. 180Taiymi, A. ............................... 178Takada, J. ...............................152Takada, R. ..............................122Takagi, M. ..............................152Takagi, R. ................................98Takagi, T............ 123, 174, 204, 253Takahara, M. ......................... 203Takahara, N. ...............95, 119, 182Takahashi, A. ................. 152, 250Takahashi, H. ................... 58, 172Takahashi, J............................. 97Takahashi, K. .............58, 103, 121,

130-131, 250Takahashi, M. ........................ 250Takahashi, S. .................. 203, 222Takahashi, Y. ......................... 205Takaki, A. ...............................166Takaki, Y. .................................58Takami, M. .............................169Takanashi, K. ......................... 226Takano, N. ............................. 258Takaoka, A. ............................ 137Takaoka, M. ............................. 62Takara, Y. ................................ 77Takasago, T. .............. 175-176, 182Takasawa, A. ......................... 243Takashima, K. .............95, 177, 250Takashima, S. ........................ 203Takashima, T. ......................... 167Takata, R. ............................... 167

Sunata, Y. ................................ 53Sundin, J. ...................92, 141, 146Sundy, J..................................140Sung, I.-K....................... 202, 252Sung, J. J. Y.......... 63, 142, 147, 192Sunjaya, D. B......................... 207Suo, J. B. ................................153Suo, M. ............................ 147, 174Suraci, E. .............................. 202Suri, V. ...................................159Surmiak, M. .......................... 104Sutton, R. ................................ 72Suvorov, A. ............................ 203Suvorova, T. S. ........................122Suyama, Y. .....................204, 253Suzuki, A. ...........129, 171, 180, 222Suzuki, H....... 85, 98, 124, 136-137,

191-193, 230, 243Suzuki, K. ...................... 61, 97-98Suzuki, M. ...................... 180, 236Suzuki, N. ...........86, 198, 226-227Suzuki, S. ................... 85, 123-124Suzuki, T. ..................129, 171, 180Suzuki, Y. ................................ 61Suzumura, K. .............93, 167, 232Svecová, H. ............................. 197Svegl, P. .................................. 79Svegliati Baroni, G. .................168Svinarov, D. ............................221Svintsitskyy, A........................ 249Swallow, K. ............................189Swaminathan, M. .................. 222Swan, M. ............................... 123Swann, J. ........................185, 233Swanson, L. ...........................145Swanström, L. ........................198Sweis, R. ....132, 149, 225, 244, 247Swinkels, D. W. ......................165Symonds, E. ............................90Szachniewicz, M. ..................... 61Szajewska, H. ............... 64, 74, 92Szalai, M. .............................. 243Szalai, Z. ................................195Szállási, Z. .............................192Szamosi, T. .. 83, 136, 234-235, 240Szapáry, L. .............................231Szapary, P. .............................. 47Szarvas-Jones, S. ....................192Szatmary, P. ............................ 72Szczyrk, U. ...............................85Székely, H. ..............................159Szentesi, A. ........................... 220Szepes, A. ...................... 234, 243Szepes, Z. ................ 83, 136, 228,

234, 238, 240Szigeti, K. ........... 143, 192-193, 243Szigeti, N. .......................192, 234Szillat, P. .................................64Szlachcic, A. .......................... 104Sztembis, J. ........................... 236

Sualeh Muhammad, J. .............85Suarez, I. ...............................221Suarez, J. ................................95Suárez Ferrer, C. .....................188Suárez González, A. ...84, 128, 245Suazo, J. .................................210Subramaniam, S. ......... 53, 72, 99,

125, 225Subramanian, V. ........135, 176, 237Súbtil Íñigo, J. C. ................... 180Subtil, C. ............................... 222Suceveanu, A. P. ...............115, 153Suceveanu, A.-I. ...............115, 153Suchanek, S. ....222, 228, 242, 244Suciu, A. ......................... 215, 217Suda, K. ...... 82, 183, 223, 232, 251Sudo, K. ........................... 89, 124Suehiro, S. ................ 123, 147, 169Suekane, T. ...................... 147, 174Sueoka, H. ........................93, 167Suga, B. .................................136Sugahara, A. .......................... 147Sugai, T. ...........................98, 243Sugaya, T. ............................... 76Sugihara, Y. ........................... 203Sugimori, K. ...........................169Sugimoto, A. .......................... 121Sugimoto, M. .... 126, 137, 203, 232Sugimoto, S. .............. 61, 138, 169Sugimura, M. ........... 144, 192, 231Sugimura, N. ........................... 79Sugisaki, N. ..................... 197, 234Sugitani, A. ............................ 172Sugiura, R. ............................. 131Sugiyama, T. .................... 85, 134Sugrue, K. ..............................237Suh, J. H................................. 139Suharoschi, R. ........................ 172Suissa, A. ............................... 179Sujendran, V. ........................200Suker, M. ............................... 123Sukovas, A. ............................ 172Sulaiman, R. ..........................135Sultana, R. .............................219Sultankhodjaeva, S. S. ............ 157Sumi, K. .................. 175, 250, 256Sumida, Y. ...........93, 144, 175-176,

182, 194, 201Sumiyama, K. ........................ 256Sumiyoshi, T. ..........................231Šumskienė, J. ......................... 115Sun, B. .................................... 72Sun, G. ................................... 132Sun, J. ................. 63, 93, 122, 140,

146, 152, 165, 234Sun, L. ......... 141, 143, 171, 201, 251Sun, Q. ...................................145Sun, S. ........................... 180, 220Sun, W. C. ...............................59Sunada, K. ..............................68

Stigliano, S........................171-172Stigliano, V. ........................... 226Stilidi, E. ............................... 220Stirand, P. ....................... 148, 174Stirbu, L. ............................... 256Stoica, O. ...............................166Stojkovic, M..................... 133, 165Stolfi, C. .................................143Stone, S. ............................... 242Storey, D. .............................. 240Storm, A. C. ............................102Storm, G. ...............................221Stornello, C. ........................... 172Storonova, O. ................. 145, 248Storr, M. A..............................247Storrie, J. .............................. 246Stotzer, P.-O. .......................... 176Stournaras, E. ........................126Strachan, J. A. ........................193Stracke, B. ..............................247Strand, D. S. ............................ 62Strasser, S. .............................. 91Straub, D. ......................... 92, 150Straumann, A. .................101, 248Strehle, K. ...............................84Streleckiene, G. .................91, 154Stremmel, W. .........................233Stricker, B. H. ..........................85Strid, H. .................................189Strijbos, D. ......................124, 149Strik, A. ............................. 73, 141Strisciuglio, C. ........................135Strnisa, L. ................................ 79Strobel, D. .............................. 121Stroux, A. .............................. 255Struijs, E. ............................... 187Strunk, M. ..............................153Stryszak, P. .............................140Strzalka, M. .............................85Stuchlik, S. ............................ 236Study Group, I. ................237, 255Stuhrmann, N. C. ....................233Sturdik, I. .............................. 236Sturgess, R. ............................. 62Sturm, A. .......................... 97, 141Sturniolo, G. C. .... 55, 187, 189, 231Stürzl, M. ................................86Su, C. .......38, 50, 56, 61, 102, 140,

169, 188, 207, 222, 256Su, L. ..........53, 68, 72, 79, 96, 99,

117, 125, 127, 141, 143, 171, 178, 201, 225, 251

Su, M.-Y. ................................142Su, T. ............... 38, 47, 52, 62, 69,

76, 85, 92, 98, 103, 112, 119, 121, 125, 128-129, 131, 134-135, 147, 157, 161, 171,

174, 180, 200, 206, 219, 229-232, 237, 243, 255

Su, X. ..................................... 141

366


Tezel, H. A. .............................159Thabut, D. ......35, 38, 84, 100, 106Thakar, K. ...............................194Thakkar, R. ........................ 49, 80Thakkar, R. B. ..........................80Thakkar, S. ....................... 58, 122Thakkinstian, A. ...................... 133Thakral, A. ............................. 157Thalagala, E. ......................... 229Thaler, J. ................................. 51Thandassery, R. B. ..................216Thangarajah, D. ................ 157, 191Thapaliya, S. ..........................164Thapar, N. ......................... 50, 65Tharsis, G. ........................ 50, 176Theilla, M. ............................. 256Theis, V. ....................58, 188, 243Thelin Schmidt, P. ...................143Theocharis, G. ........................241Theodoraki, E. ........................ 187Theodoropoulos, L. ......... 230, 243Theodoropoulou, A. .. 125, 129, 145Theodorou-Kanakari, A... 206, 251Theodorou, V. .................. 141, 145Theopistos, V. .........................241Theuerkorn, K. ...................... 222Thiele, M. ................................38Thieringer, F. .................... 98, 125Thiis-Evensen, E. ......................71Thijs, W. J. ..............................102Thijssen, J. M. ........................ 167Thomas-Gibson, S. ...... 81, 89, 94,

223, 225-226Thomas, T. .............................247Thomassen, B.........................142Thomopoulos, K. ....................241Thompson, A. .........................190Thompson, C. C. .........71, 102-103,

153, 216, 219Thomson, C. ...........................153Thorlacius, H. ........................ 228Thornton, L. .......................... 222Thorpe, A. J. ..................... 61, 140Thumshirn, M..........................52Thursz, M. ..............................165Thuss-Patience, P. ....................92Tiako-Meyo, M. ................ 93, 168Tian, J. ....................................52Tian, W. .................................144Ticlete, I. ................................. 83Tierney, M. .............................156Tighe, D. ..... 137-138, 140, 253-254Tilg, H. ..........35, 42, 70, 77, 87, 89Tilmant, C. ............................ 225Timar, R. ................................218Tiniakos, D. .................. 42, 48, 75Tinmouth, J. ...........................143Tirado, P. R. ........................... 238Tirgar Fakheri, S. ................... 203Tiribelli, C. .............................165

Tavares, D. ............................. 178Tavares, J. ............................. 207Távora, I. ............................... 258Tawara, S. ............................. 246Taya, Y.................................... 179Taylor-Robinson, S. ................165Taylor, A. J. ............................ 204Taylor, K. M. ............. 141, 196, 233Taylor, L. J. .............................. 62Taylor, M. ............ 70, 141, 196, 233Taylor, S. ..............80, 86, 163, 165Tcymbarevich, I. ................97, 233te Morsche, R. H. M. ...............165Tearney, G. ............................ 249Tebaibia, A. ............................154Techapaitoon, S. ..................... 177Teggiachi, M........................... 139Teich, N..................................140Teixeira, A. F. ..................206, 255Teixeira, C. .............................215Tekin, F. .................................143Telegin, A. ..............................153Tell, G. S. .............................. 204Tellian, A. ..............................194Telliez, J.-B. ............................ 79Temma, T. ..............................169Temperley, H. ........................ 252Ten Hove, A. ............................59Tenca, A. ................................. 91Tene Fokam, T. B. ........... 199, 249Teniente, A. ............................186Teoh, A. Y. ..............................152Teoh, A. Y. B. ..................230, 250Tepeš, B. ...........................77, 104Teppei, O......................... 191, 236Terabe, H. ...............................69Terai, S. ............................61, 103Teramoto, T. ........................... 178Teramukai, S. .........................126Terán Lantarón, Á. ................. 180Terasaki, K. ..................... 123, 174Terasaki, M.............................. 53Teresa Marzia, R. .....................171Termite, A. ....................... 117, 167Terracciano, L. ......................... 70Terreehorst, I. T. .....................149Tersaruolo, C. .................. 216, 231Teruel Sánchez-Vegazo, C. ..... 248Terveer, E. M. .........................196Terzic, S. ................................. 79Tessari, R. ............................. 238Tesselaar, M. ........................... 93Testa, A. ..................205, 235, 238Testa, G. .................................155Testa, S. ................................ 207Testelin, S. .............................135Testoni, P. A. ....................69, 242Testoni, S. G. G. ..................... 230Teubner, D...............................69Teufelhart, M. ........................215

Tan, Y. .................98, 114, 120, 251Tanabe, H............. 51, 58, 125, 129Tanabe, S. ....51, 104, 124, 151, 200Tanaka, F. ................. 79, 200, 254Tanaka, H. ................. 76, 140, 188Tanaka, K. ... 76, 122, 126, 129, 134,

152, 171-172, 180-182, 191Tanaka, M. ................51, 128, 145,

194, 242, 250Tanaka, R. ..................57, 222, 241Tanaka, S. .......... 53, 122, 144, 151,

153, 194, 223, 236, 251, 254

Tanaka, T. ................. 134, 191, 203Tanaka, Y. .................... 57, 98, 114Tandan, M. ............................. 181Tang, C................ 59, 116, 172, 257Tang, J. ..................................192Tang, K. .................................193Tang, P.-L. ...............................59Tang, R. S.............................. 207Tang, S. ......................59, 116, 207Tang, W. .................................142Tang, X. ...........................128-130Tangermann, P. H. ................. 254Tanida, S. ...............................142Tanigawa, T. ............. 79, 200, 254Taniguchi, Y. ...........................120Tanino, M. ..............................122Tanke, G. ................................ 167Tankova, L. ......................159, 236Tannapfel, A. ...........................92Tanoue, S. ....................... 121, 186Tantau, M. ......... 54-55, 64, 73-74,

166, 217, 224, 246, 256Tanzi, G. ................................ 180Tao, K. ...................... 175-176, 182Tao, Z.....................................142Tap, J. .................................... 141Tapete, G............................... 240Tarabar, D. ..............................56Tarani, F. ................................ 191Tarantino, I. ..................... 99, 130Tarantino, O. ......................... 228Tardillo, C. ............................ 235Tardón, A. ..............................143Targan, S. R............................ 141Targosz, A. ..............................85Tarli, C. ..................................166Tashiro, T. ..............................153Tasset, C. ........................... 47, 141Tata, A. ..................................188Tatarkina, M. ..........................221Tate, D. J. ....... 69, 99, 128, 175, 177Tatro, A. .................................190Tatsuguchi, A. ....................... 236Tatsumi, N. ........................51, 53Tavani, R. ...............................140Tavares de Sousa, H. .............. 236Tavares Sousa, M. H. ..............188

Takatalo-Laine, M. ..................193Takatori, Y. .............................. 53Takats, Z. ...............................184Takayama, H. .........................146Takayama, K. ......................... 206Takayama, S. ..... 123, 174, 204, 253Takayama, T. ..........................231Takeda, K. ...... 46, 72, 98, 126, 194Takeda, S. ...............................86Takeda, T. .................... 69, 95, 119Takeda, Y. ....................51, 58, 142Takei, D. ................................ 203Takei, Y. .................... 122, 172, 181Takemura, K. ..........................142Takenaka, K. ....................136, 236Takenaka, M. .................... 131, 181Takeno, S. ..............................183Takeshima, F. ........................ 252Takeshita, F. ............................89Takeuchi, C..................... 124, 205Takeuchi, H. .................... 174, 232Takeuchi, M. .......................... 232Takeuchi, T. ......................122, 172Takeuchi, Y. .....53, 84-85, 126, 201Takezawa, R. ...........................69Taki, M. .................................. 167Takihara, H. ............................194Takikawa, Y. ........................... 115Takimoto, K. ............................96Takizawa, K. ..............51, 124, 128,

151-152, 194, 242, 250-251

Takizawa, S. ............................89Takumi, K. ............................. 180Talaat, M. ............................... 118Talaat, R. ...............................153Talas, D. ..................................171Talens, J. B. ............................237Talieri, M. ............................. 243Talley, N. J. ....71, 149, 155, 197, 204Tamada, K. .............................130Tamagno, G. .......................... 223Tamai, N. ........................ 84, 256Tamaki, H. ..............................154Tamaki, Y. ..............................130Tamari, H. ........................ 69, 142Tamaru, Y. ..............................144Tamary, H. ............................. 151Tamburini, A. ........................ 242Tamegai, Y. ............................ 175Tamelis, A. ....................... 78, 146Tamminen, K. ........................ 239Tamura, T. .................130, 144, 181Tan, A. C. ............................... 121Tan, B. H. .............................. 208Tan, G. S. .............................. 208Tan, J. ........48, 72-73, 115, 133, 192Tan, L. B. ................................156Tan, V. ............................ 156, 205Tan, W. K...............................200


367

Tsuji, T. .................................. 121Tsuji, Y. ............... 96, 142, 151, 231Tsukamoto, Y. ......................... 179Tsumura, T. ............................ 167Tsunedomi, R. .........................86Tsunematsu, S. ....................... 179Tsuru, H. ................................194Tsuruoka, N. ............. 187, 193, 234Tsuruta, O. ............................ 180Tsuyama, S. ............................ 147Tsuzura, H. .............................198Tsvang, E. ................................69Tsyryuk, O. .............................155Tu, Q. ..................................... 172Tubergen, A. ...........................49Tuccillo, C...............................165Tuck, C. J. ...............................196Tucker, E. ...............................148Tulassay, Z. ........ 143, 192-193, 243Túlio, M. ............................... 208Túlio, M. A. ..................... 217, 235Tumangelova-Yuzeir, K. .......... 217Tumino, E. ............................. 177Tun, G. S. Z. ...........................189Tundia, N. ............................... 87Tundo, P. .......................... 117, 167Tuomisto, A. ............................86Turato, C. ............................... 114Turcan, S. .................. 96, 135, 185Turck, D. .................................135Turculeanu, A. ........................165Turina, M. ........................86, 233Turner, D. ................................56Tursi, A. .................. 146, 189, 199,

203, 252Tutuian, R. ..........37, 47, 69, 73, 75Tüzün Ince, A......................... 220Tuzun, S. ............................... 244Tye-Din, J. A. ...........................56Tye, M. ...................................148Tynan, S. ................................188Tysoe, O. .................................59Tytgat, G. ................................ 87Tzallas, A. ..............................165Tzatzagou, G. .........................159Tziatzios, G. ............... 127, 131, 254Tzimas, D. ............................... 62Tzivian, L. ...............................251

U Ucbilek, E. ............................. 203Uchida, D. ........................65, 168Uchida, G. ........................ 136-137Uchida, K. ............................... 62Uchima Koecklin, H. ...............227Uchino, R. .............................. 119Uchita, K. ......................... 58, 152Uchiyama, K. .................. 123, 174,

204, 253

Traini, S. .......................... 84, 130Tran, F. ............................. 89, 135Tranesh, G. .............................. 93Trang, C. .............. 73, 75, 136, 186Trauner, M. ...... 51, 53, 68, 86, 91,

132, 175, 227-228Travancinha, C. .......................145Travis, S. ............80, 139, 235, 254Trebeschi, S. ...........................144Trebicka, J. ..................... 104, 106Treling, A. .............................200Trelle, S................................. 248Trenkel, S. ............................. 254Treohan, A. .............................64Tretter, L. ................................ 170Trevisani, F. ............................168Triantafyllou, K. ............... 127, 131,

206, 251, 254Triantos, C. ..................... 241, 248Tribl, B. .................................. 132Tribler, S. ....................... 103, 256Trifan, A.-V. .........116, 131, 166-167,

216, 254Triki, W. .................................218Tringali, A. ..................36, 40, 66,

88, 130, 220, 229-230, 252

Trishkina, I. ............................153Trivedi, C. ...............................102Trojan, J. .................................92Troncone, R. ............................64Troukhmanov, A. S................. 248Trovatello, A. ......................... 238Trudgill, N. ............... 103, 170, 247Trukhmanov, A. ......................145Trunecka, P. ............... 158, 217, 221Truong, D. H. ...........................117Tsai, W.-L. ...............................59Tsamakidis, K. ....................... 230Tsapas, A. ...............................49Tschurtschenthaler, M. .............90Tse, F. .................................... 258Tsegai-Eh, E. ..........................128Tseng, C.-W. ............................82Tseng, J. .................................. 93Tseng, K.-L. ............................166Tsimperidis, A. G. .................. 245Tsipouras, M. .........................165Tsuboi, A. .............................. 254Tsuboi, M. ..............................182Tsuchida, T. ...................... 151, 174Tsuchikawa, T. ........................182Tsuchiya, J. ..................... 203, 241Tsuchiya, K. .......................97, 143Tsuchiya, T. ........................... 222Tsuda, M. ............ 53, 122, 128, 151Tsuda, T. ................................ 151Tsudome, M. .......................... 147Tsugawa, N. ............................ 79Tsuji, S. ................................. 222

Tong, H. .................................257Tong, T. S. ............................. 202Tong, W. J. ...............................85Tonon, M. ...............................166Tonozuka, R. ......................... 222Tontini, G. E. ...55, 72, 98, 125, 127Topalidis, T. ........................... 207Topazian, M. ........................... 62Tops, S. ..................................189Tordjman, G. .................... 50, 176Torimura, T. ........................... 180Tornai, I. ................................. 61Tornai, T. ................................. 61Törnblom, H. .......... 39, 55, 71, 90,

141, 146, 149, 244-245

Tornea, D. ............................. 224Török, G. ................................192Török, I. ................................ 220Toropov, V. .............................241Torralba-Gallego, A. .................71Torrano, V. ..............................117Torre, C. ........................... 65, 155Torrealba, L. ...........................237Torrella Cortes, E. A. ....... 185, 228Torres-Vicente, G. .................. 246Torres, J. ................................237Torres, T. ................................ 139Torrie, R. ................................125Torroni, F.................................55Torse, L. .................................237Tortora, R. ..................64, 118-119,

205, 218, 238Torvinen, S. ........................... 239Tosca, J. ................................ 239Toth, E. .........72, 126, 131, 170, 228Toth, G. T. ......................... 83, 136Tóth, K. ...................................171Touchefeu, Y. ....... 82, 93, 168, 252Toueg, R. .............................. 240Tougeron, D. .................... 93, 168Tounai, Y. ................................85Tounigand, C. ..........................50Tournev, I. ..............................159Touvron, M. ........................... 242Tov, N. L. ................................122Tova, R. .................................. 181Tovar Doncel, M. S. ................. 123Toxværd, A. ............................122Toya, Y. ................................... 76Toyonaga, H. ...................120, 194Toyonaga, T. .............194, 223, 251Toyoshima, N. ................ 126, 128,

193-194, 243Tozawa, K. ...............................84Tözün, N. ...............................215Traboulsi, E. .......................... 222Trad, D. ...........................228-229Traina, M. ........................ 99, 130Traini, M. .............................. 230

Tischkowitz, M......................... 83Titó, L. ...................................153Titova, M. A. ...........................164Tiwari, D. ...............................219Tjora, E. ..................................171Tjwa, E. ............................165-167Tkachenko, E. .........................241To, K. F. ............................. 91, 147To, N. .......... 38, 50, 60-61, 63-64,

67-68, 73, 81-83, 95, 102, 111-113, 115, 120-122, 124,

126-128, 132, 134, 138, 142, 149, 153, 162, 166, 175, 183, 187-188,

190, 193-194, 201, 203, 207, 211, 219, 228, 233, 240,

242-243, 246, 252, 256, 258Tobin, A. M. ...........................138Toda, N. .................................142Toda, S. ........................... 144, 231Todesca, P. ............................. 119Todorov, T...............................159Todorova, A. ...........................159Toes-Zoutendijk, E. .................192Toka, B. .................................. 132Tokai, Y. ..........................252-253Tokuda, Y. ............................... 51Tokuhara, M. ........................... 62Tokuhisa, Y. .............................86Tokumitsu, Y. ...........................86Tokushige, K. ......................... 226Toldi, A. .................................156Toleikiene, R. .........................193Tollenaar, R. ............................85Tolnai-Kriston, C. ....................143Tolone, S. .......... 69, 149, 198-200,

248-249Tolstanova, G. .................. 134, 184Tolusso, B. ....................... 75, 239Tomaz, A. .............................. 209Tomba, C. ........................156, 247Tomba, F. ...............................247Tomczyk, D. ............................135Tomé, L. ........... 158, 166, 210, 214,

217, 219, 223, 229, 232, 253, 256

Tomeno, W. ............................ 114Tomida, S. ............................. 205Tomie, A. ................. 124, 174, 252Tominaga, K. ..........................144Tomishima, K. .................198, 222Tomita, H. ............................. 246Tomita, M. ..............................144Tomita, R. .............................. 121Tomita, T. ................................84Tomita, Y. ................................85Tomlinson, I. ..................... 58, 85Tomochika, S. ..........................86Tomonori, M. .........................194Tomooka, F. ............................ 167Tomori, A. .............................. 176

368


Van Os, J. ...............................196Van Oudenhove, L. .......65, 71, 74,

92, 197, 244Van Rongen, I. .......................142Van Rood, Y. R. ........................90Van Rosmalen, B. ................... 118Van Santvoort, H. ....53, 58, 60, 71Van Tilburg, A. ...................... 235Van Veenendaal, L. .................. 93Van Vugt, J. L. A. .......120, 169-170Van Wijnen, L. E. .....................49Van Woerden, V. ...................... 93Vanags, A. ..............................251Vanásek, T. ........................ 49, 80Vanbiervliet, G. ... 88, 95, 102, 222Vanden Berghe, P. ...................50Vanden Branden, S. .................55Vandenbroucke-Grauls, C. M. J. E. ..........................196Vangravs, R. ...........................193Vanheel, H. ............................247Vanhoutvin, S. .........................98Vani, D. ................................. 253Vanuytsel, T. ................ 39, 41, 96,

101, 247Vaquero, E. ........................... 222Vaquero, J. ..............................117Varadarajulu, S. ...72, 103, 129-130Varanese, M. ......................... 226Varciu, A. .............................. 224Vardas, E.................. 125, 129, 145Vare, S. G. .......... 99, 223-224, 249Vareniuk, I. ............................134Varenne, O. ........................... 206Varga, G. .................................89Vargas, V. ................................ 91Vargo, J. J. .......................181, 246Variola, A. ......................238, 240Varol, C. ........................... 72, 242Varon, C. ............................... 252Vasconcelos, H. ......... 89, 179, 258Vasen, H. .......................... 85, 98Vasilakis, T. ..................... 128, 196Vasiliadou, I. ......................... 243Vasilyev, I. Y. ........................... 77Vásquez-Guerrero, J. ..............128Vassallo, G. A. ........................166Vassallo, R. ........................... 238Vasuka, E. ......................235, 240Vatn, M. H. ........................71, 236Vatn, S. ................................. 236Vavassori, S. ........................... 127Vavin, G. ................................135Vavricka, S. .......... 36, 40, 86, 101,

184, 233, 235, 248Vavrova, J. ..............................138Vaysse, T. ..........................75, 139Vaz, A. ...... 215, 228, 236, 241, 255Vazeille, E. ............................. 137Vazquez Sequeiros, E.......122, 180

Van Delft, S. ...........................103Van den Brand, F. F. ................. 91Van den Brink, G. R. ........ 92, 184,

192, 242Van den Burg, S. P. .................190Van der Aa, A. ................... 47, 141Van der Have, M. ................... 238Van der Heijde, D. ................. 238Van der Horst, D. ....................185Van der Leij, C. .......................124Van der Maazen, R. W. ...........192Van der Meer, J. H. M. .... 192, 242Van der Post, C. .......................84Van der Sande, M. ..................144Van der Weiden, M. M. ...........192Van der Werf, L. R. ........... 76, 182Van der Wiel, S. E. ........... 129, 251Van der Willik, E. ..................... 76Van der Woude, C. J. ....46, 65, 83,

92, 102, 105, 236, 239

Van Dijk, A. .............. 142, 166, 219Van Dijk, A.-B. .......................102Van Dijk, L. J. D................123, 255Van Dijk, S. .................... 142, 255Van Dop, W. A. ........................92Van Eeden, S. .......................... 72Van Eijck, C. H. J. .........85, 93, 123Van Erp, S. J. H. ..................... 238Van Erpecum, K. ...................... 91Van Gaal, N. .....................186-187Van Geenen, E. ........... 71, 121, 255Van Gils, T. ..............................64Van Ginderachter, J. ................. 79Van Goor, H. .............................71Van Gossum, A. ............ 42, 87, 95Van Griethuysen, J. J. ...............50Van Griethuysen, J. J. M. .........144Van Gulik, T. M. .........93, 118, 120,

169-170, 219Van Herk, E. H. ........................ 97Van Herwaarden, Y. ..... 58, 74, 112Van Hooft, J. E. ............. 55, 67, 95Van Hootegem, P. .............. 55, 90Van Keulen, K. ....................... 245Van Kimmenade, R. ................166Van Klaveren, D. ..................... 170Van Laarhoven, C. J. H. M. ................... 169, 219Van Laethem, J.-L. .........37-38, 68Van Landeghem, L. ................ 242Van Leerdam, M. E. ..... 41, 75, 192Van Leeuwen, F. E. ........... 64, 192Van Lienden, K. P. ...................169Van Lijnschoten, I. ..................124Van Loveren, H. ....................... 74Van Mil, A. ..............................85Van Munster, S. ...............200-201Van Nieuwkerk, C. M. .............. 91Van Noord, D. ..................123, 255

VVackova, Z. .............. 125, 148, 174,

197, 224, 249-250Vadala, S. ...............................122Vadamalayan, B. .................... 191Vadan, R. ............................... 116Vadillo-Calles, F. ..................... 121Vaganov, Y. .............................210Vaiarello, V. ............................138Vaillant, J. C. .......................... 181Vaiphei, K. ................103, 178, 187Vaira, B. ............................77, 104Vaishnavi, C. .......................... 187Vakhitov, T. .............................241Vakrakou, A. .......................... 243Valantiene, I. .......................... 115Valats, J.-C. ............................. 76Valcz, G. ............. 143, 192-193, 243Valdivielso Cortazar, E. ........... 178Vale Rodrigues, R. ................. 232Valean, S. ...............................165Valeeva, A. ............................ 234Valente, A. ........ 158, 208, 217, 237Valente, A. S........................... 147Valente, R. .............................120Valerii, G. .............................. 252Valero Torres, A. ....................200Valero, M. .........................49, 174Valestrand, L. ..........................59Valeur, J. ................................195Valitutti, F. ...............................65Valk, G. ................................... 93Valkov, I. ................................ 217Valle-Muñoz, J........................153Vallecillo-Hernández, J. ......... 252Valleix, D............................... 232Valli, P. V. ...........102, 127, 195, 239Vallier, L. .................................59Valmary-Degano, S................ 234Valori, R. .................. 94, 143, 223,

225-226Valpiani, D. ............... 96, 135, 185Valvano, M. R. ..... 117, 167-168, 189Valverde López, F. .............121, 197Valvo, B. .......................... 64, 155Van Aerts, R. ..........................165Van Amesfoort, J. ...................134Van Assche, G. .................56, 189Van Baar, A. ........................... 173Van Berge Henegouwen, M. I. .......................76, 80, 82,

87, 182, 250Van Beurden, Y. H. .................196Van Bodegraven, A. A. ............185Van Brunschot, S. ........ 60, 71, 162Van Cutsem, E. ............. 63, 74, 80Van de Graaf, S. .....................150Van de Laarschot, L. F. M. .58, 165Van De Winkel, A. .................... 79Van Delden, O. M. ............ 93, 169

Uebel, P. ................................125Ueda, T. .......................... 123, 174Uedo, N. ........ 53, 58, 85, 126, 201Uejima, M. ............................. 167Ueki, N. ......................82, 173, 198Ueki, T....................... 58, 125, 241Uemura, R.......................194, 201Uemura, R. S. ........................ 258Ueno, M. ................................ 175Ueno, T. ..................................86Ueo, T. ....................................58Ueyama, H. .....................174, 202Ugurlu, M. U. ......................... 114Uhlig, H. ............................... 235Uhmann, A. .............................92Ujihara, T. ....................... 123, 169Ukai, K. .................... 144, 192, 231Ulanova, M. ............................153Ullah, N. ................................ 217Ulloa, C. P. ..............................49Ulrich-Merzenich, G. ..............150Umana, J. ...............................210Umar, S. .................................122Umeda, Y. ..............................166Umegaki, E. .............194, 223, 251Umemoto, K. .......................... 172Umeno, J. ................................ 76Ümit, H. .................................159Umutlu, L. .............................. 187Ungar, B. .................. 140, 189-190Ungureanu, B. ................. 181, 229Uno, K. .................................. 180Unsal, B. ................................148Ünsal, G. ................................159Unzicker, C. ............................126Upponi, S. ...............................59Urabe, Y. ................................ 151Urakami, K. ........................... 242Urano, Y. ............................... 252Uraoka, T. ................... 53, 82, 173,

176-177, 225Urba, M. ................................142Urban, O. .............................. 220Urbanski, S. ........................... 176Urboniene, A. .........................221Ureshino, N. ........................... 172Urgesi, R. .......................206, 244Urlep, D. ................................. 79Urreta, I. ................................ 115Urusova, F. ............................. 133Usak, J. ................................. 220Ushijima, T. ......................85, 180Ushio, J. .................................130Uslan, M. I. ............................ 132Uspenskiy, Y. P. ...................... 203Usuda, H. ............................... 114Usuy, E. ..........................206, 255Uyama, N. ..................93, 167, 232Uyar Alpaslan, N. .................. 203Uzzan, M. ................................ 97


369

W Wächter, L. ............................. 116Wada, K. ......................... 114, 130Wada, M. ...............................194Wada, N. ........... 183, 223, 232, 251Wada, T. ................... 96, 104, 200Wafy, W. ................................. 119Waga, E. ............................... 226Wagner, A. .................97, 192, 233Wagner, C. A. ....................97, 233Wahib, A. A. ........................... 147Waisman, A. ........................... 170Waizbard, A. ...........................69Wakamura, K............... 46, 72, 98,

126, 128, 131, 193-194, 243

Wakatsuki, T. ..........................201Wakayama, M......................... 191Waldhör, T. ............................. 137Waldmann, E. .....50, 175, 227-228Waldner, M. J. .................... 61, 79Waldschmitt, N. .................57, 134Waldthaler, A. .........................171Walji, F. ..................................182Walker, M. M. .............71, 148-149,

155, 184, 204Wall, R. ..................................146Wallace, K. .........................47, 80Wallace, M. B. ............ 93, 98, 127,

129, 173, 249Walsh, A. .............................. 235Walsh, P. ............................... 254Walshe, M. ............................. 217Walter, B. ................................58Walter, B. M. ...........................84Walters, J. .................... 67, 82, 88Walters, T. D. ...........................56Walton, J. .............................. 250Waluga, M. ............................164Wander, P. K. ..........................216Wanders, L. K. ......................... 72Wang, A. Y.........................62, 147Wang, A.-J. ............................ 115Wang, B. ............ 64, 150, 168, 199Wang, C. ...........................79, 174Wang, G. .......................... 72, 201Wang, J. ...............72, 133, 197, 199Wang, J.-W. ............................166Wang, K. ................. 140, 145, 173,

204, 246, 248Wang, L............... 52, 79, 174, 202,

223, 244, 252Wang, M. .... 173, 197-199, 222, 232Wang, N. .............114-115, 133, 152,

174, 197, 202, 252Wang, Q. .......................... 114, 191Wang, R. .................................85Wang, S. .................................56Wang, S.-Q. ............................ 114Wang, W. ................... 61, 114, 166

Vitale, M. A. ...................206, 244Vitali, F. .................................. 121Vitalis, Z.................................. 61Vitek, P. ................................. 220Vitello, A. .............................. 238Vitiello, A. ........................ 118-119Vitorino, E. ......................158, 210Viviano, F. .............................. 191Vjero, K. ......................... 180, 207Vlachonikolou, G. ........... 206, 251Vlachou, E. ............................. 131Vladimirov, B. .......... 159, 221, 236Vladimirova, V. I. ....................158Vlasova, A. .............................156Vleugels, J. L. A. ........... 72, 84, 89Vliegen, R. F. A. ......................144Vodicka, P...............................143Vodoleev, A. ........................... 132Voest, E. .................................144Vogel, A. .................................54Vogelsang, H. ......................... 137Voicu, M................................ 224Voinea, F. .........................115, 153Voinea, F. F. ............................153Voiosu, T. ............................... 167Vojtech, Z. .............................. 197Volkers, A. G. ......................... 141Vollebregt, P. F. ......................185Vollert, J. ................................ 175Vologzhanina, L. ................77, 104Volpato, M. ........................... 243Voltà-Pardo, T. ...................... 246Volta, U. ....................... 47, 92, 99Voltarel, G. ......................247-248Von Arnim, U. ........................ 101Von Boehmer, L. ......................86Von Figura, G. ..................64, 168Von Heymann, C. ................... 225Von Wagner, C. ....................... 175Voor in ’t holt, A. F.................. 179Vora, A. A. ..............................186Vork, L. .............................71, 196Vos, M. C. ............................... 179Voska, M. .............................. 228Votto, M. ................................ 191Voudoukis, E. .................. 129, 145Vreugdenhil, A. ...................... 170Vriens, M. ............................... 93Vriezinga, S. ............................64Vrolijk, J. M. ............................ 91Vugts, J. ..........................120, 169Vuik, F. E. R. ............................ 79Vuitton, L. ............ 73, 75, 186, 234Vujasinovic, M. .......................120Vukicevic, S. ...........................214Vukova, T................................ 179Vumma, R. .............................146Vutukuru, V. ........................... 133Vyalov, S. S.............. 165, 203, 254Vymazal, J. ............................. 197

Vezzoli, A. ............................. 254Viala, J. .................................. 191Viale, E. ..................................69Vicario, M. ........................57, 247Vicente, R. ..............................189Vich Vila, A. ............................. 70Vieceli, F................................. 121Vieira, A. ......................... 188, 215Viejo-Almanzor, A. ..........170, 220Viel, A. ...................................192Vienne, A. ................ 129, 151, 229Viennois, E. ............................. 70Viennot, S. .................73, 139, 186Vierling, J. ...................54, 61, 100Vieth, M. ......................54-55, 79,

81, 87, 101Vieujean, S. ............................190Viggiani, M. T. ........................166Vignolo, P. .............................. 173Vigsnaes, L. K. ........................241Viitasalo, L. M. ...................... 254Vijayan, S. ............................. 230Vijayasingam, A...................... 197Vila, J. J. ................... 181, 229, 257Vilallonga, R. ...................68, 100Vilardell, N. ............................149Vilas-Boas, F. ........... 120, 122, 130,

173, 209Vilchez Jaimez, M. ...........157-158,

209-210, 257Vilkin, A. ............................69, 91Villa, K. ................................. 240Villafranca, D. ........................ 253Villas-Boas, R. ........................166Villoria, A. .............................. 139Villotti, G. .......................206, 244Vilmann, P. ..................36, 69, 122Vincelet, C. .............................194Vincent, C. ............................... 91Vinci, E. ......................... 189, 238Vincze, A. ................. 83, 136, 220,

229, 234, 240Vinet, O. ................................. 132Vinha Pereira, D. ................... 252Vinson, B. ..............................247Vinter-Jensen, L. .................... 256Viola, F. .................................. 191Violi, A. ................................. 252Virdone, R. .............................168Virgili, A. ................................. 63Virginijus Jonaitis, L. ................ 77Visciola, G. ............................ 203Visentin, M. ............................ 118Vishalkumar, S. ..................... 220Vissers, R. ............................. 256Vissiennon, C. ........................190Visvanathan, S. ........................ 47Vitagliano, M. ......................... 187Vital, M. ................................. 141Vitalba, A. ..............................190

Vecchi, M. ....................55, 97, 127Vecchio, F. ..............................218Vecchione, V. ..........................140Vedel Nielsen, H. .....................58Veenendaal, R. A. ....................85Vega, P. ..................................144Vega, R. .................................140Vegh, Z. ...............83, 96, 135-136,

138, 185, 238Veijola, L. ..........................77, 104Veitch, A. ...............................125Vela, M. ................................ 235Velasco Guardado, A. J. ......... 180Velayos, B. ............................ 229Velea, P.-I. ............................. 170Velho, S. ................................233Velikova, T. ............................. 217Velosa, J. .............85, 158-159, 167,

173, 207-210, 221, 225, 237, 245, 257-258

Veloso do Carmo, J. ........ 180, 208Veloso, N. ........... 52, 177, 179-180,

208, 224Veltzke-Schlieker, W. ............. 255Venâncio, J. ............................145Venerito, M. ......................77, 104Venezia, A. ............................. 133Venezia, F. ........................ 50, 176Venezia, L. .............. 158, 223, 258Venglovecz, V. .........................171Venselaar, H. ..........................165Ventimiglia, M. ................ 237-239Ver Loren van Themaat, E. .......92Vera Mendoza, I. ................... 235Vera, M. I. ............................. 240Verbeek, W. ............................. 93Verbeke, C. ..........68, 102, 120, 170Verdelho Machado, M. .... 158, 208Verdu, E. .................................56Veres, G. L. ......................136, 234Vergnolle, N. ................57, 70, 92,

107, 110Verhagen, H. J. M. ................. 255Verheij, J. ........................ 118, 219Vermeire, S. .................47, 56, 61,

96, 141, 189Vermeulen, B. ....................... 248Vernia, P. ........................138, 239Verónica Dávila-Batista, V. ......143Verset, L. ................................192Versteeg, R..............................92Verstockt, B. ...........................189Verter, E. ................................ 123Verwey, M. H. ......................... 187Veselov, V. ..............................210Vetter, M. ...............................128Vettorato, M. G. ...................... 187Vettore, E. ..............................166Vettori, G. ....................... 159, 210Veziant, J. .............................. 242

370


Woolcott, J. ............................ 141Worni, M. ...............................183Wouters, Y. ............................ 256Wright, A. ..............................189Wright, N. ..............................150Wronska, E. ............................231Wu, B.....................................199Wu, C.-K. ...............................166Wu, D.-C. ........................166, 239Wu, J. .................................... 104Wu, J. C. ................... 142, 152, 198Wu, J.-L. .................................143Wu, M.-S........................... 77, 154Wu, N. .......................48, 123, 133Wu, Q.-N. ............................... 123Wu, R.-C. ...............................142Wu, S. .............57, 77, 154, 193, 216Wu, W. ............91-92, 114, 141-143,

171, 201, 218Wu, X. .................................... 118Wu, Y. ..............................85, 166Wu, Y.-K. ................................136Wu, Z. .................... 72-73, 115, 133Wuestenberghs, F. ..................198Wunsch, E. .............................. 91Wurm Johansson, G. ................ 72Wurm, P. ......................... 124, 192Würzner, R. ............................. 70Wynter, E. ...............................69

XXavier, R. ................................ 70Xavier, S. ................. 166, 186, 191,

201, 216Xia, M. ............................ 118, 144Xia, X. .................................... 173Xia, Z. ....................... 93, 173, 248Xiang, Y. ..................................52Xiao, C. ..................................216Xiao, H.-Y. .............................. 115Xiaofeng, Z. ............................ 93Xiaoxue, S. .............................195Xie, Y. F. .................................184Xin, Y. .................................... 173Xing, T.-S. ..............................136Xinopoulos, D. ...........62, 230, 243Xiong, S. ................................. 76Xiong, W. ................................52Xu, C. .............................. 128-129Xu, G. ..................................... 72Xu, H. ............................ 200, 215Xu, J. ................48, 72-73, 115, 133,

143, 198, 202Xu, L. ................ 118, 201-202, 242Xu, M.-D. .................223, 225-226Xu, M.-M. ............................. 223Xu, N. .................... 200, 216, 223,

225-226Xu, X.-Y. .................................143

Wilflingseder, D. ...................... 70Wilhelm, C. ............................ 173Willeke, F. ............................. 249Willemssen, F. E. J. A. ...............120, 169-170Williams, E. J. .........................144Williams, H. R. T. ...... 184-185, 233Williams, L. J. .................... 56, 64Williams, S. ............................ 177Williams, S. C. R. .................... 197Williet, N. ..................135, 185-186Wills, E. S. ...............................58Wils, P. ............... 75, 139, 236, 238Wilson, A. ................. 40, 89, 100,

226, 231Wilson, B. ..............................156Wilson, I. ........................226, 231Winkens, B. ............................ 187Winker, R. ..............................215Winstanley, A. ........................158Winter, D. C. .......................81, 88Wintjens, D. S. J. ..................... 187Wirtz, S. ........................... 70, 170Wiseman, G............................196Wissniowski, T. T...... 118, 120, 164,

168, 215Withoff, S. ...............................94Witt, H. ............................ 46, 120Włodarczyk, J..........................233Wlodarczyk, M. .......................233Wohl, P. ................................ 256Wojcik, D. ....................... 104, 250Wojtowicz, A. M. ..................... 61Wolf, D. C. ............................... 61Wolfsen, H. C. ....................... 249Wölnerhanssen, B. K. ..............52Wolterbeek, R. ...................... 238Wolters-Eisfeld, G. .............46, 78,

150, 221Wolters, A. ..............................49Wolthuis, A. ............................56Wong, A. Y. ........................46, 91Wong, C. C. ................ 91, 93, 143,

147, 192, 202Wong, I. C. .........................46, 91Wong, I. O. ..............................46Wong, M. C. .......................... 242Wong, S. ................................142Wong, S. H. ...................... 82, 142Wong, S. K. ............................152Wong, V. ................. 152, 230, 250Wong, Y. J. ............................. 209Woo, H. S. ..............................146Wood, H. ................................. 70Wood, L. D. .............................66Woodcock, A. .........................199Woodland, P. ......101, 148, 247-248Woodward, J. .......................... 39Woodward, T. ............. 93, 127, 129Woodworth, D. ........................56

Wells, C. ...................223, 225-226Wen, S.-H. .............................149Wendt, E. R. ........................... 133Wenger, R. H. .........................184Weniger, M. .......................... 232Wennmacker, S. Z. ........... 169, 219Wentrup, R. ........................... 255Wenzl, H. H. ........................... 137Werge, M. ..............................221Werkstetter, K. .........................64Werlang, M. E. ....................... 127Werner, J. .............................. 232Wessels, H. J............................58West, J. ................................... 78West, M............................ 89, 139West, R. ............ 102, 135, 139, 236Westendorp, B. F. .............92, 242Westera, L. .............................184Westerveld, D. ........................ 151Westhoff, A.............................188Westhovens, R. ....................... 139Wetzka, J. ................................96Weusten, B. L. A. M. ....55, 64, 76,

90, 173, 200-201, 249

Whale, G. ......................... 89, 139Wheat, J. ............................... 232Wheeler, C. ...................... 61, 190Whelan, K. .............................156Whitaker, D. ................... 126, 245Whitcomb, D. C............76, 82, 106White, J. R. .............................148Whitehead, W. E. ....... 71, 146, 149,

244-245Whitley, L. ....................... 140, 191Whitsey, H. .............................192Whorwell, P. ............................90Wichmann, B. ...........192-193, 243Wickramasinghe, A. R. ............164Widlak, M. M. .......................... 81Wiedbrauck, F. ....................... 255Wiedbrauck, T. ........................ 53Wiedenmann, B. ................... 255Wieser, M. .............................. 187Wiest, R. ................................ 116Wieszczy, P. ........................... 245Wieten, E. ....................... 114, 143Wifi, M.-N. ........................116-117Wiggers, J. K. .......................... 93Wijmenga, C............................ 70Wijnants, T. F. ..........................58Wijnhoven, B. P. L............. 76, 182Wilasrusmee, C. ..................... 133Wilcox, C. M. ..........................103Wilcox, M. ....................... 103, 141Wild, G. ........................... 187, 189Wildenberg, M. E.............. 92, 184Wilder-Smith, C. ......................46Wildner-Christensen, M. .........154Wildner, D. .......................121, 170

Wang, X. .............. 57, 87, 132, 145, 152, 173, 175, 191, 193,

197-199, 246, 251Wang, X.-Y. ............................136Wang, Y. ..................... 62, 136, 147Wang, Y. T. .............................156Wang, Z. ..................132, 220, 257Wangermez, M. .............. 222, 232Wani, H. .................................216Wani, S. ................................. 179Wanten, G. .......................95, 256Wanzel, M. .............................164Ward, M. G. ..................... 141, 233Warner, M. ..............................92Warren, N. .............................125Warschkow, R.........................183Warusavitarne, J. ..... 43, 67, 73, 131Waschina, S. ..........................138Waschkies, C. .........................102Wasilewski, A. ......................... 79Wasmann, K. ..........................134Wassef, W. .............................. 62Wasser, M. ..............................85Watabe, T. ............................... 79Watanabe, D. ................. 126, 203Watanabe, K. ............. 61, 124, 147,

172, 174Watanabe, M. ...............65, 79, 97,

136, 143, 236, 241Watanabe, N. .........................128Watanabe, O. ................... 136-137Watanabe, S. ............ 143, 174, 202Watanabe, T. ............79, 145, 200,

243, 254Watari, J. .................................84Watfah, J. ................................ 41Watkins, J. .............................. 179Watson, D. .............................150Weber, A. ...........................72, 86Weber, J. ................................ 187Weber, S. N. ...........................146Webster, G. ............................. 62Wedemeyer, H. .................86, 106Wedi, E. .......................... 147, 225Weerasinghe, K. .....................158Weersma, R. K......................... 70Weerts, Z. Z. R. M. ...................71Wegener, M. ............................ 53Wei, H. .................................. 204Wei, J. ...............................52, 116Wei-Dong, L. ..........................247Weidlich, S. ........................... 248Weigt, J. .......................... 116, 224Weijers, G. ...................... 165, 167Weiler, N. ............................... 118Weimers, P. ..................... 136, 138Weinhage, T. ...........................89Weise, R. ............................... 249Weiss, F. U. ..............................46Weissbrod, R. ................. 126, 245


371

Yoon, H. ................... 152, 192, 251Yoon, J. Y. .............................. 243Yoon, K. C. ............................ 203Yoshida, H. ............................. 167Yoshida, M. ........ 51, 122, 124, 128,

194, 203, 231, 242, 250Yoshida, N. ........ 123, 174, 180, 253Yoshida, R. .............................166Yoshida, S. ......................144, 182Yoshifuku, Y. ...........................152Yoshihuku, Y. .......................... 151Yoshii, T. ................................ 151Yoshikawa, K. .................. 98, 205Yoshikawa, M. ........................ 123Yoshikawa, T. ........................ 205Yoshimizu, S........................... 174Yoshimura, F. .........................182Yoshimura, K. .................... 84, 86Yoshimura, N. ......................... 61Yoshino, K. ..................... 203, 241Yoshino, S. ..............................86Yoshino, T. ....................... 76, 188Yoshio, T. ..................151, 174, 246Yoshioka, M. .................. 209, 257Yoshitaka, N. ...................129, 180Yoshizaki, N. ..........................231Yoshizawa, N. ...................122, 172Yosry, A. ..................................117You, M. S. ..............................142Youd, P. .................................. 176Youk, E. G. ............................. 133Youn, Y. H...............................201Younes, Z. ..............................140Young Park, J. .................. 173, 251Young, C. ................................ 70Young, E. J. ............................198Young, G. ..................90, 143, 234Yousry, M. .............................. 147Ystad, S. O. ..................... 156, 206Yu, C. .....59, 141, 179, 219, 242, 251Yu, H.-C. .................................59Yu, J. ....................91, 93, 114, 143,

147, 164, 192, 202Yu, L. ..................................... 147Yu, T................... 119, 121, 145-146,

166, 194, 238Yu, W. ....................... 57, 193, 220Yu, Y................................ 167, 244Yuan, L. T. E. ..........................166Yuan, W. ...........................57, 193Yuen, K. .................................198Yuki, T. .................................. 238Yumura, T. .............................. 119Yun, B. C. ........................ 179, 219Yun, C. .........141, 152, 179, 219, 251Yun, S. H. .............................. 245Yung, D. E. ....72, 131, 227, 230, 237Yunoki, S. ................................ 53Yuri, Y. ................................... 167Yurtlu, D. A. ...........................148

Yaraş, S. ................................ 203Yashima, K. .............................58Yassin, K. A. ........................... 179Yasuda, H. ........................152, 191Yasuda, K. ...................... 203, 241Yasuda, M. ............................ 226Yasuda, T. ............................... 174Yasui, Y. ........................... 147, 174Yasumoto, M. ........................ 180Yasunaka, T. ...........................166Yasutomi, E. .......................... 203Yavuz, S. ................................199Yavzori, M. ................ 78, 140, 190Yazaki, E. ...............................247Yazbeck, R. ..................... 150, 204Yazumi, S. ..............................122Ye, B. .................................... 223Ye, B. D. .................... 98, 139, 239Ye, C. ......................................59Ye, J. ..................215-216, 218, 230Ye, X. .....................................125Yee, E. U. ......................... 56, 251Yee, M....................................165Yen, C.-L. ............................... 118Yener, O. ................................ 170Yeo, C. W. .................. 123, 126, 131Yeo, S. J.......................... 180, 230Yep-Gamarra, V. .....................152Yeung, K. F. .............................46Yeung, R. ...............................102Yeung, R. C. P. ........................182Yew, A....................................125Yi, C.-H. .......................... 148-149Yi, S.-W. .................................152Yiannakou, Y. .........................195Yin, S. ................................... 232Ying, L. ...........................250-251Yingyongthawat, W. ................148Yip, H. C. ................. 152, 230, 250Yip, W. M. ..............................138Ylisaukko-oja, T. .................... 239Yo, K. .............84, 86, 98, 122, 127,

130, 132, 148, 152, 167, 174, 203, 205, 241

Yoda, Y. ...............95, 177, 201, 250Yojiro, S. ................................154Yokota, I. ................................126Yokota, Y. ...............................129Yokoyama, A. ...................123, 151Yokoyama, K...........................130Yokoyama, N. ................... 61, 229Yokoyama, T. .......................... 151Yokoyama, Y. ....................76, 246Yoneda, M. ............................. 114Yoneyama, H. .......................... 61Yonezawa, M. ........................ 226Yoo, B. M. ....................... 130, 132Yoo, D. H. ............................... 139Yoo, H. G. ...............................195Yoo, I. K. ..... 127, 132, 148, 152, 203

Yamamoto, M. ...................53, 121Yamamoto, N. .........................95Yamamoto, S. ........ 85-86, 177, 201Yamamoto, Y. .................. 177, 203Yamamura, M. ........... 147, 169, 174Yamamura, T. ................... 136-137Yamano, H. ............................193Yamano, H.-O. ..................98, 243Yamanouchi, K. ............... 187, 234Yamanouchi, T. ....................... 151Yamao, K. ............................... 181Yamasaki, K..................... 125, 174Yamasaki, T. ............. 84, 174, 201,

252-253Yamasaki, Y. ........ 53, 85, 124, 203Yamashina, T. ................... 68, 167Yamashita, H. ..................128, 201Yamashita, K. .... 144, 182-183, 200Yamashita, M. ...........152, 183, 191Yamashita, N. ..................101, 238Yamashita, S. ..........................85Yamashita, T. .......................... 121Yamato, M. ............................. 147Yamauchi, A. ..........................126Yamauchi, H. ....................119, 123Yamauchi, K. .......................... 151Yamaue, H. ............................122Yamawaki, H. .............82, 173, 198Yamazaki, T. ..................... 69, 147Yan, E. X. ...............................153Yan, K. ......................98, 201, 239Yan, L. ....................................168Yan, X. ..........72, 124, 129, 153, 179Yanagisawa, A. .......................122Yanai, H. ......................... 131, 230Yanai, Y. ............................76, 147Yang, D. ...................... 76, 95, 151Yang, D.-H.......... 98, 175, 223, 239Yang, J. ...............91, 129-130, 188,

226, 244, 258Yang, M. A. ........................... 245Yang, M. J. .............................130Yang, S................................... 127Yang, S.-C. .............................166Yang, S.-K. .......................98, 239Yang, T. ..................................150Yang, W...................................59Yang, X. .................................. 72Yang, Y. ....................... 52, 87, 132Yang, Z. .......................57, 87, 193Yano, T. ........68, 95, 104, 124, 130,

151, 177, 200-201, 250-251Yanqin, W. .......................215-216Yao, C. K. .................141, 205, 233Yao, G. ..................................200Yao, K. ...............58, 125, 201, 205Yao, L. ....................................247Yao, R. ...................................140Yao, T. .......................147, 174, 202Yao, W. .....................124, 129, 179

Xu, Y. ........................ 141, 143, 153Xu, Z. ............................... 47, 248Xuan, H. .................................215Xuan, W. ................................150Xudong, L. .............................201Xudoyorova, Z. S. ................... 157Xue, L. ...................................201Xue, M. ................................. 202Xue, P. ................................... 173Xue, Q. ............................. 85, 133Xue, Y. ...................................153Xuereb, F. ...............................188

YYaacob, N. Y. ..........................120Yaari, S. ..................................69Yabe, S. .......................... 209, 257Yablecovich, D. .................137, 140Yachha, S. K. .......................... 157Yadav, T. ..................................171Yadlapati, R. ..................... 69, 148Yagawa, Y. .......................126, 194Yagel, S. .................................. 97Yagi, N. .................... 124, 174, 252Yagi, T. ............................. 65, 166Yagioka, H. ..............................95Yagüe, C. ................................. 63Yahagi, N. ............ 53, 82, 173-174,

225, 251Yahiaoui, F. ..................... 158-159Yair, M. ...................................69Yakabi, K. .............................. 206Yakushijin, T. ......................... 246Yalchin, M. .....................202, 205Yamada, A................. 76, 188, 254Yamada, H. ............................ 123Yamada, K. ................. 136-137, 172Yamada, M. .................78, 172, 177Yamada, R. ......... 122, 144, 172, 181Yamada, S. .......................152, 177Yamada, T. ........ 90, 128, 144, 153,

176, 191, 195, 246Yamagami, H. ........... 79, 200, 254Yamaguchi, A. ........... 175-176, 182Yamaguchi, N. ..... 48, 87, 201, 206Yamaguchi, R. ........................144Yamaguchi, T. ............ 175-176, 182Yamaguchi, Y. .........................194Yamairi, H. ............................ 203Yamakawa, R. ........................ 123Yamakita, K. ..................... 130-131Yamamichi, N. ...........96, 142, 205Yamamoto, E. ............ 98, 193, 243Yamamoto, H. ........ 48, 68-69, 87,

100, 130, 146, 152, 191

Yamamoto, K. ............. 51, 53, 128, 147, 151, 174, 177,

187, 209, 222

372


Zizer, E. ..................................193Zlatar, I. .................................183Zmiri, Y. ..........................185, 257Zocco, M. A. .................... 215, 218Zoheiry, M. ............................. 118Zoican, A. ...............................237Zoli, M. ..................................168Zollner, G. ..............................216Zonoozi, S. ............................ 202Zopf, S. .................................. 127Żorniak, M. ............................164Zortul, H. .............................. 256Zorzano, A. ............................164Zorzi, F. ............................187-188Zou, D. ...................................199Zou, F. ..................................... 76Zou, X. ............................. 78, 199Zsigmond, F. ................... 179, 235Zsobrak, K. ............................ 243Zubcevic, N. ...........................169Zubiaurre, L. .......................... 115Zubillaga de Diego, A. ............125Zucconi, F. ..............................190Zuffada, M. ........................... 204Zuhdi, Z. ................................158Zuin, G. ..................................190Zulli, C. ............................62, 230Zullo, A. ................................ 230Zumpano, L. E. .......................159Zundler, S. .............................184Zuñiga-Ramos, L. ................... 116Zuppardo, R. A. ..................... 242Zuppini, T. ............................. 238Zur, D. .....................................68Zuurbier, R. ............................ 187Zwahlen, M. .......................... 248Zweig, A. .............................. 206Zwinger, L. L. ........................ 255Zwolinska-Wcislo, M.............. 204Zykov, P. ................................. 157

Zhao, J. .............................. 47, 52Zhao, L. ................93, 173, 197-199Zhao, S. .................................140Zhao, X. ....................139, 172, 184Zhao, Y. ............................. 52, 88Zheng, W. ....................... 171, 204Zheng, X. .............................. 244Zheng, X.-L. ........................... 115Zheng, Z.-W. ..........................136Zhernakova, A. ........................ 70Zhong, S. ................................64Zhong, Y. ........................ 224, 227ZhongLi, L. ............................. 173Zhou, C. ................................ 220Zhou, J. ...................................52Zhou, K. ................................ 220Zhou, P. .................................125Zhou, P.-H. ...........51, 95, 123-124,

143, 174, 198, 201, 224-225, 244

Zhou, Q. .............................47, 80Zhou, Y. ............................ 91, 147Zhou, Y. L. ..............................153Zhu, B.-Q. ..............................201Zhu, C. ..............................57, 193Zhu, C.-L. ...............................146Zhu, J. ..............................132, 174Zhu, S. ..............................57, 148Zhu, X. ................................... 115Zhu, Y. .......................52, 174, 233Zhurov, A. ..............................184Zibandeh, N. .......................... 114Zibert, A. ...............................215Zielińska, M. ............ 134, 143, 184Zigdon, S. ............................. 243Zilli, A. .................................. 223Zilli, M. ........................... 122, 130Zimmer, C. ..............................46Zimmer, V. .............................146Zimmermann, J. .....................138Zippi, M. ............................... 239Zito, F. P. ..........................96, 230

Zeitz, J..................... 184, 206, 233Zelaya, R. ...............................210Zelber-Sagi, S. ..................75, 178Zelinkova, Z. .................. 235, 238Zemmour, C. ..........................169Zenda, S. ................................201Zeng, Z. ................................ 242Zenlea, T. ................................56Zentilin, P. ................149, 199, 248Zerbi, A. ..................................85Zerbib, F. ..........37, 47, 73, 105, 188Zeuner, R. ..............................138Zeuzem, S. ............................. 118Zevallos, V. F............................56Zevit, N. ................................. 151Zgradic, S. ..............................165Zhan, Q. ............ 118, 144, 221, 234Zhan, S. .................... 78, 207, 245Zhang, B. .........................115, 216Zhang, C. .... 123-124, 223, 225-226Zhang, D. .................. 128-129, 175Zhang, F. ........ 48, 73, 115, 133, 136Zhang, G. ............57, 166, 168, 257Zhang, H. ................... 56, 61, 134,

139, 184, 233Zhang, J. ................57, 91, 141, 147Zhang, L. ..............57, 82, 116, 145,

199, 202, 257Zhang, N. .................118, 129, 145,

189, 202, 242, 246Zhang, Q.-F. ...........................136Zhang, S. ......................... 78, 245Zhang, T. ................................ 114Zhang, W. ......57, 83, 144-145, 246Zhang, X. ..... 91, 128-130, 164, 258Zhang, X.-C. .....................123-124Zhang, Y. ...... 72, 119, 122, 124, 129,

141, 147, 165, 179, 201, 221, 257

Zhang, Z. ...............................201Zhao, D. ..................................65Zhao, G. .......................... 118, 202

Yusuf, A. ......................... 227-228Yzet, C. ...................................135

ZZaanan, A. ....................... 93, 168Zaballa, M. .............................153Zabana, Y. ...............................56Zaccari, P. ............................. 244Zacharioudaki, V. ..................... 57Zachou, K. ...............................68Zada, S. ................................. 118Zadorozhna, K. ...................... 220Zadrozny, D. ...........................218Zaharie, T. .............................. 172Zahi, I. ...................................158Zahran, M. .............................166Zaika, S. .................................150Zakaria, C. M. B. .....................158Zakordonets, L........................184Zalata, K. ........................168, 207Zalcman, M. ....................207, 210Zali, M. R. ..............................154Zaltzhendler, M. ......................68Zanati, S. ............................... 177Zandberga, E. .........................193Zanella, C. .............................. 191Zanetto, A. ............................. 116Zaninotto, G. ................55, 69, 80Zanoni, P. ...............................156Zapata, E. .............................. 115Zapater, P. ...........73, 143, 170, 220Zaránd, A. ............................. 234Zarate Lopez, N. .............. 244-247Zataraín Valles, A. ..................199Zatorski, H. ..................... 143, 184Zavoral, M. ............. 220, 222, 228,

242, 244Zayed, R. .................................117Zazour, A. .............................. 178Zboril, V. ................................237Zdrhova, L. .............................148

Floor PlansFira Gran Via

North Entrance Hall 8

Metro Station„Fira“ – L9 Sud

Main Entrance (North)

Overview

700m

Find out more, visit www.ueg.eu/week

Vienna, AustriaOctober 20–24, 2018Venue: Austria Center Vienna

sharing the future of digestive health

Europe’s Leading Gastroenterology MeetingYoung GI NetworkPostgraduate Teaching ProgrammeAwards and GrantsLive EndoscopyGuidelines in Clinical PracticeAbstracts on Fire: Frontiers in ResearchAdvances in Clinical GI & HepatologyEndoscopic Hands-on TrainingTranslational/Basic ScienceClinical Case SessionsPoster SessionsSurgical Learning AreaTechnical ExhibitionWorld-Renowned ExpertsTherapy UpdatesControversial DebatesUltrasound Learning Area

Registration

starts Jan. 22, 2018

and includes

free UEG Week

24/7 access

Abstract

Submission

Deadline:

April 20, 2018

17_09_Inserat_UEGWEEK_FP_Week2018_160x220mm_RZ.indd 1 14.09.17 11:36

375

Floor Plans Fira Gran Via : UEG Week Final Programme

Registration

Hall 8.1 Hall 8.1

to H

alls

6/7

Fira Gran Via – North Entrance

Hall8.1

Hall8.0

SpeakersCentre

Hall 6

Hall 7

Scienti�c Centre

Exhibition

Hall 8.0 Hall 8.0

Fira Gran Via – North Entrance

Hall 8.1

Venue Overview

376

UEG Week Final Programme : Floor Plans Fira Gran Via

A2B2

B1B3

C1

B5

F1

F3

E4E2

E1

Cloa

kroo

mCl

oakr

oom

Esca

lato

rs to

Hal

l 6, H

all 7

, Ha

ll 8.

1 (Ex

hibi

tion,

Cat

erin

g)

Congress Material

A3 Roun

d Ta

ble

Disc

ussi

ons

Core

Pr

ogra

mm

e

Core

Pr

ogra

mm

e

Core

Pr

ogra

mm

eCo

re

Prog

ram

me

Core

Pr

ogr.

Core

Pro

gram

me

Core

Pro

gram

me

Core

Pro

gram

me

ESGE

NA

Core

Pro

gram

me

A1

ESGE

Lea

rnin

g Ar

ea

NO

RT

H E

NT

RA

NC

E

Spea

kers

Cent

re

PGT

& E

SGEN

A Ca

teri

ng

(Sat

/Sun

)

Cat

erin

g Ki

osk

(Mon

–Wed

)

Hall

8.0 25

th U

EG W

eek

Anni

vers

ary

Area

UEG

Boo

th &

Mem

bers

Villa

ge

Ultr

asou

ndLe

arni

ngAr

ea

Lecture Theatre

eCa

terin

g Ki

osk

c

c

E3

ESG

ENA

Core

Pr

ogr.

Core

Pr

ogr.

Asso

ciat

ion

and

Futu

re E

vent

s Ar

ea

Core

Pr

ogra

mm

eRT

D*

Youn

g GI

Lo

unge

RTD*

ESG

ENA

ESGENA

RTD*

Core

Pr

ogr.

C2

Core

Pro

gram

me

F2Co

re P

rogr

amm

e

Surg

ical

Lear

ning

Area

* RT

D –

Roun

d Ta

ble

Disc

ussi

on

e

Hall

8.0

Regi

stra

tion

Hall 8.0

377

Floor Plans Fira Gran Via : UEG Week Final Programme

Esca

lato

rs to

Reg

istra

tion

Area

and

Sess

ion

Room

s in

Hal

l 8.0

Cate

ring

Kio

skCa

teri

ng K

iosk

Cate

ring En

tran

ce to

Hal

l 8.1

Entr

ance

to H

all 8

.1

Mee

ting

Room

s8.

1 –

8.30

Exhi

bitio

n

to H

alls

6/7

UEG

Wee

k H

otsp

otE-

Post

er L

oung

esPo

ster

Exh

ibiti

on

Hall

8.1

UEG

Mee

ting

Room

1

cc

Cate

ring

Kio

sk

Net

wor

king

& L

ive

Stre

amin

g Ar

ea

cCa

teri

ng K

iosk

Cate

ring

Ki

osk

c

Exhi

bito

r Se

rvic

e De

skFr

eigh

t Fo

rwar

ding

UEG

O�

ce

Pres

sCe

ntre

Inte

rnet

Cent

reEs

cala

tors

to

Hal

ls 6

/7

Catering

Hall

8.1

Entrance to Hall 8.1

Cate

ring

c

7070

a71

7273

69

68 67 66 656463

62 61

60 59

5857

5453

52

51

5550

5649

81

75

7477 76

7879

80

84 8385

82

4842

47 46

4544

43

3635

3130

3229

3328

273425

3837

26

243940

41

9392

9411

1

109

110

107

108

95

9610

1

9710

0

9899

8788 89 90

91

86

103

104

102

105

106

117

118

116

120119

121

126

125

124

123

122

127

133

128

129 13

0132

134

135

136

137

138

139

140

115

114

113

112

131

2311

10

22

21 2019

1312 14

9 8 7 6 5 4 3 2 116

15

1718

Hall 8.1

Prem

ium

Par

tner

s /

Maj

or P

artn

ers

Gen

eral

Exh

ibito

rs

378

UEG Week Final Programme :Floor Plans Fira Gran Via

Catering & Networking Area

Post

ers

Live

r /

Bilia

ry /

Panc

reas

Post

ers

Low

er G

IPo

ster

sCl

inic

alCa

ses

Post

ers

Upp

er G

I

Post

ers

Surg

ery

/ En

dosc

opy

/ Im

agin

g

Poster Service Desk

CC7

Foye

rHa

lls 6

/7UEG

Mee

ting

Room

3

UEG

Mee

ting

Room

2

Room

7.1

Sile

ntRo

om

Entr

ance

toM

eetin

g Ro

oms

7.7

– 7.

15

Core

Prog

ram

me

7.157.14

7.13

7.12

7.11

7.10

7.9

7.8

7.77.

6

UEG

Wee

kHo

tspo

t

toHa

ll 8.

0an

d 8.

1

e

PGT

Cate

ring

(Sat

/Sun

)

Cate

ring

Kio

sk (M

on –

Wed

)

c

E-Poster Lounge 2 E-Poster Lounge 1Ha

lls 6

/7

Firs

t Ai

d

Hall

7Sc

ient

i�c

Cent

reHa

ll 6

Core

Pro

gram

me

Mee

ting

Room

s

Halls 6/7

PP-GIP-EUR-1157-01 | September 2017 © 2017 Pfizer Inc. All rights reserved.

Visit Pfizer at booths 41 and 42

Working together to advance science and patient care

UEG gratefully acknowledges the support of this year's Premium Partners:

Final Programme available for download www.ueg.eu/week

Documents

advancing science, linking peoplepure.au.dk/portal/files/118234756/17_07_Final... · Final Programme 25th United European Gastroenterology Week Barcelona, Spain October 28 – November